PMID,Drug name,Analyte,Specimen,Population,Pregnancy Stage ,Gestational/pediatric Age,Subjectsn,Parameter type,Time,Time unit,Value,Unit,Summary Statistics,variation type,Variation value,Interval type,Interval low,interval high,P-value,Notes,_source_file,_source_folder,_source_sheet_original,_source_sheet_canonical,_row_index,_processed_at
20914.0,meperidine,meperidine,blood,maternal,labor,,7,concentration,,,1.7,nmol/ml,mean,SD,0.81,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2,2025-12-02T15:56:56.518041
20914.0,meperidine,meperidine,cord blood,neonate,delivery,,7,concentration,,,1.45,nmol/ml,mean,SD,0.53,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3,2025-12-02T15:56:56.518041
20914.0,meperidine,meperidine,urine,neonate,,,7,% dose excreted,24,h,0.13,,mean,SD,0.12,,,,,duation of collection,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,4,2025-12-02T15:56:56.518041
20914.0,meperidine,normeperidine,urine,neonate,,,7,% dose excreted,24,h,0.04,,mean,SD,0.02,,,,,duation of collection,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,5,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Labor,,12,Cmax,30,minutes (mins),21,ug/ml,mean,SD,4.7,,,,,No narcotics,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,6,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Labor,,12,Concentration,60,minutes (mins),18.7,ug/ml,mean,SD,2.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,7,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Labor,,12,Concentration,90,minutes (mins),14.5,ug/ml,mean,SD,1.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,8,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Labor,,12,Concentration,2,hours (hrs),12.4,ug/ml,mean,SD,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,9,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Labor,,12,Concentration,3,hours (hrs),9,ug/ml,mean,SD,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,10,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Labor,,12,Concentration,4,hours (hrs),6.7,ug/ml,mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,11,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Labor,,12,Concentration,6,hours (hrs),3.2,ug/ml,mean,SD,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,12,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Labor,,12,Concentration,8,hours (hrs),2,ug/ml,mean,SD,0.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,13,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Postpartum (PP),,10,Concentration,30,minutes (mins),17,ug/ml,mean,SD,3.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,14,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Postpartum (PP),,10,Cmax,60,minutes (mins),19,ug/ml,mean,SD,1.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,15,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Postpartum (PP),,10,Concentration,90,minutes (mins),16.8,ug/ml,mean,SD,1.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,16,2025-12-02T15:56:56.518041
47537.0,Paracetamol,paracetamol,plasma,Maternal,Postpartum (PP),,10,Concentration,2,hours (hrs),15.6,ug/ml,mean,SD,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,17,2025-12-02T15:56:56.518041
47537.0,meperidine,paracetamol,plasma,Maternal,Labor,,8,Concentration,30,minutes (mins),0.8,ug/ml,mean,SD,0.4,,,,,p<0.05 compared to no narcotics,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,18,2025-12-02T15:56:56.518041
47537.0,meperidine,paracetamol,plasma,Maternal,Labor,,8,Concentration,60,minutes (mins),1.9,ug/ml,mean,SD,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,19,2025-12-02T15:56:56.518041
47537.0,meperidine,paracetamol,plasma,Maternal,Labor,,8,Concentration,90,minutes (mins),2.8,ug/ml,mean,SD,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,20,2025-12-02T15:56:56.518041
47537.0,meperidine,paracetamol,plasma,Maternal,Labor,,8,Concentration,2,hours (hrs),3,ug/ml,mean,SD,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,21,2025-12-02T15:56:56.518041
47537.0,meperidine,paracetamol,plasma,Maternal,Labor,,8,Concentration,3,hours (hrs),7.2,ug/ml,mean,SD,1.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,22,2025-12-02T15:56:56.518041
47537.0,meperidine,paracetamol,plasma,Maternal,Labor,,8,Cmax,4,hours (hrs),14,ug/ml,mean,SD,3.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,23,2025-12-02T15:56:56.518041
47537.0,meperidine,paracetamol,plasma,Maternal,Labor,,8,Concentration,6,hours (hrs),7.6,ug/ml,mean,SD,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,24,2025-12-02T15:56:56.518041
47537.0,meperidine,paracetamol,plasma,Maternal,Labor,,8,Concentration,8,hours (hrs),3.9,ug/ml,mean,SD,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,25,2025-12-02T15:56:56.518041
47537.0,Diamorphine,paracetamol,plasma,Maternal,Labor,,8,Concentration,30,minutes (mins),2.2,ug/ml,mean,SD,1.1,,,,,p<0.05 compared to no narcotics,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,26,2025-12-02T15:56:56.518041
47537.0,Diamorphine,paracetamol,plasma,Maternal,Labor,,8,Concentration,60,minutes (mins),3.3,ug/ml,mean,SD,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,27,2025-12-02T15:56:56.518041
47537.0,Diamorphine,paracetamol,plasma,Maternal,Labor,,8,Concentration,90,minutes (mins),4.5,ug/ml,mean,SD,1.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,28,2025-12-02T15:56:56.518041
47537.0,Diamorphine,paracetamol,plasma,Maternal,Labor,,8,Concentration,2,hours (hrs),5.9,ug/ml,mean,SD,1.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,29,2025-12-02T15:56:56.518041
47537.0,Diamorphine,paracetamol,plasma,Maternal,Labor,,8,Concentration,3,hours (hrs),6.8,ug/ml,mean,SD,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,30,2025-12-02T15:56:56.518041
47537.0,Diamorphine,paracetamol,plasma,Maternal,Labor,,8,Cmax,4,hours (hrs),8.6,ug/ml,mean,SD,2.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,31,2025-12-02T15:56:56.518041
47537.0,Diamorphine,paracetamol,plasma,Maternal,Labor,,8,Concentration,6,hours (hrs),5.8,ug/ml,mean,SD,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,32,2025-12-02T15:56:56.518041
47537.0,Diamorphine,paracetamol,plasma,Maternal,Labor,,8,Concentration,8,hours (hrs),2.9,ug/ml,mean,SD,3.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,33,2025-12-02T15:56:56.518041
47537.0,Pentazocine,paracetamol,plasma,Maternal,Labor,,8,Concentration,15,minutes (mins),0.1,ug/ml,mean,SD,0.09,,,,,p<0.01 compared to no narcotics,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,34,2025-12-02T15:56:56.518041
47537.0,Pentazocine,paracetamol,plasma,Maternal,Labor,,8,Concentration,30,minutes (mins),0.9,ug/ml,mean,SD,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,35,2025-12-02T15:56:56.518041
47537.0,Pentazocine,paracetamol,plasma,Maternal,Labor,,8,Concentration,45,minutes (mins),1.4,ug/ml,mean,SD,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,36,2025-12-02T15:56:56.518041
47537.0,Pentazocine,paracetamol,plasma,Maternal,Labor,,8,Concentration,60,minutes (mins),2,ug/ml,mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,37,2025-12-02T15:56:56.518041
47537.0,Pentazocine,paracetamol,plasma,Maternal,Labor,,8,Concentration,75,minutes (mins),2.1,ug/ml,mean,SD,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,38,2025-12-02T15:56:56.518041
47537.0,Pentazocine,paracetamol,plasma,Maternal,Labor,,8,Concentration,90,minutes (mins),2.5,ug/ml,mean,SD,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,39,2025-12-02T15:56:56.518041
47537.0,meperidine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,15,minutes (mins),1.2,ug/ml,mean,SD,0.8,,,,,p>0.05 compared to meperidine alone,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,40,2025-12-02T15:56:56.518041
47537.0,meperidine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,30,minutes (mins),2.5,ug/ml,mean,SD,2.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,41,2025-12-02T15:56:56.518041
47537.0,meperidine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,45,minutes (mins),3,ug/ml,mean,SD,2.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,42,2025-12-02T15:56:56.518041
47537.0,meperidine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,60,minutes (mins),4.7,ug/ml,mean,SD,2.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,43,2025-12-02T15:56:56.518041
47537.0,meperidine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,75,minutes (mins),4.3,ug/ml,mean,SD,2.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,44,2025-12-02T15:56:56.518041
47537.0,meperidine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,90,minutes (mins),5.3,ug/ml,mean,SD,2.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,45,2025-12-02T15:56:56.518041
47537.0,Diamorphine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,15,minutes (mins),0.2,ug/ml,mean,SD,0.07,,,,,p>0.05 compared to diamorphine alone,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,46,2025-12-02T15:56:56.518041
47537.0,Diamorphine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,30,minutes (mins),1,ug/ml,mean,SD,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,47,2025-12-02T15:56:56.518041
47537.0,Diamorphine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,45,minutes (mins),1.5,ug/ml,mean,SD,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,48,2025-12-02T15:56:56.518041
47537.0,Diamorphine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,60,minutes (mins),2.5,ug/ml,mean,SD,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,49,2025-12-02T15:56:56.518041
47537.0,Diamorphine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,75,minutes (mins),3.6,ug/ml,mean,SD,1.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,50,2025-12-02T15:56:56.518041
47537.0,Diamorphine/metoclopramide,paracetamol,plasma,Maternal,Labor,,8,Concentration,90,minutes (mins),3.3,ug/ml,mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,51,2025-12-02T15:56:56.518041
359109.0,butorphanol,butorphanol,blood,maternal,labor,,6,concentration,128,min,0.76,ng/ml,mean,,,,,,,time of sample collection following dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,52,2025-12-02T15:56:56.518041
359109.0,meperidine,meperidine,blood,maternal,labor,,4,concentration,121,min,132,ng/ml,mean,,,,,,,time of sample collection following dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,53,2025-12-02T15:56:56.518041
359109.0,butorphanol,butorphanol,umbilical blood,neonate,delivery,,6,concentration,128,min,0.64,ng/ml,mean,,,,,,,time of sample collection following dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,54,2025-12-02T15:56:56.518041
359109.0,meperidine,meperidine,umbilical blood,neonate,delivery,,4,concentration,121,min,126,ng/ml,mean,,,,,,,time of sample collection following dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,55,2025-12-02T15:56:56.518041
359109.0,butorphanol,butorphanol,blood,maternal/fetal,delivery,,6,fetal:maternal ratio,128,min,0.84,ng/ml,mean,,,range,0.4,1.4,,time of sample collection following dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,56,2025-12-02T15:56:56.518041
359109.0,meperidine,meperidine,blood,maternal/fetal,delivery,,4,fetal:maternal ratio,121,min,0.89,ng/ml,mean,,,range,0.72,1.16,,time of sample collection following dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,57,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Maternal,Labor,,23,tmax,,,1,minutes (min),mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,58,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Maternal,Labor,,10,t1/2 alpha,,,4.7,minutes (min),mean,SD,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,59,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Maternal,Labor,,10,t1/2 beta,,,2.42,hours (h),mean,SD,0.64,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,60,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Maternal,Labor,,10,Vd area,,,221,liters (l),mean,SD,98,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,61,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Maternal,Labor,,10,Vdss,,,190,liters (l),mean,SD,81,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,62,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Maternal,Labor,,10,CL,,,1067,ml/min,mean,SD,395,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,63,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Maternal,Labor,,10,KE,,,1.55,hours (h),mean,SD,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,64,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Maternal,Labor,,10,K21,,,1.89,hours (h),mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,65,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Maternal,Labor,,10,K12,,,6.15,hours (h),mean,SD,1.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,66,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,4,t1/2 alpha,,,7.1,minutes (min),mean,SD,2.2,,,,,Volunteers from Mather,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,67,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,4,t1/2 beta,,,3.7,hours (h),mean,SD,1.6,,,,,Volunteers from Mather,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,68,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,4,Vd area,,,305,liters (l),mean,SD,120,,,,,Volunteers from Mather,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,69,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,4,Vdss,,,276,liters (l),mean,SD,100,,,,,Volunteers from Mather,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,70,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,4,CL,,,1002,ml/min,mean,SD,400,,,,,Volunteers from Mather,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,71,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,29,t1/2 alpha,,,3.3,minutes (min),mean,SD,3,,,,,Surgical patients from Mather,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,72,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,29,t1/2 beta,,,3.1,hours (h),mean,SD,1.4,,,,,Surgical patients from Mather,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,73,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,29,Vd area,,,203,liters (l),mean,SD,99,,,,,Surgical patients from Mather,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,74,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,29,Vdss,,,185,liters (l),mean,SD,87,,,,,Surgical patients from Mather,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,75,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,29,CL,,,830,ml/min,mean,SD,410,,,,,Surgical patients from Mather,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,76,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,6,t1/2 alpha,,,4.2,minutes (min),mean,SD,1.3,,,,,Medical students from Klotz,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,77,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,6,t1/2 beta,,,3.93,hours (h),mean,SD,0.33,,,,,Medical students from Klotz,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,78,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,6,Vd area,,,242,liters (l),mean,SD,57,,,,,Medical students from Klotz,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,79,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,6,Vdss,,,198,liters (l),mean,SD,94,,,,,Medical students from Klotz,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,80,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,6,CL,,,710,ml/min,mean,SD,110,,,,,Medical students from Klotz,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,81,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,8,t1/2 alpha,,,11.4,minutes (min),mean,SD,2.4,,,,,Volunteers from Stambaugh,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,82,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,8,t1/2 beta,,,3.21,hours (h),mean,SD,0.8,,,,,Volunteers from Stambaugh,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,83,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,8,Vd area,,,121,liters (l),mean,SD,43,,,,,Volunteers from Stambaugh,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,84,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,8,Vdss,,,329,liters (l),mean,SD,99,,,,,Volunteers from Stambaugh,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,85,2025-12-02T15:56:56.518041
434034.0,Meperidine,meperidine,Plasma,Nonpregnant,,,8,CL,,,1313,ml/min,mean,SD,383,,,,,Volunteers from Stambaugh,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,86,2025-12-02T15:56:56.518041
434035.0,Meperidine,meperidine,umbilical vein blood,infant,delivery,,24,concentration,,,95,ng/ml,mean,SD,43,range,11,162,,subject n represents number of samples here,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,87,2025-12-02T15:56:56.518041
434035.0,Meperidine,meperidine,umbilical artery blood,infant,delivery,,13,concentration,,,64,ng/ml,mean,SD,22,,40,99,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,88,2025-12-02T15:56:56.518041
434035.0,Meperidine,normeperidine,umbilical vein blood,infant,delivery,,13,concentration,,,17,ng/ml,mean,SD,14,,5,38,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,89,2025-12-02T15:56:56.518041
434035.0,Meperidine,normeperidine,umbilical artery blood,infant,delivery,,10,concentration,,,15,ng/ml,mean,SD,13,,2,42,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,90,2025-12-02T15:56:56.518041
434035.0,Meperidine,meperidine,cord/maternal venous blood,maternal/fetal,delivery,,24,fetal:maternal ratio,,,0.86,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,91,2025-12-02T15:56:56.518041
434035.0,Meperidine,normeperidine,cord/maternal venous blood,maternal/fetal,delivery,,13,fetal:maternal ratio,,,0.87,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,92,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,8,Cp0,,,4.08x10^3,ng/ml,,,,,,,,"group A, age 1 to 7 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,93,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,8,Cp0,,,3.3x10^3,ng/ml,,,,,,,,"group A, age 7 to 15 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,94,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,8,AUC,,,1.84x10^4,ng min/ml,,,,,,,,"group A, age 1 to 7 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,95,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,8,AUC,,,1.70x10^4,ng min/ml,,,,,,,,"group A, age 7 to 15 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,96,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,8,Cl,,,6.17,ml/min/kg,,,,,,,,"group A, age 1 to 7 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,97,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,8,Cl,,,6.71,ml/min/kg,,,,,,,,"group A, age 7 to 15 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,98,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,8,Vdarea,,,1130,ml/kg/min,,,,,,,,"group A, age 1 to 7 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,99,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,8,Vdarea,,,1360,ml/kg/min,,,,,,,,"group A, age 7 to 15 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,100,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,4,Cp0,,,3.37x10^3,ng/ml,,,,,,,,"group B, age 7 to 15 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,101,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,4,AUC,,,8.28x10^3,ng min/ml,,,,,,,,"group B, age 7 to 15 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,102,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,4,Cl,,,138,ml/min/kg,,,,,,,,"group B, age 7 to 15 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,103,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,4,Vdarea,,,3.06x10^3,ml/kg/min,,,,,,,,"group B, age 7 to 15 years",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,104,2025-12-02T15:56:56.518041
466928.0,morphine,morphine,blood,child,,,30,concentration when analgesic effect disappears,,,64.5,ng/ml,mean,SD,9.1,95% CI,46.4,82.6,,"group C, over all",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,105,2025-12-02T15:56:56.518041
656525.0,meperidine,meperidine,blood,maternal ,labor,,9,concentration,5,min,1.04,nmol/ml,mean,SD,0.63,,,,,IV group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,106,2025-12-02T15:56:56.518041
656525.0,meperidine,meperidine,blood,maternal ,labor,,4,concentration,30,min,1,nmol/ml,mean,SD,0.34,,,,,IM group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,107,2025-12-02T15:56:56.518041
656525.0,meperidine,meperidine,cord blood,neonate,delivery,,9,concentration,,,0.3,nmol/ml,mean,SD,0.15,,,,,IV group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,108,2025-12-02T15:56:56.518041
656525.0,meperidine,meperidine,cord blood,neonate,delivery,,4,concentration,,,0.4,nmol/ml,mean,SD,0.16,,,,,IM group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,109,2025-12-02T15:56:56.518041
910821.0,methadone,methadone,blood,maternal,labor,,20,concentration,,,0.19,mcg/l,mean,,,range,0,0.66,,during labor,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,110,2025-12-02T15:56:56.518041
910821.0,methadone,methadone,amniotic fluid,maternal,labor,,14,concentration,,,0.2,mcg/l,mean,,,range,0.01,0.67,,during labor,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,111,2025-12-02T15:56:56.518041
910821.0,methadone,methadone,urine,maternal,labor,,14,concentration,,,4.08,mcg/l,mean,,,range,0.01,15,,during labor,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,112,2025-12-02T15:56:56.518041
910821.0,methadone,methadone,cord blood,neonate,delivery,,19,concentration,,,0.05,mcg/l,mean,,,range,0,0.12,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,113,2025-12-02T15:56:56.518041
910821.0,methadone,methadone,urine,neonate,,,16,concentration,,,1.49,mcg/l,mean,,,range,0.095,6.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,114,2025-12-02T15:56:56.518041
1163360.0,methadone,methadone,plasma,neonate,,,27,t1/2,,,26,hours,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,115,2025-12-02T15:56:56.518041
1218165.0,morphine,morphine,plasma,maternal,trimester 1,,42,Tmax,,,1,hours,mean,,,,,,,Groups 1/2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,116,2025-12-02T15:56:56.518041
1218165.0,morphine,morphine,plasma,maternal,trimester 1,,5,Tmax,,,na,hours,,,,range,0.5,2,,Group 3,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,117,2025-12-02T15:56:56.518041
1261164.0,propoxyphene,propoxyphene,blood,child,,,9,peak concentration,2-3,hr,47,ng/ml,mean,,,,,,,time plasma sample obtained after single oral dose of propoxyphene ,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,118,2025-12-02T15:56:56.518041
1261164.0,propoxyphene,propoxyphene,blood,child,,,9,peak concentration,12,h,13,ng/ml,mean,,,,,,,time plasma sample obtained after single oral dose of propoxyphene ,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,119,2025-12-02T15:56:56.518041
1261164.0,propoxyphene,propoxyphene,blood,child,,,9,half-life,,,3.38,hr,mean,SD,1.59,range,1.65,7.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,120,2025-12-02T15:56:56.518041
1271174.0,methadone,methadone,blood,maternal,,,6,t1/2,,,16,h,,,,,,,,goup I: infants with signs of severe withdrawal,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,121,2025-12-02T15:56:56.518041
1271174.0,methadone,methadone,blood,maternal,,,14,t1/2,,,18,h,,,,,,,,goup II: infants with signs of moderate withdrawal,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,122,2025-12-02T15:56:56.518041
1271174.0,methadone,methadone,blood,maternal,,,5,t1/2,,,23,h,,,,,,,,goup III: infants with signs of mild withdrawal,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,123,2025-12-02T15:56:56.518041
1271174.0,methadone,methadone,blood,maternal,,,4,t1/2,,,25,h,,,,,,,,goup IV:  infants with signs of no symptoms ,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,124,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,9,CL,,,7.2,ml/kg/min,median,,,range,5.3,13.8,,Term (study age <1 week),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,125,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,7,CL,,,9.7,ml/kg/min,median,,,range,4.1,20.5,,Term (study age >3 weeks),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,126,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,5,CL,,,3.5,ml/kg/min,median,,,range,1.8,34.9,,preterm,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,127,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,9,Vc,,,2,L/kg,median,,,range,0.5,4.5,,Term (study age <1 week),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,128,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,7,Vc,,,3.1,L/kg,median,,,range,1.5,4.6,,Term (study age >3 weeks),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,129,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,5,Vc,,,2.1,L/kg,median,,,range,1.1,4.8,,preterm,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,130,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,9,Vss,,,5.6,L/kg,median,,,range,3.7,9.2,,Term (study age <1 week),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,131,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,7,Vss,,,8,L/kg,median,,,range,4.9,11,,Term (study age >3 weeks),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,132,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,5,Vss,,,8.8,L/kg,median,,,range,3.3,9.4,,preterm,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,133,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,9,Elimination t1/2,,,10.7,hr,median,,,range,4.9,16.8,,Term (study age <1 week),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,134,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,7,Elimination t1/2,,,8.2,hr,median,,,range,5.7,31.7,,Term (study age >3 weeks),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,135,2025-12-02T15:56:56.518041
1424407.0,meperidine ,meperidine ,blood,infant,,,5,Elimination t1/2,,,11.9,hr,median,,,range,3.3,59.4,,preterm,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,136,2025-12-02T15:56:56.518041
1437393.0,Meperidine,meperidine,umbilical vein blood,Fetal,delivery,,8,Concentration,,,0.07,ug/ml,mean,SD,0.03,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,137,2025-12-02T15:56:56.518041
1437393.0,Meperidine,meperidine,umbilical/maternal vein blood,Fetal,delivery,,8,Fetal:maternal ratio,,,0.6,,mean,SD,0.11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,138,2025-12-02T15:56:56.518041
1437393.0,Meperidine,meperidine,gastric secretions,Neonate,Postpartum,,8,Concentration,,,0.42,ug/ml,mean,SD,0.25,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,139,2025-12-02T15:56:56.518041
1467140.0,Morphine ,Morphine ,blood,neonate/infant,,,12,CL,,,53,ml/min,mean,SD,36,,,,,A single blood sample (1ml was collected after at least 48h of constant rate infusion of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,140,2025-12-02T15:56:56.518041
1467140.0,Morphine ,Morphine ,blood,infant,,,7,CL,,,108,ml/min,mean,SD,147,,,,,A single blood sample (1ml was collected after at least 48h of constant rate infusion of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,141,2025-12-02T15:56:56.518041
1467140.0,Morphine ,Morphine ,blood,neonate/infant,,,12,CL,,,23,ml/min/kg,mean,SD,18,,,,,A single blood sample (1ml was collected after at least 48h of constant rate infusion of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,142,2025-12-02T15:56:56.518041
1467140.0,Morphine ,Morphine ,blood,infant,,,7,CL,,,20,ml/min/kg,mean,SD,15,,,,,A single blood sample (1ml was collected after at least 48h of constant rate infusion of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,143,2025-12-02T15:56:56.518041
1467140.0,Morphine ,Morphine ,blood,neonate/infant,,,7,plasma M3G/M,,,7.3,,mean,SD,7.3,,,,,A single blood sample (1ml was collected after at least 48h of constant rate infusion of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,144,2025-12-02T15:56:56.518041
1467140.0,Morphine ,Morphine ,blood,infant,,,6,plasma M3G/M,,,8,,mean,SD,8.3,,,,,A single blood sample (1ml was collected after at least 48h of constant rate infusion of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,145,2025-12-02T15:56:56.518041
1467140.0,Morphine ,Morphine ,blood,neonate/infant,,,5,plasma M6G/M,,,3.4,,mean,SD,3.3,,,,,A single blood sample (1ml was collected after at least 48h of constant rate infusion of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,146,2025-12-02T15:56:56.518041
1467140.0,Morphine ,Morphine ,blood,infant,,,4,plasma M6G/M,,,3.4,,mean,SD,3.6,,,,,A single blood sample (1ml was collected after at least 48h of constant rate infusion of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,147,2025-12-02T15:56:56.518041
1467140.0,Morphine ,Morphine ,blood,neonate/infant,,,3,plasma M3G/M6G,,,2.7,,mean,SD,0.9,,,,,A single blood sample (1ml was collected after at least 48h of constant rate infusion of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,148,2025-12-02T15:56:56.518041
1467140.0,Morphine ,Morphine ,blood,infant,,,2,plasma M3G/M6G,,,2.8,,mean,SD,1.1,,,,,A single blood sample (1ml was collected after at least 48h of constant rate infusion of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,149,2025-12-02T15:56:56.518041
1467165.0,Morphine,Morphine,blood,child,prepuberty,,11,total body clearance,,,40.4,ml/kg/min,mean,SD,10,,,,,Group B: patients receiving CIV morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,150,2025-12-02T15:56:56.518041
1467165.0,Morphine,Morphine,blood,child,During puberty,,5,total body clearance,,,37.1,ml/kg/min,mean,SD,9,,,,,Group B: patients receiving CIV morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,151,2025-12-02T15:56:56.518041
1467165.0,Morphine,Morphine,blood,child,Postpuberty,,8,total body clearance,,,28,ml/kg/min,mean,SD,11,,,,,Group B: patients receiving CIV morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,152,2025-12-02T15:56:56.518041
1467165.0,Morphine,Morphine,blood,child,all,,24,total body clearance,,,35.4,ml/kg/min,mean,SD,11.3,,,,,Group B: patients receiving CIV morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,153,2025-12-02T15:56:56.518041
1467165.0,Morphine,Morphine,blood,child,all,,24,Css associated with symptoms of opioid toxicity,,,107.3,nM,mean,SD,60,range,36,190,,Group B: patients receiving CIV morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,154,2025-12-02T15:56:56.518041
1533168.0,sufentanil ,sufentanil ,blood,infant/child,,,10,concentration,,,3.14,ng/ml,mean,SD,1.13,,,,,sufentanil monoanesthesia (SM) group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,155,2025-12-02T15:56:56.518041
1533168.0,sufentanil ,sufentanil ,blood,infant/child,,,10,concentration,,,3.45,ng/ml,mean,SD,97,,,,,sufentanil/unitrazepam combination (SF) group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,156,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,infant,,,9,t1/2 of first dose,,,2.6,h,mean,SD,1.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,157,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,infant,,,7,t1/2 of first dose,,,2.3,h,mean,SD,1.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,158,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,t1/2 of first dose,,,2.6,h,mean,SD,1.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,159,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,3,t1/2 of first dose,,,1.6,h,mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,160,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,t1/2 of fifth dose,,,2,h,mean,SD,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,161,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,3,t1/2 of fifth dose,,,2.3,h,mean,SD,1.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,162,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,AUC(0-5) after fifth dose,,,1447,nmol/l h,mean,SD,,range,687,1915,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,163,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,3,AUC(0-5) after fifth dose,,,25.9,nmol/l h,mean,SD,,range,0,52.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,164,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,infant,,,9,concentration after first dose,3,h,240,nmol/l h,mean,SD,85,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,165,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,infant,,,9,concentration after first dose,4,h,163,nmol/l h,mean,SD,71,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,166,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,infant,,,9,concentration after first dose,5,h,123,nmol/l h,mean,SD,65,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,167,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,infant,,,9,concentration after first dose,3,h,8.3,nmol/l h,mean,SD,5.1,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,168,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,infant,,,9,concentration after first dose,4,h,7.4,nmol/l h,mean,SD,3.5,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,169,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,infant,,,9,concentration after first dose,5,h,4.5,nmol/l h,mean,SD,2.7,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,170,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,concentration after first dose,3,h,309,nmol/l h,mean,SD,121,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,171,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,concentration after first dose,4,h,251,nmol/l h,mean,SD,99,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,172,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,concentration after first dose,5,h,169,nmol/l h,mean,SD,57,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,173,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,4,concentration after first dose,3,h,6.8,nmol/l h,mean,SD,6.8,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,174,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,4,concentration after first dose,4,h,5.5,nmol/l h,mean,SD,6.3,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,175,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,4,concentration after first dose,5,h,2.8,nmol/l h,mean,SD,3.5,,,,,"at 3, 4/5 h after the administration of the first suppository",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,176,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,concentration after fifth dose,0,h,125,nmol/l h,mean,SD,50,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,177,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,concentration after fifth dose,1,h,527,nmol/l h,mean,SD,220,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,178,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,concentration after fifth dose,2,h,378,nmol/l h,mean,SD,148,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,179,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,concentration after fifth dose,3,h,258,nmol/l h,mean,SD,104,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,180,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,concentration after fifth dose,4,h,180,nmol/l h,mean,SD,58,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,181,2025-12-02T15:56:56.518041
1540490.0,codeine,codeine,blood,child,,,4,concentration after fifth dose,5,h,113,nmol/l h,mean,SD,38,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,182,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,4,concentration after fifth dose,0,h,3.3,nmol/l h,mean,SD,2.4,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,183,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,4,concentration after fifth dose,1,h,10.2,nmol/l h,mean,SD,9.1,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,184,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,4,concentration after fifth dose,2,h,6.1,nmol/l h,mean,SD,6,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,185,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,4,concentration after fifth dose,3,h,5.2,nmol/l h,mean,SD,4.3,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,186,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,4,concentration after fifth dose,4,h,3.5,nmol/l h,mean,SD,3.1,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,187,2025-12-02T15:56:56.518041
1540490.0,codeine,Morphine,blood,child,,,4,concentration after fifth dose,5,h,1.1,nmol/l h,mean,SD,2.1,,,,,"at 0, 1, 2,  3, 4/5 h after the administration of the fifth suppository on the day after surgery",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,188,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,blood,maternal,postpartum,,13,concentration,3/4,hours,0.19,ng/ml,mean,SD,0.019,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,189,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,blood,maternal,postpartum,,13,concentration,2,hours,0.02,ng/ml,mean,SD,0.0004,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,190,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,blood,maternal,postpartum,,13,concentration,4,hours,0.1,ng/ml,mean,SD,0.002,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,191,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,blood,maternal,postpartum,,13,concentration,6,hours,0,ng/ml,mean,SD,0.001,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,192,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,blood,maternal,postpartum,,13,concentration,8,hours,0,ng/ml,mean,SD,0,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,193,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,blood,maternal,postpartum,,13,concentration,10,hours,0,ng/ml,mean,SD,0,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,194,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,Colostrom,maternal,postpartum,,13,concentration,3/4,hours,0.4,ng/ml,mean,SD,0.059,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,195,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,Colostrom,maternal,postpartum,,13,concentration,2,hours,0.22,ng/ml,mean,SD,0.041,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,196,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,Colostrom,maternal,postpartum,,13,concentration,4,hours,0.15,ng/ml,mean,SD,0.015,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,197,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,Colostrom,maternal,postpartum,,13,concentration,6,hours,0.05,ng/ml,mean,SD,0.012,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,198,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,Colostrom,maternal,postpartum,,13,concentration,8,hours,0.07,ng/ml,mean,SD,0.018,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,199,2025-12-02T15:56:56.518041
1551153.0,fentanyl,fentanyl,Colostrom,maternal,postpartum,,13,concentration,10,hours,0.05,ng/ml,mean,SD,0.018,,,,,"Blood/colostrum samples were taken from each woman at 45 min, two, four, six, eight,/ten hours after the fentanyl was given.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,200,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,15,Cmax,,,47.7,ng/ml,mean,SD,4.4,range,17,80,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,201,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,16,Cmax,,,62.8,ng/ml,mean,SD,6,range,10,110,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,202,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,17,Tmax,,,0.5,hours (h),,,,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,203,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,18,Tmax,,,0.25,hours (h),,,,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,204,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,19,VDss,,,3.49,l/kg,mean,SD,0.5,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,205,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,20,VDss,,,2.28,l/kg,mean,SD,0.25,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,206,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,21,CL,,,14.07,ml/min/kg,mean,SD,4.8,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,207,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,22,CL,,,8.66,ml/min/kg,mean,SD,2.7,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,208,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,23,t1/2 beta,,,5.03,hours (h),mean,SD,0.8,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,209,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,24,t1/2 beta,,,4.5,hours (h),mean,SD,0.6,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,210,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,25,AUC total,,,416,ng/ml.h,mean,SD,83,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,211,2025-12-02T15:56:56.518041
1567033.0,Bupivacaine,Bupivacaine,plasma,Maternal,Labor,,26,AUC total,,,512,ng/ml.h,mean,SD,85,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,212,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,15,Cmax,,,0.61,ng/ml,mean,SD,0.07,range,0.17,1.4,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,213,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,16,Cmax,,,0.21,ng/ml,mean,SD,0.07,range,0,0.77,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,214,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,17,Tmax,,,3,hours (h),,,,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,215,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,18,Tmax,,,3,hours (h),,,,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,216,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,19,VDss,,,13.4,l/kg,mean,SD,0.9,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,217,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,20,VDss,,,13.2,l/kg,mean,SD,2.3,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,218,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,21,CL,,,17.9,ml/min/kg,mean,SD,2.8,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,219,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,22,CL,,,46.4,ml/min/kg,mean,SD,13,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,220,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,23,t1/2 beta,,,10.9,hours (h),mean,SD,1.5,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,221,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,24,t1/2 beta,,,6.04,hours (h),mean,SD,1.2,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,222,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,25,AUC total,,,10.85,ng/ml.h,mean,SD,1.7,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,223,2025-12-02T15:56:56.518041
1567033.0,Morphine,Morphine,plasma,Maternal,Labor,,26,AUC total,,,6.38,ng/ml.h,mean,SD,1.6,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,224,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,15,Concentration,0.25,hours (h),0.275,ng/ml,mean,SD,0.1,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,225,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,16,Concentration,0.25,,0.95,ng/ml,mean,SD,0.4,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,226,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,17,Concentration,0.5,,0.4,ng/ml,mean,SD,0.1,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,227,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,18,Concentration,0.5,,1.38,ng/ml,mean,SD,0.8,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,228,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,19,Concentration,1,,0.72,ng/ml,mean,SD,0.1,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,229,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,20,Concentration,1,,1.79,ng/ml,mean,SD,1,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,230,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,21,Concentration,2,,1.4,ng/ml,mean,SD,0.3,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,231,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,22,Concentration,2,,1.72,ng/ml,mean,SD,0.5,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,232,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,23,Concentration,3,,2.34,ng/ml,mean,SD,0.3,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,233,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,24,Concentration,3,,2.09,ng/ml,mean,SD,0.8,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,234,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,25,Concentration,6,,2.7,ng/ml,mean,SD,0.4,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,235,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,26,Concentration,6,,2.36,ng/ml,mean,SD,0.8,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,236,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,27,Concentration,12,,1.4,ng/ml,mean,SD,0.6,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,237,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,28,Concentration,12,,2,ng/ml,mean,SD,1,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,238,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,29,Concentration,24,,0.3,ng/ml,mean,SD,0.1,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,239,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,plasma,Maternal,Labor,,30,Concentration,24,,0.04,ng/ml,mean,SD,0.04,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,240,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,0.25,,0.75,ng/ml,mean,SD,0.4,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,241,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,0.25,,3.5,ng/ml,mean,SD,1,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,242,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,0.5,,10,ng/ml,mean,SD,3,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,243,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,0.5,,10.5,ng/ml,mean,SD,3,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,244,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,1,,25,ng/ml,mean,SD,4,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,245,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,1,,24.1,ng/ml,mean,SD,7,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,246,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,2,,40.6,ng/ml,mean,SD,10,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,247,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,2,,34,ng/ml,mean,SD,7,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,248,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,3,,57.5,ng/ml,mean,SD,12,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,249,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,3,,60,ng/ml,mean,SD,13,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,250,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,6,,90.8,ng/ml,mean,SD,15,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,251,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,6,,52,ng/ml,mean,SD,10,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,252,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,12,,26,ng/ml,mean,SD,7,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,253,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,12,,25,ng/ml,mean,SD,3,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,254,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Concentration,24,,7.3,ng/ml,mean,SD,0.8,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,255,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Excretion,24,,7.2,% dose,mean,SD,1,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,256,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Excretion,24,,5,% dose,mean,SD,0.3,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,257,2025-12-02T15:56:56.518041
1567033.0,Morphine,unconjugated morphine,urine,Maternal,Labor,,15,Excretion,24,,6.6,% dose,mean,SD,3,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,258,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,15,Concentration,0.25,,6.8,ng/ml,mean,SD,3,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,259,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,16,Concentration,0.25,,3.9,ng/ml,mean,SD,0.8,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,260,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,17,Concentration,0.5,,43.8,ng/ml,mean,SD,20,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,261,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,18,Concentration,0.5,,8.4,ng/ml,mean,SD,3,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,262,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,19,Concentration,1,,144,ng/ml,mean,SD,60,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,263,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,20,Concentration,1,,41.3,ng/ml,mean,SD,15,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,264,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,21,Concentration,2,,92.4,ng/ml,mean,SD,20,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,265,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,22,Concentration,2,,80.9,ng/ml,mean,SD,33,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,266,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,23,Concentration,3,,162,ng/ml,mean,SD,45,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,267,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,24,Concentration,3,,206,ng/ml,mean,SD,65,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,268,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,25,Concentration,6,,380,ng/ml,mean,SD,80,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,269,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,26,Concentration,6,,240,ng/ml,mean,SD,42,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,270,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,27,Concentration,12,,141,ng/ml,mean,SD,45,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,271,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,28,Concentration,12,,170,ng/ml,mean,SD,34,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,272,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,29,Concentration,24,,42.9,ng/ml,mean,SD,11,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,273,2025-12-02T15:56:56.518041
1567033.0,Morphine,conjugated morphine,urine,Maternal,Labor,,30,Concentration,24,,51.5,ng/ml,mean,SD,25,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,274,2025-12-02T15:56:56.518041
1567033.0,Morphine,total morphine,urine,Maternal,Labor,,15,Excretion,24,,45,% dose,mean,SD,5,,,,,plain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,275,2025-12-02T15:56:56.518041
1567033.0,Morphine,total morphine,urine,Maternal,Labor,,15,Excretion,24,,31,% dose,mean,SD,3,,,,,epinephrine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,276,2025-12-02T15:56:56.518041
1578319.0,Morphine ,Morphine ,urine ,preterm newborn infant,<32 weeks of gestational age,,16,concentration,4,hours,371.2,ng/ml,mean,SD,484,,,,,"Two sets of 4-hour timed urine samples were collected from each subject, the first up to 4 hours/the other from 20 to 24 hours after morphine dosing. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,277,2025-12-02T15:56:56.518041
1578319.0,Morphine ,Morphine ,urine ,preterm newborn infant,,,16,concentration,24,hours,18.8,ng/ml,mean,SD,2.3,,,,,"Two sets of 4-hour timed urine samples were collected from each subject, the first up to 4 hours/the other from 20 to 24 hours after morphine dosing. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,278,2025-12-02T15:56:56.518041
1578319.0,Morphine ,Morphine ,blood,preterm newborn infant,,,13,concentration,4,hours,34.1,ng/ml,mean,SD,20.2,,,,,"blood was obtained via the indwelling catheter or from an arterial puncture, 4 hours/24 hours after the dose",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,279,2025-12-02T15:56:56.518041
1578319.0,Morphine ,Morphine ,blood,preterm newborn infant,,,12,concentration,24,hours,5,ng/ml,mean,SD,5.5,,,,,"blood was obtained via the indwelling catheter or from an arterial puncture, 4 hours/24 hours after the dose",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,280,2025-12-02T15:56:56.518041
1578319.0,Morphine ,M3G,urine ,preterm newborn infant,<32 weeks of gestational age,,16,concentration,4,hours,17.5,ng/ml,mean,SD,27.5,,,,,"Two sets of 4-hour timed urine samples were collected from each subject, the first up to 4 hours/the other from 20 to 24 hours after morphine dosing. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,281,2025-12-02T15:56:56.518041
1578319.0,Morphine ,M3G,urine ,preterm newborn infant,,,16,concentration,24,hours,7.3,ng/ml,mean,SD,24.2,,,,,"Two sets of 4-hour timed urine samples were collected from each subject, the first up to 4 hours/the other from 20 to 24 hours after morphine dosing. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,282,2025-12-02T15:56:56.518041
1578319.0,Morphine ,M3G,blood,preterm newborn infant,,,13,concentration,4,hours,11.3,ng/ml,mean,SD,22.1,,,,,"blood was obtained via the indwelling catheter or from an arterial puncture, 4 hours/24 hours after the dose",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,283,2025-12-02T15:56:56.518041
1578319.0,Morphine ,M3G,blood,preterm newborn infant,,,12,concentration,24,hours,3.7,ng/ml,mean,SD,9.9,,,,,"blood was obtained via the indwelling catheter or from an arterial puncture, 4 hours/24 hours after the dose",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,284,2025-12-02T15:56:56.518041
1578319.0,Morphine ,M6G,urine ,preterm newborn infant,<32 weeks of gestational age,,16,concentration,4,hours,18.2,ng/ml,mean,SD,52.7,,,,,"Two sets of 4-hour timed urine samples were collected from each subject, the first up to 4 hours/the other from 20 to 24 hours after morphine dosing. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,285,2025-12-02T15:56:56.518041
1578319.0,Morphine ,M6G,urine ,preterm newborn infant,,,16,concentration,24,hours,1.4,ng/ml,mean,SD,3.5,,,,,"Two sets of 4-hour timed urine samples were collected from each subject, the first up to 4 hours/the other from 20 to 24 hours after morphine dosing. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,286,2025-12-02T15:56:56.518041
1578319.0,Morphine ,M6G,blood,preterm newborn infant,,,13,concentration,4,hours,0,ng/ml,mean,SD,0,,,,,"blood was obtained via the indwelling catheter or from an arterial puncture, 4 hours/24 hours after the dose",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,287,2025-12-02T15:56:56.518041
1578319.0,Morphine ,M6G,blood,preterm newborn infant,,,12,concentration,24,hours,0.8,ng/ml,mean,SD,3.1,,,,,"blood was obtained via the indwelling catheter or from an arterial puncture, 4 hours/24 hours after the dose",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,288,2025-12-02T15:56:56.518041
1632539.0,alfentanil,alfentanil,plasma,neonates,,,5,half life,,,43,min,median,,,range,34,237,,no rigidity,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,289,2025-12-02T15:56:56.518041
1632539.0,alfentanil,alfentanil,plasma,neonates,,,10,half life,,,153,min,median,,,range,31,650,,rigidity,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,290,2025-12-02T15:56:56.518041
1632539.0,alfentanil,alfentanil,plasma,neonates,,,5,CL,,,2.1,mL/kg/min,median,,,range,1.7,7.2,,no rigidity,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,291,2025-12-02T15:56:56.518041
1632539.0,alfentanil,alfentanil,plasma,neonates,,,10,CL,,,2.9,mL/kg/min,median,,,range,0.9,25.3,,rigidity,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,292,2025-12-02T15:56:56.518041
1632539.0,alfentanil,alfentanil,plasma,neonates,,,5,Vss,,,0.27,L/Kg,median,,,range,0.08,0.62,,no rigidity,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,293,2025-12-02T15:56:56.518041
1632539.0,alfentanil,alfentanil,plasma,neonates,,,10,Vss,,,0.66,L/Kg,median,,,range,0.15,2.94,,rigidity,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,294,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,1-7 d,,9,plasma steady-state concentration,,,45.2,ng/ml,median,,,range,21.1,68.8,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,295,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,1-7 d,,9,clearance,,,5.5,mL/kg/min,median,,,range,3.2,8.4,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,296,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,1-7 d,,10,protein-bound fraction,,,82,%,median,,,range,74,89,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,297,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,1-7 d,,6,volume of distribution,,,3.3,L/kg,median,,,range,1.7,4.5,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,298,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,1-7 d,,9,half-life,,,7.2,h,median,,,range,5.1,15.8,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,299,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,8-30 d,,5,plasma steady-state concentration,,,28.4,ng/ml,median,,,range,18.3,76.2,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,300,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,8-30 d,,5,clearance,,,7.4,mL/kg/min,median,,,range,3.4,13.8,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,301,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,8-30 d,,5,protein-bound fraction,,,81,%,median,,,range,76,86,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,302,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,8-30 d,,4,volume of distribution,,,2.6,L/kg,median,,,range,2.2,3.1,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,303,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,8-30 d,,5,half-life,,,4.1,h,median,,,range,1.8,5.6,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,304,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,31-90 d,,7,plasma steady-state concentration,,,25.2,ng/ml,median,,,range,12.1,32.5,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,305,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,31-90 d,,7,clearance,,,10.5,mL/kg/min,median,,,range,9.8,20.1,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,306,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,31-90 d,,5,protein-bound fraction,,,79,%,median,,,range,76,85,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,307,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,31-90 d,,3,volume of distribution,,,5.5,L/kg,median,,,range,3.8,9.4,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,308,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,31-90 d,,3,half-life,,,6.2,h,median,,,range,5,9.9,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,309,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,91-180 d,,11,plasma steady-state concentration,,,20.5,ng/ml,median,,,range,13.4,36.6,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,310,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,91-180 d,,11,clearance,,,13.9,mL/kg/min,median,,,range,8.3,24.1,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,311,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,91-180 d,,17,protein-bound fraction,,,82,%,median,,,range,75,89,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,312,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,91-180 d,,4,volume of distribution,,,4.7,L/kg,median,,,range,3,8.9,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,313,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,91-180 d,,5,half-life,,,4.5,h,median,,,range,3.8,7.3,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,314,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,181 d-2.5 y,,17,plasma steady-state concentration,,,14.2,ng/ml,median,,,range,6.7,36.6,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,315,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,182 d-2.5 y,,17,clearance,,,21.7,mL/kg/min,median,,,range,5.8,28.6,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,316,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,183 d-2.5 y,,15,protein-bound fraction,,,81,%,median,,,range,72,89,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,317,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,184 d-2.5 y,,7,volume of distribution,,,4.8,L/kg,median,,,range,2.2,7.3,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,318,2025-12-02T15:56:56.518041
1636668.0,Morphine ,Morphine ,blood,child,185 d-2.5 y,,7,half-life,,,22.8,h,median,,,range,1.4,7.8,,"Blood samples (1 mL) were obtained at 6-/12-hour intervals from an indwelling arterial line during infusion/at baseline, 30 minutes, 1,2, 4, 6, 8,12,/24 hours after discontinuation of the infusion.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,319,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood,fetal,delivery,,10,concentration,0-1,hr,330.7,microgram/l,mean,SD,205.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,320,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood,fetal,delivery,,12,concentration,2022-01-02 00:00:00,hr,369.3,microgram/l,mean,SD,198.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,321,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood,fetal,delivery,,7,concentration,2022-02-03 00:00:00,hr,340.6,microgram/l,mean,SD,109.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,322,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood,fetal,delivery,,3,concentration,2022-03-04 00:00:00,hr,223.7,microgram/l,mean,SD,59.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,323,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood,fetal,delivery,,8,concentration,>4,hr,253.1,microgram/l,mean,SD,83.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,324,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood,fetal,delivery,,40,concentration,,,318.8,microgram/l,mean,SD,161.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,325,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,plasma,maternal,delivery,,10,concentration,0-1,hr,638.4,microgram/l,mean,SD,394.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,326,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,plasma,maternal,delivery,,12,concentration,2022-01-02 00:00:00,hr,735.2,microgram/l,mean,SD,306.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,327,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,plasma,maternal,delivery,,7,concentration,2022-02-03 00:00:00,hr,661.4,microgram/l,mean,SD,140.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,328,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,plasma,maternal,delivery,,3,concentration,2022-03-04 00:00:00,hr,252.7,microgram/l,mean,SD,80.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,329,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,plasma,maternal,delivery,,8,concentration,>4,hr,340.1,microgram/l,mean,SD,174.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,330,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,plasma,maternal,delivery,,40,concentration,,,584.1,microgram/l,mean,SD,316.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,331,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood/plasma,fetal,delivery,,10,Fetal:maternal ratio,0-1,hr,0.59,,mean,SD,0.25,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,332,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood/plasma,fetal,delivery,,12,Fetal:maternal ratio,2022-01-02 00:00:00,hr,0.51,,mean,SD,0.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,333,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood/plasma,fetal,delivery,,7,Fetal:maternal ratio,2022-02-03 00:00:00,hr,0.52,,mean,SD,0.17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,334,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood/plasma,fetal,delivery,,3,Fetal:maternal ratio,2022-03-04 00:00:00,hr,0.95,,mean,SD,0.79,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,335,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood/plasma,fetal,delivery,,8,Fetal:maternal ratio,>4,hr,0.81,,mean,SD,0.36,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,336,2025-12-02T15:56:56.518041
1683310.0,meperidine,meperidine,cord blood/plasma,fetal,delivery,,40,Fetal:maternal ratio,,,0.63,,mean,SD,0.28,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,337,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,blood,Maternal,Labor,,16,Cmax,,,0.38,ng/ml,mean,SD,0.16,range,0.12,0.59,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,338,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,blood,Maternal,Labor,,16,Tmax,,,24,minutes (min),mean,SD,14,,5,60,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,339,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,blood,Maternal,Labor,,16,Concentration,5,minutes (mins),0.15,ng/ml,mean,SD,0.17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,340,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,blood,Maternal,Labor,,16,Concentration,15,minutes (mins),0.34,ng/ml,mean,SD,0.18,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,341,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,blood,Maternal,Labor,,16,Concentration,30,minutes (mins),0.33,ng/ml,mean,SD,0.12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,342,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,blood,Maternal,Labor,,15,Concentration,60,minutes (mins),0.2,ng/ml,mean,SD,0.04,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,343,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,blood,Maternal,Labor,,12,Concentration,120,minutes (mins),0.13,ng/ml,mean,SD,0.03,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,344,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,blood,Maternal,Labor,,12,Concentration,300,minutes (mins),0.14,ng/ml,mean,SD,0.08,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,345,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,umbilical vein,fetal,Delivery,,16,Concentration,,,0.13,ng/ml,mean,SD,0.04,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,346,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,umbilical vein,fetal,Delivery,,17,Cmax,,,0.19,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,347,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,umbilical artery,fetal,Delivery,,18,Concentration,,,0.06,ng/ml,mean,SD,0.03,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,348,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,umbilical artery,fetal,Delivery,,19,Cmax,,,0.12,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,349,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,cord blood,fetal,Delivery,,20,fetal extraction,,,53,percent (%),,,20,range,20,83,,Fetal extraction is obtained by: 100 x (umbilical vein - umbilical artery)/ umbilical vein,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,350,2025-12-02T15:56:56.518041
1765214.0,Fentanyl,fentanyl,umbilical vein/maternal blood,fetal,Delivery,,21,fetal:maternal ratio,,,43,percent (%),,,21,range,17,95,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,351,2025-12-02T15:56:56.518041
1923912.0,alfentanil,alfentanil,blood,neonate,,,12,total-body clearance,,,3.24,ml/kg/min,mean,SD,2.23,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,352,2025-12-02T15:56:56.518041
1923912.0,alfentanil,alfentanil,blood,neonate,,,12,beta half-life,,,4.14,hrs,mean,SD,2.58,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,353,2025-12-02T15:56:56.518041
1923912.0,alfentanil,alfentanil,blood,neonate,,,12,Vd,,,0.58,L/kg,mean,SD,0.21,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,354,2025-12-02T15:56:56.518041
2012289.0,morphine,morphine,plasma,children,,,6,Cmax,10,minutes,21.2,ng/ml,mean,SD,4.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,355,2025-12-02T15:56:56.518041
2012289.0,morphine,morphine,plasma,children,,,6,concentration,1,hour,10.1,ng/ml,mean,SD,3.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,356,2025-12-02T15:56:56.518041
2012289.0,morphine,morphine,plasma,children,,,6,concentration,3,hours,4.1,ng/ml,mean,SD,2.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,357,2025-12-02T15:56:56.518041
2078976.0,alfentanil,alfentanil,blood,neonate,less than 36 weeks gestational age,,5,t1/2,,,455,min,mean,SD,111,,,,,"Arterial blood samples (0.4 ml) were obtained at 1, 3, 10, 30, 120, 360, 720, 1,080,/1,440 min after infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,358,2025-12-02T15:56:56.518041
2078976.0,alfentanil,alfentanil,blood,neonate,less than 36 weeks gestational age,,5,CL,,,1.35,ml/kg/min,mean,SD,0.69,,,,,"Arterial blood samples (0.4 ml) were obtained at 1, 3, 10, 30, 120, 360, 720, 1,080,/1,440 min after infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,359,2025-12-02T15:56:56.518041
2078976.0,alfentanil,alfentanil,blood,neonate,less than 36 weeks gestational age,,5,Vd,,,0.84,1/kg,mean,SD,0.48,,,,,"Arterial blood samples (0.4 ml) were obtained at 1, 3, 10, 30, 120, 360, 720, 1,080,/1,440 min after infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,360,2025-12-02T15:56:56.518041
2078976.0,alfentanil,alfentanil,blood,neonate,less than 36 weeks gestational age,,5,Mean residual time,,,656.8,min,mean,SD,161.8,,,,,"Arterial blood samples (0.4 ml) were obtained at 1, 3, 10, 30, 120, 360, 720, 1,080,/1,440 min after infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,361,2025-12-02T15:56:56.518041
2078976.0,alfentanil,alfentanil,blood,neonate,greater than 36 weeks gestational age,,5,t1/2,,,328,min,mean,SD,48,,,,,"Arterial blood samples (0.4 ml) were obtained at 1, 3, 10, 30, 120, 360, 720, 1,080,/1,440 min after infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,362,2025-12-02T15:56:56.518041
2078976.0,alfentanil,alfentanil,blood,neonate,greater than 36 weeks gestational age,,5,CL,,,1.7,ml/kg/min,mean,SD,0.47,,,,,"Arterial blood samples (0.4 ml) were obtained at 1, 3, 10, 30, 120, 360, 720, 1,080,/1,440 min after infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,363,2025-12-02T15:56:56.518041
2078976.0,alfentanil,alfentanil,blood,neonate,greater than 36 weeks gestational age,,5,Vd,,,0.82,1/kg,mean,SD,0.3,,,,,"Arterial blood samples (0.4 ml) were obtained at 1, 3, 10, 30, 120, 360, 720, 1,080,/1,440 min after infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,364,2025-12-02T15:56:56.518041
2078976.0,alfentanil,alfentanil,blood,neonate,greater than 36 weeks gestational age,,5,Mean residual time,,,473,min,mean,SD,69.8,,,,,"Arterial blood samples (0.4 ml) were obtained at 1, 3, 10, 30, 120, 360, 720, 1,080,/1,440 min after infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,365,2025-12-02T15:56:56.518041
2097341.0,Morphine,morphine,plasma,Adult,Nonpregnant,,13,Tmax,,,na,minutes (min),,,,range,2,15,,both pregnant/nonpregnant women given im dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,366,2025-12-02T15:56:56.518041
2097341.0,Morphine,morphine,plasma,Maternal,Labor,,13,t1/2,,,43,minutes (min),mean,SD,19,,,,,p<0.05,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,367,2025-12-02T15:56:56.518041
2097341.0,Morphine,morphine,plasma,Adult,Nonpregnant,,6,t1/2,,,84,minutes (min),mean,SD,40,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,368,2025-12-02T15:56:56.518041
2097341.0,Morphine,morphine,plasma,Maternal,Labor,,13,CL,,,3.4,l/min,mean,SD,1.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,369,2025-12-02T15:56:56.518041
2097341.0,Morphine,morphine,plasma,Adult,Nonpregnant,,6,CL,,,2,l/min,mean,SD,0.5,,,,,p<0.05,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,370,2025-12-02T15:56:56.518041
2097341.0,Morphine,morphine,plasma,Maternal,Labor,,13,VD,,,200,liters (l),mean,SD,125,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,371,2025-12-02T15:56:56.518041
2097341.0,Morphine,morphine,plasma,Adult,Nonpregnant,,6,VD,,,217,liters (l),mean,SD,104,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,372,2025-12-02T15:56:56.518041
2097341.0,Morphine,morphine,plasma,Maternal,Labor,,13,AUC,,,3.9,ng/l.min,mean,SD,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,373,2025-12-02T15:56:56.518041
2097341.0,Morphine,morphine,plasma,Adult,Nonpregnant,,6,AUC,,,3.1,ng/l.min,mean,SD,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,374,2025-12-02T15:56:56.518041
2097341.0,Morphine,M3G,plasma,Maternal,Labor,,4,Tmax,,,11.3,minutes (min),mean,SD,3,,,,,"iv dose, p<0.05",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,375,2025-12-02T15:56:56.518041
2097341.0,Morphine,M3G,plasma,Adult,Nonpregnant,,4,Tmax,,,21.3,minutes (min),mean,SD,6.3,,,,,iv dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,376,2025-12-02T15:56:56.518041
2097341.0,Morphine,M3G/morphine,plasma,Maternal,Labor,,4,Concentration ratio,10,minutes (mins),6.4,,mean,SD,1,,,,,"iv dose, p<0.05",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,377,2025-12-02T15:56:56.518041
2097341.0,Morphine,M3G/morphine,plasma,Adult,Nonpregnant,,4,Concentration ratio,10,minutes (mins),3.4,,mean,SD,0.6,,,,,iv dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,378,2025-12-02T15:56:56.518041
2137997.0,sufentanil,sufentanil,blood,neonate,,,18,free fraction,,,19.5,% free,mean,SD,2.7,,,,<0.01,"neonates vs. infants, children,/adults",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,379,2025-12-02T15:56:56.518041
2137997.0,sufentanil,sufentanil,blood,infant,,,9,free fraction,,,11.5,% free,mean,SD,3.2,,,,<0.01,"infants vs. children, adults",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,380,2025-12-02T15:56:56.518041
2137997.0,sufentanil,sufentanil,blood,child,,,11,free fraction,,,8.1,% free,mean,SD,1.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,381,2025-12-02T15:56:56.518041
2137997.0,sufentanil,sufentanil,blood,adult,,,11,free fraction,,,7.8,% free,mean,SD,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,382,2025-12-02T15:56:56.518041
2240676.0,Meperidine,meperidine,breast milk,maternal,postpartum,,4,concentration,72,hrs,156,ng/ml,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,383,2025-12-02T15:56:56.518041
2240676.0,Meperidine,normeperidine,breast milk,maternal,postpartum,,4,concentration,,,469,ng/ml,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,384,2025-12-02T15:56:56.518041
2240676.0,Morphine,morphine,breast milk,maternal,postpartum,,5,concentration,72,hrs,23,ng/ml,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,385,2025-12-02T15:56:56.518041
2240676.0,Morphine,M3G,breast milk,maternal,postpartum,,5,concentration,,,19,ng/ml,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,386,2025-12-02T15:56:56.518041
2248393.0,fentanyl,fentanyl,blood,neonate,,,5,plasma concentration,,,na,,,,,,,,,plotted by ECMO day,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,387,2025-12-02T15:56:56.518041
2262875.0,Morphine,morphine,plasma,Maternal,Delivery,,5,Concentration,,,16,ng/ml,median,,,range,5,73,,12 samples used,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,388,2025-12-02T15:56:56.518041
2262875.0,Morphine,morphine,cord blood,Fetal,Delivery,,5,Concentration,,,21.5,ng/ml,median,,,range,<4,70,,12 samples used,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,389,2025-12-02T15:56:56.518041
2262875.0,Morphine,morphine,cord blood/maternal plasma,Fetal,Delivery,,5,Fetal: maternal ratio,,,1,,median,,,range,0.6,5.2,,12 samples used,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,390,2025-12-02T15:56:56.518041
2262875.0,Morphine,M3G,plasma,Maternal,Delivery,,5,Concentration,,,170,ng/ml,median,,,range,<0.3,280,,13 samples used,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,391,2025-12-02T15:56:56.518041
2262875.0,Morphine,M3G,cord blood,Fetal,Delivery,,5,Concentration,,,70.5,ng/ml,median,,,range,<0.3,300,,13 samples used,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,392,2025-12-02T15:56:56.518041
2262875.0,Morphine,M3G,cord blood/maternal plasma,Fetal,Delivery,,5,Fetal: maternal ratio,,,0.4,,median,,,range,<0.002,1.1,,13 samples used,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,393,2025-12-02T15:56:56.518041
2288836.0,morphine,morphine-3-sulphate,urine,neonate,,,7,M3S/M,,,0.045,,mean,SD,0.019,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,394,2025-12-02T15:56:56.518041
2288836.0,morphine,morphine-3-glucuronide,urine,neonate,,,7,M3S/M3G,,,0.032,,mean,SD,0.019,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,395,2025-12-02T15:56:56.518041
2288836.0,morphine,morphine-3-sulphate,urine,child,,,3,M3S/M,,,0.008,,mean,SD,0.014,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,396,2025-12-02T15:56:56.518041
2288836.0,morphine,morphine-3-glucuronide,urine,child,,,3,M3S/M3G,,,0.001,,mean,SD,0.001,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,397,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,AUC,,,1055,ug/l*h,,,,,,,,MKMODEL used for esitmating the parameters,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,398,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,ka,,,1.64,/hour,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,399,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,Tlag,,,0.45,hour,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,400,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,k,,,0.085,/hour,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,401,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,Cl/F,,,28.4,l/h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,402,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,Vd/F,,,343.2,l/h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,403,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,t1/2,,,8.1,hour,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,404,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,Cmax -30 mg bid,,,76.5,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,405,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,Cmin -30 mg bid,,,9.9,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,406,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,Cmax -15 mg bid,,,52.1,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,407,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,Cmin -15 mg bid,,,18.8,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,408,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,Cmax -45 mg qd,,,115,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,409,2025-12-02T15:56:56.518041
2485290.0,Methadone,methdaone,plasma,Maternal,Trimester 3,,1,Cmin -45 mg qd,,,14.8,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,410,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,concentration,5,min,0.3,microgram/ml,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,411,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,concentration,15,min,0.24,microgram/ml,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,412,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,concentration,30,min,0.2,microgram/ml,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,413,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,concentration,60,min,0.18,microgram/ml,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,414,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,concentration,120,min,0.15,microgram/ml,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,415,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,concentration,180,min,0.1,microgram/ml,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,416,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,t1/2 alpha,,,2.274,hr,mean,SD,1.047,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,417,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,t1/2 beta,,,13.274,hr,mean,SD,4.26,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,418,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,V1,,,260,liter,mean,SD,80,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,419,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,Vdarea,,,767,liter,mean,SD,228,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,420,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,Vdext,,,1417,liter,mean,SD,628,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,421,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,Vdss,,,503,liter,mean,SD,137,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,422,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,clearance,,,0.678,l/min,mean,SD,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,423,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,k21,,,0.124,h^-1,mean,SD,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,424,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,kel,,,0.172,h^-1,mean,SD,0.071,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,425,2025-12-02T15:56:56.518041
2568289.0,meperidine,meperidine,blood,maternal,labor,,11,k12,,,0.126,h^-1,mean,SD,0.083,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,426,2025-12-02T15:56:56.518041
2590614.0,morphine,morphine,blood,child,,,9,plasma concentration,,,34,ng/ml,mean,SD,42,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,427,2025-12-02T15:56:56.518041
2590614.0,morphine,morphine,blood,child,,,9,CL,,,25.7,ml/min/kg,mean,SD,4.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,428,2025-12-02T15:56:56.518041
2590614.0,morphine,M3G,blood,child,,,9,plasma concentration,,,837,ng/ml,mean,SD,1189,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,429,2025-12-02T15:56:56.518041
2590614.0,morphine,M6G,blood,child,,,9,plasma concentration,,,43,ng/ml,mean,SD,34,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,430,2025-12-02T15:56:56.518041
2590614.0,morphine,M3G,blood,child,,,9,plasma M3G/morphine,,,23.9,,mean,SD,6.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,431,2025-12-02T15:56:56.518041
2590614.0,morphine,M3G,urine,child,,,9,ratio of M3G/M,,,12.9,,mean,SD,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,432,2025-12-02T15:56:56.518041
2590614.0,morphine,M6G,urine,child,,,9,ratio of M6G/M,,,1.37,,mean,SD,0.62,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,433,2025-12-02T15:56:56.518041
2590614.0,morphine,M3G/M6G,urine,child,,,9,ratio of M3G/M6G,,,9.9,,mean,SD,3.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,434,2025-12-02T15:56:56.518041
2590614.0,morphine,morphine,blood,neonate,,,7,plasma concentration,,,113,ng/ml,mean,SD,70,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,435,2025-12-02T15:56:56.518041
2590614.0,morphine,morphine,blood,neonate,,,7,CL,,,4.7,ml/min/kg,mean,SD,2.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,436,2025-12-02T15:56:56.518041
2590614.0,morphine,M3G,blood,neonate,,,7,plasma concentration,,,339,ng/ml,mean,SD,136,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,437,2025-12-02T15:56:56.518041
2590614.0,morphine,M3G,blood,neonate,,,7,plasma M3G/morphine,,,5,,mean,SD,4.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,438,2025-12-02T15:56:56.518041
2590614.0,morphine,M3G,urine,neonate,,,7,ratio of M3G/M,,,2.34,,mean,SD,2.08,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,439,2025-12-02T15:56:56.518041
2590614.0,morphine,M6G,urine,neonate,,,7,ratio of M6G/M,,,0.28,,mean,SD,0.24,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,440,2025-12-02T15:56:56.518041
2590614.0,morphine,M3G/M6G,urine,neonate,,,7,ratio of M3G/M6G,,,10.3,,mean,SD,1.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,441,2025-12-02T15:56:56.518041
2729393.0,Meperidine,meperidine,plasma,Maternal,Labor,,5,Cmax,,,0.179,ug/ml,mean,,,,,,p<0.02,deltoid route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,442,2025-12-02T15:56:56.518041
2729393.0,Meperidine,meperidine,plasma,Maternal,Labor,,5,Tmax,,,10,mins,mean,,,,,,,deltoid route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,443,2025-12-02T15:56:56.518041
2729393.0,Meperidine,meperidine,plasma,Maternal,Labor,,10,Cmax,,,0.097,ug/ml,mean,,,,,,,gluteus route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,444,2025-12-02T15:56:56.518041
2729393.0,Meperidine,meperidine,plasma,Maternal,Labor,,10,Tmax,,,20,mins,mean,,,,,,,gluteus route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,445,2025-12-02T15:56:56.518041
2729393.0,Meperidine,meperidine,plasma,Adult,Nonpregnant,,5,Cmax,,,0.303,ug/ml,mean,,,,,,p<0.004,deltoid route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,446,2025-12-02T15:56:56.518041
2729393.0,Meperidine,meperidine,plasma,Adult,Nonpregnant,,5,Tmax,,,10,mins,mean,,,,,,,deltoid route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,447,2025-12-02T15:56:56.518041
2729393.0,Meperidine,meperidine,plasma,Adult,Nonpregnant,,5,Cmax,,,0.18,ug/ml,mean,,,,,,,gluteus route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,448,2025-12-02T15:56:56.518041
2729393.0,Meperidine,meperidine,plasma,Adult,Nonpregnant,,5,Tmax,,,20,mins,mean,,,,,,,gluteus route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,449,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Maternal,Trimester 3 (T3),,9,t1/2,,,1.36,hours (h),mean,SD,0.12,,,,,single-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,450,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Maternal,Trimester 3 (T3),,9,AUC,,,160.1,ng/ml*h,mean,SD,21.7,,,,,single-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,451,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Maternal,Trimester 3 (T3),,9,CL,,,56.3,ml/min*kg,mean,SD,7,,,,,single-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,452,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Maternal,Trimester 3 (T3),,9,Vz,,,6.71,l/kg,mean,SD,0.92,,,,,single-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,453,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Adult,Nonpregnant,,10,t1/2,,,1.68,hours (h),mean,SD,0.11,,,,,single-dose study; p<0.05 compared to makes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,454,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Adult,Nonpregnant,,10,AUC,,,199.2,ng/ml*h,mean,SD,12.9,,,,,single-dose study; p> 0.05 compared to males,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,455,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Adult,Nonpregnant,,10,CL,,,41.8,ml/min*kg,mean,SD,2.8,,,,,single-dose study; p<0.01 compared to males,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,456,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Adult,Nonpregnant,,10,Vz,,,5.98,l/kg,mean,SD,0.5,,,,,single-dose study; p> 0.05 compared to males,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,457,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Adult,Male,,14,t1/2,,,2.06,hours (h),mean,SD,0.13,,,,,single-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,458,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Adult,Male,,14,AUC,,,216,ng/ml*h,mean,SD,9.6,,,,,single-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,459,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Adult,Male,,14,CL,,,32.8,ml/min*kg,mean,SD,1.4,,,,,single-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,460,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Adult,Male,,14,Vz,,,5.67,l/kg,mean,SD,0.2,,,,,single-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,461,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Maternal,Trimester 3 (T3),,10,AUC,0-175,minutes (min),285,ng/ml*h,mean,SD,28.6,,,,,repeated-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,462,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Adult,Nonpregnant,,9,AUC,0-175,minutes (min),283,ng/ml*h,mean,SD,19.3,,,,,repeated-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,463,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Maternal,Trimester 3 (T3),,10,Cmax-ss,,,144,ng/ml,mean,,,,,,,repeated-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,464,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Adult,Nonpregnant,,9,Cmax-ss,,,138,ng/ml,mean,,,,,,,repeated-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,465,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Maternal,Trimester 3 (T3),,10,Cmin-ss,,,111,ng/ml,mean,,,,,,,repeated-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,466,2025-12-02T15:56:56.518041
2744067.0,Meptazinol,meptazinol,plasma,Adult,Nonpregnant,,9,Cmin-ss,,,118,ng/ml,mean,,,,,,,repeated-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,467,2025-12-02T15:56:56.518041
2800981.0,Morphine ,morphine hydrochloride,breast milk/plasma,maternal,lactation,,5,milk-to-plasma ratio,,,2.45,ng/ml,mean,SD,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,468,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,t1/2beta,,,102.8,min,mean,SD,66.6,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,469,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,Vc,,,8.696,l,mean,SD,2.782,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,470,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,Vc,,,0.134,l/kg,mean,SD,0.036,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,471,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,Vdbeta,,,61.948,l,mean,SD,39.668,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,472,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,Vdbeta,,,0.953,l/kg,mean,SD,0.583,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,473,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,Vdss,,,34.923,l,mean,SD,11.293,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,474,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,Vdss,,,0.541,l/kg,mean,SD,0.155,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,475,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,Clp,,,6.481,ml/min/kg,mean,SD,0.853,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,476,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,k10,,,0.0501,/min,mean,SD,0.0098,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,477,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,mean response time (MRT),,,91.5,min,mean,SD,28.1,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,478,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,NC-Vdss,,,40.928,l,mean,SD,12.973,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,479,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,NC-Vdss,,,0.635,l/kg,mean,SD,0.181,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,480,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,NC-Clp,,,6.993,ml/min/kg,mean,SD,0.872,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,481,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,fb,,,85.21,,mean,SD,3.54,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,482,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,fb/fu,,,6,,mean,SD,1.47,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,483,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,alpha1-AGP,,,42.23,,mean,SD,5.18,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,484,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,Concentration,,,79.1,ng/ml,mean,SD,22.5,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,485,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,umbilical vein,maternal to fetal,delivery,,5,Concentration,,,24.6,ng/ml,mean,SD,8.7,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,486,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,umbilical vein,maternal to fetal,delivery,,5,Fetal:maternal ratio,,,0.31,,mean,SD,0.08,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,487,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,umbilical vein,maternal to fetal,delivery,,5,fb,,,71.33,,mean,SD,6.93,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,488,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,umbilical vein,maternal to fetal,delivery,,5,fb/fu,,,2.61,,mean,SD,0.78,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,489,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,umbilical vein,maternal to fetal,delivery,,5,alpha1-AGP,,,22.03,mg/100ml,mean,SD,7.56,,,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,490,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,fb,,,90.01,,mean,SD,1.45,,,,,Group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,491,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,fb/fu,,,9.2,,mean,SD,1.67,,,,,Group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,492,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,alpha1-AGP,,,55.1,mg/100ml,mean,SD,12.97,,,,,Group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,493,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Maternal,term,,5,Concentration,,,33,ng/ml,mean,SD,10.4,,,,,Group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,494,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,umbilical vein,maternal to fetal,delivery,,5,Concentration,,,9.5,ng/ml,mean,SD,4.8,,,,,Group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,495,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,umbilical vein,maternal to fetal,delivery,,5,Fetal:maternal ratio,,,0.28,,mean,SD,0.06,,,,,Group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,496,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,umbilical vein,maternal to fetal,delivery,,5,fb,,,64.68,,mean,SD,5.41,,,,,Group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,497,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,umbilical vein,maternal to fetal,delivery,,5,fb/fu,,,1.89,,mean,SD,0.45,,,,,Group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,498,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,umbilical vein,maternal to fetal,delivery,,5,alpha1-AGP,,,21.64,mg/100ml,mean,SD,6.95,,,,,Group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,499,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,t1/2beta,,,103.5,min,mean,SD,49.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,500,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,Vc,,,9.65,l,mean,SD,2.107,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,501,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,Vc,,,0.169,l/kg,mean,SD,0.025,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,502,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,Vdbeta,,,51.432,l,mean,SD,19.788,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,503,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,Vdbeta,,,0.891,l/kg,mean,SD,0.34,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,504,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,Vdss,,,31.67,l,mean,SD,10.125,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,505,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,Vdss,,,0.543,l/kg,mean,SD,0.121,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,506,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,Clp,,,6.584,ml/min/kg,mean,SD,2.302,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,507,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,k10,,,0.0393,/min,mean,SD,0.0146,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,508,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,mean response time (MRT),,,103.2,min,mean,SD,66.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,509,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,NC-Vdss,,,35.52,l,mean,SD,11.207,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,510,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,NC-Vdss,,,0.611,l/kg,mean,SD,0.148,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,511,2025-12-02T15:56:56.518041
2876662.0,Alfentanil,alfentanil,plasma,Adult,nonpregnant,,5,NC-Clp,,,7.089,ml/min/kg,mean,SD,2.546,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,512,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,neonate,,,9,Vdss,,,4.15,L/kg,mean,SD,1.01,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,513,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,neonate,,,9,elimation half-life,,,737,min,mean,SD,346,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,514,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,neonate,,,9,clearance,,,6.7,mg/kg/min,mean,SD,6.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,515,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,infant,,,7,Vdss,,,3.09,L/kg,mean,SD,0.95,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,516,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,infant,,,7,elimation half-life,,,214,min,mean,SD,41,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,517,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,infant,,,7,clearance,,,18.1,mg/kg/min,mean,SD,2.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,518,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,child,,,7,Vdss,,,2.73,L/kg,mean,SD,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,519,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,child,,,7,elimation half-life,,,140,min,mean,SD,30,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,520,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,child,,,7,clearance,,,16.9,mg/kg/min,mean,SD,3.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,521,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,adolescent,,,5,Vdss,,,2.75,L/kg,mean,SD,0.53,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,522,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,adolescent,,,5,elimation half-life,,,209,min,mean,SD,23,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,523,2025-12-02T15:56:56.518041
2959170.0,Sufentanil,Sufentanil,blood,adolescent,,,5,clearance,,,13.1,mg/kg/min,mean,SD,3.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,524,2025-12-02T15:56:56.518041
2964213.0,sufentanil,sufentanil,blood,Adolescent,,,6,Vd180,180,min,1.65,L/kg,mean,SD,0.6,,,,,at 180 minutes after infusion; control patients with normal renal futiction who were undergoing other surgical procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,525,2025-12-02T15:56:56.518041
2964213.0,sufentanil,sufentanil,blood,Adolescent,,,6,redistribution phase half-life,,,2.85,min,mean,SD,1.7,,,,,control patients with normal renal futiction who were undergoing other surgical procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,526,2025-12-02T15:56:56.518041
2964213.0,sufentanil,sufentanil,blood,Adolescent,,,6,elimination half-life,180,min,89.7,min,mean,SD,15.7,,,,,at 180 minutes after infusion; control patients with normal renal futiction who were undergoing other surgical procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,527,2025-12-02T15:56:56.518041
2964213.0,sufentanil,sufentanil,blood,Adolescent,,,6,clearance,,,16.4,ml/kg/min,mean,SD,6.1,,,,,control patients with normal renal futiction who were undergoing other surgical procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,528,2025-12-02T15:56:56.518041
2964213.0,sufentanil,sufentanil,blood,Adolescent,,,6,Vd180,180,min,1.28,L/kg,mean,SD,0.62,,,,,at 180 minutes after infusion; patients undergoing renal transplantation,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,529,2025-12-02T15:56:56.518041
2964213.0,sufentanil,sufentanil,blood,Adolescent,,,6,redistribution phase half-life,,,2.5,min,mean,SD,0.73,,,,,patients undergoing renal transplantation,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,530,2025-12-02T15:56:56.518041
2964213.0,sufentanil,sufentanil,blood,Adolescent,,,6,elimination half-life,180,min,76,min,mean,SD,32.8,,,,,at 180 minutes after infusion; patients undergoing renal transplantation,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,531,2025-12-02T15:56:56.518041
2964213.0,sufentanil,sufentanil,blood,Adolescent,,,6,clearance,,,12.8,ml/kg/min,mean,SD,12,,,,,patients undergoing renal transplantation,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,532,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,infants,,,6,concentration at extubation,,,42,ng/ml,mean,SD,17,,,,<0.05,no statistically significant group differences were noted,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,533,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,infants,,,6,CL,,,8.2,ml/kg/min,mean,SD,2.2,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,534,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,infants,,,6,Vss,,,0.48,l/kg,mean,SD,0.12,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,535,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,infants,,,6,distribution t1/2,,,4,min,mean,SD,1.3,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,536,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,infants,,,6,Elimination t1/2,,,69,min,mean,SD,25,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,537,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,infants,,,6,concentration before CPB,,,,ng/ml,,,,range,65,210,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,538,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,infants,,,6,concentration during CPB,,,,ng/ml,,,,range,40,140,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,539,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,infants,,,6,concentration after CPB,,,,ng/ml,,,,range,86,150,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,540,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,children,,,5,concentration at extubation,,,58,ng/ml,mean,SD,11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,541,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,children,,,5,CL,,,6.3,ml/kg/min,mean,SD,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,542,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,children,,,5,Vss,,,0.31,l/kg,mean,SD,0.08,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,543,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,children,,,5,distribution t1/2,,,7.4,min,mean,SD,3.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,544,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,children,,,5,Elimination t1/2,,,62,min,mean,SD,9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,545,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,children,,,5,concentration before CPB,,,,ng/ml,,,,range,60,250,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,546,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,children,,,5,concentration during CPB,,,,ng/ml,,,,range,90,230,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,547,2025-12-02T15:56:56.518041
2979128.0,alfentanil,alfentanil,plasma,children,,,5,concentration after CPB,,,,ng/ml,,,,range,100,170,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,548,2025-12-02T15:56:56.518041
3098137.0,morphine,morphine,blood,child,,,7,Tmax,,,10.3,min,mean,SD,0.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,549,2025-12-02T15:56:56.518041
3098137.0,morphine,morphine,blood,child,,,7,Cmax,,,26.7,L/kg,mean,SD,9.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,550,2025-12-02T15:56:56.518041
3098137.0,morphine,morphine,blood,child,,,7,elimination half-life,,,73.8,min,mean,SD,41.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,551,2025-12-02T15:56:56.518041
3098137.0,morphine,morphine,blood,child,,,7,apparent volume of distribution,,,2.94,L/kg,mean,SD,0.93,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,552,2025-12-02T15:56:56.518041
3098137.0,morphine,morphine,blood,child,,,7,total body clearance,,,28.3,ml/min/kg,mean,SD,3.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,553,2025-12-02T15:56:56.518041
3098137.0,morphine,morphine,blood,child,,,7,AUC,,,1371,ng/min/ml,mean,SD,148,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,554,2025-12-02T15:56:56.518041
3120765.0,alfentanil ,alfentanil ,blood,child,,,20,elimination half-life,,,63,min,mean,SD,24,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,555,2025-12-02T15:56:56.518041
3120765.0,alfentanil ,alfentanil ,blood,child,,,20,Cl,,,11.1,ml/min/kg,mean,SD,3.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,556,2025-12-02T15:56:56.518041
3120765.0,alfentanil ,alfentanil ,blood,child,,,20,Vd,,,1.03,L/kg,mean,SD,0.71,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,557,2025-12-02T15:56:56.518041
3120765.0,alfentanil ,alfentanil ,blood,child,,,20,free fraction,,,11.5,%,mean,SD,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,558,2025-12-02T15:56:56.518041
3214378.0,Bupivacaine,Bupivacaine,plasma,maternal,delivery,,18,Concentration,,,0.15,mg/l,mean,SD,0.09,range,0,0.35,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,559,2025-12-02T15:56:56.518041
3214378.0,Bupivacaine,Bupivacaine,umbilical vein blood,maternal,delivery,,37,Concentration,,,0.05,mg/l,mean,SD,0.06,range,0,0.29,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,560,2025-12-02T15:56:56.518041
3214378.0,Bupivacaine,Bupivacaine,umbilical artery blood,maternal,delivery,,36,Concentration,,,0.03,mg/l,mean,SD,0.03,range,0,0.12,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,561,2025-12-02T15:56:56.518041
3214378.0,Bupivacaine,Bupivacaine,umbilical vein/maternal plasma,fetal,delivery,,36,fetal:maternal ratio,,,0.3,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,562,2025-12-02T15:56:56.518041
3214378.0,Bupivacaine,Bupivacaine,umbilival vein/artery,fetal,delivery,,36,cord concentration ratio,,,1.7,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,563,2025-12-02T15:56:56.518041
3214378.0,meperidine,meperidine,plasma,maternal,delivery,,16,Concentration,,,0.16,mg/l,mean,SD,0.07,range,0.09,0.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,564,2025-12-02T15:56:56.518041
3214378.0,meperidine,meperidine,umbilical vein blood,maternal,delivery,,48,Concentration,,,0.12,mg/l,mean,SD,0.05,range,0.03,0.24,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,565,2025-12-02T15:56:56.518041
3214378.0,meperidine,meperidine,umbilical artery blood,maternal,delivery,,45,Concentration,,,0.11,mg/l,mean,SD,0.05,range,0.03,0.25,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,566,2025-12-02T15:56:56.518041
3214378.0,meperidine,meperidine,umbilical vein/maternal plasma,fetal,delivery,,45,fetal:maternal ratio,,,0.7,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,567,2025-12-02T15:56:56.518041
3214378.0,meperidine,meperidine,umbilival vein/artery,fetal,delivery,,45,cord concentration ratio,,,1,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,568,2025-12-02T15:56:56.518041
3214378.0,meperidine,Normeperidine,plasma,maternal,delivery,,4,Concentration,,,0.027,mg/l,mean,,,range,0.013,0.039,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,569,2025-12-02T15:56:56.518041
3377945.0,meperidine ,meperidine ,blood,child,,,10,AUC240,240,min,3769,nmol/L h,mean,SD,96,,,,,IV administration; at 240 min after the administration of meperidine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,570,2025-12-02T15:56:56.518041
3377945.0,meperidine ,meperidine ,blood,child,,,10,Cmax,,,2800,nmol/L ,mean,SD,462,,,,,IV administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,571,2025-12-02T15:56:56.518041
3377945.0,meperidine ,meperidine ,blood,child,,,10,Tmax,,,5,min,mean,SD,1,,,,,IV administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,572,2025-12-02T15:56:56.518041
3377945.0,meperidine ,Normeperidine,blood,child,,,10,Cmax,,,137,nmol/L ,mean,SD,60,,,,,IV administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,573,2025-12-02T15:56:56.518041
3377945.0,meperidine ,Normeperidine,blood,child,,,10,Tmax,,,90,min,mean,SD,17,,,,,IV administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,574,2025-12-02T15:56:56.518041
3377945.0,meperidine ,meperidine ,blood,child,,,6,AUC240,240,min,3951,nmol/L h,mean,SD,110,,,,,IM administration; at 240 min after the administration of meperidine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,575,2025-12-02T15:56:56.518041
3377945.0,meperidine ,meperidine ,blood,child,,,6,Cmax,,,1609,nmol/L ,mean,SD,367,,,,,IM administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,576,2025-12-02T15:56:56.518041
3377945.0,meperidine ,meperidine ,blood,child,,,6,Tmax,,,10,min,mean,SD,2,,,,,IM administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,577,2025-12-02T15:56:56.518041
3377945.0,meperidine ,Normeperidine,blood,child,,,6,Cmax,,,103,nmol/L ,mean,SD,32,,,,,IM administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,578,2025-12-02T15:56:56.518041
3377945.0,meperidine ,Normeperidine,blood,child,,,6,Tmax,,,120,min,mean,SD,23,,,,,IM administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,579,2025-12-02T15:56:56.518041
3377945.0,meperidine ,meperidine ,blood,child,,,9,AUC240,240,min,1327,nmol/L h,mean,SD,667,,,,,Rectal administration; at 240 min after the administration of meperidine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,580,2025-12-02T15:56:56.518041
3377945.0,meperidine ,meperidine ,blood,child,,,9,Cmax,,,531,nmol/L ,mean,SD,179,,,,,Rectal administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,581,2025-12-02T15:56:56.518041
3377945.0,meperidine ,meperidine ,blood,child,,,9,Tmax,,,60,min,mean,SD,10,,,,,Rectal administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,582,2025-12-02T15:56:56.518041
3377945.0,meperidine ,Normeperidine,blood,child,,,9,Cmax,,,135,nmol/L ,mean,SD,65,,,,,Rectal administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,583,2025-12-02T15:56:56.518041
3377945.0,meperidine ,Normeperidine,blood,child,,,9,Tmax,,,180,min,mean,SD,25,,,,,Rectal administration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,584,2025-12-02T15:56:56.518041
3609115.0,fentanyl,Fentanyl,plasma,children/adolescent,,,18,concentration,5,min,6.45,ng/ml,mean,SD,0.74,,,,>0.1,times are after hyopthermia initiation,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,585,2025-12-02T15:56:56.518041
3609115.0,fentanyl,Fentanyl,plasma,children/adolescent,,,18,concentration,60-80,min,5.5,ng/ml,mean,SD,1.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,586,2025-12-02T15:56:56.518041
3609115.0,fentanyl,Fentanyl,plasma,children/adolescent,,,18,concentration,100-140,min,5.26,ng/ml,mean,SD,0.18,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,587,2025-12-02T15:56:56.518041
3609434.0,morphine,morphine,blood,maternal,labor,,12,plasma concentration ,,,1.6,ng/ml,,,,range,0.5,2.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,588,2025-12-02T15:56:56.518041
3609434.0,morphine,morphine,blood,fetal,,,12,plasma concentration ,,,1.5,ng/ml,mean,,,range,0.5,3.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,589,2025-12-02T15:56:56.518041
3670879.0,Morphine,Morphine,plasma,pediatric ,,,10,Clearance,,,24,ml/min/kg,mean,SD,7,range,9.9,36.7,,Mucositis pain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,590,2025-12-02T15:56:56.518041
3670879.0,Morphine,Morphine,plasma,pediatric ,,,11,Clearance,,,22,ml/min/kg,mean,SD,6,range,9.9,36.7,,Tumor-related pain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,591,2025-12-02T15:56:56.518041
3670879.0,Morphine,Morphine,plasma,pediatric ,,,21,t1/2,,,2.4,hours,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,592,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,10,concentration,30,mins,38.7,ng/ml,mean,SD,14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,593,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,9,concentration,30,mins,30.6,ng/ml,mean,SD,12.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,594,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,10,concentration,90,mins,27.2,ng/ml,mean,SD,8.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,595,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,9,concentration,90,mins,25.2,ng/ml,mean,SD,4.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,596,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,19,t1/2,,,102,min,,,85,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,597,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,19,t1/2,,,10.2,min,,,9.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,598,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,19,total body clearance,,,13.3,ml/kg/min,,,6.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,599,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,19,Vss,,,1203,ml/kg/min,,,777,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,600,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,8,Vss/age,,,0.85,,r,,,,,,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,601,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,8,Vss/PO2,,,0.76,,r,,,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,602,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,8,TBC/age,,,0.73,,r,,,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,603,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,8,Vss/surface area,,,0.89,,r,,,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,604,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,8,TBC/surface area,,,0.62,,r,,,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,605,2025-12-02T15:56:56.518041
3709338.0,fentanyl,Fentanyl,plasma,infants/children/adoelscents,,,8,PO2/age,,,0.85,,r,,,,,,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,606,2025-12-02T15:56:56.518041
3740151.0,nalbuphine,nalbuphine,maternal blood sample,pregnant,during labor,,6,central volume of distribution,,,409.5,ml/kg,mean,SEM,105.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,607,2025-12-02T15:56:56.518041
3740151.0,nalbuphine,nalbuphine,maternal blood sample,pregnant,during labor,,6,steady-state volume of distribution,,,2031.9,ml/kg,mean,SEM,172.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,608,2025-12-02T15:56:56.518041
3740151.0,nalbuphine,nalbuphine,maternal blood sample,pregnant,during labor,,6,rate of transfer from the central to the peripheral compartment,,,0.265,l/min,mean,SEM,0.118,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,609,2025-12-02T15:56:56.518041
3740151.0,nalbuphine,nalbuphine,maternal blood sample,pregnant,during labor,,6,rate of transfer from the peripheral to the central compartment,,,0.044,l/min,mean,SEM,0.007,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,610,2025-12-02T15:56:56.518041
3740151.0,nalbuphine,nalbuphine,maternal blood sample,pregnant,during labor,,6,rate of elimination from the central compartment,,,0.042,l/min,mean,SEM,0.011,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,611,2025-12-02T15:56:56.518041
3740151.0,nalbuphine,nalbuphine,maternal blood sample,pregnant,during labor,,6,exponent of the biexponential curve,,,0.345,l/min,mean,SEM,0.129,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,612,2025-12-02T15:56:56.518041
3740151.0,nalbuphine,nalbuphine,maternal blood sample,pregnant,during labor,,6,elimination half-life,,,141.4,min,mean,SEM,23.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,613,2025-12-02T15:56:56.518041
3740151.0,nalbuphine,nalbuphine,maternal blood sample,pregnant,during labor,,6,total body clearance,,,12.52,ml/min/kg,mean,SEM,1.76,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,614,2025-12-02T15:56:56.518041
3740151.0,nalbuphine,nalbuphine,maternal blood sample,pregnant,during labor,,6,AUC(zero to infinity),,,369,ng*hr/ml,mean,SEM,62,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,615,2025-12-02T15:56:56.518041
3740151.0,nalbuphine,nalbuphine,maternal blood sample,pregnant,during labor,,6,maternal concentration,1-3,minutes,297,ng/ml,mean,SEM,441,range,197,459,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,616,2025-12-02T15:56:56.518041
3740151.0,nalbuphine,nalbuphine,maternal blood sample,pregnant,during labor,,6,umbilical cord concentration,180-582,minutes,na,ng/ml,,,,range,4.2,46,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,617,2025-12-02T15:56:56.518041
3813075.0,morphine,morphine,blood,newborn,,,6,clearance,,,6.29,ml/kg/min,mean,SD,2.19,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,618,2025-12-02T15:56:56.518041
3813075.0,morphine,morphine,blood,newborn,,,5,volume of distribution,,,3.38,L/kg,mean,SD,0.99,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,619,2025-12-02T15:56:56.518041
3813075.0,morphine,morphine,blood,newborn,,,6,elimination half-life,,,6.81,h,mean,SD,1.64,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,620,2025-12-02T15:56:56.518041
3813075.0,morphine,morphine,blood,infant,,,3,clearance,,,23.8,ml/kg/min,mean,SD,13.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,621,2025-12-02T15:56:56.518041
3813075.0,morphine,morphine,blood,infant,,,2,volume of distribution,,,5.15,L/kg,mean,SD,2.63,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,622,2025-12-02T15:56:56.518041
3813075.0,morphine,morphine,blood,infant,,,3,elimination half-life,,,3.91,h,mean,SD,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,623,2025-12-02T15:56:56.518041
3840338.0,fentanyl,Fentanyl,plasma,infants,,,9,concentration,30,min,10.6,ng/ml,mean,SD,1.9,range,7.7,13.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,624,2025-12-02T15:56:56.518041
3840338.0,fentanyl,Fentanyl,plasma,infants,,,9,concentration,2,hours,9.6,ng/ml,mean,SD,1.6,range,6.6,11.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,625,2025-12-02T15:56:56.518041
3840338.0,fentanyl,Fentanyl,plasma,infants,,,9,t1/2,,,17.7,hours,mean,SD,9.3,range,6,32,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,626,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,14,Vc,,,1.45,L/kg,mean,SD,0.34,,,,,combination,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,627,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,14,Vdss,,,5.1,L/kg,mean,SD,1,,,,,combination,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,628,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,14,total body clearance,,,17.94,ml/kg/min,mean,SD,4.38,,,,,combination,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,629,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,14,terminal elimation half-life,,,317,min,mean,SD,70,,,,,combination,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,630,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,4,Vc,,,1.58,L/kg,mean,SD,0.38,,,,,Group I patients underwent repair of myelomeningocele,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,631,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,4,Vdss,,,4.66,L/kg,mean,SD,1.74,,,,,Group I patients underwent repair of myelomeningocele,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,632,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,4,total body clearance,,,28,ml/kg/min,mean,SD,11,,,,,Group I patients underwent repair of myelomeningocele,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,633,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,4,terminal elimation half-life,,,188,min,mean,SD,85,,,,,Group I patients underwent repair of myelomeningocele,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,634,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,4,Vc,,,2.2,L/kg,mean,SD,1,,,,,groups II underwent thoracic procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,635,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,4,Vdss,,,5.87,L/kg,mean,SD,2.65,,,,,groups II underwent thoracic procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,636,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,4,total body clearance,,,21.43,ml/kg/min,mean,SD,9.15,,,,,groups II underwent thoracic procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,637,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,4,terminal elimation half-life,,,213,min,mean,SD,37,,,,,groups II underwent thoracic procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,638,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,6,Vc,,,0.85,L/kg,mean,SD,0.32,,,,,groups III abdominal procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,639,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,6,Vdss,,,4.88,L/kg,mean,SD,1.42,,,,,groups III abdominal procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,640,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,6,total body clearance,,,9,ml/kg/min,mean,SD,1,,,,,groups III abdominal procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,641,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,6,terminal elimation half-life,,,473,min,mean,SD,132,,,,,groups III abdominal procedures,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,642,2025-12-02T15:56:56.518041
3954090.0,Fentanyl,Fentanyl,blood,neonate,,,7,extent of rebound ,,,3.5,ng/ml,mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,643,2025-12-02T15:56:56.518041
3970110.0,Meperidine,meperidine,Plasma,Neonate,Postpartum (PP),,5,t1/2,,,13.24,hours (h),mean,SD,2.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,644,2025-12-02T15:56:56.518041
3970110.0,Meperidine,meperidine,umbilical vein,Fetal,delivery,,11,Concentration,,,97.81,ng/ml,mean,SD,53.8,range,23,225.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,645,2025-12-02T15:56:56.518041
3970110.0,Meperidine,meperidine,umbilical artery,Fetal,delivery,,5,Concentration,,,94.35,ng/ml,mean,SD,32.94,range,74,153,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,646,2025-12-02T15:56:56.518041
3970110.0,Meperidine,meperidine,umbilical cord,Fetal,delivery,,5,UA/UV ratio,,,1.08,,mean,SD,0.15,range,0.84,1.22,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,647,2025-12-02T15:56:56.518041
3970110.0,Meperidine,meperidine,umbilical vein/maternal plasma,Fetal,delivery,,11,Fetal:maternal ratio,,,0.73,,mean,SD,0.28,range,0.31,1.16,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,648,2025-12-02T15:56:56.518041
3970110.0,Meperidine,normeperidine,Plasma,Neonate,Postpartum (PP),,3,t1/2,,,62.63,hours (h),mean,SD,29.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,649,2025-12-02T15:56:56.518041
3970110.0,Meperidine,normeperidine,umbilical vein,Fetal,delivery,,11,Concentration,,,27.91,ng/ml,mean,SD,17.62,range,8.1,70.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,650,2025-12-02T15:56:56.518041
3970110.0,Meperidine,normeperidine,umbilical artery,Fetal,delivery,,5,Concentration,,,23.59,ng/ml,mean,SD,19.16,range,8.1,56.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,651,2025-12-02T15:56:56.518041
3970110.0,Meperidine,normeperidine,umbilical cord,Fetal,delivery,,5,UA/UV ratio,,,0.99,,mean,SD,0.45,range,0.59,1.76,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,652,2025-12-02T15:56:56.518041
3970110.0,Meperidine,normeperidine,umbilical vein/maternal plasma,Fetal,delivery,,11,Fetal:maternal ratio,,,0.84,,mean,SD,0.15,range,0.77,1.05,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,653,2025-12-02T15:56:56.518041
3970110.0,Meperidine,normeperidine,umbilical vein,Fetal,delivery,,11,metabolite:drug ratio,,,0.37,,mean,SD,0.38,range,0.12,1.43,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,654,2025-12-02T15:56:56.518041
3970110.0,Meperidine,normeperidine,umbilical artery,Fetal,delivery,,11,metabolite:drug ratio,,,0.23,,mean,SD,0.11,range,0.1,0.37,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,655,2025-12-02T15:56:56.518041
3970110.0,Meperidine,meperidine,urine,neonate,Postpartum (PP),,3,fe,,,0.24,% dose,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,656,2025-12-02T15:56:56.518041
3970110.0,Meperidine,normeperidine,urine,neonate,Postpartum (PP),,3,fm,,,0.11,% dose,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,657,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 1 - 27 weeks gestation,,8,Absolute predose concentration,,,35,ng/ml,mean,SD,15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,658,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 2 - 37 weeks gestation,,9,Absolute predose concentration,,,34,ng/ml,mean,SD,14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,659,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 3 - 2 weeks gestation,,9,Absolute predose concentration,,,70,ng/ml,mean,SD,26,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,660,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 4 - 8 weeks gestation,,8,Absolute predose concentration,,,94,ng/ml,mean,SD,39,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,661,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 1 - 27 weeks gestation,,8,Predose concentration normaized for weight-adjusted dose during Phase 1,,,35,ng/ml,mean,SD,15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,662,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 2 - 37 weeks gestation,,9,Predose concentration normaized for weight-adjusted dose during Phase 2,,,58,ng/ml,mean,SD,57,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,663,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 3 - 2 weeks gestation,,9,Predose concentration normaized for weight-adjusted dose during Phase 3,,,93,ng/ml,mean,SD,62,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,664,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 4 - 8 weeks gestation,,8,Predose concentration normaized for weight-adjusted dose during Phase 4,,,102,ng/ml,mean,SD,61,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,665,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 1 - 27 weeks gestation,,8,Time to peak concentration,,,2,hours,mean,SD,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,666,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 2 - 37 weeks gestation,,9,Time to peak concentration,,,2.1,hours,mean,SD,1.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,667,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 3 - 2 weeks gestation,,9,Time to peak concentration,,,2.1,hours,mean,SD,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,668,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 4 - 8 weeks gestation,,8,Time to peak concentration,,,2.1,hours,mean,SD,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,669,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 1 - 27 weeks gestation,,8,Absolute total clearance,,,311,ml/min,mean,SD,118,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,670,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 2 - 37 weeks gestation,,9,Absolute total clearance,,,256,ml/min,mean,SD,97,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,671,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 3 - 2 weeks gestation,,9,Absolute total clearance,,,161,ml/min,mean,SD,69,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,672,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 4 - 8 weeks gestation,,8,Absolute total clearance,,,155,ml/min,mean,SD,62,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,673,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 1 - 27 weeks gestation,,8,Weight-adjusted total clearance,,,4.9,ml/min/kg,mean,SD,1.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,674,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 2 - 37 weeks gestation,,9,Weight-adjusted total clearance,,,3.9,ml/min/kg,mean,SD,1.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,675,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 3 - 2 weeks gestation,,9,Weight-adjusted total clearance,,,2.7,ml/min/kg,mean,SD,1.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,676,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 4 - 8 weeks gestation,,8,Weight-adjusted total clearance,,,2.7,ml/min/kg,mean,SD,1.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,677,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 1 - 27 weeks gestation,,8,Absolute unbound clearance,,,1674,ml/min,mean,SD,649,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,678,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 2 - 37 weeks gestation,,9,Absolute unbound clearance,,,1444,ml/min,mean,SD,421,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,679,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 3 - 2 weeks gestation,,9,Absolute unbound clearance,,,882,ml/min,mean,SD,350,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,680,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 4 - 8 weeks gestation,,8,Absolute unbound clearance,,,989,ml/min,mean,SD,343,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,681,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 1 - 27 weeks gestation,,8,Weight-adjusted unbound clearance,,,26.1,ml/min/kg,mean,SD,10.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,682,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 2 - 37 weeks gestation,,9,Weight-adjusted unbound clearance,,,22.1,ml/min/kg,mean,SD,6.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,683,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 3 - 2 weeks gestation,,9,Weight-adjusted unbound clearance,,,14.9,ml/min/kg,mean,SD,6.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,684,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 4 - 8 weeks gestation,,8,Weight-adjusted unbound clearance,,,16.9,ml/min/kg,mean,SD,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,685,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 1 - 27 weeks gestation,,8,Drug unbound,,,21,%,mean,SD,3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,686,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 2 - 37 weeks gestation,,9,Drug unbound,,,19,%,mean,SD,3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,687,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 3 - 2 weeks gestation,,9,Drug unbound,,,18,%,mean,SD,2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,688,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,plasma,Maternal,Phase 4 - 8 weeks gestation,,8,Drug unbound,,,16,%,mean,SD,4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,689,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 1 - 27 weeks gestation,,8,Excretion,,,8,% dose,mean,SD,3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,690,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 2 - 37 weeks gestation,,9,Excretion,,,12,% dose,mean,SD,8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,691,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 3 - 2 weeks gestation,,9,Excretion,,,13,% dose,mean,SD,9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,692,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 4 - 8 weeks gestation,,8,Excretion,,,9,% dose,mean,SD,8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,693,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 1 - 27 weeks gestation,,8,Total renal clearance,,,22,ml/min,mean,SD,8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,694,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 2 - 37 weeks gestation,,9,Total renal clearance,,,21,ml/min,mean,SD,16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,695,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 3 - 2 weeks gestation,,9,Total renal clearance,,,13,ml/min,mean,SD,6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,696,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 4 - 8 weeks gestation,,8,Total renal clearance,,,11,ml/min,mean,SD,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,697,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 1 - 27 weeks gestation,,8,Unbound renal clearance,,,106,ml/min,mean,SD,50,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,698,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 2 - 37 weeks gestation,,9,Unbound renal clearance,,,120,ml/min,mean,SD,13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,699,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 3 - 2 weeks gestation,,9,Unbound renal clearance,,,73,ml/min,mean,SD,38,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,700,2025-12-02T15:56:56.518041
3981450.0,Methadone,Methadone,Urine,Maternal,Phase 4 - 8 weeks gestation,,8,Unbound renal clearance,,,90,ml/min,mean,SD,44,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,701,2025-12-02T15:56:56.518041
3981450.0,Methadone,M1/M2,Urine,Maternal,Phase 1 - 27 weeks gestation,,8,Excretion,,,24,% dose,mean,SD,12,,,,,"M1 is EDDP, M2 is EMDP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,702,2025-12-02T15:56:56.518041
3981450.0,Methadone,M1/M2,Urine,Maternal,Phase 2 - 37 weeks gestation,,9,Excretion,,,24,% dose,mean,SD,10,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,703,2025-12-02T15:56:56.518041
3981450.0,Methadone,M1/M2,Urine,Maternal,Phase 3 - 2 weeks gestation,,9,Excretion,,,23,% dose,mean,SD,15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,704,2025-12-02T15:56:56.518041
3981450.0,Methadone,M1/M2,Urine,Maternal,Phase 4 - 8 weeks gestation,,8,Excretion,,,21,% dose,mean,SD,12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,705,2025-12-02T15:56:56.518041
3981450.0,Methadone,M1/M2,Urine,Maternal,Phase 1 - 27 weeks gestation,,8,Ratio M1+M2:AUC total,,,0.3,% dose,mean,SD,0.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,706,2025-12-02T15:56:56.518041
3981450.0,Methadone,M1/M2,Urine,Maternal,Phase 2 - 37 weeks gestation,,9,Ratio M1+M2:AUC total,,,0.24,% dose,mean,SD,0.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,707,2025-12-02T15:56:56.518041
3981450.0,Methadone,M1/M2,Urine,Maternal,Phase 3 - 2 weeks gestation,,9,Ratio M1+M2:AUC total,,,0.14,% dose,mean,SD,0.11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,708,2025-12-02T15:56:56.518041
3981450.0,Methadone,M1/M2,Urine,Maternal,Phase 4 - 8 weeks gestation,,8,Ratio M1+M2:AUC total,,,0.1,% dose,mean,SD,0.07,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,709,2025-12-02T15:56:56.518041
3981450.0,Methadone,M3,Urine,Maternal,Phase 1 - 27 weeks gestation,,8,Excretion,,,11,% dose,mean,SD,6,,,,,M3 is 1-alpha-methadol,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,710,2025-12-02T15:56:56.518041
3981450.0,Methadone,M3,Urine,Maternal,Phase 2 - 37 weeks gestation,,9,Excretion,,,7,% dose,mean,SD,11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,711,2025-12-02T15:56:56.518041
3981450.0,Methadone,M3,Urine,Maternal,Phase 3 - 2 weeks gestation,,9,Excretion,,,12,% dose,mean,SD,10,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,712,2025-12-02T15:56:56.518041
3981450.0,Methadone,M3,Urine,Maternal,Phase 4 - 8 weeks gestation,,8,Excretion,,,12,% dose,mean,SD,16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,713,2025-12-02T15:56:56.518041
3981450.0,Methadone,M3,Urine,Maternal,Phase 1 - 27 weeks gestation,,8,Ratio M3:AUC total,,,0.13,% dose,mean,SD,0.12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,714,2025-12-02T15:56:56.518041
3981450.0,Methadone,M3,Urine,Maternal,Phase 2 - 37 weeks gestation,,9,Ratio M3:AUC total,,,0.06,% dose,mean,SD,0.05,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,715,2025-12-02T15:56:56.518041
3981450.0,Methadone,M3,Urine,Maternal,Phase 3 - 2 weeks gestation,,9,Ratio M3:AUC total,,,0.05,% dose,mean,SD,0.04,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,716,2025-12-02T15:56:56.518041
3981450.0,Methadone,M3,Urine,Maternal,Phase 4 - 8 weeks gestation,,8,Ratio M3:AUC total,,,0.04,% dose,mean,SD,0.07,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,717,2025-12-02T15:56:56.518041
3981450.0,Methadone,creatinine,Urine,Maternal,Phase 1 - 27 weeks gestation,,8,Creatinine clearance,,,118,ml/min,mean,SD,9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,718,2025-12-02T15:56:56.518041
3981450.0,Methadone,creatinine,Urine,Maternal,Phase 2 - 37 weeks gestation,,9,Creatinine clearance,,,116,ml/min,mean,SD,16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,719,2025-12-02T15:56:56.518041
3981450.0,Methadone,creatinine,Urine,Maternal,Phase 3 - 2 weeks postpartum,,9,Creatinine clearance,,,108,ml/min,mean,SD,13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,720,2025-12-02T15:56:56.518041
3981450.0,Methadone,creatinine,Urine,Maternal,Phase 4 - 8 weeks postpartum,,8,Creatinine clearance,,,95,ml/min,mean,SD,24,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,721,2025-12-02T15:56:56.518041
3981450.0,Methadone,,Urine,Maternal,Phase 1 - 27 weeks gestation,,8,24-hr urinary pH,,,6.6,ml/min,mean,SD,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,722,2025-12-02T15:56:56.518041
3981450.0,Methadone,,Urine,Maternal,Phase 2 - 37 weeks gestation,,9,24-hr urinary pH,,,6.2,ml/min,mean,SD,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,723,2025-12-02T15:56:56.518041
3981450.0,Methadone,,Urine,Maternal,Phase 3 - 2 weeks postpartum,,9,24-hr urinary pH,,,6.1,ml/min,mean,SD,0.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,724,2025-12-02T15:56:56.518041
3981450.0,Methadone,,Urine,Maternal,Phase 4 - 8 weeks postpartum,,8,24-hr urinary pH,,,5.8,ml/min,mean,SD,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,725,2025-12-02T15:56:56.518041
4072588.0,Morphine,morphine,plasma,children,,,6,AUC0-480,,,29.4,ng/ml*h,mean,SD,2.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,726,2025-12-02T15:56:56.518041
4072588.0,Morphine,morphine,plasma,children,,,6,Cmax,,,6.5,ng/ml,mean,SD,0.9,range,4.3,10,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,727,2025-12-02T15:56:56.518041
4072588.0,Morphine,morphine,plasma,children,,,6,concentration,2,hours,6.4,ng/ml,mean,SD,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,728,2025-12-02T15:56:56.518041
4072588.0,Morphine,morphine,plasma,children,,,6,concentration,240,min,4,ng/ml,mean,SD,0.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,729,2025-12-02T15:56:56.518041
4072588.0,Diazepam,diazepam,plasma,children,,,6,Cmax,30-120,min,0.95,umol/l,mean,SD,0.04,range,0.82,1.11,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,730,2025-12-02T15:56:56.518041
4072588.0,Morphine,morphine,plasma,children,,,11,AUC0-480,,,98.7,ng/ml*h,mean,SD,19.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,731,2025-12-02T15:56:56.518041
4072588.0,Morphine,morphine,plasma,children,,,11,Cmax,,,25.3,ng/ml,mean,SD,5.5,range,9,67.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,732,2025-12-02T15:56:56.518041
4072588.0,Morphine,morphine,plasma,children,,,11,concentration,90,min,22.7,ng/ml,mean,SD,5.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,733,2025-12-02T15:56:56.518041
4072588.0,Morphine,morphine,plasma,children,,,11,concentration,120,min,22.1,ng/ml,mean,SD,4.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,734,2025-12-02T15:56:56.518041
6200819.0,Morphine,morphine,plasma,children/young adult,,,3,Css,,,19.6,ng/ml,median,,,range,12.9,57,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,735,2025-12-02T15:56:56.518041
6489427.0,fentanyl,Fentanyl,serum,infants/children/adolescent,,,19,calculated dilution by pump,,,50.6,%,mean,SD,12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,736,2025-12-02T15:56:56.518041
6489427.0,fentanyl,Fentanyl,serum,infants/children/adolescent,,,19,meaured decrease in concentration,,,74,%,mean,SD,8.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,737,2025-12-02T15:56:56.518041
6653402.0,morphine,morphine,serum,infants/children,,,5,Css,30-60,min,74,ug/l,mean,SD,7.1,range,66.2,77.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,738,2025-12-02T15:56:56.518041
6653402.0,morphine,morphine,serum,infants/children,,,8,Clearance,,,20.5,ml/kg/min,mean,SD,2.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,739,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,cord blood,newborn,delivery,,112,concentration,,,159,ng/ml,mean,CV,65,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,740,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,cord blood,newborn,delivery,,112,concentration,,,98,ng/ml/mg/kg,mean,CV,63,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,741,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,plasma,maternal,delivery,,41,concentration,,,228,ng/ml,mean,CV,95,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,742,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,plasma,maternal,delivery,,41,concentration,,,125,ng/ml/mg/kg,mean,CV,106,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,743,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,capillary plasma,newborn/neonate,,,84,concentration,0.5,hours,114,ng/ml,mean,CV,84,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,744,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,capillary plasma,newborn/neonate,,,84,concentration,1.5,hours,93,ng/ml,mean,CV,104,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,745,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,capillary plasma,newborn/neonate,,,94,concentration,12-24,hours,36,ng/ml,mean,CV,116,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,746,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,capillary plasma,newborn/neonate,,,84,concentration,0.5,hours,71,ng/ml/mg/kg,mean,CV,70,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,747,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,capillary plasma,newborn/neonate,,,84,concentration,1.5,hours,59,ng/ml/mg/kg,mean,CV,89,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,748,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,capillary plasma,newborn/neonate,,,94,concentration,12-24,hours,23,ng/ml/mg/kg,mean,CV,105,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,749,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,cord/maternal venous blood,maternal/newborn,delivery,,40,fetal:maternal ratio,,,0.741,,mean,SD,0.036,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,750,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,plasma,maternal,delivery,,41,estimated clearance,,,7.63,ml/kg/min,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,751,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,plasma,maternal,delivery,,41,estimated Vd,,,3.7,l/kg,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,752,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,plasma,maternal,delivery,,41,estimated t1/2,,,5.59,hours,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,753,2025-12-02T15:56:56.518041
6670461.0,Meperidine,meperidine,capillary plasma,newborn/neonate,,,89,t1/2,,,15.94,,,,0.89,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,754,2025-12-02T15:56:56.518041
6713779.0,Propoxyphene,Propoxyphene,plasma,maternal,Postpartum,,6,t1/2,,,4.4,hours,mean,SD,1.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,755,2025-12-02T15:56:56.518041
6713779.0,Propoxyphene,Propoxyphene,breast milk,maternal,Postpartum,,6,t1/2,,,3.68,hours,mean,SD,3.24,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,756,2025-12-02T15:56:56.518041
6713779.0,Propoxyphene,Norpropoxyphene,breast milk,maternal,Postpartum,,6,t1/2,,,5.49,hours,mean,SD,6.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,757,2025-12-02T15:56:56.518041
6713779.0,Propoxyphene,Propoxyphene,breast milk,maternal,Postpartum,,6,Clearance,,,3.97,ml/h,mean,SD,4.11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,758,2025-12-02T15:56:56.518041
6713779.0,Propoxyphene,Norpropoxyphene,breast milk,maternal,Postpartum,,6,Clearance,,,3.97,ml/h,mean,SD,2.89,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,759,2025-12-02T15:56:56.518041
6713779.0,Propoxyphene,Propoxyphene,breast milk,maternal,Postpartum,,6,amount,,,7.61,ug,mean,SD,5.02,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,760,2025-12-02T15:56:56.518041
6713779.0,Propoxyphene,Norpropoxyphene,breast milk,maternal,Postpartum,,6,amount,,,16.82,ug,mean,SD,10.28,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,761,2025-12-02T15:56:56.518041
6713779.0,Propoxyphene,Propoxyphene,breast milk,maternal,Postpartum,,6,milk:plasma ratio,,,0.417,,mean,SD,0.176,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,762,2025-12-02T15:56:56.518041
6713779.0,Propoxyphene,Norpropoxyphene,breast milk,maternal,Postpartum,,6,milk:plasma ratio,,,0.382,,mean,SD,0.199,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,763,2025-12-02T15:56:56.518041
6713779.0,Propoxyphene,Propoxyphene,plasma,maternal,Postpartum,,6,metabolite:drug ratio,,,2.69,,mean,SD,0.48,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,764,2025-12-02T15:56:56.518041
6713779.0,Propoxyphene,Norpropoxyphene,breast milk,maternal,Postpartum,,6,metabolite:drug ratio,,,2.73,,mean,SD,1.86,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,765,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,whole blood,healthy adults,nonpregnant,,6,Ct,,,0.56,ug/ml,mean,SD,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,766,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,whole blood,maternal,pregnancy,,2,Ct,,,0.51,ug/ml,mean,SD,0.07,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,767,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,whole blood,adult patients,nonpregnant,,4,Ct,,,0.51,ug/ml,mean,SD,0.03,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,768,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,whole blood,healthy adults,nonpregnant,,6,fu,,,63,%,mean,SD,9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,769,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,whole blood,maternal,pregnancy,,2,fu,,,74,%,mean,SD,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,770,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,whole blood,adult patients,nonpregnant,,4,fu,,,73.25,%,mean,SD,5.75,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,771,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,plasma,healthy adults,nonpregnant,,6,fu,,,56,%,mean,SD,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,772,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,plasma,maternal,pregnancy,,2,fu,,,64.5,%,mean,SD,4.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,773,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,plasma,adult patients,nonpregnant,,4,fu,,,58,%,mean,SD,2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,774,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,whole blood/plasma,healthy adults,nonpregnant,,6,blood:plasma fu,,,0.9,,mean,SD,0.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,775,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,whole blood/plasma,maternal,pregnancy,,2,blood:plasma fu,,,0.89,,mean,SD,0.12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,776,2025-12-02T15:56:56.518041
6721986.0,Meperidine,meperidine,whole blood/plasma,adult patients,nonpregnant,,4,blood:plasma fu,,,0.82,,mean,SD,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,777,2025-12-02T15:56:56.518041
6893898.0,morphine,morphine,blood,maternal,labor,,20,peak concentration,,,10.6,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,778,2025-12-02T15:56:56.518041
6893898.0,morphine,morphine,blood,newborn,delivery,,20,peak concentration,,,11.8,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,779,2025-12-02T15:56:56.518041
6896151.0,morphine,morphine,plasma,maternal,labor,,25,concentration,85-305,mins,6,ng/ml,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,780,2025-12-02T15:56:56.518041
6933942.0,Noramidopyrine methane-sulfonate sodium,Noramidopyrine methane-sulfonate sodium,blood,maternal,labor,,11,t1/2 beta,,,4.6,h,mean,SD,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,781,2025-12-02T15:56:56.518041
6933942.0,Noramidopyrine methane-sulfonate sodium,Noramidopyrine methane-sulfonate sodium,blood,maternal,stage III,,9,t1/2 beta,,,4.7,h,mean,SD,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,782,2025-12-02T15:56:56.518041
6933942.0,Noramidopyrine methane-sulfonate sodium,Noramidopyrine methane-sulfonate sodium,,adult,nonpregnant,,10,t1/2 beta,,,1.5,h,mean,SD,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,783,2025-12-02T15:56:56.518041
6933942.0,Aminophenazone,Aminophenazone,blood,maternal,labor,,10,t1/2 beta,,,13.6,h,mean,SD,3.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,784,2025-12-02T15:56:56.518041
6933942.0,Aminophenazone,Aminophenazone,blood,maternal,stage III,,na,t1/2 beta,,,na,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,785,2025-12-02T15:56:56.518041
6933942.0,Aminophenazone,Aminophenazone,blood,adult,nonpregnant,,10,t1/2 beta,,,5,h,mean,SD,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,786,2025-12-02T15:56:56.518041
6933942.0,meperidine,meperidine,blood,maternal,labor,,na,t1/2 beta,,,na,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,787,2025-12-02T15:56:56.518041
6933942.0,meperidine,meperidine,blood,maternal,stage III,,8,t1/2 beta,,,4.9,h,mean,SD,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,788,2025-12-02T15:56:56.518041
6933942.0,meperidine,meperidine,blood,adult,nonpregnant,,6,t1/2 beta,,,4.4,h,mean,SD,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,789,2025-12-02T15:56:56.518041
6933942.0,Methaqualone,Methaqualone,blood,maternal,labor,,5,t1/2 beta,,,25,h,mean,SD,19.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,790,2025-12-02T15:56:56.518041
6933942.0,Methaqualone,Methaqualone,blood,maternal,stage III,,10,t1/2 beta,,,4.36,h,mean,SD,0.84,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,791,2025-12-02T15:56:56.518041
6933942.0,Methaqualone,Methaqualone,blood,adult,nonpregnant,,13,t1/2 beta,,,6.18,h,mean,SD,0.92,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,792,2025-12-02T15:56:56.518041
6933942.0,Ampicillin,Ampicillin,blood,maternal,labor,,10,t1/2 beta,,,58.31,min,mean,SD,4.98,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,793,2025-12-02T15:56:56.518041
6933942.0,Ampicillin,Ampicillin,blood,maternal,stage III,,14,t1/2 beta,,,39.22,min,mean,SD,4.27,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,794,2025-12-02T15:56:56.518041
6933942.0,Ampicillin,Ampicillin,blood,adult,nonpregnant,,10,t1/2 beta,,,44.8,min,mean,SD,2.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,795,2025-12-02T15:56:56.518041
6933942.0,Cephalothin,Cephalothin,blood,maternal,labor,,7,t1/2 beta,,,54.45,min,mean,SD,19.73,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,796,2025-12-02T15:56:56.518041
6933942.0,Cephalothin,Cephalothin,blood,maternal,stage III,,10,t1/2 beta,,,50.72,min,mean,SD,9.98,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,797,2025-12-02T15:56:56.518041
6933942.0,Cephalothin,Cephalothin,blood,adult,nonpregnant,,10,t1/2 beta,,,55,min,mean,SD,15.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,798,2025-12-02T15:56:56.518041
6933942.0,Chlorsulfamethin,Chlorsulfamethin,blood,maternal,labor,,na,t1/2 beta,,,na,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,799,2025-12-02T15:56:56.518041
6933942.0,Chlorsulfamethin,Chlorsulfamethin,blood,maternal,stage III,,28,t1/2 beta,,,49,h,mean,SD,2.96,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,800,2025-12-02T15:56:56.518041
6933942.0,Chlorsulfamethin,Chlorsulfamethin,blood,adult,nonpregnant,,29,t1/2 beta,,,57.7,h,mean,SD,6.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,801,2025-12-02T15:56:56.518041
6933942.0,Indocyaninegreen,Indocyaninegreen,blood,maternal,labor,,5,t1/2 beta,,,2.35,h,mean,SD,0.91,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,802,2025-12-02T15:56:56.518041
6933942.0,Indocyaninegreen,Indocyaninegreen,blood,maternal,stage III,,na,t1/2 beta,,,na,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,803,2025-12-02T15:56:56.518041
6933942.0,Indocyaninegreen,Indocyaninegreen,blood,adult,nonpregnant,,6,t1/2 beta,,,0.5,h,mean,SD,0.15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,804,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,T1/2,,,8.3,min,mean,SD,2.8,,,,,intravenous group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,805,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,T1/2,,,157,min,mean,SD,79,,,,,intravenous group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,806,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,na,T1/2ka,,,na,,,,,,,,,intravenous group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,807,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,8,T1/2,,,7.4,min,mean,SD,1.9,,,,,intramuscular group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,808,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,T1/2,,,227,min,mean,SD,106,,,,,intramuscular group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,809,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,8,T1/2ka,,,5,min,mean,SD,2,,,,,intramuscular group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,810,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,T1/2,,,7.3,min,mean,SD,1.9,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,811,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,T1/2,,,188,min,mean,SD,64,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,812,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,T1/2ka,,,3.2,min,mean,SD,0.6,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,813,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,adult,nonpregnant,,8,T1/2,,,10,min,mean,SD,2.8,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,814,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,adult,nonpregnant,,8,T1/2,,,286,min,mean,SD,111,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,815,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,adult,nonpregnant,,8,T1/2ka,,,3.8,min,mean,SD,1.5,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,816,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,8,AUC0-30,0-30,min,17.5,ug/ml*min,mean,SD,2.1,,,,<0.01,intravenous group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,817,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,AUC30-60,30-60,min,10.2,ug/ml*min,mean,SD,2.8,,,,,intravenous group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,818,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,AUC60-90,60-90,min,8.4,ug/ml*min,mean,SD,2.9,,,,,intravenous group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,819,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,AUC90-100,90-100,min,7.2,ug/ml*min,mean,SD,2.4,,,,,intravenous group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,820,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,AUC0-,0-,,96.3,ug/ml*min,mean,SD,43.7,,,,,intravenous group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,821,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,AUC0-30,0-30,min,7.7,ug/ml*min,mean,SD,3.6,,,,<0.01,intramuscular group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,822,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,AUC30-60,30-60,min,7.1,ug/ml*min,mean,SD,2.7,,,,<0.01,intramuscular group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,823,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,AUC60-90,60-90,min,6.1,ug/ml*min,mean,SD,2.2,,,,<0.01,intramuscular group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,824,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,AUC90-100,90-100,min,5.7,ug/ml*min,mean,SD,2,,,,<0.01,intramuscular group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,825,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,AUC0-,0-,,87.9,ug/ml*min,mean,SD,37.8,,,,,intramuscular group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,826,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,10,AUC0-30,0-30,min,14,ug/ml*min,mean,SD,2.2,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,827,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,10,AUC30-60,30-60,min,11.8,ug/ml*min,mean,SD,1.9,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,828,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,10,AUC60-90,60-90,min,9.6,ug/ml*min,mean,SD,1.7,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,829,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,10,AUC90-100,90-100,min,8.4,ug/ml*min,mean,SD,1.7,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,830,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal,labor,,9,AUC0-,0-,,118.6,ug/ml*min,mean,SD,39.7,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,831,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,adult,nonpregnant,,8,AUC0-30,0-30,min,10.7,ug/ml*min,mean,SD,3.2,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,832,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,adult,nonpregnant,,8,AUC30-60,30-60,min,8.4,ug/ml*min,mean,SD,1.9,,,,<0.01,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,833,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,adult,nonpregnant,,8,AUC60-90,60-90,min,6.4,ug/ml*min,mean,SD,1.1,,,,<0.01,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,834,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,adult,nonpregnant,,8,AUC90-100,90-100,min,5.6,ug/ml*min,mean,SD,0.9,,,,<0.01,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,835,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,adult,nonpregnant,,8,AUC0-,0-,,10.6,ug/ml*min,mean,SD,39.9,,,,,epidural group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,836,2025-12-02T15:56:56.518041
7059414.0,meperidine,meperidine,blood,maternal to fetal,,,30,fetal:maternal ratio,,,na,,,,,range,0.3,3.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,837,2025-12-02T15:56:56.518041
7138758.0,Meptazinol,sulphate/glucuronide,urine,Neonate,Delivery,,3,metabolite ratio,,,0.37,,mean,SD,0.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,838,2025-12-02T15:56:56.518041
7138758.0,Meptazinol,sulphate/glucuronide,urine,Adult,Nonpregnant,,4,metabolite ratio,,,0.33,,,,0.12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,839,2025-12-02T15:56:56.518041
7211235.0,meperidine ,meperidine ,blood,maternal,labor,,28,concentration,,,256,ng/ml,mean,,,range,105,535,,at delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,840,2025-12-02T15:56:56.518041
7211235.0,meperidine ,normeperidine ,blood,maternal,labor,,28,concentration,,,13,ng/ml,mean,,,range,0,37,,at delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,841,2025-12-02T15:56:56.518041
7211235.0,meperidine ,meperidine ,Umbilical vein blood,newborn,delivery,,28,concentration,,,164,ng/ml,mean,,,range,69,306,,at delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,842,2025-12-02T15:56:56.518041
7211235.0,meperidine ,normeperidine ,Umbilical vein blood,newborn,delivery,,28,concentration,,,9,ng/ml,mean,,,range,0,36,,at delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,843,2025-12-02T15:56:56.518041
7211235.0,meperidine ,meperidine ,Umbilical artery blood,newborn,delivery,,28,concentration,,,135,ng/ml,mean,,,range,36,251,,at delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,844,2025-12-02T15:56:56.518041
7211235.0,meperidine ,normeperidine ,Umbilical artery blood,newborn,delivery,,28,concentration,,,7,ng/ml,mean,,,range,0,24,,at delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,845,2025-12-02T15:56:56.518041
7211235.0,meperidine ,meperidine ,blood,maternal,labor,,28,concentration,70,min,195,ng/ml,mean,,,range,118,291,,Seventy minutes after delivery a  capillary blood sample was taken from the new- born (heel puncture)  as well as a  maternal  venous sample.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,846,2025-12-02T15:56:56.518041
7211235.0,meperidine ,normeperidine ,blood,maternal,labor,,28,concentration,70,min,21,ng/ml,mean,,,range,4,45,,Seventy minutes after delivery a  capillary blood sample was taken from the new- born (heel puncture)  as well as a  maternal  venous sample.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,847,2025-12-02T15:56:56.518041
7211235.0,meperidine ,meperidine ,capillary blood,newborn,,,28,concentration,70,min,102,ng/ml,mean,,,range,6,179,,Seventy minutes after delivery a  capillary blood sample was taken from the new- born (heel puncture)  as well as a  maternal  venous sample.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,848,2025-12-02T15:56:56.518041
7211235.0,meperidine ,normeperidine ,capillary blood,newborn,,,28,concentration,70,min,9,ng/ml,mean,,,range,0,25,,Seventy minutes after delivery a  capillary blood sample was taken from the new- born (heel puncture)  as well as a  maternal  venous sample.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,849,2025-12-02T15:56:56.518041
7225299.0,meperidine ,meperidine,blood from umbilical artery,neonatal,delivery,,12,concentration,,,213.2,ng/ml,mean,SD,18.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,850,2025-12-02T15:56:56.518041
7225299.0,meperidine ,meperidine,blood from umbilical vein,neonatal,delivery,,12,concentration,,,222,ng/ml,mean,SD,22.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,851,2025-12-02T15:56:56.518041
7225299.0,meperidine ,meperidine,Capillary blood,neonatal,,,12,elimination half-life,,,22.4,hr,mean,SD,4.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,852,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Maternal,Labor,,12,t1/2 alpha,,,4.65,minutes (min),mean,SD,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,853,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Maternal,Labor,,13,t1/2 beta,,,2.53,hours (h),mean,SD,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,854,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Maternal,Labor,,14,KE,,,1.52,hours (h),mean,SD,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,855,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Maternal,Labor,,15,K21,,,1.88,hours (h),mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,856,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Maternal,Labor,,16,V1,,,43,liters (l),mean,SD,17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,857,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Maternal,Labor,,17,V2,,,145,liters (l),mean,SD,63,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,858,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Maternal,Labor,,18,Vd area,,,217,liters (l),mean,SD,90,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,859,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Maternal,Labor,,19,Vdss,,,187,liters (l),mean,SD,74,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,860,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Maternal,Labor,,20,CL,,,1010,ml/min,mean,SD,381,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,861,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Adult,Nonpregnant,,7,t1/2 alpha,,,4.82,minutes (min),mean,SD,3.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,862,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Adult,Nonpregnant,,8,t1/2 beta,,,2.95,hours (h),mean,SD,1.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,863,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Adult,Nonpregnant,,9,KE,,,2.11,hours (h),mean,SD,3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,864,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Adult,Nonpregnant,,10,K21,,,2.5,hours (h),mean,SD,1.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,865,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Adult,Nonpregnant,,11,V1,,,60,liters (l),mean,SD,38,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,866,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Adult,Nonpregnant,,12,V2,,,149,liters (l),mean,SD,43,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,867,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Adult,Nonpregnant,,13,Vd area,,,233,liters (l),mean,SD,64,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,868,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Adult,Nonpregnant,,14,Vdss,,,209,liters (l),mean,SD,59,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,869,2025-12-02T15:56:56.518041
7357807.0,Meperidine,meperidine,Plasma,Adult,Nonpregnant,,15,CL,,,964,ml/min,mean,SD,300,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,870,2025-12-02T15:56:56.518041
7437369.0,meperidine,meperidine,pharyngeal aspirates,newborn,,,13,concentration,,,543,ng/ml,mean,SD,168,,,,<0.05,pharyngeal aspirates vs. in umbilical venous blood,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,871,2025-12-02T15:56:56.518041
7437369.0,meperidine,meperidine,umbilical venous blood,newborn,delivery,,13,concentration,,,256,ng/ml,mean,SD,34,,,,<0.05,pharyngeal aspirates vs. in umbilical arterial blood,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,872,2025-12-02T15:56:56.518041
7437369.0,meperidine,meperidine,umbilical arterial blood,newborn,delivery,,13,concentration,,,197,ng/ml,mean,SD,47,,,,<0.05,umbilical venous blood as compared with umbilical arterial blood,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,873,2025-12-02T15:56:56.518041
7437369.0,meperidine,meperidine,blood & saliva,maternal,labor,,12,saliva: blood meperidine ratios,,,5.49,,mean,SD,0.31,range,2.59,7.71,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,874,2025-12-02T15:56:56.518041
7446613.0,butorphanol,butorphanol,blood/milk,maternal,postpartum,,6,milk:plasma ratio,,,0.7,,mean,,,,,,,received IM butorphanol,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,875,2025-12-02T15:56:56.518041
7446613.0,butorphanol,butorphanol,blood/milk,maternal,postpartum,,6,milk:plasma ratio,,,1.9,,mean,,,,,,,received oral butorphanol,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,876,2025-12-02T15:56:56.518041
7446613.0,butorphanol,butorphanol,maternal/cord blood,maternal,labor,,6,fetal:maternal ratio,,,0.9,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,877,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,blood,maternal,labor,,9,% bound,,,63.3,,mean,SD,6.18,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,878,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,blood,maternal,labor,,9,binding ratio,,,1.79,,mean,SD,0.45,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,879,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,cord blood,neonate,delivery,,9,% bound,,,51.7,,mean,SD,4.53,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,880,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,cord blood,neonate,delivery,,9,binding ratio,,,1.09,,mean,SD,0.21,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,881,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,blood,maternal,labor,,9,concentration of total protein,,,6.26,gm/100 ml,mean,SD,0.78,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,882,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,blood,maternal,labor,,9,concentration of albumin,,,3.56,gm/100 ml,mean,SD,0.36,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,883,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,blood,maternal,labor,,9,concentration of a1-AGP,,,49.7,gm/100 ml,mean,SD,13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,884,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,blood,maternal,labor,,9,concentration of total bilirubin,,,15.7,umole/l,mean,SD,3.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,885,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,cord blood,neonate,delivery,,9,concentration of total protein,,,6.19,gm/100 ml,mean,SD,0.58,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,886,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,cord blood,neonate,delivery,,9,concentration of albumin,,,4.35,gm/100 ml,mean,SD,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,887,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,cord blood,neonate,delivery,,9,concentration of a1-AGP,,,20.1,gm/100 ml,mean,SD,9.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,888,2025-12-02T15:56:56.518041
7471613.0,meperidine,meperidine,cord blood,neonate,delivery,,9,concentration of total bilirubin,,,35.3,umole/l,mean,SD,9.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,889,2025-12-02T15:56:56.518041
7526750.0,alfentanil,alfentanil,placenta,maternal to fetal,,,3,clearance,after 1h 10ng/ml maternal biophase perfusion,,1.44,ml/min,mean,SE,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,890,2025-12-02T15:56:56.518041
7526750.0,alfentanil,alfentanil,placenta,maternal to fetal,,,3,content,after 1h 10ng/ml maternal biophase perfusion,,6.8,ng/g,mean,SE,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,891,2025-12-02T15:56:56.518041
7526750.0,alfentanil,alfentanil,placenta,maternal to fetal,,,3,content,"after 1h 10ng/ml maternal biophase perfusion, 1h perfusion without alfentanil",,1.1,ng/g,mean,SE,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,892,2025-12-02T15:56:56.518041
7526750.0,alfentanil,alfentanil,placenta,fetal to maternal,,,3,clearance,after 1h 10ng/ml fetal biophase perfusion,,1.41,ml/min,mean,SE,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,893,2025-12-02T15:56:56.518041
7526750.0,alfentanil,alfentanil,placenta,fetal to maternal,,,3,content,after 1h 10ng/ml fetal biophase perfusion,,9.9,ng/g,mean,SE,3.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,894,2025-12-02T15:56:56.518041
7526750.0,alfentanil,alfentanil,placenta,fetal to maternal,,,3,content,"after 1h 10ng/ml fetal biophase perfusion, 1h perfusion without alfentanil",,1.2,ng/g,mean,SE,0.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,895,2025-12-02T15:56:56.518041
7526750.0,alfentanil,alfentanil,placenta,maternal to fetal,,,3,clearance,"1h 10ng/ml maternal biophase perfusion, 1h perfusion without alfentanil,/then 1h 10ng/ml maternal biophase perfusion",,1.45,ml/min,mean,SE,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,896,2025-12-02T15:56:56.518041
7526750.0,alfentanil,alfentanil,placenta,maternal to fetal,,,3,clearance,"1h 10ng/ml maternal biophase perfusion, 1h perfusion without alfentanil,/then 1h 1000ng/ml maternal biophase perfusion",,1.3,ml/min,mean,SE,0.11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,897,2025-12-02T15:56:56.518041
7526750.0,alfentanil,alfentanil,placenta,fetal to maternal,,,4,clearance,"1h 10ng/ml fetal biophase perfusion, 1h perfusion without alfentanil,/then 1h fetal biophase 10ng/ml perfusion",,1.32,ml/min,mean,SE,0.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,898,2025-12-02T15:56:56.518041
7526750.0,alfentanil,alfentanil,placenta,maternal to fetal,,,4,clearance,"1h 10ng/ml fetal biophase perfusion, 1h perfusion without alfentanil,/then 1h maternal biophase 10ng/ml perfusion",,1.34,ml/min,mean,SE,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,899,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,13,concentration,0,hours,0,ng/ml,mean,,,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,900,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,13,concentration,0.5,hours,46,ng/ml,mean,SD,46,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,901,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,13,concentration,2,hours,52,ng/ml,mean,SD,56,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,902,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,13,concentration,6,hours,69,ng/ml,mean,SD,42,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,903,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,13,concentration,12,hours,72,ng/ml,mean,SD,40,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,904,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,13,concentration,24,hours,90,ng/ml,mean,SD,52,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,905,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,13,concentration,48,hours,118,ng/ml,mean,SD,39,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,906,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,13,concentration,72,hours,124,ng/ml,mean,SD,58,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,907,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,13,concentration,0,hours,0,ng/ml,mean,,,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,908,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,13,concentration,0.5,hours,5,ng/ml,mean,SD,13,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,909,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,13,concentration,2,hours,118,ng/ml,mean,SD,99,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,910,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,13,concentration,6,hours,290,ng/ml,mean,SD,263,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,911,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,13,concentration,12,hours,534,ng/ml,mean,SD,346,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,912,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,13,concentration,24,hours,800,ng/ml,mean,SD,376,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,913,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,13,concentration,48,hours,733,ng/ml,mean,SD,465,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,914,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,13,concentration,72,hours,646,ng/ml,mean,SD,474,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,915,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,13,concentration,0,hours,0,ng/ml,mean,,,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,916,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,13,concentration,0.5,hours,1,ng/ml,mean,SD,3,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,917,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,13,concentration,2,hours,3,ng/ml,mean,SD,5,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,918,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,13,concentration,6,hours,8,ng/ml,mean,SD,10,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,919,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,13,concentration,12,hours,16,ng/ml,mean,SD,15,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,920,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,13,concentration,24,hours,21,ng/ml,mean,SD,10,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,921,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,13,concentration,48,hours,48,ng/ml,mean,SD,25,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,922,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,13,concentration,72,hours,59,ng/ml,mean,SD,25,,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,923,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,14,concentration,0,hours,0,ng/ml,mean,,,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,924,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,14,concentration,0.5,hours,50,ng/ml,mean,SD,28,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,925,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,14,concentration,2,hours,50,ng/ml,mean,SD,12,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,926,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,14,concentration,6,hours,44,ng/ml,mean,SD,25,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,927,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,14,concentration,12,hours,54,ng/ml,mean,SD,28,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,928,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,14,concentration,24,hours,51,ng/ml,mean,SD,31,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,929,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,14,concentration,48,hours,64,ng/ml,mean,SD,25,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,930,2025-12-02T15:56:56.518041
7552591.0,Morphine ,Morphine ,blood,newborn,,,14,concentration,72,hours,65,ng/ml,mean,SD,40,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,931,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,14,concentration,0,hours,0,ng/ml,mean,,,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,932,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,14,concentration,0.5,hours,16,ng/ml,mean,SD,29,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,933,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,14,concentration,2,hours,211,ng/ml,mean,SD,285,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,934,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,14,concentration,6,hours,281,ng/ml,mean,SD,252,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,935,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,14,concentration,12,hours,414,ng/ml,mean,SD,331,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,936,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,14,concentration,24,hours,647,ng/ml,mean,SD,467,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,937,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,14,concentration,48,hours,547,ng/ml,mean,SD,338,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,938,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-3-glucuronide,blood,newborn,,,14,concentration,72,hours,625,ng/ml,mean,SD,404,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,939,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,14,concentration,0,hours,0,ng/ml,mean,,,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,940,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,14,concentration,0.5,hours,1,ng/ml,mean,SD,3,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,941,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,14,concentration,2,hours,6,ng/ml,mean,SD,9,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,942,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,14,concentration,6,hours,11,ng/ml,mean,SD,11,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,943,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,14,concentration,12,hours,18,ng/ml,mean,SD,12,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,944,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,14,concentration,24,hours,27,ng/ml,mean,SD,13,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,945,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,14,concentration,48,hours,31,ng/ml,mean,SD,23,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,946,2025-12-02T15:56:56.518041
7552591.0,Morphine ,morphine-6-glucuronide ,blood,newborn,,,14,concentration,72,hours,45,ng/ml,mean,SD,37,,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,947,2025-12-02T15:56:56.518041
7574018.0,Bupivacaine,Bupivacaine,maternal vein blood,maternal,labor,,21,Concentration,,,0.5,ug/ml,mean,SD,0.16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,948,2025-12-02T15:56:56.518041
7574018.0,Bupivacaine,Bupivacaine,umbilical vein blood,maternal,labor,,21,Concentration,,,0.15,ug/ml,mean,SD,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,949,2025-12-02T15:56:56.518041
7574018.0,Bupivacaine,Bupivacaine,maternal/umbilical vein blood,maternal,labor,,21,Fetal:maternal ratio,,,0.3,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,950,2025-12-02T15:56:56.518041
7574018.0,Fentanyl,Fentanyl,maternal vein blood,maternal,labor,,21,Concentration,,,0.17,ug/ml,mean,SD,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,951,2025-12-02T15:56:56.518041
7574018.0,Fentanyl,Fentanyl,umbilical vein blood,maternal,labor,,21,Concentration,,,0.16,ug/ml,mean,SD,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,952,2025-12-02T15:56:56.518041
7574018.0,Fentanyl,Fentanyl,maternal/umbilical vein blood,maternal,labor,,21,Fetal:maternal ratio,,,0.94,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,953,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine,bupivacaine,umbilical artery blood,fetal,delivery,,13,Concentration,,,86,ng/ml,mean,SD,19,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,954,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine,bupivacaine,umbilical vein blood,maternal,delivery,,13,Concentration,,,77,ng/ml,mean,SD,19,,,,0.003,p for bupivacaine vs bupivacaine-sufentanil,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,955,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine,bupivacaine,plasma,maternal,delivery,,13,Concentration,,,278,ng/ml,mean,SD,25,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,956,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine,bupivacaine,umbilical vein/maternal plasma,fetal/maternal,delivery,,13,fetal:maternal ratio,,,0.29,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,957,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine- Sufentanil,bupivacaine,umbilical artery blood,fetal,delivery,,9,Concentration,,,137,ng/ml,mean,SD,29,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,958,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine- Sufentanil,bupivacaine,umbilical vein blood,maternal,delivery,,9,Concentration,,,103,ng/ml,mean,SD,11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,959,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine- Sufentanil,bupivacaine,plasma,maternal,delivery,,9,Concentration,,,306,ng/ml,mean,SD,74,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,960,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine- Sufentanil,bupivacaine,umbilical vein/maternal plasma,fetal/maternal,delivery,,9,fetal:maternal ratio,,,0.33,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,961,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine- Fentanyl,bupivacaine,umbilical artery blood,fetal,delivery,,14,Concentration,,,116,ng/ml,mean,SD,47,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,962,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine- Fentanyl,bupivacaine,umbilical vein blood,maternal,delivery,,14,Concentration,,,148,ng/ml,mean,SD,27,,,,0.04,p for bupivaine-fentanyl vs  bupivacaine-sufentanil,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,963,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine- Fentanyl,bupivacaine,plasma,maternal,delivery,,14,Concentration,,,346,ng/ml,mean,SD,61,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,964,2025-12-02T15:56:56.518041
7631952.0,Bupivacaine- Fentanyl,bupivacaine,umbilical vein/maternal plasma,fetal/maternal,delivery,,14,fetal:maternal ratio,,,0.43,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,965,2025-12-02T15:56:56.518041
7631952.0,Fentanyl,fentanyl,umbilical artery blood,fetal,delivery,,9,Concentration,,,0.1,ng/ml,mean,SD,0.07,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,966,2025-12-02T15:56:56.518041
7631952.0,Fentanyl,fentanyl,umbilical vein blood,maternal,delivery,,13,Concentration,,,0.18,ng/ml,mean,SD,0.03,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,967,2025-12-02T15:56:56.518041
7631952.0,Fentanyl,fentanyl,plasma,maternal,delivery,,13,Concentration,,,0.52,ng/ml,mean,SD,0.03,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,968,2025-12-02T15:56:56.518041
7631952.0,Fentanyl,fentanyl,umbilical vein/maternal plasma,fetal/maternal,delivery,,13,fetal:maternal ratio,,,0.37,,,,0.03,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,969,2025-12-02T15:56:56.518041
7631952.0,Sufentanil,sufentanil,umbilical artery blood,fetal,delivery,,5,Concentration,,,0.006,ng/ml,mean,SD,0.006,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,970,2025-12-02T15:56:56.518041
7631952.0,Sufentanil,sufentanil,umbilical vein blood,maternal,delivery,,8,Concentration,,,0.016,ng/ml,mean,SD,0.002,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,971,2025-12-02T15:56:56.518041
7631952.0,Sufentanil,sufentanil,plasma,maternal,delivery,,8,Concentration,,,0.019,ng/ml,mean,SD,0.005,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,972,2025-12-02T15:56:56.518041
7631952.0,Sufentanil,sufentanil,umbilical vein/maternal plasma,fetal/maternal,delivery,,8,fetal:maternal ratio,,,0.81,,,,,,,,0.003,p for sufentanil vs fentanyl,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,973,2025-12-02T15:56:56.518041
7841696.0,morphine,Morphine ,blood,preterm  infants,gestational age 25-32 weeks,,8,Cl,,,2.82,ml/kg/min,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,974,2025-12-02T15:56:56.518041
7841696.0,morphine,Morphine ,blood,preterm  infants,gestational age 25-32 weeks,,8,Vd,,,2366,ml/kg,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,975,2025-12-02T15:56:56.518041
7841696.0,morphine,Morphine ,blood,preterm  infants,gestational age 25-32 weeks,,8,T1/2,,,556,min,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,976,2025-12-02T15:56:56.518041
7841696.0,morphine,Morphine ,blood,term infants,gestational age 37-40 weeks,,5,Cl,,,4.73,ml/kg/min,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,977,2025-12-02T15:56:56.518041
7841696.0,morphine,Morphine ,blood,term infants,gestational age 37-40 weeks,,5,Vd,,,1758,ml/kg,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,978,2025-12-02T15:56:56.518041
7841696.0,morphine,Morphine ,blood,term infants,gestational age 37-40 weeks,,5,T1/2,,,224,min,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,979,2025-12-02T15:56:56.518041
7869211.0,morphine,Morphine ,blood,pediatric ,,,18,Plasma clearance ,,,35.5,ml/min/kg,mean,SD,12.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,980,2025-12-02T15:56:56.518041
7869211.0,morphine,Morphine ,blood,pediatric ,,,6,Plasma clearance ,,,34.4,ml/min/kg,mean,SD,14.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,981,2025-12-02T15:56:56.518041
7869211.0,morphine,Morphine ,blood,pediatric ,,,18,Terminal elimination half-life,,,78.7,min,mean,SD,21.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,982,2025-12-02T15:56:56.518041
7869211.0,morphine,Morphine ,blood,pediatric ,,,6,Terminal elimination half-life,,,77.6,min,mean,SD,19.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,983,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonates,age <1 week,,10,CL,,,6.6,ml/kg/min,mean,SD,4.4,,,,<0.001,p value for difference between age groups,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,984,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonates,age <1 week,,10,Vss,,,1.3,l/kg,mean,SD,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,985,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonates,age <1 week,,10,t1/2,,,8.1,hours,mean,SD,8.1,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,986,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonates,age <1 week,,10,AUClast-,,,22,%,mean,SD,17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,987,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonate/infants,age 1 week - 2 months,,10,CL,,,9,ml/kg/min,mean,SD,3.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,988,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonate/infants,age 1 week - 2 months,,10,Vss,,,1.8,l/kg,mean,SD,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,989,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonate/infants,age 1 week - 2 months,,10,t1/2,,,5.4,hours,mean,SD,3.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,990,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonate/infants,age 1 week - 2 months,,10,AUClast-,,,29,%,mean,SD,11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,991,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,infants,age 2-6 months,,7,CL,,,21.3,ml/kg/min,mean,SD,6.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,992,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,infants,age 2-6 months,,7,Vss,,,2.4,l/kg,mean,SD,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,993,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,infants,age 2-6 months,,7,t1/2,,,2.6,hours,mean,SD,1.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,994,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,infants,age 2-6 months,,7,AUClast-,,,16,%,mean,SD,10,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,995,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonates,age <1 week,,5,CL,,,2.1,ml/kg/min,median,,,range,1.1,6.9,,critically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,996,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonates,age <1 week,,5,Vss,,,1.3,l/kg,median,,,range,1.1,1.4,,critically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,997,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonates,age <1 week,,5,t1/2,,,18.1,hours,median,,,range,3.2,20.5,,critically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,998,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonate/infants,age 1 week - 2 months,,5,CL,,,7.5,ml/kg/min,median,,,range,3.2,12.7,,critically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,999,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonate/infants,age 1 week - 2 months,,5,Vss,,,1.8,l/kg,median,,,range,1,3.5,,critically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1000,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonate/infants,age 1 week - 2 months,,5,t1/2,,,5.1,hours,median,,,range,4.2,12,,critically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1001,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,infants,age 2-6 months,,2,CL,,,20.8,ml/kg/min,median,,,range,17.6,24,,critically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1002,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,infants,age 2-6 months,,2,Vss,,,2,l/kg,median,,,range,1.1,3.3,,critically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1003,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,infants,age 2-6 months,,2,t1/2,,,3.7,hours,median,,,range,1.2,6.1,,critically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1004,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonates,age <1 week,,5,CL,,,9.1,ml/kg/min,median,,,range,5.7,15.9,,noncritically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1005,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonates,age <1 week,,5,Vss,,,1.2,l/kg,median,,,range,0.9,2.4,,noncritically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1006,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonates,age <1 week,,5,t1/2,,,2.5,hours,median,,,range,1.2,4.9,,noncritically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1007,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonate/infants,age 1 week - 2 months,,5,CL,,,11.3,ml/kg/min,median,,,range,5.8,15.2,,noncritically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1008,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonate/infants,age 1 week - 2 months,,5,Vss,,,2,l/kg,median,,,range,1,2.3,,noncritically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1009,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,neonate/infants,age 1 week - 2 months,,5,t1/2,,,3.3,hours,median,,,range,2.7,11,,noncritically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1010,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,infants,age 2-6 months,,5,CL,,,20.2,ml/kg/min,median,,,range,10.1,31.1,,noncritically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1011,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,infants,age 2-6 months,,5,Vss,,,3.6,l/kg,median,,,range,1.7,5.6,,noncritically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1012,2025-12-02T15:56:56.518041
7924762.0,morphine,morphine,plasma,infants,age 2-6 months,,5,t1/2,,,2,hours,median,,,range,1.4,3.3,,noncritically ill patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1013,2025-12-02T15:56:56.518041
7948434.0,Morphine ,Morphine ,blood,premature neonate,,,5,concentration,2,hours,99,ng/ml,mean,SD,12.9,,,,,taken loading infusion 100 ug/kg/h for 2 h; 2 h of loading infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1014,2025-12-02T15:56:56.518041
7948434.0,Morphine ,morphine-3-glucuronide,blood,premature neonate,,,3,concentration,2,hours,20.7,ng/ml,mean,SD,7.6,,,,,taken loading infusion 100 ug/kg/h for 2 h; 2 h of loading infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1015,2025-12-02T15:56:56.518041
7948434.0,Morphine ,morphine-6-glucuronide ,blood,premature neonate,,,5,concentration,2,hours,ND,ng/ml,mean,SD,,,,,,taken loading infusion 100 ug/kg/h for 2 h; 2 h of loading infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1016,2025-12-02T15:56:56.518041
7948434.0,Morphine ,Morphine ,blood,premature neonate,,,8,concentration,2,hours,184.2,ng/ml,mean,SD,37.7,,,,,taken loading infusion 200 ug/kg/h for 2 h; 2 h of loading infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1017,2025-12-02T15:56:56.518041
7948434.0,Morphine ,morphine-3-glucuronide,blood,premature neonate,,,4,concentration,2,hours,33.3,ng/ml,mean,SD,14.3,,,,,taken loading infusion 200 ug/kg/h for 2 h; 2 h of loading infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1018,2025-12-02T15:56:56.518041
7948434.0,Morphine ,morphine-6-glucuronide ,blood,premature neonate,,,4,concentration,2,hours,ND,ng/ml,mean,SD,,,,,,taken loading infusion 200 ug/kg/h for 2 h; 2 h of loading infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1019,2025-12-02T15:56:56.518041
7948434.0,Morphine ,Morphine ,blood,premature neonate,,,7,concentration,24,hours,104.9,ng/ml,mean,SD,16,,,,,"taken loading infusion 100 ug/kg/h for 2 h, constant rate infusion 12.5 ug/kg/h; 24 h of loading infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1020,2025-12-02T15:56:56.518041
7948434.0,Morphine ,morphine-3-glucuronide,blood,premature neonate,,,7,concentration,24,hours,68.7,ng/ml,mean,SD,30.5,,,,,"taken loading infusion 100 ug/kg/h for 2 h, constant rate infusion 12.5 ug/kg/h; 24 h of loading infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1021,2025-12-02T15:56:56.518041
7948434.0,Morphine ,morphine-6-glucuronide ,blood,premature neonate,,,7,concentration,24,hours,24.3,ng/ml,mean,SD,11.8,,,,,"taken loading infusion 100 ug/kg/h for 2 h, constant rate infusion 12.5 ug/kg/h; 24 h of loading infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1022,2025-12-02T15:56:56.518041
7948434.0,Morphine ,Morphine ,blood,premature neonate,,,12,concentration,24,hours,205.7,ng/ml,mean,SD,48.4,,,,,"taken loading infusion 100 ug/kg/h for 2 h, constant rate infusion 25 ug/kg/h; 24 h of loading infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1023,2025-12-02T15:56:56.518041
7948434.0,Morphine ,morphine-3-glucuronide,blood,premature neonate,,,12,concentration,24,hours,136.3,ng/ml,mean,SD,82.8,,,,,"taken loading infusion 100 ug/kg/h for 2 h, constant rate infusion 25 ug/kg/h; 24 h of loading infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1024,2025-12-02T15:56:56.518041
7948434.0,Morphine ,morphine-6-glucuronide ,blood,premature neonate,,,12,concentration,24,hours,42.5,ng/ml,mean,SD,23.8,,,,,"taken loading infusion 100 ug/kg/h for 2 h, constant rate infusion 25 ug/kg/h; 24 h of loading infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1025,2025-12-02T15:56:56.518041
7948434.0,Morphine ,Morphine ,blood,premature neonate,,,4,concentration,24,hours,319,ng/ml,mean,SD,71.2,,,,,"taken loading infusion 200 ug/kg/h for 2 h, constant rate infusion 50 ug/kg/h; 24 h of loading infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1026,2025-12-02T15:56:56.518041
7948434.0,Morphine ,morphine-3-glucuronide,blood,premature neonate,,,4,concentration,24,hours,273.5,ng/ml,mean,SD,71.4,,,,,"taken loading infusion 200 ug/kg/h for 2 h, constant rate infusion 50 ug/kg/h; 24 h of loading infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1027,2025-12-02T15:56:56.518041
7948434.0,Morphine ,morphine-6-glucuronide ,blood,premature neonate,,,4,concentration,24,hours,78,ng/ml,mean,SD,23.8,,,,,"taken loading infusion 200 ug/kg/h for 2 h, constant rate infusion 50 ug/kg/h; 24 h of loading infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1028,2025-12-02T15:56:56.518041
7999650.0,alfentanil,alfentanil,plasma,maternal,labor,,12,Cmax,,,na,ng/ml,,,,range,5,6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1029,2025-12-02T15:56:56.518041
8026197.0,morphine,morphine,plasma,infant,,,7,mean steady-state concentration in ECMO,,,87.6,ng/mL,mean,SD,58.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1030,2025-12-02T15:56:56.518041
8026197.0,morphine,morphine,plasma,infant,,,7,mean steady-state concentration in post-ECMO,,,35.9,ng/mL,mean,SD,17.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1031,2025-12-02T15:56:56.518041
8026197.0,morphine,morphine,plasma,infant,,,7,plasma clearance in post-ECMO,,,0.574,L/kg/hr,mean,SD,0.53,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1032,2025-12-02T15:56:56.518041
8026197.0,morphine,morphine,plasma,infant,,,7,plasma clearance in post-ECMO,,,1.058,L/kg/hr,mean,SD,0.727,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1033,2025-12-02T15:56:56.518041
8213024.0,morphine,unconjugated,plasma,maternal,,,30,Tmax,1,day,=<15,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1034,2025-12-02T15:56:56.518041
8213024.0,morphine,unconjugated,plasma,maternal,,,30,Tmax,2,day,=<15,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1035,2025-12-02T15:56:56.518041
8213024.0,morphine,unconjugated,urine,maternal,,,30,Excretion 24-hour,2,day,68,%,,,,,,,,compared to day 1,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1036,2025-12-02T15:56:56.518041
8213024.0,morphine,unconjugated,urine,maternal,,,30,Excretion 24-hour,3,day,5,%,,,,,,,,compared to day 1,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1037,2025-12-02T15:56:56.518041
8213024.0,morphine,unconjugated,breast milk,maternal,,,3,Concentration,,,na,ng/ml,,,,range,0.39,0.66,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1038,2025-12-02T15:56:56.518041
8213024.0,morphine,conjugated,plasma,maternal,,,30,Tmax,1,day,2,hours,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1039,2025-12-02T15:56:56.518041
8213024.0,morphine,conjugated,plasma,maternal,,,30,Tmax,2,day,1,hour,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1040,2025-12-02T15:56:56.518041
8213024.0,morphine,conjugated,urine,maternal,,,30,Excretion 24-hour,2,day,84,%,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1041,2025-12-02T15:56:56.518041
8213024.0,morphine,conjugated,urine,maternal,,,30,Excretion 24-hour,3,day,10,%,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1042,2025-12-02T15:56:56.518041
8213024.0,morphine,conjugated,breast milk,maternal,,,3,Concentration,,,na,ng/ml,,,,range,0.6,1.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1043,2025-12-02T15:56:56.518041
8213024.0,morphine,conjugated,urine,neonate,,,1,Concentration,,,2,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1044,2025-12-02T15:56:56.518041
8213024.0,morphine,total,urine,maternal,,,30,Excretion 24-hour,2,day,82,%,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1045,2025-12-02T15:56:56.518041
8213024.0,morphine,total,urine,maternal,,,30,Excretion 24-hour,3,day,9,%,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1046,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,delivery,,10,AUC,1,day,46.3,ng * h * ml^-1,mean,SD,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1047,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,delivery,,10,AUMC,1,day,280,ng * h^2 * ml^-1,mean,SD,62,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1048,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,delivery,,10,CL,1,day,27.8,ml*min^-1*kg^-1,mean,SD,2.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1049,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,delivery,,10,Vss,1,day,9.4,l*kg^-1,mean,SD,1.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1050,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,delivery,,10,t1/2,1,day,4,h,mean,SD,0.44,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1051,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,delivery,,10,MRT,1,day,5.8,h,mean,SD,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1052,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,postpartum,,10,AUC,2,day,59.8,ng * h * ml^-1,mean,SD,8,,,,<0.05,compared to day 1,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1053,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,postpartum,,10,AUMC,2,day,513,ng * h^2 * ml^-1,mean,SD,123,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1054,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,postpartum,,10,CL,2,day,22.6,ml*min^-1*kg^-1,mean,SD,2.9,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1055,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,postpartum,,10,Vss,2,day,9.8,l*kg^-1,mean,SD,1.1,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1056,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,postpartum,,10,t1/2,2,day,5.4,h,mean,SD,0.78,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1057,2025-12-02T15:56:56.518041
8213024.0,morphine,morphine,blood,maternal,postpartum,,10,MRT,2,day,7.9,h,mean,SD,1.1,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1058,2025-12-02T15:56:56.518041
8213024.0,morphine,Morphine-3-glucuronide,plasma ,maternal,delivery,,8,Extraction,,,94,%,mean,SD,3,,,,,based on 10 ng/ml concentration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1059,2025-12-02T15:56:56.518041
8213024.0,morphine,Morphine-3-glucuronide,urine ,maternal,delivery,,8,Extraction,,,92,%,mean,SD,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1060,2025-12-02T15:56:56.518041
8213024.0,morphine,Morphine-3-glucuronide,breast milk,maternal,delivery,,8,Extraction,,,89,%,mean,SD,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1061,2025-12-02T15:56:56.518041
8213024.0,morphine,Morphine,plasma ,maternal,delivery,,8,Extraction,,,96,%,mean,SD,6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1062,2025-12-02T15:56:56.518041
8213024.0,morphine,Morphine,urine ,maternal,delivery,,8,Extraction,,,97,%,mean,SD,8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1063,2025-12-02T15:56:56.518041
8213024.0,morphine,Morphine,breast milk,maternal,delivery,,8,Extraction,,,90,%,mean,SD,6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1064,2025-12-02T15:56:56.518041
8260056.0,codeine,unconjugated,breast milk,maternal,postpartum,,7,Concentration,20-240,min,na,ng/ml,,,,range,33.8,314,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1065,2025-12-02T15:56:56.518041
8260056.0,morphine,unconjugated,breast milk,maternal,postpartum,,7,Concentration,20-240,min,na,ng/ml,,,,range,1.9,20.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1066,2025-12-02T15:56:56.518041
8260056.0,codeine,unconjugated,plasma,neonate,postpartum,,8,concentration,1,hr,1.86,ng/ml,mean,SD,1.22,range,4.5,0.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1067,2025-12-02T15:56:56.518041
8260056.0,codeine,unconjugated,plasma,neonate,postpartum,,6,concentration,2,hr,1.15,ng/ml,mean,SD,0.3,range,1.5,0.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1068,2025-12-02T15:56:56.518041
8260056.0,codeine,unconjugated,plasma,neonate,postpartum,,5,concentration,4,hr,1.4,ng/ml,mean,SD,1.07,range,3.3,0.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1069,2025-12-02T15:56:56.518041
8260056.0,morphine,unconjugated,plasma,neonate,postpartum,,8,concentration,1,hr,0.86,ng/ml,mean,SD,0.54,range,1.9,0.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1070,2025-12-02T15:56:56.518041
8260056.0,morphine,unconjugated,plasma,neonate,postpartum,,6,concentration,2,hr,0.58,ng/ml,mean,SD,0.2,range,1,0.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1071,2025-12-02T15:56:56.518041
8260056.0,morphine,unconjugated,plasma,neonate,postpartum,,5,concentration,4,hr,0.8,ng/ml,mean,SD,0.67,range,2,0.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1072,2025-12-02T15:56:56.518041
8319480.0,fentanyl,fentanyl,blood,child,,,19,clearance,,,793,mL/kg/hr,mean,,,range,207,2045,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1073,2025-12-02T15:56:56.518041
8319480.0,fentanyl,fentanyl,blood,child,,,8,T1/2,,,21.1,hrs,mean,,,range,11.2,36,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1074,2025-12-02T15:56:56.518041
8319480.0,fentanyl,fentanyl,blood,child,,,8,Vdss,,,15.2,L/kg,mean,,,range,5,30,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1075,2025-12-02T15:56:56.518041
8442811.0,morphine sulfate,morphine sulfate,blood,neonate,,,20,steady state serum morphine concentration,,,39,ng/ml,mean,SD,23,range,13,94,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1076,2025-12-02T15:56:56.518041
8442811.0,morphine sulfate,morphine sulfate,blood,neonate,,,20,half-life,,,6.6,hr,mean,SD,2.9,range,2.7,11.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1077,2025-12-02T15:56:56.518041
8442811.0,morphine sulfate,morphine sulfate,blood,neonate,,,20,elimination rate,,,0.126,/hr,mean,SD,0.056,range,0.06,0.254,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1078,2025-12-02T15:56:56.518041
8442811.0,morphine sulfate,morphine sulfate,blood,neonate,,,20,volume of distribution,,,5,L/kg,mean,SD,6.8,range,0.9,25,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1079,2025-12-02T15:56:56.518041
8442811.0,morphine sulfate,morphine sulfate,urine,neonate,,,20,percentage of unchanged morphine recovered,,,39,%,mean,SD,19,range,16,80,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1080,2025-12-02T15:56:56.518041
8471411.0,Morphine,Morphine,blood,premature neonate,,,4,plasma concentration,24,hours,96,ng/ml,mean,SD,3,,,,,after 24 h of morphine therapy; for the low dose regimes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1081,2025-12-02T15:56:56.518041
8471411.0,Morphine,M3G,blood,premature neonate,,,4,plasma concentration,24,hours,2,ng/ml,mean,SD,34,,,,,after 24 h of morphine therapy; for the low dose regimes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1082,2025-12-02T15:56:56.518041
8471411.0,Morphine,M6G,blood,premature neonate,,,4,plasma concentration,24,hours,19,ng/ml,mean,SD,7,,,,,after 24 h of morphine therapy; for the low dose regimes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1083,2025-12-02T15:56:56.518041
8471411.0,Morphine,Morphine,blood,premature neonate,,,6,plasma concentration,24,hours,318,ng/ml,mean,SD,71,,,,,after 24 h of morphine therapy; for the high dose regimes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1084,2025-12-02T15:56:56.518041
8471411.0,Morphine,M3G,blood,premature neonate,,,6,plasma concentration,24,hours,274,ng/ml,mean,SD,71,,,,,after 24 h of morphine therapy; for the high dose regimes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1085,2025-12-02T15:56:56.518041
8471411.0,Morphine,M6G,blood,premature neonate,,,6,plasma concentration,24,hours,78,ng/ml,mean,SD,24,,,,,after 24 h of morphine therapy; for the high dose regimes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1086,2025-12-02T15:56:56.518041
8487566.0,fentanyl,fentanyl,plasma,neonate/infants,,,9,concentration,,,9.8,ng/ml,mean,SD,17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1087,2025-12-02T15:56:56.518041
8487566.0,fentanyl + lorazepam,fentanyl,plasma,neonate/infants,,,3,concentration,,,7.7,ng/ml,mean,SD,8.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1088,2025-12-02T15:56:56.518041
8487566.0,fentanyl - lorazepam,fentanyl,plasma,neonate/infants,,,6,concentration,,,10.8,ng/ml,mean,SD,19.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1089,2025-12-02T15:56:56.518041
8487566.0,fentanyl,fentanyl,plasma,neonate/infants,,,3,concentration,,,38.7,ng/ml,mean,SD,45.8,,,,<0.01,p for difference between survivors/non-survivors,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1090,2025-12-02T15:56:56.518041
8487566.0,fentanyl + lorazepam,fentanyl,plasma,neonate/infants,,,2,concentration,,,10.2,ng/ml,mean,SD,6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1091,2025-12-02T15:56:56.518041
8487566.0,fentanyl - lorazepam,fentanyl,plasma,neonate/infants,,,1,concentration,,,54.7,ng/ml,mean,SD,50.6,,,,<0.001,p for difference between +/- lorazepam nonsurvivors,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1092,2025-12-02T15:56:56.518041
8487566.0,fentanyl,fentanyl,plasma,neonate/infants,,,9,CL,,,25.3,ml/min,mean,SD,41.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1093,2025-12-02T15:56:56.518041
8487566.0,fentanyl + lorazepam,fentanyl,plasma,neonate/infants,,,3,CL,,,22.1,ml/min,mean,SD,20,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1094,2025-12-02T15:56:56.518041
8487566.0,fentanyl - lorazepam,fentanyl,plasma,neonate/infants,,,6,CL,,,26.7,ml/min,mean,SD,48.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1095,2025-12-02T15:56:56.518041
8487566.0,fentanyl,fentanyl,plasma,neonate/infants,,,3,CL,,,8.1,ml/min,mean,SD,12.8,,,,<0.01,p for difference between survivors/non-survivors,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1096,2025-12-02T15:56:56.518041
8487566.0,fentanyl + lorazepam,fentanyl,plasma,neonate/infants,,,2,CL,,,5.3,ml/min,mean,SD,4.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1097,2025-12-02T15:56:56.518041
8487566.0,fentanyl - lorazepam,fentanyl,plasma,neonate/infants,,,1,CL,,,9.8,ml/min,mean,SD,15.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1098,2025-12-02T15:56:56.518041
8706774.0,Nalbuphine,nalbuphine,plasma,maternal,delivery,,28,concentration,,,19.5,ng/ml,mean,SD,18.9,,,,<0.001,p for comparison to dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1099,2025-12-02T15:56:56.518041
8706774.0,Nalbuphine,nalbuphine,cord blood,neonate,delivery,,28,concentration,,,13.4,ng/ml,mean,SD,11.7,,,,<0.001,p for comparison to dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1100,2025-12-02T15:56:56.518041
8706774.0,Nalbuphine,nalbuphine,plasma,neonate,delivery,,28,concentration,,,4.2,ng/ml,mean,SD,3.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1101,2025-12-02T15:56:56.518041
8706774.0,Nalbuphine,nalbuphine,plasma,neonate,delivery,,28,estimated t1/2,,,4.1,hrs,mean,SD,2.7,range,1.1,11,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1102,2025-12-02T15:56:56.518041
8706774.0,Nalbuphine,nalbuphine,maternal plasma/cord blood,fetal,,,28,fetal:maternal ratio,,,0.74,,mean,SD,0.2,,,,,IV/IM route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1103,2025-12-02T15:56:56.518041
8706774.0,Nalbuphine,nalbuphine,maternal plasma/cord blood,fetal,,,6,fetal:maternal ratio,,,0.75,,mean,SD,0.21,,,,,IV route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1104,2025-12-02T15:56:56.518041
8706774.0,Nalbuphine,nalbuphine,maternal plasma/cord blood,fetal,,,23,fetal:maternal ratio,,,0.69,,mean,SD,0.12,,,,,IM route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1105,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,6,Elimination half-life,,,1.2,hours,mean,,,range,0.7,2.3,,intravenous administration of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1106,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,10,Elimination half-life,,,1.5,hours,mean,,,range,0.9,2.4,,rectal gel administration of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1107,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,9,Elimination half-life,,,2.9,hours,mean,,,range,1.4,10,,rectal solution administration of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1108,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,6,Bioavailability based on AUC0-6 hours,,,100,%,mean,,,range,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1109,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,10,Bioavailability based on AUC0-6 hours,,,35,%,mean,,,range,18,59,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1110,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,9,Bioavailability based on AUC0-6 hours,,,27,%,mean,,,range,6,93,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1111,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,6,Tmax,,,,hours,mean,,,range,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1112,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,10,Tmax,,,0.73,hours,mean,,,range,0.33,2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1113,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,9,Tmax,,,0.48,hours,mean,,,range,0.17,0.67,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1114,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,6,Cmax ,,,2196,nmol/l,mean,,,range,1773,2527,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1115,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,10,Cmax ,,,76,nmol/l,mean,,,range,25,129,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1116,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine,blood,pediatric ,,,9,Cmax ,,,59,nmol/l,mean,,,range,15,140,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1117,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-3-glucuronide,blood,pediatric ,,,6,Tmax,,,2.8,hours,mean,,,range,1,6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1118,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-3-glucuronide,blood,pediatric ,,,10,Tmax,,,2.6,hours,mean,,,range,1,4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1119,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-3-glucuronide,blood,pediatric ,,,9,Tmax,,,3,hours,mean,,,range,0.67,5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1120,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-3-glucuronide,blood,pediatric ,,,6,Cmax ,,,466,nmol/l,mean,,,range,351,627,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1121,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-3-glucuronide,blood,pediatric ,,,10,Cmax ,,,307,nmol/l,mean,,,range,175,548,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1122,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-3-glucuronide,blood,pediatric ,,,9,Cmax ,,,195,nmol/l,mean,,,range,65,315,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1123,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-6-glucuronid,blood,pediatric ,,,6,Tmax,,,1.3,hours,mean,,,range,1,2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1124,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-6-glucuronid,blood,pediatric ,,,10,Tmax,,,3,hours,mean,,,range,2,4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1125,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-6-glucuronid,blood,pediatric ,,,9,Tmax,,,3,hours,mean,,,range,1,5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1126,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-6-glucuronid,blood,pediatric ,,,6,Cmax ,,,71,nmol/l,mean,,,range,51,86,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1127,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-6-glucuronid,blood,pediatric ,,,10,Cmax ,,,46,nmol/l,mean,,,range,27,62,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1128,2025-12-02T15:56:56.518041
8738689.0,morphine,morphine-6-glucuronid,blood,pediatric ,,,9,Cmax ,,,34,nmol/l,mean,,,range,5,47,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1129,2025-12-02T15:56:56.518041
8827580.0,ketobemidone,ketobemidone,breast milk,infant,Postpartum,,5,absolute infant dose,24,hours,<2,ug,,,,,,,,100 ml milk with <20 ng/ml concentration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1130,2025-12-02T15:56:56.518041
8839086.0,Morphine ,Morphine ,blood,adolescent,,,13,concentration,1st,day,26,ng/ml,mean,SD,10.2,Range,11.2,43.9,,blood samples were collected the morning after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1131,2025-12-02T15:56:56.518041
8839086.0,Morphine ,Morphine ,blood,adolescent,,,8,concentration,2nd,day,22.2,ng/ml,mean,SD,14.7,Range,7.7,54,,blood samples were collected the the  following morning,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1132,2025-12-02T15:56:56.518041
9024020.0,alfentanil,bound alfentanil,plasma,preterm,,,46,Concentration,,,65,%,mean,SD,15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1133,2025-12-02T15:56:56.518041
9024020.0,alfentanil,free alfentanil,plasma,preterm,,,46,Concentration,,,35,%,mean,SD,15,,,,<0.0001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1134,2025-12-02T15:56:56.518041
9024020.0,alfentanil,alfentanil,plasma,preterm,,,46,Binding ratio,,,2.5,,mean,SD,1.9,,,,<0.0001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1135,2025-12-02T15:56:56.518041
9024020.0,alfentanil,AAG,plasma,,,,,Concentration,,,14,mg/dl,mean,SD,10,,,,0.0001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1136,2025-12-02T15:56:56.518041
9024020.0,alfentanil,Albumin,plasma,,,,,Concentration,,,2575,mg/dl,mean,SD,1091,,,,0.794,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1137,2025-12-02T15:56:56.518041
9024020.0,alfentanil,bound alfentanil,plasma,term,,,26,Concentration,,,79,%,mean,SD,8.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1138,2025-12-02T15:56:56.518041
9024020.0,alfentanil,free alfentanil,plasma,term,,,26,Concentration,,,21,%,mean,SD,8.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1139,2025-12-02T15:56:56.518041
9024020.0,alfentanil,alfentanil,plasma,term,,,26,Binding ratio,,,4.7,,mean,SD,2.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1140,2025-12-02T15:56:56.518041
9024020.0,alfentanil,alfentanil,plasma,,,,72,AAG coefficient,,,0.404,,r,,,95% CI,0.132,0.676,0.004,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1141,2025-12-02T15:56:56.518041
9024020.0,alfentanil,alfentanil,plasma,,,,72,Albumin coefficient,,,0.0015,,r,,,95% CI,-0.00146,0.00449,0.313,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1142,2025-12-02T15:56:56.518041
9024020.0,alfentanil,alfentanil,plasma,,,,72,gestational age coefficient,,,1.49,,r,,,95% CI,0.828,2.14,<0.0001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1143,2025-12-02T15:56:56.518041
9024020.0,Fentanyl,bound fentanyl,plasma,preterm,,,46,Concentration,,,77,%,mean,SD,15,,,,0.0054,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1144,2025-12-02T15:56:56.518041
9024020.0,Fentanyl,free fentanyl,plasma,preterm,,,46,Concentration,,,23,%,mean,SD,15,,,,0.0054,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1145,2025-12-02T15:56:56.518041
9024020.0,Fentanyl,Fentanyl,plasma,preterm,,,46,Binding ratio,,,5.7,,mean,SD,4.4,,,,0.0054,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1146,2025-12-02T15:56:56.518041
9024020.0,Fentanyl,bound fentanyl,plasma,term,,,26,Concentration,,,70,%,mean,SD,9.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1147,2025-12-02T15:56:56.518041
9024020.0,Fentanyl,free fentanyl,plasma,term,,,26,Concentration,,,30,%,mean,SD,9.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1148,2025-12-02T15:56:56.518041
9024020.0,Fentanyl,Fentanyl,plasma,term,,,26,Binding ratio,,,2.8,,mean,SD,1.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1149,2025-12-02T15:56:56.518041
9024020.0,Fentanyl,Fentanyl,plasma,,,,72,AAG coefficient,,,0.531,,r,,,95% CI,0.238,0.824,0.00059,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1150,2025-12-02T15:56:56.518041
9024020.0,Fentanyl,Fentanyl,plasma,,,,72,Albumin coefficient,,,0.00011,,r,,,95% CI,-0.00297,0.00319,0.9438,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1151,2025-12-02T15:56:56.518041
9024020.0,Fentanyl,Fentanyl,plasma,,,,72,gestational age coefficient,,,-1.45,,r,,,95% CI,-2.1,0.809,3e-05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1152,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,Arterial blood,infant,,,5,concentration,0,min,32.3,ng/mL,mean,SD,21.8,range,9.8,66,,baseline,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1153,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,Arterial blood,infant,,,5,concentration,5,minutes,29.3,ng/mL,mean,SD,15.5,range,6.4,50,,time after cannulation,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1154,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,Arterial blood,infant,,,5,concentration,1,hour,28.4,ng/mL,mean,SD,15.8,range,7.1,50,,time after cannulation,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1155,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,concentration,3,hours,33.8,ng/mL,mean,SD,21.5,range,6.7,61,,time after cannulation,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1156,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,proximal concentration,5,minutes,31.9,ng/mL,mean,SD,17.7,range,7.6,53,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1157,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,proximal concentration,1,hour,28.7,ng/mL,mean,SD,17.5,range,8.2,54,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1158,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,proximal concentration,3,hours,36.3,ng/mL,mean,SD,24.3,range,7.1,69,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1159,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,distal concentration,5,minutes,29,ng/mL,mean,SD,15.7,range,6.1,50,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1160,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,distal concentration,1,hour,30.2,ng/mL,mean,SD,17.2,range,8.1,53,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1161,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,distal concentration,3,hours,34.8,ng/mL,mean,SD,23.4,range,7.5,66,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1162,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,Arterial blood,infant,,,5,concentration,0,min,32,ng/mL,median,,,,,,,baseline,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1163,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,Arterial blood,infant,,,5,concentration,5,minutes,29,ng/mL,median,,,,,,,time after cannulation,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1164,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,Arterial blood,infant,,,5,concentration,1,hour,32,ng/mL,median,,,,,,,time after cannulation,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1165,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,concentration,3,hours,33,ng/mL,median,,,,,,,time after cannulation,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1166,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,proximal concentration,5,minutes,28,ng/mL,median,,,,,,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1167,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,proximal concentration,1,hour,30,ng/mL,median,,,,,,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1168,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,proximal concentration,3,hours,35,ng/mL,median,,,,,,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1169,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,distal concentration,5,minutes,30,ng/mL,median,,,,,,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1170,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,distal concentration,1,hour,32,ng/mL,median,,,,,,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1171,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,5,distal concentration,3,hours,33,ng/mL,median,,,,,,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1172,2025-12-02T15:56:56.518041
9034277.0,Morphine,morphine,blood,infant,,,11,clearance,,,11.7,ml/min/kg,mean,SD,9.3,range,2.6,34.5,,"blood samples were simultaneously obtained from sites immediately proximal/distal to the membrane oxygenator at 5 mins, 1 hr,/3 hrs after starting ECMO",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1173,2025-12-02T15:56:56.518041
9055894.0,meperidine ,meperidine ,blood,maternal,labor,,7,plasma concentration,,,106,ng/ml,median,,,Q25-Q75,105,226,,a short DDI  group (1.1-5.3 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1174,2025-12-02T15:56:56.518041
9055894.0,meperidine ,Normeperidine ,blood,maternal,labor,,7,plasma concentration,,,17,ng/ml,median,,,Q25-Q75,13,23,,a short DDI  group (1.1-5.3 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1175,2025-12-02T15:56:56.518041
9055894.0,meperidine ,meperidine ,blood,newborn,,,7,mixed cord plasma concentration,,,103,ng/ml,median,,,Q25-Q75,96,113,,a short DDI  group (1.1-5.3 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1176,2025-12-02T15:56:56.518041
9055894.0,meperidine ,Normeperidine ,blood,newborn,,,7,mixed cord plasma concentration,,,25,ng/ml,median,,,Q25-Q75,12,32,,a short DDI  group (1.1-5.3 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1177,2025-12-02T15:56:56.518041
9055894.0,meperidine ,meperidine ,blood,maternal,labor,,6,plasma concentration,,,79,ng/ml,median,,,Q25-Q75,60,94,,long DDI  group (8.1-9.9 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1178,2025-12-02T15:56:56.518041
9055894.0,meperidine ,Normeperidine ,blood,maternal,labor,,6,plasma concentration,,,24,ng/ml,median,,,Q25-Q75,16,32,,long DDI  group (8.1-9.9 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1179,2025-12-02T15:56:56.518041
9055894.0,meperidine ,meperidine ,blood,newborn,,,6,mixed cord plasma concentration,,,91,ng/ml,median,,,Q25-Q75,58,144,,long DDI  group (8.1-9.9 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1180,2025-12-02T15:56:56.518041
9055894.0,meperidine ,Normeperidine ,blood,newborn,,,6,mixed cord plasma concentration,,,25,ng/ml,median,,,Q25-Q75,15,27,,long DDI  group (8.1-9.9 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1181,2025-12-02T15:56:56.518041
9089420.0,Methohexital,Methohexital,blood,maternal,lactation,,5,concentration,1-2,hours,114-312,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1182,2025-12-02T15:56:56.518041
9089420.0,Methohexital,Methohexital,blood,maternal,lactation,,3,concentration,2-4,hours,92-169,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1183,2025-12-02T15:56:56.518041
9089420.0,Methohexital,Methohexital,blood,maternal,lactation,,9,concentration,8-10,hours,ND-50,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1184,2025-12-02T15:56:56.518041
9089420.0,Methohexital,Methohexital,blood,maternal,lactation,,9,concentration,24-28,hours,ND-50,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1185,2025-12-02T15:56:56.518041
9089420.0,Methohexital,Methohexital,breast milk,maternal,lactation,,5,concentration,1-2,hours,100-407,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1186,2025-12-02T15:56:56.518041
9089420.0,Methohexital,Methohexital,breast milk,maternal,lactation,,4,concentration,2-4,hours,39-199,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1187,2025-12-02T15:56:56.518041
9089420.0,Methohexital,Methohexital,breast milk,maternal,lactation,,9,concentration,8-10,hours,ND-65,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1188,2025-12-02T15:56:56.518041
9089420.0,Methohexital,Methohexital,breast milk,maternal,lactation,,9,concentration,24-28,hours,ND,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1189,2025-12-02T15:56:56.518041
9089420.0,Meperidine,Meperidine,blood,maternal,lactation,,5,concentration,1-2,hours,71-94,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1190,2025-12-02T15:56:56.518041
9089420.0,Meperidine,Meperidine,blood,maternal,lactation,,2,concentration,2-4,hours,50-75,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1191,2025-12-02T15:56:56.518041
9089420.0,Meperidine,Meperidine,blood,maternal,lactation,,8,concentration,8-10,hours,ND-25,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1192,2025-12-02T15:56:56.518041
9089420.0,Meperidine,Meperidine,blood,maternal,lactation,,8,concentration,24-28,hours,ND,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1193,2025-12-02T15:56:56.518041
9089420.0,Meperidine,Meperidine,breast milk,maternal,lactation,,5,concentration,1-2,hours,134-244,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1194,2025-12-02T15:56:56.518041
9089420.0,Meperidine,Meperidine,breast milk,maternal,lactation,,3,concentration,2-4,hours,76-318,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1195,2025-12-02T15:56:56.518041
9089420.0,Meperidine,Meperidine,breast milk,maternal,lactation,,7,concentration,8-10,hours,ND-80,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1196,2025-12-02T15:56:56.518041
9089420.0,Meperidine,Meperidine,breast milk,maternal,lactation,,8,concentration,24-28,hours,ND,ng/mL,range,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1197,2025-12-02T15:56:56.518041
9107559.0,Morphine,nalbuphine ,blood,pediatric ,,,9,Cmax,,,24.8,ng/mL,mean,SD,15.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1198,2025-12-02T15:56:56.518041
9107559.0,Morphine,nalbuphine ,blood,pediatric ,,,9,tmax,,,0.42,h,mean,SD,0.18,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1199,2025-12-02T15:56:56.518041
9107559.0,Morphine,nalbuphine ,blood,pediatric ,,,9,distribution half-life,,,0.5,h,mean,SD,0.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1200,2025-12-02T15:56:56.518041
9107559.0,Morphine,nalbuphine ,blood,pediatric ,,,9,elimination half-life,,,2.7,h,mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1201,2025-12-02T15:56:56.518041
9107559.0,Morphine,nalbuphine ,blood,pediatric ,,,9,CL/F,,,7,L/h/kg,mean,SD,3.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1202,2025-12-02T15:56:56.518041
9107559.0,Morphine,nalbuphine ,blood,pediatric ,,,9,AUC,,,58.3,ngh/mL,mean,SD,39.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1203,2025-12-02T15:56:56.518041
9134513.0,fentanyl,fentanyl,umbilical artery blood,newborn,delivery,,7,total body clearance,,,1154,ml/kg/hr,mean,SD,494,range,565,2000,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1204,2025-12-02T15:56:56.518041
9134513.0,fentanyl,fentanyl,umbilical artery blood,newborn,delivery,,6,t1/2b,,,9.5,hours,mean,SD,2.6,range,5.7,12.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1205,2025-12-02T15:56:56.518041
9134513.0,fentanyl,fentanyl,umbilical artery blood,newborn,delivery,,6,Vdss,,,17,l/kg,mean,SD,9,range,10.1,30.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1206,2025-12-02T15:56:56.518041
9203876.0,Bupivacaine ,Bupivacaine ,blood,maternal,labor,,40,total drug concentraion,,,0.32,ug/mL,mean,SD,0.21,range,0.05,0.91,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1207,2025-12-02T15:56:56.518041
9203876.0,Bupivacaine ,Bupivacaine ,blood,maternal,labor,,40,free drug concentration,,,0.02,ug/mL,mean,SD,0.02,range,0,0.07,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1208,2025-12-02T15:56:56.518041
9203876.0,Bupivacaine ,Bupivacaine ,blood,maternal,labor,,40,% bound,,,94,ug/mL,mean,SD,5,range,85,99,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1209,2025-12-02T15:56:56.518041
9203876.0,Bupivacaine ,Bupivacaine ,umbilical venous blood ,neonate,delivery,,40,total drug concentraion,,,0.15,ug/mL,mean,SD,0.11,range,0.03,0.47,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1210,2025-12-02T15:56:56.518041
9203876.0,Bupivacaine ,Bupivacaine ,umbilical venous blood ,neonate,delivery,,40,free drug concentration,,,0.02,ug/mL,mean,SD,0.02,range,0,0.07,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1211,2025-12-02T15:56:56.518041
9203876.0,Bupivacaine ,Bupivacaine ,umbilical venous blood ,neonate,delivery,,40,% bound,,,84,ug/mL,mean,SD,14.7,range,52,97,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1212,2025-12-02T15:56:56.518041
9203876.0,Fentanyl ,Fentanyl ,blood,maternal,labor,,23,total drug concentraion,,,0.15,ng/mL,mean,SD,0.08,range,0.02,0.37,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1213,2025-12-02T15:56:56.518041
9203876.0,Fentanyl ,Fentanyl ,blood,maternal,labor,,23,free drug concentration,,,0.02,ng/mL,mean,SD,0.02,range,0,0.09,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1214,2025-12-02T15:56:56.518041
9203876.0,Fentanyl ,Fentanyl ,blood,maternal,labor,,23,% bound,,,88,ng/mL,mean,SD,7.8,range,60,98,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1215,2025-12-02T15:56:56.518041
9203876.0,Fentanyl ,Fentanyl ,umbilical venous blood ,neonate,delivery,,24,total drug concentraion,,,0.15,ng/mL,mean,SD,0.08,range,0.03,0.38,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1216,2025-12-02T15:56:56.518041
9203876.0,Fentanyl ,Fentanyl ,umbilical venous blood ,neonate,delivery,,24,free drug concentration,,,0.02,ng/mL,mean,SD,0.01,range,0,0.06,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1217,2025-12-02T15:56:56.518041
9203876.0,Fentanyl ,Fentanyl ,umbilical venous blood ,neonate,delivery,,24,% bound,,,86,ng/mL,mean,SD,8,range,68,99,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1218,2025-12-02T15:56:56.518041
9203876.0,Bupivacaine ,Bupivacaine ,,,,,40,total drug UV/M ratio,,,0.42,,mean,SD,0.16,range,0.14,0.82,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1219,2025-12-02T15:56:56.518041
9203876.0,Bupivacaine ,Bupivacaine ,,,,,40,free drug UV/M ratio,,,1.07,,mean,SD,0.41,range,0.47,2.67,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1220,2025-12-02T15:56:56.518041
9203876.0,Fentanyl ,Fentanyl ,,,,,23,total drug UV/M ratio,,,1.12,,mean,SD,0.04,range,0.44,1.98,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1221,2025-12-02T15:56:56.518041
9203876.0,Fentanyl ,Fentanyl ,,,,,23,free drug UV/M ratio,,,1.2,,mean,SD,0.82,range,0.06,3.41,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1222,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,umbilical artery blood,fetal to maternal,delivery,,10,CL,,,1,ml/min,,,0.4,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1223,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,umbilical artery blood,fetal to maternal,delivery,,10,clearance index,,,0.44,,,,0.2,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1224,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,umbilical artery blood,fetal to maternal,delivery,,10,transfer index,,,1.7,,,,0.5,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1225,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,placental tissue,fetal to maternal,,,5,concentration,90,min,9.8,,,,3,,,,,after 90 min perfusion with sufentanil 1 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1226,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,placental tissue,fetal to maternal,,,5,concentration,60,min,3.5,,,,1,,,,,after 60 min drug washout,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1227,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,umbilical vein blood,maternal to fetal,delivery,,10,CL,,,0.78,ml/min,mean,SD,0.3,,,,>0.05,at 1 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1228,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,umbilical vein blood,maternal to fetal,delivery,,10,clearance index,,,0.56,,,,0.2,,,,>0.05,at 1 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1229,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,umbilical vein blood,maternal to fetal,delivery,,10,transfer index,,,1.6,,,,0.4,,,,>0.05,at 1 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1230,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,umbilical vein blood,maternal to fetal,delivery,,10,CL,,,0.85,ml/min,mean,SD,0.3,,,,,at 100 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1231,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,umbilical vein blood,maternal to fetal,delivery,,10,clearance index,,,0.61,,,,0.3,,,,,at 100 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1232,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,umbilical vein blood,maternal to fetal,delivery,,10,transfer index,,,1.8,,,,0.6,,,,,at 100 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1233,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,placental tissue,maternal to fetal,,,5,concentration,90,min,7.1,ng/g,,,2,,,,<0.05,after 90 min perfusion with sufentanil 1 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1234,2025-12-02T15:56:56.518041
9305564.0,sufentanil,sufentanil,placental tissue,maternal to fetal,,,5,concentration,60,min,2.3,,,,0.5,,,,,after 60 min drug washout,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1235,2025-12-02T15:56:56.518041
9431829.0,methadone,sufentanil,plasma,pregnant,post-partum,,12,concentration,the mean value of one immediately before/one after the infant fed,hour,311,ug/L,mean,,,95CI,207,416,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1236,2025-12-02T15:56:56.518041
9431829.0,methadone,sufentanil,milk,pregnant,post-partum,,12,concentration,the mean value of one immediately before/one after the infant fed,hour,116,ug/L,mean,,,95CI,72,160,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1237,2025-12-02T15:56:56.518041
9431829.0,methadone,sufentanil,M/P ratio,pregnant,post-partum,,12,concentration,,,0.44,,mean,,,95CI,0.24,0.64,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1238,2025-12-02T15:56:56.518041
9485967.0,Bupivacaine ,paracetamol,blood,maternal,labor,,35,Tmax,,,64.3,min,mean,SD,25.3,,,,," In study A, 28 women received an oral dose of paracetamol 1.5 g after 30 ml of the infusion solution (control) had been given (mean time 2.5 h after the start of the infusion).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1239,2025-12-02T15:56:56.518041
9485967.0,Bupivacaine ,paracetamol,blood,maternal,labor,,35,Cmax,,,13.3,ug/ml,mean,SD,6.5,,,,," In study A, 28 women received an oral dose of paracetamol 1.5 g after 30 ml of the infusion solution (control) had been given (mean time 2.5 h after the start of the infusion).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1240,2025-12-02T15:56:56.518041
9485967.0,Bupivacaine ,paracetamol,blood,maternal,labor,,35,AUC,,,612,ug/min/ml,mean,SD,368,,,,," In study A, 28 women received an oral dose of paracetamol 1.5 g after 30 ml of the infusion solution (control) had been given (mean time 2.5 h after the start of the infusion).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1241,2025-12-02T15:56:56.518041
9485967.0,bupivacaine-fentanyl,paracetamol,blood,maternal,labor,,35,Tmax,,,49.8,min,mean,SD,29.9,,,,," In study A, 28 women received an oral dose of paracetamol 1.5 g after 30 ml of the infusion solution (fentanyl) had been given (mean time 2.5 h after the start of the infusion).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1242,2025-12-02T15:56:56.518041
9485967.0,bupivacaine-fentanyl,paracetamol,blood,maternal,labor,,35,Cmax,,,16.8,ug/ml,mean,SD,7.7,,,,," In study A, 28 women received an oral dose of paracetamol 1.5 g after 30 ml of the infusion solution (fentanyl) had been given (mean time 2.5 h after the start of the infusion).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1243,2025-12-02T15:56:56.518041
9485967.0,bupivacaine-fentanyl,paracetamol,blood,maternal,labor,,35,AUC,,,944,ug/min/ml,mean,SD,531,,,,," In study A, 28 women received an oral dose of paracetamol 1.5 g after 30 ml of the infusion solution (fentanyl) had been given (mean time 2.5 h after the start of the infusion).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1244,2025-12-02T15:56:56.518041
9485967.0,Bupivacaine ,paracetamol,blood,maternal,labor,,35,Tmax,,,54.2,min,mean,SD,27.8,,,,,In study B a further 28  women  received  the same  dose  of  paracetamol  after 4050 ml  of  the  infusion (control)  had  been  given  (mean  time 4.5 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1245,2025-12-02T15:56:56.518041
9485967.0,Bupivacaine ,paracetamol,blood,maternal,labor,,35,Cmax,,,17.9,ug/ml,mean,SD,8.3,,,,,In study B a further 28  women  received  the same  dose  of  paracetamol  after 4050 ml  of  the  infusion (control)  had  been  given  (mean  time 4.5 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1246,2025-12-02T15:56:56.518041
9485967.0,Bupivacaine ,paracetamol,blood,maternal,labor,,35,AUC,,,824,ug/min/ml,mean,SD,407,,,,,In study B a further 28  women  received  the same  dose  of  paracetamol  after 4050 ml  of  the  infusion (control)  had  been  given  (mean  time 4.5 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1247,2025-12-02T15:56:56.518041
9485967.0,bupivacaine-fentanyl,paracetamol,blood,maternal,labor,,35,Tmax,,,76.1,min,mean,SD,23.9,,,,,"In study B a further 28  women  received  the same  dose  of  paracetamol  after4050 ml  of  the  infusion  had  been  given  (mean  time4.5 h), equivalent to 100125mg fentanyl in the fentanylgroup.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1248,2025-12-02T15:56:56.518041
9485967.0,bupivacaine-fentanyl,paracetamol,blood,maternal,labor,,35,Cmax,,,12.2,ug/ml,mean,SD,8.6,,,,,"In study B a further 28  women  received  the same  dose  of  paracetamol  after4050 ml  of  the  infusion  had  been  given  (mean  time4.5 h), equivalent to 100125mg fentanyl in the fentanylgroup.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1249,2025-12-02T15:56:56.518041
9485967.0,bupivacaine-fentanyl,paracetamol,blood,maternal,labor,,35,AUC,,,562,ug/min/ml,mean,SD,468,,,,,"In study B a further 28  women  received  the same  dose  of  paracetamol  after4050 ml  of  the  infusion  had  been  given  (mean  time4.5 h), equivalent to 100125mg fentanyl in the fentanylgroup.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1250,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,1-7 days old,,4,serum concentration,1,day,18.9,ng/mL,median,,,range,15,29,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1251,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,8-30 days old,,0,serum concentration,1,day,,ng/mL,median,,,range,,,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1252,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,1-3 mo old ,,6,serum concentration,1,day,9.1,ng/mL,median,,,range,6.5,14.5,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1253,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,3-6 mo old ,,6,serum concentration,1,day,10.5,ng/mL,median,,,range,7,22,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1254,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,6-12 mo old,,10,serum concentration,1,day,10,ng/mL,median,,,range,6,17,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1255,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,1-7 days old,,4,clearance,1,day,9.2,mL/kg/min,median,,,range,6.3,10.4,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1256,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,8-30 days old,,0,clearance,1,day,,mL/kg/min,median,,,range,,,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1257,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,1-3 mo old ,,6,clearance,1,day,25.3,mL/kg/min,median,,,range,21.7,33.3,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1258,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,3-6 mo old ,,6,clearance,1,day,31,mL/kg/min,median,,,range,18.9,59.5,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1259,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,6-12 mo old,,10,clearance,1,day,48.9,mL/kg/min,median,,,range,34.7,69.4,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1260,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,1-7 days old,,4,Clearance after cardiac surgery,1,day,5.5,mL/kg/min,median,,,range,3.2,8.4,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1261,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,8-30 days old,,0,Clearance after cardiac surgery,1,day,7.4,mL/kg/min,median,,,range,3.4,13.8,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1262,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,1-3 mo old ,,6,Clearance after cardiac surgery,1,day,10.5,mL/kg/min,median,,,range,9.8,20.1,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1263,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,3-6 mo old ,,6,Clearance after cardiac surgery,1,day,13.9,mL/kg/min,median,,,range,8.3,24.1,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1264,2025-12-02T15:56:56.518041
9585276.0,Morphine,Morphine,blood,Infant,6-12 mo old,,10,Clearance after cardiac surgery,1,day,21.7,mL/kg/min,median,,,range,5.8,28.6,,"Blood was sampled twice on Postoperative Day 1 at times separated by at least 2 h,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1265,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,Remifentanil,maternal artery,maternal,delivery,,16,Concentration,,,1.32,ug/ml,mean,SD,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1266,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,Remifentanil,umbilical vein,fetal,delivery,,15,,,,0.73,ug/ml,,,0.27,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1267,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,Remifentanil,umbilical artery,fetal,delivery,,10,,,,0.2,ug/ml,,,0.07,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1268,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,Remifentanil,umbilical vein/maternal artery,fetal,delivery,,15,UV:MA ratio,,,0.88,,,,0.29,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1269,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,Remifentanil,umbilical artery/vein,fetal,delivery,,10,UA:UV ratio,,,0.29,,,,0.07,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1270,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,Remifentanil,plasma,,,,16,Clearance,,,93.1,ml/min/kg,,,71.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1271,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,remifentanil acid,maternal artery,maternal,delivery,,13,Concentration,,,2.42,ug/ml,,,1.55,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1272,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,remifentanil acid,umbilical vein,fetal,delivery,,12,,,,1.33,ug/ml,,,0.78,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1273,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,remifentanil acid,umbilical artery,fetal,delivery,,8,,,,1.47,ug/ml,,,0.84,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1274,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,remifentanil acid,umbilical vein/maternal artery,fetal,delivery,,10,UV:MA ratio,,,0.56,,,,0.29,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1275,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,remifentanil acid,umbilical artery/vein,fetal,delivery,,7,UA:UV ratio,,,1.18,,,,0.82,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1276,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,remifentanil acid,umbilical artery/maternal vein,fetal,delivery,,,UA:MV ratio,,,1.23,,,,0.89,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1277,2025-12-02T15:56:56.518041
9637638.0,Remifentanil,remifentanil acid,maternal artery,,,,,metabolite:drug ratio,,,2.92,,,,3.65,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1278,2025-12-02T15:56:56.518041
9662490.0,morphine,morphine,umbilical vein blood,fetal,delivery,,10,Concentration,,,0.5,nmol/l,mean,SD,0.1,,,,,"Group 1, vaginal delivery no analgesia",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1279,2025-12-02T15:56:56.518041
9662490.0,morphine,morphine,umbilical vein blood,fetal,delivery,,12,Concentration,,,69.5,,,,15,,,,,"Group 2, vaginal delivery morphine administration",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1280,2025-12-02T15:56:56.518041
9662490.0,morphine,morphine,umbilical vein blood,fetal,delivery,,11,Concentration,,,33.8,,,,8,,,,,"Group 3, cesarean section in labor",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1281,2025-12-02T15:56:56.518041
9662490.0,morphine,morphine,umbilical vein blood,fetal,delivery,,11,Concentration,,,0.7,,,,0.2,,,,,"Group 4, cesarean section before labor",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1282,2025-12-02T15:56:56.518041
9662490.0,oxytocin,oxytocin,umbilical vein blood,fetal,delivery,,10,Concentration,,,6.3,pmol/l,,,0.74,,,,,There was no difference between the log oxytocin (A/V) values of any of the four groups of patients (F=0.51),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1283,2025-12-02T15:56:56.518041
9662490.0,oxytocin,,,,,,12,Concentration,,,8.2,,,,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1284,2025-12-02T15:56:56.518041
9662490.0,oxytocin,,,,,,11,Concentration,,,8,,,,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1285,2025-12-02T15:56:56.518041
9662490.0,oxytocin,,,,,,11,Concentration,,,5.4,,,,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1286,2025-12-02T15:56:56.518041
9662490.0,oxytocin,,plasma,maternal,,,10,Concentration,,,5.7,pmol/l,,,0.4,,,,0.07,p across the 4 groups,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1287,2025-12-02T15:56:56.518041
9662490.0,oxytocin,,,,,,12,Concentration,,,7.6,,,,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1288,2025-12-02T15:56:56.518041
9662490.0,oxytocin,,,,,,11,Concentration,,,6,,,,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1289,2025-12-02T15:56:56.518041
9662490.0,oxytocin,,,,,,11,Concentration,,,4.7,,,,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1290,2025-12-02T15:56:56.518041
9662490.0,oxytocin,,umbilical artery blood,fetal,delivery,,10,Concentration,,,22.1,,,,2.4,,,,,"In summary, there was no change in the log umbilical (A/V) concentration of oxytocin if morphine had been given to the mother in labour; this applied to fetuses delivered vaginally or by Caesarean section.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1291,2025-12-02T15:56:56.518041
9662490.0,oxytocin,,,,,,12,Concentration,,,23.2,,,,2.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1292,2025-12-02T15:56:56.518041
9662490.0,oxytocin,,,,,,11,Concentration,,,22.1,,,,3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1293,2025-12-02T15:56:56.518041
9662490.0,oxytocin,,,,,,11,Concentration,,,15.1,,,,1.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1294,2025-12-02T15:56:56.518041
9667297.0,bupivacaine,bupivacaine,plasma,maternal,,,28,Concentration,,,0.497,ug/ml,mean,SD,0.174,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1295,2025-12-02T15:56:56.518041
9667297.0,bupivacaine,,,,,,33,Concentration,,,0.251,,,,0.143,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1296,2025-12-02T15:56:56.518041
9667297.0,bupivacaine,,umbilical vein plasma,fetal,delivery,,31,Concentration,,,0.197,,,,0.097,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1297,2025-12-02T15:56:56.518041
9667297.0,bupivacaine,,,,,,46,Concentration,,,0.091,,,,0.04,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1298,2025-12-02T15:56:56.518041
9667297.0,fentanyl,fentanyl,plasma,maternal,,,29,Concentration,,,0.226,ng/ml,,,0.115,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1299,2025-12-02T15:56:56.518041
9667297.0,fentanyl,,umbilical vein plasma,fetal,delivery,,48,Concentration,,,0.077,,,,0.061,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1300,2025-12-02T15:56:56.518041
10064669.0,fentanyl,fentanyl 25 ug/h,plasma,children,,,11,Cmax,,,0.91,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1301,2025-12-02T15:56:56.518041
10064669.0,fentanyl,fentanyl 25 ug/h,,,,,,Tmax,,,,hours,,,,range,18,>66,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1302,2025-12-02T15:56:56.518041
10064669.0,fentanyl,fentanyl 200 ug/h,,,,,,Cmax,,,39.3,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1303,2025-12-02T15:56:56.518041
10512263.0,remifentanil,remifentanil,plasma,children,,,12,prebypass Vss,,,234.5,ml/kg,mean,SD,105.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1304,2025-12-02T15:56:56.518041
10512263.0,remifentanil,,,,,,,prebypass Vc,,,72.7,ml/kg,,,31.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1305,2025-12-02T15:56:56.518041
10512263.0,remifentanil,,,,,,,prebypass CL,,,38.7,ml/kg/min,,,9.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1306,2025-12-02T15:56:56.518041
10512263.0,remifentanil,,,,,,,prebypass t1/2a,,,0.73,min,,,0.31,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1307,2025-12-02T15:56:56.518041
10512263.0,remifentanil,,,,,,,prebypass t1/2b,,,8.2,min,,,3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1308,2025-12-02T15:56:56.518041
10512263.0,remifentanil,,,,,,,postbypass Vss,,,235.3,,,,110.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1309,2025-12-02T15:56:56.518041
10512263.0,remifentanil,,,,,,,postbypass Vc,,,83.5,,,,26.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1310,2025-12-02T15:56:56.518041
10512263.0,remifentanil,,,,,,,postbypass CL,,,46.8,,,,14,,,,<0.05," A negative correlation is noted between increasing PCA/Css (r = 0.55, P < .001).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1311,2025-12-02T15:56:56.518041
10512263.0,remifentanil,,,,,,,postbypass t1/2a,,,0.63,,,,0.27,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1312,2025-12-02T15:56:56.518041
10512263.0,remifentanil,,,,,,,postbypass t1/2b,,,6.9,,,,2.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1313,2025-12-02T15:56:56.518041
10512263.0,remifentanil,,,,,,,AUC20/AUCinf,,,0.95,,,,0.03,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1314,2025-12-02T15:56:56.518041
10518075.0,morphine,morphine,plasma,preterm,,,9,Css,,,207.1,ng/ml,mean,SD,99.4,,,,0.002,"p value for PCA 1 vs. 2,3,4",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1315,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,13,,,,130.2,,,,34.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1316,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,13,,,,108.4,,,,54.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1317,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,3,,,,74.2,,,,46,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1318,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,9,CL,,,2.27,ml/min/kg,,,1.07,,,,0.023,p value for PCA 1 vs. 3/4 (p<0.001),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1319,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,13,,,,3.21,,,,1.57,,,,,"Regression analysis indicated a positive correlation between increasing PCA/Cl (r = 0.63, P < .001).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1320,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,13,,,,4.51,,,,1.97,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1321,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,3,,,,7.8,,,,2.67,,,,<0.001,"p value for PCA 4 vs 1,2,3",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1322,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,10,ke,,,0.066,/hour,,,0.046,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1323,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,16,,,,0.081,,,,0.027,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1324,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,13,,,,0.114,,,,0.049,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1325,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,3,,,,0.12,,,,0.077,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1326,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,10,t1/2,,,13.5,hours,,,8.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1327,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,13,,,,9.2,,,,2.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1328,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,13,,,,7,,,,2.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1329,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,3,,,,7.7,,,,4.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1330,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,9,Vd,,,2.22,l/kg,,,0.67,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1331,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,16,,,,2.44,,,,1.01,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1332,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,12,,,,2.34,,,,0.69,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1333,2025-12-02T15:56:56.518041
10518075.0,morphine,,,,,,2,,,,3.83,,,,3.32,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1334,2025-12-02T15:56:56.518041
10562792.0,Fentanyl,fentanyl,brain,Fetal,Trimester 1 (T1),,7,Concentration,,,1.5,ng/g,median,,,,,,,p=0.16,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1335,2025-12-02T15:56:56.518041
10562792.0,Fentanyl,,placenta,Fetal,Trimester 1 (T1),,7,Concentration,,,4.5,ng/g,,,,,,,,concentration from the same 7 subjects with brain samples,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1336,2025-12-02T15:56:56.518041
10562792.0,Fentanyl,,amniotic fluid,Fetal,Trimester 1 (T1),,38,Concentration,,,<0.1,ng/ml,,,,,,,,undetectable in all samples,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1337,2025-12-02T15:56:56.518041
10597891.0,Morphine,morphine,placenta,Maternal,Delivery,,4,Extraction,,,0.73,ng/ml/min,mean,SD,0.44,,,,0.89,compared to morphine-naloxone,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1338,2025-12-02T15:56:56.518041
10597891.0,Morphine,,,Fetal,,,,Transfer,,,0.3,ng/ml/min,,,0.19,,,,0.15,compared to morphine-naloxone,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1339,2025-12-02T15:56:56.518041
10597891.0,Morphine,,,Maternal,,,,Concentration,,,9.78,ng/ml,,,6.17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1340,2025-12-02T15:56:56.518041
10597891.0,Morphine,,,Fetal,,,,Concentration,,,3.43,ng/ml,,,2.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1341,2025-12-02T15:56:56.518041
10597891.0,Morphine,,,,,,,CL,,,0.89,ml/min,,,0.4,,,,0.92,compared to morphine-naloxone,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1342,2025-12-02T15:56:56.518041
10597891.0,Morphine,Antipyrine,,,,,,CL,,,1.44,ml/min,,,0.72,,,,0.93,compared to morphine-naloxone,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1343,2025-12-02T15:56:56.518041
10597891.0,Morphine,,,,,,,Clearance index,,,0.63,%,,,0.08,,,,0.99,compared to morphine-naloxone,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1344,2025-12-02T15:56:56.518041
10597891.0,Morphine,hCG,,Maternal,,,,accumulation,,,0.44,mIU/ml/g/min,,,0.19,,,,0.46,"control 1 period, p for the 3 values compared to morphine naloxone",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1345,2025-12-02T15:56:56.518041
10597891.0,Morphine,,,,,,,,,,0.32,,,,0.25,,,,,experimental 1 period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1346,2025-12-02T15:56:56.518041
10597891.0,Morphine,,,,,,,,,,0.12,,,,0.08,,,,,control 2 period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1347,2025-12-02T15:56:56.518041
10597891.0,Morphine,hCG,maternal vein,Maternal,,,,Concentration,,,10.13,mIU/ml/g,,,9.61,,,,>0.05,p for 2 values compared to morphine-naloxone ,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1348,2025-12-02T15:56:56.518041
10597891.0,Morphine,,Fetal vein,Fetal,,,,,,,0.13,,,,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1349,2025-12-02T15:56:56.518041
10597891.0,Morphine,Lactate,Placenta,,,,,Total production,,,0.02,mg/dl/g/min,,,0.01,,,,0.84,"control 1 period, p for the 3 values compared to morphine naloxone",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1350,2025-12-02T15:56:56.518041
10597891.0,Morphine,,,,,,,,,,0.02,,,,0.01,,,,,experimental 1 period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1351,2025-12-02T15:56:56.518041
10597891.0,Morphine,,,,,,,,,,0.01,,,,0.01,,,,,control 2 period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1352,2025-12-02T15:56:56.518041
10597891.0,Morphine,Glucose,,,,,,Total consumption,,,0.03,mg/dl/g/min,,,0.01,,,,0.19,"control 1 period, p for the 3 values compared to morphine naloxone",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1353,2025-12-02T15:56:56.518041
10597891.0,Morphine,,,,,,,,,,0.02,,,,0.01,,,,,experimental 1 period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1354,2025-12-02T15:56:56.518041
10597891.0,Morphine,,,,,,,,,,0.04,,,,0.01,,,,,control 2 period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1355,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,morphine,placenta,Maternal,,,5,Extraction,,,0.69,ng/ml/min,,,0.26,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1356,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,,Fetal,,,,Transfer,,,0.16,ng/ml/min,,,0.05,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1357,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,,Maternal,,,,Concentration,,,10.04,ng/ml,,,3.89,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1358,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,,Fetal,,,,Concentration,,,4.16,ng/ml,,,1.64,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1359,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,,,,,,CL,,,0.87,ml/min,,,0.27,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1360,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,Antipyrine,,,,,,CL,,,1.48,ml/min,,,0.48,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1361,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,,,,,,Clearance index,,,0.64,%,,,0.26,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1362,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,hCG,,Maternal,,,,accumulation,,,0.42,mIU/ml/g/min,,,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1363,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,,,,,,,,,0.3,,,,0.23,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1364,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,,,,,,,,,0.23,,,,0.26,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1365,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,hCG,maternal vein,Maternal,,,,Concentration,,,9.97,mIU/ml/g,,,5.16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1366,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,Fetal vein,Fetal,,,,,,,0.24,,,,0.19,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1367,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,Lactate,Placenta,,,,,Total production,,,0.02,,,,0.01,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1368,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,,,,,,,,,0.02,,,,0.01,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1369,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,,,,,,,,,0.02,,,,0.01,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1370,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,Glucose,,,,,,Total consumption,,,0.03,,,,0.01,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1371,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,,,,,,,,,0.02,,,,0.02,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1372,2025-12-02T15:56:56.518041
10597891.0,Morphine-naloxone,,,,,,,,,,0.04,,,,0.03,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1373,2025-12-02T15:56:56.518041
10631963.0,Methadone,methadone,plasma,Maternal,Trimester 3 (T3),,11,k,1,day,0.044,/hr,mean,SD,0.02,,,,<0.04,"Phase I taper, p value for k values over time",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1374,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,Nonpregnant,,5,k,1,day,0.034,/hr,,,0.01,,,,0,"Phase I taper, p value for k in non-pregnant women",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1375,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Maternal,Trimester 3 (T3),,11,k,10,day,0.023,/hr,,,0.002,,,,,Phase I taper,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1376,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,Nonpregnant,,5,k,10,day,0.018,/hr,,,0.01,,,,,Phase I taper,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1377,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Maternal,Trimester 3 (T3),,11,t1/2,,,19,hours (h),,,,,,,,Phase I,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1378,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,Nonpregnant,,5,t1/2,,,30,hours (h),,,,,,,,Phase I,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1379,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Maternal,Trimester 3 (T3),,12,k,,,0.078,/hr,,,0.069,,,,0.12,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1380,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,Nonpregnant,,11,k,,,0.042,/hr,,,0.024,,,,,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1381,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Maternal,Trimester 3 (T3),,12,ka,,,1.32,/hr,,,1,,,,0.23,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1382,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,Nonpregnant,,11,ka,,,2.6,/hr,,,3.6,,,,,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1383,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Maternal,Trimester 3 (T3),,12,Tmax,,,5.3,hours (h),,,7.5,,,,0.32,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1384,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,Nonpregnant,,11,Tmax,,,2.8,hours (h),,,1.3,,,,,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1385,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Maternal,Trimester 3 (T3),,12,Cmax,,,210,ng/ml,,,114,,,,0.09,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1386,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,Nonpregnant,,11,Cmax,,,301,ng/ml,,,128,,,,,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1387,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Maternal,Trimester 3 (T3),,12,V/F,,,165,liters (I),,,36,,,,0.21,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1388,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,Nonpregnant,,11,V/F,,,144,liters (I),,,41,,,,,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1389,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Maternal,Trimester 3 (T3),,12,CL/F,,,148,ml/min,,,53,,,,0.05,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1390,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,Nonpregnant,,11,CL/F,,,95,ml/min,,,56,,,,,Phase II,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1391,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,14,k,,,0.069,/hr,,,0.073,,,,0.44,Phase II steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1392,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,9,k,,,0.048,/hr,,,0.017,,,,,Phase II non-steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1393,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,14,ka,,,1.32,/hr,,,1.2,,,,0.44,Phase II steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1394,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,9,ka,,,1.32,/hr,,,0.12,,,,,Phase II non-steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1395,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,14,Tmax,,,376,hours (h),,,541,,,,0.47,Phase II steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1396,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,9,Tmax,,,149,hours (h),,,20,,,,,Phase II non-steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1397,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,14,Cmax,,,239,ng/ml,,,120,,,,0.24,Phase II steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1398,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,9,Cmax,,,123,ng/ml,,,75,,,,,Phase II non-steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1399,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,14,V/F,,,159,liters (I),,,33,,,,0.36,Phase II steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1400,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,9,V/F,,,181,liters (I),,,52,,,,,Phase II non-steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1401,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,14,CL/F,,,136,ml/min,,,51,,,,0.62,Phase II steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1402,2025-12-02T15:56:56.518041
10631963.0,Methadone,,,Adult,,,9,CL/F,,,171,ml/min,,,70,,,,,Phase II non-steady state,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1403,2025-12-02T15:56:56.518041
10793594.0,Tramadol,IV tramadol,plasma,children,,,9,Cmax,,,1079,ng/ml,mean,SD,442,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1404,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,Tmax,,,0.19,hours,,,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1405,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,concentration,4,h,369,ng/ml,,,133,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1406,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,AUC,,,5738,ng/ml*h,,,2794,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1407,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,t1/2,,,6.4,hours,,,2.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1408,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,Cltot,,,6.1,ml/min/kg,,,2.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1409,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,Vdbeta,,,3.1,l/kg,,,1.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1410,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,mean residence time,,,8.5,hours,,,3.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1411,2025-12-02T15:56:56.518041
10793594.0,Tramadol,caudal tramadol,,,,,5,Cmax,,,709,,,,259,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1412,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,Tmax,,,0.55,,,,0.11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1413,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,concentration,4,h,411,ng/ml,,,106,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1414,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,AUC,,,4774,,,,1581,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1415,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,t1/2,,,3.7,,,,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1416,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,Cltot,,,6.6,,,,1.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1417,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,Vdbeta,,,2,,,,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1418,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,mean residence time,,,6.5,,,,1.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1419,2025-12-02T15:56:56.518041
10793594.0,Tramadol,IV O-demethyl tramadol,,,,,9,Cmax,,,63.9,,,,30.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1420,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,Tmax,,,4.9,,,,1.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1421,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,AUC,,,1172,,,,597,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1422,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,t1/2,,,10.6,,,,8.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1423,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,mean residence time,,,17.6,,,,12.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1424,2025-12-02T15:56:56.518041
10793594.0,Tramadol,caudal O-demethyl tramadol,,,,,5,Cmax,,,40.3,,,,4.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1425,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,Tmax,,,6.4,,,,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1426,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,AUC,,,556,,,,129,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1427,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,t1/2,,,5.4,,,,2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1428,2025-12-02T15:56:56.518041
10793594.0,Tramadol,,,,,,,mean residence time,,,10.8,,,,2.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1429,2025-12-02T15:56:56.518041
10839874.0,fentanyl,fentanyl,serum,newborn,,,38,concentration,2,hours,1.4,ng/ml,mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1430,2025-12-02T15:56:56.518041
10839874.0,fentanyl,,,,,,,steady-state concentration,24-48,hours,2.5,,,,1,,,,<0.01,"The fentanyl steady-state concentration correlated significantly with the pain score during the second day of life (r = -0.57, P < .01).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1431,2025-12-02T15:56:56.518041
10839874.0,fentanyl,,,,,,,CL,,,11.5,ml/min/kg,,,4,range,4.6,18.5,<0.01,"The fentanyl clearance correlated significantly with gestational age (r = 0.46, P < .01)/birth weight (r = 0.48, P < .01) ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1432,2025-12-02T15:56:56.518041
10942481.0,morphine,morphine,plasma,maternal,,,10,concentration,,,41.8,ng/ml,mean,SD,14.6,range,23.9,60.4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1433,2025-12-02T15:56:56.518041
10942481.0,morphine,,cord blood,fetal,delivery,,10,,,,25.5,,,,11.6,,8.1,47,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1434,2025-12-02T15:56:56.518041
10942481.0,morphine,,plasma/cord blood,fetal,delivery,,,fetal:maternal ratio,,,0.61,,,,0.2,,0.33,0.97,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1435,2025-12-02T15:56:56.518041
10962165.0,morphine,morphine,plasma,preterm,,,9,,1,hours,44.5,ng/ml,mean,SD,9.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1436,2025-12-02T15:56:56.518041
10962165.0,morphine,,,,,,9,,2,,65,,,,17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1437,2025-12-02T15:56:56.518041
10962165.0,morphine,,,,,,9,,12,,98,,,,14.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1438,2025-12-02T15:56:56.518041
10962165.0,morphine,M3G,,,,,9,,1,hours,23.6,,,,5.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1439,2025-12-02T15:56:56.518041
10962165.0,morphine,,,,,,9,,2,,33.8,,,,11.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1440,2025-12-02T15:56:56.518041
10962165.0,morphine,,,,,,9,,12,,56.8,,,,12.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1441,2025-12-02T15:56:56.518041
10962165.0,morphine,M6G,,,,,6,,12,hours,1.6,,median,,,range,0,4.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1442,2025-12-02T15:56:56.518041
10976547.0,morphine,morphine,serum,newborn,,,31,concentration,2,hours,105,ng/ml,mean,SD,49,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1443,2025-12-02T15:56:56.518041
10976547.0,morphine,,,,,,31,steady-state concentration,24-48,hours,167,,,,77,,,,,The steady-state concentration was achieved between 24/48 hours in 26 infants/before 24 hours in 5 infants.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1444,2025-12-02T15:56:56.518041
10976547.0,morphine,,,,,,,CL,,,2.4,ml/min/kg,,,1.1,range,0.8,6.4,<0.01,"The clearance correlated significantly with gestational age (r = 0.6, P < .01)/birth weight (r = 0.55, P < .01) ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1445,2025-12-02T15:56:56.518041
10976547.0,morphine,,,,,,,concentration,,,187,ng/ml,,,82,,,,<0.05,higher steady-state morphine concentration in infants with decreased gastrointestinal motility vs those with normal motility.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1446,2025-12-02T15:56:56.518041
10976547.0,morphine,,,,,,,,,,128,,,,51,,,,,normal motility,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1447,2025-12-02T15:56:56.518041
10976547.0,morphine,morphine/M6G,,,,,,,,,200,,,,75,,,,,with pain relief,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1448,2025-12-02T15:56:56.518041
10976547.0,morphine,,,,,,,,,,195,,,,70,,,,,without pain relief,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1449,2025-12-02T15:56:56.518041
10976547.0,morphine,M3G,,,,,,,,,251,,,,54,,,,,with pain relief,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1450,2025-12-02T15:56:56.518041
10976547.0,morphine,,,,,,,,,,198,,,,80,,,,,without pain relief,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1451,2025-12-02T15:56:56.518041
10976547.0,morphine,M6G,,,,,,,,,48,,,,25,,,,,with pain relief,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1452,2025-12-02T15:56:56.518041
10976547.0,morphine,,,,,,,,,,49,,,,25,,,,,without pain relief,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1453,2025-12-02T15:56:56.518041
11064622.0,fentanyl,fentanyl,plasma,children,,,6,Cmax,,,0.2195,ng/ml,,,,range,0.117,0.247,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1454,2025-12-02T15:56:56.518041
11064622.0,fentanyl,,,,,,,Tmax,,,30,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1455,2025-12-02T15:56:56.518041
11064622.0,sufentanil,sufentanil,,,,,6,Cmax,,,0.041,ng/ml,,,,,0.027,0.074,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1456,2025-12-02T15:56:56.518041
11064622.0,sufentanil,,,,,,,Tmax,,,20,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1457,2025-12-02T15:56:56.518041
11098103.0,morphine,morphine,blood,infant,0-7 days,,6,concentration,,,16.4,ng/ml,median,,,range,0.5,29,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1458,2025-12-02T15:56:56.518041
11098103.0,,,,,8-30 days,,1,concentration,,,15,ng/ml,median,,,range,,,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1459,2025-12-02T15:56:56.518041
11098103.0,,,,,31-90 days,,8,concentration,,,9.8,ng/ml,median,,,range,6.5,19,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1460,2025-12-02T15:56:56.518041
11098103.0,,,,,91-180 days,,12,concentration,,,11.8,ng/ml,median,,,range,7,22.5,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1461,2025-12-02T15:56:56.518041
11098103.0,,,,,181-365 days,,18,concentration,,,12.5,ng/ml,median,,,range,7.5,23.5,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1462,2025-12-02T15:56:56.518041
11098103.0,morphine,Morphine-6-glucuronide,blood,infant,0-7 days,,6,concentration,,,20.7,ng/ml,median,,,range,7.3,31.7,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1463,2025-12-02T15:56:56.518041
11098103.0,,,,,8-30 days,,1,concentration,,,22,ng/ml,median,,,range,,,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1464,2025-12-02T15:56:56.518041
11098103.0,,,,,31-90 days,,8,concentration,,,17,ng/ml,median,,,range,10,73.5,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1465,2025-12-02T15:56:56.518041
11098103.0,,,,,91-180 days,,12,concentration,,,24.3,ng/ml,median,,,range,11.5,44,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1466,2025-12-02T15:56:56.518041
11098103.0,,,,,181-365 days,,18,concentration,,,18,ng/ml,median,,,range,10,53,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1467,2025-12-02T15:56:56.518041
11098103.0,morphine,morphine,blood,infant,0-7 days,,6,clearance during i.v. infusions (steady-state),,,9.8,ml/min/kg,median,,,range,6.3,16,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1468,2025-12-02T15:56:56.518041
11098103.0,,,,,8-30 days,,1,clearance during i.v. infusions (steady-state),,,13.3,ml/min/kg,median,,,range,,,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1469,2025-12-02T15:56:56.518041
11098103.0,,,,,31-90 days,,8,clearance during i.v. infusions (steady-state),,,23.9,ml/min/kg,median,,,range,16.7,33.3,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1470,2025-12-02T15:56:56.518041
11098103.0,,,,,91-180 days,,12,clearance during i.v. infusions (steady-state),,,32.3,ml/min/kg,median,,,range,18.5,52.1,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1471,2025-12-02T15:56:56.518041
11098103.0,,,,,181-365 days,,18,clearance during i.v. infusions (steady-state),,,38.1,ml/min/kg,median,,,range,18,69.4,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1472,2025-12-02T15:56:56.518041
11098103.0,morphine,morphine,blood,infant,,,27,,,,,ng/ml,,,,range,0,33,,bolus group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1473,2025-12-02T15:56:56.518041
11098103.0,morphine,Morphine-6-glucuronide,blood,infant,,,27,,,,,ng/ml,,,,range,0,97,,bolus group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1474,2025-12-02T15:56:56.518041
11121932.0,fentanyl,fentanyl,plasma,pediatric,,,8,Tmax,,,18,h,median,coefficient of variation,,IQR,9,24,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1475,2025-12-02T15:56:56.518041
11121932.0,fentanyl,,,,,,,Cmax,,,1.64,ng/ml,,,38.8,,1.3,2.05,0.049,Maximal plasma concentration of fentanyl was negatively correlated with  patient  age  (r=-0.71;r2=0.50;  p=0.049),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1476,2025-12-02T15:56:56.518041
11121932.0,fentanyl,,,,,,,AUC,,,91.75,ng/ml*h,,,31.8,,63,107.5,0.0016,A negative correlation was found between AUC/patient age (r=-0.91;r2=0.83; p=0.0016)/between AUC/the calculated delivery rate of fentanyl (r=0.88;r2=0.77;  p=0.039). ,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1477,2025-12-02T15:56:56.518041
11121932.0,fentanyl,,,,,,,t1/2,,,14.4,h,,,42.7,,8.28,19.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1478,2025-12-02T15:56:56.518041
11121932.0,fentanyl,,,,,,,Css,,,1.32,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1479,2025-12-02T15:56:56.518041
11153342.0,Methadone,methadone,breast milk,Maternal,Postpartum,,8,Concentration,,,95,ng/ml,mean,SD,60,range,27,260,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1480,2025-12-02T15:56:56.518041
11153342.0,Methadone,,,Neonate,,,8,calculated ingestible dose,,,0.05,mg/day,mean,,,,,,,based on intake of 475 ml/day of breast milk,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1481,2025-12-02T15:56:56.518041
11726413.0,remifentanil,remifentanil,plasma,infants,0-2 months,,8,Cmax,,,24.2,ng/ml,mean,SD,10.2,range,16,42,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1482,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,Vdss,,,452.8,ml/kg,,,144.7,,191,610,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1483,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,CL,,,90.5,ml/min/kg,,,36.8,,47,170,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1484,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,t1/2,,,5.4,min,,,1.8,,3,8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1485,2025-12-02T15:56:56.518041
11726413.0,remifentanil,remifentanil,,toddlers,0.17-2 years,,6,Cmax,,,25.4,,,,3.7,,20,30,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1486,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,Vdss,,,307.9,,,,89.2,,180,405,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1487,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,CL,,,92.1,,,,25.8,,60,123,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1488,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,t1/2,,,3.4,,,,1.19,,2,6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1489,2025-12-02T15:56:56.518041
11726413.0,remifentanil,remifentanil,,children,2-6 years,,7,Cmax,,,34.8,,,,8.2,,24,47,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1490,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,Vdss,,,240.1,,,,130.5,,110,456,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1491,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,CL,,,76,,,,22.4,,37,101,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1492,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,t1/2,,,3.6,,,,1.19,,1,6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1493,2025-12-02T15:56:56.518041
11726413.0,remifentanil,GR90291,,,,,7,Cmax,,,5.8,,,,1.1,,4,7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1494,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,t1/2,,,81,,,,44.6,,42,165,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1495,2025-12-02T15:56:56.518041
11726413.0,remifentanil,remifentanil,,children,7-12 years,,6,Cmax,,,42.5,,,,13.7,,30,68,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1496,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,Vdss,,,248.9,,,,91.4,,150,388,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1497,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,CL,,,59.7,,,,22.5,,36,92,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1498,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,t1/2,,,5.3,,,,1.4,,3,7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1499,2025-12-02T15:56:56.518041
11726413.0,remifentanil,GR90291,,,,,7,Cmax,,,6.9,,,,2.1,,4,11,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1500,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,t1/2,,,64.2,,,,25.7,,37,106,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1501,2025-12-02T15:56:56.518041
11726413.0,remifentanil,remifentanil,,adolescents,13-16 years,,4,Cmax,,,35,,,,10.2,,22,46,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1502,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,Vdss,,,223.2,,,,30.6,,180,250,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1503,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,CL,,,57.2,,,,21.1,,32,82,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1504,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,t1/2,,,3.7,,,,1.1,,2,5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1505,2025-12-02T15:56:56.518041
11726413.0,remifentanil,GR90291,,,,,3,Cmax,,,6.5,,,,1,,5,7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1506,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,t1/2,,,55.5,,,,26.9,,25,77,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1507,2025-12-02T15:56:56.518041
11726413.0,remifentanil,remifentanil,,adolescents,16-18 years,,3,Cmax,,,42.7,,,,12.9,,28,51,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1508,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,Vdss,,,242.5,,,,109.2,,157,365,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1509,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,CL,,,46.5,,,,2.1,,44,48,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1510,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,t1/2,,,5.7,,,,0.7,,5,6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1511,2025-12-02T15:56:56.518041
11726413.0,remifentanil,GR90291,,,,,3,Cmax,,,10.7,,,,6.6,,6,18,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1512,2025-12-02T15:56:56.518041
11726413.0,remifentanil,,,,,,,t1/2,,,103.2,,,,75.4,,50,190,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1513,2025-12-02T15:56:56.518041
11736879.0,methadone,R-methadone,immature milk/plasma,maternal,,,8,milk:plasma AUC,,,0.68,,mean,SD,0.25,95% CI,0.48,0.89,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1514,2025-12-02T15:56:56.518041
11736879.0,methadone,,,infant,,,8,relative infant dose,,,3.54,%,,,1.83,,2,5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1515,2025-12-02T15:56:56.518041
11736879.0,methadone,,plasma,,,,8,average concentration,,,222,ug/l,,,,,171,273,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1516,2025-12-02T15:56:56.518041
11736879.0,methadone,S-methadone,immature milk/plasma,maternal,,,8,milk:plasma AUC,,,0.38,,,,0.15,,0.26,0.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1517,2025-12-02T15:56:56.518041
11736879.0,methadone,,,infant,,,8,relative infant dose,,,2.09,,,,0.91,,1.3,2.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1518,2025-12-02T15:56:56.518041
11736879.0,methadone,,plasma,,,,8,average concentration,,,246,,,,,,158,334,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1519,2025-12-02T15:56:56.518041
11752093.0,sufentanil,,placenta,maternal,delivery,,5,hCG release,2,hrs,88,%,mean,SD,10.2,,,,,"% of control period, control placenta",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1520,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,hCG release,2,hrs,87,%,,,16.9,,,,,"% of control period, 0.5 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1521,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,hCG release,2,hrs,103,%,,,13.1,,,,,"% of control period, 2.5 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1522,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,hCG release,2,hrs,114,%,,,42.2,,,,,"% of control period, 10 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1523,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,hCG release,2,hrs,ND,%,,,ND,,,,,"% of control period, 15 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1524,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,hCG release,2,hrs,187,%,,,60.8,,,,<0.01,"% of control period, 30 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1525,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,,placenta,maternal,,,5,O2 consumption,4,hrs,4.06,ml/min*kg,,,1.6,,,,,"experimental period, control placenta",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1526,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,O2 consumption,4,hrs,3.12,ml/min*kg,,,1.2,,,,,"experimental period, 0.5 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1527,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,O2 consumption,4,hrs,3.4,ml/min*kg,,,1.11,,,,,"experimental period, 2.5 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1528,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,O2 consumption,4,hrs,3.9,ml/min*kg,,,0.52,,,,,"experimental period, 10 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1529,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,O2 consumption,4,hrs,3.87,ml/min*kg,,,0.6,,,,,"experimental period, 15 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1530,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,O2 consumption,4,hrs,3.31,ml/min*kg,,,0.63,,,,,"experimental period, 30 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1531,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,,placenta,maternal,,,5,glucose consumption,4,hrs,0.393,micromol/min*g,,,0.09,,,,,"experimental period, control placenta",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1532,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,glucose consumption,4,hrs,0.304,micromol/min*g,,,0.11,,,,,"experimental period, 0.5 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1533,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,glucose consumption,4,hrs,0.302,micromol/min*g,,,0.08,,,,,"experimental period, 2.5 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1534,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,glucose consumption,4,hrs,0.286,micromol/min*g,,,0.07,,,,,"experimental period, 10 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1535,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,glucose consumption,4,hrs,0.402,micromol/min*g,,,0.07,,,,,"experimental period, 15 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1536,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,glucose consumption,4,hrs,0.361,micromol/min*g,,,0.06,,,,,"experimental period, 30 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1537,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,,placenta,maternal,,,5,lactate production,4,hrs,0.359,micromol/min*g,,,0.09,,,,,"experimental period, control placenta",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1538,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,lactate production,4,hrs,0.378,micromol/min*g,,,0.07,,,,,"experimental period, 0.5 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1539,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,lactate production,4,hrs,0.384,micromol/min*g,,,0.03,,,,,"experimental period, 2.5 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1540,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,lactate production,4,hrs,0.296,micromol/min*g,,,0.09,,,,,"experimental period, 10 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1541,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,lactate production,4,hrs,0.366,micromol/min*g,,,0.04,,,,,"experimental period, 15 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1542,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,maternal,,,5,lactate production,4,hrs,0.336,micromol/min*g,,,0.07,,,,,"experimental period, 30 ng/ml of BUP",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1543,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,norBUP,placenta,maternal,,,5,Kd,,,0.83,nM,,,0.23,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1544,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,norBUP,placenta,maternal,,,5,Bmax,,,79,fmol/mg of protein,,,25,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1545,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,tissue/plasma,maternal,,,5,concentration ratio,,,13.1,,,,6.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1546,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,Fetal,,,5,Concentration,,,0.88,ng/ml,,,0.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1547,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,Fetal,,,5,AUC fetal:maternal ratio,,,0.29,,,,0.007,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1548,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,Fetal,,,5,Lag time,,,5.83,min,,,2.34,,,,,at 10 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1549,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,Fetal,,,5,Transfer rate,,,11.65,%,,,2.5,,,,,at 10 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1550,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,Fetal,,,5,Clerance,,,0.29,ml/min,,,0.05,,,,,at 10 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1551,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,placenta,Fetal,,,5,Clearance index,,,0.277,,,,0.09,,,,,at 10 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1552,2025-12-02T15:56:56.518041
11752093.0,buprenorphine,buprenorphine,tissue/plasma,fetal,,,5,concentration ratio,,,27.4,,,,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1553,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,plasma,Maternal,Delivery,,7,Concentration,0,hours ((h),57,ng/ml,median,IQR,66,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1554,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,7,,0,,75,ng/ml,,,376,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1555,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,7,,12,,38,ng/ml,,,16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1556,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,7,,12,,26,ng/ml,,,161,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1557,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,7,,24,,37,ng/ml,,,54,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1558,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,7,,24,,408,ng/ml,,,293,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1559,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,7,,36,,18,ng/ml,,,48,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1560,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,7,,36,,693,ng/ml,,,562,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1561,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,7,,48,,60,ng/ml,,,71,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1562,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,7,,48,,362,ng/ml,median,IQR,187,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1563,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G/morphine,,,,,7,metabolite:drug cocentration,,,6.73,,mean,SD,1.32,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1564,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,colostrum,,Postpartum,,5,,0,,34,ng/ml,,,6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1565,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,5,,0,,273,ng/ml,,,414,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1566,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,4,,12,,24,ng/ml,,,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1567,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,4,,12,,672,ng/ml,,,823,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1568,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,4,,24,,7,ng/ml,,,10,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1569,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,4,,24,,426,ng/ml,,,127,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1570,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,3,,36,,6.5,ng/ml,,,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1571,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,3,,36,,527,ng/ml,,,577,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1572,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,5,,48,,21,ng/ml,,,23,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1573,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,5,,48,,350,ng/ml,,,213,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1574,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G/morphine,,,,,,metabolite:drug cocentration,,,38.76,,mean,SD,13.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1575,2025-12-02T15:56:56.518041
11772825.0,Morphine,Morphine,,,,,,calculated ingestible dose,,,0.0048,mg/100 ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1576,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,,calculated ingestible dose,,,0.1,mg/100 ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1577,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,breast milk/plasma,,Postpartum,,5,milk:plasma ratio,0,,0.41,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1578,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,5,,0,,1.18,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1579,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,4,,12,,0.62,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1580,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,4,,12,,2.73,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1581,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,4,,24,,0.14,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1582,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,4,,24,,1.04,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1583,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,3,,36,,0.1,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1584,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,3,,36,,0.76,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1585,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,5,,48,,0.34,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1586,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,5,,48,,0.96,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1587,2025-12-02T15:56:56.518041
11772825.0,Morphine,morphine,,,,,,,,,0.32,,mean,SD,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1588,2025-12-02T15:56:56.518041
11772825.0,Morphine,M6G,,,,,,,,,1.33,,,,0.25,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1589,2025-12-02T15:56:56.518041
12535033.0,morphine,morphine,plasma,infants,1-90 days,,10,concentration,,,32,ng/ml,median,,,IQR,14,48.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1590,2025-12-02T15:56:56.518041
12535033.0,morphine,,,,1-90 days,,10,CL,,,8.1,ml/min/kg,,,,,5,22.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1591,2025-12-02T15:56:56.518041
12535033.0,morphine,,,,1-7 days,,4,,,,5.2,,,,,,4.1,6.1,,infusion rate 11 ug/kg/h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1592,2025-12-02T15:56:56.518041
12535033.0,morphine,,,,8-30 days,,2,,,,16.6,,,,,,9.8,23.5,0.015,p values for significant differences by age. infusion rate 14 ug/kg/h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1593,2025-12-02T15:56:56.518041
12535033.0,morphine,,,,31-90 days,,2,,,,26.7,,,,,,19.9,33.4,0.015,infusion rate 19 ug/kg/h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1594,2025-12-02T15:56:56.518041
12535033.0,morphine,M6G,,,1-90 days,,10,concentration,,,31.5,ng/ml,,,,,22,33.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1595,2025-12-02T15:56:56.518041
12535033.0,morphine,morphine,plasma,infants,1-90 days,,10,concentration,,,20.5,ng/ml,,,,,9.8,36,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1596,2025-12-02T15:56:56.518041
12535033.0,morphine,,,,1-90 days,,10,CL,,,10.9,ml/min/kg,,,,,6.6,18.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1597,2025-12-02T15:56:56.518041
12535033.0,morphine,,,,1-7 days,,4,,,,7.5,,,,,,3.8,13.8,,infusion rate 11 ug/kg/h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1598,2025-12-02T15:56:56.518041
12535033.0,morphine,,,,8-30 days,,5,,,,11.4,,,,,,8.4,19,0.015,infusion rate 14 ug/kg/h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1599,2025-12-02T15:56:56.518041
12535033.0,morphine,,,,31-90 days,,1,,,,38.5,,,,,,,,0.015,infusion rate 19 ug/kg/h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1600,2025-12-02T15:56:56.518041
12535033.0,morphine,M6G,,,1-90 days,,10,concentration,,,26,ng/ml,,,,,16.8,39.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1601,2025-12-02T15:56:56.518041
12587803.0,hydromorphone,hydromorphone,plasma,maternal,postpartum,,8,Tmax,,,0.27,hours,mean,SD,0.08,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1602,2025-12-02T15:56:56.518041
12587803.0,hydromorphone,,,,,,,Cmax,,,5492,pg/ml,,,2115,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1603,2025-12-02T15:56:56.518041
12587803.0,hydromorphone,,,,,,,t1/2,,,11.1,hours,,,6.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1604,2025-12-02T15:56:56.518041
12587803.0,hydromorphone,,,,,,,AUC0-t,,,9627,pg/ml*h,,,1950,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1605,2025-12-02T15:56:56.518041
12587803.0,hydromorphone,,,,,,,AUC0-inf,,,10755,pg/ml*h,,,2047,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1606,2025-12-02T15:56:56.518041
12587803.0,hydromorphone,,,,,,,CLs/F,,,2.51,l/h/kg,,,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1607,2025-12-02T15:56:56.518041
12587803.0,hydromorphone,,breast milk,,,,8,t1/2,,,10.5,,,,5.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1608,2025-12-02T15:56:56.518041
12587803.0,hydromorphone,,,,,,,AUC0-t,,,24981,,,,7950,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1609,2025-12-02T15:56:56.518041
12587803.0,hydromorphone,,,,,,,AUC0-inf,,,28021,,,,8383,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1610,2025-12-02T15:56:56.518041
12587803.0,hydromorphone,,,,,,,% infant exposure,,,0.674,,,,0.21,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1611,2025-12-02T15:56:56.518041
12587803.0,hydromorphone,,breast milk/plasma,,,,8,milk:plasma ratio,,,2.56,,,,0.47,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1612,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,placenta,,,,4,concentration,Under the steady-state conditions of an open-open system,,34.5,ng/ml,mean,SD,1.43,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1613,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,4,lag time,Under the steady-state conditions of an open-open system,,7.15,min,mean,SD,1.75,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1614,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,fetal transfer rate,Under the steady-state conditions of an open-open system,,17.4,%,mean,SD,5.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1615,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,clearance,Under the steady-state conditions of an open-open system,,0.531,ml/min,mean,SD,0.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1616,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,clearance index,Under the steady-state conditions of an open-open system,,0.492,,mean,SD,0.11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1617,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,half life,Closed-Open System,,458,min,mean,SD,93.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1618,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,elimination rate constant,Closed-Open System,,1.5,/h,mean,SD,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1619,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,placenta,,,,at least 6,O2 Delivery in Experimental Period,60,min,12.51,ml/min*kg,mean,SD,4.56,,,,,"Effects of LAAM/norLAAM on oxygen delivery, transfer,/consumption during the 4-h experimental period relative to the initial 2-h control period (no opiates)",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1620,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,120,min,13.17,ml/min*kg,mean,SD,2.49,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1621,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,180,min,12.55,ml/min*kg,mean,SD,3.21,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1622,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,240,min,13.78,ml/min*kg,mean,SD,3.39,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1623,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,O2 Delivery (Percentage of Control Period),60,min,96,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1624,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,120,min,101,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1625,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,180,min,96,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1626,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,240,min,106,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1627,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,at least 6,O2 Transfer in Experimental Period,60,min,0.405,ml/min*kg,mean,SD,0.11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1628,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,120,min,0.389,ml/min*kg,mean,SD,0.16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1629,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,180,min,0.354,ml/min*kg,mean,SD,0.02,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1630,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,240,min,0.413,ml/min*kg,mean,SD,0.01,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1631,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,O2 Transfer (Percentage of Control Period),60,min,107,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1632,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,120,min,103,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1633,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,180,min,94,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1634,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,240,min,109,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1635,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,at least 6,O2 Consumption in Experimental Period,60,min,4.74,ml/min*kg,mean,SD,2.67,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1636,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,120,min,4.96,ml/min*kg,mean,SD,0.68,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1637,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,180,min,5.27,ml/min*kg,mean,SD,1.45,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1638,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,240,min,5.48,ml/min*kg,mean,SD,2.57,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1639,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,O2 Consumption (Percentage of Control Period),60,min,88,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1640,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,120,min,91,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1641,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,180,min,97,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1642,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,240,min,101,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1643,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,placenta,,,,at least 6,Glucose Consumption in Experimental Period,60,min,0.278,umol/min*g,mean,SD,0.16,,,,,Effect of LAAM/norLAAM on the viability parameters of the tissue during the 4-h experimental period relative to the initial 2-h control period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1644,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,120,min,0.231,umol/min*g,mean,SD,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1645,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,180,min,0.229,umol/min*g,mean,SD,0.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1646,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,240,min,0.21,umol/min*g,mean,SD,0.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1647,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,Glucose Consumption (Percentage of Control Period),60,min,95,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1648,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,120,min,78,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1649,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,180,min,77,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1650,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,240,min,70,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1651,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,at least 6,Lactate Production in Experimental Period,60,min,0.364,umol/min*g,mean,SD,0.16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1652,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,120,min,0.321,umol/min*g,mean,SD,0.12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1653,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,180,min,0.338,umol/min*g,mean,SD,0.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1654,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,240,min,0.298,umol/min*g,mean,SD,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1655,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,Lactate Production (Percentage of Control Period),60,min,97,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1656,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,120,min,86,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1657,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,180,min,83,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1658,2025-12-02T15:56:56.518041
12676878.0,L--Acetylmethadol,,,,,,,,240,min,80,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1659,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,placenta,,,,4,concentration,Under the steady-state conditions of an open-open system,,35.9,ng/ml,mean,SD,2.15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1660,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,4,lag time,Under the steady-state conditions of an open-open system,,6.81,min,mean,SD,4.16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1661,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,fetal transfer rate,Under the steady-state conditions of an open-open system,,26.9,%,mean,SD,6.77,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1662,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,clearance,Under the steady-state conditions of an open-open system,,0.821,ml/min,mean,SD,0.18,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1663,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,clearance index,Under the steady-state conditions of an open-open system,,0.799,,mean,SD,0.07,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1664,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,Closed-Open System,,357,min,mean,SD,52,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1665,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,Closed-Open System,,2,/h,mean,SD,0.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1666,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,placenta,,,,at least 6,O2 Delivery in Experimental Period,60,min,12.41,ml/min*kg,mean,SD,5.25,,,,,"Effects of LAAM/norLAAM on oxygen delivery, transfer,/consumption during the 4-h experimental period relative to the initial 2-h control period (no opiates)",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1667,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,120,min,13.16,ml/min*kg,mean,SD,5.05,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1668,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,180,min,12.7,ml/min*kg,mean,SD,4.16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1669,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,240,min,12.17,ml/min*kg,mean,SD,4.01,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1670,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,O2 Delivery (Percentage of Control Period),60,min,97,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1671,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,120,min,103,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1672,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,180,min,99,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1673,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,240,min,95,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1674,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,at least 6,O2 Transfer in Experimental Period,60,min,0.45,ml/min*kg,mean,SD,0.21,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1675,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,120,min,0.364,ml/min*kg,mean,SD,0.22,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1676,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,180,min,0.482,ml/min*kg,mean,SD,0.21,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1677,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,240,min,0.468,ml/min*kg,mean,SD,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1678,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,O2 Transfer (Percentage of Control Period),60,min,88,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1679,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,120,min,71,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1680,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,180,min,94,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1681,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,240,min,91,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1682,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,at least 6,O2 Consumption in Experimental Period,60,min,3.44,ml/min*kg,mean,SD,1.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1683,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,120,min,3.88,ml/min*kg,mean,SD,1.75,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1684,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,180,min,3.47,ml/min*kg,mean,SD,1.25,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1685,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,240,min,3.15,ml/min*kg,mean,SD,1.69,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1686,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,O2 Consumption (Percentage of Control Period),60,min,75,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1687,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,120,min,84,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1688,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,180,min,75,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1689,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,240,min,68,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1690,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,placenta,,,,at least 6,Glucose Consumption in Experimental Period,60,min,0.391,umol/min*g,mean,SD,0.11,,,,,Effect of LAAM/norLAAM on the viability parameters of the tissue during the 4-h experimental period relative to the initial 2-h control period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1691,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,120,min,0.341,umol/min*g,mean,SD,0.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1692,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,180,min,0.228,umol/min*g,mean,SD,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1693,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,240,min,0.205,umol/min*g,mean,SD,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1694,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,Glucose Consumption (Percentage of Control Period),60,min,103,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1695,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,120,min,90,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1696,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,180,min,60,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1697,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,240,min,54,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1698,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,at least 6,Lactate Production in Experimental Period,60,min,0.365,umol/min*g,mean,SD,0.12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1699,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,120,min,0.339,umol/min*g,mean,SD,0.07,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1700,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,180,min,0.261,umol/min*g,mean,SD,0.11,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1701,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,240,min,0.23,umol/min*g,mean,SD,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1702,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,Lactate Production (Percentage of Control Period),60,min,91,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1703,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,120,min,84,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1704,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,180,min,65,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1705,2025-12-02T15:56:56.518041
12676878.0,L--Acetyl-N-normethadol,,,,,,,,240,min,57,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1706,2025-12-02T15:56:56.518041
12779111.0,Tramadol,tramadol,plasma,children,,,24,Cmax,,,352,ng/ml,mean,SD,83.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1707,2025-12-02T15:56:56.518041
12779111.0,Tramadol,,,,,,,t1/2beta,,,3.6,hours,,,1.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1708,2025-12-02T15:56:56.518041
12779111.0,Tramadol,,,,,,,CL,,,5.6,hours,,,2.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1709,2025-12-02T15:56:56.518041
12779111.0,Tramadol,,,,,,,Vd,,,4.1,ml/min/kg,,,1.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1710,2025-12-02T15:56:56.518041
12779111.0,Tramadol,,,,,,,AUC,,,4268,l/kg,,,2098,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1711,2025-12-02T15:56:56.518041
12779111.0,Tramadol,M1,,,,,,Cmax,,,37.5,ng/ml*h,,,5.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1712,2025-12-02T15:56:56.518041
12779111.0,Tramadol,,,,,,,Tmax,,,4.5,,,,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1713,2025-12-02T15:56:56.518041
12779111.0,Tramadol,,,,,,,t1/2beta,,,5.8,,,,1.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1714,2025-12-02T15:56:56.518041
12779111.0,Tramadol,,,,,,,AUC,,,765,,,,259,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1715,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,tramadol,blood,maternal,postpartum,,30,Tmax,,,1,h,,,,,,,>0.05,"based on 85 observations, p value in comparison to tramadol plus placebo group",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1716,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,tramadol,blood,maternal,,,,Cmax,,,216,ng/ml,,,,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1717,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,tramadol,blood,maternal,,,,elimination constant lambda-z,,,0.1095,/hr,,,,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1718,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,tramadol,blood,maternal,,,,elimination half life,,,6.33,h,,,,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1719,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,tramadol,blood,maternal,,,,AUC,,,2221.2,ng*h/ml,,,,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1720,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,tramadol,blood,maternal,,,,absorption constant Ka,,,0.75,/hr,mean,SD,0.438,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1721,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,tramadol,blood,maternal,,,,volume of distribution,,,13.8,L,,,1.14,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1722,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,tramadol,blood,maternal,,,,clearance ,,,0.00183,L/h,,,0.318,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1723,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,tramadol,blood,maternal,,,29,Tmax,,,1.33,h,,,,,,,,based on 83 observations,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1724,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,tramadol,blood,maternal,,,,Cmax,,,207,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1725,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,tramadol,blood,maternal,,,,elimination constant lambda-z,,,0.1015,/hr,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1726,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,tramadol,blood,maternal,,,,elimination half life,,,6.83,h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1727,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,tramadol,blood,maternal,,,,AUC,,,2335.46,ng*h/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1728,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,tramadol,blood,maternal,,,,absorption constant Ka,,,0.714,/hr,mean,SD,0.409,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1729,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,tramadol,blood,maternal,,,,volume of distribution,,,17.6,L,,,0.649,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1730,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,tramadol,blood,maternal,,,,clearance ,,,0.00169,L/h,,,0.371,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1731,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,O-desmethyltramadol,blood,maternal,,,30,Tmax,,,5.25,h,,,,,,,,based on 85 observations,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1732,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,O-desmethyltramadol,blood,maternal,,,,Cmax,,,35.5,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1733,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,O-desmethyltramadol,blood,maternal,,,,elimination constant lambda-z,,,0.1245,/hr,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1734,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,O-desmethyltramadol,blood,maternal,,,,elimination half life,,,5.57,h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1735,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,O-desmethyltramadol,blood,maternal,,,,AUC,,,554.99,ng*h/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1736,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,O-desmethyltramadol,blood,maternal,,,,absorption constant Ka,,,,/hr,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1737,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,O-desmethyltramadol,blood,maternal,,,,volume of distribution,,,,L,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1738,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus diclofenac,O-desmethyltramadol,blood,maternal,,,,clearance ,,,,L/h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1739,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,O-desmethyltramadol,blood,maternal,,,29,Tmax,,,6.17,h,,,,,,,,based on 83 observations,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1740,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,O-desmethyltramadol,blood,maternal,,,,Cmax,,,28.7,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1741,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,O-desmethyltramadol,blood,maternal,,,,elimination constant lambda-z,,,0.0706,/hr,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1742,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,O-desmethyltramadol,blood,maternal,,,,elimination half life,,,9.82,h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1743,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,O-desmethyltramadol,blood,maternal,,,,AUC,,,622.85,ng*h/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1744,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,O-desmethyltramadol,blood,maternal,,,,absorption constant Ka,,,,/hr,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1745,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,O-desmethyltramadol,blood,maternal,,,,volume of distribution,,,,L,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1746,2025-12-02T15:56:56.518041
12873948.0,Tramadol plus placebo,O-desmethyltramadol,blood,maternal,,,,clearance ,,,,L/h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1747,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,19,concentration,6,h,26,ng/ml,median,,,IQR,20,33,,Continuous group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1748,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,19,concentration,12,h,26,ng/ml,median,,,IQR,19.3,33,,Continuous group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1749,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,19,concentration,24,h,23,ng/ml,median,,,IQR,17.1,32,0.027,Continuous group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1750,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,19,concentration,6,h,15.7,ng/ml,median,,,IQR,12.3,21,,Continuous group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1751,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,19,concentration,12,h,18.2,ng/ml,median,,,IQR,14,22,,Continuous group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1752,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,19,concentration,24,h,16.4,ng/ml,median,,,IQR,12.1,20,,Continuous group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1753,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,18,M6G/M,6,h,0.6,ng/ml,median,,,IQR,0.4,1,,Continuous group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1754,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,18,M6G/M,12,h,0.7,ng/ml,median,,,IQR,0.5,1.4,,Continuous group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1755,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,18,M6G/M,24,h,0.6,ng/ml,median,,,IQR,0.5,1.3,0.018,Continuous group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1756,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,10,concentration,6,h,18.1,ng/ml,median,,,IQR,11.7,28.5,,Continuous group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1757,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,10,concentration,12,h,13.1,ng/ml,median,,,IQR,8.6,26.2,,Continuous group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1758,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,10,concentration,24,h,15.3,ng/ml,median,,,IQR,7.7,22.6,,Continuous group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1759,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,10,concentration,6,h,23,ng/ml,median,,,IQR,16.7,32,,Continuous group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1760,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,10,concentration,12,h,19.2,ng/ml,median,,,IQR,17.5,25.6,,Continuous group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1761,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,10,concentration,24,h,15.8,ng/ml,median,,,IQR,13.3,28.2,,Continuous group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1762,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,10,M6G/M,6,h,1.3,ng/ml,median,,,IQR,0.9,1.8,,Continuous group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1763,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,10,M6G/M,12,h,1.9,ng/ml,median,,,IQR,1.1,2.1,,Continuous group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1764,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,10,M6G/M,24,h,1.5,ng/ml,median,,,IQR,1,2.6,,Continuous group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1765,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,24,concentration,6,h,18.1,ng/ml,median,,,IQR,13.1,23.8,,Intermittent group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1766,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,24,concentration,12,h,15.9,ng/ml,median,,,IQR,11.3,26.8,,Intermittent group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1767,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,23,concentration,24,h,15.4,ng/ml,median,,,IQR,11.4,19.7,,Intermittent group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1768,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,25,concentration,6,h,12.2,ng/ml,median,,,IQR,8.9,16,,Intermittent group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1769,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,25,concentration,12,h,15.3,ng/ml,median,,,IQR,11.1,20.5,,Intermittent group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1770,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,24,concentration,24,h,13.5,ng/ml,median,,,IQR,10.6,19.3,,Intermittent group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1771,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,23,M6G/M,6,h,0.6,ng/ml,median,,,IQR,0.4,1,,Intermittent group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1772,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,23,M6G/M,12,h,0.8,ng/ml,median,,,IQR,0.6,1.6,,Intermittent group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1773,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,22,M6G/M,24,h,1.1,ng/ml,median,,,IQR,0.7,1.5,,Intermittent group: Age 7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1774,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,4,concentration,6,h,6.8,ng/ml,median,,,IQR,4.3,25.5,,Intermittent group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1775,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,4,concentration,12,h,6.4,ng/ml,median,,,IQR,6.2,18.1,,Intermittent group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1776,2025-12-02T15:56:56.518041
12897995.0,morphine,morphine,blood,neonate,,,2,concentration,24,h,2.7,ng/ml,median,,,IQR,1,16.4,,Intermittent group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1777,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,4,concentration,6,h,12.8,ng/ml,median,,,IQR,8.3,18.2,,Intermittent group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1778,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,4,concentration,12,h,10.5,ng/ml,median,,,IQR,8.9,16.1,,Intermittent group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1779,2025-12-02T15:56:56.518041
12897995.0,morphine,M6G,blood,neonate,,,2,concentration,24,h,7.6,ng/ml,median,,,IQR,7.2,8.1,,Intermittent group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1780,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,4,M6G/M,6,h,2,ng/ml,median,,,IQR,0.7,2.8,,Intermittent group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1781,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,4,M6G/M,12,h,1.5,ng/ml,median,,,IQR,0.7,2.6,,Intermittent group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1782,2025-12-02T15:56:56.518041
12897995.0,morphine,,blood,neonate,,,2,M6G/M,24,h,4.3,ng/ml,median,,,IQR,0.4,8.1,,Intermittent group: Age >7 days; time after surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1783,2025-12-02T15:56:56.518041
15001964.0,Morphine,oral morphine,plasma,children,,,4,AUC0-12,,,614.3,ng/ml*h,mean,SD,322.9,,,,0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1784,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Cmax,,,97,ng/ml,,,62.6,,,,0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1785,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Cmin,,,29.7,ng/ml,,,16.8,,,,0.002,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1786,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Tmax,,,2.5,h,,,2.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1787,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,Mean apparent CL,,,3,l/min,,,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1788,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,Mean peak-to-trough fluctuation,,,126.2,%,,,31.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1789,2025-12-02T15:56:56.518041
15001964.0,Morphine,M6G (oral),,,,,4,AUC0-12,,,1672.3,,,,1351.9,,,,0.006,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1790,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Cmax,,,248.7,,,,219.2,,,,0.006,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1791,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Cmin,,,76,,,,65.9,,,,0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1792,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Tmax,,,4.5,,,,1.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1793,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,Mean peak-to-trough fluctuation,,,119.1,,,,31.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1794,2025-12-02T15:56:56.518041
15001964.0,Morphine,CIV morphine,,,,,11,AUC0-12,,,157,,,,77.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1795,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Cmax,,,21.7,,,,12.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1796,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Cmin,,,8.8,,,,4.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1797,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Tmax,,,5.6,,,,4.85,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1798,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,Mean apparent CL,,,1.6,,,,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1799,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,Mean peak-to-trough fluctuation,,,100.8,,,,54.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1800,2025-12-02T15:56:56.518041
15001964.0,Morphine,M6G (CIV),,,,,11,AUC0-12,,,355.7,,,,222.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1801,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Cmax,,,44.7,,,,23,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1802,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Cmin,,,16.8,,,,12.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1803,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,mean Tmax,,,5.6,,,,4.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1804,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,,Mean peak-to-trough fluctuation,,,107.1,,,,40,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1805,2025-12-02T15:56:56.518041
15001964.0,Morphine,morphine,,,,,4,AUC,,,396,ng/ml*h,,,393,,,,,ACS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1806,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,9,AUC,,,221,ng/ml*h,,,172,,,,,non-ACS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1807,2025-12-02T15:56:56.518041
15001964.0,Morphine,M6G,,,,,4,AUC,,,1360,ng/ml*h,,,1365,,,,,ACS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1808,2025-12-02T15:56:56.518041
15001964.0,Morphine,,,,,,9,AUC,,,380,ng/ml*h,,,213,,,,,non-ACS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1809,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,IV oxycodone,plasma,infants/children,,,9,Cmax,,,82.2,ug/l,mean,SD,15.3,range,57,110,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1810,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,9,Tmax,,,2,min,,,,,2,2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1811,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,9,Vss,,,3.2,l/kg,,,0.4,,2.7,4.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1812,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,9,CL,,,15.6,ml/min/kg,,,2.6,,11,20,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1813,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,9,t1/2beta,,,163,min,,,26,,124,208,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1814,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,9,AUC inf,,,6612,ug/l*min,,,1114,,5037,8954,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1815,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,IM oxycodone,,,,,10,Cmax,,,33.6,,,,9.8,,23,54,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1816,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,10,Tmax,,,16,,,,11,,2,30,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1817,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,10,t1/2beta,,,150,,,,39,,102,227,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1818,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,10,AUC inf,,,4473,,,,927,,3084,5524,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1819,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,10,AUC/AUCiv,,,0.68,,,,0.14,,0.47,0.84,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1820,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,Buccal oxycodone,,,,,11,Cmax,,,9.8,,,,3.7,,3.9,14,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1821,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,11,Tmax,,,221,,,,136,,30,480,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1822,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,10,t1/2beta,,,150,,,,44,,73,234,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1823,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,10,AUC inf,,,3658,,,,1474,,1444,5560,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1824,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,10,AUC/AUCiv,,,0.55,,,,0.22,,0.22,0.84,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1825,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,Gastric oxycodone,,,,,9,Cmax,,,9.2,,,,4.9,,1.7,14.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1826,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,9,Tmax,,,193,,,,137,,60,360,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1827,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,6,t1/2beta,,,147,,,,61,,80,246,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1828,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,6,AUC inf,,,2436,,,,1111,,692,3843,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1829,2025-12-02T15:56:56.518041
15217304.0,Oxycodone,,,,,,6,AUC/AUCiv,,,0.37,,,,0.17,,0.1,0.58,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1830,2025-12-02T15:56:56.518041
15321955.0,methadone,methadone,cord blood,infants,delivery,,12,cocentration,,,31,ng/ml,median,,,range,17,70,0.029,treated for NAS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1831,2025-12-02T15:56:56.518041
15321955.0,methadone,,cord blood,infants,delivery,,13,,,,88,,,,,,0,130,,not treated for NAS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1832,2025-12-02T15:56:56.518041
15321955.0,methadone,,plasma,infants,postnatal,,6,,48,hours,23,,,,,,,,0.002,"All but one of the 12 infants who required treatment had undetectable concentrations of methadone in the postnatal sample, whereas the median postnatal methadone concentration in untreated infants was 23 ng/ml (p = 0.002). ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1833,2025-12-02T15:56:56.518041
15321955.0,methadone,,plasma,maternal,,,,,119,hours,148,,,,,,<100,403,0.03,treated for NAS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1834,2025-12-02T15:56:56.518041
15321955.0,methadone,,plasma,maternal,,,,,,,277,,,,,,166,496,,not treated for NAS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1835,2025-12-02T15:56:56.518041
15502029.0,Fentanyl,Fentanyl,plasma,children,,,10,Tmax,,,1,hours,median,,,range,0.55,6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1836,2025-12-02T15:56:56.518041
15502029.0,Fentanyl,,,,,,,Cmax,,,1.88,ng/ml,,,,,0.34,3.96,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1837,2025-12-02T15:56:56.518041
15502029.0,Fentanyl,,,,,,,t1/2,,,3.3,hours,,,,,2.5,9.4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1838,2025-12-02T15:56:56.518041
15502029.0,Fentanyl,,,,,,,AUC,,,6.86,ng/ml*h,,,,,1.64,12.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1839,2025-12-02T15:56:56.518041
15502029.0,Fentanyl,,,,,,,V/F,,,18.4,l/kg,,,,,6.2,26.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1840,2025-12-02T15:56:56.518041
15502029.0,Fentanyl,,,,,,,CL/F,,,2.3,l/kg*h,,,,,1.05,6.98,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1841,2025-12-02T15:56:56.518041
15588727.0,control,,placenta,pregnant,,,5-8,O2 delivery in Experimental period,,,10.4,mL/min*kg,mean,SD,2.5,,,,,"Effects of methadone concentrations on oxygen transfer, delivery,/consumption during the experimental period of 4 h",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1842,2025-12-02T15:56:56.518041
15588727.0,control,,,,,,,O2 delivery % of control period,,,83,%,mean,SD,16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1843,2025-12-02T15:56:56.518041
15588727.0,control,,,,,,,O2 transfer in Experimental period,,,0.39,mL/min*kg,mean,SD,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1844,2025-12-02T15:56:56.518041
15588727.0,control,,,,,,,O2 transfer % of control period,,,81,%,mean,SD,10,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1845,2025-12-02T15:56:56.518041
15588727.0,control,,,,,,,O2 consumption in Experimental period,,,4.13,mL/min*kg,mean,SD,1.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1846,2025-12-02T15:56:56.518041
15588727.0,control,,,,,,,O2 consumption % of control period,,,103,%,mean,SD,18,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1847,2025-12-02T15:56:56.518041
15588727.0,control,,,,,,,hCG release % of control period,,,87,%,mean,SD,46,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1848,2025-12-02T15:56:56.518041
15588727.0,control,,,,,,,Glucose consumption in Experimental period,,,0.28,umol/min*g,mean,SD,0.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1849,2025-12-02T15:56:56.518041
15588727.0,control,,,,,,,Glucose consumption % of control period,,,92,%,mean,SD,20,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1850,2025-12-02T15:56:56.518041
15588727.0,control,,,,,,,Lactate production in Experimental period,,,0.2,umol/min*g,mean,SD,0.04,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1851,2025-12-02T15:56:56.518041
15588727.0,control,,,,,,,Lactate production % of control period,,,83,%,mean,SD,10,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1852,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,placenta,maternal to fetal direction,,,5-8,transfer,60,min,7.9,%,mean,SD,3.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1853,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,,120,min,8.9,%,mean,SD,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1854,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,,240,min,9.4,%,mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1855,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,methadone/antipytine transfer ratio,60,min,0.58,,mean,SD,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1856,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,,120,min,0.52,,mean,SD,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1857,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,,240,min,0.52,,mean,SD,0.07,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1858,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,methadone concentration ratio in the tissue/maternal circuit,,,6.5,,mean,SD,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1859,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,methadone concentration ratio in the tissue/fetal circuit,,,9.9,,mean,SD,1.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1860,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,methadone concentration ratio in the fetal to maternal circuit,,,0.71,,mean,SD,0.16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1861,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,fetal to maternal direction,,,5-8,methadone concentration ratio in the tissue/maternal circuit,,,6.5,,mean,SD,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1862,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,methadone concentration ratio in the tissue/fetal circuit,,,6.5,,mean,SD,0.64,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1863,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,methadone concentration ratio in the maternal to fetal circuit,,,1.02,,mean,SD,0.29,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1864,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,placenta,pregnant,,,5-8,O2 delivery in Experimental period,,,11.3,mL/min*kg,mean,SD,2.6,,,,,"Effects of methadone concentrations on oxygen transfer, delivery,/consumption during the experimental period of 4 h",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1865,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,O2 delivery % of control period,,,95,%,mean,SD,13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1866,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,O2 transfer in Experimental period,,,0.42,mL/min*kg,mean,SD,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1867,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,O2 transfer % of control period,,,91,%,mean,SD,3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1868,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,O2 consumption in Experimental period,,,3.6,mL/min*kg,mean,SD,0.57,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1869,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,O2 consumption % of control period,,,104,%,mean,SD,35,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1870,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,hCG release % of control period,,,80,%,mean,SD,31,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1871,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,Glucose consumption in Experimental period,,,0.3,umol/min*g,mean,SD,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1872,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,Glucose consumption % of control period,,,107,%,mean,SD,35,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1873,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,Lactate production in Experimental period,,,0.2,umol/min*g,mean,SD,0.08,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1874,2025-12-02T15:56:56.518041
15588727.0,100ng/ml methadone,,,,,,,Lactate production % of control period,,,99,%,mean,SD,49,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1875,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,placenta,maternal to fetal direction,,,5-8,transfer,60,min,7.6,%,mean,SD,2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1876,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,,120,min,8.6,%,mean,SD,1.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1877,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,,240,min,8.8,%,mean,SD,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1878,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,methadone/antipytine transfer ratio,60,min,0.47,,mean,SD,0.08,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1879,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,,120,min,0.48,,mean,SD,0.07,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1880,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,,240,min,0.47,,mean,SD,0.04,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1881,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,lag time,,,6.36,min,mean,SD,1.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1882,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,clearance,,,0.85,ml/min,mean,SD,0.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1883,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,clearance index,,,0.83,,mean,SD,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1884,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,, fetal to maternal direction,,,5-8,lag time,,,12.3,min,mean,SD,2.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1885,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,clearance,,,1.29,ml/min,mean,SD,0.48,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1886,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,clearance index,,,0.97,,mean,SD,0.05,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1887,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,placenta,pregnant,,,5-8,O2 delivery in Experimental period,,,14.1,mL/min*kg,mean,SD,4.8,,,,,"Effects of methadone concentrations on oxygen transfer, delivery,/consumption during the experimental period of 4 h",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1888,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,O2 delivery % of control period,,,102,%,mean,SD,6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1889,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,O2 transfer in Experimental period,,,0.27,mL/min*kg,mean,SD,0.15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1890,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,O2 transfer % of control period,,,96,%,mean,SD,9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1891,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,O2 consumption in Experimental period,,,3.5,mL/min*kg,mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1892,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,O2 consumption % of control period,,,87,%,mean,SD,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1893,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,hCG release % of control period,,,81,%,mean,SD,15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1894,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,Glucose consumption in Experimental period,,,0.3,umol/min*g,mean,SD,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1895,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,Glucose consumption % of control period,,,124,%,mean,SD,27,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1896,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,Lactate production in Experimental period,,,0.3,umol/min*g,mean,SD,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1897,2025-12-02T15:56:56.518041
15588727.0,200ng/ml methadone,,,,,,,Lactate production % of control period,,,105,%,mean,SD,37,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1898,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,,placenta,maternal to fetal direction,,,5-8,transfer,60,min,6,%,mean,SD,2.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1899,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,,,,,,,,120,min,7.1,%,mean,SD,2.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1900,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,,,,,,,,240,min,8,%,mean,SD,2.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1901,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,methadone/antipytine transfer ratio,,,,,,methadone/antipytine transfer ratio,60,min,0.4,,mean,SD,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1902,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,,,,,,,,120,min,0.43,,mean,SD,0.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1903,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,,,,,,,,240,min,0.45,,mean,SD,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1904,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,O2 delivery in Experimental period,placenta,pregnant,,,5-8,O2 delivery in Experimental period,,,11.9,mL/min*kg,mean,SD,1.1,,,,,"Effects of methadone concentrations on oxygen transfer, delivery,/consumption during the experimental period of 4 h",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1905,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,O2 delivery % of control period,,,,,,O2 delivery % of control period,,,107,%,mean,SD,17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1906,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,O2 transfer in Experimental period,,,,,,O2 transfer in Experimental period,,,0.38,mL/min*kg,mean,SD,0.18,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1907,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,O2 transfer % of control period,,,,,,O2 transfer % of control period,,,97,%,mean,SD,13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1908,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,O2 consumption in Experimental period,,,,,,O2 consumption in Experimental period,,,4.4,mL/min*kg,mean,SD,1.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1909,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,O2 consumption % of control period,,,,,,O2 consumption % of control period,,,108,%,mean,SD,24,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1910,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,hCG release % of control period,,,,,,hCG release % of control period,,,91,%,mean,SD,6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1911,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,Glucose consumption in Experimental period,,,,,,Glucose consumption in Experimental period,,,0.25,umol/min*g,mean,SD,0.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1912,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,Glucose consumption % of control period,,,,,,Glucose consumption % of control period,,,94,%,mean,SD,15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1913,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,Lactate production in Experimental period,,,,,,Lactate production in Experimental period,,,0.2,umol/min*g,mean,SD,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1914,2025-12-02T15:56:56.518041
15588727.0,400ng/ml methadone,Lactate production % of control period,,,,,,Lactate production % of control period,,,100,%,mean,SD,21,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1915,2025-12-02T15:56:56.518041
15876424.0,Verapamil,,,in vitro,,,,ATPase activity,,,20,nmol/mg/min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1916,2025-12-02T15:56:56.518041
15876424.0,Morphine,,,in vitro,,,,ATPase activity,,,4.3,nmol/mg/min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1917,2025-12-02T15:56:56.518041
15876424.0,Methadone,,,in vitro,,,,ATPase activity,,,5.9,nmol/mg/min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1918,2025-12-02T15:56:56.518041
15876424.0,levo--acetylmethadol,,,in vitro,,,,ATPase activity,,,7.1,nmol/mg/min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1919,2025-12-02T15:56:56.518041
15876424.0,buprenorphine,,,in vitro,,,,ATPase activity,,,4.8,nmol/mg/min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1920,2025-12-02T15:56:56.518041
15876424.0,methadone,,placenta,,,,6,fetal transfer rate,,,26.8,%,mean,SD,4.45,,,,,in absence of P-gp inhibitor,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1921,2025-12-02T15:56:56.518041
15876424.0,methadone,,,,,,6,clearance,,,0.79,ml/min,mean,SD,0.14,,,,,in absence of P-gp inhibitor,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1922,2025-12-02T15:56:56.518041
15876424.0,methadone,,,,,,6,clearance index,,,0.84,,mean,SD,0.09,,,,,in absence of P-gp inhibitor,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1923,2025-12-02T15:56:56.518041
15876424.0,methadone,,,,,,6,fetal transfer rate,,,33.7,%,mean,SD,6.83,,,,,in presence of P-gp inhibitor,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1924,2025-12-02T15:56:56.518041
15876424.0,methadone,,,,,,6,clearance,,,0.96,ml/min,mean,SD,0.18,,,,,in presence of P-gp inhibitor,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1925,2025-12-02T15:56:56.518041
15876424.0,methadone,,,,,,6,clearance index,,,1.06,,mean,SD,0.16,,,,,in presence of P-gp inhibitor,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1926,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,oxycodone,plasma,neonates,<1 week,,10,CL,,,9.9,,median,,,range,2.3,17.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1927,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,CL allometric 3/4,,,317,,,,,,69,592,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1928,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,Vss,,,3.3,,,,,,1.9,4.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1929,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,t1/2,,,4.4,,,,,,2.4,14.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1930,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,t1/2 allometric 1/2,,,10,,,,,,4.8,32.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1931,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,infants,0.25-2 months,,6,CL,,,20.1,,,,,,3.7,40.4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1932,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,CL allometric 3/4,,,717,,,,,,137,1366,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1933,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,Vss,,,5.6,,,,,,1.3,8.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1934,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,t1/2,,,3.6,,,,,,1.6,11.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1935,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,t1/2 allometric 1/2,,,7.2,,,,,,2.9,23.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1936,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,infants,2-6 months,,6,CL,,,15.4,,,,,,14.8,80.2,<0.05,Significantly ( P < 0.05) different from neonates aged < 1 week,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1937,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,CL allometric 3/4,,,638,,,,,,438,2693,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1938,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,Vss,,,3.2,,,,,,1.8,6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1939,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,t1/2,,,2,,,,,,0.8,3.9,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1940,2025-12-02T15:56:56.518041
15960639.0,Oxycodone,,,,,,,t1/2 allometric 1/2,,,3.8,,,,,,1.6,7.5,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1941,2025-12-02T15:56:56.518041
16007420.0,tramadol,,umbilical vein,neonates,during labour,,22,Tramadol serum concentrations(umbilical vein,at time of birth,,243,ng/ml,mean,SD,102,range,122,557,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1942,2025-12-02T15:56:56.518041
16007420.0,tramadol,,,,,,22,Serum concentrations of the metabolite(O-demethyl tramadol hydrochloride)(umbilical vein,at time of birth,,52,ng/ml,mean,SD,27,range,3,112,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1943,2025-12-02T15:56:56.518041
16007420.0,tramadol,,,,,,22,Tramadol serum concentrations(umbilical artery,at time of birth,,258,ng/ml,mean,SD,103,range,132,557,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1944,2025-12-02T15:56:56.518041
16007420.0,tramadol,,,,,,22,ratio of tramadol concentrations in umbilical artery/umbilical vein,at time of birth,,107,%,mean,SD,8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1945,2025-12-02T15:56:56.518041
16007420.0,tramadol,,,,,,21,Serum concentrations of the metabolite(O-demethyl tramadol hydrochloride) (umbilical artery,at time of birth,,47,ng/ml,mean,SD,24,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1946,2025-12-02T15:56:56.518041
16007420.0,tramadol,,,,,,20,ratio of metabolite(O-demethyl tramadol hydrochloride) concentrations in umbilical artery/umbilical vein,at time of birth,,96,%,mean,SD,13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1947,2025-12-02T15:56:56.518041
16007420.0,tramadol,,peripheral vein,maternal,during labor,,22,Tramadol serum concentrations,at time of birth,,250,ng/ml,mean,SD,13,range,66,519,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1948,2025-12-02T15:56:56.518041
16007420.0,tramadol,,,,,,20,Serum concentrations of the metabolite(O-demethyl tramadol hydrochloride),at time of birth,,56,ng/ml,mean,SD,21,range,27,98,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1949,2025-12-02T15:56:56.518041
16007420.0,tramadol,,,ratio,,,21,tramadol ratio between foetal umbilical vein (representing the concentration of the drug entering the foetus)/the mothers vein (delivering the drug to the placenta),at time of birth,,94,%,mean,SD,13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1950,2025-12-02T15:56:56.518041
16007420.0,tramadol,,,,,,19,metabolite(O-demethyl tramadol hydrochloride) ratio between foetal umbilical vein (representing the concentration of the drug entering the foetus)/the mothers vein (delivering the drug to the placenta),at time of birth,,94,%,mean,SD,13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1951,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,Fentanyl,plasma,Maternal,Labor,,10,t1/2alpha,,,13.5,min,median,,,IQR,9,24.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1952,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,alpha,,,0.05,/min,,,,,0.03,0.08,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1953,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,t1/2beta,,,192.5,min,,,,,119.3,242.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1954,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,beta,,,0.004,/min,,,,,0.003,0.006,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1955,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,t1/2gamma,,,620,min,,,,,526.3,752.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1956,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,gamma,,,0.001,/min,,,,,0.001,0.001,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1957,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,AUC0-inf,,,137.4,ng/ml*min,,,,,9,150.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1958,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,Cl/f,,,465,ml/min,,,,,422,657.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1959,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,Cl/f/kg,,,6.9,ml/min/kg,,,,,6.3,8.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1960,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,Vd/f,,,300,l,,,,,149.8,400.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1961,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,Vd/f/kg,,,4.4,l/kg,,,,,2.4,5.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1962,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,8,Latency,,,28.5,min,,,,,25.75,32.25,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1963,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,Concentration,,,0.31,ng/ml,,,,,0.28,0.32,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1964,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,plasma,Fetal,Delivery,,,Concentration,,,0.25,ng/ml,,,,,0.19,0.51,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1965,2025-12-02T15:56:56.518041
16021436.0,Fentanyl,,,,,,,Fetal:maternal ratio,,,0.89,,,,,,0.75,1.62,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1966,2025-12-02T15:56:56.518041
16130057.0,Fentanyl,fentanyl,plasma,infants,,,15,Concentration postinduction,30,min,12,ng/ml,mean,SD,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1967,2025-12-02T15:56:56.518041
16130057.0,Fentanyl,,,,,,,Concentration sternotomy,,,14,,,,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1968,2025-12-02T15:56:56.518041
16130057.0,Fentanyl,,,,,,,Concentration aortic cannulation,,,15,,,,6,,,,0.01,"Mean total plasma fentanyl concentration declined from 15  6 to 11  5 ng/mL between aortic cannulation/at 4 minutes on CPB, which represented a 27% decrease (p = 0.01, paired t test).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1969,2025-12-02T15:56:56.518041
16130057.0,Fentanyl,,,,,,,Concentration on CPB,4,min,11,,,,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1970,2025-12-02T15:56:56.518041
16130057.0,Fentanyl,,,,,,,,30,,16,,,,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1971,2025-12-02T15:56:56.518041
16130057.0,Fentanyl,,,,,,,,60,,18,,,,6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1972,2025-12-02T15:56:56.518041
16130057.0,Fentanyl,,,,,,,Concentration off CPB,1,min,18,,,,6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1973,2025-12-02T15:56:56.518041
16130057.0,Fentanyl,,,,,,,,30,min,17,,,,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1974,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester  1,,4,time to peak concentration,,,2.5,h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1975,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 2,,4,time to peak concentration,,,2,h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1976,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 3,,8,time to peak concentration,,,3,h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1977,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,postpartum,,3,time to peak concentration,,,3,h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1978,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester  1,,4,trough plasma concentration,,,0.095,mg/l,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1979,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 2,,4,trough plasma concentration,,,0.109,mg/l,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1980,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 3,,8,trough plasma concentration,,,0.076,mg/l,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1981,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,postpartum,,3,trough plasma concentration,,,0.24,mg/l,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1982,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester  1,,4,AUC 0-24h,0-24,hours,5.04,mg.h/l,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1983,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 2,,4,AUC 0-24h,0-24,hours,3.59,mg.h/l,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1984,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 3,,8,AUC 0-24h,0-24,hours,2.51,mg.h/l,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1985,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,postpartum,,3,AUC 0-24h,0-24,hours,5.78,mg.h/l,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1986,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester  1,,4,total CL,,,10.11,l/h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1987,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 2,,4,total CL,,,12.25,l/h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1988,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 3,,8,total CL,,,12.49,l/h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1989,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,postpartum,,3,total CL,,,3.46,l/h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1990,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester  1,,4,total CL/weight,,,0.18,l/h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1991,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 2,,4,total CL/weight,,,0.21,l/h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1992,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 3,,8,total CL/weight,,,0.21,l/h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1993,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,postpartum,,3,total CL/weight,,,0.06,l/h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1994,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 1,,4,Tmax,,,2.5,hrs,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1995,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 2,,4,Tmax,,,1.9,hrs,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1996,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 3,,8,Tmax,,,2.5,hrs,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1997,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,postpartum,,3,Tmax,,,2.5,hrs,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1998,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 1,,4,Cmin,,,0.115,mg/l,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,1999,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 2,,4,Cmin,,,0.112,mg/l,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2000,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 3,,8,Cmin,,,0.07,mg/l,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2001,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,postpartum,,3,Cmin,,,0.226,mg/l,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2002,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 1,,4,AUC 0-24h,,,4.5,mg*h/l,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2003,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 2,,4,AUC 0-24h,,,3.77,mg*h/l,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2004,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 3,,8,AUC 0-24h,,,2.19,mg*h/l,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2005,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,postpartum,,3,AUC 0-24h,,,6.17,mg*h/l,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2006,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 1,,4,Total clearance,,,9.52,l/h,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2007,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 2,,4,Total clearance,,,7.6,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2008,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 3,,8,Total clearance,,,7.28,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2009,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,postpartum,,3,Total clearance,,,2,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2010,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 1,,4,Weight-adjusted total clearance,,,0.17,l/h/kg,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2011,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 2,,4,Weight-adjusted total clearance,,,0.19,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2012,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,Trimester 3,,8,Weight-adjusted total clearance,,,0.21,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2013,2025-12-02T15:56:56.518041
16261362.0,methadone,methadone,plasma,maternal,postpartum,,3,Weight-adjusted total clearance,,,0.11,,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2014,2025-12-02T15:56:56.518041
16283273.0,Tramadol,O-demethyl tramadol/tramadol ,plasma,infants,,,20,log M/M1 ratio,,,0.8,,mean,SD,0.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2015,2025-12-02T15:56:56.518041
16283273.0,Tramadol,,,,,,,postnatal age correlation,,,-0.58,,r,,,95% CI,-0.71,-0.42,<0.005,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2016,2025-12-02T15:56:56.518041
16283273.0,Tramadol,,,,,,,postmenstrual age correlation,,,-0.73,,r,,,,-0.79,-0.55,<0.0001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2017,2025-12-02T15:56:56.518041
16283273.0,Tramadol,,,,,,,R-adjusted postmenstrual age,,,-0.47,,R-adjusted,,,,,,<0.005,"In a multiple regression model with plasma log M/M1 as the dependent variable, only PMA (P<0.005, R adj 0.47) remained an independent variable. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2018,2025-12-02T15:56:56.518041
16283273.0,Tramadol,"Tramadol, M1, M2",urine,,,,25,Excretion,,,34.5,%,,,6.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2019,2025-12-02T15:56:56.518041
16283273.0,Tramadol,Tramadol,,,,,,Excretion unchanged drug,,,79,%,,,18,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2020,2025-12-02T15:56:56.518041
16283273.0,Tramadol,M1,,,,,,Excretion M1,,,10,%,,,17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2021,2025-12-02T15:56:56.518041
16283273.0,Tramadol,M2,,,,,,Excretion M2,,,3,%,,,3.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2022,2025-12-02T15:56:56.518041
16283273.0,Tramadol,O-demethyl tramadol/tramadol ,,,,,,log M/M1 ratio,,,0.94,,,,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2023,2025-12-02T15:56:56.518041
16283273.0,Tramadol,,,,,,,postnatal age correlation,,,-0.56,,,,,,-0.78,-0.21,0.0035,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2024,2025-12-02T15:56:56.518041
16283273.0,Tramadol,,,,,,,postmenstrual age correlation,,,-0.73,,,,,,-0.87,-0.47,<0.0001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2025,2025-12-02T15:56:56.518041
16283273.0,Tramadol,,,,,,,R-adjusted postmenstrual age,,,-0.51,,,,,,,,<0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2026,2025-12-02T15:56:56.518041
16394684.0,Remifentanil,Remifentanil,plasma,maternal,delivery,,20,MA concentration,,,0.32,ng/ml,mean,SD,0.08,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2027,2025-12-02T15:56:56.518041
16394684.0,Remifentanil,,umbilical vein blood,fetal,delivery,,20,UV concentration,,,0.23,ng/ml,,,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2028,2025-12-02T15:56:56.518041
16394684.0,Remifentanil,,umbilical artery blood,fetal,delivery,,20,UA concentration,,,0.13,ng/ml,,,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2029,2025-12-02T15:56:56.518041
16394684.0,Remifentanil,,umbilical vein/plasma,fetal,delivery,,20,UV/MA ratio,,,0.73,,,,0.17,95% CI,0.65,0.81,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2030,2025-12-02T15:56:56.518041
16394684.0,Remifentanil,,umbilical artery/vein,fetal,delivery,,20,UA/UV ratio,,,0.6,,,,0.23,,0.49,0.71,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2031,2025-12-02T15:56:56.518041
16433900.0,Tramadol,O-demethyl tramadol glucuronidated/overall,urine,neonates,,,25,molar M1G/M1GF ratio,24,hours,30,%,mean,SD,14,IQR,22,36,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2032,2025-12-02T15:56:56.518041
16433900.0,Tramadol,,,,,,,postnatal age correlation,,,0.56,,r,,,95% CI,0.19,0.79,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2033,2025-12-02T15:56:56.518041
16433900.0,Tramadol,,,,,,,postmenstrual age correlation,,,0.68,,r,,,,0.37,0.86,<0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2034,2025-12-02T15:56:56.518041
16433900.0,Tramadol,,,,,,,R-adjusted postmenstrual age,,,0.44,,R-adjusted,,,,,,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2035,2025-12-02T15:56:56.518041
16496200.0,Piritramide,piritramide,plasma,newborn,,,8,Cmax,15,min,79,ug/l,median,SD,240,range,5,723,>0.05,p for Cmax across all groups,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2036,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,8,t1/2alpha,,,37,min,,,57,,15,189,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2037,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,8,t1/2beta-compartmental,,,701.5,min,,,720,,,,<0.05,"The differences between group NB/the other three groups (IF1, IF2/YC) were statistically significant (Mann-Whitney U, P<0.05).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2038,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,8,t1/2beta-NCA,,,248.9,min,,,315,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2039,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,7,Vdss,,,1.96,l/kg,,,4.93,,,,<0.05,The differences relating to volume of distribution/total clearance between NB/IF1 vs. IF2/YC were statistically significant,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2040,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,8,CLt,,,15.9,ml/min,,,16.7,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2041,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,8,kdi-j,,,0.0052,/min,,,0.0058,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2042,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,8,kdi-j,,,0.0052,/min,,,0.0058,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2043,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,urine,,,,6,Recovery,,,2.9,%,,,4.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2044,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,plasma,infants,,,7,Cmax,15,min,36,,,,367,,6,855,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2045,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,7,t1/2alpha,,,8.4,,,,5.1,,3.6,18.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2046,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,7,t1/2beta-compartmental,,,157,,,,102,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2047,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,7,t1/2beta-NCA,,,157,,,,50,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2048,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,6,Vdss,,,1.7,,,,2.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2049,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,7,CLt,,,46.6,,,,76.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2050,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,7,kdi-j,,,0.022,,,,0.05,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2051,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,7,kdi-j,,,0.026,,,,0.035,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2052,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,urine,,,,7,Recovery,,,3,,,,0.24,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2053,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,plasma,infants,,,14,Cmax,15,min,12,,,,81,,3,315,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2054,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,14,t1/2alpha,,,13.2,,,,10.5,,2,34.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2055,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,14,t1/2beta-compartmental,,,160,,,,68,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2056,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,14,t1/2beta-NCA,,,173,,,,82,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2057,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,14,Vdss,,,6.95,,,,5.15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2058,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,14,CLt,,,235.5,,,,454.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2059,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,14,kdi-j,,,0.0192,,,,0.0627,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2060,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,14,kdi-j,,,0.0116,,,,0.0218,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2061,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,urine,,,,13,Recovery,,,2.4,,,,4.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2062,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,plasma,children,,,10,Cmax,15,min,16,,,,9,,9,35,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2063,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,9,t1/2alpha,,,17.8,,,,10.8,,7.5,38,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2064,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,9,t1/2beta-compartmental,,,165,,,,143,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2065,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,9,t1/2beta-NCA,,,170,,,,71,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2066,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,10,Vdss,,,6.7,,,,2.15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2067,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,10,CLt,,,338,,,,168.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2068,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,10,kdi-j,,,0.017,,,,0.008,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2069,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,,,,,10,kdi-j,,,0.012,,,,0.19,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2070,2025-12-02T15:56:56.518041
16496200.0,Piritramide,,urine,,,,9,Recovery,,,1.1,,,,1.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2071,2025-12-02T15:56:56.518041
16799915.0,Methadone,methadone,placenta,Maternal,17-26 wks,,12,Km,,,514,uM,mean,SD,187,,,,,conversion to EDDP,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2072,2025-12-02T15:56:56.518041
16799915.0,Methadone,,,,27-33 wks,,12,,,,519,,,,154,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2073,2025-12-02T15:56:56.518041
16799915.0,Methadone,,,,34-40 wks,,12,,,,503,,,,120,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2074,2025-12-02T15:56:56.518041
16799915.0,Methadone,,,,preterm,,36,,,,516,,,,168,,,,>0.05,compared to term placenta,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2075,2025-12-02T15:56:56.518041
16799915.0,Methadone,,,,term,,,,,,503,,,,120,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2076,2025-12-02T15:56:56.518041
16799915.0,Methadone,,,,17-26 wks,,12,Vmax,,,192,pmol*mg/protein/min,,,88,,,,<0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2077,2025-12-02T15:56:56.518041
16799915.0,Methadone,,,,27-33 wks,,12,,,,271,,,,88,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2078,2025-12-02T15:56:56.518041
16799915.0,Methadone,,,,34-40 wks,,12,,,,385,,,,129,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2079,2025-12-02T15:56:56.518041
16799915.0,Methadone,,,,17-26 wks,,12,CLint,,,0.42,pmol*mg/protein/min,,,0.25,,,,<0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2080,2025-12-02T15:56:56.518041
16799915.0,Methadone,,,,27-33 wks,,12,,,,0.57,,,,0.26,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2081,2025-12-02T15:56:56.518041
16799915.0,Methadone,,,,34-40 wks,,12,,,,0.79,,,,0.28,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2082,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,oxycodone,plasma,pediatric,,,15,Cmax,,,16,ng/ml,median,,,range,5.4,39,,buccal group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2083,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,Tmax,,,60,min,,,,,30,120,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2084,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,t1/2beta,,,140,min,,,,,104,251,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2085,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,AUClast,,,3700,ng/ml*min,,,,,2000,7600,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2086,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,AUCinf,,,4200,ng/ml*min,,,,,2400,8000,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2087,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,Time to reach plasma concentration >12 ng/ml,,,52,min,,,,,26,100,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2088,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,Time with plasma concentration >12 ng/ml,,,133,min,,,,,0,209,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2089,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,noroxycodone/oxycodone,,,,,,metabolite:drug AUC8 ratio,,,0.78,,,,,,0.52,1.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2090,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,oxymorphone,,,,,6,concentration,,,1.3,ng/ml,,,,,0.5,2.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2091,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,15,Cmax,,,22,,,,,,5.5,42,,sublingual group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2092,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,Tmax,,,60,,,,,,15,240,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2093,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,t1/2beta,,,150,,,,,,110,190,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2094,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,AUClast,,,5500,,,,,,2300,7500,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2095,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,AUCinf,,,5500,,,,,,2700,7900,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2096,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,Time to reach plasma concentration >12 ng/ml,,,45,,,,,,17,226,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2097,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,,,,,,,Time with plasma concentration >12 ng/ml,,,163,,,,,,0,262,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2098,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,noroxycodone/oxycodone,,,,,,metabolite:drug AUC8 ratio,,,0.78,,,,,,0.57,1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2099,2025-12-02T15:56:56.518041
16802855.0,Oxycodone,oxymorphone,,,,,9,concentration,,,1.4,,,,,,0.5,2.4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2100,2025-12-02T15:56:56.518041
16949720.0,diamorphine,,umbilical venous blood,pregnant,Postpartum,,100,Free morphine concentration,,,7,ug/l,median,,,quartile,5,12,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2101,2025-12-02T15:56:56.518041
16949720.0,diamorphine,,,,,,,,,,,,,,,range,<2,31,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2102,2025-12-02T15:56:56.518041
16949720.0,diamorphine,,,,,,,dose-delivery interval,,,154,min,median,,,quartile,89.5,266.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2103,2025-12-02T15:56:56.518041
16949720.0,diamorphine,,,,,,,,,,,,,,,range,20,2000,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2104,2025-12-02T15:56:56.518041
17478871.0,Methadone,methadone,breast milk,Maternal,day 1,,7,Cmin,1,day,82.3,ng/ml,mean,SD,50.5,range,27.1,179,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2105,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 1,,4,Cmin,1,day,64.8,ng/ml,,,45.5,,31.5,130.5,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2106,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 1,,6,Cmax,1,day,128.2,ng/ml,,,51.1,,63.6,187.5,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2107,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 1,,5,Cmax,1,day,144.3,ng/ml,,,79.6,,51.7,261.8,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2108,2025-12-02T15:56:56.518041
17478871.0,Methadone,,plasma,,day 1,,12,Cmin,1,day,149.4,ng/ml,,,105.1,,47,409,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2109,2025-12-02T15:56:56.518041
17478871.0,Methadone,,plasma,,day 1,,12,Cmax,1,day,253.2,ng/ml,,,101,,117,441,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2110,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk/plasma,,day 1,,7,milk:plasma ratio,1,day,0.8,,,,0.5,,0.2,1.5,,trough,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2111,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk/plasma,,day 1,,6,milk:plasma ratio,1,day,0.6,,,,0.3,,0.3,1.2,,peak,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2112,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 1,,,Ingestible infant dose,1,day,0.006,mg/day,,,0.007,,,,,estimated,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2113,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 2,,10,Cmin,2,day,76.1,ng/ml,,,66,,21,217.9,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2114,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 2,,8,Cmin,2,day,80.2,ng/ml,,,76.9,,20.6,225.1,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2115,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 2,,9,Cmax,2,day,110.3,ng/ml,,,80.3,,27.4,274.6,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2116,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 2,,8,Cmax,2,day,125.2,ng/ml,,,86.6,,31.6,274,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2117,2025-12-02T15:56:56.518041
17478871.0,Methadone,,plasma,,day 2,,12,Cmin,2,day,120.4,ng/ml,,,70.7,,45,247,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2118,2025-12-02T15:56:56.518041
17478871.0,Methadone,,plasma,,day 2,,10,Cmax,2,day,343.7,ng/ml,,,162.6,,80,592,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2119,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk/plasma,,day 2,,10,milk:plasma ratio,2,day,0.9,,,,0.8,,0.1,2.7,,trough,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2120,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk/plasma,,day 2,,8,milk:plasma ratio,2,day,0.4,,,,0.2,,0.1,0.7,,peak,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2121,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 2,,,Ingestible infant dose,2,day,0.018,mg/day,,,0.01,,,,,estimated,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2122,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 3,,12,Cmin,3,day,79.5,ng/ml,,,57.8,,38.1,241.5,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2123,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 3,,12,Cmin,3,day,80.1,ng/ml,,,40.1,,42.1,169.5,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2124,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 3,,12,Cmax,3,day,113.5,ng/ml,,,46.8,,45.1,193.3,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2125,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 3,,10,Cmax,3,day,123.4,ng/ml,,,35,,52.3,182.8,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2126,2025-12-02T15:56:56.518041
17478871.0,Methadone,,plasma,,day 3,,12,Cmin,3,day,140.9,ng/ml,,,78.16,,71,352,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2127,2025-12-02T15:56:56.518041
17478871.0,Methadone,,plasma,,day 3,,12,Cmax,3,day,337.3,ng/ml,,,146.6,,178,707,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2128,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk/plasma,,day 3,,12,milk:plasma ratio,3,day,0.7,,,,0.5,,0.2,2.1,,trough,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2129,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk/plasma,,day 3,,12,milk:plasma ratio,3,day,0.4,,,,0.2,,0.2,0.8,,peak,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2130,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 3,,,Infant dose,3,day,0.039,mg/day,,,0.016,,,,,estimated,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2131,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 4,,12,Cmin,4,day,101.8,ng/ml,,,55.9,,42.6,229.7,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2132,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 4,,12,Cmin,4,day,114.7,ng/ml,,,84.2,,49.4,314.2,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2133,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 4,,12,Cmax,4,day,166,ng/ml,,,67.8,,79.9,281.4,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2134,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 4,,12,Cmax,4,day,199.5,ng/ml,,,66.7,,101.5,301.6,0.0255,"Postfeed, there was a significant increase in methadone concentration in breast milk over time for the peak postfeed sampling time, t(22) = 2.40, P = .0255,",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2135,2025-12-02T15:56:56.518041
17478871.0,Methadone,,plasma,,day 4,,12,Cmin,4,day,188.2,ng/ml,,,73.5,,111,384,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2136,2025-12-02T15:56:56.518041
17478871.0,Methadone,,plasma,,day 4,,11,Cmax,4,day,414.2,ng/ml,,,163.3,,176,694,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2137,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk/plasma,,day 4,,12,milk:plasma ratio,4,day,0.6,,,,0.4,,0.2,1.7,,trough,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2138,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk/plasma,,day 4,,11,milk:plasma ratio,4,day,0.4,,,,0.2,,0.2,0.9,,peak,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2139,2025-12-02T15:56:56.518041
17478871.0,Methadone,,breast milk,,day 4,,,Ingestible infant dose,4,day,0.084,mg/day,,,0.036,,,,,estimated,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2140,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,maternal plasma,maternal,post partum,,50,concentration,0-24,hours,18,ng/ml,mean,,,range,0,42,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2141,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,0-24,hours,,,,,,95%CI,13,22,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2142,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,24-48,hours,12,ng/ml,mean,,,range,0,40,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2143,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,24-48,hours,,,,,,95%CI,9,16,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2144,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,48-72,hours,11,ng/ml,mean,,,range,0,31,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2145,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,48-72,hours,,,,,,95%CI,5,17,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2146,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,breast milk,maternal,post partum,,50,concentration,0-24,hours,58,ng/ml,mean,,,range,7,130,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2147,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,0-24,hours,,,,,,95%CI,42,73,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2148,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,24-48,hours,49,ng/ml,mean,,,range,0,168,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2149,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,24-48,hours,,,,,,95%CI,35,62,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2150,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,48-72,hours,35,ng/ml,mean,,,range,2,129,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2151,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,48-72,hours,,,,,,95%CI,15,55,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2152,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,50,milk to plasma ratio,0-24,hours,3.2,,median,,,IQR,2.6,4.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2153,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,24-48,hours,3.4,,median,,,IQR,2.4,4.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2154,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,24-72,hours,,,,,,range,1.3,23.4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2155,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,24-73,hours,,,,,,10-90th centile,1.6,8.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2156,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,all,,3.2,,median,,,range,1.1,8.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2157,2025-12-02T15:56:56.518041
17550483.0,oxycodone,,,,,,,,all,,,,,,,10-90th centile,2,5.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2158,2025-12-02T15:56:56.518041
17564645.0,sevoflurane,rocuronium,plasma,children,,,12,ke0,,,0.1,/min,mean,SD,0.04,,,,0.009,"T1 inhibition, p for difference between sevoflurance/fentanyl",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2159,2025-12-02T15:56:56.518041
17564645.0,sevoflurane,rocuronium,plasma,children,,,12,EC50,,,1.41,ug/ml,mean,SD,0.45,,,,0.02,T1 inhibition,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2160,2025-12-02T15:56:56.518041
17564645.0,sevoflurane,rocuronium,plasma,children,,,12,gamma,,,3.17,,mean,SD,1.57,,,,0.066,T1 inhibition,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2161,2025-12-02T15:56:56.518041
17564645.0,sevoflurane,rocuronium,plasma,children,,,12,ke0,,,0.08,/min,mean,SD,0.04,,,,0.03,T4 inhibition,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2162,2025-12-02T15:56:56.518041
17564645.0,sevoflurane,rocuronium,plasma,children,,,12,EC50,,,0.93,ug/ml,mean,SD,0.31,,,,0.009,T4 inhibition,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2163,2025-12-02T15:56:56.518041
17564645.0,sevoflurane,rocuronium,plasma,children,,,12,gamma,,,4.11,,mean,SD,2.65,,,,0.46,T4 inhibition,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2164,2025-12-02T15:56:56.518041
17564645.0,fentanyl,rocuronium,plasma,children,,,12,ke0,,,0.24,/min,mean,SD,0.14,,,,,T1 inhibition,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2165,2025-12-02T15:56:56.518041
17564645.0,fentanyl,rocuronium,plasma,children,,,12,EC50,,,2.32,ug/ml,mean,SD,1,,,,,T1 inhibition,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2166,2025-12-02T15:56:56.518041
17564645.0,fentanyl,rocuronium,plasma,children,,,12,gamma,,,4.3,,mean,SD,1.33,,,,,T1 inhibition,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2167,2025-12-02T15:56:56.518041
17564645.0,fentanyl,rocuronium,plasma,children,,,12,ke0,,,0.26,/min,mean,SD,0.22,,,,,T4 inhibition,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2168,2025-12-02T15:56:56.518041
17564645.0,fentanyl,rocuronium,plasma,children,,,12,EC50,,,1.61,ug/ml,mean,SD,0.64,,,,,T4 inhibition,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2169,2025-12-02T15:56:56.518041
17564645.0,fentanyl,rocuronium,plasma,children,,,12,gamma,,,5.05,,mean,SD,2.94,,,,,T4 inhibition,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2170,2025-12-02T15:56:56.518041
17913403.0,Tramadol,O-desmethyl tramadol glucuronide/O-desmethyl tramadol ,urine,neonates,day 1-28,,59,Fractional excretion,24,hr,27,%,mean,SD,15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2171,2025-12-02T15:56:56.518041
17913403.0,Tramadol,,,early neonates,<day 8,,40,,,,22,,,,12,,,,<0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2172,2025-12-02T15:56:56.518041
17913403.0,Tramadol,,,late neonates,ay 8-28,,19,,,,32,,,,14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2173,2025-12-02T15:56:56.518041
17913403.0,Tramadol,,,,,,,Postmenstrual age correlation,,,0.47,,r,,,95% CI,0.23,0.65,<0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2174,2025-12-02T15:56:56.518041
17913403.0,Tramadol,,,,,,,Postnatal age correlation,,,0.46,,,,,,0.22,0.65,<0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2175,2025-12-02T15:56:56.518041
17913403.0,Tramadol,,,,,,,Creatinemia correlation,,,-0.36,,,,,,-0.57,-0.1,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2176,2025-12-02T15:56:56.518041
17913403.0,Tramadol,,,,,,,Weight correlation,,,0.27,,,,,,-0.01,0.5,0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2177,2025-12-02T15:56:56.518041
17921260.0,Buprenorphine,BUP,washed hair,Maternal,Pregnancy,,9,Concentration,,,30.1,pg/mg,mean,SD,27.3,range,0.8,143.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2178,2025-12-02T15:56:56.518041
17921260.0,Buprenorphine,NBUP,,,,,,,,,336.5,pg/mg,,,359.5,,6.2,1583.4,0.0131,p for NBUP>BUP in washed hair,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2179,2025-12-02T15:56:56.518041
17921260.0,Buprenorphine,,,,,,,Drug:metabolite ratio,,,0.24,,,,0.44,,0.04,1.93,0.8,p for comparison of ratio between washed/unwashed hair,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2180,2025-12-02T15:56:56.518041
17921260.0,Buprenorphine,BUP,unwashed hair,,,,,,,,40.4,pg/mg,,,28.7,,0.9,111,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2181,2025-12-02T15:56:56.518041
17921260.0,Buprenorphine,NBUP,,,,,,,,,563.1,pg/mg,,,500.3,,10.8,2018.6,0.0097,p for NBUP>BUP in unwashed hair,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2182,2025-12-02T15:56:56.518041
17921260.0,Buprenorphine,,,,,,,Drug:metabolite ratio,,,0.1,,,,0.1,,0.04,0.49,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2183,2025-12-02T15:56:56.518041
17921260.0,Buprenorphine,BUP,,,,,,Concentration mean difference,,,10.8,pg/mg,,,15.6,,,,0.031,p for comparison of concentration between washed/unwashed hair,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2184,2025-12-02T15:56:56.518041
17921260.0,Buprenorphine,NBUP,,,,,,Concentration mean difference,,,190,pg/mg,,,345.7,,,,0.067,p for comparison of concentration between washed/unwashed hair,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2185,2025-12-02T15:56:56.518041
17934758.0,Piritramide,piritramide,plasma,neonates,1-28 days,,,Cmax,,,79,ug/l,mean,SD,240,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2186,2025-12-02T15:56:56.518041
17934758.0,Piritramide,,,infants,1-4 months,,,,,,36,,,,367,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2187,2025-12-02T15:56:56.518041
17934758.0,Piritramide,,,infants,5-12 months,,,,,,12,,,,81,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2188,2025-12-02T15:56:56.518041
17934758.0,Piritramide,,,toddlers,1-4 years,,,,,,16,,,,9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2189,2025-12-02T15:56:56.518041
17934758.0,Piritramide,,,neonates,1-28 days,,,t1/2beta,,,702,min,,,720,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2190,2025-12-02T15:56:56.518041
17934758.0,Piritramide,,,infants,1-4 months,,,,,,157,,,,102,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2191,2025-12-02T15:56:56.518041
17934758.0,Piritramide,,,infants,5-12 months,,,,,,160,,,,68,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2192,2025-12-02T15:56:56.518041
17934758.0,Piritramide,,,toddlers,1-4 years,,,,,,166,,,,143,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2193,2025-12-02T15:56:56.518041
17934758.0,Piritramide,,,neonates,1-28 days,,,Vdss,,,2,l/kg,,,4.93,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2194,2025-12-02T15:56:56.518041
17934758.0,Piritramide,,,infants,1-4 months,,,,,,1.7,,,,2.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2195,2025-12-02T15:56:56.518041
17934758.0,Piritramide,,,infants,5-12 months,,,,,,7,,,,5.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2196,2025-12-02T15:56:56.518041
17934758.0,Piritramide,,,toddlers,1-4 years,,,,,,6.7,,,,2.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2197,2025-12-02T15:56:56.518041
18032310.0,Morphine,Free morphine with HSA 40 g/l,plasma,pediatric/adults,,,,Concentration,,,64,%,mean,SD,2.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2198,2025-12-02T15:56:56.518041
18032310.0,Morphine,Free morphine with HSA/AAG 1 g/l,,,,,,,,,60.5,,,,1.4,,,,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2199,2025-12-02T15:56:56.518041
18032310.0,Morphine,Free morphine with HSA/AAG 2 g/l,,,,,,,,,59.6,,,,1.7,,,,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2200,2025-12-02T15:56:56.518041
18032310.0,Morphine,Free morphine with HSA/palmitic acid 1 mM,,,,,,,,,69.4,,,,3.2,,,,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2201,2025-12-02T15:56:56.518041
18032310.0,Morphine,Free morphine with HSA/oleic acid 1 mM,,,,,,,,,67.4,,,,2.6,,,,>0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2202,2025-12-02T15:56:56.518041
18043481.0,ketoprofen,ketoprofen,breast milk,maternal,postpartum,,18,mean concentration,,,57,ng/ml,mean,SD,37,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2203,2025-12-02T15:56:56.518041
18043481.0,ketoprofen,,,,,,18,Cmax,,,91,ng/ml,,,51,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2204,2025-12-02T15:56:56.518041
18043481.0,ketoprofen,,plasma,,,,18,concentration,,,1196,ng/ml,,,89,range,42,3367,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2205,2025-12-02T15:56:56.518041
18043481.0,ketoprofen,,breast milk/plasma,,,,10,milk:plasma ratio,3,hours,0.22,,,,0.45,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2206,2025-12-02T15:56:56.518041
18043481.0,nalbuphine,nalbuphine,breast milk,,,,14,mean concentration,,,42,ng/ml,,,26,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2207,2025-12-02T15:56:56.518041
18043481.0,nalbuphine,,,,,,14,Cmax,,,61,ng/ml,,,26,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2208,2025-12-02T15:56:56.518041
18043481.0,nalbuphine,,plasma,,,,5,concentration,,,65,ng/ml,,,62,range,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2209,2025-12-02T15:56:56.518041
18043481.0,nalbuphine,,breast milk/plasma,,,,5,milk:plasma ratio,3,hours,0.44,,,,0.23,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2210,2025-12-02T15:56:56.518041
18043481.0,ketoprofen,ketoprofen,breast milk,infant,postpartum,,18,mean infant dose,,,8512,ng/kg/day,,,5484,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2211,2025-12-02T15:56:56.518041
18043481.0,ketoprofen,,,,,,18,maximum infant dose,,,13592,ng/kg/day,,,7622,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2212,2025-12-02T15:56:56.518041
18043481.0,ketoprofen,,,,,,18,relative infant dose,,,0.31,%,,,0.17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2213,2025-12-02T15:56:56.518041
18043481.0,nalbuphine,nalbuphine,breast milk,,,,14,mean infant dose,,,7049,ng/kg/day,,,3215,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2214,2025-12-02T15:56:56.518041
18043481.0,nalbuphine,,,,,,14,maximum infant dose,,,9027,ng/kg/day,,,3833,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2215,2025-12-02T15:56:56.518041
18043481.0,nalbuphine,,,,,,14,relative infant dose,,,0.59,%,,,0.27,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2216,2025-12-02T15:56:56.518041
18166326.0,methadone,methadone,placenta,fetal,preterm,,8,Transfer rate,,,19,%,mean,SD,5.8,,,,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2217,2025-12-02T15:56:56.518041
18166326.0,methadone,,,,,,,CL index,,,0.57,,,,0.19,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2218,2025-12-02T15:56:56.518041
18166326.0,methadone,,,,term,,8,Transfer rate,,,31,,,,9.7,,,,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2219,2025-12-02T15:56:56.518041
18166326.0,methadone,,,,,,,CL index,,,0.95,,,,0.26,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2220,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,4,Cmin,1st,day,122,ng/ml,median,,,IQR,119,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2221,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,PK/PD,Cmax,1st,day,228.5,ng/ml,median,,,IQR,134,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2222,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,PK/PD,Cmin,1st,day,97.5,ng/ml,median,,,IQR,110.5,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2223,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,4,Cmax,1st,day,271.5,ng/ml,median,,,IQR,89.5,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2224,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,PK/PD,Cmin,1st,day,67,ng/ml,median,,,IQR,77.5,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2225,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,PK,Cmin,1st,day,48.5,ng/ml,median,,,IQR,23,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2226,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,2,Cmax,1st,day,98,ng/ml,median,,,IQR,68,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2227,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,2,Cmax,1st,day,115,ng/ml,median,,,IQR,10,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2228,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,4,milk:plasma ratio,1st,day,0.92,,median,,,,,,,"Prefeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2229,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,2,milk:plasma ratio,1st,day,0.34,,median,,,,,,,"Postfeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2230,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,2,milk:plasma ratio,1st,day,0.47,,median,,,,,,,"Prefeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2231,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,2,milk:plasma ratio,1st,day,0.46,,median,,,,,,,"Postfeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2232,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Neonate,Postpartum (PP),,,Ingestible infant dose,1st,day,0.004,mg/day,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2233,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmin,2nd,day,113,ng/ml,median,,,IQR,115,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2234,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,6,Cmax,2nd,day,345.5,ng/ml,median,,,IQR,255,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2235,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmin,2nd,day,107.5,ng/ml,median,,,IQR,123,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2236,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,7,Cmax,2nd,day,324,ng/ml,median,,,IQR,212,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2237,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,6,Cmin,2nd,day,35,ng/ml,median,,,IQR,27,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2238,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,5,Cmin,2nd,day,41,ng/ml,median,,,IQR,16,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2239,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,5,Cmax,2nd,day,64,ng/ml,median,,,IQR,5,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2240,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,5,Cmax,2nd,day,103,ng/ml,median,,,IQR,31,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2241,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,6,milk:plasma ratio,2nd,day,0.38,,median,,,,,,,"Prefeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2242,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,5,milk:plasma ratio,2nd,day,0.47,,median,,,,,,,"Postfeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2243,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,5,milk:plasma ratio,2nd,day,0.22,,median,,,,,,,"Prefeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2244,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,5,milk:plasma ratio,2nd,day,0.23,,median,,,,,,,"Postfeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2245,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Neonate,Postpartum (PP),,,Ingestible infant dose,2nd,day,0.012,mg/day,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2246,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmin,3rd,day,147.5,ng/ml,median,,,IQR,99,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2247,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmax,3rd,day,306.5,ng/ml,median,,,IQR,174.5,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2248,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,7,Cmin,3rd,day,124,ng/ml,median,,,IQR,159,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2249,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmax,3rd,day,299.5,ng/ml,median,,,IQR,176,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2250,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmin,3rd,day,54,ng/ml,median,,,IQR,32,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2251,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmin,3rd,day,62.5,ng/ml,median,,,IQR,48.5,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2252,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmax,3rd,day,106,ng/ml,median,,,IQR,81,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2253,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,6,Cmax,3rd,day,126.5,ng/ml,median,,,IQR,53,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2254,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,3rd,day,0.43,,median,,,,,,,"Prefeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2255,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,3rd,day,0.48,,median,,,,,,,"Postfeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2256,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,3rd,day,0.23,,median,,,,,,,"Prefeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2257,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,6,milk:plasma ratio,3rd,day,0.35,,median,,,,,,,"Postfeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2258,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Neonate,Postpartum (PP),,,Ingestible infant dose,3rd,day,0.037,mg/day,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2259,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmin,4th,day,194,ng/ml,median,IQR,86.5,,,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2260,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmax,4th,day,386.5,ng/ml,median,IQR,223.5,,,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2261,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,6,Cmin,4th,day,148,ng/ml,median,IQR,79,,,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2262,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,7,Cmax,4th,day,359,ng/ml,median,IQR,100,,,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2263,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmin,4th,day,74,ng/ml,median,IQR,27,,,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2264,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmin,4th,day,70.5,ng/ml,median,IQR,32.5,,,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2265,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmax,4th,day,161,ng/ml,median,IQR,70,,,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2266,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmax,4th,day,199,ng/ml,median,IQR,99.5,,,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2267,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,4th,day,0.41,,median,,,,,,,"Prefeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2268,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,4th,day,0.35,,median,,,,,,,"Postfeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2269,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,4th,day,0.33,,median,,,,,,,"Prefeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2270,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,4th,day,0.48,,median,,,,,,,"Postfeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2271,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Neonate,Postpartum (PP),,,Ingestible infant dose,4th,day,0.075,mg/day,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2272,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmin,14th,day,279,ng/ml,median,IQR,206.5,,,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2273,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmax,14th,day,500,ng/ml,median,IQR,244.5,,,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2274,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmin,14th,day,337.5,ng/ml,median,IQR,300,,,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2275,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmax,14th,day,477,ng/ml,median,IQR,266.5,,,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2276,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Concentration,14th,day,2.7,ng/ml,median,IQR,0.75,,,,,Breastfed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2277,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Concentration,14th,day,2.4,ng/ml,median,IQR,0.2,,,,,Formula-fed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2278,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmin,14th,day,121,ng/ml,median,IQR,136,,,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2279,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmin,14th,day,119,ng/ml,median,IQR,182,,,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2280,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmax,14th,day,201,ng/ml,median,IQR,75.5,,,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2281,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmax,14th,day,231,ng/ml,median,IQR,114.5,,,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2282,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,14th,day,0.42,,median,,,,,,,"Prefeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2283,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,14th,day,0.56,,median,,,,,,,"Postfeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2284,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,14th,day,0.53,,median,,,,,,,"Prefeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2285,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,14th,day,0.54,,median,,,,,,,"Postfeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2286,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Neonate,Postpartum (PP),,,Ingestible infant dose,14th,day,0.125,mg/day,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2287,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmin,30th,day,320.5,ng/ml,median,IQR,231.5,,,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2288,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmax,30th,day,506,ng/ml,median,IQR,368.5,,,,,Breastfeeding,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2289,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmin,30th,day,254,ng/ml,median,IQR,220.5,,,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2290,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,plasma,Maternal,Postpartum (PP),,8,Cmax,30th,day,439,ng/ml,median,IQR,277.5,,,,,Control,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2291,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmin,30th,day,92,ng/ml,median,IQR,84.5,,,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2292,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmin,30th,day,125.5,ng/ml,median,IQR,217,,,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2293,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmax,30th,day,194,ng/ml,median,IQR,81,,,,,Prefeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2294,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Maternal,Postpartum (PP),,8,Cmax,30th,day,220.5,ng/ml,median,IQR,158.5,,,,,Postfeed,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2295,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,30th,day,0.38,,median,,,,,,,"Prefeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2296,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,30th,day,0.44,,median,,,,,,,"Postfeed, trough",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2297,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,30th,day,0.49,,median,,,,,,,"Prefeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2298,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk/plasma,Maternal,Postpartum (PP),,8,milk:plasma ratio,30th,day,0.55,,median,,,,,,,"Postfeed, peak",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2299,2025-12-02T15:56:56.518041
18166563.0,Methadone,methadone,breast milk,Neonate,Postpartum (PP),,,Ingestible infant dose,30th,day,0.152,mg/day,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2300,2025-12-02T15:56:56.518041
18294329.0,Tramadol,rac-Tramadol,breast milk,Maternal,day 2-4postpartum,,73,milk:plasma ratio,,,2.2,,mean,,,95% CI,2,2.4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2301,2025-12-02T15:56:56.518041
18294329.0,Tramadol,rac-Desmethyltramadol,breast milk,Maternal,day 2-4postpartum,,73,milk:plasma ratio,,,2.8,,,,,,2.5,3.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2302,2025-12-02T15:56:56.518041
18294329.0,Tramadol,rac-Tramadol,breast milk,Maternal,day 2-4postpartum,,55,Cavg,,,748,ug/l,,,,,681,815,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2303,2025-12-02T15:56:56.518041
18294329.0,Tramadol,rac-Desmethyltramadol,breast milk,Maternal,day 2-4postpartum,,55,Cavg,,,203,ug/l,,,,,188,217,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2304,2025-12-02T15:56:56.518041
18294329.0,Tramadol,rac-Tramadol,breast milk,Neonate,day 2-4 postpartum,,55,absolute infant dose,,,112,ug/kg/day,,,,,102,122,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2305,2025-12-02T15:56:56.518041
18294329.0,Tramadol,rac-Desmethyltramadol,breast milk,Neonate,day 2-4 postpartum,,55,absolute infant dose,,,30,ug/kg/day,,,,,28,32,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2306,2025-12-02T15:56:56.518041
18294329.0,Tramadol,rac-Tramadol,breast milk,Neonate,day 2-4 postpartum,,55,relative infant dose,,,2.24,%,,,,,2.04,2.44,,assuming 100 mg tramadol HCl administered 6 hourly to a 70 kg mother (5020 mg/kg/day as tramadol base),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2307,2025-12-02T15:56:56.518041
18294329.0,Tramadol,rac-Desmethyltramadol,breast milk,Neonate,day 2-4 postpartum,,55,relative infant dose,,,0.64,%,,,,,0.59,0.69,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2308,2025-12-02T15:56:56.518041
18317231.0,tramadol,tramadol,urine,Neonate/Infant,,,86,log M/M1,24,h,0.98,,mean,SD,0.66,,,,,tramadol (M)/O-demethyl tramadol (M1),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2309,2025-12-02T15:56:56.518041
18317231.0,tramadol,tramadol,urine,Neonate/Infant,,,86,log M/M1,0-6,h,1.34,,mean,SD,0.85,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2310,2025-12-02T15:56:56.518041
18317231.0,tramadol,tramadol,urine,Neonate/Infant,,,86,log M/M1,6-12,h,1.01,,mean,SD,0.75,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2311,2025-12-02T15:56:56.518041
18317231.0,tramadol,tramadol,urine,Neonate/Infant,,,86,log M/M1,12-18,h,0.9,,mean,SD,0.67,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2312,2025-12-02T15:56:56.518041
18317231.0,tramadol,tramadol,urine,Neonate/Infant,,,86,log M/M1,18-24,h,0.9,,mean,SD,0.65,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2313,2025-12-02T15:56:56.518041
18317231.0,tramadol,tramadol,blood,Neonate/Infant,,,41,log M/M1,24,h,4,,median,,,range,1,10,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2314,2025-12-02T15:56:56.518041
18317231.0,tramadol,tramadol,blood,Neonate/Infant,,,41,log M/M1,24,h,0.78,,mean,SD,0.45,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2315,2025-12-02T15:56:56.518041
18381513.0,Morphine,morphine,plasma,neonates,,,10,Concentration,6,hours,98,ng/ml,median,,,range,12,185,,hypothermic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2316,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,9,,12,,101,,,,,,82,303,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2317,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,10,,24,,204,,,,,,63,562,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2318,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,9,,48,,228,,,,,,172,768,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2319,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,7,,72,,373,,,,,,149,506,0.02,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2320,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,,AUC0-72,,,18608,ng/ml*h,mean,SD,8384,,,,0.051,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2321,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,6,Concentration,6,hours,65,ng/ml,median,,,range,44,129,,normothermic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2322,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,,,12,,135,,,,,,79,233,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2323,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,,,24,,175,,,,,,102,300,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2324,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,,,48,,216,,,,,,160,327,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2325,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,,,72,,222,,,,,,89,309,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2326,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,,AUC0-72,,,12135,ng/ml*h,mean,SD,3481,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2327,2025-12-02T15:56:56.518041
18381513.0,Morphine,,,,,,5,CLss,48,hours,0.89,ml/min/kg,median,,,range,0.34,1.99,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2328,2025-12-02T15:56:56.518041
18454213.0,Fentanyl,fentanyl,colostrum,maternal,postpartum,,50,Concentration,45,min,0.4,ng/ml,mean,SD,0.059,,,,,Group 1 = epidural,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2329,2025-12-02T15:56:56.518041
18454213.0,Fentanyl,,,,,,,,24,h,0.08,,,,0.018,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2330,2025-12-02T15:56:56.518041
18454213.0,Fentanyl,,,,,,50,Concentration,45,min,0.19,,,,0.019,,,,,Group 2 = intravenous,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2331,2025-12-02T15:56:56.518041
18454213.0,Fentanyl,,,,,,,,24,h,0.05,,,,0.018,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2332,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,buprenorphine,urine,neonates,postpartum,,27,Concentration,0,day,15.5,ug/l,median,,,range,2.5,>200,<0.005,"We combined the highest concentration of the infants urine norbuprenorphine (n = 48) into a single set across the three days (days 02). This correlated significantly with the length of hospital stay (r = 0.57, p < 0.005). ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2333,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,,,,,,34,,1,day,7.1,,,,,,0,130,<0.008,"We combined the highest concentration of the infants urine norbuprenorphine (n = 48) into a single set across the three days (days 02). This correlated significantly with duration of morphine treatment ( r = 0.46, p < 0.008). ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2334,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,,,,,,12,,2,day,2.6,,,,,,0,43,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2335,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,norBUP,,,,,22,,0,day,112.5,,,,,,1,>200,0.9,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2336,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,,,,,,29,,1,day,54,,,,,,0,>200,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2337,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,,,,,,12,,2,day,13,,,,,,0,>200,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2338,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,buprenorphine,urine,maternal,delivery,,11,Concentration,0,day,25,,,,,,1.2,>200,0.002,"The buprenorphine dose on day 0 administered to the maternal (n = 41; Table S1) correlated with the length of the infants hospital stay (r = 0.48, p = 0.002) as well as with the morphine dose at the beginning of morphine treatment (r = 0.49, p = 0.049), but not with the infants urinary buprenorphine or  norbuprenorphine concentrations on any day ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2339,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,,,,,,7,,1,day,>200,,,,,,32,>200,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2340,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,,,,,,3,,2,day,>200,,,,,,108,>200,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2341,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,,,,,,10,,3,day,190,,,,,,49,>200,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2342,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,norBUP,,,,,9,,0,day,95,,,,,,59,>200,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2343,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,,,,,,6,,1,day,197.5,,,,,,105,>200,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2344,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,,,,,,2,,2,day,>200,,,,,,200,>200,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2345,2025-12-02T15:56:56.518041
18474065.0,buprenorphine,,,,,,9,,3,day,>200,,,,,,64,>200,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2346,2025-12-02T15:56:56.518041
18701886.0,buprenorphine,Free BUP,meconium,neonates,postpartum,,9,Concentration,,,59.6,ng/g,median,SD,22.1,range,23.9,240.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2347,2025-12-02T15:56:56.518041
18701886.0,buprenorphine,Total BUP,,,,,,,,,109.9,ng/g,,,27.4,,24.3,296.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2348,2025-12-02T15:56:56.518041
18701886.0,buprenorphine,% free BUP,,,,,,,,,67.3,%,,,5.7,,5.1,82,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2349,2025-12-02T15:56:56.518041
18701886.0,buprenorphine,Free NBUP,,,,,,,,,501.5,ng/g,,,87.7,,331.1,1228.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2350,2025-12-02T15:56:56.518041
18701886.0,buprenorphine,Total NBUP,,,,,,,,,659.5,ng/g,,,136.3,,323.9,1880.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2351,2025-12-02T15:56:56.518041
18701886.0,buprenorphine,% free NBUP,,,,,,,,,87.2,%,,,7.1,,52.9,116.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2352,2025-12-02T15:56:56.518041
18701886.0,buprenorphine,Free BUP/NBUP,,,,,,Free drug:metabolite concentration ratio,,,0.14,,,,0.02,,0.03,0.25,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2353,2025-12-02T15:56:56.518041
18701886.0,buprenorphine,Total BUP/NBUP,,,,,,Total drug:metabolite concentration ratio,,,0.17,,,,0.03,,0.05,0.33,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2354,2025-12-02T15:56:56.518041
18701886.0,Morphine,morphine,meconium,,,,3,Concentration,,,1163,ng/g,,,94.5,,891,1185,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2355,2025-12-02T15:56:56.518041
18701886.0,Opiates,,urine,maternal,pregnancy,,9,% positive tests from enrollment to birth,,,13,%,,,9,,3.9,75,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2356,2025-12-02T15:56:56.518041
18701886.0,Opiates,,,,,,,% positive tests in T3,,,13.65,,,,11.8,,0,74.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2357,2025-12-02T15:56:56.518041
18701886.0,Opiates,,,,,,,Days from last positive specimen to birth,,,55.5,,,,16,,4,146,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2358,2025-12-02T15:56:56.518041
18806024.0,Remifentanil,remifentanil,plasma,children,,,17,Concentration,2,min,1,ng/ml,mean,SD,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2359,2025-12-02T15:56:56.518041
18806024.0,Remifentanil,,,,,,,,3,,1.47,,,,0.52,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2360,2025-12-02T15:56:56.518041
18806024.0,Remifentanil,,,,,,,,4,,1.7,,,,0.46,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2361,2025-12-02T15:56:56.518041
18806024.0,Remifentanil,,,,,,,,10,,1.16,,,,0.36,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2362,2025-12-02T15:56:56.518041
18806024.0,Remifentanil,,,,,,17,Tmax,,,3.47,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2363,2025-12-02T15:56:56.518041
18806024.0,Sevoflurane,Sevoflurane,gas,children,,,47,Concentration before intubation,,,4.1,%,mean,SD,0.5,,,,0.7,Remi-2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2364,2025-12-02T15:56:56.518041
18806024.0,Sevoflurane,,,,,,48,,,,4.1,,,,0.7,,,,,Remi-3,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2365,2025-12-02T15:56:56.518041
18806024.0,Sevoflurane,,,,,,47,,,,4.1,,,,0.5,,,,,Saline-2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2366,2025-12-02T15:56:56.518041
18806024.0,Sevoflurane,,,,,,46,,,,4.2,,,,0.5,,,,,Saline-3,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2367,2025-12-02T15:56:56.518041
18806024.0,Sevoflurane,,,,,,47,Concentration after intubation,,,3.9,,,,0.6,,,,0.2,Remi-2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2368,2025-12-02T15:56:56.518041
18806024.0,Sevoflurane,,,,,,48,,,,3.6,,,,0.9,,,,,Remi-3,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2369,2025-12-02T15:56:56.518041
18806024.0,Sevoflurane,,,,,,47,,,,3.7,,,,0.7,,,,,Saline-2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2370,2025-12-02T15:56:56.518041
18806024.0,Sevoflurane,,,,,,46,,,,3.5,,,,0.9,,,,,Saline-3,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2371,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,Buprenorphine,plasma,maternal,postpartum,,6,AUC0-24,24,h,0.08,mg/l*h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2372,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,breast milk,,,,,AUC0-24,24,h,0.12,mg/l*h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2373,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,breast milk/plasma,,,,,milk:plasma ratio,24,h,1.7,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2374,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,urine,,,,,concentration,,,5.6,nmol/l,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2375,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,breast milk,neonate,,,,Infant dose24h,24,h,0.42,ug/kg,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2376,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,breast milk,,,,,Relative infant dose/kg,,,0.2,%,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2377,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,urine,,,,,concentration,,,1,nmol/l,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2378,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,norBUP,plasma,maternal,postpartum,,6,AUC0-24,24,h,0.14,mg/l*h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2379,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,breast milk,,,,,AUC0-24,24,h,0.1,mg/l*h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2380,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,breast milk/plasma,,,,,milk:plasma ratio,24,h,0.7,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2381,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,urine,,,,,concentration,,,364,nmol/l,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2382,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,breast milk,neonate,,,,Infant dose24h,24,h,0.33,ug/kg,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2383,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,breast milk,,,,,Relative infant dose/kg,,,0.12,%,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2384,2025-12-02T15:56:56.518041
19136395.0,Buprenorphine,,urine,,,,,concentration,,,2.3,nmol/l,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2385,2025-12-02T15:56:56.518041
19260034.0,Morphine,morphine,plasma,children,,,4,Cmax,,,560.5,nM,mean,,,,,,,intravenous goup,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2386,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,Tmax,,,65,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2387,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,t1/2el,,,140.4,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2388,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,AUC0-inf,,,541.4,nM*h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2389,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,CL,,,24.8,ml/min/kg,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2390,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,Vd,,,5.01,/kg,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2391,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,Kel,,,0.005,/h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2392,2025-12-02T15:56:56.518041
19260034.0,Morphine,M6G,,,,,,Cmax,,,309,nM,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2393,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,Tmax,,,65,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2394,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,t1/2el,,,328.7,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2395,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,AUC0-inf,,,2449.7,nM*h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2396,2025-12-02T15:56:56.518041
19260034.0,Morphine,morphine,plasma,children,,,3,Cmax,,,408.3,nM,,,,,,,,oral group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2397,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,Tmax,,,40,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2398,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,t1/2el,,,131,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2399,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,AUC0-inf,,,422.3,nM*h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2400,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,Vd,,,5.81,/kg,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2401,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,Kel,,,0.005,/h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2402,2025-12-02T15:56:56.518041
19260034.0,Morphine,M6G,,,,,,Cmax,,,256.3,nM,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2403,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,Tmax,,,60,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2404,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,t1/2el,,,325.8,min,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2405,2025-12-02T15:56:56.518041
19260034.0,Morphine,,,,,,,AUC0-inf,,,2177,nM*h,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2406,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,buprenorphine,urine,maternal,pregnancy/postpartum,,9,creatinine-corrected concentration,,,12.4,ng/mg,median,,,range,4.8,96.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2407,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,,,,,,,% positive samples,,,1.2,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2408,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,norBUP,,,,,,creatinine-corrected concentration,,,91.1,,,,,,10,3655.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2409,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,,,,,,,% positive samples,,,63.9,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2410,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,BUP-glucuronide,,,,,,creatinine-corrected concentration,,,54.2,,,,,,3.6,8902.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2411,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,,,,,,,% positive samples,,,89.9,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2412,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,norBUP-glucuronide,,,,,,creatinine-corrected concentration,,,561.4,,,,,,21.8,20130.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2413,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,,,,,,,% positive samples,,,96.5,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2414,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,BUP-glucuronide/norBUP-glucuronide,,,trimester 2,,,cocentration ratio,,,0.1,,,,,,0.03,1.88,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2415,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,norBUP/norBUP-glucuronide,,,,,,cocentration ratio,,,0.14,,,,,,0.04,0.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2416,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,BUP-glucuronide/norBUP-glucuronide,,,trimester 3,,,cocentration ratio,,,0.08,,,,,,0.03,0.27,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2417,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,norBUP/norBUP-glucuronide,,,,,,cocentration ratio,,,0.13,,,,,,0.02,0.39,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2418,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,BUP-glucuronide/norBUP-glucuronide,,,postpartum,,,cocentration ratio,,,0.09,,,,,,0.03,0.27,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2419,2025-12-02T15:56:56.518041
19325013.0,buprenorphine,norBUP/norBUP-glucuronide,,,,,,cocentration ratio,,,0.21,,,,,,0.07,0.77,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2420,2025-12-02T15:56:56.518041
19330322.0,Fentanyl,fentanyl,plasma,Maternal,Labor,,10,Concentration,,,0.92,nmol/l,median,,,IQR,0.68,1.07,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2421,2025-12-02T15:56:56.518041
19330322.0,Fentanyl,,placenta,Maternal,Delivery,,10,Concentration,,,2.02,,,,,,1.25,2.74,,intervillous space of the placenta,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2422,2025-12-02T15:56:56.518041
19330322.0,Fentanyl,,umbilical vein,Fetal,Delivery,,10,Concentration,,,0.71,,,,,,0.54,1.55,>0.05,No significant differences in plasma fentanyl concentrations were detected between the umbilical vein/artery.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2423,2025-12-02T15:56:56.518041
19330322.0,Fentanyl,,umbilical artery,Fetal,Delivery,,10,Concentration,,,0.57,,,,,,0.51,0.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2424,2025-12-02T15:56:56.518041
19330322.0,Fentanyl,,placenta,Fetal,Delivery,,10,Transfer rate,,,86,%,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2425,2025-12-02T15:56:56.518041
19330322.0,Fentanyl,,plasma,Maternal,Labor,,10,Concentration,,,,,,,,range,0.51,2.14,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2426,2025-12-02T15:56:56.518041
19330322.0,Fentanyl,,placenta,Maternal,Delivery,,10,Concentration,,,,,,,,,0.21,3.84,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2427,2025-12-02T15:56:56.518041
19330322.0,Fentanyl,,umbilical vein,Fetal,Delivery,,10,Concentration,,,,,,,,,0.39,1.93,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2428,2025-12-02T15:56:56.518041
19330322.0,Fentanyl,,umbilical artery,Fetal,Delivery,,10,Concentration,,,,,,,,,0.42,2.23,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2429,2025-12-02T15:56:56.518041
19519880.0,control,,,,,,6,hCG,before perfusion,,6100,mU/g,mean,SD,4538,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2430,2025-12-02T15:56:56.518041
19519880.0,control,,,,,,,,after 4 hours of perfusion,,9028,mU/g,mean,SD,7205,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2431,2025-12-02T15:56:56.518041
19519880.0,control,,,,,,,,accumulation,,11608,mU/g,mean,SD,7179,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2432,2025-12-02T15:56:56.518041
19519880.0,control,,,,,,,,net production,,14536,mU/g,mean,SD,8956,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2433,2025-12-02T15:56:56.518041
19519880.0,control,,,,,,,,percent net production of the one before perfusion,,299,%,mean,SD,80,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2434,2025-12-02T15:56:56.518041
19519880.0,control,,,,,,,leptin,before perfusion,,7944,pg/g,mean,SD,5189,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2435,2025-12-02T15:56:56.518041
19519880.0,control,,,,,,,,after 4 hours of perfusion,,10050,pg/g,mean,SD,7672,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2436,2025-12-02T15:56:56.518041
19519880.0,control,,,,,,,,accumulation,,18122,pg/g,mean,SD,6824,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2437,2025-12-02T15:56:56.518041
19519880.0,control,,,,,,,,net production,,20228,pg/g,mean,SD,8752,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2438,2025-12-02T15:56:56.518041
19519880.0,control,,,,,,,,percent net production of the one before perfusion,,320,pg/g,mean,SD,136,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2439,2025-12-02T15:56:56.518041
19519880.0,control,,,,,,,concentration of the released microparticles (MPs),,,2190,ng protein/ g/min,mean,SD,655,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2440,2025-12-02T15:56:56.518041
19519880.0,methadone,,placenta,,,,6,methadone concentration in maternal medium,,,<0.69,%recovery,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2441,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,methadone concentration in fetal medium,,,1.6,%recovery,mean,SD,1.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2442,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,methadone concentration in  perfused tissue,,,57,%recovery,mean,SD,22,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2443,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,cotyledon weight,,,20.1,g,mean,SD,3.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2444,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,hCG,before perfusion,,3422,mU/g,mean,SD,2357,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2445,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,,after 4 hours of perfusion,,3996,mU/g,mean,SD,1908,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2446,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,,accumulation,,6711,mU/g,mean,SD,3318,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2447,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,,net production,,7285,mU/g,mean,SD,2868,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2448,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,,percent net production of the one before perfusion,,269,mU/g,mean,SD,59,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2449,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,leptin,before perfusion,,3673,pg/g,mean,SD,643,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2450,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,,after 4 hours of perfusion,,5590,pg/g,mean,SD,3431,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2451,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,,accumulation,,14380,pg/g,mean,SD,4023,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2452,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,,net production,,16298,pg/g,mean,SD,6737,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2453,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,,percent net production of the one before perfusion,,480,pg/g,mean,SD,257,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2454,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,transfer of antipyrine (fetal to maternal),experiment,,0.5,,mean,SD,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2455,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,,control,,0.6,,mean,SD,0.07,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2456,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,concentration of the released microparticles (MPs) compared with control group,,,96,%,mean,SD,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2457,2025-12-02T15:56:56.518041
19519880.0,methadone,,,,,,,P-glycoprotein expression percent (percentage of actin expression) in the tissue compared with the control group,,,49,%,mean,SD,41,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2458,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,placenta,,,,6,methadone concentration in maternal medium,,,<0.69,%recovery,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2459,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,methadone concentration in fetal medium,,,<0.69,%recovery,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2460,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,methadone concentration in  perfused tissue,,,8,%recovery,mean,SD,10,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2461,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,cotyledon weight,,,19.6,g,mean,SD,2.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2462,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,hCG,before perfusion,,4530,mU/g,mean,SD,2202,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2463,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,,after 4 hours of perfusion,,5305,mU/g,mean,SD,4429,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2464,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,,accumulation,,10539,mU/g,mean,SD,6563,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2465,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,,net production,,11313,mU/g,mean,SD,8219,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2466,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,,percent net production of the one before perfusion,,224,mU/g,mean,SD,116,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2467,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,leptin,before perfusion,,2920,pg/g,mean,SD,544,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2468,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,,after 4 hours of perfusion,,4370,pg/g,mean,SD,2303,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2469,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,,accumulation,,37744,pg/g,mean,SD,20897,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2470,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,,net production,,39195,pg/g,mean,SD,22796,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2471,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,,percent net production of the one before perfusion,,1200,pg/g,mean,SD,573,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2472,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,transfer of antipyrine (fetal to maternal),experiment,,0.68,,mean,SD,0.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2473,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,,control,,0.56,,mean,SD,0.08,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2474,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,concentration of the released microparticles (MPs) compared with control group,,,128,%,mean,SD,8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2475,2025-12-02T15:56:56.518041
19519880.0,methadone+cocaine,,,,,,,P-glycoprotein expression percent (percentage of actin expression) in the tissue compared with the control group,,,75,%,mean,SD,63,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2476,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,placenta,,,,6,methadone concentration in maternal medium,,,1987,%recovery,mean,SD,587,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2477,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,methadone concentration in fetal medium,,,2814,%recovery,mean,SD,352,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2478,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,methadone concentration in  perfused tissue,,,3427,%recovery,mean,SD,374,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2479,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,cotyledon weight,,,20.3,g,mean,SD,2.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2480,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,hCG,before perfusion,,3852,mU/g,mean,SD,1649,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2481,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,,after 4 hours of perfusion,,4336,mU/g,mean,SD,2088,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2482,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,,accumulation,,5176,mU/g,mean,SD,2067,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2483,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,,net production,,5660,mU/g,mean,SD,2647,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2484,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,,percent net production of the one before perfusion,,169,mU/g,mean,SD,81,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2485,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,leptin,before perfusion,,9856,pg/g,mean,SD,6146,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2486,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,,after 4 hours of perfusion,,5568,pg/g,mean,SD,2194,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2487,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,,accumulation,,17949,pg/g,mean,SD,9578,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2488,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,,net production,,13662,pg/g,mean,SD,7026,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2489,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,,percent net production of the one before perfusion,,191,pg/g,mean,SD,573,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2490,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,transfer of antipyrine (fetal to maternal),experiment,,0.71,,mean,SD,0.24,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2491,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,,control,,0.58,,mean,SD,0.21,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2492,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,concentration of the released microparticles (MPs) compared with control group,,,134,%,mean,SD,14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2493,2025-12-02T15:56:56.518041
19519880.0,methadone+heroin,,,,,,,P-glycoprotein expression percent (percentage of actin expression) in the tissue compared with the control group,,,59,%,mean,SD,51,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2494,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,"buprenorphine, no plasma proteins",placenta,maternal,delivery,,9,Concentration,,,2.2,ng/ml,mean,SD,0.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2495,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,,,fetal,,,,Concentration,,,0.9,,,,0.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2496,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,,,fetal/maternal,,,,fetal:maternal ratio,,,0.43,,,,0.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2497,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,buprenorphine with HSA,,maternal,,,5,Concentration,,,2.3,,,,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2498,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,,,fetal,,,,Concentration,,,1.5,,,,0.3,,,,<0.05,p compared to values in the absence of plasma proteins,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2499,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,,,fetal/maternal,,,,fetal:maternal ratio,,,0.59,,,,0.06,,,,<0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2500,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,buprenorphine with AAG,,maternal,,,4,Concentration,,,3.1,,,,0.8,,,,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2501,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,,,fetal,,,,Concentration,,,1.1,,,,0.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2502,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,,,fetal/maternal,,,,fetal:maternal ratio,,,0.47,,,,0.08,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2503,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,buprenorphine with HSA/AAG,,maternal,,,7,Concentration,,,3.3,,,,0.6,,,,<0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2504,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,,,fetal,,,,Concentration,,,1.5,,,,0.2,,,,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2505,2025-12-02T15:56:56.518041
19544152.0,buprenorphine,,,fetal/maternal,,,,fetal:maternal ratio,,,0.43,,,,0.12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2506,2025-12-02T15:56:56.518041
19761699.0,fentanyl,fentanyl,exhaled gas,children/adults,,,8,Tmax,,,,min,,,,range,15,20,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2507,2025-12-02T15:56:56.518041
19793724.0,Diamorphine,morphine,plasma,children,,,12,Cmax,,,36.1,nmol/l,median,,,range,13.7,82.7,<0.001,Intranasal group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2508,2025-12-02T15:56:56.518041
19793724.0,Diamorphine,,,,,,,Tmax,,,10,min,,,,,5,60,<0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2509,2025-12-02T15:56:56.518041
19793724.0,Diamorphine,,,,,,,AUC,,,1794,nmol/l/h,,,,,608,3501,<0.001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2510,2025-12-02T15:56:56.518041
19793724.0,Diamorphine,,,,,,,Concentration,60,min,31.5,nmol/l,,,,,4.4,55.3,0.01,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2511,2025-12-02T15:56:56.518041
19793724.0,Diamorphine,,plasma,children,,,12,Cmax,,,108.6,nmol/l,median,,,range,76.5,480.1,,intravenous goup,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2512,2025-12-02T15:56:56.518041
19793724.0,Diamorphine,,,,,,,Tmax,,,2,min,,,,,2,5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2513,2025-12-02T15:56:56.518041
19793724.0,Diamorphine,,,,,,,AUC,,,3761,nmol/l/h,,,,,2150,5421,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2514,2025-12-02T15:56:56.518041
19793724.0,Diamorphine,,,,,,,Concentration,60,min,47,nmol/l,,,,,31.1,72.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2515,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,ketobemidone,plasma,0-90 days,,,5,t1/2,,,3,l,median,,,range,1.4,8.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2516,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,CL,,,0.84,l/h/kg,,,,,0.29,3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2517,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,AUC,,,79.3,mg/m2,,,,,19.8,243.4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2518,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,AUC,,,1191,mg/kg,,,,,333,3422,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2519,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,Vz,,,4.4,l/kg,,,,,3.7,6.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2520,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,1-2.5 years,,,10,t1/2,,,2,,,,,,1.2,4.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2521,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,CL,,,0.89,,,,,,0.55,1.35,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2522,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,AUC,,,57,,,,,,37.7,85.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2523,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,AUC,,,1125,,,,,,741,1813,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2524,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,Vz,,,2.6,,,,,,2,5.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2525,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,7-10 years,,,9,t1/2,,,3.7,,,,,,2.4,6.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2526,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,CL,,,0.74,,,,,,0.5,0.99,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2527,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,AUC,,,47.9,,,,,,39.6,78.1,0.5663,while AUC/mg/ m2 was unaffected by the age of the patients (P= 0.5663).,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2528,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,AUC,,,1344,,,,,,1008,1987,0.0214,"More importantly, AUC/mg/kg increased with increasing age (P = 0.0214), ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2529,2025-12-02T15:56:56.518041
19839946.0,ketobemidone,,,,,,,Vz,,,3.9,,,,,,2.7,5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2530,2025-12-02T15:56:56.518041
19996953.0,fentanyl,,cerebrospinal fluid,pregnant,post-partum,,52,concentration,60 seconds after injection,second,3.1,ug/ml,mean,SD,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2531,2025-12-02T15:56:56.518041
20592651.0,methadone,,sweat,pregnant,between 929 weeks EGA,,13,concentration,Patch Wear Duration less than 5 days,,799.8,ng/patch,mean,SD,326.4,range,367.6,1121.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2532,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,,,854.8,ng/patch,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2533,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,Patch Wear Duration 5-6 days,,2082.2,ng/patch,mean,SD,1808.3,range,144.7,6206.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2534,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,,,1933.2,ng/patch,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2535,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,Patch Wear Duration 7 days,,1609,ng/patch,mean,SD,1606.6,range,44.2,6266.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2536,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,,,1019.4,ng/patch,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2537,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,Patch Wear Duration more than 7 days,,1992.3,ng/patch,mean,SD,1113.2,range,776.2,449,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2538,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,,,1759.7,ng/patch,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2539,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,Total,,1727.3,ng/patch,mean,SD,1509.7,range,44.2,6266.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2540,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,,,1286.3,ng/patch,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2541,2025-12-02T15:56:56.518041
20592651.0,methadone,,sweat,pregnant,between 929 weeks EGA,,13,concentration,0-12h patch,,276.5,ng/patch,mean,SD,556.7,range,0,2047.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2542,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,,,62.2,ng/patch,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2543,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,12-24h patch,,377.6,ng/patch,mean,SD,729.3,range,0,2131.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2544,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,,,66.1,ng/patch,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2545,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,sum 0-12h & 12-24h patches,,654.1,ng/patch,mean,SD,1235,range,0,4178.4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2546,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,,,151.4,ng/patch,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2547,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,0-24 patch,,403.3,ng/patch,mean,SD,889.3,range,16.5,3303.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2548,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,,,83.9,ng/patch,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2549,2025-12-02T15:56:56.518041
20592651.0,methadone,,sweat,pregnant,between 929 weeks EGA,,29,concentration,weekly patches,,1650,ng/patch,mean,SD,1669,range,27,12129.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2550,2025-12-02T15:56:56.518041
20592651.0,methadone,,,,,,,,,,1200.1,ng/patch,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2551,2025-12-02T15:56:56.518041
20607647.0,Buprenorphine,buprenorphine,placenta,Maternal,17-26 weeks,,7,Km,,,15,uM,mean,SD,9,,,,,conversion to norBUP,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2552,2025-12-02T15:56:56.518041
20607647.0,Buprenorphine,,,,27-33 weeks,,17,,,,16,,,,0.2,,,,,conversion to norBUP,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2553,2025-12-02T15:56:56.518041
20607647.0,Buprenorphine,,,,34-37 weeks,,6,,,,24,,,,8,,,,,conversion to norBUP,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2554,2025-12-02T15:56:56.518041
20607647.0,Buprenorphine,,,,39-42 weeks,,9,,,,13,,,,4,,,,,conversion to norBUP; at term,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2555,2025-12-02T15:56:56.518041
20607647.0,Buprenorphine,,,,17-26 weeks,,7,Vmax,,,1.9,pmol*mg/protein/min,,,0.4,,,,,conversion to norBUP,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2556,2025-12-02T15:56:56.518041
20607647.0,Buprenorphine,,,,27-33 weeks,,17,,,,2.4,,,,0.8,,,,,conversion to norBUP,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2557,2025-12-02T15:56:56.518041
20607647.0,Buprenorphine,,,,34-37 weeks,,6,,,,2.8,,,,0.7,,,,,conversion to norBUP,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2558,2025-12-02T15:56:56.518041
20607647.0,Buprenorphine,,,,39-42 weeks,,9,,,,2.9,,,,0.7,,,,,conversion to norBUP; at term,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2559,2025-12-02T15:56:56.518041
20607647.0,Buprenorphine,,,,30-34 weeks,,8,Transfer,,,32.2,,,,1.3,,,,>0.05,compared to transfer in term placenta,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2560,2025-12-02T15:56:56.518041
20607647.0,Buprenorphine,,,,39-42 weeks,,9,Transfer,,,39.9,,,,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2561,2025-12-02T15:56:56.518041
20854338.0,Methadone,methadone,meconium,infants,,,48,concentration,,,5234,ng/g,median,,,range,85,21980,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2562,2025-12-02T15:56:56.518041
20854338.0,Methadone,EDDP,,,,,48,,,,33193,,,,,,4431,101021,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2563,2025-12-02T15:56:56.518041
20854338.0,Morphine,Morphine,,,,,17,,,,65.9,,,,,,7.5,3622,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2564,2025-12-02T15:56:56.518041
20854338.0,Codeine,Codeine,,,,,2,,,,141,,,,,,16.3,266,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2565,2025-12-02T15:56:56.518041
20854338.0,Hydromorphone,Hydromorphone,,,,,1,,,,21,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2566,2025-12-02T15:56:56.518041
21175445.0,Methadone,R-methadone,plasma,maternal,delivery,,15,concentration,,,62.75,ng/ml,median,,,range,25.1,159.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2567,2025-12-02T15:56:56.518041
21175445.0,Methadone,,umbilical cord blood,fetal,delivery,,15,concentration,,,20.74,,,,,,10.6,71.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2568,2025-12-02T15:56:56.518041
21175445.0,Methadone,,umbilical cord/venous blood,fetal/maternal,delivery,,15,fetal:maternal ratio,,,0.41,,,,,,0.19,0.56,<0.0001,compared with S-methadone,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2569,2025-12-02T15:56:56.518041
21175445.0,Methadone,S-methadone,plasma,maternal,delivery,,15,concentration,,,45.66,,,,,,20.6,197.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2570,2025-12-02T15:56:56.518041
21175445.0,Methadone,,umbilical cord blood,fetal,delivery,,15,concentration,,,15.8,,,,,,7.42,51.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2571,2025-12-02T15:56:56.518041
21175445.0,Methadone,,umbilical cord/venous blood,fetal/maternal,delivery,,15,fetal:maternal ratio,,,0.36,,,,,,0.15,0.53,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2572,2025-12-02T15:56:56.518041
21175445.0,Methadone,R-/S-methadone,plasma,maternal,delivery,,15,concentration ratio,,,1.16,,,,,,0.81,1.38,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2573,2025-12-02T15:56:56.518041
21175445.0,Methadone,,umbilical cord blood,fetal,delivery,,15,concentration ratio,,,1.4,,,,,,0.95,1.67,<0.0001,compared with maternal,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2574,2025-12-02T15:56:56.518041
21175445.0,Buprenorphine,Buprenorphine,plasma,maternal,delivery,,17,concentration,,,0.5,,,,,,0.14,3.43,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2575,2025-12-02T15:56:56.518041
21175445.0,Buprenorphine,,umbilical cord blood,fetal,delivery,,9,concentration,,,0.23,,,,,,0.13,0.75,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2576,2025-12-02T15:56:56.518041
21175445.0,Buprenorphine,,umbilical cord/venous blood,fetal/maternal,delivery,,9,fetal:maternal ratio,,,0.35,,,,,,0.14,0.47,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2577,2025-12-02T15:56:56.518041
21175445.0,Buprenorphine,norBUP,plasma,maternal,delivery,,17,concentration,,,0.71,,,,,,0.3,2.75,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2578,2025-12-02T15:56:56.518041
21175445.0,Buprenorphine,,umbilical cord blood,fetal,delivery,,16,concentration,,,0.43,,,,,,0.15,0.87,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2579,2025-12-02T15:56:56.518041
21175445.0,Buprenorphine,,umbilical cord/venous blood,fetal/maternal,delivery,,16,fetal:maternal ratio,,,0.49,,,,,,0.24,0.91,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2580,2025-12-02T15:56:56.518041
21245372.0,Methadone,methadone,placenta,,,,19,concentration,,,1467.2,,,,720.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2581,2025-12-02T15:56:56.518041
21245372.0,Methadone,EDDP,,,,,,concentration,,,152.3,,,,115.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2582,2025-12-02T15:56:56.518041
21245372.0,Methadone,methadone/EDDP,,,,,,metabolite:drug ratio,,,0.11,,,,0.05,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2583,2025-12-02T15:56:56.518041
21245372.0,Methadone,methadone,meconium,,,,17,concentration,,,6883.1,,,,5804.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2584,2025-12-02T15:56:56.518041
21245372.0,Methadone,EDDP,,,,,,concentration,,,40897.5,,,,20922.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2585,2025-12-02T15:56:56.518041
21245372.0,Methadone,methadone/EDDP,,,,,,metabolite:drug ratio,,,11.8,,,,17.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2586,2025-12-02T15:56:56.518041
21258236.0,remifentanil,remifentanil,umbilical cord,preterm/term,delivery,,40,concentration,150,min,44,nmol/l,median,IQR,15.5,range,26.8,70.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2587,2025-12-02T15:56:56.518041
21258236.0,remifentanil,GR90291,umbilical cord,preterm/term,delivery,,40,concentration,150,minutes,82.3,nmol/l,median,IQR,25.3,range,32.8,127.4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2588,2025-12-02T15:56:56.518041
21258236.0,remifentanil,GR90291/remifentanil,umbilical cord,preterm/term,delivery,,40,metabolite:drug ratio,,,1.98,,median,IQR,0.81,range,0.93,3.76,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2589,2025-12-02T15:56:56.518041
21258236.0,remifentanil,remifentanil,umbilical cord,preterm/term,delivery,,40,t1/2,,,143.1,min,median,IQR,46.6,range,76.4,220.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2590,2025-12-02T15:56:56.518041
21258236.0,remifentanil,remifentanil,umbilical cord,preterm/term,delivery,,40,km,,,92.5,ug/l,median,IQR,34.9,range,51.7,183,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2591,2025-12-02T15:56:56.518041
21258236.0,remifentanil,remifentanil,umbilical cord,preterm,delivery,,9,t1/2,,,140,min,median,IQR,62,range,118,221,0.289,"P1, p-value for comparison with T",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2592,2025-12-02T15:56:56.518041
21258236.0,remifentanil,remifentanil,umbilical cord,preterm,delivery,,10,t1/2,,,141,min,median,IQR,23,range,98,154,0.023,"P2, p-value for comparison with T",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2593,2025-12-02T15:56:56.518041
21258236.0,remifentanil,remifentanil,umbilical cord,preterm,delivery,,15,t1/2,,,128,min,median,IQR,48,range,76,193,0.013,"P3, p-value for comparison with T",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2594,2025-12-02T15:56:56.518041
21258236.0,remifentanil,remifentanil,umbilical cord,term,delivery,,6,t1/2,,,188,min,median,IQR,58,range,120,208,,Term,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2595,2025-12-02T15:56:56.518041
21258236.0,remifentanil,remifentanil,umbilical cord,preterm,delivery,,9,km,,,84.3,ug/l,median,IQR,34.7,,,,0.194,"P1, p-value for comparison with T",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2596,2025-12-02T15:56:56.518041
21258236.0,remifentanil,remifentanil,umbilical cord,preterm,delivery,,10,km,,,2.8,ug/l,median,IQR,20.3,,,,0.159,"P2, p-value for comparison with T",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2597,2025-12-02T15:56:56.518041
21258236.0,remifentanil,remifentanil,umbilical cord,preterm,delivery,,15,km,,,84.1,ug/l,median,IQR,46.2,,,,0.35,"P3, p-value for comparison with T",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2598,2025-12-02T15:56:56.518041
21258236.0,remifentanil,remifentanil,umbilical cord,term,delivery,,6,km,,,109.5,ug/l,median,IQR,27.8,,,,,Term,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2599,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,hydrocodone,breast milk,Maternal,Postpartum,,30,AUC,,,1390,ug/l*h,mean,SD,1628,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2600,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Concentration,,,25.9,ug/l,,,26.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2601,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Neonatal dosage,,,3.9,ug/kg/d,,,3.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2602,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Relative neontal dosage,,,2.4,%,,,2.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2603,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Infant therapeutic dose,,,1.1,%,,,1.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2604,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,AUC,,,828,,median,,,range,69.8,8072,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2605,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Concentration,,,14.2,,,,,,1.6,99.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2606,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Neonatal dosage,,,2.1,,,,,,0.2,14.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2607,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Relative neontal dosage,,,1.6,,,,,,0.2,9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2608,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Infant therapeutic dose,,,0.6,%,,,,,0.07,4.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2609,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,hydromorphone,breast milk,Maternal,Postpartum,,30,AUC,,,622,ug/l*h,mean,SD,981,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2610,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Concentration,,,14.2,ug/l,,,26.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2611,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Neonatal dosage,,,2.1,ug/kg/d,,,3.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2612,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Infant therapeutic dose,,,1,%,,,1.5,,0.07,4.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2613,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,AUC,,,114,,median,,,range,14,2583,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2614,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Concentration,,,1.9,,,,,,0.2,86.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2615,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Neonatal dosage,,,0.3,,,,,,0.03,13,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2616,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Infant therapeutic dose,,,0.13,,,,,,0.1,6.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2617,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,Total infant therapeutic dose,,,1.5,%,mean,SD,2.1,range,0.1,9.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2618,2025-12-02T15:56:56.518041
21343764.0,Hydrocodone,,,,,,,,,,0.7,,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2619,2025-12-02T15:56:56.518041
21348770.0,Methadone,R-methadone,breast milk,pregnant,Postpartum,,20,peak concentration,,,0.1359,mg/L,mean,SD,0.147,range,0.025,0.695,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2620,2025-12-02T15:56:56.518041
21348770.0,Methadone,S-methadone,breast milk,pregnant,Postpartum,,21,peak concentration,,,0.0837,mg/L,mean,SD,0.106,range,0.012,0.471,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2621,2025-12-02T15:56:56.518041
21348770.0,Methadone,total methadone,breast milk,pregnant,Postpartum,,22,peak concentration,,,0.2196,mg/L,mean,SD,0.253,range,0.04,1.13,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2622,2025-12-02T15:56:56.518041
21348770.0,Methadone,R/S ratio,breast milk,pregnant,Postpartum,,23,peak concentration,,,1.84,mg/L,mean,SD,0.45,range,1.35,3.08,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2623,2025-12-02T15:56:56.518041
21348770.0,Methadone,R-methadone,plasma,pregnant,Postpartum,,20,peak concentration,,,0.2554,mg/L,mean,SD,0.167,range,0.079,0.72,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2624,2025-12-02T15:56:56.518041
21348770.0,Methadone,S-methadone,plasma,pregnant,Postpartum,,21,peak concentration,,,0.2868,mg/L,mean,SD,0.238,range,0.036,1.045,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2625,2025-12-02T15:56:56.518041
21348770.0,Methadone,total methadone,plasma,pregnant,Postpartum,,22,peak concentration,,,0.5422,mg/L,mean,SD,0.402,range,0.115,0.402,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2626,2025-12-02T15:56:56.518041
21348770.0,Methadone,R/S ratio,plasma,pregnant,Postpartum,,23,peak concentration,,,1.01,mg/L,mean,SD,0.33,range,"0,33",0.67,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2627,2025-12-02T15:56:56.518041
21348770.0,Methadone,R-methadone,breast/plasma,neonate,Postpartum,,,theoretic infant dose,,,0.02,mg/kg/day,mean,SD,0.022,range,0.004,0.099,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2628,2025-12-02T15:56:56.518041
21348770.0,Methadone,R-methadone,breast/plasma,neonate,Postpartum,,,relative infant dose,,,2.7,%,mean,SD,2.1,range,0.66,10.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2629,2025-12-02T15:56:56.518041
21348770.0,Methadone,R-methadone,breast/plasma,neonate,Postpartum,,,milk/plasma ratio,,,0.52,,mean,SD,0.28,range,0.05,1.27,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2630,2025-12-02T15:56:56.518041
21348770.0,Methadone,S-methadone,breast/plasma,neonate,Postpartum,,,theoretic infant dose,,,0.013,mg/kg/day,mean,SD,0.016,range,0.002,0.71,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2631,2025-12-02T15:56:56.518041
21348770.0,Methadone,S-methadone,breast/plasma,neonate,Postpartum,,,relative infant dose,,,1.6,%,mean,SD,1.5,range,0.33,7.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2632,2025-12-02T15:56:56.518041
21348770.0,Methadone,S-methadone,breast/plasma,neonate,Postpartum,,,milk/plasma ratio,,,0.28,,mean,SD,0.15,range,0.02,0.68,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2633,2025-12-02T15:56:56.518041
21398109.0,meperidine,meperidine,milk sample 1,Maternal,Postpartum,,12,Concentration,<2,hour,421,ug/L,mean,,,95CI,303,529,,or at 48h/6h later if meperidine was used until 48h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2634,2025-12-02T15:56:56.518041
21398109.0,meperidine,meperidine,milk sample 2,Maternal,Postpartum,,14,Concentration,6,hour,176,ug/L,mean,,,95CI,120,321,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2635,2025-12-02T15:56:56.518041
21398109.0,meperidine,meperidine,plasma sample 1,Maternal,Postpartum,,13,Concentration,<2,hour,326,ug/L,mean,,,95CI,249,403,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2636,2025-12-02T15:56:56.518041
21398109.0,meperidine,meperidine,plasma sample 2,Maternal,Postpartum,,15,Concentration,6,hour,114,ug/L,mean,,,95CI,76,151,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2637,2025-12-02T15:56:56.518041
21398109.0,meperidine,normeperidine,milk sample 1,Maternal,Postpartum,,12,Concentration,<2,hour,414,ug/L,mean,,,95CI,309,490,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2638,2025-12-02T15:56:56.518041
21398109.0,meperidine,normeperidine,milk sample 2,Maternal,Postpartum,,14,Concentration,6,hour,373,ug/L,mean,,,95CI,258,487,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2639,2025-12-02T15:56:56.518041
21398109.0,meperidine,normeperidine,plasma sample 1,Maternal,Postpartum,,13,Concentration,<2,hour,257,ug/L,mean,,,95CI,193,251,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2640,2025-12-02T15:56:56.518041
21398109.0,meperidine,normeperidine,plasma sample 2,Maternal,Postpartum,,15,Concentration,6,hour,160,ug/L,mean,,,95CI,99,221,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2641,2025-12-02T15:56:56.518041
21398109.0,meperidine,meperidine,milk sample 1,neonatal,Postpartum,,12,absolute infant dose 1,,,20,ug/kg/day,mean,,,95CI,14,27,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2642,2025-12-02T15:56:56.518041
21398109.0,meperidine,meperidine,milk sample 2,neonatal,Postpartum,,14,absolute infant dose 2,,,10,ug/kg/day,mean,,,95CI,7,13,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2643,2025-12-02T15:56:56.518041
21398109.0,meperidine,meperidine,milk sample 1,neonatal,Postpartum,,12,relative infant dose 1,,,0.7,%,mean,,,95CI,0.1,1.4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2644,2025-12-02T15:56:56.518041
21398109.0,meperidine,meperidine,milk sample 2,neonatal,Postpartum,,14,relative infant dose 2,,,0.3,%,mean,,,95CI,0.1,0.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2645,2025-12-02T15:56:56.518041
21398109.0,meperidine,meperidine,plasma sample,neonatal,Postpartum,,17,infant plasma ,,,3,ug/L,mean,,,95CI,0,6.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2646,2025-12-02T15:56:56.518041
21398109.0,meperidine,meperidine,plasma sample,neonatal,Postpartum,,17,infant exposure ,,,1.4,%,mean,,,95CI,0.2,2.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2647,2025-12-02T15:56:56.518041
21398109.0,meperidine,normeperidine,milk sample 1,neonatal,Postpartum,,12,absolute infant dose 1,,,21,ug/kg/day,mean,,,95CI,16,26,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2648,2025-12-02T15:56:56.518041
21398109.0,meperidine,normeperidine,milk sample 2,neonatal,Postpartum,,14,absolute infant dose 2,,,22,ug/kg/day,mean,,,95CI,12,32,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2649,2025-12-02T15:56:56.518041
21398109.0,meperidine,normeperidine,milk sample 1,neonatal,Postpartum,,12,relative infant dose 1,,,0.7,%,mean,,,95CI,0.3,1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2650,2025-12-02T15:56:56.518041
21398109.0,meperidine,normeperidine,milk sample 2,neonatal,Postpartum,,14,relative infant dose 2,,,0.6,%,mean,,,95CI,0.2,1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2651,2025-12-02T15:56:56.518041
21398109.0,meperidine,normeperidine,plasma sample,neonatal,Postpartum,,17,infant plasma ,,,0.6,ug/L,mean,,,95CI,0.2,1,,"Neonatal capillary blood samples (0.5 mL) were collected for drug assay at the time the Guthrie test was performed, usually approximately 48 72 h after birth. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2652,2025-12-02T15:56:56.518041
21398109.0,meperidine,normeperidine,plasma sample,neonatal,Postpartum,,17,infant exposure ,,,0.4,%,mean,,,95CI,0.2,0.6,,"Neonatal capillary blood samples (0.5 mL) were collected for drug assay at the time the Guthrie test was performed, usually approximately 48 72 h after birth. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2653,2025-12-02T15:56:56.518041
21642610.0,Morphine,morphine,plasma,Maternal,Labor,,15,Cmax,,,11.1,ng/ml,mean,SD,4.9,,,,0.038,Group E,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2654,2025-12-02T15:56:56.518041
21642610.0,Morphine,,,,,,,Tmax,,,4,h,median,,,range,0.17,4,0.318,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2655,2025-12-02T15:56:56.518041
21642610.0,Morphine,,,,,,,AUC0-last,,,39.9,ng/ml*h,mean,SD,12.8,,,,0.41,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2656,2025-12-02T15:56:56.518041
21642610.0,Morphine,,,,,,14,Cmax,,,8.3,ng/ml,mean,SD,7.1,,,,,Group SE,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2657,2025-12-02T15:56:56.518041
21642610.0,Morphine,,,,,,,Tmax,,,1,h,median,,,range,0.08,1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2658,2025-12-02T15:56:56.518041
21642610.0,Morphine,,,,,,,AUC0-last,,,37,ng/ml*h,mean,SD,20.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2659,2025-12-02T15:56:56.518041
21642610.0,Morphine,,,,,,,Cmax,,,0.156,%,,,,90%CL,0.11,0.22,,Ratio of geometric means,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2660,2025-12-02T15:56:56.518041
21642610.0,Morphine,,,,,,,Tmax,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2661,2025-12-02T15:56:56.518041
21642610.0,Morphine,,,,,,,AUC0-last,,,0.124,,,,,,0.08,0.19,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2662,2025-12-02T15:56:56.518041
21743375.0,Methadone,methadone,umbilical cord,neonate,delivery,,19,concentration,,,140.3,ng/g,mean,SD,59.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2663,2025-12-02T15:56:56.518041
21743375.0,Methadone,EDDP,,,,,,concentration,,,65.6,,,,50.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2664,2025-12-02T15:56:56.518041
21743375.0,Methadone,methadone/EDDP,,,,,,metabolite:drug ratio,,,0.51,,,,0.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2665,2025-12-02T15:56:56.518041
21743375.0,Methadone,methadone,placenta,,,,19,concentration,,,1467.2,,,,720.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2666,2025-12-02T15:56:56.518041
21743375.0,Methadone,EDDP,,,,,,concentration,,,152.3,,,,115.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2667,2025-12-02T15:56:56.518041
21743375.0,Methadone,methadone/EDDP,,,,,,metabolite:drug ratio,,,0.11,,,,0.05,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2668,2025-12-02T15:56:56.518041
21743375.0,Methadone,methadone,meconium,,,,17,concentration,,,6883.1,,,,5804.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2669,2025-12-02T15:56:56.518041
21743375.0,Methadone,EDDP,,,,,,concentration,,,40897.5,,,,20922.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2670,2025-12-02T15:56:56.518041
21743375.0,Methadone,methadone/EDDP,,,,,,metabolite:drug ratio,,,11.8,,,,17.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2671,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,BUP,plasma,maternal,trimester 3/postpartum,,3,concentration,,,1.3,ng/ml,median,,,range,0,35.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2672,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,NBUP,,,,,,,,,2.9,,,,,,0,27.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2673,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,BUP-Gluc,,,,,,,,,1.7,,,,,,0,32.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2674,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,NBUP-Gluc,,,,,,,,,14.3,,,,,,1.5,81.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2675,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,BUP,oral fluid,maternal,trimester 3/postpartum,,3,concentration,,,15.4,,,,,,0.1,12300,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2676,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,NBUP,,,,,,,,,3.5,,,,,,0,122,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2677,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,BUP,oral fluid/plasma,maternal,trimester 3/postpartum,,3,oral fluid/plasma ratio,0.5,hours,1802,median,,,,range,0.2,16466,0.008,from 95 samples,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2678,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,1,,810,,,,,,28.5,1449,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2679,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,2,,85.3,,,,,,4.1,482,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2680,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,3,,59.3,,,,,,10.9,801,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2681,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,4,,25.5,,,,,,1.6,254,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2682,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,6,,2.4,,,,,,0.4,795,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2683,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,8,,3.8,,,,,,0.1,16.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2684,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,12,,1.7,,,,,,0.1,15.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2685,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,23.5,,1,,,,,,0,165,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2686,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,NBUP,oral fluid/plasma,maternal,trimester 3/postpartum,,3,oral fluid/plasma ratio,0.5,hours,23.4,,,,,,0,68.5,,from 92 samples,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2687,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,1,,7.6,,,,,,0.5,16.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2688,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,2,,1.9,,,,,,0.3,2.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2689,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,3,,1.1,,,,,,0.3,6.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2690,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,4,,1.9,,,,,,0.3,3.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2691,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,6,,0.4,,,,,,0,8.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2692,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,8,,0.5,,,,,,0.1,2.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2693,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,12,,0.8,,,,,,0.1,9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2694,2025-12-02T15:56:56.518041
21860340.0,Buprenorphine,,,,,,,,23.5,,0.2,,,,,,0.1,6.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2695,2025-12-02T15:56:56.518041
22011128.0,Buprenorphine,buprenorphine,breast milk,maternal,postpartum,,7,Cavg,0-24,h,3.65,ug/l,mean,,,95% CI,1.61,5.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2696,2025-12-02T15:56:56.518041
22011128.0,Buprenorphine,Norbuprenorphine,breast milk,maternal,postpartum,,7,Cavg,0-24,h,1.94,ug/l,,,,95% CI,0.79,3.08,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2697,2025-12-02T15:56:56.518041
22011128.0,Buprenorphine,buprenorphine,breast milk,neonate,,,7,absolute infant dose,0-24,h,0.55,ug/kg/day,,,,95% CI,0.24,0.85,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2698,2025-12-02T15:56:56.518041
22011128.0,Buprenorphine,Norbuprenorphine,breast milk,neonate,,,7,absolute infant dose,0-24,h,0.29,ug/kg/day,,,,95% CI,0.12,0.46,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2699,2025-12-02T15:56:56.518041
22011128.0,Buprenorphine,buprenorphine,breast milk,neonate,,,7,relative infant dose,0-24,h,0.38,,,,,95% CI,0.23,0.53,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2700,2025-12-02T15:56:56.518041
22011128.0,Buprenorphine,Norbuprenorphine,breast milk,neonate,,,7,relative infant dose,0-24,h,0.18,,,,,95% CI,0.11,0.25,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2701,2025-12-02T15:56:56.518041
22025493.0,Fentanyl,fentanyl,umbilical vein blood,Neonate,Delivery,,13,Concentration,,,14,ng/ml,median,,,range,4.3,64,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2702,2025-12-02T15:56:56.518041
22037641.0,methadone,R-methadone,blood,Adolescent,,,10,Cmax,,,39,ng/ml,mean,SD,35,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2703,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax,,,56,ng/ml,mean,SD,21,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2704,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Cmax,,,78,ng/ml,mean,SD,27,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2705,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax/dose,,,14,ng/ml/mg,mean,SD,11,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2706,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax/dose,,,13,ng/ml/mg,mean,SD,5,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2707,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Cmax/dose,,,10,ng/ml/mg,mean,SD,4,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2708,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC,,,594,ng*hr/ml,mean,SD,389,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2709,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC,,,837,ng*hr/ml,mean,SD,273,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2710,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC,,,1588,ng*hr/ml,mean,SD,789,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2711,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC/dose,,,228,ng*hr/ml/mg,mean,SD,164,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2712,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC/dose,,,189,ng*hr/ml/mg,mean,SD,54,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2713,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC/dose,,,205,ng*hr/ml/mg,mean,SD,102,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2714,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,CLIV,,,1.6,ml/kg/min,mean,SD,0.7,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2715,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,CLIV,,,2,ml/kg/min,mean,SD,0.6,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2716,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,CLIV,,,1.6,ml/kg/min,mean,SD,0.8,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2717,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Elimination half-life,,,55,hr,mean,SD,38,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2718,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Elimination half-life,,,43,hr,mean,SD,16,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2719,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Elimination half-life,,,59,hr,mean,SD,37,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2720,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Vss,,,6.4,L/kg,mean,SD,1.4,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2721,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Vss,,,6.6,L/kg,mean,SD,1.7,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2722,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Vss,,,6.6,L/kg,mean,SD,1.5,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2723,2025-12-02T15:56:56.518041
22037641.0,methadone,S-methadone,blood,Adolescent,,,10,Cmax,,,52,ng/ml,mean,SD,50,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2724,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax,,,75,ng/ml,mean,SD,22,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2725,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Cmax,,,106,ng/ml,mean,SD,40,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2726,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax/dose,,,19,ng/ml/mg,mean,SD,16,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2727,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax/dose,,,17,ng/ml/mg,mean,SD,6,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2728,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Cmax/dose,,,14,ng/ml/mg,mean,SD,6,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2729,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC,,,679,ng*hr/ml,mean,SD,375,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2730,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC,,,979,ng*hr/ml,mean,SD,245,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2731,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC,,,1835,ng*hr/ml,mean,SD,757,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2732,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC/dose,,,256,ng*hr/ml/mg,mean,SD,151,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2733,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC/dose,,,223,ng*hr/ml/mg,mean,SD,58,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2734,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC/dose,,,235,ng*hr/ml/mg,mean,SD,88,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2735,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,CLIV,,,1.4,ml/kg/min,mean,SD,0.8,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2736,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,CLIV,,,1.6,ml/kg/min,mean,SD,0.4,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2737,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,CLIV,,,1.3,ml/kg/min,mean,SD,0.5,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2738,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Elimination half-life,,,40,hr,mean,SD,25,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2739,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Elimination half-life,,,28,hr,mean,SD,11,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2740,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Elimination half-life,,,37,hr,mean,SD,17,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2741,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Vss,,,4,L/kg,mean,SD,1,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2742,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Vss,,,3.8,L/kg,mean,SD,1.1,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2743,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Vss,,,3.8,L/kg,mean,SD,0.9,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2744,2025-12-02T15:56:56.518041
22037641.0,methadone,R-EDDP,blood,Adolescent,,,10,Cmax,,,0.38,ng/ml,mean,SD,0.11,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2745,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax,,,0.88,ng/ml,mean,SD,0.24,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2746,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Cmax,,,1.14,ng/ml,mean,SD,0.3,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2747,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax/dose,,,0.06,ng/ml/mg,mean,SD,0.01,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2748,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax/dose,,,0.09,ng/ml/mg,mean,SD,0.04,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2749,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Cmax/dose,,,0.07,ng/ml/mg,mean,SD,0.03,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2750,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Tmax,,,14,hr,mean,SD,14,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2751,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Tmax,,,12,hr,mean,SD,6,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2752,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Tmax,,,11,hr,mean,SD,6,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2753,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC0-96,,,23,ng*hr/ml,mean,SD,10,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2754,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC0-96,,,42,ng*hr/ml,mean,SD,11,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2755,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC0-96,,,55,ng*hr/ml,mean,SD,15,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2756,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC,,,46,ng*hr/ml,mean,SD,28,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2757,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC,,,59,ng*hr/ml,mean,SD,20,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2758,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC,,,106,ng*hr/ml/mg,mean,SD,65,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2759,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC/dose,,,7.4,ng*hr/ml,mean,SD,4,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2760,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC/dose,,,6,ng*hr/ml,mean,SD,1.9,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2761,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC/dose,,,6.1,ng*hr/ml,mean,SD,3.7,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2762,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Elimination half-life,,,72,hr,mean,SD,42,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2763,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Elimination half-life,,,41,hr,mean,SD,17,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2764,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Elimination half-life,,,68,hr,mean,SD,57,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2765,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC096 (EDDP/ methadone),,,0.06,,mean,SD,0.01,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2766,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC096 (EDDP/ methadone),,,0.07,,mean,SD,0.01,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2767,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC096 (EDDP/ methadone),,,0.06,,mean,SD,0.01,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2768,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC (EDDP/ methadone),,,0.08,,mean,SD,0.03,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2769,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC (EDDP/ methadone),,,0.07,,mean,SD,0.02,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2770,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC (EDDP/ methadone),,,0.07,,mean,SD,0.02,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2771,2025-12-02T15:56:56.518041
22037641.0,methadone,S-EDDP,blood,Adolescent,,,10,Cmax,,,0.76,ng/ml,mean,SD,0.18,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2772,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax,,,1.79,ng/ml,mean,SD,0.52,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2773,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Cmax,,,2.35,ng/ml,mean,SD,0.54,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2774,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax/dose,,,0.13,ng/ml/mg,mean,SD,0.03,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2775,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Cmax/dose,,,0.19,ng/ml/mg,mean,SD,0.08,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2776,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Cmax/dose,,,0.14,ng/ml/mg,mean,SD,0.05,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2777,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Tmax,,,24,hr,mean,SD,9,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2778,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Tmax,,,17,hr,mean,SD,7,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2779,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Tmax,,,14,hr,mean,SD,6,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2780,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC0-96,,,42,ng*hr/ml,mean,SD,16,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2781,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC0-96,,,78,ng*hr/ml,mean,SD,22,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2782,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC0-96,,,111,ng*hr/ml,mean,SD,32,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2783,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC,,,60,ng*hr/ml,mean,SD,26,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2784,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC,,,107,ng*hr/ml,mean,SD,49,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2785,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC,,,192,ng*hr/ml/mg,mean,SD,93,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2786,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC/dose,,,9.8,ng*hr/ml,mean,SD,3.4,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2787,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC/dose,,,11.4,ng*hr/ml,mean,SD,7.1,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2788,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC/dose,,,11.2,ng*hr/ml,mean,SD,5.5,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2789,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Elimination half-life,,,41,hr,mean,SD,20,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2790,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,Elimination half-life,,,31,hr,mean,SD,14,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2791,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,Elimination half-life,,,49,hr,mean,SD,36,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2792,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC096 (EDDP/ methadone),,,0.09,,mean,SD,0.03,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2793,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC096 (EDDP/ methadone),,,0.09,,mean,SD,0.02,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2794,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC096 (EDDP/ methadone),,,0.09,,mean,SD,0.02,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2795,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC (EDDP/ methadone),,,0.1,,mean,SD,0.03,,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2796,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,10,AUC (EDDP/ methadone),,,0.12,,mean,SD,0.07,,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2797,2025-12-02T15:56:56.518041
22037641.0,,,,Adolescent,,,11,AUC (EDDP/ methadone),,,0.1,,mean,SD,0.04,,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2798,2025-12-02T15:56:56.518041
22037641.0,methadone,R-methadone,blood,Adolescent,,,31,Cmax/dose,,,12,ng/ml/mg,mean,SD,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2799,2025-12-02T15:56:56.518041
22037641.0,methadone,R-methadone,blood,Adolescent,,,31,AUC/dose,,,207,ng*hr/ml/mg,mean,SD,113,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2800,2025-12-02T15:56:56.518041
22037641.0,methadone,R-methadone,blood,Adolescent,,,31,CLIV,,,1.7,ml/kg/min,mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2801,2025-12-02T15:56:56.518041
22037641.0,methadone,R-methadone,blood,Adolescent,,,31,Elimination half-life,,,52,hr,mean,SD,31,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2802,2025-12-02T15:56:56.518041
22037641.0,methadone,R-methadone,blood,Adolescent,,,31,Vss,,,6.5,L/kg,mean,SD,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2803,2025-12-02T15:56:56.518041
22037641.0,methadone,S-methadone,blood,Adolescent,,,31,Cmax/dose,,,17,ng/ml/mg,mean,SD,10,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2804,2025-12-02T15:56:56.518041
22037641.0,methadone,S-methadone,blood,Adolescent,,,31,AUC/dose,,,238,ng*hr/ml/mg,mean,SD,103,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2805,2025-12-02T15:56:56.518041
22037641.0,methadone,S-methadone,blood,Adolescent,,,31,CLIV,,,1.4,ml/kg/min,mean,SD,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2806,2025-12-02T15:56:56.518041
22037641.0,methadone,S-methadone,blood,Adolescent,,,31,Elimination half-life,,,35,hr,mean,SD,18,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2807,2025-12-02T15:56:56.518041
22037641.0,methadone,S-methadone,blood,Adolescent,,,31,Vss,,,3.8,L/kg,mean,SD,0.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2808,2025-12-02T15:56:56.518041
22037641.0,methadone,R-EDDP,blood,Adolescent,,,31,Cmax/dose,,,0.07,ng/ml/mg,mean,SD,0.03,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2809,2025-12-02T15:56:56.518041
22037641.0,methadone,R-EDDP,blood,Adolescent,,,31,Tmax,,,13,hr,mean,SD,9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2810,2025-12-02T15:56:56.518041
22037641.0,methadone,R-EDDP,blood,Adolescent,,,31,AUC/dose,,,6.5,ng*hr/ml/mg,mean,SD,3.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2811,2025-12-02T15:56:56.518041
22037641.0,methadone,R-EDDP,blood,Adolescent,,,31,Elimination half-life,,,61,hr,mean,SD,43,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2812,2025-12-02T15:56:56.518041
22037641.0,methadone,R-EDDP,blood,Adolescent,,,31,AUC096 (EDDP/ methadone),,,0.06,,mean,SD,0.01,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2813,2025-12-02T15:56:56.518041
22037641.0,methadone,R-EDDP,blood,Adolescent,,,31,AUC (EDDP/ methadone),,,0.07,,mean,SD,0.02,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2814,2025-12-02T15:56:56.518041
22037641.0,methadone,S-EDDP,blood,Adolescent,,,31,Cmax/dose,,,0.15,ng/ml/mg,mean,SD,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2815,2025-12-02T15:56:56.518041
22037641.0,methadone,S-EDDP,blood,Adolescent,,,31,Tmax,,,18,hr,mean,SD,8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2816,2025-12-02T15:56:56.518041
22037641.0,methadone,S-EDDP,blood,Adolescent,,,31,AUC/dose,,,10.8,ng*hr/ml/mg,mean,SD,5.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2817,2025-12-02T15:56:56.518041
22037641.0,methadone,S-EDDP,blood,Adolescent,,,31,Elimination half-life,,,41,hr,mean,SD,25,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2818,2025-12-02T15:56:56.518041
22037641.0,methadone,S-EDDP,blood,Adolescent,,,31,AUC096 (EDDP/ methadone),,,0.09,,mean,SD,0.02,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2819,2025-12-02T15:56:56.518041
22037641.0,methadone,S-EDDP,blood,Adolescent,,,31,AUC (EDDP/ methadone),,,0.11,,mean,SD,0.05,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2820,2025-12-02T15:56:56.518041
22428721.0,Buprenorphine,Buprenorphine,blood,maternal,postpartum,,10,concentration,17.4,h,1,ug/L,mean,,,95% CI,0.6,1.4,,mean Sample time after dose (h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2821,2025-12-02T15:56:56.518041
22428721.0,,,blood,maternal,postpartum,,10,concentration,17.4,h,0.9,ug/L,median,,,IQR,0.7,1.1,,mean Sample time after dose (h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2822,2025-12-02T15:56:56.518041
22428721.0,,,cord blood,neonatal,delivery,,10,concentration,18.1,h,0.4,ug/L,mean,,,95% CI,0.3,0.5,,mean Sample time after dose (h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2823,2025-12-02T15:56:56.518041
22428721.0,,,cord blood,neonatal,delivery,,10,concentration,18.1,h,0.4,ug/L,median,,,IQR,0.3,0.6,,mean Sample time after dose (h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2824,2025-12-02T15:56:56.518041
22428721.0,,Norbuprenorphine,blood,maternal,postpartum,,10,concentration,17.4,h,1.2,ug/L,mean,,,95% CI,0.9,1.4,,mean Sample time after dose (h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2825,2025-12-02T15:56:56.518041
22428721.0,,,blood,maternal,postpartum,,10,concentration,17.4,h,1.15,ug/L,median,,,IQR,0.9,1.6,,mean Sample time after dose (h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2826,2025-12-02T15:56:56.518041
22428721.0,,,cord blood,neonatal,delivery,,10,concentration,18.1,h,0.53,ug/L,mean,,,95% CI,0.43,0.63,,mean Sample time after dose (h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2827,2025-12-02T15:56:56.518041
22428721.0,,,cord blood,neonatal,delivery,,10,concentration,18.1,h,0.5,ug/L,median,,,IQR,0.41,0.63,,mean Sample time after dose (h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2828,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,plasma,Maternal,labor,,15,Cmax,,,19,ug/l,,,,range,8.8,41,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2829,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,,,,,,t1/2,,,2.6,hours,,,,,1.8,2.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2830,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,,,,,,Concentration at birth,,,2.4,ug/l,,,,,0.1,14.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2831,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,,,,,,Clearance ,,,0.92,l/min,Coefficient estimate,RSE,0.089,Nonparametric 95%CI,0.75,1.1,,popPK estimates,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2832,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,,,,,,BSV clearance ,,,31,%,Coefficient estimate,,49,,17,49,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2833,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,,,,,,Central Vd,,,95,l/min,Coefficient estimate,,0.12,,73,116,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2834,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,,,,,,BSV central Vd,,,31,%,Coefficient estimate,,33,,20,44,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2835,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,,,,,,Peripheral Vd,,,100,l/min,Coefficient estimate,,0.093,,83,118,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2836,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,,,,,,Inter-compartmental clearance,,,2.45,l/min,Coefficient estimate,,0.45,,1,4.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2837,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,,,,,,Residual error,,,15,%,Coefficient estimate,,11,,11,17,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2838,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Noroxycodone,,,,,,Cmax,,,3,ug/l,,,,,0.76,13,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2839,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Noroxymorphone,,,,,,Cmax,,,1.4,ug/l,,,,,0.4,3.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2840,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxymorphone,,,,,,Cmax,,,0,ug/l,,,,,0,0.29,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2841,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,umbilical artery,fetal,delivery,,15,Concentration,,,3.2,ug/l,,,,,0.1,14.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2842,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Noroxycodone,,,,,,Concentration,,,2.8,ug/l,,,,,0.73,5.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2843,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Noroxymorphone,,,,,,Concentration,,,0.38,ug/l,,,,,0.05,0.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2844,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxymorphone,,,,,,Concentration,,,0,ug/l,,,,,0,0.12,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2845,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,umbilical vein,fetal,delivery,,,Concentration,,,2.7,ug/l,,,,,0.3,14.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2846,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxycodone,,,,,,fetal:maternal ratio,,,1.2,,,,,,0.9,1.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2847,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Noroxycodone,,,,,,fetal:maternal ratio,,,2.1,ug/l,,,,,0.29,5.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2848,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Noroxymorphone,,,,,,fetal:maternal ratio,,,0.36,ug/l,,,,,0,0.62,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2849,2025-12-02T15:56:56.518041
22448718.0,Oxycodone,Oxymorphone,,,,,,fetal:maternal ratio,,,0,ug/l,,,,,0,0.11,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2850,2025-12-02T15:56:56.518041
22486937.0,morphine,morphine,blood,child,,,35,AUC,,,5309,min*ng/ml,mean,SD,129,,,,,Non-Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2851,2025-12-02T15:56:56.518041
22486937.0,,morphine,blood,child,,,33,AUC,,,5528,min*ng/ml,mean,SD,1122,,,,0.51,Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2852,2025-12-02T15:56:56.518041
22486937.0,,morphine,blood,child,,,35,Cmax,,,82,ng/ml,mean,SD,15,,,,,Non-Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2853,2025-12-02T15:56:56.518041
22486937.0,,morphine,blood,child,,,33,Cmax,,,87,ng/ml,mean,SD,18,,,,0.21,Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2854,2025-12-02T15:56:56.518041
22486937.0,,M3G,blood,child,,,35,AUC,,,27105,min*ng/ml,mean,SD,6360,,,,,Non-Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2855,2025-12-02T15:56:56.518041
22486937.0,,M3G,blood,child,,,33,AUC,,,26957,min*ng/ml,mean,SD,7231,,,,0.83,Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2856,2025-12-02T15:56:56.518041
22486937.0,,M3G,blood,child,,,35,Cmax,,,138,ng/ml,mean,SD,33,,,,,Non-Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2857,2025-12-02T15:56:56.518041
22486937.0,,M3G,blood,child,,,33,Cmax,,,135,ng/ml,mean,SD,38,,,,0.73,Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2858,2025-12-02T15:56:56.518041
22486937.0,,M3G,blood,child,,,35,Tmax,,,91,min,mean,SD,36,,,,,Non-Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2859,2025-12-02T15:56:56.518041
22486937.0,,M3G,blood,child,,,33,Tmax,,,86,min,mean,SD,32,,,,0.67,Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2860,2025-12-02T15:56:56.518041
22486937.0,,M6G,blood,child,,,35,AUC,,,8418,min*ng/ml,mean,SD,1552,,,,,Non-Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2861,2025-12-02T15:56:56.518041
22486937.0,,M6G,blood,child,,,33,AUC,,,8134,min*ng/ml,mean,SD,2182,,,,0.87,Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2862,2025-12-02T15:56:56.518041
22486937.0,,M6G,blood,child,,,35,Cmax,,,47,ng/ml,mean,SD,9,,,,,Non-Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2863,2025-12-02T15:56:56.518041
22486937.0,,M6G,blood,child,,,33,Cmax,,,45,ng/ml,mean,SD,9,,,,0.43,Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2864,2025-12-02T15:56:56.518041
22486937.0,,M6G,blood,child,,,35,Tmax,,,101,min,mean,SD,29,,,,,Non-Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2865,2025-12-02T15:56:56.518041
22486937.0,,M6G,blood,child,,,33,Tmax,,,95,min,mean,SD,30,,,,0.45,Latino,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2866,2025-12-02T15:56:56.518041
22926004.0,Methadone,R-Methadone,,pregnant ,Trimester 3,,5,half-life,,,20,h,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2867,2025-12-02T15:56:56.518041
22926004.0,Methadone,S-methadone,,pregnant ,Trimester 3,,5,half-life,,,13.8,h,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2868,2025-12-02T15:56:56.518041
22926004.0,Methadone,rac-Methadone,,pregnant ,Trimester 3,,5,half-life,,,16.62,h,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2869,2025-12-02T15:56:56.518041
22926004.0,Methadone,R-Methadone,,pregnant ,Trimester 3,,5,AUC,,,5775,h(ng/mL),mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2870,2025-12-02T15:56:56.518041
22926004.0,Methadone,S-methadone,,pregnant ,Trimester 3,,5,AUC,,,4213,h(ng/mL),mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2871,2025-12-02T15:56:56.518041
22926004.0,Methadone,rac-Methadone,,pregnant ,Trimester 3,,5,AUC,,,9806,h(ng/mL),mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2872,2025-12-02T15:56:56.518041
22926004.0,Methadone,R-Methadone,,pregnant ,Trimester 3,,5,VD/F,,,3.7,1/kg,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2873,2025-12-02T15:56:56.518041
22926004.0,Methadone,S-methadone,,pregnant ,Trimester 3,,5,VD/F,,,3.56,1/kg,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2874,2025-12-02T15:56:56.518041
22926004.0,Methadone,rac-Methadone,,pregnant ,Trimester 3,,5,VD/F,,,3.65,1/kg,mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2875,2025-12-02T15:56:56.518041
22926004.0,Methadone,R-Methadone,,pregnant ,Trimester 3,,5,clearnance,,,0.141,1/(h kg),mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2876,2025-12-02T15:56:56.518041
22926004.0,Methadone,S-methadone,,pregnant ,Trimester 3,,5,clearnance,,,0.213,1/(h kg),mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2877,2025-12-02T15:56:56.518041
22926004.0,Methadone,rac-Methadone,,pregnant ,Trimester 3,,5,clearnance,,,0.172,1/(h kg),mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2878,2025-12-02T15:56:56.518041
23703421.0,Hydrocodone,Hydrocodone,blood,maternal,labor/delivery,,131,Serum concentration,3,d,27.6,ng/ml,mean,SD,24.2,,,,, OPRM1 genotype AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2879,2025-12-02T15:56:56.518041
23703421.0,Hydrocodone,Hydromorphone,blood,maternal,labor/delivery,,131,Serum concentration,3,d,4.8,ng/ml,mean,SD,7.7,,,,, OPRM1 genotype AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2880,2025-12-02T15:56:56.518041
23703421.0,Hydrocodone,Dihydrocodeine,blood,maternal,labor/delivery,,131,Serum concentration,3,d,1.8,ng/ml,mean,SD,1.6,,,,, OPRM1 genotype AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2881,2025-12-02T15:56:56.518041
23703421.0,Hydrocodone,Norhydrocodone,blood,maternal,labor/delivery,,131,Serum concentration,3,d,6.4,ng/ml,mean,SD,5,,,,, OPRM1 genotype AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2882,2025-12-02T15:56:56.518041
23703421.0,Hydrocodone,Hydrocodone,blood,maternal,labor/delivery,,27,Serum concentration,3,d,28.4,ng/ml,mean,SD,20.7,,,,, OPRM1 genotype AG/GG,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2883,2025-12-02T15:56:56.518041
23703421.0,Hydrocodone,Hydromorphone,blood,maternal,labor/delivery,,27,Serum concentration,3,d,6.3,ng/ml,mean,SD,8,,,,, OPRM1 genotype AG/GG,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2884,2025-12-02T15:56:56.518041
23703421.0,Hydrocodone,Dihydrocodeine,blood,maternal,labor/delivery,,27,Serum concentration,3,d,1.9,ng/ml,mean,SD,1.3,,,,, OPRM1 genotype AG/GG,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2885,2025-12-02T15:56:56.518041
23703421.0,Hydrocodone,Norhydrocodone,blood,maternal,labor/delivery,,27,Serum concentration,3,d,7.4,ng/ml,mean,SD,5.2,,,,, OPRM1 genotype AG/GG,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2886,2025-12-02T15:56:56.518041
23703421.0,Oxymorphone,Oxymorphone,blood,maternal,labor/delivery,,12,Serum concentration,3,d,15,ng/ml,mean,SD,28.7,,,,, OPRM1 genotype AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2887,2025-12-02T15:56:56.518041
23703421.0,Oxycodone,Oxycodone,blood,maternal,labor/delivery,,16,Serum concentration,3,d,14.4,ng/ml,mean,SD,18.6,,,,, OPRM1 genotype AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2888,2025-12-02T15:56:56.518041
23703421.0,Morphine,Morphine,blood,maternal,labor/delivery,,17,Serum concentration,3,d,5.8,ng/ml,mean,SD,6.8,,,,, OPRM1 genotype AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2889,2025-12-02T15:56:56.518041
23703421.0,Codeine,Codeine,blood,maternal,labor/delivery,,7,Serum concentration,3,d,6.7,ng/ml,mean,SD,11.7,,,,, OPRM1 genotype AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2890,2025-12-02T15:56:56.518041
23703421.0,Oxymorphone,Oxymorphone,blood,maternal,labor/delivery,,1,Serum concentration,3,d,32.6,ng/ml,mean,SD,,,,,, OPRM1 genotype AG/GG,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2891,2025-12-02T15:56:56.518041
23703421.0,Oxycodone,Oxycodone,blood,maternal,labor/delivery,,4,Serum concentration,3,d,8.6,ng/ml,mean,SD,11,,,,, OPRM1 genotype AG/GG,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2892,2025-12-02T15:56:56.518041
23703421.0,Morphine,Morphine,blood,maternal,labor/delivery,,2,Serum concentration,3,d,2.7,ng/ml,mean,SD,0.1,,,,, OPRM1 genotype AG/GG,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2893,2025-12-02T15:56:56.518041
23703421.0,Codeine,Codeine,blood,maternal,labor/delivery,,1,Serum concentration,3,d,0.6,ng/ml,mean,SD,,,,,, OPRM1 genotype AG/GG,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2894,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Hydromorphone,,pregnant ,post-partum,,8,serum concentration,,,7.1,ng/ml,mean,SD,11.9,,,,,CYP2D6 UM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2895,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Hydrocodone,,pregnant ,post-partum,,8,serum concentration,,,36.8,ng/ml,mean,SD,24.9,,,,,CYP2D6 UM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2896,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Dihydrocodone,,pregnant ,post-partum,,8,serum concentration,,,1.7,ng/ml,mean,SD,1.5,,,,,CYP2D6 UM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2897,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Norhydrocodone,,pregnant ,post-partum,,8,serum concentration,,,6.3,ng/ml,mean,SD,3.2,,,,,CYP2D6 UM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2898,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Hydromorphone,,pregnant ,post-partum,,97,serum concentration,,,5.5,ng/ml,mean,SD,8.1,,,,,CYP2D6 EM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2899,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Hydrocodone,,pregnant ,post-partum,,97,serum concentration,,,26,ng/ml,mean,SD,25.3,,,,,CYP2D6 EM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2900,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Dihydrocodone,,pregnant ,post-partum,,97,serum concentration,,,1.5,ng/ml,mean,SD,1.6,,,,,CYP2D6 EM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2901,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Norhydrocodone,,pregnant ,post-partum,,97,serum concentration,,,5.7,ng/ml,mean,SD,4.7,,,,,CYP2D6 EM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2902,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Hydromorphone,,pregnant ,post-partum,,44,serum concentration,,,3.9,ng/ml,mean,SD,6.3,,,,,CYP2D6 IM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2903,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Hydrocodone,,pregnant ,post-partum,,44,serum concentration,,,27.8,ng/ml,mean,SD,19.9,,,,,CYP2D6 IM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2904,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Dihydrocodone,,pregnant ,post-partum,,44,serum concentration,,,2.2,ng/ml,mean,SD,1.3,,,,,CYP2D6 IM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2905,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Norhydrocodone,,pregnant ,post-partum,,44,serum concentration,,,7.1,ng/ml,mean,SD,4.7,,,,,CYP2D6 IM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2906,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Hydromorphone,,pregnant ,post-partum,,7,serum concentration,,,0.7,ng/ml,mean,SD,1.1,,,,,CYP2D6 PM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2907,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Hydrocodone,,pregnant ,post-partum,,7,serum concentration,,,37,ng/ml,mean,SD,18.1,,,,,CYP2D6 PM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2908,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Dihydrocodone,,pregnant ,post-partum,,7,serum concentration,,,2.9,ng/ml,mean,SD,1.1,,,,,CYP2D6 PM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2909,2025-12-02T15:56:56.518041
24269714.0,Hydrocodone,Norhydrocodone,,pregnant ,post-partum,,7,serum concentration,,,12.5,ng/ml,mean,SD,8,,,,,CYP2D6 PM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2910,2025-12-02T15:56:56.518041
24749886.0,morphine  ,morphine  ,,pediatric ,0-3 months,,34,concentration ,,,5.9,ng/ml,median,,,IQR,4.5,16.4,,with biliary atresia. Twenty-four hours after starting the morphine infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2911,2025-12-02T15:56:56.518041
24749886.0,morphine  ,,,pediatric ,0-3 months,,16,concentration ,,,6.4,ng/ml,median,,,IQR,3.2,12,, without biliary atresia. Twenty-four hours after starting the morphine infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2912,2025-12-02T15:56:56.518041
24824135.0,sufentanil,sufentanil,plasma,infants,,,20,Clast,,,51.54,pg/ml,median,,,range,5.99,104.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2913,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,tlast,,,46,h,,,,,36,68,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2914,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,t1/2MRT,,,19.57,h,,,,,12.72,31.01,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2915,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,t1/2el,,,11.31,h,,,,,2.99,59.88,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2916,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,tmax,,,39.5,h,,,,,0,52,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2917,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,Cmax,,,78.46,pg/ml,,,,,36.57,208.85,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2918,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,AUCstop-last,,,1821.27,pg/ml*h,,,,,929.75,3772.67,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2919,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,AUMCstop-last,,,48711.11,pg/ml*h2,,,,,22155.49,168815.83,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2920,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,MRTstop-last,,,28.25,h,,,,,18.36,44.75,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2921,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,C end of surgery,,,24.7,pg/ml,median,,,,13.6,93.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2922,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,C Sx-24,24,h,48.4,,,,,,10.4,92.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2923,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,C end of infusion,,,43,,,,,,21.1,127,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2924,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,C infusion-3,3,h,57.4,,,,,,17.9,208.9,0.0018,p compared to values at the end of surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2925,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,,C infusion-6,6,h,63.2,,,,,,16.1,104.3,0.021,p compared to values at the end of surgery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2926,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,1,C infusion-18,18,h,10.1,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2927,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,1,C infusion-18,18,h,90.7,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2928,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,1,C infusion-18,18,h,7,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2929,2025-12-02T15:56:56.518041
24824135.0,sufentanil,,,,,,1,C infusion-18,18,h,6,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2930,2025-12-02T15:56:56.518041
25080430.0,buprenorphine,clonidine ,blood, neonatal,,,,maximum measured plasma concentration,,,0.73,ng/mL,median,,,range,0.15,1.55,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2931,2025-12-02T15:56:56.518041
25080430.0,buprenorphine,,, neonatal,,,,Tmax,,,190,min,median,,,range,12,478,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2932,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,hydrocodone 5 ml,plasma,children,,,3,Tmax,,,2.67,h,mean,SD,2.08,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2933,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax,,,16.1,ng/mL,,,12.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2934,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt,,,89.4,ng,,,67.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2935,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf,,,93.4,ng,,,71.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2936,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,t1/2,,,3.15,h,,,1.26,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2937,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,CL/F,,,22.2,L/h,,,11.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2938,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose,,,10.6,ng/mL/mg,,,8.37,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2939,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose/weight,,,201,ng/mL/mg/kg,,,143,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2940,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose/BSA,,,8.15,ng/mL/mg/m2,,,5.98,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2941,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose,,,59.1,ng*h/mL/mg,,,44.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2942,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose/weight,,,1120,ng*h/mL/mg/kg,,,759,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2943,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose/BSA,,,45.3,ng*h/mL/mg/m2,,,31.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2944,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose,,,61.7,ng*h/mL/mg,,,47.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2945,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose/weight,,,1170,ng*h/mL/mg/kg,,,798,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2946,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose/BSA,,,47.3,ng*h/mL/mg/m2,,,33.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2947,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,hydrocodone 7.5 ml,,,,,4,Tmax,,,2.38,,,,1.89,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2948,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax,,,10.4,,,,4.76,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2949,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt,,,62.9,,,,15.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2950,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf,,,64.4,,,,15.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2951,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,t1/2,,,3.22,,,,0.52,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2952,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,CL/F,,,36.8,,,,8.55,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2953,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose,,,4.59,,,,2.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2954,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose/weight,,,128,,,,46.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2955,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose/BSA,,,4.68,,,,1.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2956,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose,,,27.7,,,,6.95,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2957,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose/weight,,,786,,,,144,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2958,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose/BSA,,,28.6,,,,5.41,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2959,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose,,,28.4,,,,6.91,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2960,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose/weight,,,805,,,,143,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2961,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose/BSA,,,29.3,,,,5.38,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2962,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,hydrocodone 10 ml,,,,,1,Tmax,,,1,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2963,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax,,,14.5,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2964,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt,,,99.2,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2965,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf,,,101,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2966,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,t1/2,,,4.06,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2967,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,CL/F,,,30,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2968,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose,,,4.79,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2969,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose/weight,,,196,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2970,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose/BSA,,,6.31,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2971,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose,,,32.8,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2972,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose/weight,,,1340,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2973,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose/BSA,,,43.2,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2974,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose,,,33.3,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2975,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose/weight,,,1370,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2976,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose/BSA,,,43.9,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2977,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,hydrocodone 15 ml,,,,,9,Tmax,,,3.61,,,,5.57,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2978,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax,,,15.1,,,,6.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2979,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt,,,118,,,,34,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2980,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf,,,124,,,,36.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2981,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,t1/2,,,3.61,,,,1.36,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2982,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,CL/F,,,39.8,,,,12.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2983,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose,,,3.31,,,,1.36,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2984,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose/weight,,,196,,,,114,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2985,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,Cmax/dose/BSA,,,5.36,,,,2.44,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2986,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose,,,26,,,,7.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2987,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose/weight,,,1510,,,,676,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2988,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCt/dose/BSA,,,41.7,,,,13.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2989,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose,,,27.2,,,,7.98,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2990,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose/weight,,,1570,,,,694,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2991,2025-12-02T15:56:56.518041
25196888.0,Hydrocodone,,,,,,,AUCinf/dose/BSA,,,43.6,,,,13.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2992,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,acetaminophen 5 ml,plasma,children,,,3,Tmax,,,1.42,h,,,1.01,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2993,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax,,,5610,ng/mL,,,4030,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2994,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt,,,21000,ng,,,3010,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2995,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf,,,21200,ng,,,2850,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2996,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,t1/2,,,3.29,h,,,2.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2997,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,CL/F,,,7.94,L/h,,,0.99,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2998,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose,,,33.7,ng/mL/mg,,,24.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,2999,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/weight,,,640,ng/mL/mg/kg,,,410,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3000,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/BSA,,,26,ng/mL/mg/m2,,,17.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3001,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose,,,126,ng*h/mL/mg,,,18.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3002,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/weight,,,2460,ng*h/mL/mg/kg,,,160,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3003,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/BSA,,,98.7,ng*h/mL/mg/m2,,,8.85,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3004,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose,,,127,ng*h/mL/mg,,,17.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3005,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose/weight,,,2490,ng*h/mL/mg/kg,,,140,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3006,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose/BSA,,,99.9,ng*h/mL/mg/m2,,,8.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3007,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,acetaminophen 7.5 ml,,,,,4,Tmax,,,1.63,,,,0.75,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3008,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax,,,4290,,,,2090,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3009,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt,,,23500,,,,4270,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3010,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf,,,23900,,,,4130,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3011,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,t1/2,,,3.74,,,,1.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3012,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,CL/F,,,10.7,,,,1.79,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3013,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose,,,17.2,,,,8.36,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3014,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/weight,,,478,,,,192,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3015,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/BSA,,,17.4,,,,7.36,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3016,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose,,,93.9,,,,17.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3017,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/weight,,,2690,,,,515,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3018,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/BSA,,,97.5,,,,15.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3019,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose,,,95.8,,,,16.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3020,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose/weight,,,2740,,,,485,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3021,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose/BSA,,,99.4,,,,14.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3022,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,acetaminophen 10 ml,,,,,1,Tmax,,,0.55,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3023,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax,,,5290,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3024,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt,,,27800,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3025,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf,,,29400,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3026,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,t1/2,,,8.09,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3027,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,CL/F,,,11.3,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3028,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose,,,15.9,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3029,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/weight,,,651,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3030,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/BSA,,,20.9,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3031,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose,,,83.3,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3032,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/weight,,,3420,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3033,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/BSA,,,110,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3034,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose,,,88.2,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3035,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose/weight,,,3610,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3036,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose/BSA,,,116,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3037,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,acetaminophen 15 ml,,,,,9,Tmax,,,2.28,,,,2.58,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3038,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax,,,4800,,,,2110,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3039,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt,,,29700,,,,5300,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3040,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf,,,30700,,,,5710,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3041,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,t1/2,,,4.18,,,,1.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3042,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,CL/F,,,16.7,,,,2.76,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3043,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose,,,9.6,,,,4.21,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3044,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/weight,,,556,,,,283,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3045,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/BSA,,,15.5,,,,6.87,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3046,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose,,,59.3,,,,10.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3047,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/weight,,,3320,,,,546,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3048,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/BSA,,,94.5,,,,14.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3049,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose,,,61.5,,,,11.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3050,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose/weight,,,3430,,,,543,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3051,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCinf/dose/BSA,,,97.8,,,,15.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3052,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,hydrocodone,,children,,,17,Tmax,,,3,h,,,4.16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3053,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax,,,14.1,ng/mL,,,6.93,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3054,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt,,,103,ng,,,44.4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3055,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,t1/2,,,3.45,h,,,1.05,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3056,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/weight,,,181,ng/mL/mg/kg,,,102,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3057,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/BSA,,,5.75,ng/mL/mg/m2,,,3.09,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3058,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/weight,,,1310,ng*h/mL/mg/kg,,,656,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3059,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/BSA,,,40.9,ng*h/mL/mg/m2,,,16.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3060,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,CL/F/weight,,,0.92,L/h/kg,,,0.38,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3061,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,CL/F/BSA,,,27.7,L/h/m2,,,8.95,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3062,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Vdb/F/weight,,,4.57,L/kg,,,1.33,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3063,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Vdb/F/BSA,,,139,L/m2,,,30.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3064,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,hydrocodone,,adults,,,24,Tmax,,,1.33,,,,0.61,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3065,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax,,,11.3,,,,2.78,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3066,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt,,,73.3,,,,17.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3067,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,t1/2,,,4.57,,,,0.79,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3068,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/weight,,,257,,,,62.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3069,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Cmax/dose/BSA,,,6.59,,,,1.54,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3070,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/weight,,,1690,,,,475,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3071,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,AUCt/dose/BSA,,,43.2,,,,11.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3072,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,CL/F/weight,,,0.65,,,,0.22,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3073,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,CL/F/BSA,,,24.8,,,,6.91,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3074,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Vdb/F/weight,,,4.21,,,,0.95,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3075,2025-12-02T15:56:56.518041
25196888.0,acetaminophen,,,,,,,Vdb/F/BSA,,,163,,,,30.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3076,2025-12-02T15:56:56.518041
25340733.0,Morphine,morphine,plasma,Neonate,,,,Concentration,20,min,145,ng/ml,,,,range,107,173,0.036,"UGT2B7 - 842 GA,  p for association of morphine across all 3 genotypes",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3077,2025-12-02T15:56:56.518041
25340733.0,Morphine,,,,,,,,,,122,,,,,,84,146,,UGT2B7 - 842 AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3078,2025-12-02T15:56:56.518041
25340733.0,Morphine,M3G,,,,,,Concentration,,,14,,,,,,1.9,23,0.007,"UGT2B7 - 842 GA, p for association of GA with M3G concentration",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3079,2025-12-02T15:56:56.518041
25340733.0,Morphine,,,,,,,,,,26,,,,,,8.1,43,,UGT2B7 - 842 AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3080,2025-12-02T15:56:56.518041
25340733.0,Morphine,M6G,,,,,,Concentration,,,1.3,,,,,,1.1,3.9,0.034,"UGT2B7 - 842 GA, p for association of GA with M6G concentration",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3081,2025-12-02T15:56:56.518041
25340733.0,Morphine,,,,,,,,,,4,,,,,,1.3,14,0.2,"UGT2B7 - 842 AA,  p for association of M6G across all 3 genotypes",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3082,2025-12-02T15:56:56.518041
25904383.0,fentanyl,fentanyl,plasma,0.25-3 years,,,13,Clast,,,0.144,ng/ml,median,,,range,0.057,0.381,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3083,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,Concentration,18,h,0.289,ng/ml,,,,,0.057,0.364,<0.04,p for comparison of values between Group 1/2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3084,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,tlast,,,6,h,,,,,6,18,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3085,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,t1/2 MRT,,,15.9,h,,,,,3.58,31.54,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3086,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,t1/2kel,,,5.57,h,,,,,2.29,28.83,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3087,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,Cmax,,,0.257,ng/ml,,,,,0.069,0.615,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3088,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,AUCstop-tlast,,,2.38,ng/ml*h,,,,,1.12,4.74,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3089,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,AUCresidual,,,0.044,ng/ml*h,mean,SD,0.02,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3090,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,AUMCstop-tlast,,,124.55,ng/ml*h2,,,,,9,390.29,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3091,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,MRTstop-tlast,,,22.93,h,,,,,5.13,45.51,<0.05,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3092,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,3-12 years,,,11,Clast,,,0.127,,,,,,0.013,0.438,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3093,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,Concentration,18,h,0.091,ng/ml,,,,,0.014,0.286,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3094,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,tlast,,,18,,,,,,6,18,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3095,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,t1/2 MRT,,,7.96,,,,,,7.09,13.27,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3096,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,t1/2kel,,,5.97,,,,,,3.44,9.38,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3097,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,Cmax,,,0.281,,,,,,0.133,0.622,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3098,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,AUCstop-tlast,,,2.32,,,,,,1.42,7.14,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3099,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,AUCresidual,,,0.024,ng/ml*h,mean,SD,0.018,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3100,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,AUMCstop-tlast,,,45.85,,,,,,25.82,149.56,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3101,2025-12-02T15:56:56.518041
25904383.0,fentanyl,,,,,,,MRTstop-tlast,,,11.49,,,,,,10.24,19.14,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3102,2025-12-02T15:56:56.518041
26385675.0,Fentanyl,fentanyl,plasma,Maternal,Labor,,15,Concentration,15,min,0.21,ng/ml,median,,,range,0.05,0.57,,after the first 50 ug dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3103,2025-12-02T15:56:56.518041
26385675.0,Fentanyl,,,,,,15,Cmax,,,0.79,,,,,,0.26,1.38,,after last dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3104,2025-12-02T15:56:56.518041
26385675.0,Fentanyl,,,,,,10,Concentration,33-140,min,0.5,,,,,,,,,achieved analgesia,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3105,2025-12-02T15:56:56.518041
26701799.0,Fentanyl,fentanyl,urine,Maternal,Postpartum,,1,Concentration,,,2,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3106,2025-12-02T15:56:56.518041
26701799.0,Fentanyl,,urine,Neonate,Postpartum,,1,Concentration,,,2.4,ng/ml,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3107,2025-12-02T15:56:56.518041
27082504.0,Tramadol,tramadol,plasma,infants,,,50,Concentration,,,1.55,uM,median,,,IQR,1.07,2.19,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3108,2025-12-02T15:56:56.518041
27082504.0,Tramadol,O-desmethyltramadol,,,,,50,,,,0.201,,,,,,0.112,0.345,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3109,2025-12-02T15:56:56.518041
27082504.0,Tramadol,O-desmethyltramadol/tramadol,,,,,32,log metabolic ratio,,,1.76,,,,,95% CI,1.58,1.94,,CYP2D6 <2 functional alleles,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3110,2025-12-02T15:56:56.518041
27082504.0,Tramadol,,,,,,18,,,,2.35,,,,,,2.09,2.61,,CYP2D6 2 functional alleles,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3111,2025-12-02T15:56:56.518041
27082504.0,Tramadol,,,,,,23,,,,2.25,,,,,,2.01,2.48,,SLC22A1/OCT1 0 or 1 functional allele,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3112,2025-12-02T15:56:56.518041
27082504.0,Tramadol,,,,,,27,,,,1.86,,,,,,1.66,2.06,,SLC22A1/OCT1 2 functional allele,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3113,2025-12-02T15:56:56.518041
27082504.0,Tramadol,,,,,,17,,,,1.52,,,,,,1.27,1.76,7.51e-27,CYP2D6 <2 functional alleles/SLC22A1/OCT1 2 functional allele,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3114,2025-12-02T15:56:56.518041
27082504.0,Tramadol,,,,,,8,,,,2.4,,,,,,2,2.81,,CYP2D6 2 functional alleles/SLC22A1/OCT1 0 or 1 functional allele,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3115,2025-12-02T15:56:56.518041
27082504.0,Tramadol,,,,,,15,,,,2.02,,,,,,1.74,2.3,,CYP2D6 <2 functional alleles/SLC22A1/OCT1 0 or 1 functional allele,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3116,2025-12-02T15:56:56.518041
27082504.0,Tramadol,,,,,,10,,,,2.25,,,,,,1.91,2.58,,CYP2D6 2 functional alleles/SLC22A1/OCT1 2 functional allele,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3117,2025-12-02T15:56:56.518041
27083254.0,buprenorphine,,maternal plasma,pregnant,Postpartum,,5,buprenorphine concentration,,,2.7,ug/l,median,,,range,2.4,4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3118,2025-12-02T15:56:56.518041
27083254.0,buprenorphine,,,,,,,BUP-Gluc concentration,,,3.3,ug/l,median,,,range,0.8,9.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3119,2025-12-02T15:56:56.518041
27083254.0,buprenorphine,,,,,,,norbuprenorphine concentration,,,3.6,ug/l,median,,,range,3.2,4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3120,2025-12-02T15:56:56.518041
27083254.0,buprenorphine,,,,,,,NBUP-Gluc concentration,,,32.5,ug/l,median,,,range,24.9,34.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3121,2025-12-02T15:56:56.518041
27083254.0,buprenorphine,,breastmilk specimens,pregnant,Postpartum,,5,buprenorphine concentration,,,4.6,ug/l,median,,,range,2.7,9.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3122,2025-12-02T15:56:56.518041
27083254.0,buprenorphine,,,,,,,BUP-Gluc concentration,,,0.2,ug/l,median,,,range,<LOQ,0.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3123,2025-12-02T15:56:56.518041
27083254.0,buprenorphine,,,,,,,norbuprenorphine concentration,,,2.3,ug/l,median,,,range,<LOQ,3.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3124,2025-12-02T15:56:56.518041
27083254.0,buprenorphine,,,,,,,NBUP-Gluc concentration,,,1.3,ug/l,median,,,range,0.8,2.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3125,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,711 years,,36,Arithmetic dose-normalized AUC,,,5364.4,ngh/mL,mean,SD,2542,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3126,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,711 years,,27,Geometric dose-normalized AUC,,,4841.04,ngh/mL,,,,range,4031.19,5813.59,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3127,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,711 years,,36,Arithmetic dose-normalized AUC0-24h,,,3315,ngh/mL,,SD,1560,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3128,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,711 years,,32,Geometric dose-normalized AUC0-24h,,,3016.08,ngh/mL,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3129,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,711 years,,,Arithmetic dose-normalized maximum plasma concentration,,,219.9,ng/mL,,SD,86.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3130,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,711 years,,35,Geometric dose-normalized maximum plasma concentration,,,203.68,ng/mL,,,,range,177.15,234.19,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3131,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,711 years,,34,Tmax ,,,10.03,h,,,,range,9.06,11.11,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3132,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,711 years,,26,CL/F,,,376.3,mL/min,,,,range,312.96,452.46,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3133,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,711 years,,27,weight-normalized CL/F,,,9.84,mL/(minkg),,,,range,8.19,11.81,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3134,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,711 years,,27,t1/2,,,8.09,hours,,,,range,7.18,9.13,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3135,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,1217 years,,29,Arithmetic dose-normalized AUC,,,5247,ngh/mL,mean,SD,2109,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3136,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,1217 years,,28,Geometric dose-normalized AUC,,,4872.39,ngh/mL,,,,range,4187.76,5668.93,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3137,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,1217 years,,29,Arithmetic dose-normalized AUC0-24h,,,3570,ngh/mL,,SD,1136,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3138,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,1217 years,,36,Geometric dose-normalized AUC0-24h,,,3286.33,ngh/mL,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3139,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,1217 years,,,Arithmetic dose-normalized maximum plasma concentration,,,224,ng/mL,,SD,70.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3140,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,1217 years,,36,Geometric dose-normalized maximum plasma concentration,,,212.9,ng/mL,,,,range,191.04,237.26,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3141,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,1217 years,,36,Tmax ,,,11.56,h,,,,range,10.56,12.65,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3142,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,1217 years,,28,CL/F,,,665.81,mL/min,,,,range,561.45,789.57,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3143,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,1217 years,,28,weight-normalized CL/F,,,9.81,mL/(minkg),,,,range,8.14,11.82,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3144,2025-12-02T15:56:56.518041
27138295.0,Tramadol,Tramadol,blood,pediatric ,1217 years,,29,t1/2,,,8.14,hours,,,,range,7.31,9.08,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3145,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M1,blood,pediatric ,711 years,,27,Arithmetic dose-normalized AUC,,,1249,ngh/mL,mean,SD,218,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3146,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M2,blood,pediatric ,711 years,,7,Geometric dose-normalized AUC,,,1291.41,ngh/mL,,,,range,1120.03,1489.02,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3147,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M3,blood,pediatric ,711 years,,27,Arithmetic dose-normalized AUC0-24h,,,756,ngh/mL,,SD,304,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3148,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M4,blood,pediatric ,711 years,,27,Geometric dose-normalized AUC0-24h,,,633.91,ngh/mL,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3149,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M5,blood,pediatric ,711 years,,,Arithmetic dose-normalized maximum plasma concentration,,,47,ng/mL,,SD,18.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3150,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M6,blood,pediatric ,711 years,,33,Geometric dose-normalized maximum plasma concentration,,,42.93,ng/mL,,,,range,35.71,51.62,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3151,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M7,blood,pediatric ,711 years,,33,Tmax ,,,10.91,h,,,,range,9.94,11.99,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3152,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M8,blood,pediatric ,711 years,,10,t1/2,,,10.07,hours,,,,range,8.41,12.06,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3153,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M1,blood,pediatric ,1217 years,,29,Arithmetic dose-normalized AUC,,,1997,ngh/mL,mean,SD,269,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3154,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M2,blood,pediatric ,1217 years,,6,Geometric dose-normalized AUC,,,1980.87,ngh/mL,,,,range,1706.22,2299.72,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3155,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M3,blood,pediatric ,1217 years,,29,Arithmetic dose-normalized AUC0-24h,,,1093,ngh/mL,,SD,261,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3156,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M4,blood,pediatric ,1217 years,,29,Geometric dose-normalized AUC0-24h,,,1056.05,ngh/mL,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3157,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M5,blood,pediatric ,1217 years,,,Arithmetic dose-normalized maximum plasma concentration,,,69.8,ng/mL,,SD,15.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3158,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M6,blood,pediatric ,1217 years,,32,Geometric dose-normalized maximum plasma concentration,,,67.67,ng/mL,,,,range,61.47,74.49,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3159,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M7,blood,pediatric ,1217 years,,32,Tmax ,,,11.8,h,,,,range,10.65,13.08,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3160,2025-12-02T15:56:56.518041
27138295.0,Tramadol,M8,blood,pediatric ,1217 years,,9,t1/2,,,10.63,hours,,,,range,8.93,12.65,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3161,2025-12-02T15:56:56.518041
27140798.0,Tramadol,tramadol,plasma,7-11 years,,,13,AUCinf,,,1527.1,ng/ml*h,mean,SD,514.6,,,,,single dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3162,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,Cmax,,,254.1,ng/ml,,,51,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3163,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,t1/2,,,4.74,h,,,0.89,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3164,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,CL/F,,,13.14,ml/min/kg,,,4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3165,2025-12-02T15:56:56.518041
27140798.0,Tramadol,O-desmethyltramadol,plasma,7-11 years,,,13,AUCinf,,,389.6,ng/ml*h,,,227.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3166,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,Cmax,,,38.57,ng/ml,,,18.17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3167,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,metabolic ratio,,,0.28,,,,0.12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3168,2025-12-02T15:56:56.518041
27140798.0,Tramadol,tramadol,plasma,12-16 years,,,17,AUCinf,,,1601.1,,,,787.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3169,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,Cmax,,,212.5,,,,87,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3170,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,t1/2,,,5.19,,,,1.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3171,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,CL/F,,,13.13,,,,6.79,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3172,2025-12-02T15:56:56.518041
27140798.0,Tramadol,O-desmethyltramadol,plasma,12-16 years,,,16,AUCinf,,,45.6,,,,27.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3173,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,Cmax,,,41.37,,,,39.01,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3174,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,metabolic ratio,,,0.36,,,,0.15,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3175,2025-12-02T15:56:56.518041
27140798.0,Tramadol,tramadol,plasma,adults,,,68,AUCinf,,,1922.5,,,,582,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3176,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,Cmax,,,233.48,,,,58.29,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3177,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,t1/2,,,5.72,,,,1.51,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3178,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,CL/F,,,9.47,,,,2.88,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3179,2025-12-02T15:56:56.518041
27140798.0,Tramadol,O-desmethyltramadol,plasma,adults,,,67,AUCinf,,,661.78,,,,180.52,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3180,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,Cmax,,,55.08,,,,18.16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3181,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,t1/2,,,8.01,,,,2.47,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3182,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,CL/F,,,27.36,,,,8.59,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3183,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,metabolic ratio,,,0.37,,,,0.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3184,2025-12-02T15:56:56.518041
27140798.0,Tramadol,tramadol,plasma,7-11 years,,,6,Tmax,,,1.7,h,,,0.5,,,,,multiple-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3185,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,Cmax,,,362,ng/ml,,,94.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3186,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,AUC0-6,,,1879.8,ng/ml*h,,,540,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3187,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,CLss/F/weight,,,8.2,ml/min/kg,,,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3188,2025-12-02T15:56:56.518041
27140798.0,Tramadol,O-desmethyltramadol,,,,,,Tmax,,,1.8,,,,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3189,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,Cmax,,,89.4,,,,39.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3190,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,AUC0-6,,,442.7,,,,195.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3191,2025-12-02T15:56:56.518041
27140798.0,Tramadol,tramadol,plasma,12-16 years,,,11,Tmax,,,1.9,,,,0.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3192,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,Cmax,,,242,,,,116,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3193,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,AUC0-6,,,2054.6,,,,276,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3194,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,CLss/F/weight,,,9.7,,,,3.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3195,2025-12-02T15:56:56.518041
27140798.0,Tramadol,O-desmethyltramadol,,,,,,Tmax,,,2.1,,,,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3196,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,Cmax,,,88.8,,,,32.8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3197,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,AUC0-6,,,440.7,,,,146.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3198,2025-12-02T15:56:56.518041
27140798.0,Tramadol,tramadol,plasma,adults,,,18,Cmax,,,529,,,,140,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3199,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,AUC0-6,,,2469,,,,520,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3200,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,CLss/F/weight,,,7,,,,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3201,2025-12-02T15:56:56.518041
27140798.0,Tramadol,O-desmethyltramadol,,,,,,Cmax,,,96.7,,,,27.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3202,2025-12-02T15:56:56.518041
27140798.0,Tramadol,,,,,,,AUC0-6,,,512,,,,150,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3203,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine,breast milk,pregnant ,post-partum,,10,concentration,2,days,2.3,ug/L,median,,,range,0.2,4.2,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3204,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine,breast milk,pregnant ,post-partum,,10,concentration,3,days,1.5,ug/L,median,,,range,0.2,5,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3205,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine,breast milk,pregnant ,post-partum,,8,concentration,4,days,1.4,ug/L,median,,,range,0.3,55.2,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3206,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine,breast milk,pregnant ,post-partum,,9,concentration,14,days,4.8,ug/L,median,,,range,1,10.5,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3207,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine,breast milk,pregnant ,post-partum,,7,concentration,30,days,3.3,ug/L,median,,,range,2.2,20.8,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3208,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine-glucuronide,breast milk,pregnant ,post-partum,,10,concentration,2,days,0.2,ug/L,median,,,range,LOQ,0.3,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3209,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine-glucuronide,breast milk,pregnant ,post-partum,,10,concentration,3,days,0.1,ug/L,median,,,range,LOQ,0.2,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3210,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine-glucuronide,breast milk,pregnant ,post-partum,,8,concentration,4,days,0.2,ug/L,median,,,range,LOQ,0.2,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3211,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine-glucuronide,breast milk,pregnant ,post-partum,,9,concentration,14,days,0.2,ug/L,median,,,range,LOQ,0.2,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3212,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine-glucuronide,breast milk,pregnant ,post-partum,,7,concentration,30,days,0.2,ug/L,median,,,range,LOQ,0.2,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3213,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine,breast milk,pregnant ,post-partum,,10,concentration,2,days,3.2,ug/L,median,,,range,LOQ,3.7,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3214,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine,breast milk,pregnant ,post-partum,,10,concentration,3,days,2.3,ug/L,median,,,range,LOQ,2.6,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3215,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine,breast milk,pregnant ,post-partum,,8,concentration,4,days,2.4,ug/L,median,,,range,LOQ,2.7,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3216,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine,breast milk,pregnant ,post-partum,,9,concentration,14,days,2.9,ug/L,median,,,range,LOQ,3.7,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3217,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine,breast milk,pregnant ,post-partum,,7,concentration,30,days,2.9,ug/L,median,,,range,LOQ,4.1,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3218,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine-glucuronide,breast milk,pregnant ,post-partum,,10,concentration,2,days,1.6,ug/L,median,,,range,0.3,2.9,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3219,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine-glucuronide,breast milk,pregnant ,post-partum,,10,concentration,3,days,0.7,ug/L,median,,,range,LOQ,1.7,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3220,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine-glucuronide,breast milk,pregnant ,post-partum,,8,concentration,4,days,0.4,ug/L,median,,,range,LOQ,1.3,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3221,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine-glucuronide,breast milk,pregnant ,post-partum,,9,concentration,14,days,0.9,ug/L,median,,,range,LOQ,4.9,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3222,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine-glucuronide,breast milk,pregnant ,post-partum,,7,concentration,30,days,1.8,ug/L,median,,,range,LOQ,5.1,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3223,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine,blood,pregnant ,post-partum,,10,concentration,2,days,1.2,ug/L,median,,,range,0.4,6.1,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3224,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine,blood,pregnant ,post-partum,,10,concentration,3,days,1.7,ug/L,median,,,range,0.7,7,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3225,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine,blood,pregnant ,post-partum,,9,concentration,4,days,2,ug/L,median,,,range,0.5,5.9,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3226,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine,blood,pregnant ,post-partum,,9,concentration,14,days,2.4,ug/L,median,,,range,0.7,3.3,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3227,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine,blood,pregnant ,post-partum,,8,concentration,30,days,2.2,ug/L,median,,,range,1.2,6.1,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3228,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine-glucuronide,blood,pregnant ,post-partum,,10,concentration,2,days,1.3,ug/L,median,,,range,0.2,9.3,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3229,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine-glucuronide,blood,pregnant ,post-partum,,10,concentration,3,days,1.2,ug/L,median,,,range,0.3,9.3,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3230,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine-glucuronide,blood,pregnant ,post-partum,,9,concentration,4,days,1.2,ug/L,median,,,range,0.4,6.2,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3231,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine-glucuronide,blood,pregnant ,post-partum,,9,concentration,14,days,0.6,ug/L,median,,,range,LOQ,1.1,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3232,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine-glucuronide,blood,pregnant ,post-partum,,8,concentration,30,days,0.8,ug/L,median,,,range,LOQ,2.4,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3233,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine,blood,pregnant ,post-partum,,10,concentration,2,days,3.9,ug/L,median,,,range,LOQ,5.7,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3234,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine,blood,pregnant ,post-partum,,10,concentration,3,days,4.1,ug/L,median,,,range,LOQ,5.5,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3235,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine,blood,pregnant ,post-partum,,9,concentration,4,days,3.7,ug/L,median,,,range,LOQ,5.6,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3236,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine,blood,pregnant ,post-partum,,9,concentration,14,days,4.7,ug/L,median,,,range,LOQ,6.7,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3237,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine,blood,pregnant ,post-partum,,8,concentration,30,days,3.4,ug/L,median,,,range,LOQ,12.4,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3238,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine-glucuronide,blood,pregnant ,post-partum,,10,concentration,2,days,10.4,ug/L,median,,,range,1.2,24.9,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3239,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine-glucuronide,blood,pregnant ,post-partum,,10,concentration,3,days,9.7,ug/L,median,,,range,2.7,34.5,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3240,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine-glucuronide,blood,pregnant ,post-partum,,9,concentration,4,days,7.9,ug/L,median,,,range,1.7,30.7,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3241,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine-glucuronide,blood,pregnant ,post-partum,,9,concentration,14,days,8.1,ug/L,median,,,range,1.6,32.5,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3242,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine-glucuronide,blood,pregnant ,post-partum,,8,concentration,30,days,11.9,ug/L,median,,,range,1.8,42.2,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3243,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine,blood, neonatal,,,9,concentration,14,days,< LOQ,ug/L,median,,,range,< LOQ,2.9,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3244,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,buprenorphine-glucuronide,blood, neonatal,,,9,concentration,14,days,< LOQ,ug/L,median,,,range,,,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3245,2025-12-02T15:56:56.518041
27563013.0,buprenorphine,norbuprenorphine,blood, neonatal,,,9,concentration,14,days,< LOQ,ug/L,median,,,range,,,,days after delivery,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3246,2025-12-02T15:56:56.518041
27572136.0,methadone,R-methadone,plasma,children,,,12,Cmax,,,17,ng/ml,mean,SD,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3247,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Cmax/D,,,6,ng/ml/mg,,,2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3248,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96,,,429,ng/ml/h,,,248,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3249,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf,,,523,ng/ml/h,,,248,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3250,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf/D,,,190,ng/ml/mg/h,,,99,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3251,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,CL,,,2.1,ml/kg/min,,,1.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3252,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Elimination t1/2,,,34,h,,,16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3253,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Vss,,,5.9,l/kg,,,3.9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3254,2025-12-02T15:56:56.518041
27572136.0,methadone,S-methadone,,children,,,12,Cmax,,,28,,,,12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3255,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Cmax/D,,,10,,,,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3256,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96,,,635,,,,424,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3257,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf,,,716,,,,439,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3258,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf/D,,,262,,,,178,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3259,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,CL,,,1.7,,,,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3260,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Elimination t1/2,,,24,,,,9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3261,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Vss,,,3.3,,,,2.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3262,2025-12-02T15:56:56.518041
27572136.0,methadone,R-EDDP,,children,,,12,Cmax,,,0.49,,,,0.26,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3263,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Cmax/D,,,0.18,,,,0.13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3264,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Tmax,,,6,h,,,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3265,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96,,,19,,,,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3266,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf,,,27,,,,10,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3267,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf/D,,,10,,,,3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3268,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Elimination t1/2,,,42,,,,13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3269,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96 (EDDP/methadone),,,0.05,,,,0.03,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3270,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUCinf (EDDP/methadone),,,0.06,,,,0.04,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3271,2025-12-02T15:56:56.518041
27572136.0,methadone,S-EDDP,,children,,,12,Cmax,,,0.9,,,,0.44,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3272,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Cmax/D,,,0.33,,,,0.22,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3273,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Tmax,,,9,,,,8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3274,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96,,,31,,,,12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3275,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf,,,41,,,,13,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3276,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf/D,,,14,,,,5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3277,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Elimination t1/2,,,31,,,,8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3278,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96 (EDDP/methadone),,,0.06,,,,0.04,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3279,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUCinf (EDDP/methadone),,,0.07,,,,0.04,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3280,2025-12-02T15:56:56.518041
27572136.0,methadone,R-methadone,,adults,,,12,Cmax,,,16,,,,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3281,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Cmax/D,,,5,,,,4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3282,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96,,,421,,,,168,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3283,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf,,,637,,,,324,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3284,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf/D,,,191,,,,94,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3285,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,CL,,,1.6,,,,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3286,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Elimination t1/2,,,52,,,,17,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3287,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Vss,,,6.5,,,,1.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3288,2025-12-02T15:56:56.518041
27572136.0,methadone,S-methadone,,adults,,,12,Cmax,,,23,,,,9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3289,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Cmax/D,,,7,,,,4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3290,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96,,,601,,,,276,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3291,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf,,,790,,,,397,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3292,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf/D,,,241,,,,123,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3293,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,CL,,,1.3,,,,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3294,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Elimination t1/2,,,38,,,,12,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3295,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Vss,,,3.9,,,,1.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3296,2025-12-02T15:56:56.518041
27572136.0,methadone,R-EDDP,,adults,,,12,Cmax,,,0.37,,,,0.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3297,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Cmax/D,,,0.11,,,,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3298,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Tmax,,,11,,,,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3299,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96,,,20,,,,7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3300,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf,,,30,,,,10,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3301,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf/D,,,12,,,,8,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3302,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Elimination t1/2,,,54,,,,29,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3303,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96 (EDDP/methadone),,,0.05,,,,0.02,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3304,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUCinf (EDDP/methadone),,,0.06,,,,0.02,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3305,2025-12-02T15:56:56.518041
27572136.0,methadone,S-EDDP,,adults,,,12,Cmax,,,0.6,,,,0.16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3306,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Cmax/D,,,0.18,,,,0.06,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3307,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Tmax,,,11,,,,6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3308,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96,,,32,,,,9,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3309,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf,,,43,,,,16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3310,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-inf/D,,,13,,,,4,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3311,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,Elimination t1/2,,,41,,,,22,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3312,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUC0-96 (EDDP/methadone),,,0.06,,,,0.02,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3313,2025-12-02T15:56:56.518041
27572136.0,methadone,,,,,,,AUCinf (EDDP/methadone),,,0.06,,,,0.02,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3314,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,buprenorphine,plasma,maternal,Trimester 2,,7,Tmax,,,1.6,hours,,SD,2.8,,,,0.8411,"p for comparison of pregnancy vspostpartum, all p-values for comparison between trimester 2/3 were not significant",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3315,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Trimester 3,,11,Tmax,,,1,,,,1.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3316,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Postpartum,,10,Tmax,,,1.9,,,,3.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3317,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Trimester 2,,7,Dose-normalized Cmax,,,0.5,ng/ml,,,0.1,,,,0.0365,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3318,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Trimester 3,,11,Dose-normalized Cmax,,,0.5,,,,0.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3319,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Postpartum,,10,Dose-normalized Cmax,,,0.7,,,,0.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3320,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Trimester 2,,7,Dose-normalized C0,,,0.1,,,,,,,,0.0032,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3321,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Trimester 3,,11,Dose-normalized C0,,,0.2,,,,0.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3322,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Postpartum,,10,Dose-normalized C0,,,0.3,,,,0.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3323,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Trimester 2,,7,Dose-normalized C12,,,0.1,,,,,,,,0.0001,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3324,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Trimester 3,,11,Dose-normalized C12,,,0.1,,,,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3325,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Postpartum,,10,Dose-normalized C12,,,0.3,,,,0.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3326,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Trimester 2,,7,Dose-normalized Cavg,,,0.2,,,,0.1,,,,0.0068,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3327,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Trimester 3,,11,Dose-normalized Cavg,,,0.2,,,,0.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3328,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Postpartum,,10,Dose-normalized Cavg,,,0.3,,,,0.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3329,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Trimester 2,,7,Dose-normalized AUC,,,1.9,ng/ml*h,,,1.4,,,,0.0068,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3330,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Trimester 3,,11,Dose-normalized AUC,,,2.2,,,,1.2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3331,2025-12-02T15:56:56.518041
27687214.0,Buprenorphine,,,maternal,Postpartum,,10,Dose-normalized AUC,,,4,,,,2.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3332,2025-12-02T15:56:56.518041
28238111.0,fentanyl,fentanyl,blood,pediatric ,,,6,"CL normalized to
total body weight",,,11.2,mL/min*kg,mean,SD,2.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3333,2025-12-02T15:56:56.518041
28238111.0,fentanyl,fentanyl,blood,pediatric ,,,6,CL,,,1522,mL/min,mean,SD,310,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3334,2025-12-02T15:56:56.518041
28238111.0,fentanyl,fentanyl,blood,pediatric ,,,6,"Vd normalized to
total body weight",,,4.7,L/kg,mean,SD,2.1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3335,2025-12-02T15:56:56.518041
28238111.0,fentanyl,fentanyl,blood,pediatric ,,,6,Vd,,,635,L,mean,SD,282,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3336,2025-12-02T15:56:56.518041
28238111.0,fentanyl,fentanyl,blood,pediatric ,,,6,t1/2,,,4.8,h,mean,SD,2,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3337,2025-12-02T15:56:56.518041
28238111.0,fentanyl,,,,,,,AUC0,,,1.5,h*ng/mL,mean,SD,0.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3338,2025-12-02T15:56:56.518041
28244808.0,oxycodone,oxycodone,blood,pediatric ,,,,terminal half-life,,,2.7,h,mean,SD,0.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3339,2025-12-02T15:56:56.518041
28244808.0,oxycodone,oxymorphone,blood,pediatric ,,,,terminal half-life,,,3.6,h,mean,SD,1,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3340,2025-12-02T15:56:56.518041
28244808.0,oxycodone,oxycodone,blood,pediatric ,,,,Dose-normalized Cmax,,,2.2,AU,mean,SD,1.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3341,2025-12-02T15:56:56.518041
28244808.0,oxycodone,oxymorphone,blood,pediatric ,,,,Dose-normalized Cmax,,,0.054,AU,mean,SD,0.056,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3342,2025-12-02T15:56:56.518041
28244808.0,oxycodone,oxycodone,blood,pediatric ,,,,dose-normalized AUC024,,,10.9,AU,mean,SD,4.5,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3343,2025-12-02T15:56:56.518041
28244808.0,oxycodone,oxymorphone,blood,pediatric ,,,,dose-normalized AUC024,,,0.22,AU,mean,SD,0.14,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3344,2025-12-02T15:56:56.518041
28320034.0,methadone,methadone,blood,pregnant ,post-partum,,21,plasma concentration,,,200,ug/L,median,,,range,20,720,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3345,2025-12-02T15:56:56.518041
28320034.0,methadone,methadone,blood,pregnant ,post-partum,,11,plasma concentration,,,320,ug/L,median,,,range,80,660,,Infants requiring NAS treatment,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3346,2025-12-02T15:56:56.518041
28320034.0,methadone,methadone,blood,pregnant ,post-partum,,10,plasma concentration,,,165,ug/L,median,,,range,20,720,,Infants not requiring NAS treatment,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3347,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,blood,pregnant,Trimester 1,,,Time That Dose-Normalized Plasma Concentrations Are Below 1ng/ml,,,10,,,,,,,,,4 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3348,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,,,,,,,,,8,,,,,,,,,8 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3349,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,,,,,,,,,8,,,,,,,,,12 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3350,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,,pregnant,Trimester 3,,,Time That Dose-Normalized Plasma Concentrations Are Below 1ng/ml,,,10,,,,,,,,,4 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3351,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,,,,,,,,,4,,,,,,,,,8 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3352,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,,,,,,,,,0,,,,,,,,,12 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3353,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,,pregnant,Pregnancy average (2nd/3rd trimesters),,,Time That Dose-Normalized Plasma Concentrations Are Below 1ng/ml,,,10,,,,,,,,,4 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3354,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,,,,,,,,,6,,,,,,,,,8 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3355,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,,,,,,,,,4,,,,,,,,,12 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3356,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,,pregnant,Postpartum,,,Time That Dose-Normalized Plasma Concentrations Are Below 1ng/ml,,,8,,,,,,,,,4 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3357,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,,,,,,,,,0,,,,,,,,,8 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3358,2025-12-02T15:56:56.518041
28669739.0,Buprenorphine,,,,,,,,,,0,,,,,,,,,12 mg BID,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3359,2025-12-02T15:56:56.518041
28805611.0,Propofol,,maternal arterial blood,pregnant ,post-partum,,20,Plasma concentration,,,1.91,ug/mL,mean,SD,0.46,,,,,patients undergoing elective CS were administered anesthesia at short I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3360,2025-12-02T15:56:56.518041
28805611.0,Propofol,,fetal umbilical arterial blood,fetal,delivery,,20,Plasma concentration,,,1.17,ug/mL,mean,SD,0.29,,,,,patients undergoing elective CS were administered anesthesia at short I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3361,2025-12-02T15:56:56.518041
28805611.0,Propofol,,fetal venous arterial blood,pregnant ,post-partum,,20,Plasma concentration,,,0.51,ug/mL,mean,SD,0.17,,,,,patients undergoing elective CS were administered anesthesia at short I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3362,2025-12-02T15:56:56.518041
28805611.0,Propofol,,,pregnant ,post-partum,,20,UV/MA ratio,,,0.63,,mean,SD,0.09,,,,,patients undergoing elective CS were administered anesthesia at short I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3363,2025-12-02T15:56:56.518041
28805611.0,Propofol,,,pregnant ,post-partum,,20,UA/UV ratio,,,0.47,,mean,SD,0.07,,,,,patients undergoing elective CS were administered anesthesia at short I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3364,2025-12-02T15:56:56.518041
28805611.0,Propofol,,maternal arterial blood,pregnant ,post-partum,,20,Plasma concentration,,,1.57,ug/mL,mean,SD,0.3,,,,,patients undergoing elective CS were administered anesthesia at  long I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3365,2025-12-02T15:56:56.518041
28805611.0,Propofol,,fetal umbilical arterial blood,fetal,delivery,,20,Plasma concentration,,,1.07,ug/mL,mean,SD,0.19,,,,,patients undergoing elective CS were administered anesthesia at  long I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3366,2025-12-02T15:56:56.518041
28805611.0,Propofol,,fetal venous arterial blood,pregnant ,post-partum,,20,Plasma concentration,,,0.61,ug/mL,mean,SD,0.1,,,,,patients undergoing elective CS were administered anesthesia at  long I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3367,2025-12-02T15:56:56.518041
28805611.0,Propofol,,,pregnant ,post-partum,,20,UV/MA ratio,,,0.69,,mean,SD,0.07,,,,,patients undergoing elective CS were administered anesthesia at  long I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3368,2025-12-02T15:56:56.518041
28805611.0,Propofol,,,pregnant ,post-partum,,20,UA/UV ratio,,,0.52,,mean,SD,0.07,,,,,patients undergoing elective CS were administered anesthesia at  long I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3369,2025-12-02T15:56:56.518041
28805611.0,Remifentanil,,maternal arterial blood,pregnant ,post-partum,,20,Plasma concentration,,,2.25,ug/mL,mean,SD,0.46,,,,,patients undergoing elective CS were administered anesthesia at short I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3370,2025-12-02T15:56:56.518041
28805611.0,Remifentanil,,fetal umbilical arterial blood,fetal,delivery,,20,Plasma concentration,,,1.43,ug/mL,mean,SD,0.36,,,,,patients undergoing elective CS were administered anesthesia at short I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3371,2025-12-02T15:56:56.518041
28805611.0,Remifentanil,,fetal venous arterial blood,pregnant ,post-partum,,20,Plasma concentration,,,0.65,ug/mL,mean,SD,0.11,,,,,patients undergoing elective CS were administered anesthesia at short I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3372,2025-12-02T15:56:56.518041
28805611.0,Remifentanil,,,pregnant ,post-partum,,20,UV/MA ratio,,,0.63,,mean,SD,0..07,,,,,patients undergoing elective CS were administered anesthesia at short I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3373,2025-12-02T15:56:56.518041
28805611.0,Remifentanil,,,pregnant ,post-partum,,20,UA/UV ratio,,,0.49,,mean,SD,0..07,,,,,patients undergoing elective CS were administered anesthesia at short I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3374,2025-12-02T15:56:56.518041
28805611.0,Remifentanil,,maternal arterial blood,pregnant ,post-partum,,20,Plasma concentration,,,1.96,ug/mL,mean,SD,0.43,,,,,patients undergoing elective CS were administered anesthesia at  long I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3375,2025-12-02T15:56:56.518041
28805611.0,Remifentanil,,fetal umbilical arterial blood,fetal,delivery,,20,Plasma concentration,,,1.25,ug/mL,mean,SD,0.24,,,,,patients undergoing elective CS were administered anesthesia at  long I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3376,2025-12-02T15:56:56.518041
28805611.0,Remifentanil,,fetal venous arterial blood,pregnant ,post-partum,,20,Plasma concentration,,,0.75,ug/mL,mean,SD,0.18,,,,,patients undergoing elective CS were administered anesthesia at  long I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3377,2025-12-02T15:56:56.518041
28805611.0,Remifentanil,,,pregnant ,post-partum,,20,UV/MA ratio,,,0.65,,mean,SD,0.09,,,,,patients undergoing elective CS were administered anesthesia at  long I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3378,2025-12-02T15:56:56.518041
28805611.0,Remifentanil,,,pregnant ,post-partum,,20,UA/UV ratio,,,0.56,,mean,SD,0.11,,,,,patients undergoing elective CS were administered anesthesia at  long I-D intervals,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3379,2025-12-02T15:56:56.518041
29521669.0,Methadone,Methadone,serum,Maternal,Pregnancy,,23,Concentration,,,288,ng/ml,mean,,,range,78,854,<0.0001,"Means use within period patient averages, p for positive correlation with dose",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3380,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Postpartum,,23,,,,434,,,,,,169,1020,0.001,p for increase in serum levels from T3 to PP,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3381,2025-12-02T15:56:56.518041
29521669.0,Methadone,EDDP,serum,Maternal,Pregnancy,,23,Concentration,,,50,ng/ml,mean,,,range,16.9,142.3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3382,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Postpartum,,23,,,,66,,,,,,21,231.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3383,2025-12-02T15:56:56.518041
29521669.0,Methadone,methadone/EDDP,serum,Maternal,Pregnancy,,23,drug:metabolite ratio,,,5.9,,mean,,,range,2.6,11.6,0.002,p for positive correlation with serum levels,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3384,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Postpartum,,23,,,,7.2,,,,,,3.7,19.8,0.29,p for negative correlation with dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3385,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 1,,11,drug:metabolite ratio,,,7.2,,mean,SD,1.9,,,,0.0007,"Data using each patients average ratio per trimester, p for comparison of T1 to T3",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3386,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 2,,16,drug:metabolite ratio,,,5.9,,,,2.7,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3387,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 3,,16,drug:metabolite ratio,,,5.1,,,,1.3,,,,0.001,p for comparison of T3 to PP,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3388,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Postpartum,,11,drug:metabolite ratio,,,7.2,,,,3.3,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3389,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 1,,11,drug:metabolite ratio,,,7.2,,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3390,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 2,,16,drug:metabolite ratio,,,5.2,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3391,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 3,,16,drug:metabolite ratio,,,4.9,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3392,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Postpartum,,11,drug:metabolite ratio,,,6.5,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3393,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 1,,,Ratio <4,,,8,%,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3394,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 2,,,Ratio <4,,,30,%,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3395,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 3,,,Ratio <4,,,38,%,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3396,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Postpartum,,,Ratio <4,,,5,%,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3397,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 1,,,Ultra-rapid metabolizers,,,1,count,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3398,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 2,,,Ultra-rapid metabolizers,,,7,count,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3399,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Trimester 3,,,Ultra-rapid metabolizers,,,5,count,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3400,2025-12-02T15:56:56.518041
29521669.0,Methadone,,,,Postpartum,,,Ultra-rapid metabolizers,,,1,count,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3401,2025-12-02T15:56:56.518041
29943508.0,Fentanyl,Fentanyl,blood,pregnant ,post-partum,,16,"concentration,umbilical vein",,,0.162,nmol/L,mean,SD,0.009,,,,,Adrenaline group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3402,2025-12-02T15:56:56.518041
29943508.0,Fentanyl,Fentanyl,blood,pregnant ,post-partum,,20,"concentration,umbilical vein",,,0.151,nmol/L,mean,SD,0.007,,,,,Control group (w/o adrenaline),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3403,2025-12-02T15:56:56.518041
29943508.0,Fentanyl,Fentanyl,blood,pregnant ,post-partum,,16,maternal serum concentration,at birth,,0.268,nmol/L,median,,,25th; 75th percentile,0.193,0.493,,Adrenaline group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3404,2025-12-02T15:56:56.518041
29943508.0,Fentanyl,Fentanyl,blood,pregnant ,post-partum,,19,maternal serum concentration,at birth,,0.291,nmol/L,median,,,25th; 75th percentile,0.212,0.502,,Control group (w/o adrenaline),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3405,2025-12-02T15:56:56.518041
29943508.0,Fentanyl,Fentanyl,blood,pregnant ,post-partum,,18,AUC 0-120 min,120,minutes,0.428,nmol h/L,mean,SD,0.162,,,,,Adrenaline group; time after epidural placement,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3406,2025-12-02T15:56:56.518041
29943508.0,Fentanyl,Fentanyl,blood,pregnant ,post-partum,,15,AUC 0-120 min,120,minutes,0.59,nmol h/L,mean,SD,0.197,,,,,Control group (w/o adrenaline); time after epidural placement,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3407,2025-12-02T15:56:56.518041
30300922.0,morphine,,,neonate,postmenstrual age 24-34 weeks,,,clearance,,,19,L/h/70kg,mean,SD,19,,,,,OCT1 wild,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3408,2025-12-02T15:56:56.518041
30300922.0,morphine,,,neonate,postmenstrual age 24-34 weeks,,,clearance,,,20,L/h/70kg,mean,SD,2,,,,,OCT hetero,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3409,2025-12-02T15:56:56.518041
30300922.0,morphine,,,neonate,postmenstrual age 24-34 weeks,,,clearance,,,23,L/h/70kg,mean,SD,1,,,,>0.05,OCT1 homo,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3410,2025-12-02T15:56:56.518041
30300922.0,morphine,,,neonate,postmenstrual age 34-40 weeks,,,clearance,,,19.3,L/h/70kg,mean,SD,9.6,,,,,OCT1 wild,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3411,2025-12-02T15:56:56.518041
30300922.0,morphine,,,neonate,postmenstrual age 34-40 weeks,,,clearance,,,15,L/h/70kg,mean,SD,7.2,,,,,OCT hetero,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3412,2025-12-02T15:56:56.518041
30300922.0,morphine,,,neonate,postmenstrual age 34-40 weeks,,,clearance,,,11.7,L/h/70kg,mean,SD,4.2,,,,<0.05,OCT1 homo,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3413,2025-12-02T15:56:56.518041
30300922.0,morphine,,,neonate,postmenstrual age 40-50 weeks,,,clearance,,,38.7,L/h/70kg,mean,SD,18,,,,,OCT1 wild,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3414,2025-12-02T15:56:56.518041
30300922.0,morphine,,,neonate,postmenstrual age 40-50 weeks,,,clearance,,,30.3,L/h/70kg,mean,SD,18,,,,,OCT hetero,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3415,2025-12-02T15:56:56.518041
30300922.0,morphine,,,neonate,postmenstrual age 40-50 weeks,,,clearance,,,20.3,L/h/70kg,mean,SD,8,,,,<0.05,OCT1 homo,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3416,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,19,serum concentration,0.25,hours,23.2,ng/mL,mean,SD,34,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3417,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,serum concentration,0.5,hours,45.6,ng/mL,mean,SD,33,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3418,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,serum concentration,1,hours,49.4,ng/mL,mean,SD,21.2,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3419,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,serum concentration,2,hours,43.1,ng/mL,mean,SD,14.2,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3420,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,17,serum concentration,4,hours,32.8,ng/mL,mean,SD,10.8,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3421,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,serum concentration,6,hours,22.3,ng/mL,mean,SD,11.9,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3422,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,serum concentration,11,hours,8.14,ng/mL,mean,SD,6.35,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3423,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,serum concentration,15,hours,3.66,ng/mL,mean,SD,3.26,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3424,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,serum concentration,0.25,hours,404,ng/mL,mean,SD,581,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3425,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,17,serum concentration,0.5,hours,855,ng/mL,mean,SD,672,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3426,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,17,serum concentration,1,hours,1424,ng/mL,mean,SD,542,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3427,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,serum concentration,2,hours,1202,ng/mL,mean,SD,366,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3428,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,17,serum concentration,4,hours,824,ng/mL,mean,SD,191,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3429,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,serum concentration,6,hours,497,ng/mL,mean,SD,138,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3430,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,serum concentration,11,hours,150,ng/mL,mean,SD,69,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3431,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,17,serum concentration,15,hours,66.9,ng/mL,mean,SD,35.4,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3432,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,6-<12 years,,22,serum concentration,0.25-0.5,hours,36.5,ng/mL,mean,SD,21.8,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3433,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,6-<12 years,,22,serum concentration,1-3,hours,36.5,ng/mL,mean,SD,15.7,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3434,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,6-<12 years,,22,serum concentration,4-8,hours,13.5,ng/mL,mean,SD,6.52,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3435,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6-<12 years,,22,serum concentration,11-15,hours,3.71,ng/mL,mean,SD,1.96,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3436,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6-<12 years,,20,serum concentration,0.25-0.5,hours,676,ng/mL,mean,SD,343,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3437,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6-<12 years,,22,serum concentration,1-3,hours,900,ng/mL,mean,SD,330,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3438,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6-<12 years,,22,serum concentration,4-8,hours,321,ng/mL,mean,SD,123,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3439,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6-<12 years,,22,serum concentration,11-15,hours,86.3,ng/mL,mean,SD,37.8,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3440,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,3-<6 years,,11,serum concentration,0.25-0.5,hours,30.1,ng/mL,mean,SD,19.2,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3441,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,3-<6 years,,11,serum concentration,4-8,hours,26.4,ng/mL,mean,SD,10.7,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3442,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,3-<6 years,,10,serum concentration,0.25-0.5,hours,494,ng/mL,mean,SD,377,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3443,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,3-<6 years,,11,serum concentration,4-8,hours,504,ng/mL,mean,SD,112,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3444,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,2-<3 years,,4,serum concentration,1.25,hours,19.9,ng/mL,mean,SD,13.2,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3445,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,2-<3 years,,4,serum concentration,3,hours,37.7,ng/mL,mean,SD,18.2,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3446,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,2-<3 years,,3,serum concentration,5,hours,23.4,ng/mL,mean,SD,6.36,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3447,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,2-<3 years,,4,serum concentration,8,hours,10,ng/mL,mean,SD,4.33,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3448,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,2-<3 years,,4,serum concentration,1.25,hours,497,ng/mL,mean,SD,513,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3449,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,2-<3 years,,4,serum concentration,3,hours,938,ng/mL,mean,SD,407,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3450,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,2-<3 years,,3,serum concentration,5,hours,624,ng/mL,mean,SD,235,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3451,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,2-<3 years,,4,serum concentration,8,hours,253,ng/mL,mean,SD,103,,,,,PK sampling was performed post-dose.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3452,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,Cmax,,,76.5,ng/mL,mean,SD,26.3,range,31.7,139,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3453,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,tmax ,,,1.4,h,mean,SD,1.1,range,0.32,4.12,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3454,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,AUC0-t,,,302,ngh/mL,mean,SD,92.4,range,218,636,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3455,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,t1/2,,,3.4,h,mean,SD,0.82,range,2.29,5.84,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3456,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,Cmax,,,63.1,ng/mL,geometric mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3457,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,tmax ,,,1.1,h,geometric mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3458,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,AUC0-t,,,292,ngh/mL,geometric mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3459,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,t1/2,,,3.3,h,geometric mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3460,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,Cmax,,,61.5,ng/mL,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3461,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,tmax ,,,1.08,h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3462,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,AUC0-t,,,274,ngh/mL,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3463,2025-12-02T15:56:56.518041
31213888.0,tapentadol,tapentadol,blood,pediatric ,12-<18 years,,18,t1/2,,,3.2,h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3464,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,Cmax,,,1487,ng/mL,mean,SD,495,range,725,2488,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3465,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,tmax ,,,1.7,h,mean,SD,1.19,range,0.68,4.27,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3466,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,AUC0-t,,,7082,ngh/mL,mean,SD,1348,range,4946,9689,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3467,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,t1/2,,,3,h,mean,SD,0.6,range,2.33,4.43,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3468,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,Cmax,,,1406,ng/mL,geometric mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3469,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,tmax ,,,1.4,h,geometric mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3470,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,AUC0-t,,,6962,ngh/mL,geometric mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3471,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,t1/2,,,3,h,geometric mean,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3472,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,Cmax,,,1495,ng/mL,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3473,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,tmax ,,,1.08,h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3474,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,AUC0-t,,,6897,ngh/mL,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3475,2025-12-02T15:56:56.518041
31213888.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,12-<18 years,,18,t1/2,,,2.9,h,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3476,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,10,serum concentration,>5 to <30,minutes,10.9,ng/mL,mean,SD,13.8,range,0.87,38.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3477,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,19,serum concentration,30 to <45,minutes,39.1,ng/mL,mean,SD,32.4,range,0.33,109,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3478,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,10,serum concentration,45 to < 60,minutes,59.2,ng/mL,mean,SD,26.7,range,23.8,111,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3479,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,16,serum concentration,1 to <1.5,hours,51.5,ng/mL,mean,SD,26.3,range,0.23,96.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3480,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,1,serum concentration,1.5 to <2,hours,66.8,ng/mL,mean,SD,,range,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3481,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,12,serum concentration,2 to <3,hours,47.1,ng/mL,mean,SD,21.9,range,4.27,97,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3482,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,10,serum concentration,3 to <4,hours,34.4,ng/mL,mean,SD,8.46,range,25,47.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3483,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,17,serum concentration,4 to <5,hours,30.1,ng/mL,mean,SD,13.6,range,6.52,67.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3484,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,6,serum concentration,5 to <6,hours,26.5,ng/mL,mean,SD,9.39,range,16.2,42.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3485,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,9,serum concentration,6 to <8,hours,18,ng/mL,mean,SD,7.88,range,9.05,30.9,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3486,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,11,serum concentration,8 to <12,hours,6.97,ng/mL,mean,SD,3.89,range,1.75,4.7,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3487,2025-12-02T15:56:56.518041
31303784.0,tapentadol,tapentadol,blood,pediatric ,6<18 years,,11,serum concentration,>12,hours,4.26,ng/mL,mean,SD,2.95,range,3.51,15,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3488,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,8,serum concentration,>5 to <30,minutes,203,ng/mL,mean,SD,183,range,15.4,512,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3489,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,18,serum concentration,30 to <45,minutes,834,ng/mL,mean,SD,706,range,30.4,2400,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3490,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,10,serum concentration,45 to < 60,minutes,1250,ng/mL,mean,SD,460,range,346,1800,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3491,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,15,serum concentration,1 to <1.5,hours,1033,ng/mL,mean,SD,441,range,393,1810,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3492,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,1,serum concentration,1.5 to <2,hours,1840,ng/mL,mean,SD,,range,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3493,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,12,serum concentration,2 to <3,hours,1241,ng/mL,mean,SD,489,range,99.7,1790,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3494,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,10,serum concentration,3 to <4,hours,1110,ng/mL,mean,SD,359,range,407,1580,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3495,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,17,serum concentration,4 to <5,hours,769,ng/mL,mean,SD,287,range,140,1270,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3496,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,6,serum concentration,5 to <6,hours,714,ng/mL,mean,SD,237,range,365,1040,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3497,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,9,serum concentration,6 to <8,hours,402,ng/mL,mean,SD,210,range,170,893,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3498,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,22,serum concentration,8 to <12,hours,167,ng/mL,mean,SD,91.8,range,55.8,390,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3499,2025-12-02T15:56:56.518041
31303784.0,tapentadol,Tapentadol-O-Glucuronide,blood,pediatric ,6<18 years,,21,serum concentration,>12,hours,93.7,ng/mL,mean,SD,66.9,range,43.3,359,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3500,2025-12-02T15:56:56.518041
31688081.0,Morphine,morphine,plasma,children,,,16,AUC dose-adjusted,540,minutes,2505.6,ng/ml*min,mean,SD,149.7,,,,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3501,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,2083,,,,194.6,,,,0.17,OSAS. P-value compared to control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3502,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,2206.6,,,,316,,,,0.72,Obese/OSAS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3503,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,16,Cmax dose-adjusted,,,30.1,ng/ml,,,3.4,,,,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3504,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,29,,,,2.6,,,,1,OSAS. P-value compared to control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3505,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,47.6,,,,4,,,,<0.001,"Obese/OSAS, p=0.01 between Obese/OSAS vs. OSAS only group",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3506,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,16,AUC,540,minutes,2505.6,ng/ml*min,,,598.6,,,,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3507,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,2083,,,,550.5,,,,0.16,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3508,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,1537.9,,,,764.6,,,,0.004,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3509,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,16,Cmax,,,30.1,ng/ml,,,13.5,,,,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3510,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,29,,,,7.4,,,,0.87,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3511,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,33.5,,,,12.3,,,,0.55,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3512,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,16,Tmax,,,10,minutes,median,,,range,10,60,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3513,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,10,,,,,,10,45,0.7,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3514,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,10,,,,,,10,10,0.14,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3515,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,16,T1/2,,,138,minutes,median,,,range,27.1,780.1,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3516,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,171.9,,,,,,53.3,898.8,1,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3517,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,61.8,,,,,,22.9,392.9,0.13,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3518,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,16,Clearance,,,0.02,ml/min/kg,mean,SD,0.001,,,,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3519,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,0.02,,,,0.003,,,,0.7,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3520,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,0.02,,,,0.004,,,,0.28,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3521,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,16,Vd,,,0.18,ml/kg,mean,SD,0.03,,,,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3522,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,0.29,,,,0.09,,,,0.32,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3523,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,0.09,,,,0.03,,,,0.07,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3524,2025-12-02T15:56:56.518041
31688081.0,Morphine,M3G,plasma,children,,,16,Cmax,,,41.4,ng/ml,mean,SD,4.6,,,,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3525,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,45.5,,,,3.3,,,,0.52,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3526,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,56.4,,,,4.1,,,,0.01,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3527,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,16,Tmax,,,90,minutes,median,,,range,30,220,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3528,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,90,,,,,,45,180,0.82,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3529,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,60,,,,,,30,120,0.03,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3530,2025-12-02T15:56:56.518041
31688081.0,Morphine,M6G,plasma,children,,,16,Tmax,,,120,minutes,median,,,range,90,480,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3531,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,90,,,,,,45,90,<0.002,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3532,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,60,,,,,,45,120,<0.001,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3533,2025-12-02T15:56:56.518041
31688081.0,Morphine,M3G/morphine,plasma,children,,,16,metabolite:drug ratio,,,5.5,,mean,SD,0.76,,,,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3534,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,6,,,,0.79,,,,0.5,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3535,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,10.1,,,,1.83,,,,0.01,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3536,2025-12-02T15:56:56.518041
31688081.0,Morphine,M6G/morphine,plasma,children,,,16,metabolite:drug ratio,,,0.001,,,,0.0004,,,,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3537,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,8,,,,0.0007,,,,0.0002,,,,0.67,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3538,2025-12-02T15:56:56.518041
31688081.0,Morphine,,,,,,10,,,,0.0009,,,,0.0002,,,,0.05,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3539,2025-12-02T15:56:56.518041
31929398.0,Buprenorphine,(NorBUP+norBUPG)/BUP,plasma,Maternal,<29 weeks,,19,AUC ratio,,,1.89,,mean,SD,0.56,,,,0.004,p for first/second trimesters versuspostpartum,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3540,2025-12-02T15:56:56.518041
31929398.0,Buprenorphine,,,,Trimester 3,,18,,,,1.84,,,,0.59,,,,0.013,p for third trimester versus postpartum,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3541,2025-12-02T15:56:56.518041
31929398.0,Buprenorphine,,,,Postpartum,,14,,,,1.33,,,,0.6,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3542,2025-12-02T15:56:56.518041
31929398.0,Buprenorphine,BUPG/BUP,,,<29 weeks,,19,AUC ratio,,,0.71,,,,0.7,,,,<0.001,p for first/second trimesters versus postpartum,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3543,2025-12-02T15:56:56.518041
31929398.0,Buprenorphine,,,,Trimester 3,,18,,,,2.07,,,,3.62,,,,<0.001,p for third trimester versus postpartum,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3544,2025-12-02T15:56:56.518041
31929398.0,Buprenorphine,,,,Postpartum,,14,,,,0.3,,,,0.24,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3545,2025-12-02T15:56:56.518041
32044215.0,fentanyl ,fentanyl ,maternal blood,pregnant ,,,13,plasma concentration,,,0.54,ng/mL,median,,,IQR,0.36,1.13,,Intranasal fentanyl;  at time of birth,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3546,2025-12-02T15:56:56.518041
32044215.0,fentanyl ,fentanyl ,Cord arterial blood,fetal,delivery,,10,plasma concentration,,,0.25,ng/mL,median,,,IQR,0.12,0.38,,Intranasal fentanyl;  at time of birth,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3547,2025-12-02T15:56:56.518041
32044215.0,fentanyl ,fentanyl ,Cord venous blood,fetal,delivery,,13,plasma concentration,,,0.28,ng/mL,median,,,IQR,0.1,0.52,,Intranasal fentanyl;  at time of birth,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3548,2025-12-02T15:56:56.518041
32044215.0,fentanyl ,fentanyl ,,,,,13,Umbilical cord venous/maternal ratio,,,0.44,,median,,,IQR,0.33,0.52,,Intranasal fentanyl;  at time of birth,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3549,2025-12-02T15:56:56.518041
32044215.0,fentanyl ,fentanyl ,,,,,10,Umbilical cord arterial/maternal ratio ,,,0.4,,median,,,IQR,0.34,0.54,,Intranasal fentanyl;  at time of birth,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3550,2025-12-02T15:56:56.518041
32044215.0,fentanyl ,fentanyl ,maternal blood,pregnant ,,,17,plasma concentration,,,0.3,ng/mL,median,,,IQR,0.21,0.37,,Subcutaneous fentanyl;  at time of birth,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3551,2025-12-02T15:56:56.518041
32044215.0,fentanyl ,fentanyl ,Cord arterial blood,fetal,delivery,,10,plasma concentration,,,0.13,ng/mL,median,,,IQR,0.1,0.22,,Subcutaneous fentanyl;  at time of birth,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3552,2025-12-02T15:56:56.518041
32044215.0,fentanyl ,fentanyl ,Cord venous blood,fetal,delivery,,11,plasma concentration,,,0.13,ng/mL,median,,,IQR,0.1,0.16,,Subcutaneous fentanyl;  at time of birth,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3553,2025-12-02T15:56:56.518041
32044215.0,fentanyl ,fentanyl ,,,,,11,Umbilical cord venous/maternal ratio,,,0.4,,median,,,IQR,0.35,0.56,,Subcutaneous fentanyl;  at time of birth,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3554,2025-12-02T15:56:56.518041
32044215.0,fentanyl ,fentanyl ,,,,,10,Umbilical cord arterial/maternal ratio ,,,0.4,,median,,,IQR,0.34,0.54,,Subcutaneous fentanyl;  at time of birth,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3555,2025-12-02T15:56:56.518041
32052397.0,methadone ,R-methadone ,maternal blood,pregnant ,post-partum,,16,concentration,,,146,ng/mL,mean,SD,74,,,,,NAS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3556,2025-12-02T15:56:56.518041
32052397.0,methadone ,,maternal blood,pregnant ,post-partum,,4,concentration,,,202,ng/mL,mean,SD,65,,,,,No NAS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3557,2025-12-02T15:56:56.518041
32052397.0,methadone ,,cord blood,neonatal,delivery,,16,concentration,,,103,ng/mL,mean,SD,63,,,,,NAS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3558,2025-12-02T15:56:56.518041
32052397.0,methadone ,,cord blood,neonatal,delivery,,4,concentration,,,150,ng/mL,mean,SD,71,,,,,No NAS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3559,2025-12-02T15:56:56.518041
32090339.0,morphine,,,neonate,,,,clearance,,,32,L/h/70kg,mean,SD,19,,,,,"MRP3 -211 C>T rs4793665, C/C",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3560,2025-12-02T15:56:56.518041
32090339.0,morphine,,,neonate,,,,clearance,,,28,L/h/70kg,mean,SD,18,,,,,"MRP3 -211 C>T rs4793665, C/T",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3561,2025-12-02T15:56:56.518041
32090339.0,morphine,,,neonate,,,,clearance,,,22,L/h/70kg,mean,SD,12,,,,0.06,"MRP3 -211 C>T rs4793665, TT",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3562,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,,,,clearance,,,78,L/h/70kg,mean,SD,14,,,,,"MRP3 -211 C>T rs4793665, C/C",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3563,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,,,,clearance,,,73,L/h/70kg,mean,SD,13,,,,,"MRP3 -211 C>T rs4793665, C/T",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3564,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,,,,clearance,,,71,L/h/70kg,mean,SD,10,,,,<0.05,"MRP3 -211 C>T rs4793665, TT",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3565,2025-12-02T15:56:56.518041
32090339.0,morphine,,,neonate,0-1 month,,,OCT1,,,0.13,/ug protein,mean,SD,0.16,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3566,2025-12-02T15:56:56.518041
32090339.0,morphine,,,neonate,2 - 6 month,,,OCT1,,,0.72,/ug protein,mean,SD,0.47,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3567,2025-12-02T15:56:56.518041
32090339.0,morphine,,,neonate,7 - 11 month,,,OCT1,,,0.7,/ug protein,mean,SD,0.29,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3568,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,1-2 year,,,OCT1,,,0.83,/ug protein,mean,SD,0.39,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3569,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,3.-6 year,,,OCT1,,,0.97,/ug protein,mean,SD,0.55,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3570,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,7-14 year,,,OCT1,,,0.85,/ug protein,mean,SD,0.53,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3571,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,17-33 year,,,OCT1,,,1,/ug protein,mean,SD,0.76,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3572,2025-12-02T15:56:56.518041
32090339.0,morphine,,,neonate,0-1 month,,,MRP3,,,0.41,/ug protein,mean,SD,0.18,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3573,2025-12-02T15:56:56.518041
32090339.0,morphine,,,neonate,2 - 6 month,,,MRP3,,,0.69,/ug protein,mean,SD,0.36,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3574,2025-12-02T15:56:56.518041
32090339.0,morphine,,,neonate,7 - 11 month,,,MRP3,,,1.04,/ug protein,mean,SD,0.65,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3575,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,1-2 year,,,MRP3,,,0.84,/ug protein,mean,SD,0.42,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3576,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,3.-6 year,,,MRP3,,,0.66,/ug protein,mean,SD,0.31,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3577,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,7-14 year,,,MRP3,,,0.66,/ug protein,mean,SD,0.32,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3578,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,17-33 year,,,MRP3,,,1,/ug protein,mean,SD,0.36,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3579,2025-12-02T15:56:56.518041
32090339.0,morphine,,,neonate,1-11 month,,,OCT1,,,0.6,/ug protein,mean,SD,0.5,,,,,OCT-1 haplotype wild type,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3580,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,1-33 years,,,OCT1,,,1,/ug protein,mean,SD,0.5,,,,,OCT-1 haplotype wild type,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3581,2025-12-02T15:56:56.518041
32090339.0,morphine,,,pediatric,1-33 years,,,OCT1,,,0.4,/ug protein,mean,SD,0.2,,,,<0.0001,OCT-1 haplotype variants *1/*3,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3582,2025-12-02T15:56:56.518041
32363420.0,Hydromorphone,,plasma,Maternal,labor,,7,Dose-normalized Cmax,,,2.44,ug/l/mg,median,SD,0.23,range,2.15,3.57,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3583,2025-12-02T15:56:56.518041
32363420.0,Hydromorphone,,,,,,,Dose-normalized AUClast,,,487,min*ug/l/mg,,,0.27,,369,713,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3584,2025-12-02T15:56:56.518041
32363420.0,Hydromorphone,,,,,,,Dose-normalized AUCinf,,,619,min*ug/l/mg,,,0.28,,453,938,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3585,2025-12-02T15:56:56.518041
32363420.0,Hydromorphone,,,,,,,t1/2,,,162,min*ug/l/mg,,,,,87,260,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3586,2025-12-02T15:56:56.518041
33481403.0,Methadone,R-methdone,plasma,children,,,38,Cmax,,,11,ng/ml,median,,,range,8.2,16.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3587,2025-12-02T15:56:56.518041
33481403.0,Methadone,S-methadone,,,,,,,,,13.1,,,,,,10.3,24.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3588,2025-12-02T15:56:56.518041
33481403.0,Methadone,Total methadone,,,,,,,,,24.7,,,,,,19.2,40.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3589,2025-12-02T15:56:56.518041
33481403.0,Methadone,R-methdone,plasma,children,,,38,Cmin,,,1.5,ng/ml,median,,,range,1.2,2.2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3590,2025-12-02T15:56:56.518041
33481403.0,Methadone,S-methadone,,,,,,,,,2.38,,,,,,1.52,3.82,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3591,2025-12-02T15:56:56.518041
33481403.0,Methadone,Total methadone,,,,,,,,,4.09,,,,,,2.74,6.4,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3592,2025-12-02T15:56:56.518041
33481403.0,Methadone,Alpha-1 acid glycoprotein (AAG),,,,,,Binding,,,95.2,ug/ml,,,,,75.6,129.1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3593,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,3,serum concentration,0.5,hours,9.8,ng/mL,mean,SD,5.2,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3594,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,1,serum concentration,1,hours,18.8,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3595,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,2,serum concentration,2,hours,32.2,ng/mL,mean,SD,14.9,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3596,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,3,serum concentration,4,hours,11.1,ng/mL,mean,SD,6,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3597,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,1,serum concentration,6,hours,14,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3598,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,2,serum concentration,8,hours,10.7,ng/mL,mean,SD,4.2,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3599,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,2,serum concentration,0.5,hours,8.3,ng/mL,mean,SD,6.3,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3600,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,1,serum concentration,1,hours,35.3,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3601,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,3,serum concentration,2,hours,27.3,ng/mL,mean,SD,0.8,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3602,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,2,serum concentration,4,hours,25.9,ng/mL,mean,SD,10.3,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3603,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,1,serum concentration,6,hours,32.8,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3604,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,2,serum concentration,8,hours,5.6,ng/mL,mean,SD,1.8,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3605,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,1,serum concentration,0.5,hours,26.6,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3606,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,1,serum concentration,1,hours,43.6,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3607,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,2,hours,19.9,ng/mL,mean,SD,7.7,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3608,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,4,hours,15,ng/mL,mean,SD,8.9,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3609,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,1,serum concentration,6,hours,18.8,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3610,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,8,hours,14.6,ng/mL,mean,SD,6.3,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3611,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,3,serum concentration,0.5,hours,105.7,ng/mL,mean,SD,125,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3612,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,1,serum concentration,1,hours,430.7,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3613,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,2,serum concentration,2,hours,468,ng/mL,mean,SD,248.4,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3614,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,3,serum concentration,4,hours,358.7,ng/mL,mean,SD,228.2,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3615,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,1,serum concentration,6,hours,370.2,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3616,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,2,serum concentration,8,hours,285.1,ng/mL,mean,SD,107.1,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3617,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,1,serum concentration,0.5,hours,128.8,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3618,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,1,serum concentration,1,hours,136.3,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3619,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,3,serum concentration,2,hours,324.9,ng/mL,mean,SD,116.6,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3620,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,2,serum concentration,4,hours,449.7,ng/mL,mean,SD,7.4,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3621,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,1,serum concentration,6,hours,253.3,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3622,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,2,serum concentration,8,hours,92.2,ng/mL,mean,SD,63.8,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3623,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,1,serum concentration,0.5,hours,74.4,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3624,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,1,serum concentration,1,hours,209,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3625,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,2,serum concentration,2,hours,98.5,ng/mL,mean,SD,2.6,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3626,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,2,serum concentration,4,hours,147.6,ng/mL,mean,SD,53.7,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3627,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,1,serum concentration,6,hours,224.8,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3628,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,2,serum concentration,8,hours,174.1,ng/mL,mean,SD,11,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3629,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,0.5,hours,22.1,ng/mL,mean,SD,20.8,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3630,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,1,serum concentration,1,hours,33.2,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3631,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,2,hours,50.3,ng/mL,mean,SD,7,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3632,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,3,serum concentration,4,hours,10.1,ng/mL,mean,SD,10.2,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3633,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,1,serum concentration,6,hours,15.8,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3634,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,8,hours,8.7,ng/mL,mean,SD,0.7,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3635,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,2,serum concentration,0.5,hours,14.6,ng/mL,mean,SD,9,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3636,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,1,serum concentration,1,hours,26.1,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3637,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,3,serum concentration,2,hours,24.9,ng/mL,mean,SD,6.1,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3638,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,2,serum concentration,4,hours,22.6,ng/mL,mean,SD,4.7,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3639,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,1,serum concentration,6,hours,20.8,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3640,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,2,serum concentration,8,hours,4,ng/mL,mean,SD,3.2,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3641,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,1,serum concentration,0.5,hours,72.5,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3642,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,1,serum concentration,1,hours,52.7,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3643,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,2,hours,36.4,ng/mL,mean,SD,3.9,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3644,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,4,hours,27.7,ng/mL,mean,SD,3.5,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3645,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,1,serum concentration,6,hours,12.4,ng/mL,mean,SD,,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3646,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,8,hours,20.7,ng/mL,mean,SD,12.6,,,,,Time after treatment; Tapentadol Oral Solution Single Dose Trial,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3647,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,4,serum concentration,0.25,hours,188,ng/mL,mean,SD,332,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3648,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,2,serum concentration,0.5,hours,46.2,ng/mL,mean,SD,16,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3649,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,4,serum concentration,1,hours,68.9,ng/mL,mean,SD,23.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3650,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,2,serum concentration,1.25,hours,57.7,ng/mL,mean,SD,14.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3651,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,2,serum concentration,1.5,hours,118,ng/mL,mean,SD,101,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3652,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,2,serum concentration,2,hours,46.6,ng/mL,mean,SD,6.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3653,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,2,serum concentration,3,hours,32.5,ng/mL,mean,SD,12.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3654,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,2,serum concentration,4,hours,17.6,ng/mL,mean,SD,14.6,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3655,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,4,serum concentration,6,hours,20.9,ng/mL,mean,SD,19.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3656,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,2,serum concentration,7,hours,10.2,ng/mL,mean,SD,3.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3657,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,2,serum concentration,8,hours,8.6,ng/mL,mean,SD,3.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3658,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,6 months to <2 years,,2,serum concentration,10,hours,12.4,ng/mL,mean,SD,12.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3659,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,4,serum concentration,0.25,hours,18.2,ng/mL,mean,SD,12.6,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3660,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,3,serum concentration,0.5,hours,38.2,ng/mL,mean,SD,11,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3661,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,4,serum concentration,1,hours,51.4,ng/mL,mean,SD,19.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3662,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,2,serum concentration,1.25,hours,67.2,ng/mL,mean,SD,15.9,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3663,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,2,serum concentration,1.5,hours,113,ng/mL,mean,SD,101,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3664,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,3,serum concentration,2,hours,45.1,ng/mL,mean,SD,3.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3665,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,2,serum concentration,3,hours,39.3,ng/mL,mean,SD,18.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3666,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,2,serum concentration,4,hours,35.2,ng/mL,mean,SD,6.2,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3667,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,4,serum concentration,6,hours,10.2,ng/mL,mean,SD,5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3668,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,2,serum concentration,7,hours,17.9,ng/mL,mean,SD,19.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3669,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,3,serum concentration,8,hours,12.7,ng/mL,mean,SD,9.2,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3670,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,1 month to <6 months,,2,serum concentration,10,hours,11.5,ng/mL,mean,SD,,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3671,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,3,serum concentration,0.25,hours,51,ng/mL,mean,SD,61.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3672,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,0.5,hours,25.7,ng/mL,mean,SD,9.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3673,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,3,serum concentration,1,hours,56.8,ng/mL,mean,SD,14.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3674,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,1.25,hours,38.6,ng/mL,mean,SD,3.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3675,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,1.5,hours,37.5,ng/mL,mean,SD,8.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3676,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,2,hours,37.6,ng/mL,mean,SD,12,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3677,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,3,hours,25.7,ng/mL,mean,SD,0.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3678,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,4,hours,19.2,ng/mL,mean,SD,2.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3679,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,3,serum concentration,6,hours,18.3,ng/mL,mean,SD,3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3680,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,7,hours,12.7,ng/mL,mean,SD,5.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3681,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,8,hours,10.7,ng/mL,mean,SD,5.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3682,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Birth to <1 month,,2,serum concentration,10,hours,5.3,ng/mL,mean,SD,3.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3683,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,0.25,hours,30.5,ng/mL,mean,SD,3.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3684,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,0.5,hours,23.9,ng/mL,mean,SD,9.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3685,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,1,hours,37.5,ng/mL,mean,SD,28.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3686,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,1.25,hours,26.1,ng/mL,mean,SD,16.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3687,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,1.5,hours,41.3,ng/mL,mean,SD,2.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3688,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,2,hours,29.4,ng/mL,mean,SD,0.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3689,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,3,hours,33.6,ng/mL,mean,SD,5.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3690,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,4,hours,12.2,ng/mL,mean,SD,5.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3691,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,6,hours,29.7,ng/mL,mean,SD,24,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3692,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,7,hours,22.8,ng/mL,mean,SD,6,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3693,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,8,hours,7.6,ng/mL,mean,SD,6.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3694,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol,blood,pediatric ,Preterm neonates,,2,serum concentration,10,hours,4.4,ng/mL,mean,SD,0.2,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3695,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,,serum concentration,0.25,hours,,ng/mL,mean,SD,,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3696,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,2,serum concentration,0.5,hours,24.7,ng/mL,mean,SD,7.9,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3697,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,4,serum concentration,1,hours,90.1,ng/mL,mean,SD,57,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3698,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,2,serum concentration,1.25,hours,214,ng/mL,mean,SD,16.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3699,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,2,serum concentration,1.5,hours,109,ng/mL,mean,SD,26.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3700,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,2,serum concentration,2,hours,172,ng/mL,mean,SD,28.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3701,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,2,serum concentration,3,hours,172,ng/mL,mean,SD,81.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3702,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,2,serum concentration,4,hours,99.2,ng/mL,mean,SD,31.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3703,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,4,serum concentration,6,hours,99.2,ng/mL,mean,SD,18.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3704,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,2,serum concentration,7,hours,70,ng/mL,mean,SD,25.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3705,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,2,serum concentration,8,hours,116,ng/mL,mean,SD,28.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3706,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,6 months to <2 years,,2,serum concentration,10,hours,154,ng/mL,mean,SD,99.2,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3707,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,,serum concentration,0.25,hours,,ng/mL,mean,SD,,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3708,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,2,serum concentration,0.5,hours,19.5,ng/mL,mean,SD,12.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3709,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,4,serum concentration,1,hours,81.2,ng/mL,mean,SD,34.9,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3710,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,2,serum concentration,1.25,hours,129,ng/mL,mean,SD,122,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3711,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,2,serum concentration,1.5,hours,165,ng/mL,mean,SD,1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3712,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,3,serum concentration,2,hours,127,ng/mL,mean,SD,79.9,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3713,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,2,serum concentration,3,hours,187,ng/mL,mean,SD,28.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3714,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,2,serum concentration,4,hours,224,ng/mL,mean,SD,48.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3715,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,4,serum concentration,6,hours,158,ng/mL,mean,SD,130,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3716,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,2,serum concentration,7,hours,88.4,ng/mL,mean,SD,48.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3717,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,3,serum concentration,8,hours,99.7,ng/mL,mean,SD,24.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3718,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,1 month to <6 months,,2,serum concentration,10,hours,158,ng/mL,mean,SD,,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3719,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,,serum concentration,0.25,hours,,ng/mL,mean,SD,,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3720,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,,serum concentration,0.5,hours,,ng/mL,mean,SD,,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3721,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,3,serum concentration,1,hours,63.1,ng/mL,mean,SD,15.6,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3722,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,2,serum concentration,1.25,hours,209,ng/mL,mean,SD,154,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3723,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,2,serum concentration,1.5,hours,92.6,ng/mL,mean,SD,53.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3724,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,2,serum concentration,2,hours,159,ng/mL,mean,SD,67.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3725,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,2,serum concentration,3,hours,153,ng/mL,mean,SD,50.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3726,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,2,serum concentration,4,hours,486,ng/mL,mean,SD,399,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3727,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,3,serum concentration,6,hours,267,ng/mL,mean,SD,49.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3728,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,2,serum concentration,7,hours,187,ng/mL,mean,SD,48.9,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3729,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,2,serum concentration,8,hours,221,ng/mL,mean,SD,38.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3730,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Birth to <1 month,,2,serum concentration,10,hours,408,ng/mL,mean,SD,278,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3731,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,,serum concentration,0.25,hours,,ng/mL,mean,SD,,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3732,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,2,serum concentration,0.5,hours,26.3,ng/mL,mean,SD,13.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3733,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,2,serum concentration,1,hours,157,ng/mL,mean,SD,133.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3734,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,2,serum concentration,1.25,hours,59.4,ng/mL,mean,SD,58.6,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3735,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,2,serum concentration,1.5,hours,54.6,ng/mL,mean,SD,0.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3736,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,2,serum concentration,2,hours,244.9,ng/mL,mean,SD,0.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3737,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,2,serum concentration,3,hours,92.1,ng/mL,mean,SD,8.6,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3738,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,2,serum concentration,4,hours,149.8,ng/mL,mean,SD,153.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3739,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,2,serum concentration,6,hours,117.7,ng/mL,mean,SD,87.9,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3740,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,2,serum concentration,7,hours,146.3,ng/mL,mean,SD,15.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3741,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,2,serum concentration,8,hours,222.1,ng/mL,mean,SD,206.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3742,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-glucuronide,blood,pediatric ,Preterm neonates,,2,serum concentration,10,hours,148.1,ng/mL,mean,SD,126.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3743,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,0.25,hours,5.1,ng/mL,mean,SD,2.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3744,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,0.5,hours,6.3,ng/mL,mean,SD,0.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3745,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,4,serum concentration,1,hours,17.6,ng/mL,mean,SD,6.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3746,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,1.25,hours,37.8,ng/mL,mean,SD,6.2,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3747,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,1.5,hours,17.5,ng/mL,mean,SD,4.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3748,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,2,hours,22.3,ng/mL,mean,SD,8.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3749,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,3,hours,16.8,ng/mL,mean,SD,6.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3750,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,4,hours,8,ng/mL,mean,SD,5.2,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3751,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,4,serum concentration,6,hours,7.5,ng/mL,mean,SD,2,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3752,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,7,hours,5.3,ng/mL,mean,SD,2.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3753,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,8,hours,6.1,ng/mL,mean,SD,3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3754,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,6 months to <2 years,,2,serum concentration,10,hours,9,ng/mL,mean,SD,7.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3755,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,3,serum concentration,0.25,hours,2,ng/mL,mean,SD,0.9,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3756,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,3,serum concentration,0.5,hours,9.1,ng/mL,mean,SD,4.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3757,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,4,serum concentration,1,hours,14.5,ng/mL,mean,SD,5.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3758,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,2,serum concentration,1.25,hours,33.1,ng/mL,mean,SD,6.9,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3759,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,2,serum concentration,1.5,hours,19,ng/mL,mean,SD,5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3760,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,3,serum concentration,2,hours,28,ng/mL,mean,SD,4.6,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3761,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,2,serum concentration,3,hours,13.9,ng/mL,mean,SD,0.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3762,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,2,serum concentration,4,hours,34.7,ng/mL,mean,SD,22.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3763,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,4,serum concentration,6,hours,10.2,ng/mL,mean,SD,8.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3764,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,2,serum concentration,7,hours,3.9,ng/mL,mean,SD,1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3765,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,3,serum concentration,8,hours,10.3,ng/mL,mean,SD,4.2,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3766,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,1 month to <6 months,,2,serum concentration,10,hours,19.4,ng/mL,mean,SD,,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3767,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,0.25,hours,2.2,ng/mL,mean,SD,0.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3768,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,0.5,hours,5.9,ng/mL,mean,SD,0.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3769,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,3,serum concentration,1,hours,21.6,ng/mL,mean,SD,6.6,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3770,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,1.25,hours,16.6,ng/mL,mean,SD,1.6,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3771,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,1.5,hours,22.2,ng/mL,mean,SD,9.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3772,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,2,hours,32.7,ng/mL,mean,SD,2.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3773,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,3,hours,29.6,ng/mL,mean,SD,14.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3774,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,4,hours,19.4,ng/mL,mean,SD,0.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3775,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,3,serum concentration,6,hours,35.8,ng/mL,mean,SD,8.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3776,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,7,hours,22,ng/mL,mean,SD,15,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3777,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,8,hours,15,ng/mL,mean,SD,3.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3778,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Birth to <1 month,,2,serum concentration,10,hours,6.2,ng/mL,mean,SD,1.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3779,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,0.25,hours,2.8,ng/mL,mean,SD,0.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3780,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,0.5,hours,5.1,ng/mL,mean,SD,1.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3781,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,1,hours,22.1,ng/mL,mean,SD,4.9,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3782,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,1.25,hours,10.4,ng/mL,mean,SD,7.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3783,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,1.5,hours,18.3,ng/mL,mean,SD,0.1,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3784,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,2,hours,22.1,ng/mL,mean,SD,9.3,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3785,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,3,hours,28.5,ng/mL,mean,SD,4.4,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3786,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,4,hours,16.3,ng/mL,mean,SD,10.8,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3787,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,6,hours,27,ng/mL,mean,SD,7.9,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3788,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,7,hours,34.3,ng/mL,mean,SD,8.5,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3789,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,8,hours,10.1,ng/mL,mean,SD,10.6,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3790,2025-12-02T15:56:56.518041
33542653.0,Tapentadol,Tapentadol-O-sulfate,blood,pediatric ,Preterm neonates,,2,serum concentration,10,hours,12.6,ng/mL,mean,SD,8.7,,,,,Tapentadol Intravenous Single Dose Trial; time after start of infusion,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3791,2025-12-02T15:56:56.518041
33864131.0,Buprenorphine,,maternal blood,pregnant ,First Trimester,,4,relative clearance,,,,ng/mL,mean,,,,,,,all participants; the exact values were not reported,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3792,2025-12-02T15:56:56.518041
33864131.0,Buprenorphine,,maternal blood,pregnant ,Second Trimester,,19,relative clearance,,,,ng/mL,mean,,,,,,,all participants; the exact values were not reported,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3793,2025-12-02T15:56:56.518041
33864131.0,Buprenorphine,,maternal blood,pregnant ,Third Trimester,,22,relative clearance,,,,ng/mL,mean,,,,,,,all participants; the exact values were not reported,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3794,2025-12-02T15:56:56.518041
33864131.0,Buprenorphine,,maternal blood,pregnant ,Postpartum,,21,relative clearance,,,,ng/mL,mean,,,,,,,all participants; the exact values were not reported,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3795,2025-12-02T15:56:56.518041
33864131.0,Buprenorphine,,maternal blood,pregnant ,First Trimester,,3,relative clearance,,,,ng/mL,mean,,,,,,,women required an increase in their BUP daily dose across the perinatal period. the exact values were not reported,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3796,2025-12-02T15:56:56.518041
33864131.0,Buprenorphine,,maternal blood,pregnant ,Second Trimester,,9,relative clearance,,,,ng/mL,mean,,,,,,,women required an increase in their BUP daily dose across the perinatal period. the exact values were not reported,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3797,2025-12-02T15:56:56.518041
33864131.0,Buprenorphine,,maternal blood,pregnant ,Third Trimester,,10,relative clearance,,,,ng/mL,mean,,,,,,,women required an increase in their BUP daily dose across the perinatal period. the exact values were not reported,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3798,2025-12-02T15:56:56.518041
33864131.0,Buprenorphine,,maternal blood,pregnant ,Postpartum,,11,relative clearance,,,,ng/mL,mean,,,,,,,women required an increase in their BUP daily dose across the perinatal period. the exact values were not reported,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3799,2025-12-02T15:56:56.518041
34037761.0,Tramadol,Tramadol,breast milk,pregnant ,Postpartum,,1,concentration,12,day of life,63,ng/mL,,,,,,,,samples collected on day of life 12/20,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3800,2025-12-02T15:56:56.518041
34037761.0,Tramadol,Tramadol,breast milk,pregnant ,Postpartum,,1,concentration,20,day of life,1254,ng/mL,,,,,,,,samples collected on day of life 12/21,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3801,2025-12-02T15:56:56.518041
34037761.0,Tramadol,O-desmethyltramadol,breast milk,pregnant ,Postpartum,,1,concentration,12,day of life,22,ng/mL,,,,,,,,samples collected on day of life 12/22,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3802,2025-12-02T15:56:56.518041
34037761.0,Tramadol,O-desmethyltramadol,breast milk,pregnant ,Postpartum,,1,concentration,20,day of life,388,ng/mL,,,,,,,,samples collected on day of life 12/23,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3803,2025-12-02T15:56:56.518041
34037761.0,Tramadol,N-desmethyltramadol,breast milk,pregnant ,Postpartum,,1,concentration,12,day of life,76,ng/mL,,,,,,,,samples collected on day of life 12/24,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3804,2025-12-02T15:56:56.518041
34037761.0,Tramadol,N-desmethyltramadol,breast milk,pregnant ,Postpartum,,1,concentration,20,day of life,937,ng/mL,,,,,,,,samples collected on day of life 12/25,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3805,2025-12-02T15:56:56.518041
34037761.0,Tramadol,Tramadol,Oral fluid, neonatal,,,1,concentration,12,day of life,None Detected,ng/mL,,,,,,,,samples collected on day of life 12/26,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3806,2025-12-02T15:56:56.518041
34037761.0,Tramadol,Tramadol,Oral fluid, neonatal,,,1,concentration,20,day of life,1011,ng/mL,,,,,,,,samples collected on day of life 12/27,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3807,2025-12-02T15:56:56.518041
34037761.0,Tramadol,O-desmethyltramadol,Oral fluid, neonatal,,,1,concentration,12,day of life,None Detected,ng/mL,,,,,,,,samples collected on day of life 12/28,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3808,2025-12-02T15:56:56.518041
34037761.0,Tramadol,O-desmethyltramadol,Oral fluid, neonatal,,,1,concentration,20,day of life,1499,ng/mL,,,,,,,,samples collected on day of life 12/29,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3809,2025-12-02T15:56:56.518041
34037761.0,Tramadol,N-desmethyltramadol,Oral fluid, neonatal,,,1,concentration,12,day of life,None Detected,ng/mL,,,,,,,,samples collected on day of life 12/30,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3810,2025-12-02T15:56:56.518041
34037761.0,Tramadol,N-desmethyltramadol,Oral fluid, neonatal,,,1,concentration,20,day of life,406,ng/mL,,,,,,,,samples collected on day of life 12/31,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3811,2025-12-02T15:56:56.518041
34037761.0,Tramadol,Tramadol,Urine, neonatal,,,1,concentration,12,day of life,None Detected,ng/mL,,,,,,,,samples collected on day of life 12/32,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3812,2025-12-02T15:56:56.518041
34037761.0,Tramadol,Tramadol,Urine, neonatal,,,1,concentration,20,day of life,14,ng/mL,,,,,,,,samples collected on day of life 12/33,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3813,2025-12-02T15:56:56.518041
34037761.0,Tramadol,O-desmethyltramadol,Urine, neonatal,,,1,concentration,12,day of life,None Detected,ng/mL,,,,,,,,samples collected on day of life 12/34,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3814,2025-12-02T15:56:56.518041
34037761.0,Tramadol,O-desmethyltramadol,Urine, neonatal,,,1,concentration,20,day of life,<10,ng/mL,,,,,,,,samples collected on day of life 12/35,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3815,2025-12-02T15:56:56.518041
34037761.0,Tramadol,N-desmethyltramadol,Urine, neonatal,,,1,concentration,12,day of life,None Detected,ng/mL,,,,,,,,samples collected on day of life 12/36,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3816,2025-12-02T15:56:56.518041
34037761.0,Tramadol,N-desmethyltramadol,Urine, neonatal,,,1,concentration,20,day of life,<10,ng/mL,,,,,,,,samples collected on day of life 12/37,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3817,2025-12-02T15:56:56.518041
34037761.0,Tramadol,Tramadol,, neonatal,,,,absolute infant dose,12,day of life,10,ug/kg/day,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3818,2025-12-02T15:56:56.518041
34037761.0,Tramadol,Tramadol,, neonatal,,,,absolute infant dose,20,day of life,294,ug/kg/day,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3819,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 0.5 mg,plasma,2-5 years,,,1,Concentration,,,186,pg/ml,median,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3820,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 1 mg,,,,,1,,,,310,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3821,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 2 mg,,,,,2,,,,2570,,,,,range,1170,3960,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3822,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 0.5 mg,plasma,6-19 years,,,3,,,,112,,,,,,39.3,237,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3823,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 1 mg,,,,,2,,,,261,,,,,,183,339,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3824,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 2 mg,,,,,2,,,,1580,,,,,,1000,2150,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3825,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 0.5 mg,plasma,pediatric/adolescent,,,1,,,,186,,,,,,,,,Weight <20 kg,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3826,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 1 mg,,,,,2,,,,247,,,,,,183,310,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3827,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 2 mg,,,,,3,,,,1170,,,,,,1000,3960,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3828,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 0.5 mg,plasma,pediatric/adolescent,,,1,,,,237,,,,,,,,,Weight 20-39 kg,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3829,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 1 mg,,,,,1,,,,339,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3830,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 0.5 mg,plasma,pediatric/adolescent,,,2,,,,75.7,,,,,,39.3,112,,weight 40 kg,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3831,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 2 mg,,,,,1,,,,2150,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3832,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 0.5 mg,plasma,pediatric/adolescent,,,4,Estimated absorbed dose,,,0.353,mg,median,,,range,0.318,0.391,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3833,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 1 mg,,,,,3,,,,0.702,,,,,,0.627,0.727,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3834,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 2 mg,,,,,4,,,,1.62,,,,,,1.53,1.64,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3835,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 0.5 mg,plasma,pediatric/adolescent,,,4,Estimated % absorbed,,,69.3,%,,,,,62.5,76.8,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3836,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 1 mg,,,,,3,,,,69.1,,,,,,61.7,71.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3837,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl 2 mg,,,,,4,,,,80.8,,,,,,76.4,81.6,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3838,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl,plasma,2-5 years,,,3,Concentration normalized to 0.5 mg dose,,,183,pg/ml,median,,,range,134,990,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3839,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl,plasma,6-19 years,,,7,Concentration normalized to 0.5 mg dose,,,151,,,,,,25.9,537.5,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3840,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl,plasma,2-5 years,,,3,mean dose children:adults,,,1.6,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3841,2025-12-02T15:56:56.518041
34784012.0,Fentanyl,fentanyl,plasma,6-19 years,,,7,mean dose children:adults,,,0.9,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Pk param (summary data),PKparam_summary,3842,2025-12-02T15:56:56.518041
26723196.0,pravastatin,pravastatin,plasma,maternal,2nd trimester,18-24 weeks,11.0,Cmax,,,14.9,ng/mL,mean,SD,11.3,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,2,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,3rd trimester,30-34 weeks,10.0,Cmax,,,11.1,ng/mL,mean,SD,6.2,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,3,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,Postpartum,4-6 months,9.0,Cmax,,,17.2,ng/mL,mean,SD,11.5,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,4,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,2nd trimester,18-24 weeks,11.0,Tmax,,,1.6,hr,mean,SD,0.6,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,5,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,3rd trimester,30-34 weeks,10.0,Tmax,,,1.5,hr,mean,SD,0.4,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,6,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,Postpartum,4-6 months,9.0,Tmax,,,1.6,hr,mean,SD,1.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,7,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,2nd trimester,18-24 weeks,11.0,Half-life apparent,,,2.1,hr,mean,SD,0.9,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,8,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,3rd trimester,30-34 weeks,10.0,Half-life apparent,,,3.0,hr,mean,SD,1.6,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,9,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,Postpartum,4-6 months,9.0,Half-life apparent,,,2.4,hr,mean,SD,1.3,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,10,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,2nd trimester,18-24 weeks,11.0,CL/F,,,396.0,L/hr,mean,SD,190.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,11,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,3rd trimester,30-34 weeks,10.0,CL/F,,,389.0,L/hr,mean,SD,215.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,12,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,Postpartum,4-6 months,9.0,CL/F,,,289.0,L/hr,mean,SD,142.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,13,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,2nd trimester,18-24 weeks,11.0,CL/F,,,4.6,L/hr/kg,mean,SD,2.4,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,14,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,3rd trimester,30-34 weeks,10.0,CL/F,,,4.2,L/hr/kg,mean,SD,2.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,15,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,Postpartum,4-6 months,9.0,CL/F,,,3.2,L/hr/kg,mean,SD,1.5,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,16,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,2nd trimester,18-24 weeks,11.0,AUC(024),,,31.0,ng/hr/mL,mean,SD,16.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,17,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,3rd trimester,30-34 weeks,10.0,AUC(024),,,32.0,ng/hr/mL,mean,SD,16.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,18,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,Postpartum,4-6 months,9.0,AUC(024),,,43.0,ng/hr/mL,mean,SD,20.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,19,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,2nd trimester,18-24 weeks,11.0,Amount excreted (024 hr),,,0.98,mg,mean,SD,0.6,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,20,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,3rd trimester,30-34 weeks,10.0,Amount excreted (024 hr),,,1.04,mg,mean,SD,0.57,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,21,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,Postpartum,4-6 months,9.0,Amount excreted (024 hr),,,0.93,mg,mean,SD,0.6,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,22,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,2nd trimester,18-24 weeks,11.0,Percent excreted unchanged,,,10.0,,mean,SD,6.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,23,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,3rd trimester,30-34 weeks,10.0,Percent excreted unchanged,,,10.0,,mean,SD,6.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,24,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,Postpartum,4-6 months,9.0,Percent excreted unchanged,,,9.0,,mean,SD,6.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,25,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,2nd trimester,18-24 weeks,11.0,CL Renal,,,34.0,L/hr,mean,SD,16.0,,,,<0.05,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,26,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,3rd trimester,30-34 weeks,10.0,CL Renal,,,34.0,L/hr,mean,SD,11.0,,,,<0.05,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,27,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,Postpartum,4-6 months,9.0,CL Renal,,,23.0,L/hr,mean,SD,4.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,28,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,2nd trimester,18-24 weeks,11.0,CL Secretion,,,480.0,mL/min,mean,SD,273.0,,,,<0.05,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,29,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,3rd trimester,30-34 weeks,10.0,CL Secretion,,,471.0,mL/min,mean,SD,151.0,,,,<0.05,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,30,2025-12-02T15:57:20.658398
26723196.0,pravastatin,pravastatin,plasma,maternal,Postpartum,4-6 months,9.0,CL Secretion,,,325.0,mL/min,mean,SD,65.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,31,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,2nd trimester,18-24 weeks,11.0,Cmax,,,19.7,ng/mL,arithmetic mean,SD,15.4,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,32,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,3rd trimester,30-34 weeks,10.0,Cmax,,,8.0,ng/mL,arithmetic mean,SD,5.9,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,33,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,Postpartum,4-6 months,9.0,Cmax,,,10.9,ng/mL,arithmetic mean,SD,7.2,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,34,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,2nd trimester,18-24 weeks,11.0,Tmax,,,1.3,h,arithmetic mean,SD,0.7,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,35,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,3rd trimester,30-34 weeks,10.0,Tmax,,,1.2,h,arithmetic mean,SD,0.5,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,36,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,Postpartum,4-6 months,9.0,Tmax,,,1.3,h,arithmetic mean,SD,0.8,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,37,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,2nd trimester,18-24 weeks,11.0,Half-life,,,1.3,h,arithmetic mean,SD,0.8,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,38,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,3rd trimester,30-34 weeks,10.0,Half-life,,,2.7,h,arithmetic mean,SD,1.6,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,39,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,Postpartum,4-6 months,9.0,Half-life,,,2.0,h,arithmetic mean,SD,1.2,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,40,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,2nd trimester,18-24 weeks,11.0,AUC(0-24h),,,27.0,ng/h/mL,arithmetic mean,SD,14.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,41,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,3rd trimester,30-34 weeks,10.0,AUC(0-24h),,,19.0,ng/h/mL,arithmetic mean,SD,11.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,42,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,Postpartum,4-6 months,9.0,AUC(0-24h),,,21.0,ng/h/mL,arithmetic mean,SD,12.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,43,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,2nd trimester,18-24 weeks,11.0,Metabolic ratio,,,1.0,,arithmetic mean,SD,0.7,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,44,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,3rd trimester,30-34 weeks,10.0,Metabolic ratio,,,0.6,,arithmetic mean,SD,0.3,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,45,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,Postpartum,4-6 months,9.0,Metabolic ratio,,,0.7,,arithmetic mean,SD,0.5,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,46,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,2nd trimester,18-24 weeks,11.0,Amount excreted(0-24 h),,,0.2,mg,arithmetic mean,SD,0.1,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,47,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,3rd trimester,30-34 weeks,10.0,Amount excreted(0-24 h),,,0.2,mg,arithmetic mean,SD,0.1,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,48,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,Postpartum,4-6 months,9.0,Amount excreted(0-24 h),,,0.2,mg,arithmetic mean,SD,0.1,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,49,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,2nd trimester,18-24 weeks,11.0,Percentage excreted as 3-isopravastatin,,,2.1,,arithmetic mean,SD,1.4,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,50,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,3rd trimester,30-34 weeks,10.0,Percentage excreted as 3-isopravastatin,,,1.5,,arithmetic mean,SD,1.4,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,51,2025-12-02T15:57:20.658398
26723196.0,pravastatin,3a-isopravastatin ,blood,maternal,Postpartum,4-6 months,9.0,Percentage excreted as 3-isopravastatin,,,1.7,,arithmetic mean,SD,1.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,52,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,concentration,0.0,hr,0.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,53,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,concentration,0.5,hr,358.4,ng/ml,mean,% CV,103.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,54,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,concentration,1.0,hr,484.6,ng/ml,mean,% CV,55.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,55,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,concentration,2.0,hr,185.5,ng/ml,mean,% CV,44.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,56,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,concentration,4.0,hr,85.1,ng/ml,mean,% CV,46.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,57,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,concentration,6.0,hr,46.9,ng/ml,mean,% CV,38.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,58,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,concentration,8.0,hr,30.2,ng/ml,mean,% CV,42.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,59,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,concentration,12.0,hr,17.6,ng/ml,mean,% CV,30.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,60,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,concentration,24.0,hr,7.4,ng/ml,mean,% CV,26.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,61,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,concentration,36.0,hr,2.0,ng/ml,mean,% CV,85.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,62,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,concentration,48.0,hr,1.0,ng/ml,mean,% CV,136.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,63,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,Cmax,,,485.0,ng/ml,mean,% CV,55.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,64,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,Tmax,,,0.8,hr,mean,% CV,36.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,65,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,AUC(48h),,,1435.0,ng/ml*h,mean,% CV,44.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,66,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,AUC(inf),,,1465.0,ng/ml*h,mean,% CV,43.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,67,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,t1/2alpha,,,0.9,hr,mean,% CV,27.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,68,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,plasma,maternal,lactation,,6.0,t1/2beta,,,8.2,hr,mean,% CV,29.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,69,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,concentration,0.0,hr,0.0,ng/ml,mean,% CV,,,,,,"Times shown are the midpoints of the collection intervals 0-2. 2-4, 4-6, 6-8, 8-12, 12-24, 24-36, and 36-48 hours",PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,70,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,concentration,1.0,hr,148.8,ng/ml,mean,% CV,57.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,71,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,concentration,3.0,hr,81.6,ng/ml,mean,% CV,50.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,72,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,concentration,5.0,hr,37.1,ng/ml,mean,% CV,46.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,73,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,concentration,7.0,hr,23.4,ng/ml,mean,% CV,38.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,74,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,concentration,10.0,hr,11.3,ng/ml,mean,% CV,29.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,75,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,concentration,18.0,hr,3.8,ng/ml,mean,% CV,28.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,76,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,concentration,30.0,hr,2.9,ng/ml,mean,% CV,33.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,77,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,concentration,42.0,hr,1.4,ng/ml,mean,% CV,66.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,78,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,Cmax,,,149.0,ng/ml,mean,% CV,57.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,79,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,Tmax,,,1.0,hr,mean,% CV,0.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,80,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk,maternal,lactation,,6.0,AUC(42h),,,663.0,ng/ml*h,mean,% CV,43.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,81,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk and maternal plasma,maternal,lactation,,6.0,milk:plasma Cmax ratio,,,0.3,,mean,% CV,50.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,82,2025-12-02T15:57:20.658398
2899094.0,dilevalol,unchanged dilevalol,breast milk and maternal plasma,maternal,lactation,,6.0,milk:plasma AUC ratio,,,0.46,,mean,% CV,17.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,83,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,concentration,0.0,hr,0.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,84,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,concentration,0.5,hr,828.3,ng/ml,mean,% CV,93.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,85,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,concentration,1.0,hr,2712.2,ng/ml,mean,% CV,43.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,86,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,concentration,2.0,hr,2684.1,ng/ml,mean,% CV,16.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,87,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,concentration,4.0,hr,1023.7,ng/ml,mean,% CV,15.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,88,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,concentration,6.0,hr,417.3,ng/ml,mean,% CV,17.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,89,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,concentration,8.0,hr,218.9,ng/ml,mean,% CV,21.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,90,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,concentration,12.0,hr,93.6,ng/ml,mean,% CV,23.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,91,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,concentration,24.0,hr,39.4,ng/ml,mean,% CV,27.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,92,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,concentration,36.0,hr,9.2,ng/ml,mean,% CV,71.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,93,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,concentration,48.0,hr,6.1,ng/ml,mean,% CV,82.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,94,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,Cmax,,,3067.0,ng/ml,mean,% CV,26.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,95,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,Tmax,,,1.5,hr,mean,% CV,36.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,96,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,plasma,maternal,lactation,,6.0,AUC(48h),,,11382.2,ng/ml*h,mean,% CV,17.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,97,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,concentration,0.0,hr,0.0,ng/ml,mean,% CV,,,,,,"Times shown are the midpoints of the collection intervals 0-2. 2-4, 4-6, 6-8, 8-12, 12-24, 24-36, and 36-48 hours",PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,98,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,concentration,1.0,hr,155.2,ng/ml,mean,% CV,54.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,99,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,concentration,3.0,hr,111.2,ng/ml,mean,% CV,46.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,100,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,concentration,5.0,hr,66.3,ng/ml,mean,% CV,24.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,101,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,concentration,7.0,hr,44.5,ng/ml,mean,% CV,25.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,102,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,concentration,10.0,hr,23.8,ng/ml,mean,% CV,12.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,103,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,concentration,18.0,hr,8.4,ng/ml,mean,% CV,45.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,104,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,concentration,30.0,hr,8.5,ng/ml,mean,% CV,53.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,105,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,concentration,42.0,hr,3.1,ng/ml,mean,% CV,77.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,106,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,Cmax,,,155.0,ng/ml,mean,% CV,54.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,107,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,Tmax,,,1.0,hr,mean,% CV,0.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,108,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk,maternal,lactation,,6.0,AUC(42h),,,1034.0,ng/ml*h,mean,% CV,266.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,109,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk and maternal plasma,maternal,lactation,,6.0,milk:plasma Cmax ratio,,,0.05,,mean,% CV,40.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,110,2025-12-02T15:57:20.658398
2899094.0,dilevalol,total dilevalol,breast milk and maternal plasma,maternal,lactation,,6.0,milk:plasma AUC ratio,,,0.09,,mean,% CV,22.0,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,111,2025-12-02T15:57:20.658398
2899094.0,dilevalol,dilevalol,breast milk,infant,lactation,,,maximum relative infant dose,,,0.04,%,,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,112,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,plasma,maternal,pregnancy,,4.0,concentration,,,64.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,113,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,plasma,maternal,pregnancy,,11.0,concentration,,,123.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,114,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,plasma,maternal,pregnancy,,6.0,concentration,,,135.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,115,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,plasma,maternal,pregnancy,,2.0,concentration,,,158.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,116,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,plasma,maternal,pregnancy,,1.0,concentration,,,174.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,117,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,plasma,maternal,pregnancy,,1.0,concentration,,,321.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,118,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,cord blood,fetal,delivery,,4.0,concentration,,,42.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,119,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,cord blood,fetal,delivery,,11.0,concentration,,,23.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,120,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,cord blood,fetal,delivery,,6.0,concentration,,,60.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,121,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,cord blood,fetal,delivery,,2.0,concentration,,,68.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,122,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,cord blood,fetal,delivery,,1.0,concentration,,,70.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,123,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,cord blood,fetal,delivery,,1.0,concentration,,,260.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,124,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,breast milk,maternal,lactation,3 days postpartum,4.0,concentration,3.0,day,29.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,125,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,breast milk,maternal,lactation,3 days postpartum,11.0,concentration,3.0,day,27.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,126,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,breast milk,maternal,lactation,3 days postpartum,6.0,concentration,3.0,day,39.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,127,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,breast milk,maternal,lactation,3 days postpartum,2.0,concentration,3.0,day,46.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,128,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,breast milk,maternal,lactation,3 days postpartum,1.0,concentration,3.0,day,43.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,129,2025-12-02T15:57:20.658398
26635169.0,labetalol,labetalol,breast milk,maternal,lactation,3 days postpartum,1.0,concentration,3.0,day,600.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,130,2025-12-02T15:57:20.658398
18507654.0,Domperidone 30mg,Domperidone,breast milk,maternal,lactation,,6.0,concentration,,,0.28,ug/l,Median,,,IQR,0.24,,0.43,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,131,2025-12-02T15:57:20.658398
18507654.0,Domperidone 60mg,Domperidone,breast milk,maternal,lactation,,5.0,concentration,,,0.49,ug/l,Median,,,IQR,0.33,,0.72,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,132,2025-12-02T15:57:20.658398
18507654.0,Domperidone 30mg,Domperidone,breast milk,infant,lactation,,6.0,Absolute infant dose,,,0.04,ug/kg/day,Median,,,IQR,0.03,,0.07,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,133,2025-12-02T15:57:20.658398
18507654.0,Domperidone 60mg,Domperidone,breast milk,infant,lactation,,5.0,Absolute infant dose,,,0.07,ug/kg/day,Median,,,IQR,0.05,,0.11,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,134,2025-12-02T15:57:20.658398
18507654.0,Domperidone 30mg,Domperidone,breast milk,infant,lactation,,6.0,Relative infant dose,,,0.012,%,Median,,,IQR,0.009,,0.014,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,135,2025-12-02T15:57:20.658398
18507654.0,Domperidone 60mg,Domperidone,breast milk,infant,lactation,,5.0,Relative infant dose,,,0.009,%,Median,,,IQR,0.006,,0.012,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,136,2025-12-02T15:57:20.658398
3882143.0,Domperidone 20 mg single dose,Domperidone,serum,maternal,lactation,early postpartum,5.0,concentration,2.0,hours,8.0,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,137,2025-12-02T15:57:20.658398
3882143.0,Domperidone 20 mg single dose,Domperidone,breast milk,maternal,lactation,early postpartum,5.0,concentration,2.0,hours,0.24,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,138,2025-12-02T15:57:20.658398
3882143.0,Domperidone 20 mg single dose,Domperidone,breast milk,maternal,lactation,early postpartum,5.0,concentration per 10 mg of drug taken,2.0,hours,0.12,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,139,2025-12-02T15:57:20.658398
3882143.0,Domperidone 20 mg single dose,Domperidone,breast milk and serum,maternal,lactation,early postpartum,5.0,milk:plasma ratio,2.0,hours,0.03,,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,140,2025-12-02T15:57:20.658398
3882143.0,Domperidone 20 mg single dose,Domperidone,breast milk,maternal,lactation,early postpartum,5.0,concentration,4.0,hours,1.1,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,141,2025-12-02T15:57:20.658398
3882143.0,Domperidone 20 mg single dose,Domperidone,breast milk,maternal,lactation,early postpartum,5.0,concentration per 10 mg of drug taken,4.0,hours,0.6,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,142,2025-12-02T15:57:20.658398
3882143.0,domperidone 10 mg tid,Domperidone,breast milk,maternal,lactation,1-3 month postpartum,4.0,concentration,,,2.3,ng/ml,mean,,,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,143,2025-12-02T15:57:20.658398
37565541.0,lemborexant,lemborexant,breast milk,maternal,lactation,,8.0,cumulative total excretion,,,0.0174,mg,mean,% CV,54.5,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,144,2025-12-02T15:57:20.658398
37565541.0,lemborexant,lemborexant,breast milk,maternal,lactation,,8.0,fractional dose excreted,,,0.174,%,mean,% CV,54.5,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,145,2025-12-02T15:57:20.658398
37565541.0,lemborexant,lemborexant,breast milk,maternal,lactation,,8.0,daily infant dose,,,0.0029,mg/kg,mean,% CV,54.5,,,,,,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,146,2025-12-02T15:57:20.658398
37565541.0,lemborexant,lemborexant,breast milk,maternal,lactation,,8.0,relative infant dose,,,1.96,%,mean,% CV,63.1,,,,,percentage of mothers weight-adjusted dose,PRGLAC PK curations_AS.xlsx,Aditi,Pk param (summary data),PKparam_summary,147,2025-12-02T15:57:20.658398
16433870.0,Fluoxetine,RFX,serum,maternal,3rd trimester,,9.0,concentration,,,20,g/l,mean,,,95% CI,7.3,32.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,951,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SFX,serum,maternal,3rd trimester,,9.0,concentration,,,41,g/l,mean,,,95% CI,13.7,68.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,952,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,FX,serum,maternal,3rd trimester,,9.0,concentration,,,61,g/l,mean,,,95% CI,21.3,100.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,953,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S/R FX,serum,maternal,3rd trimester,,9.0,S:R concentration ratio,,,1.93,,mean,,,95% CI,1.47,2.39,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,954,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RFX,serum,maternal,Delivery,,9.0,concentration,,,10.9,g/l,mean,,,95% CI,6.3,15.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,955,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SFX,serum,maternal,Delivery,,9.0,concentration,,,27.7,g/l,mean,,,95% CI,8.4,47,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,956,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,FX,serum,maternal,Delivery,,9.0,concentration,,,38.5,g/l,mean,,,95% CI,15.1,62.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,957,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S/R FX,serum,maternal,Delivery,,9.0,concentration ratio,,,2.06,,mean,,,95% CI,1.31,2.82,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,958,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,8.9,g/l,mean,,,95% CI,5.2,12.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,959,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,32.4,g/l,mean,,,95% CI,11.6,53.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,960,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,FX,umbilical serum,pediatric,,fetus,9.0,concentration,,,41.3,g/l,mean,,,95% CI,16.9,59.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,961,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S/R FX,umbilical serum,pediatric,,fetus,9.0,concentration ratio,,,3.01,,mean,,,95% CI,2.05,3.97,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,962,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RFX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,0.84,,mean,,,95% CI,0.61,1.07,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,963,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SFX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,1.11,,mean,,,95% CI,0.95,1.27,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,964,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,FX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,0.91,,mean,,,95% CI,0.6,1.02,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,965,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,9,g/l,mean,,,95% CI,4.7,13.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,966,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,31.3,g/l,mean,,,95% CI,14.6,48,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,967,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,FX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,36.4,g/l,mean,,,95% CI,16.7,56,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,968,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S/R FX,serum,pediatric,,newborn,9.0,S:R concentration ratio,,,3.24,,mean,,,95% CI,2.2,4.39,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,969,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RFX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,0.99,,mean,,,95% CI,0.78,1.19,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,970,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SFX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.01,,mean,,,95% CI,0.72,1.29,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,971,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,FX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.01,,mean,,,95% CI,0.79,1.23,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,972,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RNFX,serum,maternal,3rd trimester,,9.0,concentration,,,32.6,g/l,mean,,,95% CI,19.8,1.19,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,973,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SNFX,serum,maternal,3rd trimester,,9.0,concentration,,,80.6,g/l,mean,,,95% CI,41.8,119.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,974,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,NFX,serum,maternal,3rd trimester,,9.0,concentration,,,113.1,g/l,mean,,,95% CI,63.5,162.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,975,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S/R NFX,serum,maternal,3rd trimester,,9.0,S:R concentration ratio,,,2.48,,mean,,,95% CI,1.75,3.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,976,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RNFX,serum,maternal,Delivery,,9.0,concentration,,,22.4,g/l,mean,,,95% CI,15.8,29,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,977,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SNFX,serum,maternal,Delivery,,9.0,concentration,,,52.2,g/l,mean,,,95% CI,24.4,80,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,978,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,NFX,serum,maternal,Delivery,,9.0,concentration,,,74.6,g/l,mean,,,95% CI,41.7,107.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,979,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S/R NFX,serum,maternal,Delivery,,9.0,S:R concentration ratio,,,2.2,,mean,,,95% CI,1.45,2.96,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,980,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RNFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,17.5,g/l,mean,,,95% CI,13.5,21.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,981,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SNFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,61,g/l,mean,,,95% CI,27.3,94.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,982,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,NFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,78.5,g/l,mean,,,95% CI,42.3,114.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,983,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S/R NFX,umbilical serum,pediatric,,fetus,9.0,S:R concentration ratio,,,3.25,,mean,,,95% CI,1.86,4.84,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,984,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RNFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,0.84,,mean,,,95% CI,0.71,0.97,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,985,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SNFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,1.15,,mean,,,95% CI,1.06,1.25,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,986,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,NFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,1.04,,mean,,,95% CI,0.93,1.15,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,987,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RNFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,22.7,g/l,mean,,,95% CI,17.7,27.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,988,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SNFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,71.7,g/l,mean,,,95% CI,39.3,104.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,989,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,NFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,94.4,g/l,mean,,,95% CI,57.3,131.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,990,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S/R NFX,serum,pediatric,,newborn,9.0,concentration ratio,,,2.9,,mean,,,95% CI,2.06,3.75,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,991,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RNFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.28,,mean,,,95% CI,1.1,1.47,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,992,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SNFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.21,,mean,,,95% CI,0.98,1.44,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,993,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,NFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.23,,mean,,,95% CI,1.04,1.41,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,994,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RFX,serum,maternal,postpartum,,30.0,concentration,,,32.4,g/l,mean,,,95% CI,24.3,40.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,995,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SFX,serum,maternal,postpartum,,30.0,concentration,,,100.5,g/l,mean,,,95% CI,69.3,131.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,996,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,FX,serum,maternal,postpartum,,30.0,concentration,,,132.9,g/l,mean,,,95% CI,94.9,171,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,997,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S : R FX,serum,maternal,postpartum,,30.0,S:R concentration ratio,,,2.91,,mean,,,95% CI,2.46,3.36,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,998,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,concentration,,,26.8,g/l,mean,,,95% CI,17.8,35.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,999,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,concentration,,,50.4,g/l,mean,,,95% CI,33.7,67.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1000,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,concentration,,,77.2,g/l,mean,,,95% CI,52.1,102.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1001,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S/R FX,breast milk,maternal,lactation,,30.0,S:R concentration ratio,,,1.92,,mean,,,95% CI,1.66,2.19,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1002,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RFX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.84,,mean,,,95% CI,0.67,1.01,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1003,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SFX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.54,,mean,,,95% CI,0.45,0.64,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1004,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,FX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.62,,mean,,,95% CI,0.5,0.73,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1005,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,infant dose,,,0.54,g/kg/day,mean,,,95% CI,0.37,0.71,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1006,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.02,g/kg/day,mean,,,95% CI,0.69,1.35,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1007,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,infant dose,,,1.56,g/kg/day,mean,,,95% CI,1.08,2.04,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1008,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.34,%,mean,,,95% CI,0.23,0.45,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1009,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.63,%,mean,,,95% CI,0.44,0.81,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1010,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.54,%,mean,,,95% CI,0.37,0.71,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1011,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RNFX,serum,maternal,postpartum,,30.0,concentration,,,42.3,g/l,mean,,,95% CI,31.6,53.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1012,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SNFX,serum,maternal,postpartum,,30.0,concentration,,,109.3,g/l,mean,,,95% CI,81.4,137.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1013,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,NFX,serum,maternal,postpartum,,30.0,concentration,,,151.6,g/l,mean,,,95% CI,114.7,188.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1014,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S/R NFX,serum,maternal,postpartum,,30.0,S:R concentration ratio,,,2.78,,mean,,,95% CI,2.28,3.27,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1015,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,concentration,,,32.3,g/l,mean,,,95% CI,22.7,41.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1016,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,concentration,,,49,g/l,mean,,,95% CI,36.9,61.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1017,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,concentration,,,81.3,g/l,mean,,,95% CI,60.6,101.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1018,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,S/R NFX,breast milk,maternal,lactation,,30.0,S:R concentration ratio,,,1.86,,mean,,,95% CI,1.53,2.19,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1019,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RNFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.75,,mean,,,95% CI,0.68,0.86,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1020,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SNFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.55,,mean,,,95% CI,0.44,0.67,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1021,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,NFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.6,,mean,,,95% CI,0.5,0.71,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1022,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,infant dose,,,0.68,g/kg/day,mean,,,95% CI,0.46,0.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1023,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.03,g/kg/day,mean,,,95% CI,0.72,1.33,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1024,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.69,g/kg/day,mean,,,95% CI,1.18,2.21,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1025,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.43,%,mean,,,95% CI,0.3,0.56,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1026,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.71,%,mean,,,95% CI,0.5,0.92,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1027,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.57,%,mean,,,95% CI,0.41,0.57,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1028,2025-12-02T16:05:09.448543
16433870.0,Fluoxetine,RFX,serum,maternal,3rd trimester,,9.0,concentration,,,20,g/l,mean,,,95% CI,7.3,32.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,951,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SFX,serum,maternal,3rd trimester,,9.0,concentration,,,41,g/l,mean,,,95% CI,13.7,68.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,952,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,FX,serum,maternal,3rd trimester,,9.0,concentration,,,61,g/l,mean,,,95% CI,21.3,100.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,953,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S/R FX,serum,maternal,3rd trimester,,9.0,S:R concentration ratio,,,1.93,,mean,,,95% CI,1.47,2.39,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,954,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RFX,serum,maternal,Delivery,,9.0,concentration,,,10.9,g/l,mean,,,95% CI,6.3,15.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,955,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SFX,serum,maternal,Delivery,,9.0,concentration,,,27.7,g/l,mean,,,95% CI,8.4,47,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,956,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,FX,serum,maternal,Delivery,,9.0,concentration,,,38.5,g/l,mean,,,95% CI,15.1,62.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,957,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S/R FX,serum,maternal,Delivery,,9.0,concentration ratio,,,2.06,,mean,,,95% CI,1.31,2.82,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,958,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,8.9,g/l,mean,,,95% CI,5.2,12.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,959,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,32.4,g/l,mean,,,95% CI,11.6,53.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,960,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,FX,umbilical serum,pediatric,,fetus,9.0,concentration,,,41.3,g/l,mean,,,95% CI,16.9,59.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,961,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S/R FX,umbilical serum,pediatric,,fetus,9.0,concentration ratio,,,3.01,,mean,,,95% CI,2.05,3.97,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,962,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RFX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,0.84,,mean,,,95% CI,0.61,1.07,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,963,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SFX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,1.11,,mean,,,95% CI,0.95,1.27,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,964,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,FX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,0.91,,mean,,,95% CI,0.6,1.02,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,965,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,9,g/l,mean,,,95% CI,4.7,13.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,966,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,31.3,g/l,mean,,,95% CI,14.6,48,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,967,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,FX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,36.4,g/l,mean,,,95% CI,16.7,56,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,968,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S/R FX,serum,pediatric,,newborn,9.0,S:R concentration ratio,,,3.24,,mean,,,95% CI,2.2,4.39,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,969,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RFX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,0.99,,mean,,,95% CI,0.78,1.19,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,970,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SFX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.01,,mean,,,95% CI,0.72,1.29,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,971,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,FX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.01,,mean,,,95% CI,0.79,1.23,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,972,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RNFX,serum,maternal,3rd trimester,,9.0,concentration,,,32.6,g/l,mean,,,95% CI,19.8,1.19,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,973,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SNFX,serum,maternal,3rd trimester,,9.0,concentration,,,80.6,g/l,mean,,,95% CI,41.8,119.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,974,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,NFX,serum,maternal,3rd trimester,,9.0,concentration,,,113.1,g/l,mean,,,95% CI,63.5,162.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,975,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S/R NFX,serum,maternal,3rd trimester,,9.0,S:R concentration ratio,,,2.48,,mean,,,95% CI,1.75,3.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,976,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RNFX,serum,maternal,Delivery,,9.0,concentration,,,22.4,g/l,mean,,,95% CI,15.8,29,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,977,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SNFX,serum,maternal,Delivery,,9.0,concentration,,,52.2,g/l,mean,,,95% CI,24.4,80,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,978,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,NFX,serum,maternal,Delivery,,9.0,concentration,,,74.6,g/l,mean,,,95% CI,41.7,107.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,979,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S/R NFX,serum,maternal,Delivery,,9.0,S:R concentration ratio,,,2.2,,mean,,,95% CI,1.45,2.96,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,980,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RNFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,17.5,g/l,mean,,,95% CI,13.5,21.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,981,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SNFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,61,g/l,mean,,,95% CI,27.3,94.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,982,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,NFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,78.5,g/l,mean,,,95% CI,42.3,114.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,983,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S/R NFX,umbilical serum,pediatric,,fetus,9.0,S:R concentration ratio,,,3.25,,mean,,,95% CI,1.86,4.84,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,984,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RNFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,0.84,,mean,,,95% CI,0.71,0.97,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,985,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SNFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,1.15,,mean,,,95% CI,1.06,1.25,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,986,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,NFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,1.04,,mean,,,95% CI,0.93,1.15,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,987,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RNFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,22.7,g/l,mean,,,95% CI,17.7,27.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,988,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SNFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,71.7,g/l,mean,,,95% CI,39.3,104.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,989,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,NFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,94.4,g/l,mean,,,95% CI,57.3,131.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,990,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S/R NFX,serum,pediatric,,newborn,9.0,concentration ratio,,,2.9,,mean,,,95% CI,2.06,3.75,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,991,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RNFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.28,,mean,,,95% CI,1.1,1.47,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,992,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SNFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.21,,mean,,,95% CI,0.98,1.44,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,993,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,NFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.23,,mean,,,95% CI,1.04,1.41,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,994,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RFX,serum,maternal,postpartum,,30.0,concentration,,,32.4,g/l,mean,,,95% CI,24.3,40.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,995,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SFX,serum,maternal,postpartum,,30.0,concentration,,,100.5,g/l,mean,,,95% CI,69.3,131.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,996,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,FX,serum,maternal,postpartum,,30.0,concentration,,,132.9,g/l,mean,,,95% CI,94.9,171,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,997,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S : R FX,serum,maternal,postpartum,,30.0,S:R concentration ratio,,,2.91,,mean,,,95% CI,2.46,3.36,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,998,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,concentration,,,26.8,g/l,mean,,,95% CI,17.8,35.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,999,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,concentration,,,50.4,g/l,mean,,,95% CI,33.7,67.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1000,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,concentration,,,77.2,g/l,mean,,,95% CI,52.1,102.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1001,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S/R FX,breast milk,maternal,lactation,,30.0,S:R concentration ratio,,,1.92,,mean,,,95% CI,1.66,2.19,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1002,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RFX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.84,,mean,,,95% CI,0.67,1.01,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1003,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SFX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.54,,mean,,,95% CI,0.45,0.64,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1004,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,FX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.62,,mean,,,95% CI,0.5,0.73,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1005,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,infant dose,,,0.54,g/kg/day,mean,,,95% CI,0.37,0.71,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1006,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.02,g/kg/day,mean,,,95% CI,0.69,1.35,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1007,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,infant dose,,,1.56,g/kg/day,mean,,,95% CI,1.08,2.04,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1008,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.34,%,mean,,,95% CI,0.23,0.45,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1009,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.63,%,mean,,,95% CI,0.44,0.81,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1010,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.54,%,mean,,,95% CI,0.37,0.71,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1011,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RNFX,serum,maternal,postpartum,,30.0,concentration,,,42.3,g/l,mean,,,95% CI,31.6,53.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1012,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SNFX,serum,maternal,postpartum,,30.0,concentration,,,109.3,g/l,mean,,,95% CI,81.4,137.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1013,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,NFX,serum,maternal,postpartum,,30.0,concentration,,,151.6,g/l,mean,,,95% CI,114.7,188.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1014,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S/R NFX,serum,maternal,postpartum,,30.0,S:R concentration ratio,,,2.78,,mean,,,95% CI,2.28,3.27,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1015,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,concentration,,,32.3,g/l,mean,,,95% CI,22.7,41.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1016,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,concentration,,,49,g/l,mean,,,95% CI,36.9,61.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1017,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,concentration,,,81.3,g/l,mean,,,95% CI,60.6,101.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1018,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,S/R NFX,breast milk,maternal,lactation,,30.0,S:R concentration ratio,,,1.86,,mean,,,95% CI,1.53,2.19,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1019,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RNFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.75,,mean,,,95% CI,0.68,0.86,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1020,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SNFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.55,,mean,,,95% CI,0.44,0.67,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1021,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,NFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.6,,mean,,,95% CI,0.5,0.71,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1022,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,infant dose,,,0.68,g/kg/day,mean,,,95% CI,0.46,0.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1023,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.03,g/kg/day,mean,,,95% CI,0.72,1.33,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1024,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.69,g/kg/day,mean,,,95% CI,1.18,2.21,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1025,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.43,%,mean,,,95% CI,0.3,0.56,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1026,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.71,%,mean,,,95% CI,0.5,0.92,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1027,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.57,%,mean,,,95% CI,0.41,0.57,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1028,2025-12-02T16:05:12.001940
16433870.0,Fluoxetine,RFX,serum,maternal,3rd trimester,,9.0,concentration,,,20,g/l,mean,,,95% CI,7.3,32.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,945,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SFX,serum,maternal,3rd trimester,,9.0,concentration,,,41,g/l,mean,,,95% CI,13.7,68.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,946,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,FX,serum,maternal,3rd trimester,,9.0,concentration,,,61,g/l,mean,,,95% CI,21.3,100.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,947,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S/R FX,serum,maternal,3rd trimester,,9.0,S:R concentration ratio,,,1.93,,mean,,,95% CI,1.47,2.39,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,948,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RFX,serum,maternal,Delivery,,9.0,concentration,,,10.9,g/l,mean,,,95% CI,6.3,15.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,949,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SFX,serum,maternal,Delivery,,9.0,concentration,,,27.7,g/l,mean,,,95% CI,8.4,47,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,950,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,FX,serum,maternal,Delivery,,9.0,concentration,,,38.5,g/l,mean,,,95% CI,15.1,62.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,951,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S/R FX,serum,maternal,Delivery,,9.0,concentration ratio,,,2.06,,mean,,,95% CI,1.31,2.82,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,952,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,8.9,g/l,mean,,,95% CI,5.2,12.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,953,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,32.4,g/l,mean,,,95% CI,11.6,53.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,954,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,FX,umbilical serum,pediatric,,fetus,9.0,concentration,,,41.3,g/l,mean,,,95% CI,16.9,59.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,955,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S/R FX,umbilical serum,pediatric,,fetus,9.0,concentration ratio,,,3.01,,mean,,,95% CI,2.05,3.97,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,956,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RFX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,0.84,,mean,,,95% CI,0.61,1.07,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,957,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SFX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,1.11,,mean,,,95% CI,0.95,1.27,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,958,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,FX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,0.91,,mean,,,95% CI,0.6,1.02,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,959,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,9,g/l,mean,,,95% CI,4.7,13.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,960,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,31.3,g/l,mean,,,95% CI,14.6,48,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,961,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,FX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,36.4,g/l,mean,,,95% CI,16.7,56,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,962,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S/R FX,serum,pediatric,,newborn,9.0,S:R concentration ratio,,,3.24,,mean,,,95% CI,2.2,4.39,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,963,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RFX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,0.99,,mean,,,95% CI,0.78,1.19,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,964,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SFX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.01,,mean,,,95% CI,0.72,1.29,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,965,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,FX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.01,,mean,,,95% CI,0.79,1.23,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,966,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RNFX,serum,maternal,3rd trimester,,9.0,concentration,,,32.6,g/l,mean,,,95% CI,19.8,1.19,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,967,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SNFX,serum,maternal,3rd trimester,,9.0,concentration,,,80.6,g/l,mean,,,95% CI,41.8,119.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,968,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,NFX,serum,maternal,3rd trimester,,9.0,concentration,,,113.1,g/l,mean,,,95% CI,63.5,162.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,969,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S/R NFX,serum,maternal,3rd trimester,,9.0,S:R concentration ratio,,,2.48,,mean,,,95% CI,1.75,3.2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,970,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RNFX,serum,maternal,Delivery,,9.0,concentration,,,22.4,g/l,mean,,,95% CI,15.8,29,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,971,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SNFX,serum,maternal,Delivery,,9.0,concentration,,,52.2,g/l,mean,,,95% CI,24.4,80,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,972,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,NFX,serum,maternal,Delivery,,9.0,concentration,,,74.6,g/l,mean,,,95% CI,41.7,107.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,973,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S/R NFX,serum,maternal,Delivery,,9.0,S:R concentration ratio,,,2.2,,mean,,,95% CI,1.45,2.96,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,974,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RNFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,17.5,g/l,mean,,,95% CI,13.5,21.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,975,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SNFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,61,g/l,mean,,,95% CI,27.3,94.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,976,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,NFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,78.5,g/l,mean,,,95% CI,42.3,114.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,977,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S/R NFX,umbilical serum,pediatric,,fetus,9.0,S:R concentration ratio,,,3.25,,mean,,,95% CI,1.86,4.84,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,978,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RNFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,0.84,,mean,,,95% CI,0.71,0.97,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,979,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SNFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,1.15,,mean,,,95% CI,1.06,1.25,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,980,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,NFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,1.04,,mean,,,95% CI,0.93,1.15,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,981,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RNFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,22.7,g/l,mean,,,95% CI,17.7,27.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,982,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SNFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,71.7,g/l,mean,,,95% CI,39.3,104.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,983,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,NFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,94.4,g/l,mean,,,95% CI,57.3,131.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,984,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S/R NFX,serum,pediatric,,newborn,9.0,concentration ratio,,,2.9,,mean,,,95% CI,2.06,3.75,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,985,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RNFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.28,,mean,,,95% CI,1.1,1.47,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,986,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SNFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.21,,mean,,,95% CI,0.98,1.44,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,987,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,NFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.23,,mean,,,95% CI,1.04,1.41,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,988,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RFX,serum,maternal,postpartum,,30.0,concentration,,,32.4,g/l,mean,,,95% CI,24.3,40.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,989,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SFX,serum,maternal,postpartum,,30.0,concentration,,,100.5,g/l,mean,,,95% CI,69.3,131.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,990,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,FX,serum,maternal,postpartum,,30.0,concentration,,,132.9,g/l,mean,,,95% CI,94.9,171,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,991,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S : R FX,serum,maternal,postpartum,,30.0,S:R concentration ratio,,,2.91,,mean,,,95% CI,2.46,3.36,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,992,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,concentration,,,26.8,g/l,mean,,,95% CI,17.8,35.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,993,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,concentration,,,50.4,g/l,mean,,,95% CI,33.7,67.2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,994,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,concentration,,,77.2,g/l,mean,,,95% CI,52.1,102.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,995,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S/R FX,breast milk,maternal,lactation,,30.0,S:R concentration ratio,,,1.92,,mean,,,95% CI,1.66,2.19,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,996,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RFX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.84,,mean,,,95% CI,0.67,1.01,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,997,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SFX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.54,,mean,,,95% CI,0.45,0.64,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,998,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,FX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.62,,mean,,,95% CI,0.5,0.73,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,999,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,infant dose,,,0.54,g/kg/day,mean,,,95% CI,0.37,0.71,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1000,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.02,g/kg/day,mean,,,95% CI,0.69,1.35,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1001,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,infant dose,,,1.56,g/kg/day,mean,,,95% CI,1.08,2.04,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1002,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.34,%,mean,,,95% CI,0.23,0.45,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1003,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.63,%,mean,,,95% CI,0.44,0.81,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1004,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.54,%,mean,,,95% CI,0.37,0.71,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1005,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RNFX,serum,maternal,postpartum,,30.0,concentration,,,42.3,g/l,mean,,,95% CI,31.6,53.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1006,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SNFX,serum,maternal,postpartum,,30.0,concentration,,,109.3,g/l,mean,,,95% CI,81.4,137.2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1007,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,NFX,serum,maternal,postpartum,,30.0,concentration,,,151.6,g/l,mean,,,95% CI,114.7,188.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1008,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S/R NFX,serum,maternal,postpartum,,30.0,S:R concentration ratio,,,2.78,,mean,,,95% CI,2.28,3.27,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1009,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,concentration,,,32.3,g/l,mean,,,95% CI,22.7,41.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1010,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,concentration,,,49,g/l,mean,,,95% CI,36.9,61.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1011,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,concentration,,,81.3,g/l,mean,,,95% CI,60.6,101.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1012,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,S/R NFX,breast milk,maternal,lactation,,30.0,S:R concentration ratio,,,1.86,,mean,,,95% CI,1.53,2.19,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1013,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RNFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.75,,mean,,,95% CI,0.68,0.86,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1014,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SNFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.55,,mean,,,95% CI,0.44,0.67,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1015,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,NFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.6,,mean,,,95% CI,0.5,0.71,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1016,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,infant dose,,,0.68,g/kg/day,mean,,,95% CI,0.46,0.9,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1017,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.03,g/kg/day,mean,,,95% CI,0.72,1.33,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1018,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.69,g/kg/day,mean,,,95% CI,1.18,2.21,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1019,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.43,%,mean,,,95% CI,0.3,0.56,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1020,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.71,%,mean,,,95% CI,0.5,0.92,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1021,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.57,%,mean,,,95% CI,0.41,0.57,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1022,2025-12-02T16:05:15.923463
16433870.0,Fluoxetine,RFX,serum,maternal,3rd trimester,,9.0,concentration,,,20,g/l,mean,,,95% CI,7.3,32.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,945,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SFX,serum,maternal,3rd trimester,,9.0,concentration,,,41,g/l,mean,,,95% CI,13.7,68.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,946,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,FX,serum,maternal,3rd trimester,,9.0,concentration,,,61,g/l,mean,,,95% CI,21.3,100.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,947,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S/R FX,serum,maternal,3rd trimester,,9.0,S:R concentration ratio,,,1.93,,mean,,,95% CI,1.47,2.39,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,948,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RFX,serum,maternal,Delivery,,9.0,concentration,,,10.9,g/l,mean,,,95% CI,6.3,15.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,949,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SFX,serum,maternal,Delivery,,9.0,concentration,,,27.7,g/l,mean,,,95% CI,8.4,47,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,950,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,FX,serum,maternal,Delivery,,9.0,concentration,,,38.5,g/l,mean,,,95% CI,15.1,62.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,951,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S/R FX,serum,maternal,Delivery,,9.0,concentration ratio,,,2.06,,mean,,,95% CI,1.31,2.82,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,952,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,8.9,g/l,mean,,,95% CI,5.2,12.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,953,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,32.4,g/l,mean,,,95% CI,11.6,53.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,954,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,FX,umbilical serum,pediatric,,fetus,9.0,concentration,,,41.3,g/l,mean,,,95% CI,16.9,59.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,955,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S/R FX,umbilical serum,pediatric,,fetus,9.0,concentration ratio,,,3.01,,mean,,,95% CI,2.05,3.97,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,956,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RFX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,0.84,,mean,,,95% CI,0.61,1.07,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,957,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SFX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,1.11,,mean,,,95% CI,0.95,1.27,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,958,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,FX,umbilical serum/maternal serum,maternal/pediatric,Delivery,fetus,9.0,F: M concentration ratio,,,0.91,,mean,,,95% CI,0.6,1.02,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,959,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,9,g/l,mean,,,95% CI,4.7,13.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,960,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,31.3,g/l,mean,,,95% CI,14.6,48,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,961,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,FX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,36.4,g/l,mean,,,95% CI,16.7,56,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,962,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S/R FX,serum,pediatric,,newborn,9.0,S:R concentration ratio,,,3.24,,mean,,,95% CI,2.2,4.39,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,963,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RFX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,0.99,,mean,,,95% CI,0.78,1.19,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,964,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SFX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.01,,mean,,,95% CI,0.72,1.29,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,965,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,FX,umbilical serum/serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.01,,mean,,,95% CI,0.79,1.23,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,966,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RNFX,serum,maternal,3rd trimester,,9.0,concentration,,,32.6,g/l,mean,,,95% CI,19.8,1.19,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,967,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SNFX,serum,maternal,3rd trimester,,9.0,concentration,,,80.6,g/l,mean,,,95% CI,41.8,119.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,968,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,NFX,serum,maternal,3rd trimester,,9.0,concentration,,,113.1,g/l,mean,,,95% CI,63.5,162.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,969,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S/R NFX,serum,maternal,3rd trimester,,9.0,S:R concentration ratio,,,2.48,,mean,,,95% CI,1.75,3.2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,970,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RNFX,serum,maternal,Delivery,,9.0,concentration,,,22.4,g/l,mean,,,95% CI,15.8,29,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,971,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SNFX,serum,maternal,Delivery,,9.0,concentration,,,52.2,g/l,mean,,,95% CI,24.4,80,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,972,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,NFX,serum,maternal,Delivery,,9.0,concentration,,,74.6,g/l,mean,,,95% CI,41.7,107.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,973,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S/R NFX,serum,maternal,Delivery,,9.0,S:R concentration ratio,,,2.2,,mean,,,95% CI,1.45,2.96,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,974,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RNFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,17.5,g/l,mean,,,95% CI,13.5,21.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,975,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SNFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,61,g/l,mean,,,95% CI,27.3,94.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,976,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,NFX,umbilical serum,pediatric,,fetus,9.0,concentration,,,78.5,g/l,mean,,,95% CI,42.3,114.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,977,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S/R NFX,umbilical serum,pediatric,,fetus,9.0,S:R concentration ratio,,,3.25,,mean,,,95% CI,1.86,4.84,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,978,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RNFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,0.84,,mean,,,95% CI,0.71,0.97,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,979,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SNFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,1.15,,mean,,,95% CI,1.06,1.25,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,980,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,NFX,umbilical serum,pediatric,,fetus,9.0,F: M concentration ratio,,,1.04,,mean,,,95% CI,0.93,1.15,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,981,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RNFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,22.7,g/l,mean,,,95% CI,17.7,27.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,982,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SNFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,71.7,g/l,mean,,,95% CI,39.3,104.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,983,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,NFX,serum,pediatric,,newborn,9.0,concentration,48 h after birth,,94.4,g/l,mean,,,95% CI,57.3,131.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,984,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S/R NFX,serum,pediatric,,newborn,9.0,concentration ratio,,,2.9,,mean,,,95% CI,2.06,3.75,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,985,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RNFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.28,,mean,,,95% CI,1.1,1.47,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,986,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SNFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.21,,mean,,,95% CI,0.98,1.44,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,987,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,NFX,serum/umbilical serum,pediatric,,newborn/fetus,9.0,infant : foetus concentration ratio,,,1.23,,mean,,,95% CI,1.04,1.41,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,988,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RFX,serum,maternal,postpartum,,30.0,concentration,,,32.4,g/l,mean,,,95% CI,24.3,40.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,989,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SFX,serum,maternal,postpartum,,30.0,concentration,,,100.5,g/l,mean,,,95% CI,69.3,131.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,990,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,FX,serum,maternal,postpartum,,30.0,concentration,,,132.9,g/l,mean,,,95% CI,94.9,171,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,991,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S : R FX,serum,maternal,postpartum,,30.0,S:R concentration ratio,,,2.91,,mean,,,95% CI,2.46,3.36,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,992,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,concentration,,,26.8,g/l,mean,,,95% CI,17.8,35.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,993,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,concentration,,,50.4,g/l,mean,,,95% CI,33.7,67.2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,994,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,concentration,,,77.2,g/l,mean,,,95% CI,52.1,102.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,995,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S/R FX,breast milk,maternal,lactation,,30.0,S:R concentration ratio,,,1.92,,mean,,,95% CI,1.66,2.19,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,996,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RFX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.84,,mean,,,95% CI,0.67,1.01,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,997,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SFX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.54,,mean,,,95% CI,0.45,0.64,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,998,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,FX,milk : serum ratio,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.62,,mean,,,95% CI,0.5,0.73,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,999,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,infant dose,,,0.54,g/kg/day,mean,,,95% CI,0.37,0.71,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1000,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.02,g/kg/day,mean,,,95% CI,0.69,1.35,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1001,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,infant dose,,,1.56,g/kg/day,mean,,,95% CI,1.08,2.04,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1002,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.34,%,mean,,,95% CI,0.23,0.45,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1003,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.63,%,mean,,,95% CI,0.44,0.81,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1004,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,FX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.54,%,mean,,,95% CI,0.37,0.71,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1005,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RNFX,serum,maternal,postpartum,,30.0,concentration,,,42.3,g/l,mean,,,95% CI,31.6,53.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1006,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SNFX,serum,maternal,postpartum,,30.0,concentration,,,109.3,g/l,mean,,,95% CI,81.4,137.2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1007,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,NFX,serum,maternal,postpartum,,30.0,concentration,,,151.6,g/l,mean,,,95% CI,114.7,188.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1008,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S/R NFX,serum,maternal,postpartum,,30.0,S:R concentration ratio,,,2.78,,mean,,,95% CI,2.28,3.27,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1009,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,concentration,,,32.3,g/l,mean,,,95% CI,22.7,41.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1010,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,concentration,,,49,g/l,mean,,,95% CI,36.9,61.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1011,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,concentration,,,81.3,g/l,mean,,,95% CI,60.6,101.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1012,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,S/R NFX,breast milk,maternal,lactation,,30.0,S:R concentration ratio,,,1.86,,mean,,,95% CI,1.53,2.19,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1013,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RNFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.75,,mean,,,95% CI,0.68,0.86,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1014,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SNFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.55,,mean,,,95% CI,0.44,0.67,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1015,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,NFX,milk/serum ,maternal,lactation,,30.0,milk:serum concentration ratio,,,0.6,,mean,,,95% CI,0.5,0.71,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1016,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,infant dose,,,0.68,g/kg/day,mean,,,95% CI,0.46,0.9,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1017,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.03,g/kg/day,mean,,,95% CI,0.72,1.33,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1018,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,infant dose,,,1.69,g/kg/day,mean,,,95% CI,1.18,2.21,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1019,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,RNFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.43,%,mean,,,95% CI,0.3,0.56,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1020,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,SNFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.71,%,mean,,,95% CI,0.5,0.92,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1021,2025-12-02T16:05:22.346295
16433870.0,Fluoxetine,NFX,breast milk,maternal,lactation,,30.0,infant dose (%),,,0.57,%,mean,,,95% CI,0.41,0.57,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1022,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,1st trimester,,7.0,concentration,,,65,ug/L,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,389,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,2nd trimester,,7.0,concentration,,,66,ug/L,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,390,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,3rd trimester,,7.0,concentration,,,25,ug/L,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,391,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,postpartum,,7.0,concentration,,,92,ug/L,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,392,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,1st trimester,,7.0,concentration,,,110,ug/L,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,393,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,2nd trimester,,7.0,concentration,,,100,ug/L,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,394,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,3rd trimester,,7.0,concentration,,,100,ug/L,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,395,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,postpartum,,7.0,concentration,,,210,ug/L,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,396,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,1st trimester,,7.0,ratio of ODV/V,,,1.5,,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,397,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,2nd trimester,,7.0,ratio of ODV/V,,,2,,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,398,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,3rd trimester,,7.0,ratio of ODV/V,,,3.3,,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,399,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,postpartum,,7.0,ratio of ODV/V,,,2.2,,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,400,2025-12-02T16:05:09.448543
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,1st trimester,,7.0,concentration,,,65,ug/L,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,389,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,2nd trimester,,7.0,concentration,,,66,ug/L,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,390,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,3rd trimester,,7.0,concentration,,,25,ug/L,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,391,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,postpartum,,7.0,concentration,,,92,ug/L,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,392,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,1st trimester,,7.0,concentration,,,110,ug/L,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,393,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,2nd trimester,,7.0,concentration,,,100,ug/L,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,394,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,3rd trimester,,7.0,concentration,,,100,ug/L,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,395,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,postpartum,,7.0,concentration,,,210,ug/L,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,396,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,1st trimester,,7.0,ratio of ODV/V,,,1.5,,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,397,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,2nd trimester,,7.0,ratio of ODV/V,,,2,,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,398,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,3rd trimester,,7.0,ratio of ODV/V,,,3.3,,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,399,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,postpartum,,7.0,ratio of ODV/V,,,2.2,,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,400,2025-12-02T16:05:12.001940
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,1st trimester,,7.0,concentration,,,65,ug/L,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,383,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,2nd trimester,,7.0,concentration,,,66,ug/L,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,384,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,3rd trimester,,7.0,concentration,,,25,ug/L,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,385,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,postpartum,,7.0,concentration,,,92,ug/L,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,386,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,1st trimester,,7.0,concentration,,,110,ug/L,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,387,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,2nd trimester,,7.0,concentration,,,100,ug/L,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,388,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,3rd trimester,,7.0,concentration,,,100,ug/L,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,389,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,postpartum,,7.0,concentration,,,210,ug/L,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,390,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,1st trimester,,7.0,ratio of ODV/V,,,1.5,,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,391,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,2nd trimester,,7.0,ratio of ODV/V,,,2,,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,392,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,3rd trimester,,7.0,ratio of ODV/V,,,3.3,,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,393,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,postpartum,,7.0,ratio of ODV/V,,,2.2,,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,394,2025-12-02T16:05:15.923463
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,1st trimester,,7.0,concentration,,,65,ug/L,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,383,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,2nd trimester,,7.0,concentration,,,66,ug/L,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,384,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,3rd trimester,,7.0,concentration,,,25,ug/L,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,385,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,Venlafaxine,plasma,maternal,postpartum,,7.0,concentration,,,92,ug/L,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,386,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,1st trimester,,7.0,concentration,,,110,ug/L,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,387,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,2nd trimester,,7.0,concentration,,,100,ug/L,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,388,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,3rd trimester,,7.0,concentration,,,100,ug/L,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,389,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,maternal,postpartum,,7.0,concentration,,,210,ug/L,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,390,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,1st trimester,,7.0,ratio of ODV/V,,,1.5,,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,391,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,2nd trimester,,7.0,ratio of ODV/V,,,2,,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,392,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,3rd trimester,,7.0,ratio of ODV/V,,,3.3,,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,393,2025-12-02T16:05:22.346295
24989434.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,plasma,maternal,postpartum,,7.0,ratio of ODV/V,,,2.2,,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,394,2025-12-02T16:05:22.346295
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,the first trimester,,6.0,ratio of Venlafaxine and its metabolite,,,1.1,,mean,SD,0.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,372,2025-12-02T16:05:09.448543
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,postpartum,,6.0,ratio of Venlafaxine and its metabolite,,,1.03,,mean,SD,0.06,,,,0.192,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,373,2025-12-02T16:05:09.448543
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,the third trimester,,6.0,ratio of Venlafaxine and its metabolite,,,0.8,,mean,SD,0.2,,,,0.192,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,374,2025-12-02T16:05:09.448543
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,the first trimester,,4.0,ratio of citalopram:norcitalopram ,,,0.89,,mean,SD,0.26,,,,0.022,compared to the postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,375,2025-12-02T16:05:09.448543
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,postpartum,,4.0,ratio of citalopram:norcitalopram ,,,1.4,,mean,SD,0.24,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,376,2025-12-02T16:05:09.448543
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,the third trimester,,4.0,ratio of citalopram:norcitalopram ,,,0.9,,mean,SD,0.14,,,,0.048,compared to the postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,377,2025-12-02T16:05:09.448543
20060670.0,fluoxetine,fluoxetine and norfluoxetine,hair,maternal,the first trimester,,1.0,the fluoxetine:norfluoxetine ratio ,,,14,,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,378,2025-12-02T16:05:09.448543
20060670.0,fluoxetine,fluoxetine and norfluoxetine,hair,maternal,the third trimester,,1.0,the fluoxetine:norfluoxetine ratio ,,,5.4,,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,379,2025-12-02T16:05:09.448543
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,the first trimester,,6.0,ratio of Venlafaxine and its metabolite,,,1.1,,mean,SD,0.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,372,2025-12-02T16:05:12.001940
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,postpartum,,6.0,ratio of Venlafaxine and its metabolite,,,1.03,,mean,SD,0.06,,,,0.192,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,373,2025-12-02T16:05:12.001940
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,the third trimester,,6.0,ratio of Venlafaxine and its metabolite,,,0.8,,mean,SD,0.2,,,,0.192,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,374,2025-12-02T16:05:12.001940
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,the first trimester,,4.0,ratio of citalopram:norcitalopram ,,,0.89,,mean,SD,0.26,,,,0.022,compared to the postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,375,2025-12-02T16:05:12.001940
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,postpartum,,4.0,ratio of citalopram:norcitalopram ,,,1.4,,mean,SD,0.24,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,376,2025-12-02T16:05:12.001940
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,the third trimester,,4.0,ratio of citalopram:norcitalopram ,,,0.9,,mean,SD,0.14,,,,0.048,compared to the postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,377,2025-12-02T16:05:12.001940
20060670.0,fluoxetine,fluoxetine and norfluoxetine,hair,maternal,the first trimester,,1.0,the fluoxetine:norfluoxetine ratio ,,,14,,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,378,2025-12-02T16:05:12.001940
20060670.0,fluoxetine,fluoxetine and norfluoxetine,hair,maternal,the third trimester,,1.0,the fluoxetine:norfluoxetine ratio ,,,5.4,,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,379,2025-12-02T16:05:12.001940
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,the first trimester,,6.0,ratio of Venlafaxine and its metabolite,,,1.1,,mean,SD,0.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,366,2025-12-02T16:05:15.923463
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,postpartum,,6.0,ratio of Venlafaxine and its metabolite,,,1.03,,mean,SD,0.06,,,,0.192,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,367,2025-12-02T16:05:15.923463
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,the third trimester,,6.0,ratio of Venlafaxine and its metabolite,,,0.8,,mean,SD,0.2,,,,0.192,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,368,2025-12-02T16:05:15.923463
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,the first trimester,,4.0,ratio of citalopram:norcitalopram ,,,0.89,,mean,SD,0.26,,,,0.022,compared to the postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,369,2025-12-02T16:05:15.923463
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,postpartum,,4.0,ratio of citalopram:norcitalopram ,,,1.4,,mean,SD,0.24,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,370,2025-12-02T16:05:15.923463
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,the third trimester,,4.0,ratio of citalopram:norcitalopram ,,,0.9,,mean,SD,0.14,,,,0.048,compared to the postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,371,2025-12-02T16:05:15.923463
20060670.0,fluoxetine,fluoxetine and norfluoxetine,hair,maternal,the first trimester,,1.0,the fluoxetine:norfluoxetine ratio ,,,14,,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,372,2025-12-02T16:05:15.923463
20060670.0,fluoxetine,fluoxetine and norfluoxetine,hair,maternal,the third trimester,,1.0,the fluoxetine:norfluoxetine ratio ,,,5.4,,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,373,2025-12-02T16:05:15.923463
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,the first trimester,,6.0,ratio of Venlafaxine and its metabolite,,,1.1,,mean,SD,0.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,366,2025-12-02T16:05:22.346295
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,postpartum,,6.0,ratio of Venlafaxine and its metabolite,,,1.03,,mean,SD,0.06,,,,0.192,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,367,2025-12-02T16:05:22.346295
20060670.0,Venlafaxine,Venlafaxine and its metabolite,hair,maternal,the third trimester,,6.0,ratio of Venlafaxine and its metabolite,,,0.8,,mean,SD,0.2,,,,0.192,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,368,2025-12-02T16:05:22.346295
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,the first trimester,,4.0,ratio of citalopram:norcitalopram ,,,0.89,,mean,SD,0.26,,,,0.022,compared to the postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,369,2025-12-02T16:05:22.346295
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,postpartum,,4.0,ratio of citalopram:norcitalopram ,,,1.4,,mean,SD,0.24,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,370,2025-12-02T16:05:22.346295
20060670.0,citalopram,citalopram and norcitalopram,hair,maternal,the third trimester,,4.0,ratio of citalopram:norcitalopram ,,,0.9,,mean,SD,0.14,,,,0.048,compared to the postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,371,2025-12-02T16:05:22.346295
20060670.0,fluoxetine,fluoxetine and norfluoxetine,hair,maternal,the first trimester,,1.0,the fluoxetine:norfluoxetine ratio ,,,14,,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,372,2025-12-02T16:05:22.346295
20060670.0,fluoxetine,fluoxetine and norfluoxetine,hair,maternal,the third trimester,,1.0,the fluoxetine:norfluoxetine ratio ,,,5.4,,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,373,2025-12-02T16:05:22.346295
7893588.0,nortriptyline,nortriptyline,plasma,,,,283,concentration,,,244,nM,mean,SD,,range,50,1450,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,80,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,80,concentration,,,313,nM,mean,SD,,range,50,1830,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,81,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,186,concentration,,,256,nM,mean,SD,,range,50,1440,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,82,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,29,concentration,,,269,nM,mean,SD,,range,50,1170,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,83,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,283,ka (absorption rate constant),,,,h^-1,median,,,range,0.07,1.99,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,84,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,80,ka,,,,h^-1,median,,,range,0.19,2.96,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,85,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,186,ka,,,,h^-1,median,,,range,0.1,2.87,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,86,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,283,V/F (volume of distribution),,,,L,median,,,range,200,5000,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,87,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,80,V/F,,,,L,median,,,range,200,4725,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,88,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,186,V/F,,,,L,median,,,range,200,4950,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,89,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,283,k (elimination rate constant),,,,h^-1,median,,,range,0.005,0.137,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,90,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,80,k,,,,h^-1,median,,,range,0.003,0.113,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,91,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,186,k,,,,h^-1,median,,,range,0.004,0.154,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,92,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,283,CL (oral clearance),,,,L h^-1,median,,,range,8,304,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,93,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,80,CL,,,,L h^-1,median,,,range,4,57,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,94,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,186,CL,,,,L h^-1,median,,,range,10,270,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,95,2025-12-02T15:59:37.490403
7893588.0,nortriptyline,nortriptyline,plasma,,,,29,CL,,,,L h^-1,median,,,range,15,61,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,96,2025-12-02T15:59:37.490403
26416100.0,clomipramine,clomipramine,plasma,,1st trimester,,,concentration (normalized),,,,,median,,,range,0.03,1.44,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,105,2025-12-02T15:59:37.490403
26416100.0,clomipramine,clomipramine,plasma,,2nd trimester,,,concentration (normalized),,,,,median,,,range,0.13,3.07,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,106,2025-12-02T15:59:37.490403
26416100.0,clomipramine,clomipramine,plasma,,3rd trimester,,,concentration (normalized),,,,,median,,,range,0.03,1.99,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,107,2025-12-02T15:59:37.490403
26416100.0,clomipramine,clomipramine,plasma,,post-partum,,,concentration (normalized),,,,,median,,,range,0.33,1.29,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,108,2025-12-02T15:59:37.490403
26416100.0,clomipramine,desmethylclomipramine,plasma,,1st trimester,,,concentration (normalized),,,,,median,,,range,0.03,1.87,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,109,2025-12-02T15:59:37.490403
26416100.0,clomipramine,desmethylclomipramine,plasma,,2nd trimester,,,concentration (normalized),,,,,median,,,range,0.03,2.53,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,110,2025-12-02T15:59:37.490403
26416100.0,clomipramine,desmethylclomipramine,plasma,,3rd trimester,,,concentration (normalized),,,,,median,,,range,0.03,1.72,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,111,2025-12-02T15:59:37.490403
26416100.0,clomipramine,desmethylclomipramine,plasma,,post-partum,,,concentration (normalized),,,,,median,,,range,0.38,2.78,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,112,2025-12-02T15:59:37.490403
36103361.0,Amitriptyline,Amitriptyline,serum,,1st trimester,,2,C/D (Conc./Dose),,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,113,2025-12-02T15:59:37.490403
36103361.0,,,serum,,2nd trimester,,4,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,114,2025-12-02T15:59:37.490403
36103361.0,,,serum,,3rd trimester,,3,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,115,2025-12-02T15:59:37.490403
36103361.0,Aripiprazole,Aripiprazole,serum,,1st trimester,,na,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,116,2025-12-02T15:59:37.490403
36103361.0,,,serum,,2nd trimester,,2,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,117,2025-12-02T15:59:37.490403
36103361.0,,,serum,,3rd trimester,,2,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,118,2025-12-02T15:59:37.490403
36103361.0,Citalopram,Citalopram,serum,,1st trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,119,2025-12-02T15:59:37.490403
36103361.0,,,serum,,2nd trimester,,2,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,120,2025-12-02T15:59:37.490403
36103361.0,,,serum,,3rd trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,121,2025-12-02T15:59:37.490403
36103361.0,Clomipramine,Clomipramine,serum,,1st trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,122,2025-12-02T15:59:37.490403
36103361.0,,,serum,,2nd trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,123,2025-12-02T15:59:37.490403
36103361.0,,,serum,,3rd trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,124,2025-12-02T15:59:37.490403
36103361.0,Duloxetine,Duloxetine,serum,,1st trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,125,2025-12-02T15:59:37.490403
36103361.0,,,serum,,2nd trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,126,2025-12-02T15:59:37.490403
36103361.0,,,serum,,3rd trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,127,2025-12-02T15:59:37.490403
36103361.0,Escitalopram,Escitalopram,serum,,1st trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,128,2025-12-02T15:59:37.490403
36103361.0,,,serum,,2nd trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,129,2025-12-02T15:59:37.490403
36103361.0,,,serum,,3rd trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,130,2025-12-02T15:59:37.490403
36103361.0,Mirtazapine,Mirtazapine,serum,,1st trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,131,2025-12-02T15:59:37.490403
36103361.0,,,serum,,2nd trimester,,2,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,132,2025-12-02T15:59:37.490403
36103361.0,,,serum,,3rd trimester,,3,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,133,2025-12-02T15:59:37.490403
36103361.0,Quetiapine,Quetiapine,serum,,1st trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,134,2025-12-02T15:59:37.490403
36103361.0,,,serum,,2nd trimester,,4,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,135,2025-12-02T15:59:37.490403
36103361.0,,,serum,,3rd trimester,,3,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,136,2025-12-02T15:59:37.490403
36103361.0,Sertraline,Sertraline,serum,,1st trimester,,1,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,137,2025-12-02T15:59:37.490403
36103361.0,,,serum,,2nd trimester,,4,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,138,2025-12-02T15:59:37.490403
36103361.0,,,serum,,3rd trimester,,4,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,139,2025-12-02T15:59:37.490403
36103361.0,Venlafaxine,Venlafaxine,serum,,1st trimester,,0,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,140,2025-12-02T15:59:37.490403
36103361.0,,,serum,,2nd trimester,,3,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,141,2025-12-02T15:59:37.490403
36103361.0,,,serum,,3rd trimester,,3,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,142,2025-12-02T15:59:37.490403
36103361.0,Mirtazapine,Mirtazapine,serum,,postpartum,,3,C/D,trough,,-0.17,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,143,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,trough,,3.61,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,144,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,directly before breastfeeding,,0.44,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,145,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,1,hours,0.38,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,146,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,directly before next breastfeeding (4-5 hrs),,0.24,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,147,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,4,hours,0.33,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,148,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,8,hours,0.3,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,149,2025-12-02T15:59:37.490403
36103361.0,citalopram,citalopram,serum,,postpartum,,2,C/D,trough,,0.14,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,150,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,trough,,na,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,151,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,directly before breastfeeding,,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,152,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,1,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,153,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,directly before next breastfeeding (4-5 hrs),,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,154,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,4,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,155,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,8,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,156,2025-12-02T15:59:37.490403
36103361.0,escitalopram,escitalopram,serum,,postpartum,,4,C/D,trough,,1.41,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,157,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,4,C/D,trough,,0.08,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,158,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,4,C/D,directly before breastfeeding,,1.08,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,159,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,4,C/D,1,hours,0.45,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,160,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,4,C/D,directly before next breastfeeding (4-5 hrs),,0,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,161,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,4,C/D,4,hours,0.43,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,162,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,4,C/D,8,hours,0.03,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,163,2025-12-02T15:59:37.490403
36103361.0,sertraline,sertraline,serum,,postpartum,,2,C/D,trough,,1.27,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,164,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,trough,,1.09,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,165,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,directly before breastfeeding,,2.83,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,166,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,1,hours,0.23,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,167,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,directly before next breastfeeding (4-5 hrs),,11.27,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,168,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,4,hours,8.75,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,169,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,8,hours,4.36,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,170,2025-12-02T15:59:37.490403
36103361.0,lamotrigine,lamotrigine,serum,,postpartum,,1,C/D,trough,,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,171,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,1,C/D,trough,,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,172,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,1,C/D,directly before breastfeeding,,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,173,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,1,C/D,1,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,174,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,1,C/D,directly before next breastfeeding (4-5 hrs),,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,175,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,1,C/D,4,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,176,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,1,C/D,8,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,177,2025-12-02T15:59:37.490403
36103361.0,venlafaxine,venlafaxine,serum,,postpartum,,3,C/D,trough,,0.17,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,178,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,trough,,2.22,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,179,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,directly before breastfeeding,,2.77,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,180,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,1,hours,2.9,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,181,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,directly before next breastfeeding (4-5 hrs),,3.67,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,182,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,4,hours,3.5,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,183,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,8,hours,6.47,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,184,2025-12-02T15:59:37.490403
36103361.0,clomipramine,clomipramine,serum,,postpartum,,2,C/D,trough,,0.11,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,185,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,trough,,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,186,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,directly before breastfeeding,,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,187,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,1,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,188,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,directly before next breastfeeding (4-5 hrs),,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,189,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,4,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,190,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,8,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,191,2025-12-02T15:59:37.490403
36103361.0,amitriptyline,amitriptyline,serum,,postpartum,,2,C/D,trough,,0.38,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,192,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,trough,,0.41,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,193,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,directly before breastfeeding,,0.05,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,194,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,1,hours,-0.13,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,195,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,directly before next breastfeeding (4-5 hrs),,0.61,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,196,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,4,hours,0.11,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,197,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,8,hours,1.12,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,198,2025-12-02T15:59:37.490403
36103361.0,quetiapine,quetiapine,serum,,postpartum,,3,C/D,trough,,0.28,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,199,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,trough,,0.02,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,200,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,directly before breastfeeding,,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,201,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,1,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,202,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,directly before next breastfeeding (4-5 hrs),,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,203,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,4,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,204,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,8,hours,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,205,2025-12-02T15:59:37.490403
36103361.0,Amitriptyline,Amitriptyline,serum,,postpartum,,4,C/D,<2,weeks,0.23,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,206,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,4,C/D,<2,weeks,1.27,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,207,2025-12-02T15:59:37.490403
36103361.0,Quetiapine,Quetiapine,serum,,postpartum,,3,C/D,<2,weeks,0.18,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,208,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,<2,weeks,0.08,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,209,2025-12-02T15:59:37.490403
36103361.0,Sertraline,Sertraline,serum,,postpartum,,2,C/D,<2,weeks,0.02,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,210,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,<2,weeks,0.18,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,211,2025-12-02T15:59:37.490403
36103361.0,Venlafaxine,Venlafaxine,serum,,postpartum,,3,C/D,<2,weeks,0.72,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,212,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,<2,weeks,2.41,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,213,2025-12-02T15:59:37.490403
36103361.0,Amitriptyline ,Amitriptyline ,serum,,postpartum,,9,C/D,>2,weeks,1.14,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,214,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,9,C/D,>2,weeks,0.87,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,215,2025-12-02T15:59:37.490403
36103361.0,Citalopram ,Citalopram ,serum,,postpartum,,1,C/D,>2,weeks,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,216,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,1,C/D,>2,weeks,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,217,2025-12-02T15:59:37.490403
36103361.0,Clomipramine ,Clomipramine ,serum,,postpartum,,2,C/D,>2,weeks,0.11,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,218,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,>2,weeks,0,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,219,2025-12-02T15:59:37.490403
36103361.0,Escitalopram ,Escitalopram ,serum,,postpartum,,5,C/D,>2,weeks,1.35,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,220,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,5,C/D,>2,weeks,0.45,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,221,2025-12-02T15:59:37.490403
36103361.0,Lamotrigine ,Lamotrigine ,serum,,postpartum,,1,C/D,>2,weeks,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,222,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,1,C/D,>2,weeks,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,223,2025-12-02T15:59:37.490403
36103361.0,Mirtazapine ,Mirtazapine ,serum,,postpartum,,4,C/D,>2,weeks,0.66,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,224,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,4,C/D,>2,weeks,3.29,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,225,2025-12-02T15:59:37.490403
36103361.0,Paroxetine ,Paroxetine ,serum,,postpartum,,1,C/D,>2,weeks,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,226,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,1,C/D,>2,weeks,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,227,2025-12-02T15:59:37.490403
36103361.0,Quetiapine ,Quetiapine ,serum,,postpartum,,3,C/D,>2,weeks,0.22,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,228,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,3,C/D,>2,weeks,0.02,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,229,2025-12-02T15:59:37.490403
36103361.0,Sertraline ,Sertraline ,serum,,postpartum,,8,C/D,>2,weeks,0.79,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,230,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,8,C/D,>2,weeks,1.6,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,231,2025-12-02T15:59:37.490403
36103361.0,Venlafaxine,Venlafaxine,serum,,postpartum,,2,C/D,>2,weeks,0.08,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,232,2025-12-02T15:59:37.490403
36103361.0,,,breastmilk,,postpartum,,2,C/D,>2,weeks,,,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,233,2025-12-02T15:59:37.490403
33751155.0,Sertraline,Sertraline,blood,maternal,2nd trimester,,7.0,concentration,,,7.65,ng/ml,median,,,Q1-Q3,5.81,12.09,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2047,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,2nd trimester,,7.0,concentration,,,,,,,,minmax,3.98,17.14,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2048,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,3rd trimester,,9.0,concentration,,,9.49,ng/ml,median,,,Q1-Q3,7.34,17.14,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2049,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,3rd trimester,,9.0,concentration,,,,,,,,minmax,1.53,20.81,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2050,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,labor,,8.0,concentration,,,14.38,ng/ml,median,,,Q1-Q3,7.65,18.67,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2051,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,labor,,8.0,concentration,,,,,,,,minmax,3.64,24.17,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2052,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,postpartum,,8.0,concentration,,,17.9,ng/ml,median,,,Q1-Q3,8.87,19.35,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2053,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,postpartum,,8.0,concentration,,,,,,,,minmax,6.12,52.02,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2054,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,2nd trimester,,7.0,concentration,,,24.25,ng/ml,median,,,Q1-Q4,22.65,32.29,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2055,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,2nd trimester,,7.0,concentration,,,,,,,,minmax,15.78,10.52,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2056,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,3rd trimester,,9.0,concentration,,,35.06,ng/ml,median,,,Q1-Q5,28.05,55.52,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2057,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,3rd trimester,,9.0,concentration,,,,,,,,minmax,10.52,61.36,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2058,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,labor,,8.0,concentration,,,33.6,ng/ml,median,,,Q1-Q6,22.95,46.75,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2059,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,labor,,8.0,concentration,,,,,,,,minmax,7.01,61.36,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2060,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,postpartum,,8.0,concentration,,,45.29,ng/ml,median,,,Q1-Q7,28.56,78.89,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2061,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,postpartum,,8.0,concentration,,,,,,,,minmax,16.95,87.66,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2062,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,2nd trimester,,7.0,dose-adjusted concentration,,,0.15,(ng/ml)/(mg/day),median,,,Q1-Q3,0.12,0.24,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2063,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,2nd trimester,,7.0,dose-adjusted concentration,,,,,,,,minmax,0.08,0.34,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2064,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,3rd trimester,,9.0,dose-adjusted concentration,,,0.19,(ng/ml)/(mg/day),median,,,Q1-Q4,0.12,0.23,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2065,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,3rd trimester,,9.0,dose-adjusted concentration,,,,,,,,minmax,0.03,0.38,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2066,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,labor,,8.0,dose-adjusted concentration,,,0.19,(ng/ml)/(mg/day),median,,,Q1-Q5,0.15,0.25,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2067,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,labor,,8.0,dose-adjusted concentration,,,,,,,,minmax,0.07,0.32,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2068,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,postpartum,,8.0,dose-adjusted concentration,,,0.25,(ng/ml)/(mg/day),median,,,Q1-Q6,0.17,0.29,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2069,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,maternal,postpartum,,8.0,dose-adjusted concentration,,,,,,,,minmax,0.12,0.69,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2070,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,2nd trimester,,7.0,dose-adjusted concentration,,,0.49,(ng/ml)/(mg/day),median,,,Q1-Q7,0.45,0.65,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2071,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,2nd trimester,,7.0,dose-adjusted concentration,,,,,,,,minmax,0.32,0.88,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2072,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,3rd trimester,,9.0,dose-adjusted concentration,,,0.7,(ng/ml)/(mg/day),median,,,Q1-Q8,0.47,0.74,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2073,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,3rd trimester,,9.0,dose-adjusted concentration,,,,,,,,minmax,0.21,1.11,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2074,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,labor,,8.0,dose-adjusted concentration,,,0.46,(ng/ml)/(mg/day),median,,,Q1-Q9,0.37,0.62,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2075,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,labor,,8.0,dose-adjusted concentration,,,,,,,,minmax,0.14,0.82,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2076,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,postpartum,,8.0,dose-adjusted concentration,,,0.69,(ng/ml)/(mg/day),median,,,Q1-Q10,0.43,1.05,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2077,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,maternal,postpartum,,8.0,dose-adjusted concentration,,,,,,,,minmax,0.34,1.17,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2078,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,cord blood,pediatric,,fetus,5.0,concentration,,,4.28,ng/ml,median,,,minmax,1.22,6.12,,at delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2079,2025-12-02T16:03:31.981487
33751155.0,Sertraline,Sertraline,blood,pediatric,,infants,5.0,concentration,48,h,4.59,ng/ml,median,,,minmax,1.25,7.04,,at 48 h of age ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2080,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,cord blood,pediatric,,fetus,5.0,concentration,,,9.93,ng/ml,median,,,minmax,4.96,17.23,,at delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2081,2025-12-02T16:03:31.981487
33751155.0,Sertraline,desmethylsertraline,blood,pediatric,,infants,5.0,concentration,48,h,17.52,ng/ml,median,,,minmax,9.93,20.44,,at 48 h of age ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2082,2025-12-02T16:03:31.981487
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,20 weeks gestation,6.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.4,minmax,0.07,0.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,118,2025-12-02T16:05:09.448543
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,20 weeks gestation,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.3,minmax,0.3,1.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,119,2025-12-02T16:05:09.448543
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,30 weeks gestation,6.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.2,minmax,0.1,0.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,120,2025-12-02T16:05:09.448543
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,30 weeks gestation,6.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.3,minmax,0.2,1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,121,2025-12-02T16:05:09.448543
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,36 weeks gestation,6.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.2,0.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,122,2025-12-02T16:05:09.448543
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,36 weeks gestation,6.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.1,minmax,0.7,1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,123,2025-12-02T16:05:09.448543
18426260.0,sertraline,sertraline,plasma,maternal,delivery,,6.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.1,minmax,0.1,0.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,124,2025-12-02T16:05:09.448543
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,delivery,,6.0,drug level-to-dose ratio,,,0.7,,mean,SD,0.2,minmax,0.5,1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,125,2025-12-02T16:05:09.448543
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 2 weeks,6.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.2,minmax,0.1,0.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,126,2025-12-02T16:05:09.448543
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 2 weeks,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.3,minmax,0.3,0.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,127,2025-12-02T16:05:09.448543
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 4-6 weeks,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.2,minmax,0.3,0.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,128,2025-12-02T16:05:09.448543
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 4-6 weeks,6.0,drug level-to-dose ratio,,,0.9,,mean,SD,0.3,minmax,0.6,1.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,129,2025-12-02T16:05:09.448543
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 12weeks,6.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.3,minmax,0.1,0.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,130,2025-12-02T16:05:09.448543
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 12weeks,6.0,drug level-to-dose ratio,,,0.9,,mean,SD,0.7,minmax,0.1,1.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,131,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.7,,mean,SD,1,minmax,0.6,0.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,132,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,1.4,,mean,SD,0.2,minmax,1.2,1.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,133,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.3,0.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,134,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.3,0.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,135,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,2.0,drug level-to-dose ratio,,,2.3,,mean,SD,0.8,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,136,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,2.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.2,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,137,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.7,,mean,SD,0.4,minmax,0.3,1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,138,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,1.2,,mean,SD,0.4,minmax,0.7,1.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,139,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.2,minmax,0.2,0.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,140,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.2,0.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,141,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,2.0,drug level-to-dose ratio,,,2.2,,mean,SD,1.8,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,142,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,2.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.1,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,143,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.3,0.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,144,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.1,minmax,0.7,0.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,145,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.02,minmax,0.21,0.24,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,146,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.03,minmax,0.2,0.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,147,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,2.0,drug level-to-dose ratio,,,2.3,,mean,SD,1.5,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,148,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,2.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.01,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,149,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-Citalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,150,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-Citalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,151,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.1,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,152,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.1,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,153,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,delivery,,2.0,drug level-to-dose ratio,,,1.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,154,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,delivery,,2.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,155,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,1.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,156,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,2.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,157,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,158,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,159,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,2.0,drug level-to-dose ratio,,,3.6,,mean,SD,1.6,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,160,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,2.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,161,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,162,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,163,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,164,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,165,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,2.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,166,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,2.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,167,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.2,minmax,0.4,0.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,168,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,1.3,,mean,SD,0.8,minmax,0.7,1.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,169,2025-12-02T16:05:09.448543
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.2,0.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,170,2025-12-02T16:05:09.448543
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.2,minmax,0.2,0.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,171,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,2.0,drug level-to-dose ratio,,,3.2,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,172,2025-12-02T16:05:09.448543
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,2.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,173,2025-12-02T16:05:09.448543
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,20 weeks gestation,6.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.4,minmax,0.07,0.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,118,2025-12-02T16:05:12.001940
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,20 weeks gestation,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.3,minmax,0.3,1.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,119,2025-12-02T16:05:12.001940
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,30 weeks gestation,6.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.2,minmax,0.1,0.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,120,2025-12-02T16:05:12.001940
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,30 weeks gestation,6.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.3,minmax,0.2,1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,121,2025-12-02T16:05:12.001940
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,36 weeks gestation,6.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.2,0.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,122,2025-12-02T16:05:12.001940
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,36 weeks gestation,6.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.1,minmax,0.7,1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,123,2025-12-02T16:05:12.001940
18426260.0,sertraline,sertraline,plasma,maternal,delivery,,6.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.1,minmax,0.1,0.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,124,2025-12-02T16:05:12.001940
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,delivery,,6.0,drug level-to-dose ratio,,,0.7,,mean,SD,0.2,minmax,0.5,1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,125,2025-12-02T16:05:12.001940
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 2 weeks,6.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.2,minmax,0.1,0.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,126,2025-12-02T16:05:12.001940
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 2 weeks,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.3,minmax,0.3,0.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,127,2025-12-02T16:05:12.001940
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 4-6 weeks,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.2,minmax,0.3,0.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,128,2025-12-02T16:05:12.001940
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 4-6 weeks,6.0,drug level-to-dose ratio,,,0.9,,mean,SD,0.3,minmax,0.6,1.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,129,2025-12-02T16:05:12.001940
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 12weeks,6.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.3,minmax,0.1,0.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,130,2025-12-02T16:05:12.001940
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 12weeks,6.0,drug level-to-dose ratio,,,0.9,,mean,SD,0.7,minmax,0.1,1.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,131,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.7,,mean,SD,1,minmax,0.6,0.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,132,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,1.4,,mean,SD,0.2,minmax,1.2,1.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,133,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.3,0.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,134,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.3,0.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,135,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,2.0,drug level-to-dose ratio,,,2.3,,mean,SD,0.8,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,136,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,2.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.2,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,137,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.7,,mean,SD,0.4,minmax,0.3,1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,138,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,1.2,,mean,SD,0.4,minmax,0.7,1.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,139,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.2,minmax,0.2,0.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,140,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.2,0.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,141,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,2.0,drug level-to-dose ratio,,,2.2,,mean,SD,1.8,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,142,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,2.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.1,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,143,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.3,0.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,144,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.1,minmax,0.7,0.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,145,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.02,minmax,0.21,0.24,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,146,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.03,minmax,0.2,0.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,147,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,2.0,drug level-to-dose ratio,,,2.3,,mean,SD,1.5,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,148,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,2.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.01,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,149,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-Citalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,150,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-Citalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,151,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.1,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,152,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.1,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,153,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,delivery,,2.0,drug level-to-dose ratio,,,1.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,154,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,delivery,,2.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,155,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,1.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,156,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,2.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,157,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,158,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,159,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,2.0,drug level-to-dose ratio,,,3.6,,mean,SD,1.6,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,160,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,2.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,161,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,162,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,163,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,164,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,165,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,2.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,166,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,2.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,167,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.2,minmax,0.4,0.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,168,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,1.3,,mean,SD,0.8,minmax,0.7,1.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,169,2025-12-02T16:05:12.001940
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.2,0.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,170,2025-12-02T16:05:12.001940
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.2,minmax,0.2,0.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,171,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,2.0,drug level-to-dose ratio,,,3.2,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,172,2025-12-02T16:05:12.001940
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,2.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,173,2025-12-02T16:05:12.001940
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,20 weeks gestation,6.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.4,minmax,0.07,0.9,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,118,2025-12-02T16:05:15.923463
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,20 weeks gestation,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.3,minmax,0.3,1.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,119,2025-12-02T16:05:15.923463
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,30 weeks gestation,6.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.2,minmax,0.1,0.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,120,2025-12-02T16:05:15.923463
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,30 weeks gestation,6.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.3,minmax,0.2,1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,121,2025-12-02T16:05:15.923463
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,36 weeks gestation,6.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.2,0.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,122,2025-12-02T16:05:15.923463
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,36 weeks gestation,6.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.1,minmax,0.7,1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,123,2025-12-02T16:05:15.923463
18426260.0,sertraline,sertraline,plasma,maternal,delivery,,6.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.1,minmax,0.1,0.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,124,2025-12-02T16:05:15.923463
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,delivery,,6.0,drug level-to-dose ratio,,,0.7,,mean,SD,0.2,minmax,0.5,1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,125,2025-12-02T16:05:15.923463
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 2 weeks,6.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.2,minmax,0.1,0.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,126,2025-12-02T16:05:15.923463
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 2 weeks,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.3,minmax,0.3,0.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,127,2025-12-02T16:05:15.923463
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 4-6 weeks,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.2,minmax,0.3,0.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,128,2025-12-02T16:05:15.923463
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 4-6 weeks,6.0,drug level-to-dose ratio,,,0.9,,mean,SD,0.3,minmax,0.6,1.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,129,2025-12-02T16:05:15.923463
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 12weeks,6.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.3,minmax,0.1,0.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,130,2025-12-02T16:05:15.923463
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 12weeks,6.0,drug level-to-dose ratio,,,0.9,,mean,SD,0.7,minmax,0.1,1.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,131,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.7,,mean,SD,1,minmax,0.6,0.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,132,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,1.4,,mean,SD,0.2,minmax,1.2,1.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,133,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.3,0.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,134,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.3,0.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,135,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,2.0,drug level-to-dose ratio,,,2.3,,mean,SD,0.8,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,136,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,2.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.2,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,137,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.7,,mean,SD,0.4,minmax,0.3,1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,138,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,1.2,,mean,SD,0.4,minmax,0.7,1.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,139,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.2,minmax,0.2,0.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,140,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.2,0.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,141,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,2.0,drug level-to-dose ratio,,,2.2,,mean,SD,1.8,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,142,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,2.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.1,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,143,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.3,0.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,144,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.1,minmax,0.7,0.9,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,145,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.02,minmax,0.21,0.24,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,146,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.03,minmax,0.2,0.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,147,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,2.0,drug level-to-dose ratio,,,2.3,,mean,SD,1.5,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,148,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,2.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.01,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,149,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-Citalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,150,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-Citalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,151,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.1,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,152,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.1,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,153,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,delivery,,2.0,drug level-to-dose ratio,,,1.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,154,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,delivery,,2.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,155,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,1.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,156,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,2.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,157,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,158,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,159,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,2.0,drug level-to-dose ratio,,,3.6,,mean,SD,1.6,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,160,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,2.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,161,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,162,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,163,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,164,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,165,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,2.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,166,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,2.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,167,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.2,minmax,0.4,0.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,168,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,1.3,,mean,SD,0.8,minmax,0.7,1.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,169,2025-12-02T16:05:15.923463
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.2,0.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,170,2025-12-02T16:05:15.923463
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.2,minmax,0.2,0.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,171,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,2.0,drug level-to-dose ratio,,,3.2,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,172,2025-12-02T16:05:15.923463
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,2.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,173,2025-12-02T16:05:15.923463
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,20 weeks gestation,6.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.4,minmax,0.07,0.9,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,118,2025-12-02T16:05:22.346295
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,20 weeks gestation,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.3,minmax,0.3,1.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,119,2025-12-02T16:05:22.346295
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,30 weeks gestation,6.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.2,minmax,0.1,0.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,120,2025-12-02T16:05:22.346295
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,30 weeks gestation,6.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.3,minmax,0.2,1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,121,2025-12-02T16:05:22.346295
18426260.0,sertraline,sertraline,plasma,maternal,pregnancy,36 weeks gestation,6.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.2,0.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,122,2025-12-02T16:05:22.346295
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,pregnancy,36 weeks gestation,6.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.1,minmax,0.7,1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,123,2025-12-02T16:05:22.346295
18426260.0,sertraline,sertraline,plasma,maternal,delivery,,6.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.1,minmax,0.1,0.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,124,2025-12-02T16:05:22.346295
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,delivery,,6.0,drug level-to-dose ratio,,,0.7,,mean,SD,0.2,minmax,0.5,1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,125,2025-12-02T16:05:22.346295
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 2 weeks,6.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.2,minmax,0.1,0.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,126,2025-12-02T16:05:22.346295
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 2 weeks,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.3,minmax,0.3,0.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,127,2025-12-02T16:05:22.346295
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 4-6 weeks,6.0,drug level-to-dose ratio,,,0.6,,mean,SD,0.2,minmax,0.3,0.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,128,2025-12-02T16:05:22.346295
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 4-6 weeks,6.0,drug level-to-dose ratio,,,0.9,,mean,SD,0.3,minmax,0.6,1.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,129,2025-12-02T16:05:22.346295
18426260.0,sertraline,sertraline,plasma,maternal,postpartum,postpartum 12weeks,6.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.3,minmax,0.1,0.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,130,2025-12-02T16:05:22.346295
18426260.0,sertraline,N-demethylsertaline,plasma,maternal,postpartum,postpartum 12weeks,6.0,drug level-to-dose ratio,,,0.9,,mean,SD,0.7,minmax,0.1,1.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,131,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.7,,mean,SD,1,minmax,0.6,0.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,132,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,1.4,,mean,SD,0.2,minmax,1.2,1.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,133,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.3,0.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,134,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.3,0.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,135,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,20 weeks gestation,2.0,drug level-to-dose ratio,,,2.3,,mean,SD,0.8,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,136,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,20 weeks gestation,2.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.2,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,137,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.7,,mean,SD,0.4,minmax,0.3,1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,138,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,1.2,,mean,SD,0.4,minmax,0.7,1.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,139,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.2,minmax,0.2,0.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,140,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.2,0.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,141,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,30 weeks gestation,2.0,drug level-to-dose ratio,,,2.2,,mean,SD,1.8,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,142,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,30 weeks gestation,2.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.1,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,143,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,0.3,0.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,144,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.8,,mean,SD,0.1,minmax,0.7,0.9,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,145,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.2,,mean,SD,0.02,minmax,0.21,0.24,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,146,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.03,minmax,0.2,0.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,147,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,pregnancy,36 weeks gestation,2.0,drug level-to-dose ratio,,,2.3,,mean,SD,1.5,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,148,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,pregnancy,36 weeks gestation,2.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.01,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,149,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-Citalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,150,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-Citalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,151,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.1,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,152,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,delivery,,3.0,drug level-to-dose ratio,,,0.1,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,153,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,delivery,,2.0,drug level-to-dose ratio,,,1.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,154,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,delivery,,2.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,155,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,1.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,156,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,2.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,157,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,158,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,159,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 2 weeks,2.0,drug level-to-dose ratio,,,3.6,,mean,SD,1.6,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,160,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 2 weeks,2.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.1,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,161,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,162,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,163,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,164,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,3.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,165,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,2.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,166,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 4-6 weeks,2.0,drug level-to-dose ratio,,,,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,167,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.5,,mean,SD,0.2,minmax,0.4,0.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,168,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,1.3,,mean,SD,0.8,minmax,0.7,1.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,169,2025-12-02T16:05:22.346295
18426260.0,Citalopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.3,,mean,SD,0.1,minmax,0.2,0.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,170,2025-12-02T16:05:22.346295
18426260.0,Citalopram,R-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,3.0,drug level-to-dose ratio,,,0.4,,mean,SD,0.2,minmax,0.2,0.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,171,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-Citalopram,plasma,maternal,postpartum,postpartum 12weeks,2.0,drug level-to-dose ratio,,,3.2,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,172,2025-12-02T16:05:22.346295
18426260.0,Escitlopram,S-desmethylcitalopram,plasma,maternal,postpartum,postpartum 12weeks,2.0,drug level-to-dose ratio,,,0.3,,mean,SD,,minmax,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,173,2025-12-02T16:05:22.346295
30380149.0,citalopram,citalopram,S1-S4,ID 1,,,1,concentration,,,,,,,,range (ng/mg),3.58,9.59,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,352,2025-12-02T15:59:37.490403
30380149.0,sertraline,sertraline,S1-S5,ID 1,,,1,concentration,,,,,,,,range (ng/mg),1.37,3.63,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,353,2025-12-02T15:59:37.490403
30380149.0,sertraline,sertraline,S6-13,ID 1,,,,,,,,,,,,,,,,presence of drug in these segments does not necessarily indicate the ingestion of the drug during that time period. It could be due to sweat or sebum diffusion,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,354,2025-12-02T15:59:37.490403
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration,,,223.8,ng/ml,median,,,"Q1, Q3",90,289.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,285,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration,,,,,,,,minmax,33.9,338,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,286,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,5.0,concentration,,,789,ng/ml,median,,,"Q1, Q3",722.6,962.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,287,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,5.0,concentration,,,,,,,,minmax,309.5,1052.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,288,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration,,,291,ng/ml,median,,,"Q1, Q3",89,336,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,289,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration,,,,,,,,minmax,21.1,448.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,290,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration-by-dose-ratio,,,1.5,,median,,,"Q1, Q3",1.43,2.46,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,291,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration-by-dose-ratio,,,,,,,,minmax,0.63,4.03,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,292,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,9.0,concentration-by-dose-ratio,,,7.02,,median,,,"Q1, Q3",3.51,9.63,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,293,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,9.0,concentration-by-dose-ratio,,,,,,,,minmax,2.75,12.83,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,294,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration-by-dose-ratio,,,2.37,,median,,,"Q1, Q3",1.29,2.99,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,295,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration-by-dose-ratio,,,,,,,,minmax,0.56,4.48,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,296,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid/maternal serum,maternal,delivery,,5.0,penetration ratio from maternal blood into amniotic fluid,,,2.5,,median,,,"Q1, Q3",2.33,3.19,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,297,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid/maternal serum,maternal,delivery,,5.0,penetration ratio from maternal blood into amniotic fluid,,,,,,,,minmax,1.12,4.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,298,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood/maternal serum,maternal/pediatric,delivery,fetus,9.0,penetration ratio from maternal blood into umbilicalcord blood,,,1.05,,median,,,"Q1, Q3",0.99,1.16,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,299,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood/maternal serum,maternal/pediatric,delivery,fetus,9.0,penetration ratio from maternal blood into umbilicalcord blood,,,,,,,,minmax,0.62,2.08,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,300,2025-12-02T16:05:09.448543
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration,,,223.8,ng/ml,median,,,"Q1, Q3",90,289.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,285,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration,,,,,,,,minmax,33.9,338,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,286,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,5.0,concentration,,,789,ng/ml,median,,,"Q1, Q3",722.6,962.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,287,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,5.0,concentration,,,,,,,,minmax,309.5,1052.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,288,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration,,,291,ng/ml,median,,,"Q1, Q3",89,336,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,289,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration,,,,,,,,minmax,21.1,448.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,290,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration-by-dose-ratio,,,1.5,,median,,,"Q1, Q3",1.43,2.46,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,291,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration-by-dose-ratio,,,,,,,,minmax,0.63,4.03,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,292,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,9.0,concentration-by-dose-ratio,,,7.02,,median,,,"Q1, Q3",3.51,9.63,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,293,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,9.0,concentration-by-dose-ratio,,,,,,,,minmax,2.75,12.83,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,294,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration-by-dose-ratio,,,2.37,,median,,,"Q1, Q3",1.29,2.99,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,295,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration-by-dose-ratio,,,,,,,,minmax,0.56,4.48,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,296,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid/maternal serum,maternal,delivery,,5.0,penetration ratio from maternal blood into amniotic fluid,,,2.5,,median,,,"Q1, Q3",2.33,3.19,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,297,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid/maternal serum,maternal,delivery,,5.0,penetration ratio from maternal blood into amniotic fluid,,,,,,,,minmax,1.12,4.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,298,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood/maternal serum,maternal/pediatric,delivery,fetus,9.0,penetration ratio from maternal blood into umbilicalcord blood,,,1.05,,median,,,"Q1, Q3",0.99,1.16,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,299,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood/maternal serum,maternal/pediatric,delivery,fetus,9.0,penetration ratio from maternal blood into umbilicalcord blood,,,,,,,,minmax,0.62,2.08,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,300,2025-12-02T16:05:12.001940
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration,,,223.8,ng/ml,median,,,"Q1, Q3",90,289.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,279,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration,,,,,,,,minmax,33.9,338,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,280,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,5.0,concentration,,,789,ng/ml,median,,,"Q1, Q3",722.6,962.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,281,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,5.0,concentration,,,,,,,,minmax,309.5,1052.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,282,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration,,,291,ng/ml,median,,,"Q1, Q3",89,336,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,283,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration,,,,,,,,minmax,21.1,448.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,284,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration-by-dose-ratio,,,1.5,,median,,,"Q1, Q3",1.43,2.46,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,285,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration-by-dose-ratio,,,,,,,,minmax,0.63,4.03,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,286,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,9.0,concentration-by-dose-ratio,,,7.02,,median,,,"Q1, Q3",3.51,9.63,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,287,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,9.0,concentration-by-dose-ratio,,,,,,,,minmax,2.75,12.83,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,288,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration-by-dose-ratio,,,2.37,,median,,,"Q1, Q3",1.29,2.99,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,289,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration-by-dose-ratio,,,,,,,,minmax,0.56,4.48,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,290,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid/maternal serum,maternal,delivery,,5.0,penetration ratio from maternal blood into amniotic fluid,,,2.5,,median,,,"Q1, Q3",2.33,3.19,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,291,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid/maternal serum,maternal,delivery,,5.0,penetration ratio from maternal blood into amniotic fluid,,,,,,,,minmax,1.12,4.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,292,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood/maternal serum,maternal/pediatric,delivery,fetus,9.0,penetration ratio from maternal blood into umbilicalcord blood,,,1.05,,median,,,"Q1, Q3",0.99,1.16,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,293,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood/maternal serum,maternal/pediatric,delivery,fetus,9.0,penetration ratio from maternal blood into umbilicalcord blood,,,,,,,,minmax,0.62,2.08,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,294,2025-12-02T16:05:15.923463
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration,,,223.8,ng/ml,median,,,"Q1, Q3",90,289.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,279,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration,,,,,,,,minmax,33.9,338,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,280,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,5.0,concentration,,,789,ng/ml,median,,,"Q1, Q3",722.6,962.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,281,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,5.0,concentration,,,,,,,,minmax,309.5,1052.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,282,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration,,,291,ng/ml,median,,,"Q1, Q3",89,336,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,283,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration,,,,,,,,minmax,21.1,448.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,284,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration-by-dose-ratio,,,1.5,,median,,,"Q1, Q3",1.43,2.46,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,285,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,serum,maternal,delivery,,9.0,concentration-by-dose-ratio,,,,,,,,minmax,0.63,4.03,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,286,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,9.0,concentration-by-dose-ratio,,,7.02,,median,,,"Q1, Q3",3.51,9.63,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,287,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid,maternal,delivery,,9.0,concentration-by-dose-ratio,,,,,,,,minmax,2.75,12.83,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,288,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration-by-dose-ratio,,,2.37,,median,,,"Q1, Q3",1.29,2.99,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,289,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood,pediatric,,fetus,9.0,concentration-by-dose-ratio,,,,,,,,minmax,0.56,4.48,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,290,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid/maternal serum,maternal,delivery,,5.0,penetration ratio from maternal blood into amniotic fluid,,,2.5,,median,,,"Q1, Q3",2.33,3.19,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,291,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,amniotic fluid/maternal serum,maternal,delivery,,5.0,penetration ratio from maternal blood into amniotic fluid,,,,,,,,minmax,1.12,4.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,292,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood/maternal serum,maternal/pediatric,delivery,fetus,9.0,penetration ratio from maternal blood into umbilicalcord blood,,,1.05,,median,,,"Q1, Q3",0.99,1.16,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,293,2025-12-02T16:05:22.346295
32056930.0,Venlafaxine,sum of VEN+ODV,umbilical cord blood/maternal serum,maternal/pediatric,delivery,fetus,9.0,penetration ratio from maternal blood into umbilicalcord blood,,,,,,,,minmax,0.62,2.08,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,294,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,plasma,maternal,delivery,,12.0,concentration ,,,32.75,ng/ml,median,,,"Q1, Q3",14.4,47.75,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1216,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,plasma,maternal,delivery,,12.0,concentration ,,,,ng/ml,,,,minmax,7,84.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1217,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,amniotic fluid,maternal,delivery,,9.0,concentration ,,,62.8,ng/ml,median,,,"Q1, Q3",16.6,81.55,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1218,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,amniotic fluid,maternal,delivery,,9.0,concentration ,,,,ng/ml,,,,minmax,10.1,123,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1219,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,cord blood,pediatric,,fetus,12.0,concentration ,,,25.15,ng/ml,median,,,"Q1, Q3",13.38,40.98,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1220,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,cord blood,pediatric,,fetus,12.0,concentration ,,,,ng/ml,,,,minmax,5.1,61.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1221,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,serum,maternal,delivery,,12.0,concentration to dose ratio,,,1.75,,median,,,"Q1, Q3",0.93,2.52,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1222,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,serum,maternal,delivery,,12.0,concentration to dose ratio,,,,,,,,minmax,0.53,4.24,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1223,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,Amniotic fluid/maternal serum,maternal,delivery,,12.0,amniotic fluid to maternal serum ratio,,,1.8,,median,,,"Q1, Q3",1.07,2.64,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1224,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,Amniotic fluid/maternal serum,maternal,delivery,,12.0,amniotic fluid to maternal serum ratio,,,,,,,,minmax,0.52,6.97,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1225,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,cord blood/maternal serum,maternal/pediatric,delivery,fetus,12.0,cord-maternal ratio,,,0.78,,median,,,"Q1, Q3",0.52,1.16,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1226,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,cord blood/maternal serum,maternal/pediatric,delivery,fetus,12.0,cord-maternal ratio,,,,,,,,minmax,0.46,1.66,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1227,2025-12-02T16:05:09.448543
28663113.0,citalopram,citalopram,plasma,maternal,delivery,,12.0,concentration ,,,32.75,ng/ml,median,,,"Q1, Q3",14.4,47.75,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1216,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,plasma,maternal,delivery,,12.0,concentration ,,,,ng/ml,,,,minmax,7,84.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1217,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,amniotic fluid,maternal,delivery,,9.0,concentration ,,,62.8,ng/ml,median,,,"Q1, Q3",16.6,81.55,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1218,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,amniotic fluid,maternal,delivery,,9.0,concentration ,,,,ng/ml,,,,minmax,10.1,123,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1219,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,cord blood,pediatric,,fetus,12.0,concentration ,,,25.15,ng/ml,median,,,"Q1, Q3",13.38,40.98,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1220,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,cord blood,pediatric,,fetus,12.0,concentration ,,,,ng/ml,,,,minmax,5.1,61.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1221,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,serum,maternal,delivery,,12.0,concentration to dose ratio,,,1.75,,median,,,"Q1, Q3",0.93,2.52,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1222,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,serum,maternal,delivery,,12.0,concentration to dose ratio,,,,,,,,minmax,0.53,4.24,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1223,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,Amniotic fluid/maternal serum,maternal,delivery,,12.0,amniotic fluid to maternal serum ratio,,,1.8,,median,,,"Q1, Q3",1.07,2.64,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1224,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,Amniotic fluid/maternal serum,maternal,delivery,,12.0,amniotic fluid to maternal serum ratio,,,,,,,,minmax,0.52,6.97,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1225,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,cord blood/maternal serum,maternal/pediatric,delivery,fetus,12.0,cord-maternal ratio,,,0.78,,median,,,"Q1, Q3",0.52,1.16,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1226,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,cord blood/maternal serum,maternal/pediatric,delivery,fetus,12.0,cord-maternal ratio,,,,,,,,minmax,0.46,1.66,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1227,2025-12-02T16:05:12.001940
28663113.0,citalopram,citalopram,plasma,maternal,delivery,,12.0,concentration ,,,32.75,ng/ml,median,,,"Q1, Q3",14.4,47.75,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1210,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,plasma,maternal,delivery,,12.0,concentration ,,,,ng/ml,,,,minmax,7,84.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1211,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,amniotic fluid,maternal,delivery,,9.0,concentration ,,,62.8,ng/ml,median,,,"Q1, Q3",16.6,81.55,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1212,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,amniotic fluid,maternal,delivery,,9.0,concentration ,,,,ng/ml,,,,minmax,10.1,123,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1213,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,cord blood,pediatric,,fetus,12.0,concentration ,,,25.15,ng/ml,median,,,"Q1, Q3",13.38,40.98,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1214,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,cord blood,pediatric,,fetus,12.0,concentration ,,,,ng/ml,,,,minmax,5.1,61.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1215,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,serum,maternal,delivery,,12.0,concentration to dose ratio,,,1.75,,median,,,"Q1, Q3",0.93,2.52,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1216,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,serum,maternal,delivery,,12.0,concentration to dose ratio,,,,,,,,minmax,0.53,4.24,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1217,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,Amniotic fluid/maternal serum,maternal,delivery,,12.0,amniotic fluid to maternal serum ratio,,,1.8,,median,,,"Q1, Q3",1.07,2.64,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1218,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,Amniotic fluid/maternal serum,maternal,delivery,,12.0,amniotic fluid to maternal serum ratio,,,,,,,,minmax,0.52,6.97,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1219,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,cord blood/maternal serum,maternal/pediatric,delivery,fetus,12.0,cord-maternal ratio,,,0.78,,median,,,"Q1, Q3",0.52,1.16,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1220,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,cord blood/maternal serum,maternal/pediatric,delivery,fetus,12.0,cord-maternal ratio,,,,,,,,minmax,0.46,1.66,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1221,2025-12-02T16:05:15.923463
28663113.0,citalopram,citalopram,plasma,maternal,delivery,,12.0,concentration ,,,32.75,ng/ml,median,,,"Q1, Q3",14.4,47.75,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1210,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,plasma,maternal,delivery,,12.0,concentration ,,,,ng/ml,,,,minmax,7,84.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1211,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,amniotic fluid,maternal,delivery,,9.0,concentration ,,,62.8,ng/ml,median,,,"Q1, Q3",16.6,81.55,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1212,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,amniotic fluid,maternal,delivery,,9.0,concentration ,,,,ng/ml,,,,minmax,10.1,123,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1213,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,cord blood,pediatric,,fetus,12.0,concentration ,,,25.15,ng/ml,median,,,"Q1, Q3",13.38,40.98,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1214,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,cord blood,pediatric,,fetus,12.0,concentration ,,,,ng/ml,,,,minmax,5.1,61.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1215,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,serum,maternal,delivery,,12.0,concentration to dose ratio,,,1.75,,median,,,"Q1, Q3",0.93,2.52,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1216,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,serum,maternal,delivery,,12.0,concentration to dose ratio,,,,,,,,minmax,0.53,4.24,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1217,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,Amniotic fluid/maternal serum,maternal,delivery,,12.0,amniotic fluid to maternal serum ratio,,,1.8,,median,,,"Q1, Q3",1.07,2.64,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1218,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,Amniotic fluid/maternal serum,maternal,delivery,,12.0,amniotic fluid to maternal serum ratio,,,,,,,,minmax,0.52,6.97,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1219,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,cord blood/maternal serum,maternal/pediatric,delivery,fetus,12.0,cord-maternal ratio,,,0.78,,median,,,"Q1, Q3",0.52,1.16,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1220,2025-12-02T16:05:22.346295
28663113.0,citalopram,citalopram,cord blood/maternal serum,maternal/pediatric,delivery,fetus,12.0,cord-maternal ratio,,,,,,,,minmax,0.46,1.66,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1221,2025-12-02T16:05:22.346295
19452377.0,Venlafaxine,Venlafaxine,plasma,maternal,delivery,,11.0,concentration,,,45,ug/L,median,,,IQR,23,64,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,334,2025-12-02T16:05:09.448543
19452377.0,Venlafaxine,Venlafaxine,cord venous plasma,pediatric,,fetus,11.0,concentration,,,20,ug/L,median,,,IQR,9,53,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,335,2025-12-02T16:05:09.448543
19452377.0,Venlafaxine,Venlafaxine,plasma,pediatric,,neonate,11.0,concentration,3,days,6,ug/L,median,,,IQR,1.5,12,,on day 3,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,336,2025-12-02T16:05:09.448543
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,,delivery,maternal,11.0,concentration,,,256,ug/L,median,,,IQR,151,294,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,337,2025-12-02T16:05:09.448543
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,cord venous plasma,,,pediatric,11.0,concentration,,,184,ug/L,median,,,IQR,1223,348,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,338,2025-12-02T16:05:09.448543
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,neonate,11.0,concentration,3,days,64,ug/L,median,,,IQR,56,118,,on day 3,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,339,2025-12-02T16:05:09.448543
19452377.0,Venlafaxine,Venlafaxine,maternal /cord venous plasma,,delivery,"maternal, pediatric",11.0,cord/maternal concentration ratio,,,0.72,,median,,,IQR,0.41,1.11,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,340,2025-12-02T16:05:09.448543
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,maternal /cord venous plasma,,delivery,"maternal, pediatric",11.0,cord/maternal concentration ratio,,,1.08,,median,,,IQR,0.68,1.17,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,341,2025-12-02T16:05:09.448543
19452377.0,citalopram,citalopram,plasma,,delivery,maternal,9.0,concentration,,,33,ug/L,median,,,IQR,24,51,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,342,2025-12-02T16:05:09.448543
19452377.0,citalopram,citalopram,cord venous plasma,,,pediatric,9.0,concentration,,,27,ug/L,median,,,IQR,20,50,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,343,2025-12-02T16:05:09.448543
19452377.0,citalopram,citalopram,plasma,pediatric,,neonate,9.0,concentration,3,days,19,ug/L,median,,,IQR,9,31,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,344,2025-12-02T16:05:09.448543
19452377.0,citalopram,N-desmethylcitalopram,plasma,,delivery,maternal,9.0,concentration,,,14,ug/L,median,,,IQR,10,18,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,345,2025-12-02T16:05:09.448543
19452377.0,citalopram,N-desmethylcitalopram,cord venous plasma,,,pediatric,9.0,concentration,,,12,ug/L,median,,,IQR,9,23,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,346,2025-12-02T16:05:09.448543
19452377.0,citalopram,N-desmethylcitalopram,plasma,pediatric,,neonate,9.0,concentration,3,days,11,ug/L,median,,,IQR,6,17,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,347,2025-12-02T16:05:09.448543
19452377.0,citalopram,citalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",9.0,cord/maternal concentration ratio,,,0.83,,median,,,IQR,0.77,0.86,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,348,2025-12-02T16:05:09.448543
19452377.0,citalopram,N-desmethylcitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",9.0,cord/maternal concentration ratio,,,0.86,,median,,,IQR,0.82,1.06,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,349,2025-12-02T16:05:09.448543
19452377.0,escitalopram,escitalopram,plasma,,delivery,maternal,8.0,concentration,,,21,ug/L,median,,,IQR,12,52,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,350,2025-12-02T16:05:09.448543
19452377.0,escitalopram,escitalopram,cord venous plasma,,,pediatric,8.0,concentration,,,17,ug/L,median,,,IQR,10,36,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,351,2025-12-02T16:05:09.448543
19452377.0,escitalopram,escitalopram,plasma,pediatric,,neonate,8.0,concentration,3,days,6,ug/L,median,,,IQR,6,13,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,352,2025-12-02T16:05:09.448543
19452377.0,escitalopram,N-desmethylescitalopram,plasma,,delivery,maternal,8.0,concentration,,,13,ug/L,median,,,IQR,9,16,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,353,2025-12-02T16:05:09.448543
19452377.0,escitalopram,N-desmethylescitalopram,cord venous plasma,,,pediatric,8.0,concentration,,,10,ug/L,median,,,IQR,7,16,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,354,2025-12-02T16:05:09.448543
19452377.0,escitalopram,N-desmethylescitalopram,plasma,pediatric,,neonate,8.0,concentration,3,days,5,ug/L,median,,,IQR,5,7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,355,2025-12-02T16:05:09.448543
19452377.0,escitalopram,escitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",8.0,cord/maternal concentration ratio,,,0.73,,median,,,IQR,0.71,0.91,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,356,2025-12-02T16:05:09.448543
19452377.0,escitalopram,N-desmethylescitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",8.0,cord/maternal concentration ratio,,,0.7,,median,,,IQR,0.66,0.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,357,2025-12-02T16:05:09.448543
19452377.0,fluoxetine,fluoxetine,plasma,,delivery,maternal,2.0,concentration,,,"192, 52",ug/L,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,358,2025-12-02T16:05:09.448543
19452377.0,fluoxetine,fluoxetine,cord venous plasma,,,pediatric,2.0,concentration,,,"141, 37",ug/L,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,359,2025-12-02T16:05:09.448543
19452377.0,fluoxetine,fluoxetine,plasma,pediatric,,neonate,2.0,concentration,3,days,"NA, 20",ug/L,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,360,2025-12-02T16:05:09.448543
19452377.0,fluoxetine,norfluoxetine,plasma,,delivery,maternal,2.0,concentration,,,"52, 126",ug/L,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,361,2025-12-02T16:05:09.448543
19452377.0,fluoxetine,norfluoxetine,cord venous plasma,,,pediatric,2.0,concentration,,,"226, 99",ug/L,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,362,2025-12-02T16:05:09.448543
19452377.0,fluoxetine,norfluoxetine,plasma,pediatric,,neonate,2.0,concentration,3,days,"NA, 45",ug/L,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,363,2025-12-02T16:05:09.448543
19452377.0,fluoxetine,fluoxetine,maternal /cord venous plasma,,delivery,"maternal, pediatric",2.0,cord/maternal concentration ratio,,,"0.73, 0.71",,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,364,2025-12-02T16:05:09.448543
19452377.0,fluoxetine,norfluoxetine,maternal /cord venous plasma,,delivery,"maternal, pediatric",2.0,cord/maternal concentration ratio,,,"0.77, 0.79",,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,365,2025-12-02T16:05:09.448543
19452377.0,paroxetine,paroxetine,plasma,,delivery,maternal,1.0,concentration,,,13,ug/L,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,366,2025-12-02T16:05:09.448543
19452377.0,paroxetine,paroxetine,cord venous plasma,,,pediatric,1.0,concentration,,,2,ug/L,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,367,2025-12-02T16:05:09.448543
19452377.0,paroxetine,paroxetine,plasma,pediatric,,neonate,1.0,concentration,3,days,,ug/L,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,368,2025-12-02T16:05:09.448543
19452377.0,paroxetine,paroxetine,cord venous plasma,pediatric,,fetus,1.0,cord/maternal concentration ratio,,,0.15,,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,369,2025-12-02T16:05:09.448543
19452377.0,Venlafaxine,Venlafaxine,plasma,maternal,delivery,,11.0,concentration,,,45,ug/L,median,,,IQR,23,64,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,334,2025-12-02T16:05:12.001940
19452377.0,Venlafaxine,Venlafaxine,cord venous plasma,pediatric,,fetus,11.0,concentration,,,20,ug/L,median,,,IQR,9,53,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,335,2025-12-02T16:05:12.001940
19452377.0,Venlafaxine,Venlafaxine,plasma,pediatric,,neonate,11.0,concentration,3,days,6,ug/L,median,,,IQR,1.5,12,,on day 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,336,2025-12-02T16:05:12.001940
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,,delivery,maternal,11.0,concentration,,,256,ug/L,median,,,IQR,151,294,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,337,2025-12-02T16:05:12.001940
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,cord venous plasma,,,pediatric,11.0,concentration,,,184,ug/L,median,,,IQR,1223,348,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,338,2025-12-02T16:05:12.001940
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,neonate,11.0,concentration,3,days,64,ug/L,median,,,IQR,56,118,,on day 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,339,2025-12-02T16:05:12.001940
19452377.0,Venlafaxine,Venlafaxine,maternal /cord venous plasma,,delivery,"maternal, pediatric",11.0,cord/maternal concentration ratio,,,0.72,,median,,,IQR,0.41,1.11,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,340,2025-12-02T16:05:12.001940
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,maternal /cord venous plasma,,delivery,"maternal, pediatric",11.0,cord/maternal concentration ratio,,,1.08,,median,,,IQR,0.68,1.17,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,341,2025-12-02T16:05:12.001940
19452377.0,citalopram,citalopram,plasma,,delivery,maternal,9.0,concentration,,,33,ug/L,median,,,IQR,24,51,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,342,2025-12-02T16:05:12.001940
19452377.0,citalopram,citalopram,cord venous plasma,,,pediatric,9.0,concentration,,,27,ug/L,median,,,IQR,20,50,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,343,2025-12-02T16:05:12.001940
19452377.0,citalopram,citalopram,plasma,pediatric,,neonate,9.0,concentration,3,days,19,ug/L,median,,,IQR,9,31,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,344,2025-12-02T16:05:12.001940
19452377.0,citalopram,N-desmethylcitalopram,plasma,,delivery,maternal,9.0,concentration,,,14,ug/L,median,,,IQR,10,18,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,345,2025-12-02T16:05:12.001940
19452377.0,citalopram,N-desmethylcitalopram,cord venous plasma,,,pediatric,9.0,concentration,,,12,ug/L,median,,,IQR,9,23,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,346,2025-12-02T16:05:12.001940
19452377.0,citalopram,N-desmethylcitalopram,plasma,pediatric,,neonate,9.0,concentration,3,days,11,ug/L,median,,,IQR,6,17,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,347,2025-12-02T16:05:12.001940
19452377.0,citalopram,citalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",9.0,cord/maternal concentration ratio,,,0.83,,median,,,IQR,0.77,0.86,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,348,2025-12-02T16:05:12.001940
19452377.0,citalopram,N-desmethylcitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",9.0,cord/maternal concentration ratio,,,0.86,,median,,,IQR,0.82,1.06,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,349,2025-12-02T16:05:12.001940
19452377.0,escitalopram,escitalopram,plasma,,delivery,maternal,8.0,concentration,,,21,ug/L,median,,,IQR,12,52,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,350,2025-12-02T16:05:12.001940
19452377.0,escitalopram,escitalopram,cord venous plasma,,,pediatric,8.0,concentration,,,17,ug/L,median,,,IQR,10,36,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,351,2025-12-02T16:05:12.001940
19452377.0,escitalopram,escitalopram,plasma,pediatric,,neonate,8.0,concentration,3,days,6,ug/L,median,,,IQR,6,13,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,352,2025-12-02T16:05:12.001940
19452377.0,escitalopram,N-desmethylescitalopram,plasma,,delivery,maternal,8.0,concentration,,,13,ug/L,median,,,IQR,9,16,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,353,2025-12-02T16:05:12.001940
19452377.0,escitalopram,N-desmethylescitalopram,cord venous plasma,,,pediatric,8.0,concentration,,,10,ug/L,median,,,IQR,7,16,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,354,2025-12-02T16:05:12.001940
19452377.0,escitalopram,N-desmethylescitalopram,plasma,pediatric,,neonate,8.0,concentration,3,days,5,ug/L,median,,,IQR,5,7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,355,2025-12-02T16:05:12.001940
19452377.0,escitalopram,escitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",8.0,cord/maternal concentration ratio,,,0.73,,median,,,IQR,0.71,0.91,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,356,2025-12-02T16:05:12.001940
19452377.0,escitalopram,N-desmethylescitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",8.0,cord/maternal concentration ratio,,,0.7,,median,,,IQR,0.66,0.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,357,2025-12-02T16:05:12.001940
19452377.0,fluoxetine,fluoxetine,plasma,,delivery,maternal,2.0,concentration,,,"192, 52",ug/L,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,358,2025-12-02T16:05:12.001940
19452377.0,fluoxetine,fluoxetine,cord venous plasma,,,pediatric,2.0,concentration,,,"141, 37",ug/L,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,359,2025-12-02T16:05:12.001940
19452377.0,fluoxetine,fluoxetine,plasma,pediatric,,neonate,2.0,concentration,3,days,"NA, 20",ug/L,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,360,2025-12-02T16:05:12.001940
19452377.0,fluoxetine,norfluoxetine,plasma,,delivery,maternal,2.0,concentration,,,"52, 126",ug/L,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,361,2025-12-02T16:05:12.001940
19452377.0,fluoxetine,norfluoxetine,cord venous plasma,,,pediatric,2.0,concentration,,,"226, 99",ug/L,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,362,2025-12-02T16:05:12.001940
19452377.0,fluoxetine,norfluoxetine,plasma,pediatric,,neonate,2.0,concentration,3,days,"NA, 45",ug/L,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,363,2025-12-02T16:05:12.001940
19452377.0,fluoxetine,fluoxetine,maternal /cord venous plasma,,delivery,"maternal, pediatric",2.0,cord/maternal concentration ratio,,,"0.73, 0.71",,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,364,2025-12-02T16:05:12.001940
19452377.0,fluoxetine,norfluoxetine,maternal /cord venous plasma,,delivery,"maternal, pediatric",2.0,cord/maternal concentration ratio,,,"0.77, 0.79",,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,365,2025-12-02T16:05:12.001940
19452377.0,paroxetine,paroxetine,plasma,,delivery,maternal,1.0,concentration,,,13,ug/L,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,366,2025-12-02T16:05:12.001940
19452377.0,paroxetine,paroxetine,cord venous plasma,,,pediatric,1.0,concentration,,,2,ug/L,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,367,2025-12-02T16:05:12.001940
19452377.0,paroxetine,paroxetine,plasma,pediatric,,neonate,1.0,concentration,3,days,,ug/L,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,368,2025-12-02T16:05:12.001940
19452377.0,paroxetine,paroxetine,cord venous plasma,pediatric,,fetus,1.0,cord/maternal concentration ratio,,,0.15,,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,369,2025-12-02T16:05:12.001940
19452377.0,Venlafaxine,Venlafaxine,plasma,maternal,delivery,,11.0,concentration,,,45,ug/L,median,,,IQR,23,64,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,328,2025-12-02T16:05:15.923463
19452377.0,Venlafaxine,Venlafaxine,cord venous plasma,pediatric,,fetus,11.0,concentration,,,20,ug/L,median,,,IQR,9,53,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,329,2025-12-02T16:05:15.923463
19452377.0,Venlafaxine,Venlafaxine,plasma,pediatric,,neonate,11.0,concentration,3,days,6,ug/L,median,,,IQR,1.5,12,,on day 3,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,330,2025-12-02T16:05:15.923463
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,,delivery,maternal,11.0,concentration,,,256,ug/L,median,,,IQR,151,294,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,331,2025-12-02T16:05:15.923463
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,cord venous plasma,,,pediatric,11.0,concentration,,,184,ug/L,median,,,IQR,1223,348,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,332,2025-12-02T16:05:15.923463
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,neonate,11.0,concentration,3,days,64,ug/L,median,,,IQR,56,118,,on day 3,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,333,2025-12-02T16:05:15.923463
19452377.0,Venlafaxine,Venlafaxine,maternal /cord venous plasma,,delivery,"maternal, pediatric",11.0,cord/maternal concentration ratio,,,0.72,,median,,,IQR,0.41,1.11,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,334,2025-12-02T16:05:15.923463
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,maternal /cord venous plasma,,delivery,"maternal, pediatric",11.0,cord/maternal concentration ratio,,,1.08,,median,,,IQR,0.68,1.17,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,335,2025-12-02T16:05:15.923463
19452377.0,citalopram,citalopram,plasma,,delivery,maternal,9.0,concentration,,,33,ug/L,median,,,IQR,24,51,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,336,2025-12-02T16:05:15.923463
19452377.0,citalopram,citalopram,cord venous plasma,,,pediatric,9.0,concentration,,,27,ug/L,median,,,IQR,20,50,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,337,2025-12-02T16:05:15.923463
19452377.0,citalopram,citalopram,plasma,pediatric,,neonate,9.0,concentration,3,days,19,ug/L,median,,,IQR,9,31,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,338,2025-12-02T16:05:15.923463
19452377.0,citalopram,N-desmethylcitalopram,plasma,,delivery,maternal,9.0,concentration,,,14,ug/L,median,,,IQR,10,18,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,339,2025-12-02T16:05:15.923463
19452377.0,citalopram,N-desmethylcitalopram,cord venous plasma,,,pediatric,9.0,concentration,,,12,ug/L,median,,,IQR,9,23,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,340,2025-12-02T16:05:15.923463
19452377.0,citalopram,N-desmethylcitalopram,plasma,pediatric,,neonate,9.0,concentration,3,days,11,ug/L,median,,,IQR,6,17,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,341,2025-12-02T16:05:15.923463
19452377.0,citalopram,citalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",9.0,cord/maternal concentration ratio,,,0.83,,median,,,IQR,0.77,0.86,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,342,2025-12-02T16:05:15.923463
19452377.0,citalopram,N-desmethylcitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",9.0,cord/maternal concentration ratio,,,0.86,,median,,,IQR,0.82,1.06,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,343,2025-12-02T16:05:15.923463
19452377.0,escitalopram,escitalopram,plasma,,delivery,maternal,8.0,concentration,,,21,ug/L,median,,,IQR,12,52,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,344,2025-12-02T16:05:15.923463
19452377.0,escitalopram,escitalopram,cord venous plasma,,,pediatric,8.0,concentration,,,17,ug/L,median,,,IQR,10,36,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,345,2025-12-02T16:05:15.923463
19452377.0,escitalopram,escitalopram,plasma,pediatric,,neonate,8.0,concentration,3,days,6,ug/L,median,,,IQR,6,13,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,346,2025-12-02T16:05:15.923463
19452377.0,escitalopram,N-desmethylescitalopram,plasma,,delivery,maternal,8.0,concentration,,,13,ug/L,median,,,IQR,9,16,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,347,2025-12-02T16:05:15.923463
19452377.0,escitalopram,N-desmethylescitalopram,cord venous plasma,,,pediatric,8.0,concentration,,,10,ug/L,median,,,IQR,7,16,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,348,2025-12-02T16:05:15.923463
19452377.0,escitalopram,N-desmethylescitalopram,plasma,pediatric,,neonate,8.0,concentration,3,days,5,ug/L,median,,,IQR,5,7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,349,2025-12-02T16:05:15.923463
19452377.0,escitalopram,escitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",8.0,cord/maternal concentration ratio,,,0.73,,median,,,IQR,0.71,0.91,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,350,2025-12-02T16:05:15.923463
19452377.0,escitalopram,N-desmethylescitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",8.0,cord/maternal concentration ratio,,,0.7,,median,,,IQR,0.66,0.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,351,2025-12-02T16:05:15.923463
19452377.0,fluoxetine,fluoxetine,plasma,,delivery,maternal,2.0,concentration,,,"192, 52",ug/L,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,352,2025-12-02T16:05:15.923463
19452377.0,fluoxetine,fluoxetine,cord venous plasma,,,pediatric,2.0,concentration,,,"141, 37",ug/L,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,353,2025-12-02T16:05:15.923463
19452377.0,fluoxetine,fluoxetine,plasma,pediatric,,neonate,2.0,concentration,3,days,"NA, 20",ug/L,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,354,2025-12-02T16:05:15.923463
19452377.0,fluoxetine,norfluoxetine,plasma,,delivery,maternal,2.0,concentration,,,"52, 126",ug/L,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,355,2025-12-02T16:05:15.923463
19452377.0,fluoxetine,norfluoxetine,cord venous plasma,,,pediatric,2.0,concentration,,,"226, 99",ug/L,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,356,2025-12-02T16:05:15.923463
19452377.0,fluoxetine,norfluoxetine,plasma,pediatric,,neonate,2.0,concentration,3,days,"NA, 45",ug/L,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,357,2025-12-02T16:05:15.923463
19452377.0,fluoxetine,fluoxetine,maternal /cord venous plasma,,delivery,"maternal, pediatric",2.0,cord/maternal concentration ratio,,,"0.73, 0.71",,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,358,2025-12-02T16:05:15.923463
19452377.0,fluoxetine,norfluoxetine,maternal /cord venous plasma,,delivery,"maternal, pediatric",2.0,cord/maternal concentration ratio,,,"0.77, 0.79",,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,359,2025-12-02T16:05:15.923463
19452377.0,paroxetine,paroxetine,plasma,,delivery,maternal,1.0,concentration,,,13,ug/L,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,360,2025-12-02T16:05:15.923463
19452377.0,paroxetine,paroxetine,cord venous plasma,,,pediatric,1.0,concentration,,,2,ug/L,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,361,2025-12-02T16:05:15.923463
19452377.0,paroxetine,paroxetine,plasma,pediatric,,neonate,1.0,concentration,3,days,,ug/L,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,362,2025-12-02T16:05:15.923463
19452377.0,paroxetine,paroxetine,cord venous plasma,pediatric,,fetus,1.0,cord/maternal concentration ratio,,,0.15,,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,363,2025-12-02T16:05:15.923463
19452377.0,Venlafaxine,Venlafaxine,plasma,maternal,delivery,,11.0,concentration,,,45,ug/L,median,,,IQR,23,64,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,328,2025-12-02T16:05:22.346295
19452377.0,Venlafaxine,Venlafaxine,cord venous plasma,pediatric,,fetus,11.0,concentration,,,20,ug/L,median,,,IQR,9,53,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,329,2025-12-02T16:05:22.346295
19452377.0,Venlafaxine,Venlafaxine,plasma,pediatric,,neonate,11.0,concentration,3,days,6,ug/L,median,,,IQR,1.5,12,,on day 3,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,330,2025-12-02T16:05:22.346295
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,,delivery,maternal,11.0,concentration,,,256,ug/L,median,,,IQR,151,294,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,331,2025-12-02T16:05:22.346295
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,cord venous plasma,,,pediatric,11.0,concentration,,,184,ug/L,median,,,IQR,1223,348,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,332,2025-12-02T16:05:22.346295
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,neonate,11.0,concentration,3,days,64,ug/L,median,,,IQR,56,118,,on day 3,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,333,2025-12-02T16:05:22.346295
19452377.0,Venlafaxine,Venlafaxine,maternal /cord venous plasma,,delivery,"maternal, pediatric",11.0,cord/maternal concentration ratio,,,0.72,,median,,,IQR,0.41,1.11,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,334,2025-12-02T16:05:22.346295
19452377.0,Venlafaxine,O-Desmethylvenlafaxine,maternal /cord venous plasma,,delivery,"maternal, pediatric",11.0,cord/maternal concentration ratio,,,1.08,,median,,,IQR,0.68,1.17,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,335,2025-12-02T16:05:22.346295
19452377.0,citalopram,citalopram,plasma,,delivery,maternal,9.0,concentration,,,33,ug/L,median,,,IQR,24,51,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,336,2025-12-02T16:05:22.346295
19452377.0,citalopram,citalopram,cord venous plasma,,,pediatric,9.0,concentration,,,27,ug/L,median,,,IQR,20,50,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,337,2025-12-02T16:05:22.346295
19452377.0,citalopram,citalopram,plasma,pediatric,,neonate,9.0,concentration,3,days,19,ug/L,median,,,IQR,9,31,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,338,2025-12-02T16:05:22.346295
19452377.0,citalopram,N-desmethylcitalopram,plasma,,delivery,maternal,9.0,concentration,,,14,ug/L,median,,,IQR,10,18,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,339,2025-12-02T16:05:22.346295
19452377.0,citalopram,N-desmethylcitalopram,cord venous plasma,,,pediatric,9.0,concentration,,,12,ug/L,median,,,IQR,9,23,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,340,2025-12-02T16:05:22.346295
19452377.0,citalopram,N-desmethylcitalopram,plasma,pediatric,,neonate,9.0,concentration,3,days,11,ug/L,median,,,IQR,6,17,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,341,2025-12-02T16:05:22.346295
19452377.0,citalopram,citalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",9.0,cord/maternal concentration ratio,,,0.83,,median,,,IQR,0.77,0.86,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,342,2025-12-02T16:05:22.346295
19452377.0,citalopram,N-desmethylcitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",9.0,cord/maternal concentration ratio,,,0.86,,median,,,IQR,0.82,1.06,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,343,2025-12-02T16:05:22.346295
19452377.0,escitalopram,escitalopram,plasma,,delivery,maternal,8.0,concentration,,,21,ug/L,median,,,IQR,12,52,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,344,2025-12-02T16:05:22.346295
19452377.0,escitalopram,escitalopram,cord venous plasma,,,pediatric,8.0,concentration,,,17,ug/L,median,,,IQR,10,36,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,345,2025-12-02T16:05:22.346295
19452377.0,escitalopram,escitalopram,plasma,pediatric,,neonate,8.0,concentration,3,days,6,ug/L,median,,,IQR,6,13,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,346,2025-12-02T16:05:22.346295
19452377.0,escitalopram,N-desmethylescitalopram,plasma,,delivery,maternal,8.0,concentration,,,13,ug/L,median,,,IQR,9,16,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,347,2025-12-02T16:05:22.346295
19452377.0,escitalopram,N-desmethylescitalopram,cord venous plasma,,,pediatric,8.0,concentration,,,10,ug/L,median,,,IQR,7,16,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,348,2025-12-02T16:05:22.346295
19452377.0,escitalopram,N-desmethylescitalopram,plasma,pediatric,,neonate,8.0,concentration,3,days,5,ug/L,median,,,IQR,5,7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,349,2025-12-02T16:05:22.346295
19452377.0,escitalopram,escitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",8.0,cord/maternal concentration ratio,,,0.73,,median,,,IQR,0.71,0.91,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,350,2025-12-02T16:05:22.346295
19452377.0,escitalopram,N-desmethylescitalopram,maternal /cord venous plasma,,delivery,"maternal, pediatric",8.0,cord/maternal concentration ratio,,,0.7,,median,,,IQR,0.66,0.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,351,2025-12-02T16:05:22.346295
19452377.0,fluoxetine,fluoxetine,plasma,,delivery,maternal,2.0,concentration,,,"192, 52",ug/L,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,352,2025-12-02T16:05:22.346295
19452377.0,fluoxetine,fluoxetine,cord venous plasma,,,pediatric,2.0,concentration,,,"141, 37",ug/L,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,353,2025-12-02T16:05:22.346295
19452377.0,fluoxetine,fluoxetine,plasma,pediatric,,neonate,2.0,concentration,3,days,"NA, 20",ug/L,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,354,2025-12-02T16:05:22.346295
19452377.0,fluoxetine,norfluoxetine,plasma,,delivery,maternal,2.0,concentration,,,"52, 126",ug/L,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,355,2025-12-02T16:05:22.346295
19452377.0,fluoxetine,norfluoxetine,cord venous plasma,,,pediatric,2.0,concentration,,,"226, 99",ug/L,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,356,2025-12-02T16:05:22.346295
19452377.0,fluoxetine,norfluoxetine,plasma,pediatric,,neonate,2.0,concentration,3,days,"NA, 45",ug/L,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,357,2025-12-02T16:05:22.346295
19452377.0,fluoxetine,fluoxetine,maternal /cord venous plasma,,delivery,"maternal, pediatric",2.0,cord/maternal concentration ratio,,,"0.73, 0.71",,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,358,2025-12-02T16:05:22.346295
19452377.0,fluoxetine,norfluoxetine,maternal /cord venous plasma,,delivery,"maternal, pediatric",2.0,cord/maternal concentration ratio,,,"0.77, 0.79",,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,359,2025-12-02T16:05:22.346295
19452377.0,paroxetine,paroxetine,plasma,,delivery,maternal,1.0,concentration,,,13,ug/L,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,360,2025-12-02T16:05:22.346295
19452377.0,paroxetine,paroxetine,cord venous plasma,,,pediatric,1.0,concentration,,,2,ug/L,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,361,2025-12-02T16:05:22.346295
19452377.0,paroxetine,paroxetine,plasma,pediatric,,neonate,1.0,concentration,3,days,,ug/L,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,362,2025-12-02T16:05:22.346295
19452377.0,paroxetine,paroxetine,cord venous plasma,pediatric,,fetus,1.0,cord/maternal concentration ratio,,,0.15,,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,363,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,152,nmol/L,mean,SD,107,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,892,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,364,nmol/L,mean,SD,73,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,893,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,516,nmol/L,mean,SD,180,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,894,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,480,nmol/L,mean,SD,115,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,895,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,Delivery,,10.0,concentration,,,184,nmol/L,mean,SD,121,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,896,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,Delivery,,10.0,concentration,,,310,nmol/L,mean,SD,102,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,897,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,Delivery,,10.0,concentration,,,494,nmol/L,mean,SD,223,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,898,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,Delivery,,10.0,concentration,,,421,nmol/L,mean,SD,108,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,899,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 d,11.0,concentration,,,154,nmol/L,mean,SD,109,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,900,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 d,11.0,concentration,,,274,nmol/L,mean,SD,85,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,901,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 d,11.0,concentration,,,428,nmol/L,mean,SD,194,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,902,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 d,11.0,concentration,,,383,nmol/L,mean,SD,89,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,903,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,4 d,11.0,concentration,,,183,nmol/L,mean,SD,122,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,904,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,4 d,11.0,concentration,,,281,nmol/L,mean,SD,87,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,905,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,4 d,11.0,concentration,,,464,nmol/L,mean,SD,197,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,906,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,4 d,11.0,concentration,,,413,nmol/L,mean,SD,116,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,907,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 wk,9.0,concentration,,,338,nmol/L,mean,SD,166,,,,,<.05,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,908,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 wk,9.0,concentration,,,365,nmol/L,mean,SD,109,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,909,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 wk,9.0,concentration,,,703,nmol/L,mean,SD,275,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,910,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 wk,9.0,concentration,,,627,nmol/L,mean,SD,187,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,911,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 mo,8.0,concentration,,,388,nmol/L,mean,SD,190,,,,,<.05,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,912,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 mo,8.0,concentration,,,310,nmol/L,mean,SD,161,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,913,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 mo,8.0,concentration,,,770,nmol/L,mean,SD,287,,,,,<.05,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,914,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 mo,8.0,concentration,,,705,nmol/L,mean,SD,222,,,,,<.05,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,915,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,at birth,10.0,concentration,,,112,nmol/L,mean,SD,75,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,916,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,at birth,10.0,concentration,,,209,nmol/L,mean,SD,79,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,917,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,at birth,10.0,concentration,,,322,nmol/L,mean,SD,154,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,918,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,at birth,10.0,concentration,,,278,nmol/L,mean,SD,85,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,919,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 d,,119,nmol/L,mean,SD,104,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,920,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 d,,215,nmol/L,mean,SD,69,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,921,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 d,,334,nmol/L,mean,SD,173,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,922,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 d,,303,nmol/L,mean,SD,139,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,923,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,4 d,,71,nmol/L,mean,SD,52,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,924,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,4 d,,169,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,925,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,4 d,,239,nmol/L,mean,SD,102,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,926,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,4 d,,219,nmol/L,mean,SD,91,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,927,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 wk,,24,nmol/L,mean,SD,38,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,928,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 wk,,140,nmol/L,mean,SD,86,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,929,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 wk,,164,nmol/L,mean,SD,123,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,930,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 wk,,155,nmol/L,mean,SD,125,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,931,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,infant,8.0,concentration,2 mo,,ND,nmol/L,mean,SD,ND,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,932,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,infant,8.0,concentration,2 mo,,20,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,933,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,infant,8.0,concentration,2 mo,,22,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,934,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,infant,8.0,concentration,2 mo,,22,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,935,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,4 d,11.0,concentration,,,159,nmol/L,mean,SD,117,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,936,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,4 d,11.0,concentration,,,143,nmol/L,mean,SD,113,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,937,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,4 d,11.0,concentration,,,340,nmol/L,mean,SD,256,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,938,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,4 d,11.0,concentration,,,296,nmol/L,mean,SD,201,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,939,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,2 wk,9.0,concentration,,,183,nmol/L,mean,SD,113,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,940,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,2 wk,9.0,concentration,,,86,nmol/L,mean,SD,59,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,941,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 wk,9.0,concentration,,,269,nmol/L,mean,SD,172,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,942,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 wk,9.0,concentration,,,244,nmol/L,mean,SD,140,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,943,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,2 mo,8.0,concentration,,,193,nmol/L,mean,SD,87,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,944,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,2 mo,8.0,concentration,,,92,nmol/L,mean,SD,34,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,945,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 mo,8.0,concentration,,,385,nmol/L,mean,SD,112,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,946,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 mo,8.0,concentration,,,285,nmol/L,mean,SD,112,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,947,2025-12-02T16:05:09.448543
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,152,nmol/L,mean,SD,107,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,892,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,364,nmol/L,mean,SD,73,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,893,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,516,nmol/L,mean,SD,180,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,894,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,480,nmol/L,mean,SD,115,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,895,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,Delivery,,10.0,concentration,,,184,nmol/L,mean,SD,121,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,896,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,Delivery,,10.0,concentration,,,310,nmol/L,mean,SD,102,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,897,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,Delivery,,10.0,concentration,,,494,nmol/L,mean,SD,223,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,898,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,Delivery,,10.0,concentration,,,421,nmol/L,mean,SD,108,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,899,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 d,11.0,concentration,,,154,nmol/L,mean,SD,109,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,900,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 d,11.0,concentration,,,274,nmol/L,mean,SD,85,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,901,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 d,11.0,concentration,,,428,nmol/L,mean,SD,194,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,902,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 d,11.0,concentration,,,383,nmol/L,mean,SD,89,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,903,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,4 d,11.0,concentration,,,183,nmol/L,mean,SD,122,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,904,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,4 d,11.0,concentration,,,281,nmol/L,mean,SD,87,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,905,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,4 d,11.0,concentration,,,464,nmol/L,mean,SD,197,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,906,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,4 d,11.0,concentration,,,413,nmol/L,mean,SD,116,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,907,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 wk,9.0,concentration,,,338,nmol/L,mean,SD,166,,,,,<.05,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,908,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 wk,9.0,concentration,,,365,nmol/L,mean,SD,109,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,909,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 wk,9.0,concentration,,,703,nmol/L,mean,SD,275,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,910,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 wk,9.0,concentration,,,627,nmol/L,mean,SD,187,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,911,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 mo,8.0,concentration,,,388,nmol/L,mean,SD,190,,,,,<.05,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,912,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 mo,8.0,concentration,,,310,nmol/L,mean,SD,161,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,913,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 mo,8.0,concentration,,,770,nmol/L,mean,SD,287,,,,,<.05,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,914,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 mo,8.0,concentration,,,705,nmol/L,mean,SD,222,,,,,<.05,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,915,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,at birth,10.0,concentration,,,112,nmol/L,mean,SD,75,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,916,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,at birth,10.0,concentration,,,209,nmol/L,mean,SD,79,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,917,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,at birth,10.0,concentration,,,322,nmol/L,mean,SD,154,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,918,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,at birth,10.0,concentration,,,278,nmol/L,mean,SD,85,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,919,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 d,,119,nmol/L,mean,SD,104,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,920,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 d,,215,nmol/L,mean,SD,69,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,921,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 d,,334,nmol/L,mean,SD,173,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,922,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 d,,303,nmol/L,mean,SD,139,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,923,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,4 d,,71,nmol/L,mean,SD,52,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,924,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,4 d,,169,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,925,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,4 d,,239,nmol/L,mean,SD,102,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,926,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,4 d,,219,nmol/L,mean,SD,91,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,927,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 wk,,24,nmol/L,mean,SD,38,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,928,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 wk,,140,nmol/L,mean,SD,86,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,929,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 wk,,164,nmol/L,mean,SD,123,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,930,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 wk,,155,nmol/L,mean,SD,125,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,931,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,infant,8.0,concentration,2 mo,,ND,nmol/L,mean,SD,ND,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,932,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,infant,8.0,concentration,2 mo,,20,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,933,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,infant,8.0,concentration,2 mo,,22,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,934,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,infant,8.0,concentration,2 mo,,22,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,935,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,4 d,11.0,concentration,,,159,nmol/L,mean,SD,117,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,936,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,4 d,11.0,concentration,,,143,nmol/L,mean,SD,113,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,937,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,4 d,11.0,concentration,,,340,nmol/L,mean,SD,256,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,938,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,4 d,11.0,concentration,,,296,nmol/L,mean,SD,201,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,939,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,2 wk,9.0,concentration,,,183,nmol/L,mean,SD,113,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,940,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,2 wk,9.0,concentration,,,86,nmol/L,mean,SD,59,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,941,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 wk,9.0,concentration,,,269,nmol/L,mean,SD,172,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,942,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 wk,9.0,concentration,,,244,nmol/L,mean,SD,140,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,943,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,2 mo,8.0,concentration,,,193,nmol/L,mean,SD,87,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,944,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,2 mo,8.0,concentration,,,92,nmol/L,mean,SD,34,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,945,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 mo,8.0,concentration,,,385,nmol/L,mean,SD,112,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,946,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 mo,8.0,concentration,,,285,nmol/L,mean,SD,112,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,947,2025-12-02T16:05:12.001940
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,152,nmol/L,mean,SD,107,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,886,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,364,nmol/L,mean,SD,73,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,887,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,516,nmol/L,mean,SD,180,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,888,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,480,nmol/L,mean,SD,115,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,889,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,Delivery,,10.0,concentration,,,184,nmol/L,mean,SD,121,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,890,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,Delivery,,10.0,concentration,,,310,nmol/L,mean,SD,102,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,891,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,Delivery,,10.0,concentration,,,494,nmol/L,mean,SD,223,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,892,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,Delivery,,10.0,concentration,,,421,nmol/L,mean,SD,108,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,893,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 d,11.0,concentration,,,154,nmol/L,mean,SD,109,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,894,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 d,11.0,concentration,,,274,nmol/L,mean,SD,85,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,895,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 d,11.0,concentration,,,428,nmol/L,mean,SD,194,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,896,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 d,11.0,concentration,,,383,nmol/L,mean,SD,89,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,897,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,4 d,11.0,concentration,,,183,nmol/L,mean,SD,122,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,898,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,4 d,11.0,concentration,,,281,nmol/L,mean,SD,87,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,899,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,4 d,11.0,concentration,,,464,nmol/L,mean,SD,197,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,900,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,4 d,11.0,concentration,,,413,nmol/L,mean,SD,116,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,901,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 wk,9.0,concentration,,,338,nmol/L,mean,SD,166,,,,,<.05,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,902,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 wk,9.0,concentration,,,365,nmol/L,mean,SD,109,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,903,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 wk,9.0,concentration,,,703,nmol/L,mean,SD,275,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,904,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 wk,9.0,concentration,,,627,nmol/L,mean,SD,187,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,905,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 mo,8.0,concentration,,,388,nmol/L,mean,SD,190,,,,,<.05,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,906,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 mo,8.0,concentration,,,310,nmol/L,mean,SD,161,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,907,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 mo,8.0,concentration,,,770,nmol/L,mean,SD,287,,,,,<.05,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,908,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 mo,8.0,concentration,,,705,nmol/L,mean,SD,222,,,,,<.05,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,909,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,at birth,10.0,concentration,,,112,nmol/L,mean,SD,75,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,910,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,at birth,10.0,concentration,,,209,nmol/L,mean,SD,79,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,911,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,at birth,10.0,concentration,,,322,nmol/L,mean,SD,154,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,912,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,at birth,10.0,concentration,,,278,nmol/L,mean,SD,85,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,913,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 d,,119,nmol/L,mean,SD,104,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,914,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 d,,215,nmol/L,mean,SD,69,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,915,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 d,,334,nmol/L,mean,SD,173,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,916,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 d,,303,nmol/L,mean,SD,139,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,917,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,4 d,,71,nmol/L,mean,SD,52,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,918,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,4 d,,169,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,919,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,4 d,,239,nmol/L,mean,SD,102,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,920,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,4 d,,219,nmol/L,mean,SD,91,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,921,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 wk,,24,nmol/L,mean,SD,38,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,922,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 wk,,140,nmol/L,mean,SD,86,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,923,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 wk,,164,nmol/L,mean,SD,123,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,924,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 wk,,155,nmol/L,mean,SD,125,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,925,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,infant,8.0,concentration,2 mo,,ND,nmol/L,mean,SD,ND,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,926,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,infant,8.0,concentration,2 mo,,20,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,927,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,infant,8.0,concentration,2 mo,,22,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,928,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,infant,8.0,concentration,2 mo,,22,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,929,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,4 d,11.0,concentration,,,159,nmol/L,mean,SD,117,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,930,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,4 d,11.0,concentration,,,143,nmol/L,mean,SD,113,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,931,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,4 d,11.0,concentration,,,340,nmol/L,mean,SD,256,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,932,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,4 d,11.0,concentration,,,296,nmol/L,mean,SD,201,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,933,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,2 wk,9.0,concentration,,,183,nmol/L,mean,SD,113,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,934,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,2 wk,9.0,concentration,,,86,nmol/L,mean,SD,59,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,935,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 wk,9.0,concentration,,,269,nmol/L,mean,SD,172,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,936,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 wk,9.0,concentration,,,244,nmol/L,mean,SD,140,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,937,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,2 mo,8.0,concentration,,,193,nmol/L,mean,SD,87,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,938,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,2 mo,8.0,concentration,,,92,nmol/L,mean,SD,34,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,939,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 mo,8.0,concentration,,,385,nmol/L,mean,SD,112,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,940,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 mo,8.0,concentration,,,285,nmol/L,mean,SD,112,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,941,2025-12-02T16:05:15.923463
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,152,nmol/L,mean,SD,107,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,886,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,364,nmol/L,mean,SD,73,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,887,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,516,nmol/L,mean,SD,180,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,888,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,pregnancy,3637 wk,8.0,concentration,,,480,nmol/L,mean,SD,115,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,889,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,Delivery,,10.0,concentration,,,184,nmol/L,mean,SD,121,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,890,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,Delivery,,10.0,concentration,,,310,nmol/L,mean,SD,102,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,891,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,Delivery,,10.0,concentration,,,494,nmol/L,mean,SD,223,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,892,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,Delivery,,10.0,concentration,,,421,nmol/L,mean,SD,108,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,893,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 d,11.0,concentration,,,154,nmol/L,mean,SD,109,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,894,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 d,11.0,concentration,,,274,nmol/L,mean,SD,85,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,895,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 d,11.0,concentration,,,428,nmol/L,mean,SD,194,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,896,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 d,11.0,concentration,,,383,nmol/L,mean,SD,89,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,897,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,4 d,11.0,concentration,,,183,nmol/L,mean,SD,122,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,898,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,4 d,11.0,concentration,,,281,nmol/L,mean,SD,87,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,899,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,4 d,11.0,concentration,,,464,nmol/L,mean,SD,197,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,900,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,4 d,11.0,concentration,,,413,nmol/L,mean,SD,116,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,901,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 wk,9.0,concentration,,,338,nmol/L,mean,SD,166,,,,,<.05,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,902,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 wk,9.0,concentration,,,365,nmol/L,mean,SD,109,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,903,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 wk,9.0,concentration,,,703,nmol/L,mean,SD,275,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,904,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 wk,9.0,concentration,,,627,nmol/L,mean,SD,187,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,905,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,plasma,maternal,postpartum,2 mo,8.0,concentration,,,388,nmol/L,mean,SD,190,,,,,<.05,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,906,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,plasma,maternal,postpartum,2 mo,8.0,concentration,,,310,nmol/L,mean,SD,161,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,907,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 mo,8.0,concentration,,,770,nmol/L,mean,SD,287,,,,,<.05,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,908,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,maternal,postpartum,2 mo,8.0,concentration,,,705,nmol/L,mean,SD,222,,,,,<.05,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,909,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,at birth,10.0,concentration,,,112,nmol/L,mean,SD,75,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,910,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,at birth,10.0,concentration,,,209,nmol/L,mean,SD,79,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,911,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,at birth,10.0,concentration,,,322,nmol/L,mean,SD,154,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,912,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,at birth,10.0,concentration,,,278,nmol/L,mean,SD,85,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,913,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 d,,119,nmol/L,mean,SD,104,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,914,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 d,,215,nmol/L,mean,SD,69,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,915,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 d,,334,nmol/L,mean,SD,173,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,916,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 d,,303,nmol/L,mean,SD,139,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,917,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,4 d,,71,nmol/L,mean,SD,52,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,918,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,4 d,,169,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,919,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,4 d,,239,nmol/L,mean,SD,102,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,920,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,4 d,,219,nmol/L,mean,SD,91,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,921,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 wk,,24,nmol/L,mean,SD,38,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,922,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,newborn,10.0,concentration,2 wk,,140,nmol/L,mean,SD,86,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,923,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 wk,,164,nmol/L,mean,SD,123,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,924,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,newborn,10.0,concentration,2 wk,,155,nmol/L,mean,SD,125,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,925,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,plasma,pediatric,,infant,8.0,concentration,2 mo,,ND,nmol/L,mean,SD,ND,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,926,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,infant,8.0,concentration,2 mo,,20,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,927,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,infant,8.0,concentration,2 mo,,22,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,928,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),plasma,pediatric,,infant,8.0,concentration,2 mo,,22,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,929,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,4 d,11.0,concentration,,,159,nmol/L,mean,SD,117,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,930,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,4 d,11.0,concentration,,,143,nmol/L,mean,SD,113,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,931,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,4 d,11.0,concentration,,,340,nmol/L,mean,SD,256,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,932,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,4 d,11.0,concentration,,,296,nmol/L,mean,SD,201,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,933,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,2 wk,9.0,concentration,,,183,nmol/L,mean,SD,113,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,934,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,2 wk,9.0,concentration,,,86,nmol/L,mean,SD,59,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,935,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 wk,9.0,concentration,,,269,nmol/L,mean,SD,172,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,936,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 wk,9.0,concentration,,,244,nmol/L,mean,SD,140,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,937,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Fluoxetine,milk,maternal,postpartum,2 mo,8.0,concentration,,,193,nmol/L,mean,SD,87,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,938,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Norfluoxetine,milk,maternal,postpartum,2 mo,8.0,concentration,,,92,nmol/L,mean,SD,34,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,939,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,Active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 mo,8.0,concentration,,,385,nmol/L,mean,SD,112,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,940,2025-12-02T16:05:22.346295
12709723.0,Fluoxetine,DDD-corrected active moiety (fluoxetine plus norfluoxetine),milk,maternal,postpartum,2 mo,8.0,concentration,,,285,nmol/L,mean,SD,112,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,941,2025-12-02T16:05:22.346295
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,22-26 weeks,8.0, AUCss BUP,,,640, ng  h/ml, mean, SD,263, , , , ,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1791,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,8.0, AUCss BUP,,,554, ng  h/ml, mean, SD,214, , , , ,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1792,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,12.0, AUCss BUP,,,654, ng  h/ml, mean, SD,301, , , , ,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1793,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,postpartum,,12.0, AUCss BUP,,,775, ng  h/ml, mean, SD,291, , , , ,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1794,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,22-26 weeks,8.0, CL/Fss,,,359, L/h, mean, SD,389,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1795,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,8.0, CL/Fss,,,321, L/h, mean, SD,152,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1796,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,12.0, CL/Fss,,,259, L/h, mean, SD,117,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1797,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,postpartum,,12.0, CL/Fss,,,208, L/h, mean, SD,93,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1798,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,22-26 weeks,8.0, CL/Fss,,,4.37, L/h/kg, mean, SD,4.41,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1799,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,8.0, CL/Fss,,,3.74, L/h/kg, mean, SD,2.29,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1800,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,12.0, CL/Fss,,,3.1, L/h/kg, mean, SD,1.27,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1801,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,postpartum,,12.0, CL/Fss,,,2.85, L/h/kg, mean, SD,1.79,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1802,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,22-26 weeks,8.0, AUCss OHBUP,,,9008, ng  h/ml, mean, SD,3191,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1803,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,34-38 weeks,8.0, AUCss OHBUP,,,10092, ng  h/ml, mean, SD,3865,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1804,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,34-38 weeks,12.0, AUCss OHBUP,,,9499, ng  h/ml, mean, SD,3893,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1805,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,plasma,maternal,postpartum,,12.0, AUCss OHBUP,,,9857, ng  h/ml, mean, SD,6032,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1806,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,22-26 weeks,8.0, OHBUP/BUP M.R.,,,22.5, , mean, SD,28.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1807,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,34-38 weeks,8.0, OHBUP/BUP M.R.,,,21.3, , mean, SD,10.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1808,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,34-38 weeks,12.0, OHBUP/BUP M.R.,,,17.7, , mean, SD,10.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1809,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,plasma,maternal,postpartum,,12.0, OHBUP/BUP M.R.,,,14.1, , mean, SD,8.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1810,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,22-26 weeks,8.0, AUCss TB,,,4843, ng  h/ml, mean, SD,3196,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1811,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,34-38 weeks,8.0, AUCss TB,,,3911, ng  h/ml, mean, SD,2896,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1812,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,34-38 weeks,12.0, AUCss TB,,,4105, ng  h/ml, mean, SD,2564,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1813,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,plasma,maternal,postpartum,,12.0, AUCss TB,,,4164, ng  h/ml, mean, SD,3232,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1814,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,22-26 weeks,8.0, TB/BUP M.R.,,,7.91, , mean, SD,4.01,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1815,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,34-38 weeks,8.0, TB/BUP M.R.,,,7.58, , mean, SD,4.63,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1816,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,34-38 weeks,12.0, TB/BUP M.R.,,,6.79, , mean, SD,3.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1817,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,plasma,maternal,postpartum,,12.0, TB/BUP M.R.,,,5.21, , mean, SD,3.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1818,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,22-26 weeks,8.0, AUCss EB,,,759, ng  h/ml, mean, SD,447,,,,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1819,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,34-38 weeks,8.0, AUCss EB,,,541, ng  h/ml, mean, SD,370,,,,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1820,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,34-38 weeks,12.0, AUCss EB,,,621, ng  h/ml, mean, SD,387,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1821,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,plasma,maternal,postpartum,,12.0, AUCss EB,,,871, ng  h/ml, mean, SD,586,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1822,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,22-26 weeks,8.0, EB/BUP M.R.,,,1.33, , mean, SD,0.65,,,,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1823,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,34-38 weeks,8.0, EB/BUP M.R.,,,1.06, , mean, SD,0.57,,,,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1824,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,34-38 weeks,12.0, EB/BUP M.R.,,,1.01, , mean, SD,0.51,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1825,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,plasma,maternal,postpartum,,12.0, EB/BUP M.R.,,,1.1, , mean, SD,0.59,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1826,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,22-26 weeks,4.0, renal clearance,,,23.1, mL/min, mean, SD,12.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1827,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,34-38 weeks,4.0, renal clearance,,,9.06, mL/min, mean, SD,5.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1828,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,34-38 weeks,11.0, renal clearance,,,17.2, mL/min, mean, SD,19,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1829,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,urine,maternal,postpartum,,11.0, renal clearance,,,38.9, mL/min, mean, SD,77.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1830,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,urine,maternal,pregnancy,22-26 weeks,4.0, renal clearance,,,3.77, mL/min, mean, SD,3.19,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1831,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,urine,maternal,pregnancy,34-38 weeks,4.0, renal clearance,,,1.34, mL/min, mean, SD,0.22,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1832,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,urine,maternal,pregnancy,34-38 weeks,11.0, renal clearance,,,2.98, mL/min, mean, SD,3.58,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1833,2025-12-02T16:05:09.448543
27528039.0,Bupropion, OHBUP,urine,maternal,postpartum,,11.0, renal clearance,,,3.08, mL/min, mean, SD,3.44,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1834,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,urine,maternal,pregnancy,22-26 weeks,4.0, renal clearance,,,72.1, mL/min, mean, SD,48.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1835,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,urine,maternal,pregnancy,34-38 weeks,4.0, renal clearance,,,34.6, mL/min, mean, SD,12.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1836,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,urine,maternal,pregnancy,34-38 weeks,11.0, renal clearance,,,56.8, mL/min, mean, SD,50,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1837,2025-12-02T16:05:09.448543
27528039.0,Bupropion, TB,urine,maternal,postpartum,,11.0, renal clearance,,,49.1, mL/min, mean, SD,32.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1838,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,urine,maternal,pregnancy,22-26 weeks,4.0, renal clearance,,,50.9, mL/min, mean, SD,40.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1839,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,urine,maternal,pregnancy,34-38 weeks,4.0, renal clearance,,,20.4, mL/min, mean, SD,7.13,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1840,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,urine,maternal,pregnancy,34-38 weeks,11.0, renal clearance,,,32.5, mL/min, mean, SD,32.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1841,2025-12-02T16:05:09.448543
27528039.0,Bupropion, EB,urine,maternal,postpartum,,11.0, renal clearance,,,27.8, mL/min, mean, SD,18.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1842,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,0.59, %, mean, SD,0.24,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1843,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,0.25, %, mean, SD,0.24,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1844,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,0.51, %, mean, SD,0.59,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1845,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,0.87, %, mean, SD,1.01,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1846,2025-12-02T16:05:09.448543
27528039.0,Bupropion,OHBUP-free,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,1.2, %, mean, SD,1.03,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1847,2025-12-02T16:05:09.448543
27528039.0,Bupropion,OHBUP-free,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,0.53, %, mean, SD,0.17,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1848,2025-12-02T16:05:09.448543
27528039.0,Bupropion,OHBUP-free,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,1.27, %, mean, SD,1.63,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1849,2025-12-02T16:05:09.448543
27528039.0,Bupropion,OHBUP-free,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,1.47, %, mean, SD,1.98,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1850,2025-12-02T16:05:09.448543
27528039.0,Bupropion,OHBUP-glucuronide,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,7.97, %, mean, SD,4.47,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1851,2025-12-02T16:05:09.448543
27528039.0,Bupropion,OHBUP-glucuronide,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,11.69, %, mean, SD,8.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1852,2025-12-02T16:05:09.448543
27528039.0,Bupropion,OHBUP-glucuronide,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,13.8, %, mean, SD,15.7,,,,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1853,2025-12-02T16:05:09.448543
27528039.0,Bupropion,OHBUP-glucuronide,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,6.25, %, mean, SD,5.47,,,,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1854,2025-12-02T16:05:09.448543
27528039.0,Bupropion,TB-free,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,15.9, %, mean, SD,11.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1855,2025-12-02T16:05:09.448543
27528039.0,Bupropion,TB-free,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,6.37, %, mean, SD,6.71,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1856,2025-12-02T16:05:09.448543
27528039.0,Bupropion,TB-free,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,10, %, mean, SD,9.52,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1857,2025-12-02T16:05:09.448543
27528039.0,Bupropion,TB-free,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,8.3, %, mean, SD,6.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1858,2025-12-02T16:05:09.448543
27528039.0,Bupropion,TB-glucuronide,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,1.07, %, mean, SD,0.73,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1859,2025-12-02T16:05:09.448543
27528039.0,Bupropion,TB-glucuronide,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,0.82, %, mean, SD,0.83,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1860,2025-12-02T16:05:09.448543
27528039.0,Bupropion,TB-glucuronide,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,3.1, %, mean, SD,2.2,,,,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1861,2025-12-02T16:05:09.448543
27528039.0,Bupropion,TB-glucuronide,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,1, %, mean, SD,1.15,,,,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1862,2025-12-02T16:05:09.448543
27528039.0,Bupropion,EB-free,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,1.71, %, mean, SD,1.54,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1863,2025-12-02T16:05:09.448543
27528039.0,Bupropion,EB-free,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,0.47, %, mean, SD,0.48,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1864,2025-12-02T16:05:09.448543
27528039.0,Bupropion,EB-free,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,0.76, %, mean, SD,0.68,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1865,2025-12-02T16:05:09.448543
27528039.0,Bupropion,EB-free,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,1, %, mean, SD,0.76,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1866,2025-12-02T16:05:09.448543
27528039.0,Bupropion,EB-glucuronide,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,2.55, %, mean, SD,1.93,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1867,2025-12-02T16:05:09.448543
27528039.0,Bupropion,EB-glucuronide,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,4, %, mean, SD,3.88,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1868,2025-12-02T16:05:09.448543
27528039.0,Bupropion,EB-glucuronide,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,0.56, %, mean, SD,0.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1869,2025-12-02T16:05:09.448543
27528039.0,Bupropion,EB-glucuronide,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,0.42, %, mean, SD,0.37,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1870,2025-12-02T16:05:09.448543
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,22-26 weeks,8.0, AUCss BUP,,,640, ng  h/ml, mean, SD,263, , , , ,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1791,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,8.0, AUCss BUP,,,554, ng  h/ml, mean, SD,214, , , , ,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1792,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,12.0, AUCss BUP,,,654, ng  h/ml, mean, SD,301, , , , ,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1793,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,plasma,maternal,postpartum,,12.0, AUCss BUP,,,775, ng  h/ml, mean, SD,291, , , , ,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1794,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,22-26 weeks,8.0, CL/Fss,,,359, L/h, mean, SD,389,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1795,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,8.0, CL/Fss,,,321, L/h, mean, SD,152,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1796,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,12.0, CL/Fss,,,259, L/h, mean, SD,117,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1797,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,plasma,maternal,postpartum,,12.0, CL/Fss,,,208, L/h, mean, SD,93,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1798,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,22-26 weeks,8.0, CL/Fss,,,4.37, L/h/kg, mean, SD,4.41,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1799,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,8.0, CL/Fss,,,3.74, L/h/kg, mean, SD,2.29,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1800,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,plasma,maternal,pregnancy,34-38 weeks,12.0, CL/Fss,,,3.1, L/h/kg, mean, SD,1.27,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1801,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,plasma,maternal,postpartum,,12.0, CL/Fss,,,2.85, L/h/kg, mean, SD,1.79,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1802,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,22-26 weeks,8.0, AUCss OHBUP,,,9008, ng  h/ml, mean, SD,3191,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1803,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,34-38 weeks,8.0, AUCss OHBUP,,,10092, ng  h/ml, mean, SD,3865,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1804,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,34-38 weeks,12.0, AUCss OHBUP,,,9499, ng  h/ml, mean, SD,3893,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1805,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,plasma,maternal,postpartum,,12.0, AUCss OHBUP,,,9857, ng  h/ml, mean, SD,6032,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1806,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,22-26 weeks,8.0, OHBUP/BUP M.R.,,,22.5, , mean, SD,28.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1807,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,34-38 weeks,8.0, OHBUP/BUP M.R.,,,21.3, , mean, SD,10.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1808,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,plasma,maternal,pregnancy,34-38 weeks,12.0, OHBUP/BUP M.R.,,,17.7, , mean, SD,10.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1809,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,plasma,maternal,postpartum,,12.0, OHBUP/BUP M.R.,,,14.1, , mean, SD,8.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1810,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,22-26 weeks,8.0, AUCss TB,,,4843, ng  h/ml, mean, SD,3196,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1811,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,34-38 weeks,8.0, AUCss TB,,,3911, ng  h/ml, mean, SD,2896,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1812,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,34-38 weeks,12.0, AUCss TB,,,4105, ng  h/ml, mean, SD,2564,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1813,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,plasma,maternal,postpartum,,12.0, AUCss TB,,,4164, ng  h/ml, mean, SD,3232,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1814,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,22-26 weeks,8.0, TB/BUP M.R.,,,7.91, , mean, SD,4.01,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1815,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,34-38 weeks,8.0, TB/BUP M.R.,,,7.58, , mean, SD,4.63,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1816,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,plasma,maternal,pregnancy,34-38 weeks,12.0, TB/BUP M.R.,,,6.79, , mean, SD,3.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1817,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,plasma,maternal,postpartum,,12.0, TB/BUP M.R.,,,5.21, , mean, SD,3.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1818,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,22-26 weeks,8.0, AUCss EB,,,759, ng  h/ml, mean, SD,447,,,,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1819,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,34-38 weeks,8.0, AUCss EB,,,541, ng  h/ml, mean, SD,370,,,,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1820,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,34-38 weeks,12.0, AUCss EB,,,621, ng  h/ml, mean, SD,387,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1821,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,plasma,maternal,postpartum,,12.0, AUCss EB,,,871, ng  h/ml, mean, SD,586,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1822,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,22-26 weeks,8.0, EB/BUP M.R.,,,1.33, , mean, SD,0.65,,,,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1823,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,34-38 weeks,8.0, EB/BUP M.R.,,,1.06, , mean, SD,0.57,,,,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1824,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,plasma,maternal,pregnancy,34-38 weeks,12.0, EB/BUP M.R.,,,1.01, , mean, SD,0.51,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1825,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,plasma,maternal,postpartum,,12.0, EB/BUP M.R.,,,1.1, , mean, SD,0.59,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1826,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,22-26 weeks,4.0, renal clearance,,,23.1, mL/min, mean, SD,12.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1827,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,34-38 weeks,4.0, renal clearance,,,9.06, mL/min, mean, SD,5.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1828,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,34-38 weeks,11.0, renal clearance,,,17.2, mL/min, mean, SD,19,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1829,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,urine,maternal,postpartum,,11.0, renal clearance,,,38.9, mL/min, mean, SD,77.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1830,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,urine,maternal,pregnancy,22-26 weeks,4.0, renal clearance,,,3.77, mL/min, mean, SD,3.19,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1831,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,urine,maternal,pregnancy,34-38 weeks,4.0, renal clearance,,,1.34, mL/min, mean, SD,0.22,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1832,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,urine,maternal,pregnancy,34-38 weeks,11.0, renal clearance,,,2.98, mL/min, mean, SD,3.58,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1833,2025-12-02T16:05:12.001940
27528039.0,Bupropion, OHBUP,urine,maternal,postpartum,,11.0, renal clearance,,,3.08, mL/min, mean, SD,3.44,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1834,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,urine,maternal,pregnancy,22-26 weeks,4.0, renal clearance,,,72.1, mL/min, mean, SD,48.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1835,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,urine,maternal,pregnancy,34-38 weeks,4.0, renal clearance,,,34.6, mL/min, mean, SD,12.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1836,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,urine,maternal,pregnancy,34-38 weeks,11.0, renal clearance,,,56.8, mL/min, mean, SD,50,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1837,2025-12-02T16:05:12.001940
27528039.0,Bupropion, TB,urine,maternal,postpartum,,11.0, renal clearance,,,49.1, mL/min, mean, SD,32.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1838,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,urine,maternal,pregnancy,22-26 weeks,4.0, renal clearance,,,50.9, mL/min, mean, SD,40.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1839,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,urine,maternal,pregnancy,34-38 weeks,4.0, renal clearance,,,20.4, mL/min, mean, SD,7.13,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1840,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,urine,maternal,pregnancy,34-38 weeks,11.0, renal clearance,,,32.5, mL/min, mean, SD,32.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1841,2025-12-02T16:05:12.001940
27528039.0,Bupropion, EB,urine,maternal,postpartum,,11.0, renal clearance,,,27.8, mL/min, mean, SD,18.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1842,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,0.59, %, mean, SD,0.24,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1843,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,0.25, %, mean, SD,0.24,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1844,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,0.51, %, mean, SD,0.59,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1845,2025-12-02T16:05:12.001940
27528039.0,Bupropion,Bupropion,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,0.87, %, mean, SD,1.01,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1846,2025-12-02T16:05:12.001940
27528039.0,Bupropion,OHBUP-free,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,1.2, %, mean, SD,1.03,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1847,2025-12-02T16:05:12.001940
27528039.0,Bupropion,OHBUP-free,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,0.53, %, mean, SD,0.17,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1848,2025-12-02T16:05:12.001940
27528039.0,Bupropion,OHBUP-free,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,1.27, %, mean, SD,1.63,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1849,2025-12-02T16:05:12.001940
27528039.0,Bupropion,OHBUP-free,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,1.47, %, mean, SD,1.98,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1850,2025-12-02T16:05:12.001940
27528039.0,Bupropion,OHBUP-glucuronide,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,7.97, %, mean, SD,4.47,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1851,2025-12-02T16:05:12.001940
27528039.0,Bupropion,OHBUP-glucuronide,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,11.69, %, mean, SD,8.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1852,2025-12-02T16:05:12.001940
27528039.0,Bupropion,OHBUP-glucuronide,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,13.8, %, mean, SD,15.7,,,,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1853,2025-12-02T16:05:12.001940
27528039.0,Bupropion,OHBUP-glucuronide,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,6.25, %, mean, SD,5.47,,,,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1854,2025-12-02T16:05:12.001940
27528039.0,Bupropion,TB-free,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,15.9, %, mean, SD,11.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1855,2025-12-02T16:05:12.001940
27528039.0,Bupropion,TB-free,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,6.37, %, mean, SD,6.71,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1856,2025-12-02T16:05:12.001940
27528039.0,Bupropion,TB-free,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,10, %, mean, SD,9.52,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1857,2025-12-02T16:05:12.001940
27528039.0,Bupropion,TB-free,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,8.3, %, mean, SD,6.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1858,2025-12-02T16:05:12.001940
27528039.0,Bupropion,TB-glucuronide,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,1.07, %, mean, SD,0.73,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1859,2025-12-02T16:05:12.001940
27528039.0,Bupropion,TB-glucuronide,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,0.82, %, mean, SD,0.83,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1860,2025-12-02T16:05:12.001940
27528039.0,Bupropion,TB-glucuronide,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,3.1, %, mean, SD,2.2,,,,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1861,2025-12-02T16:05:12.001940
27528039.0,Bupropion,TB-glucuronide,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,1, %, mean, SD,1.15,,,,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1862,2025-12-02T16:05:12.001940
27528039.0,Bupropion,EB-free,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,1.71, %, mean, SD,1.54,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1863,2025-12-02T16:05:12.001940
27528039.0,Bupropion,EB-free,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,0.47, %, mean, SD,0.48,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1864,2025-12-02T16:05:12.001940
27528039.0,Bupropion,EB-free,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,0.76, %, mean, SD,0.68,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1865,2025-12-02T16:05:12.001940
27528039.0,Bupropion,EB-free,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,1, %, mean, SD,0.76,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1866,2025-12-02T16:05:12.001940
27528039.0,Bupropion,EB-glucuronide,urine,maternal,pregnancy,22-26 weeks,4.0, percentage of dose recovered,,,2.55, %, mean, SD,1.93,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1867,2025-12-02T16:05:12.001940
27528039.0,Bupropion,EB-glucuronide,urine,maternal,pregnancy,34-38 weeks,4.0, percentage of dose recovered,,,4, %, mean, SD,3.88,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1868,2025-12-02T16:05:12.001940
27528039.0,Bupropion,EB-glucuronide,urine,maternal,pregnancy,34-38 weeks,11.0, percentage of dose recovered,,,0.56, %, mean, SD,0.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1869,2025-12-02T16:05:12.001940
27528039.0,Bupropion,EB-glucuronide,urine,maternal,postpartum,,11.0, percentage of dose recovered,,,0.42, %, mean, SD,0.37,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1870,2025-12-02T16:05:12.001940
27180885.0,Bupropion,Bupropion,umbilical cord venous plasma,pedatric,,fetus,18.0,concentration,,,5.3,ng/ml,median,,,IQR,11.5,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2012,2025-12-02T16:05:09.448543
27180885.0,Bupropion,hydroxybupropion,umbilical cord venous plasma,pedatric,,fetus,18.0,concentration,,,103.6,ng/ml,median,,,IQR,108.3,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2013,2025-12-02T16:05:09.448543
27180885.0,Bupropion,threohydrobupropion,umbilical cord venous plasma,pedatric,,fetus,21.0,concentration,,,59.6,ng/ml,median,,,IQR,93.3,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2014,2025-12-02T16:05:09.448543
27180885.0,Bupropion,Bupropion,plasma,maternal,delivery,,20.0,concentration,,,5,ng/ml,median,,,IQR,12.3,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2015,2025-12-02T16:05:09.448543
27180885.0,Bupropion,hydroxybupropion,plasma,maternal,delivery,,20.0,concentration,,,424.7,ng/ml,median,,,IQR,489.5,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2016,2025-12-02T16:05:09.448543
27180885.0,Bupropion,threohydrobupropion,plasma,maternal,delivery,,21.0,concentration,,,97.3,ng/ml,median,,,IQR,169.2,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2017,2025-12-02T16:05:09.448543
27180885.0,Bupropion,Bupropion,umbilical cord venous plasma/maternal plasma,maternal/pediatric,delivery,fetus,18.0,Umbilical cord venous plasma to maternal plasma ratio,,,0.53,,median,,,IQR,0.35,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2018,2025-12-02T16:05:09.448543
27180885.0,Bupropion,hydroxybupropion,umbilical cord venous plasma/maternal plasma,maternal/pediatric,delivery,fetus,18.0,Umbilical cord venous plasma to maternal plasma ratio,,,0.21,,median,,,IQR,0.12,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2019,2025-12-02T16:05:09.448543
27180885.0,Bupropion,threohydrobupropion,umbilical cord venous plasma/maternal plasma,maternal/pediatric,delivery,fetus,21.0,Umbilical cord venous plasma to maternal plasma ratio,,,0.61,,median,,,IQR,0.11,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2020,2025-12-02T16:05:09.448543
27180885.0,Bupropion,Bupropion,amniotic fluid,maternal,delivery,,8.0,concentration,,,10.9,ng/ml,median,,,IQR,14.8,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2021,2025-12-02T16:05:09.448543
27180885.0,Bupropion,hydroxybupropion,amniotic fluid,maternal,delivery,,8.0,concentration,,,74.6,ng/ml,median,,,IQR,69.5,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2022,2025-12-02T16:05:09.448543
27180885.0,Bupropion,threohydrobupropion,amniotic fluid,maternal,delivery,,9.0,concentration,,,112.5,ng/ml,median,,,IQR,227.4,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2023,2025-12-02T16:05:09.448543
27180885.0,Bupropion,threohydrobupropion,amniotic fluid/umbilical cord venous plasma,maternal/pediatric,delivery,fetus,9.0,amniotic fluid : umbilical cord venous plasma ratio,,,2.2,,median,,,IQR,1.6,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2024,2025-12-02T16:05:09.448543
27180885.0,Bupropion,Bupropion,umbilical cord venous plasma,pedatric,,fetus,18.0,concentration,,,5.3,ng/ml,median,,,IQR,11.5,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2012,2025-12-02T16:05:12.001940
27180885.0,Bupropion,hydroxybupropion,umbilical cord venous plasma,pedatric,,fetus,18.0,concentration,,,103.6,ng/ml,median,,,IQR,108.3,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2013,2025-12-02T16:05:12.001940
27180885.0,Bupropion,threohydrobupropion,umbilical cord venous plasma,pedatric,,fetus,21.0,concentration,,,59.6,ng/ml,median,,,IQR,93.3,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2014,2025-12-02T16:05:12.001940
27180885.0,Bupropion,Bupropion,plasma,maternal,delivery,,20.0,concentration,,,5,ng/ml,median,,,IQR,12.3,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2015,2025-12-02T16:05:12.001940
27180885.0,Bupropion,hydroxybupropion,plasma,maternal,delivery,,20.0,concentration,,,424.7,ng/ml,median,,,IQR,489.5,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2016,2025-12-02T16:05:12.001940
27180885.0,Bupropion,threohydrobupropion,plasma,maternal,delivery,,21.0,concentration,,,97.3,ng/ml,median,,,IQR,169.2,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2017,2025-12-02T16:05:12.001940
27180885.0,Bupropion,Bupropion,umbilical cord venous plasma/maternal plasma,maternal/pediatric,delivery,fetus,18.0,Umbilical cord venous plasma to maternal plasma ratio,,,0.53,,median,,,IQR,0.35,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2018,2025-12-02T16:05:12.001940
27180885.0,Bupropion,hydroxybupropion,umbilical cord venous plasma/maternal plasma,maternal/pediatric,delivery,fetus,18.0,Umbilical cord venous plasma to maternal plasma ratio,,,0.21,,median,,,IQR,0.12,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2019,2025-12-02T16:05:12.001940
27180885.0,Bupropion,threohydrobupropion,umbilical cord venous plasma/maternal plasma,maternal/pediatric,delivery,fetus,21.0,Umbilical cord venous plasma to maternal plasma ratio,,,0.61,,median,,,IQR,0.11,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2020,2025-12-02T16:05:12.001940
27180885.0,Bupropion,Bupropion,amniotic fluid,maternal,delivery,,8.0,concentration,,,10.9,ng/ml,median,,,IQR,14.8,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2021,2025-12-02T16:05:12.001940
27180885.0,Bupropion,hydroxybupropion,amniotic fluid,maternal,delivery,,8.0,concentration,,,74.6,ng/ml,median,,,IQR,69.5,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2022,2025-12-02T16:05:12.001940
27180885.0,Bupropion,threohydrobupropion,amniotic fluid,maternal,delivery,,9.0,concentration,,,112.5,ng/ml,median,,,IQR,227.4,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2023,2025-12-02T16:05:12.001940
27180885.0,Bupropion,threohydrobupropion,amniotic fluid/umbilical cord venous plasma,maternal/pediatric,delivery,fetus,9.0,amniotic fluid : umbilical cord venous plasma ratio,,,2.2,,median,,,IQR,1.6,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2024,2025-12-02T16:05:12.001940
33814540.0,Bupropion,Bupropion,plasma,maternal,2nd trimester,,5.0,Css,,,0.33,uM/g,mean,,,minmax,0.08,1.2,0.4787,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1880,2025-12-02T16:05:09.448543
33814540.0,Bupropion,Bupropion,plasma,maternal,postpartum,,5.0,Css,,,0.53,uM/g,mean,,,minmax,0.11,1.3,0.4787,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1881,2025-12-02T16:05:09.448543
33814540.0,Bupropion,Bupropion,plasma,maternal,3rd trimester,,5.0,Css,,,0.44,uM/g,mean,,,minmax,0.19,1.2,0.8056,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1882,2025-12-02T16:05:09.448543
33814540.0,Bupropion,Bupropion,plasma,maternal,postpartum,,5.0,Css,,,0.41,uM/g,mean,,,minmax,0.11,1.1,0.8056,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1883,2025-12-02T16:05:09.448543
33814540.0,Bupropion,Bupropion,urine,maternal,2nd trimester,,5.0,CLR,,,2.4,L/h,mean,,,minmax,0.77,6.4,0.4548,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1884,2025-12-02T16:05:09.448543
33814540.0,Bupropion,Bupropion,urine,maternal,postpartum,,5.0,CLR,,,1.1,L/h,mean,,,minmax,0.09,18.5,0.4548,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1885,2025-12-02T16:05:09.448543
33814540.0,Bupropion,Bupropion,urine,maternal,3rd trimester,,5.0,CLR,,,1.8,L/h,mean,,,minmax,0.26,11.8,0.97,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1886,2025-12-02T16:05:09.448543
33814540.0,Bupropion,Bupropion,urine,maternal,postpartum,,5.0,CLR,,,1.9,L/h,mean,,,minmax,0.26,18.5,0.97,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1887,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,plasma,maternal,2nd trimester,,5.0,Css,,,15.1,uM/g,mean,,,minmax,10.6,18.7,0.7839,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1888,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,plasma,maternal,postpartum,,5.0,Css,,,16.3,uM/g,mean,,,minmax,4.9,39.6,0.7839,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1889,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,plasma,maternal,3rd trimester,,5.0,Css,,,16.5,uM/g,mean,,,minmax,6.3,30.9,0.6896,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1890,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,plasma,maternal,postpartum,,5.0,Css,,,13.3,uM/g,mean,,,minmax,4.9,39.6,0.6896,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1891,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,urine,maternal,2nd trimester,,5.0,CLR,,,0.2,L/h,mean,,,minmax,0.11,0.36,0.2937,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1892,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,urine,maternal,postpartum,,5.0,CLR,,,0.1,L/h,mean,,,minmax,0.02,0.54,0.2937,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1893,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,urine,maternal,3rd trimester,,5.0,CLR,,,0.08,L/h,mean,,,minmax,0.04,0.12,0.5539,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1894,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,urine,maternal,postpartum,,5.0,CLR,,,0.1,L/h,mean,,,minmax,0.03,0.46,0.5539,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1895,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,50.7,L/h,mean,,,minmax,9.9,400.9,0.1619,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1896,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,urine/plasma,maternal,postpartum,,5.0,CLf,,,13.4,L/h,mean,,,minmax,1.7,120.8,0.1619,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1897,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,24.9,L/h,mean,,,minmax,5.8,71.2,0.228,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1898,2025-12-02T16:05:09.448543
33814540.0,Bupropion,OH-BUP,urine/plasma,maternal,postpartum,,5.0,CLf,,,15.9,L/h,mean,,,minmax,3.1,120.8,0.228,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1899,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP",plasma,maternal,2nd trimester,,5.0,Css,,,0.73,uM/g,mean,,,minmax,0.2,1.4,0.7772,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1900,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP",plasma,maternal,postpartum,,5.0,Css,,,0.78,uM/g,mean,,,minmax,0.1,2.2,0.7772,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1901,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP",plasma,maternal,3rd trimester,,5.0,Css,,,0.83,uM/g,mean,,,minmax,0.36,1.7,0.4699,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1902,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP",plasma,maternal,postpartum,,5.0,Css,,,0.64,uM/g,mean,,,minmax,0.1,2.2,0.4699,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1903,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP",urine,maternal,2nd trimester,,5.0,CLR,,,0.093,L/h,mean,,,minmax,0.31,3.4,0.1707,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1904,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP",urine,maternal,postpartum,,5.0,CLR,,,0.35,L/h,mean,,,minmax,0.09,3.5,0.1707,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1905,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP",urine,maternal,3rd trimester,,5.0,CLR,,,0.4,L/h,mean,,,minmax,0.24,0.72,0.7751,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1906,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP",urine,maternal,postpartum,,5.0,CLR,,,0.47,L/h,mean,,,minmax,0.09,3.5,0.7751,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1907,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP/BUP",urine/plasma,maternal,2nd trimester,,5.0,"S,S-OH-BUP/BUP",,,2.2,,mean,,,minmax,1,6,0.4729,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1908,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP/BUP",urine/plasma,maternal,postpartum,,5.0,"S,S-OH-BUP/BUP",,,1.5,,mean,,,minmax,0.7,5.9,0.4729,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1909,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP/BUP",urine/plasma,maternal,3rd trimester,,5.0,"S,S-OH-BUP/BUP",,,1.9,,mean,,,minmax,0.9,8.7,0.4943,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1910,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP/BUP",urine/plasma,maternal,postpartum,,5.0,"S,S-OH-BUP/BUP",,,1.6,,mean,,,minmax,0.8,5.9,0.4943,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1911,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP",plasma,maternal,2nd trimester,,5.0,Css,,,15.8,uM/g,mean,,,minmax,10,22.2,0.9786,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1912,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP",plasma,maternal,postpartum,,5.0,Css,,,15.9,uM/g,mean,,,minmax,5.5,35.7,0.9786,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1913,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP",plasma,maternal,3rd trimester,,5.0,Css,,,13.7,uM/g,mean,,,minmax,5.9,21.2,0.9647,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1914,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP",plasma,maternal,postpartum,,5.0,Css,,,14,uM/g,mean,,,minmax,5.5,35.7,0.9647,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1915,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP",urine,maternal,2nd trimester,,5.0,CLR,,,0.15,L/h,mean,,,minmax,0.07,0.32,0.3564,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1916,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP",urine,maternal,postpartum,,5.0,CLR,,,0.08,L/h,mean,,,minmax,0.02,0.45,0.3564,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1917,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP",urine,maternal,3rd trimester,,5.0,CLR,,,0.07,L/h,mean,,,minmax,0.05,0.09,0.6659,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1918,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP",urine,maternal,postpartum,,5.0,CLR,,,0.09,L/h,mean,,,minmax,0.03,0.35,0.6659,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1919,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP/BUP",urine/plasma,maternal,2nd trimester,,5.0,"R,R-OH-BUP/BUP",,,43.8,,mean,,,minmax,16.4,178.7,0.5907,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1920,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP/BUP",urine/plasma,maternal,postpartum,,5.0,"R,R-OH-BUP/BUP",,,32.5,,mean,,,minmax,15.8,77.2,0.5907,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1921,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP/BUP",urine/plasma,maternal,3rd trimester,,5.0,"R,R-OH-BUP/BUP",,,33.7,,mean,,,minmax,13.5,99.1,0.8544,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1922,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP/BUP",urine/plasma,maternal,postpartum,,5.0,"R,R-OH-BUP/BUP",,,35.6,,mean,,,minmax,15.2,77.2,0.8544,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1923,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,plasma,maternal,2nd trimester,,5.0,Css,,,3.4,uM/g,mean,,,minmax,1.8,6.7,0.4896,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1924,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,plasma,maternal,postpartum,,5.0,Css,,,4.1,uM/g,mean,,,minmax,1.2,10.8,0.4896,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1925,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,plasma,maternal,3rd trimester,,5.0,Css,,,4.9,uM/g,mean,,,minmax,3.1,10.7,0.8675,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1926,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,plasma,maternal,postpartum,,5.0,Css,,,4.7,uM/g,mean,,,minmax,1.2,10.8,0.8675,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1927,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,urine,maternal,2nd trimester,,5.0,CLR,,,3.9,L/h,mean,,,minmax,1.7,8.6,0.381,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1928,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,urine,maternal,postpartum,,5.0,CLR,,,2.4,L/h,mean,,,minmax,0.55,17.6,0.381,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1929,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,urine,maternal,3rd trimester,,5.0,CLR,,,2,L/h,mean,,,minmax,1.1,2.8,0.5748,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1930,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,urine,maternal,postpartum,,5.0,CLR,,,2.9,L/h,mean,,,minmax,0.59,17.6,0.5748,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1931,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,89.4,L/h,mean,,,minmax,20.1,275.8,0.2477,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1932,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,urine/plasma,maternal,postpartum,,5.0,CLf,,,34.5,L/h,mean,,,minmax,2.9,166.4,0.2477,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1933,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,56.6,L/h,mean,,,minmax,17,208,0.5949,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1934,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,urine/plasma,maternal,postpartum,,5.0,CLf,,,68.5,L/h,mean,,,minmax,15.8,166.4,0.5949,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1935,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion/BUP,urine/plasma,maternal,2nd trimester,,5.0,threohydrobupropion/BUP,,,10.3,,mean,,,minmax,4.8,23.1,0.545,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1936,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion/BUP,urine/plasma,maternal,postpartum,,5.0,threohydrobupropion/BUP,,,7.8,,mean,,,minmax,3.5,17.6,0.545,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1937,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion/BUP,urine/plasma,maternal,3rd trimester,,5.0,threohydrobupropion/BUP,,,11.2,,mean,,,minmax,5.6,16.6,0.8878,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1938,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion/BUP,urine/plasma,maternal,postpartum,,5.0,threohydrobupropion/BUP,,,11.5,,mean,,,minmax,9.7,17.6,0.8878,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1939,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,plasma,maternal,2nd trimester,,5.0,Css,,,0.49,uM/g,mean,,,minmax,0.33,0.78,0.2739,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1940,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,plasma,maternal,postpartum,,5.0,Css,,,0.67,uM/g,mean,,,minmax,0.25,1.7,0.2739,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1941,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,plasma,maternal,3rd trimester,,5.0,Css,,,0.63,uM/g,mean,,,minmax,0.52,0.79,0.4811,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1942,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,plasma,maternal,postpartum,,5.0,Css,,,0.8,uM/g,mean,,,minmax,0.25,1.7,0.4811,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1943,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine,maternal,2nd trimester,,5.0,CLR,,,2.1,L/h,mean,,,minmax,0.9,4.4,0.5107,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1944,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine,maternal,postpartum,,5.0,CLR,,,1.6,L/h,mean,,,minmax,0.36,9.7,0.5107,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1945,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine,maternal,3rd trimester,,5.0,CLR,,,1.2,L/h,mean,,,minmax,0.74,1.7,0.4811,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1946,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine,maternal,postpartum,,5.0,CLR,,,1.9,L/h,mean,,,minmax,0.36,9.7,0.4811,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1947,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,23.8,L/h,mean,,,minmax,3.9,105.8,0.3067,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1948,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,postpartum,,5.0,CLf,,,10.6,L/h,mean,,,minmax,1.3,70.7,0.3067,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1949,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,17.9,L/h,mean,,,minmax,1.4,112.1,0.5992,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1950,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,postpartum,,5.0,CLf,,,21.1,L/h,mean,,,minmax,0.9,70.7,0.5992,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1951,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,2nd trimester,,5.0,erythrohydrobupropion/BUP,,,1.5,,mean,,,minmax,0.4,4.2,0.771,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1952,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,postpartum,,5.0,erythrohydrobupropion/BUP,,,1.3,,mean,,,minmax,0.5,3.2,0.771,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1953,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,3rd trimester,,5.0,erythrohydrobupropion/BUP,,,1.4,,mean,,,minmax,0.6,2.7,0.1358,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1954,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,postpartum,,5.0,erythrohydrobupropion/BUP,,,1.9,,mean,,,minmax,1.2,3.2,0.1358,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1955,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion-OH,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,2.4,L/h,mean,,,minmax,0.4,12.4,0.0809,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1956,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion-OH,urine/plasma,maternal,postpartum,,5.0,CLf,,,1.2,L/h,mean,,,minmax,0.4,4.9,0.0809,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1957,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion-OH,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,1.7,L/h,mean,,,minmax,0.2,8.9,0.9983,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1958,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion-OH,urine/plasma,maternal,postpartum,,5.0,CLf,,,1.7,L/h,mean,,,minmax,0.4,4.9,0.9983,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1959,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion-OH,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,10.8,L/h,mean,,,minmax,3.2,39.8,0.025,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1960,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion-OH,urine/plasma,maternal,postpartum,,5.0,CLf,,,5.1,L/h,mean,,,minmax,1.7,20.8,0.025,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1961,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion-OH,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,9.4,L/h,mean,,,minmax,2.5,36.7,0.556,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1962,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion-OH,urine/plasma,maternal,postpartum,,5.0,CLf,,,7.6,L/h,mean,,,minmax,2.6,20.8,0.556,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1963,2025-12-02T16:05:09.448543
33814540.0,Bupropion,4'OH-BUP,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,1.5,L/h,mean,,,minmax,0.1,28.2,0.6186,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1964,2025-12-02T16:05:09.448543
33814540.0,Bupropion,4'OH-BUP,urine/plasma,maternal,postpartum,,5.0,CLf,,,0.7,L/h,mean,,,minmax,0,5.7,0.6186,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1965,2025-12-02T16:05:09.448543
33814540.0,Bupropion,4'OH-BUP,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,0.8,L/h,mean,,,minmax,0.1,4.8,0.3921,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1966,2025-12-02T16:05:09.448543
33814540.0,Bupropion,4'OH-BUP,urine/plasma,maternal,postpartum,,5.0,CLf,,,1,L/h,mean,,,minmax,0.3,5.7,0.3921,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1967,2025-12-02T16:05:09.448543
33814540.0,Bupropion,Bupropion,umbilical cord plasma,pedatric,,fetus,3.0,concentration,,,0.2,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1968,2025-12-02T16:05:09.448543
33814540.0,Bupropion,Bupropion,plasma,maternal,delivery,,3.0,concentration,,,0.5,,mean,SD,0.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1969,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP",umbilical cord plasma,pedatric,,fetus,3.0,concentration,,,0.4,,mean,SD,0.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1970,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"S,S-OH-BUP",plasma,maternal,delivery,,3.0,concentration,,,0.8,,mean,SD,0.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1971,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP",umbilical cord plasma,pedatric,,fetus,3.0,concentration,,,6.4,,mean,SD,3.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1972,2025-12-02T16:05:09.448543
33814540.0,Bupropion,"R,R-OH-BUP",plasma,maternal,delivery,,3.0,concentration,,,19.1,,mean,SD,12,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1973,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,umbilical cord plasma,pedatric,,fetus,3.0,concentration,,,3.7,,mean,SD,4.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1974,2025-12-02T16:05:09.448543
33814540.0,Bupropion,threohydrobupropion,plasma,maternal,delivery,,3.0,concentration,,,4.9,,mean,SD,5.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1975,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,umbilical cord plasma,pedatric,,fetus,3.0,concentration,,,0.3,,mean,SD,0.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1976,2025-12-02T16:05:09.448543
33814540.0,Bupropion,erythrohydrobupropion,plasma,maternal,delivery,,3.0,concentration,,,0.5,,mean,SD,0.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1977,2025-12-02T16:05:09.448543
33814540.0,Bupropion,Bupropion,plasma,maternal,2nd trimester,,5.0,Css,,,0.33,uM/g,mean,,,minmax,0.08,1.2,0.4787,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1880,2025-12-02T16:05:12.001940
33814540.0,Bupropion,Bupropion,plasma,maternal,postpartum,,5.0,Css,,,0.53,uM/g,mean,,,minmax,0.11,1.3,0.4787,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1881,2025-12-02T16:05:12.001940
33814540.0,Bupropion,Bupropion,plasma,maternal,3rd trimester,,5.0,Css,,,0.44,uM/g,mean,,,minmax,0.19,1.2,0.8056,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1882,2025-12-02T16:05:12.001940
33814540.0,Bupropion,Bupropion,plasma,maternal,postpartum,,5.0,Css,,,0.41,uM/g,mean,,,minmax,0.11,1.1,0.8056,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1883,2025-12-02T16:05:12.001940
33814540.0,Bupropion,Bupropion,urine,maternal,2nd trimester,,5.0,CLR,,,2.4,L/h,mean,,,minmax,0.77,6.4,0.4548,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1884,2025-12-02T16:05:12.001940
33814540.0,Bupropion,Bupropion,urine,maternal,postpartum,,5.0,CLR,,,1.1,L/h,mean,,,minmax,0.09,18.5,0.4548,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1885,2025-12-02T16:05:12.001940
33814540.0,Bupropion,Bupropion,urine,maternal,3rd trimester,,5.0,CLR,,,1.8,L/h,mean,,,minmax,0.26,11.8,0.97,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1886,2025-12-02T16:05:12.001940
33814540.0,Bupropion,Bupropion,urine,maternal,postpartum,,5.0,CLR,,,1.9,L/h,mean,,,minmax,0.26,18.5,0.97,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1887,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,plasma,maternal,2nd trimester,,5.0,Css,,,15.1,uM/g,mean,,,minmax,10.6,18.7,0.7839,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1888,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,plasma,maternal,postpartum,,5.0,Css,,,16.3,uM/g,mean,,,minmax,4.9,39.6,0.7839,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1889,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,plasma,maternal,3rd trimester,,5.0,Css,,,16.5,uM/g,mean,,,minmax,6.3,30.9,0.6896,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1890,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,plasma,maternal,postpartum,,5.0,Css,,,13.3,uM/g,mean,,,minmax,4.9,39.6,0.6896,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1891,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,urine,maternal,2nd trimester,,5.0,CLR,,,0.2,L/h,mean,,,minmax,0.11,0.36,0.2937,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1892,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,urine,maternal,postpartum,,5.0,CLR,,,0.1,L/h,mean,,,minmax,0.02,0.54,0.2937,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1893,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,urine,maternal,3rd trimester,,5.0,CLR,,,0.08,L/h,mean,,,minmax,0.04,0.12,0.5539,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1894,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,urine,maternal,postpartum,,5.0,CLR,,,0.1,L/h,mean,,,minmax,0.03,0.46,0.5539,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1895,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,50.7,L/h,mean,,,minmax,9.9,400.9,0.1619,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1896,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,urine/plasma,maternal,postpartum,,5.0,CLf,,,13.4,L/h,mean,,,minmax,1.7,120.8,0.1619,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1897,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,24.9,L/h,mean,,,minmax,5.8,71.2,0.228,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1898,2025-12-02T16:05:12.001940
33814540.0,Bupropion,OH-BUP,urine/plasma,maternal,postpartum,,5.0,CLf,,,15.9,L/h,mean,,,minmax,3.1,120.8,0.228,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1899,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP",plasma,maternal,2nd trimester,,5.0,Css,,,0.73,uM/g,mean,,,minmax,0.2,1.4,0.7772,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1900,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP",plasma,maternal,postpartum,,5.0,Css,,,0.78,uM/g,mean,,,minmax,0.1,2.2,0.7772,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1901,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP",plasma,maternal,3rd trimester,,5.0,Css,,,0.83,uM/g,mean,,,minmax,0.36,1.7,0.4699,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1902,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP",plasma,maternal,postpartum,,5.0,Css,,,0.64,uM/g,mean,,,minmax,0.1,2.2,0.4699,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1903,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP",urine,maternal,2nd trimester,,5.0,CLR,,,0.093,L/h,mean,,,minmax,0.31,3.4,0.1707,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1904,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP",urine,maternal,postpartum,,5.0,CLR,,,0.35,L/h,mean,,,minmax,0.09,3.5,0.1707,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1905,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP",urine,maternal,3rd trimester,,5.0,CLR,,,0.4,L/h,mean,,,minmax,0.24,0.72,0.7751,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1906,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP",urine,maternal,postpartum,,5.0,CLR,,,0.47,L/h,mean,,,minmax,0.09,3.5,0.7751,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1907,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP/BUP",urine/plasma,maternal,2nd trimester,,5.0,"S,S-OH-BUP/BUP",,,2.2,,mean,,,minmax,1,6,0.4729,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1908,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP/BUP",urine/plasma,maternal,postpartum,,5.0,"S,S-OH-BUP/BUP",,,1.5,,mean,,,minmax,0.7,5.9,0.4729,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1909,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP/BUP",urine/plasma,maternal,3rd trimester,,5.0,"S,S-OH-BUP/BUP",,,1.9,,mean,,,minmax,0.9,8.7,0.4943,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1910,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP/BUP",urine/plasma,maternal,postpartum,,5.0,"S,S-OH-BUP/BUP",,,1.6,,mean,,,minmax,0.8,5.9,0.4943,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1911,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP",plasma,maternal,2nd trimester,,5.0,Css,,,15.8,uM/g,mean,,,minmax,10,22.2,0.9786,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1912,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP",plasma,maternal,postpartum,,5.0,Css,,,15.9,uM/g,mean,,,minmax,5.5,35.7,0.9786,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1913,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP",plasma,maternal,3rd trimester,,5.0,Css,,,13.7,uM/g,mean,,,minmax,5.9,21.2,0.9647,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1914,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP",plasma,maternal,postpartum,,5.0,Css,,,14,uM/g,mean,,,minmax,5.5,35.7,0.9647,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1915,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP",urine,maternal,2nd trimester,,5.0,CLR,,,0.15,L/h,mean,,,minmax,0.07,0.32,0.3564,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1916,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP",urine,maternal,postpartum,,5.0,CLR,,,0.08,L/h,mean,,,minmax,0.02,0.45,0.3564,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1917,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP",urine,maternal,3rd trimester,,5.0,CLR,,,0.07,L/h,mean,,,minmax,0.05,0.09,0.6659,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1918,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP",urine,maternal,postpartum,,5.0,CLR,,,0.09,L/h,mean,,,minmax,0.03,0.35,0.6659,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1919,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP/BUP",urine/plasma,maternal,2nd trimester,,5.0,"R,R-OH-BUP/BUP",,,43.8,,mean,,,minmax,16.4,178.7,0.5907,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1920,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP/BUP",urine/plasma,maternal,postpartum,,5.0,"R,R-OH-BUP/BUP",,,32.5,,mean,,,minmax,15.8,77.2,0.5907,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1921,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP/BUP",urine/plasma,maternal,3rd trimester,,5.0,"R,R-OH-BUP/BUP",,,33.7,,mean,,,minmax,13.5,99.1,0.8544,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1922,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP/BUP",urine/plasma,maternal,postpartum,,5.0,"R,R-OH-BUP/BUP",,,35.6,,mean,,,minmax,15.2,77.2,0.8544,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1923,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,plasma,maternal,2nd trimester,,5.0,Css,,,3.4,uM/g,mean,,,minmax,1.8,6.7,0.4896,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1924,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,plasma,maternal,postpartum,,5.0,Css,,,4.1,uM/g,mean,,,minmax,1.2,10.8,0.4896,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1925,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,plasma,maternal,3rd trimester,,5.0,Css,,,4.9,uM/g,mean,,,minmax,3.1,10.7,0.8675,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1926,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,plasma,maternal,postpartum,,5.0,Css,,,4.7,uM/g,mean,,,minmax,1.2,10.8,0.8675,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1927,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,urine,maternal,2nd trimester,,5.0,CLR,,,3.9,L/h,mean,,,minmax,1.7,8.6,0.381,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1928,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,urine,maternal,postpartum,,5.0,CLR,,,2.4,L/h,mean,,,minmax,0.55,17.6,0.381,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1929,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,urine,maternal,3rd trimester,,5.0,CLR,,,2,L/h,mean,,,minmax,1.1,2.8,0.5748,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1930,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,urine,maternal,postpartum,,5.0,CLR,,,2.9,L/h,mean,,,minmax,0.59,17.6,0.5748,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1931,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,89.4,L/h,mean,,,minmax,20.1,275.8,0.2477,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1932,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,urine/plasma,maternal,postpartum,,5.0,CLf,,,34.5,L/h,mean,,,minmax,2.9,166.4,0.2477,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1933,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,56.6,L/h,mean,,,minmax,17,208,0.5949,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1934,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,urine/plasma,maternal,postpartum,,5.0,CLf,,,68.5,L/h,mean,,,minmax,15.8,166.4,0.5949,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1935,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion/BUP,urine/plasma,maternal,2nd trimester,,5.0,threohydrobupropion/BUP,,,10.3,,mean,,,minmax,4.8,23.1,0.545,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1936,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion/BUP,urine/plasma,maternal,postpartum,,5.0,threohydrobupropion/BUP,,,7.8,,mean,,,minmax,3.5,17.6,0.545,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1937,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion/BUP,urine/plasma,maternal,3rd trimester,,5.0,threohydrobupropion/BUP,,,11.2,,mean,,,minmax,5.6,16.6,0.8878,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1938,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion/BUP,urine/plasma,maternal,postpartum,,5.0,threohydrobupropion/BUP,,,11.5,,mean,,,minmax,9.7,17.6,0.8878,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1939,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,plasma,maternal,2nd trimester,,5.0,Css,,,0.49,uM/g,mean,,,minmax,0.33,0.78,0.2739,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1940,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,plasma,maternal,postpartum,,5.0,Css,,,0.67,uM/g,mean,,,minmax,0.25,1.7,0.2739,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1941,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,plasma,maternal,3rd trimester,,5.0,Css,,,0.63,uM/g,mean,,,minmax,0.52,0.79,0.4811,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1942,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,plasma,maternal,postpartum,,5.0,Css,,,0.8,uM/g,mean,,,minmax,0.25,1.7,0.4811,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1943,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine,maternal,2nd trimester,,5.0,CLR,,,2.1,L/h,mean,,,minmax,0.9,4.4,0.5107,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1944,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine,maternal,postpartum,,5.0,CLR,,,1.6,L/h,mean,,,minmax,0.36,9.7,0.5107,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1945,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine,maternal,3rd trimester,,5.0,CLR,,,1.2,L/h,mean,,,minmax,0.74,1.7,0.4811,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1946,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine,maternal,postpartum,,5.0,CLR,,,1.9,L/h,mean,,,minmax,0.36,9.7,0.4811,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1947,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,23.8,L/h,mean,,,minmax,3.9,105.8,0.3067,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1948,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,postpartum,,5.0,CLf,,,10.6,L/h,mean,,,minmax,1.3,70.7,0.3067,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1949,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,17.9,L/h,mean,,,minmax,1.4,112.1,0.5992,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1950,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,postpartum,,5.0,CLf,,,21.1,L/h,mean,,,minmax,0.9,70.7,0.5992,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1951,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,2nd trimester,,5.0,erythrohydrobupropion/BUP,,,1.5,,mean,,,minmax,0.4,4.2,0.771,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1952,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,postpartum,,5.0,erythrohydrobupropion/BUP,,,1.3,,mean,,,minmax,0.5,3.2,0.771,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1953,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,3rd trimester,,5.0,erythrohydrobupropion/BUP,,,1.4,,mean,,,minmax,0.6,2.7,0.1358,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1954,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,urine/plasma,maternal,postpartum,,5.0,erythrohydrobupropion/BUP,,,1.9,,mean,,,minmax,1.2,3.2,0.1358,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1955,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion-OH,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,2.4,L/h,mean,,,minmax,0.4,12.4,0.0809,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1956,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion-OH,urine/plasma,maternal,postpartum,,5.0,CLf,,,1.2,L/h,mean,,,minmax,0.4,4.9,0.0809,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1957,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion-OH,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,1.7,L/h,mean,,,minmax,0.2,8.9,0.9983,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1958,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion-OH,urine/plasma,maternal,postpartum,,5.0,CLf,,,1.7,L/h,mean,,,minmax,0.4,4.9,0.9983,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1959,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion-OH,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,10.8,L/h,mean,,,minmax,3.2,39.8,0.025,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1960,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion-OH,urine/plasma,maternal,postpartum,,5.0,CLf,,,5.1,L/h,mean,,,minmax,1.7,20.8,0.025,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1961,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion-OH,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,9.4,L/h,mean,,,minmax,2.5,36.7,0.556,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1962,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion-OH,urine/plasma,maternal,postpartum,,5.0,CLf,,,7.6,L/h,mean,,,minmax,2.6,20.8,0.556,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1963,2025-12-02T16:05:12.001940
33814540.0,Bupropion,4'OH-BUP,urine/plasma,maternal,2nd trimester,,5.0,CLf,,,1.5,L/h,mean,,,minmax,0.1,28.2,0.6186,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1964,2025-12-02T16:05:12.001940
33814540.0,Bupropion,4'OH-BUP,urine/plasma,maternal,postpartum,,5.0,CLf,,,0.7,L/h,mean,,,minmax,0,5.7,0.6186,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1965,2025-12-02T16:05:12.001940
33814540.0,Bupropion,4'OH-BUP,urine/plasma,maternal,3rd trimester,,5.0,CLf,,,0.8,L/h,mean,,,minmax,0.1,4.8,0.3921,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1966,2025-12-02T16:05:12.001940
33814540.0,Bupropion,4'OH-BUP,urine/plasma,maternal,postpartum,,5.0,CLf,,,1,L/h,mean,,,minmax,0.3,5.7,0.3921,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1967,2025-12-02T16:05:12.001940
33814540.0,Bupropion,Bupropion,umbilical cord plasma,pedatric,,fetus,3.0,concentration,,,0.2,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1968,2025-12-02T16:05:12.001940
33814540.0,Bupropion,Bupropion,plasma,maternal,delivery,,3.0,concentration,,,0.5,,mean,SD,0.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1969,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP",umbilical cord plasma,pedatric,,fetus,3.0,concentration,,,0.4,,mean,SD,0.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1970,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"S,S-OH-BUP",plasma,maternal,delivery,,3.0,concentration,,,0.8,,mean,SD,0.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1971,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP",umbilical cord plasma,pedatric,,fetus,3.0,concentration,,,6.4,,mean,SD,3.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1972,2025-12-02T16:05:12.001940
33814540.0,Bupropion,"R,R-OH-BUP",plasma,maternal,delivery,,3.0,concentration,,,19.1,,mean,SD,12,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1973,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,umbilical cord plasma,pedatric,,fetus,3.0,concentration,,,3.7,,mean,SD,4.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1974,2025-12-02T16:05:12.001940
33814540.0,Bupropion,threohydrobupropion,plasma,maternal,delivery,,3.0,concentration,,,4.9,,mean,SD,5.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1975,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,umbilical cord plasma,pedatric,,fetus,3.0,concentration,,,0.3,,mean,SD,0.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1976,2025-12-02T16:05:12.001940
33814540.0,Bupropion,erythrohydrobupropion,plasma,maternal,delivery,,3.0,concentration,,,0.5,,mean,SD,0.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1977,2025-12-02T16:05:12.001940
12860776.0,serotonin,serotonin,cord blood,SSRI group,delivery,,15,concentration,,,89,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,584,2025-12-02T15:59:37.490403
12860776.0,serotonin,serotonin,cord blood,control group,delivery,,18,concentration,,,112,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,585,2025-12-02T15:59:37.490403
12860776.0,serotonin,serotonin,cord blood,,,,,% reduction,,,,%,mean,,,95% CI,57,78,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,586,2025-12-02T15:59:37.490403
12860776.0,5-hydroxyindoleacetic acid,5-hydroxyindoleacetic acid,cord blood,SSRI group,delivery,,15,concentration,,,13,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,587,2025-12-02T15:59:37.490403
12860776.0,5-hydroxyindoleacetic acid,5-hydroxyindoleacetic acid,cord blood,control group,delivery,,18,concentration,,,16,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,588,2025-12-02T15:59:37.490403
12860776.0,5-hydroxyindoleacetic acid,5-hydroxyindoleacetic acid,cord blood,,,,,% reduction,,,,%,mean,,,95% CI,5,29,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,589,2025-12-02T15:59:37.490403
12860776.0,homovalinic acid,homovalinic acid,cord blood,SSRI group,delivery,,15,concentration,,,26,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,590,2025-12-02T15:59:37.490403
12860776.0,homovalinic acid,homovalinic acid,cord blood,control group,delivery,,18,concentration,,,40,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,591,2025-12-02T15:59:37.490403
12860776.0,homovalinic acid,homovalinic acid,cord blood,,,,,% reduction,,,,%,mean,,,95% CI,8,35,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,592,2025-12-02T15:59:37.490403
12860776.0,noradrenaline,noradrenaline,cord blood,SSRI group,delivery,,15,concentration,,,19,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,593,2025-12-02T15:59:37.490403
12860776.0,noradrenaline,noradrenaline,cord blood,control group,delivery,,18,concentration,,,33,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,594,2025-12-02T15:59:37.490403
12860776.0,noradrenaline,noradrenaline,cord blood,,,,,% reduction,,,,%,mean,,,95% CI,0,87,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,595,2025-12-02T15:59:37.490403
12860776.0,"3,4-dihydroxyphenylgycol","3,4-dihydroxyphenylgycol",cord blood,SSRI group,delivery,,15,concentration,,,3.4,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,596,2025-12-02T15:59:37.490403
12860776.0,"3,4-dihydroxyphenylgycol","3,4-dihydroxyphenylgycol",cord blood,control group,delivery,,18,concentration,,,6.8,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,597,2025-12-02T15:59:37.490403
12860776.0,"3,4-dihydroxyphenylgycol","3,4-dihydroxyphenylgycol",cord blood,,,,,% reduction,,,,%,mean,,,95% CI,-2,53,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,598,2025-12-02T15:59:37.490403
12860776.0,dihydroxyphenylacetic acid,dihydroxyphenylacetic acid,cord blood,SSRI group,delivery,,15,concentration,,,6,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,599,2025-12-02T15:59:37.490403
12860776.0,dihydroxyphenylacetic acid,dihydroxyphenylacetic acid,cord blood,control group,delivery,,18,concentration,,,7.6,nmol/L,mean,SD,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,600,2025-12-02T15:59:37.490403
12860776.0,dihydroxyphenylacetic acid,dihydroxyphenylacetic acid,cord blood,,,,,% reduction,,,,%,mean,,,95% CI,-17,40,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,601,2025-12-02T15:59:37.490403
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,5.94,ng/mL,median,,,25th-75th percentile,5.14,9.16,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1091,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,6.05,ng/mL,median,,,25th-75th percentile,4.04,11.46,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1092,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,3.29,ng/mL,median,,,25th-75th percentile,2.83,3.67,<0.05 ,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1093,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,6.29,ng/mL,median,,,25th-75th percentile,5.76,8.02,<0.05 ,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1094,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,4.41,hour,median,,,25th-75th percentile,2.39,5.26,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1095,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,2.35,hour,median,,,25th-75th percentile,1.62,3.59,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1096,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,21.65,hour,median,,,25th-75th percentile,12.46,24.57,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1097,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,13.66,hour,median,,,25th-75th percentile,7.74,26.95,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1098,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,209.2,ng hour/mL,median,,,25th-75th percentile,113.9,263,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1099,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,97.81,ng hour/mL,median,,,25th-75th percentile,39.54,258.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1100,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,498.6,ng hour/mL,median,,,25th-75th percentile,464.4,1259,<0.05 ,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1101,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,942.7,ng hour/mL,median,,,25th-75th percentile,746.4,1483,<0.05 ,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1102,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.18,hour1,median,,,25th-75th percentile,0.11,0.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1103,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.16,hour1,median,,,25th-75th percentile,0.11,0.36,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1104,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,2.33,hour,median,,,25th-75th percentile,1.07,4.14,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1105,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,1.94,hour,median,,,25th-75th percentile,1.32,4.47,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1106,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.03,hour1,median,,,25th-75th percentile,0.02,0.04,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1107,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.04,hour1,median,,,25th-75th percentile,0.03,0.07,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1108,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,,,,0.007,hour1,median,,,25th-75th percentile,0.004,0.009,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1109,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,,,,0.008,hour1,median,,,25th-75th percentile,0.005,0.011,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1110,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,24.72,hour,median,,,25th-75th percentile,18.07,34.56,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1111,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,17.19,hour,median,,,25th-75th percentile,9.73,22.2,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1112,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,95.15,hour,median,,,25th-75th percentile,78.93,207.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1113,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,83.48,hour,median,,,25th-75th percentile,62.18,156.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1114,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Vd/f,,,23.25,L/kg,median,,,25th-75th percentile,20.22,24.55,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1115,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Vd/f,,,19,L/kg,median,,,25th-75th percentile,17.24,28.18,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1116,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Cl/f,,,0.66,L/hour/kg,median,,,25th-75th percentile,0.52,1.16,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1117,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Cl/f,,,1.45,L/hour/kg,median,,,25th-75th percentile,0.63,3.24,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1118,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.33,,median,,,25th-75th percentile,0.27,0.38,0.0039,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1119,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.44,,median,,,25th-75th percentile,0.31,0.5,0.0039,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1120,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.32,,median,,,25th-75th percentile,0.24,0.42,0.1289,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1121,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.37,,median,,,25th-75th percentile,0.23,0.46,0.1289,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1122,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.27,,median,,,25th-75th percentile,0.19,0.32,0.0039,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1123,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.39,,median,,,25th-75th percentile,0.25,0.4,0.0039,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1124,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.27,,median,,,25th-75th percentile,0.19,0.37,0.0273,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1125,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.34,,median,,,25th-75th percentile,0.23,0.39,0.0273,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1126,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(R)-(-)-FLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.28,,median,,,25th-75th percentile,1.1,1.63,0.3008,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1127,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(S)-(+)-FLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.3,,median,,,25th-75th percentile,1.03,1.4,0.3008,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1128,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.06,,median,,,25th-75th percentile,0.97,1.35,0.1289,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1129,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,0.95,,median,,,25th-75th percentile,0.79,1.24,0.1289,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1130,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.86,,median,,,25th-75th percentile,0.69,1.06,0.6523,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1131,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.74,,median,,,25th-75th percentile,0.68,1.07,0.6523,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1132,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.87,,median,,,25th-75th percentile,0.75,1.03,0.4961,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1133,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.96,,median,,,25th-75th percentile,0.76,1.09,0.4961,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1134,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(R)-(-)-FLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.01,0.14,0.125,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1135,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(S)-(+)-FLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.01,0.15,0.125,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1136,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.06,0.11,0.625,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1137,2025-12-02T16:05:09.448543
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.11,,median,,,25th-75th percentile,0.1,0.12,0.625,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1138,2025-12-02T16:05:09.448543
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,5.94,ng/mL,median,,,25th-75th percentile,5.14,9.16,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1091,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,6.05,ng/mL,median,,,25th-75th percentile,4.04,11.46,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1092,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,3.29,ng/mL,median,,,25th-75th percentile,2.83,3.67,<0.05 ,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1093,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,6.29,ng/mL,median,,,25th-75th percentile,5.76,8.02,<0.05 ,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1094,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,4.41,hour,median,,,25th-75th percentile,2.39,5.26,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1095,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,2.35,hour,median,,,25th-75th percentile,1.62,3.59,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1096,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,21.65,hour,median,,,25th-75th percentile,12.46,24.57,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1097,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,13.66,hour,median,,,25th-75th percentile,7.74,26.95,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1098,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,209.2,ng hour/mL,median,,,25th-75th percentile,113.9,263,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1099,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,97.81,ng hour/mL,median,,,25th-75th percentile,39.54,258.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1100,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,498.6,ng hour/mL,median,,,25th-75th percentile,464.4,1259,<0.05 ,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1101,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,942.7,ng hour/mL,median,,,25th-75th percentile,746.4,1483,<0.05 ,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1102,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.18,hour1,median,,,25th-75th percentile,0.11,0.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1103,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.16,hour1,median,,,25th-75th percentile,0.11,0.36,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1104,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,2.33,hour,median,,,25th-75th percentile,1.07,4.14,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1105,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,1.94,hour,median,,,25th-75th percentile,1.32,4.47,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1106,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.03,hour1,median,,,25th-75th percentile,0.02,0.04,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1107,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.04,hour1,median,,,25th-75th percentile,0.03,0.07,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1108,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,,,,0.007,hour1,median,,,25th-75th percentile,0.004,0.009,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1109,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,,,,0.008,hour1,median,,,25th-75th percentile,0.005,0.011,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1110,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,24.72,hour,median,,,25th-75th percentile,18.07,34.56,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1111,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,17.19,hour,median,,,25th-75th percentile,9.73,22.2,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1112,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,95.15,hour,median,,,25th-75th percentile,78.93,207.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1113,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,83.48,hour,median,,,25th-75th percentile,62.18,156.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1114,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Vd/f,,,23.25,L/kg,median,,,25th-75th percentile,20.22,24.55,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1115,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Vd/f,,,19,L/kg,median,,,25th-75th percentile,17.24,28.18,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1116,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Cl/f,,,0.66,L/hour/kg,median,,,25th-75th percentile,0.52,1.16,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1117,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Cl/f,,,1.45,L/hour/kg,median,,,25th-75th percentile,0.63,3.24,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1118,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.33,,median,,,25th-75th percentile,0.27,0.38,0.0039,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1119,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.44,,median,,,25th-75th percentile,0.31,0.5,0.0039,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1120,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.32,,median,,,25th-75th percentile,0.24,0.42,0.1289,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1121,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.37,,median,,,25th-75th percentile,0.23,0.46,0.1289,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1122,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.27,,median,,,25th-75th percentile,0.19,0.32,0.0039,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1123,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.39,,median,,,25th-75th percentile,0.25,0.4,0.0039,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1124,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.27,,median,,,25th-75th percentile,0.19,0.37,0.0273,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1125,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.34,,median,,,25th-75th percentile,0.23,0.39,0.0273,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1126,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(R)-(-)-FLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.28,,median,,,25th-75th percentile,1.1,1.63,0.3008,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1127,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(S)-(+)-FLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.3,,median,,,25th-75th percentile,1.03,1.4,0.3008,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1128,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.06,,median,,,25th-75th percentile,0.97,1.35,0.1289,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1129,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,0.95,,median,,,25th-75th percentile,0.79,1.24,0.1289,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1130,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.86,,median,,,25th-75th percentile,0.69,1.06,0.6523,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1131,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.74,,median,,,25th-75th percentile,0.68,1.07,0.6523,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1132,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.87,,median,,,25th-75th percentile,0.75,1.03,0.4961,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1133,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.96,,median,,,25th-75th percentile,0.76,1.09,0.4961,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1134,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(R)-(-)-FLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.01,0.14,0.125,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1135,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(S)-(+)-FLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.01,0.15,0.125,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1136,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.06,0.11,0.625,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1137,2025-12-02T16:05:12.001940
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.11,,median,,,25th-75th percentile,0.1,0.12,0.625,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1138,2025-12-02T16:05:12.001940
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,5.94,ng/mL,median,,,25th-75th percentile,5.14,9.16,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1085,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,6.05,ng/mL,median,,,25th-75th percentile,4.04,11.46,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1086,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,3.29,ng/mL,median,,,25th-75th percentile,2.83,3.67,<0.05 ,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1087,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,6.29,ng/mL,median,,,25th-75th percentile,5.76,8.02,<0.05 ,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1088,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,4.41,hour,median,,,25th-75th percentile,2.39,5.26,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1089,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,2.35,hour,median,,,25th-75th percentile,1.62,3.59,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1090,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,21.65,hour,median,,,25th-75th percentile,12.46,24.57,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1091,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,13.66,hour,median,,,25th-75th percentile,7.74,26.95,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1092,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,209.2,ng hour/mL,median,,,25th-75th percentile,113.9,263,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1093,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,97.81,ng hour/mL,median,,,25th-75th percentile,39.54,258.2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1094,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,498.6,ng hour/mL,median,,,25th-75th percentile,464.4,1259,<0.05 ,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1095,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,942.7,ng hour/mL,median,,,25th-75th percentile,746.4,1483,<0.05 ,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1096,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.18,hour1,median,,,25th-75th percentile,0.11,0.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1097,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.16,hour1,median,,,25th-75th percentile,0.11,0.36,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1098,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,2.33,hour,median,,,25th-75th percentile,1.07,4.14,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1099,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,1.94,hour,median,,,25th-75th percentile,1.32,4.47,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1100,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.03,hour1,median,,,25th-75th percentile,0.02,0.04,<0.05,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1101,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.04,hour1,median,,,25th-75th percentile,0.03,0.07,<0.05,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1102,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,,,,0.007,hour1,median,,,25th-75th percentile,0.004,0.009,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1103,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,,,,0.008,hour1,median,,,25th-75th percentile,0.005,0.011,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1104,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,24.72,hour,median,,,25th-75th percentile,18.07,34.56,<0.05,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1105,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,17.19,hour,median,,,25th-75th percentile,9.73,22.2,<0.05,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1106,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,95.15,hour,median,,,25th-75th percentile,78.93,207.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1107,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,83.48,hour,median,,,25th-75th percentile,62.18,156.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1108,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Vd/f,,,23.25,L/kg,median,,,25th-75th percentile,20.22,24.55,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1109,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Vd/f,,,19,L/kg,median,,,25th-75th percentile,17.24,28.18,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1110,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Cl/f,,,0.66,L/hour/kg,median,,,25th-75th percentile,0.52,1.16,<0.05,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1111,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Cl/f,,,1.45,L/hour/kg,median,,,25th-75th percentile,0.63,3.24,<0.05,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1112,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.33,,median,,,25th-75th percentile,0.27,0.38,0.0039,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1113,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.44,,median,,,25th-75th percentile,0.31,0.5,0.0039,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1114,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.32,,median,,,25th-75th percentile,0.24,0.42,0.1289,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1115,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.37,,median,,,25th-75th percentile,0.23,0.46,0.1289,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1116,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.27,,median,,,25th-75th percentile,0.19,0.32,0.0039,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1117,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.39,,median,,,25th-75th percentile,0.25,0.4,0.0039,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1118,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.27,,median,,,25th-75th percentile,0.19,0.37,0.0273,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1119,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.34,,median,,,25th-75th percentile,0.23,0.39,0.0273,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1120,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(R)-(-)-FLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.28,,median,,,25th-75th percentile,1.1,1.63,0.3008,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1121,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(S)-(+)-FLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.3,,median,,,25th-75th percentile,1.03,1.4,0.3008,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1122,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.06,,median,,,25th-75th percentile,0.97,1.35,0.1289,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1123,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,0.95,,median,,,25th-75th percentile,0.79,1.24,0.1289,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1124,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.86,,median,,,25th-75th percentile,0.69,1.06,0.6523,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1125,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.74,,median,,,25th-75th percentile,0.68,1.07,0.6523,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1126,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.87,,median,,,25th-75th percentile,0.75,1.03,0.4961,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1127,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.96,,median,,,25th-75th percentile,0.76,1.09,0.4961,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1128,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(R)-(-)-FLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.01,0.14,0.125,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1129,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(S)-(+)-FLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.01,0.15,0.125,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1130,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.06,0.11,0.625,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1131,2025-12-02T16:05:15.923463
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.11,,median,,,25th-75th percentile,0.1,0.12,0.625,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1132,2025-12-02T16:05:15.923463
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,5.94,ng/mL,median,,,25th-75th percentile,5.14,9.16,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1085,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,6.05,ng/mL,median,,,25th-75th percentile,4.04,11.46,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1086,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,3.29,ng/mL,median,,,25th-75th percentile,2.83,3.67,<0.05 ,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1087,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,Cmax,,,6.29,ng/mL,median,,,25th-75th percentile,5.76,8.02,<0.05 ,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1088,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,4.41,hour,median,,,25th-75th percentile,2.39,5.26,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1089,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,2.35,hour,median,,,25th-75th percentile,1.62,3.59,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1090,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,21.65,hour,median,,,25th-75th percentile,12.46,24.57,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1091,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,Tmax,,,13.66,hour,median,,,25th-75th percentile,7.74,26.95,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1092,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,209.2,ng hour/mL,median,,,25th-75th percentile,113.9,263,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1093,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,97.81,ng hour/mL,median,,,25th-75th percentile,39.54,258.2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1094,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,498.6,ng hour/mL,median,,,25th-75th percentile,464.4,1259,<0.05 ,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1095,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,AUC0,,,942.7,ng hour/mL,median,,,25th-75th percentile,746.4,1483,<0.05 ,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1096,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.18,hour1,median,,,25th-75th percentile,0.11,0.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1097,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.16,hour1,median,,,25th-75th percentile,0.11,0.36,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1098,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,2.33,hour,median,,,25th-75th percentile,1.07,4.14,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1099,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,1.94,hour,median,,,25th-75th percentile,1.32,4.47,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1100,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.03,hour1,median,,,25th-75th percentile,0.02,0.04,<0.05,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1101,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,,,,0.04,hour1,median,,,25th-75th percentile,0.03,0.07,<0.05,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1102,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,,,,0.007,hour1,median,,,25th-75th percentile,0.004,0.009,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1103,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,,,,0.008,hour1,median,,,25th-75th percentile,0.005,0.011,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1104,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,24.72,hour,median,,,25th-75th percentile,18.07,34.56,<0.05,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1105,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,17.19,hour,median,,,25th-75th percentile,9.73,22.2,<0.05,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1106,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-NorFLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,95.15,hour,median,,,25th-75th percentile,78.93,207.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1107,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-NorFLX,plasma,maternal,3rd trimester,,9.0,t1/2,,,83.48,hour,median,,,25th-75th percentile,62.18,156.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1108,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Vd/f,,,23.25,L/kg,median,,,25th-75th percentile,20.22,24.55,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1109,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Vd/f,,,19,L/kg,median,,,25th-75th percentile,17.24,28.18,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1110,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(R)-()-FLX,plasma,maternal,3rd trimester,,9.0,Cl/f,,,0.66,L/hour/kg,median,,,25th-75th percentile,0.52,1.16,<0.05,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1111,2025-12-02T16:05:22.346295
30346625.0,fluoxetine,(S)-(+)-FLX,plasma,maternal,3rd trimester,,9.0,Cl/f,,,1.45,L/hour/kg,median,,,25th-75th percentile,0.63,3.24,<0.05,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1112,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.33,,median,,,25th-75th percentile,0.27,0.38,0.0039,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1113,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.44,,median,,,25th-75th percentile,0.31,0.5,0.0039,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1114,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.32,,median,,,25th-75th percentile,0.24,0.42,0.1289,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1115,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical vein/maternal vein,maternal/pediatric,delivery,fetus,9.0,Umbilical vein/maternal vein concentration ratio,,,0.37,,median,,,25th-75th percentile,0.23,0.46,0.1289,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1116,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.27,,median,,,25th-75th percentile,0.19,0.32,0.0039,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1117,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.39,,median,,,25th-75th percentile,0.25,0.4,0.0039,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1118,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.27,,median,,,25th-75th percentile,0.19,0.37,0.0273,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1119,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical vein/intervillous space,maternal,delivery,,9.0,Umbilical vein/intervillous space concentration ratio,,,0.34,,median,,,25th-75th percentile,0.23,0.39,0.0273,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1120,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(R)-(-)-FLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.28,,median,,,25th-75th percentile,1.1,1.63,0.3008,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1121,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(S)-(+)-FLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.3,,median,,,25th-75th percentile,1.03,1.4,0.3008,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1122,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,1.06,,median,,,25th-75th percentile,0.97,1.35,0.1289,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1123,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Intervillous space/maternal vein,maternal/pediatric,delivery,fetus,9.0,Intervillous space/maternal vein concentration ratio,,,0.95,,median,,,25th-75th percentile,0.79,1.24,0.1289,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1124,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(R)-(-)-FLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.86,,median,,,25th-75th percentile,0.69,1.06,0.6523,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1125,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(S)-(+)-FLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.74,,median,,,25th-75th percentile,0.68,1.07,0.6523,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1126,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.87,,median,,,25th-75th percentile,0.75,1.03,0.4961,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1127,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Umbilical artery/umbilical vein,pediatric,delivery,fetus,9.0,Umbilical artery/umbilical vein concentration ratio,,,0.96,,median,,,25th-75th percentile,0.76,1.09,0.4961,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1128,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(R)-(-)-FLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.01,0.14,0.125,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1129,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(S)-(+)-FLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.01,0.15,0.125,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1130,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(R)-(-)-NorFLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.08,,median,,,25th-75th percentile,0.06,0.11,0.625,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1131,2025-12-02T16:05:22.346295
30346625.0,Fluoxetine,(S)-(+)-NorFLX,Amniotic fluid/maternal vein,maternal,delivery,,9.0,Amniotic fluid/maternal vein concentration ratio,,,0.11,,median,,,25th-75th percentile,0.1,0.12,0.625,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1132,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,78,nmol/L,mean,SD,21,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1152,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,99,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1153,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,38,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1154,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,13,nmol/L,mean,SD,5.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1155,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,75,nmol/L,mean,SD,18,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1156,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,92,nmol/L,mean,SD,39,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1157,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,37,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1158,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,15,nmol/L,mean,SD,4.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1159,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,77,nmol/L,mean,SD,25,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1160,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,100,nmol/L,mean,SD,52,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1161,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,42,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1162,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,19,nmol/L,mean,SD,8.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1163,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,delivery,,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,98,nmol/L,mean,SD,32,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1164,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,delivery,,11.0,concentration ,,,126,nmol/L,mean,SD,61,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1165,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,delivery,,11.0,concentration ,,,46,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1166,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,delivery,,11.0,concentration ,,,20,nmol/L,mean,SD,7.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1167,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,87,nmol/L,mean,SD,44,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1168,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,103,nmol/L,mean,SD,45,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1169,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,39,nmol/L,mean,SD,9.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1170,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,17,nmol/L,mean,SD,6.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1171,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,4 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,101,nmol/L,mean,SD,28,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1172,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,124,nmol/L,mean,SD,45,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1173,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,42,nmol/L,mean,SD,10,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1174,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,17,nmol/L,mean,SD,7.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1175,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 wk,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,141,nmol/L,mean,SD,25,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1176,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,199,nmol/L,mean,SD,75,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1177,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,55,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1178,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,17,nmol/L,mean,SD,6.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1179,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 mo,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,132,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1180,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,169,nmol/L,mean,SD,69,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1181,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,59,nmol/L,mean,SD,21,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1182,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,15,nmol/L,mean,SD,7.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1183,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,4 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,251,nmol/L,mean,SD,95,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1184,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,303,nmol/L,mean,SD,133,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1185,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,126,nmol/L,mean,SD,57,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1186,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,59,nmol/L,mean,SD,29,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1187,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 wk,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,319,nmol/L,mean,SD,53,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1188,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,445,nmol/L,mean,SD,141,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1189,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,155,nmol/L,mean,SD,51,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1190,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,41,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1191,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 mo,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,234,nmol/L,mean,SD,81,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1192,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,278,nmol/L,mean,SD,91,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1193,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,104,nmol/L,mean,SD,48,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1194,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,31,nmol/L,mean,SD,20,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1195,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,umbilical cord plasma,pediatric,,fetus,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,62,nmol/L,mean,SD,22,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1196,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,82,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1197,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,30,nmol/L,mean,SD,11,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1198,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,13,nmol/L,mean,SD,6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1199,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,mo,39,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1200,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,50,nmol/L,mean,SD,24,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1201,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,24,nmol/L,mean,SD,7.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1202,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,13,nmol/L,mean,SD,5.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1203,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,4,d,24,nmol/L,mean,SD,8.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1204,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,30,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1205,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,16,nmol/L,mean,SD,4.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1206,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,10,nmol/L,mean,SD,5.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1207,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,wk,6.4,nmol/L,mean,SD,4.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1208,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,8.9,nmol/L,mean,SD,6.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1209,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,5,nmol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1210,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,4.3,nmol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1211,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,mo,2.7,nmol/L,mean,SD,1.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1212,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,3.3,nmol/L,mean,SD,2.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1213,2025-12-02T16:05:09.448543
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,2.8,nmol/L,mean,SD,1.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1214,2025-12-02T16:05:09.448543
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,2.2,nmol/L,mean,SD,1.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1215,2025-12-02T16:05:09.448543
12189365.0,citalopram,citalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,78,nmol/L,mean,SD,21,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1152,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,99,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1153,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,38,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1154,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,13,nmol/L,mean,SD,5.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1155,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,75,nmol/L,mean,SD,18,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1156,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,92,nmol/L,mean,SD,39,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1157,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,37,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1158,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,15,nmol/L,mean,SD,4.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1159,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,77,nmol/L,mean,SD,25,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1160,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,100,nmol/L,mean,SD,52,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1161,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,42,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1162,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,19,nmol/L,mean,SD,8.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1163,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,delivery,,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,98,nmol/L,mean,SD,32,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1164,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,delivery,,11.0,concentration ,,,126,nmol/L,mean,SD,61,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1165,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,delivery,,11.0,concentration ,,,46,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1166,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,delivery,,11.0,concentration ,,,20,nmol/L,mean,SD,7.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1167,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,87,nmol/L,mean,SD,44,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1168,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,103,nmol/L,mean,SD,45,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1169,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,39,nmol/L,mean,SD,9.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1170,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,17,nmol/L,mean,SD,6.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1171,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,4 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,101,nmol/L,mean,SD,28,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1172,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,124,nmol/L,mean,SD,45,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1173,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,42,nmol/L,mean,SD,10,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1174,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,17,nmol/L,mean,SD,7.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1175,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 wk,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,141,nmol/L,mean,SD,25,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1176,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,199,nmol/L,mean,SD,75,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1177,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,55,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1178,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,17,nmol/L,mean,SD,6.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1179,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 mo,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,132,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1180,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,169,nmol/L,mean,SD,69,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1181,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,59,nmol/L,mean,SD,21,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1182,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,15,nmol/L,mean,SD,7.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1183,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,4 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,251,nmol/L,mean,SD,95,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1184,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,303,nmol/L,mean,SD,133,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1185,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,126,nmol/L,mean,SD,57,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1186,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,59,nmol/L,mean,SD,29,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1187,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 wk,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,319,nmol/L,mean,SD,53,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1188,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,445,nmol/L,mean,SD,141,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1189,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,155,nmol/L,mean,SD,51,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1190,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,41,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1191,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 mo,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,234,nmol/L,mean,SD,81,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1192,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,278,nmol/L,mean,SD,91,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1193,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,104,nmol/L,mean,SD,48,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1194,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,31,nmol/L,mean,SD,20,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1195,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,umbilical cord plasma,pediatric,,fetus,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,62,nmol/L,mean,SD,22,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1196,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,82,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1197,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,30,nmol/L,mean,SD,11,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1198,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,13,nmol/L,mean,SD,6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1199,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,mo,39,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1200,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,50,nmol/L,mean,SD,24,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1201,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,24,nmol/L,mean,SD,7.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1202,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,13,nmol/L,mean,SD,5.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1203,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,4,d,24,nmol/L,mean,SD,8.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1204,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,30,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1205,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,16,nmol/L,mean,SD,4.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1206,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,10,nmol/L,mean,SD,5.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1207,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,wk,6.4,nmol/L,mean,SD,4.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1208,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,8.9,nmol/L,mean,SD,6.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1209,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,5,nmol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1210,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,4.3,nmol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1211,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,mo,2.7,nmol/L,mean,SD,1.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1212,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,3.3,nmol/L,mean,SD,2.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1213,2025-12-02T16:05:12.001940
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,2.8,nmol/L,mean,SD,1.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1214,2025-12-02T16:05:12.001940
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,2.2,nmol/L,mean,SD,1.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1215,2025-12-02T16:05:12.001940
12189365.0,citalopram,citalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,78,nmol/L,mean,SD,21,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1146,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,99,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1147,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,38,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1148,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,13,nmol/L,mean,SD,5.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1149,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,75,nmol/L,mean,SD,18,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1150,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,92,nmol/L,mean,SD,39,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1151,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,37,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1152,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,15,nmol/L,mean,SD,4.8,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1153,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,77,nmol/L,mean,SD,25,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1154,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,100,nmol/L,mean,SD,52,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1155,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,42,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1156,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,19,nmol/L,mean,SD,8.6,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1157,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,delivery,,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,98,nmol/L,mean,SD,32,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1158,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,delivery,,11.0,concentration ,,,126,nmol/L,mean,SD,61,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1159,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,delivery,,11.0,concentration ,,,46,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1160,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,delivery,,11.0,concentration ,,,20,nmol/L,mean,SD,7.5,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1161,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,87,nmol/L,mean,SD,44,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1162,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,103,nmol/L,mean,SD,45,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1163,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,39,nmol/L,mean,SD,9.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1164,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,17,nmol/L,mean,SD,6.7,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1165,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,4 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,101,nmol/L,mean,SD,28,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1166,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,124,nmol/L,mean,SD,45,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1167,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,42,nmol/L,mean,SD,10,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1168,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,17,nmol/L,mean,SD,7.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1169,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 wk,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,141,nmol/L,mean,SD,25,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1170,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,199,nmol/L,mean,SD,75,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1171,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,55,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1172,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,17,nmol/L,mean,SD,6.1,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1173,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 mo,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,132,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1174,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,169,nmol/L,mean,SD,69,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1175,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,59,nmol/L,mean,SD,21,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1176,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,15,nmol/L,mean,SD,7.9,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1177,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,4 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,251,nmol/L,mean,SD,95,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1178,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,303,nmol/L,mean,SD,133,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1179,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,126,nmol/L,mean,SD,57,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1180,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,59,nmol/L,mean,SD,29,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1181,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 wk,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,319,nmol/L,mean,SD,53,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1182,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,445,nmol/L,mean,SD,141,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1183,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,155,nmol/L,mean,SD,51,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1184,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,41,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1185,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 mo,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,234,nmol/L,mean,SD,81,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1186,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,278,nmol/L,mean,SD,91,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1187,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,104,nmol/L,mean,SD,48,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1188,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,31,nmol/L,mean,SD,20,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1189,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,umbilical cord plasma,pediatric,,fetus,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,62,nmol/L,mean,SD,22,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1190,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,82,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1191,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,30,nmol/L,mean,SD,11,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1192,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,13,nmol/L,mean,SD,6,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1193,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,mo,39,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1194,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,50,nmol/L,mean,SD,24,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1195,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,24,nmol/L,mean,SD,7.1,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1196,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,13,nmol/L,mean,SD,5.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1197,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,4,d,24,nmol/L,mean,SD,8.9,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1198,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,30,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1199,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,16,nmol/L,mean,SD,4.5,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1200,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,10,nmol/L,mean,SD,5.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1201,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,wk,6.4,nmol/L,mean,SD,4.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1202,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,8.9,nmol/L,mean,SD,6.5,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1203,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,5,nmol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1204,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,4.3,nmol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1205,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,mo,2.7,nmol/L,mean,SD,1.6,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1206,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,3.3,nmol/L,mean,SD,2.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1207,2025-12-02T16:05:15.923463
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,2.8,nmol/L,mean,SD,1.6,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1208,2025-12-02T16:05:15.923463
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,2.2,nmol/L,mean,SD,1.8,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1209,2025-12-02T16:05:15.923463
12189365.0,citalopram,citalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,78,nmol/L,mean,SD,21,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1146,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,99,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1147,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,38,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1148,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,2nd trimester,20-24 weeks,11.0,concentration ,,,13,nmol/L,mean,SD,5.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1149,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,75,nmol/L,mean,SD,18,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1150,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,92,nmol/L,mean,SD,39,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1151,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,37,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1152,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,3rd trimester,28-32 weeks,11.0,concentration ,,,15,nmol/L,mean,SD,4.8,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1153,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,77,nmol/L,mean,SD,25,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1154,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,100,nmol/L,mean,SD,52,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1155,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,42,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1156,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,3rd trimester,36-37 weeks,11.0,concentration ,,,19,nmol/L,mean,SD,8.6,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1157,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,delivery,,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,98,nmol/L,mean,SD,32,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1158,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,delivery,,11.0,concentration ,,,126,nmol/L,mean,SD,61,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1159,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,delivery,,11.0,concentration ,,,46,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1160,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,delivery,,11.0,concentration ,,,20,nmol/L,mean,SD,7.5,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1161,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,87,nmol/L,mean,SD,44,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1162,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,103,nmol/L,mean,SD,45,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1163,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,39,nmol/L,mean,SD,9.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1164,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 d,11.0,concentration ,,,17,nmol/L,mean,SD,6.7,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1165,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,4 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,101,nmol/L,mean,SD,28,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1166,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,124,nmol/L,mean,SD,45,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1167,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,42,nmol/L,mean,SD,10,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1168,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,4 d,11.0,concentration ,,,17,nmol/L,mean,SD,7.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1169,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 wk,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,141,nmol/L,mean,SD,25,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1170,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,199,nmol/L,mean,SD,75,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1171,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,55,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1172,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 wk,11.0,concentration ,,,17,nmol/L,mean,SD,6.1,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1173,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 mo,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,132,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1174,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,169,nmol/L,mean,SD,69,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1175,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,59,nmol/L,mean,SD,21,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1176,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,maternal,postpartum,2 mo,11.0,concentration ,,,15,nmol/L,mean,SD,7.9,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1177,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,4 d,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,251,nmol/L,mean,SD,95,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1178,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,303,nmol/L,mean,SD,133,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1179,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,126,nmol/L,mean,SD,57,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1180,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,4 d,11.0,concentration ,,,59,nmol/L,mean,SD,29,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1181,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 wk,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,319,nmol/L,mean,SD,53,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1182,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,445,nmol/L,mean,SD,141,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1183,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,155,nmol/L,mean,SD,51,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1184,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,2 wk,11.0,concentration ,,,41,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1185,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 mo,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,234,nmol/L,mean,SD,81,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1186,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,278,nmol/L,mean,SD,91,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1187,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,104,nmol/L,mean,SD,48,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1188,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,breast milk,maternal,lactation,2 mo,11.0,concentration ,,,31,nmol/L,mean,SD,20,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1189,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,umbilical cord plasma,pediatric,,fetus,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,,,62,nmol/L,mean,SD,22,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1190,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,82,nmol/L,mean,SD,50,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1191,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,30,nmol/L,mean,SD,11,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1192,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,umbilical cord plasma,maternal,,fetus,11.0,concentration ,,,13,nmol/L,mean,SD,6,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1193,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,mo,39,nmol/L,mean,SD,14,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1194,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,50,nmol/L,mean,SD,24,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1195,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,24,nmol/L,mean,SD,7.1,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1196,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,13,nmol/L,mean,SD,5.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1197,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,4,d,24,nmol/L,mean,SD,8.9,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1198,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,30,nmol/L,mean,SD,12,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1199,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,16,nmol/L,mean,SD,4.5,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1200,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,4,d,10,nmol/L,mean,SD,5.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1201,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,wk,6.4,nmol/L,mean,SD,4.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1202,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,8.9,nmol/L,mean,SD,6.5,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1203,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,5,nmol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1204,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,newborn,11.0,concentration ,2,wk,4.3,nmol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1205,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration corrected to correspond to the defined daily dose of 20 mg of citalopram,2,mo,2.7,nmol/L,mean,SD,1.6,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1206,2025-12-02T16:05:22.346295
12189365.0,citalopram,citalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,3.3,nmol/L,mean,SD,2.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1207,2025-12-02T16:05:22.346295
12189365.0,citalopram,desmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,2.8,nmol/L,mean,SD,1.6,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1208,2025-12-02T16:05:22.346295
12189365.0,citalopram,didesmethylcitalopram,plasma,pediatric,,infant,11.0,concentration ,2,mo,2.2,nmol/L,mean,SD,1.8,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1209,2025-12-02T16:05:22.346295
36094046.0,sertraline,sertraline,maternal plasma,,,[4-8) wks,2,concentration/dose ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,-0.02,0.27,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,706,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[8-12) wks,17,concentration/dose ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.18,0.31,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,707,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[12-16) wks,27,concentration/dose ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.21,0.32,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,708,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[16-20) wks,40,concentration/dose ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.21,0.32,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,709,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[20-24) wks,32,concentration/dose ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.22,0.32,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,710,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[24-28) wks,42,concentration/dose ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.26,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,711,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[28-32) wks,33,concentration/dose ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.22,0.33,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,712,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[32-36) wks,32,concentration/dose ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.23,0.34,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,713,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,36+ wks,32,concentration/dose ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.19,0.3,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,714,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,<8 wks postpartum,29,concentration/dose ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.31,0.42,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,715,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,>8 wks postpartum,36,concentration/dose ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.27,0.37,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,716,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[4-8) wks,2,sertraline/desmethylsertraline concentration ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.31,0.65,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,717,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[8-12) wks,17,sertraline/desmethylsertraline concentration ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.4,0.54,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,718,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[12-16) wks,27,sertraline/desmethylsertraline concentration ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.34,0.43,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,719,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[16-20) wks,40,sertraline/desmethylsertraline concentration ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.36,0.45,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,720,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[20-24) wks,32,sertraline/desmethylsertraline concentration ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.32,0.4,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,721,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[24-28) wks,42,sertraline/desmethylsertraline concentration ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.34,0.42,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,722,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[28-32) wks,33,sertraline/desmethylsertraline concentration ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.29,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,723,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[32-36) wks,32,sertraline/desmethylsertraline concentration ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.32,0.41,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,724,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,36+ wks,29,sertraline/desmethylsertraline concentration ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.28,0.35,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,725,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,<8 wks postpartum,36,sertraline/desmethylsertraline concentration ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.42,0.54,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,726,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,>8 wks postpartum,,sertraline/desmethylsertraline concentration ratio,,,,ng/mL per dose (mg per day),LS mean estimate,,,95% CI,0.45,0.56,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,727,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[4-8) wks,2,concentration/dose ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,-0.26,0.02,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,728,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[8-12) wks,17,concentration/dose ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,-0.06,0.06,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,729,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[12-16) wks,27,concentration/dose ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,-0.03,0.07,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,730,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[16-20) wks,40,concentration/dose ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,-0.03,0.06,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,731,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[20-24) wks,32,concentration/dose ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,-0.02,0.07,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,732,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[24-28) wks,42,concentration/dose ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,0.02,0.11,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,733,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[28-32) wks,33,concentration/dose ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,-0.02,0.08,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,734,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,[32-36) wks,32,concentration/dose ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,-0.01,0.09,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,735,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,36+ wks,32,concentration/dose ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,reference,reference,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,736,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,<8 wks postpartum,29,concentration/dose ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,0.08,0.17,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,737,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,,,>8 wks postpartum,36,concentration/dose ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,0.03,0.12,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,738,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[4-8) wks,2,sertraline/desmethylsertraline concentration ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,0.99,2.09,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,739,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[8-12) wks,17,sertraline/desmethylsertraline concentration ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,1.28,1.77,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,740,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[12-16) wks,27,sertraline/desmethylsertraline concentration ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,1.08,1.4,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,741,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[16-20) wks,40,sertraline/desmethylsertraline concentration ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,1.15,1.46,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,742,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[20-24) wks,32,sertraline/desmethylsertraline concentration ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,1.02,1.31,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,743,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[24-28) wks,42,sertraline/desmethylsertraline concentration ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,1.09,1.38,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,744,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[28-32) wks,33,sertraline/desmethylsertraline concentration ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,0.92,1.18,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,745,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,[32-36) wks,32,sertraline/desmethylsertraline concentration ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,1.03,1.32,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,746,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,36+ wks,32,sertraline/desmethylsertraline concentration ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,ref,ref,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,747,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,<8 wks postpartum,29,sertraline/desmethylsertraline concentration ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,1.35,1.75,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,748,2025-12-02T15:59:37.490403
36094046.0,sertraline,desmethylsertraline,maternal plasma,,,>8 wks postpartum,36,sertraline/desmethylsertraline concentration ratio,,,,,coefficient estimate (vs 36+ wks),,,95% CI,1.43,1.83,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,749,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[4-8) wks,20,concentration/dose,,,,,LS mean,,,95% CI,na,na,,Population = metabolizer status of pregnant persons,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,750,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[8-12) wks,20,concentration/dose,,,,,LS mean,,,95% CI,0.14,0.33,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,751,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[12-16) wks,20,concentration/dose,,,,,LS mean,,,95% CI,0.15,0.31,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,752,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[16-20) wks,20,concentration/dose,,,,,LS mean,,,95% CI,0.16,0.31,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,753,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[20-24) wks,20,concentration/dose,,,,,LS mean,,,95% CI,0.18,0.34,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,754,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[24-28) wks,20,concentration/dose,,,,,LS mean,,,95% CI,0.27,0.41,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,755,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[28-32) wks,20,concentration/dose,,,,,LS mean,,,95% CI,0.21,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,756,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[32-36) wks,20,concentration/dose,,,,,LS mean,,,95% CI,0.19,0.35,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,757,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,36+ wks,20,concentration/dose,,,,,LS mean,,,95% CI,0.17,0.33,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,758,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,<8 wks postpartum,20,concentration/dose,,,,,LS mean,,,95% CI,0.27,0.43,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,759,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,>8 wks postpartum,20,concentration/dose,,,,,LS mean,,,95% CI,0.21,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,760,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[4-8) wks,7,concentration/dose,,,,,LS mean,,,95% CI,-0.16,0.43,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,761,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[8-12) wks,7,concentration/dose,,,,,LS mean,,,95% CI,0.08,0.48,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,762,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[12-16) wks,7,concentration/dose,,,,,LS mean,,,95% CI,0.15,0.52,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,763,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[16-20) wks,7,concentration/dose,,,,,LS mean,,,95% CI,0.17,0.5,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,764,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[20-24) wks,7,concentration/dose,,,,,LS mean,,,95% CI,0.2,0.57,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,765,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[24-28) wks,7,concentration/dose,,,,,LS mean,,,95% CI,0.22,0.55,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,766,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[28-32) wks,7,concentration/dose,,,,,LS mean,,,95% CI,0.23,0.58,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,767,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[32-36) wks,7,concentration/dose,,,,,LS mean,,,95% CI,0.22,0.56,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,768,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,36+ wks,7,concentration/dose,,,,,LS mean,,,95% CI,0.11,0.45,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,769,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,<8 wks postpartum,7,concentration/dose,,,,,LS mean,,,95% CI,0.42,0.77,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,770,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,>8 wks postpartum,7,concentration/dose,,,,,LS mean,,,95% CI,0.39,0.74,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,771,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,rapid or ultrarapid,,[4-8) wks,19,concentration/dose,,,,,LS mean,,,95% CI,0.04,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,772,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,rapid or ultrarapid,,[8-12) wks,19,concentration/dose,,,,,LS mean,,,95% CI,0.16,0.35,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,773,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,rapid or ultrarapid,,[12-16) wks,19,concentration/dose,,,,,LS mean,,,95% CI,0.19,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,774,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,rapid or ultrarapid,,[16-20) wks,19,concentration/dose,,,,,LS mean,,,95% CI,0.18,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,775,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,rapid or ultrarapid,,[20-24) wks,19,concentration/dose,,,,,LS mean,,,95% CI,0.16,0.32,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,776,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,rapid or ultrarapid,,[24-28) wks,19,concentration/dose,,,,,LS mean,,,95% CI,0.17,0.34,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,777,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,rapid or ultrarapid,,[28-32) wks,19,concentration/dose,,,,,LS mean,,,95% CI,0.14,0.31,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,778,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,rapid or ultrarapid,,[32-36) wks,19,concentration/dose,,,,,LS mean,,,95% CI,0.17,0.34,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,779,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,rapid or ultrarapid,,36+ wks,19,concentration/dose,,,,,LS mean,,,95% CI,0.16,0.33,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,780,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,rapid or ultrarapid,,<8 wks postpartum,19,concentration/dose,,,,,LS mean,,,95% CI,0.21,0.38,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,781,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,rapid or ultrarapid,,>8 wks postpartum,19,concentration/dose,,,,,LS mean,,,95% CI,0.19,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,782,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[4-8) wks,29,concentration/dose,,,,,LS mean,,,95% CI,-0.01,0.28,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,783,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[8-12) wks,29,concentration/dose,,,,,LS mean,,,95% CI,0.18,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,784,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[12-16) wks,29,concentration/dose,,,,,LS mean,,,95% CI,0.22,0.37,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,785,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[16-20) wks,29,concentration/dose,,,,,LS mean,,,95% CI,0.22,0.37,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,786,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[20-24) wks,29,concentration/dose,,,,,LS mean,,,95% CI,0.2,0.35,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,787,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[24-28) wks,29,concentration/dose,,,,,LS mean,,,95% CI,0.23,0.38,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,788,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[28-32) wks,29,concentration/dose,,,,,LS mean,,,95% CI,0.19,0.34,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,789,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[32-36) wks,29,concentration/dose,,,,,LS mean,,,95% CI,0.23,0.38,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,790,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,36+ wks,29,concentration/dose,,,,,LS mean,,,95% CI,0.17,0.32,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,791,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,<8 wks postpartum,29,concentration/dose,,,,,LS mean,,,95% CI,0.3,0.46,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,792,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,>8 wks postpartum,29,concentration/dose,,,,,LS mean,,,95% CI,0.27,0.41,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,793,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[4-8) wks,17,concentration/dose,,,,,LS mean,,,95% CI,na,na,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,794,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[8-12) wks,17,concentration/dose,,,,,LS mean,,,95% CI,0.12,0.31,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,795,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[12-16) wks,17,concentration/dose,,,,,LS mean,,,95% CI,0.13,0.3,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,796,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[16-20) wks,17,concentration/dose,,,,,LS mean,,,95% CI,0.14,0.3,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,797,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[20-24) wks,17,concentration/dose,,,,,LS mean,,,95% CI,0.18,0.35,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,798,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[24-28) wks,17,concentration/dose,,,,,LS mean,,,95% CI,0.24,0.39,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,799,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[28-32) wks,17,concentration/dose,,,,,LS mean,,,95% CI,0.21,0.37,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,800,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[32-36) wks,17,concentration/dose,,,,,LS mean,,,95% CI,0.16,0.34,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,801,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,36+ wks,17,concentration/dose,,,,,LS mean,,,95% CI,0.16,0.33,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,802,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,<8 wks postpartum,17,concentration/dose,,,,,LS mean,,,95% CI,0.27,0.43,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,803,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,>8 wks postpartum,17,concentration/dose,,,,,LS mean,,,95% CI,0.21,0.37,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,804,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[4-8) wks,28,concentration/dose,,,,,LS mean,,,95% CI,0,0.33,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,805,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[8-12) wks,28,concentration/dose,,,,,LS mean,,,95% CI,0.18,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,806,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[12-16) wks,28,concentration/dose,,,,,LS mean,,,95% CI,0.22,0.37,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,807,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[16-20) wks,28,concentration/dose,,,,,LS mean,,,95% CI,0.22,0.37,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,808,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[20-24) wks,28,concentration/dose,,,,,LS mean,,,95% CI,0.23,0.38,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,809,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[24-28) wks,28,concentration/dose,,,,,LS mean,,,95% CI,0.3,0.45,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,810,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[28-32) wks,28,concentration/dose,,,,,LS mean,,,95% CI,0.22,0.38,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,811,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,[32-36) wks,28,concentration/dose,,,,,LS mean,,,95% CI,0.25,0.41,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,812,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,36+ wks,28,concentration/dose,,,,,LS mean,,,95% CI,0.21,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,813,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,<8 wks postpartum,28,concentration/dose,,,,,LS mean,,,95% CI,0.33,0.49,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,814,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,extensive,,>8 wks postpartum,28,concentration/dose,,,,,LS mean,,,95% CI,0.29,0.44,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,815,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[4-8) wks,15,concentration/dose,,,,,LS mean,,,95% CI,na,na,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,816,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[8-12) wks,15,concentration/dose,,,,,LS mean,,,95% CI,0.12,0.31,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,817,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[12-16) wks,15,concentration/dose,,,,,LS mean,,,95% CI,0.12,0.28,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,818,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[16-20) wks,15,concentration/dose,,,,,LS mean,,,95% CI,0.13,0.28,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,819,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[20-24) wks,15,concentration/dose,,,,,LS mean,,,95% CI,0.14,0.29,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,820,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[24-28) wks,15,concentration/dose,,,,,LS mean,,,95% CI,0.14,0.28,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,821,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[28-32) wks,15,concentration/dose,,,,,LS mean,,,95% CI,0.16,0.31,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,822,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,[32-36) wks,15,concentration/dose,,,,,LS mean,,,95% CI,0.14,0.29,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,823,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,36+ wks,15,concentration/dose,,,,,LS mean,,,95% CI,0.12,0.26,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,824,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,<8 wks postpartum,15,concentration/dose,,,,,LS mean,,,95% CI,0.21,0.36,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,825,2025-12-02T15:59:37.490403
36094046.0,sertraline,sertraline,maternal plasma,poor or intermediate,,>8 wks postpartum,15,concentration/dose,,,,,LS mean,,,95% CI,0.13,0.28,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,826,2025-12-02T15:59:37.490403
37982307.0,sertraline,sertraline,maternal blood,,3rd tri,,43,concentration,,,22.75,ng/mL,mean,SD,,range,2.5,90.7,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,969,2025-12-02T15:59:37.490403
37982307.0,paroxetine,paroxetine,maternal blood,,3rd tri,,13,concentration,,,16.05,ng/mL,mean,SD,,range,2.5,41.9,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,970,2025-12-02T15:59:37.490403
37982307.0,escitalopram,escitalopram,maternal blood,,3rd tri,,11,concentration,,,21.33,ng/mL,mean,SD,,range,2.5,68.8,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,971,2025-12-02T15:59:37.490403
37982307.0,citalopram,citalopram,maternal blood,,3rd tri,,3,concentration,,,38.15,ng/mL,mean,SD,,range,14.9,90.2,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,972,2025-12-02T15:59:37.490403
37982307.0,fluoxetine,fluoxetine,maternal blood,,3rd tri,,4,concentration,,,,ng/mL,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,973,2025-12-02T15:59:37.490403
37982307.0,venlafaxine,venlafaxine,maternal blood,,3rd tri,,11,concentration,,,86.68,ng/mL,mean,SD,,range,37.6,260.1,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,974,2025-12-02T15:59:37.490403
37982307.0,duloxetine,duloxetine,maternal blood,,3rd tri,,2,concentration,,,,ng/mL,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,975,2025-12-02T15:59:37.490403
37982307.0,sertraline,sertraline,maternal blood,,3rd tri,,43,C/D,,,0.22,,mean,SD,,range,0.03,0.85,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,976,2025-12-02T15:59:37.490403
37982307.0,paroxetine,paroxetine,maternal blood,,3rd tri,,13,C/D,,,1.58,,mean,SD,,range,0.13,4.19,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,977,2025-12-02T15:59:37.490403
37982307.0,escitalopram,escitalopram,maternal blood,,3rd tri,,11,C/D,,,2.19,,mean,SD,,range,0.25,6.88,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,978,2025-12-02T15:59:37.490403
37982307.0,citalopram,citalopram,maternal blood,,3rd tri,,3,C/D,,,1.9,,mean,SD,,range,0.75,4.51,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,979,2025-12-02T15:59:37.490403
37982307.0,fluoxetine,fluoxetine,maternal blood,,3rd tri,,4,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,980,2025-12-02T15:59:37.490403
37982307.0,venlafaxine,venlafaxine,maternal blood,,3rd tri,,11,C/D,,,1.03,,mean,SD,,range,0.33,3.27,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,981,2025-12-02T15:59:37.490403
37982307.0,duloxetine,duloxetine,maternal blood,,3rd tri,,2,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,982,2025-12-02T15:59:37.490403
37982307.0,sertraline,sertraline,cord blood,,3rd tri,,43,concentration,,,7.8,ng/mL,mean,SD,,range,2.5,35.5,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,983,2025-12-02T15:59:37.490403
37982307.0,paroxetine,paroxetine,cord blood,,3rd tri,,13,concentration,,,2.95,ng/mL,mean,SD,,range,2.5,10.3,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,984,2025-12-02T15:59:37.490403
37982307.0,escitalopram,escitalopram,cord blood,,3rd tri,,11,concentration,,,6.75,ng/mL,mean,SD,,range,2.5,15.9,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,985,2025-12-02T15:59:37.490403
37982307.0,citalopram,citalopram,cord blood,,3rd tri,,3,concentration,,,,ng/mL,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,986,2025-12-02T15:59:37.490403
37982307.0,fluoxetine,fluoxetine,cord blood,,3rd tri,,4,concentration,,,76.91,ng/mL,mean,SD,,range,2.5,152,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,987,2025-12-02T15:59:37.490403
37982307.0,venlafaxine,venlafaxine,cord blood,,3rd tri,,11,concentration,,,67.46,ng/mL,mean,SD,,range,78.9,234.7,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,988,2025-12-02T15:59:37.490403
37982307.0,duloxetine,duloxetine,cord blood,,3rd tri,,2,concentration,,,,ng/mL,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,989,2025-12-02T15:59:37.490403
37982307.0,sertraline,sertraline,cord blood,,3rd tri,,43,C/D,,,0.1,,mean,SD,,range,0,0.38,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,990,2025-12-02T15:59:37.490403
37982307.0,paroxetine,paroxetine,cord blood,,3rd tri,,13,C/D,,,0.14,,mean,SD,,range,0.13,0.52,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,991,2025-12-02T15:59:37.490403
37982307.0,escitalopram,escitalopram,cord blood,,3rd tri,,11,C/D,,,0.76,,mean,SD,,range,0.25,1.59,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,992,2025-12-02T15:59:37.490403
37982307.0,citalopram,citalopram,cord blood,,3rd tri,,3,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,993,2025-12-02T15:59:37.490403
37982307.0,fluoxetine,fluoxetine,cord blood,,3rd tri,,4,C/D,,,3.84,,mean,SD,,range,0.13,7.6,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,994,2025-12-02T15:59:37.490403
37982307.0,venlafaxine,venlafaxine,cord blood,,3rd tri,,11,C/D,,,0.84,,mean,SD,,range,0.53,2.46,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,995,2025-12-02T15:59:37.490403
37982307.0,duloxetine,duloxetine,cord blood,,3rd tri,,2,C/D,,,,,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,996,2025-12-02T15:59:37.490403
19658039.0,bupropion,bupropion,placental tissue,,delivery,,17,concentration,,,,ng/mL,mean,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Pk param (summary data),PKparam_summary,997,2025-12-02T15:59:37.490403
30116895.0,Sertraline,Sertraline,blood,maternal,lactation,,6.0,concentration,,,9.55,ng/ml,median,,,minmax,3.3,17.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2084,2025-12-02T16:03:31.981487
30116895.0,Sertraline,Sertraline,blood,maternal,lactation,,6.0,Concentration-by-dose-ratio ,,,0.23,(ng/ml)/(mg/day),median,,,minmax,0.007,0.39,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2085,2025-12-02T16:03:31.981487
30116895.0,Sertraline,Sertraline,breast milk,maternal,lactation,,6.0,concentration,,,11.3,ng/ml,median,,,minmax,3.6,35.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2086,2025-12-02T16:03:31.981487
30116895.0,Sertraline,Sertraline,breast milk,maternal,lactation,,6.0,Concentration-by-dose-ratio ,,,0.228,(ng/ml)/(mg/day),median,,,minmax,0.07,0.71,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2087,2025-12-02T16:03:31.981487
30116895.0,Venlafaxine,Venlafaxine,serum,maternal,lacation,,5.0,concentration,,,38,ng/ml,median,,,minmax,10,265,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,401,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration,,,169,ng/ml,median,,,minmax,84,424,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,402,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration,,,240.9,ng/ml,median,,,minmax,94,462,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,403,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,102,ng/ml,median,,,minmax,7.5,568,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,404,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,371,ng/ml,median,,,minmax,72,1031,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,405,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,514,ng/ml,median,,,minmax,79.5,1086,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,406,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.015,mg per kg b.w./day,median,,,minmax,0.001,0.0852,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,407,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.056,mg per kg b.w./day,median,,,minmax,0.011,0.155,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,408,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine and O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.077,mg per kg b.w./day,median,,,minmax,0.0119,0.1629,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,409,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,metabolite to parent (ODV/VEN) ratio,,,7.03,,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,410,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,metabolite to parent (ODV/VEN) ratio,,,6.81,,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,411,2025-12-02T16:05:09.448543
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration,,,56.45,ng/ml,median,,,minmax,36.4,174,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,412,2025-12-02T16:05:09.448543
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration,,,111.5,ng/ml,median,,,minmax,41.5,260,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,413,2025-12-02T16:05:09.448543
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,Absolute infant dose per kg body weight,,,0.0167,mg per kg b.w./day,median,,,minmax,0.0062,0.039,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,414,2025-12-02T16:05:09.448543
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration-by-dose-ratio,,,3.42,,median,,,minmax,2.45,5.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,415,2025-12-02T16:05:09.448543
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration-by-dose-ratio,,,4.4,,median,,,minmax,3.75,9.05,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,416,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,0.51,,median,,,minmax,0.11,1.77,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,417,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,1.36,,median,,,minmax,0.21,3.79,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,418,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,2.13,,median,,,minmax,1.13,5.65,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,419,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,3.17,,median,,,minmax,2.02,6.87,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,420,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,2.89,,median,,,minmax,1.49,6.16,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,421,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,6.65,,median,,,minmax,2.23,7.24,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,422,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,2.14,,median,,,minmax,0.75,3.76,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,423,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,1.49,,median,,,minmax,0.86,4.96,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,424,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,1.41,,median,,,minmax,0.85,4.85,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,425,2025-12-02T16:05:09.448543
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration-by-dose-ratio,,,3.42,,median,,,minmax,2.45,5.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,426,2025-12-02T16:05:09.448543
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration-by-dose-ratio,,,4.4,,median,,,minmax,3.75,9.05,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,427,2025-12-02T16:05:09.448543
30116895.0,Citalopram,Citalopram,maternal serum/breast milk,maternal,lacation,,6.0,M/P penetration ratio,,,1.65,,median,,,minmax,0.78,2.83,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,428,2025-12-02T16:05:09.448543
30116895.0,Venlafaxine,Venlafaxine,serum,maternal,lacation,,5.0,concentration,,,38,ng/ml,median,,,minmax,10,265,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,401,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration,,,169,ng/ml,median,,,minmax,84,424,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,402,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration,,,240.9,ng/ml,median,,,minmax,94,462,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,403,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,102,ng/ml,median,,,minmax,7.5,568,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,404,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,371,ng/ml,median,,,minmax,72,1031,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,405,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,514,ng/ml,median,,,minmax,79.5,1086,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,406,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.015,mg per kg b.w./day,median,,,minmax,0.001,0.0852,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,407,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.056,mg per kg b.w./day,median,,,minmax,0.011,0.155,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,408,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine and O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.077,mg per kg b.w./day,median,,,minmax,0.0119,0.1629,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,409,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,metabolite to parent (ODV/VEN) ratio,,,7.03,,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,410,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,metabolite to parent (ODV/VEN) ratio,,,6.81,,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,411,2025-12-02T16:05:12.001940
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration,,,56.45,ng/ml,median,,,minmax,36.4,174,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,412,2025-12-02T16:05:12.001940
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration,,,111.5,ng/ml,median,,,minmax,41.5,260,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,413,2025-12-02T16:05:12.001940
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,Absolute infant dose per kg body weight,,,0.0167,mg per kg b.w./day,median,,,minmax,0.0062,0.039,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,414,2025-12-02T16:05:12.001940
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration-by-dose-ratio,,,3.42,,median,,,minmax,2.45,5.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,415,2025-12-02T16:05:12.001940
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration-by-dose-ratio,,,4.4,,median,,,minmax,3.75,9.05,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,416,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,0.51,,median,,,minmax,0.11,1.77,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,417,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,1.36,,median,,,minmax,0.21,3.79,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,418,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,2.13,,median,,,minmax,1.13,5.65,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,419,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,3.17,,median,,,minmax,2.02,6.87,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,420,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,2.89,,median,,,minmax,1.49,6.16,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,421,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,6.65,,median,,,minmax,2.23,7.24,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,422,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,2.14,,median,,,minmax,0.75,3.76,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,423,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,1.49,,median,,,minmax,0.86,4.96,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,424,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,1.41,,median,,,minmax,0.85,4.85,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,425,2025-12-02T16:05:12.001940
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration-by-dose-ratio,,,3.42,,median,,,minmax,2.45,5.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,426,2025-12-02T16:05:12.001940
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration-by-dose-ratio,,,4.4,,median,,,minmax,3.75,9.05,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,427,2025-12-02T16:05:12.001940
30116895.0,Citalopram,Citalopram,maternal serum/breast milk,maternal,lacation,,6.0,M/P penetration ratio,,,1.65,,median,,,minmax,0.78,2.83,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,428,2025-12-02T16:05:12.001940
30116895.0,Venlafaxine,Venlafaxine,serum,maternal,lacation,,5.0,concentration,,,38,ng/ml,median,,,minmax,10,265,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,395,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration,,,169,ng/ml,median,,,minmax,84,424,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,396,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration,,,240.9,ng/ml,median,,,minmax,94,462,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,397,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,102,ng/ml,median,,,minmax,7.5,568,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,398,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,371,ng/ml,median,,,minmax,72,1031,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,399,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,514,ng/ml,median,,,minmax,79.5,1086,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,400,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.015,mg per kg b.w./day,median,,,minmax,0.001,0.0852,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,401,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.056,mg per kg b.w./day,median,,,minmax,0.011,0.155,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,402,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine and O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.077,mg per kg b.w./day,median,,,minmax,0.0119,0.1629,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,403,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,metabolite to parent (ODV/VEN) ratio,,,7.03,,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,404,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,metabolite to parent (ODV/VEN) ratio,,,6.81,,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,405,2025-12-02T16:05:15.923463
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration,,,56.45,ng/ml,median,,,minmax,36.4,174,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,406,2025-12-02T16:05:15.923463
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration,,,111.5,ng/ml,median,,,minmax,41.5,260,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,407,2025-12-02T16:05:15.923463
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,Absolute infant dose per kg body weight,,,0.0167,mg per kg b.w./day,median,,,minmax,0.0062,0.039,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,408,2025-12-02T16:05:15.923463
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration-by-dose-ratio,,,3.42,,median,,,minmax,2.45,5.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,409,2025-12-02T16:05:15.923463
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration-by-dose-ratio,,,4.4,,median,,,minmax,3.75,9.05,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,410,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,0.51,,median,,,minmax,0.11,1.77,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,411,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,1.36,,median,,,minmax,0.21,3.79,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,412,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,2.13,,median,,,minmax,1.13,5.65,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,413,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,3.17,,median,,,minmax,2.02,6.87,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,414,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,2.89,,median,,,minmax,1.49,6.16,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,415,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,6.65,,median,,,minmax,2.23,7.24,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,416,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,2.14,,median,,,minmax,0.75,3.76,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,417,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,1.49,,median,,,minmax,0.86,4.96,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,418,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,1.41,,median,,,minmax,0.85,4.85,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,419,2025-12-02T16:05:15.923463
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration-by-dose-ratio,,,3.42,,median,,,minmax,2.45,5.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,420,2025-12-02T16:05:15.923463
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration-by-dose-ratio,,,4.4,,median,,,minmax,3.75,9.05,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,421,2025-12-02T16:05:15.923463
30116895.0,Citalopram,Citalopram,maternal serum/breast milk,maternal,lacation,,6.0,M/P penetration ratio,,,1.65,,median,,,minmax,0.78,2.83,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,422,2025-12-02T16:05:15.923463
30116895.0,Venlafaxine,Venlafaxine,serum,maternal,lacation,,5.0,concentration,,,38,ng/ml,median,,,minmax,10,265,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,395,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration,,,169,ng/ml,median,,,minmax,84,424,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,396,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration,,,240.9,ng/ml,median,,,minmax,94,462,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,397,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,102,ng/ml,median,,,minmax,7.5,568,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,398,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,371,ng/ml,median,,,minmax,72,1031,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,399,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration,,,514,ng/ml,median,,,minmax,79.5,1086,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,400,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.015,mg per kg b.w./day,median,,,minmax,0.001,0.0852,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,401,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.056,mg per kg b.w./day,median,,,minmax,0.011,0.155,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,402,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine and O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,Absolute infant dose per kg body weight,,,0.077,mg per kg b.w./day,median,,,minmax,0.0119,0.1629,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,403,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,metabolite to parent (ODV/VEN) ratio,,,7.03,,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,404,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,metabolite to parent (ODV/VEN) ratio,,,6.81,,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,405,2025-12-02T16:05:22.346295
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration,,,56.45,ng/ml,median,,,minmax,36.4,174,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,406,2025-12-02T16:05:22.346295
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration,,,111.5,ng/ml,median,,,minmax,41.5,260,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,407,2025-12-02T16:05:22.346295
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,Absolute infant dose per kg body weight,,,0.0167,mg per kg b.w./day,median,,,minmax,0.0062,0.039,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,408,2025-12-02T16:05:22.346295
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration-by-dose-ratio,,,3.42,,median,,,minmax,2.45,5.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,409,2025-12-02T16:05:22.346295
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration-by-dose-ratio,,,4.4,,median,,,minmax,3.75,9.05,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,410,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,0.51,,median,,,minmax,0.11,1.77,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,411,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,1.36,,median,,,minmax,0.21,3.79,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,412,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,2.13,,median,,,minmax,1.13,5.65,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,413,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,3.17,,median,,,minmax,2.02,6.87,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,414,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,serum,maternal,lacation,,5.0,concentration-by-dose-ratio,,,2.89,,median,,,minmax,1.49,6.16,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,415,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,maternal,lacation,,5.0,concentration-by-dose-ratio,,,6.65,,median,,,minmax,2.23,7.24,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,416,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,2.14,,median,,,minmax,0.75,3.76,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,417,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,O-Desmethylvenlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,1.49,,median,,,minmax,0.86,4.96,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,418,2025-12-02T16:05:22.346295
30116895.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,maternal serum/breast milk,maternal,lacation,,5.0,M/P penetration ratio,,,1.41,,median,,,minmax,0.85,4.85,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,419,2025-12-02T16:05:22.346295
30116895.0,Citalopram,Citalopram,serum,maternal,lacation,,6.0,concentration-by-dose-ratio,,,3.42,,median,,,minmax,2.45,5.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,420,2025-12-02T16:05:22.346295
30116895.0,Citalopram,Citalopram,breast milk,maternal,lacation,,6.0,concentration-by-dose-ratio,,,4.4,,median,,,minmax,3.75,9.05,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,421,2025-12-02T16:05:22.346295
30116895.0,Citalopram,Citalopram,maternal serum/breast milk,maternal,lacation,,6.0,M/P penetration ratio,,,1.65,,median,,,minmax,0.78,2.83,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,422,2025-12-02T16:05:22.346295
10485633.0,paroxetine,paroxetine,breast milk/maternal serum,maternal,lactation,,6.0,mean milk/maternal serum concentration ratio,,,0.69,,mean,SD,0.29,minmax,0.39,1.11,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1406,2025-12-02T16:05:09.448543
10485633.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,estimated mean relative doses to infants ,,,1.4,%,mean,SD,,minmax,0.7,2.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1407,2025-12-02T16:05:09.448543
10485633.0,paroxetine,paroxetine,breast milk/maternal serum,maternal,lactation,,6.0,mean milk/maternal serum concentration ratio,,,0.69,,mean,SD,0.29,minmax,0.39,1.11,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1406,2025-12-02T16:05:12.001940
10485633.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,estimated mean relative doses to infants ,,,1.4,%,mean,SD,,minmax,0.7,2.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1407,2025-12-02T16:05:12.001940
10485633.0,paroxetine,paroxetine,breast milk/maternal serum,maternal,lactation,,6.0,mean milk/maternal serum concentration ratio,,,0.69,,mean,SD,0.29,minmax,0.39,1.11,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1400,2025-12-02T16:05:15.923463
10485633.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,estimated mean relative doses to infants ,,,1.4,%,mean,SD,,minmax,0.7,2.9,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1401,2025-12-02T16:05:15.923463
10485633.0,paroxetine,paroxetine,breast milk/maternal serum,maternal,lactation,,6.0,mean milk/maternal serum concentration ratio,,,0.69,,mean,SD,0.29,minmax,0.39,1.11,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1400,2025-12-02T16:05:22.346295
10485633.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,estimated mean relative doses to infants ,,,1.4,%,mean,SD,,minmax,0.7,2.9,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1401,2025-12-02T16:05:22.346295
35880962.0,ketamine,ketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,3,h,51.2,ng/ml,mean,SD,18.8,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2,2025-12-02T16:03:31.981487
35880962.0,ketamine,ketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,6,h,22.6,ng/ml,mean,SD,8.4,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3,2025-12-02T16:03:31.981487
35880962.0,ketamine,ketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,9,h,10.6,ng/ml,mean,SD,5.4,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4,2025-12-02T16:03:31.981487
35880962.0,ketamine,ketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,12,h,4.5,ng/ml,mean,SD,4.4,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5,2025-12-02T16:03:31.981487
35880962.0,ketamine,ketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,3,h,125,ng/ml,mean,SD,44.1,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,6,2025-12-02T16:03:31.981487
35880962.0,ketamine,ketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,6,h,48.2,ng/ml,mean,SD,17.3,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,7,2025-12-02T16:03:31.981487
35880962.0,ketamine,ketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,9,h,21.6,ng/ml,mean,SD,13.9,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,8,2025-12-02T16:03:31.981487
35880962.0,ketamine,ketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,12,h,18.5,ng/ml,mean,SD,6.7,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,9,2025-12-02T16:03:31.981487
35880962.0,ketamine,norketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,3,h,42.6,ng/ml,mean,SD,10.5,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,10,2025-12-02T16:03:31.981487
35880962.0,ketamine,norketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,6,h,28.6,ng/ml,mean,SD,5.2,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,11,2025-12-02T16:03:31.981487
35880962.0,ketamine,norketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,9,h,18.8,ng/ml,mean,SD,5.1,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,12,2025-12-02T16:03:31.981487
35880962.0,ketamine,norketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,12,h,8.7,ng/ml,mean,SD,6.4,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,13,2025-12-02T16:03:31.981487
35880962.0,ketamine,norketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,3,h,92.7,ng/ml,mean,SD,14.8,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,14,2025-12-02T16:03:31.981487
35880962.0,ketamine,norketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,6,h,62.4,ng/ml,mean,SD,12.9,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,15,2025-12-02T16:03:31.981487
35880962.0,ketamine,norketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,9,h,37.3,ng/ml,mean,SD,10.5,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,16,2025-12-02T16:03:31.981487
35880962.0,ketamine,norketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,12,h,32.3,ng/ml,mean,SD,10.3,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,17,2025-12-02T16:03:31.981487
35880962.0,ketamine,dehydronorketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,3,h,0.56,ng/ml,mean,SD,0.3,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,18,2025-12-02T16:03:31.981487
35880962.0,ketamine,dehydronorketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,6,h,0.55,ng/ml,mean,SD,0.2,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,19,2025-12-02T16:03:31.981487
35880962.0,ketamine,dehydronorketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,9,h,0.45,ng/ml,mean,SD,0.3,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,20,2025-12-02T16:03:31.981487
35880962.0,ketamine,dehydronorketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,12,h,0.21,ng/ml,mean,SD,0.1,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,21,2025-12-02T16:03:31.981487
35880962.0,ketamine,dehydronorketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,3,h,2,ng/ml,mean,SD,1.1,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,22,2025-12-02T16:03:31.981487
35880962.0,ketamine,dehydronorketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,6,h,1.8,ng/ml,mean,SD,1.1,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,23,2025-12-02T16:03:31.981487
35880962.0,ketamine,dehydronorketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,9,h,1.4,ng/ml,mean,SD,0.7,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,24,2025-12-02T16:03:31.981487
35880962.0,ketamine,dehydronorketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,12,h,1.1,ng/ml,mean,SD,0.6,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,25,2025-12-02T16:03:31.981487
35880962.0,ketamine,hydroxynorketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,3,h,29.9,ng/ml,mean,SD,9,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,26,2025-12-02T16:03:31.981487
35880962.0,ketamine,hydroxynorketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,6,h,28.3,ng/ml,mean,SD,10.2,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,27,2025-12-02T16:03:31.981487
35880962.0,ketamine,hydroxynorketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,9,h,25.6,ng/ml,mean,SD,8,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,28,2025-12-02T16:03:31.981487
35880962.0,ketamine,hydroxynorketamine,breast milk,maternal,lactation,,4.0,concentration after the first dose,12,h,17.5,ng/ml,mean,SD,9.9,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,29,2025-12-02T16:03:31.981487
35880962.0,ketamine,hydroxynorketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,3,h,64.1,ng/ml,mean,SD,21.1,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,30,2025-12-02T16:03:31.981487
35880962.0,ketamine,hydroxynorketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,6,h,66.9,ng/ml,mean,SD,13.1,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,31,2025-12-02T16:03:31.981487
35880962.0,ketamine,hydroxynorketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,9,h,54.6,ng/ml,mean,SD,11.2,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,32,2025-12-02T16:03:31.981487
35880962.0,ketamine,hydroxynorketamine,breast milk,maternal,lactation,,4.0,concentration after the second dose,12,h,41.5,ng/ml,mean,SD,9.8,,,,,"collected samples of breast milk from each woman during two separate sessions prior to injection for baseline measurement, and timed for pumping at 3, 6, 9 and 12 hours, i.e., 3-h intervals  choosing greater than the maximum half-life duration",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,33,2025-12-02T16:03:31.981487
35880962.0,ketamine,ketamine,breast milk,maternal,lactation,,4.0,AUC0-12 after the second dose,,,259.8,ng h/mL,mean,,,95% CI,170.3,349.2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,34,2025-12-02T16:03:31.981487
35880962.0,ketamine,ketamine,breast milk,maternal,lactation,,4.0,AUC0-12 after the first dose,,,612.4,ng h/mL,mean,,,95% CI,406.2,818.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,35,2025-12-02T16:03:31.981487
35880962.0,ketamine,norketamine,breast milk,maternal,lactation,,4.0,AUC0-12 after the second dose,,,283.2,ng h/mL,mean,,,95% CI,226.7,339.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,36,2025-12-02T16:03:31.981487
35880962.0,ketamine,norketamine,breast milk,maternal,lactation,,4.0,AUC0-12 after the first dose,,,625.8,ng h/mL,mean,,,95% CI,528.5,723,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,37,2025-12-02T16:03:31.981487
35880962.0,ketamine,dehydronorketamine,breast milk,maternal,lactation,,4.0,AUC0-12 after the second dose,,,5,ng h/mL,mean,,,95% CI,3.2,6.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,38,2025-12-02T16:03:31.981487
35880962.0,ketamine,dehydronorketamine,breast milk,maternal,lactation,,4.0,AUC0-12 after the first dose,,,17.4,ng h/mL,mean,,,95% CI,10.2,24.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,39,2025-12-02T16:03:31.981487
35880962.0,ketamine,hydroxynorketamine,breast milk,maternal,lactation,,4.0,AUC0-12 after the second dose,,,227.7,ng h/mL,mean,,,95% CI,205.9,349.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,40,2025-12-02T16:03:31.981487
35880962.0,ketamine,hydroxynorketamine,breast milk,maternal,lactation,,4.0,AUC0-12 after the first dose,,,619.1,ng h/mL,mean,,,95% CI,502.2,736,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,41,2025-12-02T16:03:31.981487
30825333.0,Ketamine,Ketamine,plasma,pediatric,,child,19.0,concentration,,,485,ug/l,mean,SD,549,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,59,2025-12-02T16:03:31.981487
30825333.0,Ketamine,Ketamine,plasma,pediatric,,child,19.0,Total area under curve,,,91,Mg/min/L,mean,SD,30,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,60,2025-12-02T16:03:31.981487
30825333.0,Ketamine,Ketamine,plasma,pediatric,,child,19.0,Maximum concentration,,,1.6,mg/L,mean,SD,0.68,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,61,2025-12-02T16:03:31.981487
30825333.0,Ketamine,Ketamine,plasma,pediatric,,child,19.0,Total body clearance,,,0.52,L/min,mean,SD,0.26,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,62,2025-12-02T16:03:31.981487
30825333.0,Ketamine,Ketamine,plasma,pediatric,,child,19.0,Body weight normalizedclearance,,,0.025,L/kg/min,mean,SD,0.008,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,63,2025-12-02T16:03:31.981487
30825333.0,Ketamine,Ketamine,plasma,pediatric,,child,19.0,Mean residence time,,,2.3,hr,mean,SD,0.64,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,64,2025-12-02T16:03:31.981487
30825333.0,Ketamine,Ketamine,plasma,pediatric,,child,19.0,Distribution volumeat steady state,,,69,L,mean,SD,39,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,65,2025-12-02T16:03:31.981487
30825333.0,Ketamine,Ketamine,plasma,pediatric,,child,19.0,Body weight normalizeddistribution volume,,,3.3,L/kg,mean,SD,1.3,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,66,2025-12-02T16:03:31.981487
30825333.0,Ketamine,Ketamine,plasma,pediatric,,child,19.0,Elimination half-life,,,2.6,hr,mean,SD,1,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,67,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,10.0,Cmax,,,12.96,ng/ml,mean,,,95% CI,9.42,16.49,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,161,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,10.0,tmax,,,3.1,h,mean,,,95% CI,2.57,3.63,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,162,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,10.0,t1/2,,,3.16,h,mean,,,95% CI,2.62,3.68,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,163,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,10.0,Ka,,,0.23,h-1,mean,,,95% CI,0.19,0.28,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,164,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,10.0,t1/2,,,10.35,h,mean,,,95% CI,0.39,11.32,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,165,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,10.0,,,,0.068,h-1,mean,,,95% CI,0.061,0.075,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,166,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,10.0,AUC0-,,,175.25,ng h/ml,mean,,,95% CI,145.74,204.75,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,167,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,10.0,ClT/F,,,2.61,ml/min/kg,mean,,,95% CI,2.34,2.88,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,168,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,10.0,Vd/F,,,178.78,l,mean,,,95% CI,146.46,211.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,169,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,plasma,maternal,delivery,,10.0,Cmax,,,35.55,ng/ml,mean,,,95% CI,8.27,62.83,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,170,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,plasma,maternal,delivery,,10.0,tmax,,,4.33,h,mean,,,95% CI,2.9,5.77,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,171,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,plasma,maternal,delivery,,10.0,t1/2,,,1.37,h,mean,,,95% CI,1.15,1.58,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,172,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,plasma,maternal,delivery,,10.0,Ka,,,0.52,h-1,mean,,,95% CI,0.44,0.59,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,173,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,plasma,maternal,delivery,,10.0,t1/2,,,18.17,h,mean,,,95% CI,14.1,22.23,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,174,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,plasma,maternal,delivery,,10.0,,,,0.039,h-1,mean,,,95% CI,0.032,0.047,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,175,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,plasma,maternal,delivery,,10.0,AUC0-,,,481.19,ng h/ml,mean,,,95% CI,252.87,709.51,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,176,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,plasma,maternal,delivery,,10.0,ClT/F,,,-,ml/min/kg,mean,,,95% CI,-,-,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,177,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,plasma,maternal,delivery,,10.0,Vd/F,,,-,l,mean,,,95% CI,-,-,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,178,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,urine,maternal,delivery,,10.0,Ae total,,,8.18,ug,mean,,,95% CI,2.67,13.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,179,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,urine,maternal,delivery,,10.0,Fel,,,0.29,%,mean,,,95% CI,0.12,0.45,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,180,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,urine,maternal,delivery,,10.0,ClR,,,0.0099,ml/min/kg,mean,,,95% CI,0.0049,0.015,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,181,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,urine,maternal,delivery,,10.0,t1/2,,,12.75,h,mean,,,95% CI,10.71,14.79,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,182,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,urine,maternal,delivery,,10.0,Kel,,,0.057,h-1,mean,,,95% CI,0.048,0.065,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,183,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,urine,maternal,delivery,,10.0,Ae total,,,899.77,ug,mean,,,95% CI,534.58,1265,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,184,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,urine,maternal,delivery,,10.0,Fel,,,44.97,%,mean,,,95% CI,26.65,63.29,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,185,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,urine,maternal,delivery,,10.0,ClR,,,1.12,ml/min/kg,mean,,,95% CI,0.69,1.55,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,186,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,urine,maternal,delivery,,10.0,t1/2,,,11.5,h,mean,,,95% CI,6.14,16.86,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,187,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam-glucuronide,urine,maternal,delivery,,10.0,Kel,,,0.066,h-1,mean,,,95% CI,0.04,0.093,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,188,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,blood,maternal,delivery,,8.0,Transplacental distribution,,,9.91,ng/ml,mean,,,95% CI,7.68,12.14,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,189,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,cord plasma,pediatric,,fetus,8.0,Transplacental distribution,,,6.78,ng/ml,mean,,,95% CI,5.39,8.17,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,190,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,8.0,collection time,,,293.4,min,mean,,,95% CI,163.2,423,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,191,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,cord plasma,pediatric,,fetus,8.0,collection time,,,293.4,min,mean,,,95% CI,163.2,423,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,192,2025-12-02T16:03:31.981487
16143486.0,Lorazepam,Lorazepam,cord/maternal plasma,maternal and pediatric,delivery,fetus,8.0,cord blood/maternal blood,,,0.73,,mean,,,95% CI,0.52,0.94,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,193,2025-12-02T16:03:31.981487
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,Cmax,,,12.96,ng/ml,mean,,,CI 95%,9.42,16.49,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2069,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,Cmax,,,35.55,ng/ml,mean,,,CI 95%,8.27,62.83,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2070,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,tmax,,,3.1,h,mean,,,CI 95%,2.57,3.63,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2071,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,tmax,,,4.33,h,mean,,,CI 95%,2.9,5.77,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2072,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,t1/2a,,,3.16,h,mean,,,CI 95%,2.62,3.68,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2073,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,t1/2a,,,1.37,h,mean,,,CI 95%,1.15,1.58,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2074,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,Ka,,,0.23,/h,mean,,,CI 95%,0.19,0.28,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2075,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,Ka,,,0.52,/h,mean,,,CI 95%,0.44,0.49,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2076,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,t1/2,,,10.35,h,mean,,,CI 95%,9.39,11.32,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2077,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,t1/2,,,18.17,h,mean,,,CI 95%,14.1,22.23,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2078,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,,,,0.068,/h,mean,,,CI 95%,0.061,0.075,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2079,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,,,,0.039,/h,mean,,,CI 95%,0.032,0.047,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2080,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,AUC0-,,,175.25,ng h/ml,mean,,,CI 95%,145.74,204.75,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2081,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,AUC0-,,,481.19,ng h/ml,mean,,,CI 95%,252.87,709.51,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2082,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,ClT/F,,,2.61,ml/(min kg),mean,,,CI 95%,2.34,2.88,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2083,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,Vd/F,,,178.78,l,mean,,,CI 95%,146.46,211.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2084,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,urine,maternal,delivery,,10.0,Ae total,,,8.18,ug,mean,,,CI 95%,2.67,13.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2085,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,urine,maternal,delivery,,10.0,Ae total,,,899.77,ug,mean,,,CI 95%,534.58,1265,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2086,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,urine,maternal,delivery,,10.0,Fel,,,0.29,%,mean,,,CI 95%,0.12,0.45,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2087,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,urine,maternal,delivery,,10.0,Fel,,,44.97,%,mean,,,CI 95%,26.65,63.29,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2088,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,urine,maternal,delivery,,10.0,CLR,,,0.0099,ml/(min kg),mean,,,CI 95%,0.0049,0.015,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2089,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,urine,maternal,delivery,,10.0,CLR,,,1.12,ml/(min kg),mean,,,CI 95%,0.69,1.55,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2090,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,urine,maternal,delivery,,10.0,t1/2,,,12.75,h,mean,,,CI 95%,10.71,14.79,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2091,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,urine,maternal,delivery,,10.0,t1/2,,,11.5,h,mean,,,CI 95%,6.14,16.85,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2092,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,urine,maternal,delivery,,10.0,Kel,,,0.057,/h,mean,,,CI 95%,0.048,0.065,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2093,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam glucuronide,urine,maternal,delivery,,10.0,Kel,,,0.066,/h,mean,,,CI 95%,0.04,0.093,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2094,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,8.0,concentration,,,9.91,ng/ml,mean,,,CI 95%,7.68,12.14,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2095,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,cord plasma,pedatric,,fetus,8.0,concentration,,,6.78,ng/ml,mean,,,CI 95%,5.39,8.17,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2096,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,8.0,the ratio of cord plasma to maternal plasma concentration,,,0.73,,mean,,,CI 95%,0.52,0.94,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2097,2025-12-02T16:05:09.448543
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,Cmax,,,12.96,ng/ml,mean,,,CI 95%,9.42,16.49,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2069,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,Cmax,,,35.55,ng/ml,mean,,,CI 95%,8.27,62.83,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2070,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,tmax,,,3.1,h,mean,,,CI 95%,2.57,3.63,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2071,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,tmax,,,4.33,h,mean,,,CI 95%,2.9,5.77,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2072,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,t1/2a,,,3.16,h,mean,,,CI 95%,2.62,3.68,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2073,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,t1/2a,,,1.37,h,mean,,,CI 95%,1.15,1.58,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2074,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,Ka,,,0.23,/h,mean,,,CI 95%,0.19,0.28,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2075,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,Ka,,,0.52,/h,mean,,,CI 95%,0.44,0.49,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2076,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,t1/2,,,10.35,h,mean,,,CI 95%,9.39,11.32,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2077,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,t1/2,,,18.17,h,mean,,,CI 95%,14.1,22.23,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2078,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,,,,0.068,/h,mean,,,CI 95%,0.061,0.075,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2079,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,,,,0.039,/h,mean,,,CI 95%,0.032,0.047,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2080,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,AUC0-,,,175.25,ng h/ml,mean,,,CI 95%,145.74,204.75,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2081,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,10.0,AUC0-,,,481.19,ng h/ml,mean,,,CI 95%,252.87,709.51,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2082,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,ClT/F,,,2.61,ml/(min kg),mean,,,CI 95%,2.34,2.88,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2083,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,10.0,Vd/F,,,178.78,l,mean,,,CI 95%,146.46,211.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2084,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,urine,maternal,delivery,,10.0,Ae total,,,8.18,ug,mean,,,CI 95%,2.67,13.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2085,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,urine,maternal,delivery,,10.0,Ae total,,,899.77,ug,mean,,,CI 95%,534.58,1265,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2086,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,urine,maternal,delivery,,10.0,Fel,,,0.29,%,mean,,,CI 95%,0.12,0.45,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2087,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,urine,maternal,delivery,,10.0,Fel,,,44.97,%,mean,,,CI 95%,26.65,63.29,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2088,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,urine,maternal,delivery,,10.0,CLR,,,0.0099,ml/(min kg),mean,,,CI 95%,0.0049,0.015,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2089,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,urine,maternal,delivery,,10.0,CLR,,,1.12,ml/(min kg),mean,,,CI 95%,0.69,1.55,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2090,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,urine,maternal,delivery,,10.0,t1/2,,,12.75,h,mean,,,CI 95%,10.71,14.79,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2091,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,urine,maternal,delivery,,10.0,t1/2,,,11.5,h,mean,,,CI 95%,6.14,16.85,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2092,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,urine,maternal,delivery,,10.0,Kel,,,0.057,/h,mean,,,CI 95%,0.048,0.065,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2093,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam glucuronide,urine,maternal,delivery,,10.0,Kel,,,0.066,/h,mean,,,CI 95%,0.04,0.093,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2094,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,plasma,maternal,delivery,,8.0,concentration,,,9.91,ng/ml,mean,,,CI 95%,7.68,12.14,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2095,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,cord plasma,pedatric,,fetus,8.0,concentration,,,6.78,ng/ml,mean,,,CI 95%,5.39,8.17,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2096,2025-12-02T16:05:12.001940
16143486.0,lorazepam,lorazepam,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,8.0,the ratio of cord plasma to maternal plasma concentration,,,0.73,,mean,,,CI 95%,0.52,0.94,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2097,2025-12-02T16:05:12.001940
6117307.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,5.0,concentration,,,42,ng/ml,mean,SD,22,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,194,2025-12-02T16:03:31.981487
6117307.0,Lorazepam,Lorazepam,cord plasma,pediatric,,fetus,5.0,concentration,,,32,ng/ml,mean,SD,12,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,195,2025-12-02T16:03:31.981487
6117307.0,Lorazepam,Lorazepam-glucuronide,plasma,maternal,delivery,,5.0,concentration,,,26,ng/ml,mean,SD,12,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,196,2025-12-02T16:03:31.981487
6117307.0,Lorazepam,Lorazepam-glucuronide,cord plasma,pediatric,,fetus,5.0,concentration,,,52,ng/ml,mean,SD,15,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,197,2025-12-02T16:03:31.981487
6117307.0,a-methyldopa,a-methyldopa,plasma,maternal,delivery,,3.0,concentration,,,880,ng/ml,mean,SD,670,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,198,2025-12-02T16:03:31.981487
6117307.0,a-methyldopa,a-methyldopa,cord plasma,pediatric,,fetus,3.0,concentration,,,690,ng/ml,mean,SD,570,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,199,2025-12-02T16:03:31.981487
6117307.0,a-methyldopa,a-methyldopa sulphate,plasma,maternal,delivery,,3.0,concentration,,,1030,ng/ml,mean,SD,611,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,200,2025-12-02T16:03:31.981487
6117307.0,a-methyldopa,a-methyldopa sulphate,cord plasma,pediatric,,fetus,3.0,concentration,,,1240,ng/ml,mean,SD,910,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,201,2025-12-02T16:03:31.981487
6117307.0,lorazepam,lorazepam,umbilical cord plasma,pedatric,,fetus,12.0,concentration,,,32,ng/ml,mean,SD,12,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2116,2025-12-02T16:05:09.448543
6117307.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,12.0,concentration,,,42,ng/ml,mean,SD,22,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2117,2025-12-02T16:05:09.448543
6117307.0,lorazepam,lorazepam,umbilical cord plasma,pedatric,,fetus,12.0,concentration,,,26,ng/ml,mean,SD,12,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2118,2025-12-02T16:05:09.448543
6117307.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,12.0,concentration,,,52,ng/ml,mean,SD,15,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2119,2025-12-02T16:05:09.448543
6117307.0,lorazepam,lorazepam,umbilical cord plasma,pedatric,,fetus,12.0,concentration,,,32,ng/ml,mean,SD,12,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2116,2025-12-02T16:05:12.001940
6117307.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,12.0,concentration,,,42,ng/ml,mean,SD,22,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2117,2025-12-02T16:05:12.001940
6117307.0,lorazepam,lorazepam,umbilical cord plasma,pedatric,,fetus,12.0,concentration,,,26,ng/ml,mean,SD,12,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2118,2025-12-02T16:05:12.001940
6117307.0,lorazepam,lorazepam glucuronide,plasma,maternal,delivery,,12.0,concentration,,,52,ng/ml,mean,SD,15,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2119,2025-12-02T16:05:12.001940
6108045.0,Lorazepam,Lorazepam,vein serum,maternal,delivery,,13.0,unconjugated concentration,,,8.1,ng/ml,mean,SD,3.4,,,,,group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,202,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,umbilical vein serum,pediatric,,fetus,13.0,unconjugated concentration,,,7.1,ng/ml,mean,SD,2.7,,,,,group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,203,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,umbilical artery serum,pediatric,,fetus,13.0,unconjugated concentration,,,6.9,ng/ml,mean,SD,2,,,,,group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,204,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,vein serum,maternal,delivery,fetus,13.0,conjugated concentration,,,18.1,ng/ml,mean,SD,17.2,,,,,group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,205,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,umbilical vein serum,pediatric,,fetus,13.0,conjugated concentration,,,4.8,ng/ml,mean,SD,3.8,,,,,group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,206,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,umbilical artery serum,pediatric,,,13.0,conjugated concentration,,,4.8,ng/ml,mean,SD,3.6,,,,,group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,207,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,vein serum,maternal,delivery,,10.0,unconjugated concentration,,,7,ng/ml,mean,SD,2.3,,,,,group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,208,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,umbilical vein serum,pediatric,,fetus,10.0,unconjugated concentration,,,8.8,ng/ml,mean,SD,5.6,,,,,group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,209,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,umbilical artery serum,pediatric,,fetus,10.0,unconjugated concentration,,,8.7,ng/ml,mean,SD,3.6,,,,,group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,210,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,vein serum,maternal,delivery,fetus,10.0,conjugated concentration,,,33.9,ng/ml,mean,SD,23.7,,,,,group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,211,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,umbilical vein serum,pediatric,,fetus,10.0,conjugated concentration,,,23.5,ng/ml,mean,SD,11.7,,,,,group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,212,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,umbilical artery serum,pediatric,,,10.0,conjugated concentration,,,25.4,ng/ml,mean,SD,13.3,,,,,group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,213,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,vein serum,maternal,delivery,,13.0,time after the administration,,,1.8,hours,mean,,,minmax,0.8,7.7,,group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,214,2025-12-02T16:03:31.981487
6108045.0,Lorazepam,Lorazepam,umbilical vein serum,pediatric,,fetus,10.0,time after the administration,,,12.5,hours,mean,,,minmax,11,15.5,,group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,215,2025-12-02T16:03:31.981487
6108045.0,lorazepam,unconjugated lorazepam,serum,maternal,delivery,,13.0,concentration,,,8.1,ng/ml,mean,SD,3.4,,,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2100,2025-12-02T16:05:09.448543
6108045.0,lorazepam,conjugated lorazepam,serum,maternal,delivery,,13.0,concentration,,,18.1,ng/ml,mean,SD,17.2,,,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2101,2025-12-02T16:05:09.448543
6108045.0,lorazepam,unconjugated lorazepam,Umbilical vein serum,pedatric,,fetus,13.0,concentration,,,7.1,ng/ml,mean,SD,2.7,,,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2102,2025-12-02T16:05:09.448543
6108045.0,lorazepam,conjugated lorazepam,Umbilical vein serum,pedatric,,fetus,13.0,concentration,,,4.8,ng/ml,mean,SD,3.8,,,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2103,2025-12-02T16:05:09.448543
6108045.0,lorazepam,unconjugated lorazepam,umbilical cord artery serum,pedatric,,fetus,13.0,concentration,,,6.9,ng/ml,mean,SD,2,,,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2104,2025-12-02T16:05:09.448543
6108045.0,lorazepam,conjugated lorazepam,umbilical cord artery serum,pedatric,,fetus,13.0,concentration,,,4.8,ng/ml,mean,SD,3.6,,,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2105,2025-12-02T16:05:09.448543
6108045.0,lorazepam,unconjugated lorazepam,amniotic fluid,maternal,delivery,,13.0,concentration,,,2,ng/ml,mean,SD,2.2,,,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2106,2025-12-02T16:05:09.448543
6108045.0,lorazepam,conjugated lorazepam,amniotic fluid,maternal,delivery,,13.0,concentration,,,4.9,ng/ml,mean,SD,3,,,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2107,2025-12-02T16:05:09.448543
6108045.0,lorazepam,unconjugated lorazepam,serum,maternal,delivery,,10.0,concentration,,,7,ng/ml,mean,SD,2.3,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2108,2025-12-02T16:05:09.448543
6108045.0,lorazepam,conjugated lorazepam,serum,maternal,delivery,,10.0,concentration,,,33.9,ng/ml,mean,SD,23.7,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2109,2025-12-02T16:05:09.448543
6108045.0,lorazepam,unconjugated lorazepam,Umbilical vein serum,pedatric,,fetus,10.0,concentration,,,8.8,ng/ml,mean,SD,5.6,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2110,2025-12-02T16:05:09.448543
6108045.0,lorazepam,conjugated lorazepam,Umbilical vein serum,pedatric,,fetus,10.0,concentration,,,23.5,ng/ml,mean,SD,11.7,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2111,2025-12-02T16:05:09.448543
6108045.0,lorazepam,unconjugated lorazepam,umbilical cord artery serum,pedatric,,fetus,10.0,concentration,,,8.7,ng/ml,mean,SD,3.6,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2112,2025-12-02T16:05:09.448543
6108045.0,lorazepam,conjugated lorazepam,umbilical cord artery serum,pedatric,,fetus,10.0,concentration,,,25.4,ng/ml,mean,SD,13.3,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2113,2025-12-02T16:05:09.448543
6108045.0,lorazepam,unconjugated lorazepam,amniotic fluid,maternal,delivery,,10.0,concentration,,,4.2,ng/ml,mean,SD,2.3,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2114,2025-12-02T16:05:09.448543
6108045.0,lorazepam,conjugated lorazepam,amniotic fluid,maternal,delivery,,10.0,concentration,,,19.1,ng/ml,mean,SD,13,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2115,2025-12-02T16:05:09.448543
6108045.0,lorazepam,unconjugated lorazepam,serum,maternal,delivery,,13.0,concentration,,,8.1,ng/ml,mean,SD,3.4,,,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2100,2025-12-02T16:05:12.001940
6108045.0,lorazepam,conjugated lorazepam,serum,maternal,delivery,,13.0,concentration,,,18.1,ng/ml,mean,SD,17.2,,,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2101,2025-12-02T16:05:12.001940
6108045.0,lorazepam,unconjugated lorazepam,Umbilical vein serum,pedatric,,fetus,13.0,concentration,,,7.1,ng/ml,mean,SD,2.7,,,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2102,2025-12-02T16:05:12.001940
6108045.0,lorazepam,conjugated lorazepam,Umbilical vein serum,pedatric,,fetus,13.0,concentration,,,4.8,ng/ml,mean,SD,3.8,,,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2103,2025-12-02T16:05:12.001940
6108045.0,lorazepam,unconjugated lorazepam,umbilical cord artery serum,pedatric,,fetus,13.0,concentration,,,6.9,ng/ml,mean,SD,2,,,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2104,2025-12-02T16:05:12.001940
6108045.0,lorazepam,conjugated lorazepam,umbilical cord artery serum,pedatric,,fetus,13.0,concentration,,,4.8,ng/ml,mean,SD,3.6,,,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2105,2025-12-02T16:05:12.001940
6108045.0,lorazepam,unconjugated lorazepam,amniotic fluid,maternal,delivery,,13.0,concentration,,,2,ng/ml,mean,SD,2.2,,,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2106,2025-12-02T16:05:12.001940
6108045.0,lorazepam,conjugated lorazepam,amniotic fluid,maternal,delivery,,13.0,concentration,,,4.9,ng/ml,mean,SD,3,,,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2107,2025-12-02T16:05:12.001940
6108045.0,lorazepam,unconjugated lorazepam,serum,maternal,delivery,,10.0,concentration,,,7,ng/ml,mean,SD,2.3,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2108,2025-12-02T16:05:12.001940
6108045.0,lorazepam,conjugated lorazepam,serum,maternal,delivery,,10.0,concentration,,,33.9,ng/ml,mean,SD,23.7,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2109,2025-12-02T16:05:12.001940
6108045.0,lorazepam,unconjugated lorazepam,Umbilical vein serum,pedatric,,fetus,10.0,concentration,,,8.8,ng/ml,mean,SD,5.6,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2110,2025-12-02T16:05:12.001940
6108045.0,lorazepam,conjugated lorazepam,Umbilical vein serum,pedatric,,fetus,10.0,concentration,,,23.5,ng/ml,mean,SD,11.7,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2111,2025-12-02T16:05:12.001940
6108045.0,lorazepam,unconjugated lorazepam,umbilical cord artery serum,pedatric,,fetus,10.0,concentration,,,8.7,ng/ml,mean,SD,3.6,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2112,2025-12-02T16:05:12.001940
6108045.0,lorazepam,conjugated lorazepam,umbilical cord artery serum,pedatric,,fetus,10.0,concentration,,,25.4,ng/ml,mean,SD,13.3,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2113,2025-12-02T16:05:12.001940
6108045.0,lorazepam,unconjugated lorazepam,amniotic fluid,maternal,delivery,,10.0,concentration,,,4.2,ng/ml,mean,SD,2.3,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2114,2025-12-02T16:05:12.001940
6108045.0,lorazepam,conjugated lorazepam,amniotic fluid,maternal,delivery,,10.0,concentration,,,19.1,ng/ml,mean,SD,13,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2115,2025-12-02T16:05:12.001940
42422.0,Lorazepam,Lorazepam,plasma,pediatric,,neonate,10.0,concentration,24,h,17.6,ng/ml,mean,SD,1.3,,,,,first stage group; time from injection to delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,216,2025-12-02T16:03:31.981487
42422.0,Lorazepam,Lorazepam,plasma,pediatric,,neonate,10.0,concentration,48,h,13.4,ng/ml,mean,SD,1.83,,,,,first stage group; time from injection to delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,217,2025-12-02T16:03:31.981487
42422.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,10.0,concentration,24,h,17,ng/ml,mean,SD,1.79,,,,,first stage group; time from injection to delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,218,2025-12-02T16:03:31.981487
42422.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,10.0,concentration,48,h,12.5,ng/ml,mean,SD,1.83,,,,,first stage group; time from injection to delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,219,2025-12-02T16:03:31.981487
42422.0,Lorazepam,Lorazepam,plasma,pediatric,,neonate,12.0,concentration,24,h,13.25,ng/ml,mean,SD,1.2,,,,,second stage group; time from injection to delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,220,2025-12-02T16:03:31.981487
42422.0,Lorazepam,Lorazepam,plasma,pediatric,,neonate,12.0,concentration,48,h,10.3,ng/ml,mean,SD,1.3,,,,,second stage group; time from injection to delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,221,2025-12-02T16:03:31.981487
42422.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,12.0,concentration,24,h,12.4,ng/ml,mean,SD,0.8,,,,,second stage group; time from injection to delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,222,2025-12-02T16:03:31.981487
42422.0,Lorazepam,Lorazepam,plasma,maternal,delivery,,12.0,concentration,48,h,7.8,ng/ml,mean,SD,1.2,,,,,second stage group; time from injection to delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,223,2025-12-02T16:03:31.981487
42422.0,Lorazepam,Lorazepam,plasma,maternal and pediatric,delivery,neonate,10.0,plasma neonate-maternal ratio,,,1.05,,mean,SD,0.05,minmax,0.85,1.33,,second stage group; time from injection to delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,224,2025-12-02T16:03:31.981487
42422.0,Lorazepam,Lorazepam,plasma,maternal and pediatric,delivery,neonate,12.0,plasma neonate-maternal ratio,,,0.76,,mean,SD,0.05,minmax,0.59,1.21,,first stage group; at delivery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,225,2025-12-02T16:03:31.981487
42422.0,lorazepam,lorazepam,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,10.0,the ratio of cord plasma to maternal plasma concentration,,,1.04,,mean,SD,0.05,minmax,0.85,1.33,,first stage group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2098,2025-12-02T16:05:09.448543
42422.0,lorazepam,lorazepam,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,12.0,the ratio of cord plasma to maternal plasma concentration,,,0.76,,mean,SD,0.05,minmax,0.59,1.21,,second stage group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2099,2025-12-02T16:05:09.448543
42422.0,lorazepam,lorazepam,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,10.0,the ratio of cord plasma to maternal plasma concentration,,,1.04,,mean,SD,0.05,minmax,0.85,1.33,,first stage group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2098,2025-12-02T16:05:12.001940
42422.0,lorazepam,lorazepam,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,12.0,the ratio of cord plasma to maternal plasma concentration,,,0.76,,mean,SD,0.05,minmax,0.59,1.21,,second stage group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2099,2025-12-02T16:05:12.001940
33813550.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,11.0,body weight-adjusted clearance,,,1.15,L/hr/kg,mean,SD,0.29,,,,,infant,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,409,2025-12-02T16:03:31.981487
33813550.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,11.0,body weight-adjusted volume of distribution at seady state,,,2.52,Lkg,mean,SD,0.4,,,,,infant,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,410,2025-12-02T16:03:31.981487
33813550.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,16.0,body weight-adjusted clearance,,,0.99,L/hr/kg,mean,SD,0.26,,,,,toddler,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,411,2025-12-02T16:03:31.981487
33813550.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,16.0,body weight-adjusted volume of distribution at seady state,,,2.26,Lkg,mean,SD,0.34,,,,,toddler,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,412,2025-12-02T16:03:31.981487
33813550.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,11.0,body weight-adjusted clearance,,,1.07,L/hr/kg,mean,SD,0.19,,,,,preschooler,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,413,2025-12-02T16:03:31.981487
33813550.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,11.0,body weight-adjusted volume of distribution at seady state,,,2.21,Lkg,mean,SD,0.25,,,,,preschooler,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,414,2025-12-02T16:03:31.981487
33813550.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,8.0,body weight-adjusted clearance,,,0.83,L/hr/kg,mean,SD,0.12,,,,,school children,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,415,2025-12-02T16:03:31.981487
33813550.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,8.0,body weight-adjusted volume of distribution at seady state,,,1.79,Lkg,mean,SD,0.24,,,,,school children,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,416,2025-12-02T16:03:31.981487
32158472.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate,7.0,Cmax,,,537,pg/ml,mean,SD,180,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,417,2025-12-02T16:03:31.981487
32158472.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate,7.0,Tmax,,,31,hr,mean,SD,16.8,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,418,2025-12-02T16:03:31.981487
32158472.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate,7.0,AUC0-,,,28.4,ng/ml/h,mean,SD,8.6,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,419,2025-12-02T16:03:31.981487
32158472.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate,7.0,CL,,,0.761,L/h/kg,mean,SD,0.155,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,420,2025-12-02T16:03:31.981487
32158472.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate,7.0,MRT,,,6.84,hr,mean,SD,3.2,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,421,2025-12-02T16:03:31.981487
32158472.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate,7.0,Vss,,,5.22,L/kg,mean,SD,2.62,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,422,2025-12-02T16:03:31.981487
31333469.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child,13.0,Cmax,,,748,pg/ml,mean,SD,29.6,minmax,713,795,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,423,2025-12-02T16:03:31.981487
31333469.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,13.0,Tmax,,,49.6,min,mean,SD,7.21,minmax,45,60,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,424,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,50.0,Cmax,,,0.54,ng/ml,mean,SD,0.17,,,,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,425,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,50.0,Cmax/dexmedetominine Dose,,,0.011,/L,mean,SD,0.0051,,,,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,426,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,50.0,Cmax/dexmedetominine Dose,,,0.01,/L,Geometric mean,,,90% CI,0.0086,0.013,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,427,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,50.0,Tmax,,,37,min,median,,,minmax,30,45,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,428,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,50.0,AUC0-4,,,68,ng min/L,mean,SD,23,,,,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,429,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,50.0,AUC0-4/dexmedetominine dose,,,1.4,min/L,mean,SD,0.61,,,,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,430,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,50.0,AUC0-4/dexmedetominine dose,,,1.39,min/L,Geometric mean,,,90% CI,1.15,1.6,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,431,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,50.0,Vd/F,,,109,L,mean,SD,56,,,,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,432,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,50.0,Vd/F/dexmedetominine Dose,,,1.98,L/ug,mean,SD,0.75,,,,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,433,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,,50.0,Vd/F/dexmedetominine Dose,,,1.98,L/ug,Geometric mean,,,90% CI,1.7,2.2,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,434,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate/infant/child (age 0-2 y),8.0,Cmax,,,0.46,ng/ml,mean,SD,0.11,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,435,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate/infant/child (age 0-2 y),8.0,Cmax/dexmedetominine Dose,,,0.016,/L,mean,SD,0.0046,,,,<0.001,"P Value, 1-Way ANOVA",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,436,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate/infant/child (age 0-2 y),8.0,Tmax,,,32,min,median,,,minmax,22,43,0.52,"P Value, 1-Way ANOVA",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,437,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate/infant/child (age 0-2 y),8.0,AUC0-4,,,61,ng min/L,mean,SD,21,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,438,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate/infant/child (age 0-2 y),8.0,AUC0-4/dexmedetominine dose,,,1.9,min/L,mean,SD,0.51,,,,0.0035,"P Value, 1-Way ANOVA",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,439,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate/infant/child (age 0-2 y),8.0,Vd/F,,,134,L,mean,SD,68,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,440,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,neonate/infant/child (age 0-2 y),8.0,Vd/F/dexmedetominine Dose,,,2.28,L/ug,mean,SD,0.82,,,,0.16,"P Value, 1-Way ANOVA",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,441,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 2-6 y),24.0,Cmax,,,0.51,ng/ml,mean,SD,0.17,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,442,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 2-6 y),24.0,Cmax/dexmedetominine Dose,,,0.011,/L,mean,SD,0.0046,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,443,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 2-6 y),24.0,Tmax,,,32,min,median,,,minmax,28,45,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,444,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 2-6 y),24.0,AUC0-4,,,69,ng min/L,mean,SD,25,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,445,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 2-6 y),24.0,AUC0-4/dexmedetominine dose,,,1.42,min/L,mean,SD,0.66,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,446,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 2-6 y),24.0,Vd/F,,,118,L,mean,SD,58,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,447,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 2-6 y),24.0,Vd/F/dexmedetominine Dose,,,1.97,L/ug,mean,SD,0.72,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,448,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 6-11y),18.0,Cmax,,,0.61,ng/ml,mean,SD,0.18,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,449,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 6-11y),18.0,Cmax/dexmedetominine Dose,,,0.0086,/L,mean,SD,0.004,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,450,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 6-11y),18.0,Tmax,,,41,min,median,,,minmax,30,47,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,451,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 6-11y),18.0,AUC0-4,,,77,ng min/L,mean,SD,21,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,452,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 6-11y),18.0,AUC0-4/dexmedetominine dose,,,1.14,min/L,mean,SD,0.45,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,453,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 6-11y),18.0,Vd/F,,,87,L,mean,SD,45,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,454,2025-12-02T16:03:31.981487
31206433.0,Dexmedetomidine ,Dexmedetomidine ,plasma,pediatric,,child (age 6-11y),18.0,Vd/F/dexmedetominine Dose,,,1.85,L/ug,mean,SD,0.74,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,455,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,pregnancy,,14.0,AUC0-,,,9.5,ng h/ml,mean,SD,4.3,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,615,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,postpartum,,14.0,AUC0-,,,17.9,ng h/ml,mean,SD,6,,,,<0.002,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,616,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,pregnancy,,14.0,CL/F,,,4.2,l/min,mean,SD,1.8,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,617,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,postpartum,,14.0,CL/F,,,2,l/min,mean,SD,0.6,,,,0.002,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,618,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,pregnancy,,14.0,CL/Funbounded,,,593,l/min,mean,SD,237,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,619,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,postpartum,,14.0,CL/Funbounded,,,343,l/min,mean,SD,103,,,,0.007,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,620,2025-12-02T16:03:31.981487
18288078.0,midazolam,1'OH-mid,blood,maternal,pregnancy,,14.0,CLformation,,,3,l/min,mean,SD,1.1,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,621,2025-12-02T16:03:31.981487
18288078.0,midazolam,1'OH-mid,blood,maternal,postpartum,,14.0,CLformation,,,1.4,l/min,mean,SD,0.4,,,,<0.002,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,622,2025-12-02T16:03:31.981487
18288078.0,midazolam,1'OH-mid,blood,maternal,pregnancy,,14.0,"CLformation, unbound",,,418,l/min,mean,SD,150,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,623,2025-12-02T16:03:31.981487
18288078.0,midazolam,1'OH-mid,blood,maternal,postpartum,,14.0,"CLformation, unbound",,,228,l/min,mean,SD,67,,,,<0.005,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,624,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,pregnancy,,14.0,fu,,,0.71,%,mean,SD,0.11,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,625,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,postpartum,,14.0,fu,,,0.61,%,mean,SD,0.16,,,,<0.05,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,626,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,pregnancy,,14.0,Cmax,,,6.4,ng/ml,mean,SD,2.6,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,627,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,postpartum,,14.0,Cmax,,,9.3,ng/ml,mean,SD,2,,,,0.01,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,628,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,pregnancy,,14.0,Tmax,,,0.56,h,mean,SD,0.15,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,629,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,postpartum,,14.0,Tmax,,,0.54,h,mean,SD,0.14,,,,0.8,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,630,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,pregnancy,,14.0,half-life,,,2.4,h,mean,SD,0.7,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,631,2025-12-02T16:03:31.981487
18288078.0,midazolam,midazolam,blood,maternal,postpartum,,14.0,half-life,,,2.5,h,mean,SD,1.3,,,,0.6,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,632,2025-12-02T16:03:31.981487
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,AUC0-,,,9.5,ng h/ml,mean,SD,4.3,,,,<0.002,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1291,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CL/F,,,4.2,l/min,mean,SD,1.8,,,,0.002,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1292,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CL/Funbound,,,593,l/min,mean,SD,237,,,,0.007,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1293,2025-12-02T16:05:09.448543
18288078.0,Midazolam,1-hydroxymidazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CLformation,,,3,l/min,mean,SD,1.1,,,,<0.002,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1294,2025-12-02T16:05:09.448543
18288078.0,Midazolam,1-hydroxymidazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,"Clformation, unbound",,,418,l/min,mean,SD,150,,,,<0.005,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1295,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,fu,,,0.71,%,mean,SD,0.11,,,,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1296,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Cmax,,,6.4,ng/ml,mean,SD,2.6,,,,0.01,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1297,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Tmax,,,0.56,h,mean,SD,0.15,,,,0.8,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1298,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Half-life,,,2.4,h,mean,SD,0.7,,,,0.6,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1299,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,AUC0-,,,17.9,ng h/ml,mean,SD,6,,,,<0.002,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1300,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CL/F,,,2,l/min,mean,SD,0.6,,,,0.002,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1301,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CL/Funbound,,,343,l/min,mean,SD,103,,,,0.007,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1302,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CLformation,,,1.4,l/min,mean,SD,0.4,,,,<0.002,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1303,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,"Clformation, unbound",,,228,l/min,mean,SD,67,,,,<0.005,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1304,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,fu,,,0.61,%,mean,SD,0.16,,,,<0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1305,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Cmax,,,9.3,ng/ml,mean,SD,2,,,,0.01,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1306,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Tmax,,,0.54,h,mean,SD,0.14,,,,0.8,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1307,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Half-life,,,2.5,h,mean,SD,1.3,,,,0.6,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1308,2025-12-02T16:05:09.448543
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,AUC0-,,,9.5,ng h/ml,mean,SD,4.3,,,,<0.002,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1291,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CL/F,,,4.2,l/min,mean,SD,1.8,,,,0.002,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1292,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CL/Funbound,,,593,l/min,mean,SD,237,,,,0.007,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1293,2025-12-02T16:05:12.001940
18288078.0,Midazolam,1-hydroxymidazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CLformation,,,3,l/min,mean,SD,1.1,,,,<0.002,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1294,2025-12-02T16:05:12.001940
18288078.0,Midazolam,1-hydroxymidazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,"Clformation, unbound",,,418,l/min,mean,SD,150,,,,<0.005,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1295,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,fu,,,0.71,%,mean,SD,0.11,,,,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1296,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Cmax,,,6.4,ng/ml,mean,SD,2.6,,,,0.01,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1297,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Tmax,,,0.56,h,mean,SD,0.15,,,,0.8,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1298,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Half-life,,,2.4,h,mean,SD,0.7,,,,0.6,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1299,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,AUC0-,,,17.9,ng h/ml,mean,SD,6,,,,<0.002,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1300,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CL/F,,,2,l/min,mean,SD,0.6,,,,0.002,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1301,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CL/Funbound,,,343,l/min,mean,SD,103,,,,0.007,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1302,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CLformation,,,1.4,l/min,mean,SD,0.4,,,,<0.002,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1303,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,"Clformation, unbound",,,228,l/min,mean,SD,67,,,,<0.005,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1304,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,fu,,,0.61,%,mean,SD,0.16,,,,<0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1305,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Cmax,,,9.3,ng/ml,mean,SD,2,,,,0.01,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1306,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Tmax,,,0.54,h,mean,SD,0.14,,,,0.8,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1307,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Half-life,,,2.5,h,mean,SD,1.3,,,,0.6,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1308,2025-12-02T16:05:12.001940
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,AUC0-,,,9.5,ng h/ml,mean,SD,4.3,,,,<0.002,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1285,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CL/F,,,4.2,l/min,mean,SD,1.8,,,,0.002,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1286,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CL/Funbound,,,593,l/min,mean,SD,237,,,,0.007,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1287,2025-12-02T16:05:15.923463
18288078.0,Midazolam,1-hydroxymidazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CLformation,,,3,l/min,mean,SD,1.1,,,,<0.002,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1288,2025-12-02T16:05:15.923463
18288078.0,Midazolam,1-hydroxymidazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,"Clformation, unbound",,,418,l/min,mean,SD,150,,,,<0.005,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1289,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,fu,,,0.71,%,mean,SD,0.11,,,,<0.05,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1290,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Cmax,,,6.4,ng/ml,mean,SD,2.6,,,,0.01,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1291,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Tmax,,,0.56,h,mean,SD,0.15,,,,0.8,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1292,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Half-life,,,2.4,h,mean,SD,0.7,,,,0.6,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1293,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,AUC0-,,,17.9,ng h/ml,mean,SD,6,,,,<0.002,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1294,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CL/F,,,2,l/min,mean,SD,0.6,,,,0.002,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1295,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CL/Funbound,,,343,l/min,mean,SD,103,,,,0.007,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1296,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CLformation,,,1.4,l/min,mean,SD,0.4,,,,<0.002,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1297,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,"Clformation, unbound",,,228,l/min,mean,SD,67,,,,<0.005,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1298,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,fu,,,0.61,%,mean,SD,0.16,,,,<0.05,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1299,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Cmax,,,9.3,ng/ml,mean,SD,2,,,,0.01,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1300,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Tmax,,,0.54,h,mean,SD,0.14,,,,0.8,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1301,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Half-life,,,2.5,h,mean,SD,1.3,,,,0.6,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1302,2025-12-02T16:05:15.923463
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,AUC0-,,,9.5,ng h/ml,mean,SD,4.3,,,,<0.002,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1285,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CL/F,,,4.2,l/min,mean,SD,1.8,,,,0.002,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1286,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CL/Funbound,,,593,l/min,mean,SD,237,,,,0.007,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1287,2025-12-02T16:05:22.346295
18288078.0,Midazolam,1-hydroxymidazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,CLformation,,,3,l/min,mean,SD,1.1,,,,<0.002,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1288,2025-12-02T16:05:22.346295
18288078.0,Midazolam,1-hydroxymidazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,"Clformation, unbound",,,418,l/min,mean,SD,150,,,,<0.005,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1289,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,fu,,,0.71,%,mean,SD,0.11,,,,<0.05,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1290,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Cmax,,,6.4,ng/ml,mean,SD,2.6,,,,0.01,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1291,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Tmax,,,0.56,h,mean,SD,0.15,,,,0.8,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1292,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,3rd trimester,28-32 weeks gestation,13.0,Half-life,,,2.4,h,mean,SD,0.7,,,,0.6,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1293,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,AUC0-,,,17.9,ng h/ml,mean,SD,6,,,,<0.002,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1294,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CL/F,,,2,l/min,mean,SD,0.6,,,,0.002,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1295,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CL/Funbound,,,343,l/min,mean,SD,103,,,,0.007,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1296,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,CLformation,,,1.4,l/min,mean,SD,0.4,,,,<0.002,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1297,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,"Clformation, unbound",,,228,l/min,mean,SD,67,,,,<0.005,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1298,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,fu,,,0.61,%,mean,SD,0.16,,,,<0.05,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1299,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Cmax,,,9.3,ng/ml,mean,SD,2,,,,0.01,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1300,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Tmax,,,0.54,h,mean,SD,0.14,,,,0.8,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1301,2025-12-02T16:05:22.346295
18288078.0,Midazolam,Midazolam,plasma,maternal,postpartum,6-10 weeks,13.0,Half-life,,,2.5,h,mean,SD,1.3,,,,0.6,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1302,2025-12-02T16:05:22.346295
16765143.0,midazolam,midazolam,breast milk,maternal,lactation,,5.0,Vc,,,0.14,L/kg,mean,SD,0.07,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,633,2025-12-02T16:03:31.981487
16765143.0,midazolam,midazolam,breast milk,maternal,lactation,,5.0,VF,,,0.29,L/kg,mean,SD,0.13,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,634,2025-12-02T16:03:31.981487
16765143.0,midazolam,midazolam,breast milk,maternal,lactation,,5.0,Vs,,,0.72,L/kg,mean,SD,0.18,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,635,2025-12-02T16:03:31.981487
16765143.0,midazolam,midazolam,breast milk,maternal,lactation,,5.0,Vss,,,1.15,L/kg,mean,SD,0.29,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,636,2025-12-02T16:03:31.981487
16765143.0,midazolam,midazolam,breast milk,maternal,lactation,,5.0,CLF,,,31,ml/min/kg,mean,SD,12,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,637,2025-12-02T16:03:31.981487
16765143.0,midazolam,midazolam,breast milk,maternal,lactation,,5.0,CLs,,,6,ml/min/kg,mean,SD,4,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,638,2025-12-02T16:03:31.981487
16765143.0,midazolam,midazolam,breast milk,maternal,lactation,,5.0,CLE,,,5,ml/min/kg,mean,SD,1,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,639,2025-12-02T16:03:31.981487
16765143.0,midazolam,midazolam,breast milk,maternal,lactation,,5.0,T1/2,,,213,min,mean,SD,33,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,640,2025-12-02T16:03:31.981487
16765143.0,midazolam,midazolam,breast milk,maternal,lactation,,5.0,delay time for transfer into breast milk,,,537,min,mean,SD,220,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,641,2025-12-02T16:03:31.981487
16765143.0,midazolam,midazolam,breast milk,maternal,lactation,,5.0,fe,,,0.09 x10^-3,,mean,SD,0.05 x10^-3,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,642,2025-12-02T16:03:31.981487
16765143.0,propofol,propofol,breast milk,maternal,lactation,,5.0,Vc,,,0.23,L/kg,mean,SD,0.11,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,643,2025-12-02T16:03:31.981487
16765143.0,propofol,propofol,breast milk,maternal,lactation,,5.0,VF,,,0.57,L/kg,mean,SD,0.42,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,644,2025-12-02T16:03:31.981487
16765143.0,propofol,propofol,breast milk,maternal,lactation,,5.0,Vs,,,1.77,L/kg,mean,SD,0.26,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,645,2025-12-02T16:03:31.981487
16765143.0,propofol,propofol,breast milk,maternal,lactation,,5.0,Vss,,,2.57,L/kg,mean,SD,0.49,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,646,2025-12-02T16:03:31.981487
16765143.0,propofol,propofol,breast milk,maternal,lactation,,5.0,CLF,,,42,ml/min/kg,mean,SD,20,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,647,2025-12-02T16:03:31.981487
16765143.0,propofol,propofol,breast milk,maternal,lactation,,5.0,CLs,,,21,ml/min/kg,mean,SD,9,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,648,2025-12-02T16:03:31.981487
16765143.0,propofol,propofol,breast milk,maternal,lactation,,5.0,CLE,,,22,ml/min/kg,mean,SD,6,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,649,2025-12-02T16:03:31.981487
16765143.0,propofol,propofol,breast milk,maternal,lactation,,5.0,T1/2,,,146,min,mean,SD,54,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,650,2025-12-02T16:03:31.981487
16765143.0,propofol,propofol,breast milk,maternal,lactation,,5.0,delay time for transfer into breast milk,,,321,min,mean,SD,56,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,651,2025-12-02T16:03:31.981487
16765143.0,propofol,propofol,breast milk,maternal,lactation,,5.0,fe,,,0.25 x10^-3,,mean,SD,0.3 x10^-3,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,652,2025-12-02T16:03:31.981487
16765143.0,fentanyl,fentanyl,breast milk,maternal,lactation,,5.0,Vc,,,0.27,L/kg,mean,SD,0.07,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,653,2025-12-02T16:03:31.981487
16765143.0,fentanyl,fentanyl,breast milk,maternal,lactation,,5.0,VF,,,0.46,L/kg,mean,SD,0.16,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,654,2025-12-02T16:03:31.981487
16765143.0,fentanyl,fentanyl,breast milk,maternal,lactation,,5.0,Vs,,,2.02,L/kg,mean,SD,0.45,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,655,2025-12-02T16:03:31.981487
16765143.0,fentanyl,fentanyl,breast milk,maternal,lactation,,5.0,Vss,,,2.75,L/kg,mean,SD,0.49,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,656,2025-12-02T16:03:31.981487
16765143.0,fentanyl,fentanyl,breast milk,maternal,lactation,,5.0,CLF,,,50,ml/min/kg,mean,SD,34,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,657,2025-12-02T16:03:31.981487
16765143.0,fentanyl,fentanyl,breast milk,maternal,lactation,,5.0,CLs,,,40,ml/min/kg,mean,SD,15,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,658,2025-12-02T16:03:31.981487
16765143.0,fentanyl,fentanyl,breast milk,maternal,lactation,,5.0,CLE,,,14,ml/min/kg,mean,SD,4,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,659,2025-12-02T16:03:31.981487
16765143.0,fentanyl,fentanyl,breast milk,maternal,lactation,,5.0,T1/2,,,185,min,mean,SD,67,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,660,2025-12-02T16:03:31.981487
16765143.0,fentanyl,fentanyl,breast milk,maternal,lactation,,5.0,delay time for transfer into breast milk,,,379,min,mean,SD,121,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,661,2025-12-02T16:03:31.981487
16765143.0,fentanyl,fentanyl,breast milk,maternal,lactation,,5.0,fe,,,0.39 x10^-3,,mean,SD,0.41 x10^-3,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,662,2025-12-02T16:03:31.981487
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_C,,,0.14,L/kg,mean,SD,0.07,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1252,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_F,,,0.29,L/kg,mean,SD,0.13,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1253,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_S,,,0.72,L/kg,mean,SD,0.18,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1254,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_SS,,,1.15,L/kg,mean,SD,0.29,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1255,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_F,,,31,mL/min/kg,mean,SD,12,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1256,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_S,,,6,mL/min/kg,mean,SD,4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1257,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_E,,,5,mL/min/kg,mean,SD,1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1258,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,t_1/2,,,213,min,mean,SD,33,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1259,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,d,,,537,min,mean,SD,220,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1260,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,f_e,,,0.09,10^3,mean,SD,0.05,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1261,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_C,,,0.23,L/kg,mean,SD,0.11,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1262,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_F,,,0.57,L/kg,mean,SD,0.42,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1263,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_S,,,1.77,L/kg,mean,SD,0.26,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1264,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_SS,,,2.57,L/kg,mean,SD,0.49,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1265,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_F,,,42,mL/min/kg,mean,SD,20,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1266,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_S,,,21,mL/min/kg,mean,SD,9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1267,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_E,,,22,mL/min/kg,mean,SD,6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1268,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,t_1/2,,,146,min,mean,SD,54,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1269,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,d,,,321,min,mean,SD,56,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1270,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,f_e,,,0.25,10^3,mean,SD,0.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1271,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_C,,,0.27,L/kg,mean,SD,0.07,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1272,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_F,,,0.46,L/kg,mean,SD,0.16,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1273,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_S,,,2.02,L/kg,mean,SD,0.45,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1274,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_SS,,,2.75,L/kg,mean,SD,0.49,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1275,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_F,,,50,mL/min/kg,mean,SD,34,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1276,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_S,,,40,mL/min/kg,mean,SD,15,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1277,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_E,,,14,mL/min/kg,mean,SD,4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1278,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,t_1/2,,,185,min,mean,SD,67,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1279,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,d,,,379,min,mean,SD,121,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1280,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,f_e,,,0.39,10^3,mean,SD,0.41,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1281,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,8e-05,mg,median,,,minmax,3e-05,0.00026,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1282,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,4e-05,,median,,,minmax,2e-05,0.00013,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1283,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,1.6e-05,mg/kg,median,,,minmax,6e-06,5.3e-05,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1284,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,0.026,mg,median,,,minmax,0.008,0.148,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1285,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,0.00015,,median,,,minmax,4e-05,0.00082,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1286,2025-12-02T16:05:09.448543
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,0.0052,mg/kg,median,,,minmax,0.0015,0.0296,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1287,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,2.4e-05,mg,median,,,minmax,6e-06,7.3e-05,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1288,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,0.00024,,median,,,minmax,6e-05,0.00073,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1289,2025-12-02T16:05:09.448543
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,5e-06,mg/kg,median,,,minmax,1e-06,1.5e-05,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1290,2025-12-02T16:05:09.448543
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_C,,,0.14,L/kg,mean,SD,0.07,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1252,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_F,,,0.29,L/kg,mean,SD,0.13,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1253,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_S,,,0.72,L/kg,mean,SD,0.18,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1254,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_SS,,,1.15,L/kg,mean,SD,0.29,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1255,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_F,,,31,mL/min/kg,mean,SD,12,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1256,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_S,,,6,mL/min/kg,mean,SD,4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1257,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_E,,,5,mL/min/kg,mean,SD,1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1258,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,t_1/2,,,213,min,mean,SD,33,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1259,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,d,,,537,min,mean,SD,220,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1260,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,f_e,,,0.09,10^3,mean,SD,0.05,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1261,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_C,,,0.23,L/kg,mean,SD,0.11,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1262,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_F,,,0.57,L/kg,mean,SD,0.42,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1263,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_S,,,1.77,L/kg,mean,SD,0.26,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1264,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_SS,,,2.57,L/kg,mean,SD,0.49,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1265,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_F,,,42,mL/min/kg,mean,SD,20,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1266,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_S,,,21,mL/min/kg,mean,SD,9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1267,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_E,,,22,mL/min/kg,mean,SD,6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1268,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,t_1/2,,,146,min,mean,SD,54,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1269,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,d,,,321,min,mean,SD,56,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1270,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,f_e,,,0.25,10^3,mean,SD,0.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1271,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_C,,,0.27,L/kg,mean,SD,0.07,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1272,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_F,,,0.46,L/kg,mean,SD,0.16,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1273,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_S,,,2.02,L/kg,mean,SD,0.45,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1274,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_SS,,,2.75,L/kg,mean,SD,0.49,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1275,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_F,,,50,mL/min/kg,mean,SD,34,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1276,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_S,,,40,mL/min/kg,mean,SD,15,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1277,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_E,,,14,mL/min/kg,mean,SD,4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1278,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,t_1/2,,,185,min,mean,SD,67,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1279,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,d,,,379,min,mean,SD,121,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1280,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,f_e,,,0.39,10^3,mean,SD,0.41,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1281,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,8e-05,mg,median,,,minmax,3e-05,0.00026,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1282,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,4e-05,,median,,,minmax,2e-05,0.00013,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1283,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,1.6e-05,mg/kg,median,,,minmax,6e-06,5.3e-05,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1284,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,0.026,mg,median,,,minmax,0.008,0.148,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1285,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,0.00015,,median,,,minmax,4e-05,0.00082,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1286,2025-12-02T16:05:12.001940
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,0.0052,mg/kg,median,,,minmax,0.0015,0.0296,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1287,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,2.4e-05,mg,median,,,minmax,6e-06,7.3e-05,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1288,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,0.00024,,median,,,minmax,6e-05,0.00073,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1289,2025-12-02T16:05:12.001940
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,5e-06,mg/kg,median,,,minmax,1e-06,1.5e-05,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1290,2025-12-02T16:05:12.001940
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_C,,,0.14,L/kg,mean,SD,0.07,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1246,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_F,,,0.29,L/kg,mean,SD,0.13,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1247,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_S,,,0.72,L/kg,mean,SD,0.18,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1248,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_SS,,,1.15,L/kg,mean,SD,0.29,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1249,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_F,,,31,mL/min/kg,mean,SD,12,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1250,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_S,,,6,mL/min/kg,mean,SD,4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1251,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_E,,,5,mL/min/kg,mean,SD,1,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1252,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,t_1/2,,,213,min,mean,SD,33,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1253,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,d,,,537,min,mean,SD,220,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1254,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,f_e,,,0.09,10^3,mean,SD,0.05,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1255,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_C,,,0.23,L/kg,mean,SD,0.11,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1256,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_F,,,0.57,L/kg,mean,SD,0.42,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1257,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_S,,,1.77,L/kg,mean,SD,0.26,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1258,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_SS,,,2.57,L/kg,mean,SD,0.49,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1259,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_F,,,42,mL/min/kg,mean,SD,20,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1260,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_S,,,21,mL/min/kg,mean,SD,9,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1261,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_E,,,22,mL/min/kg,mean,SD,6,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1262,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,t_1/2,,,146,min,mean,SD,54,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1263,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,d,,,321,min,mean,SD,56,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1264,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,f_e,,,0.25,10^3,mean,SD,0.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1265,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_C,,,0.27,L/kg,mean,SD,0.07,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1266,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_F,,,0.46,L/kg,mean,SD,0.16,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1267,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_S,,,2.02,L/kg,mean,SD,0.45,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1268,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_SS,,,2.75,L/kg,mean,SD,0.49,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1269,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_F,,,50,mL/min/kg,mean,SD,34,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1270,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_S,,,40,mL/min/kg,mean,SD,15,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1271,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_E,,,14,mL/min/kg,mean,SD,4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1272,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,t_1/2,,,185,min,mean,SD,67,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1273,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,d,,,379,min,mean,SD,121,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1274,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,f_e,,,0.39,10^3,mean,SD,0.41,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1275,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,8e-05,mg,median,,,minmax,3e-05,0.00026,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1276,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,4e-05,,median,,,minmax,2e-05,0.00013,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1277,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,1.6e-05,mg/kg,median,,,minmax,6e-06,5.3e-05,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1278,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,0.026,mg,median,,,minmax,0.008,0.148,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1279,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,0.00015,,median,,,minmax,4e-05,0.00082,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1280,2025-12-02T16:05:15.923463
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,0.0052,mg/kg,median,,,minmax,0.0015,0.0296,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1281,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,2.4e-05,mg,median,,,minmax,6e-06,7.3e-05,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1282,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,0.00024,,median,,,minmax,6e-05,0.00073,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1283,2025-12-02T16:05:15.923463
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,5e-06,mg/kg,median,,,minmax,1e-06,1.5e-05,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1284,2025-12-02T16:05:15.923463
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_C,,,0.14,L/kg,mean,SD,0.07,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1246,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_F,,,0.29,L/kg,mean,SD,0.13,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1247,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_S,,,0.72,L/kg,mean,SD,0.18,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1248,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,V_SS,,,1.15,L/kg,mean,SD,0.29,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1249,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_F,,,31,mL/min/kg,mean,SD,12,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1250,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_S,,,6,mL/min/kg,mean,SD,4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1251,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,CL_E,,,5,mL/min/kg,mean,SD,1,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1252,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,t_1/2,,,213,min,mean,SD,33,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1253,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,d,,,537,min,mean,SD,220,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1254,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,plasma,maternal,lactation,,5.0,f_e,,,0.09,10^3,mean,SD,0.05,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1255,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_C,,,0.23,L/kg,mean,SD,0.11,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1256,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_F,,,0.57,L/kg,mean,SD,0.42,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1257,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_S,,,1.77,L/kg,mean,SD,0.26,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1258,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,V_SS,,,2.57,L/kg,mean,SD,0.49,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1259,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_F,,,42,mL/min/kg,mean,SD,20,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1260,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_S,,,21,mL/min/kg,mean,SD,9,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1261,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,CL_E,,,22,mL/min/kg,mean,SD,6,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1262,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,t_1/2,,,146,min,mean,SD,54,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1263,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,d,,,321,min,mean,SD,56,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1264,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,plasma,maternal,lactation,,5.0,f_e,,,0.25,10^3,mean,SD,0.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1265,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_C,,,0.27,L/kg,mean,SD,0.07,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1266,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_F,,,0.46,L/kg,mean,SD,0.16,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1267,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_S,,,2.02,L/kg,mean,SD,0.45,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1268,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,V_SS,,,2.75,L/kg,mean,SD,0.49,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1269,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_F,,,50,mL/min/kg,mean,SD,34,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1270,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_S,,,40,mL/min/kg,mean,SD,15,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1271,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,CL_E,,,14,mL/min/kg,mean,SD,4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1272,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,t_1/2,,,185,min,mean,SD,67,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1273,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,d,,,379,min,mean,SD,121,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1274,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,plasma,maternal,lactation,,5.0,f_e,,,0.39,10^3,mean,SD,0.41,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1275,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,8e-05,mg,median,,,minmax,3e-05,0.00026,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1276,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,4e-05,,median,,,minmax,2e-05,0.00013,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1277,2025-12-02T16:05:22.346295
16765143.0,Midazolam,Midazolam,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,1.6e-05,mg/kg,median,,,minmax,6e-06,5.3e-05,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1278,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,0.026,mg,median,,,minmax,0.008,0.148,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1279,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,0.00015,,median,,,minmax,4e-05,0.00082,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1280,2025-12-02T16:05:22.346295
16765143.0,Propofol,Propofol,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,0.0052,mg/kg,median,,,minmax,0.0015,0.0296,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1281,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Amount recovered in milk,,,2.4e-05,mg,median,,,minmax,6e-06,7.3e-05,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1282,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Fraction of maternal dose transferred to milk,,,0.00024,,median,,,minmax,6e-05,0.00073,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1283,2025-12-02T16:05:22.346295
16765143.0,Fentanyl,Fentanyl,breast milk,maternal,lactation,,5.0,Weight-normalized infant dose,,,5e-06,mg/kg,median,,,minmax,1e-06,1.5e-05,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1284,2025-12-02T16:05:22.346295
6711257.0,midazolam,midazolam,serum,maternal,labor,,6.0,t1/2,,,4.19,min,mean,SD,2.47,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,663,2025-12-02T16:03:31.981487
6711257.0,midazolam,midazolam,serum,maternal,labor,,6.0,Vd,,,0.23,l/kg,mean,SD,0.29,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,664,2025-12-02T16:03:31.981487
6711257.0,midazolam,midazolam,serum,maternal,labor,,6.0,t1/2,,,67.85,min,mean,SD,32.31,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,665,2025-12-02T16:03:31.981487
6711257.0,midazolam,midazolam,serum,maternal,labor,,6.0,Vd,,,1.2,l/kg,mean,SD,0.53,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,666,2025-12-02T16:03:31.981487
6711257.0,midazolam,midazolam,serum,maternal,labor,,6.0,clearance,,,13.18,ml/min/kg,mean,SD,4.9,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,667,2025-12-02T16:03:31.981487
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,t1/2,,,4.19,min,mean,SD,2.47,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1352,2025-12-02T16:05:09.448543
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Vd,,,0.23,l/kg,mean,SD,0.29,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1353,2025-12-02T16:05:09.448543
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,t1/2,,,67.85,min,mean,SD,32.31,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1354,2025-12-02T16:05:09.448543
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Vd,,,1.2,l/kg,mean,SD,0.53,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1355,2025-12-02T16:05:09.448543
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Clearance,,,13.18,ml/min/kg,mean,SD,4.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1356,2025-12-02T16:05:09.448543
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,t1/2,,,4.19,min,mean,SD,2.47,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1352,2025-12-02T16:05:12.001940
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Vd,,,0.23,l/kg,mean,SD,0.29,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1353,2025-12-02T16:05:12.001940
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,t1/2,,,67.85,min,mean,SD,32.31,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1354,2025-12-02T16:05:12.001940
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Vd,,,1.2,l/kg,mean,SD,0.53,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1355,2025-12-02T16:05:12.001940
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Clearance,,,13.18,ml/min/kg,mean,SD,4.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1356,2025-12-02T16:05:12.001940
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,t1/2,,,4.19,min,mean,SD,2.47,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1346,2025-12-02T16:05:15.923463
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Vd,,,0.23,l/kg,mean,SD,0.29,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1347,2025-12-02T16:05:15.923463
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,t1/2,,,67.85,min,mean,SD,32.31,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1348,2025-12-02T16:05:15.923463
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Vd,,,1.2,l/kg,mean,SD,0.53,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1349,2025-12-02T16:05:15.923463
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Clearance,,,13.18,ml/min/kg,mean,SD,4.9,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1350,2025-12-02T16:05:15.923463
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,t1/2,,,4.19,min,mean,SD,2.47,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1346,2025-12-02T16:05:22.346295
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Vd,,,0.23,l/kg,mean,SD,0.29,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1347,2025-12-02T16:05:22.346295
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,t1/2,,,67.85,min,mean,SD,32.31,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1348,2025-12-02T16:05:22.346295
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Vd,,,1.2,l/kg,mean,SD,0.53,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1349,2025-12-02T16:05:22.346295
6711257.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,Clearance,,,13.18,ml/min/kg,mean,SD,4.9,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1350,2025-12-02T16:05:22.346295
36428856.0,midazolam,midazolam,plasma,pediatric,,children,2.0,concentration,3,h,386.61,ng/ml,median,,,Q25-Q75,191.98,581.24,,"CC+CT in rs2740574 in CYP3A4, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,668,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,2.0,concentration,24,h,111.49,ng/ml,median,,,Q25-Q75,0,222.9,,"CC+CT in rs2740574 in CYP3A4, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,669,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,concentration,3,h,0,ng/ml,median,,,Q25-Q75,0,459,,"TT  in rs2740574 in CYP3A4, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,670,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,0,,"TT  in rs2740574 in CYP3A4, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,671,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,3,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"CC  in rs2740574 in CYP3A4, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,672,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,24,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"CC  in rs2740574 in CYP3A4, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,673,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,23.0,concentration,3,h,79.52,ng/ml,median,,,Q25-Q75,0,487.96,,"CT+TT  in rs2740574 in CYP3A4, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,674,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,23.0,concentration,24,h,1,ng/ml,median,,,Q25-Q75,0,85.14,,"CT+TT  in rs2740574 in CYP3A4, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,675,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,5.0,concentration,3,h,23.51,ng/ml,median,,,Q25-Q75,0,96.2,,"CC+CT in rs2740574 in CYP3A4, > 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,676,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,5.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,79.03,,"CC+CT in rs2740574 in CYP3A4, > 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,677,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,27.0,concentration,3,h,146.83,ng/ml,median,,,Q25-Q75,0,332.5,,"TT  in rs2740574 in CYP3A4, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,678,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,27.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,133.23,,"TT  in rs2740574 in CYP3A4, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,679,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,3,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"CC  in rs2740574 in CYP3A4, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,680,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,24,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"CC  in rs2740574 in CYP3A4, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,681,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,32.0,concentration,3,h,119.67,ng/ml,median,,,Q25-Q75,0,332.5,,"TT+TC in rs776746 in CYP3A5, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,682,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,32.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,133.23,,"TT+TC in rs776746 in CYP3A5, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,683,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,11.0,concentration,3,h,0,ng/ml,median,,,Q25-Q75,0,0,,"TT+TC in rs776746 in CYP3A5, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,684,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,11.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,0,,"TT+TC in rs776746 in CYP3A5, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,685,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,12.0,concentration,3,h,438.17,ng/ml,median,,,Q25-Q75,135.75,580.24,,"CC in rs776746 in CYP3A5, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,686,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,12.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,196.64,,"CC in rs776746 in CYP3A5, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,687,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,3,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"TT in rs776746 in CYP3A5, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,688,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,24,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"TT in rs776746 in CYP3A5, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,689,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,23.0,concentration,3,h,79.52,ng/ml,median,,,Q25-Q75,0,487.96,,"TC+CC  in rs776746 in CYP3A5, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,690,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,23.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,85.14,,"TC+CC  in rs776746 in CYP3A5, <= 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,691,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,16.0,concentration,3,h,27.45,ng/ml,median,,,Q25-Q75,0,206.96,,"TT+TC in rs776746 in CYP3A5, > 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,692,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,16.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,89.09,,"TT+TC in rs776746 in CYP3A5, > 5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,693,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,16.0,concentration,3,h,276.04,ng/ml,median,,,Q25-Q75,15.05,370.29,,"CC in rs776746 in CYP3A5, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,694,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,16.0,concentration,24,h,62.97,ng/ml,median,,,Q25-Q75,0,172,,"CC in rs776746 in CYP3A5, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,695,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,2.0,concentration,3,h,104.7,ng/ml,median,,,Q25-Q75,0,209.5,,"TT in rs776746 in CYP3A5, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,696,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,2.0,concentration,24,h,84.46,ng/ml,median,,,Q25-Q75,0,168.9,,"TT in rs776746 in CYP3A5, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,697,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,30.0,concentration,3,h,119.67,ng/ml,median,,,Q25-Q75,0,342.5,,"TC+CC  in rs776746 in CYP3A5, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,698,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,30.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,99.1,,"TC+CC  in rs776746 in CYP3A5, >5 years old",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,699,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,6.0,concentration,3,h,107.7,ng/ml,median,,,Q25-Q75,0,342.6,,"CC+CT in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,700,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,6.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,195.2,,"CC+CT in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,701,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,28.0,concentration,3,h,27.4,ng/ml,median,,,Q25-Q75,0,301.3,,"TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,702,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,28.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,133.9,,"TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,703,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,1.0,concentration,3,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"CC+CT in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,704,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,1.0,concentration,24,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"CC+CT in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,705,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,20.0,concentration,3,h,288.4,ng/ml,median,,,Q25-Q75,0,563.6,,"TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,706,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,20.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,133.2,,"TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,707,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,3,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"CC  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,708,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,24,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"CC  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,709,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,34.0,concentration,3,h,39.21,ng/ml,median,,,Q25-Q75,0,322.5,,"CT+TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,710,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,34.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,168.9,,"CT+TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,711,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,3,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"CC  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,712,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,24,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"CC  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,713,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,concentration,3,h,275.6,ng/ml,median,,,Q25-Q75,0,548,,"CT+TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,714,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,99.1,,"CT+TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,715,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,concentration,3,h,0,ng/ml,median,,,Q25-Q75,0,146.8,,"TT+TC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,716,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,concentration,24,h,1,ng/ml,median,,,Q25-Q75,0,0,,"TT+TC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,717,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,concentration,3,h,140.3,ng/ml,median,,,Q25-Q75,0,342.6,,"CC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,718,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,171,,"CC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,719,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,10.0,concentration,3,h,0,ng/ml,median,,,Q25-Q75,0,204.3,,"TT+TC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,720,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,10.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,79,,"TT+TC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,721,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,11.0,concentration,3,h,459,ng/ml,median,,,Q25-Q75,296.9,789.7,,"CC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,722,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,11.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,171.6,,"CC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,723,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,2.0,concentration,3,h,104.7,ng/ml,median,,,Q25-Q75,0,209.5,,"TT in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,724,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,2.0,concentration,24,h,84.4,ng/ml,median,,,Q25-Q75,0,168.9,,"TT in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,725,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,32.0,concentration,3,h,39.2,ng/ml,median,,,Q25-Q75,0,332.5,,"TC+CC  in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,726,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,32.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,135,,"TC+CC  in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,727,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,3,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"TT in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,728,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,concentration,24,h,NC,ng/ml,median,,,Q25-Q75,NC,,,"TT in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,729,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,concentration,3,h,275.6,ng/ml,median,,,Q25-Q75,0,548,,"TC+CC  in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,730,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,concentration,24,h,0,ng/ml,median,,,Q25-Q75,0,99.1,,"TC+CC  in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,731,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,6.0,ke,,,0.026,/h,median,,,Q25-Q75,0.12,0.008,,"CC+CT in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,732,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,6.0,T1/2,,,25.2,h,median,,,Q25-Q75,5.5,25.7,,"CC+CT in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,733,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,6.0,Vd,,,5.8,L/kg,median,,,Q25-Q75,0.2,6.2,,"CC+CT in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,734,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,6.0,CL,,,0.11,L/kg/h,median,,,Q25-Q75,0.03,0.16,,"CC+CT in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,735,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,28.0,ke,,,0.046,/h,median,,,Q25-Q75,0.2,0.01,,"TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,736,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,28.0,T1/2,,,15,h,median,,,Q25-Q75,3.3,35.5,,"TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,737,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,28.0,Vd,,,3.3,L/kg,median,,,Q25-Q75,0.5,10.5,,"TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,738,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,28.0,CL,,,0.13,L/kg/h,median,,,Q25-Q75,0.02,0.38,,"TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,739,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,1.0,ke,,,0.04,/h,median,,,Q25-Q75,0.08,0.07,,"CC+CT in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,740,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,1.0,T1/2,,,53.7,h,median,,,Q25-Q75,8.45,99,,"CC+CT in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,741,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,1.0,Vd,,,18.1,L/kg,median,,,Q25-Q75,7.5,28.7,,"CC+CT in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,742,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,1.0,CL,,,1.2,L/kg/h,median,,,Q25-Q75,0.05,2.35,,"CC+CT in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,743,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,20.0,ke,,,0.05,/h,median,,,Q25-Q75,0.1,0.02,,"TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,744,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,20.0,T1/2,,,10.9,h,median,,,Q25-Q75,6.5,34.6,,"TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,745,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,20.0,Vd,,,0.38,L/kg,median,,,Q25-Q75,0.02,1.5,,"TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,746,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,20.0,CL,,,0.01,L/kg/h,median,,,Q25-Q75,0.001,0.06,,"TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,747,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,ke,,,0,/h,median,,,Q25-Q75,,,,"CC  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,748,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,T1/2,,,0,h,median,,,Q25-Q75,,,,"CC  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,749,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,Vd,,,0,L/kg,median,,,Q25-Q75,,,,"CC  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,750,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,CL,,,0,L/kg/h,median,,,Q25-Q75,,,,"CC  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,751,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,34.0,ke,,,0.03,/h,median,,,Q25-Q75,0.2,0.01,,"CT+TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,752,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,34.0,T1/2,,,16.2,h,median,,,Q25-Q75,3.3,35.6,,"CT+TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,753,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,34.0,Vd,,,3.5,L/kg,median,,,Q25-Q75,0.2,9.8,,"CT+TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,754,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,34.0,CL,,,0.1,L/kg/h,median,,,Q25-Q75,0.02,0.3,,"CT+TT  in rs2740574 in CYP3A4, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,755,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,ke,,,0,/h,median,,,Q25-Q75,,,,"CC  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,756,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,T1/2,,,0,h,median,,,Q25-Q75,,,,"CC  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,757,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,Vd,,,0,L/kg,median,,,Q25-Q75,,,,"CC  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,758,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,CL,,,0,L/kg/h,median,,,Q25-Q75,,,,"CC  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,759,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,ke,,,0.05,/h,median,,,Q25-Q75,0.08,0.02,,"CT+TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,760,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,T1/2,,,10.9,h,median,,,Q25-Q75,6.6,42.1,,"CT+TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,761,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,Vd,,,0.5,L/kg,median,,,Q25-Q75,0.03,1.7,,"CT+TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,762,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,CL,,,0.02,L/kg/h,median,,,Q25-Q75,0.001,0.06,,"CT+TT  in rs2740574 in CYP3A4, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,763,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,ke,,,0.078,/h,median,,,Q25-Q75,0.25,0.018,,"TT+TC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,764,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,T1/2,,,8.8,h,median,,,Q25-Q75,2.7,36.4,,"TT+TC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,765,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,Vd,,,3.3,L/kg,median,,,Q25-Q75,0.8,18,,"TT+TC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,766,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,CL,,,0.16,L/kg/h,median,,,Q25-Q75,0.03,0.45,,"TT+TC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,767,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,ke,,,0.33,/h,median,,,Q25-Q75,0.1,0.01,,"CC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,768,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,T1/2,,,21,h,median,,,Q25-Q75,7.4,55.4,,"CC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,769,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,Vd,,,4,L/kg,median,,,Q25-Q75,0.2,9.6,,"CC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,770,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,17.0,CL,,,0.08,L/kg/h,median,,,Q25-Q75,0.015,0.23,,"CC in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,771,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,10.0,ke,,,0.06,/h,median,,,Q25-Q75,0.1,0.02,,"TT+TC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,772,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,10.0,T1/2,,,9.03,h,median,,,Q25-Q75,2.6,18.2,,"TT+TC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,773,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,10.0,Vd,,,1,L/kg,median,,,Q25-Q75,0.01,8.4,,"TT+TC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,774,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,10.0,CL,,,0.07,L/kg/h,median,,,Q25-Q75,0.001,0.105,,"TT+TC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,775,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,11.0,ke,,,0.05,/h,median,,,Q25-Q75,0.08,0.1,,"CC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,776,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,11.0,T1/2,,,12.3,h,median,,,Q25-Q75,7.9,42.07,,"CC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,777,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,11.0,Vd,,,0.49,L/kg,median,,,Q25-Q75,0.05,1.35,,"CC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,778,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,11.0,CL,,,0.018,L/kg/h,median,,,Q25-Q75,0.002,0.049,,"CC in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,779,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,2.0,ke,,,0.11,/h,median,,,Q25-Q75,0.2,0.009,,"TT in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,780,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,2.0,T1/2,,,40.1,h,median,,,Q25-Q75,3.2,77,,"TT in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,781,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,2.0,Vd,,,9,L/kg,median,,,Q25-Q75,0,18.07,,"TT in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,782,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,2.0,CL,,,0.08,L/kg/h,median,,,Q25-Q75,0,0.16,,"TT in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,783,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,32.0,ke,,,0.038,/h,median,,,Q25-Q75,0.16,0.01,,"TC+CC  in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,784,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,32.0,T1/2,,,17.7,h,median,,,Q25-Q75,4.2,45.9,,"TC+CC  in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,785,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,32.0,Vd,,,4.6,L/kg,median,,,Q25-Q75,0.5,10.7,,"TC+CC  in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,786,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,32.0,CL,,,0.13,L/kg/h,median,,,Q25-Q75,0.02,0.42,,"TC+CC  in rs776746 in CYP3A5, male",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,787,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,ke,,,0,/h,median,,,Q25-Q75,,,,"TT in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,788,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,T1/2,,,0,h,median,,,Q25-Q75,,,,"TT in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,789,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,Vd,,,0,L/kg,median,,,Q25-Q75,,,,"TT in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,790,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,0.0,CL,,,0,L/kg/h,median,,,Q25-Q75,,,,"TT in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,791,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,ke,,,0.05,/h,median,,,Q25-Q75,0.08,0.02,,"TC+CC  in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,792,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,T1/2,,,12.1,h,median,,,Q25-Q75,6.8,34.6,,"TC+CC  in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,793,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,Vd,,,0.5,L/kg,median,,,Q25-Q76,0.05,1.8,,"TC+CC  in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,794,2025-12-02T16:03:31.981487
36428856.0,midazolam,midazolam,plasma,pediatric,,children,21.0,CL,,,0.023,L/kg/h,median,,,Q25-Q77,0.001,0.09,,"TC+CC  in rs776746 in CYP3A5, female",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,795,2025-12-02T16:03:31.981487
36388077.0,midazolam,midazolam,plasma,pediatric,,child,54.0,concentration at time of score,,,0.169,mg/L,median,,,minmax,0,14.214,,delirium (score >=9),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,796,2025-12-02T16:03:31.981487
36388077.0,midazolam,midazolam,plasma,pediatric,,child,7.0,concentration at time of score,,,0.153,mg/L,median,,,minmax,0,7.108,,not delirium (score <9),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,797,2025-12-02T16:03:31.981487
36388077.0,midazolam,midazolam,plasma,pediatric,,child,54.0,AUC0-12,,,2.954,mg h/L,median,,,minmax,0.005,153.587,,delirium (score >=9),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,798,2025-12-02T16:03:31.981487
36388077.0,midazolam,midazolam,plasma,pediatric,,child,7.0,AUC0-12,,,2.14,mg h/L,median,,,minmax,0.001,86.284,,not delirium (score <9),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,799,2025-12-02T16:03:31.981487
36388077.0,midazolam,midazolam,plasma,pediatric,,child,54.0,AUC0-24,,,5.736,mg h/L,median,,,minmax,0.005,271.155,,delirium (score >=9),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,800,2025-12-02T16:03:31.981487
36388077.0,midazolam,midazolam,plasma,pediatric,,child,7.0,AUC0-24,,,3.979,mg h/L,median,,,minmax,0.007,169.816,,not delirium (score <9),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,801,2025-12-02T16:03:31.981487
36388077.0,midazolam,midazolam,plasma,pediatric,,child,61.0,V1,,,0.21,L/kg,mean,,,0.95,0.2075,0.2125,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,802,2025-12-02T16:03:31.981487
36388077.0,midazolam,midazolam,plasma,pediatric,,child,61.0,Vss,,,0.73,L/kg,mean,,,0.95,0.7049,0.7551,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,803,2025-12-02T16:03:31.981487
36388077.0,midazolam,midazolam,plasma,pediatric,,child,61.0,CL,,,0.24,L/kg,mean,,,0.95,0.2224,0.2576,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,804,2025-12-02T16:03:31.981487
36036654.0,midazolam,midazolam,blood,pediatric,,,35.0,concentration,,,28,ng/ml,mean,,,minmax,5,356,,surgical,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,805,2025-12-02T16:03:31.981487
36036654.0,midazolam,midazolam,blood,pediatric,,,54.0,concentration,,,332,ng/ml,mean,,,minmax,5,1987,,ICU,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,806,2025-12-02T16:03:31.981487
36036654.0,midazolam,1-OH Midazolam ,blood,pediatric,,,35.0,concentration,,,9,ng/ml,mean,,,minmax,5,64,,surgical,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,807,2025-12-02T16:03:31.981487
36036654.0,midazolam,midazolam,blood,pediatric,,,54.0,concentration,,,56,ng/ml,mean,,,minmax,5,1507,,ICU,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,808,2025-12-02T16:03:31.981487
35488482.0,midazolam,midazolam,serum,pediatric,,infants and children,72.0,concentration,,,47.6,ng/ml,median,,,IQR,35.5,61.3,,patients with a sedative effect,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,809,2025-12-02T16:03:31.981487
35488482.0,midazolam,midazolam,serum,pediatric,,infants and children,26.0,concentration,,,49.8,ng/ml,median,,,IQR,44.6,63.5,,patients without a sedative effect,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,810,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,72.0,ke,,,0.043,/h,median,,,minmax,0.0001,4.243,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,811,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,72.0,t1/2,,,14.065,h,median,,,minmax,0.163,173.25,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,812,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,72.0,Vd,,,3.465,L/kg,median,,,minmax,0.004,90.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,813,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,72.0,CL,,,0.072,L/kg/h,median,,,minmax,0.003,6.739,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,814,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,9.0,concentration,3,h,96.23,ng/ml,median,,,Q25-Q75,0.01,267.2,,variant CC+CT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,815,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,9.0,concentration,24,h,0.01,ng/ml,median,,,Q25-Q75,0.01,137.1,,variant CC+CT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,816,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,49.0,concentration,3,h,146.83,ng/ml,median,,,Q25-Q75,0.01,407.6,,variant TT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,817,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,49.0,concentration,24,h,0.01,ng/ml,median,,,Q25-Q75,0.01,168.1,,variant TT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,818,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,1.0,concentration,3,h,,ng/ml,median,,,Q25-Q75,0.01,,,variant CC in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,819,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,1.0,concentration,24,h,,ng/ml,median,,,Q25-Q75,0.01,,,variant CC in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,820,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,concentration,3,h,146.83,ng/ml,median,,,Q25-Q75,0.01,370.29,,variant CT+TT rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,821,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,concentration,24,h,0.01,ng/ml,median,,,Q25-Q75,0.01,168.1,,variant CT+TT rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,822,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,28.0,concentration,3,h,320.3,ng/ml,median,,,Q25-Q75,37.5,529.5,,variant TT+TC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,823,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,28.0,concentration,24,h,0.01,ng/ml,median,,,Q25-Q75,0.01,84,,variant TT+TC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,824,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,30.0,concentration,3,h,0.01,ng/ml,median,,,Q25-Q75,0.01,196.09,,variant C/C  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,825,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,30.0,concentration,24,h,0.01,ng/ml,median,,,Q25-Q75,0.01,172.4,,variant C/C  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,826,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,2.0,concentration,3,h,104.7,ng/ml,median,,,Q25-Q75,0.01,NC,,variant TT  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,827,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,2.0,concentration,24,h,84.4,ng/ml,median,,,Q25-Q75,0.01,NC,,variant TT  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,828,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,concentration,3,h,143.5,ng/ml,median,,,Q25-Q75,0.01,384.1,,variant TC+CC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,829,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,concentration,24,h,0.01,ng/ml,median,,,Q25-Q76,0.01,150.2,,variant TC+CC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,830,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,,,,,,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,831,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,9.0,ke,,,0.02,/h,median,,,Q25-Q75,0.11,0.12,,variant CC+CT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,832,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,9.0,t1/2,,,25.2,h,median,,,Q25-Q75,6.2,71.3,,variant CC+CT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,833,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,9.0,Vd,,,6.1,L/kg,median,,,Q25-Q75,1.5,9.4,,variant CC+CT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,834,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,9.0,CL,,,0.11,L/kg/h,median,,,Q25-Q75,0.03,0.16,,variant CC+CT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,835,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,49.0,ke,,,0.04,/h,median,,,Q25-Q75,0.13,0.01,,variant TT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,836,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,49.0,t1/2,,,12.7,h,median,,,Q25-Q75,3.8,46.2,,variant TT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,837,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,49.0,Vd,,,1.5,L/kg,median,,,Q25-Q75,0.05,7.7,,variant TT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,838,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,49.0,CL,,,0.05,L/kg/h,median,,,Q25-Q75,0.003,0.22,,variant TT in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,839,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,1.0,ke,,,,/h,median,,,Q25-Q75,,,,variant CC in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,840,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,1.0,t1/2,,,,h,median,,,Q25-Q75,,,,variant CC in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,841,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,1.0,Vd,,,,L/kg,median,,,Q25-Q75,,,,variant CC in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,842,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,1.0,CL,,,,L/kg/h,median,,,Q25-Q75,,,,variant CC in rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,843,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,ke,,,0.04,/h,median,,,Q25-Q75,0.12,0.001,,variant CT+TT rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,844,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,t1/2,,,13,h,median,,,Q25-Q75,5,49.5,,variant CT+TT rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,845,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,Vd,,,1.64,L/kg,median,,,Q25-Q75,0.05,8.4,,variant CT+TT rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,846,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,CL,,,0.06,L/kg/h,median,,,Q25-Q75,0.003,0.2,,variant CT+TT rs2740574 (CYP3A4) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,847,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,28.0,ke,,,0.05,/h,median,,,Q25-Q75,0.23,0.015,,variant TT+TC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,848,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,28.0,t1/2,,,9.6,h,median,,,Q25-Q75,2.7,47.1,,variant TT+TC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,849,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,28.0,Vd,,,2.7,L/kg,median,,,Q25-Q75,0.15,14.07,,variant TT+TC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,850,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,28.0,CL,,,0.1,L/kg/h,median,,,Q25-Q75,0.001,0.34,,variant TT+TC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,851,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,30.0,ke,,,0.03,/h,median,,,Q25-Q75,0.1,0.01,,variant C/C  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,852,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,30.0,t1/2,,,18.2,h,median,,,Q25-Q75,7.4,49.5,,variant C/C  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,853,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,30.0,Vd,,,1.2,L/kg,median,,,Q25-Q75,0.05,5.5,,variant C/C  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,854,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,30.0,CL,,,0.03,L/kg/h,median,,,Q25-Q75,0.002,0.13,,variant C/C  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,855,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,2.0,ke,,,0.04,/h,median,,,Q25-Q75,0.11,0.01,,variant TT  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,856,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,2.0,t1/2,,,14,h,median,,,Q25-Q75,5.3,39.7,,variant TT  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,857,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,2.0,Vd,,,1.72,L/kg,median,,,Q25-Q75,0.07,7.7,,variant TT  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,858,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,2.0,CL,,,0.06,L/kg/h,median,,,Q25-Q75,0.003,"0,21",,variant TT  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,859,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,ke,,,0.1,/h,median,,,Q25-Q75,0.2,0.009,,variant TC+CC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,860,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,t1/2,,,40.1,h,median,,,Q25-Q75,3.2,77,,variant TC+CC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,861,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,Vd,,,9.03,L/kg,median,,,Q25-Q75,0,18,,variant TC+CC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,862,2025-12-02T16:03:31.981487
33638195.0,midazolam,midazolam,plasma,pediatric,,,56.0,CL,,,0.08,L/kg/h,median,,,Q25-Q75,0,0.16,,variant TC+CC  in rs776746 (CYP3A5) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,863,2025-12-02T16:03:31.981487
32403162.0,midazolam,midazolam,plasma,pediatric,,child,43.0,AUC0-tlast,,,162.6,Bq/L/h,median,,,minmax,10.4,898.4,,AUC from time zero to the last sampling time point,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,864,2025-12-02T16:03:31.981487
32403162.0,midazolam,midazolam,plasma,pediatric,,child,43.0,AUC0-tlast,,,50.4,ng/L/h,median,,,minmax,3.2,278.5,,AUC from time zero to the last sampling time point,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,865,2025-12-02T16:03:31.981487
32403162.0,midazolam,midazolam,plasma,pediatric,,child,32.0,AUC0-,,,160.9,Bq/L/h,median,,,minmax,10.6,753.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,866,2025-12-02T16:03:31.981487
32403162.0,midazolam,midazolam,plasma,pediatric,,child,32.0,AUC0-,,,49,ng/L/h,median,,,minmax,3.3,233.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,867,2025-12-02T16:03:31.981487
32403162.0,midazolam,1-OH-midazolam,plasma,pediatric,,child,38.0,AUC0-tlast,,,12,Bq/L/h,median,,,minmax,1.1,77,,AUC from time zero to the last sampling time point,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,868,2025-12-02T16:03:31.981487
32403162.0,midazolam,1-OH-midazolam,plasma,pediatric,,child,38.0,AUC0-tlast,,,4,ng/L/h,median,,,minmax,0.4,25.4,,AUC from time zero to the last sampling time point,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,869,2025-12-02T16:03:31.981487
32403162.0,midazolam,1-OH-midazolam,plasma,pediatric,,child,29.0,AUC0-,,,17.9,Bq/L/h,median,,,minmax,3,81.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,870,2025-12-02T16:03:31.981487
32403162.0,midazolam,1-OH-midazolam,plasma,pediatric,,child,29.0,AUC0-,,,5.9,ng/L/h,median,,,minmax,1,27,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,871,2025-12-02T16:03:31.981487
32403162.0,midazolam,1-OH-midazolam-glucuronide,plasma,pediatric,,child,43.0,AUC0-tlast,,,254.4,Bq/L/h,median,,,minmax,62.6,821.6,,AUC from time zero to the last sampling time point,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,872,2025-12-02T16:03:31.981487
32403162.0,midazolam,1-OH-midazolam-glucuronide,plasma,pediatric,,child,43.0,AUC0-tlast,,,127.2,ng/L/h,median,,,minmax,31.3,410.8,,AUC from time zero to the last sampling time point,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,873,2025-12-02T16:03:31.981487
32403162.0,midazolam,1-OH-midazolam-glucuronide,plasma,pediatric,,child,22.0,AUC0-,,,272.2,Bq/L/h,median,,,minmax,71.6,921.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,874,2025-12-02T16:03:31.981487
32403162.0,midazolam,1-OH-midazolam-glucuronide,plasma,pediatric,,child,22.0,AUC0-,,,136.1,ng/L/h,median,,,minmax,35.8,460.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,875,2025-12-02T16:03:31.981487
31269280.0,midazolam,midazolam,plasma,pediatric,,child,15.0,AUC0-t,,,46.77,ng h/L,median,,,minmax,32.42,196.77,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,876,2025-12-02T16:03:31.981487
31269280.0,midazolam,midazolam,plasma,pediatric,,child,14.0,AUC0-,,,48.9,ng h/L,median,,,minmax,34.15,218.8,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,877,2025-12-02T16:03:31.981487
31269280.0,midazolam,1-OH-midazolam,plasma,pediatric,,child,15.0,AUC0-t,,,10.89,ng h/L,median,,,minmax,5.28,24.21,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,878,2025-12-02T16:03:31.981487
31269280.0,midazolam,1-OH-midazolam,plasma,pediatric,,child,14.0,AUC0-,,,12.39,ng h/L,median,,,minmax,5.99,26.41,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,879,2025-12-02T16:03:31.981487
31269280.0,midazolam,midazolam,plasma,pediatric,,child,9.0,AUC0-t,,,46.77,ng h/L,median,,,minmax,32.42,196.77,,microdose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,880,2025-12-02T16:03:31.981487
31269280.0,midazolam,midazolam,plasma,pediatric,,child,8.0,AUC0-,,,48.9,ng h/L,median,,,minmax,34.15,218.8,,microdose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,881,2025-12-02T16:03:31.981487
31269280.0,midazolam,1-OH-midazolam,plasma,pediatric,,child,9.0,AUC0-t,,,10.19,ng h/L,median,,,minmax,5.28,24.21,,microdose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,882,2025-12-02T16:03:31.981487
31269280.0,midazolam,1-OH-midazolam,plasma,pediatric,,child,8.0,AUC0-,,,13.14,ng h/L,median,,,minmax,7.4,26.41,,microdose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,883,2025-12-02T16:03:31.981487
31269280.0,midazolam,midazolam,plasma,pediatric,,child,6.0,AUC0-t,,,48.28,ng h/L,median,,,minmax,39.17,81.4,0.86,microtracer,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,884,2025-12-02T16:03:31.981487
31269280.0,midazolam,midazolam,plasma,pediatric,,child,6.0,AUC0-,,,49.11,ng h/L,median,,,minmax,39.75,82.45,0.66,microtracer,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,885,2025-12-02T16:03:31.981487
31269280.0,midazolam,1-OH-midazolam,plasma,pediatric,,child,6.0,AUC0-t,,,11.2,ng h/L,median,,,minmax,5.84,19.93,0.86,microtracer,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,886,2025-12-02T16:03:31.981487
31269280.0,midazolam,1-OH-midazolam,plasma,pediatric,,child,6.0,AUC0-,,,12.39,ng h/L,median,,,minmax,5.99,26.27,0.95,microtracer,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,887,2025-12-02T16:03:31.981487
30472551.0,midazolam,midazolam,plasma,pediatric,,child,22.0,concentration,30,min,122.6,ng/ml,mean,SD,249.5,,,,,time after intravenous bolus treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,888,2025-12-02T16:03:31.981487
30472551.0,midazolam,midazolam,plasma,pediatric,,child,7.0,t1/2,,,0.999,h,mean,SD,0.241,,,,,patients receiving only intravenous bonus treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,889,2025-12-02T16:03:31.981487
30472551.0,midazolam,midazolam,plasma,pediatric,,child,7.0,CLtot,,,864,ml/h/kg,mean,SD,584,,,,,among the patients who received a continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,890,2025-12-02T16:03:31.981487
30472551.0,midazolam,midazolam,plasma,pediatric,,child,3.0,t1/2,,,0.938,h,mean,SD,0.395,,,,,"patients 1 to < 6 years, receiving only intravenous bonus treatment",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,891,2025-12-02T16:03:31.981487
30472551.0,midazolam,midazolam,plasma,pediatric,,child,2.0,t1/2,,,1.09,h,mean,,,minmax,1.02,1.16,,"patients 6 to < 12 years, receiving only intravenous bonus treatment",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,892,2025-12-02T16:03:31.981487
30472551.0,midazolam,midazolam,plasma,pediatric,,child,2.0,t1/2,,,1,h,mean,,,minmax,1,1,,"patients >= 12 years, receiving only intravenous bonus treatment",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,893,2025-12-02T16:03:31.981487
30472551.0,midazolam,midazolam,plasma,pediatric,,child,1.0,CLtot,,,2010,ml/h/kg,mean,,,,,,,"patients 1 month to  < 1 year, receiving CIV treatment",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,894,2025-12-02T16:03:31.981487
30472551.0,midazolam,midazolam,plasma,pediatric,,child,2.0,CLtot,,,494,ml/h/kg,mean,,,minmax,478,510,,"patients 1 to < 6 years, receiving CIV treatment",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,895,2025-12-02T16:03:31.981487
30472551.0,midazolam,midazolam,plasma,pediatric,,child,2.0,CLtot,,,858,ml/h/kg,mean,,,minmax,496,1220,,"patients 6 to < 12 years, receiving CIV treatment",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,896,2025-12-02T16:03:31.981487
30472551.0,midazolam,midazolam,plasma,pediatric,,child,2.0,CLtot,,,668,ml/h/kg,mean,SD,,minmax,423,912,,"patients >= 12 years, receiving CIV treatment",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,897,2025-12-02T16:03:31.981487
19838691.0,midazolam,midazolam,urine,pediatric,,preterm ,15.0,total amount recovered in urine,6,h,396,ng,median,,,minmax,21,2080,,IV group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,914,2025-12-02T16:03:31.981487
19838691.0,midazolam,1-OH-midazolam,urine,pediatric,,preterm ,15.0,total amount recovered in urine,6,h,5,ng,median,,,minmax,11,200,,IV group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,915,2025-12-02T16:03:31.981487
19838691.0,midazolam,1-OH-midazolam-glucuronide,urine,pediatric,,preterm ,15.0,total amount recovered in urine,6,h,2253,ng,median,,,minmax,561,14681,,IV group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,916,2025-12-02T16:03:31.981487
19838691.0,midazolam,midazolam,urine,pediatric,,preterm ,7.0,total amount recovered in urine,6,h,128,ng,median,,,minmax,22,562,,oral group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,917,2025-12-02T16:03:31.981487
19838691.0,midazolam,1-OH-midazolam,urine,pediatric,,preterm ,7.0,total amount recovered in urine,6,h,21,ng,median,,,minmax,2,101,,oral group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,918,2025-12-02T16:03:31.981487
19838691.0,midazolam,1-OH-midazolam-glucuronide,urine,pediatric,,preterm ,7.0,total amount recovered in urine,6,h,2906,ng,median,,,minmax,754,9988,,oral group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,919,2025-12-02T16:03:31.981487
19838691.0,midazolam,midazolam,urine,pediatric,,preterm ,15.0,percentage of midazolam excreted,6,h,0.44,,median,,,minmax,0.02,1.39,,IV group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,920,2025-12-02T16:03:31.981487
19838691.0,midazolam,1-OH-midazolam,urine,pediatric,,preterm ,15.0,percentage of midazolam excreted,6,h,0.04,,median,,,minmax,0.01,0.13,,IV group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,921,2025-12-02T16:03:31.981487
19838691.0,midazolam,1-OH-midazolam-glucuronide,urine,pediatric,,preterm ,15.0,percentage of midazolam excreted,6,h,1.57,,median,,,minmax,0.36,7.7,,IV group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,922,2025-12-02T16:03:31.981487
19838691.0,midazolam,midazolam,urine,pediatric,,preterm ,7.0,percentage of midazolam excreted,6,h,0.11,,median,,,minmax,0.02,0.59,,oral group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,923,2025-12-02T16:03:31.981487
19838691.0,midazolam,1-OH-midazolam,urine,pediatric,,preterm ,7.0,percentage of midazolam excreted,6,h,0.02,,median,,,minmax,0,0.1,,oral group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,924,2025-12-02T16:03:31.981487
19838691.0,midazolam,1-OH-midazolam-glucuronide,urine,pediatric,,infant,7.0,percentage of midazolam excreted,6,h,1.69,,median,,,minmax,0.58,7.31,,oral group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,925,2025-12-02T16:03:31.981487
11753268.0,midazolam,midazolam,plasma,pediatric,,preterm infants,24.0,AUC0-t,,,804,ng h/ml,median,,,minmax,153,2118,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1125,2025-12-02T16:03:31.981487
11753268.0,midazolam,midazolam,plasma,pediatric,,preterm infants,24.0,AUC0-,,,971,ng h/ml,median,,,minmax,248,2353,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1126,2025-12-02T16:03:31.981487
11753268.0,midazolam,midazolam,plasma,pediatric,,preterm infants,24.0,t1/2,,,6.3,h,median,,,minmax,2.6,17.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1127,2025-12-02T16:03:31.981487
11753268.0,midazolam,midazolam,plasma,pediatric,,preterm infants,24.0,Varea,,,1.1,L/kg,median,,,minmax,0.4,4.2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1128,2025-12-02T16:03:31.981487
11753268.0,midazolam,midazolam,plasma,pediatric,,preterm infants,24.0,CL,,,1.8,ml/kg/min,median,,,minmax,0.7,6.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1129,2025-12-02T16:03:31.981487
11753268.0,midazolam,midazolam,plasma,pediatric,,preterm infants,24.0,MRT,,,10.3,h,median,,,minmax,4,25.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1130,2025-12-02T16:03:31.981487
11753268.0,midazolam,midazolam,plasma,pediatric,,preterm infants,24.0,Cmax,,,108,ng/ml,median,,,minmax,48.8,217,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1131,2025-12-02T16:03:31.981487
11753268.0,midazolam,midazolam,plasma,pediatric,,preterm infants,24.0,tmax,,,0.5,h,median,,,minmax,0.5,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1132,2025-12-02T16:03:31.981487
11753268.0,midazolam,1-OH-midazolam,plasma,pediatric,,preterm infants,24.0,AUC0-t,,,66.7,ng h/ml,median,,,minmax,<6,997.87,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1133,2025-12-02T16:03:31.981487
11753268.0,midazolam,1-OH-midazolam,plasma,pediatric,,preterm infants,24.0,AUC0-,,,76,ng h/ml,median,,,minmax,<6,1222.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1134,2025-12-02T16:03:31.981487
11753268.0,midazolam,1-OH-midazolam,plasma,pediatric,,preterm infants,24.0,t1/2,,,,h,median,,,minmax,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1135,2025-12-02T16:03:31.981487
11753268.0,midazolam,1-OH-midazolam,plasma,pediatric,,preterm infants,24.0,Varea,,,,L/kg,median,,,minmax,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1136,2025-12-02T16:03:31.981487
11753268.0,midazolam,1-OH-midazolam,plasma,pediatric,,preterm infants,24.0,CL,,,,ml/kg/min,median,,,minmax,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1137,2025-12-02T16:03:31.981487
11753268.0,midazolam,1-OH-midazolam,plasma,pediatric,,preterm infants,24.0,MRT,,,,h,median,,,minmax,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1138,2025-12-02T16:03:31.981487
11753268.0,midazolam,1-OH-midazolam,plasma,pediatric,,preterm infants,24.0,Cmax,,,8.2,ng/ml,median,,,minmax,<0.5,68.2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1139,2025-12-02T16:03:31.981487
11753268.0,midazolam,1-OH-midazolam,plasma,pediatric,,preterm infants,24.0,tmax,,,6,h,median,,,minmax,1,12,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1140,2025-12-02T16:03:31.981487
11753268.0,midazolam,1-OH-midazolam,plasma,pediatric,,preterm infants,24.0,AUC ratio,,,0.09,,median,,,minmax,<0.001,1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1141,2025-12-02T16:03:31.981487
9323623.0,midazolam,midazolam,serum,pediatric,,neonate,9.0,concentration,6,min,135.1,ng/ml,mean,SD,39.3,minmax,74.9,183.3,,sampling time after drug administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1160,2025-12-02T16:03:31.981487
9323623.0,midazolam,midazolam,serum,pediatric,,neonate,9.0,concentration,20.1,min,107.1,ng/ml,mean,SD,30.4,minmax,54.9,146.4,,sampling time after drug administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1161,2025-12-02T16:03:31.981487
9323623.0,midazolam,midazolam,serum,pediatric,,neonate,9.0,concentration,61.6,min,86.5,ng/ml,mean,SD,23.8,minmax,43.3,111.5,,sampling time after drug administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1162,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,11.0,concentration,,,12.7,ng/ml,mean,SD,13.8,,,,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1198,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,umbilical venous blood,pediatric,,fetus,11.0,concentration,,,8.4,ng/ml,mean,SD,9.7,,,,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1199,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,umbilical artery blood,pediatric,,fetus,10.0,concentration,,,5.7,ng/ml,mean,SD,7.1,,,,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1200,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,umbilical venous/maternal blood,maternal/pediatric,labor,fetus,7.0,UV/MV,,,0.74,,mean,SD,0.14,,,,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1201,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,umbilical artery/maternal blood,maternal/pediatric,labor,fetus,6.0,UA/MV,,,0.45,,mean,SD,0.25,,,,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1202,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,6.0,concentration,,,40,ng/ml,mean,SD,10.1,,,,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1203,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,umbilical venous blood,pediatric,,fetus,6.0,concentration,,,21.7,ng/ml,mean,SD,4,,,,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1204,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,umbilical artery blood,pediatric,,fetus,6.0,concentration,,,0.56,ng/ml,mean,SD,0.15,,,,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1205,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,umbilical venous/maternal blood,maternal/pediatric,labor,fetus,5.0,UV/MV,,,12.8,,mean,SD,5.5,,,,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1206,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,umbilical artery/maternal blood,maternal/pediatric,labor,fetus,5.0,UA/MV,,,0.32,,mean,SD,0.12,,,,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1207,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,5.0,Cmax,,,28.2,ng/ml,mean,SD,7.1,minmax,20.4,35.9,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1208,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,5.0,tmax,,,27.1,min,mean,SD,7.8,minmax,16.5,36,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1209,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,5.0,AUC,,,3172,ng min/ml,mean,SD,1426,,,,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1210,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,8.0,Cmax,,,37.9,ng/ml,mean,SD,21.1,minmax,9.1,74,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1211,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,8.0,tmax,,,27.2,min,mean,SD,12,minmax,9,45.1,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1212,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,8.0,AUC,,,2229,ng min/ml,mean,SD,1028,,,,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1213,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,8.0,T1/2,,,10.1,min,mean,SD,3.4,,,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1214,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,8.0,T1/2,,,103.5,min,mean,SD,22.3,,,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1215,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,8.0,V1,,,0.39,l/kg,mean,SD,0.14,,,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1216,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,8.0,Vdss,,,1.01,l/kg,mean,SD,0.17,,,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1217,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,8.0,Vd,,,2.97,l/kg,mean,SD,1.31,,,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1218,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,8.0,Cltot,,,11.5,ml/min/kg,mean,SD,3.9,,,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1219,2025-12-02T16:03:31.981487
6851409.0,midazolam,midazolam,blood,maternal,labor,,8.0,AUC,,,7272,ng min/ml,mean,SD,2641,,,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1220,2025-12-02T16:03:31.981487
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,1.0,concentration,11.4,hr,12,ng/ml,,,,,,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1357,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,umbilical serum,pediatric,,fetus,1.0,concentration,11.4,hr,7,ng/ml,,,,,,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1358,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,amniotic fluid,maternal,delivery,,13.0,concentration,11.4,hr,ND,ng/ml,,,,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1359,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,11.0,concentration,,,12.7,ng/ml,mean,SD,13.8,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1360,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,umbilical venous serum,pediatric,,fetus,11.0,concentration,,,8.4,ng/ml,mean,SD,9.7,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1361,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,umbilical venous /maternal serum,maternal/pediatric,delivery,fetus,11.0,UV/MV ratio,,,0.74,,mean,SD,0.14,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1362,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,umbilical artery serum,pediatric,,fetus,11.0,concentration,,,5.7,ng/ml,mean,SD,7.1,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1363,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,umbilical artery /maternal serum,maternal/pediatric,delivery,fetus,11.0,UA/MV ratio,,,0.45,,mean,SD,0.25,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1364,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,concentration,,,40,ng/ml,mean,SD,10.1,,,,,Group 3,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1365,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,umbilical venous serum,pediatric,,fetus,6.0,concentration,,,21.7,ng/ml,mean,SD,4,,,,,Group 3,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1366,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,umbilical venous /maternal serum,maternal/pediatric,delivery,fetus,6.0,UV/MV ratio,,,0.56,,mean,SD,0.15,,,,,Group 3,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1367,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,umbilical artery serum,pediatric,,fetus,6.0,concentration,,,12.8,ng/ml,mean,SD,5.5,,,,,Group 3,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1368,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,umbilical artery /maternal serum,maternal/pediatric,delivery,fetus,6.0,UA/MV ratio,,,0.32,,mean,SD,0.12,,,,,Group 3,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1369,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,t1/2,,,10.1,min,mean,SD,3.4,,,,,Group 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1370,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,t1/2,,,103.5,min,mean,SD,22.3,,,,,Group 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1371,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,V1,,,0.39,l/kg,mean,SD,0.14,,,,,Group 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1372,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Vdss,,,1.01,l/kg,mean,SD,0.17,,,,,Group 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1373,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Vd,,,2.97,l/kg,mean,SD,1.31,,,,,Group 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1374,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Cltot,,,11.5,ml/min/kg,mean,SD,3.9,,,,,Group 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1375,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,AUC,,,7272,ng min/ml,mean,SD,2641,,,,,Group 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1376,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,Cmax,,,28.2,ng/ml,mean,SD,7.1,minmax,20.4,35.9,,Group 3,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1377,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Cmax,,,37.9,ng/ml,mean,SD,21.1,minmax,9.1,74,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1378,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,tmax,,,27.1,min,mean,SD,7.8,minmax,16.5,36,,Group 3,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1379,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,tmax,,,27.2,min,mean,SD,12,minmax,9,45.1,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1380,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,AUC,,,3172,ng min/ml,mean,SD,1426,,,,,Group 3,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1381,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,AUC,,,2229,ng min/ml,mean,SD,1028,,,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1382,2025-12-02T16:05:09.448543
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,1.0,concentration,11.4,hr,12,ng/ml,,,,,,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1357,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,umbilical serum,pediatric,,fetus,1.0,concentration,11.4,hr,7,ng/ml,,,,,,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1358,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,amniotic fluid,maternal,delivery,,13.0,concentration,11.4,hr,ND,ng/ml,,,,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1359,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,11.0,concentration,,,12.7,ng/ml,mean,SD,13.8,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1360,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,umbilical venous serum,pediatric,,fetus,11.0,concentration,,,8.4,ng/ml,mean,SD,9.7,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1361,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,umbilical venous /maternal serum,maternal/pediatric,delivery,fetus,11.0,UV/MV ratio,,,0.74,,mean,SD,0.14,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1362,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,umbilical artery serum,pediatric,,fetus,11.0,concentration,,,5.7,ng/ml,mean,SD,7.1,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1363,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,umbilical artery /maternal serum,maternal/pediatric,delivery,fetus,11.0,UA/MV ratio,,,0.45,,mean,SD,0.25,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1364,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,concentration,,,40,ng/ml,mean,SD,10.1,,,,,Group 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1365,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,umbilical venous serum,pediatric,,fetus,6.0,concentration,,,21.7,ng/ml,mean,SD,4,,,,,Group 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1366,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,umbilical venous /maternal serum,maternal/pediatric,delivery,fetus,6.0,UV/MV ratio,,,0.56,,mean,SD,0.15,,,,,Group 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1367,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,umbilical artery serum,pediatric,,fetus,6.0,concentration,,,12.8,ng/ml,mean,SD,5.5,,,,,Group 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1368,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,umbilical artery /maternal serum,maternal/pediatric,delivery,fetus,6.0,UA/MV ratio,,,0.32,,mean,SD,0.12,,,,,Group 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1369,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,t1/2,,,10.1,min,mean,SD,3.4,,,,,Group 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1370,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,t1/2,,,103.5,min,mean,SD,22.3,,,,,Group 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1371,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,V1,,,0.39,l/kg,mean,SD,0.14,,,,,Group 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1372,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Vdss,,,1.01,l/kg,mean,SD,0.17,,,,,Group 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1373,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Vd,,,2.97,l/kg,mean,SD,1.31,,,,,Group 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1374,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Cltot,,,11.5,ml/min/kg,mean,SD,3.9,,,,,Group 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1375,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,AUC,,,7272,ng min/ml,mean,SD,2641,,,,,Group 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1376,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,Cmax,,,28.2,ng/ml,mean,SD,7.1,minmax,20.4,35.9,,Group 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1377,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Cmax,,,37.9,ng/ml,mean,SD,21.1,minmax,9.1,74,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1378,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,tmax,,,27.1,min,mean,SD,7.8,minmax,16.5,36,,Group 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1379,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,tmax,,,27.2,min,mean,SD,12,minmax,9,45.1,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1380,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,AUC,,,3172,ng min/ml,mean,SD,1426,,,,,Group 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1381,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,AUC,,,2229,ng min/ml,mean,SD,1028,,,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1382,2025-12-02T16:05:12.001940
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,1.0,concentration,11.4,hr,12,ng/ml,,,,,,,,Group 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1351,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,umbilical serum,pediatric,,fetus,1.0,concentration,11.4,hr,7,ng/ml,,,,,,,,Group 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1352,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,amniotic fluid,maternal,delivery,,13.0,concentration,11.4,hr,ND,ng/ml,,,,,,,,Group 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1353,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,11.0,concentration,,,12.7,ng/ml,mean,SD,13.8,,,,,Group 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1354,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,umbilical venous serum,pediatric,,fetus,11.0,concentration,,,8.4,ng/ml,mean,SD,9.7,,,,,Group 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1355,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,umbilical venous /maternal serum,maternal/pediatric,delivery,fetus,11.0,UV/MV ratio,,,0.74,,mean,SD,0.14,,,,,Group 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1356,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,umbilical artery serum,pediatric,,fetus,11.0,concentration,,,5.7,ng/ml,mean,SD,7.1,,,,,Group 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1357,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,umbilical artery /maternal serum,maternal/pediatric,delivery,fetus,11.0,UA/MV ratio,,,0.45,,mean,SD,0.25,,,,,Group 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1358,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,concentration,,,40,ng/ml,mean,SD,10.1,,,,,Group 3,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1359,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,umbilical venous serum,pediatric,,fetus,6.0,concentration,,,21.7,ng/ml,mean,SD,4,,,,,Group 3,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1360,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,umbilical venous /maternal serum,maternal/pediatric,delivery,fetus,6.0,UV/MV ratio,,,0.56,,mean,SD,0.15,,,,,Group 3,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1361,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,umbilical artery serum,pediatric,,fetus,6.0,concentration,,,12.8,ng/ml,mean,SD,5.5,,,,,Group 3,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1362,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,umbilical artery /maternal serum,maternal/pediatric,delivery,fetus,6.0,UA/MV ratio,,,0.32,,mean,SD,0.12,,,,,Group 3,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1363,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,t1/2,,,10.1,min,mean,SD,3.4,,,,,Group 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1364,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,t1/2,,,103.5,min,mean,SD,22.3,,,,,Group 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1365,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,V1,,,0.39,l/kg,mean,SD,0.14,,,,,Group 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1366,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Vdss,,,1.01,l/kg,mean,SD,0.17,,,,,Group 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1367,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Vd,,,2.97,l/kg,mean,SD,1.31,,,,,Group 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1368,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Cltot,,,11.5,ml/min/kg,mean,SD,3.9,,,,,Group 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1369,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,AUC,,,7272,ng min/ml,mean,SD,2641,,,,,Group 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1370,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,Cmax,,,28.2,ng/ml,mean,SD,7.1,minmax,20.4,35.9,,Group 3,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1371,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Cmax,,,37.9,ng/ml,mean,SD,21.1,minmax,9.1,74,,Group 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1372,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,tmax,,,27.1,min,mean,SD,7.8,minmax,16.5,36,,Group 3,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1373,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,tmax,,,27.2,min,mean,SD,12,minmax,9,45.1,,Group 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1374,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,AUC,,,3172,ng min/ml,mean,SD,1426,,,,,Group 3,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1375,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,AUC,,,2229,ng min/ml,mean,SD,1028,,,,,Group 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1376,2025-12-02T16:05:15.923463
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,1.0,concentration,11.4,hr,12,ng/ml,,,,,,,,Group 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1351,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,umbilical serum,pediatric,,fetus,1.0,concentration,11.4,hr,7,ng/ml,,,,,,,,Group 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1352,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,amniotic fluid,maternal,delivery,,13.0,concentration,11.4,hr,ND,ng/ml,,,,,,,,Group 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1353,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,11.0,concentration,,,12.7,ng/ml,mean,SD,13.8,,,,,Group 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1354,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,umbilical venous serum,pediatric,,fetus,11.0,concentration,,,8.4,ng/ml,mean,SD,9.7,,,,,Group 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1355,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,umbilical venous /maternal serum,maternal/pediatric,delivery,fetus,11.0,UV/MV ratio,,,0.74,,mean,SD,0.14,,,,,Group 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1356,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,umbilical artery serum,pediatric,,fetus,11.0,concentration,,,5.7,ng/ml,mean,SD,7.1,,,,,Group 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1357,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,umbilical artery /maternal serum,maternal/pediatric,delivery,fetus,11.0,UA/MV ratio,,,0.45,,mean,SD,0.25,,,,,Group 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1358,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,6.0,concentration,,,40,ng/ml,mean,SD,10.1,,,,,Group 3,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1359,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,umbilical venous serum,pediatric,,fetus,6.0,concentration,,,21.7,ng/ml,mean,SD,4,,,,,Group 3,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1360,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,umbilical venous /maternal serum,maternal/pediatric,delivery,fetus,6.0,UV/MV ratio,,,0.56,,mean,SD,0.15,,,,,Group 3,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1361,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,umbilical artery serum,pediatric,,fetus,6.0,concentration,,,12.8,ng/ml,mean,SD,5.5,,,,,Group 3,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1362,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,umbilical artery /maternal serum,maternal/pediatric,delivery,fetus,6.0,UA/MV ratio,,,0.32,,mean,SD,0.12,,,,,Group 3,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1363,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,t1/2,,,10.1,min,mean,SD,3.4,,,,,Group 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1364,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,t1/2,,,103.5,min,mean,SD,22.3,,,,,Group 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1365,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,V1,,,0.39,l/kg,mean,SD,0.14,,,,,Group 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1366,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Vdss,,,1.01,l/kg,mean,SD,0.17,,,,,Group 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1367,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Vd,,,2.97,l/kg,mean,SD,1.31,,,,,Group 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1368,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Cltot,,,11.5,ml/min/kg,mean,SD,3.9,,,,,Group 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1369,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,AUC,,,7272,ng min/ml,mean,SD,2641,,,,,Group 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1370,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,Cmax,,,28.2,ng/ml,mean,SD,7.1,minmax,20.4,35.9,,Group 3,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1371,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,Cmax,,,37.9,ng/ml,mean,SD,21.1,minmax,9.1,74,,Group 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1372,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,tmax,,,27.1,min,mean,SD,7.8,minmax,16.5,36,,Group 3,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1373,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,tmax,,,27.2,min,mean,SD,12,minmax,9,45.1,,Group 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1374,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,5.0,AUC,,,3172,ng min/ml,mean,SD,1426,,,,,Group 3,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1375,2025-12-02T16:05:22.346295
6851409.0,Midazolam,Midazolam,serum,maternal,delivery,,8.0,AUC,,,2229,ng min/ml,mean,SD,1028,,,,,Group 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1376,2025-12-02T16:05:22.346295
3688386.0,midazolam,midazolam,blood,maternal,labor,,12.0,concentration,2,min,411,ng/ml,mean,SEM,23,,,,,Group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1226,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,12.0,concentration,5,min,321,ng/ml,mean,SEM,32,,,,,Group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1227,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,12.0,concentration,10,min,230,ng/ml,mean,SEM,23,,,,,Group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1228,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,18.0,concentration,2,min,236,ng/ml,mean,SEM,18,,,,<0.001,Group 2 and 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1229,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,18.0,concentration,5,min,171,ng/ml,mean,SEM,13,,,,<0.000,Group 2 and 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1230,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,18.0,concentration,10,min,131,ng/ml,mean,SEM,8,,,,<0.001,Group 2 and 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1231,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,non-pregnant,,,20.0,concentration,2,min,212,ng/ml,mean,SEM,14,,,,<0.001,Group 2 and 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1232,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,non-pregnant,,,20.0,concentration,5,min,175,ng/ml,mean,SEM,8,,,,<0.000,Group 4 and 5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1233,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,non-pregnant,,,20.0,concentration,10,min,150,ng/ml,mean,SEM,7,,,,<0.001,Group 4 and 5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1234,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,12.0,T1/2,,,46,min,mean,SEM,4.5,,,,,Group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1235,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,12.0,AUC2h,,,9695,min ng/ml,mean,SEM,695,,,,Significantly higher than groups I1 (p < 0.001) and I11 and IV (p < 0.05),Group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1236,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,12.0,Vdarea,,,0.4,L/kg,mean,SEM,0.06,,,,Significantly lower than groups 11 (p < 0.01) and 1V (p < 0.05),Group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1237,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,12.0,clearance,,,6.5,ml/min/kg,mean,SEM,0.48,,,,,Group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1238,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,8.0,T1/2,,,47,min,mean,SEM,3.8,,,,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1239,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,8.0,AUC2h,,,4692,min ng/ml,mean,SEM,402,,,,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1240,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,8.0,Vdarea,,,0.9,L/kg,mean,SEM,0.05,,,,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1241,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,8.0,clearance,,,13.9,ml/min/kg,mean,SEM,2.08,,,,Significantly higher than all other groups (p < 0.014.001),Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1242,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,10.0,T1/2,,,52,min,mean,SEM,2.5,,,,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1243,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,10.0,AUC2h,,,7077,min ng/ml,mean,SEM,673,,,,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1244,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,10.0,Vdarea,,,0.7,L/kg,mean,SEM,0.05,,,,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1245,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,maternal,labor,,10.0,clearance,,,9,ml/min/kg,mean,SEM,1.24,,,,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1246,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,non-pregnant,delivery,,10.0,T1/2,,,59,min,mean,SEM,6.2,,,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1247,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,non-pregnant,,,10.0,AUC2h,,,7493,min ng/ml,mean,SEM,646,,,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1248,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,non-pregnant,,,10.0,Vdarea,,,0.8,L/kg,mean,SEM,0.1,,,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1249,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,non-pregnant,,,10.0,clearance,,,8.7,ml/min/kg,mean,SEM,0.61,,,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1250,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,non-pregnant,,,10.0,T1/2,,,57,min,mean,SEM,4.2,,,,,Group 5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1251,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,non-pregnant,,,10.0,AUC2h,,,8942,min ng/ml,mean,SEM,489,,,,,Group 5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1252,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,non-pregnant,,,10.0,Vdarea,,,0.6,L/kg,mean,SEM,0.05,,,,,Group 5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1253,2025-12-02T16:03:31.981487
3688386.0,midazolam,midazolam,blood,non-pregnant,,,10.0,clearance,,,7,ml/min/kg,mean,SEM,0.65,,,,,Group 5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1254,2025-12-02T16:03:31.981487
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,2,min,411,ng/ml,mean,SEM,23,,,,,Labour  group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1323,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,2,min,236,ng/ml,mean,SEM,18,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1324,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,2,min,212,ng/ml,mean,SEM,14,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1325,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,5,min,321,ng/ml,mean,SEM,32,,,,,Labour  group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1326,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,5,min,171,ng/ml,mean,SEM,13,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1327,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,5,min,175,ng/ml,mean,SEM,8,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1328,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,10,min,230,ng/ml,mean,SEM,23,,,,,Labour  group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1329,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,10,min,131,ng/ml,mean,SEM,8,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1330,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,10,min,150,ng/ml,mean,SEM,7,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1331,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,t1/2,,,46,min,mean,SEM,4.5,,,,,Labour  group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1332,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,t1/2,,,7,min,mean,SEM,3.8,,,,,Caesarean section group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1333,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,52,min,mean,SEM,2.5,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1334,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,59,min,mean,SEM,6.2,,,,,Gynaecological group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1335,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,57,min,mean,SEM,4.2,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1336,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,AUC2h,,,9695,min ng/ml,mean,SEM,695,,,,,Labour  group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1337,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,AUC2h,,,4692,min ng/ml,mean,SEM,402,,,,<0.001 vs. Labour group,Caesarean section group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1338,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,7077,min ng/ml,mean,SEM,673,,,,<0.05 vs. Labour group,Awaiting Caesarean section,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1339,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,7493,min ng/ml,mean,SEM,646,,,,<0.05 vs. Labour group,Gynaecological group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1340,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,8942,min ng/ml,mean,SEM,489,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1341,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,Vd area,,,0.4,L/kg,mean,SEM,0.06,,,,,Labour  group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1342,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,Vd area,,,0.9,L/kg,mean,SEM,0.05,,,,<0.01 vs. Labour group,Caesarean section group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1343,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.7,L/kg,mean,SEM,0.05,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1344,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.8,L/kg,mean,SEM,0.1,,,,<0.05 vs. Labour group,Gynaecological group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1345,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.6,L/kg,mean,SEM,0.05,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1346,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,Clearance,,,6.5,ml/min/kg,mean,SEM,0.48,,,,,Labour  group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1347,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,Clearance,,,13.9,ml/min/kg,mean,SEM,2.08,,,,"<0.01-0.001, vs. all other groups",Caesarean section group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1348,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,9,ml/min/kg,mean,SEM,1.24,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1349,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,8.7,ml/min/kg,mean,SEM,0.61,,,,,Gynaecological group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1350,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,7,ml/min/kg,mean,SEM,0.65,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1351,2025-12-02T16:05:09.448543
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,2,min,411,ng/ml,mean,SEM,23,,,,,Labour  group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1323,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,2,min,236,ng/ml,mean,SEM,18,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1324,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,2,min,212,ng/ml,mean,SEM,14,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1325,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,5,min,321,ng/ml,mean,SEM,32,,,,,Labour  group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1326,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,5,min,171,ng/ml,mean,SEM,13,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1327,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,5,min,175,ng/ml,mean,SEM,8,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1328,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,10,min,230,ng/ml,mean,SEM,23,,,,,Labour  group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1329,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,10,min,131,ng/ml,mean,SEM,8,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1330,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,10,min,150,ng/ml,mean,SEM,7,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1331,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,t1/2,,,46,min,mean,SEM,4.5,,,,,Labour  group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1332,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,t1/2,,,7,min,mean,SEM,3.8,,,,,Caesarean section group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1333,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,52,min,mean,SEM,2.5,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1334,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,59,min,mean,SEM,6.2,,,,,Gynaecological group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1335,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,57,min,mean,SEM,4.2,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1336,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,AUC2h,,,9695,min ng/ml,mean,SEM,695,,,,,Labour  group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1337,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,AUC2h,,,4692,min ng/ml,mean,SEM,402,,,,<0.001 vs. Labour group,Caesarean section group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1338,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,7077,min ng/ml,mean,SEM,673,,,,<0.05 vs. Labour group,Awaiting Caesarean section,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1339,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,7493,min ng/ml,mean,SEM,646,,,,<0.05 vs. Labour group,Gynaecological group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1340,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,8942,min ng/ml,mean,SEM,489,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1341,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,Vd area,,,0.4,L/kg,mean,SEM,0.06,,,,,Labour  group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1342,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,Vd area,,,0.9,L/kg,mean,SEM,0.05,,,,<0.01 vs. Labour group,Caesarean section group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1343,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.7,L/kg,mean,SEM,0.05,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1344,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.8,L/kg,mean,SEM,0.1,,,,<0.05 vs. Labour group,Gynaecological group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1345,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.6,L/kg,mean,SEM,0.05,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1346,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,Clearance,,,6.5,ml/min/kg,mean,SEM,0.48,,,,,Labour  group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1347,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,Clearance,,,13.9,ml/min/kg,mean,SEM,2.08,,,,"<0.01-0.001, vs. all other groups",Caesarean section group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1348,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,9,ml/min/kg,mean,SEM,1.24,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1349,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,8.7,ml/min/kg,mean,SEM,0.61,,,,,Gynaecological group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1350,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,7,ml/min/kg,mean,SEM,0.65,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1351,2025-12-02T16:05:12.001940
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,2,min,411,ng/ml,mean,SEM,23,,,,,Labour  group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1317,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,2,min,236,ng/ml,mean,SEM,18,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1318,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,2,min,212,ng/ml,mean,SEM,14,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1319,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,5,min,321,ng/ml,mean,SEM,32,,,,,Labour  group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1320,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,5,min,171,ng/ml,mean,SEM,13,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1321,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,5,min,175,ng/ml,mean,SEM,8,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1322,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,10,min,230,ng/ml,mean,SEM,23,,,,,Labour  group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1323,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,10,min,131,ng/ml,mean,SEM,8,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1324,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,10,min,150,ng/ml,mean,SEM,7,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1325,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,t1/2,,,46,min,mean,SEM,4.5,,,,,Labour  group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1326,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,t1/2,,,7,min,mean,SEM,3.8,,,,,Caesarean section group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1327,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,52,min,mean,SEM,2.5,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1328,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,59,min,mean,SEM,6.2,,,,,Gynaecological group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1329,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,57,min,mean,SEM,4.2,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1330,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,AUC2h,,,9695,min ng/ml,mean,SEM,695,,,,,Labour  group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1331,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,AUC2h,,,4692,min ng/ml,mean,SEM,402,,,,<0.001 vs. Labour group,Caesarean section group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1332,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,7077,min ng/ml,mean,SEM,673,,,,<0.05 vs. Labour group,Awaiting Caesarean section,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1333,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,7493,min ng/ml,mean,SEM,646,,,,<0.05 vs. Labour group,Gynaecological group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1334,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,8942,min ng/ml,mean,SEM,489,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1335,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,Vd area,,,0.4,L/kg,mean,SEM,0.06,,,,,Labour  group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1336,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,Vd area,,,0.9,L/kg,mean,SEM,0.05,,,,<0.01 vs. Labour group,Caesarean section group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1337,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.7,L/kg,mean,SEM,0.05,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1338,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.8,L/kg,mean,SEM,0.1,,,,<0.05 vs. Labour group,Gynaecological group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1339,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.6,L/kg,mean,SEM,0.05,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1340,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,Clearance,,,6.5,ml/min/kg,mean,SEM,0.48,,,,,Labour  group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1341,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,Clearance,,,13.9,ml/min/kg,mean,SEM,2.08,,,,"<0.01-0.001, vs. all other groups",Caesarean section group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1342,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,9,ml/min/kg,mean,SEM,1.24,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1343,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,8.7,ml/min/kg,mean,SEM,0.61,,,,,Gynaecological group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1344,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,7,ml/min/kg,mean,SEM,0.65,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1345,2025-12-02T16:05:15.923463
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,2,min,411,ng/ml,mean,SEM,23,,,,,Labour  group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1317,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,2,min,236,ng/ml,mean,SEM,18,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1318,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,2,min,212,ng/ml,mean,SEM,14,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1319,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,5,min,321,ng/ml,mean,SEM,32,,,,,Labour  group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1320,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,5,min,171,ng/ml,mean,SEM,13,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1321,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,5,min,175,ng/ml,mean,SEM,8,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1322,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,concentration,10,min,230,ng/ml,mean,SEM,23,,,,,Labour  group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1323,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,18.0,concentration,10,min,131,ng/ml,mean,SEM,8,,,,"<0.001, vs. labour group",Caesarean section group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1324,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,10,min,150,ng/ml,mean,SEM,7,,,,"<0.001, vs. labour group",Gynaecological group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1325,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,t1/2,,,46,min,mean,SEM,4.5,,,,,Labour  group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1326,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,t1/2,,,7,min,mean,SEM,3.8,,,,,Caesarean section group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1327,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,52,min,mean,SEM,2.5,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1328,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,59,min,mean,SEM,6.2,,,,,Gynaecological group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1329,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,t1/2,,,57,min,mean,SEM,4.2,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1330,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,AUC2h,,,9695,min ng/ml,mean,SEM,695,,,,,Labour  group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1331,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,AUC2h,,,4692,min ng/ml,mean,SEM,402,,,,<0.001 vs. Labour group,Caesarean section group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1332,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,7077,min ng/ml,mean,SEM,673,,,,<0.05 vs. Labour group,Awaiting Caesarean section,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1333,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,7493,min ng/ml,mean,SEM,646,,,,<0.05 vs. Labour group,Gynaecological group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1334,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,AUC2h,,,8942,min ng/ml,mean,SEM,489,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1335,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,Vd area,,,0.4,L/kg,mean,SEM,0.06,,,,,Labour  group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1336,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,Vd area,,,0.9,L/kg,mean,SEM,0.05,,,,<0.01 vs. Labour group,Caesarean section group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1337,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.7,L/kg,mean,SEM,0.05,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1338,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.8,L/kg,mean,SEM,0.1,,,,<0.05 vs. Labour group,Gynaecological group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1339,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Vd area,,,0.6,L/kg,mean,SEM,0.05,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1340,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,12.0,Clearance,,,6.5,ml/min/kg,mean,SEM,0.48,,,,,Labour  group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1341,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,8.0,Clearance,,,13.9,ml/min/kg,mean,SEM,2.08,,,,"<0.01-0.001, vs. all other groups",Caesarean section group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1342,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,9,ml/min/kg,mean,SEM,1.24,,,,,Awaiting Caesarean section,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1343,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,8.7,ml/min/kg,mean,SEM,0.61,,,,,Gynaecological group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1344,2025-12-02T16:05:22.346295
3688386.0,Midazolam,Midazolam,plasma,maternal,delivery,,10.0,Clearance,,,7,ml/min/kg,mean,SEM,0.65,,,,,Gynaecological/oxytocin group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1345,2025-12-02T16:05:22.346295
2919760.0,thiopental,thiopental,blood,maternal,labor,,20.0,concentration,,,4.31,mg/L,median,,,interquartile,3.12,6.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1294,2025-12-02T16:03:31.981487
2919760.0,thiopental,thiopental,umbilical,pediatric,,fetus,20.0,concentration,,,4.65,mg/L,median,,,interquartile,3.25,5.69,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1295,2025-12-02T16:03:31.981487
2919760.0,thiopental,thiopental,umbilical/maternal blood,maternal/pediatric,,fetus,20.0,umbilical/mother concentration,,,0.96,mg/L,median,,,interquartile,0.79,1.15,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1296,2025-12-02T16:03:31.981487
2919760.0,thiopental,thiopental,blood,pediatric,,neonate,20.0,Elimination half-life,,,14.7,hours,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1297,2025-12-02T16:03:31.981487
2919760.0,midazolam,midazolam,blood,maternal,labor,,20.0,concentration,,,339,ug/L,median,,,interquartile,234,617,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1298,2025-12-02T16:03:31.981487
2919760.0,midazolam,midazolam,blood,pediatric,,neonate,20.0,Elimination half-life,,,6.3,hours,mean,,,minmax,3.3,12,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1299,2025-12-02T16:03:31.981487
2919760.0,midazolam,midazolam,umbilical,pediatric,,fetus,20.0,concentration,,,318,ug/L,median,,,interquartile,188,411,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1300,2025-12-02T16:03:31.981487
2919760.0,midazolam,midazolam,umbilical/maternal blood,maternal/pediatric,,fetus,20.0,umbilical/mother concentration,,,0.66,ug/L,median,,,interquartile,0.5,1.05,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1301,2025-12-02T16:03:31.981487
2919760.0,midazolam,1-OH-midazolam,blood,maternal,labor,,20.0,concentration,,,22,ug/L,median,,,interquartile,11.8,50.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1302,2025-12-02T16:03:31.981487
2919760.0,midazolam,1-OH-midazolam,umbilical,pediatric,,fetus,20.0,concentration,,,5,ug/L,median,,,interquartile,3,9.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1303,2025-12-02T16:03:31.981487
2919760.0,midazolam,1-OH-midazolam,umbilical/maternal blood,maternal/pediatric,,fetus,20.0,umbilical/mother concentration,,,0.28,ug/L,median,,,interquartile,0.12,0.48,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1304,2025-12-02T16:03:31.981487
2919760.0,thiopental,thiopental,plasma,maternal,delivery,,20.0,concentration,,,4.31,mg/L,median,,,minmax,3.12,6.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1313,2025-12-02T16:05:09.448543
2919760.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,,,339,ug/L,median,,,minmax,234,617,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1314,2025-12-02T16:05:09.448543
2919760.0,thiopental,a-Hydroxymidazolam,plasma,maternal,delivery,,20.0,concentration,,,22,ug/L,median,,,minmax,11.8,50.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1315,2025-12-02T16:05:09.448543
2919760.0,thiopental,thiopental,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,4.65,mg/L,median,,,minmax,3.25,5.69,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1316,2025-12-02T16:05:09.448543
2919760.0,Midazolam,Midazolam,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,318,ug/L,median,,,minmax,188,411,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1317,2025-12-02T16:05:09.448543
2919760.0,thiopental,a-Hydroxymidazolam,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,5,ug/L,median,,,minmax,3,9.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1318,2025-12-02T16:05:09.448543
2919760.0,thiopental,thiopental,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.96,,median,,,minmax,0.79,1.15,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1319,2025-12-02T16:05:09.448543
2919760.0,Midazolam,Midazolam,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.66,,median,,,minmax,0.5,1.05,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1320,2025-12-02T16:05:09.448543
2919760.0,thiopental,a-Hydroxymidazolam,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.28,,median,,,minmax,0.12,0.48,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1321,2025-12-02T16:05:09.448543
2919760.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,Half-life,,,6.3,h,mean,,,minmax,3.3,12,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1322,2025-12-02T16:05:09.448543
2919760.0,thiopental,thiopental,plasma,maternal,delivery,,20.0,concentration,,,4.31,mg/L,median,,,minmax,3.12,6.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1313,2025-12-02T16:05:12.001940
2919760.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,,,339,ug/L,median,,,minmax,234,617,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1314,2025-12-02T16:05:12.001940
2919760.0,thiopental,a-Hydroxymidazolam,plasma,maternal,delivery,,20.0,concentration,,,22,ug/L,median,,,minmax,11.8,50.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1315,2025-12-02T16:05:12.001940
2919760.0,thiopental,thiopental,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,4.65,mg/L,median,,,minmax,3.25,5.69,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1316,2025-12-02T16:05:12.001940
2919760.0,Midazolam,Midazolam,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,318,ug/L,median,,,minmax,188,411,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1317,2025-12-02T16:05:12.001940
2919760.0,thiopental,a-Hydroxymidazolam,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,5,ug/L,median,,,minmax,3,9.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1318,2025-12-02T16:05:12.001940
2919760.0,thiopental,thiopental,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.96,,median,,,minmax,0.79,1.15,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1319,2025-12-02T16:05:12.001940
2919760.0,Midazolam,Midazolam,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.66,,median,,,minmax,0.5,1.05,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1320,2025-12-02T16:05:12.001940
2919760.0,thiopental,a-Hydroxymidazolam,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.28,,median,,,minmax,0.12,0.48,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1321,2025-12-02T16:05:12.001940
2919760.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,Half-life,,,6.3,h,mean,,,minmax,3.3,12,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1322,2025-12-02T16:05:12.001940
2919760.0,thiopental,thiopental,plasma,maternal,delivery,,20.0,concentration,,,4.31,mg/L,median,,,minmax,3.12,6.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1307,2025-12-02T16:05:15.923463
2919760.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,,,339,ug/L,median,,,minmax,234,617,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1308,2025-12-02T16:05:15.923463
2919760.0,thiopental,a-Hydroxymidazolam,plasma,maternal,delivery,,20.0,concentration,,,22,ug/L,median,,,minmax,11.8,50.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1309,2025-12-02T16:05:15.923463
2919760.0,thiopental,thiopental,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,4.65,mg/L,median,,,minmax,3.25,5.69,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1310,2025-12-02T16:05:15.923463
2919760.0,Midazolam,Midazolam,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,318,ug/L,median,,,minmax,188,411,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1311,2025-12-02T16:05:15.923463
2919760.0,thiopental,a-Hydroxymidazolam,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,5,ug/L,median,,,minmax,3,9.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1312,2025-12-02T16:05:15.923463
2919760.0,thiopental,thiopental,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.96,,median,,,minmax,0.79,1.15,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1313,2025-12-02T16:05:15.923463
2919760.0,Midazolam,Midazolam,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.66,,median,,,minmax,0.5,1.05,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1314,2025-12-02T16:05:15.923463
2919760.0,thiopental,a-Hydroxymidazolam,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.28,,median,,,minmax,0.12,0.48,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1315,2025-12-02T16:05:15.923463
2919760.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,Half-life,,,6.3,h,mean,,,minmax,3.3,12,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1316,2025-12-02T16:05:15.923463
2919760.0,thiopental,thiopental,plasma,maternal,delivery,,20.0,concentration,,,4.31,mg/L,median,,,minmax,3.12,6.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1307,2025-12-02T16:05:22.346295
2919760.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,concentration,,,339,ug/L,median,,,minmax,234,617,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1308,2025-12-02T16:05:22.346295
2919760.0,thiopental,a-Hydroxymidazolam,plasma,maternal,delivery,,20.0,concentration,,,22,ug/L,median,,,minmax,11.8,50.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1309,2025-12-02T16:05:22.346295
2919760.0,thiopental,thiopental,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,4.65,mg/L,median,,,minmax,3.25,5.69,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1310,2025-12-02T16:05:22.346295
2919760.0,Midazolam,Midazolam,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,318,ug/L,median,,,minmax,188,411,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1311,2025-12-02T16:05:22.346295
2919760.0,thiopental,a-Hydroxymidazolam,umbilical cord plasma,pediatric,,fetus,20.0,concentration,,,5,ug/L,median,,,minmax,3,9.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1312,2025-12-02T16:05:22.346295
2919760.0,thiopental,thiopental,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.96,,median,,,minmax,0.79,1.15,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1313,2025-12-02T16:05:22.346295
2919760.0,Midazolam,Midazolam,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.66,,median,,,minmax,0.5,1.05,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1314,2025-12-02T16:05:22.346295
2919760.0,thiopental,a-Hydroxymidazolam,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,20.0,umbilical/maternal concentration ratios,,,0.28,,median,,,minmax,0.12,0.48,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1315,2025-12-02T16:05:22.346295
2919760.0,Midazolam,Midazolam,plasma,maternal,delivery,,20.0,Half-life,,,6.3,h,mean,,,minmax,3.3,12,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1316,2025-12-02T16:05:22.346295
2288825.0,midazolam,midazolam,breast milk,maternal,lactation,,9.0,milk/plasma ratio,3,days,0.268,,,,,,,,NS,days postpartum,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1364,2025-12-02T16:03:31.981487
2288825.0,midazolam,midazolam,breast milk,maternal,lactation,,9.0,milk/plasma ratio,4,days,0.286,,,,,,,,NS,days postpartum,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1365,2025-12-02T16:03:31.981487
2288825.0,midazolam,midazolam,breast milk,maternal,lactation,,9.0,milk/plasma ratio,5,days,0.29,,,,,,,,NS,days postpartum,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1366,2025-12-02T16:03:31.981487
2288825.0,midazolam,midazolam,breast milk,maternal,lactation,,9.0,milk/plasma ratio,,,0.283,,mean,SD,0.06,,,,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1367,2025-12-02T16:03:31.981487
2288825.0,Midazolam,Midazolam,plasma,maternal,lactation,,12.0,concentration,7,h,32.1,nmol/l,mean,SD,1.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1309,2025-12-02T16:05:09.448543
2288825.0,Midazolam,hydroxymidazolam,plasma,maternal,lactation,,12.0,concentration,7,h,11.5,nmol/l,mean,SD,3.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1310,2025-12-02T16:05:09.448543
2288825.0,Midazolam,Midazolam,breast milk,maternal,lactation,,11.0,concentration,,,<10,nmol/l,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1311,2025-12-02T16:05:09.448543
2288825.0,Midazolam,Midazolam,breast milk/plasma,maternal,lactation,,6.0,milk-to-plasma ratio,,,0.15,,mean,SD,0.06,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1312,2025-12-02T16:05:09.448543
2288825.0,Midazolam,Midazolam,plasma,maternal,lactation,,12.0,concentration,7,h,32.1,nmol/l,mean,SD,1.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1309,2025-12-02T16:05:12.001940
2288825.0,Midazolam,hydroxymidazolam,plasma,maternal,lactation,,12.0,concentration,7,h,11.5,nmol/l,mean,SD,3.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1310,2025-12-02T16:05:12.001940
2288825.0,Midazolam,Midazolam,breast milk,maternal,lactation,,11.0,concentration,,,<10,nmol/l,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1311,2025-12-02T16:05:12.001940
2288825.0,Midazolam,Midazolam,breast milk/plasma,maternal,lactation,,6.0,milk-to-plasma ratio,,,0.15,,mean,SD,0.06,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1312,2025-12-02T16:05:12.001940
2288825.0,Midazolam,Midazolam,plasma,maternal,lactation,,12.0,concentration,7,h,32.1,nmol/l,mean,SD,1.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1303,2025-12-02T16:05:15.923463
2288825.0,Midazolam,hydroxymidazolam,plasma,maternal,lactation,,12.0,concentration,7,h,11.5,nmol/l,mean,SD,3.7,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1304,2025-12-02T16:05:15.923463
2288825.0,Midazolam,Midazolam,breast milk,maternal,lactation,,11.0,concentration,,,<10,nmol/l,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1305,2025-12-02T16:05:15.923463
2288825.0,Midazolam,Midazolam,breast milk/plasma,maternal,lactation,,6.0,milk-to-plasma ratio,,,0.15,,mean,SD,0.06,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1306,2025-12-02T16:05:15.923463
2288825.0,Midazolam,Midazolam,plasma,maternal,lactation,,12.0,concentration,7,h,32.1,nmol/l,mean,SD,1.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1303,2025-12-02T16:05:22.346295
2288825.0,Midazolam,hydroxymidazolam,plasma,maternal,lactation,,12.0,concentration,7,h,11.5,nmol/l,mean,SD,3.7,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1304,2025-12-02T16:05:22.346295
2288825.0,Midazolam,Midazolam,breast milk,maternal,lactation,,11.0,concentration,,,<10,nmol/l,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1305,2025-12-02T16:05:22.346295
2288825.0,Midazolam,Midazolam,breast milk/plasma,maternal,lactation,,6.0,milk-to-plasma ratio,,,0.15,,mean,SD,0.06,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1306,2025-12-02T16:05:22.346295
1577053.0,midazolam,midazolam,blood,pediatric,,neonate,15.0,clearance,,,3.9,ml/min,mean,SD,6.4,minmax,0.8,3.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1387,2025-12-02T16:03:31.981487
1577053.0,midazolam,midazolam,blood,pediatric,,neonate,15.0,clearance,,,1.7,ml/min/kg,mean,SD,1.8,minmax,0.6,2.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1388,2025-12-02T16:03:31.981487
1577053.0,midazolam,midazolam,blood,pediatric,,neonate,15.0,Vss,,,2.4,l,mean,SD,2.2,minmax,1,9.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1389,2025-12-02T16:03:31.981487
1577053.0,midazolam,midazolam,blood,pediatric,,neonate,15.0,Vss,,,1.2,l/kg,mean,SD,0.6,minmax,0.8,2.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1390,2025-12-02T16:03:31.981487
1577053.0,midazolam,midazolam,blood,pediatric,,neonate,15.0,T1/2,,,0.6,h,mean,SD,1,minmax,0.1,1.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1391,2025-12-02T16:03:31.981487
1577053.0,midazolam,midazolam,blood,pediatric,,neonate,15.0,T1/2,,,12,h,mean,SD,4.9,minmax,4.9,22.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1392,2025-12-02T16:03:31.981487
1577053.0,midazolam,midazolam,blood,pediatric,,neonate,15.0,concentration,,,0.54,ug/ml,mean,SD,0.46,,,,,after tht bolus administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1393,2025-12-02T16:03:31.981487
1577053.0,midazolam,midazolam,blood,pediatric,,neonate,15.0,concentration,24,h,0.55,,,,0.24,,,,,time during the CIV,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1394,2025-12-02T16:03:31.981487
1577053.0,midazolam,midazolam,blood,pediatric,,neonate,15.0,concentration,48,h,0.83,,,,0.39,,,,,time during the CIV,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1395,2025-12-02T16:03:31.981487
1577053.0,midazolam,midazolam,blood,pediatric,,neonate,15.0,concentration,,,0.83,,,,0.39,,,,,time at the end of the CIV,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1396,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,146.0,concentration,24,h,29.68,umol/L,median,,,minmax,10.17,93.67,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1410,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,146.0,concentration,42,h,0.18,umol/L,median,,,minmax,0,9.77,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1411,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,118.0,concentration,24,h,29.85,umol/L,median,,,minmax,10.17,93.67,,ABCC2 rs2273697 GG genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1412,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,118.0,concentration,42,h,0.18,umol/L,median,,,minmax,0,9.77,,ABCC2 rs2273697 GG genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1413,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,28.0,concentration,24,h,26.64,umol/L,median,,,minmax,11.28,64.34,,ABCC2 rs2273697 GA+AA genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1414,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,28.0,concentration,42,h,0.21,umol/L,median,,,minmax,0.07,1.67,,ABCC2 rs2273697 GA+AA genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1415,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,68.0,concentration,24,h,26.81,umol/L,median,,,minmax,10.17,60.51,,ABCC2 rs2231142 GG genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1416,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,68.0,concentration,42,h,0.18,umol/L,median,,,minmax,0,3.86,,ABCC2 rs2231142 GG genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1417,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,78.0,concentration,24,h,31.85,umol/L,median,,,minmax,11.62,93.67,,ABCC2 rs2231142 GT+TT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1418,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,78.0,concentration,42,h,0.18,umol/L,median,,,minmax,0.07,9.77,,ABCC2 rs2231142 GT+TT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1419,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,53.0,concentration,24,h,30.16,umol/L,median,,,minmax,10.17,62.68,,ABCB1 rs1128503 AA genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1420,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,53.0,concentration,42,h,0.2,umol/L,median,,,minmax,0.07,8.41,,ABCB1 rs1128503 AA genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1421,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,93.0,concentration,24,h,29.5,umol/L,median,,,minmax,11.62,93.67,,ABCB1 rs1128503 AG+GG genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1422,2025-12-02T16:03:31.981487
36463535.0,Methotrexate,Methotrexate,blood,pediatric,,children,93.0,concentration,42,h,0.18,umol/L,median,,,minmax,0,9.77,,ABCB1 rs1128503 AG+GG genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1423,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,141.0,concentration,24,h,79.46,umol/L,mean,SD,7.83,,,,,SLCO1B1 rs11045879 TT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1424,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,141.0,concentration,48,h,2.04,umol/L,mean,SD,0.26,,,,,SLCO1B1 rs11045879 TT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1425,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,141.0,concentration,72,h,0.71,umol/L,mean,SD,0.11,,,,,SLCO1B1 rs11045879 TT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1426,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,141.0,concentration,96,h,0.65,umol/L,mean,SD,0.22,,,,,SLCO1B1 rs11045879 TT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1427,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,123.0,concentration,24,h,82.31,umol/L,mean,SD,17.5,,,,,SLCO1B1 rs11045879 CT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1428,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,123.0,concentration,48,h,3.57,umol/L,mean,SD,0.74,,,,,SLCO1B1 rs11045879 CT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1429,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,123.0,concentration,72,h,1.39,umol/L,mean,SD,0.37,,,,,SLCO1B1 rs11045879 CT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1430,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,123.0,concentration,96,h,1.21,umol/L,mean,SD,0.26,,,,,SLCO1B1 rs11045879 CT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1431,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,37.0,concentration,24,h,79.61,umol/L,mean,SD,13.7,,,,,SLCO1B1 rs11045879 CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1432,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,37.0,concentration,48,h,2.62,umol/L,mean,SD,0.77,,,,,SLCO1B1 rs11045879 CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1433,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,37.0,concentration,72,h,1.13,umol/L,mean,SD,0.39,,,,,SLCO1B1 rs11045879 CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1434,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,37.0,concentration,96,h,1.55,umol/L,mean,SD,0.63,,,,,SLCO1B1 rs11045879 CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1435,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,160.0,concentration,24,h,80.53,umol/L,mean,SD,7.74,,,,,SLCO1B1 rs11045879 CT+ CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1436,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,160.0,concentration,48,h,3.35,umol/L,mean,SD,0.6,,,,,SLCO1B1 rs11045879 CT+ CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1437,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,160.0,concentration,72,h,1.33,umol/L,mean,SD,0.3,,,,,SLCO1B1 rs11045879 CT+ CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1438,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,160.0,concentration,96,h,1.29,umol/L,mean,SD,0.25,,,,,SLCO1B1 rs11045879 CT+ CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1439,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,223.0,concentration,24,h,86.7,umol/L,mean,SD,11.12,,,,,SLCO1B1 rs4149056 TT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1440,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,223.0,concentration,48,h,2.67,umol/L,mean,SD,0.39,,,,,SLCO1B1 rs4149056 TT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1441,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,223.0,concentration,72,h,0.9,umol/L,mean,SD,0.12,,,,,SLCO1B1 rs4149056 TT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1442,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,223.0,concentration,96,h,0.88,umol/L,mean,SD,0.12,,,,,SLCO1B1 rs4149056 TT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1443,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,66.0,concentration,24,h,65.47,umol/L,mean,SD,8.13,,,,,SLCO1B1 rs4149056 CT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1444,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,66.0,concentration,48,h,2.69,umol/L,mean,SD,0.8,,,,,SLCO1B1 rs4149056 CT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1445,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,66.0,concentration,72,h,1.31,umol/L,mean,SD,0.6,,,,,SLCO1B1 rs4149056 CT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1446,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,66.0,concentration,96,h,1..04,umol/L,mean,SD,0.41,,,,,SLCO1B1 rs4149056 CT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1447,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,12.0,concentration,24,h,82.57,umol/L,mean,SD,14.92,,,,,SLCO1B1 rs4149056 CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1448,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,12.0,concentration,48,h,4.19,umol/L,mean,SD,1.6,,,,,SLCO1B1 rs4149056 CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1449,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,12.0,concentration,72,h,1.93,umol/L,mean,SD,0.79,,,,,SLCO1B1 rs4149056 CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1450,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,12.0,concentration,96,h,2.54,umol/L,mean,SD,1.29,,,,,SLCO1B1 rs4149056 CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1451,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,78.0,concentration,24,h,80.53,umol/L,mean,SD,7.74,,,,,SLCO1B1 rs4149056 CT+ CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1452,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,78.0,concentration,48,h,2.92,umol/L,mean,SD,0.72,,,,,SLCO1B1 rs4149056 CT+ CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1453,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,78.0,concentration,72,h,1.4,umol/L,mean,SD,0.52,,,,,SLCO1B1 rs4149056 CT+ CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1454,2025-12-02T16:03:31.981487
36193736.0,Methotrexate,Methotrexate,blood,pediatric,,children,78.0,concentration,96,h,1.3,umol/L,mean,SD,0.41,,,,,SLCO1B1 rs4149056 CT+ CC genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1455,2025-12-02T16:03:31.981487
31867853.0,Methotrexate,Methotrexate,blood,pediatric,,,32.0,peak concentration,4,h,1278.2,uM,mean,SD,219.5,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1456,2025-12-02T16:03:31.981487
31867853.0,Methotrexate,Methotrexate,blood,pediatric,,,17.0,concentration,4,h,1329.51,uM,mean,SD,303.65,,,,,No Delayed clearance at 72 hours,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1457,2025-12-02T16:03:31.981487
31867853.0,Methotrexate,Methotrexate,blood,pediatric,,,16.0,concentration,4,h,1419.56,uM,mean,SD,357.59,,,,,Delayed clearance at 72 hours,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1458,2025-12-02T16:03:31.981487
31867853.0,Methotrexate,Methotrexate,blood,pediatric,,,24.0,concentration,4,h,1361.86,uM,mean,SD,319.14,,,,,No mucositis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1459,2025-12-02T16:03:31.981487
31867853.0,Methotrexate,Methotrexate,blood,pediatric,,,9.0,concentration,4,h,1237.45,uM,mean,SD,342.81,,,,,mucositis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1460,2025-12-02T16:03:31.981487
31867853.0,Methotrexate,Methotrexate,blood,pediatric,,,24.0,concentration,4,h,1352.94,uM,mean,SD,331.91,,,,,No thrombocytopenia,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1461,2025-12-02T16:03:31.981487
31867853.0,Methotrexate,Methotrexate,blood,pediatric,,,9.0,concentration,4,h,1382.99,uM,mean,SD,212.51,,,,,thrombocytopenia,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1462,2025-12-02T16:03:31.981487
31867853.0,Methotrexate,Methotrexate,blood,pediatric,,,14.0,concentration,4,h,1359.97,uM,mean,SD,334.85,,,,,No neutropenia,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1463,2025-12-02T16:03:31.981487
31867853.0,Methotrexate,Methotrexate,blood,pediatric,,,19.0,concentration,4,h,1330.72,uM,mean,SD,233.33,,,,,neutropenia,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1464,2025-12-02T16:03:31.981487
31867853.0,Methotrexate,Methotrexate,blood,pediatric,,,29.0,concentration,4,h,1346.77,uM,mean,SD,323.98,,,,,No chemotherapy holds,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1465,2025-12-02T16:03:31.981487
31867853.0,Methotrexate,Methotrexate,blood,pediatric,,,4.0,concentration,4,h,1472.41,uM,mean,SD,267.21,,,,,chemotherapy holds,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1466,2025-12-02T16:03:31.981487
30835935.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,140.0,clearance,,,117.4,ml/min/m2,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1467,2025-12-02T16:03:31.981487
30835935.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,140.0,concentration,42,h,0.53,uM,median,,,IQR,0.37,0.89,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1468,2025-12-02T16:03:31.981487
30835935.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,140.0,end-of-infusion concentration,,,69,uM,median,,,IQR,51,87,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1469,2025-12-02T16:03:31.981487
30488179.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,22.0,Cpss (MTX 24h),,,57,uM,mean,SD,14,,,,,54 subject-cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1470,2025-12-02T16:03:31.981487
30488179.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,8.0,Cpss (MTX 24h),,,54,uM,mean,SD,16,,,,,21no-dose-adjusted cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1471,2025-12-02T16:03:31.981487
30488179.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,14.0,Cpss (MTX 24h),,,61,uM,mean,SD,12,,,,0.085,33 dose-adjusted cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1472,2025-12-02T16:03:31.981487
30488179.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,22.0,time to clearance,,,48,h,median,,,IQR,48,84,,54 subject-cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1473,2025-12-02T16:03:31.981487
30488179.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,8.0,time to clearance,,,48,h,median,,,IQR,48,60,,21no-dose-adjusted cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1474,2025-12-02T16:03:31.981487
30488179.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,14.0,time to clearance,,,48,h,median,,,IQR,48,84,0.199,33 dose-adjusted cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1475,2025-12-02T16:03:31.981487
30488179.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,22.0,AUC,,,2022,uM h/l,median,,,IQR,992,2883,,54 subject-cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1476,2025-12-02T16:03:31.981487
30488179.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,8.0,AUC,,,1646,uM h/l,median,,,IQR,992,2507,,21no-dose-adjusted cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1477,2025-12-02T16:03:31.981487
30488179.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,14.0,AUC,,,2141,uM h/l,median,,,IQR,1741,2883,<0.0001,33 dose-adjusted cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1478,2025-12-02T16:03:31.981487
32612964.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,123.0,Css,,,38.5,uM,mean,,,95% CI,36.5,40.5,,MTX dose 2 g/m2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1707,2025-12-02T16:03:31.981487
32612964.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,13.0,Css,,,137,uM,mean,,,95% CI,24,230,,MTX dose 5 g/m2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1708,2025-12-02T16:03:31.981487
32612964.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,123.0,AUC0-,,,717,uM h,mean,,,95% CI,680,755,,MTX dose 2 g/m2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1709,2025-12-02T16:03:31.981487
32612964.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,13.0,AUC0-,,,2510,uM h,mean,,,95% CI,446,5467,,MTX dose 5 g/m2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1710,2025-12-02T16:03:31.981487
32612964.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,123.0,CL,,,8.92,L/h/m2,mean,,,95% CI,7.96,9.88,,MTX dose 2 g/m2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1711,2025-12-02T16:03:31.981487
32612964.0,Methotrexate,Methotrexate,blood,pediatric,,children/adolescents,13.0,CL,,,4.35,L/h/m2,mean,,,95% CI,0.8,24.6,,MTX dose 5 g/m2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1712,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,infants,9.0,half-life,,,17.3,h,median,CV%,0.37,minmax,4.7,20.1,,Vincristine group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1713,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,infants,9.0,CL,,,13.7,L/h/m2,median,CV%,0.43,minmax,5,25.3,,Vincristine group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1714,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,infants,9.0,AUC0-,,,43.9,ng h/ml,median,CV%,0.72,minmax,26.2,180,,Vincristine group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1715,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,children,36.0,half-life,,,12.4,h,median,CV%,0.58,minmax,4,38.8,,Vincristine group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1716,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,children,36.0,CL,,,14.9,L/h/m2,median,CV%,0.8,minmax,2.3,78.9,,Vincristine group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1717,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,children,36.0,AUC0-,,,95.8,ng h/ml,median,CV%,0.84,minmax,8.1,510,,Vincristine group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1718,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,children,62.0,half-life,,,14.5,h,median,CV%,0.82,minmax,3.4,85.9,,Vincristine group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1719,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,children,62.0,CL,,,16.7,L/h/m2,median,CV%,0.57,minmax,1.6,45.8,,Vincristine group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1720,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,children,62.0,AUC0-,,,84.8,ng h/ml,median,CV%,1.06,minmax,33.7,935,,Vincristine group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1721,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,adolescents,25.0,half-life,,,16,h,median,CV%,0.38,minmax,6.2,30.8,,Vincristine group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1722,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,adolescents,25.0,CL,,,18.3,L/h/m2,median,CV%,0.67,minmax,5,73.3,,Vincristine group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1723,2025-12-02T16:03:31.981487
34023919.0,Vincristine,Vincristine,blood,pediatric,,adolescents,25.0,AUC0-,,,62.8,ng h/ml,median,CV%,0.58,minmax,20.8,191,,Vincristine group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1724,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,infants,4.0,half-life,,,23.6,h,median,CV%,0.36,minmax,8.8,30.6,,Actinomycin-D group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1725,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,infants,4.0,CL,,,3.3,L/h/m2,median,CV%,0.61,minmax,1.9,7.9,,Actinomycin-D group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1726,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,infants,4.0,AUC0-,,,153,ng h/ml,median,CV%,0.53,minmax,64,322,,Actinomycin-D group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1727,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,children,13.0,half-life,,,21.5,h,median,CV%,0.71,minmax,8.6,80.1,,Actinomycin-D group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1728,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,children,13.0,CL,,,4.9,L/h/m2,median,CV%,0.81,minmax,0.5,17.4,,Actinomycin-D group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1729,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,children,13.0,AUC0-,,,201,ng h/ml,median,CV%,1.3,minmax,33.1,1934,,Actinomycin-D group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1730,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,children,28.0,half-life,,,24.8,h,median,CV%,0.56,minmax,4.9,86.3,,Actinomycin-D group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1731,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,children,28.0,CL,,,4.6,L/h/m2,median,CV%,1.05,minmax,0.6,35.2,,Actinomycin-D group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1732,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,children,28.0,AUC0-,,,266,ng h/ml,median,CV%,1.01,minmax,34,1961,,Actinomycin-D group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1733,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,adolescents,7.0,half-life,,,32.6,h,median,CV%,0.2,minmax,24.4,40.3,,Actinomycin-D group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1734,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,adolescents,7.0,CL,,,5.3,L/h/m2,median,CV%,0.29,minmax,2.9,7.8,,Actinomycin-D group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1735,2025-12-02T16:03:31.981487
34023919.0,Actinomycin-D,Actinomycin-D,blood,pediatric,,adolescents,7.0,AUC0-,,,241,ng h/ml,median,CV%,0.43,minmax,134,498,,Actinomycin-D group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1736,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,64.0,CL,,,224.9,ml/min/m2,median,,,25th-75th,172.6,265.9,,"B-lineage, 15 min infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1737,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,51.0,CL,,,211.2,ml/min/m2,median,,,25th-75th,151.3,250.1,0.38,"B-lineage, 3-h infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1738,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,64.0,V1,,,3.4,L,median,,,25th-75th,2.5,5,,"B-lineage, 15 min infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1739,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,51.0,V1,,,4.7,L,median,,,25th-75th,2.6,8.1,0.03,"B-lineage, 3-h infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1740,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,64.0,Q,,,18.9,L/h,median,,,25th-75th,16.5,22.2,,"B-lineage, 15 min infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1741,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,51.0,Q,,,21.7,L/h,median,,,25th-75th,17.6,27.6,0.06,"B-lineage, 3-h infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1742,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,64.0,V2,,,166.7,L,median,,,25th-75th,140.1,217.5,,"B-lineage, 15 min infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1743,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,51.0,V2,,,197.9,L,median,,,25th-75th,159.6,279.1,0.13,"B-lineage, 3-h infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1744,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,10.0,CL,,,140,ml/min/m2,median,,,25th-75th,121.5,188.4,,"T-lineage, 15 min infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1745,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,10.0,CL,,,175.1,ml/min/m2,median,,,25th-75th,135.1,237.5,0.2,"T-lineage, 3-h infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1746,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,10.0,V1,,,5.9,L,median,,,25th-75th,5.1,8.6,,"T-lineage, 15 min infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1747,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,10.0,V1,,,8.9,L,median,,,25th-75th,6.2,12.3,0.25,"T-lineage, 3-h infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1748,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,10.0,Q,,,26.6,L/h,median,,,25th-75th,22.3,37.2,,"T-lineage, 15 min infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1749,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,10.0,Q,,,31,L/h,median,,,25th-75th,26.8,34.9,0.48,"T-lineage, 3-h infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1750,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,10.0,V2,,,225.9,L,median,,,25th-75th,174.2,346.9,,"T-lineage, 15 min infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1751,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,10.0,V2,,,221.1,L,median,,,25th-75th,192.8,342.4,0.73,"T-lineage, 3-h infusion",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1752,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,115.0,CL,,,220.3,ml/min/m2,median,,,,,,,all B-ALL patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1753,2025-12-02T16:03:31.981487
33037681.0,Vincristine,Vincristine,blood,pediatric,,children/adolescents,20.0,CL,,,167.8,ml/min/m2,median,,,,,,0.005,all T-ALL patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1754,2025-12-02T16:03:31.981487
31958904.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,140.0,concentration,,,6.41,ng/ml,mean,SD,9.91,minmax,0.1,58,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1755,2025-12-02T16:03:31.981487
31958904.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,140.0,concentration,,,15.96,ng/ml,mean,SD,14.63,minmax,1,113,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1756,2025-12-02T16:03:31.981487
31958904.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,140.0,RIS/9-OH-RIS ratio,,,0.51,,mean,SD,1.04,minmax,0.003,5.31,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1757,2025-12-02T16:03:31.981487
31958904.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,140.0,dose-correlated concentration,,,4.46,(ng/ml) (mg/day),mean,SD,5.61,minmax,0.07,29.64,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1758,2025-12-02T16:03:31.981487
31958904.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,140.0,dose-correlated concentration,,,16.33,(ng/ml) (mg/day),mean,SD,25.51,minmax,0.33,196.02,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1759,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,64.0,Concentration of active moiety,,,32.2,ng/ml,mean,SD,22.1,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1760,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,64.0,Concentration of active moiety,,,27.5,ng/ml,median,,,IQR,17,43.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1761,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,64.0,concentration,,,8.6,ng/ml,mean,SD,11.1,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1762,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,64.0,concentration,,,3.5,ng/ml,median,,,IQR,2,12,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1763,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,64.0,concentration,,,23.7,ng/ml,mean,SD,16.8,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1764,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,64.0,concentration,,,20.5,ng/ml,median,,,IQR,12.2,30,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1765,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,45.0,Concentration of active moiety,,,23.1,ng/ml,mean,SD,21.1,,,,,Boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1766,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,45.0,Concentration of active moiety,,,28,ng/ml,median,,,IQR,17,43.5,,Boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1767,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,45.0,concentration,,,9.2,ng/ml,mean,SD,11.1,,,,,Boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1768,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,45.0,concentration,,,4,ng/ml,median,,,IQR,2,15.5,,Boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1769,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,45.0,concentration,,,22.6,ng/ml,mean,SD,15.8,,,,,Boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1770,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,45.0,concentration,,,20,ng/ml,median,,,IQR,11.5,30,,Boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1771,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,19.0,Concentration of active moiety,,,33.4,ng/ml,mean,SD,24.8,,,,,Girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1772,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,19.0,Concentration of active moiety,,,26,ng/ml,median,,,IQR,16,44,,Girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1773,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,19.0,concentration,,,7.1,ng/ml,mean,SD,11.2,,,,,Girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1774,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,19.0,concentration,,,3,ng/ml,median,,,IQR,2,9,,Girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1775,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,19.0,concentration,,,26.3,ng/ml,mean,SD,19.3,,,,,Girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1776,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,19.0,concentration,,,23,ng/ml,median,,,IQR,13,31,,Girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1777,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,13.0,Concentration of active moiety,,,22.2,ng/ml,mean,SD,8.4,,,,,Mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1778,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,13.0,Concentration of active moiety,,,24,ng/ml,median,,,IQR,17,29,,Mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1779,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,13.0,concentration,,,3.8,ng/ml,mean,SD,4.3,,,,,Mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1780,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,13.0,concentration,,,3,ng/ml,median,,,IQR,1.5,4,,Mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1781,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,13.0,concentration,,,18.5,ng/ml,mean,SD,8.5,,,,,Mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1782,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,13.0,concentration,,,20,ng/ml,median,,,IQR,10.6,26,,Mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1783,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,50.0,Concentration of active moiety,,,34.9,ng/ml,mean,SD,24,,,,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1784,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,50.0,Concentration of active moiety,,,30,ng/ml,median,,,IQR,15.8,44,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1785,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,50.0,concentration,,,10,ng/ml,mean,SD,12,,,,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1786,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,50.0,concentration,,,4,ng/ml,median,,,IQR,2,13.3,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1787,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,50.0,concentration,,,25,ng/ml,mean,SD,18.4,,,,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1788,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,50.0,concentration,,,21,ng/ml,median,,,IQR,12.8,33,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1789,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,43.0,Concentration of active moiety,,,31.9,ng/ml,mean,SD,23.3,,,,,Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1790,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,43.0,Concentration of active moiety,,,26,ng/ml,median,,,IQR,16,43,,Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1791,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,43.0,concentration,,,7.8,ng/ml,mean,SD,9.9,,,,,Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1792,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,43.0,concentration,,,3,ng/ml,median,,,IQR,3,13,,Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1793,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,43.0,concentration,,,24.4,ng/ml,mean,SD,17.9,,,,,Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1794,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,43.0,concentration,,,20.5,ng/ml,median,,,IQR,12,31,,Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1795,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,16.0,Concentration of active moiety,,,33.8,ng/ml,mean,SD,21.3,,,,,Non-Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1796,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,16.0,Concentration of active moiety,,,29,ng/ml,median,,,IQR,17,44,,Non-Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1797,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,16.0,concentration,,,9.7,ng/ml,mean,SD,14.1,,,,,Non-Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1798,2025-12-02T16:03:31.981487
35303169.0,risperidone,risperidone,blood,pediatric,,Children and Adolescents,16.0,concentration,,,3.5,ng/ml,median,,,IQR,2,9,,Non-Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1799,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,16.0,concentration,,,24.2,ng/ml,mean,SD,17.1,,,,,Non-Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1800,2025-12-02T16:03:31.981487
35303169.0,risperidone,9-OH-risperidone,blood,pediatric,,Children and Adolescents,16.0,concentration,,,20.5,ng/ml,median,,,IQR,11.8,29.5,,Non-Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1801,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,130.0,concentration,,,202.5,ng/ml,mean,SD,142.8,,,,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1802,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,130.0,concentration,,,171,ng/ml,median,,,IQR,98,276,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1803,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,77.0,concentration,,,173.4,ng/ml,mean,SD,111.4,,,,,boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1804,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,77.0,concentration,,,143,ng/ml,median,,,IQR,90,235,,boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1805,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,53.0,concentration,,,244.9,ng/ml,mean,SD,173.4,,,,,girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1806,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,53.0,concentration,,,193,ng/ml,median,,,IQR,124,347,,girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1807,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,37.0,concentration,,,160.7,ng/ml,mean,SD,126.1,,,,,Children < 14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1808,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,37.0,concentration,,,70,ng/ml,median,,,IQR,48,114,,Children < 14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1809,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,93.0,concentration,,,219.2,ng/ml,mean,SD,146.2,,,,,Children >= 14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1810,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,93.0,concentration,,,124,ng/ml,median,,,IQR,61,183,,Children >= 14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1811,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,45.0,concentration,,,181.4,ng/ml,mean,SD,137.3,,,,,mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1812,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,45.0,concentration,,,152,ng/ml,median,,,IQR,95,226,,mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1813,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,85.0,concentration,,,213.7,ng/ml,mean,SD,145.1,,,,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1814,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,85.0,concentration,,,180,ng/ml,median,,,IQR,106,305,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1815,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,57.0,concentration,,,242.9,ng/ml,mean,SD,138.4,,,,,Schizophrenia/psychotic disorders (ICD-10 F2) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1816,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,57.0,concentration,,,207,ng/ml,median,,,IQR,152,305,,Schizophrenia/psychotic disorders (ICD-10 F2) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1817,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,13.0,concentration,,,182.1,ng/ml,mean,SD,133.8,,,,,Affective disorders (ICD-10 F3) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1818,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,13.0,concentration,,,140,ng/ml,median,,,IQR,62,307,,Affective disorders (ICD-10 F3) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1819,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,31.0,concentration,,,143.8,ng/ml,mean,SD,110.5,,,,,Behavior and tic disorders (ICD-10 F9) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1820,2025-12-02T16:03:31.981487
32997183.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,31.0,concentration,,,104,ng/ml,median,,,IQR,58,198,,Behavior and tic disorders (ICD-10 F9) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1821,2025-12-02T16:03:31.981487
34735099.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,4.0,dose adjusted concentration,4,week,24.03,ng/ml/mg,mean,SD,6.4,,,,,Poor metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1822,2025-12-02T16:03:31.981487
34735099.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,17.0,dose adjusted concentration,4,week,17.26,ng/ml/mg,mean,SD,7.19,,,,,Intermediate metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1823,2025-12-02T16:03:31.981487
34735099.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,29.0,dose adjusted concentration,4,week,14.85,ng/ml/mg,mean,SD,6.15,,,,,Normal metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1824,2025-12-02T16:03:31.981487
34735099.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,1.0,dose adjusted concentration,4,week,4.06,ng/ml/mg,mean,SD,,,,,0.019,Ultrarapid metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1825,2025-12-02T16:03:31.981487
34735099.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,4.0,dose adjusted concentration,12,week,22.15,ng/ml/mg,mean,SD,11.04,,,,,Poor metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1826,2025-12-02T16:03:31.981487
34735099.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,17.0,dose adjusted concentration,12,week,16.21,ng/ml/mg,mean,SD,4.58,,,,,Intermediate metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1827,2025-12-02T16:03:31.981487
34735099.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,29.0,dose adjusted concentration,12,week,14.32,ng/ml/mg,mean,SD,4.52,,,,,Normal metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1828,2025-12-02T16:03:31.981487
34735099.0,Aripiprazole,Aripiprazole,blood,pediatric,,Children and Adolescents,1.0,dose adjusted concentration,12,week,6.73,ng/ml/mg,mean,SD,,,,,0.067,Ultrarapid metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1829,2025-12-02T16:03:31.981487
30681278.0,Levetiracetam,Levetiracetam,blood,pediatric,,children,35.0,concentration,,,10.5,mg/L,median,,,interquartile range ,7.1,14.1,,LEV+LTG group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1830,2025-12-02T16:03:31.981487
30681278.0,Levetiracetam,Levetiracetam,blood,pediatric,,children,35.0,concentration,,,8.3,mg/L,median,,,interquartile range ,6.3,11.7,,LEV+LTG+VPA  group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1831,2025-12-02T16:03:31.981487
30681278.0,Topiramate,Topiramate,blood,pediatric,,children,37.0,concentration,,,6.4,mg/L,median,,,interquartile range ,5,7.9,,TPM + LTG,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1832,2025-12-02T16:03:31.981487
30681278.0,Topiramate,Topiramate,blood,pediatric,,children,32.0,concentration,,,5.6,mg/L,median,,,interquartile range ,3.1,7.2,,TPM + LTG+VPA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1833,2025-12-02T16:03:31.981487
32890316.0,Levetiracetam,Levetiracetam,blood,pediatric,,children,117.0,Css,,,12.6,ug/mL,mean,SD,4.36,,,,,Drug-resistant group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1834,2025-12-02T16:03:31.981487
32890316.0,Levetiracetam,Levetiracetam,blood,pediatric,,children,128.0,Css,,,14.09,ug/mL,mean,SD,4.67,,,,0.037,Drug-responsive group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1835,2025-12-02T16:03:31.981487
32890316.0,Levetiracetam,Levetiracetam,blood,pediatric,,children,117.0,serum concentration/body mass dose ratios ,,,0.37,ug/mL kg/mg,mean,SD,0.13,,,,,Drug-resistant group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1836,2025-12-02T16:03:31.981487
32890316.0,Levetiracetam,Levetiracetam,blood,pediatric,,children,128.0,serum concentration/body mass dose ratios ,,,0.4,ug/mL kg/mg,mean,SD,0.13,,,,<0.001,Drug-responsive group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1837,2025-12-02T16:03:31.981487
33336359.0,Levetiracetam,Levetiracetam,blood,pediatric,,children,27.0,concentration,,,,ug/ml,,,,minmax,69,151.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1838,2025-12-02T16:03:31.981487
33336359.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,27.0,total concentration,,,,ug/ml,,,,minmax,126,223,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1881,2025-12-02T16:03:31.981487
33336359.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,27.0,unbound concentration,,,,ug/ml,,,,minmax,31,114,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1882,2025-12-02T16:03:31.981487
33336359.0,Fosphenytoin ,phenytoin,blood,pediatric,,children ,11.0,total concentration,,,,ug/mL,,,,minmax,11.3,26.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3127,2025-12-02T16:03:31.981487
33336359.0,Fosphenytoin ,phenytoin,blood,pediatric,,children ,11.0,unbound concentration,,,,ug/mL,,,,minmax,1,0.028,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3128,2025-12-02T16:03:31.981487
33336359.0,Fosphenytoin ,phenytoin,blood,pediatric,,children ,11.0,free fraction,,,,,,,,minmax,0.04,0.19,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3129,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,8.0,Cmax,,,19.19,ug/mL,mean,SD,4.12,,,,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1839,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,9.0,Cmax,,,35.12,ug/mL,mean,SD,10.54,,,,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1840,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,2.0,Cmax,,,36.11,ug/mL,median,,,minmax,27.58,44.64,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1841,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,8.0,AUC0-12,,,167,h ug/ml,mean,SD,45.6,,,,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1842,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,9.0,AUC0-12,,,316.5,h ug/ml,mean,SD,108.4,,,,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1843,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,2.0,AUC0-12,,,290.9,h ug/ml,median,,,minmax,176.14,405.59,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1844,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,8.0,Ctrough,,,9.99,ug/mL,mean,SD,3.86,,,,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1845,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,9.0,Ctrough,,,19.25,ug/mL,mean,SD,8.48,,,,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1846,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,2.0,Ctrough,,,13.03,ug/mL,median,,,minmax,2.98,23.07,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1847,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,8.0,Tmax,,,1.5,h,median,,,minmax,1.5,2.5,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1848,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,9.0,Tmax,,,2.5,h,median,,,minmax,2,3.3,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1849,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,2.0,Tmax,,,1.5,h,median,,,,,,,dose range 5-15 mg/kg/12 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1850,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,14.0,AUC0-12,,,220,h ug/ml,median,,,IQR,157.5,355.4,,NG/OG administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1851,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,5.0,AUC0-12,,,213.8,h ug/ml,median,,,IQR,154,348.8,0.9,oral administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1852,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,14.0,Cmax,,,23.8,ug/mL,median,,,IQR,18.8,41.3,,NG/OG administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1853,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,5.0,Cmax,,,26.4,ug/mL,median,,,IQR,19.3,34.2,0.84,oral administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1854,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,14.0,Tmax,,,1.5,h,median,,,IQR,1.5,2.5,,NG/OG administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1855,2025-12-02T16:03:31.981487
34114632.0,Levetiracetam,Levetiracetam,blood,pediatric,,neonate,5.0,Tmax,,,2.5,h,median,,,IQR,1.5,2.9,0.46,oral administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1856,2025-12-02T16:03:31.981487
34131926.0,Levetiracetam,Levetiracetam,blood,maternal,lactation,,20.0,trough concentration,,,24.8,mg/L,mean,SD,6.4,minmax,17.4,37.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1857,2025-12-02T16:03:31.981487
34131926.0,Levetiracetam,Levetiracetam,breast milk,maternal,lactation,,20.0,trough concentration,,,24.4,mg/L,mean,SD,8.3,minmax,8.6,42.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1858,2025-12-02T16:03:31.981487
34131926.0,Levetiracetam,Levetiracetam,breast milk,maternal,lactation,,20.0,AUC0-12,,,432,mg h/mL,mean,SD,157,minmax,235,835,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1859,2025-12-02T16:03:31.981487
34131926.0,Levetiracetam,Levetiracetam,breast milk,maternal,lactation,,20.0,concentration,,,36,mg/L,mean,SD,13.1,minmax,19.6,69.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1860,2025-12-02T16:03:31.981487
31191874.0,Levetiracetam,Levetiracetam,blood,maternal,pre-pregnancy,,,concentration,,,18.22,mg/L,mean,,,minmax,0.25,45.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1861,2025-12-02T16:03:31.981487
31191874.0,Levetiracetam,Levetiracetam,blood,maternal,trimester 1,,21.0,concentration,,,12.45,mg/L,mean,,,minmax,0.25,32.5,<0.001,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1862,2025-12-02T16:03:31.981487
31191874.0,Levetiracetam,Levetiracetam,blood,maternal,trimester 2,,26.0,concentration,,,14.83,mg/L,mean,,,minmax,0.25,65.6,0.039,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1863,2025-12-02T16:03:31.981487
31191874.0,Levetiracetam,Levetiracetam,blood,maternal,trimester 3,,19.0,concentration,,,13.81,mg/L,mean,,,minmax,3.2,39.4,0.009,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1864,2025-12-02T16:03:31.981487
31191874.0,Levetiracetam,Levetiracetam,blood,maternal,post-partum,,,concentration,,,28.4,mg/L,mean,,,minmax,11.1,76.5,0.02,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1865,2025-12-02T16:03:31.981487
31191874.0,Levetiracetam,Levetiracetam,blood,maternal,pre-pregnancy,,,apparent clearance,,,166.48,L/day,mean,,,minmax,56.6,1000,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1866,2025-12-02T16:03:31.981487
31191874.0,Levetiracetam,Levetiracetam,blood,maternal,trimester 1,,21.0,apparent clearance,,,237.56,L/day,mean,,,minmax,97.4,1000,0.011,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1867,2025-12-02T16:03:31.981487
31191874.0,Levetiracetam,Levetiracetam,blood,maternal,trimester 2,,26.0,apparent clearance,,,236.02,L/day,mean,,,minmax,45.7,1000,0.012,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1868,2025-12-02T16:03:31.981487
31191874.0,Levetiracetam,Levetiracetam,blood,maternal,trimester 3,,19.0,apparent clearance,,,242.56,L/day,mean,,,minmax,62.11,784.31,0.019,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1869,2025-12-02T16:03:31.981487
31191874.0,Levetiracetam,Levetiracetam,blood,maternal,post-partum,,,apparent clearance,,,107.8,L/day,mean,,,minmax,52.96,171.42,0.039,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1870,2025-12-02T16:03:31.981487
36260320.0,Levetiracetam,Levetiracetam,blood,maternal,pregnancy,,37.0,Concentration ,,,6.78,ug/ml,median,,,minmax,1.2,33,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1871,2025-12-02T16:03:31.981487
35997547.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,434.0,trough concentration,,,63.49,mg/L,median,,,IQR,50.27,79.743,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1872,2025-12-02T16:03:31.981487
35997547.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,305.0,trough concentration,,,64,mg/L,median,,,IQR,50.93,79.73,,No comedication with ibuprofen,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1873,2025-12-02T16:03:31.981487
35997547.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,151.0,trough concentration,,,62.23,mg/L,median,,,IQR,46.58,78.75,,Comedication with ibuprofen,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1874,2025-12-02T16:03:31.981487
35997547.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,434.0,trough concentration to dose ratio,,,2.58,,median,,,IQR,1.99,3.3,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1875,2025-12-02T16:03:31.981487
35997547.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,305.0,trough concentration to dose ratio,,,2.67,,median,,,IQR,2.03,3.4,,No comedication with ibuprofen,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1876,2025-12-02T16:03:31.981487
35997547.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,151.0,trough concentration to dose ratio,,,2.47,,median,,,IQR,1.89,3.05,,Comedication with ibuprofen,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1877,2025-12-02T16:03:31.981487
35997547.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,,,,,,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1878,2025-12-02T16:03:31.981487
34000957.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,229.0,trough concentration,,,49.6,ug/ml,median,,,1st-3rd quartiles,40.85,64.25,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1879,2025-12-02T16:03:31.981487
34000957.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,229.0,trough concentration to dose ratio,,,2.1,,median,,,1st-3rd quartiles,1.8,2.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1880,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,486.0,concentration,,,48.9,ug/ml,mean,SD,8.9,,,,,Total: 0-12 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1883,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,486.0,concentration,,,62.5,ug/ml,mean,SD,5.1,,,,,Total: 13-24 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1884,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,486.0,concentration,,,69.2,ug/ml,mean,SD,1.5,,,,,Total: 2-5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1885,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,486.0,concentration,,,88.4,ug/ml,mean,SD,2.1,,,,,Total: 6-11 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1886,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,486.0,concentration,,,99.8,ug/ml,mean,SD,4.5,,,,<0.001,Total: 12-18 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1887,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,194.0,concentration,,,31.1,ug/ml,mean,SD,,,,,,Controlled: 0-12 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1888,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,194.0,concentration,,,54.6,ug/ml,mean,SD,4.3,,,,,Controlled: 13-24 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1889,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,194.0,concentration,,,65.5,ug/ml,mean,SD,1.7,,,,,Controlled: 2-5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1890,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,194.0,concentration,,,86.1,ug/ml,mean,SD,2.4,,,,,Controlled: 6-11 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1891,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,194.0,concentration,,,98.7,ug/ml,mean,SD,5.4,,,,<0.001,Controlled: 12-18 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1892,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,186.0,concentration,,,57.8,ug/ml,mean,SD,0.5,,,,,Uncontrolled: 0-12 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1893,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,186.0,concentration,,,68.3,ug/ml,mean,SD,8,,,,,Uncontrolled: -24 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1894,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,186.0,concentration,,,73.9,ug/ml,mean,SD,2.5,,,,,Uncontrolled: 2-5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1895,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,186.0,concentration,,,93.9,ug/ml,mean,SD,3.9,,,,,Uncontrolled: 6-11 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1896,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,186.0,concentration,,,92.1,ug/ml,mean,SD,8.5,,,,<0.001,Uncontrolled: 12-18 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1897,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,486.0,concentration,,,78,ug/ml,mean,SD,1.5,,,,,Total: Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1898,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,486.0,concentration,,,77.5,ug/ml,mean,SD,2.1,,,,,Total: Female,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1899,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,194.0,concentration,,,76.3,ug/ml,mean,SD,1.9,,,,,Controlled: Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1900,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,194.0,concentration,,,75.9,ug/ml,mean,SD,2.6,,,,,Controlled: Female,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1901,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,186.0,concentration,,,80.7,ug/ml,mean,SD,2.6,,,,,Uncontrolled: Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1902,2025-12-02T16:03:31.981487
32276895.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,186.0,concentration,,,80.4,ug/ml,mean,SD,3.6,,,,,Uncontrolled: Female,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1903,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,57.0,concentration,,,52.64,mcg/mL,mean,SD,18.13,,,,,0-2 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1904,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,28.0,concentration,,,61.32,mcg/mL,mean,SD,28.6,,,,,3-6 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1905,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,37.0,concentration,,,68,mcg/mL,mean,SD,24.36,,,,<0.05,7-16 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1906,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,57.0,concentration:dose ratio ,,,2.87,mcg/mL per mg/kg,mean,SD,0.97,,,,,0-2 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1907,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,28.0,concentration:dose ratio ,,,2.96,mcg/mL per mg/kg,mean,SD,1.18,,,,,3-6 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1908,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,Valproic Acid,blood,pediatric,,children,37.0,concentration:dose ratio ,,,3.4,mcg/mL per mg/kg,mean,SD,1.16,,,,<0.05,7-16 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1909,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,2-propyl-4-pentenoic acidA,blood,pediatric,,children,57.0,concentration,,,210.28,ng/mL,mean,SD,131.66,,,,,0-2 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1910,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,2-propyl-4-pentenoic acidA,blood,pediatric,,children,28.0,concentration,,,167.19,ng/mL,mean,SD,124.94,,,,,3-6 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1911,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,2-propyl-4-pentenoic acidA,blood,pediatric,,children,37.0,concentration,,,131.46,ng/mL,mean,SD,88.5,,,,<0.05,7-16 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1912,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,2-propyl-4-pentenoic acidA,blood,pediatric,,children,57.0,concentration:dose ratio ,,,11.23,ng/mL per mg/kg,mean,SD,6.1,,,,,0-2 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1913,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,2-propyl-4-pentenoic acidA,blood,pediatric,,children,28.0,concentration:dose ratio ,,,8.35,ng/mL per mg/kg,mean,SD,5.97,,,,,3-6 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1914,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,2-propyl-4-pentenoic acidA,blood,pediatric,,children,37.0,concentration:dose ratio ,,,6.75,ng/mL per mg/kg,mean,SD,4.52,,,,<0.05,7-16 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1915,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,"2-propyl-2,4-pentadienoic acid ",blood,pediatric,,children,57.0,concentration,,,234.91,ng/mL,mean,SD,129.93,,,,,0-2 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1916,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,"2-propyl-2,4-pentadienoic acid ",blood,pediatric,,children,28.0,concentration,,,215.03,ng/mL,mean,SD,133.75,,,,,3-6 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1917,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,"2-propyl-2,4-pentadienoic acid ",blood,pediatric,,children,37.0,concentration,,,160.14,ng/mL,mean,SD,104.13,,,,<0.05,7-16 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1918,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,"2-propyl-2,4-pentadienoic acid ",blood,pediatric,,children,57.0,concentration:dose ratio ,,,12.74,ng/mL per mg/kg,mean,SD,6.57,,,,,0-2 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1919,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,"2-propyl-2,4-pentadienoic acid ",blood,pediatric,,children,28.0,concentration:dose ratio ,,,10.69,ng/mL per mg/kg,mean,SD,6.53,,,,,3-6 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1920,2025-12-02T16:03:31.981487
32107351.0,Valproic Acid,"2-propyl-2,4-pentadienoic acid ",blood,pediatric,,children,37.0,concentration:dose ratio ,,,8.37,ng/mL per mg/kg,mean,SD,6.16,,,,<0.05,7-16 years old,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1921,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,Cmax,,,8.07,ng/ml,mean,SD,1.7,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1922,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,Cmax/dose,,,0.81,ng/ml/mg,mean,SD,0.17,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1923,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,AUC0-4,,,21.8,h ng/ml,mean,SD,7.06,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1924,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,AUC4-8,,,19.81,h ng/ml,mean,SD,3.14,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1925,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,AUC8-12,,,19.73,h ng/ml,mean,SD,5.1,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1926,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,AUC0-t,,,89.18,h ng/ml,mean,SD,25.05,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1927,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,AUC0-inf,,,105.26,h ng/ml,mean,SD,21.83,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1928,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,Tmax,,,2,h,median,,,minmax,1,3,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1929,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,t1/2,,,4.8,h,mean,SD,0.466,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1930,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,Vd/F,,,682.49,L,mean,SD,182.61,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1931,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,Vd/F/kg,,,4.88,,mean,SD,0.94,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1932,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,CL/F,,,97.51,L/h,mean,SD,18.1,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1933,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,5.0,CL/F/kg,,,4.88,L/h/kg,mean,SD,0.94,,,,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1934,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,Cmax,,,10.09,ng/ml,mean,SD,0.62,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1935,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,Cmax/dose,,,0.67,ng/ml/mg,mean,SD,0.041,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1936,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,AUC0-4,,,25.69,h ng/ml,mean,SD,3.67,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1937,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,AUC4-8,,,25.72,h ng/ml,mean,SD,2.72,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1938,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,AUC8-12,,,20.73,h ng/ml,mean,SD,6.342,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1939,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,AUC0-t,,,118.49,h ng/ml,mean,SD,18.21,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1940,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,AUC0-inf,,,140.68,h ng/ml,mean,SD,NE,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1941,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,Tmax,,,3,h,median,,,minmax,3,12,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1942,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,t1/2,,,12.69,h,mean,SD,NE,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1943,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,Vd/F,,,1952,L,mean,SD,NE,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1944,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,Vd/F/kg,,,5.18,,mean,SD,NE,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1945,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,CL/F,,,106.63,L/h,mean,SD,NE,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1946,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,3.0,CL/F/kg,,,5.18,L/h/kg,mean,SD,NE,,,,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1947,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,Cmax,,,15.45,ng/ml,mean,SD,1.06,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1948,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,Cmax/dose,,,0.77,ng/ml/mg,mean,SD,0.053,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1949,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,AUC0-4,,,42.01,h ng/ml,mean,SD,2.93,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1950,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,AUC4-8,,,38.26,h ng/ml,mean,SD,10.71,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1951,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,AUC8-12,,,28.2,h ng/ml,mean,SD,9.48,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1952,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,AUC0-t,,,155.95,h ng/ml,mean,SD,35.21,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1953,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,AUC0-inf,,,144.26,h ng/ml,mean,SD,NE,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1954,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,Tmax,,,2,h,median,,,minmax,2,2,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1955,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,t1/2,,,6.98,h,mean,SD,NE,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1956,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,Vd/F,,,1396.96,L,mean,SD,NE,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1957,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,Vd/F/kg,,,5.8,,mean,SD,NE,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1958,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,CL/F,,,138.64,L/h,mean,SD,NE,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1959,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,2.0,CL/F/kg,,,5.8,L/h/kg,mean,SD,NE,,,,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1960,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,Cmax,,,10.16,ng/ml,mean,SD,3.18,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1961,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,Cmax/dose,,,0.76,ng/ml/mg,mean,SD,0.132,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1962,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,AUC0-4,,,27.01,h ng/ml,mean,SD,9.58,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1963,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,AUC4-8,,,25.27,h ng/ml,mean,SD,8.54,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1964,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,AUC8-12,,,21.72,h ng/ml,mean,SD,6.51,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1965,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,AUC0-t,,,111.33,h ng/ml,mean,SD,34.96,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1966,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,AUC0-inf,,,120.14,h ng/ml,mean,SD,25.6,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1967,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,Tmax,,,2.5,h,median,,,minmax,1,12,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1968,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,t1/2,,,6.81,h,mean,SD,3.436,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1969,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,Vd/F,,,1079.32,L,mean,SD,592,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1970,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,Vd/F/kg,,,5.13,,mean,SD,0.776,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1971,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,CL/F,,,107.56,L/h,mean,SD,21.94,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1972,2025-12-02T16:03:31.981487
32776159.0,Methylphenidate,Methylphenidate,blood,pediatric,,children,10.0,CL/F/kg,,,5.13,L/h/kg,mean,SD,0.78,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1973,2025-12-02T16:03:31.981487
36006433.0,Oxcarbazepine,MHD,blood,pediatric,,children,125.0,concentration,,,9.88,ug/mL,median,,,P25P75,6.81,13.77,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1974,2025-12-02T16:03:31.981487
36006433.0,Oxcarbazepine,MHD,blood,pediatric,,children,125.0,concentration-dose ratio ,,,0.74,ug kg/mg/mL,mean,SD,0.27,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1975,2025-12-02T16:03:31.981487
36006433.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,pediatrics,,children ,125.0,trough concentration,,,9.88,ug/mL,median,,,P25-P75,6.81,13.77,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3220,2025-12-02T16:03:31.981487
36006433.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,pediatrics,,children ,125.0,concentration-dose ratio,,,0.74,ug kg/mg/ml,mean,SD,0.27,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3221,2025-12-02T16:03:31.981487
33848384.0,Furosemide,Furosemide,blood,pediatric,,preterm,10.0,concentration,,,1.4,mg/L,mean,,,minmax,0.09,10.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1976,2025-12-02T16:03:31.981487
33848384.0,Furosemide,Furosemide,blood,pediatric,,preterm,10.0,Vd,,,0.37,L/kg,mean,,,minmax,0.077,1.2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1977,2025-12-02T16:03:31.981487
33848384.0,Furosemide,Furosemide,blood,pediatric,,preterm,10.0,CL,,,16.5,ml/kg/h,mean,,,minmax,3.43,49.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1978,2025-12-02T16:03:31.981487
33848384.0,Furosemide,Furosemide,blood,pediatric,,preterm,10.0,ke,,,4.7,x10^-2/h,mean,,,minmax,3.6,6.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1979,2025-12-02T16:03:31.981487
33848384.0,Furosemide,Furosemide,blood,pediatric,,preterm,10.0,half-life,,,15.3,h,mean,,,minmax,10.4,19.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1980,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,blood,maternal,the third trimester,,12.0,Cmax,,,403,ng/ml,median,,,IQR,229,715,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1981,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,blood,maternal,the third trimester,,12.0,Tmax,,,2,h,median,,,IQR,1.5,4.83,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1982,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,blood,maternal,the third trimester,,12.0,t1/2,,,2.5,h,median,,,IQR,1.77,2.97,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1983,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,blood,maternal,the third trimester,,12.0,Kel,,,0.27,l/h,median,,,IQR,0.24,0.38,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1984,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,blood,maternal,the third trimester,,12.0,AUC0-12h,,,1366,ng h/mL,median,,,IQR,927,2531,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1985,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,blood,maternal,the third trimester,,12.0,AUC0-,,,1580,ng h/mL,median,,,IQR,1270,2881,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1986,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,blood,maternal,the third trimester,,12.0,Vd/F,,,82.8,L,median,,,IQR,34.4,173,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1987,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,blood,maternal,the third trimester,,12.0,CL/F,,,25.3,L/h,median,,,IQR,13.8,31.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1988,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,urine,maternal,the third trimester,,12.0,CLR,,,2.5,L/h,median,,,IQR,1.77,2.97,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1989,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,blood,maternal,the third trimester,,12.0,CLNR,,,22.7,L/h,median,,,IQR,12.1,25.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1990,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,amniotic fluid,maternal,delivery,,4.0,concentration,,,11,ng/mL,median,,,IQR,5.51,14.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1991,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,blood,maternal,delivery,,8.0,concentration,,,140,ng/mL,median,,,IQR,47.8,372,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1992,2025-12-02T16:03:31.981487
32562572.0,Furosemide,Furosemide,umbilical vein blood,pediatric,,fetus,8.0,concentration,,,45.8,ng/mL,median,,,IQR,18.7,57,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,1993,2025-12-02T16:03:31.981487
35248877.0,Sertraline,Sertraline,blood,pediatric,,children and adolescents,78.0,concentration,,,42.367,ng/mL,mean,SD,26.434,minmax,7,139,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2044,2025-12-02T16:03:31.981487
35248877.0,Sertraline,Sertraline,blood,pediatric,,children and adolescents,21.0,concentration,,,49.743,ng/mL,mean,SD,23.643,minmax,7,80,,OCD,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2045,2025-12-02T16:03:31.981487
35248877.0,Sertraline,Sertraline,blood,pediatric,,children and adolescents,36.0,concentration,,,36.639,ng/mL,mean,SD,23.265,minmax,7,101,,Depression,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2046,2025-12-02T16:03:31.981487
33253437.0,Sertraline,Sertraline,blood,maternal,3rd trimester,,24.0,concentration,,,15.5,ng/ml,median,,,,,,,Blood samples for plasma dosages were taken approximately 12 h after the last SSRI/SNRI administration ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2083,2025-12-02T16:03:31.981487
33253437.0,Escitalopram,Escitalopram,blood,maternal,at third trimester,,4.0, concentration,,,12.1,ng/ml,median,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2207,2025-12-02T16:03:31.981487
33253437.0,Escitalopram,Escitalopram,umbilical/maternal  blood,materna/pediatric,at delivery,fetus,2.0,umbilical/maternal ratio,,,0.678,,median,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2208,2025-12-02T16:03:31.981487
33253437.0,Venlafaxine,Venlafaxine,plasma,maternal,third trimester,,7.0,concentration,,,86.1,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,284,2025-12-02T16:05:09.448543
33253437.0,Venlafaxine,Venlafaxine,plasma,maternal,third trimester,,7.0,concentration,,,86.1,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,284,2025-12-02T16:05:12.001940
33253437.0,Venlafaxine,Venlafaxine,plasma,maternal,third trimester,,7.0,concentration,,,86.1,ng/ml,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,278,2025-12-02T16:05:15.923463
33253437.0,Venlafaxine,Venlafaxine,plasma,maternal,third trimester,,7.0,concentration,,,86.1,ng/ml,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,278,2025-12-02T16:05:22.346295
31950485.0,Oxycodone,Oxycodone,blood,maternal,labor,,58.0,concentration,,,0.9,ng/ml,median,,,minmax,0,17,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2088,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Noroxycodone,blood,maternal,labor,,58.0,concentration,,,1.7,ng/ml,median,,,minmax,0,14,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2089,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,oxymorphone,blood,maternal,labor,,58.0,concentration,,,0,ng/ml,median,,,minmax,0,0.2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2090,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Noroxymorphone,blood,maternal,labor,,58.0,concentration,,,0.63,ng/ml,median,,,minmax,0,1.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2091,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Oxycodone,umbilical venous blood,pediatric,,fetus,61.0,concentration,,,1.2,ng/ml,median,,,minmax,0.21,7.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2092,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Noroxycodone,umbilical venous blood,pediatric,,fetus,61.0,concentration,,,2.2,ng/ml,median,,,minmax,0,11,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2093,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,oxymorphone,umbilical venous blood,pediatric,,fetus,61.0,concentration,,,0.14,ng/ml,median,,,minmax,0,0.26,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2094,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Noroxymorphone,umbilical venous blood,pediatric,,fetus,61.0,concentration,,,0,ng/ml,median,,,minmax,0,1.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2095,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Oxycodone,blood,maternal,labor,,58.0,foetal to maternal ratio,,,1.3,,median,,,minmax,0.36,3.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2096,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Oxycodone,blood,maternal,labor,,58.0,concentration,,,0.9,ng/ml,median,,,minmax,0,17,,"Maternal contraction pain was assessed before and 30, 60 and 120 minutes after the first oxycodone administration ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3233,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Noroxycodone,blood,maternal,labor,,58.0,concentration,,,1.7,ng/ml,median,,,minmax,0,14,,"Maternal contraction pain was assessed before and 30, 60 and 120 minutes after the first oxycodone administration ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3234,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Oxymorphone,blood,maternal,labor,,58.0,concentration,,,0,ng/ml,median,,,minmax,0,0.2,,"Maternal contraction pain was assessed before and 30, 60 and 120 minutes after the first oxycodone administration ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3235,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Noroxymorphone,blood,maternal,labor,,58.0,concentration,,,0.63,ng/ml,median,,,minmax,0,1.9,,"Maternal contraction pain was assessed before and 30, 60 and 120 minutes after the first oxycodone administration ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3236,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Oxycodone,umbilical venous blood,pediatric,,fetus,58.0,concentration,,,1.2,ng/ml,median,,,minmax,0.21,7.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3237,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Noroxycodone,umbilical venous blood,pediatric,,fetus,61.0,concentration,,,2.2,ng/ml,median,,,minmax,0,11,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3238,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Oxymorphone,umbilical venous blood,pediatric,,fetus,61.0,concentration,,,0.14,ng/ml,median,,,minmax,0,0.26,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3239,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Noroxymorphone,umbilical venous blood,pediatric,,fetus,61.0,concentration,,,0,ng/ml,median,,,minmax,0,1.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3240,2025-12-02T16:03:31.981487
31950485.0,Oxycodone,Oxycodone,maternal blood and umbilical venous blood,maternal/pediatric,,fetus,58.0,F/M concentration ratio,,,1.3,,median,,,minmax,0.36,3.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3241,2025-12-02T16:03:31.981487
33180318.0,Coffeine,Coffeine,blood,pediatric,,preterm neonates,96.0,C0/dose,7,days,14.6,uM/(mg/kg),mean,SD,4.3,,,,,These data are for 96 infants who were monitored the C0 of caffeine on day 7 of therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2097,2025-12-02T16:03:31.981487
33116005.0,Coffeine,Coffeine,blood,pediatric,,preterm neonates,10.0,apparent clearance,0,day,2.26,ml/min/1.73m2,mean,SD,0.73,,,,,additive blood sampling was conducted periodically for 10 of the 23 patients after discontinuation of CAF treatment (day 0),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2098,2025-12-02T16:03:31.981487
33116005.0,Coffeine,Coffeine,blood,pediatric,,preterm neonates,10.0,t1/2,0,day,124.6,h,mean,SD,44.6,,,,,additive blood sampling was conducted periodically for 10 of the 23 patients after discontinuation of CAF treatment (day 0),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2099,2025-12-02T16:03:31.981487
31101409.0,Coffeine,Coffeine,blood,pediatric,,premature infants,24.0,concentration,,,26,mg/L,median,,,IQR,22,30,,Site 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2100,2025-12-02T16:03:31.981487
31101409.0,Coffeine,Coffeine,blood,pediatric,,premature infants,24.0,Maximum concentration,,,29,mg/L,median,,,IQR,26,33,,Site 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2101,2025-12-02T16:03:31.981487
31101409.0,Coffeine,Coffeine,blood,pediatric,,premature infants,3.0,concentration,,,24,mg/L,median,,,IQR,22,26,,Site 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2102,2025-12-02T16:03:31.981487
31101409.0,Coffeine,Coffeine,blood,pediatric,,premature infants,3.0,Maximum concentration,,,24,mg/L,median,,,IQR,22,26,,Site 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2103,2025-12-02T16:03:31.981487
31101409.0,Coffeine,Coffeine,blood,pediatric,,premature infants,101.0,concentration,,,16,mg/L,median,,,IQR,14,18,,Site 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2104,2025-12-02T16:03:31.981487
31101409.0,Coffeine,Coffeine,blood,pediatric,,premature infants,101.0,Maximum concentration,,,24,mg/L,median,,,IQR,21,27,,Site 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2105,2025-12-02T16:03:31.981487
31101409.0,Coffeine,Coffeine,blood,pediatric,,premature infants,46.0,concentration,,,24,mg/L,median,,,IQR,18,29,,Site 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2106,2025-12-02T16:03:31.981487
31101409.0,Coffeine,Coffeine,blood,pediatric,,premature infants,46.0,Maximum concentration,,,27,mg/L,median,,,IQR,18,35,,Site 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2107,2025-12-02T16:03:31.981487
31101409.0,Coffeine,Coffeine,blood,pediatric,,premature infants,174.0,concentration,,,18,mg/L,median,,,IQR,15,24,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2108,2025-12-02T16:03:31.981487
31101409.0,Coffeine,Coffeine,blood,pediatric,,premature infants,174.0,Maximum concentration,,,25,mg/L,median,,,IQR,21,29,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2109,2025-12-02T16:03:31.981487
35489632.0,Meropenem,Meropenem,blood,pediatric,,infants/childern,28.0,Cmid,4,h,19.9,mg/L,mean,,,95%CI,13.5,29.5,,EI patients without ARC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2110,2025-12-02T16:03:31.981487
35489632.0,Meropenem,Meropenem,blood,pediatric,,infants/childern,26.0,Cmid,4,h,14.8,mg/L,mean,,,95%CI,11.4,19.1,0.2,EI patients with ARC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2111,2025-12-02T16:03:31.981487
35489632.0,Meropenem,Meropenem,blood,pediatric,,infants/childern,28.0,Ctrough,8,h,3.5,mg/L,mean,,,95%CI,2,6.1,,EI patients without ARC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2112,2025-12-02T16:03:31.981487
35489632.0,Meropenem,Meropenem,blood,pediatric,,infants/childern,26.0,Ctrough,8,h,1.6,mg/L,mean,,,95%CI,1,2.6,0.04,EI patients with ARC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2113,2025-12-02T16:03:31.981487
35489632.0,Meropenem,Meropenem,blood,pediatric,,infants/childern,11.0,Cmid,4,h,4.9,mg/L,mean,,,95%CI,2.6,9.2,,IB patients without ARC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2114,2025-12-02T16:03:31.981487
35489632.0,Meropenem,Meropenem,blood,pediatric,,infants/childern,7.0,Cmid,4,h,1.9,mg/L,mean,,,95%CI,0.4,0.6,0.14,IB patients with ARC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2115,2025-12-02T16:03:31.981487
35489632.0,Meropenem,Meropenem,blood,pediatric,,infants/childern,11.0,Ctrough,8,h,0.8,mg/L,mean,,,95%CI,0.4,1.6,,IB patients without ARC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2116,2025-12-02T16:03:31.981487
35489632.0,Meropenem,Meropenem,blood,pediatric,,infants/childern,7.0,Ctrough,8,h,0.9,mg/L,mean,,,95%CI,0.2,4.2,0.85,IB patients with ARC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2117,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,Cmax,,,20.43,ug/ml,median,,,IQR,14.49,27.79,,pre-filter during CRRT ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2118,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,Cmax,,,14.15,ug/ml,median,,,IQR,8.92,18.8,0.002,post-filter during CRRT ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2119,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,t1/2,,,1.97,h,median,,,IQR,1.23,4.3,,"Group II, children receiving CRRT ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2120,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,t1/2,,,1.91,h,median,,,IQR,1.75,3.12,0.742,"Group II, children receiving CRRT ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2121,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,AUCtau,,,28.29,ug h/ml,median,,,IQR,23.91,63.83,,"Group II, children receiving CRRT ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2122,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,AUCtau,,,17.73,ug h/ml,median,,,IQR,11.23,49.64,0.0137,"Group II, children receiving CRRT ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2123,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,AUC0-,,,40.57,ug h/ml,median,,,IQR,24.19,129.6,,"Group II, children receiving CRRT ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2124,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,AUC0-,,,18.99,ug h/ml,median,,,IQR,11.83,95.08,0.0234,"Group II, children receiving CRRT ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2125,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,t1/2,1,h,2.27,h,median,,,IQR,1.76,3.55,,"Group I, children receiving ECMO ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2126,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,t1/2,1,h,2.22,h,median,,,IQR,1.77,3.76,,"Group II, children receiving CRRT ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2127,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,15.0,t1/2,1,h,2.25,h,median,,,IQR,1.46,3.06,0.45,"Group III, children receiving neither ECMO nor CRRT (non-ECLS group) ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2128,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,AUCtau,1,h,24.13,ug h/ml,median,,,IQR,7.78,86.2,,"Group I, children receiving ECMO ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2129,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,AUCtau,1,h,24.47,ug h/ml,median,,,IQR,16.2,109.1,,"Group II, children receiving CRRT ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2130,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,15.0,AUCtau,1,h,23.04,ug h/ml,median,,,IQR,15.69,34.62,0.28,"Group III, children receiving neither ECMO nor CRRT (non-ECLS group) ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2131,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,AUC0-,1,h,26.29,ug h/ml,median,,,IQR,8.38,64.85,,"Group I, children receiving ECMO ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2132,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,AUC0-,1,h,37.41,ug h/ml,median,,,IQR,15.71,124,,"Group II, children receiving CRRT ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2133,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,15.0,AUC0-,1,h,23.39,ug h/ml,median,,,IQR,19.32,56.21,0.25,"Group III, children receiving neither ECMO nor CRRT (non-ECLS group) ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2134,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,CL,1,h,11.59,L/h,median,,,IQR,5.92,20.19,,"Group I, children receiving ECMO ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2135,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,CL,1,h,15.73,L/h,median,,,IQR,2.11,39.29,,"Group II, children receiving CRRT ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2136,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,15.0,CL,1,h,13.51,L/h,median,,,IQR,3.71,20.8,0.71,"Group III, children receiving neither ECMO nor CRRT (non-ECLS group) ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2137,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,Vz,1,h,31.67,L,median,,,IQR,20.95,81.54,,"Group I, children receiving ECMO ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2138,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,6.0,Vz,1,h,19.42,L,median,,,IQR,8.76,108.8,,"Group II, children receiving CRRT ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2139,2025-12-02T16:03:31.981487
33476064.0,Meropenem,Meropenem,blood,pediatric,,children,15.0,Vz,1,h,34.41,L,median,,,IQR,9.57,113.5,0.94,"Group III, children receiving neither ECMO nor CRRT (non-ECLS group) ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2140,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,Cmax,20.34,h,50.88,ng/mL,geometric mean,,,95% CI,36.48,70.96,,"singleton, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2141,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,8.0,Cmax,6.04,h,50.49,ng/mL,geometric mean,,,95% CI,40.07,63.61,,"MC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2142,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,Cmax,2.02,h,40.9,ng/mL,geometric mean,,,95% CI,29.44,56.82,0.5299,"DC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2143,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,tmax,20.34,h,1.73,h,geometric mean,,,95% CI,1.03,2.9,,"singleton, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2144,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,8.0,tmax,6.04,h,1.31,h,geometric mean,,,95% CI,0.86,2.01,,"MC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2145,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,tmax,2.02,h,1.44,h,geometric mean,,,95% CI,0.83,2.52,0.5665,"DC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2146,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,t1/2,20.34,h,7.4,h,geometric mean,,,95% CI,3.88,14.1,,"singleton, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2147,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,8.0,t1/2,6.04,h,7.05,h,geometric mean,,,95% CI,5.12,9.6,,"MC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2148,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,t1/2,2.02,h,6.2,h,geometric mean,,,95% CI,4.61,8.35,0.4565,"DC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2149,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,AUC0-,20.34,h,645.1,ng h/mL,geometric mean,,,95% CI,504.3,825.2,,"singleton, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2150,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,8.0,AUC0-,6.04,h,471,ng h/mL,geometric mean,,,95% CI,355.4,624.1,,"MC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2151,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,AUC0-,2.02,h,409.8,ng h/mL,geometric mean,,,95% CI,311.2,539.6,0.0345,"DC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2152,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,CL/F,20.34,h,17.7,L/h,geometric mean,,,95% CI,13.84,22.65,,"singleton, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2153,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,8.0,CL/F,6.04,h,24.25,L/h,geometric mean,,,95% CI,18.3,32.13,,"MC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2154,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,CL/F,2.02,h,27.87,L/h,geometric mean,,,95% CI,21.17,36.69,0.0324,"DC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2155,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,Vd/F,20.34,h,189,L,geometric mean,,,95% CI,112.7,316.9,,"singleton, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2156,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,8.0,Vd/F,6.04,h,246.6,L,geometric mean,,,95% CI,172,353.6,,"MC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2157,2025-12-02T16:03:31.981487
34665470.0,Betamethasone,Betamethasone,blood,maternal,the third trimester of pregnancy,,9.0,Vd/F,2.02,h,249.4,L,geometric mean,,,95% CI,159.6,389.6,0.6746,"DC twin, time between a single dose of betamethasone acetate plus betamethasone phosphate and blood sampling",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2158,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,5.0,concentration,0-24,h,,ng/ml,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2159,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,4.0,concentration,24-48,h,63,ng/ml,mean,SD,59,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2160,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,4.0,concentration,48-72,h,53,ng/ml,mean,SD,41,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2161,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,4.0,concentration,72-96,h,33,ng/ml,mean,SD,23,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2162,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,2.0,concentration,96-120,h,27,ng/ml,mean,SD,16,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2163,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,3.0,concentration,120-144,h,53,ng/ml,mean,SD,22,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2164,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,2.0,concentration,144-168,h,27,ng/ml,mean,SD,18,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2165,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,1.0,concentration,168-172,h,18,ng/ml,mean,SD,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2166,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,5.0,concentration,0-24,h,,ng/ml,median,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2167,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,4.0,concentration,24-48,h,46,ng/ml,median,,,IQR,18,102,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2168,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,4.0,concentration,48-72,h,42,ng/ml,median,,,IQR,19,97,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2169,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,4.0,concentration,72-96,h,25,ng/ml,median,,,IQR,21,41,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2170,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,2.0,concentration,96-120,h,21,ng/ml,median,,,IQR,7,42,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2171,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,3.0,concentration,120-144,h,54,ng/ml,median,,,IQR,45,71,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2172,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,2.0,concentration,144-168,h,27,ng/ml,median,,,IQR,10,45,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2173,2025-12-02T16:03:31.981487
34310083.0,Azithromycin,Azithromycin,amniotic fluid,maternal,delivery,,1.0,concentration,168-172,h,18,ng/ml,median,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2174,2025-12-02T16:03:31.981487
32168220.0,Tranexamic acid,Tranexamic acid,blood,maternal,Postpartum,,12.0,Cmax,,,10.06,ug/ml,mean,,,minmax,8.56,12.22,,"Blood samples (1.8 mL) were collected in tubes containing 0.2 mL of 3% sodium citrate at 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 10, and 12 hours after administration of tranexamic acid",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2175,2025-12-02T16:03:31.981487
32168220.0,Tranexamic acid,Tranexamic acid,blood,maternal,Postpartum,,12.0,Tmax,,,2.92,h,mean,,,minmax,2.5,3.5,,"Blood samples (1.8 mL) were collected in tubes containing 0.2 mL of 3% sodium citrate at 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 10, and 12 hours after administration of tranexamic acid",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2176,2025-12-02T16:03:31.981487
32168220.0,Tranexamic acid,Tranexamic acid,blood,maternal,Postpartum,,12.0,AUC0-12,,,49.16,ug h/ml,mean,,,minmax,43.75,52.69,,"Blood samples (1.8 mL) were collected in tubes containing 0.2 mL of 3% sodium citrate at 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 10, and 12 hours after administration of tranexamic acid",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2177,2025-12-02T16:03:31.981487
32168220.0,Tranexamic acid,Tranexamic acid,blood,maternal,Postpartum,,12.0,T1/2,,,1.65,h,mean,,,,,,,"Blood samples (1.8 mL) were collected in tubes containing 0.2 mL of 3% sodium citrate at 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 10, and 12 hours after administration of tranexamic acid",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2178,2025-12-02T16:03:31.981487
32168220.0,Tranexamic acid,Tranexamic acid,blood,maternal,Postpartum,,12.0,Final Time course of concentration >= 5 ug/ml ,,,6.73,h,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2179,2025-12-02T16:03:31.981487
32168220.0,Tranexamic acid,Tranexamic acid,blood,maternal,Postpartum,,12.0,Time course of concentration >= 5 ug/ml ,,,0.87,h,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2180,2025-12-02T16:03:31.981487
32168220.0,Tranexamic acid,Tranexamic acid,blood,maternal,Postpartum,,12.0,The duration for which plasma tranexamic acid concentration remained greater than 5 micrograms/mL,,,5.86,h,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2181,2025-12-02T16:03:31.981487
33248975.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,10.0,concentration,Within 5 to 10 minutes after the infusion was completed ,,19.9,ug/ml,mean,SD,10.2,,,,,Cohort 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2182,2025-12-02T16:03:31.981487
33248975.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,10.0,concentration,Within 5 to 10 minutes after the infusion was completed ,,30.2,ug/ml,mean,SD,6.13,,,,,Cohort 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2183,2025-12-02T16:03:31.981487
33248975.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,10.0,concentration,Within 5 to 10 minutes after the infusion was completed ,,36.9,ug/ml,mean,SD,6.7,,,,,Cohort 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2184,2025-12-02T16:03:31.981487
33248975.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,30.0,time to achieve PK threshold,,,3,min,mean,,,minmax,1.8,6.6,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2185,2025-12-02T16:03:31.981487
32620262.0,Tranexamic acid,Tranexamic acid,blood,pediatric,,children,34.0,initial peak concintration,,,67.5,ug/ml,mean,SEM,14,,,,,Low-dose scheme,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2186,2025-12-02T16:03:31.981487
32620262.0,Tranexamic acid,Tranexamic acid,blood,pediatric,,children,32.0,initial peak concintration,,,199.4,ug/ml,mean,SEM,10.6,,,,,High-dose scheme,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2187,2025-12-02T16:03:31.981487
32620262.0,Tranexamic acid,Tranexamic acid,blood,pediatric,,children,34.0,concentration during the maintenance phase of the surgery at 2.5 h,2.5,h,29.6,ug/ml,mean,SEM,7.6,,,,,Low-dose scheme; during the surgery at 2.5 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2188,2025-12-02T16:03:31.981487
32620262.0,Tranexamic acid,Tranexamic acid,blood,pediatric,,children,32.0,concentration during the maintenance phase of the surgery at 2.5 h,2.5,h,50.2,ug/ml,mean,SEM,8,,,,,High-dose scheme; during the surgery at 2.5 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2189,2025-12-02T16:03:31.981487
32620262.0,Tranexamic acid,Tranexamic acid,blood,pediatric,,children,34.0,concentration at the end of surgry,3.5,h,27.8,ug/ml,mean,SEM,5,,,,,"Low-dose scheme; at the end of surgery, surgery duration: 3.5[1.8] h",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2190,2025-12-02T16:03:31.981487
32620262.0,Tranexamic acid,Tranexamic acid,blood,pediatric,,children,32.0,concentration at the end of surgry,3.6,h,40,ug/ml,mean,SEM,6,,,,,"High-dose scheme; at the end of surgery, surgery duration: 3.6[0.2] h",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2191,2025-12-02T16:03:31.981487
32620262.0,Tranexamic acid,Tranexamic acid,blood,pediatric,,children,6.0,concentration,4.5,h,16.1,ug/ml,mean,SEM,10.6,,,,,Low-dose scheme in patients whose surgeries lasted more than 4 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2192,2025-12-02T16:03:31.981487
32620262.0,Tranexamic acid,Tranexamic acid,blood,pediatric,,children,3.0,concentration,4.5,h,17.8,ug/ml,mean,SEM,5.9,,,,,High-dose scheme in patients whose surgeries lasted more than 4 h,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2193,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,10.0, concentration,3,min,59.8,ug/ml,mean,SEM,4.7,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2194,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,20.0, concentration,7,min,45.5,ug/ml,mean,SEM,2.5,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2195,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,20.0, concentration,15,min,36,ug/ml,mean,SEM,2.2,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2196,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,18.0, concentration,30,min,26.2,ug/ml,mean,SEM,1.7,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2197,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,18.0, concentration,1,h,20.2,ug/ml,mean,SEM,1.7,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2198,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,18.0, concentration,1.5,h,17,ug/ml,mean,SEM,1.6,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2199,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,19.0, concentration,2,h,13.9,ug/ml,mean,SEM,1.1,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2200,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,19.0, concentration,2.5,h,11.4,ug/ml,mean,SEM,1.1,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2201,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,13.0, concentration,3,h,10.9,ug/ml,mean,SEM,1.2,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2202,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,13.0, concentration,3.5,h,8.7,ug/ml,mean,SEM,0.9,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2203,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,9.0, concentration,4,h,8.5,ug/ml,mean,SEM,0.5,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2204,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,6.0, concentration,4.5,h,8.4,ug/ml,mean,SEM,0.8,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2205,2025-12-02T16:03:31.981487
35679896.0,Tranexamic acid,Tranexamic acid,blood,maternal,delivery,,6.0, concentration,5,h,6.8,ug/ml,mean,SEM,0.9,,,,,"Defining t0 after the 10-minute TXA infusion, blood samples were collected at 3, 7, 15, and 30 minutes and then every 30 minutes up to 5 hours. ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2206,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,39.0,half-life,,,4.2,h,mean,SD,1.1,,,,0.4,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2209,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,9.0,half-life,,,4,h,mean,SD,0.8,,,,0.4,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2210,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,15.0,half-life,,,4.3,h,mean,SD,0.7,,,,0.2,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2211,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,14.0,half-life,,,3.7,h,mean,SD,0.6,,,,0.2,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2212,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,39.0,F,,,0.64,,mean,SD,0.2,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2213,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,9.0,F,,,0.49,,mean,SD,0.08,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2214,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,15.0,F,,,0.53,,mean,SD,0.11,,,,<0.01,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2215,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,14.0,F,,,0.37,,mean,SD,0.14,,,,<0.01,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2216,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,39.0,Tmax,,,2.6,h,mean,SD,1.3,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2217,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,9.0,Tmax,,,2.1,h,mean,SD,0.5,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2218,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,15.0,Tmax,,,2.4,h,mean,SD,1.1,,,,0.7,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2219,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,14.0,Tmax,,,2.2,h,mean,SD,1.3,,,,0.7,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2220,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,39.0,Vb/F,,,368,l,mean,SD,133,,,,<0.05,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2221,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,9.0,Vb/F,,,276,l,mean,SD,52,,,,<0.05,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2222,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,15.0,Vb/F,,,450,l,mean,SD,136,,,,0.6,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2223,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,14.0,Vb/F,,,486,l,mean,SD,207,,,,0.6,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2224,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,39.0,Vb/F,,,4,l/kg,mean,SD,1.68,,,,0.08,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2225,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,9.0,Vb/F,,,1.5,l/kg,mean,SD,0.3,,,,0.08,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2226,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,15.0,Vb/F,,,4.99,l/kg,mean,SD,1.64,,,,0.9,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2227,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,14.0,Vb/F,,,5,l/kg,mean,SD,2.07,,,,0.9,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2228,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,39.0,Vb,,,242,l,mean,SD,138,,,,<0.001,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2229,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,9.0,Vb,,,134,l,mean,SD,23,,,,<0.001,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2230,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,15.0,Vb,,,234,l,mean,SD,66,,,,<0.005,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2231,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,14.0,Vb,,,163,l,mean,SD,48,,,,<0.005,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2232,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,39.0,Vb,,,2.6,l/kg,mean,SD,1.6,,,,<0.005,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2233,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,9.0,Vb,,,1.5,l/kg,mean,SD,0.3,,,,<0.005,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2234,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,15.0,Vb,,,2.6,l/kg,mean,SD,0.9,,,,<0.005,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2235,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,14.0,Vb,,,1.7,l/kg,mean,SD,0.6,,,,<0.005,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2236,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,39.0,CL/F,,,1085,ml/min,mean,SD,328,,,,<0.05,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2237,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,9.0,CL/F,,,854,ml/min,mean,SD,230,,,,<0.05,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2238,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,15.0,CL/F,,,1405,ml/min,mean,SD,384,,,,0.4,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2239,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,14.0,CL/F,,,1678,ml/min,mean,SD,574,,,,0.4,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2240,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,39.0,CL/F,,,11.7,ml/min per kg,mean,SD,3.8,,,,0.05,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2241,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,9.0,CL/F,,,9.5,ml/min per kg,mean,SD,2.4,,,,0.05,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2242,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,15.0,CL/F,,,15.6,ml/min per kg,mean,SD,4.5,,,,0.3,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2243,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,14.0,CL/F,,,17.5,ml/min per kg,mean,SD,6.5,,,,0.3,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2244,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,39.0,CL,,,731,ml/min,mean,SD,339,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2245,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,9.0,CL,,,444,ml/min,mean,SD,121,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2246,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,15.0,CL,,,758,ml/min,mean,SD,179,,,,<0.05,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2247,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,14.0,CL,,,572,ml/min,mean,SD,153,,,,<0.05,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2248,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,39.0,CL,,,7.9,ml/min per kg,mean,SD,3.9,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2249,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,9.0,CL,,,4.9,ml/min per kg,mean,SD,1.3,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2250,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,pregnancy,,15.0,CL,,,8.5,ml/min per kg,mean,SD,2.5,,,,<0.01,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2251,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,nonpregnant,,,14.0,CL,,,6.1,ml/min per kg,mean,SD,2.4,,,,<0.01,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2252,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,39.0,Percent of dose recovered in the urine unchanged,,,64,%,mean,SD,20,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2253,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,9.0,Percent of dose recovered in the urine unchanged,,,48,%,mean,SD,8,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2254,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,15.0,Percent of dose recovered in the urine unchanged,,,53,%,mean,SD,11,,,,<0.01,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2255,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,14.0,Percent of dose recovered in the urine unchanged,,,37,%,mean,SD,14,,,,<0.01,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2256,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,39.0,CLR,,,731,ml/min,mean,SD,339,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2257,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,9.0,CLR,,,444,ml/min,mean,SD,121,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2258,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,15.0,CLR,,,758,ml/min,mean,SD,179,,,,<0.05,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2259,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,14.0,CLR,,,572,ml/min,mean,SD,153,,,,<0.05,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2260,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,39.0,CLR,,,7.9,ml/min per kg,mean,SD,3.9,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2261,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,9.0,CLR,,,4.9,ml/min per kg,mean,SD,1.3,,,,<0.01,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2262,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,15.0,CLR,,,8.5,ml/min per kg,mean,SD,2.5,,,,<0.05,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2263,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,14.0,CLR,,,6.1,ml/min per kg,mean,SD,2.4,,,,<0.05,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2264,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,39.0,CrCL,,,233,ml/min,mean,SD,68,,,,<0.001,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2265,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,9.0,CrCL,,,148,ml/min,mean,SD,41,,,,<0.001,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2266,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,15.0,CrCL,,,233,ml/min,mean,SD,46,,,,<0.001,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2267,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,14.0,CrCL,,,166,ml/min,mean,SD,25,,,,<0.001,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2268,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,39.0,CLsec,,,497,ml/min,mean,SD,312,,,,0.06,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2269,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,9.0,CLsec,,,296,ml/min,mean,SD,97,,,,0.06,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2270,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,15.0,CLsec,,,530,ml/min,mean,SD,168,,,,0.1,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2271,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,14.0,CLsec,,,406,ml/min,mean,SD,143,,,,0.1,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2272,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,39.0,CLsec,,,5.4,ml/min per kg,mean,SD,3.6,,,,<0.05,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2273,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,9.0,CLsec,,,3.3,ml/min per kg,mean,SD,1.1,,,,<0.05,500 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2274,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,maternal,pregnancy,,15.0,CLsec,,,5.9,ml/min per kg,mean,SD,2.3,,,,0.2,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2275,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,urine,nonpregnant,,,14.0,CLsec,,,4.3,ml/min per kg,mean,SD,2,,,,0.2,1000 mg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2276,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,umbilical cord arterial blood,pediatric,,fetus,11.0,concentration,,,290,ng/ml,mean,SD,233,minmax,13,910,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2277,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,umbilical cord venous blood,pediatric,,fetus,14.0,concentration,,,331,ng/ml,mean,SD,257,minmax,11,1070,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2278,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,umbilical cord venous  blood and arterial blood,pediatric,,fetus,13.0,umbilical cord arterial-to-venous plasma concentration ratio ,,,1,,mean,SD,0.1,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2279,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,blood,maternal,delivery,,38.0,concentration,,,262,ng/ml,mean,SD,231,minmax,6,1020,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2280,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,umbilical cord arterial blood/maternal blood,maternal/pediatric,delivery,fetus,11.0,umbilical cord arterial-to-maternal plasma concentration ratio ,,,1.5,,mean,SD,0.5,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2281,2025-12-02T16:03:31.981487
31980499.0,Metformin,Metformin,umbilical cord venousl blood and maternal blood,maternal/pediatric,delivery,fetus,14.0,umbilical cord venous-to-maternal plasma concentration ratio ,,,1.4,,mean,SD,0.5,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2282,2025-12-02T16:03:31.981487
34964262.0,Metformin,Metformin,blood,maternal,pregnancy,Gestational week 19,13.0,concentration,,,9.87,umol/L,mean,SD,2.52,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2283,2025-12-02T16:03:31.981487
34964262.0,Metformin,Metformin,blood,maternal,pregnancy,Gestational week 28,17.0,concentration,,,8.24,umol/L,mean,SD,2.81,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2284,2025-12-02T16:03:31.981487
34964262.0,Metformin,Metformin,blood,maternal,pregnancy,Gestational week 32,23.0,concentration,,,9.96,umol/L,mean,SD,2.99,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2285,2025-12-02T16:03:31.981487
34964262.0,Metformin,Metformin,blood,maternal,Postpartum,week 2 post partum,12.0,concentration,,,11.95,umol/L,mean,SD,2.64,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2286,2025-12-02T16:03:31.981487
34964262.0,Metformin,Metformin,blood,maternal,Postpartum,week 4 post partum,10.0,concentration,,,12.24,umol/L,mean,SD,4.5,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2287,2025-12-02T16:03:31.981487
34964262.0,Metformin,Metformin,blood,maternal,Postpartum,week 8 post partum,15.0,concentration,,,12.76,umol/L,mean,SD,3.83,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2288,2025-12-02T16:03:31.981487
34602916.0,Metformin,Metformin,blood,pediatric,,children,17.0,Cmax,,,1521.4,ng/ml,mean,SD,525.4,,,,,tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2289,2025-12-02T16:03:31.981487
34602916.0,Metformin,Metformin,blood,pediatric,,children,17.0,Cmax,,,1503.2,ng/ml,mean,SD,824.4,,,,,liquid solution,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2290,2025-12-02T16:03:31.981487
34602916.0,Metformin,Metformin,blood,pediatric,,children,17.0,Tmax,,,1.5,h,mean,SD,0.8,,,,,tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2291,2025-12-02T16:03:31.981487
34602916.0,Metformin,Metformin,blood,pediatric,,children,17.0,Tmax,,,2.3,h,mean,SD,1.8,,,,,liquid solution,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2292,2025-12-02T16:03:31.981487
34602916.0,Metformin,Metformin,blood,pediatric,,children,17.0,half-life,,,8.2,h,mean,SD,2.8,,,,,tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2293,2025-12-02T16:03:31.981487
34602916.0,Metformin,Metformin,blood,pediatric,,children,17.0,half-life,,,7.5,h,mean,SD,4.4,,,,,liquid solution,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2294,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,AUC0-,,,80.4,mg h/L,mean,SD,20,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2295,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,AUC0-,,,80,mg h/L,median,,,IQR,67,91,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2296,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,half-life,,,2.6,h,mean,SD,1.2,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2297,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,half-life,,,2.2,h,median,,,IQR,1.9,3.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2298,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,CL/F,,,3.6,L/h,mean,SD,2.5,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2299,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,CL/F,,,2.6,L/h,median,,,IQR,2.1,3.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2300,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,CL/F (per 70kg),,,11.9,L/h,mean,SD,3.4,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2301,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,CL/F (per 70kg),,,11.4,L/h,median,,,IQR,9.7,14,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2302,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,V/F,,,14.1,L,mean,SD,14.3,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2303,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,V/F,,,8,L,median,,,IQR,6.1,14.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2304,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,V/F (per kg),,,1,L,mean,SD,0.4,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2305,2025-12-02T16:03:31.981487
31106898.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,infants,50.0,V/F (per kg),,,0.9,L,median,,,IQR,0.6,1.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2306,2025-12-02T16:03:31.981487
31623213.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,children,9.0,Cmax,,,24.1,mg/L,mean,SD,9.1,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2307,2025-12-02T16:03:31.981487
31623213.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,children,9.0,Tmax,,,1.5,h,mean,SD,0.6,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2308,2025-12-02T16:03:31.981487
31623213.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,children,9.0,AUC,,,81.3,h mg/L,mean,SD,25.2,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2309,2025-12-02T16:03:31.981487
31623213.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,children,9.0,Cmax,,,24,mg/L,median,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2310,2025-12-02T16:03:31.981487
31623213.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,children,9.0,Tmax,,,1.33,h,median,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2311,2025-12-02T16:03:31.981487
31623213.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,children,9.0,AUC,,,75.1,h mg/L,median,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2312,2025-12-02T16:03:31.981487
33029796.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,adolescents,11.0,mean CL/F,,,27.1,L/h/70kg,median,,,IQR,14.9,37.2,0.02,PK1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2313,2025-12-02T16:03:31.981487
33029796.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,adolescents,9.0,mean CL/F,,,14.1,L/h/70kg,median,,,IQR,12.4,15.5,0.02,PK2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2314,2025-12-02T16:03:31.981487
33029796.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,adolescents,11.0,V/F,,,106,L/70kg,median,,,IQR,68.3,114.8,0.15,PK1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2315,2025-12-02T16:03:31.981487
33029796.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,adolescents,9.0,V/F,,,162.1,L/70kg,median,,,IQR,89.3,243.3,0.15,PK2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2316,2025-12-02T16:03:31.981487
33029796.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,adolescents,11.0,AUCinf,,,60.9,ug h/ml,median,,,IQR,22.6,88.4,0.77,PK1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2317,2025-12-02T16:03:31.981487
33029796.0,Hydroxyurea,Hydroxyurea,blood,pediatric,,adolescents,9.0,AUCinf,,,68.6,ug h/ml,median,,,IQR,43.5,93.8,0.77,PK2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2318,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,28.0,t1/2,,,0.87,h,mean,SD,0.3,,,,0.7,Normal BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2319,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,16.0,t1/2,,,1.04,h,mean,SD,0.37,,,,0.7,Overweight BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2320,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,13.0,t1/2,,,0.95,h,mean,SD,0.32,,,,0.7,Obese BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2321,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,28.0,Tmax,,,0.73,h,mean,SD,0.29,,,,0.07,Normal BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2322,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,16.0,Tmax,,,0.75,h,mean,SD,0.26,,,,0.07,Overweight BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2323,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,13.0,Tmax,,,0.54,h,mean,SD,0.14,,,,0.07,Obese BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2324,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,28.0,Cmax,,,1.81,mcg/ml,mean,SD,0.72,,,,0.005,Normal BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2325,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,16.0,Cmax,,,1.94,mcg/ml,mean,SD,0.71,,,,0.005,Overweight BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2326,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,13.0,Cmax,,,2.68,mcg/ml,mean,SD,0.98,,,,0.005,Obese BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2327,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,28.0,AUC0-,,,3.03,mcg h/ml,mean,SD,1.92,,,,0.2,Normal BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2328,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,16.0,AUC0-,,,3.25,mcg h/ml,mean,SD,1.63,,,,0.2,Overweight BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2329,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,13.0,AUC0-,,,4.33,mcg h/ml,mean,SD,2.61,,,,0.2,Obese BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2330,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,28.0,CL/F,,,20.4,L/h,mean,SD,14.2,,,,0.6,Normal BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2331,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,16.0,CL/F,,,18.7,L/h,mean,SD,7.43,,,,0.6,Overweight BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2332,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,13.0,CL/F,,,16.8,L/h,mean,SD,8.55,,,,0.6,Obese BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2333,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,28.0,Vd/F,,,30.1,L,mean,SD,21.5,,,,0.4,Normal BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2334,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,16.0,Vd/F,,,30.2,L,mean,SD,12.3,,,,0.4,Overweight BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2335,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,13.0,Vd/F,,,22.8,L,mean,SD,10.1,,,,0.4,Obese BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2336,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,28.0,adjusted Cmax,,,2.03,mcg/ml per mg/kg TBW,mean,SD,0.92,,,,0.0001,Normal BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2337,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,16.0,adjusted Cmax,,,2.46,mcg/ml per mg/kg TBW,mean,SD,0.93,,,,0.0001,Overweight BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2338,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,13.0,adjusted Cmax,,,3.52,mcg/ml per mg/kg TBW,mean,SD,1.13,,,,0.0001,Obese BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2339,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,28.0,adjusted AUC0-,,,3.45,mcg h/ml per mg/kg TBW,mean,SD,2.48,,,,0.04,Normal BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2340,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,16.0,adjusted AUC0-,,,4.23,mcg h/ml per mg/kg TBW,mean,SD,2.61,,,,0.04,Overweight BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2341,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,13.0,adjusted AUC0-,,,5.82,mcg h/ml per mg/kg TBW,mean,SD,3.86,,,,0.04,Obese BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2342,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,28.0,adjusted CL/F,,,0.42,L/h/kg TBW,mean,SD,0.27,,,,0.03,Normal BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2343,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,16.0,adjusted CL/F,,,0.29,L/h/kg TBW,mean,SD,0.12,,,,0.03,Overweight BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2344,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,13.0,adjusted CL/F,,,0.23,L/h/kg TBW,mean,SD,0.13,,,,0.03,Obese BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2345,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,28.0,adjusted Vd/F,,,0.59,L/kg TBW,mean,SD,0.36,,,,0.008,Normal BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2346,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,16.0,adjusted Vd/F,,,0.46,L/kg TBW,mean,SD,0.2,,,,0.008,Overweight BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2347,2025-12-02T16:03:31.981487
30257076.0,Pantoprazole,Pantoprazole,blood,pediatric,,children,13.0,adjusted Vd/F,,,0.3,L/kg TBW,mean,SD,0.1,,,,0.008,Obese BMI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2348,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,AUC0-last,,,1139.5,h pg/L,mean,SD,800.8,,,,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2349,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,AUC0-last,,,1026,h pg/L,median,,,minmax,286,2220,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2350,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,AUC0-last,,,743.8,h pg/L,mean,SD,425.3,,,,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2351,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,AUC0-last,,,551,h pg/L,median,,,minmax,328,1390,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2352,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,AUC0-last,,,3259.3,h pg/L,mean,SD,2109.4,,,,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2353,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,AUC0-last,,,2580,h pg/L,median,,,minmax,320,8270,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2354,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,AUC0-last,,,3636.9,h pg/L,mean,SD,1769.9,,,,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2355,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,AUC0-last,,,2700,h pg/L,median,,,minmax,1730,7240,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2356,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,AUC0-last,,,903.9,h pg/L,geometric LS mean,,,95% CI,401.8,2033.4,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2357,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,AUC0-last,,,654.5,h pg/L,geometric LS mean,,,95% CI,410.9,1042.6,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2358,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,AUC0-last,,,2636.4,h pg/L,geometric LS mean,,,95% CI,1734.6,4007.1,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2359,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,AUC0-last,,,3282.7,h pg/L,geometric LS mean,,,95% CI,2459.5,4381.5,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2360,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,Cmax,,,355.2,pg/ml,geometric LS mean,,,95% CI,143.9,877,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2361,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,Cmax,,,187.2,pg/ml,geometric LS mean,,,95% CI,118.4,296.1,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2362,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,Cmax,,,805.2,pg/ml,geometric LS mean,,,95% CI,504.9,1284,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2363,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,Cmax,,,841.1,pg/ml,geometric LS mean,,,95% CI,633,1117.7,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2364,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,AUC0-tau,,,1710,h pg/L,mean,SD,846,,,,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2365,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,AUC0-tau,,,1780,h pg/L,median,,,minmax,613,2670,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2366,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,AUC0-tau,,,1270,h pg/L,mean,SD,713,,,,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2367,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,AUC0-tau,,,1050,h pg/L,median,,,minmax,726,2230,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2368,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,AUC0-tau,,,4260,h pg/L,mean,SD,2380,,,,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2369,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,AUC0-tau,,,3150,h pg/L,median,,,minmax,1750,10100,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2370,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,AUC0-tau,,,4840,h pg/L,mean,SD,2580,,,,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2371,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,AUC0-tau,,,3640,h pg/L,median,,,minmax,2460,10100,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2372,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,Cmax,,,492,pg/mL,mean,SD,417.8,,,,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2373,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,Cmax,,,402,pg/mL,median,,,minmax,104,1060,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2374,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,Cmax,,,195,pg/mL,mean,SD,64.4,,,,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2375,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,Cmax,,,191,pg/mL,median,,,minmax,139,296,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2376,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,Cmax,,,1019.5,pg/mL,mean,SD,670.2,,,,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2377,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,Cmax,,,812,pg/mL,median,,,minmax,70,1550,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2378,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,Cmax,,,958.4,pg/mL,mean,SD,527.6,,,,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2379,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,Cmax,,,708,pg/mL,median,,,minmax,359,2210,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2380,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,Tmax,,,0.7,h,mean,SD,0.4,,,,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2381,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,Tmax,,,0.5,h,median,,,minmax,0.5,1.2,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2382,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,Tmax,,,1.2,h,mean,SD,0.4,,,,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2383,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,Tmax,,,1,h,median,,,minmax,1,2,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2384,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,Tmax,,,0.9,h,mean,SD,0.4,,,,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2385,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,Tmax,,,1,h,median,,,minmax,0.5,2,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2386,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,Tmax,,,1.1,h,mean,SD,0.5,,,,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2387,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,Tmax,,,1,h,median,,,minmax,0.5,2,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2388,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,T1/2,,,3.3,h,mean,SD,0.8,,,,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2389,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,T1/2,,,3.2,h,median,,,minmax,2.4,4.4,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2390,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,T1/2,,,3.4,h,mean,SD,0.8,,,,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2391,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,T1/2,,,3.5,h,median,,,minmax,2.3,4.2,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2392,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,T1/2,,,3.5,h,mean,SD,2.7,,,,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2393,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,T1/2,,,2.7,h,median,,,minmax,1.9,12.7,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2394,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,T1/2,,,3.5,h,mean,SD,1,,,,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2395,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,T1/2,,,3.6,h,median,,,minmax,2.1,5.1,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2396,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,CL/F,,,274,L/h,mean,SD,200,,,,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2397,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,CL/F,,,198,L/h,median,,,minmax,131,571,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2398,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,CL/F,,,491,L/h,mean,SD,235,,,,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2399,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,CL/F,,,525,L/h,median,,,minmax,224,689,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2400,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,CL/F,,,417,L/h,mean,SD,192,,,,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2401,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,CL/F,,,446,L/h,median,,,minmax,139,800,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2402,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,CL/F,,,516,L/h,mean,SD,219,,,,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2403,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,CL/F,,,550,L/h,median,,,minmax,199,814,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2404,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,Vz/F,,,1300,L,mean,SD,888,,,,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2405,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,4.0,Vz/F,,,1110,L,median,,,minmax,447,2520,,"Low-dose BOS, 2-9 years old, 0.35 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2406,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,Vz/F,,,2240,L,mean,SD,856,,,,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2407,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,5.0,Vz/F,,,2110,L,median,,,minmax,1360,3380,,"Low-dose BOS, 10-18 years old, 0.5 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2408,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,Vz/F,,,1860,L,mean,SD,1220,,,,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2409,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,15.0,Vz/F,,,1760,L,median,,,minmax,496,5490,,"High-dose BOS, 2-9 years, 1.4 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2410,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,Vz/F,,,2570,L,mean,SD,1200,,,,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2411,2025-12-02T16:03:31.981487
35666852.0,budesonide ,budesonide ,blood,pediatric,,Children and Adolescents,13.0,Vz/F,,,2660,L,median,,,minmax,1030,4460,,"High-dose BOS, 10-18 years, 2 mg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2412,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,Ke,,,0.224,1/h,mean,%CV,0.4,,,,0.71,0.025 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2413,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,Ke,,,0.242,1/h,mean,%CV,0.26,,,,0.71,0.05 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2414,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,Ke,,,0.268,1/h,mean,%CV,0.43,,,,0.71,0.1 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2415,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,half-life,,,3.78,h,mean,%CV,0.57,,,,0.77,0.025 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2416,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,half-life,,,3.2,h,mean,%CV,0.37,,,,0.77,0.05 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2417,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,half-life,,,3.2,h,mean,%CV,0.56,,,,0.77,0.1 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2418,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,Cmax,,,7.7,ng/ml,mean,%CV,0.57,,,,0.95,0.025 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2419,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,Cmax,,,8.6,ng/ml,mean,%CV,0.71,,,,0.95,0.05 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2420,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,Cmax,,,18.7,ng/ml,mean,%CV,0.35,,,,0.95,0.1 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2421,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,Cmax/Dose,,,0.308,(ng/ml)/(mg/kg),mean,%CV,0.57,,,,0.11,0.025 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2422,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,Cmax/Dose,,,0.172,(ng/ml)/(mg/kg),mean,%CV,0.71,,,,0.11,0.05 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2423,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,Cmax/Dose,,,0.187,(ng/ml)/(mg/kg),mean,%CV,0.35,,,,0.11,0.1 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2424,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,AUC24,,,39.4,ng h/ml,mean,%CV,0.39,,,,0.99,0.025 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2425,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,AUC24,,,37.2,ng h/ml,mean,%CV,0.57,,,,0.99,0.05 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2426,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,AUC24,,,73.5,ng h/ml,mean,%CV,0.44,,,,0.99,0.1 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2427,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,AUC24/Dose,,,1.58,(ng h/ml)/(mg/kg),mean,%CV,0.39,,,,0.007,0.025 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2428,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,AUC24/Dose,,,0.744,(ng h/ml)/(mg/kg),mean,%CV,0.57,,,,0.007,0.05 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2429,2025-12-02T16:03:31.981487
32006953.0,budesonide ,budesonide ,Dried blood spot,pediatric,,infants,8.0,AUC24/Dose,,,0.735,(ng h/ml)/(mg/kg),mean,%CV,0.44,,,,0.007,0.1 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2430,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,Cmax,,,5.8,ng/mL,median,,,minmax,2.32,8.53,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2431,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,C24,,,BQL,ng/mL,median,,,minmax,BQL,0.38,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2432,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,Trough 2 weeks,,,BQL,ng/mL,median,,,minmax,BQL,0.91,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2433,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,Trough 6 weeks,,,BQL,ng/mL,median,,,minmax,BQL,0.26,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2434,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,Tmax,,,1.5,h,median,,,minmax,1,2,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2435,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,half-life,,,5.5,h,median,,,minmax,4.4,7.9,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2436,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,AUC0-,,,41.9,ng h/mL,median,,,minmax,31.5,42.9,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2437,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,CL/F,,,29.8,L/hr/kg,median,,,minmax,16.6,39.8,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2438,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,Vd/F,,,222,L/kg,median,,,minmax,190,287,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2439,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,Cmax,,,1.87,ng/mL,median,,,minmax,0/92,3.42,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2440,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,C24,,,BQL,ng/mL,median,,,minmax,BQL,0.67,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2441,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,Trough 2 weeks,,,BQL,ng/mL,median,,,minmax,BQL,1.97,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2442,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,Trough 6 weeks,,,BQL,ng/mL,median,,,minmax,BQL,0.87,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2443,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,Tmax,,,6,h,median,,,minmax,2,6,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2444,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,half-life,,,6.2,h,median,,,minmax,4.1,9.1,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2445,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,AUC0-,,,40.2,ng h/mL,median,,,minmax,18.1,42.7,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2446,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,CL/F,,,,L/hr/kg,median,,,minmax,,,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2447,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,Vd/F,,,,L/kg,median,,,minmax,,,,dose level 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2448,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,5.0,Cmax,,,9.49,ng/mL,median,,,minmax,4.02,22.5,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2449,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,5.0,C24,,,BQL,ng/mL,median,,,minmax,BQL,1.54,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2450,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,5.0,Trough 2 weeks,,,BQL,ng/mL,median,,,minmax,BQL,1.11,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2451,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,5.0,Trough 6 weeks,,,BQL,ng/mL,median,,,minmax,BQL,2.19,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2452,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,5.0,Tmax,,,1,h,median,,,minmax,1,6,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2453,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,5.0,half-life,,,6,h,median,,,minmax,5.6,6.2,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2454,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,5.0,AUC0-,,,122.8,ng h/mL,median,,,minmax,38.4,171.7,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2455,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,5.0,CL/F,,,20.2,L/hr/kg,median,,,minmax,14.6,60,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2456,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,5.0,Vd/F,,,163,L/kg,median,,,minmax,130,519,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2457,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,5.0,Cmax,,,4.91,ng/mL,median,,,minmax,3.86,5.35,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2458,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,5.0,C24,,,BQL,ng/mL,median,,,minmax,BQL,1.07,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2459,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,5.0,Trough 2 weeks,,,BQL,ng/mL,median,,,minmax,BQL,1.55,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2460,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,5.0,Trough 6 weeks,,,BQL,ng/mL,median,,,minmax,BQL,2.59,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2461,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,5.0,Tmax,,,2,h,median,,,minmax,1,6,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2462,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,5.0,half-life,,,5.6,h,median,,,minmax,2.7,8.5,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2463,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,5.0,AUC0-,,,64.6,ng h/mL,median,,,minmax,45.6,81,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2464,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,5.0,CL/F,,,,L/hr/kg,median,,,minmax,,,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2465,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,5.0,Vd/F,,,,L/kg,median,,,minmax,,,,dose level 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2466,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,2.0,Cmax,,,"21.7, 82.6",ng/mL,median,,,minmax,,,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2467,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,2.0,C24,,,"BQL, 1.33",ng/mL,median,,,minmax,,,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2468,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,3.0,Trough 2 weeks,,,4.3,ng/mL,median,,,minmax,BQL,12.8,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2469,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,2.0,Trough 6 weeks,,,"BQL, 6",ng/mL,median,,,minmax,,,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2470,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,2.0,Tmax,,,"1, 2",h,median,,,minmax,,,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2471,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,3.0,half-life,,,5.3,h,median,,,minmax,4.2,6.3,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2472,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,3.0,AUC0-,,,330.9,ng h/mL,median,,,minmax,188.1,473.6,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2473,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,3.0,CL/F,,,18.7,L/hr/kg,median,,,minmax,10.6,26.8,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2474,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,3.0,Vd/F,,,153,L/kg,median,,,minmax,65,242,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2475,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,2.0,Cmax,,,"11.1, 18.1",ng/mL,median,,,minmax,,,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2476,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,2.0,C24,,,"BQL, 2.13",ng/mL,median,,,minmax,,,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2477,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,3.0,Trough 2 weeks,,,7.01,ng/mL,median,,,minmax,BQL,17.7,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2478,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,2.0,Trough 6 weeks,,,"BQL, 12.4",ng/mL,median,,,minmax,,,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2479,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,2.0,Tmax,,,"1, 2",h,median,,,minmax,,,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2480,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,3.0,half-life,,,6.8,h,median,,,minmax,6.3,7.3,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2481,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,3.0,AUC0-,,,178.6,ng h/mL,median,,,minmax,145.5,211.8,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2482,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,3.0,CL/F,,,,L/hr/kg,median,,,minmax,,,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2483,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,3.0,Vd/F,,,,L/kg,median,,,minmax,,,,dose level 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2484,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,Cmax,,,41.4,ng/mL,median,,,minmax,29.3,469,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2485,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,C24,,,BQL,ng/mL,median,,,minmax,BQL,2.89,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2486,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,Trough 2 weeks,,,BQL,ng/mL,median,,,minmax,BQL,10.7,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2487,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,Trough 6 weeks,,,BQL,ng/mL,median,,,minmax,BQL,5.56,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2488,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,Tmax,,,1,h,median,,,minmax,1,2,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2489,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,half-life,,,4.3,h,median,,,minmax,3.1,5.1,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2490,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,AUC0-,,,356.5,ng h/mL,median,,,minmax,210.6,2890.9,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2491,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,CL/F,,,21.7,L/hr/kg,median,,,minmax,14.7,34.2,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2492,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,Atorvastatin ,blood,pediatric,,children,6.0,Vd/F,,,158,L/kg,median,,,minmax,65,212,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2493,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,Cmax,,,24.6,ng/mL,median,,,minmax,9.27,49.9,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2494,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,C24,,,BQL,ng/mL,median,,,minmax,BQL,5.64,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2495,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,Trough 2 weeks,,,BQL,ng/mL,median,,,minmax,BQL,9.57,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2496,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,Trough 6 weeks,,,BQL,ng/mL,median,,,minmax,BQL,13.1,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2497,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,Tmax,,,2,h,median,,,minmax,1,6,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2498,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,half-life,,,5.3,h,median,,,minmax,4.3,6.9,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2499,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,AUC0-,,,238.4,ng h/mL,median,,,minmax,154.9,1062.1,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2500,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,CL/F,,,,L/hr/kg,median,,,minmax,,,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2501,2025-12-02T16:03:31.981487
31561960.0,Atorvastatin ,O-hydroxyatorvastatin ,blood,pediatric,,children,6.0,Vd/F,,,,L/kg,median,,,minmax,,,,dose level 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2502,2025-12-02T16:03:31.981487
34033812.0,Pravastatin,Pravastatin,blood,maternal,first trimester,,10.0,Cmax,,,33.9,ng/mL,mean,SD,25.8,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2503,2025-12-02T16:03:31.981487
34033812.0,Pravastatin,Pravastatin,blood,maternal,first trimester,,10.0,AUC,,,81.6,ng/h/mL,mean,SD,60.3,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2504,2025-12-02T16:03:31.981487
34033812.0,Pravastatin,Pravastatin,blood,maternal,first trimester,,10.0,apparent oral clearance,,,392,L/h,mean,SD,264,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2505,2025-12-02T16:03:31.981487
34033812.0,Pravastatin,Pravastatin,blood,maternal,second trimester,,10.0,Cmax,,,39.8,ng/mL,mean,SD,31.4,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2506,2025-12-02T16:03:31.981487
34033812.0,Pravastatin,Pravastatin,blood,maternal,second trimester,,10.0,AUC,,,82.9,ng/h/mL,mean,SD,56.4,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2507,2025-12-02T16:03:31.981487
34033812.0,Pravastatin,Pravastatin,blood,maternal,second trimester,,10.0,apparent oral clearance,,,356,L/h,mean,SD,208,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2508,2025-12-02T16:03:31.981487
34033812.0,Pravastatin,Pravastatin,blood,maternal,postpartum,,10.0,Cmax,,,48.4,ng/mL,mean,SD,8.2,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2509,2025-12-02T16:03:31.981487
34033812.0,Pravastatin,Pravastatin,blood,maternal,postpartum,,10.0,AUC,,,131,ng/h/mL,mean,SD,32.9,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2510,2025-12-02T16:03:31.981487
34033812.0,Pravastatin,Pravastatin,blood,maternal,postpartum,,10.0,apparent oral clearance,,,158,L/h,mean,SD,40,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2511,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,32.0,Cmax,,,77.3,ng/ml,mean,SD,56.4,minmax,18,233.3,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2512,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,32.0,Cmax,,,82.3,ng/ml,mean,SD,54.3,minmax,17.4,218.4,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2513,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,32.0,Cmax,,,4.1,ng/ml,mean,SD,1.9,minmax,1.2,9.7,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2514,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,32.0,Cmax,,,46.1,ng/ml,mean,SD,34.7,minmax,12.1,126.3,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2515,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,32.0,AUC0-,,,186.4,ng/ml h,mean,SD,126.5,minmax,43.4,466.5,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2516,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,32.0,AUC0-,,,170.9,ng/ml h,mean,SD,119.6,minmax,36.7,510,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2517,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,32.0,AUC0-,,,9,ng/ml h,mean,SD,4.5,minmax,2.7,25.9,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2518,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,32.0,AUC0-,,,80.7,ng/ml h,mean,SD,58.5,minmax,22.1,223.6,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2519,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,32.0,t1/2,,,1.9,h,mean,SD,0.5,minmax,0.9,2.9,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2520,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,32.0,t1/2,,,1.4,h,mean,SD,0.4,minmax,0.8,2.4,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2521,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,32.0,t1/2,,,1.5,h,mean,SD,0.9,minmax,0.5,4.4,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2522,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,32.0,t1/2,,,1.2,h,mean,SD,0.4,minmax,0.5,2.3,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2523,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,32.0,Vz/F,,,9.5,L/kg,mean,SD,6.7,minmax,1.7,27.6,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2524,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,32.0,Vz/F,,,7.4,L/kg,mean,SD,4.8,minmax,1.4,18.4,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2525,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,32.0,Vz/F,,,120.6,L/kg,mean,SD,89.5,minmax,36.3,412.4,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2526,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,32.0,Vz/F,,,14.1,L/kg,mean,SD,9.8,minmax,2.8,38.9,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2527,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,32.0,Vss/F,,,10.5,L/kg,mean,SD,7.3,minmax,1.9,27.5,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2528,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,32.0,Vss/F,,,8.3,L/kg,mean,SD,5.5,minmax,2,24.7,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2529,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,32.0,Vss/F,,,145,L/kg,mean,SD,83.4,minmax,61.7,369,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2530,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,32.0,Vss/F,,,15,L/kg,mean,SD,8.2,minmax,4.4,30.9,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2531,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,32.0,Recovery in urine,,,62,%,mean,SD,17,minmax,31,88,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2532,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,32.0,Recovery in urine,,,37,%,mean,SD,17,minmax,12,67,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2533,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,32.0,Recovery in urine,,,<0.01,%,mean,SD,,minmax,,,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2534,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,32.0,Recovery in urine,,,<0.01,%,mean,SD,,minmax,,,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2535,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,15.0,Cmax,,,45.7,ng/ml,mean,SD,30.1,,,,0.005,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2536,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,15.0,Cmax,,,98.3,ng/ml,mean,SD,59.8,,,,0.005,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2537,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,2.0,Cmax,,,157,ng/ml,mean,SD,40.1,,,,0.005,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2538,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,15.0,Tmax,,,1,h,median,,,minmax,1,2,,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2539,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,15.0,Tmax,,,1,h,median,,,minmax,0.5,3,,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2540,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,2.0,Tmax,,,1,h,median,,,minmax,0.5,1.5,,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2541,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,15.0,t1/2,,,1.8,h,mean,SD,0.6,,,,0.898,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2542,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,15.0,t1/2,,,1.9,h,mean,SD,0.53,,,,0.898,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2543,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,2.0,t1/2,,,1.8,h,mean,SD,0.6,,,,0.898,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2544,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,15.0,AUC0-,,,133.1,ng/ml h,mean,SD,113.4,,,,0.03,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2545,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,15.0,AUC0-,,,225.4,ng/ml h,mean,SD,127.4,,,,0.03,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2546,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravastatin,blood,pediatric,,children and adolescents,2.0,AUC0-,,,293.8,ng/ml h,mean,SD,16.1,,,,0.03,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2547,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,15.0,Cmax,,,53.3,ng/ml,mean,SD,24.3,,,,0.002,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2548,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,15.0,Cmax,,,93.5,ng/ml,mean,SD,48.3,,,,0.002,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2549,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,2.0,Cmax,,,216.5,ng/ml,mean,SD,2.7,,,,0.002,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2550,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,15.0,Tmax,,,1,h,median,,,minmax,0.5,3,,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2551,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,15.0,Tmax,,,1,h,median,,,minmax,0.5,2,,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2552,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,2.0,Tmax,,,1.5,h,median,,,minmax,1,2,,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2553,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,15.0,t1/2,,,1.4,h,mean,SD,0.4,,,,0.941,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2554,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,15.0,t1/2,,,1.4,h,mean,SD,0.3,,,,0.941,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2555,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,2.0,t1/2,,,1.4,h,mean,SD,0.5,,,,0.941,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2556,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,15.0,AUC0-,,,114.7,ng/ml h,mean,SD,68.1,,,,0.009,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2557,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,15.0,AUC0-,,,197.8,ng/ml h,mean,SD,122.6,,,,0.009,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2558,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin acid,blood,pediatric,,children and adolescents,2.0,AUC0-,,,391.3,ng/ml h,mean,SD,113.6,,,,0.009,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2559,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,15.0,Cmax,,,4.2,ng/ml,mean,SD,2.4,,,,0.999,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2560,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,15.0,Cmax,,,4,ng/ml,mean,SD,1.6,,,,0.999,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2561,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,2.0,Cmax,,,4,ng/ml,mean,SD,1.4,,,,0.999,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2562,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,15.0,Tmax,,,1,h,median,,,minmax,0.5,1.5,,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2563,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,15.0,Tmax,,,1,h,median,,,minmax,0.5,2,,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2564,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,2.0,Tmax,,,1,h,median,,,minmax,0.5,1.5,,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2565,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,15.0,t1/2,,,1.6,h,mean,SD,1,,,,0.347,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2566,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,15.0,t1/2,,,1.5,h,mean,SD,1,,,,0.347,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2567,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,2.0,t1/2,,,0.9,h,mean,SD,0.3,,,,0.347,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2568,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,15.0,AUC0-,,,8.9,ng/ml h,mean,SD,5.5,,,,0.359,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2569,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,15.0,AUC0-,,,9.4,ng/ml h,mean,SD,3.7,,,,0.359,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2570,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,Pravalactone,blood,pediatric,,children and adolescents,2.0,AUC0-,,,6.7,ng/ml h,mean,SD,1,,,,0.359,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2571,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,15.0,Cmax,,,50.3,ng/ml,mean,SD,37.5,,,,0.824,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2572,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,15.0,Cmax,,,43.7,ng/ml,mean,SD,34.8,,,,0.824,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2573,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,2.0,Cmax,,,31.9,ng/ml,mean,SD,1.6,,,,0.824,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2574,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,15.0,Tmax,,,1,h,median,,,minmax,0.5,1.5,,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2575,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,15.0,Tmax,,,1,h,median,,,minmax,0.5,2,,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2576,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,2.0,Tmax,,,1,h,median,,,minmax,0.5,1.5,,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2577,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,15.0,t1/2,,,1.3,h,mean,SD,0.4,,,,0.577,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2578,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,15.0,t1/2,,,1.2,h,mean,SD,0.5,,,,0.577,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2579,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,2.0,t1/2,,,0.9,h,mean,SD,0.04,,,,0.577,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2580,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,15.0,AUC0-,,,87.7,ng/ml h,mean,SD,63.4,,,,0.747,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2581,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,15.0,AUC0-,,,78.3,ng/ml h,mean,SD,57.8,,,,0.747,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2582,2025-12-02T16:03:31.981487
30549267.0,Pravastatin,3-iso-pravastatin lactone,blood,pediatric,,children and adolescents,2.0,AUC0-,,,46.6,ng/ml h,mean,SD,1.5,,,,0.747,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2583,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin ,blood,pediatric,,children and adolescents,28.0,Cmax,,,5.4,ng/mL,meadian,,,IQR,3.4,7.3,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2584,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin lactone ,blood,pediatric,,children and adolescents,28.0,Cmax,,,1.1,ng/mL,meadian,,,IQR,0.4,1.5,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2585,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,N-desmethyl rosuvastatin ,blood,pediatric,,children and adolescents,28.0,Cmax,,,0.8,ng/mL,meadian,,,IQR,0.5,1.1,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2586,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin ,blood,pediatric,,children and adolescents,28.0,AUC0-24,,,42.7,ng/ml h,meadian,,,IQR,31.1,60.3,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2587,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin lactone ,blood,pediatric,,children and adolescents,28.0,AUC0-24,,,12.9,ng/ml h,meadian,,,IQR,7.3,21.5,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2588,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,N-desmethyl rosuvastatin ,blood,pediatric,,children and adolescents,28.0,AUC0-24,,,4.7,ng/ml h,meadian,,,0,3,6.3,,Entire cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2589,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin ,blood,pediatric,,children and adolescents,13.0,Cmax,,,4.3,ng/ml,mean,SD,2.3,,,,0.01,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2590,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin ,blood,pediatric,,children and adolescents,13.0,Cmax,,,6.2,ng/ml,mean,SD,2.2,,,,0.01,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2591,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin ,blood,pediatric,,children and adolescents,2.0,Cmax,,,10.1,ng/ml,mean,SD,0.6,,,,0.01,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2592,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin ,blood,pediatric,,children and adolescents,13.0,Tmax,,,5,h,median,,,minmax,4,5,,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2593,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin ,blood,pediatric,,children and adolescents,13.0,Tmax,,,4,h,median,,,minmax,1,5,,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2594,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin ,blood,pediatric,,children and adolescents,2.0,Tmax,,,4,h,median,,,minmax,3,7,,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2595,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin ,blood,pediatric,,children and adolescents,13.0,AUC0-24,,,36,ng/ml h,mean,SD,18.5,,,,0.01,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2596,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin ,blood,pediatric,,children and adolescents,13.0,AUC0-24,,,49.2,ng/ml h,mean,SD,14,,,,0.01,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2597,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin ,blood,pediatric,,children and adolescents,2.0,AUC0-24,,,79.7,ng/ml h,mean,SD,18.2,,,,0.01,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2598,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin lactone ,blood,pediatric,,children and adolescents,13.0,Cmax,,,0.8,ng/ml,mean,SD,0.5,,,,0.09,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2599,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin lactone ,blood,pediatric,,children and adolescents,13.0,Cmax,,,1.2,ng/ml,mean,SD,0.7,,,,0.09,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2600,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin lactone ,blood,pediatric,,children and adolescents,2.0,Cmax,,,1.4,ng/ml,mean,SD,0.4,,,,0.09,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2601,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin lactone ,blood,pediatric,,children and adolescents,13.0,Tmax,,,5,h,median,,,minmax,1,9,,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2602,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin lactone ,blood,pediatric,,children and adolescents,13.0,Tmax,,,4.5,h,median,,,minmax,2.5,7,,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2603,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin lactone ,blood,pediatric,,children and adolescents,2.0,Tmax,,,5,h,median,,,minmax,1,9,,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2604,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin lactone ,blood,pediatric,,children and adolescents,13.0,AUC0-24,,,11.8,ng/ml h,mean,SD,8.6,,,,0.17,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2605,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin lactone ,blood,pediatric,,children and adolescents,13.0,AUC0-24,,,17.2,ng/ml h,mean,SD,10.2,,,,0.17,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2606,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,Rosuvastatin lactone ,blood,pediatric,,children and adolescents,2.0,AUC0-24,,,18.5,ng/ml h,mean,SD,2,,,,0.17,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2607,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,N-desmethyl rosuvastatin ,blood,pediatric,,children and adolescents,13.0,Cmax,,,0.8,ng/ml,mean,SD,0.5,,,,0.5,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2608,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,N-desmethyl rosuvastatin ,blood,pediatric,,children and adolescents,13.0,Cmax,,,1,ng/ml,mean,SD,0.5,,,,0.5,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2609,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,N-desmethyl rosuvastatin ,blood,pediatric,,children and adolescents,2.0,Cmax,,,1,ng/ml,mean,SD,0,,,,0.5,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2610,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,N-desmethyl rosuvastatin ,blood,pediatric,,children and adolescents,13.0,Tmax,,,4,h,median,,,minmax,2.5,7,,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2611,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,N-desmethyl rosuvastatin ,blood,pediatric,,children and adolescents,13.0,Tmax,,,4,h,median,,,minmax,2,7,,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2612,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,N-desmethyl rosuvastatin ,blood,pediatric,,children and adolescents,2.0,Tmax,,,5,h,median,,,minmax,3,7,,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2613,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,N-desmethyl rosuvastatin ,blood,pediatric,,children and adolescents,13.0,AUC0-24,,,5.4,ng/ml h,mean,SD,5.5,,,,0.44,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2614,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,N-desmethyl rosuvastatin ,blood,pediatric,,children and adolescents,13.0,AUC0-24,,,5.8,ng/ml h,mean,SD,3.4,,,,0.44,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2615,2025-12-02T16:03:31.981487
31981411.0,Rosuvastatin ,N-desmethyl rosuvastatin ,blood,pediatric,,children and adolescents,2.0,AUC0-24,,,5.7,ng/ml h,mean,SD,0.9,,,,0.44,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2616,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,third trimester,,15.0,AUC0-last,,,19.5,ng h/mL,mean,,,95% CI,16.8,22.3,<0.05,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2617,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,postpartum,,10.0,AUC0-last,,,13.3,ng h/mL,mean,,,95% CI,9.3,17.4,<0.05,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2618,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,nonpregnant,,,12.0,AUC0-last,,,13.8,ng h/mL,mean,,,95% CI,10,17.6,NS,Health nonpregnant women,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2619,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,third trimester,,15.0,AUC0-,,,22.2,ng h/mL,mean,,,95% CI,18.6,25.8,NS,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2620,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,postpartum,,10.0,AUC0-,,,17.3,ng h/mL,mean,,,95% CI,11,23.5,NS,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2621,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,nonpregnant,,,12.0,AUC0-,,,15,ng h/mL,mean,,,95% CI,10.7,19.4,NS,Health nonpregnant women,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2622,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,third trimester,,15.0,Cmax,,,2.5,ng/ml,mean,,,95% CI,2.1,2.9,NS,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2623,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,postpartum,,10.0,Cmax,,,2.1,ng/ml,mean,,,95% CI,1.2,2.9,NS,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2624,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,nonpregnant,,,12.0,Cmax,,,1.8,ng/ml,mean,,,95% CI,1.2,2.3,NS,Health nonpregnant women,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2625,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,third trimester,,15.0,tmax,,,2.9,h,mean,,,95% CI,2.2,3.6,NS,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2626,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,postpartum,,10.0,tmax,,,2.6,h,mean,,,95% CI,1.8,3.4,NS,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2627,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,nonpregnant,,,12.0,tmax,,,3,h,mean,,,95% CI,1.5,4.5,NS,Health nonpregnant women,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2628,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,third trimester,,15.0,CL/F,,,252.7,L/h,mean,,,95% CI,192.6,312.8,NS,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2629,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,postpartum,,10.0,CL/F,,,378.5,L/h,mean,,,95% CI,222.9,534,NS,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2630,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,nonpregnant,,,12.0,CL/F,,,390.6,L/h,mean,,,95% CI,291.2,490,NS,Health nonpregnant women,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2631,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,third trimester,,15.0,Vd/F,,,1982.9,L,mean,,,95% CI,1641.1,2323.6,<0.05,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2632,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,postpartum,,10.0,Vd/F,,,3792.3,L,mean,,,95% CI,2563.3,5021.4,<0.05,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2633,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,nonpregnant,,,12.0,Vd/F,,,3490.4,L,mean,,,95% CI,1912.6,5068.3,NS,Health nonpregnant women,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2634,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,third trimester,,15.0,t1/2,,,5.8,h,mean,,,95% CI,4.8,6.8,NS,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2635,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,maternal,postpartum,,10.0,t1/2,,,9.1,h,mean,,,95% CI,4.4,13.9,NS,Women Living with HIV ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2636,2025-12-02T16:03:31.981487
36087110.0,Rosuvastatin ,Rosuvastatin ,blood,nonpregnant,,,12.0,t1/2,,,6.1,h,mean,,,95% CI,4.5,7.6,NS,Health nonpregnant women,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2637,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,AUCdose-normalized,,,1.5,ng h/mL,mean,SD,0.8,,,,<0.05,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2638,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,AUCdose-normalized,,,5.9,ng h/mL,mean,SD,3.7,,,,<0.05,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2639,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,Tmax,,,0.8,h,mean,SD,0.4,,,,NS,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2640,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,Tmax,,,0.6,h,mean,SD,0.1,,,,NS,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2641,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,"Cmax, dose-normalized",,,0.8,ng/ml,mean,SD,0.5,,,,<0.05,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2642,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,"Cmax, dose-normalized",,,4,ng/ml,mean,SD,3.2,,,,<0.05,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2643,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,CL/F,,,8999,L/h,mean,SD,4981,,,,<0.05,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2644,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,CL/F,,,2129,L/h,mean,SD,883,,,,<0.05,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2645,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,CL/F,,,70.01,L/h/kg,mean,SD,13.55,,,,<0.05,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2646,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,CL/F,,,20.1,L/h/kg,mean,SD,6.9,,,,<0.05,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2647,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,Vz/F,,,39483,L,mean,SD,26369,,,,<0.05,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2648,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,Vz/F,,,12617,L,mean,SD,6353,,,,<0.05,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2649,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,Vz/F,,,302,L/kg,mean,SD,112,,,,<0.05,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2650,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,Vz/F,,,116,L/kg,mean,SD,45,,,,<0.05,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2651,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,Elmination half-life,,,2.96,h,mean,SD,0.92,,,,NS,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2652,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,Elmination half-life,,,4,h,mean,SD,1.1,,,,NS,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2653,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,Elmination rate constant,,,0.3,1/h,mean,SD,0.1,,,,NS,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2654,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,Hydralazine,blood,maternal,pregnancy,,6.0,Elmination rate constant,,,0.2,1/h,mean,SD,0.1,,,,NS,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2655,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"Hydralazine and 3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,MTP/hydralazine AUC ratio,,,78,,mean,SD,30,,,,<0.05,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2656,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"Hydralazine and 3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,MTP/hydralazine AUC ratio,,,8,,mean,SD,3,,,,<0.05,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2657,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,AUCdose-normalized,,,118.1,ng h/mL,mean,SD,64.9,,,,<0.05,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2658,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,AUCdose-normalized,,,56.4,ng h/mL,mean,SD,40.7,,,,<0.05,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2659,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,Tmax,,,1.2,h,mean,SD,0.6,,,,NS,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2660,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,Tmax,,,0.7,h,mean,SD,0.2,,,,NS,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2661,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,"Cmax, dose-normalized",,,32.3,ng/ml,mean,SD,11.7,,,,<0.05,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2662,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,"Cmax, dose-normalized",,,15,ng/ml,mean,SD,8.8,,,,<0.05,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2663,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,Elmination half-life,,,2.6,h,mean,SD,1.1,,,,NS,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2664,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,Elmination half-life,,,3.2,h,mean,SD,1.4,,,,NS,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2665,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,Elmination rate constant,,,0.3,1/h,mean,SD,0.1,,,,NS,Rapid acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2666,2025-12-02T16:03:31.981487
31257615.0,Hydralazine,"3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)",blood,maternal,pregnancy,,6.0,Elmination rate constant,,,0.3,1/h,mean,SD,0.1,,,,NS,Slow acetylators,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2667,2025-12-02T16:03:31.981487
32519032.0,6-mercaptopurine ,6-mercaptopurine ,blood,pediatric,,children ,8.0,AUC0-,,,1215,h nmol/l,median,,,IQR,854,1761,0.02,6MP liquid formulation ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2668,2025-12-02T16:03:31.981487
32519032.0,6-mercaptopurine ,6-mercaptopurine ,blood,pediatric,,children ,8.0,AUC0-,,,1805,h nmol/l,median,,,IQR,1161,2389,0.02,6MP tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2669,2025-12-02T16:03:31.981487
32519032.0,6-mercaptopurine ,6-mercaptopurine ,blood,pediatric,,children ,8.0,AUC0-n,,,1196,h nmol/l,median,,,IQR,833,1721,0.056,6MP liquid formulation ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2670,2025-12-02T16:03:31.981487
32519032.0,6-mercaptopurine ,6-mercaptopurine ,blood,pediatric,,children ,8.0,AUC0-n,,,1773,h nmol/l,median,,,IQR,1149,2345,0.056,6MP tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2671,2025-12-02T16:03:31.981487
32519032.0,6-mercaptopurine ,6-mercaptopurine ,blood,pediatric,,children ,8.0,Cmax,,,911,nmol/l,median,,,IQR,458,1071,0.28,6MP liquid formulation ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2672,2025-12-02T16:03:31.981487
32519032.0,6-mercaptopurine ,6-mercaptopurine ,blood,pediatric,,children ,8.0,Cmax,,,1080,nmol/l,median,,,IQR,724,1331,0.28,6MP tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2673,2025-12-02T16:03:31.981487
32519032.0,6-mercaptopurine ,6-mercaptopurine ,blood,pediatric,,children ,8.0,Tmax,,,0.88,h,median,,,IQR,0.69,1,0.09,6MP liquid formulation ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2674,2025-12-02T16:03:31.981487
32519032.0,6-mercaptopurine ,6-mercaptopurine ,blood,pediatric,,children ,8.0,Tmax,,,1,h,median,,,IQR,0.75,1,0.09,6MP tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2675,2025-12-02T16:03:31.981487
32519032.0,6-mercaptopurine ,6-mercaptopurine ,blood,pediatric,,children ,8.0,T1/2,,,1.06,h,median,,,IQR,0.89,1.3,0.41,6MP liquid formulation ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2676,2025-12-02T16:03:31.981487
32519032.0,6-mercaptopurine ,6-mercaptopurine ,blood,pediatric,,children ,8.0,T1/2,,,1.08,h,median,,,IQR,0.96,1.32,0.41,6MP tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2677,2025-12-02T16:03:31.981487
31415566.0,nifurtimox ,nifurtimox ,blood,maternal,lactation,,10.0,concentration,9.25,h,0.3,mg/L,median,,,IQR,0.2,0.95,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2678,2025-12-02T16:03:31.981487
31415566.0,nifurtimox ,nifurtimox ,breast milk,maternal,lactation,,10.0,concentration,9.1,h,2.15,mg/L,median,,,IQR,1.32,4.55,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2679,2025-12-02T16:03:31.981487
31415566.0,nifurtimox ,nifurtimox ,breast milk and blood,maternal,lactation,,10.0,milk/plasma concentration,,,16,,median,,,IQR,9.75,30.25,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2680,2025-12-02T16:03:31.981487
31415566.0,nifurtimox ,nifurtimox ,breast milk,maternal,lactation,,10.0,infant daily dose,,,0.5,mg/kg,median,,,IQR,0.2,0.69,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2681,2025-12-02T16:03:31.981487
31415566.0,nifurtimox ,nifurtimox ,breast milk,maternal,lactation,,10.0,relative infant NF dose (% weight-adjusted maternal dose),,,6.7,,median,,,IQR,2.35,7.19,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2682,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,Tmax,,,1,h,median,%CV,37,minmax,0.83,2.08,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2683,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,Cmax,,,17.64,mg/ml,median,%CV,41,minmax,7.58,22.23,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2684,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,AUC0-24,,,78,mg h/l,median,%CV,40,minmax,46,103,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2685,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,Vz/F,,,1.37,l/kg,median,%CV,51,minmax,0.84,3.17,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2686,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,CL/F,,,0.31,l/h/kg,median,%CV,25,minmax,0.25,0.51,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2687,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,t1/2,,,3.29,h,median,%CV,29,minmax,1.86,4.92,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2688,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,urine,pediatric,,children ,12.0,CLR,,,1.65,l/h,median,%CV,45,minmax,0.93,3.04,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2689,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,Tmax,,,1.04,h,median,,,minmax,1,1.08,,Whole Tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2690,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,Cmax,,,19.89,mg/ml,median,,,minmax,17.12,22.23,,Whole Tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2691,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,AUC0-24,,,91,mg h/l,median,,,minmax,80,103,<0.05 comparing whole vs crushed,Whole Tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2692,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,Vz/F,,,1.24,l/kg,median,,,minmax,1.11,1.57,,Whole Tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2693,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,CL/F,,,0.27,l/h/kg,median,,,minmax,0.25,0.31,<0.05 comparing whole vs crushed,Whole Tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2694,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,t1/2,,,3.19,h,median,,,minmax,0.09,3.51,,Whole Tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2695,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,urine,pediatric,,children ,4.0,CLR,,,2.28,l/h,median,,,minmax,1.23,3.04,,Whole Tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2696,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,7.0,Tmax,,,1,h,median,,,minmax,0.83,2.08,,Crushed Tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2697,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,7.0,Cmax,,,16.05,mg/ml,median,,,minmax,7.58,21.88,,Crushed Tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2698,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,7.0,AUC0-24,,,73,mg h/l,median,,,minmax,46,87,<0.05 comparing whole vs crushed,Crushed Tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2699,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,7.0,Vz/F,,,1.6,l/kg,median,,,minmax,0.84,3.17,,Crushed Tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2700,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,7.0,CL/F,,,0.32,l/h/kg,median,,,minmax,0.3,0.51,<0.05 comparing whole vs crushed,Crushed Tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2701,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,7.0,t1/2,,,3.66,h,median,,,minmax,1.86,4.92,,Crushed Tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2702,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,urine,pediatric,,children ,7.0,CLR,,,1.2,l/h,median,,,minmax,0.93,3.04,,Crushed Tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2703,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,Tmax,,,1,h,median,,,minmax,0.83,1.92,,Fasting statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2704,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,Cmax,,,19.73,mg/ml,median,,,minmax,7.58,22.23,,Fasting statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2705,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,AUC0-24,,,75,mg h/l,median,,,minmax,46,94,,Fasting statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2706,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,Vz/F,,,1.42,l/kg,median,,,minmax,0.84,3.17,,Fasting statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2707,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,CL/F,,,0.32,l/h/kg,median,,,minmax,0.26,0.46,,Fasting statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2708,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,t1/2,,,3.48,h,median,,,minmax,1.86,4.92,,Fasting statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2709,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,urine,pediatric,,children ,6.0,CLR,,,3.45,l/h,median,,,minmax,2.84,4.91,<0.05 fasting vs food,Fasting statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2710,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,Tmax,,,1.08,h,median,,,minmax,1,2.08,,Food statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2711,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,Cmax,,,17.12,mg/ml,median,,,minmax,8.17,21.61,,Food statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2712,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,AUC0-24,,,80,mg h/l,median,,,minmax,46,103,,Food statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2713,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,Vz/F,,,1.37,l/kg,median,,,minmax,1.11,2.98,,Food statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2714,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,CL/F,,,0.31,l/h/kg,median,,,minmax,0.25,0.51,,Food statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2715,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,t1/2,,,3.09,h,median,,,minmax,2.96,4.06,,Food statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2716,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,urine,pediatric,,children ,5.0,CLR,,,8.95,l/h,median,,,minmax,5.35,12.44,<0.05 fasting vs food,Food statis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2717,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,Tmax,,,1.08,h,median,,,minmax,1,2.08,,NAT2 phenotypes RA and IA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2718,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,Cmax,,,17.11,mg/ml,median,,,minmax,9.17,21.61,,NAT2 phenotypes RA and IA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2719,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,AUC0-24,,,776,mg h/l,median,,,minmax,46,103,,NAT2 phenotypes RA and IA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2720,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,Vz/F,,,1.47,l/kg,median,,,minmax,0.84,2.98,,NAT2 phenotypes RA and IA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2721,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,CL/F,,,0.32,l/h/kg,median,,,minmax,0.25,0.51,,NAT2 phenotypes RA and IA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2722,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,t1/2,,,3.3,h,median,,,minmax,1.86,4.92,,NAT2 phenotypes RA and IA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2723,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,urine,pediatric,,children ,6.0,CLR,,,1.93,l/h,median,,,minmax,1.06,3.04,,NAT2 phenotypes RA and IA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2724,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,Tmax,,,1,h,median,,,minmax,0.83,1.92,,NAT2 phenotypes SA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2725,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,Cmax,,,18.82,mg/ml,median,,,minmax,7.58,22.23,,NAT2 phenotypes SA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2726,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,AUC0-24,,,87,mg h/l,median,,,minmax,46,93,,NAT2 phenotypes SA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2727,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,Vz/F,,,1.24,l/kg,median,,,minmax,0.89,3.17,,NAT2 phenotypes SA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2728,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,CL/F,,,0.3,l/h/kg,median,,,minmax,0.26,0.46,,NAT2 phenotypes SA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2729,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,t1/2,,,3.29,h,median,,,minmax,1.94,4.83,,NAT2 phenotypes SA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2730,2025-12-02T16:03:31.981487
35868608.0,isoniazid ,isoniazid ,urine,pediatric,,children ,5.0,CLR,,,1.23,l/h,median,,,minmax,0.93,2.35,,NAT2 phenotypes SA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2731,2025-12-02T16:03:31.981487
35659902.0,isoniazid ,isoniazid ,blood,pediatric,,children ,44.0,Cmax,,,3.2,mg/L,median,,,IQR,2.1,5.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2732,2025-12-02T16:03:31.981487
35659902.0,isoniazid ,isoniazid ,blood,pediatric,,children ,44.0,AUC0-24,,,13,mg h/L,median,,,IQR,7.1,21.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2733,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,children ,43.0,adjusted for the dose concentration ,,,1.95,ug/ml,mean,SD,1.25,,,,,2-4 h after drug intake in the first blood sample,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2734,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,children ,37.0,adjusted for the dose concentration ,,,2.04,ug/ml,mean,SD,1.79,,,,,2-4 h after drug intake in the second blood sample,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2735,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,children ,73.0,adjusted for the dose concentration ,,,1.99,ug/ml,mean,SD,1.51,,,,,overvall,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2736,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,children ,10.0,adjusted for the dose concentration ,,,0.78,ug/ml,median,,,IQR,0.43,1.86,,Age <=2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2737,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,children ,42.0,adjusted for the dose concentration ,,,2.27,ug/ml,median,,,IQR,1.34,3.39,0.001,Age 2-12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2738,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,adolescents,21.0,adjusted for the dose concentration ,,,1.55,ug/ml,median,,,IQR,0.5,2.47,0.0024,Age >12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2739,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,children ,52.0,adjusted for the dose concentration ,,,2.22,ug/ml,median,,,IQR,1.13,3.29,0.0115,Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2740,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,children ,21.0,adjusted for the dose concentration ,,,0.75,ug/ml,median,,,IQR,0.44,1.67,0.0115,Female,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2741,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,adjusted for the dose concentration ,,,2.61,ug/ml,median,,,IQR,2.2,3.24,,African,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2742,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,children ,7.0,adjusted for the dose concentration ,,,0.94,ug/ml,median,,,IQR,0.44,4.35,,Asiatic,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2743,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,children ,14.0,adjusted for the dose concentration ,,,2.05,ug/ml,median,,,IQR,0.52,2.96,,South American,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2744,2025-12-02T16:03:31.981487
34674665.0,isoniazid ,isoniazid ,blood,pediatric,,children ,47.0,adjusted for the dose concentration ,,,1.67,ug/ml,median,,,IQR,0.8,3.12,,Caucasian,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2745,2025-12-02T16:03:31.981487
34420049.0,isoniazid ,isoniazid ,blood,pediatric,,children ,76.0,AUC0-24,,,16.7,mg h/L,median,,,IQR,9.2,25.9,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2746,2025-12-02T16:03:31.981487
34420049.0,isoniazid ,isoniazid ,blood,pediatric,,children ,76.0,Cmax,,,5.1,mg/L,median,,,IQR,2.8,7.7,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2747,2025-12-02T16:03:31.981487
34420049.0,isoniazid ,isoniazid ,blood,pediatric,,children ,76.0,T1/2,,,3.2,h,median,,,IQR,2.6,4.2,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2748,2025-12-02T16:03:31.981487
34420049.0,isoniazid ,isoniazid ,blood,pediatric,,children ,76.0,Tmax,,,1,h,median,,,IQR,1,2,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2749,2025-12-02T16:03:31.981487
34420049.0,isoniazid ,isoniazid ,blood,pediatric,,children ,76.0,Ke,,,0.22,/h,median,,,IQR,0.16,0.26,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2750,2025-12-02T16:03:31.981487
34420049.0,isoniazid ,isoniazid ,blood,pediatric,,children ,16.0,AUC0-24,,,11.9,mg h/L,median,,,IQR,8.4,22.4,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2751,2025-12-02T16:03:31.981487
34420049.0,isoniazid ,isoniazid ,blood,pediatric,,children ,14.0,AUC0-24,,,20.9,mg h/L,median,,,IQR,16.5,28.5,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2752,2025-12-02T16:03:31.981487
34420049.0,isoniazid ,isoniazid ,blood,pediatric,,children ,16.0,AUC0-24,,,21,mg h/L,median,,,IQR,17.5,33.3,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2753,2025-12-02T16:03:31.981487
34420049.0,isoniazid ,isoniazid ,blood,pediatric,,children ,15.0,AUC0-24,,,21.5,mg h/L,median,,,IQR,14.1,32.8,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2754,2025-12-02T16:03:31.981487
34420049.0,isoniazid ,isoniazid ,blood,pediatric,,children ,15.0,AUC0-24,,,5.8,mg h/L,median,,,IQR,3.5,8.8,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2755,2025-12-02T16:03:31.981487
34183327.0,isoniazid ,isoniazid ,blood,pediatric,,children and adolescents ,20.0,AUC0-24,,,18.5,mg h/L,median,,,IQR,5.1,47.4,0.888,First PK assessment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2756,2025-12-02T16:03:31.981487
34183327.0,isoniazid ,isoniazid ,blood,pediatric,,children and adolescents ,12.0,AUC0-24,,,14.5,mg h/L,median,,,IQR,5.9,44.2,0.888,Second PK assessment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2757,2025-12-02T16:03:31.981487
34183327.0,isoniazid ,isoniazid ,blood,pediatric,,children and adolescents ,20.0,Cmax,,,4.6,mg/L,median,,,IQR,1,10,0.366,First PK assessment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2758,2025-12-02T16:03:31.981487
34183327.0,isoniazid ,isoniazid ,blood,pediatric,,children and adolescents ,12.0,Cmax,,,4.7,mg/L,median,,,IQR,2.5,13.6,0.366,Second PK assessment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2759,2025-12-02T16:03:31.981487
34183327.0,isoniazid ,isoniazid ,CSF,pediatric,,children and adolescents ,20.0,CCSF0-2,,,1.4,mg/L,median,,,IQR,0.5,6.1,,First PK assessment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2760,2025-12-02T16:03:31.981487
34183327.0,isoniazid ,isoniazid ,CSF,pediatric,,children and adolescents ,12.0,CCSF0-2,,,1.6,mg/L,median,,,IQR,1.2,2.5,,Second PK assessment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2761,2025-12-02T16:03:31.981487
34183327.0,isoniazid ,isoniazid ,CSF,pediatric,,children and adolescents ,20.0,CCSF3-5,,,1.6,mg/L,median,,,IQR,0.3,5,,First PK assessment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2762,2025-12-02T16:03:31.981487
34183327.0,isoniazid ,isoniazid ,CSF,pediatric,,children and adolescents ,12.0,CCSF3-5,,,1.7,mg/L,median,,,IQR,0.6,5,,Second PK assessment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2763,2025-12-02T16:03:31.981487
34183327.0,isoniazid ,isoniazid ,CSF,pediatric,,children and adolescents ,20.0,CCSF6-8,,,1.3,mg/L,median,,,IQR,1.2,4.3,,First PK assessment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2764,2025-12-02T16:03:31.981487
34183327.0,isoniazid ,isoniazid ,CSF,pediatric,,children and adolescents ,12.0,CCSF6-8,,,2.3,mg/L,median,,,IQR,1.9,2.8,,Second PK assessment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2765,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,0,h,0.06,ug/mL,mean,SD,0.15,,,,,INH dose at 5 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2766,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,0,h,0.17,ug/mL,mean,SD,0.37,,,,,INH dose at 10 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2767,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,0,h,0,ug/mL,median,,,IQR,0,0.48,,INH dose at 5 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2768,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,0,h,0,ug/mL,median,,,IQR,0,1.27,,INH dose at 10 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2769,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,2,h,2.68,ug/mL,mean,SD,1.19,,,,<0.05,INH dose at 5 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2770,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,2,h,8.86,ug/mL,mean,SD,3.94,,,,,INH dose at 10 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2771,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,2,h,2.55,ug/mL,median,,,IQR,0.66,4.47,,INH dose at 5 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2772,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,2,h,7.62,ug/mL,median,,,IQR,4.78,19.29,,INH dose at 10 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2773,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,4,h,1.37,ug/mL,mean,SD,1.08,,,,0.0018,INH dose at 5 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2774,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,4,h,5.15,ug/mL,mean,SD,4.73,,,,,INH dose at 10 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2775,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,4,h,1.13,ug/mL,median,,,IQR,0.32,3.81,,INH dose at 5 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2776,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,4,h,4.42,ug/mL,median,,,IQR,0.51,18.93,,INH dose at 10 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2777,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,6,h,0.73,ug/mL,mean,SD,0.64,,,,0.0032,INH dose at 5 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2778,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,6,h,2.9,ug/mL,mean,SD,3.08,,,,,INH dose at 10 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2779,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,6,h,0.51,ug/mL,median,,,IQR,0.13,2.03,,INH dose at 5 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2780,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,6,h,2.5,ug/mL,median,,,IQR,0.42,11.99,,INH dose at 10 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2781,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,8,h,0.46,ug/mL,mean,SD,0.5,,,,0.0072,INH dose at 5 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2782,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,8,h,1.77,ug/mL,mean,SD,2.07,,,,,INH dose at 10 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2783,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,8,h,0.28,ug/mL,median,,,IQR,0,1.42,,INH dose at 5 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2784,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,concentration,8,h,1.36,ug/mL,median,,,IQR,0.18,7.89,,INH dose at 10 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2785,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,3.0,AUC,,,8.1,ug h/mL,mean,SD,2.36,,,,0.552,"Male, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2786,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,9.0,AUC,,,10.69,ug h/mL,mean,SD,6.95,,,,,"Female, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2787,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,AUC,,,34.33,ug h/mL,mean,SD,8.08,,,,0.337,"Male, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2788,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,AUC,,,37.54,ug h/mL,mean,SD,36.67,,,,,"Female, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2789,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,3.0,Cmax,,,2.45,ul/mL,mean,SD,0.26,,,,0.72,"Male, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2790,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,9.0,Cmax,,,2.76,ul/mL,mean,SD,1.39,,,,,"Female, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2791,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,Cmax,,,8.59,ul/mL,mean,SD,2.21,,,,0.526,"Male, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2792,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,Cmax,,,9.13,ul/mL,mean,SD,5.39,,,,,"Female, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2793,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,AUC,,,7.53,ug h/mL,mean,SD,5.19,,,,0.401,"Age group 1-4.9y, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2794,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,3.0,AUC,,,13.88,ug h/mL,mean,SD,2.77,,,,0.401,"Age group 5-10y, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2795,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,AUC,,,10.3,ug h/mL,mean,SD,8.43,,,,0.401,"Age group >10y, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2796,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,AUC,,,42.54,ug h/mL,mean,SD,38.73,,,,0.303,"Age group 1-4.9y, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2797,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,AUC,,,25.39,ug h/mL,mean,SD,9.56,,,,0.303,"Age group 5-10y, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2798,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,3.0,AUC,,,38.98,ug h/mL,mean,SD,7.58,,,,0.303,"Age group >10y, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2799,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,Cmax,,,2.35,ul/mL,mean,SD,1.04,,,,0.49,"Age group 1-4.9y, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2800,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,3.0,Cmax,,,3.43,ul/mL,mean,SD,0.95,,,,0.49,"Age group 5-10y, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2801,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,Cmax,,,2.54,ul/mL,mean,SD,1.56,,,,0.49,"Age group >10y, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2802,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,Cmax,,,10.2,ul/mL,mean,SD,5.38,,,,0.526,"Age group 1-4.9y, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2803,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,Cmax,,,7.02,ul/mL,mean,SD,2.45,,,,0.526,"Age group 5-10y, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2804,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,3.0,Cmax,,,9.09,ul/mL,mean,SD,2.64,,,,0.526,"Age group >10y, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2805,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,AUC,,,6.34,ug h/mL,mean,SD,3.28,,,,0.146,"pulmonary TB, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2806,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,8.0,AUC,,,11.89,ug h/mL,mean,SD,6.52,,,,0.146,"Extrapulmonary TB, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2807,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,3.0,AUC,,,57.15,ug h/mL,mean,SD,49.48,,,,0.405,"pulmonary TB, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2808,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,9.0,AUC,,,28.86,ug h/mL,mean,SD,6.93,,,,0.405,"Extrapulmonary TB, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2809,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,Cmax,,,1.99,ul/mL,mean,SD,0.61,,,,0.163,"pulmonary TB, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2810,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,8.0,Cmax,,,3.03,ul/mL,mean,SD,1.29,,,,0.163,"Extrapulmonary TB, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2811,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,3.0,Cmax,,,12.04,ul/mL,mean,SD,7.26,,,,0.405,"pulmonary TB, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2812,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,9.0,Cmax,,,7.8,ul/mL,mean,SD,1.76,,,,0.405,"Extrapulmonary TB, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2813,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,7.0,AUC,,,9.51,ug h/mL,mean,SD,6.92,,,,0.739,"crushing of tablets, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2814,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,AUC,,,10.79,ug h/mL,mean,SD,5.48,,,,0.739,"No crushing of tablets, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2815,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,AUC,,,40.59,ug h/mL,mean,SD,34.95,,,,0.873,"crushing of tablets, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2816,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,AUC,,,31.27,ug h/mL,mean,SD,11.95,,,,0.873,"No crushing of tablets, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2817,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,7.0,Cmax,,,2.67,ul/mL,mean,SD,1.16,,,,0.965,"crushing of tablets, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2818,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,Cmax,,,2.703,ul/mL,mean,SD,1.38,,,,0.965,"No crushing of tablets, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2819,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,Cmax,,,9.51,ul/mL,mean,SD,5.09,,,,0.873,"crushing of tablets, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2820,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,6.0,Cmax,,,8.22,ul/mL,mean,SD,2.67,,,,0.873,"No crushing of tablets, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2821,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,AUC,,,9.76,ug h/mL,mean,SD,5.57,,,,0.901,"Malnourished, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2822,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,7.0,AUC,,,10.24,ug h/mL,mean,SD,6.93,,,,0.901,"Normal, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2823,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,3.0,AUC,,,27.5,ug h/mL,mean,SD,9.94,,,,0.644,"Malnourished, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2824,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,9.0,AUC,,,38.74,ug h/mL,mean,SD,28.72,,,,0.644,"Normal, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2825,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,5.0,Cmax,,,2.94,ul/mL,mean,SD,1.19,,,,0.56,"Malnourished, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2826,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,7.0,Cmax,,,2.5,ul/mL,mean,SD,1.26,,,,0.56,"Normal, INH dose at 5 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2827,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,3.0,Cmax,,,7.11,ul/mL,mean,SD,1.04,,,,0.4,"Malnourished, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2828,2025-12-02T16:03:31.981487
31909887.0,isoniazid ,isoniazid ,blood,pediatric,,children ,9.0,Cmax,,,9.45,ul/mL,mean,SD,4.42,,,,0.4,"Normal, INH dose at 10 mg/kg/day",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2829,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,77.0,Cmax,,,5.14,ug/ml,median,,,IQR,2.69,13.2,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2830,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,58.0,Cmax,,,5.88,ug/ml,median,,,IQR,2.59,15,,Age <5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2831,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,19.0,Cmax,,,4.57,ug/ml,median,,,IQR,2.69,7.8,,Age >=5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2832,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,77.0,Tmax,,,1,h,median,,,IQR,1,1,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2833,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,58.0,Tmax,,,1,h,median,,,IQR,1,1,,Age <5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2834,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,19.0,Tmax,,,1,h,median,,,IQR,1,1,,Age >=5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2835,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,74.0,T1/2,,,2.41,h,median,,,IQR,1.43,3.25,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2836,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,57.0,T1/2,,,2.52,h,median,,,IQR,1.52,3.25,,Age <5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2837,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,17.0,T1/2,,,1.65,h,median,,,IQR,1.37,2.7,,Age >=5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2838,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,77.0,AUC0-8,,,14.33,ug h/mL,median,,,IQR,8.51,48.27,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2839,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,58.0,AUC0-8,,,15.08,ug h/mL,median,,,IQR,8.51,53.25,,Age <5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2840,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,19.0,AUC0-8,,,11.81,ug h/mL,median,,,IQR,8.06,22.54,,Age >=5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2841,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,74.0,AUC0-24,,,19.46,ug h/mL,median,,,IQR,10.76,50.06,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2842,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,57.0,AUC0-24,,,21.18,ug h/mL,median,,,IQR,10.98,74.07,,Age <5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2843,2025-12-02T16:03:31.981487
34686231.0,isoniazid ,isoniazid ,blood,pediatric,,children ,17.0,AUC0-24,,,13.34,ug h/mL,median,,,IQR,10.76,23.95,,Age >=5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2844,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,35.0,Cmax,,,8.3,ug/ml,mean,SD,4.28,,,,,Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2845,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,35.0,Cmax,,,8.11,ug/ml,median,,,IQR,2.88,24.74,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2846,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,35.0,Tmax,,,1.22,h,mean,SD,0.5,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2847,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,35.0,Tmax,,,1,h,median,,,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2848,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,35.0,AUC,,,46.23,ug h/mL,mean,SD,34.82,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2849,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,35.0,AUC,,,38.53,ug h/mL,median,,,IQR,6.63,192.11,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2850,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,35.0,T1/2,,,2.45,h,mean,SD,1.17,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2851,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,35.0,T1/2,,,2.32,h,median,,,IQR,1.16,6.68,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2852,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,19.0,AUC,,,49.7,ug h/mL,mean,SD,43.22,,,,,Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2853,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,19.0,AUC,,,34.31,ug h/mL,median,,,,,,,Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2854,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,16.0,AUC,,,42.06,ug h/mL,mean,SD,21.74,,,,,Female,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2855,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,16.0,AUC,,,41.76,ug h/mL,median,,,,,,,Female,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2856,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,19.0,Cmax,,,8.71,ug/ml,mean,SD,5.18,,,,,Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2857,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,19.0,Cmax,,,7.57,ug/ml,median,,,,,,,Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2858,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,16.0,Cmax,,,7.86,ug/ml,mean,SD,2.97,,,,,Female,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2859,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,16.0,Cmax,,,9.07,ug/ml,median,,,,,,,Female,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2860,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,13.0,AUC,,,60.97,ug h/mL,mean,SD,49.9,,,,,<5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2861,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,13.0,AUC,,,52.87,ug h/mL,median,,,,,,,<5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2862,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,AUC,,,38.95,ug h/mL,mean,SD,22.28,,,,,5-10 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2863,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,AUC,,,37.59,ug h/mL,median,,,,,,,5-10 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2864,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,AUC,,,36.09,ug h/mL,mean,SD,13.56,,,,,>10 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2865,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,AUC,,,34.31,ug h/mL,median,,,,,,,>10 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2866,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,13.0,Cmax,,,9.87,ug/ml,mean,SD,5.75,,,,,<5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2867,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,13.0,Cmax,,,9.09,ug/ml,median,,,,,,,<5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2868,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,Cmax,,,7.62,ug/ml,mean,SD,3.37,,,,,5-10 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2869,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,Cmax,,,7.05,ug/ml,median,,,,,,,5-10 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2870,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,Cmax,,,7.21,ug/ml,mean,SD,2.5,,,,,>10 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2871,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,Cmax,,,7.13,ug/ml,median,,,,,,,>10 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2872,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,AUC,,,37.61,ug h/mL,mean,SD,18.49,,,,,pulmonary TB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2873,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,22.0,AUC,,,51.17,ug h/mL,mean,SD,41.41,,,,,Extrapulmonary TB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2874,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,12.0,Cmax,,,7.6,ug/ml,mean,SD,2.6,,,,,pulmonary TB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2875,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,22.0,Cmax,,,8.69,ug/ml,mean,SD,5.06,,,,,Extrapulmonary TB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2876,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,19.0,AUC,,,50.48,ug h/mL,mean,SD,38.38,,,,,FDC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2877,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,19.0,AUC,,,42.32,ug h/mL,median,,,,,,,FDC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2878,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,16.0,AUC,,,41.2,ug h/mL,mean,SD,30.52,,,,,single-drug,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2879,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,16.0,AUC,,,32.6,ug h/mL,median,,,,,,,single-drug,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2880,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,19.0,Cmax,,,9.07,ug/ml,mean,SD,4.67,,,,,FDC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2881,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,19.0,Cmax,,,9.01,ug/ml,median,,,,,,,FDC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2882,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,16.0,Cmax,,,7.43,ug/ml,mean,SD,3.71,,,,,single-drug,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2883,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,16.0,Cmax,,,6.72,ug/ml,median,,,,,,,single-drug,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2884,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,15.0,AUC,,,52.59,ug h/mL,mean,SD,48.47,,,,,Breaking of tablets,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2885,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,15.0,AUC,,,34.31,ug h/mL,median,,,,,,,Breaking of tablets,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2886,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,20.0,AUC,,,41.47,ug h/mL,mean,SD,19.58,,,,,No breaking of tablets,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2887,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,20.0,AUC,,,38.53,ug h/mL,median,,,,,,,No breaking of tablets,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2888,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,15.0,Cmax,,,8.84,ug/ml,mean,SD,5.58,,,,,Breaking of tablets,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2889,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,15.0,Cmax,,,8.11,ug/ml,median,,,,,,,Breaking of tablets,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2890,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,20.0,Cmax,,,7.93,ug/ml,mean,SD,3.07,,,,,No breaking of tablets,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2891,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,20.0,Cmax,,,8.3,ug/ml,median,,,,,,,No breaking of tablets,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2892,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,AUC,,,40.25,ug h/mL,mean,SD,20.22,,,,,Malnourished,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2893,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,AUC,,,40.25,ug h/mL,median,,,,,,,Malnourished,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2894,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,24.0,AUC,,,48.98,ug h/mL,mean,SD,39.87,,,,,Healthy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2895,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,24.0,AUC,,,35.95,ug h/mL,median,,,,,,,Healthy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2896,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,Cmax,,,8.17,ug/ml,mean,SD,3.3,,,,,Malnourished,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2897,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,11.0,Cmax,,,8.3,ug/ml,median,,,,,,,Malnourished,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2898,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,24.0,Cmax,,,8.39,ug/ml,mean,SD,4.72,,,,,Healthy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2899,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,24.0,Cmax,,,7.86,ug/ml,median,,,,,,,Healthy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2900,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,9.0,AUC,,,20.18,ug h/mL,mean,SD,9.03,,,,0.007,fast acetylators ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2901,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,9.0,T1/2,,,1.39,h,median,,,,,,,fast acetylators ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2902,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,26.0,AUC,,,55.25,ug h/mL,mean,SD,35.98,,,,0.007,slow acetylator ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2903,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,9.0,Cmax,,,6.15,ug/ml,mean,SD,2.74,,,,0.07,fast acetylators ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2904,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,9.0,T1/2,,,2.8,h,median,,,,,,,fast acetylators ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2905,2025-12-02T16:03:31.981487
30572983.0,isoniazid ,isoniazid ,blood,pediatric,,children ,26.0,Cmax,,,9.08,ug/ml,mean,SD,4.5,,,,0.07,slow acetylator ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2906,2025-12-02T16:03:31.981487
30395239.0,isoniazid ,isoniazid ,blood,pediatric,,children ,47.0,concentration,2,h,1.01,ug/ml,median,,,IQR,0.54,2.38,0.624,previous recommendations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2907,2025-12-02T16:03:31.981487
30395239.0,isoniazid ,isoniazid ,blood,pediatric,,children ,4.0,concentration,2,h,2.05,ug/ml,median,,,IQR,0.41,4.6,0.624,revised recommendations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2908,2025-12-02T16:03:31.981487
35083184.0,piperacillin,piperacillin,blood,pediatric,,children ,18.0,trough plasma concentration,,,3.4,mg/L,geometric mean,SD,33.6,,,,,at first monitored level of the treatment cycle,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2909,2025-12-02T16:03:31.981487
35083184.0,piperacillin,piperacillin,blood,pediatric,,children ,18.0,trough plasma concentration,,,1.6,mg/L,geometric mean,SD,7.1,,,,,subsequent measurements during the cycle,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2910,2025-12-02T16:03:31.981487
34029707.0,piperacillin,piperacillin,blood,pediatric,,children ,45.0,Cmid,,,51.9,mg/L,geometric mean,,,95% CI,40.6,66.6,<0.001,Extended infusion ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2911,2025-12-02T16:03:31.981487
34029707.0,piperacillin,piperacillin,blood,pediatric,,children ,45.0,Cmid,,,6,mg/L,geometric mean,,,95% CI,4.2,8.6,<0.001,Intermittent bolus  ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2912,2025-12-02T16:03:31.981487
34270797.0,dupilumab,dupilumab,blood,pediatric,,adolescents,40.0,concentration,16,weekes,51.3,mg/L,mean,,,,,,,200 mg q2w < 60 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2913,2025-12-02T16:03:31.981487
34270797.0,dupilumab,dupilumab,blood,pediatric,,adolescents,36.0,concentration,16,weekes,57.9,mg/L,mean,,,,,,,300 mg q2w  60 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2914,2025-12-02T16:03:31.981487
34270797.0,dupilumab,dupilumab,blood,pediatric,,adolescents,41.0,concentration,16,weekes,27.2,mg/L,mean,,,,,,,300 mg q4w < 60 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2915,2025-12-02T16:03:31.981487
34270797.0,dupilumab,dupilumab,blood,pediatric,,adolescents,40.0,concentration,16,weekes,12.7,mg/L,mean,,,,,,,300 mg q4w  60 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2916,2025-12-02T16:03:31.981487
34270797.0,dupilumab,dupilumab,blood,pediatric,,children ,60.0,concentration,16,weekes,62.6,mg/L,mean,,,,,,,100 mg q2w < 30 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2917,2025-12-02T16:03:31.981487
34270797.0,dupilumab,dupilumab,blood,pediatric,,children ,56.0,concentration,16,weekes,86,mg/L,mean,,,,,,,200 mg q2w  30 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2918,2025-12-02T16:03:31.981487
34270797.0,dupilumab,dupilumab,blood,pediatric,,children ,57.0,concentration,16,weekes,98.7,mg/L,mean,,,,,,,300 mg q4w < 30 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2919,2025-12-02T16:03:31.981487
34270797.0,dupilumab,dupilumab,blood,pediatric,,children ,57.0,concentration,16,weekes,53.9,mg/L,mean,,,,,,,300 mg q4w  30 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2920,2025-12-02T16:03:31.981487
34270797.0,dupilumab,dupilumab,blood,adults,,,442.0,concentration,16,weekes,74.6,mg/L,mean,,,,,,,300 mg q2w,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2921,2025-12-02T16:03:31.981487
32969489.0,dupilumab,dupilumab,blood,pediatric,,children ,18.0,AUClast,,,160,day mg/L,mean,,,,,,,"2 mg/kg group, Following a single dose on day 1 of the Phase IIa study",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2922,2025-12-02T16:03:31.981487
32969489.0,dupilumab,dupilumab,blood,pediatric,,children ,19.0,AUClast,,,330,day mg/L,mean,,,,,,,"4 mg/kg group, Following a single dose on day 1 of the Phase IIa study",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2923,2025-12-02T16:03:31.981487
32969489.0,dupilumab,dupilumab,blood,pediatric,,children ,18.0,Tmax,,,2,days,mean,,,,,,,"2 mg/kg group, Following a single dose on day 1 of the Phase IIa study",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2924,2025-12-02T16:03:31.981487
32969489.0,dupilumab,dupilumab,blood,pediatric,,children ,19.0,Tmax,,,4,days,mean,,,,,,,"4 mg/kg group, Following a single dose on day 1 of the Phase IIa study",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2925,2025-12-02T16:03:31.981487
32969489.0,dupilumab,dupilumab,blood,pediatric,,children ,18.0,Cmax,,,14.3,mg/L,mean,SD,5.9,,,,,"2 mg/kg group, Following a single dose on day 1 of the Phase IIa study",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2926,2025-12-02T16:03:31.981487
32969489.0,dupilumab,dupilumab,blood,pediatric,,children ,19.0,Cmax,,,32.4,mg/L,mean,SD,7,,,,,"4 mg/kg group, Following a single dose on day 1 of the Phase IIa study",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2927,2025-12-02T16:03:31.981487
32969489.0,dupilumab,dupilumab,blood,pediatric,,children ,17.0,min steady-state trough concentration,,,61.3,mg/L,mean,SD,35,,,,,"at weeks 2448, Phase III OLE study, 2 mg/kg qw",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2928,2025-12-02T16:03:31.981487
32969489.0,dupilumab,dupilumab,blood,pediatric,,children ,17.0,max steady-state trough concentration,,,76.8,mg/L,mean,SD,35.8,,,,,"at weeks 2448, Phase III OLE study, 2 mg/kg qw",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2929,2025-12-02T16:03:31.981487
32969489.0,dupilumab,dupilumab,blood,pediatric,,children ,16.0,min steady-state trough concentration,,,143,mg/L,mean,SD,40.3,,,,,"at weeks 2448, Phase III OLE study, 4 mg/kg qw",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2930,2025-12-02T16:03:31.981487
32969489.0,dupilumab,dupilumab,blood,pediatric,,children ,16.0,max steady-state trough concentration,,,181,mg/L,mean,SD,65.9,,,,,"at weeks 2448, Phase III OLE study, 4 mg/kg qw",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2931,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,9.0,Cmax,,,25.3,mg/L,mean,SD,7.44,,,,,">=2 to <6 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2932,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,10.0,Cmax,,,9.8,mg/L,mean,SD,11.3,,,,,">=2 to <6 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2933,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,Cmax,,,20.1,mg/L,mean,SD,6.81,,,,,">=6 months to <2 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2934,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,Cmax,,,46.1,mg/L,mean,SD,11.1,,,,,">=6 months to <2 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2935,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,9.0,Cmax/dose,,,8.39,mg/L/[mg/kg],mean,SD,2.48,,,,,">=2 to <6 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2936,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,10.0,Cmax/dose,,,8.3,mg/L/[mg/kg],mean,SD,1.89,,,,,">=2 to <6 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2937,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,Cmax/dose,,,6.7,mg/L/[mg/kg],mean,SD,2.27,,,,,">=6 months to <2 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2938,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,Cmax/dose,,,7.68,mg/L/[mg/kg],mean,SD,1.86,,,,,">=6 months to <2 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2939,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,9.0,Tmax,,,1.92,days,median,,,minmax,1.72,3.02,,">=2 to <6 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2940,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,10.0,Tmax,,,1.97,days,median,,,minmax,1.87,7.82,,">=2 to <6 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2941,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,Tmax,,,1.95,days,median,,,minmax,1.75,3.08,,">=6 months to <2 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2942,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,Tmax,,,2.1,days,median,,,minmax,1.8,7.99,,">=6 months to <2 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2943,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,9.0,Clast,,,6.64,mg/L,mean,SD,6.16,,,,,">=2 to <6 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2944,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,10.0,Clast,,,6.14,mg/L,mean,SD,4.69,,,,,">=2 to <6 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2945,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,Clast,,,5.64,mg/L,mean,SD,4.52,,,,,">=6 months to <2 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2946,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,Clast,,,15.1,mg/L,mean,SD,9.48,,,,,">=6 months to <2 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2947,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,9.0,Tlast,,,14.8,days,median,,,minmax,6.79,28,,">=2 to <6 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2948,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,10.0,Tlast,,,26.5,days,median,,,minmax,15,32,,">=2 to <6 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2949,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,Tlast,,,13.9,days,median,,,minmax,6.88,16.8,,">=6 months to <2 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2950,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,Tlast,,,16,days,median,,,minmax,6.95,28,,">=6 months to <2 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2951,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,9.0,AUClast,,,198,day mg/L,mean,SD,125,,,,,">=2 to <6 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2952,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,10.0,AUClast,,,622,day mg/L,mean,SD,184,,,,,">=2 to <6 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2953,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,AUClast,,,123,day mg/L,mean,SD,86,,,,,">=6 months to <2 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2954,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,AUClast,,,493,day mg/L,mean,SD,294,,,,,">=6 months to <2 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2955,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,9.0,AUClast/dose,,,66,day mg/L/[mg/kg],mean,SD,41.6,,,,,">=2 to <6 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2956,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,children ,10.0,AUClast/dose,,,104,day mg/L/[mg/kg],mean,SD,30.6,,,,,">=2 to <6 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2957,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,AUClast/dose,,,41,day mg/L/[mg/kg],,SD,28.7,,,,,">=6 months to <2 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2958,2025-12-02T16:03:31.981487
32893393.0,dupilumab,dupilumab,blood,pediatric,,infants/children ,10.0,AUClast/dose,,,82.1,day mg/L/[mg/kg],,SD,48.9,,,,,">=6 months to <2 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2959,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,concentration,0,min,0,ng/ml,median,,,IQR,0,0,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2960,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,concentration,0,min,2.5,ng/ml,mean,SD,9.7,minmax,0,38,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2961,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,11.0,concentration,15,min,10,ng/ml,median,,,IQR,4,46,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2962,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,11.0,concentration,15,min,52,ng/ml,mean,SD,119,minmax,0,406,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2963,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,concentration,30,min,115,ng/ml,median,,,IQR,46,223,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2964,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,concentration,30,min,195,ng/ml,mean,SD,291,minmax,0,1184,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2965,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,11.0,concentration,45,min,237,ng/ml,median,,,IQR,77,396,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2966,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,11.0,concentration,45,min,46,ng/ml,mean,SD,2,minmax,0,2043,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2967,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,concentration,60,min,348,ng/ml,median,,,IQR,123,678,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2968,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,concentration,60,min,524,ng/ml,mean,SD,549,minmax,0,2030,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2969,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,concentration,120,min,938,ng/ml,median,,,IQR,514,1887,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2970,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,concentration,120,min,1136,ng/ml,mean,SD,806,minmax,9,2769,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2971,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,14.0,concentration,180,min,1346,ng/ml,median,,,IQR,929,1967,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2972,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,14.0,concentration,180,min,1578,ng/ml,mean,SD,1075,minmax,16,4262,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2973,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,12.0,concentration,240,min,1279,ng/ml,median,,,IQR,807,1669,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2974,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,12.0,concentration,240,min,1484,ng/ml,mean,SD,1230,minmax,13,2895,,Blood sampling time after oral montelukast (minutes),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2975,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,Tmax,,,2.9,h,mean,,,minmax,2,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2976,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,Tmax,,,3,h,median,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2977,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,Cmax,,,1620,ng/ml,mean,,,minmax,16,4895,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2978,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,Cmax,,,1378,ng/ml,median,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2979,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,AUClast,,,3579,ng h/ml,mean,,,minmax,32,9017,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2980,2025-12-02T16:03:31.981487
32960980.0,Montelukast ,Montelukast ,blood,pediatric,,children ,15.0,AUClast,,,2924,ng h/ml,median,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2981,2025-12-02T16:03:31.981487
31920289.0,Montelukast ,Montelukast ,blood,pediatric,,children ,50.0,concentration,,,181.7,ng/ml,mean,SD,172.4,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2982,2025-12-02T16:03:31.981487
31920289.0,Montelukast ,Montelukast ,blood,pediatric,,children ,50.0,concentration,,,123.3,ng/ml,median,,,minmax,12.9,769.9,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2983,2025-12-02T16:03:31.981487
31920289.0,Montelukast ,Montelukast ,blood,pediatric,,children ,50.0,CL,,,0.87,L/h,mean,SD,0.25,,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2984,2025-12-02T16:03:31.981487
31920289.0,Montelukast ,Montelukast ,blood,pediatric,,children ,50.0,CL,,,0.83,L/h,median,,,minmax,0.5,1.5,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2985,2025-12-02T16:03:31.981487
31920289.0,Montelukast ,Montelukast ,blood,pediatric,,children ,29.0,CL,,,0.94,L/h,mean,SD,0.26,,,,0.02,SLCO2B1 c.935GA and c.935AA subjects ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2986,2025-12-02T16:03:31.981487
31920289.0,Montelukast ,Montelukast ,blood,pediatric,,children ,21.0,CL,,,0.77,L/h,mean,SD,0.21,,,,,SLCO2B1 c.935GG subjects ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2987,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,pediatric,,adolescents,40.0,Cmax,,,20.9,pg/ml,mean,SD,8.27,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2988,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,pediatric,,adolescents,40.0,Tmax,,,0.08,h,median,,,minmax,0.08,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2989,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,pediatric,,adolescents,40.0,AUC0-30min,,,7.12,h pg/ml,mean,SD,2.95,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2990,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,pediatric,,adolescents,40.0,AUC0-t,,,73.8,h pg/ml,mean,SD,21.8,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2991,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,pediatric,,adolescents,40.0,AUC0-,,,93,h pg/ml,mean,SD,26.5,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2992,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,pediatric,,adolescents,40.0,T1/2,,,4.46,h,mean,SD,1.2,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2993,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,adults,,,40.0,Cmax,,,27.2,pg/ml,mean,SD,12,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2994,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,adults,,,40.0,Tmax,,,0.08,h,median,,,minmax,0.08,2.02,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2995,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,adults,,,40.0,AUC0-30min,,,9.75,h pg/ml,mean,SD,4.59,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2996,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,adults,,,40.0,AUC0-t,,,84.6,h pg/ml,mean,SD,26.6,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2997,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,adults,,,40.0,AUC0-,,,92.8,h pg/ml,mean,SD,36.5,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2998,2025-12-02T16:03:31.981487
35733414.0,Formoterol,Formoterol,blood,adults,,,40.0,T1/2,,,5.25,h,mean,SD,1.43,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,2999,2025-12-02T16:03:31.981487
35733414.0,Beclometasone,Beclometasone,blood,pediatric,,adolescents,40.0,Cmax,,,607,pg/ml,mean,SD,623,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3000,2025-12-02T16:03:31.981487
35733414.0,Beclometasone,Beclometasone,blood,pediatric,,adolescents,40.0,Tmax,,,0.08,h,median,,,minmax,0.08,0.25,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3001,2025-12-02T16:03:31.981487
35733414.0,Beclometasone,Beclometasone,blood,pediatric,,adolescents,40.0,AUC0-t,,,111,h pg/ml,mean,SD,118,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3002,2025-12-02T16:03:31.981487
35733414.0,Beclometasone,Beclometasone,blood,adults,,,40.0,Cmax,,,1724,pg/ml,mean,SD,1508,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3003,2025-12-02T16:03:31.981487
35733414.0,Beclometasone,Beclometasone,blood,adults,,,40.0,Tmax,,,0.08,h,median,,,minmax,0.08,0.27,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3004,2025-12-02T16:03:31.981487
35733414.0,Beclometasone,Beclometasone,blood,adults,,,40.0,AUC0-t,,,282,h pg/ml,mean,SD,235,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3005,2025-12-02T16:03:31.981487
30539740.0,amikacin ,amikacin ,blood,pediatric,,neonates,20.0,peak concentration,,,29.1,ug/ml,mean,,,minmax,19.4,42.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3006,2025-12-02T16:03:31.981487
30539740.0,amikacin ,amikacin ,blood,pediatric,,neonates,20.0,trough plasma concentration,,,7.86,ug/ml,mean,,,minmax,1.8,28.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3007,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,54.0,Ke,,,0.11,/h,mean,,,95% CI,0.1,0.11,0.763,"CHD, total",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3008,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,54.0,Ke,,,0.11,/h,mean,,,95% CI,0.1,0.11,0.763,Non-CHD,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3009,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,54.0,T1/2,,,6.9,h,mean,,,95% CI,6.4,7.3,0.783,"CHD, total",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3010,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,54.0,T1/2,,,6.9,h,mean,,,95% CI,6.4,7.3,0.783,Non-CHD,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3011,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,54.0,Vd,,,0.47,L/kg,mean,,,95% CI,0.44,0.5,0.548,"CHD, total",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3012,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,54.0,Vd,,,0.46,L/kg,mean,,,95% CI,0.43,0.49,0.548,Non-CHD,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3013,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,54.0,CL,,,0.05,L/h,mean,,,95% CI,0.05,0.05,0.481,"CHD, total",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3014,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,54.0,CL,,,0.05,L/h,mean,,,95% CI,0.05,0.05,0.481,Non-CHD,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3015,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,33.0,Ke,,,0.11,/h,mean,,,95% CI,0.1,0.12,0.73,Acyanotic,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3016,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,21.0,Ke,,,0.11,/h,mean,,,95% CI,0.1,0.12,0.73,Cyanotic,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3017,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,33.0,T1/2,,,6.8,h,mean,,,95% CI,6.2,7.4,0.691,Acyanotic,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3018,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,21.0,T1/2,,,7.2,h,mean,,,95% CI,6.5,7.9,0.691,Cyanotic,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3019,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,33.0,Vd,,,0.48,L/kg,mean,,,95% CI,0.44,0.52,0.753,Acyanotic,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3020,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,21.0,Vd,,,0.46,L/kg,mean,,,95% CI,0.41,0.51,0.753,Cyanotic,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3021,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,33.0,CL,,,0.05,L/h,mean,,,95% CI,0.05,0.06,0.36,Acyanotic,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3022,2025-12-02T16:03:31.981487
34035682.0,amikacin ,amikacin ,blood,pediatric,,neonates,21.0,CL,,,0.05,L/h,mean,,,95% CI,0.05,0.05,0.36,Cyanotic,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3023,2025-12-02T16:03:31.981487
34142330.0,amikacin ,amikacin ,blood,pediatric,,children ,30.0,Cmax,,,50,mg/L,median,,,minmax,31.3,79.6,,Cmax was measured 30 min after the end of the infusion via a peripheral blood sample or a CVC other than that used for amikacin whenever possible,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3024,2025-12-02T16:03:31.981487
31306396.0,ceftazidime,ceftazidime,blood,pediatric,,Infants and children,60.0,concentration,15 min prior to or after stopping,,62.3,ug/ml,median,CV,1.094,,,,,on day 3 of the study,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3025,2025-12-02T16:03:31.981487
31306396.0,ceftazidime,ceftazidime,blood,pediatric,,Infants and children,60.0,concentration,30-90 min after stopping,,39.45,ug/ml,median,CV,0.558,,,,,on day 3 of the study,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3026,2025-12-02T16:03:31.981487
31306396.0,ceftazidime,ceftazidime,blood,pediatric,,Infants and children,60.0,concentration,300-360 min after stopping,,4.42,ug/ml,median,CV,0.895,,,,,on day 3 of the study,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3027,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,8.0,Cmax,,,22.32,ug/ml,mean,SD,13.15,,,,,26 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3028,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,8.0,Cmax,,,,,,CV,0.589,,,,,26 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3029,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,14.0,Cmax,,,26.4,ug/ml,mean,SD,11.33,,,,,612 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3030,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,14.0,Cmax,,,,,,CV,0.4289,,,,,612 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3031,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,adolescents,11.0,Cmax,,,23.63,ug/ml,mean,SD,9.51,,,,,1218 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3032,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,adolescents,11.0,Cmax,,,,,,CV,0.4024,,,,,1218 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3033,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,8.0,Tmax,,,1.68,h,mean,SD,0.53,,,,,26 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3034,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,8.0,Tmax,,,,,,CV,0.3142,,,,,26 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3035,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,14.0,Tmax,,,2.67,h,mean,SD,1.2,,,,,612 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3036,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,14.0,Tmax,,,,,,CV,0.4489,,,,,612 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3037,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,adolescents,11.0,Tmax,,,2.72,h,mean,SD,1.47,,,,,1218 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3038,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,adolescents,11.0,Tmax,,,,,,CV,53.99,,,,,1218 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3039,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,8.0,AUC0-t,7.5,h,69.84,ug h/ml,mean,SD,35.29,,,,,"26 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3040,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,8.0,AUC0-t,7.5,h,,,,CV,0.5054,,,,,"26 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3041,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,14.0,AUC0-t,7.5,h,85.44,ug h/ml,mean,SD,38.55,,,,,"612 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3042,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,14.0,AUC0-t,7.5,h,,,,CV,0.4513,,,,,"612 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3043,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,adolescents,11.0,AUC0-t,7.5,h,100.53,ug h/ml,mean,SD,46.6,,,,,"1218 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3044,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,adolescents,11.0,AUC0-t,7.5,h,,,,CV,0.4631,,,,,"1218 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3045,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,8.0,AUC0-t_norm,7.5,h,3.33,(ug h/ml)/(mg/kg),mean,SD,1.98,,,,,"26 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3046,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,8.0,AUC0-t_norm,7.5,h,,,,CV,0.5954,,,,,"26 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3047,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,14.0,AUC0-t_norm,7.5,h,3.88,(ug h/ml)/(mg/kg),mean,SD,1.46,,,,,"612 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3048,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,14.0,AUC0-t_norm,7.5,h,,,,CV,0.3771,,,,,"612 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3049,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,adolescents,11.0,AUC0-t_norm,7.5,h,4.77,(ug h/ml)/(mg/kg),mean,SD,2.2,,,,,"1218 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3050,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,adolescents,11.0,AUC0-t_norm,7.5,h,,,,CV,0.4618,,,,,"1218 Years, time after dosing",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3051,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,8.0,Cmax_norm,,,1.03,(ug/ml)/(mg/kg),mean,SD,0.545,,,,,26 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3052,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,8.0,Cmax_norm,,,,,,CV,0.5298,,,,,26 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3053,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,14.0,Cmax_norm,,,1.1886,(ug/ml)/(mg/kg),mean,SD,0.4,,,,,612 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3054,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,14.0,Cmax_norm,,,,,,CV,33.47,,,,,612 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3055,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,adolescents,11.0,Cmax_norm,,,1.12,(ug/ml)/(mg/kg),mean,SD,0.47,,,,,1218 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3056,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,adolescents,11.0,Cmax_norm,,,,,,CV,0.417,,,,,1218 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3057,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,8.0,Tmax,,,1.5,h,median,,,minmax,1.5,3,,26 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3058,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,children,14.0,Tmax,,,3,h,median,,,,,,,612 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3059,2025-12-02T16:03:31.981487
35625789.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,adolescents,11.0,Tmax,,,3,h,median,,,,,,,1218 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3060,2025-12-02T16:03:31.981487
35988360.0,Ciprofloxacin,Ciprofloxacin,blood,pediatric,,infants/children,12.0,concentration,,,Not detectable ,ng/ml,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3061,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,53.0,concentration,0,hours,0.42,ng/ml,median,,,IQR,0.35,0.46,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3062,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,53.0,concentration,2,hours,0.45,ng/ml,median,,,IQR,0.39,0.69,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3063,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,53.0,concentration,8,hours,0.49,ng/ml,median,,,IQR,0.44,0.7,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3064,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,53.0,concentration,24,hours,0.5,ng/ml,median,,,IQR,0.46,0.87,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3065,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,53.0,concentration,36,hours,0.61,ng/ml,median,,,IQR,0.47,0.89,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3066,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,53.0,concentration,48,hours,0.47,ng/ml,median,,,IQR,0.46,0.49,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3067,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,Peak concentration,,,2.27,ng/ml,median,,,IQR,0.75,4.13,,2nd intermittent bolus dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3068,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,Peak concentration,,,2.7,ng/ml,median,,,IQR,1.04,3.78,,6rd intermittent bolus dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3069,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,Peak concentration,,,2.21,ng/ml,median,,,IQR,1.82,3.55,,9th intermittent bolus dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3070,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,Peak concentration,,,3.61,ng/ml,median,,,IQR,2.91,4.51,,12th intermittent bolus dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3071,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,Peak concentration,,,0.41,ng/ml,median,,,IQR,0.33,0.48,,2nd intermittent bolus dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3072,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,Trough concentration,,,0.48,ng/ml,median,,,IQR,0.43,0.83,,6rd intermittent bolus dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3073,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,Trough concentration,,,0.37,ng/ml,median,,,IQR,0.37,0.48,,9th intermittent bolus dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3074,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,Trough concentration,,,0.97,ng/ml,median,,,IQR,0.56,1.25,,12th intermittent bolus dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3075,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,53.0,Cmax0-24,,,0.78,ng/ml,median,,,IQR,0.49,1.73,<0.001,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3076,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,Cmax0-24,,,3.06,ng/ml,median,,,IQR,1.09,4.5,<0.001,intermittent bolus doses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3077,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,53.0,Cmin0-24,,,0.4,ng/ml,median,,,IQR,0.33,0.45,0.51,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3078,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,Cmin0-24,,,0.39,ng/ml,median,,,IQR,0.32,0.49,0.51,intermittent bolus doses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3079,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,53.0,AUC0-24,,,13.2,ug h/L,median,,,IQR,10.8,22.6,0.12,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3080,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,AUC0-24,,,19.6,ug h/L,median,,,IQR,10.4,33.5,0.12,intermittent bolus doses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3081,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,7.0,Cmax0-24,,,1.22,ng/ml,median,,,IQR,0.88,2.03,0.01,"continuous infusion, <32 weeks group",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3082,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,8.0,Cmax0-24,,,4.21,ng/ml,median,,,IQR,1.92,5,0.01,"intermittent bolus doses, <32 weeks group",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3083,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,7.0,Cmin0-24,,,0.43,ng/ml,median,,,IQR,0.42,0.69,0.09,"continuous infusion, <32 weeks group",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3084,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,8.0,Cmin0-24,,,0.54,ng/ml,median,,,IQR,0.46,0.94,0.09,"intermittent bolus doses, <32 weeks group",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3085,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,7.0,AUC0-24,,,14.08,ug h/L,median,,,IQR,11.03,27.02,0.24,"continuous infusion, <32 weeks group",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3086,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,8.0,AUC0-24,,,35.9,ug h/L,median,,,IQR,12.33,38.18,0.24,"intermittent bolus doses, <32 weeks group",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3087,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,53.0,CL,,,4.1,L/h,median,,,IQR,2,6.4,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3088,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,53.0,T1/2,,,8.4,h,median,,,IQR,7.9,9.7,0.002,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3089,2025-12-02T16:03:31.981487
30322973.0,fentanyl ,fentanyl ,blood,pediatric,,neonates,47.0,T1/2,,,26.7,h,median,,,IQR,8.1,65.2,0.002,intermittent bolus doses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3090,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,16.0,concentration,10,min,0.18,ng/ml,median,,,minmax,0.14,0.99,,0.5 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3091,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,7.0,concentration,10,min,0.57,ng/ml,median,,,minmax,0.33,0.71,,2 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3092,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,15.0,concentration,2,h,0.15,ng/ml,median,,,minmax,0.14,0.29,,0.5 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3093,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,6.0,concentration,2,h,0.37,ng/ml,median,,,minmax,0.27,1.34,,2 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3094,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,10.0,concentration,4,h,0.15,ng/ml,median,,,minmax,0.14,0.19,,0.5 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3095,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,6.0,concentration,4,h,0.35,ng/ml,median,,,minmax,0.17,0.56,,2 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3096,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,4.0,concentration,8,h,0.32,ng/ml,median,,,minmax,0.15,0.39,,2 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3097,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,2.0,concentration,24,h,0.16,ng/ml,median,,,minmax,0.15,0.17,,2 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3098,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,9.0,T1/2,,,12.5,h,mean,SD,6.64,minmax,1.6,20.5,,0.5 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3099,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,5.0,T1/2,,,16,h,mean,SD,13.5,minmax,4.14,32.6,,2 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3100,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,9.0,Volume of distribution,,,2.44,L/kg,mean,SD,0.87,minmax,0.52,3.21,,0.5 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3101,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,5.0,Volume of distribution,,,4.53,L/kg,mean,SD,1.24,minmax,3.52,6.68,,2 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3102,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,9.0,CL,,,0.16,L/kg/h,mean,SD,0.07,minmax,0.11,0.3,,0.5 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3103,2025-12-02T16:03:31.981487
30721546.0,fentanyl ,fentanyl ,blood,pediatric,,preterm infants ,5.0,CL,,,0.36,L/kg/h,mean,SD,0.28,minmax,0.09,0.71,,2 ug/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3104,2025-12-02T16:03:31.981487
31168770.0,fentanyl ,fentanyl ,blood,pediatric,,children ,66.0,concentration,,,2.29,ng/ml,median,,,minmax,0.11,84.32,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3105,2025-12-02T16:03:31.981487
33855449.0,fosfomycin ,fosfomycin ,CSF,pediatric,,neonates,15.0,concentration,,,37.6,mg/L,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3116,2025-12-02T16:03:31.981487
33855449.0,fosfomycin ,fosfomycin ,blood,pediatric,,neonates,58.0,concentration,,,201.7,mg/L,mean,,,,,,,following the first IV dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3117,2025-12-02T16:03:31.981487
33855449.0,fosfomycin ,fosfomycin ,blood,pediatric,,neonates,58.0,concentration,,,70.1,mg/L,mean,,,,,,,following the first oral dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3118,2025-12-02T16:03:31.981487
33041716.0,Fosphenytoin ,phenytoin,blood,pediatric,,Infants and Neonates,12.0,free phenytoin concentration,,,2.45,mg/L,mean,SD,0.54,,,,0.747,15 mg/kg Group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3119,2025-12-02T16:03:31.981487
33041716.0,Fosphenytoin ,phenytoin,blood,pediatric,,Infants and Neonates,29.0,free phenytoin concentration,,,2.52,mg/L,mean,SD,0.66,,,,0.747,20 mg/kg Group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3120,2025-12-02T16:03:31.981487
33041716.0,Fosphenytoin ,phenytoin,blood,pediatric,,Infants and Neonates,16.0,free phenytoin concentration,,,2.53,mg/L,mean,SD,0.68,,,,0.883,patients achieved seizure cessation,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3121,2025-12-02T16:03:31.981487
33041716.0,Fosphenytoin ,phenytoin,blood,pediatric,,Infants and Neonates,25.0,free phenytoin concentration,,,2.5,mg/L,mean,SD,0.6,,,,0.883,patients did not achieve seizure cessation,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3122,2025-12-02T16:03:31.981487
33041716.0,Fosphenytoin ,phenytoin,blood,pediatric,,Infants and Neonates,3.0,free phenytoin concentration,,,2,mg/L,mean,SD,0.46,,,,0.0759,"In 15 mg/kg Group, patients achieved seizure cessation",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3123,2025-12-02T16:03:31.981487
33041716.0,Fosphenytoin ,phenytoin,blood,pediatric,,Infants and Neonates,9.0,free phenytoin concentration,,,2.6,mg/L,mean,SD,0.5,,,,0.0759,"In 15 mg/kg Group, patients without seizure cessation",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3124,2025-12-02T16:03:31.981487
33041716.0,Fosphenytoin ,phenytoin,blood,pediatric,,Infants and Neonates,13.0,free phenytoin concentration,,,2.65,mg/L,mean,SD,0.67,,,,0.4275,"In 20 mg/kg Group, patients achieved seizure cessation",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3125,2025-12-02T16:03:31.981487
33041716.0,Fosphenytoin ,phenytoin,blood,pediatric,,Infants and Neonates,16.0,free phenytoin concentration,,,2.45,mg/L,mean,SD,0.66,,,,0.4275,"In 20 mg/kg Group, patients without seizure cessation",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3126,2025-12-02T16:03:31.981487
35879140.0,Fosphenytoin ,phenytoin,blood,pediatric,,children ,12.0,concentration after the loading dose,2-4,h,13.4,ug/mL,median,,,minmax,8.6,18.9,,at 24 h after the loading dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3130,2025-12-02T16:03:31.981487
35879140.0,Fosphenytoin ,phenytoin,blood,pediatric,,children ,10.0,trough concentration of  maintenance doses,,,11.4,ug/mL,median,,,minmax,3,19.4,,patients whose Alb levels >= 3.5 g/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3131,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,13.0,AUC0-6,,,33.5,ug h/ml,median,,,minmax,16.7,68.9,,2-5 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3132,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,11.0,AUC0-6,,,16.8,ug h/ml,median,,,minmax,7.7,47.5,,6-10 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3133,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,4.0,AUC0-6,,,35.3,ug h/ml,median,,,minmax,21.6,68.9,,"2-5 yrs, 15-20 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3134,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,AUC0-6,,,36.6,ug h/ml,median,,,minmax,16.7,41.5,,"2-5 yrs,  >20 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3135,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,4.0,AUC0-6,,,13.4,ug h/ml,median,,,minmax,9.5,24.9,,"6-10 yrs, 7.5-10 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3136,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,7.0,AUC0-6,,,21.8,ug h/ml,median,,,minmax,7.7,47.5,,"6-10 yrs, 10-15 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3137,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,13.0,Tmax,,,2,h,median,,,minmax,1,6,,2-5 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3138,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,11.0,Tmax,,,2,h,median,,,minmax,1,6,,6-10 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3139,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,4.0,Tmax,,,1.5,h,median,,,minmax,1,2,,"2-5 yrs, 15-20 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3140,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,Tmax,,,1,h,median,,,minmax,1,6,,"2-5 yrs,  >20 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3141,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,4.0,Tmax,,,4,h,median,,,minmax,2,6,,"6-10 yrs, 7.5-10 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3142,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,7.0,Tmax,,,2,h,median,,,minmax,1,6,,"6-10 yrs, 10-15 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3143,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,13.0,Cmax,,,8.2,ug/ml,median,,,minmax,4.6,21,,2-5 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3144,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,11.0,Cmax,,,4.8,ug/ml,median,,,minmax,2.3,14.3,,6-10 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3145,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,4.0,Cmax,,,7.9,ug/ml,median,,,minmax,6,21,,"2-5 yrs, 15-20 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3146,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,Cmax,,,8.5,ug/ml,median,,,minmax,5.1,12.5,,"2-5 yrs,  >20 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3147,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,4.0,Cmax,,,3.2,ug/ml,median,,,minmax,2.4,5.4,,"6-10 yrs, 7.5-10 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3148,2025-12-02T16:03:31.981487
30803975.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,7.0,Cmax,,,5.5,ug/ml,median,,,minmax,2.3,14.3,,"6-10 yrs, 10-15 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3149,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,Tmax,,,2,h,median,,,IQR,1,2,0.32,WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3150,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,Tmax,,,1,h,median,,,IQR,1,2,0.32,Higher-than-WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3151,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,T1/2,,,4.4,h,median,,,IQR,2.3,9.1,0.12,WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3152,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,T1/2,,,5.4,h,median,,,IQR,4.6,7.9,0.12,Higher-than-WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3153,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,Cmax,,,10.5,mg/L,mean,,,95% CI,7.3,15.1,0.07,WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3154,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,Cmax,,,16.7,mg/L,mean,,,95% CI,10.3,27.1,0.07,Higher-than-WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3155,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,AUC0-24,,,80.6,mg h/L,mean,,,95% CI,58,112,0.02,WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3156,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,AUC0-24,,,137.6,mg h/L,mean,,,95% CI,93.5,202.4,0.02,Higher-than-WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3157,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,Volume of distribution,,,30.6,L,mean,,,95% CI,14.2,66.2,0.29,WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3158,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,Volume of distribution,,,44.3,L,mean,,,95% CI,27.2,71.9,0.29,Higher-than-WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3159,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,CL,,,4.6,l/h,mean,,,95% CI,2.3,9,0.67,WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3160,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,CL,,,5.2,l/h,mean,,,95% CI,3.1,8.9,0.67,Higher-than-WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3161,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,fAUC/MIC,,,60.4,,mean,,,95% CI,43.5,84,0.02,WHO dosage group (15-20 mg/kg/day); fAUC as determined using a protein unbound fraction of 0.75 and MIC of 1 mg/l,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3162,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,fAUC/MIC,,,103.2,,mean,,,95% CI,70.1,151.8,0.02,Higher-than-WHO dosage group (15-20 mg/kg/day); fAUC as determined using a protein unbound fraction of 0.75 and MIC of 1 mg/l,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3163,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,fAUC/MIC,,,120.8,,mean,,,95% CI,87,168,0.02,WHO dosage group (15-20 mg/kg/day). fAUC as determined using a protein unbound fraction of 0.75 and MIC of 0.5 mg/l,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3164,2025-12-02T16:03:31.981487
35842213.0,Levofloxacin,Levofloxacin,blood,pediatric,,children ,5.0,fAUC/MIC,,,206.4,,mean,,,95% CI,140.3,303.6,0.02,Higher-than-WHO dosage group (15-20 mg/kg/day). fAUC as determined using a protein unbound fraction of 0.75 and MIC of 0.5 mg/l,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3165,2025-12-02T16:03:31.981487
34213821.0,Lidocaine,Lidocaine,blood,pediatric,,children ,50.0,concentration,5,min,2575.8,ng/ml,mean,SD,1185.47,minmax,88.7,5630,,time post lidocaine administration ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3166,2025-12-02T16:03:31.981487
34213821.0,Lidocaine,Lidocaine,blood,pediatric,,children ,50.0,concentration,10,min,2960,ng/ml,mean,SD,1154.45,minmax,191,5440,,time post lidocaine administration ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3167,2025-12-02T16:03:31.981487
34213821.0,Lidocaine,Lidocaine,blood,pediatric,,children ,50.0,concentration,15,min,2851,ng/ml,mean,SD,1078.01,minmax,245,5530,,time post lidocaine administration ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3168,2025-12-02T16:03:31.981487
34213821.0,Lidocaine,Lidocaine,blood,pediatric,,children ,50.0,concentration,20,min,2614,ng/ml,mean,SD,986.85,minmax,252,5290,,time post lidocaine administration ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3169,2025-12-02T16:03:31.981487
34213821.0,Lidocaine,Lidocaine,blood,pediatric,,children ,50.0,Peak concentration,,,3275,ng/ml,mean,SD,1164.43,minmax,252,5630,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3170,2025-12-02T16:03:31.981487
34213821.0,Lidocaine,Lidocaine,blood,pediatric,,children ,50.0,time to peak concentration,,,10,min,median,,,IQR,10,15,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3171,2025-12-02T16:03:31.981487
34213821.0,Lidocaine,Lidocaine,blood,pediatric,,children ,50.0,time to peak concentration,,,,min,,,,minmax,5,20,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3172,2025-12-02T16:03:31.981487
34213821.0,Lidocaine,Lidocaine,blood,pediatric,,children ,50.0,Plasma concentration above toxicity level of 5000ng/ml,,,4,,N,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3173,2025-12-02T16:03:31.981487
31646767.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,neonates,64.0,concentration,,,849,ng/ml,median,,,minmax,1.07,12700,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3174,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,concentration,0,min,BLQ,,,,,,,,,pre-infusion ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3175,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,blood,maternal,lactation,,12.0,concentration,0,min,BLQ,,,,,,,,,pre-infusion ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3176,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,concentration,30,min,1,ug/ml,mean,SD,1.61,minmax,0.009,2.69,,at 30th minutes of infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3177,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,blood,maternal,lactation,,12.0,concentration,30,min,3.33,ug/ml,mean,SD,0.81,minmax,0.87,7.12,,at 30th minutes of infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3178,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,concentration,,,2.09,ug/ml,mean,SD,1.96,minmax,0.27,3.28,,end of infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3179,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,blood,maternal,lactation,,12.0,concentration,,,6.09,ug/ml,mean,SD,0.91,minmax,3.26,9.16,,end of infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3180,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,concentration,1,h,1.9,ug/ml,mean,SD,1.05,minmax,1.35,2.32,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3181,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,blood,maternal,lactation,,12.0,concentration,1,h,5.24,ug/ml,mean,SD,0.39,minmax,3.16,7.09,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3182,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,concentration,2,h,1.17,ug/ml,mean,SD,0.7,minmax,0.73,1.46,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3183,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,blood,maternal,lactation,,12.0,concentration,2,h,2.44,ug/ml,mean,SD,0.2,minmax,1.5,3.19,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3184,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,concentration,4,h,0.59,ug/ml,mean,SD,0.71,minmax,0.39,0.68,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3185,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,blood,maternal,lactation,,12.0,concentration,4,h,2.18,ug/ml,mean,SD,0.13,minmax,1.01,2.93,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3186,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,concentration,8,h,0.04,ug/ml,mean,SD,0.57,minmax,0,0.2,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3187,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,blood,maternal,lactation,,12.0,concentration,8,h,0.42,ug/ml,mean,SD,0.09,minmax,0,1.36,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3188,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,concentration,12,h,BLQ,ug/ml,mean,SD,,minmax,,,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3189,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,blood,maternal,lactation,,12.0,concentration,12,h,0.56,ug/ml,mean,SD,0,minmax,0.56,0.56,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3190,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,concentration,24,h,BLQ,ug/ml,mean,SD,,minmax,,,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3191,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,blood,maternal,lactation,,12.0,concentration,24,h,BLQ,ug/ml,mean,SD,,minmax,,,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3192,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk and blood,maternal,lactation,,12.0,S/MAUC,30,min,2.65,,,,,,,,,at 30th minutes of infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3193,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk and blood,maternal,lactation,,12.0,S/MAUC,,,2.73,,,,,,,,,end of infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3194,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk and blood,maternal,lactation,,12.0,S/MAUC,1,h,2.9,,,,,,,,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3195,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk and blood,maternal,lactation,,12.0,S/MAUC,2,h,2.72,,,,,,,,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3196,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk and blood,maternal,lactation,,12.0,S/MAUC,4,h,2.86,,,,,,,,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3197,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk and blood,maternal,lactation,,12.0,S/MAUC,8,h,4.93,,,,,,,,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3198,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk and blood,maternal,lactation,,12.0,S/MAUC,12,h,4.93,,,,,,,,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3199,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk and blood,maternal,lactation,,12.0,S/MAUC,24,h,9.81,,,,,,,,,time after infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3200,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,AUC0-24,,,11.12,ug h/ml,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3201,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,blood,maternal,lactation,,12.0,AUC0-24,,,41.01,ug h/ml,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3202,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,Cav,,,0.46,ug/ml,mean,,,,,,,average drug concentration across the dose interval ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3203,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,blood,maternal,lactation,,12.0,Cav,,,1.71,ug/ml,mean,,,,,,,average drug concentration across the dose interval ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3204,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,Absolute infant dose,,,69.5,ug/kg/day,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3205,2025-12-02T16:03:31.981487
32768896.0,Methylprednisolone ,Methylprednisolone ,breast milk,maternal,lactation,,12.0,Relative infant dose,,,0.5,%,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3206,2025-12-02T16:03:31.981487
34513939.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,children ,29.0,concentration,,,10.6,ug/L,median,,,minmax,5.3,23.3,<0.001,immediately before the initiation of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3207,2025-12-02T16:03:31.981487
34513939.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,children ,29.0,concentration,,,7.3,ug/L,median,,,minmax,4.1,7.4,<0.001,immediately after the initiation of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3208,2025-12-02T16:03:31.981487
34513939.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,children ,29.0,time difference between plasma concentration measurements immediately before and after initiation of CPB,,,13,min,median,,,minmax,7,36,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3209,2025-12-02T16:03:31.981487
34513939.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,neonates,5.0,concentration,,,7.1,ug/L,median,,,minmax,5.3,14.5,>0.05,immediately before the initiation of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3210,2025-12-02T16:03:31.981487
34513939.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,neonates,5.0,concentration,,,5.7,ug/L,median,,,minmax,4.2,7.7,>0.05,immediately after the initiation of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3211,2025-12-02T16:03:31.981487
34513939.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,infants,17.0,concentration,,,11.9,ug/L,median,,,minmax,7.1,23.3,>0.05,immediately before the initiation of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3212,2025-12-02T16:03:31.981487
34513939.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,infants,17.0,concentration,,,9,ug/L,median,,,minmax,4.5,17.4,>0.05,immediately after the initiation of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3213,2025-12-02T16:03:31.981487
34513939.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,preschool (1-4 years),7.0,concentration,,,8.3,ug/L,median,,,minmax,5.9,14.8,>0.05,immediately before the initiation of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3214,2025-12-02T16:03:31.981487
34513939.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,preschool (1-4 years),7.0,concentration,,,6.1,ug/L,median,,,minmax,4.1,10.2,>0.05,immediately after the initiation of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3215,2025-12-02T16:03:31.981487
34513939.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,school (4-12 years),7.0,concentration,,,10.6,ug/L,median,,,minmax,8.7,13.3,>0.05,immediately before the initiation of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3216,2025-12-02T16:03:31.981487
34513939.0,Methylprednisolone ,Methylprednisolone ,blood,pediatric,,school (4-12 years),7.0,concentration,,,7.6,ug/L,median,,,minmax,5.2,11.2,>0.05,immediately after the initiation of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3217,2025-12-02T16:03:31.981487
30456415.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,pediatrics,,,141.0,trough concentrations at steady state,,,13.4,mg/L,mean,SD,4.63,minmax,2.1,31.4,,Model building set,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3218,2025-12-02T16:03:31.981487
30456415.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,pediatrics,,,20.0,trough concentrations at steady state,,,14.54,mg/L,mean,SD,4.29,minmax,6.32,25.91,,Validation set,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3219,2025-12-02T16:03:31.981487
35037389.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,maternal,1st trimester,,0.0,ratio to target concentration,,,,,mean,SD,,,,,,patients with seizures worsening,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3222,2025-12-02T16:03:31.981487
35037389.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,maternal,1st trimester,,6.0,ratio to target concentration,,,1.12,,mean,SD,1.52,,,,,patients without increased seizure frequency,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3223,2025-12-02T16:03:31.981487
35037389.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,maternal,2nd trimester,,6.0,ratio to target concentration,,,0.71,,mean,SD,0.15,,,,0.77,patients with seizures worsening,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3224,2025-12-02T16:03:31.981487
35037389.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,maternal,2nd trimester,,6.0,ratio to target concentration,,,0.82,,mean,SD,0.69,,,,0.77,patients without increased seizure frequency,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3225,2025-12-02T16:03:31.981487
35037389.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,maternal,3rd trimester,,6.0,ratio to target concentration,,,0.63,,mean,SD,0.2,,,,0.23,patients with seizures worsening,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3226,2025-12-02T16:03:31.981487
35037389.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,maternal,3rd trimester,,6.0,ratio to target concentration,,,0.99,,mean,SD,0.48,,,,0.23,patients without increased seizure frequency,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3227,2025-12-02T16:03:31.981487
35037389.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,maternal,pregnant,,6.0,ratio to target concentration,,,0.68,,mean,SD,0.16,,,,0.44,patients with seizures worsening,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3228,2025-12-02T16:03:31.981487
35037389.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,maternal,pregnant,,6.0,ratio to target concentration,,,0.98,,mean,SD,0.91,,,,0.44,patients without increased seizure frequency,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3229,2025-12-02T16:03:31.981487
35037389.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,maternal,pregnant,,14.0,relative CL of peak CL/baseline CL,,,2.11,,,,,,,,,at the 3rd trimester,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3230,2025-12-02T16:03:31.981487
35037389.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,nonpregnancy,,,14.0,baseline level CL ,,,71,L/24 h,,,,IQR,58.4,102.1,<0.03,"Nonpregnant baseline clearance was defined as obtained before pregnancy and, if unavailable, as postpartum values after six weeks of delivery",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3231,2025-12-02T16:03:31.981487
35037389.0,Oxcarbazepine,10-monohydroxy derivative (MHD),blood,maternal,,,14.0,Relative CLat the 3rd trimester,,,150,L/24 h,,,,IQR,95.1,214.3,<0.03,The relative AED clearance (L/24 h) was calculated as the ratio of the daily dose (mg/day) to total plasma drug concentration (mg/L).,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3232,2025-12-02T16:03:31.981487
31910460.0,tazobactam,tazobactam,blood,pediatric,,"neonates and infants, >32 weeks",7.0,Vd,,,0.679,L,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3242,2025-12-02T16:03:31.981487
31910460.0,tazobactam,tazobactam,blood,pediatric,,"neonates and infants, >32 weeks",7.0,T1/2,,,1.14,h,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3243,2025-12-02T16:03:31.981487
31910460.0,tazobactam,tazobactam,blood,pediatric,,"neonates and infants, <=32 weeks",6.0,Vd,,,0.599,L,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3244,2025-12-02T16:03:31.981487
31910460.0,tazobactam,tazobactam,blood,pediatric,,"neonates and infants, <=32 weeks",6.0,T1/2,,,1.423,h,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3245,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Cmax,,,6.8,ug/ml,mean,SD,3.1,,,,0.0875,control (neostigmine),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3246,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Cmax,,,5.3,ug/ml,mean,SD,1.9,,,,0.0875,Sugammadex 2mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3247,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Cmax,,,8,ug/ml,mean,SD,2.1,,,,0.0875,Sugammadex 4mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3248,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Cmax,,,5.4,ug/ml,mean,SD,3,,,,0.0875,Sugammadex 8mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3249,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUClast,,,2.9,h ug/ml,mean,SD,0.9,,,,0.01,control (neostigmine),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3250,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUClast,,,3.7,h ug/ml,mean,SD,1,,,,0.01,Sugammadex 2mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3251,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUClast,,,4.8,h ug/ml,mean,SD,1.1,,,,0.01,Sugammadex 4mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3252,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUClast,,,4,h ug/ml,mean,SD,1.4,,,,0.01,Sugammadex 8mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3253,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUC0-15min,,,1.5,h ug/ml,mean,SD,0.4,,,,0.192,control (neostigmine),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3254,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUC0-15min,,,1.7,h ug/ml,mean,SD,0.6,,,,0.192,Sugammadex 2mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3255,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUC0-15min,,,1.8,h ug/ml,mean,SD,0.3,,,,0.192,Sugammadex 4mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3256,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUC0-15min,,,1.4,h ug/ml,mean,SD,0.5,,,,0.192,Sugammadex 8mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3257,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUC0-1h,,,2.3,h ug/ml,mean,SD,0.6,,,,0.0143,control (neostigmine),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3258,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUC0-1h,,,2.6,h ug/ml,mean,SD,0.6,,,,0.0143,Sugammadex 2mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3259,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUC0-1h,,,3.2,h ug/ml,mean,SD,0.5,,,,0.0143,Sugammadex 4mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3260,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUC0-1h,,,2.5,h ug/ml,mean,SD,0.9,,,,0.0143,Sugammadex 8mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3261,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUCinf,,,2.9,h ug/ml,mean,SD,0.9,,,,0.0098,control (neostigmine),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3262,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUCinf,,,3.7,h ug/ml,mean,SD,1,,,,0.0098,Sugammadex 2mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3263,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUCinf,,,4.9,h ug/ml,mean,SD,1.1,,,,0.0098,Sugammadex 4mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3264,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,AUCinf,,,4.3,h ug/ml,mean,SD,1.8,,,,0.0098,Sugammadex 8mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3265,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Tmax,,,0.08,h,median,,,minmax,0.03,0.22,,control (neostigmine),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3266,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Tmax,,,0.1,h,median,,,minmax,0.07,0.25,,Sugammadex 2mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3267,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Tmax,,,0.07,h,median,,,minmax,0.03,0.13,,Sugammadex 4mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3268,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Tmax,,,0.12,h,median,,,minmax,0.03,0.43,,Sugammadex 8mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3269,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,T1/2,,,1.1,h,mean,SD,0.4,,,,,control (neostigmine),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3270,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,T1/2,,,1.2,h,mean,SD,0.3,,,,,Sugammadex 2mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3271,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,T1/2,,,1.2,h,mean,SD,0.2,,,,,Sugammadex 4mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3272,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,T1/2,,,1.3,h,mean,SD,0.2,,,,,Sugammadex 8mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3273,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Vz,,,21.4,L,mean,SD,10.8,,,,,control (neostigmine),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3274,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Vz,,,14.5,L,mean,SD,11.8,,,,,Sugammadex 2mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3275,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Vz,,,10.8,L,mean,SD,3.5,,,,,Sugammadex 4mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3276,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,Vz,,,13,L,mean,SD,5.9,,,,,Sugammadex 8mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3277,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,CL,,,0.22,L/min,mean,SD,0.07,,,,,control (neostigmine),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3278,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,CL,,,0.13,L/min,mean,SD,0.08,,,,,Sugammadex 2mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3279,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,CL,,,0.11,L/min,mean,SD,0.04,,,,,Sugammadex 4mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3280,2025-12-02T16:03:31.981487
36181377.0,Rocuronium ,Rocuronium ,blood,pediatric,,children ,10.0,CL,,,0.12,L/min,mean,SD,0.05,,,,,Sugammadex 8mg/kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3281,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,children/adolescents,22.0,AUC0-24,,,12.27,h mg/ml,mean,SD,7.95,95% CI,8.74,15.8,0.575,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3282,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,children/adolescents,22.0,AUC0-24,,,11.21,h mg/ml,mean,SD,7.29,95% CI,7.98,14.45,0.575,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3283,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"children, 6-11 years",12.0,AUC0-24,,,12.26,h mg/ml,mean,SD,9.91,95% CI,5.96,18.56,0.947,nebulization with Ineb,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3284,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"children, 6-11 years",12.0,AUC0-24,,,11.65,h mg/ml,mean,SD,8.52,95% CI,6.23,17.06,0.947,nebulization with PARILC Plus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3285,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"adolescents, 12-18 years",10.0,AUC0-24,,,12.28,h mg/ml,mean,SD,5.25,95% CI,8.52,20.68,0.401,nebulization with Ineb,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3286,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"adolescents, 12-18 years",10.0,AUC0-24,,,10.7,h mg/ml,mean,SD,5.88,95% CI,6.49,20.11,0.401,nebulization with PARILC Plus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3287,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,children/adolescents,22.0,Cmax,,,2.07,mg/l,mean,SD,1.35,95% CI,1.47,2.66,0.739,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3288,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,children/adolescents,22.0,Cmax,,,1.93,mg/l,mean,SD,1.34,95% CI,1.33,2.52,0.739,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3289,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"children, 6-11 years",12.0,Cmax,,,1.82,mg/l,mean,SD,1.46,95% CI,0.89,2.74,0.661,nebulization with Ineb,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3290,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"children, 6-11 years",12.0,Cmax,,,2.05,mg/l,mean,SD,1.69,95% CI,0.97,3.12,0.661,nebulization with PARILC Plus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3291,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"adolescents, 12-18 years",10.0,Cmax,,,2.37,mg/l,mean,SD,1.21,95% CI,1.5,4.29,0.177,nebulization with Ineb,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3292,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"adolescents, 12-18 years",10.0,Cmax,,,1.79,mg/l,mean,SD,0.8,95% CI,1.22,3.07,0.177,nebulization with PARILC Plus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3293,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,children/adolescents,22.0,Ctrough,12,h,0.25,mg/l,mean,SD,0.19,95% CI,0.16,0.33,0.929,12 and 24 hours after nebulization,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3294,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,children/adolescents,22.0,Ctrough,12,h,0.25,mg/l,mean,SD,0.24,95% CI,0.15,0.36,0.929,12 and 24 hours after nebulization,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3295,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"children, 6-11 years",12.0,Ctrough,12,h,0.21,mg/l,mean,SD,0.18,95% CI,0.09,0.32,0.43,nebulization with Ineb,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3296,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"children, 6-11 years",12.0,Ctrough,12,h,0.24,mg/l,mean,SD,0.26,95% CI,0.08,0.41,0.43,nebulization with PARILC Plus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3297,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"adolescents, 12-18 years",10.0,Ctrough,12,h,0.3,mg/l,mean,SD,0.2,95% CI,0.16,0.62,0.686,nebulization with Ineb,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3298,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"adolescents, 12-18 years",10.0,Ctrough,12,h,0.1,mg/l,mean,SD,0.24,95% CI,0.1,0.65,0.686,nebulization with PARILC Plus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3299,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,children/adolescents,22.0,Ctrough,24,h,0.1,mg/l,mean,SD,0.11,95% CI,0.05,0.15,0.365,12 and 24 hours after nebulization,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3300,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,children/adolescents,22.0,Ctrough,24,h,0.13,mg/l,mean,SD,0.17,95% CI,0.05,0.2,0.365,12 and 24 hours after nebulization,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3301,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"children, 6-11 years",12.0,Ctrough,24,h,0.09,mg/l,mean,SD,0.13,95% CI,0.01,0.17,0.152,nebulization with Ineb,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3302,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"children, 6-11 years",12.0,Ctrough,24,h,0.14,mg/l,mean,SD,0.21,95% CI,0.01,0.27,0.152,nebulization with PARILC Plus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3303,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"adolescents, 12-18 years",10.0,Ctrough,24,h,0.12,mg/l,mean,SD,0.09,95% CI,0.05,0.26,0.802,nebulization with Ineb,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3304,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"adolescents, 12-18 years",10.0,Ctrough,24,h,0.11,mg/l,mean,SD,0.1,95% CI,0.04,0.27,0.802,nebulization with PARILC Plus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3305,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,children/adolescents,22.0,Tmax,,,0.57,h,mean,SD,0.41,95% CI,0.39,0.75,0.777,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3306,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,children/adolescents,22.0,Tmax,,,0.52,h,mean,SD,0.55,95% CI,0.28,0.77,0.777,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3307,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"children, 6-11 years",12.0,Tmax,,,0.49,h,mean,SD,0.25,95% CI,0.33,0.66,0.043,nebulization with Ineb,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3308,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"children, 6-11 years",12.0,Tmax,,,0.33,h,mean,SD,0.23,95% CI,0.19,0.48,0.043,nebulization with PARILC Plus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3309,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"adolescents, 12-18 years",10.0,Tmax,,,0.66,h,mean,SD,0.54,95% CI,0.28,1.53,0.764,nebulization with Ineb,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3310,2025-12-02T16:03:31.981487
31112621.0,tobramycin,tobramycin,Dried blood spot,pediatric,,"adolescents, 12-18 years",10.0,Tmax,,,0.75,h,mean,SD,0.73,95% CI,0.23,1.92,0.764,nebulization with PARILC Plus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3311,2025-12-02T16:03:31.981487
32507958.0,tobramycin,tobramycin,blood,pediatric,,neonates ,221.0,trough concentration,,,0.6,mg/L,median,,,IQR,0.3,1,,Tobramycin NICU,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3312,2025-12-02T16:03:31.981487
32507958.0,Vancomycin,Vancomycin,blood,pediatric,,children ,62.0,trough concentration,,,12.5,mg/L,median,,,IQR,8.8,20.7,,Vancomycin PICU,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3313,2025-12-02T16:03:31.981487
32507958.0,Vancomycin,Vancomycin,blood,pediatric,,neonates,102.0,trough concentration,,,12.6,mg/L,median,,,IQR,8.6,17,,Vancomycin NICU,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3314,2025-12-02T16:03:31.981487
32568427.0,tobramycin,tobramycin,blood,pediatric,,children ,34.0,Ke,,,0.41,/h,median,,,IQR,0.21,,0.5,PreCFTRmodulator,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3315,2025-12-02T16:03:31.981487
32568427.0,tobramycin,tobramycin,blood,pediatric,,children ,34.0,Ke,,,0.39,/h,median,,,IQR,0.09,,0.5,PostCFTRmodulator,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3316,2025-12-02T16:03:31.981487
32568427.0,tobramycin,tobramycin,blood,pediatric,,children ,34.0,Vd,,,0.33,L/kg,median,,,IQR,0.11,,0.99,PreCFTRmodulator,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3317,2025-12-02T16:03:31.981487
32568427.0,tobramycin,tobramycin,blood,pediatric,,children ,34.0,Vd,,,0.34,L/kg,median,,,IQR,0.09,,0.99,PostCFTRmodulator,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3318,2025-12-02T16:03:31.981487
32568427.0,tobramycin,tobramycin,blood,pediatric,,children ,34.0,Cmax,,,28.9,mcg/ml,median,,,IQR,10,,0.22,PreCFTRmodulator,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3319,2025-12-02T16:03:31.981487
32568427.0,tobramycin,tobramycin,blood,pediatric,,children ,34.0,Cmax,,,27.2,mcg/ml,median,,,IQR,8.7,,0.22,PostCFTRmodulator,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3320,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"infants/children, >31 days to <2 years",13.0,initial SS SVS,,,10.4,ug/ml,mean,SD,1.6,,,,0.077,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3321,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, 2 to <8 years",28.0,initial SS SVS,,,11.2,ug/ml,mean,SD,2.4,,,,0.077,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3322,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children/adoleschents, 8 to <18 years",18.0,initial SS SVS,,,12.5,ug/ml,mean,SD,3.4,,,,0.077,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3323,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"infants/children, >31 days to <2 years",32.0,initial SS SVS,,,13.4,ug/ml,mean,SD,4.5,,,,0.009,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3324,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, 2 to <8 years",39.0,initial SS SVS,,,13.6,ug/ml,mean,SD,3.7,,,,0.009,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3325,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children/adoleschents, 8 to <18 years",52.0,initial SS SVS,,,15.6,ug/ml,mean,SD,3.1,,,,0.009,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3326,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"infants/children, >31 days to <2 years",14.0,time to therapeutic SVC,,,1.4,days,mean,SD,0.7,,,,0.813,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3327,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, 2 to <8 years",31.0,time to therapeutic SVC,,,2.1,days,mean,SD,4.6,,,,0.813,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3328,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children/adoleschents, 8 to <18 years",14.0,time to therapeutic SVC,,,1.8,days,mean,SD,1.1,,,,0.813,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3329,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"infants/children, >31 days to <2 years",19.0,time to therapeutic SVC,,,1.9,days,mean,SD,1.6,,,,0.535,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3330,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, 2 to <8 years",23.0,time to therapeutic SVC,,,1.9,days,mean,SD,1,,,,0.535,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3331,2025-12-02T16:03:31.981487
29718415.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children/adoleschents, 8 to <18 years",54.0,time to therapeutic SVC,,,1.6,days,mean,SD,1.3,,,,0.535,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3332,2025-12-02T16:03:31.981487
29742643.0,Vancomycin ,Vancomycin ,blood,pediatric,,children/adolescents,30.0,final trough concentration,,,12.6,mg/L,median,,,IQR,11,13.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3333,2025-12-02T16:03:31.981487
29742643.0,Vancomycin ,Vancomycin ,blood,pediatric,,children/adolescents,30.0,number of patients with final trough concentration 5 to <10 mg/L,,,3,,N,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3334,2025-12-02T16:03:31.981487
29742643.0,Vancomycin ,Vancomycin ,blood,pediatric,,children/adolescents,30.0,number of patients with final trough concentration 10 to <15 mg/L,,,24,,N,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3335,2025-12-02T16:03:31.981487
29742643.0,Vancomycin ,Vancomycin ,blood,pediatric,,children/adolescents,30.0,number of patients with final trough concentration 15 to <20 mg/L,,,2,,N,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3336,2025-12-02T16:03:31.981487
29742643.0,Vancomycin ,Vancomycin ,blood,pediatric,,children/adolescents,30.0,number of patients with final trough concentration >=20 mg/L,,,1,,N,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3337,2025-12-02T16:03:31.981487
30371946.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,27.0,postdistributive concentration,,,25.1,ug/ml,median,,,IQR,21,29.9,,postdistributive concentration was obtained at least 90 minutes after the end of the infusion ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3342,2025-12-02T16:03:31.981487
30371946.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,27.0,trough cencentration,,,12.4,ug/ml,median,,,IQR,10.7,16.3,,trough concentration was drawn within 90 minutes of the next dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3343,2025-12-02T16:03:31.981487
30785491.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,10.0,Trough Cmin,,,4.12,ug/ml,median,,,IQR,2.98,4.95,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3344,2025-12-02T16:03:31.981487
30785491.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,10.0,,,,,,,,,minmax,2.68,22.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3345,2025-12-02T16:03:31.981487
30785491.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,10.0,T1/2,,,4.37,h,median,,,IQR,4.2,6.93,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3346,2025-12-02T16:03:31.981487
30785491.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,10.0,,,,,,,,,minmax,1.93,37.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3347,2025-12-02T16:03:31.981487
30785491.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,10.0,CL,,,2.2,ml/min,median,,,IQR,1.29,2.65,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3348,2025-12-02T16:03:31.981487
30785491.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,10.0,,,,,,,,,minmax,0.019,4.06,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3349,2025-12-02T16:03:31.981487
30785491.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,10.0,Kel,,,0.22,/h,median,,,IQR,0.14,0.27,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3350,2025-12-02T16:03:31.981487
30785491.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,10.0,,,,,,,,,minmax,0.02,0.49,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3351,2025-12-02T16:03:31.981487
30785491.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,10.0,Vd,,,0.6,L/kg,median,,,IQR,0.29,0.66,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3352,2025-12-02T16:03:31.981487
30785491.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,10.0,,,,,,,,,minmax,0.04,1.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3353,2025-12-02T16:03:31.981487
30937470.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,138.0,concentration,,,11.3,mg/L,mean,SD,3.4,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3354,2025-12-02T16:03:31.981487
30950674.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,22.0,Vd,,,3.62,L,mean,SD,1.94,minmax,0.31,8.88,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3355,2025-12-02T16:03:31.981487
30950674.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,22.0,Vd,,,3.5,L,median,CV%,53,IQR,2.64,4.35,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3356,2025-12-02T16:03:31.981487
30950674.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,22.0,Vd,,,0.7,L/kg,mean,SD,0.48,IQR,0.39,0.94,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3357,2025-12-02T16:03:31.981487
30950674.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,22.0,Vd,,,0.5,L/kg,median,CV%,69,minmax,0.28,2.31,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3358,2025-12-02T16:03:31.981487
30950674.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,22.0,CL,,,0.749,L/h,mean,SD,0.454,IQR,0.414,0.955,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3359,2025-12-02T16:03:31.981487
30950674.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,22.0,CL,,,0.737,L/h,median,CV%,61,minmax,0.02,1.82,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3360,2025-12-02T16:03:31.981487
30950674.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,22.0,CL,,,0.124,L/h/kg,mean,SD,0.052,IQR,0.095,0.133,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3361,2025-12-02T16:03:31.981487
30950674.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,22.0,CL,,,0.112,L/h/kg,median,CV%,42,minmax,0.025,0.268,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3362,2025-12-02T16:03:31.981487
30950674.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,22.0,T1/2,,,4.3,h,mean,SD,2.6,IQR,2.5,5.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3363,2025-12-02T16:03:31.981487
30950674.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,22.0,T1/2,,,3.8,h,median,CV%,61,minmax,1.5,11.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3364,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,Peak concentration,,,26,mg/L,median,,,IQR,22.9,31,,sample collection 12h after infusion completion ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3365,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,Peak concentration,,,,mg/L,,,,minmax,11.9,60,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3366,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,trough cencentration,,,13.4,mg/L,median,,,IQR,8.7,16.1,,sample collection 01 h before the next dose administration ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3367,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,trough cencentration,,,,mg/L,,,,minmax,0.7,39.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3368,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,Vd,,,1.48,L,mean,SD,0.79,IQR,0.89,1.96,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3369,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,Vd,,,1.36,L,median,CV%,54,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3370,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,Vd,,,0.73,L/kg,mean,SD,0.31,IQR,0.48,0.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3371,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,Vd,,,0.71,L/kg,median,CV%,42,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3372,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,CL,,,0.122,L/h,mean,SD,0.096,IQR,0.05,0.17,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3373,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,CL,,,0.08,L/h,median,CV%,79,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3374,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,CL,,,0.052,L/h/kg,mean,SD,0.02,IQR,0.039,0.064,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3375,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,CL,,,0.047,L/h/kg,median,CV%,39,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3376,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,T1/2,,,11.2,h,mean,SD,6.7,IQR,6.2,14.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3377,2025-12-02T16:03:31.981487
30983533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,T1/2,,,9.4,h,median,CV%,60,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3378,2025-12-02T16:03:31.981487
31019403.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,261.0,concentration,,,11.5,mg/L,mean,SD,5.5,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3379,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,20.0,concentration at first dose,,,6.7,mg/L,mean,SD,4.4,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3380,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,63.0,concentration at steady state,,,9,mg/L,mean,SD,6.3,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3381,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,20.0,CL,,,4.5,L/hr,median,,,minmax,1.4,16.9,,At first dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3382,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,63.0,CL,,,4.8,L/hr,median,,,minmax,0.9,28.3,,At steady state,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3383,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,20.0,Vd,,,0.1,L/kg,median,,,minmax,0.01,0.3,,At first dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3384,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,63.0,Vd,,,0.1,L/kg,median,,,minmax,0.01,0.5,,At steady state,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3385,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,20.0,T1/2,,,7.7,h,median,,,minmax,2,23.9,,At first dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3386,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,63.0,T1/2,,,7.2,h,median,,,minmax,1.2,38.4,,At steady state,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3387,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,20.0,AUCinf,,,120.3,mg h/L,median,,,minmax,20.4,376.7,,At first dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3388,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,63.0,AUCinf,,,116.4,mg h/L,median,,,minmax,15,629.4,,At steady state,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3389,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,20.0,AUC0-24,,,323.6,mg h/L,median,,,minmax,61.1,1130.1,,At first dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3390,2025-12-02T16:03:31.981487
31301023.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,63.0,AUC0-24,,,375.5,mg h/L,median,,,minmax,36.1,2029.2,,At steady state,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3391,2025-12-02T16:03:31.981487
31342543.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,43.0,Peak concentration,,,18,mg/l,median,,,minmax,6.1,34,,2 hours after infusion completion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3392,2025-12-02T16:03:31.981487
31342543.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,43.0,trough cencentration,,,10.6,mg/l,median,,,minmax,2.8,23.8,,within30 minutes before the next dosing,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3393,2025-12-02T16:03:31.981487
31342543.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,4.0,trough cencentration,,,15.1,mg/l,median,,,minmax,7.6,16,,Patients developed AKI after vancomycin administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3394,2025-12-02T16:03:31.981487
31342543.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,4.0,AUC24,,,568,mg h/L,median,,,minmax,392,610,,Patients developed AKI after vancomycin administration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3395,2025-12-02T16:03:31.981487
31403243.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,201.0,Cmin,,,7.6,mg/L,median,,,IQR,3.6,8.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3396,2025-12-02T16:03:31.981487
31403243.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,201.0,Cmin,,,,,,,,minmax,1.1,17.9,,within 30 minutes before a dose or after the end of infusion at steady state,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3397,2025-12-02T16:03:31.981487
31911739.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,12.0,Cssmax,,,40.94,ug/mL,mean,SD,15.07,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3398,2025-12-02T16:03:31.981487
31911739.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,12.0,Tssmax,,,1,h,mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3399,2025-12-02T16:03:31.981487
31911739.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,12.0,T1/2,,,4.82,h,mean,SD,2.71,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3400,2025-12-02T16:03:31.981487
31911739.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,12.0,T1/2,,,3.78,h,median,,,minmax,2.44,11.88,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3401,2025-12-02T16:03:31.981487
31911739.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,12.0,AUCss0-8h,,,124.15,ug/mL,mean,SD,51.27,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3402,2025-12-02T16:03:31.981487
31911739.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,12.0,Vd,,,12.48,L,mean,SD,4.43,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3403,2025-12-02T16:03:31.981487
31911739.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,12.0,CL,,,2.08,mL/min,mean,SD,0.89,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3404,2025-12-02T16:03:31.981487
31911739.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,12.0,AUC0-24h,,,372.44,ug/mL,mean,SD,153.82,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3405,2025-12-02T16:03:31.981487
31911739.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,12.0,trough concentration,48,h,10.55,ug/mL,mean,SD,8.51,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3406,2025-12-02T16:03:31.981487
31911739.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,12.0,trough concentration,56,h,7.63,ug/mL,mean,SD,5.6,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3407,2025-12-02T16:03:31.981487
31911739.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,12.0,trough concentration,72,h,10.05,ug/mL,mean,SD,6.72,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3408,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,Ke,,,0.293,/h,mean,SD,0.09,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3409,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,Ke,,,0.297,/h,median,,,IQR,0.244,0.328,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3410,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,Vd,,,0.55,L/kg,mean,SD,0.1,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3411,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,Vd,,,0.58,L/kg,median,,,IQR,0.48,0.62,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3412,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,Vss,,,0.49,L/kg,mean,SD,0.09,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3413,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,Vss,,,0.49,L/kg,median,,,IQR,0.33,0.62,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3414,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,T1/2,,,2.65,h,mean,SD,1.12,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3415,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,T1/2,,,2.33,h,median,,,IQR,2.11,2.84,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3416,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,CL,,,2.63,mL/kg/min,mean,SD,0.69,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3417,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,CL,,,2.82,mL/kg/min,median,,,IQR,2.17,3.03,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3418,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,Ctrough,6,h,5.69,mg/L,mean,SD,3,,,,,6 hour after the first dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3419,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,Ctrough,6,h,4.81,mg/L,median,,,IQR,3.66,7.67,,6 hour after the first dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3420,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,"AUC24, ss",,,450.2,mg h/L,mean,SD,184.5,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3421,2025-12-02T16:03:31.981487
31935538.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,14.0,"AUC24, ss",,,359,mg h/L,median,,,IQR,320.3,576.2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3422,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,trough cencentration,,,17.86,mg/L,mean,SD,10.04,,,,<0.001,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3423,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,trough cencentration,,,15,mg/L,median,,,IQR,10.5,24.2,,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3424,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,trough cencentration,,,10.94,mg/L,mean,SD,6.93,,,,<0.001,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3425,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,trough cencentration,,,8.3,mg/L,median,,,IQR,6.65,13.6,,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3426,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,Peak concentration,,,31.51,mg/L,mean,SD,12.82,,,,<0.001,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3427,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,Peak concentration,,,29.4,mg/L,median,,,IQR,21.6,39.7,,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3428,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,Peak concentration,,,23.43,mg/L,mean,SD,9.65,,,,<0.001,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3429,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,Peak concentration,,,21.1,mg/L,median,,,IQR,16.85,27.2,,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3430,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,Vd,,,0.63,L/kg,mean,SD,0.3,,,,0.596,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3431,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,Vd,,,0.55,L/kg,median,,,IQR,0.48,0.72,,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3432,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,Vd,,,0.57,L/kg,mean,SD,0.14,,,,0.596,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3433,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,Vd,,,0.56,L/kg,median,,,IQR,0.46,0.68,,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3434,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,T1/2,,,17.45,h,mean,SD,11.01,,,,<0..001,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3435,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,T1/2,,,13.7,h,median,,,IQR,9.62,22.4,,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3436,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,T1/2,,,5.92,h,mean,SD,2.7,,,,<0..001,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3437,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,T1/2,,,5.5,h,median,,,IQR,3.97,7.38,,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3438,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,k,,,0.06,/h,mean,SD,0.04,,,,<0..001,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3439,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,k,,,0.14,/h,mean,SD,0.06,,,,<0..001,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3440,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,CL,,,0.03,L/kg/h,mean,SD,0.02,,,,<0..001,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3441,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,CL,,,0.03,L/kg/h,median,,,IQR,0.02,0.04,,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3442,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,CL,,,0.08,L/kg/h,mean,SD,0.05,,,,<0..001,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3443,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,25.0,CL,,,0.07,L/kg/h,median,,,IQR,0.05,0.09,,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3444,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,17.0,Vd,,,0.75,L/kg,mean,SD,0.41,,,,0.141,SCr <0.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3445,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,26.0,Vd,,,0.62,L/kg,mean,SD,0.27,,,,0.141,SCr 0.5-0.9 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3446,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,14.0,Vd,,,0.51,L/kg,mean,SD,0.18,,,,0.141,SCr 1-1.4 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3447,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,15.0,Vd,,,0.63,L/kg,mean,SD,0.3,,,,0.141,SCr >=1.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3448,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,17.0,T1/2,,,11.52,h,mean,SD,6.31,,,,<0.001,SCr <0.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3449,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,26.0,T1/2,,,12.31,h,mean,SD,4.88,,,,<0.001,SCr 0.5-0.9 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3450,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,14.0,T1/2,,,16.13,h,mean,SD,6.93,,,,<0.001,SCr 1-1.4 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3451,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,15.0,T1/2,,,31.53,h,mean,SD,11.45,,,,<0.001,SCr >=1.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3452,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,17.0,k,,,0.08,/h,mean,SD,0.04,,,,<0.001,SCr <0.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3453,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,26.0,k,,,0.07,/h,mean,SD,0.03,,,,<0.001,SCr 0.5-0.9 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3454,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,14.0,k,,,0.05,/h,mean,SD,0.17,,,,<0.001,SCr 1-1.4 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3455,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,15.0,k,,,0.06,/h,mean,SD,0.04,,,,<0.001,SCr >=1.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3456,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,17.0,CL,,,0.05,L/kg/h,mean,SD,0.02,,,,<0.002,SCr <0.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3457,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,26.0,CL,,,0.04,L/kg/h,mean,SD,0.02,,,,<0.003,SCr 0.5-0.9 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3458,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,14.0,CL,,,0.02,L/kg/h,mean,SD,0.01,,,,<0.004,SCr 1-1.4 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3459,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,15.0,CL,,,0.01,L/kg/h,mean,SD,0.02,,,,<0.005,SCr >=1.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3460,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,13.0,Vd,,,0.75,L/kg,mean,SD,0.41,,,,0.069,SCr <0.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3461,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,26.0,Vd,,,0.59,L/kg,mean,SD,0.41,,,,0.069,SCr <0.5 mg/dL in patients without ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3462,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,13.0,T1/2,,,11.52,h,mean,SD,6.31,,,,,SCr <0.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3463,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,13.0,T1/2,,,10.59,h,median,,,IQR,6.7,14.75,<0.001,SCr <0.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3464,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,26.0,T1/2,,,5.44,h,mean,SD,2.36,,,,,SCr <0.5 mg/dL in patients without ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3465,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,26.0,T1/2,,,5.06,h,median,,,IQR,3.7,6.71,<0.001,SCr <0.5 mg/dL in patients without ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3466,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,13.0,k,,,0.08,/h,mean,SD,0.04,,,,<0.001,SCr <0.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3467,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,26.0,k,,,0.15,/h,mean,SD,0.06,,,,<0.001,SCr <0.5 mg/dL in patients without ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3468,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,13.0,CL,,,0.05,L/kg/h,mean,SD,0.02,,,,0.001,SCr <0.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3469,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,26.0,CL,,,0.05,L/kg/h,median,,,IQR,0.03,0.06,,SCr <0.5 mg/dL in patients without ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3470,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,13.0,CL,,,0.09,L/kg/h,mean,SD,0.05,,,,0.001,SCr <0.5 mg/dL in patients undergoing ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3471,2025-12-02T16:03:31.981487
32296501.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,26.0,CL,,,0.08,L/kg/h,median,,,IQR,0.06,0.1,,SCr <0.5 mg/dL in patients without ECMO,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3472,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children ,60.0,initial steady-state trough concentration,,,3.2,mg/L,mean,SD,1,,,,"<0.001, Lower-Trough vs
High-Trough",Lower-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3473,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children ,30.0,initial steady-state trough concentration,,,17.5,mg/L,mean,SD,7.7,,,,,High-Trough cohort (reference),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3474,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children ,60.0,initial steady-state trough concentration,,,7,mg/L,mean,SD,1.4,,,,"<0.001, Low-Trough vs
High-Trough",Low-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3475,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children ,18.0,initial steady-state trough concentration,,,3.4,mg/L,mean,SD,1.2,,,,"<0.001, Lower-Trough vs
High-Trough",Lower-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3476,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,15.0,initial steady-state trough concentration,,,15.3,mg/L,mean,SD,4.3,,,,,High-Trough cohort (reference),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3477,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,22.0,initial steady-state trough concentration,,,7.4,mg/L,mean,SD,1.5,,,,"<0.001, Low-Trough vs
High-Trough",Low-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3478,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,42.0,initial steady-state trough concentration,,,3.1,mg/L,mean,SD,1,,,,"<0.001, Lower-Trough vs
High-Trough",Lower-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3479,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,15.0,initial steady-state trough concentration,,,19.7,mg/L,mean,SD,9.7,,,,,High-Trough cohort (reference),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3480,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,38.0,initial steady-state trough concentration,,,6.9,mg/L,mean,SD,1.3,,,,"<0.001, Low-Trough vs
High-Trough",Low-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3481,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children ,60.0,Final steady-state trough concentration,,,5.3,mg/L,mean,SD,3.3,,,,"<0.001, Lower-Trough vs
High-Trough",Lower-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3482,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children ,30.0,Final steady-state trough concentration,,,14.4,mg/L,mean,SD,7.9,,,,,High-Trough cohort (reference),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3483,2025-12-02T16:03:31.981487
32636687.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children ,60.0,Final steady-state trough concentration,,,10.1,mg/L,mean,SD,6.2,,,,"0.005, Low-Trough vs
High-Trough",Low-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3484,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,77.0,Initial trough concentration,,,9.2,mg/dL,mean,,,,,,<0.0001,Standard dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3485,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,74.0,Initial trough concentration,,,13,mg/dL,mean,,,,,,<0.0001,Loading dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3486,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,77.0,No troughs <10 mg/dL,,,29.3,%,mean,,,,,,0.0002,Standard dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3487,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,74.0,No troughs <10 mg/dL,,,57.5,%,mean,,,,,,0.0002,Loading dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3488,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,77.0,Initial trough >10 mg/dL,,,32.9,%,mean,,,,,,<0.0001,Standard dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3489,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,74.0,Initial trough >10 mg/dL,,,64.4,%,mean,,,,,,<0.0001,Loading dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3490,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,77.0,Therapeutic initial trough,,,10.4,%,mean,,,,,,<0.0001,Standard dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3491,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,74.0,Therapeutic initial trough,,,37,%,mean,,,,,,<0.0001,Loading dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3492,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,77.0,Time to therapeutic trough,,,58.8,h,mean,,,,,,0.0118,Standard dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3493,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,74.0,Time to therapeutic trough,,,41.1,h,mean,,,,,,0.0118,Loading dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3494,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,77.0,Therapeutic trough concentration at some point during therapy,,,32.9,%,mean,,,,,,0.0081,Standard dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3495,2025-12-02T16:03:31.981487
32641912.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,74.0,Therapeutic trough concentration at some point during therapy,,,52.1,%,mean,,,,,,0.0081,Loading dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3496,2025-12-02T16:03:31.981487
32922785.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,28.0,initial trough concentration,,,7.3,ug/ml,mean,SD,3.2,,,,0.014,2-5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3497,2025-12-02T16:03:31.981487
32922785.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,19.0,initial trough concentration,,,8.2,ug/ml,mean,SD,3.5,,,,0.014,6-12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3498,2025-12-02T16:03:31.981487
32922785.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children ,28.0,initial trough concentration,,,10.1,ug/ml,mean,SD,3.8,,,,0.014,1-23 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3499,2025-12-02T16:03:31.981487
32984899.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,100.0,trough cencentration,,,16.9,mg/L,mean,SD,11.4,,,,0.003,on postoperative day (POD) 2  after paediatric cardio-surgery ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3500,2025-12-02T16:03:31.981487
32984899.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,100.0,trough cencentration,,,14.6,mg/L,mean,SD,8.5,,,,0.003,on postoperative day (POD) 3 after paediatric cardio-surgery ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3501,2025-12-02T16:03:31.981487
33053028.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,22.0,Peak concentration,1,h,21,mg/L,median,,,IQR,19,27,,at the 3rd hour after the beginning of the infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3502,2025-12-02T16:03:31.981487
33053028.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,22.0,trough cencentration,6,h,9,mg/L,median,,,IQR,6,11,,at the 5th hour after the beginning of the infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3503,2025-12-02T16:03:31.981487
33053028.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, <7 years",11.0,AUCss0-24,,,310,mg h/L,median,,,IQR,267,478,0.6693,G1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3504,2025-12-02T16:03:31.981487
33053028.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, >=7 years",11.0,AUCss0-24,,,236,mg h/L,median,,,IQR,340,465,0.6693,G2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3505,2025-12-02T16:03:31.981487
33053028.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, <7 years",11.0,CLT,,,2.7,mL/kg,median,,,IQR,2.3,3,0.015,G1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3506,2025-12-02T16:03:31.981487
33053028.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, >=7 years",11.0,CLT,,,2,mL/kg,median,,,IQR,1.5,2.2,0.015,G2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3507,2025-12-02T16:03:31.981487
33053028.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, <7 years",11.0,T1/2,,,2.9,h,median,,,IQR,2.5,3.7,0.03,G1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3508,2025-12-02T16:03:31.981487
33053028.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, >=7 years",11.0,T1/2,,,4.3,h,median,,,IQR,3.6,4.9,0.03,G2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3509,2025-12-02T16:03:31.981487
33068298.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,350.0,concentration,,,11,mg/L,median,,,minmax,1,56,>0.1,model training population,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3510,2025-12-02T16:03:31.981487
33068298.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,323.0,concentration,,,11,mg/L,median,,,minmax,0,60,>0.1,model evaluation population,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3511,2025-12-02T16:03:31.981487
33070357.0,Vancomycin ,Vancomycin ,blood,pediatric,,,92.0,trough cencentration,,,7.5,mg/L,mean,SD,5.8,,,,,trough cconcentration sampled after last dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3512,2025-12-02T16:03:31.981487
33070357.0,Vancomycin ,Vancomycin ,blood,pediatric,,,92.0,trough cencentration,,,5.9,mg/L,median,,,minmax,3,49.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3513,2025-12-02T16:03:31.981487
33189901.0,Vancomycin ,Vancomycin ,CSF,pediatric,,infants,8.0,concentration,,,24.9,mg/L,median,,,minmax,2.5,230.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3514,2025-12-02T16:03:31.981487
33189901.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,5.0,concentration,,,8.6,mg/L,median,,,minmax,2.2,26.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3515,2025-12-02T16:03:31.981487
33318009.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,19.0,trough concentration,,,15.6,mg/L,mean,SD,6.59,,,,,The plasma concentration of VAN was collected immediately before administration (before 30min to 1 h).,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3516,2025-12-02T16:03:31.981487
33318009.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,19.0,trough concentration,,,15.2,mg/L,median,,,minmax,6.2,33,,The plasma concentration of VAN was collected immediately before administration (before 30min to 1 h).,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3517,2025-12-02T16:03:31.981487
33708851.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,35.0,trough concentration,,,14.9,mg/L,median,,,IQR,9.6,19.6,<0.001,continuous venovenous hemofiltration Group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3518,2025-12-02T16:03:31.981487
33708851.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,84.0,trough concentration,,,9.3,mg/L,median,,,IQR,7,13.4,<0.001,Non-continuous venovenous hemofiltration Group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3519,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,Neonates,8.0,concentration,,,26.18,mg/L,median,,,IQR,15.82,51.68,0.15,at skin incision (~1 hour after vancomycin bolus),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3520,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,Infants,12.0,concentration,,,41.51,mg/L,median,,,IQR,29.49,49.5,0.15,at skin incision (~1 hour after vancomycin bolus),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3521,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, <10 years",9.0,concentration,,,45.01,mg/L,median,,,IQR,30,51.73,0.15,at skin incision (~1 hour after vancomycin bolus),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3522,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, >=10 years",11.0,concentration,,,60.8,mg/L,median,,,IQR,44.64,69.34,0.15,at skin incision (~1 hour after vancomycin bolus),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3523,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,Neonates,8.0,concentration,,,19.52,mg/L,median,,,IQR,25.66,62,0.16,15 minutes after CPB start (CPB1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3524,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,Infants,12.0,concentration,,,37.51,mg/L,median,,,IQR,25.66,62,0.16,15 minutes after CPB start (CPB1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3525,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, <10 years",9.0,concentration,,,51.17,mg/L,median,,,IQR,29.95,62.1,0.16,15 minutes after CPB start (CPB1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3526,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, >=10 years",11.0,concentration,,,41.44,mg/L,median,,,IQR,33.22,48.23,0.16,15 minutes after CPB start (CPB1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3527,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,Neonates,8.0,concentration,,,11.56,mg/L,median,,,IQR,7.32,25.97,0.01,at the end of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3528,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,Infants,12.0,concentration,,,20.15,mg/L,median,,,IQR,16.12,32.54,0.01,at the end of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3529,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, <10 years",9.0,concentration,,,21.89,mg/L,median,,,IQR,11.72,27.86,0.01,at the end of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3530,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, >=10 years",11.0,concentration,,,27.65,mg/L,median,,,IQR,22.9,34.39,0.01,at the end of CPB,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3531,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,Neonates,8.0,concentration,,,11.42,mg/L,median,,,IQR,6.46,20.03,0.45,at the end of surgery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3532,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,Infants,12.0,concentration,,,15.29,mg/L,median,,,IQR,14.03,28.78,0.45,at the end of surgery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3533,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, <10 years",9.0,concentration,,,20.16,mg/L,median,,,IQR,16.42,22.51,0.45,at the end of surgery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3534,2025-12-02T16:03:31.981487
33789546.0,Vancomycin ,Vancomycin ,blood,pediatric,,"children, >=10 years",11.0,concentration,,,18.18,mg/L,median,,,IQR,13.66,28.29,0.45,at the end of surgery,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3535,2025-12-02T16:03:31.981487
33793589.0,Vancomycin ,Vancomycin ,blood,pediatric,,children ,73.0,initial trough concentration,,,6.4,mg/L,median,,,IQR,4.3,11.6,,sampled before the 4th or 5th dose within the 30 minutes before the next dose of vancomycin ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3536,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,65.0,time to reach a therapeutic serum level of 15-20 ug/ml,,,2,days,median,,,IQR,2,4.5,0.98,"Pre-protocl, 2016",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3537,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,65.0,time to reach a therapeutic serum level of 15-20 ug/ml,,,2,days,median,,,IQR,1,4.2,0.98,"Post-protocl, 2018",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3538,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,65.0,trough concentration,,,18.1,ug/ml,mean,SD,1.3,,,,0.208,"1st evaluation, Pre-protocl, 2016",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3539,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,65.0,trough concentration,,,21.1,ug/ml,mean,SD,2,,,,0.208,"1st evaluation,Post-protocl, 2018",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3540,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,62.0,trough concentration,,,20.5,ug/ml,mean,SD,1.5,,,,0.344,"2nd evaluation, Pre-protocl, 2016",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3541,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,64.0,trough concentration,,,22.4,ug/ml,mean,SD,1.3,,,,0.344,"2nd evaluation,Post-protocl, 2018",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3542,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,57.0,trough concentration,,,18.1,ug/ml,mean,SD,1.1,,,,0.153,"3rd evaluation, Pre-protocl, 2016",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3543,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,60.0,trough concentration,,,21.8,ug/ml,mean,SD,2.3,,,,0.153,"3rd evaluation,Post-protocl, 2018",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3544,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,37.0,trough concentration,,,17.2,ug/ml,mean,SD,1.3,,,,0.223,"4th evaluation, Pre-protocl, 2016",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3545,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,53.0,trough concentration,,,19.9,ug/ml,mean,SD,1.9,,,,0.223,"4th evaluation,Post-protocl, 2018",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3546,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,24.0,trough concentration,,,27.1,ug/ml,mean,SD,5.9,,,,0.383,"5th evaluation, Pre-protocl, 2016",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3547,2025-12-02T16:03:31.981487
33830468.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates/infants,43.0,trough concentration,,,21.5,ug/ml,mean,SD,2.4,,,,0.383,"5th evaluation,Post-protocl, 2018",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3548,2025-12-02T16:03:31.981487
33472817.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,trough concentration,,,11.88,mg/L,mean,SD,4.84,,,,0.003,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3549,2025-12-02T16:03:31.981487
33472817.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,32.0,trough concentration,,,14.3,mg/L,mean,SD,4.5,,,,0.003,Clinical cure,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3550,2025-12-02T16:03:31.981487
33472817.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,8.0,trough concentration,,,8.7,mg/L,mean,SD,4.3,,,,0.003,Clinical failure,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3551,2025-12-02T16:03:31.981487
33472817.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,AUC0-24,,,482.19,mg h/L,mean,SD,140.35,,,,0.037,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3552,2025-12-02T16:03:31.981487
33472817.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,32.0,AUC0-25,,,515.4,mg h/L,mean,SD,131.7,,,,0.037,Clinical cure,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3553,2025-12-02T16:03:31.981487
33472817.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,8.0,AUC0-26,,,404.3,mg h/L,mean,SD,122.8,,,,0.037,Clinical failure,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3554,2025-12-02T16:03:31.981487
33472817.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,40.0,CL,,,0.22,L/h,mean,SD,0.15,,,,0.386,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3555,2025-12-02T16:03:31.981487
33472817.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,32.0,CL,,,0.21,L/h,mean,SD,0.15,,,,0.386,Clinical cure,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3556,2025-12-02T16:03:31.981487
33472817.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,8.0,CL,,,0.22,L/h,mean,SD,0.14,,,,0.386,Clinical failure,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3557,2025-12-02T16:03:31.981487
33947475.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,94.0,concentration,,,13.35,ug/ml,mean,SD,10.82,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3558,2025-12-02T16:03:31.981487
33947475.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,94.0,concentration,,,10.6,ug/ml,median,,,minmax,3.31,51.93,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3559,2025-12-02T16:03:31.981487
34197665.0,Vancomycin ,Vancomycin ,blood,pediatric,,premature neonates and infants,20.0,trough concentration,,,9.3,ug/ml,median,,,minmax,3,24.9,,during Initial therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3560,2025-12-02T16:03:31.981487
34197665.0,Vancomycin ,Vancomycin ,blood,pediatric,,premature neonates and infants,20.0,trough concentration,,,12.4,ug/ml,median,,,minmax,9.1,16.1,,during maintenance therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3561,2025-12-02T16:03:31.981487
34544677.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,82.0,peak concentration,,,22.15,ug/mL,mean,SD,5.34,minmax,4.1,41.2,,half an hour after the end of the intravenous infusion (peak concentration) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3562,2025-12-02T16:03:31.981487
34544677.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,82.0,trough concentration,,,7.39,ug/mL,mean,SD,4.9,minmax,2,30.6,,half an hour before the dose (trough concentration) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3563,2025-12-02T16:03:31.981487
34612690.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,161.0,concentration,,,11.9,ug/mL,median,,,IQR,7.7,16,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3564,2025-12-02T16:03:31.981487
34612690.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,161.0,concentration,,,,ug/mL,,,,minmax,0.3,61.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3565,2025-12-02T16:03:31.981487
34645692.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,162.0,trough concetration,,,7,ug/mL,mean,SD,3.9,,,,<0.001,Underweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3566,2025-12-02T16:03:31.981487
34645692.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,599.0,trough concetration,,,7.7,ug/mL,mean,SD,4.8,,,,<0.001,Normal weight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3567,2025-12-02T16:03:31.981487
34645692.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,153.0,trough concetration,,,8.6,ug/mL,mean,SD,5.3,,,,<0.001,Overweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3568,2025-12-02T16:03:31.981487
34645692.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,185.0,trough concetration,,,9.2,ug/mL,mean,SD,5.3,,,,<0.001,Obese,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3569,2025-12-02T16:03:31.981487
34645692.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,1099.0,trough concetration,,,8,ug/mL,mean,SD,4,,,,<0.001,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3570,2025-12-02T16:03:31.981487
34645692.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,109.0,AUC,,,343,ug h/mL,mean,SD,94,,,,<0.001,Underweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3571,2025-12-02T16:03:31.981487
34645692.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,408.0,AUC,,,384,ug h/mL,mean,SD,108,,,,<0.001,Normal weight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3572,2025-12-02T16:03:31.981487
34645692.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,90.0,AUC,,,396,ug h/mL,mean,SD,119,,,,<0.001,Overweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3573,2025-12-02T16:03:31.981487
34645692.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,122.0,AUC,,,409,ug h/mL,mean,SD,108,,,,<0.001,Obese,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3574,2025-12-02T16:03:31.981487
34645692.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,729.0,AUC,,,383,ug h/mL,mean,SD,109,,,,<0.001,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3575,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,470.0,trough concentration,,,6.9,mg/L,median,,,IQR,4.5,10.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3576,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,470.0,peak concentration,,,19.3,mg/L,median,,,IQR,14.9,25.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3577,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,470.0,AUC24,,,342,mg h/L,median,,,IQR,255,455,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3578,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,Neonates,20.0,trough concentration,,,9.2,mg/L,mean,SD,5,IQR,5.9,11.7,0.026,<1 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3579,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,209.0,trough concentration,,,8.8,mg/L,mean,SD,6,IQR,4.6,11.2,0.026,1-23 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3580,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,122.0,trough concentration,,,7.7,mg/L,mean,SD,5.8,IQR,4.3,9.3,0.026,2-5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3581,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,105.0,trough concentration,,,7.2,mg/L,mean,SD,4.6,IQR,3.6,9.5,0.026,6-14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3582,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,Neonates,20.0,peak concentration,,,24.9,mg/L,mean,SD,13,IQR,18.6,25.9,0.189,<1 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3583,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,209.0,peak concentration,,,20.8,mg/L,mean,SD,9.3,IQR,15.2,25.3,0.189,1-23 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3584,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,122.0,peak concentration,,,19.5,mg/L,mean,SD,8.7,IQR,13.6,25.2,0.189,2-5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3585,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,105.0,peak concentration,,,21.5,mg/L,mean,SD,11.6,IQR,14,23.8,0.189,6-14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3586,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,Neonates,20.0,AUC24,,,409,mg h/L,mean,SD,202,IQR,273,472,0.227,<1 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3587,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,209.0,AUC24,,,378,mg h/L,mean,SD,169,IQR,262,460,0.227,1-23 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3588,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,122.0,AUC24,,,350,mg h/L,mean,SD,170,IQR,241,420,0.227,2-5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3589,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,105.0,AUC24,,,360,mg h/L,mean,SD,178,IQR,238,440,0.227,6-14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3590,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,Neonates,20.0,t1/2,,,4.41,h,mean,SD,2.46,IQR,2.95,5.06,0.03,<1 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3591,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,209.0,t1/3,,,3.27,h,mean,SD,1.8,IQR,1.99,3.98,0.03,1-23 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3592,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,122.0,t1/4,,,2.95,h,mean,SD,1.96,IQR,1.95,3.31,0.03,2-5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3593,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,105.0,t1/2,,,2.89,h,mean,SD,1.46,IQR,2.05,3.4,0.03,6-14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3594,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,Neonates,20.0,Vd,,,0.62,L/kg,mean,SD,0.27,IQR,0.43,0.8,0.78,<1 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3595,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,209.0,Vd,,,0.61,L/kg,mean,SD,0.33,IQR,0.38,0.73,0.78,1-23 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3596,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,122.0,Vd,,,0.63,L/kg,mean,SD,0.35,IQR,0.39,0.76,0.78,2-5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3597,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,105.0,Vd,,,0.57,L/kg,mean,SD,0.29,IQR,0.37,0.72,0.78,6-14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3598,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,Neonates,20.0,CL,,,0.11,L/kg/h,mean,SD,0.06,IQR,0.07,0.14,0.818,<1 month,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3599,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,209.0,CL,,,0.14,L/kg/h,mean,SD,0.07,IQR,0.1,0.18,0.818,1-23 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3600,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,122.0,CL,,,0.16,L/kg/h,mean,SD,0.08,IQR,0.1,0.2,0.818,2-5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3601,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,105.0,CL,,,0.15,L/kg/h,mean,SD,0.07,IQR,0.1,0.19,0.818,6-14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3602,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,10.0,trough concentration,,,11.7,mg/L,mean,SD,6.2,IQR,8,16.7,0.066,daily dose of vancomycin 40 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3603,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,267.0,trough concentration,,,8.4,mg/L,mean,SD,6.2,IQR,4.4,10.4,,daily dose of vancomycin 40 mg/kg/d (reference),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3604,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,119.0,trough concentration,,,10.5,mg/L,mean,SD,12.8,IQR,4.9,11.3,0.098,daily dose of vancomycin 60 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3605,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,10.0,peak concentration,,,28.9,mg/L,mean,SD,17,IQR,18.2,33.5,0.05,daily dose of vancomycin 40 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3606,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,267.0,peak concentration,,,20.2,mg/L,mean,SD,10.5,IQR,12.9,25.1,,daily dose of vancomycin 40 mg/kg/d (reference),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3607,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,119.0,peak concentration,,,24.6,mg/L,mean,SD,14.7,IQR,17.2,27.9,<0.001,daily dose of vancomycin 60 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3608,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,10.0,AUC24,,,487,mg h/L,mean,SD,255,IQR,288,604,0.074,daily dose of vancomycin 40 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3609,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,267.0,AUC24,,,363,mg h/L,mean,SD,189,IQR,230,438,,daily dose of vancomycin 40 mg/kg/d (reference),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3610,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,>=1 month,119.0,AUC24,,,455,mg h/L,mean,SD,318,IQR,303,489,<0.001,daily dose of vancomycin 60 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3611,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,180.0,trough concentration,,,8.8,mg/L,mean,SD,5.5,IQR,4.8,11.2,<0.001,eGFR 50-130 ml/min with daily dose of vancomycin 40 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3612,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,80.0,trough concentration,,,5.8,mg/L,mean,SD,3.3,IQR,3.2,7.7,<0.001,eGFR >130 ml/min with daily dose of vancomycin 40 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3613,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,86.0,trough concentration,,,10.2,mg/L,mean,SD,6.6,IQR,5.6,12.7,0.002,eGFR 50-130 ml/min with daily dose of vancomycin 60 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3614,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,29.0,trough concentration,,,6.3,mg/L,mean,SD,3,IQR,4,8.2,0.002,eGFR >130 ml/min with daily dose of vancomycin 60 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3615,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,180.0,peak concentration,,,21.7,mg/L,mean,SD,10.7,IQR,15.3,26.8,<0.001,eGFR 50-130 ml/min with daily dose of vancomycin 40 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3616,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,80.0,peak concentration,,,15.2,mg/L,mean,SD,6.6,IQR,10.1,18.7,<0.001,eGFR >130 ml/min with daily dose of vancomycin 40 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3617,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,86.0,peak concentration,,,24.9,mg/L,mean,SD,10.3,IQR,18.8,28,<0.001,eGFR 50-130 ml/min with daily dose of vancomycin 60 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3618,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,29.0,peak concentration,,,18.5,mg/L,mean,SD,6.5,IQR,13.5,21.4,<0.001,eGFR >130 ml/min with daily dose of vancomycin 60 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3619,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,180.0,AUC24,,,386,mg h/L,mean,SD,180,IQR,260,469,<0.001,eGFR 50-130 ml/min with daily dose of vancomycin 40 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3620,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,80.0,AUC24,,,268,mg h/L,mean,SD,104,IQR,180,339,<0.001,eGFR >130 ml/min with daily dose of vancomycin 40 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3621,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,86.0,AUC24,,,459,mg h/L,mean,SD,185,IQR,341,517,<0.001,eGFR 50-130 ml/min with daily dose of vancomycin 60 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3622,2025-12-02T16:03:31.981487
34664790.0,Vancomycin ,Vancomycin ,blood,pediatric,,,29.0,AUC24,,,3223,mg h/L,mean,SD,93,IQR,252,384,<0.001,eGFR >130 ml/min with daily dose of vancomycin 60 mg/kg/d,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3623,2025-12-02T16:03:31.981487
35037934.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,28.0,AUC0-24,,,338,mg h/L,median,,,IQR,265,391,,with CoNS bacteraemia,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3624,2025-12-02T16:03:31.981487
35037934.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,1.0,AUC0-24,,,362,mg h/L,,,,,,,,with MRSA bacteraemia,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3625,2025-12-02T16:03:31.981487
35037934.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,1.0,AUC0-24,,,302,mg h/L,,,,,,,,with MRSA bacteraemia,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3626,2025-12-02T16:03:31.981487
35094368.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,1600.0,CL,,,0.057,L/h/lg,median,,,minmax,0.012,0.28,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3627,2025-12-02T16:03:31.981487
35049078.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,47.0,Cmin,,,6.8,mg/L,median,,,minmax,2,18,<0.0001,Augmented renal clearance,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3628,2025-12-02T16:03:31.981487
35049078.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,47.0,Cmin,,,7.6,mg/L,mean,SD,4,,,,,Augmented renal clearance,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3629,2025-12-02T16:03:31.981487
35049078.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,19.0,Cmin,,,13.4,mg/L,median,,,minmax,4.4,36.3,<0.0001,Normal renal function,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3630,2025-12-02T16:03:31.981487
35049078.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,19.0,Cmin,,,14.2,mg/L,mean,SD,6.3,,,,,Normal renal function,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3631,2025-12-02T16:03:31.981487
35049078.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,47.0,Cmax,,,21,mg/L,median,,,minmax,11.1,50,0.0036,Augmented renal clearance,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3632,2025-12-02T16:03:31.981487
35049078.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,47.0,Cmax,,,22.7,mg/L,mean,SD,8.2,,,,,Augmented renal clearance,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3633,2025-12-02T16:03:31.981487
35049078.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,19.0,Cmax,,,32.6,mg/L,median,,,minmax,16.8,58.8,0.0036,Normal renal function,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3634,2025-12-02T16:03:31.981487
35049078.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,19.0,Cmax,,,33.7,mg/L,mean,SD,13.3,,,,,Normal renal function,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3635,2025-12-02T16:03:31.981487
35293782.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates and infants,934.0,concentration,,,13.01,mg/L,mean,,,IQR,8.5,15.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3636,2025-12-02T16:03:31.981487
35293782.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates and infants,934.0,concentration,,,11.7,mg/L,median,,,minmax,5,49.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3637,2025-12-02T16:03:31.981487
35465728.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,60.0,initial concentration,,,12.9,mg/L,median,,,25th-75th percentiles,11.3,17,<0.001,before-implementation group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3638,2025-12-02T16:03:31.981487
35465728.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,59.0,initial concentration,,,20.3,mg/L,median,,,25th-75th percentiles,17,22.2,<0.001,after-implementation group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3639,2025-12-02T16:03:31.981487
35465728.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,116.0,all concentration,,,13.1,mg/L,median,,,25th-75th percentiles,11.3,16.2,<0.001,before-implementation group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3640,2025-12-02T16:03:31.981487
35465728.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,103.0,all concentration,,,19.8,mg/L,median,,,25th-75th percentiles,16.8,22.1,<0.001,after-implementation group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3641,2025-12-02T16:03:31.981487
35383737.0,Vancomycin ,Vancomycin ,blood,pediatric,,"neonates (<=29 weeks of CGA, 0-14 days of PNA)",26.0,trough concentration,,,7,mg/L,median,,,minmax,3,15,,No of samples,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3642,2025-12-02T16:03:31.981487
35383737.0,Vancomycin ,Vancomycin ,blood,pediatric,,"neonates (<=29 weeks of CGA, >14 days of PNA)",14.0,trough concentration,,,11,mg/L,median,,,minmax,6,16,,No of samples,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3643,2025-12-02T16:03:31.981487
35383737.0,Vancomycin ,Vancomycin ,blood,pediatric,,"neonates (30-36 weeks of CGA, 0-14 days of PNA)",23.0,trough concentration,,,13,mg/L,median,,,minmax,4,26,,No of samples,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3644,2025-12-02T16:03:31.981487
35383737.0,Vancomycin ,Vancomycin ,blood,pediatric,,"neonates (30-36 weeks of CGA, >14 days of PNA)",46.0,trough concentration,,,15,mg/L,median,,,minmax,4,36,,No of samples,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3645,2025-12-02T16:03:31.981487
35383737.0,Vancomycin ,Vancomycin ,blood,pediatric,,"neonates (37-44 weeks of CGA, 0-14 days of PNA)",0.0,trough concentration,,,,mg/L,median,,,minmax,,,,No of samples,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3646,2025-12-02T16:03:31.981487
35383737.0,Vancomycin ,Vancomycin ,blood,pediatric,,"neonates (37-44 weeks of CGA, >14 days of PNA)",10.0,trough concentration,,,12,mg/L,median,,,minmax,5,16,,No of samples,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3647,2025-12-02T16:03:31.981487
35383737.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,119.0,trough concentration,,,13,mg/L,median,,,minmax,3,36,,No of samples,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3648,2025-12-02T16:03:31.981487
35255798.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,40.0,trough concentration,,,11.09,ug/L,median,,,IQR,7.84,16.46,,Blood samples were drawn 5 - 6 hours after the 3rd dose of vancomycin and 30 minutes before the fourth dose to meas- ure vancomycin trough concentration ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3649,2025-12-02T16:03:31.981487
35581390.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,70.0,concentration,,,18.7,mg/L,median,,,IQR,15.4,22.4,,"Vancomycin C24h
(mg/L) was
 drawn 24 h after treatment initiation.",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3650,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,48.0,initial trough level at steady state,,,9.3,mcg/ml,median,,,IQR,5.54,,0.007,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3651,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,36.0,initial trough level at steady state,,,9.75,mcg/ml,median,,,IQR,5.35,,0.007,non-SCD patients ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3652,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,12.0,initial trough level at steady state,,,6,mcg/ml,median,,,IQR,4.55,,0.007,sickle cell disease patients with  acute chest syndrome ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3653,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,48.0,Post dose adjustment trough level,,,9.4,mcg/ml,median,,,IQR,3.7,,0.039,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3654,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,36.0,Post dose adjustment trough level,,,10,mcg/ml,median,,,IQR,2.9,,0.039,non-SCD patients ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3655,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,12.0,Post dose adjustment trough level,,,6.65,mcg/ml,median,,,IQR,4.68,,0.039,sickle cell disease patients with  acute chest syndrome ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3656,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,48.0,AUC,,,392,mg h/L,median,,,IQR,163.5,,0.007,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3657,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,36.0,AUC,,,405.5,mg h/L,median,,,IQR,160.5,,0.007,non-SCD patients ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3658,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,12.0,AUC,,,293,mg h/L,median,,,IQR,136.75,,0.007,sickle cell disease patients with  acute chest syndrome ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3659,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,48.0,Volume of destribution,,,9.55,L,median,,,IQR,6.38,,0.504,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3660,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,36.0,Volume of destribution,,,8.59,L,median,,,IQR,6.44,,0.504,non-SCD patients ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3661,2025-12-02T16:03:31.981487
35688759.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,12.0,Volume of destribution,,,11.2,L,median,,,IQR,6.23,,0.504,sickle cell disease patients with  acute chest syndrome ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3662,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,5.0,Ke,,,-0.23,/h,median,,,IQR,-0.24,-0.22,0.042,<1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3663,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,8.0,Ke,,,-0.25,/h,median,,,IQR,-0.33,-0.24,0.042,>=1 and 7years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3664,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,4.0,Ke,,,-0.18,/h,median,,,IQR,-0.19,-0.16,0.042,>7 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3665,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,5.0,peak concentration,,,17.9,mg/L,median,,,IQR,14.4,34.1,0.173,<1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3666,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,8.0,peak concentration,,,35.3,mg/L,median,,,IQR,19.9,40.3,0.173,>=1 and 7years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3667,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,4.0,peak concentration,,,26.8,mg/L,median,,,IQR,15.6,37.3,0.173,>7 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3668,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,5.0,trough concentration,,,7.9,mg/L,median,,,IQR,4.3,11.2,0.416,<1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3669,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,8.0,trough concentration,,,7.5,mg/L,median,,,IQR,6,9.2,0.416,>=1 and 7years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3670,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,4.0,trough concentration,,,10.6,mg/L,median,,,IQR,7.3,14,0.416,>7 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3671,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,5.0,t1/2,,,3.1,h,median,,,IQR,2.9,3.2,0.034,<1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3672,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,8.0,t1/2,,,2.7,h,median,,,IQR,2.1,3,0.034,>=1 and 7years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3673,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,4.0,t1/2,,,3.8,h,median,,,IQR,3.6,4.7,0.034,>7 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3674,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,5.0,CL,,,2.1,ml/min/kg,median,,,IQR,1.7,3.2,0.574,<1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3675,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,8.0,CL,,,1.6,ml/min/kg,median,,,IQR,1.1,2.3,0.574,>=1 and 7years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3676,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,4.0,CL,,,2,ml/min/kg,median,,,IQR,1.1,3,0.574,>7 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3677,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,5.0,Vd,,,0.7,L/kg,median,,,IQR,0.5,0.8,0.317,<1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3678,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,8.0,Vd,,,0.3,L/kg,median,,,IQR,0.2,0.7,0.317,>=1 and 7years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3679,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,4.0,Vd,,,0.6,L/kg,median,,,IQR,0.3,1.2,0.317,>7 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3680,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,5.0,AUCtau,,,77.4,mg h/L,median,,,IQR,56.1,137.7,0.444,<1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3681,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,8.0,AUCtau,,,125.7,mg h/L,median,,,IQR,83.2,151.8,0.444,>=1 and 7years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3682,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,4.0,AUCtau,,,113.6,mg h/L,median,,,IQR,68.8,155.6,0.444,>7 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3683,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants,5.0,AUC24,,,309.8,mg h/L,median,,,IQR,224.3,551,0.444,<1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3684,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,8.0,AUC24,,,502.8,mg h/L,median,,,IQR,332.8,607.2,0.444,>=1 and 7years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3685,2025-12-02T16:03:31.981487
35821590.0,Vancomycin ,Vancomycin ,blood,pediatric,,children,4.0,AUC24,,,454.2,mg h/L,median,,,IQR,275.1,622.3,0.444,>7 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3686,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,76.0,steady-state trough concentration,,,9.56,mg/L,median,,,IQR,6.15,13.7,0.159,effective group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3687,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,34.0,steady-state trough concentration,,,10.71,mg/L,median,,,IQR,7.18,16.51,0.159,ineffective group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3688,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,76.0,steady-state peak concentration,,,25.16,mg/L,median,,,IQR,20.33,33.26,0.874,effective group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3689,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,34.0,steady-state peak concentration,,,25.43,mg/L,median,,,IQR,20.03,34.29,0.874,ineffective group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3690,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,76.0,AUC0-24,,,503.53,mg h/L,median,,,IQR,386.02,609.17,0.518,effective group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3691,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,34.0,AUC0-24,,,480.74,mg h/L,median,,,IQR,386.48,779.11,0.518,ineffective group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3692,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,49.0,steady-state trough concentration,,,11.12,mg/L,median,,,IQR,7.12,13.83,0.104,Pathogen-cleared group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3693,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,17.0,steady-state trough concentration,,,7.7,mg/L,median,,,IQR,5.75,10.71,0.104,Pathogen-uncleared group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3694,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,49.0,steady-state peak concentration,,,26.47,mg/L,median,,,IQR,20.19,32.34,0.433,Pathogen-cleared group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3695,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,17.0,steady-state peak concentration,,,24.3,mg/L,median,,,IQR,19.28,29.87,0.433,Pathogen-uncleared group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3696,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,95.0,steady-state trough concentration,,,9.33,mg/L,median,,,IQR,6.09,12.94,<0.001,Non-nephrotoxic group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3697,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,15.0,steady-state trough concentration,,,16.41,mg/L,median,,,IQR,11.59,34.24,<0.001,Nephrotoxic group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3698,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,95.0,steady-state peak concentration,,,25.32,mg/L,median,,,IQR,20.06,30.93,0.009,Non-nephrotoxic group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3699,2025-12-02T16:03:31.981487
35844752.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children/adolescents,15.0,steady-state peak concentration,,,33.6,mg/L,median,,,IQR,23.23,45.86,0.009,Nephrotoxic group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3700,2025-12-02T16:03:31.981487
36222533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,43.0,Volume of destribution,,,0.844,L/kg,median,,,IQR,0.819,0.877,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3701,2025-12-02T16:03:31.981487
36222533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,43.0,total clearance,,,0.19,L/h,median,,,IQR,0.09,0.29,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3702,2025-12-02T16:03:31.981487
36222533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,43.0,t1/2,,,7,h,median,,,IQR,5.25,8.32,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3703,2025-12-02T16:03:31.981487
36222533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,24.0,trough concentration,,,9.9,ug/ml,median,,,IQR,7.3,13.4,0.002,favorable group according to early clinical evolution (ECE) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3704,2025-12-02T16:03:31.981487
36222533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,18.0,trough concentration,,,6.15,ug/ml,median,,,IQR,4.5,8.85,0.002,unfavorable group according to early clinical evolution (ECE) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3705,2025-12-02T16:03:31.981487
36222533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,24.0,AUC24,,,332.26,mg h/L,median,,,IQR,269.41,380.63,0.001,favorable group according to early clinical evolution (ECE) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3706,2025-12-02T16:03:31.981487
36222533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,18.0,AUC24,,,228.4,mg h/L,median,,,IQR,171.34,395.79,0.001,unfavorable group according to early clinical evolution (ECE) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3707,2025-12-02T16:03:31.981487
36222533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,13.0,trough concentration,,,14.2,ug/ml,median,,,IQR,11.75,17.15,0.023,cured patients in late clinical evolution (ECE) analysis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3708,2025-12-02T16:03:31.981487
36222533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,5.0,trough concentration,,,8.6,ug/ml,median,,,IQR,7.15,12.6,0.023,failed patients in late clinical evolution (ECE) analysis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3709,2025-12-02T16:03:31.981487
36222533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,13.0,AUC24,,,392.34,mg h/L,median,,,IQR,346.94,419.35,0.654,cured patients in late clinical evolution (LCE) analysis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3710,2025-12-02T16:03:31.981487
36222533.0,Vancomycin ,Vancomycin ,blood,pediatric,,neonates,5.0,AUC24,,,363.92,mg h/L,median,,,IQR,307.69,395.45,0.654,failed patients in late clinical evolution (LCE) analysis,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3711,2025-12-02T16:03:31.981487
36254077.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,3.0,trough concentration,,,9.25,mg/L,mean,SD,3.9,,,,"0.54, compared to patients with normal renal function",AKI after treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3712,2025-12-02T16:03:31.981487
36254077.0,Vancomycin ,Vancomycin ,blood,pediatric,,infants/children,15.0,trough concentration,,,8.17,mg/L,mean,SD,4.08,,,,"0.115, compared to patients with normal renal function",Elevated Scr post-treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3713,2025-12-02T16:03:31.981487
34302760.0,bictegravir ,bictegravir ,blood,pediatric,,adolescents ,50.0,AUCtau,,,89100,ng h/ml,mean,coefficient of variation,0.31,,,,,aged 12 to <18 years ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3714,2025-12-02T16:03:31.981487
34302760.0,bictegravir ,bictegravir ,blood,pediatric,,adolescents ,50.0,Cmax,,,6240,mg/mL,mean,coefficient of variation,0.271,,,,,aged 12 to <18 years ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3715,2025-12-02T16:03:31.981487
34302760.0,bictegravir ,bictegravir ,blood,pediatric,,adolescents ,50.0,Ctau,,,1780,mg/mL,mean,coefficient of variation,0.444,,,,,at steady state at weeks 2 and 4 ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3716,2025-12-02T16:03:31.981487
34302760.0,bictegravir ,bictegravir ,blood,pediatric,,children,50.0,AUCtau,,,128000,ng h/ml,mean,coefficient of variation,0.278,,,,,aged 6 to <12 years ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3717,2025-12-02T16:03:31.981487
34302760.0,bictegravir ,bictegravir ,blood,pediatric,,children,50.0,Cmax,,,9460,mg/mL,mean,coefficient of variation,0.243,,,,,aged 6 to <12 years ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3718,2025-12-02T16:03:31.981487
34302760.0,bictegravir ,bictegravir ,blood,pediatric,,children,50.0,Ctau,,,2360,mg/mL,mean,coefficient of variation,0.39,,,,,at steady state at weeks 2 and 4 ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3719,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Third Trimester, GA 33 (3136) wk ",,13.0,AUC0-24h,,,14.1,mg h/L,median,CV%,39,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3720,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Postpartum, 6(4-8) wk Postdelivery",,10.0,AUC0-24h,,,21.7,mg h/L,median,CV%,29,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3721,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Third Trimester, GA 33 (3136) wk ",,13.0,Ctrough,,,0.06,mg/L,median,CV%,104,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3722,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Postpartum, 6(4-8) wk Postdelivery",,10.0,Ctrough,,,0.28,mg/L,median,CV%,63,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3723,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Third Trimester, GA 33 (3136) wk ",,13.0,Cmax,,,1.4,mg/L,median,CV%,42,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3724,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Postpartum, 6(4-8) wk Postdelivery",,10.0,Cmax,,,1.8,mg/L,median,CV%,26,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3725,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Third Trimester, GA 33 (3136) wk ",,13.0,Tmax,,,4,h,median,,,minmax,2,6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3726,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Postpartum, 6(4-8) wk Postdelivery",,10.0,Tmax,,,5,h,median,,,minmax,3,7.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3727,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Third Trimester, GA 33 (3136) wk ",,13.0,CL/Fss,,,10.7,L/h,median,CV%,39,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3728,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Postpartum, 6(4-8) wk Postdelivery",,10.0,CL/Fss,,,6.9,L/h,median,CV%,29,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3729,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Third Trimester, GA 33 (3136) wk ",,13.0,T1/2,,,4.3,h,median,CV%,37,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3730,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Postpartum, 6(4-8) wk Postdelivery",,10.0,T1/2,,,7.7,h,median,CV%,30,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3731,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Third Trimester, GA 33 (3136) wk ",,13.0,Vd/Fss,,,65.7,L,median,CV%,60,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3732,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,blood,maternal,"Postpartum, 6(4-8) wk Postdelivery",,10.0,Vd/Fss,,,76.5,L,median,CV%,28,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3733,2025-12-02T16:03:31.981487
32330231.0,Elvitegravir,Elvitegravir,cord blood and maternal blood,maternal/pediatric ,delivery,fetus,7.0,cord blood/maternal blood plasma ratio,,,0.75,,median,,,minmax,0.35,0.99,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3734,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,second trimester,,8.0,AUC0-12,,,43.5,ug h/ml,median,,,IQR,38.5,50.4,2T/PP: 0.22,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3735,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,third trimester,,28.0,AUC0-12,,,32.15,ug h/ml,median,,,IQR,21.45,39.7,3T/PP: <0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3736,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,postpartum,,22.0,AUC0-12,,,51.6,ug h/ml,median,,,IQR,45.2,59.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3737,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,second trimester,,8.0,CL/F,,,13.79,L/h,median,,,IQR,11.91,15.58,2T/PP: 0.22,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3738,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,third trimester,,28.0,CL/F,,,18.66,L/h,median,,,IQR,15.11,28.23,3T/PP: <0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3739,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,postpartum,,22.0,CL/F,,,11.63,L/h,median,,,IQR,10.07,13.27,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3740,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,second trimester,,8.0,T1/2,,,8.67,h,median,,,IQR,5.9,13.57,2T/PP: 1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3741,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,third trimester,,28.0,T1/2,,,12.98,h,median,,,IQR,8.5,31.62,3T/PP: 0.637,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3742,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,postpartum,,22.0,T1/2,,,14.26,h,median,,,IQR,8.22,28.25,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3743,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,second trimester,,8.0,Cmin,,,1.91,ug/ml,median,,,IQR,0.34,2.39,2T/PP: 0.16,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3744,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,third trimester,,28.0,Cmin,,,1.48,ug/ml,median,,,IQR,0.86,1.8,3T/PP: 0.01,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3745,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,postpartum,,22.0,Cmin,,,2.42,ug/ml,median,,,IQR,1.36,3.08,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3746,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,second trimester,,8.0,Clast,,,2.05,ug/ml,median,,,IQR,1.56,2.65,2T/PP: 0.22,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3747,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,third trimester,,28.0,Clast,,,1.67,ug/ml,median,,,IQR,1.13,2.24,3T/PP:0.004,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3748,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,postpartum,,22.0,Clast,,,2.8,ug/ml,median,,,IQR,1.93,3.82,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3749,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,second trimester,,8.0,Cmax,,,5.61,ug/ml,median,,,IQR,4.47,6.64,2T/PP: 0.16,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3750,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,third trimester,,28.0,Cmax,,,5.12,ug/ml,median,,,IQR,3.6,6.26,3T/PP: 0.03,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3751,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,postpartum,,22.0,Cmax,,,6.75,ug/ml,median,,,IQR,4.31,9.24,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3752,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,second trimester,,8.0,C0,,,2.19,ug/ml,median,,,IQR,1.05,3.13,2T/PP: 0.47,initial concentration at time 0,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3753,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,third trimester,,28.0,C0,,,1.7,ug/ml,median,,,IQR,1.34,2.28,3T/PP: <0.001,initial concentration at time 0,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3754,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,postpartum,,22.0,C0,,,3.14,ug/ml,median,,,IQR,1.56,4.94,,initial concentration at time 0,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3755,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,second trimester,,8.0,C12,,,2.12,ug/ml,median,,,IQR,1.39,2.67,2T/PP: 0.44,concentration at 12 h postdose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3756,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,third trimester,,28.0,C12,,,1.64,ug/ml,median,,,IQR,1.16,2.21,3T/PP: <0.001,concentration at 12 h postdose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3757,2025-12-02T16:03:31.981487
32015036.0,Fosamprenavir,amprenavir,blood,maternal,postpartum,,22.0,C12,,,2.87,ug/ml,median,,,IQR,2.34,3.41,,concentration at 12 h postdose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3758,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,second trimester,,8.0,AUC0-12,,,2.52,ug h/ml,median,,,IQR,1.35,4.1,2T/PP: 0.09,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3759,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,third trimester,,28.0,AUC0-12,,,3.68,ug h/ml,median,,,IQR,2.76,5.64,3T/PP: 0.005,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3760,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,postpartum,,22.0,AUC0-12,,,4.86,ug h/ml,median,,,IQR,2.73,6.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3761,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,second trimester,,8.0,CL/F,,,47.16,L/h,median,,,IQR,24.61,74.15,2T/PP: 0.06,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3762,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,third trimester,,28.0,CL/F,,,27.2,L/h,median,,,IQR,17.74,36.22,3T/PP: 0.009,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3763,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,postpartum,,22.0,CL/F,,,20.63,L/h,median,,,IQR,15.15,36.72,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3764,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,second trimester,,8.0,T1/2,,,3.71,h,median,,,IQR,3.06,10.92,2T/PP: 1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3765,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,third trimester,,28.0,T1/2,,,4.08,h,median,,,IQR,3.47,6.65,3T/PP: 0.52,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3766,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,postpartum,,22.0,T1/2,,,4.92,h,median,,,IQR,3.03,6.64,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3767,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,second trimester,,8.0,Cmin,,,0.07,ug/ml,median,,,IQR,0.05,0.12,2T/PP: 0.08,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3768,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,third trimester,,28.0,Cmin,,,0.12,ug/ml,median,,,IQR,0.05,0.15,3T/PP: 0.72,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3769,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,postpartum,,22.0,Cmin,,,0.1,ug/ml,median,,,IQR,0.05,0.2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3770,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,second trimester,,8.0,Clast,,,0.09,ug/ml,median,,,IQR,0.06,0.16,2T/PP: 0.08,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3771,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,third trimester,,28.0,Clast,,,0.13,ug/ml,median,,,IQR,0.06,0.24,3T/PP:0.25,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3772,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,postpartum,,22.0,Clast,,,0.18,ug/ml,median,,,IQR,0.08,0.26,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3773,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,second trimester,,8.0,Cmax,,,0.41,ug/ml,median,,,IQR,0.25,0.73,2T/PP: 0.3,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3774,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,third trimester,,28.0,Cmax,,,0.64,ug/ml,median,,,IQR,0.51,1.07,3T/PP: 0.475,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3775,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,postpartum,,22.0,Cmax,,,0.19,ug/ml,median,,,IQR,0.51,1.08,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3776,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,second trimester,,8.0,C0,,,0.13,ug/ml,median,,,IQR,0.06,0.24,2T/PP: 0.3,initial concentration at time 0,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3777,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,third trimester,,28.0,C0,,,0.16,ug/ml,median,,,IQR,0.11,0.31,3T/PP: 0.134,initial concentration at time 0,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3778,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,postpartum,,22.0,C0,,,0.19,ug/ml,median,,,IQR,0.09,0.41,,initial concentration at time 0,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3779,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,second trimester,,8.0,C12,,,0.12,ug/ml,median,,,IQR,0.05,0.29,2T/PP: 0.69,concentration at 12 h postdose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3780,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,third trimester,,28.0,C12,,,0.16,ug/ml,median,,,IQR,0.05,0.2,3T/PP: 0.029,concentration at 12 h postdose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3781,2025-12-02T16:03:31.981487
32015036.0,ritonavir,ritonavir,blood,maternal,postpartum,,22.0,C12,,,0.19,ug/ml,median,,,IQR,0.08,0.26,,concentration at 12 h postdose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3782,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Nelfinavir,blood,maternal,third trimester,,18.0,AUC0-12,,,34.2,ug h/ml,median,,,IQR,27.2,46.9,0.78,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3783,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Nelfinavir,blood,maternal,postpartum,,16.0,AUC0-12,,,33.5,ug h/ml,median,,,IQR,28.6,43.5,0.78,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3784,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Nelfinavir,blood,maternal,third trimester,,18.0,Cmin,,,0.47,ug/ml,median,,,IQR,0.35,1.33,0.49,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3785,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Nelfinavir,blood,maternal,postpartum,,16.0,Cmin,,,0.52,ug/ml,median,,,IQR,0.22,0.8,0.49,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3786,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Nelfinavir,blood,maternal,third trimester,,18.0,Cmax,,,5.1,ug/ml,median,,,IQR,4.3,6.5,0.67,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3787,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Nelfinavir,blood,maternal,postpartum,,16.0,Cmax,,,5,ug/ml,median,,,IQR,4.2,5.9,0.67,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3788,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Nelfinavir,blood,maternal,third trimester,,18.0,CL/F,,,54.9,L/h,median,,,IQR,40.4,68.9,0.04,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3789,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Nelfinavir,blood,maternal,postpartum,,16.0,CL/F,,,37.4,L/h,median,,,IQR,28.7,43.7,0.04,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3790,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Nelfinavir,blood,maternal,third trimester,,18.0,AUC0-12,,,60.2,uM h,median,,,IQR,47.9,82.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3791,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Nelfinavir,blood,maternal,postpartum,,16.0,AUC0-12,,,58.9,uM h,median,,,IQR,50.3,76.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3792,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Hydroxyl-tert-butylamide,blood,maternal,third trimester,,18.0,AUC0-12,,,3.9,ug h/ml,median,,,IQR,2.7,7.4,0.03,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3793,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Hydroxyl-tert-butylamide,blood,maternal,postpartum,,16.0,AUC0-12,,,8.6,ug h/ml,median,,,IQR,6.5,11.6,0.03,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3794,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Hydroxyl-tert-butylamide,blood,maternal,third trimester,,18.0,AUC0-12,,,6.7,uM h,median,,,IQR,4.7,12.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3795,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Hydroxyl-tert-butylamide,blood,maternal,postpartum,,16.0,AUC0-12,,,14.8,uM h,median,,,IQR,11.2,19.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3796,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Hydroxyl-tert-butylamide,blood,maternal,third trimester,,18.0,Cmin,,,0.11,ug/ml,median,,,IQR,0.05,0.15,0.24,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3797,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Hydroxyl-tert-butylamide,blood,maternal,postpartum,,16.0,Cmin,,,0.14,ug/ml,median,,,IQR,0.04,0.21,0.24,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3798,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Hydroxyl-tert-butylamide,blood,maternal,third trimester,,18.0,Cmax,,,0.66,ug/ml,median,,,IQR,0.48,1.12,0.005,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3799,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Hydroxyl-tert-butylamide,blood,maternal,postpartum,,16.0,Cmax,,,1.2,ug/ml,median,,,IQR,1.07,1.71,0.005,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3800,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Hydroxyl-tert-butylamide,blood,maternal,third trimester,,18.0,M8/NFV AUC ratio,,,0.11,,median,,,IQR,0.08,0.22,0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3801,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,Hydroxyl-tert-butylamide,blood,maternal,postpartum,,16.0,M8/NFV AUC ratio,,,0.3,,median,,,IQR,0.17,0.35,0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3802,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,"Nelfinavir, Hydroxyl-tert-butylamide",blood,maternal,third trimester,,18.0,NFV+M8 AUC0-12,,,71.6,uM h,median,,,IQR,54.3,93.1,0.6,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3803,2025-12-02T16:03:31.981487
30358179.0,Nelfinavir,"Nelfinavir, Hydroxyl-tert-butylamide",blood,maternal,postpartum,,16.0,NFV+M8 AUC0-12,,,73.3,uM h,median,,,IQR,66.3,91.7,0.6,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3804,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,AUC12h,,,3823.1,ng h/ml,GM,CV%,0.751,,,,,from time of administration to 12 h after dosing,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3805,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,AUC12h,,,4813.6,ng h/ml,mean,SD,3614,,,,,from time of administration to 12 h after dosing,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3806,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,AUC12h,,,3709.4,ng h/ml,median,,,minmax,1220.5,12998.6,,from time of administration to 12 h after dosing,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3807,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,Cmax,,,465.8,mg/ml,GM,CV%,0.69,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3808,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,Cmax,,,564.6,mg/ml,mean,SD,389.4,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3809,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,Cmax,,,199.1,mg/ml,median,,,minmax,199.1,1494,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3810,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,Clast,,,232.4,mg/ml,GM,CV%,0.878,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3811,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,Clast,,,328.2,mg/ml,mean,SD,288.3,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3812,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,Clast,,,253,mg/ml,median,,,minmax,54.3,962,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3813,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,Tmax,,,4.5,h,GM,CV%,0.403,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3814,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,Tmax,,,4.8,h,mean,SD,1.9,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3815,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,Tmax,,,4,h,median,,,minmax,2,9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3816,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,CL/F,,,39.8,l/h/m2,GM,CV%,0.622,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3817,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,CL/F,,,48.9,l/h/m2,mean,SD,30.4,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3818,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,CL/F,,,41.7,l/h/m2,median,,,minmax,10.6,117.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3819,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (2 to<6 years),15.0,Individual ETR dose increase required (AUC12h <2350 ng h//ml),,,5,,GM,CV%,0.33,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3820,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,AUC12h,,,3328.1,ng h/ml,GM,CV%,0.755,,,,,from time of administration to 12 h after dosing,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3821,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,AUC12h,,,4158.6,ng h/ml,mean,SD,3137.8,,,,,from time of administration to 12 h after dosing,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3822,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,AUC12h,,,3389.7,ng h/ml,median,,,minmax,1148.1,9989.8,,from time of administration to 12 h after dosing,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3823,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,Cmax,,,390.4,mg/ml,GM,CV%,0.713,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3824,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,Cmax,,,489.9,mg/ml,mean,SD,349.4,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3825,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,Cmax,,,379.3,mg/ml,median,,,minmax,121.9,1085,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3826,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,Clast,,,225.5,mg/ml,GM,CV%,0.8,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3827,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,Clast,,,278.3,mg/ml,mean,SD,222.6,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3828,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,Clast,,,186.5,mg/ml,median,,,minmax,101.9,706,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3829,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,Tmax,,,2,h,GM,CV%,0.657,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3830,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,Tmax,,,2.5,h,mean,SD,1.6,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3831,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,Tmax,,,2.5,h,median,,,minmax,1,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3832,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,CL/F,,,54.3,l/h/m2,GM,CV%,0.727,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3833,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,CL/F,,,67.1,l/h/m2,mean,SD,48.8,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3834,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,CL/F,,,54.6,l/h/m2,median,,,minmax,18.4,156.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3835,2025-12-02T16:03:31.981487
33831904.0,Etravirine,Etravirine,blood,pediatric,,children (1 to <2 years),6.0,Individual ETR dose increase required (AUC12h <2350 ng h//ml),,,2,,GM,CV%,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3836,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,13.0,Cmax,,,510,ng/ml,median,,,minmax,30,1618,,Cohort 1 (Entry),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3837,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,13.0,Cmax,,,137,ng/ml,median,,,minmax,9,609,,Cohort 1 (Week 1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3838,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,25.0,Cmax,,,284,ng/ml,median,,,minmax,34,1468,,Cohort 2 (Week 1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3839,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,25.0,Cmax,,,304,ng/ml,median,,,minmax,77,793,,Cohort 2 (Week 4),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3840,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,13.0,Tmax,,,1.8,h,median,,,minmax,1.1,12.8,,Cohort 1 (Entry),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3841,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,13.0,Tmax,,,1.2,h,median,,,minmax,1.1,1.3,,Cohort 1 (Week 1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3842,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,25.0,Tmax,,,1.6,h,median,,,minmax,0.8,6.2,,Cohort 2 (Week 1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3843,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,25.0,Tmax,,,1.5,h,median,,,minmax,0,11.4,,Cohort 2 (Week 4),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3844,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,13.0,AUC,,,3734,ng h/ml,median,,,minmax,1123,15343,,Cohort 1 (Entry),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3845,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,13.0,AUC,,,ND,ng h/ml,median,,,minmax,,,,Cohort 1 (Week 1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3846,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,25.0,AUC,,,1616,ng h/ml,median,,,minmax,205,6788,,Cohort 2 (Week 1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3847,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,25.0,AUC,,,1123,ng h/ml,median,,,minmax,395,5859,,Cohort 2 (Week 4),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3848,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,13.0,CL/F,,,6.7,L/hr,median,,,minmax,2,30.2,,Cohort 1 (Entry),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3849,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,13.0,CL/F,,,ND,L/hr,median,,,minmax,,,,Cohort 1 (Week 1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3850,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,25.0,CL/F,,,15.9,L/hr,median,,,minmax,3,122,,Cohort 2 (Week 1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3851,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,25.0,CL/F,,,22.6,L/hr,median,,,minmax,4.3,63.3,,Cohort 2 (Week 4),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3852,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,13.0,Cavg,,,311,ng/ml,median,,,minmax,94,1279,,Cohort 1 (Entry),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3853,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,13.0,Cavg,,,ND,ng/ml,median,,,minmax,,,,Cohort 1 (Week 1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3854,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,25.0,Cavg,,,135,ng/ml,median,,,minmax,17,566,,Cohort 2 (Week 1),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3855,2025-12-02T16:03:31.981487
33252481.0,Maraviroc,Maraviroc,blood,pediatric,,infants,25.0,Cavg,,,93.6,ng/ml,median,,,minmax,33,488,,Cohort 2 (Week 4),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3856,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,T1/2,,,8.6,hr,GM,,,,,,,>=2 years to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3857,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,T1/2,,,8.7,hr,median,,,minmax,4.9,17.4,,>=2 years to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3858,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,13.0,T1/2,,,9.6,hr,GM,,,,,,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3859,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,13.0,T1/2,,,9.3,hr,median,,,minmax,5.9,13.8,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3860,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants,13.0,T1/2,,,15,hr,GM,,,,,,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3861,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants,13.0,T1/2,,,15,hr,median,,,minmax,7.2,33.9,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3862,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,Tmax,,,1.97,hr,GM,,,,,,,>=2 years to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3863,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,Tmax,,,2,hr,median,,,minmax,0.8,8.2,,>=2 years to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3864,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,13.0,Tmax,,,2.3,hr,GM,,,,,,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3865,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,13.0,Tmax,,,2,hr,median,,,minmax,1,7.2,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3866,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants,13.0,Tmax,,,2.11,hr,GM,,,,,,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3867,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants,13.0,Tmax,,,2,hr,median,,,minmax,1,6,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3868,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,Cmax,,,4990.2,ng/mL,GM,,,,,,,>=2 years to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3869,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,Cmax,,,5605.9,ng/mL,median,,,minmax,2215,10406,,>=2 years to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3870,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,13.0,Cmax,,,5852.8,ng/mL,GM,,,,,,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3871,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,13.0,Cmax,,,5615,ng/mL,median,,,minmax,3293,11612,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3872,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants,13.0,Cmax,,,4542.7,ng/mL,GM,,,,,,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3873,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants,13.0,Cmax,,,4729,ng/mL,median,,,minmax,2255,7716,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3874,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,C24h,,,688.2,ng/mL,GM,,,,,,,>=2 years to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3875,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,C24h,,,782,ng/mL,median,,,minmax,104,4579,,>=2 years to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3876,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,13.0,C24h,,,1178.9,ng/mL,GM,,,,,,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3877,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,13.0,C24h,,,1226,ng/mL,median,,,minmax,474,4279,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3878,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants,13.0,C24h,,,1445.6,ng/mL,GM,,,,,,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3879,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants,13.0,C24h,,,1834,ng/mL,median,,,minmax,315,3495,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3880,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,AUC24,,,53.5,mg h/L,GM,,,,,,,>=2 years to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3881,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,AUC24,,,62.2,mg h/L,median,,,minmax,18.9,170.3,,>=2 years to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3882,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,13.0,AUC24,,,73.7,mg h/L,GM,,,,,,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3883,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,13.0,AUC24,,,67.9,mg h/L,median,,,minmax,39.1,190,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3884,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants,13.0,AUC24,,,65.3,mg h/L,GM,,,,,,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3885,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants,13.0,AUC24,,,76,mg h/L,median,,,minmax,21,122,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3886,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,T1/2,,,15.4,hr,GM,,,,,,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3887,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,T1/2,,,16.9,hr,median,,,minmax,7.2,33.9,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3888,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,11.0,T1/2,,,8.87,hr,GM,,,,,,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3889,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,11.0,T1/2,,,9.2,hr,median,,,minmax,4.9,13.8,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3890,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,10.0,T1/2,,,9.1,hr,GM,,,,,,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3891,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,10.0,T1/2,,,8.8,hr,median,,,minmax,5.3,17.4,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3892,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,T1/2,,,9.05,hr,GM,,,,,,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3893,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,T1/2,,,8.7,hr,median,,,minmax,5.5,13.5,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3894,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,Tmax,,,1.6,hr,GM,,,,,,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3895,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,Tmax,,,1.5,hr,median,,,minmax,1,4.2,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3896,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,11.0,Tmax,,,1.9,hr,GM,,,,,,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3897,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,11.0,Tmax,,,2,hr,median,,,minmax,0.8,6,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3898,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,10.0,Tmax,,,2.2,hr,GM,,,,,,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3899,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,10.0,Tmax,,,2,hr,median,,,minmax,1,8.2,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3900,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,Tmax,,,2.1,hr,GM,,,,,,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3901,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,Tmax,,,2,hr,median,,,minmax,1,7.2,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3902,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,Cmax,,,3888,ng/mL,GM,,,,,,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3903,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,Cmax,,,4183.2,ng/mL,median,,,minmax,2255,6069.5,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3904,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,11.0,Cmax,,,5249.3,ng/mL,GM,,,,,,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3905,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,11.0,Cmax,,,5579.2,ng/mL,median,,,minmax,2291.9,11612,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3906,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,10.0,Cmax,,,6053,ng/mL,GM,,,,,,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3907,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,10.0,Cmax,,,5971.1,ng/mL,median,,,minmax,3231,10405.6,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3908,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,Cmax,,,4515.7,ng/mL,GM,,,,,,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3909,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,Cmax,,,4814.9,ng/mL,median,,,minmax,2214.8,10768,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3910,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,C24h,,,1452.8,ng/mL,GM,,,,,,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3911,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,C24h,,,1496.8,ng/mL,median,,,minmax,214.9,2461.3,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3912,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,11.0,C24h,,,882.9,ng/mL,GM,,,,,,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3913,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,11.0,C24h,,,1092.5,ng/mL,median,,,minmax,103.5,3576.5,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3914,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,10.0,C24h,,,1026.2,ng/mL,GM,,,,,,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3915,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,10.0,C24h,,,1115.1,ng/mL,median,,,minmax,157.6,4578.7,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3916,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,C24h,,,657.4,ng/mL,GM,,,,,,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3917,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,C24h,,,552.1,ng/mL,median,,,minmax,246.4,4278.6,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3918,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,AUC24,,,53.6,mg h/L,GM,,,,,,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3919,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,AUC24,,,62.2,mg h/L,median,,,minmax,1.89,170.3,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3920,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,11.0,AUC24,,,62.3,mg h/L,GM,,,,,,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3921,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,11.0,AUC24,,,67.9,mg h/L,median,,,minmax,39.1,190,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3922,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,10.0,AUC24,,,70,mg h/L,GM,,,,,,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3923,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,10.0,AUC24,,,76,mg h/L,median,,,minmax,21,122,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3924,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,AUC24,,,49,mg h/L,GM,,,,,,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3925,2025-12-02T16:03:31.981487
35489377.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants and children,8.0,AUC24,,,41.9,mg h/L,median,,,minmax,19.9,189.5,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3926,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,AUC0-24,,,43659,ng h/ml,GM,,,90%CI,39939,47726,0.004,DTG-based ART + DP (Sequence 3) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3927,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,AUC0-24,,,33555,ng h/ml,GM,,,90%CI,29479,38196,0.004,DTG-based ART only (Sequence 2) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3928,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,Cmax,,,3270,ng/ml,GM,,,90%CI,3030,3529,0.001,DTG-based ART + DP (Sequence 3) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3929,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,Cmax,,,2504,ng/ml,GM,,,90%CI,2213,2832,0.001,DTG-based ART only (Sequence 2) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3930,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,C24,,,701,ng/ml,GM,,,90%CI,593,830,0.008,DTG-based ART + DP (Sequence 3) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3931,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,C24,,,495,ng/ml,GM,,,90%CI,404,606,0.008,DTG-based ART only (Sequence 2) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3932,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,Tmax,,,2.6,hr,GM,,,90%CI,2.1,3.3,0.379,DTG-based ART + DP (Sequence 3) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3933,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,Tmax,,,2.3,hr,GM,,,90%CI,1.8,3.1,0.379,DTG-based ART only (Sequence 2) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3934,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,T1/2,,,9.9,hr,GM,,,90%CI,8.8,11.1,0.063,DTG-based ART + DP (Sequence 3) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3935,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,T1/2,,,9,hr,GM,,,90%CI,8.2,9.9,0.063,DTG-based ART only (Sequence 2) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3936,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,CL/F,,,1.15,L/h,GM,,,90%CI,1.05,1.25,0.004,DTG-based ART + DP (Sequence 3) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3937,2025-12-02T16:03:31.981487
35288747.0,dolutegravir ,dolutegravir ,blood,maternal,2nd and 3rd trimester,,12.0,CL/F,,,1.49,L/h,GM,,,90%CI,1.31,1.7,0.004,DTG-based ART only (Sequence 2) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3938,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,Ctrough,,,0.55,mg/l,,,,,,,,Dolutegravir 25 mg dispersible tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3939,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,Ctrough,,,0.54,mg/l,,,,,,,,Dolutegravir 25 mg dispersible tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3940,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,Ctrough,,,0.9,mg/l,GM,CV,0.16,,,,,Dolutegravir 25 mg film-coated tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3941,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,Ctrough,,,0.43,mg/l,GM,CV,0.58,,,,,Dolutegravir 25 mg film-coated tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3942,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,7.0,Ctrough,,,1.11,mg/l,GM,CV,0.99,,,,,Dolutegravir 50 mg film-coated tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3943,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,7.0,Ctrough,,,0.89,mg/l,GM,CV,0.53,,,,,Dolutegravir 50 mg film-coated tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3944,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,AUC0-24h,,,78,mg h/ml,,,,,,,,Dolutegravir 25 mg dispersible tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3945,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,AUC0-24h,,,54.2,mg h/ml,,,,,,,,Dolutegravir 25 mg dispersible tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3946,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,AUC0-24h,,,53.4,mg h/ml,GM,CV,0.21,,,,,Dolutegravir 25 mg film-coated tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3947,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,AUC0-24h,,,36.2,mg h/ml,GM,CV,0.29,,,,,Dolutegravir 25 mg film-coated tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3948,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,7.0,AUC0-24h,,,64.4,mg h/ml,GM,CV,0.61,,,,,Dolutegravir 50 mg film-coated tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3949,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,7.0,AUC0-24h,,,61.9,mg h/ml,GM,CV,0.43,,,,,Dolutegravir 50 mg film-coated tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3950,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,Cmax,,,8.44,mg/l,,,,,,,,Dolutegravir 25 mg dispersible tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3951,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,Cmax,,,7.52,mg/l,,,,,,,,Dolutegravir 25 mg dispersible tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3952,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,Cmax,,,3.62,mg/l,GM,CV,0.24,,,,,Dolutegravir 25 mg film-coated tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3953,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,Cmax,,,3.56,mg/l,GM,CV,0.25,,,,,Dolutegravir 25 mg film-coated tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3954,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,7.0,Cmax,,,4.5,mg/l,GM,CV,0.47,,,,,Dolutegravir 50 mg film-coated tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3955,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,7.0,Cmax,,,5.21,mg/l,GM,CV,0.47,,,,,Dolutegravir 50 mg film-coated tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3956,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,Tmax,,,2,hr,,,,,,,,Dolutegravir 25 mg dispersible tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3957,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,Tmax,,,2.02,hr,,,,,,,,Dolutegravir 25 mg dispersible tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3958,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,Tmax,,,3,hr,median,,,IQR,1.58,4.5,,Dolutegravir 25 mg film-coated tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3959,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,Tmax,,,2,hr,median,,,IQR,1.5,2.5,,Dolutegravir 25 mg film-coated tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3960,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,7.0,Tmax,,,3,hr,median,,,IQR,2,3,,Dolutegravir 50 mg film-coated tablet once daily ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3961,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,7.0,Tmax,,,3,hr,median,,,IQR,3,3.08,,Dolutegravir 50 mg film-coated tablet Twice daily with rifampicin,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3962,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,Ctrough,,,1.03,mg/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,,,,,Dolutegravir 25 mg dispersible tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3963,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,Ctrough,,,2.1,mg/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,1.2,3.67,,Dolutegravir 25 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3964,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,8.0,Ctrough,,,1.25,mg/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.71,2.18,,Dolutegravir 50 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3965,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,Ctrough,,,1.51,mg/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,1.08,2.11,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3966,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,AUC0-24,,,1.44,mg h/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,,,,,Dolutegravir 25 mg dispersible tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3967,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,AUC0-24,,,1.47,mg h/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.99,2.19,,Dolutegravir 25 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3968,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,8.0,AUC0-24,,,1.05,mg h/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.74,1.49,,Dolutegravir 50 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3969,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,AUC0-24,,,1.23,mg h/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.99,1.53,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3970,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,Cmax,,,1.12,mg/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,,,,,Dolutegravir 25 mg dispersible tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3971,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,Cmax,,,1.02,mg/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.73,1.41,,Dolutegravir 25 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3972,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,8.0,Cmax,,,0.86,mg/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.59,1.27,,Dolutegravir 50 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3973,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,Cmax,,,0.94,mg/L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.76,1.16,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3974,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,T1/2,,,0.39,hr,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,,,,,Dolutegravir 25 mg dispersible tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3975,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,T1/2,,,0.6,hr,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.46,0.78,,Dolutegravir 25 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3976,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,8.0,T1/2,,,0.6,hr,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.44,0.83,,Dolutegravir 50 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3977,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,T1/2,,,0.59,hr,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.49,0.7,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3978,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,Vd/F,,,0.54,L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,,,,,Dolutegravir 25 mg dispersible tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3979,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,Vd/F,,,0.81,L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.48,1.37,,Dolutegravir 25 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3980,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,8.0,Vd/F,,,1.19,L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.81,1.74,,Dolutegravir 50 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3981,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,Vd/F,,,0.96,L,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.72,1.28,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3982,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,1.0,CL/F,,,1.39,L/h,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,,,,,Dolutegravir 25 mg dispersible tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3983,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,5.0,CL/F,,,1.39,L/h,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,0.92,2.01,,Dolutegravir 25 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3984,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,8.0,CL/F,,,1.91,L/h,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,1.35,2.72,,Dolutegravir 50 mg film-coated tablet ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3985,2025-12-02T16:03:31.981487
35868341.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,CL/F,,,1.63,L/h,Geometric mean ratiosof twice-daily dolutegravir with rifampicin vs. once-daily dolutegravir (reference),,,90%CI,1.3,2.04,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3986,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),5.0,C0,,,0.52,mg/L,geometric mean,CV%,0.75,,,,,"3 kg to <6 kg, receiving 5 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3987,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),13.0,C0,,,0.46,mg/L,geometric mean,CV%,3.02,,,,,"6 kg to <10 kg, receiving 15 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3988,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),11.0,C0,,,0.79,mg/L,geometric mean,CV%,0.59,,,,,"10 kg to <14 kg, receiving 20 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3989,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),16.0,C0,,,0.98,mg/L,geometric mean,CV%,0.52,,,,,"14 kg to <20 kg, receiving 25 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3990,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),19.0,C0,,,0.6,mg/L,geometric mean,CV%,0.74,,,,,"14 kg to <20 kg, receiving 25 mg film-coated tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3991,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),5.0,Ctrough,24,h,0.64,mg/L,geometric mean,CV%,0.51,,,,,"3 kg to <6 kg, receiving 5 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3992,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),13.0,Ctrough,24,h,0.53,mg/L,geometric mean,CV%,1.5,,,,,"6 kg to <10 kg, receiving 15 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3993,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),11.0,Ctrough,24,h,0.77,mg/L,geometric mean,CV%,0.57,,,,,"10 kg to <14 kg, receiving 20 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3994,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),16.0,Ctrough,24,h,0.87,mg/L,geometric mean,CV%,0.64,,,,,"14 kg to <20 kg, receiving 25 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3995,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),19.0,Ctrough,24,h,0.44,mg/L,geometric mean,CV%,0.5,,,,,"14 kg to <20 kg, receiving 25 mg film-coated tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3996,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),5.0,AUC0-24,,,45.2,mg h/L,geometric mean,CV%,0.33,,,,,"3 kg to <6 kg, receiving 5 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3997,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),13.0,AUC0-24,,,52.23,mg h/L,geometric mean,CV%,0.72,,,,,"6 kg to <10 kg, receiving 15 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3998,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),11.0,AUC0-24,,,76.1,mg h/L,geometric mean,CV%,0.21,,,,,"10 kg to <14 kg, receiving 20 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,3999,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),16.0,AUC0-24,,,69.93,mg h/L,geometric mean,CV%,0.28,,,,,"14 kg to <20 kg, receiving 25 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4000,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),19.0,AUC0-24,,,39.57,mg h/L,geometric mean,CV%,0.32,,,,,"14 kg to <20 kg, receiving 25 mg film-coated tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4001,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),5.0,Cmax,,,4,mg/L,geometric mean,CV%,0.32,,,,,"3 kg to <6 kg, receiving 5 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4002,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),13.0,Cmax,,,5.61,mg/L,geometric mean,CV%,0.47,,,,,"6 kg to <10 kg, receiving 15 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4003,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),11.0,Cmax,,,8.06,mg/L,geometric mean,CV%,0.21,,,,,"10 kg to <14 kg, receiving 20 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4004,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),16.0,Cmax,,,7.2,mg/L,geometric mean,CV%,0.19,,,,,"14 kg to <20 kg, receiving 25 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4005,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),19.0,Cmax,,,4.03,mg/L,geometric mean,CV%,0.31,,,,,"14 kg to <20 kg, receiving 25 mg film-coated tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4006,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),5.0,Tmax,,,2,hr,median,,,IQR,1,2,,"3 kg to <6 kg, receiving 5 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4007,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),13.0,Tmax,,,2,hr,median,,,IQR,1,2.2,,"6 kg to <10 kg, receiving 15 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4008,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),11.0,Tmax,,,2,hr,median,,,IQR,2,2.3,,"10 kg to <14 kg, receiving 20 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4009,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),16.0,Tmax,,,2,hr,median,,,IQR,2,2,,"14 kg to <20 kg, receiving 25 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4010,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),19.0,Tmax,,,2,hr,median,,,IQR,2,2,,"14 kg to <20 kg, receiving 25 mg film-coated tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4011,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),5.0,T1/2,,,8.79,hr,geometric mean,CV%,0.22,,,,,"3 kg to <6 kg, receiving 5 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4012,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),13.0,T1/2,,,6.98,hr,geometric mean,CV%,0.29,,,,,"6 kg to <10 kg, receiving 15 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4013,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),11.0,T1/2,,,6.95,hr,geometric mean,CV%,0.27,,,,,"10 kg to <14 kg, receiving 20 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4014,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),16.0,T1/2,,,8,hr,geometric mean,CV%,0.32,,,,,"14 kg to <20 kg, receiving 25 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4015,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),19.0,T1/2,,,7.28,hr,geometric mean,CV%,0.21,,,,,"14 kg to <20 kg, receiving 25 mg film-coated tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4016,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),5.0,Oral clearance,,,0.11,L/h,geometric mean,CV%,0.33,,,,,"3 kg to <6 kg, receiving 5 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4017,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),13.0,Oral clearance,,,0.29,L/h,geometric mean,CV%,0.72,,,,,"6 kg to <10 kg, receiving 15 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4018,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),11.0,Oral clearance,,,0.26,L/h,geometric mean,CV%,0.21,,,,,"10 kg to <14 kg, receiving 20 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4019,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),16.0,Oral clearance,,,0.36,L/h,geometric mean,CV%,0.28,,,,,"14 kg to <20 kg, receiving 25 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4020,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),19.0,Oral clearance,,,0.63,L/h,geometric mean,CV%,0.32,,,,,"14 kg to <20 kg, receiving 25 mg film-coated tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4021,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),5.0,Volume of distribution,,,1.4,L,geometric mean,CV%,0.34,,,,,"3 kg to <6 kg, receiving 5 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4022,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),13.0,Volume of distribution,,,2.89,L,geometric mean,CV%,0.43,,,,,"6 kg to <10 kg, receiving 15 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4023,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),11.0,Volume of distribution,,,2.63,L,geometric mean,CV%,0.25,,,,,"10 kg to <14 kg, receiving 20 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4024,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),16.0,Volume of distribution,,,4.13,L,geometric mean,CV%,0.19,,,,,"14 kg to <20 kg, receiving 25 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4025,2025-12-02T16:03:31.981487
35189082.0,dolutegravir ,dolutegravir ,blood,pediatric,,children (<6 months),19.0,Volume of distribution,,,6.64,L,geometric mean,CV%,0.34,,,,,"14 kg to <20 kg, receiving 25 mg film-coated tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4026,2025-12-02T16:03:31.981487
36111542.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,20.0,Ctrough,24,h,1.93,mg/L,geometric mean,CV%,0.32,,,,,T = 24 h from a TDM sample ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4027,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,total AUC0-24h ,,,40.8,mg h/L,geometric mean,CV%,0.35,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4028,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,total AUC0-24h ,,,47,mg h/L,geometric mean,CV%,0.42,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4029,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,total Cmax,,,3.15,mg/L,geometric mean,CV%,0.31,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4030,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,total Cmax,,,3.34,mg/L,geometric mean,CV%,0.32,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4031,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,total Tmax,,,3,hr,median,,,minmax,1,4.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4032,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,total Tmax,,,3.8,hr,median,,,minmax,0.5,8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4033,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,total C0,,,1,mg/L,geometric mean,CV%,0.9,,,,,predose concentration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4034,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,total C0,,,1.22,mg/L,geometric mean,CV%,1.05,,,,,predose concentration,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4035,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,total Ctrough,,,0.68,mg/L,geometric mean,CV%,0.84,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4036,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,total Ctrough,,,1.03,mg/L,geometric mean,CV%,0.68,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4037,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,total Cmin,,,0.66,mg/L,geometric mean,CV%,0.9,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4038,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,total Cmin,,,0.92,mg/L,geometric mean,CV%,0.84,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4039,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,total CL/Fss,,,1.23,L/h,geometric mean,CV%,0.35,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4040,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,total CL/Fss,,,1.06,L/h,geometric mean,CV%,0.42,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4041,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,total t1/2,,,10.5,hr,geometric mean,CV%,0.49,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4042,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,total t1/2,,,14.4,hr,geometric mean,CV%,46$,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4043,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,total Vd/F,,,18.6,L,geometric mean,CV%,0.45,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4044,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,total Vd/F,,,22.1,L,geometric mean,CV%,0.49,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4045,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,unbound Cmax,,,12.3,ug/L,geometric mean,CV%,0.44,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4046,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,unbound Cmax,,,9.18,ug/L,geometric mean,CV%,0.63,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4047,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,unbound fu,,,0.36,%,median,,,IQR,0.27,0.46,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4048,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,unbound fu,,,0.29,%,median,,,IQR,0.22,0.38,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4049,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,unbound Cmin,,,2.89,ug/L,geometric mean,CV%,0.87,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4050,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,unbound Cmin,,,3.38,ug/L,geometric mean,CV%,1.02,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4051,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Third trimester,,15.0,unbound fu,,,0.4,%,median,,,IQR,0.28,0.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4052,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,blood,maternal,Postpartum,,10.0,unbound fu,,,0.34,%,median,,,IQR,0.23,0.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4053,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,Dolutegravir-glucuronide ,blood,maternal,Third trimester,,14.0,AUC0-24,,,4.6,mg h/L,geometric mean,CV%,0.65,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4054,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,Dolutegravir-glucuronide ,blood,maternal,Postpartum,,9.0,AUC0-24,,,3.94,mg h/L,geometric mean,CV%,0.44,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4055,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,Dolutegravir-glucuronide ,blood,maternal,Third trimester,,14.0,metabolic ratio,,,0.11,,median,,,minmax,0.07,0.12,,Median molar metabolic ratio for dolutegravir-glucuronide divided by dolutegravir AUC024h based on total plasma concentrations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4056,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,Dolutegravir-glucuronide ,blood,maternal,Postpartum,,9.0,metabolic ratio,,,0.08,,median,,,minmax,0.05,0.09,,Median molar metabolic ratio for dolutegravir-glucuronide divided by dolutegravir AUC024h based on total plasma concentrations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4057,2025-12-02T16:03:31.981487
32103260.0,dolutegravir ,dolutegravir ,maternal and cord blood,maternal/pediatric ,at delivery,fetus,10.0,cord blood-to-maternal blood plasma concentration ratio ,,,1.29,,geometric mean,,,IQR,1.23,1.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4058,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,C0,,,0.49,mg/L,geometric mean,CV%,0.8,,,,,20 kg to <25 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4059,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,C0,,,0.85,mg/L,geometric mean,CV%,0.76,,,,,20 kg to <25 kg with 30 mg DT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4060,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,C0,,,1.26,mg/L,geometric mean,CV%,0.49,,,,,20 kg to <25 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4061,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,C0,,,0.53,mg/L,geometric mean,CV%,0.59,,,,,25 kg to <30 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4062,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,16.0,C0,,,1.05,mg/L,geometric mean,CV%,0.45,,,,,25 kg to <30 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4063,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,C0,,,0.51,mg/L,geometric mean,CV%,0.97,,,,,35 kg to <40 kg with 35 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4064,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,10.0,C0,,,1,mg/L,geometric mean,CV%,0.37,,,,,35 kg to <40 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4065,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,Ctrough,,,0.32,mg/L,geometric mean,CV%,0.94,,,,,20 kg to <25 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4066,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Ctrough,,,0.76,mg/L,geometric mean,CV%,0.73,,,,,20 kg to <25 kg with 30 mg DT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4067,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Ctrough,,,0.75,mg/L,geometric mean,CV%,0.44,,,,,20 kg to <25 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4068,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,Ctrough,,,0.39,mg/L,geometric mean,CV%,0.48,,,,,25 kg to <30 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4069,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,16.0,Ctrough,,,0.77,mg/L,geometric mean,CV%,0.43,,,,,25 kg to <30 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4070,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Ctrough,,,0.46,mg/L,geometric mean,CV%,0.63,,,,,35 kg to <40 kg with 35 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4071,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,10.0,Ctrough,,,0.63,mg/L,geometric mean,CV%,0.49,,,,,35 kg to <40 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4072,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,AUC0-24h,,,30,mg h/L,geometric mean,CV%,0.41,,,,,20 kg to <25 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4073,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,AUC0-24h,,,71.4,mg h/L,geometric mean,CV%,0.26,,,,,20 kg to <25 kg with 30 mg DT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4074,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,AUC0-24h,,,63.7,mg h/L,geometric mean,CV%,0.26,,,,,20 kg to <25 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4075,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,AUC0-24h,,,33.1,mg h/L,geometric mean,CV%,0.23,,,,,25 kg to <30 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4076,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,16.0,AUC0-24h,,,58.6,mg h/L,geometric mean,CV%,0.28,,,,,25 kg to <30 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4077,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,AUC0-24h,,,40.3,mg h/L,geometric mean,CV%,0.35,,,,,35 kg to <40 kg with 35 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4078,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,10.0,AUC0-24h,,,53.5,mg h/L,geometric mean,CV%,0.32,,,,,35 kg to <40 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4079,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,Cmax,,,3.2,mg/L,geometric mean,CV%,0.4,,,,,20 kg to <25 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4080,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Cmax,,,7.16,mg/L,geometric mean,CV%,0.26,,,,,20 kg to <25 kg with 30 mg DT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4081,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Cmax,,,6.34,mg/L,geometric mean,CV%,0.27,,,,,20 kg to <25 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4082,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,Cmax,,,3.16,mg/L,geometric mean,CV%,0.24,,,,,25 kg to <30 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4083,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,16.0,Cmax,,,5.41,mg/L,geometric mean,CV%,0.25,,,,,25 kg to <30 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4084,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Cmax,,,3.98,mg/L,geometric mean,CV%,0.28,,,,,35 kg to <40 kg with 35 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4085,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,10.0,Cmax,,,5.22,mg/L,geometric mean,CV%,0.25,,,,,35 kg to <40 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4086,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,Tmax,,,2,hr,median,,,IQR,1,3,,20 kg to <25 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4087,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Tmax,,,3,hr,median,,,IQR,2,4,,20 kg to <25 kg with 30 mg DT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4088,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Tmax,,,2,hr,median,,,IQR,1,3,,20 kg to <25 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4089,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,Tmax,,,2,hr,median,,,IQR,2,4,,25 kg to <30 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4090,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,16.0,Tmax,,,3,hr,median,,,IQR,3,6,,25 kg to <30 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4091,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Tmax,,,3,hr,median,,,IQR,1,4,,35 kg to <40 kg with 35 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4092,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,10.0,Tmax,,,2.5,hr,median,,,IQR,2,4,,35 kg to <40 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4093,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,T1/2,,,7.65,hr,geometric mean,CV%,0.51,,,,,20 kg to <25 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4094,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,T1/2,,,7.14,hr,geometric mean,CV%,0.3,,,,,20 kg to <25 kg with 30 mg DT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4095,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,T1/2,,,7.49,hr,geometric mean,CV%,0.19,,,,,20 kg to <25 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4096,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,T1/2,,,7.26,hr,geometric mean,CV%,0.23,,,,,25 kg to <30 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4097,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,16.0,T1/2,,,8.14,hr,geometric mean,CV%,0.16,,,,,25 kg to <30 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4098,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,T1/2,,,6.85,hr,geometric mean,CV%,0.17,,,,,35 kg to <40 kg with 35 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4099,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,10.0,T1/2,,,7.45,hr,geometric mean,CV%,0.15,,,,,35 kg to <40 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4100,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,CL/F,,,0.83,L/h,geometric mean,CV%,0.41,,,,,20 kg to <25 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4101,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,CL/F,,,0.42,L/h,geometric mean,CV%,0.26,,,,,20 kg to <25 kg with 30 mg DT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4102,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,CL/F,,,0.79,L/h,geometric mean,CV%,0.26,,,,,20 kg to <25 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4103,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,CL/F,,,0.76,L/h,geometric mean,CV%,0.23,,,,,25 kg to <30 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4104,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,16.0,CL/F,,,0.85,L/h,geometric mean,CV%,0.28,,,,,25 kg to <30 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4105,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,CL/F,,,0.87,L/h,geometric mean,CV%,0.35,,,,,35 kg to <40 kg with 35 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4106,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,10.0,CL/F,,,0.93,L/h,geometric mean,CV%,0.32,,,,,35 kg to <40 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4107,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,14.0,Vd/F,,,9.19,L,geometric mean,CV%,0.62,,,,,20 kg to <25 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4108,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Vd/F,,,4.33,L,geometric mean,CV%,0.25,,,,,20 kg to <25 kg with 30 mg DT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4109,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Vd/F,,,8.48,L,geometric mean,CV%,0.28,,,,,20 kg to <25 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4110,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,17.0,Vd/F,,,7.94,L,geometric mean,CV%,0.27,,,,,25 kg to <30 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4111,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,16.0,Vd/F,,,9.66,L,geometric mean,CV%,0.29,,,,,25 kg to <30 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4112,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,9.0,Vd/F,,,8.61,L,geometric mean,CV%,0.31,,,,,35 kg to <40 kg with 35 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4113,2025-12-02T16:03:31.981487
32763217.0,dolutegravir ,dolutegravir ,blood,pediatric,,children,10.0,Vd/F,,,10.1,L,geometric mean,CV%,0.29,,,,,35 kg to <40 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4114,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,blood,maternal,T3,,28.0,Cmax,,,2534,ng/ml,geometric mean,,,minmax,1462,3986,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4115,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,blood,maternal,2 weeks postpartum,,17.0,Cmax,,,2899,ng/ml,geometric mean,,,minmax,1397,4224,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4116,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,blood,maternal,T3,,28.0,C24,,,642,ng/ml,geometric mean,,,minmax,188,3088,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4117,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,blood,maternal,2 weeks postpartum,,17.0,C24,,,777,ng/ml,geometric mean,,,minmax,348,1210,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4118,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,blood,maternal,T3,,28.0,AUC0-24,,,35322,ng h/ml,geometric mean,,,minmax,19196,67922,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4119,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,blood,maternal,2 weeks postpartum,,17.0,AUC0-24,,,40127,ng h/ml,geometric mean,,,minmax,22795,59633,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4120,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,breast milk,maternal,2 weeks postpartum,,17.0,Cmax,,,84.6,ng/ml,geometric mean,,,minmax,43.8,171,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4121,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,blood,maternal,2 weeks postpartum,,17.0,Ctrough,,,22.3,ng/ml,geometric mean,,,minmax,3,64.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4122,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants ,17.0,Cmax,,,66.7,ng/ml,geometric mean,,,minmax,21,654,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4123,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants ,17.0,Ctrough,,,60.9,ng/ml,geometric mean,,,minmax,16.3,479,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4124,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,breast milk and blood,maternal,2 weeks postpartum,,17.0,BM:MP ratio of Cmax,,,0.03,,geometric mean,,,minmax,0.03,0.04,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4125,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,blood,maternal/pediatric ,2 weeks postpartum,infants ,17.0,IP:MP ratio of Cmax,,,0.03,,geometric mean,,,minmax,0,0.06,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4126,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,breast milk and blood,maternal,2 weeks postpartum,,17.0,BM:MP ratio of Ctrough,,,0.03,,geometric mean,,,minmax,0.02,0.04,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4127,2025-12-02T16:03:31.981487
31539371.0,dolutegravir ,dolutegravir ,blood,maternal/pediatric ,2 weeks postpartum,infants ,17.0,IP:MP ratio of Ctrough,,,0.08,,geometric mean,,,minmax,0,0.17,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4128,2025-12-02T16:03:31.981487
36177836.0,Rilpivirine,Rilpivirine,blood,maternal,lactation,,2.0,concentration,,,113,ng/ml,median,,,IQR,120,126,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4129,2025-12-02T16:03:31.981487
36177836.0,Rilpivirine,Rilpivirine,breast milk,maternal,lactation,,2.0,concentration,,,123,ng/ml,median,,,IQR,107,140,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4130,2025-12-02T16:03:31.981487
36177836.0,Rilpivirine,Rilpivirine,blood and breast milk,maternal,lactation,,2.0,milk/plasma concentration,,,1.08,,median,,,IQR,1.1,1.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4131,2025-12-02T16:03:31.981487
36177836.0,Rilpivirine,Rilpivirine,breast milk,maternal,lactation,,2.0,estimated infant daily dose from breastmilk,,,0.02,mg/kg,median,,,IQR,0.02,0.02,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4132,2025-12-02T16:03:31.981487
36177836.0,Rilpivirine,Rilpivirine,blood,pediatric,,infants ,1.0,concentration,,,4,ng/ml,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4133,2025-12-02T16:03:31.981487
36177836.0,Bictegravir,Bictegravir,blood,maternal,lactation,,3.0,concentration,,,5177,ng/ml,median,,,IQR,3576,6010,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4134,2025-12-02T16:03:31.981487
36177836.0,Bictegravir,Bictegravir,breast milk,maternal,lactation,,3.0,concentration,,,57,ng/ml,median,,,IQR,44,67,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4135,2025-12-02T16:03:31.981487
36177836.0,Bictegravir,Bictegravir,blood and breast milk,maternal,lactation,,3.0,milk/plasma concentration,,,0.01,,median,,,IQR,0.01,0.01,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4136,2025-12-02T16:03:31.981487
36177836.0,Bictegravir,Bictegravir,breast milk,maternal,lactation,,3.0,estimated infant daily dose from breastmilk,,,0.01,mg/kg,median,,,IQR,0.01,0.01,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4137,2025-12-02T16:03:31.981487
36177836.0,Bictegravir,Bictegravir,blood,pediatric,,infants ,1.0,concentration,,,103,ng/ml,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4138,2025-12-02T16:03:31.981487
36177836.0,dolutegravir ,dolutegravir ,blood,maternal,lactation,,6.0,concentration,,,2627,ng/ml,median,,,IQR,2360,3244,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4139,2025-12-02T16:03:31.981487
36177836.0,dolutegravir ,dolutegravir ,breast milk,maternal,lactation,,6.0,concentration,,,107,ng/ml,median,,,IQR,83,142,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4140,2025-12-02T16:03:31.981487
36177836.0,dolutegravir ,dolutegravir ,blood and breast milk,maternal,lactation,,6.0,milk/plasma concentration,,,0.04,,median,,,IQR,0.03,0.05,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4141,2025-12-02T16:03:31.981487
36177836.0,dolutegravir ,dolutegravir ,breast milk,maternal,lactation,,6.0,estimated infant daily dose from breastmilk,,,0.02,mg/kg,median,,,IQR,0.01,0.02,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4142,2025-12-02T16:03:31.981487
36177836.0,dolutegravir ,dolutegravir ,blood,pediatric,,infants ,2.0,concentration,,,"79, and 100",ng/ml,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4143,2025-12-02T16:03:31.981487
36177836.0,raltegravir,raltegravir,blood,maternal,lactation,,3.0,concentration,,,4250,ng/ml,median,,,IQR,2520,5111,,400 mg twice daily,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4144,2025-12-02T16:03:31.981487
36177836.0,raltegravir,raltegravir,breast milk,maternal,lactation,,3.0,concentration,,,1635,ng/ml,median,,,IQR,973,2142,,400 mg twice daily,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4145,2025-12-02T16:03:31.981487
36177836.0,raltegravir,raltegravir,blood and breast milk,maternal,lactation,,3.0,milk/plasma concentration,,,0.39,,median,,,IQR,0.39,0.42,,400 mg twice daily,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4146,2025-12-02T16:03:31.981487
36177836.0,raltegravir,raltegravir,breast milk,maternal,lactation,,3.0,estimated infant daily dose from breastmilk,,,0.25,mg/kg,median,,,IQR,0.15,0.32,,400 mg twice daily,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4147,2025-12-02T16:03:31.981487
36177836.0,raltegravir,raltegravir,blood,pediatric,,infants ,1.0,concentration,,,21,ng/ml,,,,,,,,400 mg twice daily,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4148,2025-12-02T16:03:31.981487
36177836.0,raltegravir,raltegravir,blood,maternal,lactation,,14.0,concentration,,,160,ng/ml,median,,,IQR,82,274,,1200 mg once daily,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4149,2025-12-02T16:03:31.981487
36177836.0,raltegravir,raltegravir,breast milk,maternal,lactation,,14.0,concentration,,,111,ng/ml,median,,,IQR,69,566,,1200 mg once daily,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4150,2025-12-02T16:03:31.981487
36177836.0,raltegravir,raltegravir,blood and breast milk,maternal,lactation,,14.0,milk/plasma concentration,,,0.96,,median,,,IQR,0.44,2.68,,1200 mg once daily,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4151,2025-12-02T16:03:31.981487
36177836.0,raltegravir,raltegravir,breast milk,maternal,lactation,,14.0,estimated infant daily dose from breastmilk,,,0.02,mg/kg,median,,,IQR,0.01,0.08,,1200 mg once daily,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4152,2025-12-02T16:03:31.981487
36177836.0,raltegravir,raltegravir,blood,pediatric,,infants ,6.0,concentration,,,"0, 0, 0, 14, 0, and 0",ng/ml,,,,,,,,1200 mg once daily,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4153,2025-12-02T16:03:31.981487
36177836.0,Darunavir,Darunavir,blood,maternal,lactation,,4.0,concentration,,,2419,ng/ml,median,,,IQR,2135,3503,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4154,2025-12-02T16:03:31.981487
36177836.0,Darunavir,Darunavir,breast milk,maternal,lactation,,4.0,concentration,,,316,ng/ml,median,,,IQR,284,325,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4155,2025-12-02T16:03:31.981487
36177836.0,Darunavir,Darunavir,blood and breast milk,maternal,lactation,,4.0,milk/plasma concentration,,,0.12,,median,,,IQR,0.1,0.14,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4156,2025-12-02T16:03:31.981487
36177836.0,Darunavir,Darunavir,breast milk,maternal,lactation,,4.0,estimated infant daily dose from breastmilk,,,0.05,mg/kg,median,,,IQR,0.04,0.05,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4157,2025-12-02T16:03:31.981487
36177836.0,Darunavir,Darunavir,blood,pediatric,,infants ,1.0,concentration,,,0,ng/ml,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4158,2025-12-02T16:03:31.981487
36177836.0,tenofovir alafenamide,tenofovir alafenamide,blood,maternal,lactation,,24.0,concentration,,,61,ng/ml,median,,,IQR,53.3,97,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4159,2025-12-02T16:03:31.981487
36177836.0,tenofovir alafenamide,tenofovir alafenamide,breast milk,maternal,lactation,,24.0,concentration,,,5,ng/ml,median,,,IQR,4,10,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4160,2025-12-02T16:03:31.981487
36177836.0,tenofovir alafenamide,tenofovir alafenamide,blood and breast milk,maternal,lactation,,24.0,milk/plasma concentration,,,0.08,,median,,,IQR,0.06,0.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4161,2025-12-02T16:03:31.981487
36177836.0,tenofovir alafenamide,tenofovir alafenamide,breast milk,maternal,lactation,,24.0,estimated infant daily dose from breastmilk,,,0.001,mg/kg,median,,,IQR,0.001,0.002,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4162,2025-12-02T16:03:31.981487
36177836.0,tenofovir alafenamide,tenofovir alafenamide,blood,pediatric,,infants ,10.0,concentration,,,0,ng/ml,median,,,IQR,0,0,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4163,2025-12-02T16:03:31.981487
32448902.0,raltegravir,raltegravir,blood,pediatric,,children,13.0,AUC0-12h,,,32.7,uM h,geometric mean,CV%,0.49,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4164,2025-12-02T16:03:31.981487
32448902.0,raltegravir,raltegravir,blood,pediatric,,children,13.0,C12h,,,106.5,nM,geometric mean,CV%,0.57,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4165,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,T3,,43.0,unbound AUC8-20h evening,,,853,ng h/ml,median,,,minmax,204,3298,<10-6,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4166,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,postpartum,,39.0,unbound AUC8-20h evening,,,1292,ng h/ml,median,,,minmax,273,4174,<10-6,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4167,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,T3,,43.0,total AUC8-20h evening,,,3921,ng h/ml,median,,,minmax,699,14706,<10-6,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4168,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,postpartum,,39.0,total AUC8-20h evening,,,6770,ng h/ml,median,,,minmax,1506,21859,<10-6,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4169,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir glucuronide,blood,maternal,T3,,43.0,AUC8-20h evening,,,5175,ng h/ml,median,,,minmax,2169,216977,<10-3,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4170,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir glucuronide,blood,maternal,postpartum,,39.0,AUC8-20h evening,,,3938,ng h/ml,median,,,minmax,1073,15362,<10-3,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4171,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,T3,,43.0,unbound Ctrough evening,,,14,ng/ml,median,,,minmax,1,86,0.12,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4172,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,postpartum,,39.0,unbound Ctrough evening,,,13,ng/ml,median,,,minmax,1,77,0.12,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4173,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,T3,,43.0,Total Ctrough evening,,,57,ng/ml,median,,,minmax,3,277,<10-5,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4174,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,postpartum,,39.0,Total Ctrough evening,,,69,ng/ml,median,,,minmax,5,248,<10-5,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4175,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir glucuronide,blood,maternal,T3,,43.0,Ctrough evening,,,149,ng/ml,median,,,minmax,10,898,<10-5,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4176,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir glucuronide,blood,maternal,postpartum,,39.0,Ctrough evening,,,102,ng/ml,median,,,minmax,11,385,<10-5,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4177,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,T3,,43.0,unbound AUC8-20h morning,,,1212,ng h/ml,median,,,minmax,278,4263,<10-6,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4178,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,postpartum,,39.0,unbound AUC8-20h morning,,,1725,ng h/ml,median,,,minmax,379,5617,<10-6,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4179,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,T3,,43.0,total AUC8-20h morning,,,5359,ng h/ml,median,,,minmax,956,18614,<10-6,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4180,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,postpartum,,39.0,total AUC8-20h morning,,,9209,ng h/ml,median,,,minmax,2095,29414,<10-6,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4181,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir glucuronide,blood,maternal,T3,,43.0,AUC8-20h morning,,,5254,ng h/ml,median,,,minmax,281,24669,0.33,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4182,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir glucuronide,blood,maternal,postpartum,,39.0,AUC8-20h morning,,,4122,ng h/ml,median,,,minmax,1595,16228,0.33,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4183,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,T3,,43.0,unbound Ctrough morning,,,56,ng/ml,median,,,minmax,8,176,0.26,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4184,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,postpartum,,39.0,unbound Ctrough morning,,,65,ng/ml,median,,,minmax,12,219,0.26,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4185,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,T3,,43.0,Total Ctrough morning,,,253,ng/ml,median,,,minmax,37,605,0.84,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4186,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir,blood,maternal,postpartum,,39.0,Total Ctrough morning,,,321,ng/ml,median,,,minmax,63,931,0.84,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4187,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir glucuronide,blood,maternal,T3,,43.0,Ctrough morning,,,269,ng/ml,median,,,minmax,38,880,<10-4,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4188,2025-12-02T16:03:31.981487
32661003.0,raltegravir,raltegravir glucuronide,blood,maternal,postpartum,,39.0,Ctrough morning,,,207,ng/ml,median,,,minmax,55,795,<10-4,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4189,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,6.0,AUC0-24h,,,53.9,mg h/L,geometric mean,CV%,0.346,,,,,Cohort 1 RAL-nave 3 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4190,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,3.0,AUC0-24h,,,44.3,mg h/L,geometric mean,CV%,0.719,,,,,Cohort 1 RAL-nave 2 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4191,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,6.0,AUC0-24h,,,37.4,mg h/L,geometric mean,CV%,0.927,,,,,Cohort 1 RAL-exposed 1.5 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4192,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,6.0,C24trough,,,1444,ng/ml,geometric mean,CV%,0.631,,,,,Cohort 1 RAL-nave 3 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4193,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,3.0,C24trough,,,806,ng/ml,geometric mean,CV%,2.463,,,,,Cohort 1 RAL-nave 2 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4194,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,6.0,C24trough,,,906,ng/ml,geometric mean,CV%,2.095,,,,,Cohort 1 RAL-exposed 1.5 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4195,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,6.0,Cmax,,,3361,ng/ml,geometric mean,CV%,0.355,,,,,Cohort 1 RAL-nave 3 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4196,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,3.0,Cmax,,,3405,ng/ml,geometric mean,CV%,0.381,,,,,Cohort 1 RAL-nave 2 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4197,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,6.0,Cmax,,,2189,ng/ml,geometric mean,CV%,0.733,,,,,Cohort 1 RAL-exposed 1.5 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4198,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,6.0,Tmax,,,6.5,h,geometric mean,CV%,0.765,,,,,Cohort 1 RAL-nave 3 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4199,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,3.0,Tmax,,,0.4,h,geometric mean,CV%,0.044,,,,,Cohort 1 RAL-nave 2 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4200,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,6.0,Tmax,,,5.2,h,geometric mean,CV%,0.859,,,,,Cohort 1 RAL-exposed 1.5 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4201,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,6.0,T1/2,,,11.8,h,geometric mean,CV%,0.272,,,,,Cohort 1 RAL-nave 3 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4202,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,3.0,T1/2,,,17.2,h,geometric mean,CV%,1.072,,,,,Cohort 1 RAL-nave 2 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4203,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,6.0,T1/2,,,12.6,h,geometric mean,CV%,0.487,,,,,Cohort 1 RAL-exposed 1.5 mg/kg single dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4204,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,25.0,AUC0-24h,,,38.2,mg h/L,geometric mean,CV%,0.42,,,,,Cohort 2 Initial dose 1.5 mg/kg once daily RAL-Nave,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4205,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,10.0,AUC0-24h,,,42.9,mg h/L,geometric mean,CV%,0.253,,,,,Cohort 2 Initial dose 1.5 mg/kg once daily RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4206,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,24.0,AUC0-12h,,,14.3,mg h/L,geometric mean,CV%,0.495,,,,,Cohort 2 days 15-18: 3 mg/kg once daily RAL-Nave,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4207,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,10.0,AUC0-12h,,,18.3,mg h/L,geometric mean,CV%,0.628,,,,,Cohort 2 days 15-18: 3 mg/kg once daily RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4208,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,25.0,C24trough,,,948,ng/ml,geometric mean,CV%,0.84,,,,,Cohort 2 Initial dose 1.5 mg/kg once daily RAL-Nave,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4209,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,10.0,C24trough,,,946,ng/ml,geometric mean,CV%,0.74,,,,,Cohort 2 Initial dose 1.5 mg/kg once daily RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4210,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,24.0,C24trough,,,176,ng/ml,geometric mean,CV%,1.621,,,,,Cohort 2 days 15-18: 3 mg/kg once daily RAL-Nave,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4211,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,10.0,C24trough,,,274,ng/ml,geometric mean,CV%,1.764,,,,,Cohort 2 days 15-18: 3 mg/kg once daily RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4212,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,25.0,Cmax,,,2350,ng/ml,geometric mean,CV%,0.365,,,,,Cohort 2 Initial dose 1.5 mg/kg once daily RAL-Nave,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4213,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,10.0,Cmax,,,2565,ng/ml,geometric mean,CV%,0.231,,,,,Cohort 2 Initial dose 1.5 mg/kg once daily RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4214,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,24.0,Cmax,,,2849,ng/ml,geometric mean,CV%,0.475,,,,,Cohort 2 days 15-18: 3 mg/kg once daily RAL-Nave,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4215,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,10.0,Cmax,,,3667,ng/ml,geometric mean,CV%,0.463,,,,,Cohort 2 days 15-18: 3 mg/kg once daily RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4216,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,25.0,Tmax,,,5.4,h,geometric mean,CV%,0.715,,,,,Cohort 2 Initial dose 1.5 mg/kg once daily RAL-Nave,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4217,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,10.0,Tmax,,,3.8,h,geometric mean,CV%,0.888,,,,,Cohort 2 Initial dose 1.5 mg/kg once daily RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4218,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,24.0,Tmax,,,2.3,h,geometric mean,CV%,0.771,,,,,Cohort 2 days 15-18: 3 mg/kg once daily RAL-Nave,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4219,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,10.0,Tmax,,,1.9,h,geometric mean,CV%,0.523,,,,,Cohort 2 days 15-18: 3 mg/kg once daily RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4220,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,25.0,T1/2,,,15.8,h,geometric mean,CV%,1.014,,,,,Cohort 2 Initial dose 1.5 mg/kg once daily RAL-Nave,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4221,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,10.0,T1/2,,,14.4,h,geometric mean,CV%,0.695,,,,,Cohort 2 Initial dose 1.5 mg/kg once daily RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4222,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,24.0,T1/2,,,2.5,h,geometric mean,CV%,0.341,,,,,Cohort 2 days 15-18: 3 mg/kg once daily RAL-Nave,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4223,2025-12-02T16:03:31.981487
31913995.0,raltegravir,raltegravir,blood,pediatric,,neoantes,10.0,T1/2,,,2.9,h,geometric mean,CV%,0.207,,,,,Cohort 2 days 15-18: 3 mg/kg once daily RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4224,2025-12-02T16:03:31.981487
31689263.0,raltegravir,raltegravir,blood,pediatric,,children (2 to <6 yr),12.0,Cmax,,,11.7,uM,geometric mean,CV%,0.762,,,,,cohort 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4225,2025-12-02T16:03:31.981487
31689263.0,raltegravir,raltegravir,blood,pediatric,,children (6 to <12 yr),14.0,Cmax,,,13.9,uM,geometric mean,CV%,0.706,,,,,cohort 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4226,2025-12-02T16:03:31.981487
31689263.0,raltegravir,raltegravir,blood,pediatric,,children (2 to <6 yr),12.0,T1/2,,,4.3,h,geometric mean,CV%,0.745,,,,,cohort 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4227,2025-12-02T16:03:31.981487
31689263.0,raltegravir,raltegravir,blood,pediatric,,children (6 to <12 yr),14.0,T1/2,,,3.1,h,geometric mean,CV%,0.5,,,,,cohort 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4228,2025-12-02T16:03:31.981487
31689263.0,raltegravir,raltegravir,blood,pediatric,,children (2 to <6 yr),12.0,AUC12h,,,28.8,uM h,geometric mean,CV%,0.502,,,,,cohort 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4229,2025-12-02T16:03:31.981487
31689263.0,raltegravir,raltegravir,blood,pediatric,,children (6 to <12 yr),14.0,AUC12h,,,38.8,uM h,geometric mean,CV%,0.381,,,,,cohort 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4230,2025-12-02T16:03:31.981487
31689263.0,raltegravir,raltegravir,blood,pediatric,,children (2 to <6 yr),12.0,C12h,,,229,nM,geometric mean,CV%,0.763,,,,,cohort 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4231,2025-12-02T16:03:31.981487
31689263.0,raltegravir,raltegravir,blood,pediatric,,children (6 to <12 yr),14.0,C12h,,,228,nM,geometric mean,CV%,0.784,,,,,cohort 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4232,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,2T,,16.0,AUC0-24,,,50,ug h/ml,median,,,IQR,27.032,58.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4233,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,3T,,26.0,AUC0-24,,,42.05,ug h/ml,median,,,IQR,26.83,50.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4234,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,postpartum,,19.0,AUC0-24,,,95.55,ug h/ml,median,,,IQR,67.2,118.95,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4235,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,2T,,16.0,C0,,,0.28,ug/ml,median,,,IQR,0.045,0.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4236,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,3T,,26.0,C0,,,0.25,ug/ml,median,,,IQR,0.045,1.13,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4237,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,postpartum,,19.0,C0,,,1.62,ug/ml,median,,,IQR,0.045,3.44,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4238,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,2T,,16.0,Cmax,,,4.59,ug/ml,median,,,IQR,2.38,6.12,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4239,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,3T,,26.0,Cmax,,,3.67,ug/ml,median,,,IQR,3.29,4.65,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4240,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,postpartum,,19.0,Cmax,,,7.04,ug/ml,median,,,IQR,5.7,10.75,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4241,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,2T,,16.0,Tmax,,,3,h,median,,,IQR,2,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4242,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,3T,,26.0,Tmax,,,2,h,median,,,IQR,2,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4243,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,postpartum,,19.0,Tmax,,,2,h,median,,,IQR,2,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4244,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,2T,,16.0,C24,,,0.33,ug/ml,median,,,IQR,0.045,0.47,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4245,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,3T,,26.0,C24,,,0.27,ug/ml,median,,,IQR,0.045,0.63,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4246,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,postpartum,,19.0,C24,,,1.43,ug/ml,median,,,IQR,0.73,1.86,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4247,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,2T,,16.0,Cmin,,,0.33,ug/ml,median,,,IQR,0.045,0.47,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4248,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,3T,,26.0,Cmin,,,0.25,ug/ml,median,,,IQR,0.045,0.45,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4249,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,postpartum,,19.0,Cmin,,,1.34,ug/ml,median,,,IQR,0.56,1.86,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4250,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,2T,,16.0,CL/F,,,16,L/h,median,,,IQR,13.64,29.74,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4251,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,3T,,26.0,CL/F,,,19.04,L/h,median,,,IQR,15.84,29.82,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4252,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,postpartum,,19.0,CL/F,,,8.37,L/h,median,,,IQR,6.73,11.91,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4253,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,2T,,16.0,T1/2,,,4.8,h,median,,,IQR,3.91,6.07,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4254,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,3T,,26.0,T1/2,,,5.18,h,median,,,IQR,3.76,6.61,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4255,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,postpartum,,19.0,T1/2,,,8.11,h,median,,,IQR,6.19,10.55,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4256,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,12.0,GMR of AUC0-24 2T/PP,,,0.47,,median,,,90%CI,0.33,0.68,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4257,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,18.0,GMR of AUC0-24 3T/PP,,,0.44,,median,,,90%CI,0.36,0.54,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4258,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,12.0,GMR of C0 2T/PP,,,0.29,,median,,,90%CI,0.07,1.16,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4259,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,18.0,GMR of C0 3T/PP,,,0.32,,median,,,90%CI,0.1,1.05,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4260,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,12.0,GMR of Cmax 2T/PP,,,0.56,,median,,,90%CI,0.41,0.76,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4261,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,18.0,GMR of Cmax 3T/PP,,,0.54,,median,,,90%CI,0.46,0.63,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4262,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,12.0,GMR of C24 2T/PP,,,0.15,,median,,,90%CI,0.08,0.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4263,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,18.0,GMR of C24 3T/PP,,,0.21,,median,,,90%CI,0.12,0.36,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4264,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,12.0,GMR of Cmin 2T/PP,,,0.15,,median,,,90%CI,0.08,0.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4265,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,18.0,GMR of Cmin 3T/PP,,,0.21,,median,,,90%CI,0.11,0.38,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4266,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,12.0,GMR of CL/F 2T/PP,,,2.12,,median,,,90%CI,1.47,3.05,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4267,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,18.0,GMR of CL/F 3T/PP,,,2.28,,median,,,90%CI,1.87,2.77,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4268,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,12.0,GMT of T1/2 2T/PP,,,0.55,,median,,,90%CI,0.44,0.67,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4269,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,18.0,GMT of T1/2 3T/PP,,,0.62,,median,,,90%CI,0.5,0.76,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4270,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,maternal,at delivery,,20.0,concentration,,,0.61,ug/mL,median,,,IQR,0.045,1.78,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4271,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,cord blood,pediatric,,fetus,19.0,Cmax,,,0.3,ug/mL,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4272,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood and cord blood,maternal/pediatric ,at delivery,fetus,13.0,concentration ratio of cord blood to maternal plasma,,,0.07,,median,,,IQR,0.03,0.15,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4273,2025-12-02T16:03:31.981487
34076612.0,darunavir,darunavir,blood,pediatric,,infants,9.0,Cmax,,,0.43,ug/ml,median,,,IQR,0.27,2.23,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4274,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,2T,,9.0,AUC0-12,,,55.1,ug h/ml,median,,,IQR,46.4,57.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4275,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,3T,,24.0,AUC0-12,,,0.8,ug h/ml,median,,,IQR,41.2,57.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4276,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,postpartum,,24.0,AUC0-12,,,79.6,ug h/ml,median,,,IQR,66.6,103,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4277,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,2T,,9.0,CL/F,,,14.2,L/h,median,,,IQR,12.3,15.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4278,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,3T,,24.0,CL/F,,,15.6,L/h,median,,,IQR,13.9,19.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4279,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,postpartum,,24.0,CL/F,,,7.72,L/h,median,,,IQR,6.19,10.32,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4280,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,2T,,9.0,V/F,,,152.7,L,median,,,IQR,137,259.2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4281,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,3T,,24.0,V/F,,,174.6,L,median,,,IQR,143.3,233.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4282,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,postpartum,,24.0,V/F,,,101.2,L,median,,,IQR,62.1,133.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4283,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,2T,,9.0,T1/2,,,7.95,h,median,,,IQR,6.21,9.82,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4284,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,3T,,24.0,T1/2,,,7.65,h,median,,,IQR,6.57,9.04,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4285,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,postpartum,,24.0,T1/2,,,8.66,h,median,,,IQR,6.72,10.38,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4286,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,2T,,9.0,Cmin,,,2.84,ug/ml,median,,,IQR,1.12,3.23,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4287,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,3T,,24.0,Cmin,,,2.39,ug/ml,median,,,IQR,1.72,2.82,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4288,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,postpartum,,24.0,Cmin,,,1.12,ug/ml,median,,,IQR,0.52,5.01,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4289,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,2T,,9.0,Clast,,,2.84,ug/ml,median,,,IQR,2.24,3.23,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4290,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,3T,,24.0,Clast,,,2.52,ug/ml,median,,,IQR,2.06,2.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4291,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,postpartum,,24.0,Clast,,,4.51,ug/ml,median,,,IQR,3.72,5.28,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4292,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,2T,,9.0,Cmax,,,6.22,ug/ml,median,,,IQR,5.3,8.42,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4293,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,3T,,24.0,Cmax,,,6.55,ug/ml,median,,,IQR,5.38,7.43,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4294,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,postpartum,,24.0,Cmax,,,8.96,ug/ml,median,,,IQR,7.93,10.85,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4295,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,2T,,9.0,C0,,,2.91,ug/ml,median,,,IQR,1.55,5.61,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4296,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,3T,,24.0,C0,,,3.57,ug/ml,median,,,IQR,2.79,4.09,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4297,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,postpartum,,24.0,C0,,,3.56,ug/ml,median,,,IQR,2.14,6.42,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4298,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,2T,,9.0,C12h,,,2.84,ug/ml,median,,,IQR,2.24,3.23,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4299,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,3T,,24.0,C12h,,,2.52,ug/ml,median,,,IQR,2.06,2.91,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4300,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,postpartum,,24.0,C12h,,,4.41,ug/ml,median,,,IQR,3.72,5.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4301,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,8.0,AUC0-12,,,0.62,,geometric mean ratio,,,90% CI,0.44,0.88,0.055,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4302,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,23.0,AUC0-12,,,0.64,,geometric mean ratio,,,90% CI,0.55,0.73,<0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4303,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,8.0,CL/F,,,1.77,,geometric mean ratio,,,90% CI,1.24,2.51,0.039,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4304,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,23.0,CL/F,,,2.01,,geometric mean ratio,,,90% CI,1.17,2.35,<0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4305,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,8.0,V/F,,,1.58,,geometric mean ratio,,,90% CI,1.23,2.04,0.016,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4306,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,23.0,V/F,,,2.01,,geometric mean ratio,,,90% CI,1.53,2.65,<0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4307,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,8.0,T1/2,,,0.9,,geometric mean ratio,,,90% CI,0.74,1.08,0.313,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4308,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,23.0,T1/2,,,1.01,,geometric mean ratio,,,90% CI,0.83,1.22,0.637,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4309,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,8.0,Cmin,,,2.52,,geometric mean ratio,,,90% CI,0.68,9.35,0.578,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4310,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,23.0,Cmin,,,0.9,,geometric mean ratio,,,90% CI,0.52,1.58,0.011,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4311,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,8.0,Clast,,,0.66,,geometric mean ratio,,,90% CI,0.39,1.12,0.109,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4312,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,23.0,Clast,,,0.59,,geometric mean ratio,,,90% CI,0.5,0.69,<0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4313,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,8.0,Cmax,,,0.81,,geometric mean ratio,,,90% CI,0.64,1.01,0.148,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4314,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,23.0,Cmax,,,0.71,,geometric mean ratio,,,90% CI,0.62,0.81,<0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4315,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,8.0,C0,,,2.97,,geometric mean ratio,,,90% CI,0.75,11.8,0.469,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4316,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,23.0,C0,,,1,,geometric mean ratio,,,90% CI,0.56,1.81,0.045,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4317,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"2T, and postpartum",,8.0,C12h,,,0.66,,geometric mean ratio,,,90% CI,0.39,1.12,0.109,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4318,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,"3T, and postpartum",,23.0,C12h,,,0.58,,geometric mean ratio,,,90% CI,0.49,0.69,<0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4319,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,cord blood,pediatric,,fetus,20.0,concentration,,,0.27,ug/ml,median,,,IQR,0.14,0.55,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4320,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,at delivery,,21.0,concentration,,,2.33,ug/ml,median,,,IQR,1.07,3.21,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4321,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,cord blood and maternal blood,maternal/pediatric ,at delivery,fetus,16.0,ratio of cord/maternal concentration,,,0.15,,median,,,IQR,0.12,0.17,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4322,2025-12-02T16:03:31.981487
31923087.0,darunavir,darunavir,blood,maternal,2T,,9.0,AUC0-12,,,3.19,ug h/ml,median,,,IQR,2.67,6.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4323,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,3T,,24.0,AUC0-12,,,4.83,ug h/ml,median,,,IQR,3.23,7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4324,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,postpartum,,24.0,AUC0-12,,,6.68,ug h/ml,median,,,IQR,5.07,11.2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4325,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,2T,,9.0,CL/F,,,14.2,L/h,median,,,IQR,12.3,15.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4326,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,3T,,24.0,CL/F,,,15.6,L/h,median,,,IQR,13.9,19.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4327,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,postpartum,,24.0,CL/F,,,7.72,L/h,median,,,IQR,6.2,10.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4328,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,2T,,9.0,V/F,,,245,L,median,,,IQR,194.4,389.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4329,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,3T,,24.0,V/F,,,210.7,L,median,,,IQR,131,328.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4330,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,postpartum,,24.0,V/F,,,89.6,L,median,,,IQR,48.3,163.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4331,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,2T,,9.0,T1/2,,,7.21,h,median,,,IQR,5.16,17.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4332,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,3T,,24.0,T1/2,,,6.51,h,median,,,IQR,3.67,12.33,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4333,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,postpartum,,24.0,T1/2,,,4.73,h,median,,,IQR,3.85,6.35,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4334,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,2T,,9.0,Cmin,,,0.12,ug/ml,median,,,IQR,0.05,0.34,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4335,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,3T,,24.0,Cmin,,,0.2,ug/ml,median,,,IQR,0.08,0.29,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4336,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,postpartum,,24.0,Cmin,,,0.29,ug/ml,median,,,IQR,0.05,0.44,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4337,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,2T,,9.0,Clast,,,0.16,ug/ml,median,,,IQR,0.12,0.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4338,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,3T,,24.0,Clast,,,0.2,ug/ml,median,,,IQR,0.11,0.39,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4339,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,postpartum,,24.0,Clast,,,0.35,ug/ml,median,,,IQR,0.19,0.64,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4340,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,2T,,9.0,Cmax,,,0.4,ug/ml,median,,,IQR,0.35,0.66,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4341,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,3T,,24.0,Cmax,,,0.62,ug/ml,median,,,IQR,0.45,0.89,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4342,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,postpartum,,24.0,Cmax,,,0.92,ug/ml,median,,,IQR,0.65,1.43,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4343,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,2T,,9.0,C0,,,0.23,ug/ml,median,,,IQR,0.11,0.34,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4344,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,3T,,24.0,C0,,,0.32,ug/ml,median,,,IQR,0.16,0.51,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4345,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,postpartum,,24.0,C0,,,0.48,ug/ml,median,,,IQR,0.08,0.71,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4346,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,2T,,9.0,C12h,,,0.16,ug/ml,median,,,IQR,0.12,0.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4347,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,3T,,24.0,C12h,,,0.2,ug/ml,median,,,IQR,0.11,0.39,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4348,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,postpartum,,24.0,C12h,,,0.34,ug/ml,median,,,IQR,0.18,0.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4349,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"2T, and postpartum",,8.0,AUC0-12,,,0.88,,geometric mean ratio,,,90% CI,0.61,1.27,0.547,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4350,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"3T, and postpartum",,23.0,AUC0-12,,,0.65,,geometric mean ratio,,,90% CI,0.52,0.82,0.007,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4351,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"2T, and postpartum",,8.0,CL/F,,,1.14,,geometric mean ratio,,,90% CI,0.79,1.64,0.383,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4352,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"3T, and postpartum",,23.0,CL/F,,,1.53,,geometric mean ratio,,,90% CI,1.22,1.92,0.008,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4353,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"2T, and postpartum",,8.0,V/F,,,1.41,,geometric mean ratio,,,90% CI,0.73,2.72,0.547,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4354,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"3T, and postpartum",,23.0,V/F,,,2.12,,geometric mean ratio,,,90% CI,1.42,3.16,0.012,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4355,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"2T, and postpartum",,8.0,T1/2,,,1.24,,geometric mean ratio,,,90% CI,0.78,1.97,0.383,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4356,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"3T, and postpartum",,23.0,T1/2,,,1.5,,geometric mean ratio,,,90% CI,0.95,2.37,0.226,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4357,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"2T, and postpartum",,8.0,Cmin,,,1.26,,geometric mean ratio,,,90% CI,0.76,2.11,0.313,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4358,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"3T, and postpartum",,23.0,Cmin,,,0.9,,geometric mean ratio,,,90% CI,0.48,1.69,0.164,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4359,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"2T, and postpartum",,8.0,Clast,,,0.85,,geometric mean ratio,,,90% CI,0.67,1.08,0.469,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4360,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"3T, and postpartum",,23.0,Clast,,,0.64,,geometric mean ratio,,,90% CI,0.4,1.04,0.065,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4361,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"2T, and postpartum",,8.0,Cmax,,,0.92,,geometric mean ratio,,,90% CI,0.68,1.23,0.547,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4362,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"3T, and postpartum",,23.0,Cmax,,,0.67,,geometric mean ratio,,,90% CI,0.54,0.83,0.004,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4363,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"2T, and postpartum",,8.0,C0,,,1.8,,geometric mean ratio,,,90% CI,1.02,3.18,0.078,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4364,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"3T, and postpartum",,23.0,C0,,,0.88,,geometric mean ratio,,,90% CI,0.56,1.37,0.143,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4365,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"2T, and postpartum",,8.0,C12h,,,0.85,,geometric mean ratio,,,90% CI,0.67,1.08,0.469,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4366,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,"3T, and postpartum",,23.0,C12h,,,0.67,,geometric mean ratio,,,90% CI,0.41,1.11,0.116,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4367,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,cord blood,pediatric,,fetus,7.0,concentration,,,,ug/ml,median,,,minmax,0.013,0.035,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4368,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,blood,maternal,at delivery,,20.0,concentration,,,0.154,ug/ml,median,,,IQR,0.106,0.279,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4369,2025-12-02T16:03:31.981487
31923087.0,ritonavir,ritonavir,cord blood and maternal blood,maternal/pediatric ,at delivery,fetus,7.0,ratio of cord/maternal concentration,,,0.07,,median,,,IQR,0.05,0.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4370,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,Total C0,,,435,ng/ml,median,,,minmax,BLQ,2300,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4371,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,Total C0,,,624,ng/ml,median,,,minmax,247,1850,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4372,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Postpartum(612 weekspostpartum),,6.0,Total C0,,,2625,ng/ml,median,,,minmax,BLQ,5820,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4373,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,second triester and postpartum,,6.0,LSM raio of Total C0: 2T/PP,,,ND,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4374,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,third trimester and postpartum,,6.0,LSM raio of Total C0: 3T/PP,,,ND,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4375,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,Total Cmin,,,134,ng/ml,median,,,minmax,BLQ,369,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4376,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,Total Cmin,,,162,ng/ml,median,,,minmax,50.9,304,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4377,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Postpartum(612 weekspostpartum),,6.0,Total Cmin,,,1381,ng/ml,median,,,minmax,BLQ,3220,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4378,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,second triester and postpartum,,6.0,LSM raio of Total Cmin: 2T/PP,,,0.08,,median,,,minmax,0.01,0.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4379,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,third trimester and postpartum,,6.0,LSM raio of Total Cmin: 3T/PP,,,0.11,,median,,,minmax,0.04,0.79,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4380,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,Total Cmax,,,4710,ng/ml,median,,,minmax,1050,5760,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4381,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,Total Cmax,,,4855,ng/ml,median,,,minmax,3530,6210,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4382,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Postpartum(612 weekspostpartum),,6.0,Total Cmax,,,7445,ng/ml,median,,,minmax,5880,12000,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4383,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,second triester and postpartum,,6.0,LSM raio of Total Cmax: 2T/PP,,,0.51,,median,,,minmax,0.3,0.86,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4384,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,third trimester and postpartum,,6.0,LSM raio of Total Cmax: 3T/PP,,,0.63,,median,,,minmax,0.5,0.79,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4385,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,total daruanir Tmax,,,4,h,median,,,minmax,3,6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4386,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,total daruanir Tmax,,,3.5,h,median,,,minmax,2,6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4387,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Postpartum(612 weekspostpartum),,6.0,total daruanir Tmax,,,4,h,median,,,minmax,2,6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4388,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,second triester and postpartum,,6.0,LSM raio of Total Tmax: 2T/PP,,,ND,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4389,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,third trimester and postpartum,,6.0,LSM raio of Total Tmax: 3T/PP,,,ND,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4390,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,total AUC24h,,,52009,ng h/ml,median,,,minmax,10547,71497,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4391,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,total AUC24h,,,50214,ng h/ml,median,,,minmax,34068,57509,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4392,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Postpartum(612 weekspostpartum),,6.0,total AUC24h,,,91644,ng h/ml,median,,,minmax,64573,157934,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4393,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,second triester and postpartum,,6.0,LSM raio of Total AUC24h: 2T/PP,,,0.44,,median,,,minmax,0.24,0.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4394,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,third trimester and postpartum,,6.0,LSM raio of Total AUC24h: 3T/PP,,,0.5,,median,,,minmax,0.37,0.66,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4395,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,unbound  C0,,,56.5,ng/ml,median,,,minmax,BLQ,361,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4396,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,unbound  C1,,,89.2,ng/ml,median,,,minmax,56.7,439,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4397,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Postpartum(612 weekspostpartum),,6.0,unbound  C2,,,399,ng/ml,median,,,minmax,BLQ,826,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4398,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,second triester and postpartum,,6.0,LSM raio of unbound C0: 2T/PP,,,ND,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4399,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,third trimester and postpartum,,6.0,LSM raio of unbound C0: 2T/PP,,,ND,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4400,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,Unbound Cmin,,,17.5,ng/ml,median,,,minmax,BLQ,54.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4401,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,Unbound Cmin,,,31.2,ng/ml,median,,,minmax,9.35,57.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4402,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Postpartum(612 weekspostpartum),,6.0,Unbound Cmin,,,229,ng/ml,median,,,minmax,BLQ,420,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4403,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,second triester and postpartum,,6.0,LSM raio of unbound Cmin: 2T/PP,,,0.08,,median,,,minmax,0.02,0.42,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4404,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,third trimester and postpartum,,6.0,LSM raio of unbound Cmin: 3T/PP,,,0.12,,median,,,minmax,0.05,0.27,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4405,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,unbound Cmax,,,945,ng/ml,median,,,minmax,168,1110,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4406,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,unbound Cmax,,,1058,ng/ml,median,,,minmax,77,1109,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4407,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Postpartum(612 weekspostpartum),,6.0,unbound Cmax,,,1199,ng/ml,median,,,minmax,866,2065,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4408,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,second triester and postpartum,,6.0,LSM raio of unbound Cmax: 2T/PP,,,0.59,,median,,,minmax,0.34,1.02,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4409,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,third trimester and postpartum,,6.0,LSM raio of unbound Cmax: 3T/PP,,,0.77,,median,,,minmax,0.59,1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4410,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,unbound daruanir Tmax,,,4.05,h,median,,,minmax,1.03,6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4411,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,unbound daruanir Tmax,,,4,h,median,,,minmax,2,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4412,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Postpartum(612 weekspostpartum),,6.0,unbound daruanir Tmax,,,3.5,h,median,,,minmax,2,6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4413,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,second triester and postpartum,,6.0,LSM raio of unbound Tmax: 2T/PP,,,ND,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4414,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,third trimester and postpartum,,6.0,LSM raio of unbound Tmax: 3T/PP,,,ND,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4415,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,Unbound AUC24h,,,9725,ng h/ml,median,,,minmax,1885,12310,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4416,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,Unbound AUC24h,,,8883,ng h/ml,median,,,minmax,6132,11883,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4417,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,Postpartum(612 weekspostpartum),,6.0,Unbound AUC24h,,,15429,ng h/ml,median,,,minmax,6958,23792,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4418,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,second triester and postpartum,,6.0,LSM raio of Unbound AUC24h: 2T/PP,,,0.55,,median,,,minmax,0.28,1.06,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4419,2025-12-02T16:03:31.981487
30873741.0,darunavir,darunavir,blood,maternal,third trimester and postpartum,,6.0,LSM raio of Unbound AUC24h: 3T/PP,,,0.6,,median,,,minmax,0.44,0.83,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4420,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,Cmin,,,BLQ,ng/ml,median,,,minmax,BLQ,10,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4421,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,Cmin,,,BLQ,ng/ml,median,,,minmax,BLQ,7.02,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4422,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Postpartum(612 weekspostpartum),,6.0,Cmin,,,29.1,ng/ml,median,,,minmax,BLQ,134,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4423,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,second triester and postpartum,,6.0,LSM raio of Cmin: 2T/PP,,,0.17,,median,,,minmax,0.05,0.61,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4424,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,third trimester and postpartum,,6.0,LSM raio of Cmin: 2T/PP,,,0.17,,median,,,minmax,0.04,0.74,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4425,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,Cmax,,,523,ng/ml,median,,,minmax,173,1190,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4426,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,Cmax,,,671,ng/ml,median,,,minmax,365,1430,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4427,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Postpartum(612 weekspostpartum),,6.0,Cmax,,,971,ng/ml,median,,,minmax,629,1460,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4428,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,second triester and postpartum,,6.0,LSM raio of Cmax: 2T/PP,,,0.5,,median,,,minmax,0.28,0.91,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4429,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,third trimester and postpartum,,6.0,LSM raio of Cmax: 3T/PP,,,0.73,,median,,,minmax,0.52,1.02,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4430,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,Tmax,,,4.03,h,median,,,minmax,2,6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4431,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,Tmax,,,3.5,h,median,,,minmax,2,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4432,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Postpartum(612 weekspostpartum),,6.0,Tmax,,,4,h,median,,,minmax,2,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4433,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,second triester and postpartum,,6.0,LSM raio of Tmax: 2T/PP,,,ND,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4434,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,third trimester and postpartum,,6.0,LSM raio of Tmax: 3T/PP,,,ND,,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4435,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Second trimester(2428 weeks ofgestation),,7.0,AUC24h,,,3654,ng h/ml,median,,,minmax,1088,892,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4436,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Third trimester(3438 weeks ofgestation,,6.0,AUC24h,,,4072,ng h/ml,median,,,minmax,1963,10379,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4437,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,Postpartum(612 weekspostpartum),,6.0,AUC24h,,,4801,ng h/ml,median,,,minmax,4801,11989,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4438,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,second triester and postpartum,,6.0,LSM raio of AUC24h: 3T/PP,,,0.37,,median,,,minmax,0.17,0.79,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4439,2025-12-02T16:03:31.981487
30873741.0,cobicistat,cobicistat,blood,maternal,third trimester and postpartum,,6.0,LSM raio of AUC24h: 2T/PP,,,0.51,,median,,,minmax,0.33,0.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4440,2025-12-02T16:03:31.981487
30728322.0,darunavir,darunavir,blood,maternal,T1,,1.0,C24,,,3790,ng/ml,geometric mean,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4441,2025-12-02T16:03:31.981487
30728322.0,darunavir,darunavir,blood,maternal,T2,,14.0,C24,,,1401,ng/ml,geometric mean,,,95% CI,1041,1760,<0.0001 all comparisons,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4442,2025-12-02T16:03:31.981487
30728322.0,darunavir,darunavir,blood,maternal,T3,,32.0,C24,,,1201,ng/ml,geometric mean,,,95% CI,910,1493,"0.003, T2 vs. PP",,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4443,2025-12-02T16:03:31.981487
30728322.0,darunavir,darunavir,blood,maternal,postpartum,,29.0,C24,,,2588,ng/ml,geometric mean,,,95% CI,1655,3521,"<0.0001, T3 vs. PP",,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4444,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T2,,6.0,AUC0-24,,,25.33,ug h/ml,median,,,IQR,20.95,27.32,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4445,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T3,,8.0,AUC0-24,,,18.85,ug h/ml,median,,,IQR,11.9,31.48,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4446,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,postpartum,,9.0,AUC0-24,,,36.2,ug h/ml,median,,,IQR,24.09,46.14,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4447,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of AUC0-24, 2T/PP",,,0.74,,median,,,IQR,0.53,1.04,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4448,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"3T, and postpartum",,6.0,"GMR2 of AUC0-24, 3T/PP",,,0.46,,median,,,IQR,0.19,1.11,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4449,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T2,,6.0,C0,,,0.29,ug/ml,median,,,IQR,0.22,0.42,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4450,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T3,,8.0,C0,,,0.11,ug/ml,median,,,IQR,0.04,0.27,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4451,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,postpartum,,9.0,C0,,,0.44,ug/ml,median,,,IQR,0.39,0.96,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4452,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of C0, 2T/PP",,,0.57,,median,,,IQR,0.49,0.66,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4453,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"3T, and postpartum",,6.0,"GMR2 of C0, 3T/PP",,,0.22,,median,,,IQR,0.074,0.63,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4454,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T2,,6.0,Cmax,,,2.82,ug/ml,median,,,IQR,2.65,3.65,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4455,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T3,,8.0,Cmax,,,2.2,ug/ml,median,,,IQR,0.94,3.35,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4456,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,postpartum,,9.0,Cmax,,,3.9,ug/ml,median,,,IQR,1.93,4.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4457,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of Cmax, 2T/PP",,,0.8,,median,,,IQR,0.5,1.27,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4458,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"3T, and postpartum",,6.0,"GMR2 of Cmax, 3T/PP",,,0.53,,median,,,IQR,0.19,1.51,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4459,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T2,,6.0,Tmax,,,2,h,median,,,IQR,2,2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4460,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T3,,8.0,Tmax,,,4,h,median,,,IQR,2,9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4461,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,postpartum,,9.0,Tmax,,,2,h,median,,,IQR,1,2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4462,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T2,,6.0,C24,,,0.21,ug/ml,median,,,IQR,0.16,0.28,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4463,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T3,,8.0,C24,,,0.21,ug/ml,median,,,IQR,0.11,0.56,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4464,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,postpartum,,9.0,C24,,,0.61,ug/ml,median,,,IQR,0.42,1.03,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4465,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of C24, 2T/PP",,,0.32,,median,,,IQR,0.2,0.51,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4466,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"3T, and postpartum",,6.0,"GMR2 of C24, 3T/PP",,,0.32,,median,,,IQR,0.11,0.94,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4467,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T2,,6.0,Cmin,,,0.21,ug/ml,median,,,IQR,0.16,0.28,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4468,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T3,,8.0,Cmin,,,0.16,ug/ml,median,,,IQR,0.1,0.56,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4469,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,postpartum,,9.0,Cmin,,,0.61,ug/ml,median,,,IQR,0.42,1.03,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4470,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of Cmin, 2T/PP",,,0.34,,median,,,IQR,0.22,0.51,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4471,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"3T, and postpartum",,6.0,"GMR2 of Cmin, 3T/PP",,,0.28,,median,,,IQR,0.11,0.73,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4472,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T2,,6.0,CL/F,,,11.89,L/h,median,,,IQR,10.98,14.32,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4473,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T3,,8.0,CL/F,,,16.08,L/h,median,,,IQR,9.68,26.89,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4474,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,postpartum,,9.0,CL/F,,,8.29,L/h,median,,,IQR,6.5,12.45,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4475,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of CL/F, 2T/PP",,,1.35,,median,,,IQR,0.97,1.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4476,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"3T, and postpartum",,6.0,"GMR2 of CL/F, 3T/PP",,,2.18,,median,,,IQR,0.9,5.27,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4477,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T2,,6.0,T1/2,,,6.39,h,median,,,IQR,5.76,6.99,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4478,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,T3,,8.0,T1/2,,,6.85,h,median,,,IQR,5.26,8.33,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4479,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,postpartum,,9.0,T1/2,,,14.78,h,median,,,IQR,10.98,22.28,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4480,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of T1/2, 2T/PP",,,0.5,,median,,,IQR,0.37,0.68,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4481,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,"3T, and postpartum",,6.0,"GMR2 of T1/2, 3T/PP",,,0.47,,median,,,IQR,0.32,0.68,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4482,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T2,,6.0,AUC0-24,,,7.39,ug h/ml,median,,,IQR,5.39,8.31,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4483,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T3,,9.0,AUC0-24,,,4.89,ug h/ml,median,,,IQR,2.98,6.89,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4484,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,postpartum,,9.0,AUC0-24,,,9.38,ug h/ml,median,,,IQR,8.57,10.28,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4485,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of AUC0-24, 2T/PP",,,0.65,,median,,,IQR,0.49,0.86,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4486,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"3T, and postpartum",,7.0,"GMR2 of AUC0-24, 3T/PP",,,0.48,,median,,,IQR,0.3,0.77,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4487,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T2,,6.0,C0,,,11.9,ug/ml,median,,,IQR,2.5,19.2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4488,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T3,,9.0,C0,,,6,ug/ml,median,,,IQR,2.5,15.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4489,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,postpartum,,9.0,C0,,,62.6,ug/ml,median,,,IQR,25,87.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4490,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of C0, 2T/PP",,,0.17,,median,,,IQR,0.068,0.44,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4491,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"3T, and postpartum",,7.0,"GMR2 of C0, 3T/PP",,,0.11,,median,,,IQR,0.041,0.323,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4492,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T2,,6.0,Cmax,,,1238.5,ug/ml,median,,,IQR,830,1530,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4493,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T3,,9.0,Cmax,,,857,ug/ml,median,,,IQR,634,981,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4494,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,postpartum,,9.0,Cmax,,,1450,ug/ml,median,,,IQR,1130,1700,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4495,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of Cmax, 2T/PP",,,0.77,,median,,,IQR,0.57,1.04,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4496,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"3T, and postpartum",,7.0,"GMR2 of Cmax, 3T/PP",,,0.61,,median,,,IQR,0.43,0.87,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4497,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T2,,6.0,Tmax,,,2,h,median,,,IQR,2,2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4498,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T3,,9.0,Tmax,,,2,h,median,,,IQR,2,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4499,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,postpartum,,9.0,Tmax,,,2,h,median,,,IQR,1,2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4500,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T2,,6.0,C24,,,6.3,ug/ml,median,,,IQR,2.5,10.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4501,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T3,,9.0,C24,,,6.2,ug/ml,median,,,IQR,2.5,29.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4502,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,postpartum,,9.0,C24,,,28.6,ug/ml,median,,,IQR,23.7,37,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4503,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of C24, 2T/PP",,,0.17,,median,,,IQR,0.086,0.35,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4504,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"3T, and postpartum",,7.0,"GMR2 of C24, 3T/PP",,,0.46,,median,,,IQR,0.075,2.79,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4505,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T2,,6.0,Cmin,,,6.3,ug/ml,median,,,IQR,2.5,10.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4506,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T3,,9.0,Cmin,,,2.5,ug/ml,median,,,IQR,2.5,29.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4507,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,postpartum,,9.0,Cmin,,,28.6,ug/ml,median,,,IQR,23.7,37,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4508,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of Cmin, 2T/PP",,,0.17,,median,,,IQR,0.086,0.35,<0.1,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4509,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"3T, and postpartum",,7.0,"GMR2 of Cmin, 3T/PP",,,0.27,,median,,,IQR,0.081,0.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4510,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T2,,6.0,CL/F,,,20.4,L/h,median,,,IQR,18.1,27.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4511,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T3,,9.0,CL/F,,,30.7,L/h,median,,,IQR,21.8,50.2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4512,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,postpartum,,9.0,CL/F,,,15.9,L/h,median,,,IQR,14.6,17.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4513,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of CL/F, 2T/PP",,,1.54,,median,,,IQR,1.17,2.03,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4514,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"3T, and postpartum",,7.0,"GMR2 of CL/F, 3T/PP",,,2.08,,median,,,IQR,1.3,3.35,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4515,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T2,,6.0,T1/2,,,2.77,h,median,,,IQR,2.43,3.01,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4516,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,T3,,9.0,T1/2,,,2.84,h,median,,,IQR,2.55,3.15,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4517,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,postpartum,,9.0,T1/2,,,4.01,h,median,,,IQR,3.42,4.42,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4518,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"2T, and postpartum",,5.0,"GMR2 of T1/2, 2T/PP",,,0.71,,median,,,IQR,0.61,0.83,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4519,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,"3T, and postpartum",,7.0,"GMR2 of T1/2, 3T/PP",,,0.7,,median,,,IQR,0.64,0.77,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4520,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,blood,maternal,delivery,,8.0,concentration,,,0.61,ug/ml,median,,,IQR,0.05,0.89,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4521,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,cord blood,pediatric,,fetus,8.0,concentration,,,0.13,ug/ml,max,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4522,2025-12-02T16:03:31.981487
34732682.0,Atazanavir ,Atazanavir ,cord blood and maternal blood,maternal/pediatric ,delivery,fetus,6.0,ratio of cord/maternal concentration,,,0.07,,median,,,IQR,0.02,0.19,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4523,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,blood,maternal,delivery,,8.0,concentration,,,47.95,ng/ml,median,,,IQR,12.16,219.25,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4524,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,cord blood,pediatric,,fetus,8.0,concentration,,,576,ng/ml,max,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4525,2025-12-02T16:03:31.981487
34732682.0,Cobicistat ,Cobicistat ,cord blood and maternal blood,maternal/pediatric ,delivery,fetus,6.0,ratio of cord/maternal concentration,,,0.1,,median,,,IQR,0.1,0.16,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4526,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,AUC0-12,,,31.12,ug h/ml,median,,,minmax,13.85,63.35,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4527,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,AUC0-12,,,29.87,ug h/ml,geometric mean,,,90% CI,26.29,33.93,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4528,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,AUC0-inf,,,36.12,ug h/ml,median,,,minmax,16.37,89.91,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4529,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,AUC0-inf,,,34.81,ug h/ml,geometric mean,,,90% CI,29.9,40.53,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4530,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,AUC0-12/AUC0-inf ratio,,,0.87,,median,,,minmax,0.7,0.98,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4531,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,AUC0-12/AUC0-inf ratio,,,0.86,,geometric mean,,,90% CI,0.83,0.89,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4532,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,Cmax,,,4.93,ug/ml,median,,,minmax,2.55,7.24,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4533,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,Cmax,,,4.79,ug/ml,geometric mean,,,90% CI,4.38,5.23,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4534,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,Tmax,,,2,h,median,,,minmax,0.9,4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4535,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,C12,,,0.93,ug/ml,median,,,minmax,0.12,2.95,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4536,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,C12,,,0.757,ug/ml,geometric mean,,,90% CI,0.57,1.01,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4537,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,CL/F,,,0.23,L/h/kg,median,,,minmax,0.13,0.51,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4538,2025-12-02T16:03:31.981487
34855626.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,16.0,CL/F,,,0.25,L/h/kg,geometric mean,,,90% CI,0.22,0.29,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4539,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,AUC0-12,,,13.38,ug h/ml,median,,,minmax,2.8,22.14,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4540,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,AUC0-12,,,12.61,ug h/ml,geometric mean,,,90% CI,10.72,14.83,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4541,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,AUC0-inf,,,16,ug h/ml,median,,,minmax,3.26,26.47,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4542,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,AUC0-inf,,,14.28,ug h/ml,geometric mean,,,90% CI,12.06,16.92,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4543,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,AUC0-12/AUC0-inf ratio,,,0.9,,median,,,minmax,0.75,0.95,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4544,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,AUC0-12/AUC0-inf ratio,,,0.88,,geometric mean,,,90% CI,0.86,0.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4545,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,Cmax,,,2.09,ug/ml,median,,,minmax,0.57,3.18,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4546,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,Cmax,,,2,ug/ml,geometric mean,,,90% CI,1.75,2.29,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4547,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,Tmax,,,3.1,h,median,,,minmax,2,4.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4548,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,C12,,,0.39,ug/ml,median,,,minmax,0.09,0.75,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4549,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,C12,,,0.33,ug/ml,geometric mean,,,90% CI,0.26,0.41,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4550,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,CL/F,,,0.27,L/h/kg,median,,,minmax,0.16,1.23,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4551,2025-12-02T16:03:31.981487
34855626.0,lamivudine ,lamivudine ,blood,pediatric,,neonates,16.0,CL/F,,,0.31,L/h/kg,geometric mean,,,90% CI,0.26,0.35,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4552,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,AUC0-12,,,4.89,ug h/ml,median,,,minmax,0,26.33,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4553,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,AUC0-12,,,3.49,ug h/ml,geometric mean,,,90% CI,2.13,5.72,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4554,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,AUC0-inf,,,NC,ug h/ml,median,,,minmax,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4555,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,AUC0-inf,,,NC,ug h/ml,geometric mean,,,90% CI,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4556,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,AUC0-12/AUC0-inf ratio,,,NC,,median,,,minmax,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4557,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,AUC0-12/AUC0-inf ratio,,,NC,,geometric mean,,,90% CI,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4558,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,Cmax,,,0.75,ug/ml,median,,,minmax,<0.05,4.06,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4559,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,Cmax,,,0.58,ug/ml,geometric mean,,,90% CI,0.38,0.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4560,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,Tmax,,,4.1,h,median,,,minmax,1.1,8.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4561,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,C12,,,0.11,ug/ml,median,,,minmax,<0.05,2.31,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4562,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,C12,,,0.21,ug/ml,geometric mean,,,90% CI,0.12,0.37,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4563,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,CL/F,,,NC,L/h/kg,median,,,minmax,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4564,2025-12-02T16:03:31.981487
34855626.0,lopinavir,lopinavir,blood,pediatric,,neonates,16.0,CL/F,,,NC,L/h/kg,geometric mean,,,90% CI,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4565,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,22.0,AUC,1,week,49.8,ug h/ml,geometric mean,,,95% CI,28.5,87.2,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4566,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,23.0,AUC,1,week,64.8,ug h/ml,geometric mean,,,95% CI,37.6,111.9,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4567,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,45.0,GMR of AUC SAM/non-SAM,1,week,0.77,,geometric mean,,,95% CI,0.4,1.6,0.49,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4568,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,21.0,AUC,12,week,53,ug h/ml,geometric mean,,,95% CI,26.1,107.5,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4569,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,23.0,AUC,12,week,83.4,ug h/ml,geometric mean,,,95% CI,60.4,115,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4570,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,,GMR of AUC SAM/non-SAM,,week,0.64,,geometric mean,,,95% CI,0.3,1.4,0.23,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4571,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,19.0,AUC,24,week,64.6,ug h/ml,geometric mean,,,95% CI,28.3,147.5,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4572,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,23.0,AUC,24,week,79.4,ug h/ml,geometric mean,,,95% CI,56.8,111,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4573,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,,GMR of AUC SAM/non-SAM,,week,0.81,,geometric mean,,,95% CI,0.3,2,0.63,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4574,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,22.0,CL/F,1,week,2.2,L/h,geometric mean,,,95% CI,1.2,3.9,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4575,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,23.0,CL/F,1,week,2,L/h,geometric mean,,,95% CI,1.2,3.5,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4576,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,1,week,1.06,,geometric mean,,,95% CI,0.5,2.3,0.89,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4577,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,21.0,CL/F,12,week,2.3,L/h,geometric mean,,,95% CI,1.1,4.7,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4578,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,23.0,CL/F,12,week,1.6,L/h,geometric mean,,,95% CI,1.2,2.3,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4579,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,,week,1.42,,geometric mean,,,95% CI,0.7,3.1,0.37,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4580,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,19.0,CL/F,24,week,2.1,L/h,geometric mean,,,95% CI,0.9,4.8,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4581,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,23.0,CL/F,24,week,1.7,L/h,geometric mean,,,95% CI,1.2,2.5,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4582,2025-12-02T16:03:31.981487
33464021.0,lopinavir,lopinavir,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,,week,1.23,,geometric mean,,,95% CI,0.5,2.9,0.63,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4583,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,22.0,AUC,1,week,1.6,ug h/ml,geometric mean,,,95% CI,1,2.5,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4584,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,23.0,AUC,1,week,2.1,ug h/ml,geometric mean,,,95% CI,1.2,3.6,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4585,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,,GMR of AUC SAM/non-SAM,1,week,0.76,,geometric mean,,,95% CI,0.4,1.5,0.42,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4586,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,21.0,AUC,12,week,1.8,ug h/ml,geometric mean,,,95% CI,1,3.1,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4587,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,23.0,AUC,12,week,3,ug h/ml,geometric mean,,,95% CI,2.1,4.5,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4588,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,,GMR of AUC SAM/non-SAM,,week,0.58,,geometric mean,,,95% CI,0.3,1.1,0.11,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4589,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,19.0,AUC,24,week,2.3,ug h/ml,geometric mean,,,95% CI,1.3,4.3,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4590,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,23.0,AUC,24,week,3,ug h/ml,geometric mean,,,95% CI,2.2,4,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4591,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,,GMR of AUC SAM/non-SAM,,week,0.77,,geometric mean,,,95% CI,0.4,1.5,0.44,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4592,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,22.0,CL/F,1,week,16.9,L/h,geometric mean,,,95% CI,10.5,27.2,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4593,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,23.0,CL/F,1,week,15.8,L/h,geometric mean,,,95% CI,9.2,27.2,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4594,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,1,week,1.07,,geometric mean,,,95% CI,0.5,0.2,0.84,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4595,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,21.0,CL/F,12,week,17.3,L/h,geometric mean,,,95% CI,9.6,31,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4596,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,23.0,CL/F,12,week,11.2,L/h,geometric mean,,,95% CI,7.6,16.6,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4597,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,,week,1.54,,geometric mean,,,95% CI,0.8,3.1,0.21,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4598,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,19.0,CL/F,24,week,14.8,L/h,geometric mean,,,95% CI,8.1,27.2,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4599,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,23.0,CL/F,24,week,11.5,L/h,geometric mean,,,95% CI,8.4,15.7,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4600,2025-12-02T16:03:31.981487
33464021.0,ritonavir ,ritonavir ,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,,week,1.29,,geometric mean,,,95% CI,0.7,2.5,0.44,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4601,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,22.0,AUC,1,week,4245,ug h/ml,geometric mean,,,95% CI,2959.3,6089.3,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4602,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,23.0,AUC,1,week,5520.2,ug h/ml,geometric mean,,,95% CI,3981.4,7653.7,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4603,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,,GMR of AUC SAM/non-SAM,1,week,0.77,,geometric mean,,,95% CI,0.5,1.2,0.27,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4604,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,21.0,AUC,12,week,4365.5,ug h/ml,geometric mean,,,95% CI,2743.6,6946.4,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4605,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,23.0,AUC,12,week,7233,ug h/ml,geometric mean,,,95% CI,5896.4,8872.6,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4606,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,,GMR of AUC SAM/non-SAM,,week,0.6,,geometric mean,,,95% CI,0.4,1,0.047,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4607,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,19.0,AUC,24,week,6359,ug h/ml,geometric mean,,,95% CI,5221.9,7743.8,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4608,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,23.0,AUC,24,week,5849.2,ug h/ml,geometric mean,,,95% CI,3453.5,9907,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4609,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,,GMR of AUC SAM/non-SAM,,week,1.09,,geometric mean,,,95% CI,0.6,1.9,0.76,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4610,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,22.0,CL/F,1,week,8.7,L/h,geometric mean,,,95% CI,6,12.7,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4611,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,23.0,CL/F,1,week,8.4,L/h,geometric mean,,,95% CI,6.2,11.5,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4612,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,1,week,1.03,,geometric mean,,,95% CI,0.6,1.7,0.89,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4613,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,21.0,CL/F,12,week,9.5,L/h,geometric mean,,,95% CI,5.9,15.4,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4614,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,23.0,CL/F,12,week,6.8,L/h,geometric mean,,,95% CI,5.7,8.1,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4615,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,,week,1.4,,geometric mean,,,95% CI,0.8,2.3,0.18,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4616,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,19.0,CL/F,24,week,7.5,L/h,geometric mean,,,95% CI,6.2,9,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4617,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,23.0,CL/F,24,week,8.8,L/h,geometric mean,,,95% CI,5.3,14.7,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4618,2025-12-02T16:03:31.981487
33464021.0,lamivudine ,lamivudine ,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,,week,0.85,,geometric mean,,,95% CI,0.5,1.4,0.53,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4619,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,15.0,AUC,1,week,2261,ug h/ml,geometric mean,,,95% CI,1652,3094.4,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4620,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,16.0,AUC,1,week,1774,ug h/ml,geometric mean,,,95% CI,1079.6,2915.1,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4621,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,,GMR of AUC SAM/non-SAM,1,week,1.27,,geometric mean,,,95% CI,0.7,2.2,0.39,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4622,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,12.0,AUC,12,week,1826,ug h/ml,geometric mean,,,95% CI,977.8,3410,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4623,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,16.0,AUC,12,week,1335.7,ug h/ml,geometric mean,,,95% CI,758.5,2352.2,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4624,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,,GMR of AUC SAM/non-SAM,,week,1.37,,geometric mean,,,95% CI,0.6,3,0.43,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4625,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,13.0,AUC,24,week,2449.7,ug h/ml,geometric mean,,,95% CI,2053.5,2922.5,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4626,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,15.0,AUC,24,week,1609.3,ug h/ml,geometric mean,,,95% CI,1306.7,1981.9,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4627,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,,GMR of AUC SAM/non-SAM,,week,1.52,,geometric mean,,,95% CI,1.2,2,0.003,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4628,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,15.0,CL/F,1,week,34.8,L/h,geometric mean,,,95% CI,24.4,49.5,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4629,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,16.0,CL/F,1,week,58.3,L/h,geometric mean,,,95% CI,34.8,97.9,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4630,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,1,week,0.6,,geometric mean,,,95% CI,0.3,1.1,0.09,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4631,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,12.0,CL/F,12,week,48.8,L/h,geometric mean,,,95% CI,24.8,95.8,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4632,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,16.0,CL/F,12,week,81.8,L/h,geometric mean,,,95% CI,44.9,148.9,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4633,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,,week,0.6,,geometric mean,,,95% CI,0.3,1.4,0.23,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4634,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,13.0,CL/F,24,week,40..8,L/h,geometric mean,,,95% CI,33,50.4,,Severe malnutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4635,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,15.0,CL/F,24,week,64,L/h,geometric mean,,,95% CI,51.7,79.1,,Mid malnutrition/Normal mutrition,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4636,2025-12-02T16:03:31.981487
33464021.0,Zidovudine ,Zidovudine ,blood,pediatric,,children,,GMR of CL/F SAM/non-SAM,,week,0.64,,geometric mean,,,95% CI,0.5,0.8,0.003,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4637,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,11.0,AUC2-10,,,48.7,mg h/L,median,,,IQR,4.6,72.7,0.008,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4638,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,7.0,AUC2-10,,,67.6,mg h/L,median,,,IQR,48.7,119.1,0.008,Adequate lopinavir trough (Cmin>=1 mg/L) acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4639,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,4.0,AUC2-10,,,2.7,mg h/L,median,,,IQR,0.5,5.6,0.008,Adequate lopinavir trough not acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4640,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,11.0,Tmax,,,8,h,median,,,IQR,2,10,0.32,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4641,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,7.0,Tmax,,,4,h,median,,,IQR,2,10,0.32,Adequate lopinavir trough (Cmin>=1 mg/L) acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4642,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,4.0,Tmax,,,10,h,median,,,IQR,6,10,0.32,Adequate lopinavir trough not acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4643,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,11.0,Cmax,,,7.3,mg/L,median,,,IQR,2,13.4,0.008,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4644,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,7.0,Cmax,,,10.9,mg/L,median,,,IQR,7.3,14.5,0.008,Adequate lopinavir trough (Cmin>=1 mg/L) acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4645,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,4.0,Cmax,,,1.2,mg/L,median,,,IQR,0.3,2.2,0.008,Adequate lopinavir trough not acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4646,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,11.0,Cmin,,,3,mg/L,median,,,IQR,0.1,5.5,0.008,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4647,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,7.0,Cmin,,,3.8,mg/L,median,,,IQR,3,10.6,0.008,Adequate lopinavir trough (Cmin>=1 mg/L) acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4648,2025-12-02T16:03:31.981487
31081020.0,lopinavir,lopinavir,blood,pediatric,,children,4.0,Cmin,,,0.03,mg/L,median,,,IQR,0,0.05,0.008,Adequate lopinavir trough not acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4649,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,11.0,AUC2-10,,,2.09,mg h/L,median,,,IQR,0.41,3.34,0.008,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4650,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,7.0,AUC2-10,,,3.01,mg h/L,median,,,IQR,2.09,3.82,0.008,Adequate lopinavir trough (Cmin>=1 mg/L) acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4651,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,4.0,AUC2-10,,,0.26,mg h/L,median,,,IQR,0.06,0.47,0.008,Adequate lopinavir trough not acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4652,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,11.0,Tmax,,,10,h,median,,,IQR,4,10,0.53,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4653,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,7.0,Tmax,,,10,h,median,,,IQR,4,10,0.53,Adequate lopinavir trough (Cmin>=1 mg/L) acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4654,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,4.0,Tmax,,,7,h,median,,,IQR,3,10,0.53,Adequate lopinavir trough not acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4655,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,11.0,Cmax,,,0.39,mg/L,median,,,IQR,0.07,0.81,0.008,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4656,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,7.0,Cmax,,,0.51,mg/L,median,,,IQR,0.39,0.81,0.008,Adequate lopinavir trough (Cmin>=1 mg/L) acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4657,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,4.0,Cmax,,,0.05,mg/L,median,,,IQR,0.01,0.16,0.008,Adequate lopinavir trough not acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4658,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,11.0,Cmin,,,0.11,mg/L,median,,,IQR,0.02,0.22,0.008,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4659,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,7.0,Cmin,,,0.2,mg/L,median,,,IQR,0.11,0.23,0.008,Adequate lopinavir trough (Cmin>=1 mg/L) acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4660,2025-12-02T16:03:31.981487
31081020.0,ritonavir ,ritonavir ,blood,pediatric,,children,4.0,Cmin,,,0.01,mg/L,median,,,IQR,0.001,0.02,0.008,Adequate lopinavir trough not acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4661,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,12.0,Cmax,,,1090,ng/ml,geometric mean,%CV,67,minmax,199,3050,,15-29 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4662,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,9.0,Cmax,,,1830,ng/ml,geometric mean,%CV,42,minmax,851,3230,,30-44 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4663,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,13.0,Cmax,,,1180,ng/ml,geometric mean,%CV,35,minmax,397,1940,,>=45 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4664,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,12.0,Tmax,,,2,h,geometric mean,,,minmax,2,4,,15-29 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4665,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,9.0,Tmax,,,2.4,h,geometric mean,,,minmax,2,4,,30-44 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4666,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,13.0,Tmax,,,4,h,geometric mean,,,minmax,2,8,,>=45 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4667,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,12.0,AUC0-24,,,6570,ng h/ml,geometric mean,%CV,60,minmax,1520,16200,,15-29 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4668,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,9.0,AUC0-24,,,14100,ng h/ml,geometric mean,%CV,49,minmax,6760,29700,,30-44 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4669,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,12.0,AUC0-24,,,8900,ng h/ml,geometric mean,%CV,37,minmax,3640,17800,,>=45 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4670,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,12.0,Week 2 Ctrough,,,16.1,ng/mL,geometric mean,%CV,72,minmax,8.57,54.6,,15-29 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4671,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,9.0,Week 2 Ctrough,,,32.1,ng/mL,geometric mean,%CV,63,minmax,8.14,89.3,,30-44 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4672,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,12.0,Week 2 Ctrough,,,29.8,ng/mL,geometric mean,%CV,54,minmax,12.2,81.2,,>=45 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4673,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,12.0,Week 8 Ctrough,,,91.8,ng/mL,geometric mean,%CV,268,minmax,0,855,,15-29 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4674,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,7.0,Week 8 Ctrough,,,38.1,ng/mL,geometric mean,%CV,112,minmax,12.1,133,,30-44 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4675,2025-12-02T16:03:31.981487
32451952.0,Ritonavir,Ritonavir,blood,pediatric,,children,11.0,Week 8 Ctrough,,,58.2,ng/mL,geometric mean,%CV,138,minmax,0,278,,>=45 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4676,2025-12-02T16:03:31.981487
32697327.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,10.0,Cmax,,,4.41,ug/mL,median,,,minmax,2.91,7.19,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4677,2025-12-02T16:03:31.981487
32697327.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,10.0,AUC0-8h,,,26.26,ug h/ml,median,,,minmax,15.49,35.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4678,2025-12-02T16:03:31.981487
32697327.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,10.0,AUC0-inf,,,39.12,ug h/ml,median,,,minmax,22.34,50.89,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4679,2025-12-02T16:03:31.981487
32697327.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,10.0,Half-life,,,3.93,h,median,,,minmax,2.47,6.35,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4680,2025-12-02T16:03:31.981487
32697327.0,Abacavir ,Abacavir ,blood,pediatric,,neonates,10.0,CL/F,,,3.5,ml/min/kg,median,,,minmax,2.63,6.28,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4681,2025-12-02T16:03:31.981487
30767719.0,tenofovir diproxil fumarate,tenofovir ,dried blood spots ,maternal,pregnancy,,31.0,concentration,,,80.6,ng/ml,mean,,,minmax,35.52,334.93,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4682,2025-12-02T16:03:31.981487
30767719.0,tenofovir diproxil fumarate,tenofovir ,dried blood spots ,maternal,postpartum,,30.0,concentration,,,106.74,ng/ml,mean,,,minmax,17.23,192.16,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4683,2025-12-02T16:03:31.981487
30767719.0,emtricitabine ,emtricitabine ,dried blood spots ,maternal,pregnancy,,31.0,concentration,,,122.95,ng/ml,mean,,,minmax,20.39,449.89,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4684,2025-12-02T16:03:31.981487
30767719.0,emtricitabine ,emtricitabine ,dried blood spots ,maternal,postpartum,,30.0,concentration,,,157.23,ng/ml,mean,,,minmax,19.27,553.25,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4685,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,Tenofovir alafenamide ,blood,maternal,lactation,,8.0,Half-life,,,40.5,h,median,,,IQR,18.5,65.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4686,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,Tenofovir alafenamide ,blood,maternal,lactation,,8.0,Cmax,,,16.7,ng/ml,median,,,IQR,11.3,19.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4687,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,Tenofovir alafenamide ,blood,maternal,lactation,,8.0,Tmax,,,1.3,h,median,,,IQR,0.7,2.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4688,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,Tenofovir alafenamide ,blood,maternal,lactation,,8.0,AUCall,,,207.4,ng h/ml,median,,,IQR,146.4,305.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4689,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,tenofovir ,blood,maternal,lactation,,8.0,Half-life,,,0.9,h,median,,,IQR,0.7,1.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4690,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,tenofovir ,blood,maternal,lactation,,8.0,Cmax,,,120.5,ng/ml,median,,,IQR,41.6,308.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4691,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,tenofovir ,blood,maternal,lactation,,8.0,Tmax,,,0.5,h,median,,,IQR,0.5,1.1,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4692,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,tenofovir ,blood,maternal,lactation,,8.0,AUCall,,,149.9,ng h/ml,median,,,IQR,70.9,214.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4693,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,Tenofovir alafenamide ,breast milk,maternal,lactation,,8.0,Half-life,,,27.7,h,median,,,IQR,20,35.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4694,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,Tenofovir alafenamide ,breast milk,maternal,lactation,,8.0,Cmax,,,53.1,ng/ml,median,,,IQR,29.6,57.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4695,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,Tenofovir alafenamide ,breast milk,maternal,lactation,,8.0,Tmax,,,5.5,h,median,,,IQR,3,8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4696,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,Tenofovir alafenamide ,breast milk,maternal,lactation,,8.0,AUCall,,,584.7,ng h/ml,median,,,IQR,453.7,1015.8,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4697,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation,,8.0,Half-life,,,0.8,h,median,,,IQR,0.8,3.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4698,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation,,8.0,Cmax,,,1.7,ng/ml,median,,,IQR,0.22,5.65,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4699,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation,,8.0,Tmax,,,0.5,h,median,,,IQR,0.5,1.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4700,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation,,8.0,AUCall,,,2.9,ng h/ml,median,,,IQR,2.4,3.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4701,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,Tenofovir alafenamide ,breast milk and blood,maternal,lactation,,8.0,milk to plasma concentration ratio,,,0.029,,median,,,IQR,0.016,0.039,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4702,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,tenofovir ,breast milk and blood,maternal,lactation,,8.0,milk to plasma concentration ratio,,,2.81,,median,,,IQR,2.03,3.98,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4703,2025-12-02T16:03:31.981487
35599363.0,Tenofovir alafenamide ,tenofovir ,urine,pediatric,,infants,7.0,Css,,,5,ng/ml,median,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4704,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,59.0,AUC0-24h,,,2.14,ug h/ml,GM,,,95% CI,1.97,2.33,,HIV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4705,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,59.0,AUC0-24h,,,2.84,ug h/ml,GM,,,95% CI,2.59,3.1,,HIV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4706,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,"third trimester, postpartum",,51.0,AUC0-24h ratio third trimester/postpartum,,,0.75,,GM,,,90% CI,0.7,0.8,,HIV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4707,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,32.0,AUC0-24h,,,2.41,ug h/ml,GM,,,95% CI,2.2,2.65,"<0.01, compared to women with HIV without r/PI use; compared to women with HBV",HIV-infected patients with r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4708,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,32.0,AUC0-24h,,,3.21,ug h/ml,GM,,,95% CI,2.83,3.64,"<0.01, compared to women with HIV without r/PI use; compared to women with HBV",HIV-infected patients with r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4709,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,"third trimester, postpartum",,32.0,AUC0-24h ratio third trimester/postpartum,,,0.76,,GM,,,90% CI,0.69,0.83,,HIV-infected patients with r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4710,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,27.0,AUC0-24h,,,1.86,ug h/ml,GM,,,95% CI,1.64,2.11,,HIV-infected patients without r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4711,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,27.0,AUC0-24h,,,2.51,ug h/ml,GM,,,95% CI,2.24,2.83,,HIV-infected patients without r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4712,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,"third trimester, postpartum",,27.0,AUC0-24h ratio third trimester/postpartum,,,0.74,,GM,,,90% CI,0.68,0.82,,HIV-infected patients without r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4713,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,137.0,AUC0-24h,,,1.84,ug h/ml,GM,,,95% CI,1.77,1.92,,HBV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4714,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,137.0,AUC0-24h,,,2.35,ug h/ml,GM,,,95% CI,2.24,2.47,,HBV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4715,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,"third trimester, postpartum",,102.0,AUC0-24h ratio third trimester/postpartum,,,0.79,,GM,,,90% CI,0.78,0.8,,HBV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4716,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,59.0,Ctrough,,,0.043,ug/ml,GM,,,95% CI,0.039,0.047,,HIV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4717,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,59.0,Ctrough,,,0.059,ug/ml,GM,,,95% CI,0.053,0.066,,HIV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4718,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,"third trimester, postpartum",,51.0,Ctrough ratio third trimester/postpartum,,,0.74,,GM,,,90% CI,0.67,0.81,,HIV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4719,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,32.0,Ctrough,,,0.048,ug/ml,GM,,,95% CI,0.043,0.054,"<0.01, compared to women with HIV without r/PI use; compared to women with HBV",HIV-infected patients with r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4720,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,32.0,Ctrough,,,0.063,ug/ml,GM,,,95% CI,0.053,0.075,,HIV-infected patients with r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4721,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,"third trimester, postpartum",,32.0,Ctrough ratio third trimester/postpartum,,,0.81,,GM,,,90% CI,0.69,0.94,,HIV-infected patients with r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4722,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,27.0,Ctrough,,,0.038,ug/ml,GM,,,95% CI,0.033,0.043,,HIV-infected patients without r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4723,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,27.0,Ctrough,,,0.056,ug/ml,GM,,,95% CI,0.05,0.064,,HIV-infected patients without r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4724,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,"third trimester, postpartum",,27.0,Ctrough ratio third trimester/postpartum,,,0.68,,GM,,,90% CI,0.62,0.75,,HIV-infected patients without r/PI,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4725,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,137.0,Ctrough,,,0.039,ug/ml,GM,,,95% CI,0.038,0.042,,HBV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4726,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,137.0,Ctrough,,,0.058,ug/ml,GM,,,95% CI,0.055,0.061,,HBV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4727,2025-12-02T16:03:31.981487
32960984.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,"third trimester, postpartum",,102.0,Ctrough ratio third trimester/postpartum,,,0.69,,GM,,,90% CI,0.68,0.71,,HBV-infected patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4728,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,12.0,AUC0-24,,,3,mcg h/ml,median,,,IQR,2.4,3.4,0.062,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4729,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,22.0,AUC0-24,,,2.1,mcg h/ml,median,,,IQR,1.6,2.4,0.062,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4730,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,10.0,AUC0-24,,,2.4,mcg h/ml,median,,,IQR,2.2,2.9,0.062,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4731,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,12.0,Vd/F,,,1103,L/h,median,,,IQR,973,1312,0.311,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4732,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,22.0,Vd/F,,,1284,L/h,median,,,IQR,1120,2181,0.311,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4733,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,10.0,Vd/F,,,1159,L/h,median,,,IQR,1037,1709,0.311,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4734,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,12.0,CL/F,,,46,L/h,median,,,IQR,40,60,0.062,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4735,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,22.0,CL/F,,,64,L/h,median,,,IQR,57,85,0.062,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4736,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,10.0,CL/F,,,57,L/h,median,,,IQR,47,62,0.062,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4737,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,12.0,Cmin,,,65,ng/ml,median,,,IQR,48,76,0.039,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4738,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,22.0,Cmin,,,43,ng/ml,median,,,IQR,29,52,0.039,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4739,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,10.0,Cmin,,,49,ng/ml,median,,,IQR,40,61,0.039,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4740,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,12.0,Cmax,,,301,ng/ml,median,,,IQR,218,406,0.053,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4741,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,22.0,Cmax,,,210,ng/ml,median,,,IQR,191,269,0.053,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4742,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,10.0,Cmax,,,284,ng/ml,median,,,IQR,233,344,0.153,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4743,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,12.0,C0,,,70,ng/ml,median,,,IQR,53,85,0.153,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4744,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,22.0,C0,,,48,ng/ml,median,,,IQR,36,59,0.153,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4745,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,10.0,C0,,,54,ng/ml,median,,,IQR,42,67,0.153,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4746,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,12.0,C24,,,68,ng/ml,median,,,IQR,51,78,0.087,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4747,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,22.0,C24,,,47,ng/ml,median,,,IQR,31,64,0.087,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4748,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,10.0,C24,,,55,ng/ml,median,,,IQR,44,69,0.087,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4749,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,12.0,T1/2,,,17.5,h,median,,,IQR,15.2,18.5,0.783,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4750,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,22.0,T1/2,,,15.6,h,median,,,IQR,13.9,18.3,0.783,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4751,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,third trimester,,10.0,T1/2,,,15.9,h,median,,,IQR,14.3,19.2,0.783,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4752,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,10.0,AUC0-24,,,3,mcg h/ml,median,,,IQR,1.8,3.8,0.944,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4753,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,20.0,AUC0-24,,,2.8,mcg h/ml,median,,,IQR,2.2,3.6,0.944,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4754,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,8.0,AUC0-24,,,2.8,mcg h/ml,median,,,IQR,2.4,4.9,0.944,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4755,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,10.0,Vd/F,,,1224,L/h,median,,,IQR,643,1312,0.446,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4756,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,20.0,Vd/F,,,949,L/h,median,,,IQR,676,1246,0.446,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4757,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,8.0,Vd/F,,,757,L/h,median,,,IQR,514,1133,0.446,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4758,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,10.0,CL/F,,,49,L/h,median,,,IQR,36,75,0.944,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4759,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,20.0,CL/F,,,48,L/h,median,,,IQR,38,63,0.944,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4760,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,8.0,CL/F,,,49,L/h,median,,,IQR,30,58,0.944,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4761,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,10.0,Cmin,,,58,ng/ml,median,,,IQR,5,76,0.67,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4762,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,20.0,Cmin,,,53,ng/ml,median,,,IQR,31,67,0.67,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4763,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,8.0,Cmin,,,73,ng/ml,median,,,IQR,39,83,0.67,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4764,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,10.0,Cmax,,,257,ng/ml,median,,,IQR,191,335,0.852,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4765,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,20.0,Cmax,,,295,ng/ml,median,,,IQR,219,366,0.852,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4766,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,8.0,Cmax,,,289,ng/ml,median,,,IQR,174,453,0.852,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4767,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,10.0,C0,,,59.4,ng/ml,median,,,IQR,5,77.8,0.7,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4768,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,20.0,C0,,,60,ng/ml,median,,,IQR,31,93,0.7,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4769,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,8.0,C0,,,74,ng/ml,median,,,IQR,50,118,0.7,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4770,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,10.0,C24,,,48.2,ng/ml,median,,,IQR,32.1,77.2,0.486,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4771,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,20.0,C24,,,59,ng/ml,median,,,IQR,46,78,0.486,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4772,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,8.0,C24,,,81,ng/ml,median,,,IQR,39,102,0.486,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4773,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,10.0,T1/2,,,12.5,h,median,,,IQR,11.9,19.9,0.781,with LPV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4774,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,20.0,T1/2,,,12.8,h,median,,,IQR,11.6,19.7,0.781,with ATV/r,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4775,2025-12-02T16:03:31.981487
34254323.0,tenofovir disoproxil fumarate ,tenofovir ,blood,maternal,postpartum,,8.0,T1/2,,,12.4,h,median,,,IQR,10.6,15.7,0.781,other,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4776,2025-12-02T16:03:31.981487
34483946.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,12.0,concentration,0,h,93.1,ng/ml,median,,,IQR,67.7,112.7,<0.01, Prior to dosing,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4777,2025-12-02T16:03:31.981487
34483946.0,tenofovir disoproxil fumarate ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,4.0,concentration,0,h,17.3,ng/ml,median,,,IQR,16.5,18.1,<0.01,Prior to dosing,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4778,2025-12-02T16:03:31.981487
34483946.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,12.0,concentration,1,h,90.8,ng/ml,median,,,IQR,61.2,108.5,<0.05,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4779,2025-12-02T16:03:31.981487
34483946.0,tenofovir disoproxil fumarate ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,4.0,concentration,1,h,23.2,ng/ml,median,,,IQR,20.9,25.4,<0.05,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4780,2025-12-02T16:03:31.981487
34483946.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,12.0,concentration,2,h,83.8,ng/ml,median,,,IQR,69.2,112.7,<0.01,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4781,2025-12-02T16:03:31.981487
34483946.0,tenofovir disoproxil fumarate ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,4.0,concentration,2,h,18.5,ng/ml,median,,,IQR,16.8,20.2,<0.01,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4782,2025-12-02T16:03:31.981487
34483946.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,12.0,concentration,4,h,101.1,ng/ml,median,,,IQR,74.9,123,<0.01,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4783,2025-12-02T16:03:31.981487
34483946.0,tenofovir disoproxil fumarate ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,4.0,concentration,4,h,19,ng/ml,median,,,IQR,14.9,23.1,<0.01,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4784,2025-12-02T16:03:31.981487
34483946.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,12.0,concentration,6,h,96.4,ng/ml,median,,,IQR,72.1,109.8,<0.01,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4785,2025-12-02T16:03:31.981487
34483946.0,tenofovir disoproxil fumarate ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,4.0,concentration,6,h,20.5,ng/ml,median,,,IQR,14.6,26.5,<0.01,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4786,2025-12-02T16:03:31.981487
34483946.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,12.0,concentration,8,h,85.9,ng/ml,median,,,IQR,73.1,111.7,<0.05,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4787,2025-12-02T16:03:31.981487
34483946.0,tenofovir disoproxil fumarate ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,4.0,concentration,8,h,16.2,ng/ml,median,,,IQR,11.6,20.8,<0.05,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4788,2025-12-02T16:03:31.981487
34483946.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,12.0,Cmax,,,101.2,ng/ml,median,,,IQR,83,123,<0.01,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4789,2025-12-02T16:03:31.981487
34483946.0,tenofovir disoproxil fumarate ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,4.0,Cmax,,,21.6,ng/ml,median,,,IQR,16.8,26.5,<0.01,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4790,2025-12-02T16:03:31.981487
34483946.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,12.0,Tmax,,,4,h,median,,,IQR,4,6,,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4791,2025-12-02T16:03:31.981487
34483946.0,tenofovir disoproxil fumarate ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,4.0,Tmax,,,4,h,median,,,IQR,2,6,,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4792,2025-12-02T16:03:31.981487
34483946.0,Tenofovir alafenamide ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,12.0,AUC0-t,,,755.6,ng h/ml,median,,,IQR,581.6,894.4,<0.01,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4793,2025-12-02T16:03:31.981487
34483946.0,tenofovir disoproxil fumarate ,tenofovir ,breast milk,maternal,lactation (3rd postpartum day),,4.0,AUC0-t,,,150.8,ng h/ml,median,,,IQR,120.7,180.9,<0.01,sampling time post dose ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4794,2025-12-02T16:03:31.981487
33242457.0,nevirapine ,nevirapine ,dried blood spots ,pediatric,,neonates,349.0,concentration,,,8.36,mcg/ml,median,,,IQR,4.82,12.86,,at week 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4795,2025-12-02T16:03:31.981487
33242457.0,nevirapine ,nevirapine ,dried blood spots ,pediatric,,neonates,201.0,concentration,,,5.89,mcg/ml,median,,,IQR,3.92,8.73,,at week 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4796,2025-12-02T16:03:31.981487
33710978.0,nevirapine ,nevirapine ,blood,pediatric,,neonates,15.0,concentration,,,1.762,mg/L,median,,,IQR,0.645,6.361,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4797,2025-12-02T16:03:31.981487
33710978.0,nevirapine ,nevirapine ,blood,pediatric,,neonates,11.0,concentration,,,0.482,mg/L,median,,,IQR,0.135,1.124,,at day 11,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4798,2025-12-02T16:03:31.981487
33839311.0,nevirapine ,nevirapine ,blood,pediatric,,children,53.0,Cmin,,,3.3,mg/L,median,,,minmax,1,14,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4799,2025-12-02T16:03:31.981487
33839311.0,nevirapine ,nevirapine ,blood,pediatric,,children,53.0,AUC0-12,,,56,mg h/L,median,,,minmax,16.7,202.6,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4800,2025-12-02T16:03:31.981487
33839311.0,nevirapine ,nevirapine ,blood,pediatric,,children,53.0,CL/F,,,1.4,L/h,median,,,minmax,0.4,4.3,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4801,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,53.0,Tmax,,,3.5,h,GM,,,95% Cl,2.9,4.1,,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4802,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,30.0,Tmax,,,3.3,h,GM,,,95% Cl,2.6,4.2,,HIV infected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4803,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,23.0,Tmax,,,3.7,h,GM,,,95% Cl,2.9,4.7,"0.529, vs. HIV infected",TB/HIV coinfected on ATT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4804,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,16.0,Tmax,,,3,h,GM,,,95% Cl,2.2,4,"0.574, vs. HIV infected",TB/HIV coinfected off ATT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4805,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,53.0,Cmax,,,5.7,mg/L,GM,,,95% Cl,4.9,6.6,,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4806,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,30.0,Cmax,,,7.4,mg/L,GM,,,95% Cl,5.3,7.7,,HIV infected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4807,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,23.0,Cmax,,,4.8,mg/L,GM,,,95% Cl,3.8,6.2,"0.066, vs. HIV infected",TB/HIV coinfected on ATT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4808,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,16.0,Cmax,,,7.6,mg/L,GM,,,95% Cl,6.4,9.1,"0.209, vs. HIV infected",TB/HIV coinfected off ATT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4809,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,53.0,Cmin,,,3.1,mg/L,GM,,,95% Cl,2.4,4.1,,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4810,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,30.0,Cmin,,,3.3,mg/L,GM,,,95% Cl,2.2,5,,HIV infected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4811,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,23.0,Cmin,,,2.8,mg/L,GM,,,95% Cl,2,3.9,"0.579, vs. HIV infected",TB/HIV coinfected on ATT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4812,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,16.0,Cmin,,,4.8,mg/L,GM,,,95% Cl,3.8,6.1,"0.117, vs. HIV infected",TB/HIV coinfected off ATT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4813,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,53.0,AUC0-12,,,56,mg h/L,GM,,,95% Cl,47.8,65.7,,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4814,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,30.0,AUC0-12,,,64.1,mg h/L,GM,,,95% Cl,52.8,77.7,,HIV infected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4815,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,23.0,AUC0-12,,,47,mg h/L,GM,,,95% Cl,36,61.4,"0.053, vs. HIV infected",TB/HIV coinfected on ATT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4816,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,16.0,AUC0-12,,,75.2,mg h/L,GM,,,95% Cl,62.2,91,"0.274, vs. HIV infected",TB/HIV coinfected off ATT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4817,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,53.0,CL/F,,,1.3,L/h,GM,,,95% Cl,1.1,1.6,,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4818,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,30.0,CL/F,,,1.2,L/h,GM,,,95% Cl,1,1.5,,HIV infected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4819,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,23.0,CL/F,,,1.5,L/h,GM,,,95% Cl,1.2,2,"0.03, vs. HIV infected",TB/HIV coinfected on ATT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4820,2025-12-02T16:03:31.981487
31332062.0,nevirapine ,nevirapine ,blood,pediatric,,children,16.0,CL/F,,,1,L/h,GM,,,95% Cl,0.8,1.2,"0.498, vs. HIV infected",TB/HIV coinfected off ATT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4821,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,48.0,concentration,4,week,1.787,ug/ml,GM,SD,1.12,,,,,CYP2B6*6 *1/*1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4822,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,44.0,concentration,4,week,2.505,ug/ml,GM,SD,1.14,,,,<0.001,CYP2B6*6 *1/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4823,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,9.0,concentration,4,week,6.183,ug/ml,GM,SD,1.28,,,,<0.001,CYP2B6*6 *6/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4824,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,48.0,concentration,8,week,2.265,ug/ml,GM,SD,1.13,,,,<0.001,CYP2B6*6 *1/*1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4825,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,44.0,concentration,8,week,2.095,ug/ml,GM,SD,1.19,,,,0.002,CYP2B6*6 *1/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4826,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,9.0,concentration,8,week,8.193,ug/ml,GM,SD,1.43,,,,0.002,CYP2B6*6 *6/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4827,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,48.0,concentration,12,week,1.76,ug/ml,GM,SD,1.15,,,,0.002,CYP2B6*6 *1/*1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4828,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,44.0,concentration,12,week,2.281,ug/ml,GM,SD,1.24,,,,0.002,CYP2B6*6 *1/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4829,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,9.0,concentration,12,week,8.715,ug/ml,GM,SD,1.64,,,,0.002,CYP2B6*6 *6/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4830,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,48.0,concentration,24,week,1.663,ug/ml,GM,SD,1.13,,,,<0.001,CYP2B6*6 *1/*1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4831,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,44.0,concentration,24,week,2.648,ug/ml,GM,SD,1.13,,,,<0.001,CYP2B6*6 *1/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4832,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,9.0,concentration,24,week,11.219,ug/ml,GM,SD,1.52,,,,<0.001,CYP2B6*6 *6/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4833,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,48.0,concentration,48,week,2.196,ug/ml,GM,SD,1.13,,,,<0.001,CYP2B6*6 *1/*1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4834,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,44.0,concentration,48,week,1.81,ug/ml,GM,SD,1.22,,,,<0.001,CYP2B6*6 *1/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4835,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,9.0,concentration,48,week,8.361,ug/ml,GM,SD,1.22,,,,<0.001,CYP2B6*6 *6/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4836,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,6.0,concentration,4,week,2.253,ug/ml,GM,SD,1.2,,,,0.98,CYP3A5 *1/*1 ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4837,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,34.0,concentration,4,week,2.308,ug/ml,GM,SD,1.24,,,,0.98,CYP3A5 *1/*3 or *1/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4838,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,61.0,concentration,4,week,2.373,ug/ml,GM,SD,1.11,,,,0.98,CYP3A5 *3/*3 or *3/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4839,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,6.0,concentration,8,week,2.628,ug/ml,GM,SD,1.09,,,,0.64,CYP3A5 *1/*1 ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4840,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,34.0,concentration,8,week,2.322,ug/ml,GM,SD,1.27,,,,0.64,CYP3A5 *1/*3 or *1/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4841,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,61.0,concentration,8,week,2.513,ug/ml,GM,SD,1.15,,,,0.64,CYP3A5 *3/*3 or *3/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4842,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,6.0,concentration,12,week,0.827,ug/ml,GM,SD,1.53,,,,0.23,CYP3A5 *1/*1 ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4843,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,34.0,concentration,12,week,2.129,ug/ml,GM,SD,1.39,,,,0.23,CYP3A5 *1/*3 or *1/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4844,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,61.0,concentration,12,week,2.532,ug/ml,GM,SD,1.12,,,,0.23,CYP3A5 *3/*3 or *3/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4845,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,6.0,concentration,24,week,1.537,ug/ml,GM,SD,1.43,,,,0.28,CYP3A5 *1/*1 ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4846,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,34.0,concentration,24,week,3.048,ug/ml,GM,SD,1.29,,,,0.28,CYP3A5 *1/*3 or *1/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4847,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,61.0,concentration,24,week,2.315,ug/ml,GM,SD,1.11,,,,0.28,CYP3A5 *3/*3 or *3/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4848,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,6.0,concentration,48,week,1.008,ug/ml,GM,SD,1.57,,,,0.07,CYP3A5 *1/*1 ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4849,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,34.0,concentration,48,week,3.754,ug/ml,GM,SD,1.22,,,,0.07,CYP3A5 *1/*3 or *1/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4850,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,61.0,concentration,48,week,1.894,ug/ml,GM,SD,1.16,,,,0.07,CYP3A5 *3/*3 or *3/*6,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4851,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,17.0,concentration,4,week,2.336,ug/ml,GM,SD,1.21,,,,0.38,UGT2B7rs372G>A A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4852,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,57.0,concentration,4,week,2.582,ug/ml,GM,SD,1.12,,,,0.38,UGT2B7rs372G>A A/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4853,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,27.0,concentration,4,week,1.92,ug/ml,GM,SD,1.23,,,,0.38,UGT2B7rs372G>A G/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4854,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,17.0,concentration,8,week,2.398,ug/ml,GM,SD,1.39,,,,0.59,UGT2B7rs372G>A A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4855,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,57.0,concentration,8,week,2.259,ug/ml,GM,SD,1.17,,,,0.59,UGT2B7rs372G>A A/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4856,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,27.0,concentration,8,week,2.957,ug/ml,GM,SD,1.18,,,,0.59,UGT2B7rs372G>A G/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4857,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,17.0,concentration,12,week,3.237,ug/ml,GM,SD,1.33,,,,0.43,UGT2B7rs372G>A A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4858,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,57.0,concentration,12,week,2.321,ug/ml,GM,SD,1.19,,,,0.43,UGT2B7rs372G>A A/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4859,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,27.0,concentration,12,week,1.878,ug/ml,GM,SD,1.3,,,,0.43,UGT2B7rs372G>A G/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4860,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,17.0,concentration,24,week,2.416,ug/ml,GM,SD,1.42,,,,0.91,UGT2B7rs372G>A A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4861,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,57.0,concentration,24,week,2.564,ug/ml,GM,SD,1.15,,,,0.91,UGT2B7rs372G>A A/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4862,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,27.0,concentration,24,week,2.309,ug/ml,GM,SD,1.18,,,,0.91,UGT2B7rs372G>A G/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4863,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,17.0,concentration,48,week,2.97,ug/ml,GM,SD,1.3,,,,0.45,UGT2B7rs372G>A A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4864,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,57.0,concentration,48,week,2.029,ug/ml,GM,SD,1.19,,,,0.45,UGT2B7rs372G>A A/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4865,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,27.0,concentration,48,week,2.646,ug/ml,GM,SD,1.22,,,,0.45,UGT2B7rs372G>A G/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4866,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,65.0,concentration,4,week,1.97,ug/ml,GM,SD,1.12,,,,0.004,ABCB1c.3435C>T C/C,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4867,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,36.0,concentration,4,week,3.464,ug/ml,GM,SD,1.15,,,,0.004,ABCB1c.3435C>T T carriers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4868,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,65.0,concentration,8,week,2.173,ug/ml,GM,SD,1.15,,,,0.09,ABCB1c.3435C>T C/C,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4869,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,36.0,concentration,8,week,3.19,ug/ml,GM,SD,1.22,,,,0.09,ABCB1c.3435C>T T carriers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4870,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,65.0,concentration,12,week,1.877,ug/ml,GM,SD,1.16,,,,0.03,ABCB1c.3435C>T C/C,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4871,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,36.0,concentration,12,week,3.821,ug/ml,GM,SD,1.26,,,,0.03,ABCB1c.3435C>T T carriers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4872,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,65.0,concentration,24,week,2.187,ug/ml,GM,SD,1.11,,,,0.05,ABCB1c.3435C>T C/C,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4873,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,36.0,concentration,24,week,3.334,ug/ml,GM,SD,1.29,,,,0.05,ABCB1c.3435C>T T carriers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4874,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,65.0,concentration,48,week,2.342,ug/ml,GM,SD,1.12,,,,0.77,ABCB1c.3435C>T C/C,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4875,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,36.0,concentration,48,week,2.22,ug/ml,GM,SD,1.34,,,,0.77,ABCB1c.3435C>T T carriers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4876,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,70.0,concentration,4,week,2.241,ug/ml,GM,SD,1.11,,,,0.49,ABCB1c.4036A>G A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4877,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,31.0,concentration,4,week,2.566,ug/ml,GM,SD,1.2,,,,0.49,ABCB1c.4036A>G C carriers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4878,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,70.0,concentration,8,week,2.308,ug/ml,GM,SD,1.15,,,,0.44,ABCB1c.4036A>G A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4879,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,31.0,concentration,8,week,2.786,ug/ml,GM,SD,1.21,,,,0.44,ABCB1c.4036A>G C carriers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4880,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,70.0,concentration,12,week,2.073,ug/ml,GM,SD,1.18,,,,0.44,ABCB1c.4036A>G A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4881,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,31.0,concentration,12,week,2.798,ug/ml,GM,SD,1.22,,,,0.44,ABCB1c.4036A>G C carriers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4882,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,70.0,concentration,24,week,2.508,ug/ml,GM,SD,1.13,,,,0.84,ABCB1c.4036A>G A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4883,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,31.0,concentration,24,week,2.402,ug/ml,GM,SD,1.23,,,,0.84,ABCB1c.4036A>G C carriers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4884,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,70.0,concentration,48,week,2.246,ug/ml,GM,SD,1.16,,,,0.76,ABCB1c.4036A>G A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4885,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,31.0,concentration,48,week,2.416,ug/ml,GM,SD,1.23,,,,0.76,ABCB1c.4036A>G C carriers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4886,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,11.0,concentration,4,week,2.883,ug/ml,GM,SD,1.49,,,,0.5,SLCO1B 1*B A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4887,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,50.0,concentration,4,week,2.541,ug/ml,GM,SD,1.13,,,,0.5,SLCO1B 1*B A/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4888,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,40.0,concentration,4,week,2.087,ug/ml,GM,SD,1.16,,,,0.5,SLCO1B 1*B G/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4889,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,76.0,concentration,8,week,2.088,ug/ml,GM,SD,1.43,,,,0.89,SLCO1B 1*B A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4890,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,31.0,concentration,8,week,2.553,ug/ml,GM,SD,1.22,,,,0.89,SLCO1B 1*B A/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4891,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,11.0,concentration,8,week,2.439,ug/ml,GM,SD,1.14,,,,0.89,SLCO1B 1*B G/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4892,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,50.0,concentration,12,week,2.328,ug/ml,GM,SD,1.39,,,,0.12,SLCO1B 1*B A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4893,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,40.0,concentration,12,week,3.002,ug/ml,GM,SD,1.2,,,,0.12,SLCO1B 1*B A/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4894,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,76.0,concentration,12,week,1.697,ug/ml,GM,SD,1.23,,,,0.12,SLCO1B 1*B G/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4895,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,31.0,concentration,24,week,2.934,ug/ml,GM,SD,1.35,,,,0.54,SLCO1B 1*B A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4896,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,11.0,concentration,24,week,2.708,ug/ml,GM,SD,1.17,,,,0.54,SLCO1B 1*B A/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4897,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,50.0,concentration,24,week,2.141,ug/ml,GM,SD,1.17,,,,0.54,SLCO1B 1*B G/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4898,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,40.0,concentration,48,week,3.006,ug/ml,GM,SD,1.35,,,,0.78,SLCO1B 1*B A/A,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4899,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,76.0,concentration,48,week,2.234,ug/ml,GM,SD,1.22,,,,0.78,SLCO1B 1*B A/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4900,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,31.0,concentration,48,week,2.256,ug/ml,GM,SD,1.16,,,,0.78,SLCO1B 1*B G/G,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4901,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,76.0,concentration,4,week,2.23,ug/ml,GM,SD,1.12,,,,0.57,SLCO1B 1*5 *1/*1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4902,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,22.0,concentration,4,week,2.775,ug/ml,GM,SD,1.17,,,,0.57,SLCO1B 1*5 *1/*5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4903,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,3.0,concentration,4,week,1.968,ug/ml,GM,SD,1.07,,,,0.57,SLCO1B 1*5 *5/*5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4904,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,76.0,concentration,8,week,2.831,ug/ml,GM,SD,1.13,,,,0.14,SLCO1B 1*5 *1/*1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4905,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,22.0,concentration,8,week,1.715,ug/ml,GM,SD,1.32,,,,0.14,SLCO1B 1*5 *1/*5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4906,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,3.0,concentration,8,week,1.635,ug/ml,GM,SD,1.27,,,,0.14,SLCO1B 1*5 *5/*5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4907,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,76.0,concentration,12,week,2.277,ug/ml,GM,SD,1.19,,,,0.99,SLCO1B 1*5 *1/*1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4908,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,22.0,concentration,12,week,2.344,ug/ml,GM,SD,1.17,,,,0.99,SLCO1B 1*5 *1/*5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4909,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,3.0,concentration,12,week,2.178,ug/ml,GM,SD,1.55,,,,0.99,SLCO1B 1*5 *5/*5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4910,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,76.0,concentration,24,week,2.679,ug/ml,GM,SD,1.15,,,,0.42,SLCO1B 1*5 *1/*1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4911,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,22.0,concentration,24,week,2.099,ug/ml,GM,SD,1.14,,,,0.42,SLCO1B 1*5 *1/*5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4912,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,3.0,concentration,24,week,1.432,ug/ml,GM,SD,1.96,,,,0.42,SLCO1B 1*5 *5/*5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4913,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,76.0,concentration,48,week,2.394,ug/ml,GM,SD,1.16,,,,0.65,SLCO1B 1*5 *1/*1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4914,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,22.0,concentration,48,week,1.998,ug/ml,GM,SD,1.25,,,,0.65,SLCO1B 1*5 *1/*5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4915,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,3.0,concentration,48,week,3.583,ug/ml,GM,SD,1.09,,,,0.65,SLCO1B 1*5 *5/*5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4916,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,25.0,concentration,4,week,2.617,ug/ml,GM,SD,1.2,,,,0.76,SLCO1 g.38664C>T C/C,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4917,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,47.0,concentration,4,week,2.211,ug/ml,GM,SD,1.15,,,,0.76,SLCO1 g.38664C>T C/T,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4918,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,29.0,concentration,4,week,2.325,ug/ml,GM,SD,1.19,,,,0.76,SLCO1 g.38664C>T T/T,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4919,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,25.0,concentration,8,week,2,ug/ml,GM,SD,1.33,,,,0.49,SLCO1 g.38664C>T C/C,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4920,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,47.0,concentration,8,week,2.79,ug/ml,GM,SD,1.17,,,,0.49,SLCO1 g.38664C>T C/T,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4921,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,29.0,concentration,8,week,2.448,ug/ml,GM,SD,1.18,,,,0.49,SLCO1 g.38664C>T T/T,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4922,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,25.0,concentration,12,week,2.525,ug/ml,GM,SD,1.19,,,,0.43,SLCO1 g.38664C>T C/C,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4923,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,47.0,concentration,12,week,2.563,ug/ml,GM,SD,1.26,,,,0.43,SLCO1 g.38664C>T C/T,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4924,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,29.0,concentration,12,week,1.741,ug/ml,GM,SD,1.26,,,,0.43,SLCO1 g.38664C>T T/T,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4925,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,25.0,concentration,24,week,2.445,ug/ml,GM,SD,1.17,,,,0.65,SLCO1 g.38664C>T C/C,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4926,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,47.0,concentration,24,week,2.708,ug/ml,GM,SD,1.17,,,,0.65,SLCO1 g.38664C>T C/T,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4927,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,29.0,concentration,24,week,2.144,ug/ml,GM,SD,1.26,,,,0.65,SLCO1 g.38664C>T T/T,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4928,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,25.0,concentration,48,week,2.204,ug/ml,GM,SD,1.23,,,,0.85,SLCO1 g.38664C>T C/C,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4929,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,47.0,concentration,48,week,2.211,ug/ml,GM,SD,1.24,,,,0.85,SLCO1 g.38664C>T C/T,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4930,2025-12-02T16:03:31.981487
34945777.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,29.0,concentration,48,week,2.566,ug/ml,GM,SD,1.18,,,,0.85,SLCO1 g.38664C>T T/T,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4931,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy,,19.0,Tmax,,,2.11,h,GM,,,95% Cl,1.6,2.78,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4932,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,6 weeks postpartum,,19.0,Tmax,,,2.92,h,GM,,,95% Cl,1.9,4.48,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4933,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy and postpartum,,19.0,GMR of Tmax P/PP,,,0.75,,GM,,,90% Cl,0.45,1.26,0.578,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4934,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy,,19.0,Cmax,,,4.33,mg/L,GM,,,95% Cl,3.42,5.48,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4935,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,6 weeks postpartum,,19.0,Cmax,,,3.93,mg/L,GM,,,95% Cl,3.08,5.02,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4936,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy and postpartum,,19.0,GMR of Cmax P/PP,,,1.1,,GM,,,90% Cl,0.93,1.31,0.107,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4937,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy,,19.0,C12h,12,h,1.79,mg/L,GM,,,95% Cl,1.24,2.59,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4938,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,6 weeks postpartum,,19.0,C12h,12,h,2.47,mg/L,GM,,,95% Cl,1.81,3.37,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4939,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy and postpartum,,19.0,GMR of C12h P/PP,12,h,0.73,,GM,,,90% Cl,0.56,0.94,0.738,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4940,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy,,19.0,Cmin,,,1.12,mg/L,GM,,,95% Cl,0.75,1.67,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4941,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,6 weeks postpartum,,19.0,Cmin,,,1.27,mg/L,GM,,,95% Cl,0.84,1.92,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4942,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy and postpartum,,19.0,GMR of Cmin P/PP,,,0.88,,GM,,,90% Cl,0.67,1.17,0.277,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4943,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy,,19.0,CL/F,,,11.47,ml/hr,GM,,,95% Cl,8.56,15.36,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4944,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,6 weeks postpartum,,19.0,CL/F,,,9.59,ml/hr,GM,,,95% Cl,7.28,12.63,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4945,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy and postpartum,,19.0,GMR of CL/F P/PP,,,1.2,,GM,,,90% Cl,1.02,1.4,0.317,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4946,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy,,19.0,AUC0-24h,,,52.32,mg h/L,GM,,,95% Cl,39.07,70.06,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4947,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,6 weeks postpartum,,19.0,AUC0-24h,,,62.56,mg h/L,GM,,,95% Cl,47.51,82.37,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4948,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,pregnancy and postpartum,,19.0,GMR of AUC0-24h P/PP,,,0.84,,GM,,,90% Cl,0.71,0.98,0.317,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4949,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,blood,maternal,at delivery,,15.0,concentration,,,1.33,mg/L,GM,,,95% Cl,0.19,2.76,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4950,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,cord blood,maternal,at delivery,,15.0,concentration,,,1.02,mg/L,GM,,,95% Cl,0.45,2.76,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4951,2025-12-02T16:03:31.981487
32811669.0,Efavirenz ,Efavirenz ,maternal blood and cord blood,maternal,at delivery,,15.0,cord blood/maternal concentration ratio,,,0.85,,GM,,,95% Cl,0.51,3.58,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4952,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,2nd trimester,,15.0,AUC0-24h,,,47.3,ug h/ml,GM,,,90% Cl,40.1,79.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4953,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 2nd trimester",,14.0,GMR of AUC0-24h 2T/PP,,,0.94,,GM,,,90% Cl,0.85,1.02,0.241,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4954,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,3rd trimester,,42.0,AUC0-24h,,,60.02,ug h/ml,GM,,,90% Cl,42.96,85.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4955,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 3rd trimester",,40.0,GMR of AUC0-24h 3T/PP,,,1.09,,GM,,,90% Cl,0.9,1.32,0.837,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4956,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,postpartum,,40.0,AUC0-24h,,,62.7,ug h/ml,GM,,,90% Cl,43.75,87.51,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4957,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,2nd trimester,,15.0,Cmax,,,3.87,ug/ml,GM,,,90% Cl,2.82,5.67,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4958,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 2nd trimester",,14.0,GMR of Cmax 2T/PP,,,1.05,,GM,,,90% Cl,0.94,1.18,0.296,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4959,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,3rd trimester,,42.0,Cmax,,,5.13,ug/ml,GM,,,90% Cl,3.62,5.9,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4960,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 3rd trimester",,40.0,GMR of Cmax 3T/PP,,,1.26,,GM,,,90% Cl,1.01,1.56,0.007,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4961,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,postpartum,,40.0,Cmax,,,4.41,ug/ml,GM,,,90% Cl,3.38,5.79,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4962,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,2nd trimester,,15.0,Cmin,,,1.47,ug/ml,GM,,,90% Cl,0.96,2.23,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4963,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 2nd trimester",,14.0,GMR of Cmin 2T/PP,,,0.86,,GM,,,90% Cl,0.76,0.97,0.104,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4964,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,3rd trimester,,42.0,Cmin,,,1.36,ug/ml,GM,,,90% Cl,1.059,2.57,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4965,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 3rd trimester",,40.0,GMR of Cmin 3T/PP,,,0.86,,GM,,,90% Cl,0.68,1.1,0.01,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4966,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,postpartum,,40.0,Cmin,,,1.6,ug/ml,GM,,,90% Cl,1.19,2.67,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4967,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,2nd trimester,,15.0,C12h,12,h,1.69,ug/ml,GM,,,90% Cl,1.37,3.12,,time post-dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4968,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 2nd trimester",,14.0,GMR of C12h 2T/PP,12,h,0.89,,GM,,,90% Cl,0.81,0.97,0.119,time post-dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4969,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,3rd trimester,,42.0,C12h,12,h,1.99,ug/ml,GM,,,90% Cl,1.5,3.02,,time post-dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4970,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 3rd trimester",,40.0,GMR of C12h 3T/PP,12,h,1,,GM,,,90% Cl,0.83,1.21,0.071,time post-dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4971,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,postpartum,,40.0,C12h,12,h,2.21,ug/ml,GM,,,90% Cl,1.72,3.27,,time post-dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4972,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,2nd trimester,,15.0,C24h,24,h,1.49,ug/ml,GM,,,90% Cl,1.14,2.23,,time post-dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4973,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 2nd trimester",,14.0,GMR of C24h 2T/PP,24,h,0.87,,GM,,,90% Cl,0.78,0.97,0.079,time post-dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4974,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,3rd trimester,,42.0,C24h,24,h,1.48,ug/ml,GM,,,90% Cl,1.1,2.61,,time post-dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4975,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 3rd trimester",,40.0,GMR of C24h 3T/PP,24,h,0.92,,GM,,,90% Cl,0.77,1.09,0.01,time post-dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4976,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,postpartum,,40.0,C24h,24,h,1.94,ug/ml,GM,,,90% Cl,1.28,3.09,,time post-dose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4977,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,2nd trimester,,15.0,CL/F,,,12.69,L/h,GM,,,90% Cl,7.53,14.96,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4978,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 2nd trimester",,14.0,GMR of CL/F 2T/PP,,,1.07,,GM,,,90% Cl,0.97,1.18,0.104,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4979,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,3rd trimester,,42.0,CL/F,,,10,L/h,GM,,,90% Cl,7.03,14,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4980,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 3rd trimester",,40.0,GMR of CL/F 3T/PP,,,0.91,,GM,,,90% Cl,0.76,1.11,0.691,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4981,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,postpartum,,40.0,CL/F,,,9.59,L/h,GM,,,90% Cl,25.4,59.62,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4982,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,2nd trimester,,15.0,T1/2,,,27.82,h,GM,,,90% Cl,16.95,34.98,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4983,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 2nd trimester",,14.0,GMR of T1/2 2T/PP,,,0.66,,GM,,,90% Cl,0.47,0.93,0.191,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4984,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,3rd trimester,,42.0,T1/2,,,32.71,h,GM,,,90% Cl,25.22,49.14,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4985,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,"postpartum, 3rd trimester",,40.0,GMR of T1/2 3T/PP,,,0.96,,GM,,,90% Cl,0.82,1.12,0.285,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4986,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,postpartum,,40.0,T1/2,,,34.67,h,GM,,,90% Cl,25.4,59.62,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4987,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,pediatric,,neonates,18.0,T1/2,,,65.6,h,median,,,IQR,40.6,128.7,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4988,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,pediatric,,neonates,22.0,Cmax,,,1.2,mcg/ml,median,,,IQR,0.9,1.5,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4989,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,pediatric,,neonates,20.0,Tmax,,,20.2,mcg/ml,median,,,IQR,6.3,45.4,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4990,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,pediatric,,neonates,18.0,Concentration,,,1.1,mcg/ml,median,,,IQR,0.8,1.5,,at 2-10 hours after birth,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4991,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,pediatric,,neonates,21.0,Concentration,,,1,mcg/ml,median,,,IQR,0.8,1.2,,at 18-28 hours after birth,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4992,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,pediatric,,neonates,20.0,Concentration,,,0.9,mcg/ml,median,,,IQR,0.6,1.4,,at 36-72 hours after birth,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4993,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,pediatric,,neonates,22.0,Concentration,,,0.4,mcg/ml,median,,,IQR,0.2,0.9,,at 5-9 days after birth,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4994,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,blood,maternal,at delivery,,17.0,Concentration,,,1.43,mcg/ml,median,,,minmax,0.68,5.95,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4995,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,cord blood,pediatric,,fetus,17.0,Concentration,,,0.95,mcg/ml,median,,,minmax,0.4,3.99,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4996,2025-12-02T16:03:31.981487
30530925.0,Efavirenz ,Efavirenz ,"cord blood, maternal blood",maternal/pediatric ,at delivery,fetus,17.0,ratio of cord blood to maternal blood,,,0.67,,median,,,minmax,0.36,0.95,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4997,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,infants/children,8.0,AUC,,,92.87,mcg h/ml,median,,,IQR,40.95,160.81,0.028,3-<24 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4998,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,5.0,AUC,,,319.05,mcg h/ml,median,,,IQR,172.56,360.48,0.028,24-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,4999,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,13.0,AUC,,,160.1,mcg h/ml,median,,,IQR,72.79,238.99,0.028,3-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5000,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,infants/children,8.0,Trough concentration,,,1.42,mcg/ml,median,,,IQR,0.55,3.47,0.028,3-<24 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5001,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,5.0,Trough concentration,,,9.18,mcg/ml,median,,,IQR,4.99,11.02,0.028,24-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5002,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,13.0,Trough concentration,,,2,mcg/ml,median,,,IQR,0.99,6.46,0.028,3-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5003,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,infants/children,8.0,CL/F,,,0.62,L/h/kg,median,,,IQR,0.45,1.65,0.012,3-<24 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5004,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,5.0,CL/F,,,0.14,L/h/kg,median,,,IQR,0.12,0.25,0.012,24-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5005,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,13.0,CL/F,,,0.51,L/h/kg,median,,,IQR,0.24,0.66,0.012,3-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5006,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,infants/children,8.0,Cmax,,,7.99,mcg/ml,median,,,IQR,5.29,12.84,0.079,3-<24 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5007,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,5.0,Cmax,,,19.62,mcg/ml,median,,,IQR,13.85,22.55,0.079,24-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5008,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,13.0,Cmax,,,8.63,mcg/ml,median,,,IQR,7.36,17.56,0.079,3-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5009,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,infants/children,8.0,Tmax,,,2,h,median,,,IQR,2,4,0.1128,3-<24 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5010,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,5.0,Tmax,,,4.1,h,median,,,IQR,2.1,7.1,0.1128,24-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5011,2025-12-02T16:03:31.981487
31241542.0,Efavirenz ,Efavirenz ,blood,pediatric,,children,13.0,Tmax,,,2.1,h,median,,,IQR,2,4,0.1128,3-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5012,2025-12-02T16:03:31.981487
31250045.0,nitroglycerin,nitroglycerin,blood,pediatric,,infants,18.0,concentration,,,,ng/ml,,,,max,322,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5013,2025-12-02T16:03:31.981487
31250045.0,nitroglycerin,nitroglycerin,blood,pediatric,,infants,18.0,concentration <230 ng/ml,,,16,N,,,,,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5014,2025-12-02T16:03:31.981487
33604895.0,Fentanyl,Fentanyl,blood,pediatric,,infants and children,5.0,24-h average concentration on day 1,,,1.14,ng/ml,median,,,IQR,1.07,1.56,0.81,Non-sedated,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5015,2025-12-02T16:03:31.981487
33604895.0,Fentanyl,Fentanyl,blood,pediatric,,infants and children,7.0,24-h average concentration on day 1,,,1.29,ng/ml,median,,,IQR,0.78,2.05,0.81,Sedated,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5016,2025-12-02T16:03:31.981487
33604895.0,Fentanyl,Fentanyl,blood,pediatric,,infants and children,17.0,24-h average concentration on day 1,,,1.29,ng/ml,median,,,IQR,0.99,2,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Pk param (summary data),PKparam_summary,5017,2025-12-02T16:03:31.981487
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,18.0,Cmax,,,5134,ng/ml,mean,SD,2071,,,,0.08,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2,2025-12-02T16:05:09.448543
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,14.0,Cmax,,,4044,ng/ml,mean,SD,1392,,,,0.08,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,3,2025-12-02T16:05:09.448543
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,18.0,Tmax,,,1.08,h,mean,SD,0.7,,,,0.48,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,4,2025-12-02T16:05:09.448543
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,14.0,Tmax,,,1.3,h,mean,SD,0.9,,,,0.48,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,5,2025-12-02T16:05:09.448543
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,17.0,AUC0-6h,,,15417,ng/mlxh,mean,SD,6831,,,,0.53,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,6,2025-12-02T16:05:09.448543
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,11.0,AUC0-6h,,,14008,ng/mlxh,mean,SD,5016,,,,0.53,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,7,2025-12-02T16:05:09.448543
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,18.0,Cmax,,,5134,ng/ml,mean,SD,2071,,,,0.08,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2,2025-12-02T16:05:12.001940
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,14.0,Cmax,,,4044,ng/ml,mean,SD,1392,,,,0.08,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,3,2025-12-02T16:05:12.001940
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,18.0,Tmax,,,1.08,h,mean,SD,0.7,,,,0.48,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,4,2025-12-02T16:05:12.001940
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,14.0,Tmax,,,1.3,h,mean,SD,0.9,,,,0.48,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,5,2025-12-02T16:05:12.001940
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,17.0,AUC0-6h,,,15417,ng/mlxh,mean,SD,6831,,,,0.53,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,6,2025-12-02T16:05:12.001940
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,11.0,AUC0-6h,,,14008,ng/mlxh,mean,SD,5016,,,,0.53,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,7,2025-12-02T16:05:12.001940
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,18.0,Cmax,,,5134,ng/ml,mean,SD,2071,,,,0.08,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2,2025-12-02T16:05:15.923463
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,14.0,Cmax,,,4044,ng/ml,mean,SD,1392,,,,0.08,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,3,2025-12-02T16:05:15.923463
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,18.0,Tmax,,,1.08,h,mean,SD,0.7,,,,0.48,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,4,2025-12-02T16:05:15.923463
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,14.0,Tmax,,,1.3,h,mean,SD,0.9,,,,0.48,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,5,2025-12-02T16:05:15.923463
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,17.0,AUC0-6h,,,15417,ng/mlxh,mean,SD,6831,,,,0.53,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,6,2025-12-02T16:05:15.923463
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,11.0,AUC0-6h,,,14008,ng/mlxh,mean,SD,5016,,,,0.53,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,7,2025-12-02T16:05:15.923463
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,18.0,Cmax,,,5134,ng/ml,mean,SD,2071,,,,0.08,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2,2025-12-02T16:05:22.346295
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,14.0,Cmax,,,4044,ng/ml,mean,SD,1392,,,,0.08,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,3,2025-12-02T16:05:22.346295
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,18.0,Tmax,,,1.08,h,mean,SD,0.7,,,,0.48,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,4,2025-12-02T16:05:22.346295
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,14.0,Tmax,,,1.3,h,mean,SD,0.9,,,,0.48,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,5,2025-12-02T16:05:22.346295
38145726.0,aspirin,salicylic acid ,plasma,maternal,1st trimester,10 to 15 weeks of gestation,17.0,AUC0-6h,,,15417,ng/mlxh,mean,SD,6831,,,,0.53,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,6,2025-12-02T16:05:22.346295
38145726.0,aspirin,salicylic acid ,plasma,maternal,3rd trimester,28 to 32 weeks of gestation,11.0,AUC0-6h,,,14008,ng/mlxh,mean,SD,5016,,,,0.53,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,7,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,12187.3,ng/mlxh,mean,SD,100,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,8,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,21096.6,ng/mlxh,mean,SD,532,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,9,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,19993.3,ng/mlxh,mean,SD,240,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,10,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,29288.3,ng/mlxh,mean,SD,430,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,11,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,12,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,13,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,14,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,15,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,2417.2,ng/ml,mean,SD,71,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,16,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,3214.7,ng/ml,mean,SD,98,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,17,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3289.3,ng/ml,mean,SD,117,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,18,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4797.5,ng/ml,mean,SD,182,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,19,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,20,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.7,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,21,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,22,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,23,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.08,mg/(ng/ml),mean,SD,0.005,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,24,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.06,mg/(ng/ml),mean,SD,0.005,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,25,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.09,mg/(ng/ml),mean,SD,0.002,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,26,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.003,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,27,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.006,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,28,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.003,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,29,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.009,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,30,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.005,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,31,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,11927.3,ng/mlxh,mean,SD,104,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,32,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,22007.3,ng/mlxh,mean,SD,118,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,33,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,6,h,mean,SD,,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,34,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,6,h,mean,SD,,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,35,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,1275,ng/ml,mean,SD,97,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,36,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,1808.3,ng/ml,mean,SD,154,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,37,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.1,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,38,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,0.3,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,39,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.16,mg/(ng/ml),mean,SD,0.01,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,40,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.13,mg/(ng/ml),mean,SD,0.01,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,41,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.007,mg/(ng/ml)/h,mean,SD,0.001,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,42,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.004,mg/(ng/ml)/h,mean,SD,0.001,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,43,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,19993.3,ng/mlxh,mean,SD,240,,,,0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,44,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,29288.3,ng/mlxh,mean,SD,430,,,,0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,45,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,21417.7,ng/mlxh,mean,SD,428,,,,0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,46,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,30048.2,ng/mlxh,mean,SD,296,,,,0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,47,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,48,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,49,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,50,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,51,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3289.3,ng/ml,mean,SD,117,,,,0.02,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,52,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4797.5,ng/ml,mean,SD,182,,,,0.02,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,53,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3439.6,ng/ml,mean,SD,256,,,,0.02,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,54,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4276.5,ng/ml,mean,SD,238,,,,0.02,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,55,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.2,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,56,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.4,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,57,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.8,h,mean,SD,0.5,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,58,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,0.5,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,59,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.09,mg/(ng/ml),mean,SD,0.002,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,60,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.003,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,61,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.08,mg/(ng/ml),mean,SD,0.01,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,62,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.01,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,63,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.009,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,64,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.005,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,65,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.008,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,66,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.003,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,67,2025-12-02T16:05:09.448543
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,12187.3,ng/mlxh,mean,SD,100,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,8,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,21096.6,ng/mlxh,mean,SD,532,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,9,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,19993.3,ng/mlxh,mean,SD,240,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,10,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,29288.3,ng/mlxh,mean,SD,430,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,11,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,12,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,13,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,14,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,15,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,2417.2,ng/ml,mean,SD,71,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,16,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,3214.7,ng/ml,mean,SD,98,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,17,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3289.3,ng/ml,mean,SD,117,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,18,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4797.5,ng/ml,mean,SD,182,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,19,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,20,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.7,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,21,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,22,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,23,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.08,mg/(ng/ml),mean,SD,0.005,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,24,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.06,mg/(ng/ml),mean,SD,0.005,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,25,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.09,mg/(ng/ml),mean,SD,0.002,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,26,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.003,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,27,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.006,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,28,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.003,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,29,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.009,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,30,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.005,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,31,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,11927.3,ng/mlxh,mean,SD,104,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,32,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,22007.3,ng/mlxh,mean,SD,118,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,33,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,6,h,mean,SD,,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,34,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,6,h,mean,SD,,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,35,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,1275,ng/ml,mean,SD,97,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,36,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,1808.3,ng/ml,mean,SD,154,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,37,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.1,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,38,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,0.3,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,39,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.16,mg/(ng/ml),mean,SD,0.01,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,40,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.13,mg/(ng/ml),mean,SD,0.01,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,41,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.007,mg/(ng/ml)/h,mean,SD,0.001,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,42,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.004,mg/(ng/ml)/h,mean,SD,0.001,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,43,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,19993.3,ng/mlxh,mean,SD,240,,,,0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,44,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,29288.3,ng/mlxh,mean,SD,430,,,,0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,45,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,21417.7,ng/mlxh,mean,SD,428,,,,0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,46,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,30048.2,ng/mlxh,mean,SD,296,,,,0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,47,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,48,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,49,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,50,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,51,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3289.3,ng/ml,mean,SD,117,,,,0.02,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,52,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4797.5,ng/ml,mean,SD,182,,,,0.02,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,53,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3439.6,ng/ml,mean,SD,256,,,,0.02,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,54,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4276.5,ng/ml,mean,SD,238,,,,0.02,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,55,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.2,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,56,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.4,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,57,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.8,h,mean,SD,0.5,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,58,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,0.5,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,59,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.09,mg/(ng/ml),mean,SD,0.002,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,60,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.003,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,61,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.08,mg/(ng/ml),mean,SD,0.01,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,62,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.01,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,63,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.009,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,64,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.005,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,65,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.008,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,66,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.003,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,67,2025-12-02T16:05:12.001940
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,12187.3,ng/mlxh,mean,SD,100,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,8,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,21096.6,ng/mlxh,mean,SD,532,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,9,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,19993.3,ng/mlxh,mean,SD,240,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,10,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,29288.3,ng/mlxh,mean,SD,430,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,11,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,12,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,13,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,14,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,15,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,2417.2,ng/ml,mean,SD,71,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,16,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,3214.7,ng/ml,mean,SD,98,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,17,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3289.3,ng/ml,mean,SD,117,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,18,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4797.5,ng/ml,mean,SD,182,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,19,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,20,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.7,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,21,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,22,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,23,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.08,mg/(ng/ml),mean,SD,0.005,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,24,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.06,mg/(ng/ml),mean,SD,0.005,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,25,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.09,mg/(ng/ml),mean,SD,0.002,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,26,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.003,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,27,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.006,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,28,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.003,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,29,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.009,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,30,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.005,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,31,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,11927.3,ng/mlxh,mean,SD,104,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,32,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,22007.3,ng/mlxh,mean,SD,118,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,33,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,6,h,mean,SD,,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,34,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,6,h,mean,SD,,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,35,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,1275,ng/ml,mean,SD,97,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,36,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,1808.3,ng/ml,mean,SD,154,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,37,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.1,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,38,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,0.3,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,39,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.16,mg/(ng/ml),mean,SD,0.01,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,40,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.13,mg/(ng/ml),mean,SD,0.01,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,41,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.007,mg/(ng/ml)/h,mean,SD,0.001,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,42,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.004,mg/(ng/ml)/h,mean,SD,0.001,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,43,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,19993.3,ng/mlxh,mean,SD,240,,,,0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,44,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,29288.3,ng/mlxh,mean,SD,430,,,,0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,45,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,21417.7,ng/mlxh,mean,SD,428,,,,0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,46,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,30048.2,ng/mlxh,mean,SD,296,,,,0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,47,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,48,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,49,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,50,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,51,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3289.3,ng/ml,mean,SD,117,,,,0.02,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,52,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4797.5,ng/ml,mean,SD,182,,,,0.02,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,53,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3439.6,ng/ml,mean,SD,256,,,,0.02,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,54,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4276.5,ng/ml,mean,SD,238,,,,0.02,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,55,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.2,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,56,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.4,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,57,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.8,h,mean,SD,0.5,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,58,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,0.5,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,59,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.09,mg/(ng/ml),mean,SD,0.002,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,60,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.003,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,61,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.08,mg/(ng/ml),mean,SD,0.01,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,62,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.01,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,63,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.009,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,64,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.005,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,65,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.008,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,66,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.003,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,67,2025-12-02T16:05:15.923463
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,12187.3,ng/mlxh,mean,SD,100,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,8,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,21096.6,ng/mlxh,mean,SD,532,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,9,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,19993.3,ng/mlxh,mean,SD,240,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,10,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,29288.3,ng/mlxh,mean,SD,430,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,11,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,12,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,13,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,14,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,15,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,2417.2,ng/ml,mean,SD,71,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,16,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,3214.7,ng/ml,mean,SD,98,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,17,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3289.3,ng/ml,mean,SD,117,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,18,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4797.5,ng/ml,mean,SD,182,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,19,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,20,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.7,h,mean,SD,,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,21,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,22,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,23,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.08,mg/(ng/ml),mean,SD,0.005,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,24,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.06,mg/(ng/ml),mean,SD,0.005,,,,NS,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,25,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.09,mg/(ng/ml),mean,SD,0.002,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,26,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.003,,,,NS,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,27,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.006,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,28,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.003,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,100 mg non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,29,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.009,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,30,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.005,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,150 mg  non-EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,31,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,11927.3,ng/mlxh,mean,SD,104,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,32,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,22007.3,ng/mlxh,mean,SD,118,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,33,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,6,h,mean,SD,,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,34,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,6,h,mean,SD,,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,35,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,1275,ng/ml,mean,SD,97,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,36,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,1808.3,ng/ml,mean,SD,154,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,37,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.1,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,38,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,0.3,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,39,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.16,mg/(ng/ml),mean,SD,0.01,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,40,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.13,mg/(ng/ml),mean,SD,0.01,,,,<0.01,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,41,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.007,mg/(ng/ml)/h,mean,SD,0.001,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,42,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.004,mg/(ng/ml)/h,mean,SD,0.001,,,,NS,100 mg EC aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,43,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,19993.3,ng/mlxh,mean,SD,240,,,,0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,44,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,29288.3,ng/mlxh,mean,SD,430,,,,0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,45,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,AUCt-24,,,21417.7,ng/mlxh,mean,SD,428,,,,0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,46,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,AUCt-24,,,30048.2,ng/mlxh,mean,SD,296,,,,0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,47,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,48,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,49,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,50,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Tmax,,,2,h,mean,SD,,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,51,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3289.3,ng/ml,mean,SD,117,,,,0.02,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,52,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4797.5,ng/ml,mean,SD,182,,,,0.02,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,53,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Cmax,,,3439.6,ng/ml,mean,SD,256,,,,0.02,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,54,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Cmax,,,4276.5,ng/ml,mean,SD,238,,,,0.02,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,55,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.2,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,56,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.6,h,mean,SD,0.4,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,57,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,t1/2,,,2.8,h,mean,SD,0.5,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,58,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,t1/2,,,2.5,h,mean,SD,0.5,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,59,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.09,mg/(ng/ml),mean,SD,0.002,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,60,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.003,,,,NS,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,61,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,Vd,,,0.08,mg/(ng/ml),mean,SD,0.01,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,62,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,Vd,,,0.07,mg/(ng/ml),mean,SD,0.01,,,,NS,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,63,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.009,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,64,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.005,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, morning dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,65,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,pregnancy,,3.0,CL,,,0.008,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,66,2025-12-02T16:05:22.346295
31051121.0,aspirin,salicylic acid ,plasma,maternal,non-pregnancy,,3.0,CL,,,0.003,mg/(ng/ml)/h,mean,SD,0.001,,,,<0.01,"150 mg  non-EC aspirin, evening dosing",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,67,2025-12-02T16:05:22.346295
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,AUC0-240min,,,269,ng/mlxh,mean,SD,118,,,,NS,Group A,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,68,2025-12-02T16:05:09.448543
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,AUC0-240min,,,294,ng/mlxh,mean,SD,119,,,,NS,Group B,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,69,2025-12-02T16:05:09.448543
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,AUC0-240min,,,384,ng/mlxh,mean,SD,122,,,,NS,Controls,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,70,2025-12-02T16:05:09.448543
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,Cmax,,,5.1,uM/L,mean,SD,2.6,,,,<0.005,Group A,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,71,2025-12-02T16:05:09.448543
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,Cmax,,,5.1,uM/L,mean,SD,1.8,,,,<0.005,Group B,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,72,2025-12-02T16:05:09.448543
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,Cmax,,,7.4,uM/L,mean,SD,1.3,,,,<0.005,Controls,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,73,2025-12-02T16:05:09.448543
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,tmax,,,41.5,min,mean,SD,17.3,,,,<0.05,Group A,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,74,2025-12-02T16:05:09.448543
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,tmax,,,41.5,min,mean,SD,26.5,,,,<0.05,Group B,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,75,2025-12-02T16:05:09.448543
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,tmax,,,25.5,min,mean,SD,6.9,,,,<0.05,Controls,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,76,2025-12-02T16:05:09.448543
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,AUC0-240min,,,3288,ng/mlxh,mean,SD,881,,,,<0.01,Group A,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,77,2025-12-02T16:05:09.448543
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,AUC0-240min,,,2683,ng/mlxh,mean,SD,508,,,,<0.01,Group B,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,78,2025-12-02T16:05:09.448543
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,AUC0-240min,,,4284,ng/mlxh,mean,SD,1456,,,,<0.01,Controls,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,79,2025-12-02T16:05:09.448543
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,Cmax,,,23.2,uM/L,mean,SD,5.9,,,,<0.05,Group A,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,80,2025-12-02T16:05:09.448543
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,Cmax,,,17.8,uM/L,mean,SD,3,,,,<0.05,Group B,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,81,2025-12-02T16:05:09.448543
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,Cmax,,,29.6,uM/L,mean,SD,8.4,,,,<0.05,Controls,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,82,2025-12-02T16:05:09.448543
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,tmax,,,81,min,mean,SD,27.6,,,,NS,Group A,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,83,2025-12-02T16:05:09.448543
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,tmax,,,75.5,min,mean,SD,40,,,,NS,Group B,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,84,2025-12-02T16:05:09.448543
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,tmax,,,66.4,min,mean,SD,28.4,,,,NS,Controls,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,85,2025-12-02T16:05:09.448543
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,AUC0-240min,,,269,ng/mlxh,mean,SD,118,,,,NS,Group A,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,68,2025-12-02T16:05:12.001940
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,AUC0-240min,,,294,ng/mlxh,mean,SD,119,,,,NS,Group B,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,69,2025-12-02T16:05:12.001940
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,AUC0-240min,,,384,ng/mlxh,mean,SD,122,,,,NS,Controls,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,70,2025-12-02T16:05:12.001940
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,Cmax,,,5.1,uM/L,mean,SD,2.6,,,,<0.005,Group A,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,71,2025-12-02T16:05:12.001940
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,Cmax,,,5.1,uM/L,mean,SD,1.8,,,,<0.005,Group B,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,72,2025-12-02T16:05:12.001940
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,Cmax,,,7.4,uM/L,mean,SD,1.3,,,,<0.005,Controls,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,73,2025-12-02T16:05:12.001940
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,tmax,,,41.5,min,mean,SD,17.3,,,,<0.05,Group A,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,74,2025-12-02T16:05:12.001940
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,tmax,,,41.5,min,mean,SD,26.5,,,,<0.05,Group B,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,75,2025-12-02T16:05:12.001940
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,tmax,,,25.5,min,mean,SD,6.9,,,,<0.05,Controls,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,76,2025-12-02T16:05:12.001940
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,AUC0-240min,,,3288,ng/mlxh,mean,SD,881,,,,<0.01,Group A,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,77,2025-12-02T16:05:12.001940
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,AUC0-240min,,,2683,ng/mlxh,mean,SD,508,,,,<0.01,Group B,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,78,2025-12-02T16:05:12.001940
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,AUC0-240min,,,4284,ng/mlxh,mean,SD,1456,,,,<0.01,Controls,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,79,2025-12-02T16:05:12.001940
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,Cmax,,,23.2,uM/L,mean,SD,5.9,,,,<0.05,Group A,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,80,2025-12-02T16:05:12.001940
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,Cmax,,,17.8,uM/L,mean,SD,3,,,,<0.05,Group B,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,81,2025-12-02T16:05:12.001940
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,Cmax,,,29.6,uM/L,mean,SD,8.4,,,,<0.05,Controls,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,82,2025-12-02T16:05:12.001940
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,tmax,,,81,min,mean,SD,27.6,,,,NS,Group A,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,83,2025-12-02T16:05:12.001940
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,tmax,,,75.5,min,mean,SD,40,,,,NS,Group B,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,84,2025-12-02T16:05:12.001940
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,tmax,,,66.4,min,mean,SD,28.4,,,,NS,Controls,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,85,2025-12-02T16:05:12.001940
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,AUC0-240min,,,269,ng/mlxh,mean,SD,118,,,,NS,Group A,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,68,2025-12-02T16:05:15.923463
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,AUC0-240min,,,294,ng/mlxh,mean,SD,119,,,,NS,Group B,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,69,2025-12-02T16:05:15.923463
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,AUC0-240min,,,384,ng/mlxh,mean,SD,122,,,,NS,Controls,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,70,2025-12-02T16:05:15.923463
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,Cmax,,,5.1,uM/L,mean,SD,2.6,,,,<0.005,Group A,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,71,2025-12-02T16:05:15.923463
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,Cmax,,,5.1,uM/L,mean,SD,1.8,,,,<0.005,Group B,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,72,2025-12-02T16:05:15.923463
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,Cmax,,,7.4,uM/L,mean,SD,1.3,,,,<0.005,Controls,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,73,2025-12-02T16:05:15.923463
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,tmax,,,41.5,min,mean,SD,17.3,,,,<0.05,Group A,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,74,2025-12-02T16:05:15.923463
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,tmax,,,41.5,min,mean,SD,26.5,,,,<0.05,Group B,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,75,2025-12-02T16:05:15.923463
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,tmax,,,25.5,min,mean,SD,6.9,,,,<0.05,Controls,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,76,2025-12-02T16:05:15.923463
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,AUC0-240min,,,3288,ng/mlxh,mean,SD,881,,,,<0.01,Group A,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,77,2025-12-02T16:05:15.923463
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,AUC0-240min,,,2683,ng/mlxh,mean,SD,508,,,,<0.01,Group B,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,78,2025-12-02T16:05:15.923463
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,AUC0-240min,,,4284,ng/mlxh,mean,SD,1456,,,,<0.01,Controls,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,79,2025-12-02T16:05:15.923463
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,Cmax,,,23.2,uM/L,mean,SD,5.9,,,,<0.05,Group A,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,80,2025-12-02T16:05:15.923463
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,Cmax,,,17.8,uM/L,mean,SD,3,,,,<0.05,Group B,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,81,2025-12-02T16:05:15.923463
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,Cmax,,,29.6,uM/L,mean,SD,8.4,,,,<0.05,Controls,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,82,2025-12-02T16:05:15.923463
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,tmax,,,81,min,mean,SD,27.6,,,,NS,Group A,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,83,2025-12-02T16:05:15.923463
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,tmax,,,75.5,min,mean,SD,40,,,,NS,Group B,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,84,2025-12-02T16:05:15.923463
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,tmax,,,66.4,min,mean,SD,28.4,,,,NS,Controls,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,85,2025-12-02T16:05:15.923463
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,AUC0-240min,,,269,ng/mlxh,mean,SD,118,,,,NS,Group A,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,68,2025-12-02T16:05:22.346295
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,AUC0-240min,,,294,ng/mlxh,mean,SD,119,,,,NS,Group B,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,69,2025-12-02T16:05:22.346295
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,AUC0-240min,,,384,ng/mlxh,mean,SD,122,,,,NS,Controls,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,70,2025-12-02T16:05:22.346295
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,Cmax,,,5.1,uM/L,mean,SD,2.6,,,,<0.005,Group A,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,71,2025-12-02T16:05:22.346295
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,Cmax,,,5.1,uM/L,mean,SD,1.8,,,,<0.005,Group B,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,72,2025-12-02T16:05:22.346295
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,Cmax,,,7.4,uM/L,mean,SD,1.3,,,,<0.005,Controls,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,73,2025-12-02T16:05:22.346295
7823260.0,aspirin,aspirin,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,tmax,,,41.5,min,mean,SD,17.3,,,,<0.05,Group A,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,74,2025-12-02T16:05:22.346295
7823260.0,aspirin,aspirin,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,tmax,,,41.5,min,mean,SD,26.5,,,,<0.05,Group B,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,75,2025-12-02T16:05:22.346295
7823260.0,aspirin,aspirin,plasma,maternal,non-pregnancy,,11.0,tmax,,,25.5,min,mean,SD,6.9,,,,<0.05,Controls,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,76,2025-12-02T16:05:22.346295
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,AUC0-240min,,,3288,ng/mlxh,mean,SD,881,,,,<0.01,Group A,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,77,2025-12-02T16:05:22.346295
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,AUC0-240min,,,2683,ng/mlxh,mean,SD,508,,,,<0.01,Group B,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,78,2025-12-02T16:05:22.346295
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,AUC0-240min,,,4284,ng/mlxh,mean,SD,1456,,,,<0.01,Controls,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,79,2025-12-02T16:05:22.346295
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,Cmax,,,23.2,uM/L,mean,SD,5.9,,,,<0.05,Group A,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,80,2025-12-02T16:05:22.346295
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,Cmax,,,17.8,uM/L,mean,SD,3,,,,<0.05,Group B,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,81,2025-12-02T16:05:22.346295
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,Cmax,,,29.6,uM/L,mean,SD,8.4,,,,<0.05,Controls,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,82,2025-12-02T16:05:22.346295
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 2 and 3,27 weeks + 0 days to 29 weeks +6 days,10.0,tmax,,,81,min,mean,SD,27.6,,,,NS,Group A,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,83,2025-12-02T16:05:22.346295
7823260.0,aspirin,salicylic acid,plasma,maternal,trimester 3,36 weeks +0 days to 38 weeks +6 days,10.0,tmax,,,75.5,min,mean,SD,40,,,,NS,Group B,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,84,2025-12-02T16:05:22.346295
7823260.0,aspirin,salicylic acid,plasma,maternal,non-pregnancy,,11.0,tmax,,,66.4,min,mean,SD,28.4,,,,NS,Controls,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,85,2025-12-02T16:05:22.346295
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Clearance,5,min,2.22,ml/min,mean,SD,0.24,,,,,during the first 5 minutes into the fetal-placental circulation,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,86,2025-12-02T16:05:09.448543
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Transfer ,5,min,22.19,%,mean,SD,2.38,,,,,during the first 5 minutes into the fetal-placental circulation,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,87,2025-12-02T16:05:09.448543
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,"Clearance, steady-state",,,1.54,ml/min,mean,SD,0.28,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,88,2025-12-02T16:05:09.448543
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,"Transfer, steady-state",,,15.41,%,mean,SD,2.75,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,89,2025-12-02T16:05:09.448543
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Permeability surface area produce,,,17,ml/min,mean,SD,1.78,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,90,2025-12-02T16:05:09.448543
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Normalized permeability surface area produce,,,0.65,ml/min/gm,mean,SD,1.31,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,91,2025-12-02T16:05:09.448543
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Clearance,5,min,2.22,ml/min,mean,SD,0.24,,,,,during the first 5 minutes into the fetal-placental circulation,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,86,2025-12-02T16:05:12.001940
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Transfer ,5,min,22.19,%,mean,SD,2.38,,,,,during the first 5 minutes into the fetal-placental circulation,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,87,2025-12-02T16:05:12.001940
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,"Clearance, steady-state",,,1.54,ml/min,mean,SD,0.28,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,88,2025-12-02T16:05:12.001940
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,"Transfer, steady-state",,,15.41,%,mean,SD,2.75,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,89,2025-12-02T16:05:12.001940
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Permeability surface area produce,,,17,ml/min,mean,SD,1.78,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,90,2025-12-02T16:05:12.001940
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Normalized permeability surface area produce,,,0.65,ml/min/gm,mean,SD,1.31,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,91,2025-12-02T16:05:12.001940
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Clearance,5,min,2.22,ml/min,mean,SD,0.24,,,,,during the first 5 minutes into the fetal-placental circulation,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,86,2025-12-02T16:05:15.923463
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Transfer ,5,min,22.19,%,mean,SD,2.38,,,,,during the first 5 minutes into the fetal-placental circulation,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,87,2025-12-02T16:05:15.923463
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,"Clearance, steady-state",,,1.54,ml/min,mean,SD,0.28,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,88,2025-12-02T16:05:15.923463
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,"Transfer, steady-state",,,15.41,%,mean,SD,2.75,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,89,2025-12-02T16:05:15.923463
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Permeability surface area produce,,,17,ml/min,mean,SD,1.78,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,90,2025-12-02T16:05:15.923463
1951559.0,aspirin,aspirin,perfusate,maternal/pediatric,pregnancy,fetus,11.0,Normalized permeability surface area produce,,,0.65,ml/min/gm,mean,SD,1.31,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,91,2025-12-02T16:05:15.923463
1951559.0,aspirin,aspirin,perfusate,"maternal, fetal",pregnancy,,11.0,Clearance,5,min,2.22,ml/min,mean,SD,0.24,,,,,during the first 5 minutes into the fetal-placental circulation,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,86,2025-12-02T16:05:22.346295
1951559.0,aspirin,aspirin,perfusate,"maternal, fetal",pregnancy,,11.0,Transfer ,5,min,22.19,%,mean,SD,2.38,,,,,during the first 5 minutes into the fetal-placental circulation,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,87,2025-12-02T16:05:22.346295
1951559.0,aspirin,aspirin,perfusate,"maternal, fetal",pregnancy,,11.0,"Clearance, steady-state",,,1.54,ml/min,mean,SD,0.28,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,88,2025-12-02T16:05:22.346295
1951559.0,aspirin,aspirin,perfusate,"maternal, fetal",pregnancy,,11.0,"Transfer, steady-state",,,15.41,%,mean,SD,2.75,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,89,2025-12-02T16:05:22.346295
1951559.0,aspirin,aspirin,perfusate,"maternal, fetal",pregnancy,,11.0,Permeability surface area produce,,,17,ml/min,mean,SD,1.78,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,90,2025-12-02T16:05:22.346295
1951559.0,aspirin,aspirin,perfusate,"maternal, fetal",pregnancy,,11.0,Normalized permeability surface area produce,,,0.65,ml/min/gm,mean,SD,1.31,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,91,2025-12-02T16:05:22.346295
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,AUC0-24h,,,576.4,ng.hr/ml,mean,,,minmax,98.75,967.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,92,2025-12-02T16:05:09.448543
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Cavg,,,24,ng/ml,mean,,,minmax,4.1,40.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,93,2025-12-02T16:05:09.448543
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Cmax,,,114.9,ng/ml,mean,,,minmax,27.1,165.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,94,2025-12-02T16:05:09.448543
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Tmax,,,4,h,mean,,,minmax,2,4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,95,2025-12-02T16:05:09.448543
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Infant dose,,,3.6,ug/kg/day,mean,,,minmax,0.6,6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,96,2025-12-02T16:05:09.448543
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Relative infant dose for aspirin in milk,,,0.4,%,mean,,,minmax,0.09,0.55,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,97,2025-12-02T16:05:09.448543
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,AUC0-24h,,,576.4,ng.hr/ml,mean,,,minmax,98.75,967.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,92,2025-12-02T16:05:12.001940
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Cavg,,,24,ng/ml,mean,,,minmax,4.1,40.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,93,2025-12-02T16:05:12.001940
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Cmax,,,114.9,ng/ml,mean,,,minmax,27.1,165.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,94,2025-12-02T16:05:12.001940
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Tmax,,,4,h,mean,,,minmax,2,4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,95,2025-12-02T16:05:12.001940
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Infant dose,,,3.6,ug/kg/day,mean,,,minmax,0.6,6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,96,2025-12-02T16:05:12.001940
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Relative infant dose for aspirin in milk,,,0.4,%,mean,,,minmax,0.09,0.55,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,97,2025-12-02T16:05:12.001940
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,AUC0-24h,,,576.4,ng.hr/ml,mean,,,minmax,98.75,967.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,92,2025-12-02T16:05:15.923463
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Cavg,,,24,ng/ml,mean,,,minmax,4.1,40.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,93,2025-12-02T16:05:15.923463
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Cmax,,,114.9,ng/ml,mean,,,minmax,27.1,165.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,94,2025-12-02T16:05:15.923463
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Tmax,,,4,h,mean,,,minmax,2,4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,95,2025-12-02T16:05:15.923463
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Infant dose,,,3.6,ug/kg/day,mean,,,minmax,0.6,6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,96,2025-12-02T16:05:15.923463
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Relative infant dose for aspirin in milk,,,0.4,%,mean,,,minmax,0.09,0.55,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,97,2025-12-02T16:05:15.923463
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,AUC0-24h,,,576.4,ng.hr/ml,mean,,,minmax,98.75,967.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,92,2025-12-02T16:05:22.346295
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Cavg,,,24,ng/ml,mean,,,minmax,4.1,40.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,93,2025-12-02T16:05:22.346295
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Cmax,,,114.9,ng/ml,mean,,,minmax,27.1,165.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,94,2025-12-02T16:05:22.346295
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Tmax,,,4,h,mean,,,minmax,2,4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,95,2025-12-02T16:05:22.346295
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Infant dose,,,3.6,ug/kg/day,mean,,,minmax,0.6,6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,96,2025-12-02T16:05:22.346295
28418802.0,aspirin,salicylic acid,breast milk,maternal,lactation,,6.0,Relative infant dose for aspirin in milk,,,0.4,%,mean,,,minmax,0.09,0.55,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,97,2025-12-02T16:05:22.346295
8329296.0,aspirin,salicylic acid,plasma,maternal,delivery,,6.0,plasma concentration,,,364,ng/ml,mean,SD,460,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,98,2025-12-02T16:05:09.448543
8329296.0,aspirin,salicylic acid,umbilical cord venous blood,pediatric,,fetus,7.0,plasma concentration,,,294,ng/ml,mean,SD,347,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,99,2025-12-02T16:05:09.448543
8329296.0,aspirin,salicylic acid,"umbilical cord venous blood, maternal vein Blood",maternal/pediatric,delivery,fetus,6.0,cord/maternal ratio of plasma concentration,,,0.62,,mean,SD,0.19,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,100,2025-12-02T16:05:09.448543
8329296.0,aspirin,salicylic acid,plasma,maternal,delivery,,6.0,plasma concentration,,,364,ng/ml,mean,SD,460,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,98,2025-12-02T16:05:12.001940
8329296.0,aspirin,salicylic acid,umbilical cord venous blood,pediatric,,fetus,7.0,plasma concentration,,,294,ng/ml,mean,SD,347,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,99,2025-12-02T16:05:12.001940
8329296.0,aspirin,salicylic acid,"umbilical cord venous blood, maternal vein Blood",maternal/pediatric,delivery,fetus,6.0,cord/maternal ratio of plasma concentration,,,0.62,,mean,SD,0.19,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,100,2025-12-02T16:05:12.001940
8329296.0,aspirin,salicylic acid,plasma,maternal,delivery,,6.0,plasma concentration,,,364,ng/ml,mean,SD,460,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,98,2025-12-02T16:05:15.923463
8329296.0,aspirin,salicylic acid,umbilical cord venous blood,pediatric,,fetus,7.0,plasma concentration,,,294,ng/ml,mean,SD,347,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,99,2025-12-02T16:05:15.923463
8329296.0,aspirin,salicylic acid,"umbilical cord venous blood, maternal vein Blood",maternal/pediatric,delivery,fetus,6.0,cord/maternal ratio of plasma concentration,,,0.62,,mean,SD,0.19,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,100,2025-12-02T16:05:15.923463
8329296.0,aspirin,salicylic acid,plasma,maternal,delivery,,6.0,plasma concentration,,,364,ng/ml,mean,SD,460,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,98,2025-12-02T16:05:22.346295
8329296.0,aspirin,salicylic acid,umbilical cord venous blood,pediatric,,fetus,7.0,plasma concentration,,,294,ng/ml,mean,SD,347,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,99,2025-12-02T16:05:22.346295
8329296.0,aspirin,salicylic acid,"umbilical cord venous blood, maternal vein Blood",maternal/pediatric,delivery,fetus,6.0,cord/maternal ratio of plasma concentration,,,0.62,,mean,SD,0.19,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,100,2025-12-02T16:05:22.346295
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,K,,,0.171,/h,mean,SD,0.05,,,,<0.05,single dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,101,2025-12-02T16:05:09.448543
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,CL,,,2.402,l/h,mean,SD,0.091,,,,<0.05,single dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,102,2025-12-02T16:05:09.448543
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,Vd,,,14.5,l,mean,SD,9.71,,,,NS,single dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,103,2025-12-02T16:05:09.448543
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,,,,0.238,l/kg,mean,SD,0.156,,,,NS,single dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,104,2025-12-02T16:05:09.448543
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,AUC,,,374.71,ugxh/ml,mean,SD,198.6,,,,NS,single dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,105,2025-12-02T16:05:09.448543
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,K,,,0.0928,/h,mean,SD,0.031,,,,<0.05,multiple dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,106,2025-12-02T16:05:09.448543
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,CL,,,1.669,l/h,mean,SD,0.65,,,,<0.05,multiple dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,107,2025-12-02T16:05:09.448543
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,Vd,,,22.12,l,mean,SD,16.59,,,,NS,multiple dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,108,2025-12-02T16:05:09.448543
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,,,,0.358,l/kg,mean,SD,0.254,,,,NS,multiple dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,109,2025-12-02T16:05:09.448543
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,AUC,,,529.25,ugxh/ml,mean,SD,358.5,,,,NS,multiple dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,110,2025-12-02T16:05:09.448543
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,K,,,0.171,/h,mean,SD,0.05,,,,<0.05,single dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,101,2025-12-02T16:05:12.001940
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,CL,,,2.402,l/h,mean,SD,0.091,,,,<0.05,single dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,102,2025-12-02T16:05:12.001940
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,Vd,,,14.5,l,mean,SD,9.71,,,,NS,single dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,103,2025-12-02T16:05:12.001940
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,,,,0.238,l/kg,mean,SD,0.156,,,,NS,single dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,104,2025-12-02T16:05:12.001940
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,AUC,,,374.71,ugxh/ml,mean,SD,198.6,,,,NS,single dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,105,2025-12-02T16:05:12.001940
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,K,,,0.0928,/h,mean,SD,0.031,,,,<0.05,multiple dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,106,2025-12-02T16:05:12.001940
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,CL,,,1.669,l/h,mean,SD,0.65,,,,<0.05,multiple dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,107,2025-12-02T16:05:12.001940
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,Vd,,,22.12,l,mean,SD,16.59,,,,NS,multiple dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,108,2025-12-02T16:05:12.001940
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,,,,0.358,l/kg,mean,SD,0.254,,,,NS,multiple dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,109,2025-12-02T16:05:12.001940
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,AUC,,,529.25,ugxh/ml,mean,SD,358.5,,,,NS,multiple dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,110,2025-12-02T16:05:12.001940
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,K,,,0.171,/h,mean,SD,0.05,,,,<0.05,single dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,101,2025-12-02T16:05:15.923463
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,CL,,,2.402,l/h,mean,SD,0.091,,,,<0.05,single dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,102,2025-12-02T16:05:15.923463
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,Vd,,,14.5,l,mean,SD,9.71,,,,NS,single dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,103,2025-12-02T16:05:15.923463
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,,,,0.238,l/kg,mean,SD,0.156,,,,NS,single dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,104,2025-12-02T16:05:15.923463
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,AUC,,,374.71,ugxh/ml,mean,SD,198.6,,,,NS,single dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,105,2025-12-02T16:05:15.923463
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,K,,,0.0928,/h,mean,SD,0.031,,,,<0.05,multiple dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,106,2025-12-02T16:05:15.923463
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,CL,,,1.669,l/h,mean,SD,0.65,,,,<0.05,multiple dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,107,2025-12-02T16:05:15.923463
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,Vd,,,22.12,l,mean,SD,16.59,,,,NS,multiple dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,108,2025-12-02T16:05:15.923463
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,,,,0.358,l/kg,mean,SD,0.254,,,,NS,multiple dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,109,2025-12-02T16:05:15.923463
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,AUC,,,529.25,ugxh/ml,mean,SD,358.5,,,,NS,multiple dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,110,2025-12-02T16:05:15.923463
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,K,,,0.171,/h,mean,SD,0.05,,,,<0.05,single dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,101,2025-12-02T16:05:22.346295
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,CL,,,2.402,l/h,mean,SD,0.091,,,,<0.05,single dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,102,2025-12-02T16:05:22.346295
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,Vd,,,14.5,l,mean,SD,9.71,,,,NS,single dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,103,2025-12-02T16:05:22.346295
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,,,,0.238,l/kg,mean,SD,0.156,,,,NS,single dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,104,2025-12-02T16:05:22.346295
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,25.0,AUC,,,374.71,ugxh/ml,mean,SD,198.6,,,,NS,single dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,105,2025-12-02T16:05:22.346295
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,K,,,0.0928,/h,mean,SD,0.031,,,,<0.05,multiple dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,106,2025-12-02T16:05:22.346295
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,CL,,,1.669,l/h,mean,SD,0.65,,,,<0.05,multiple dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,107,2025-12-02T16:05:22.346295
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,Vd,,,22.12,l,mean,SD,16.59,,,,NS,multiple dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,108,2025-12-02T16:05:22.346295
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,,,,0.358,l/kg,mean,SD,0.254,,,,NS,multiple dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,109,2025-12-02T16:05:22.346295
4093506.0,aspirin,salicylic acid,blood,maternal,pregnancy,,21.0,AUC,,,529.25,ugxh/ml,mean,SD,358.5,,,,NS,multiple dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,110,2025-12-02T16:05:22.346295
7165392.0,aspirin,salicylic acid,plasma,maternal,pregnancy,,10.0,concentration,,,,mg/l,,,,minmax,156,213,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,111,2025-12-02T16:05:09.448543
7165392.0,aspirin,aspirin,umbilical cord blood/venous blood plasma,pediatric,,newborn,5.0,Ke,,,0.554,/h,mean,SD,0.41,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,112,2025-12-02T16:05:09.448543
7165392.0,aspirin,aspirin,plasma,pediatric,,newborn,5.0,half-life,,,1.27,h,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,113,2025-12-02T16:05:09.448543
7165392.0,aspirin,salicylic acid,umbilical cord blood/venous blood plasma,pediatric,,newborn,7.0,Ke,,,0.147,/h,mean,SD,0.075,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,114,2025-12-02T16:05:09.448543
7165392.0,aspirin,salicylic acid,plasma,pediatric,,newborn,7.0,half-life,,,4.71,h,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,115,2025-12-02T16:05:09.448543
7165392.0,aspirin,salicylic acid,plasma,maternal,pregnancy,,10.0,concentration,,,,mg/l,,,,minmax,156,213,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,111,2025-12-02T16:05:12.001940
7165392.0,aspirin,aspirin,umbilical cord blood/venous blood plasma,pediatric,,newborn,5.0,Ke,,,0.554,/h,mean,SD,0.41,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,112,2025-12-02T16:05:12.001940
7165392.0,aspirin,aspirin,plasma,pediatric,,newborn,5.0,half-life,,,1.27,h,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,113,2025-12-02T16:05:12.001940
7165392.0,aspirin,salicylic acid,umbilical cord blood/venous blood plasma,pediatric,,newborn,7.0,Ke,,,0.147,/h,mean,SD,0.075,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,114,2025-12-02T16:05:12.001940
7165392.0,aspirin,salicylic acid,plasma,pediatric,,newborn,7.0,half-life,,,4.71,h,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,115,2025-12-02T16:05:12.001940
7165392.0,aspirin,salicylic acid,plasma,maternal,pregnancy,,10.0,concentration,,,,mg/l,,,,minmax,156,213,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,111,2025-12-02T16:05:15.923463
7165392.0,aspirin,aspirin,umbilical cord blood/venous blood plasma,pediatric,,newborn,5.0,Ke,,,0.554,/h,mean,SD,0.41,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,112,2025-12-02T16:05:15.923463
7165392.0,aspirin,aspirin,plasma,pediatric,,newborn,5.0,half-life,,,1.27,h,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,113,2025-12-02T16:05:15.923463
7165392.0,aspirin,salicylic acid,umbilical cord blood/venous blood plasma,pediatric,,newborn,7.0,Ke,,,0.147,/h,mean,SD,0.075,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,114,2025-12-02T16:05:15.923463
7165392.0,aspirin,salicylic acid,plasma,pediatric,,newborn,7.0,half-life,,,4.71,h,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,115,2025-12-02T16:05:15.923463
7165392.0,aspirin,salicylic acid,plasma,maternal,pregnancy,,10.0,concentration,,,,mg/l,,,,minmax,156,213,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,111,2025-12-02T16:05:22.346295
7165392.0,aspirin,aspirin,umbilical cord blood/venous blood plasma,pediatric,,newborn,5.0,Ke,,,0.554,/h,mean,SD,0.41,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,112,2025-12-02T16:05:22.346295
7165392.0,aspirin,aspirin,plasma,pediatric,,newborn,5.0,half-life,,,1.27,h,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,113,2025-12-02T16:05:22.346295
7165392.0,aspirin,salicylic acid,umbilical cord blood/venous blood plasma,pediatric,,newborn,7.0,Ke,,,0.147,/h,mean,SD,0.075,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,114,2025-12-02T16:05:22.346295
7165392.0,aspirin,salicylic acid,plasma,pediatric,,newborn,7.0,half-life,,,4.71,h,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,115,2025-12-02T16:05:22.346295
6662181.0,metoclopramide,metoclopramide,breast milk,maternal,lactation,,18.0,concentration,,,47.9,ng/ml,mean,SD,26.5,,,,,during the late puerperium,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,116,2025-12-02T16:05:09.448543
6662181.0,metoclopramide,metoclopramide,breast milk,maternal,lactation,,18.0,estimated exposure to metoclopramide,,,5.2,ug/kg/day,mean,SD,3.7,,,,,during the late puerperium,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,117,2025-12-02T16:05:09.448543
6662181.0,metoclopramide,metoclopramide,breast milk,maternal,lactation,,18.0,concentration,,,47.9,ng/ml,mean,SD,26.5,,,,,during the late puerperium,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,116,2025-12-02T16:05:12.001940
6662181.0,metoclopramide,metoclopramide,breast milk,maternal,lactation,,18.0,estimated exposure to metoclopramide,,,5.2,ug/kg/day,mean,SD,3.7,,,,,during the late puerperium,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,117,2025-12-02T16:05:12.001940
6662181.0,metoclopramide,metoclopramide,breast milk,maternal,lactation,,18.0,concentration,,,47.9,ng/ml,mean,SD,26.5,,,,,during the late puerperium,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,116,2025-12-02T16:05:15.923463
6662181.0,metoclopramide,metoclopramide,breast milk,maternal,lactation,,18.0,estimated exposure to metoclopramide,,,5.2,ug/kg/day,mean,SD,3.7,,,,,during the late puerperium,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,117,2025-12-02T16:05:15.923463
6662181.0,metoclopramide,metoclopramide,breast milk,maternal,lactation,,18.0,concentration,,,47.9,ng/ml,mean,SD,26.5,,,,,during the late puerperium,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,116,2025-12-02T16:05:22.346295
6662181.0,metoclopramide,metoclopramide,breast milk,maternal,lactation,,18.0,estimated exposure to metoclopramide,,,5.2,ug/kg/day,mean,SD,3.7,,,,,during the late puerperium,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,117,2025-12-02T16:05:22.346295
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,25.0,serum concentration,week 3,,34.17,ng/ml,mean,,,minmax,0,79.4,0.009,responders at week 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,174,2025-12-02T16:05:09.448543
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,15.0,serum concentration,week 3,,19.91,ng/ml,mean,,,minmax,0,36.7,0.009,nonresponders at week 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,175,2025-12-02T16:05:09.448543
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,25.0,serum concentration,week 3,,69.3,ng/ml,mean,,,minmax,0,158,0.004,responders at week 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,176,2025-12-02T16:05:09.448543
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,15.0,serum concentration,week 3,,32.89,ng/ml,mean,,,minmax,0,68.5,0.004,nonresponders at week 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,177,2025-12-02T16:05:09.448543
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,24.0,serum concentration,week 3,,50.42,ng/ml,mean,,,minmax,0,168,0.36,responders at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,178,2025-12-02T16:05:09.448543
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,4.0,serum concentration,week 3,,62.58,ng/ml,mean,,,minmax,1,110,0.36,nonresponders at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,179,2025-12-02T16:05:09.448543
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,24.0,serum concentration,week 3,,84.87,ng/ml,mean,,,minmax,,,0.42,responders at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,180,2025-12-02T16:05:09.448543
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,4.0,serum concentration,week 3,,157.5,ng/ml,mean,,,minmax,,,0.42,nonresponders at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,181,2025-12-02T16:05:09.448543
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,54.51,ng/ml,mean,,,minmax,0,168,0.25,Remission at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,182,2025-12-02T16:05:09.448543
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,8.0,serum concentration,week 8,,46.29,ng/ml,mean,,,minmax,0,110,0.25,No remission at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,183,2025-12-02T16:05:09.448543
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,,ng/ml,mean,,,minmax,0,360,0.81,Remission at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,184,2025-12-02T16:05:09.448543
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,8.0,serum concentration,week 8,,87.42,ng/ml,mean,,,minmax,0,360,0.81,No remission at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,185,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,29.0,serum concentration,week 3,,106.91,ng/ml,mean,,,minmax,2,361,0.006,responders at week 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,186,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,21.0,serum concentration,week 3,,74.29,ng/ml,mean,,,minmax,7.5,169,0.006,nonresponders at week 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,187,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,29.0,serum concentration,week 3,,90.11,ng/ml,mean,,,minmax,2,218,0.03,responders at week 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,188,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,21.0,serum concentration,week 3,,59.75,ng/ml,mean,,,minmax,9,132,0.03,nonresponders at week 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,189,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,29.0,serum concentration,week 3,,13.36,ng/ml,mean,,,minmax,0,26,0.04,responders at week 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,190,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,21.0,serum concentration,week 3,,9.81,ng/ml,mean,,,minmax,0,18.4,0.04,nonresponders at week 4,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,191,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,28.0,serum concentration,week 3,,72.93,ng/ml,mean,,,minmax,0,175.8,0.19,responders at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,192,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,5.0,serum concentration,week 3,,102.72,ng/ml,mean,,,minmax,24,128.4,0.19,nonresponders at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,193,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,28.0,serum concentration,week 3,,68.15,ng/ml,mean,,,minmax,0,162,0.27,responders at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,194,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,5.0,serum concentration,week 3,,110.08,ng/ml,mean,,,minmax,6,156.7,0.27,nonresponders at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,195,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,28.0,serum concentration,week 3,,12.77,ng/ml,mean,,,minmax,0,60,0.07,responders at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,196,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,5.0,serum concentration,week 3,,9.31,ng/ml,mean,,,minmax,2,42.2,0.07,nonresponders at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,197,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,69.91,ng/ml,mean,,,minmax,0,175.8,0.25,Remission at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,198,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,13.0,serum concentration,week 8,,89.04,ng/ml,mean,,,minmax,1.9,134,0.25,No remission at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,199,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,20.0,serum concentration,week 8,,65.57,ng/ml,mean,,,minmax,0,141,0.22,Remission at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,200,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,13.0,serum concentration,week 8,,88.26,ng/ml,mean,,,minmax,0,162,0.22,No remission at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,201,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,20.0,serum concentration,week 8,,13.2,ng/ml,mean,,,minmax,0,60,0.5,Remission at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,202,2025-12-02T16:05:09.448543
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,13.0,serum concentration,week 8,,16.07,ng/ml,mean,,,minmax,0,42.4,0.5,No remission at week 8,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,203,2025-12-02T16:05:09.448543
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,25.0,serum concentration,week 3,,34.17,ng/ml,mean,,,minmax,0,79.4,0.009,responders at week 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,174,2025-12-02T16:05:12.001940
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,15.0,serum concentration,week 3,,19.91,ng/ml,mean,,,minmax,0,36.7,0.009,nonresponders at week 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,175,2025-12-02T16:05:12.001940
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,25.0,serum concentration,week 3,,69.3,ng/ml,mean,,,minmax,0,158,0.004,responders at week 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,176,2025-12-02T16:05:12.001940
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,15.0,serum concentration,week 3,,32.89,ng/ml,mean,,,minmax,0,68.5,0.004,nonresponders at week 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,177,2025-12-02T16:05:12.001940
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,24.0,serum concentration,week 3,,50.42,ng/ml,mean,,,minmax,0,168,0.36,responders at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,178,2025-12-02T16:05:12.001940
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,4.0,serum concentration,week 3,,62.58,ng/ml,mean,,,minmax,1,110,0.36,nonresponders at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,179,2025-12-02T16:05:12.001940
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,24.0,serum concentration,week 3,,84.87,ng/ml,mean,,,minmax,,,0.42,responders at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,180,2025-12-02T16:05:12.001940
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,4.0,serum concentration,week 3,,157.5,ng/ml,mean,,,minmax,,,0.42,nonresponders at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,181,2025-12-02T16:05:12.001940
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,54.51,ng/ml,mean,,,minmax,0,168,0.25,Remission at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,182,2025-12-02T16:05:12.001940
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,8.0,serum concentration,week 8,,46.29,ng/ml,mean,,,minmax,0,110,0.25,No remission at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,183,2025-12-02T16:05:12.001940
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,,ng/ml,mean,,,minmax,0,360,0.81,Remission at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,184,2025-12-02T16:05:12.001940
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,8.0,serum concentration,week 8,,87.42,ng/ml,mean,,,minmax,0,360,0.81,No remission at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,185,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,29.0,serum concentration,week 3,,106.91,ng/ml,mean,,,minmax,2,361,0.006,responders at week 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,186,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,21.0,serum concentration,week 3,,74.29,ng/ml,mean,,,minmax,7.5,169,0.006,nonresponders at week 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,187,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,29.0,serum concentration,week 3,,90.11,ng/ml,mean,,,minmax,2,218,0.03,responders at week 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,188,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,21.0,serum concentration,week 3,,59.75,ng/ml,mean,,,minmax,9,132,0.03,nonresponders at week 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,189,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,29.0,serum concentration,week 3,,13.36,ng/ml,mean,,,minmax,0,26,0.04,responders at week 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,190,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,21.0,serum concentration,week 3,,9.81,ng/ml,mean,,,minmax,0,18.4,0.04,nonresponders at week 4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,191,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,28.0,serum concentration,week 3,,72.93,ng/ml,mean,,,minmax,0,175.8,0.19,responders at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,192,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,5.0,serum concentration,week 3,,102.72,ng/ml,mean,,,minmax,24,128.4,0.19,nonresponders at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,193,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,28.0,serum concentration,week 3,,68.15,ng/ml,mean,,,minmax,0,162,0.27,responders at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,194,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,5.0,serum concentration,week 3,,110.08,ng/ml,mean,,,minmax,6,156.7,0.27,nonresponders at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,195,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,28.0,serum concentration,week 3,,12.77,ng/ml,mean,,,minmax,0,60,0.07,responders at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,196,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,5.0,serum concentration,week 3,,9.31,ng/ml,mean,,,minmax,2,42.2,0.07,nonresponders at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,197,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,69.91,ng/ml,mean,,,minmax,0,175.8,0.25,Remission at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,198,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,13.0,serum concentration,week 8,,89.04,ng/ml,mean,,,minmax,1.9,134,0.25,No remission at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,199,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,20.0,serum concentration,week 8,,65.57,ng/ml,mean,,,minmax,0,141,0.22,Remission at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,200,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,13.0,serum concentration,week 8,,88.26,ng/ml,mean,,,minmax,0,162,0.22,No remission at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,201,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,20.0,serum concentration,week 8,,13.2,ng/ml,mean,,,minmax,0,60,0.5,Remission at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,202,2025-12-02T16:05:12.001940
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,13.0,serum concentration,week 8,,16.07,ng/ml,mean,,,minmax,0,42.4,0.5,No remission at week 8,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,203,2025-12-02T16:05:12.001940
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,25.0,serum concentration,week 3,,34.17,ng/ml,mean,,,minmax,0,79.4,0.009,responders at week 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,174,2025-12-02T16:05:15.923463
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,15.0,serum concentration,week 3,,19.91,ng/ml,mean,,,minmax,0,36.7,0.009,nonresponders at week 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,175,2025-12-02T16:05:15.923463
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,25.0,serum concentration,week 3,,69.3,ng/ml,mean,,,minmax,0,158,0.004,responders at week 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,176,2025-12-02T16:05:15.923463
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,15.0,serum concentration,week 3,,32.89,ng/ml,mean,,,minmax,0,68.5,0.004,nonresponders at week 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,177,2025-12-02T16:05:15.923463
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,24.0,serum concentration,week 3,,50.42,ng/ml,mean,,,minmax,0,168,0.36,responders at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,178,2025-12-02T16:05:15.923463
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,4.0,serum concentration,week 3,,62.58,ng/ml,mean,,,minmax,1,110,0.36,nonresponders at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,179,2025-12-02T16:05:15.923463
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,24.0,serum concentration,week 3,,84.87,ng/ml,mean,,,minmax,,,0.42,responders at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,180,2025-12-02T16:05:15.923463
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,4.0,serum concentration,week 3,,157.5,ng/ml,mean,,,minmax,,,0.42,nonresponders at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,181,2025-12-02T16:05:15.923463
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,54.51,ng/ml,mean,,,minmax,0,168,0.25,Remission at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,182,2025-12-02T16:05:15.923463
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,8.0,serum concentration,week 8,,46.29,ng/ml,mean,,,minmax,0,110,0.25,No remission at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,183,2025-12-02T16:05:15.923463
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,,ng/ml,mean,,,minmax,0,360,0.81,Remission at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,184,2025-12-02T16:05:15.923463
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,8.0,serum concentration,week 8,,87.42,ng/ml,mean,,,minmax,0,360,0.81,No remission at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,185,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,29.0,serum concentration,week 3,,106.91,ng/ml,mean,,,minmax,2,361,0.006,responders at week 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,186,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,21.0,serum concentration,week 3,,74.29,ng/ml,mean,,,minmax,7.5,169,0.006,nonresponders at week 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,187,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,29.0,serum concentration,week 3,,90.11,ng/ml,mean,,,minmax,2,218,0.03,responders at week 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,188,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,21.0,serum concentration,week 3,,59.75,ng/ml,mean,,,minmax,9,132,0.03,nonresponders at week 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,189,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,29.0,serum concentration,week 3,,13.36,ng/ml,mean,,,minmax,0,26,0.04,responders at week 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,190,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,21.0,serum concentration,week 3,,9.81,ng/ml,mean,,,minmax,0,18.4,0.04,nonresponders at week 4,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,191,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,28.0,serum concentration,week 3,,72.93,ng/ml,mean,,,minmax,0,175.8,0.19,responders at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,192,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,5.0,serum concentration,week 3,,102.72,ng/ml,mean,,,minmax,24,128.4,0.19,nonresponders at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,193,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,28.0,serum concentration,week 3,,68.15,ng/ml,mean,,,minmax,0,162,0.27,responders at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,194,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,5.0,serum concentration,week 3,,110.08,ng/ml,mean,,,minmax,6,156.7,0.27,nonresponders at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,195,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,28.0,serum concentration,week 3,,12.77,ng/ml,mean,,,minmax,0,60,0.07,responders at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,196,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,5.0,serum concentration,week 3,,9.31,ng/ml,mean,,,minmax,2,42.2,0.07,nonresponders at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,197,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,69.91,ng/ml,mean,,,minmax,0,175.8,0.25,Remission at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,198,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,13.0,serum concentration,week 8,,89.04,ng/ml,mean,,,minmax,1.9,134,0.25,No remission at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,199,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,20.0,serum concentration,week 8,,65.57,ng/ml,mean,,,minmax,0,141,0.22,Remission at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,200,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,13.0,serum concentration,week 8,,88.26,ng/ml,mean,,,minmax,0,162,0.22,No remission at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,201,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,20.0,serum concentration,week 8,,13.2,ng/ml,mean,,,minmax,0,60,0.5,Remission at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,202,2025-12-02T16:05:15.923463
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,13.0,serum concentration,week 8,,16.07,ng/ml,mean,,,minmax,0,42.4,0.5,No remission at week 8,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,203,2025-12-02T16:05:15.923463
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,25.0,serum concentration,week 3,,34.17,ng/ml,mean,,,minmax,0,79.4,0.009,responders at week 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,174,2025-12-02T16:05:22.346295
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,15.0,serum concentration,week 3,,19.91,ng/ml,mean,,,minmax,0,36.7,0.009,nonresponders at week 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,175,2025-12-02T16:05:22.346295
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,25.0,serum concentration,week 3,,69.3,ng/ml,mean,,,minmax,0,158,0.004,responders at week 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,176,2025-12-02T16:05:22.346295
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,15.0,serum concentration,week 3,,32.89,ng/ml,mean,,,minmax,0,68.5,0.004,nonresponders at week 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,177,2025-12-02T16:05:22.346295
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,24.0,serum concentration,week 3,,50.42,ng/ml,mean,,,minmax,0,168,0.36,responders at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,178,2025-12-02T16:05:22.346295
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,4.0,serum concentration,week 3,,62.58,ng/ml,mean,,,minmax,1,110,0.36,nonresponders at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,179,2025-12-02T16:05:22.346295
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,24.0,serum concentration,week 3,,84.87,ng/ml,mean,,,minmax,,,0.42,responders at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,180,2025-12-02T16:05:22.346295
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,4.0,serum concentration,week 3,,157.5,ng/ml,mean,,,minmax,,,0.42,nonresponders at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,181,2025-12-02T16:05:22.346295
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,54.51,ng/ml,mean,,,minmax,0,168,0.25,Remission at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,182,2025-12-02T16:05:22.346295
16855451.0,sertraline,sertraline,serum,maternal,postpartum,,8.0,serum concentration,week 8,,46.29,ng/ml,mean,,,minmax,0,110,0.25,No remission at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,183,2025-12-02T16:05:22.346295
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,,ng/ml,mean,,,minmax,0,360,0.81,Remission at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,184,2025-12-02T16:05:22.346295
16855451.0,sertraline,N-demethylsertaline,serum,maternal,postpartum,,8.0,serum concentration,week 8,,87.42,ng/ml,mean,,,minmax,0,360,0.81,No remission at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,185,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,29.0,serum concentration,week 3,,106.91,ng/ml,mean,,,minmax,2,361,0.006,responders at week 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,186,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,21.0,serum concentration,week 3,,74.29,ng/ml,mean,,,minmax,7.5,169,0.006,nonresponders at week 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,187,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,29.0,serum concentration,week 3,,90.11,ng/ml,mean,,,minmax,2,218,0.03,responders at week 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,188,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,21.0,serum concentration,week 3,,59.75,ng/ml,mean,,,minmax,9,132,0.03,nonresponders at week 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,189,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,29.0,serum concentration,week 3,,13.36,ng/ml,mean,,,minmax,0,26,0.04,responders at week 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,190,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,21.0,serum concentration,week 3,,9.81,ng/ml,mean,,,minmax,0,18.4,0.04,nonresponders at week 4,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,191,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,28.0,serum concentration,week 3,,72.93,ng/ml,mean,,,minmax,0,175.8,0.19,responders at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,192,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,5.0,serum concentration,week 3,,102.72,ng/ml,mean,,,minmax,24,128.4,0.19,nonresponders at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,193,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,28.0,serum concentration,week 3,,68.15,ng/ml,mean,,,minmax,0,162,0.27,responders at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,194,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,5.0,serum concentration,week 3,,110.08,ng/ml,mean,,,minmax,6,156.7,0.27,nonresponders at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,195,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,28.0,serum concentration,week 3,,12.77,ng/ml,mean,,,minmax,0,60,0.07,responders at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,196,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,5.0,serum concentration,week 3,,9.31,ng/ml,mean,,,minmax,2,42.2,0.07,nonresponders at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,197,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,20.0,serum concentration,week 8,,69.91,ng/ml,mean,,,minmax,0,175.8,0.25,Remission at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,198,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,nortriptyline,serum,maternal,postpartum,,13.0,serum concentration,week 8,,89.04,ng/ml,mean,,,minmax,1.9,134,0.25,No remission at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,199,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,20.0,serum concentration,week 8,,65.57,ng/ml,mean,,,minmax,0,141,0.22,Remission at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,200,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,E-10-hydroxyNTP,serum,maternal,postpartum,,13.0,serum concentration,week 8,,88.26,ng/ml,mean,,,minmax,0,162,0.22,No remission at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,201,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,20.0,serum concentration,week 8,,13.2,ng/ml,mean,,,minmax,0,60,0.5,Remission at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,202,2025-12-02T16:05:22.346295
16855451.0,nortriptyline,Z-10-hydroxyNTP,serum,maternal,postpartum,,13.0,serum concentration,week 8,,16.07,ng/ml,mean,,,minmax,0,42.4,0.5,No remission at week 8,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,203,2025-12-02T16:05:22.346295
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,tmax,,,2.25,h,Median,,,25th and 75th percentiles,1.75,2.28,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,204,2025-12-02T16:05:09.448543
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,Cmax,,,1161,g l1,mean,,,95% CI,588,1734,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,205,2025-12-02T16:05:09.448543
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,Caverage,,,638,g l1,mean,,,95% CI,322,954,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,206,2025-12-02T16:05:09.448543
11849190.0,Venlafaxine,Venlafaxine,breast milk/blood,maternal,lactation,,6.0,M/PAUC,,,2.5,,mean,,,95% CI,2,3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,207,2025-12-02T16:05:09.448543
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,tmax,,,2.96,h,Median,,,25th and 75th percentiles,2.25,4.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,208,2025-12-02T16:05:09.448543
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,Cmax,,,796,g l1,mean,,,95% CI,362,1230,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,209,2025-12-02T16:05:09.448543
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,Caverage,,,608,g l1,mean,,,95% CI,358,858,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,210,2025-12-02T16:05:09.448543
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk/blood,maternal,lactation,,6.0,M/PAUC,,,2.74,,mean,,,95% CI,2.36,3.12,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,211,2025-12-02T16:05:09.448543
11849190.0,Venlafaxine,Venlafaxine,breast milk,pediatric,,infant,6.0,Infant dose as percentage of maternal dose,,,3.2,%,Mean,,,95% CI,1.7,4.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,212,2025-12-02T16:05:09.448543
11849190.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,pediatric,,infant,6.0,Infant dose as percentage of maternal dose,,,3.2,%,Mean,,,95% CI,1.9,4.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,213,2025-12-02T16:05:09.448543
11849190.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,pediatric,,infant,6.0,Total dose V equivalents,,,6.4,%,Mean,,,95% CI,5.5,7.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,214,2025-12-02T16:05:09.448543
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,tmax,,,2.25,h,Median,,,25th and 75th percentiles,1.75,2.28,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,204,2025-12-02T16:05:12.001940
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,Cmax,,,1161,g l1,mean,,,95% CI,588,1734,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,205,2025-12-02T16:05:12.001940
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,Caverage,,,638,g l1,mean,,,95% CI,322,954,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,206,2025-12-02T16:05:12.001940
11849190.0,Venlafaxine,Venlafaxine,breast milk/blood,maternal,lactation,,6.0,M/PAUC,,,2.5,,mean,,,95% CI,2,3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,207,2025-12-02T16:05:12.001940
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,tmax,,,2.96,h,Median,,,25th and 75th percentiles,2.25,4.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,208,2025-12-02T16:05:12.001940
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,Cmax,,,796,g l1,mean,,,95% CI,362,1230,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,209,2025-12-02T16:05:12.001940
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,Caverage,,,608,g l1,mean,,,95% CI,358,858,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,210,2025-12-02T16:05:12.001940
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk/blood,maternal,lactation,,6.0,M/PAUC,,,2.74,,mean,,,95% CI,2.36,3.12,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,211,2025-12-02T16:05:12.001940
11849190.0,Venlafaxine,Venlafaxine,breast milk,pediatric,,infant,6.0,Infant dose as percentage of maternal dose,,,3.2,%,Mean,,,95% CI,1.7,4.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,212,2025-12-02T16:05:12.001940
11849190.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,pediatric,,infant,6.0,Infant dose as percentage of maternal dose,,,3.2,%,Mean,,,95% CI,1.9,4.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,213,2025-12-02T16:05:12.001940
11849190.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,pediatric,,infant,6.0,Total dose V equivalents,,,6.4,%,Mean,,,95% CI,5.5,7.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,214,2025-12-02T16:05:12.001940
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,tmax,,,2.25,h,Median,,,25th and 75th percentiles,1.75,2.28,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,204,2025-12-02T16:05:15.923463
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,Cmax,,,1161,g l1,mean,,,95% CI,588,1734,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,205,2025-12-02T16:05:15.923463
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,Caverage,,,638,g l1,mean,,,95% CI,322,954,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,206,2025-12-02T16:05:15.923463
11849190.0,Venlafaxine,Venlafaxine,breast milk/blood,maternal,lactation,,6.0,M/PAUC,,,2.5,,mean,,,95% CI,2,3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,207,2025-12-02T16:05:15.923463
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,tmax,,,2.96,h,Median,,,25th and 75th percentiles,2.25,4.2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,208,2025-12-02T16:05:15.923463
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,Cmax,,,796,g l1,mean,,,95% CI,362,1230,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,209,2025-12-02T16:05:15.923463
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,Caverage,,,608,g l1,mean,,,95% CI,358,858,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,210,2025-12-02T16:05:15.923463
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk/blood,maternal,lactation,,6.0,M/PAUC,,,2.74,,mean,,,95% CI,2.36,3.12,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,211,2025-12-02T16:05:15.923463
11849190.0,Venlafaxine,Venlafaxine,breast milk,pediatric,,infant,6.0,Infant dose as percentage of maternal dose,,,3.2,%,Mean,,,95% CI,1.7,4.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,212,2025-12-02T16:05:15.923463
11849190.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,pediatric,,infant,6.0,Infant dose as percentage of maternal dose,,,3.2,%,Mean,,,95% CI,1.9,4.9,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,213,2025-12-02T16:05:15.923463
11849190.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,pediatric,,infant,6.0,Total dose V equivalents,,,6.4,%,Mean,,,95% CI,5.5,7.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,214,2025-12-02T16:05:15.923463
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,tmax,,,2.25,h,Median,,,25th and 75th percentiles,1.75,2.28,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,204,2025-12-02T16:05:22.346295
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,Cmax,,,1161,g l1,mean,,,95% CI,588,1734,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,205,2025-12-02T16:05:22.346295
11849190.0,Venlafaxine,Venlafaxine,breast milk,maternal,lactation,,6.0,Caverage,,,638,g l1,mean,,,95% CI,322,954,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,206,2025-12-02T16:05:22.346295
11849190.0,Venlafaxine,Venlafaxine,breast milk/blood,maternal,lactation,,6.0,M/PAUC,,,2.5,,mean,,,95% CI,2,3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,207,2025-12-02T16:05:22.346295
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,tmax,,,2.96,h,Median,,,25th and 75th percentiles,2.25,4.2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,208,2025-12-02T16:05:22.346295
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,Cmax,,,796,g l1,mean,,,95% CI,362,1230,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,209,2025-12-02T16:05:22.346295
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk,maternal,lactation,,6.0,Caverage,,,608,g l1,mean,,,95% CI,358,858,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,210,2025-12-02T16:05:22.346295
11849190.0,Venlafaxine,O-Desmethylvenlafixine,breast milk/blood,maternal,lactation,,6.0,M/PAUC,,,2.74,,mean,,,95% CI,2.36,3.12,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,211,2025-12-02T16:05:22.346295
11849190.0,Venlafaxine,Venlafaxine,breast milk,pediatric,,infant,6.0,Infant dose as percentage of maternal dose,,,3.2,%,Mean,,,95% CI,1.7,4.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,212,2025-12-02T16:05:22.346295
11849190.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,pediatric,,infant,6.0,Infant dose as percentage of maternal dose,,,3.2,%,Mean,,,95% CI,1.9,4.9,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,213,2025-12-02T16:05:22.346295
11849190.0,Venlafaxine,Venlafaxine/O-Desmethylvenlafaxine,breast milk,pediatric,,infant,6.0,Total dose V equivalents,,,6.4,%,Mean,,,95% CI,5.5,7.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,214,2025-12-02T16:05:22.346295
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,maternal,lactation,,3.0,concentration,,,965,nmol/L,mean,,,minmax,407,1432,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,215,2025-12-02T16:05:09.448543
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk,maternal,lactation,,3.0,concentration,,,2314,nmol/L,mean,,,minmax,1012,3203,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,216,2025-12-02T16:05:09.448543
15367050.0,Venlafaxine,Venlafaxine ,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,2.6,,mean,,,minmax,1.6,3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,217,2025-12-02T16:05:09.448543
15367050.0,Venlafaxine,O-Desmethylvenlafixine,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,3.5,,mean,,,minmax,0.7,8.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,218,2025-12-02T16:05:09.448543
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,2.4,,mean,,,minmax,2.2,2.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,219,2025-12-02T16:05:09.448543
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk,maternal,lactation,,3.0,relative dose to infant,,,5.2,%,mean,,,minmax,3.8,6.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,220,2025-12-02T16:05:09.448543
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,pediatric,,infant,3.0,concentration,,,91,nmol/L,mean,,,minmax,31,128,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,221,2025-12-02T16:05:09.448543
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,pediatric/maternal,lactation,infant,3.0,infant concentration as % of maternal serum concentration,,,10.2,%,mean,,,minmax,5.3,19,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,222,2025-12-02T16:05:09.448543
15367050.0,citalopram,citalopram,serum,maternal,lactation,,9.0,concentration,,,221,nmol/L,mean,,,minmax,57,508,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,223,2025-12-02T16:05:09.448543
15367050.0,citalopram,citalopram,breast milk,maternal,lactation,,9.0,concentration,,,389,nmol/L,mean,,,minmax,157,725,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,224,2025-12-02T16:05:09.448543
15367050.0,citalopram,citalopram,breast milk/serum ,maternal,lactation,,9.0,milk/maternal serum concentration ratio,,,2.1,,mean,,,minmax,1.1,4.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,225,2025-12-02T16:05:09.448543
15367050.0,citalopram,desmethylcitalopram ,breast milk/serum ,maternal,lactation,,9.0,milk/maternal serum concentration ratio,,,2.9,,mean,,,minmax,0.9,6.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,226,2025-12-02T16:05:09.448543
15367050.0,citalopram,citalopram,breast milk,maternal,lactation,,9.0,relative dose to infant,,,5.2,%,mean,,,minmax,2.5,9.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,227,2025-12-02T16:05:09.448543
15367050.0,citalopram,citalopram,serum,pediatric,,infant,6.0,concentration,,,1.9,nmol/L,mean,,,minmax,0,8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,228,2025-12-02T16:05:09.448543
15367050.0,citalopram,citalopram,serum,pediatric/maternal,lactation,infant,9.0,infant concentration as % of maternal serum concentration,,,0.9,%,mean,,,minmax,0,4.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,229,2025-12-02T16:05:09.448543
15367050.0,paroxetine,paroxetine,serum,maternal,lactation,,6.0,concentration,,,145,nmol/L,mean,,,minmax,22,210,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,230,2025-12-02T16:05:09.448543
15367050.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,concentration,,,88,nmol/L,mean,,,minmax,18,152,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,231,2025-12-02T16:05:09.448543
15367050.0,paroxetine,paroxetine,breast milk/serum ,maternal,lactation,,6.0,milk/maternal serum concentration ratio,,,0.7,,mean,,,minmax,0.6,0.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,232,2025-12-02T16:05:09.448543
15367050.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative dose to infant,,,1.4,%,mean,,,minmax,0.5,2.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,233,2025-12-02T16:05:09.448543
15367050.0,paroxetine,paroxetine,serum,pediatric,,infant,6.0,concentration,,,0,nmol/L,mean,,,minmax,0,0,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,234,2025-12-02T16:05:09.448543
15367050.0,paroxetine,paroxetine,serum,pediatric/maternal,lactation,infant,6.0,infant concentration as % of maternal serum concentration,,,0,%,mean,,,minmax,0,0,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,235,2025-12-02T16:05:09.448543
15367050.0,fluoxetine,fluoxetine and norfluoxetine,serum,maternal,lactation,,1.0,concentration,,,734,nmol/L,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,236,2025-12-02T16:05:09.448543
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk,maternal,lactation,,1.0,concentration,,,218,nmol/L,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,237,2025-12-02T16:05:09.448543
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.3,,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,238,2025-12-02T16:05:09.448543
15367050.0,fluoxetine,fluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.4,,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,239,2025-12-02T16:05:09.448543
15367050.0,fluoxetine,norfluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.3,,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,240,2025-12-02T16:05:09.448543
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk,maternal,lactation,,1.0,relative dose to infant,,,3.3,,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,241,2025-12-02T16:05:09.448543
15367050.0,fluoxetine,norfluoxetine,serum,pediatric,,infant,1.0,concentration,,,47,,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,242,2025-12-02T16:05:09.448543
15367050.0,fluoxetine,fluoxetine and norfluoxetine,serum,pediatric/maternal,lactation,infant,1.0,infant concentration as % of maternal serum concentration,,,6.4,,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,243,2025-12-02T16:05:09.448543
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,maternal,lactation,,3.0,concentration,,,965,nmol/L,mean,,,minmax,407,1432,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,215,2025-12-02T16:05:12.001940
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk,maternal,lactation,,3.0,concentration,,,2314,nmol/L,mean,,,minmax,1012,3203,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,216,2025-12-02T16:05:12.001940
15367050.0,Venlafaxine,Venlafaxine ,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,2.6,,mean,,,minmax,1.6,3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,217,2025-12-02T16:05:12.001940
15367050.0,Venlafaxine,O-Desmethylvenlafixine,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,3.5,,mean,,,minmax,0.7,8.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,218,2025-12-02T16:05:12.001940
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,2.4,,mean,,,minmax,2.2,2.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,219,2025-12-02T16:05:12.001940
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk,maternal,lactation,,3.0,relative dose to infant,,,5.2,%,mean,,,minmax,3.8,6.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,220,2025-12-02T16:05:12.001940
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,pediatric,,infant,3.0,concentration,,,91,nmol/L,mean,,,minmax,31,128,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,221,2025-12-02T16:05:12.001940
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,pediatric/maternal,lactation,infant,3.0,infant concentration as % of maternal serum concentration,,,10.2,%,mean,,,minmax,5.3,19,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,222,2025-12-02T16:05:12.001940
15367050.0,citalopram,citalopram,serum,maternal,lactation,,9.0,concentration,,,221,nmol/L,mean,,,minmax,57,508,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,223,2025-12-02T16:05:12.001940
15367050.0,citalopram,citalopram,breast milk,maternal,lactation,,9.0,concentration,,,389,nmol/L,mean,,,minmax,157,725,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,224,2025-12-02T16:05:12.001940
15367050.0,citalopram,citalopram,breast milk/serum ,maternal,lactation,,9.0,milk/maternal serum concentration ratio,,,2.1,,mean,,,minmax,1.1,4.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,225,2025-12-02T16:05:12.001940
15367050.0,citalopram,desmethylcitalopram ,breast milk/serum ,maternal,lactation,,9.0,milk/maternal serum concentration ratio,,,2.9,,mean,,,minmax,0.9,6.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,226,2025-12-02T16:05:12.001940
15367050.0,citalopram,citalopram,breast milk,maternal,lactation,,9.0,relative dose to infant,,,5.2,%,mean,,,minmax,2.5,9.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,227,2025-12-02T16:05:12.001940
15367050.0,citalopram,citalopram,serum,pediatric,,infant,6.0,concentration,,,1.9,nmol/L,mean,,,minmax,0,8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,228,2025-12-02T16:05:12.001940
15367050.0,citalopram,citalopram,serum,pediatric/maternal,lactation,infant,9.0,infant concentration as % of maternal serum concentration,,,0.9,%,mean,,,minmax,0,4.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,229,2025-12-02T16:05:12.001940
15367050.0,paroxetine,paroxetine,serum,maternal,lactation,,6.0,concentration,,,145,nmol/L,mean,,,minmax,22,210,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,230,2025-12-02T16:05:12.001940
15367050.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,concentration,,,88,nmol/L,mean,,,minmax,18,152,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,231,2025-12-02T16:05:12.001940
15367050.0,paroxetine,paroxetine,breast milk/serum ,maternal,lactation,,6.0,milk/maternal serum concentration ratio,,,0.7,,mean,,,minmax,0.6,0.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,232,2025-12-02T16:05:12.001940
15367050.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative dose to infant,,,1.4,%,mean,,,minmax,0.5,2.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,233,2025-12-02T16:05:12.001940
15367050.0,paroxetine,paroxetine,serum,pediatric,,infant,6.0,concentration,,,0,nmol/L,mean,,,minmax,0,0,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,234,2025-12-02T16:05:12.001940
15367050.0,paroxetine,paroxetine,serum,pediatric/maternal,lactation,infant,6.0,infant concentration as % of maternal serum concentration,,,0,%,mean,,,minmax,0,0,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,235,2025-12-02T16:05:12.001940
15367050.0,fluoxetine,fluoxetine and norfluoxetine,serum,maternal,lactation,,1.0,concentration,,,734,nmol/L,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,236,2025-12-02T16:05:12.001940
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk,maternal,lactation,,1.0,concentration,,,218,nmol/L,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,237,2025-12-02T16:05:12.001940
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.3,,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,238,2025-12-02T16:05:12.001940
15367050.0,fluoxetine,fluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.4,,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,239,2025-12-02T16:05:12.001940
15367050.0,fluoxetine,norfluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.3,,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,240,2025-12-02T16:05:12.001940
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk,maternal,lactation,,1.0,relative dose to infant,,,3.3,,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,241,2025-12-02T16:05:12.001940
15367050.0,fluoxetine,norfluoxetine,serum,pediatric,,infant,1.0,concentration,,,47,,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,242,2025-12-02T16:05:12.001940
15367050.0,fluoxetine,fluoxetine and norfluoxetine,serum,pediatric/maternal,lactation,infant,1.0,infant concentration as % of maternal serum concentration,,,6.4,,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,243,2025-12-02T16:05:12.001940
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,maternal,lactation,,3.0,concentration,,,965,nmol/L,mean,,,minmax,407,1432,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,215,2025-12-02T16:05:15.923463
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk,maternal,lactation,,3.0,concentration,,,2314,nmol/L,mean,,,minmax,1012,3203,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,216,2025-12-02T16:05:15.923463
15367050.0,Venlafaxine,Venlafaxine ,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,2.6,,mean,,,minmax,1.6,3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,217,2025-12-02T16:05:15.923463
15367050.0,Venlafaxine,O-Desmethylvenlafixine,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,3.5,,mean,,,minmax,0.7,8.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,218,2025-12-02T16:05:15.923463
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,2.4,,mean,,,minmax,2.2,2.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,219,2025-12-02T16:05:15.923463
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk,maternal,lactation,,3.0,relative dose to infant,,,5.2,%,mean,,,minmax,3.8,6.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,220,2025-12-02T16:05:15.923463
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,pediatric,,infant,3.0,concentration,,,91,nmol/L,mean,,,minmax,31,128,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,221,2025-12-02T16:05:15.923463
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,pediatric/maternal,lactation,infant,3.0,infant concentration as % of maternal serum concentration,,,10.2,%,mean,,,minmax,5.3,19,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,222,2025-12-02T16:05:15.923463
15367050.0,citalopram,citalopram,serum,maternal,lactation,,9.0,concentration,,,221,nmol/L,mean,,,minmax,57,508,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,223,2025-12-02T16:05:15.923463
15367050.0,citalopram,citalopram,breast milk,maternal,lactation,,9.0,concentration,,,389,nmol/L,mean,,,minmax,157,725,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,224,2025-12-02T16:05:15.923463
15367050.0,citalopram,citalopram,breast milk/serum ,maternal,lactation,,9.0,milk/maternal serum concentration ratio,,,2.1,,mean,,,minmax,1.1,4.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,225,2025-12-02T16:05:15.923463
15367050.0,citalopram,desmethylcitalopram ,breast milk/serum ,maternal,lactation,,9.0,milk/maternal serum concentration ratio,,,2.9,,mean,,,minmax,0.9,6.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,226,2025-12-02T16:05:15.923463
15367050.0,citalopram,citalopram,breast milk,maternal,lactation,,9.0,relative dose to infant,,,5.2,%,mean,,,minmax,2.5,9.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,227,2025-12-02T16:05:15.923463
15367050.0,citalopram,citalopram,serum,pediatric,,infant,6.0,concentration,,,1.9,nmol/L,mean,,,minmax,0,8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,228,2025-12-02T16:05:15.923463
15367050.0,citalopram,citalopram,serum,pediatric/maternal,lactation,infant,9.0,infant concentration as % of maternal serum concentration,,,0.9,%,mean,,,minmax,0,4.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,229,2025-12-02T16:05:15.923463
15367050.0,paroxetine,paroxetine,serum,maternal,lactation,,6.0,concentration,,,145,nmol/L,mean,,,minmax,22,210,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,230,2025-12-02T16:05:15.923463
15367050.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,concentration,,,88,nmol/L,mean,,,minmax,18,152,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,231,2025-12-02T16:05:15.923463
15367050.0,paroxetine,paroxetine,breast milk/serum ,maternal,lactation,,6.0,milk/maternal serum concentration ratio,,,0.7,,mean,,,minmax,0.6,0.9,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,232,2025-12-02T16:05:15.923463
15367050.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative dose to infant,,,1.4,%,mean,,,minmax,0.5,2.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,233,2025-12-02T16:05:15.923463
15367050.0,paroxetine,paroxetine,serum,pediatric,,infant,6.0,concentration,,,0,nmol/L,mean,,,minmax,0,0,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,234,2025-12-02T16:05:15.923463
15367050.0,paroxetine,paroxetine,serum,pediatric/maternal,lactation,infant,6.0,infant concentration as % of maternal serum concentration,,,0,%,mean,,,minmax,0,0,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,235,2025-12-02T16:05:15.923463
15367050.0,fluoxetine,fluoxetine and norfluoxetine,serum,maternal,lactation,,1.0,concentration,,,734,nmol/L,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,236,2025-12-02T16:05:15.923463
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk,maternal,lactation,,1.0,concentration,,,218,nmol/L,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,237,2025-12-02T16:05:15.923463
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.3,,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,238,2025-12-02T16:05:15.923463
15367050.0,fluoxetine,fluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.4,,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,239,2025-12-02T16:05:15.923463
15367050.0,fluoxetine,norfluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.3,,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,240,2025-12-02T16:05:15.923463
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk,maternal,lactation,,1.0,relative dose to infant,,,3.3,,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,241,2025-12-02T16:05:15.923463
15367050.0,fluoxetine,norfluoxetine,serum,pediatric,,infant,1.0,concentration,,,47,,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,242,2025-12-02T16:05:15.923463
15367050.0,fluoxetine,fluoxetine and norfluoxetine,serum,pediatric/maternal,lactation,infant,1.0,infant concentration as % of maternal serum concentration,,,6.4,,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,243,2025-12-02T16:05:15.923463
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,maternal,lactation,,3.0,concentration,,,965,nmol/L,mean,,,minmax,407,1432,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,215,2025-12-02T16:05:22.346295
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk,maternal,lactation,,3.0,concentration,,,2314,nmol/L,mean,,,minmax,1012,3203,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,216,2025-12-02T16:05:22.346295
15367050.0,Venlafaxine,Venlafaxine ,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,2.6,,mean,,,minmax,1.6,3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,217,2025-12-02T16:05:22.346295
15367050.0,Venlafaxine,O-Desmethylvenlafixine,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,3.5,,mean,,,minmax,0.7,8.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,218,2025-12-02T16:05:22.346295
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk/serum ,maternal,lactation,,3.0,milk/maternal serum concentration ratio,,,2.4,,mean,,,minmax,2.2,2.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,219,2025-12-02T16:05:22.346295
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,breast milk,maternal,lactation,,3.0,relative dose to infant,,,5.2,%,mean,,,minmax,3.8,6.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,220,2025-12-02T16:05:22.346295
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,pediatric,,infant,3.0,concentration,,,91,nmol/L,mean,,,minmax,31,128,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,221,2025-12-02T16:05:22.346295
15367050.0,Venlafaxine,Venlafaxine andO-Desmethylvenlafaxine,serum,pediatric/maternal,lactation,infant,3.0,infant concentration as % of maternal serum concentration,,,10.2,%,mean,,,minmax,5.3,19,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,222,2025-12-02T16:05:22.346295
15367050.0,citalopram,citalopram,serum,maternal,lactation,,9.0,concentration,,,221,nmol/L,mean,,,minmax,57,508,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,223,2025-12-02T16:05:22.346295
15367050.0,citalopram,citalopram,breast milk,maternal,lactation,,9.0,concentration,,,389,nmol/L,mean,,,minmax,157,725,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,224,2025-12-02T16:05:22.346295
15367050.0,citalopram,citalopram,breast milk/serum ,maternal,lactation,,9.0,milk/maternal serum concentration ratio,,,2.1,,mean,,,minmax,1.1,4.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,225,2025-12-02T16:05:22.346295
15367050.0,citalopram,desmethylcitalopram ,breast milk/serum ,maternal,lactation,,9.0,milk/maternal serum concentration ratio,,,2.9,,mean,,,minmax,0.9,6.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,226,2025-12-02T16:05:22.346295
15367050.0,citalopram,citalopram,breast milk,maternal,lactation,,9.0,relative dose to infant,,,5.2,%,mean,,,minmax,2.5,9.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,227,2025-12-02T16:05:22.346295
15367050.0,citalopram,citalopram,serum,pediatric,,infant,6.0,concentration,,,1.9,nmol/L,mean,,,minmax,0,8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,228,2025-12-02T16:05:22.346295
15367050.0,citalopram,citalopram,serum,pediatric/maternal,lactation,infant,9.0,infant concentration as % of maternal serum concentration,,,0.9,%,mean,,,minmax,0,4.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,229,2025-12-02T16:05:22.346295
15367050.0,paroxetine,paroxetine,serum,maternal,lactation,,6.0,concentration,,,145,nmol/L,mean,,,minmax,22,210,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,230,2025-12-02T16:05:22.346295
15367050.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,concentration,,,88,nmol/L,mean,,,minmax,18,152,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,231,2025-12-02T16:05:22.346295
15367050.0,paroxetine,paroxetine,breast milk/serum ,maternal,lactation,,6.0,milk/maternal serum concentration ratio,,,0.7,,mean,,,minmax,0.6,0.9,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,232,2025-12-02T16:05:22.346295
15367050.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative dose to infant,,,1.4,%,mean,,,minmax,0.5,2.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,233,2025-12-02T16:05:22.346295
15367050.0,paroxetine,paroxetine,serum,pediatric,,infant,6.0,concentration,,,0,nmol/L,mean,,,minmax,0,0,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,234,2025-12-02T16:05:22.346295
15367050.0,paroxetine,paroxetine,serum,pediatric/maternal,lactation,infant,6.0,infant concentration as % of maternal serum concentration,,,0,%,mean,,,minmax,0,0,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,235,2025-12-02T16:05:22.346295
15367050.0,fluoxetine,fluoxetine and norfluoxetine,serum,maternal,lactation,,1.0,concentration,,,734,nmol/L,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,236,2025-12-02T16:05:22.346295
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk,maternal,lactation,,1.0,concentration,,,218,nmol/L,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,237,2025-12-02T16:05:22.346295
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.3,,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,238,2025-12-02T16:05:22.346295
15367050.0,fluoxetine,fluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.4,,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,239,2025-12-02T16:05:22.346295
15367050.0,fluoxetine,norfluoxetine,breast milk/serum ,maternal,lactation,,1.0,milk/maternal serum concentration ratio,,,0.3,,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,240,2025-12-02T16:05:22.346295
15367050.0,fluoxetine,fluoxetine and norfluoxetine,breast milk,maternal,lactation,,1.0,relative dose to infant,,,3.3,,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,241,2025-12-02T16:05:22.346295
15367050.0,fluoxetine,norfluoxetine,serum,pediatric,,infant,1.0,concentration,,,47,,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,242,2025-12-02T16:05:22.346295
15367050.0,fluoxetine,fluoxetine and norfluoxetine,serum,pediatric/maternal,lactation,infant,1.0,infant concentration as % of maternal serum concentration,,,6.4,,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,243,2025-12-02T16:05:22.346295
9643618.0,Venlafaxine,Venlafaxine,breast milk/plasma,maternal,lacation,,3.0,milk/plasma ratio (M/P),,,4.14,,mean,s.e.mean,0.56,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,301,2025-12-02T16:05:09.448543
9643618.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,3.0,estimated infant dose,,,3.49,%,mean,s.e.mean,0.37,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,302,2025-12-02T16:05:09.448543
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,3.0,milk/plasma ratio (M/P),,,3.06,,mean,s.e.mean,0.08,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,303,2025-12-02T16:05:09.448543
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,3.0,estimated infant dose,,,4.08,%,mean,s.e.mean,1.09,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,304,2025-12-02T16:05:09.448543
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,infant,3.0,concentration,,,100,ug/l,median,,,IQR,42,194,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,305,2025-12-02T16:05:09.448543
9643618.0,Venlafaxine,Venlafaxine,breast milk/plasma,maternal,lacation,,3.0,milk/plasma ratio (M/P),,,4.14,,mean,s.e.mean,0.56,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,301,2025-12-02T16:05:12.001940
9643618.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,3.0,estimated infant dose,,,3.49,%,mean,s.e.mean,0.37,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,302,2025-12-02T16:05:12.001940
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,3.0,milk/plasma ratio (M/P),,,3.06,,mean,s.e.mean,0.08,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,303,2025-12-02T16:05:12.001940
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,3.0,estimated infant dose,,,4.08,%,mean,s.e.mean,1.09,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,304,2025-12-02T16:05:12.001940
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,infant,3.0,concentration,,,100,ug/l,median,,,IQR,42,194,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,305,2025-12-02T16:05:12.001940
9643618.0,Venlafaxine,Venlafaxine,breast milk/plasma,maternal,lacation,,3.0,milk/plasma ratio (M/P),,,4.14,,mean,s.e.mean,0.56,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,295,2025-12-02T16:05:15.923463
9643618.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,3.0,estimated infant dose,,,3.49,%,mean,s.e.mean,0.37,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,296,2025-12-02T16:05:15.923463
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,3.0,milk/plasma ratio (M/P),,,3.06,,mean,s.e.mean,0.08,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,297,2025-12-02T16:05:15.923463
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,3.0,estimated infant dose,,,4.08,%,mean,s.e.mean,1.09,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,298,2025-12-02T16:05:15.923463
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,infant,3.0,concentration,,,100,ug/l,median,,,IQR,42,194,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,299,2025-12-02T16:05:15.923463
9643618.0,Venlafaxine,Venlafaxine,breast milk/plasma,maternal,lacation,,3.0,milk/plasma ratio (M/P),,,4.14,,mean,s.e.mean,0.56,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,295,2025-12-02T16:05:22.346295
9643618.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,3.0,estimated infant dose,,,3.49,%,mean,s.e.mean,0.37,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,296,2025-12-02T16:05:22.346295
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,3.0,milk/plasma ratio (M/P),,,3.06,,mean,s.e.mean,0.08,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,297,2025-12-02T16:05:22.346295
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,breast milk,maternal,lacation,,3.0,estimated infant dose,,,4.08,%,mean,s.e.mean,1.09,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,298,2025-12-02T16:05:22.346295
9643618.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,infant,3.0,concentration,,,100,ug/l,median,,,IQR,42,194,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,299,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal,lacation,,11.0,concentration,,,308.2,ng/ml,mean,,,95% CI,-177.7,794.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,306,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal,lacation,,11.0,concentration,,,232.8,ng/ml,mean,,,95% CI,150.1,315.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,307,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,minimum concentration,,,262.7,ng/ml,mean,,,95% CI,-6.3,531.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,308,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,minimum concentration,,,584,ng/ml,mean,,,95% CI,311.6,856.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,309,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,maximum concentration,,,803.9,ng/ml,mean,,,95% CI,194.1,1413.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,310,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,maximum concentration,,,1424.2,ng/ml,mean,,,95% CI,796,2052.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,311,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,mean concentration,,,469.8,ng/ml,mean,,,95% CI,49.5,853.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,312,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,mean concentration,,,919,ng/ml,mean,,,95% CI,547.7,1290.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,313,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,minimum M/P ratio,,,179.5,%,mean,,,95% CI,142.6,216.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,314,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,maximum M/P ratio,,,423.7,%,mean,,,95% CI,49.5,798,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,315,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,mean M/P ratio,,,275.3,%,mean,,,95% CI,144.8,405.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,316,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,estimated theoretical daily dose,,,0.208,mg/kg/d,mean,,,95% CI,0.143,0.274,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,317,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,estimated relative daily dose,,,8.1,%,mean,,,95% CI,6.3,9.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,318,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,6.0,estimated theoretical daily dose,,,0.192,mg/kg/d,mean,,,95% CI,0.106,0.278,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,319,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,6.0,estimated relative daily dose,,,6.9,%,mean,,,95% CI,1.6,12.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,320,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,Venlafaxine,plasma,pediatric,,infants,6.0,concentration,,,2.5,ng/ml,mean,,,95% CI,1.2,3.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,321,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,pediatric,,infants,6.0,concentration,,,58.7,ng/ml,mean,,,95% CI,-39.3,156.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,322,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal,lacation,,6.0,concentration,,,71.6,ng/ml,mean,,,95% CI,11.3,132,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,323,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal,lacation,,6.0,concentration,,,245.6,ng/ml,mean,,,95% CI,64.7,426.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,324,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,6.2,%,mean,,,95% CI,-1.2,13.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,325,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,58,%,mean,,,95% CI,-47.9,164,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,326,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,37.1,%,mean,,,95% CI,-18.9,93,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,327,2025-12-02T16:05:09.448543
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal,lacation,,11.0,concentration,,,308.2,ng/ml,mean,,,95% CI,-177.7,794.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,306,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal,lacation,,11.0,concentration,,,232.8,ng/ml,mean,,,95% CI,150.1,315.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,307,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,minimum concentration,,,262.7,ng/ml,mean,,,95% CI,-6.3,531.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,308,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,minimum concentration,,,584,ng/ml,mean,,,95% CI,311.6,856.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,309,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,maximum concentration,,,803.9,ng/ml,mean,,,95% CI,194.1,1413.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,310,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,maximum concentration,,,1424.2,ng/ml,mean,,,95% CI,796,2052.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,311,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,mean concentration,,,469.8,ng/ml,mean,,,95% CI,49.5,853.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,312,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,mean concentration,,,919,ng/ml,mean,,,95% CI,547.7,1290.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,313,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,minimum M/P ratio,,,179.5,%,mean,,,95% CI,142.6,216.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,314,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,maximum M/P ratio,,,423.7,%,mean,,,95% CI,49.5,798,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,315,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,mean M/P ratio,,,275.3,%,mean,,,95% CI,144.8,405.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,316,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,estimated theoretical daily dose,,,0.208,mg/kg/d,mean,,,95% CI,0.143,0.274,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,317,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,estimated relative daily dose,,,8.1,%,mean,,,95% CI,6.3,9.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,318,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,6.0,estimated theoretical daily dose,,,0.192,mg/kg/d,mean,,,95% CI,0.106,0.278,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,319,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,6.0,estimated relative daily dose,,,6.9,%,mean,,,95% CI,1.6,12.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,320,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,Venlafaxine,plasma,pediatric,,infants,6.0,concentration,,,2.5,ng/ml,mean,,,95% CI,1.2,3.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,321,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,pediatric,,infants,6.0,concentration,,,58.7,ng/ml,mean,,,95% CI,-39.3,156.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,322,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal,lacation,,6.0,concentration,,,71.6,ng/ml,mean,,,95% CI,11.3,132,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,323,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal,lacation,,6.0,concentration,,,245.6,ng/ml,mean,,,95% CI,64.7,426.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,324,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,6.2,%,mean,,,95% CI,-1.2,13.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,325,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,58,%,mean,,,95% CI,-47.9,164,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,326,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,37.1,%,mean,,,95% CI,-18.9,93,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,327,2025-12-02T16:05:12.001940
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal,lacation,,11.0,concentration,,,308.2,ng/ml,mean,,,95% CI,-177.7,794.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,300,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal,lacation,,11.0,concentration,,,232.8,ng/ml,mean,,,95% CI,150.1,315.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,301,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,minimum concentration,,,262.7,ng/ml,mean,,,95% CI,-6.3,531.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,302,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,minimum concentration,,,584,ng/ml,mean,,,95% CI,311.6,856.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,303,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,maximum concentration,,,803.9,ng/ml,mean,,,95% CI,194.1,1413.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,304,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,maximum concentration,,,1424.2,ng/ml,mean,,,95% CI,796,2052.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,305,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,mean concentration,,,469.8,ng/ml,mean,,,95% CI,49.5,853.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,306,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,mean concentration,,,919,ng/ml,mean,,,95% CI,547.7,1290.2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,307,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,minimum M/P ratio,,,179.5,%,mean,,,95% CI,142.6,216.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,308,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,maximum M/P ratio,,,423.7,%,mean,,,95% CI,49.5,798,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,309,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,mean M/P ratio,,,275.3,%,mean,,,95% CI,144.8,405.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,310,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,estimated theoretical daily dose,,,0.208,mg/kg/d,mean,,,95% CI,0.143,0.274,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,311,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,estimated relative daily dose,,,8.1,%,mean,,,95% CI,6.3,9.9,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,312,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,6.0,estimated theoretical daily dose,,,0.192,mg/kg/d,mean,,,95% CI,0.106,0.278,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,313,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,6.0,estimated relative daily dose,,,6.9,%,mean,,,95% CI,1.6,12.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,314,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,Venlafaxine,plasma,pediatric,,infants,6.0,concentration,,,2.5,ng/ml,mean,,,95% CI,1.2,3.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,315,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,pediatric,,infants,6.0,concentration,,,58.7,ng/ml,mean,,,95% CI,-39.3,156.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,316,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal,lacation,,6.0,concentration,,,71.6,ng/ml,mean,,,95% CI,11.3,132,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,317,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal,lacation,,6.0,concentration,,,245.6,ng/ml,mean,,,95% CI,64.7,426.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,318,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,6.2,%,mean,,,95% CI,-1.2,13.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,319,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,58,%,mean,,,95% CI,-47.9,164,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,320,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,37.1,%,mean,,,95% CI,-18.9,93,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,321,2025-12-02T16:05:15.923463
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal,lacation,,11.0,concentration,,,308.2,ng/ml,mean,,,95% CI,-177.7,794.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,300,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal,lacation,,11.0,concentration,,,232.8,ng/ml,mean,,,95% CI,150.1,315.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,301,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,minimum concentration,,,262.7,ng/ml,mean,,,95% CI,-6.3,531.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,302,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,minimum concentration,,,584,ng/ml,mean,,,95% CI,311.6,856.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,303,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,maximum concentration,,,803.9,ng/ml,mean,,,95% CI,194.1,1413.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,304,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,maximum concentration,,,1424.2,ng/ml,mean,,,95% CI,796,2052.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,305,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,Venlafaxine,breast milk,maternal,lacation,,11.0,mean concentration,,,469.8,ng/ml,mean,,,95% CI,49.5,853.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,306,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,mean concentration,,,919,ng/ml,mean,,,95% CI,547.7,1290.2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,307,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,minimum M/P ratio,,,179.5,%,mean,,,95% CI,142.6,216.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,308,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,maximum M/P ratio,,,423.7,%,mean,,,95% CI,49.5,798,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,309,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk/plasma,maternal,lacation,,11.0,mean M/P ratio,,,275.3,%,mean,,,95% CI,144.8,405.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,310,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,estimated theoretical daily dose,,,0.208,mg/kg/d,mean,,,95% CI,0.143,0.274,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,311,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,11.0,estimated relative daily dose,,,8.1,%,mean,,,95% CI,6.3,9.9,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,312,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,6.0,estimated theoretical daily dose,,,0.192,mg/kg/d,mean,,,95% CI,0.106,0.278,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,313,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,breast milk,maternal,lacation,,6.0,estimated relative daily dose,,,6.9,%,mean,,,95% CI,1.6,12.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,314,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,Venlafaxine,plasma,pediatric,,infants,6.0,concentration,,,2.5,ng/ml,mean,,,95% CI,1.2,3.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,315,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,pediatric,,infants,6.0,concentration,,,58.7,ng/ml,mean,,,95% CI,-39.3,156.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,316,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal,lacation,,6.0,concentration,,,71.6,ng/ml,mean,,,95% CI,11.3,132,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,317,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal,lacation,,6.0,concentration,,,245.6,ng/ml,mean,,,95% CI,64.7,426.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,318,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,Venlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,6.2,%,mean,,,95% CI,-1.2,13.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,319,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,desmethylvenlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,58,%,mean,,,95% CI,-47.9,164,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,320,2025-12-02T16:05:22.346295
19607765.0,Venlafaxine,venlafaxine+desmethylvenlafaxine,plasma,maternal/pediatric,lacation,infants,6.0,infant-maternal plasma ratio,,,37.1,%,mean,,,95% CI,-18.9,93,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,321,2025-12-02T16:05:22.346295
16390902.0,Venlafaxine,Venlafaxine,serum,maternal,pregnancy,,3.0,concentration,,,50,ng/ml,mean,SD,16.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,328,2025-12-02T16:05:09.448543
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,pregnancy,,3.0,concentration,,,270.7,ng/ml,mean,SD,126.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,329,2025-12-02T16:05:09.448543
16390902.0,Venlafaxine,Venlafaxine,amniotic fluid,maternal,delivery,,4.0,concentration,,,71.5,ng/ml,mean,SD,68.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,330,2025-12-02T16:05:09.448543
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,amniotic fluid,maternal,delivery,,4.0,concentration,,,661.5,ng/ml,mean,SD,673.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,331,2025-12-02T16:05:09.448543
16390902.0,Venlafaxine,Venlafaxine,amniotic fluid/serum,maternal,,,3.0,amniotic fluid as a percentage of maternal serum,,,172.7,,mean,SD,91.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,332,2025-12-02T16:05:09.448543
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,amniotic fluid/serum,maternal,,,3.0,amniotic fluid as a percentage of maternal serum,,,299.8,,mean,SD,229.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,333,2025-12-02T16:05:09.448543
16390902.0,Venlafaxine,Venlafaxine,serum,maternal,pregnancy,,3.0,concentration,,,50,ng/ml,mean,SD,16.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,328,2025-12-02T16:05:12.001940
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,pregnancy,,3.0,concentration,,,270.7,ng/ml,mean,SD,126.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,329,2025-12-02T16:05:12.001940
16390902.0,Venlafaxine,Venlafaxine,amniotic fluid,maternal,delivery,,4.0,concentration,,,71.5,ng/ml,mean,SD,68.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,330,2025-12-02T16:05:12.001940
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,amniotic fluid,maternal,delivery,,4.0,concentration,,,661.5,ng/ml,mean,SD,673.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,331,2025-12-02T16:05:12.001940
16390902.0,Venlafaxine,Venlafaxine,amniotic fluid/serum,maternal,,,3.0,amniotic fluid as a percentage of maternal serum,,,172.7,,mean,SD,91.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,332,2025-12-02T16:05:12.001940
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,amniotic fluid/serum,maternal,,,3.0,amniotic fluid as a percentage of maternal serum,,,299.8,,mean,SD,229.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,333,2025-12-02T16:05:12.001940
16390902.0,Venlafaxine,Venlafaxine,serum,maternal,pregnancy,,3.0,concentration,,,50,ng/ml,mean,SD,16.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,322,2025-12-02T16:05:15.923463
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,pregnancy,,3.0,concentration,,,270.7,ng/ml,mean,SD,126.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,323,2025-12-02T16:05:15.923463
16390902.0,Venlafaxine,Venlafaxine,amniotic fluid,maternal,delivery,,4.0,concentration,,,71.5,ng/ml,mean,SD,68.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,324,2025-12-02T16:05:15.923463
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,amniotic fluid,maternal,delivery,,4.0,concentration,,,661.5,ng/ml,mean,SD,673.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,325,2025-12-02T16:05:15.923463
16390902.0,Venlafaxine,Venlafaxine,amniotic fluid/serum,maternal,,,3.0,amniotic fluid as a percentage of maternal serum,,,172.7,,mean,SD,91.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,326,2025-12-02T16:05:15.923463
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,amniotic fluid/serum,maternal,,,3.0,amniotic fluid as a percentage of maternal serum,,,299.8,,mean,SD,229.9,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,327,2025-12-02T16:05:15.923463
16390902.0,Venlafaxine,Venlafaxine,serum,maternal,pregnancy,,3.0,concentration,,,50,ng/ml,mean,SD,16.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,322,2025-12-02T16:05:22.346295
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,serum,maternal,pregnancy,,3.0,concentration,,,270.7,ng/ml,mean,SD,126.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,323,2025-12-02T16:05:22.346295
16390902.0,Venlafaxine,Venlafaxine,amniotic fluid,maternal,delivery,,4.0,concentration,,,71.5,ng/ml,mean,SD,68.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,324,2025-12-02T16:05:22.346295
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,amniotic fluid,maternal,delivery,,4.0,concentration,,,661.5,ng/ml,mean,SD,673.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,325,2025-12-02T16:05:22.346295
16390902.0,Venlafaxine,Venlafaxine,amniotic fluid/serum,maternal,,,3.0,amniotic fluid as a percentage of maternal serum,,,172.7,,mean,SD,91.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,326,2025-12-02T16:05:22.346295
16390902.0,Venlafaxine,O-Desmethylvenlafaxine,amniotic fluid/serum,maternal,,,3.0,amniotic fluid as a percentage of maternal serum,,,299.8,,mean,SD,229.9,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,327,2025-12-02T16:05:22.346295
19455083.0,Venlafaxine,Venlafaxine,plasma,pediatric,,neonate,3.0,elimination half-life,,,,h,,,,minmax,12,15,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,370,2025-12-02T16:05:09.448543
19455083.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,neonate,3.0,elimination half-life,,,,h,,,,minmax,10,37,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,371,2025-12-02T16:05:09.448543
19455083.0,Venlafaxine,Venlafaxine,plasma,pediatric,,neonate,3.0,elimination half-life,,,,h,,,,minmax,12,15,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,370,2025-12-02T16:05:12.001940
19455083.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,neonate,3.0,elimination half-life,,,,h,,,,minmax,10,37,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,371,2025-12-02T16:05:12.001940
19455083.0,Venlafaxine,Venlafaxine,plasma,pediatric,,neonate,3.0,elimination half-life,,,,h,,,,minmax,12,15,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,364,2025-12-02T16:05:15.923463
19455083.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,neonate,3.0,elimination half-life,,,,h,,,,minmax,10,37,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,365,2025-12-02T16:05:15.923463
19455083.0,Venlafaxine,Venlafaxine,plasma,pediatric,,neonate,3.0,elimination half-life,,,,h,,,,minmax,12,15,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,364,2025-12-02T16:05:22.346295
19455083.0,Venlafaxine,O-Desmethylvenlafaxine,plasma,pediatric,,neonate,3.0,elimination half-life,,,,h,,,,minmax,10,37,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,365,2025-12-02T16:05:22.346295
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,AUC0-24h,,,13543,ug h/L,mean,,,95% CI,8401,18654,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,380,2025-12-02T16:05:09.448543
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Cavg,24,h,564,ug/kg/day,mean,,,95% CI,351,777,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,381,2025-12-02T16:05:09.448543
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Cmax,,,785,ug/L,mean,,,95% CI,535,938,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,382,2025-12-02T16:05:09.448543
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Tmax,,,3.28,h,mean,,,95% CI,2.44,3.79,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,383,2025-12-02T16:05:09.448543
20960017.0,desvenlafaxine ,desvenlafaxine ,plasma,maternal,lacation,,10.0,concentration,6.37,h,309,ug/L,mean,,,95% CI,194,424,,at about 67 h after dosing ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,384,2025-12-02T16:05:09.448543
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,theoretic infant dose,,,85,ug/kg/day,mean,,,95% CI,53,117,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,385,2025-12-02T16:05:09.448543
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,relative infant dose,,,6.8,%,mean,,,95% CI,5.5,81,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,386,2025-12-02T16:05:09.448543
20960017.0,desvenlafaxine ,desvenlafaxine ,plasma,pediatric,,infant,10.0,concentration,6.5,h,16,ug/L,mean,,,95% CI,8,23,,at about 67 h after dosing ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,387,2025-12-02T16:05:09.448543
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,estimated infant exposure,,,4.8,%,mean,,,95% CI,3.5,6.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,388,2025-12-02T16:05:09.448543
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,AUC0-24h,,,13543,ug h/L,mean,,,95% CI,8401,18654,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,380,2025-12-02T16:05:12.001940
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Cavg,24,h,564,ug/kg/day,mean,,,95% CI,351,777,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,381,2025-12-02T16:05:12.001940
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Cmax,,,785,ug/L,mean,,,95% CI,535,938,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,382,2025-12-02T16:05:12.001940
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Tmax,,,3.28,h,mean,,,95% CI,2.44,3.79,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,383,2025-12-02T16:05:12.001940
20960017.0,desvenlafaxine ,desvenlafaxine ,plasma,maternal,lacation,,10.0,concentration,6.37,h,309,ug/L,mean,,,95% CI,194,424,,at about 67 h after dosing ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,384,2025-12-02T16:05:12.001940
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,theoretic infant dose,,,85,ug/kg/day,mean,,,95% CI,53,117,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,385,2025-12-02T16:05:12.001940
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,relative infant dose,,,6.8,%,mean,,,95% CI,5.5,81,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,386,2025-12-02T16:05:12.001940
20960017.0,desvenlafaxine ,desvenlafaxine ,plasma,pediatric,,infant,10.0,concentration,6.5,h,16,ug/L,mean,,,95% CI,8,23,,at about 67 h after dosing ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,387,2025-12-02T16:05:12.001940
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,estimated infant exposure,,,4.8,%,mean,,,95% CI,3.5,6.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,388,2025-12-02T16:05:12.001940
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,AUC0-24h,,,13543,ug h/L,mean,,,95% CI,8401,18654,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,374,2025-12-02T16:05:15.923463
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Cavg,24,h,564,ug/kg/day,mean,,,95% CI,351,777,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,375,2025-12-02T16:05:15.923463
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Cmax,,,785,ug/L,mean,,,95% CI,535,938,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,376,2025-12-02T16:05:15.923463
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Tmax,,,3.28,h,mean,,,95% CI,2.44,3.79,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,377,2025-12-02T16:05:15.923463
20960017.0,desvenlafaxine ,desvenlafaxine ,plasma,maternal,lacation,,10.0,concentration,6.37,h,309,ug/L,mean,,,95% CI,194,424,,at about 67 h after dosing ,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,378,2025-12-02T16:05:15.923463
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,theoretic infant dose,,,85,ug/kg/day,mean,,,95% CI,53,117,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,379,2025-12-02T16:05:15.923463
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,relative infant dose,,,6.8,%,mean,,,95% CI,5.5,81,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,380,2025-12-02T16:05:15.923463
20960017.0,desvenlafaxine ,desvenlafaxine ,plasma,pediatric,,infant,10.0,concentration,6.5,h,16,ug/L,mean,,,95% CI,8,23,,at about 67 h after dosing ,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,381,2025-12-02T16:05:15.923463
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,estimated infant exposure,,,4.8,%,mean,,,95% CI,3.5,6.2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,382,2025-12-02T16:05:15.923463
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,AUC0-24h,,,13543,ug h/L,mean,,,95% CI,8401,18654,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,374,2025-12-02T16:05:22.346295
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Cavg,24,h,564,ug/kg/day,mean,,,95% CI,351,777,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,375,2025-12-02T16:05:22.346295
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Cmax,,,785,ug/L,mean,,,95% CI,535,938,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,376,2025-12-02T16:05:22.346295
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,Tmax,,,3.28,h,mean,,,95% CI,2.44,3.79,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,377,2025-12-02T16:05:22.346295
20960017.0,desvenlafaxine ,desvenlafaxine ,plasma,maternal,lacation,,10.0,concentration,6.37,h,309,ug/L,mean,,,95% CI,194,424,,at about 67 h after dosing ,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,378,2025-12-02T16:05:22.346295
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,theoretic infant dose,,,85,ug/kg/day,mean,,,95% CI,53,117,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,379,2025-12-02T16:05:22.346295
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,relative infant dose,,,6.8,%,mean,,,95% CI,5.5,81,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,380,2025-12-02T16:05:22.346295
20960017.0,desvenlafaxine ,desvenlafaxine ,plasma,pediatric,,infant,10.0,concentration,6.5,h,16,ug/L,mean,,,95% CI,8,23,,at about 67 h after dosing ,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,381,2025-12-02T16:05:22.346295
20960017.0,desvenlafaxine ,desvenlafaxine ,breast milk,maternal,lacation,,10.0,estimated infant exposure,,,4.8,%,mean,,,95% CI,3.5,6.2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,382,2025-12-02T16:05:22.346295
31371035.0,Venlafaxine,Venlafaxine,plasma,maternal,delivery,,3.0,concentration,,,151.9,ng/ml,mean,SD,65.736,,,,,at the time of delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,429,2025-12-02T16:05:09.448543
31371035.0,sertraline,sertraline,plasma,maternal,delivery,,20.0,concentration,,,18.185,ng/ml,mean,SD,19.496,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,430,2025-12-02T16:05:09.448543
31371035.0,paroxetine,paroxetine,plasma,maternal,delivery,,11.0,concentration,,,11.809,ng/ml,mean,SD,13.479,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,431,2025-12-02T16:05:09.448543
31371035.0,fluoxetine,fluoxetine,plasma,maternal,delivery,,2.0,concentration,,,181.9,ng/ml,mean,SD,49.356,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,432,2025-12-02T16:05:09.448543
31371035.0,Citalopram,Citalopram,plasma,maternal,delivery,,1.0,concentration,,,<5,ng/ml,mean,SD,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,433,2025-12-02T16:05:09.448543
31371035.0,Venlafaxine,Venlafaxine,plasma,maternal,delivery,,3.0,concentration,,,151.9,ng/ml,mean,SD,65.736,,,,,at the time of delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,429,2025-12-02T16:05:12.001940
31371035.0,sertraline,sertraline,plasma,maternal,delivery,,20.0,concentration,,,18.185,ng/ml,mean,SD,19.496,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,430,2025-12-02T16:05:12.001940
31371035.0,paroxetine,paroxetine,plasma,maternal,delivery,,11.0,concentration,,,11.809,ng/ml,mean,SD,13.479,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,431,2025-12-02T16:05:12.001940
31371035.0,fluoxetine,fluoxetine,plasma,maternal,delivery,,2.0,concentration,,,181.9,ng/ml,mean,SD,49.356,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,432,2025-12-02T16:05:12.001940
31371035.0,Citalopram,Citalopram,plasma,maternal,delivery,,1.0,concentration,,,<5,ng/ml,mean,SD,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,433,2025-12-02T16:05:12.001940
31371035.0,Venlafaxine,Venlafaxine,plasma,maternal,delivery,,3.0,concentration,,,151.9,ng/ml,mean,SD,65.736,,,,,at the time of delivery,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,423,2025-12-02T16:05:15.923463
31371035.0,sertraline,sertraline,plasma,maternal,delivery,,20.0,concentration,,,18.185,ng/ml,mean,SD,19.496,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,424,2025-12-02T16:05:15.923463
31371035.0,paroxetine,paroxetine,plasma,maternal,delivery,,11.0,concentration,,,11.809,ng/ml,mean,SD,13.479,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,425,2025-12-02T16:05:15.923463
31371035.0,fluoxetine,fluoxetine,plasma,maternal,delivery,,2.0,concentration,,,181.9,ng/ml,mean,SD,49.356,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,426,2025-12-02T16:05:15.923463
31371035.0,Citalopram,Citalopram,plasma,maternal,delivery,,1.0,concentration,,,<5,ng/ml,mean,SD,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,427,2025-12-02T16:05:15.923463
31371035.0,Venlafaxine,Venlafaxine,plasma,maternal,delivery,,3.0,concentration,,,151.9,ng/ml,mean,SD,65.736,,,,,at the time of delivery,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,423,2025-12-02T16:05:22.346295
31371035.0,sertraline,sertraline,plasma,maternal,delivery,,20.0,concentration,,,18.185,ng/ml,mean,SD,19.496,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,424,2025-12-02T16:05:22.346295
31371035.0,paroxetine,paroxetine,plasma,maternal,delivery,,11.0,concentration,,,11.809,ng/ml,mean,SD,13.479,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,425,2025-12-02T16:05:22.346295
31371035.0,fluoxetine,fluoxetine,plasma,maternal,delivery,,2.0,concentration,,,181.9,ng/ml,mean,SD,49.356,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,426,2025-12-02T16:05:22.346295
31371035.0,Citalopram,Citalopram,plasma,maternal,delivery,,1.0,concentration,,,<5,ng/ml,mean,SD,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,427,2025-12-02T16:05:22.346295
32153014.0,Infliximab,Infliximab,plasma,maternal,delivery,,3.0,placenta-to-maternal ratio,,,0.28,,mean,SD,0.11,,,,,at the time of delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,434,2025-12-02T16:05:09.448543
32153014.0,Infliximab,Infliximab,plasma,maternal,delivery,,3.0,placenta-to-maternal ratio,,,0.28,,mean,SD,0.11,,,,,at the time of delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,434,2025-12-02T16:05:12.001940
32153014.0,Infliximab,Infliximab,plasma,maternal,delivery,,3.0,placenta-to-maternal ratio,,,0.28,,mean,SD,0.11,,,,,at the time of delivery,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,428,2025-12-02T16:05:15.923463
32153014.0,Infliximab,Infliximab,plasma,maternal,delivery,,3.0,placenta-to-maternal ratio,,,0.28,,mean,SD,0.11,,,,,at the time of delivery,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,428,2025-12-02T16:05:22.346295
23834232.0,Infliximab,Infliximab,serum,maternal,delivery,,8.0,concentration,,,4.1,ug/ml,mean,,,minmax,0,18,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,435,2025-12-02T16:05:09.448543
23834232.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,11.0,concentration,,,11.1,ug/ml,mean,,,minmax,0.5,25,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,436,2025-12-02T16:05:09.448543
23834232.0,Infliximab,Infliximab,cord blood/maternal serum,maternal/pediatric,delivery,fetus,,raio of cord to maternal IFX levels,,,3.8,,mean,,,minmax,0.9,10.7,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,437,2025-12-02T16:05:09.448543
23834232.0,Infliximab,Infliximab,serum,maternal,delivery,,8.0,concentration,,,4.1,ug/ml,mean,,,minmax,0,18,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,435,2025-12-02T16:05:12.001940
23834232.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,11.0,concentration,,,11.1,ug/ml,mean,,,minmax,0.5,25,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,436,2025-12-02T16:05:12.001940
23834232.0,Infliximab,Infliximab,cord blood/maternal serum,maternal/pediatric,delivery,fetus,,raio of cord to maternal IFX levels,,,3.8,,mean,,,minmax,0.9,10.7,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,437,2025-12-02T16:05:12.001940
23834232.0,Infliximab,Infliximab,serum,maternal,delivery,,8.0,concentration,,,4.1,ug/ml,mean,,,minmax,0,18,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,429,2025-12-02T16:05:15.923463
23834232.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,11.0,concentration,,,11.1,ug/ml,mean,,,minmax,0.5,25,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,430,2025-12-02T16:05:15.923463
23834232.0,Infliximab,Infliximab,cord blood/maternal serum,maternal/pediatric,delivery,fetus,,raio of cord to maternal IFX levels,,,3.8,,mean,,,minmax,0.9,10.7,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,431,2025-12-02T16:05:15.923463
23834232.0,Infliximab,Infliximab,serum,maternal,delivery,,8.0,concentration,,,4.1,ug/ml,mean,,,minmax,0,18,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,429,2025-12-02T16:05:22.346295
23834232.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,11.0,concentration,,,11.1,ug/ml,mean,,,minmax,0.5,25,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,430,2025-12-02T16:05:22.346295
23834232.0,Infliximab,Infliximab,cord blood/maternal serum,maternal/pediatric,delivery,fetus,,raio of cord to maternal IFX levels,,,3.8,,mean,,,minmax,0.9,10.7,,After a mean time of 75 days (range 28103) between the last administration of IFX and childbirth,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,431,2025-12-02T16:05:22.346295
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,12.0,concentration,,,6.4,ug/ml,mean,SEM,1.6,,,,,Overall,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,438,2025-12-02T16:05:09.448543
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,6.0,concentration,,,2.8,ug/ml,mean,SEM,1.1,,,,0.02,early discontinuation group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,439,2025-12-02T16:05:09.448543
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,6.0,concentration,,,10,ug/ml,mean,SEM,2.3,,,,0.02,the group with 10 or less weeks from the last infusion to delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,440,2025-12-02T16:05:09.448543
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,12.0,concentration,,,6.4,ug/ml,mean,SEM,1.6,,,,,Overall,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,438,2025-12-02T16:05:12.001940
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,6.0,concentration,,,2.8,ug/ml,mean,SEM,1.1,,,,0.02,early discontinuation group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,439,2025-12-02T16:05:12.001940
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,6.0,concentration,,,10,ug/ml,mean,SEM,2.3,,,,0.02,the group with 10 or less weeks from the last infusion to delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,440,2025-12-02T16:05:12.001940
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,12.0,concentration,,,6.4,ug/ml,mean,SEM,1.6,,,,,Overall,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,432,2025-12-02T16:05:15.923463
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,6.0,concentration,,,2.8,ug/ml,mean,SEM,1.1,,,,0.02,early discontinuation group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,433,2025-12-02T16:05:15.923463
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,6.0,concentration,,,10,ug/ml,mean,SEM,2.3,,,,0.02,the group with 10 or less weeks from the last infusion to delivery,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,434,2025-12-02T16:05:15.923463
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,12.0,concentration,,,6.4,ug/ml,mean,SEM,1.6,,,,,Overall,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,432,2025-12-02T16:05:22.346295
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,6.0,concentration,,,2.8,ug/ml,mean,SEM,1.1,,,,0.02,early discontinuation group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,433,2025-12-02T16:05:22.346295
23103819.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,6.0,concentration,,,10,ug/ml,mean,SEM,2.3,,,,0.02,the group with 10 or less weeks from the last infusion to delivery,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,434,2025-12-02T16:05:22.346295
23200982.0,Infliximab,Infliximab,cord blood/maternal serum,maternal,delivery,,9.0,ratio cord/maternal,,,160,%,median,,,minmax,87,400,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,441,2025-12-02T16:05:09.448543
23200982.0,Infliximab,Infliximab,plasma,pediatric,,neonate,11.0,concentration,,,,ug/ml,median,,,minmax,2.9,39.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,442,2025-12-02T16:05:09.448543
23200982.0,Infliximab,Infliximab,cord blood/maternal serum,maternal,delivery,,9.0,ratio cord/maternal,,,160,%,median,,,minmax,87,400,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,441,2025-12-02T16:05:12.001940
23200982.0,Infliximab,Infliximab,plasma,pediatric,,neonate,11.0,concentration,,,,ug/ml,median,,,minmax,2.9,39.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,442,2025-12-02T16:05:12.001940
23200982.0,Infliximab,Infliximab,cord blood/maternal serum,maternal,delivery,,9.0,ratio cord/maternal,,,160,%,median,,,minmax,87,400,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,435,2025-12-02T16:05:15.923463
23200982.0,Infliximab,Infliximab,plasma,pediatric,,neonate,11.0,concentration,,,,ug/ml,median,,,minmax,2.9,39.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,436,2025-12-02T16:05:15.923463
23200982.0,Infliximab,Infliximab,cord blood/maternal serum,maternal,delivery,,9.0,ratio cord/maternal,,,160,%,median,,,minmax,87,400,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,435,2025-12-02T16:05:22.346295
23200982.0,Infliximab,Infliximab,plasma,pediatric,,neonate,11.0,concentration,,,,ug/ml,median,,,minmax,2.9,39.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,436,2025-12-02T16:05:22.346295
29771301.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,52.0,concentration,,,4.9,ug/ml,median,,,IQR,1.9,14.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,443,2025-12-02T16:05:09.448543
29771301.0,Infliximab,Infliximab,blood,maternal,delivery,,52.0,concentration,,,1.7,ug/ml,median,,,IQR,0.4,6.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,444,2025-12-02T16:05:09.448543
29771301.0,Infliximab,Infliximab,cord blood/maternal blood,maternal/pediatric,delivery,fetus,52.0,ratio cord blood level/maternal level,,,2.63,,median,,,IQR,1.67,4.03,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,445,2025-12-02T16:05:09.448543
29771301.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,52.0,concentration,,,4.9,ug/ml,median,,,IQR,1.9,14.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,443,2025-12-02T16:05:12.001940
29771301.0,Infliximab,Infliximab,blood,maternal,delivery,,52.0,concentration,,,1.7,ug/ml,median,,,IQR,0.4,6.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,444,2025-12-02T16:05:12.001940
29771301.0,Infliximab,Infliximab,cord blood/maternal blood,maternal/pediatric,delivery,fetus,52.0,ratio cord blood level/maternal level,,,2.63,,median,,,IQR,1.67,4.03,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,445,2025-12-02T16:05:12.001940
29771301.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,52.0,concentration,,,4.9,ug/ml,median,,,IQR,1.9,14.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,437,2025-12-02T16:05:15.923463
29771301.0,Infliximab,Infliximab,blood,maternal,delivery,,52.0,concentration,,,1.7,ug/ml,median,,,IQR,0.4,6.9,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,438,2025-12-02T16:05:15.923463
29771301.0,Infliximab,Infliximab,cord blood/maternal blood,maternal/pediatric,delivery,fetus,52.0,ratio cord blood level/maternal level,,,2.63,,median,,,IQR,1.67,4.03,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,439,2025-12-02T16:05:15.923463
29771301.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,52.0,concentration,,,4.9,ug/ml,median,,,IQR,1.9,14.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,437,2025-12-02T16:05:22.346295
29771301.0,Infliximab,Infliximab,blood,maternal,delivery,,52.0,concentration,,,1.7,ug/ml,median,,,IQR,0.4,6.9,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,438,2025-12-02T16:05:22.346295
29771301.0,Infliximab,Infliximab,cord blood/maternal blood,maternal/pediatric,delivery,fetus,52.0,ratio cord blood level/maternal level,,,2.63,,median,,,IQR,1.67,4.03,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,439,2025-12-02T16:05:22.346295
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,19.0,peak concentration,,,0.74,ug/ml,mean,,,minmax,0.15,0.74,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,446,2025-12-02T16:05:09.448543
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,19.0,peak time range,,,,hr,,,,minmax,24,48,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,447,2025-12-02T16:05:09.448543
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,17.0,peak concentration,48,hr,0.2,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,448,2025-12-02T16:05:09.448543
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,19.0,peak concentration,,,0.74,ug/ml,mean,,,minmax,0.15,0.74,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,446,2025-12-02T16:05:12.001940
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,19.0,peak time range,,,,hr,,,,minmax,24,48,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,447,2025-12-02T16:05:12.001940
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,17.0,peak concentration,48,hr,0.2,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,448,2025-12-02T16:05:12.001940
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,19.0,peak concentration,,,0.74,ug/ml,mean,,,minmax,0.15,0.74,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,440,2025-12-02T16:05:15.923463
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,19.0,peak time range,,,,hr,,,,minmax,24,48,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,441,2025-12-02T16:05:15.923463
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,17.0,peak concentration,48,hr,0.2,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,442,2025-12-02T16:05:15.923463
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,19.0,peak concentration,,,0.74,ug/ml,mean,,,minmax,0.15,0.74,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,440,2025-12-02T16:05:22.346295
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,19.0,peak time range,,,,hr,,,,minmax,24,48,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,441,2025-12-02T16:05:22.346295
29857090.0,Infliximab,Infliximab,breast milk,maternal,lacation,,17.0,peak concentration,48,hr,0.2,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,442,2025-12-02T16:05:22.346295
32981127.0,Infliximab,Infliximab,serum,maternal,pre-pregnancy,,6.0,concentration,,,7.9,ug/ml,median,,,IQR,6.3,11,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,449,2025-12-02T16:05:09.448543
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 1,,15.0,concentration,,,8.8,ug/ml,median,,,IQR,5.5,12.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,450,2025-12-02T16:05:09.448543
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 2,,30.0,concentration,,,10,ug/ml,median,,,IQR,7.1,13.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,451,2025-12-02T16:05:09.448543
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 3,,20.0,concentration,,,11,ug/ml,median,,,IQR,7.1,16.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,452,2025-12-02T16:05:09.448543
32981127.0,Infliximab,Infliximab,serum,maternal,delivery,,8.0,concentration,,,11.2,ug/ml,median,,,IQR,8.4,15.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,453,2025-12-02T16:05:09.448543
32981127.0,Infliximab,Infliximab,serum,maternal,postpartum,,12.0,concentration,,,10.3,ug/ml,median,,,IQR,4.3,13.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,454,2025-12-02T16:05:09.448543
32981127.0,Infliximab,Infliximab,serum,maternal,pre-pregnancy,,6.0,concentration,,,7.9,ug/ml,median,,,IQR,6.3,11,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,449,2025-12-02T16:05:12.001940
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 1,,15.0,concentration,,,8.8,ug/ml,median,,,IQR,5.5,12.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,450,2025-12-02T16:05:12.001940
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 2,,30.0,concentration,,,10,ug/ml,median,,,IQR,7.1,13.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,451,2025-12-02T16:05:12.001940
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 3,,20.0,concentration,,,11,ug/ml,median,,,IQR,7.1,16.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,452,2025-12-02T16:05:12.001940
32981127.0,Infliximab,Infliximab,serum,maternal,delivery,,8.0,concentration,,,11.2,ug/ml,median,,,IQR,8.4,15.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,453,2025-12-02T16:05:12.001940
32981127.0,Infliximab,Infliximab,serum,maternal,postpartum,,12.0,concentration,,,10.3,ug/ml,median,,,IQR,4.3,13.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,454,2025-12-02T16:05:12.001940
32981127.0,Infliximab,Infliximab,serum,maternal,pre-pregnancy,,6.0,concentration,,,7.9,ug/ml,median,,,IQR,6.3,11,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,443,2025-12-02T16:05:15.923463
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 1,,15.0,concentration,,,8.8,ug/ml,median,,,IQR,5.5,12.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,444,2025-12-02T16:05:15.923463
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 2,,30.0,concentration,,,10,ug/ml,median,,,IQR,7.1,13.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,445,2025-12-02T16:05:15.923463
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 3,,20.0,concentration,,,11,ug/ml,median,,,IQR,7.1,16.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,446,2025-12-02T16:05:15.923463
32981127.0,Infliximab,Infliximab,serum,maternal,delivery,,8.0,concentration,,,11.2,ug/ml,median,,,IQR,8.4,15.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,447,2025-12-02T16:05:15.923463
32981127.0,Infliximab,Infliximab,serum,maternal,postpartum,,12.0,concentration,,,10.3,ug/ml,median,,,IQR,4.3,13.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,448,2025-12-02T16:05:15.923463
32981127.0,Infliximab,Infliximab,serum,maternal,pre-pregnancy,,6.0,concentration,,,7.9,ug/ml,median,,,IQR,6.3,11,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,443,2025-12-02T16:05:22.346295
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 1,,15.0,concentration,,,8.8,ug/ml,median,,,IQR,5.5,12.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,444,2025-12-02T16:05:22.346295
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 2,,30.0,concentration,,,10,ug/ml,median,,,IQR,7.1,13.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,445,2025-12-02T16:05:22.346295
32981127.0,Infliximab,Infliximab,serum,maternal,trmester 3,,20.0,concentration,,,11,ug/ml,median,,,IQR,7.1,16.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,446,2025-12-02T16:05:22.346295
32981127.0,Infliximab,Infliximab,serum,maternal,delivery,,8.0,concentration,,,11.2,ug/ml,median,,,IQR,8.4,15.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,447,2025-12-02T16:05:22.346295
32981127.0,Infliximab,Infliximab,serum,maternal,postpartum,,12.0,concentration,,,10.3,ug/ml,median,,,IQR,4.3,13.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,448,2025-12-02T16:05:22.346295
33079627.0,Infliximab,Infliximab,serum,maternal,second trimester,,20.0,dose-normalized concentration,,,15,mg/ml/kg,median,,,IQR,9.8,20.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,455,2025-12-02T16:05:09.448543
33079627.0,Infliximab,Infliximab,serum,maternal,pre-pregnancy,,23.0,dose-normalized concentration,,,7.3,mg/ml/kg,median,,,IQR,2,11.6,0.003,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,456,2025-12-02T16:05:09.448543
33079627.0,Infliximab,Infliximab,serum,maternal,first trimester,,23.0,dose-normalized concentration,,,8.5,mg/ml/kg,median,,,IQR,1.4,11.5,0.04,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,457,2025-12-02T16:05:09.448543
33079627.0,Infliximab,Infliximab,serum,maternal,postpartum,,12.0,dose-normalized concentration,,,5.9,mg/ml/kg,median,,,IQR,3.3,11.1,>0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,458,2025-12-02T16:05:09.448543
33079627.0,Infliximab,Infliximab,serum,maternal,third trimester,,7.0,dose-normalized concentration,,,13,mg/ml/kg,median,,,IQR,6.5,35.8,>0.05,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,459,2025-12-02T16:05:09.448543
33079627.0,Infliximab,Infliximab,serum,maternal,second trimester,,20.0,dose-normalized concentration,,,15,mg/ml/kg,median,,,IQR,9.8,20.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,455,2025-12-02T16:05:12.001940
33079627.0,Infliximab,Infliximab,serum,maternal,pre-pregnancy,,23.0,dose-normalized concentration,,,7.3,mg/ml/kg,median,,,IQR,2,11.6,0.003,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,456,2025-12-02T16:05:12.001940
33079627.0,Infliximab,Infliximab,serum,maternal,first trimester,,23.0,dose-normalized concentration,,,8.5,mg/ml/kg,median,,,IQR,1.4,11.5,0.04,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,457,2025-12-02T16:05:12.001940
33079627.0,Infliximab,Infliximab,serum,maternal,postpartum,,12.0,dose-normalized concentration,,,5.9,mg/ml/kg,median,,,IQR,3.3,11.1,>0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,458,2025-12-02T16:05:12.001940
33079627.0,Infliximab,Infliximab,serum,maternal,third trimester,,7.0,dose-normalized concentration,,,13,mg/ml/kg,median,,,IQR,6.5,35.8,>0.05,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,459,2025-12-02T16:05:12.001940
33079627.0,Infliximab,Infliximab,serum,maternal,second trimester,,20.0,dose-normalized concentration,,,15,mg/ml/kg,median,,,IQR,9.8,20.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,449,2025-12-02T16:05:15.923463
33079627.0,Infliximab,Infliximab,serum,maternal,pre-pregnancy,,23.0,dose-normalized concentration,,,7.3,mg/ml/kg,median,,,IQR,2,11.6,0.003,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,450,2025-12-02T16:05:15.923463
33079627.0,Infliximab,Infliximab,serum,maternal,first trimester,,23.0,dose-normalized concentration,,,8.5,mg/ml/kg,median,,,IQR,1.4,11.5,0.04,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,451,2025-12-02T16:05:15.923463
33079627.0,Infliximab,Infliximab,serum,maternal,postpartum,,12.0,dose-normalized concentration,,,5.9,mg/ml/kg,median,,,IQR,3.3,11.1,>0.05,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,452,2025-12-02T16:05:15.923463
33079627.0,Infliximab,Infliximab,serum,maternal,third trimester,,7.0,dose-normalized concentration,,,13,mg/ml/kg,median,,,IQR,6.5,35.8,>0.05,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,453,2025-12-02T16:05:15.923463
33079627.0,Infliximab,Infliximab,serum,maternal,second trimester,,20.0,dose-normalized concentration,,,15,mg/ml/kg,median,,,IQR,9.8,20.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,449,2025-12-02T16:05:22.346295
33079627.0,Infliximab,Infliximab,serum,maternal,pre-pregnancy,,23.0,dose-normalized concentration,,,7.3,mg/ml/kg,median,,,IQR,2,11.6,0.003,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,450,2025-12-02T16:05:22.346295
33079627.0,Infliximab,Infliximab,serum,maternal,first trimester,,23.0,dose-normalized concentration,,,8.5,mg/ml/kg,median,,,IQR,1.4,11.5,0.04,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,451,2025-12-02T16:05:22.346295
33079627.0,Infliximab,Infliximab,serum,maternal,postpartum,,12.0,dose-normalized concentration,,,5.9,mg/ml/kg,median,,,IQR,3.3,11.1,>0.05,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,452,2025-12-02T16:05:22.346295
33079627.0,Infliximab,Infliximab,serum,maternal,third trimester,,7.0,dose-normalized concentration,,,13,mg/ml/kg,median,,,IQR,6.5,35.8,>0.05,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,453,2025-12-02T16:05:22.346295
34493490.0,Infliximab,Infliximab,blood,maternal,first trimester,,14.0,concentration,,,14,ug/ml,median,,,IQR,8,21,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,460,2025-12-02T16:05:09.448543
34493490.0,Infliximab,Infliximab,blood,maternal,second trimester,,14.0,concentration,,,6.4,ug/ml,median,,,IQR,4.2,20,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,461,2025-12-02T16:05:09.448543
34493490.0,Infliximab,Infliximab,blood,maternal,third trimester,,14.0,concentration,,,1.4,ug/ml,median,,,IQR,0.1,1.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,462,2025-12-02T16:05:09.448543
34493490.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,8.0,concentration,,,0.4,ug/ml,median,,,IQR,0.1,1.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,463,2025-12-02T16:05:09.448543
34493490.0,Infliximab,Infliximab,cord blood/maternal blood,maternal/pediatric,first trimester,fetus,8.0,concentration ratio cord blood to maternal blood,,,0.012,,median,,,IQR,0.006,0.081,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,464,2025-12-02T16:05:09.448543
34493490.0,Infliximab,Infliximab,blood,maternal,first trimester,,14.0,concentration,,,14,ug/ml,median,,,IQR,8,21,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,460,2025-12-02T16:05:12.001940
34493490.0,Infliximab,Infliximab,blood,maternal,second trimester,,14.0,concentration,,,6.4,ug/ml,median,,,IQR,4.2,20,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,461,2025-12-02T16:05:12.001940
34493490.0,Infliximab,Infliximab,blood,maternal,third trimester,,14.0,concentration,,,1.4,ug/ml,median,,,IQR,0.1,1.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,462,2025-12-02T16:05:12.001940
34493490.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,8.0,concentration,,,0.4,ug/ml,median,,,IQR,0.1,1.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,463,2025-12-02T16:05:12.001940
34493490.0,Infliximab,Infliximab,cord blood/maternal blood,maternal/pediatric,first trimester,fetus,8.0,concentration ratio cord blood to maternal blood,,,0.012,,median,,,IQR,0.006,0.081,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,464,2025-12-02T16:05:12.001940
34493490.0,Infliximab,Infliximab,blood,maternal,first trimester,,14.0,concentration,,,14,ug/ml,median,,,IQR,8,21,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,454,2025-12-02T16:05:15.923463
34493490.0,Infliximab,Infliximab,blood,maternal,second trimester,,14.0,concentration,,,6.4,ug/ml,median,,,IQR,4.2,20,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,455,2025-12-02T16:05:15.923463
34493490.0,Infliximab,Infliximab,blood,maternal,third trimester,,14.0,concentration,,,1.4,ug/ml,median,,,IQR,0.1,1.9,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,456,2025-12-02T16:05:15.923463
34493490.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,8.0,concentration,,,0.4,ug/ml,median,,,IQR,0.1,1.2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,457,2025-12-02T16:05:15.923463
34493490.0,Infliximab,Infliximab,cord blood/maternal blood,maternal/pediatric,first trimester,fetus,8.0,concentration ratio cord blood to maternal blood,,,0.012,,median,,,IQR,0.006,0.081,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,458,2025-12-02T16:05:15.923463
34493490.0,Infliximab,Infliximab,blood,maternal,first trimester,,14.0,concentration,,,14,ug/ml,median,,,IQR,8,21,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,454,2025-12-02T16:05:22.346295
34493490.0,Infliximab,Infliximab,blood,maternal,second trimester,,14.0,concentration,,,6.4,ug/ml,median,,,IQR,4.2,20,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,455,2025-12-02T16:05:22.346295
34493490.0,Infliximab,Infliximab,blood,maternal,third trimester,,14.0,concentration,,,1.4,ug/ml,median,,,IQR,0.1,1.9,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,456,2025-12-02T16:05:22.346295
34493490.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,8.0,concentration,,,0.4,ug/ml,median,,,IQR,0.1,1.2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,457,2025-12-02T16:05:22.346295
34493490.0,Infliximab,Infliximab,cord blood/maternal blood,maternal/pediatric,first trimester,fetus,8.0,concentration ratio cord blood to maternal blood,,,0.012,,median,,,IQR,0.006,0.081,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,458,2025-12-02T16:05:22.346295
36120653.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,8.0,concentration,,,8.8,ug/ml,median,,,IQR,4.5,13.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,465,2025-12-02T16:05:09.448543
36120653.0,Infliximab,Infliximab,blood,maternal,delivery,,8.0,concentration,,,10.4,ug/ml,median,,,IQR,4.3,15.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,466,2025-12-02T16:05:09.448543
36120653.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,8.0,concentration,,,8.8,ug/ml,median,,,IQR,4.5,13.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,465,2025-12-02T16:05:12.001940
36120653.0,Infliximab,Infliximab,blood,maternal,delivery,,8.0,concentration,,,10.4,ug/ml,median,,,IQR,4.3,15.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,466,2025-12-02T16:05:12.001940
36120653.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,8.0,concentration,,,8.8,ug/ml,median,,,IQR,4.5,13.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,459,2025-12-02T16:05:15.923463
36120653.0,Infliximab,Infliximab,blood,maternal,delivery,,8.0,concentration,,,10.4,ug/ml,median,,,IQR,4.3,15.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,460,2025-12-02T16:05:15.923463
36120653.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,8.0,concentration,,,8.8,ug/ml,median,,,IQR,4.5,13.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,459,2025-12-02T16:05:22.346295
36120653.0,Infliximab,Infliximab,blood,maternal,delivery,,8.0,concentration,,,10.4,ug/ml,median,,,IQR,4.3,15.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,460,2025-12-02T16:05:22.346295
25966992.0,Infliximab,Infliximab,blood,materanl,delivery,,27.0,concentration,,,0.55,ug/ml,median,,,IQR,0.3,1.1,0.0001,Anti-TNF stop group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,467,2025-12-02T16:05:09.448543
25966992.0,Infliximab,Infliximab,blood,materanl,delivery,,21.0,concentration,,,6.19,ug/ml,median,,,IQR,4.75,10,0.0001,Anti-TNF continue group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,468,2025-12-02T16:05:09.448543
25966992.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,27.0,concentration,,,1.94,ug/ml,median,,,IQR,0.77,2.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,469,2025-12-02T16:05:09.448543
25966992.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,21.0,concentration,,,13.14,ug/ml,median,,,IQR,8.8,16.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,470,2025-12-02T16:05:09.448543
25966992.0,Infliximab,Infliximab,blood,materanl,delivery,,27.0,concentration,,,0.55,ug/ml,median,,,IQR,0.3,1.1,0.0001,Anti-TNF stop group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,467,2025-12-02T16:05:12.001940
25966992.0,Infliximab,Infliximab,blood,materanl,delivery,,21.0,concentration,,,6.19,ug/ml,median,,,IQR,4.75,10,0.0001,Anti-TNF continue group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,468,2025-12-02T16:05:12.001940
25966992.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,27.0,concentration,,,1.94,ug/ml,median,,,IQR,0.77,2.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,469,2025-12-02T16:05:12.001940
25966992.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,21.0,concentration,,,13.14,ug/ml,median,,,IQR,8.8,16.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,470,2025-12-02T16:05:12.001940
25966992.0,Infliximab,Infliximab,blood,materanl,delivery,,27.0,concentration,,,0.55,ug/ml,median,,,IQR,0.3,1.1,0.0001,Anti-TNF stop group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,461,2025-12-02T16:05:15.923463
25966992.0,Infliximab,Infliximab,blood,materanl,delivery,,21.0,concentration,,,6.19,ug/ml,median,,,IQR,4.75,10,0.0001,Anti-TNF continue group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,462,2025-12-02T16:05:15.923463
25966992.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,27.0,concentration,,,1.94,ug/ml,median,,,IQR,0.77,2.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,463,2025-12-02T16:05:15.923463
25966992.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,21.0,concentration,,,13.14,ug/ml,median,,,IQR,8.8,16.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,464,2025-12-02T16:05:15.923463
25966992.0,Infliximab,Infliximab,blood,materanl,delivery,,27.0,concentration,,,0.55,ug/ml,median,,,IQR,0.3,1.1,0.0001,Anti-TNF stop group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,461,2025-12-02T16:05:22.346295
25966992.0,Infliximab,Infliximab,blood,materanl,delivery,,21.0,concentration,,,6.19,ug/ml,median,,,IQR,4.75,10,0.0001,Anti-TNF continue group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,462,2025-12-02T16:05:22.346295
25966992.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,27.0,concentration,,,1.94,ug/ml,median,,,IQR,0.77,2.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,463,2025-12-02T16:05:22.346295
25966992.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,21.0,concentration,,,13.14,ug/ml,median,,,IQR,8.8,16.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,464,2025-12-02T16:05:22.346295
27063728.0,Infliximab,Infliximab,blood,materanl,delivery,,18.0,concentration,,,0.6,ug/ml,median,,,minmax,0,3.3,<0.0001,Last infusion < GW 30,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,471,2025-12-02T16:05:09.448543
27063728.0,Infliximab,Infliximab,blood,materanl,delivery,,26.0,concentration,,,4,ug/ml,median,,,minmax,0,22.2,<0.0001,Last infusion >= GW 30,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,472,2025-12-02T16:05:09.448543
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,18.0,concentration,,,2.2,ug/ml,median,,,minmax,0.1,8.9,<0.0001,Last infusion < GW 30,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,473,2025-12-02T16:05:09.448543
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,26.0,concentration,,,10,ug/ml,median,,,minmax,1.9,28.7,<0.0001,Last infusion >= GW 30,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,474,2025-12-02T16:05:09.448543
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,44.0,concentration,,,2,ug/ml,median,,,minmax,0,22.2,,all,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,475,2025-12-02T16:05:09.448543
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,44.0,concentration,,,5.9,ug/ml,median,,,minmax,0.12,28.7,,all,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,476,2025-12-02T16:05:09.448543
27063728.0,Infliximab,Infliximab,cord blood/maternal blood,materanl/pediatric,delivery,fetus,44.0,ratio of infant to materanl concentration,,,1.97,,median,,,95% CI,1.5,2.43,,all,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,477,2025-12-02T16:05:09.448543
27063728.0,Infliximab,Infliximab,blood,materanl,delivery,,18.0,concentration,,,0.6,ug/ml,median,,,minmax,0,3.3,<0.0001,Last infusion < GW 30,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,471,2025-12-02T16:05:12.001940
27063728.0,Infliximab,Infliximab,blood,materanl,delivery,,26.0,concentration,,,4,ug/ml,median,,,minmax,0,22.2,<0.0001,Last infusion >= GW 30,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,472,2025-12-02T16:05:12.001940
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,18.0,concentration,,,2.2,ug/ml,median,,,minmax,0.1,8.9,<0.0001,Last infusion < GW 30,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,473,2025-12-02T16:05:12.001940
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,26.0,concentration,,,10,ug/ml,median,,,minmax,1.9,28.7,<0.0001,Last infusion >= GW 30,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,474,2025-12-02T16:05:12.001940
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,44.0,concentration,,,2,ug/ml,median,,,minmax,0,22.2,,all,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,475,2025-12-02T16:05:12.001940
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,44.0,concentration,,,5.9,ug/ml,median,,,minmax,0.12,28.7,,all,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,476,2025-12-02T16:05:12.001940
27063728.0,Infliximab,Infliximab,cord blood/maternal blood,materanl/pediatric,delivery,fetus,44.0,ratio of infant to materanl concentration,,,1.97,,median,,,95% CI,1.5,2.43,,all,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,477,2025-12-02T16:05:12.001940
27063728.0,Infliximab,Infliximab,blood,materanl,delivery,,18.0,concentration,,,0.6,ug/ml,median,,,minmax,0,3.3,<0.0001,Last infusion < GW 30,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,465,2025-12-02T16:05:15.923463
27063728.0,Infliximab,Infliximab,blood,materanl,delivery,,26.0,concentration,,,4,ug/ml,median,,,minmax,0,22.2,<0.0001,Last infusion >= GW 30,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,466,2025-12-02T16:05:15.923463
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,18.0,concentration,,,2.2,ug/ml,median,,,minmax,0.1,8.9,<0.0001,Last infusion < GW 30,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,467,2025-12-02T16:05:15.923463
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,26.0,concentration,,,10,ug/ml,median,,,minmax,1.9,28.7,<0.0001,Last infusion >= GW 30,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,468,2025-12-02T16:05:15.923463
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,44.0,concentration,,,2,ug/ml,median,,,minmax,0,22.2,,all,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,469,2025-12-02T16:05:15.923463
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,44.0,concentration,,,5.9,ug/ml,median,,,minmax,0.12,28.7,,all,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,470,2025-12-02T16:05:15.923463
27063728.0,Infliximab,Infliximab,cord blood/maternal blood,materanl/pediatric,delivery,fetus,44.0,ratio of infant to materanl concentration,,,1.97,,median,,,95% CI,1.5,2.43,,all,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,471,2025-12-02T16:05:15.923463
27063728.0,Infliximab,Infliximab,blood,materanl,delivery,,18.0,concentration,,,0.6,ug/ml,median,,,minmax,0,3.3,<0.0001,Last infusion < GW 30,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,465,2025-12-02T16:05:22.346295
27063728.0,Infliximab,Infliximab,blood,materanl,delivery,,26.0,concentration,,,4,ug/ml,median,,,minmax,0,22.2,<0.0001,Last infusion >= GW 30,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,466,2025-12-02T16:05:22.346295
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,18.0,concentration,,,2.2,ug/ml,median,,,minmax,0.1,8.9,<0.0001,Last infusion < GW 30,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,467,2025-12-02T16:05:22.346295
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,26.0,concentration,,,10,ug/ml,median,,,minmax,1.9,28.7,<0.0001,Last infusion >= GW 30,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,468,2025-12-02T16:05:22.346295
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,44.0,concentration,,,2,ug/ml,median,,,minmax,0,22.2,,all,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,469,2025-12-02T16:05:22.346295
27063728.0,Infliximab,Infliximab,cord blood,pediatric,,fetus,44.0,concentration,,,5.9,ug/ml,median,,,minmax,0.12,28.7,,all,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,470,2025-12-02T16:05:22.346295
27063728.0,Infliximab,Infliximab,cord blood/maternal blood,materanl/pediatric,delivery,fetus,44.0,ratio of infant to materanl concentration,,,1.97,,median,,,95% CI,1.5,2.43,,all,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,471,2025-12-02T16:05:22.346295
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 1,,5.0,trough concentration,,,8.5,ug/ml,median,,,IQR,7.23,10.07,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,478,2025-12-02T16:05:09.448543
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 2,,15.0,trough concentration,,,10.31,ug/ml,median,,,IQR,7.66,15.63,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,479,2025-12-02T16:05:09.448543
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 3,,16.0,trough concentration,,,21.02,ug/ml,median,,,IQR,16.01,26.7,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,480,2025-12-02T16:05:09.448543
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 1,,5.0,trough concentration,,,8.5,ug/ml,median,,,IQR,7.23,10.07,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,478,2025-12-02T16:05:12.001940
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 2,,15.0,trough concentration,,,10.31,ug/ml,median,,,IQR,7.66,15.63,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,479,2025-12-02T16:05:12.001940
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 3,,16.0,trough concentration,,,21.02,ug/ml,median,,,IQR,16.01,26.7,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,480,2025-12-02T16:05:12.001940
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 1,,5.0,trough concentration,,,8.5,ug/ml,median,,,IQR,7.23,10.07,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,472,2025-12-02T16:05:15.923463
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 2,,15.0,trough concentration,,,10.31,ug/ml,median,,,IQR,7.66,15.63,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,473,2025-12-02T16:05:15.923463
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 3,,16.0,trough concentration,,,21.02,ug/ml,median,,,IQR,16.01,26.7,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,474,2025-12-02T16:05:15.923463
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 1,,5.0,trough concentration,,,8.5,ug/ml,median,,,IQR,7.23,10.07,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,472,2025-12-02T16:05:22.346295
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 2,,15.0,trough concentration,,,10.31,ug/ml,median,,,IQR,7.66,15.63,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,473,2025-12-02T16:05:22.346295
28318043.0,Infliximab,Infliximab,serum,materanl,trimester 3,,16.0,trough concentration,,,21.02,ug/ml,median,,,IQR,16.01,26.7,,The median time between the trough blood draw and subsequent infusion was 0 days (IQR: 03 days),PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,474,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Renal clearance,,,456,ml/min,mean,SD,192,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,481,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Renal clearance,,,723,ml/min,mean,SD,243,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,482,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Renal clearance,,,625,ml/min,mean,SD,130,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,483,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Renal clearance,,,477,ml/min,mean,SD,132,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,484,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Renal clearance,,,5,ml/min/kg,mean,SD,1.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,485,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Renal clearance,,,7,ml/min/kg,mean,SD,2.3,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,486,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Renal clearance,,,5.5,ml/min/kg,mean,SD,1,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,487,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Renal clearance,,,4.9,ml/min/kg,mean,SD,1.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,488,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Secretion clearance,,,266,ml/min,mean,SD,160,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,489,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Secretion clearance,,,480,ml/min,mean,SD,190,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,490,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Secretion clearance,,,419,ml/min,mean,SD,78,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,491,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Secretion clearance,,,313,ml/min,mean,SD,98,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,492,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Secretion clearance,,,2.8,ml/min/kg,mean,SD,1.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,493,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Secretion clearance,,,4.7,ml/min/kg,mean,SD,1.8,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,494,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Secretion clearance,,,3.7,ml/min/kg,mean,SD,0.6,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,495,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Secretion clearance,,,3.2,ml/min/kg,mean,SD,0.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,496,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral clearance,,,1935,ml/min,mean,SD,1662,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,497,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral clearance,,,2038,ml/min,mean,SD,848,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,498,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral clearance,,,1759,ml/min,mean,SD,960,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,499,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral clearance,,,1590,ml/min,mean,SD,864,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,500,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral clearance,,,18.8,ml/min/kg,mean,SD,10.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,501,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral clearance,,,19.5,ml/min/kg,mean,SD,7.5,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,502,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral clearance,,,15.2,ml/min/kg,mean,SD,7.1,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,503,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral clearance,,,15.6,ml/min/kg,mean,SD,6.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,504,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Half-life,,,4.3,h,mean,SD,0.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,505,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Half-life,,,4.3,h,mean,SD,0.9,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,506,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Half-life,,,4.1,h,mean,SD,0.6,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,507,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Half-life,,,3.8,h,mean,SD,1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,508,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Percent dose recovered in the urine unchanged,,,32,%,mean,SD,18,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,509,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Percent dose recovered in the urine unchanged,,,39,%,mean,SD,12,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,510,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Percent dose recovered in the urine unchanged,,,40,%,mean,SD,11,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,511,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Percent dose recovered in the urine unchanged,,,35,%,mean,SD,11,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,512,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral volume of distribution,,,743,liters,mean,SD,714,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,513,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral volume of distribution,,,768,liters,mean,SD,364,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,514,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral volume of distribution,,,632,liters,mean,SD,396,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,515,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral volume of distribution,,,534,liters,mean,SD,364,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,516,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral volume of distribution,,,7.2,l/kg,mean,SD,4.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,517,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral volume of distribution,,,7.1,l/kg,mean,SD,3.2,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,518,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral volume of distribution,,,5.1,l/kg,mean,SD,2.1,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,519,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral volume of distribution,,,5.1,l/kg,mean,SD,2.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,520,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Creatinine clearance,,,191,ml/min,mean,SD,70,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,521,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Creatinine clearance,,,240,ml/min,mean,SD,70,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,522,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Creatinine clearance,,,207,ml/min,mean,SD,56,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,523,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Creatinine clearance,,,165,ml/min,mean,SD,44,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,524,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Area under the concentration-time curve,,,6544,ngh/ml,mean,SD,2834,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,525,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Area under the concentration-time curve,,,6144,ngh/ml,mean,SD,3381,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,526,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Area under the concentration-time curve,,,6937,ngh/ml,mean,SD,1839,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,527,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Area under the concentration-time curve,,,9804,ngh/ml,mean,SD,3140,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,528,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Time to maximal concentration,,,1.4,h,mean,SD,0.2,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,529,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Time to maximal concentration,,,2,h,mean,SD,0.7,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,530,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Time to maximal concentration,,,2,h,mean,SD,0.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,531,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Time to maximal concentration,,,1.8,h,mean,SD,0.3,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,532,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Maximal concentration,,,1218,ng/ml,mean,SD,465,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,533,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Maximal concentration,,,1063,ng/ml,mean,SD,485,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,534,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Maximal concentration,,,1135,ng/ml,mean,SD,304,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,535,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Maximal concentration,,,1611,ng/ml,mean,SD,386,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,536,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral clearance,,,1457,ml/min,mean,SD,560,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,537,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral clearance,,,1629,ml/min,mean,SD,648,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,538,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral clearance,,,1283,ml/min,mean,SD,418,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,539,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral clearance,,,928,ml/min,mean,SD,285,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,540,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral clearance,,,15.1,ml/min/kg,mean,SD,4.1,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,541,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral clearance,,,16.6,ml/min/kg,mean,SD,5.4,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,542,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral clearance,,,11.9,ml/min/kg,mean,SD,3.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,543,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral clearance,,,10.7,ml/min/kg,mean,SD,2.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,544,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Renal clearance,,,524,ml/min,mean,SD,221,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,545,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Renal clearance,,,710,ml/min,mean,SD,276,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,546,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Renal clearance,,,549,ml/min,mean,SD,63,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,547,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Renal clearance,,,415,ml/min,mean,SD,147,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,548,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Renal clearance,,,5.5,ml/min/kg,mean,SD,1.9,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,549,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Renal clearance,,,7.3,ml/min/kg,mean,SD,2.7,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,550,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Renal clearance,,,5.1,ml/min/kg,mean,SD,0.5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,551,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Renal clearance,,,4.7,ml/min/kg,mean,SD,1.4,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,552,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Percentage of dose recovered in the urine unchanged,,,37,%,mean,SD,12,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,553,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Percentage of dose recovered in the urine unchanged,,,44,%,mean,SD,6,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,554,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Percentage of dose recovered in the urine unchanged,,,46,%,mean,SD,14,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,555,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Percentage of dose recovered in the urine unchanged,,,45,%,mean,SD,5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,556,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral volume of distribution,,,509,liters,mean,SD,213,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,557,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral volume of distribution,,,542,liters,mean,SD,229,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,558,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral volume of distribution,,,432,liters,mean,SD,168,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,559,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral volume of distribution,,,303,liters,mean,SD,66,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,560,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral volume of distribution,,,5.3,l/kg,mean,SD,1.8,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,561,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral volume of distribution,,,5.6,l/kg,mean,SD,2.1,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,562,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral volume of distribution,,,4,l/kg,mean,SD,1.5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,563,2025-12-02T16:05:09.448543
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral volume of distribution,,,3.6,l/kg,mean,SD,1.2,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,564,2025-12-02T16:05:09.448543
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Renal clearance,,,456,ml/min,mean,SD,192,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,481,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Renal clearance,,,723,ml/min,mean,SD,243,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,482,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Renal clearance,,,625,ml/min,mean,SD,130,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,483,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Renal clearance,,,477,ml/min,mean,SD,132,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,484,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Renal clearance,,,5,ml/min/kg,mean,SD,1.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,485,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Renal clearance,,,7,ml/min/kg,mean,SD,2.3,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,486,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Renal clearance,,,5.5,ml/min/kg,mean,SD,1,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,487,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Renal clearance,,,4.9,ml/min/kg,mean,SD,1.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,488,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Secretion clearance,,,266,ml/min,mean,SD,160,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,489,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Secretion clearance,,,480,ml/min,mean,SD,190,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,490,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Secretion clearance,,,419,ml/min,mean,SD,78,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,491,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Secretion clearance,,,313,ml/min,mean,SD,98,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,492,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Secretion clearance,,,2.8,ml/min/kg,mean,SD,1.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,493,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Secretion clearance,,,4.7,ml/min/kg,mean,SD,1.8,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,494,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Secretion clearance,,,3.7,ml/min/kg,mean,SD,0.6,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,495,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Secretion clearance,,,3.2,ml/min/kg,mean,SD,0.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,496,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral clearance,,,1935,ml/min,mean,SD,1662,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,497,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral clearance,,,2038,ml/min,mean,SD,848,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,498,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral clearance,,,1759,ml/min,mean,SD,960,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,499,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral clearance,,,1590,ml/min,mean,SD,864,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,500,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral clearance,,,18.8,ml/min/kg,mean,SD,10.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,501,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral clearance,,,19.5,ml/min/kg,mean,SD,7.5,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,502,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral clearance,,,15.2,ml/min/kg,mean,SD,7.1,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,503,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral clearance,,,15.6,ml/min/kg,mean,SD,6.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,504,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Half-life,,,4.3,h,mean,SD,0.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,505,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Half-life,,,4.3,h,mean,SD,0.9,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,506,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Half-life,,,4.1,h,mean,SD,0.6,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,507,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Half-life,,,3.8,h,mean,SD,1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,508,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Percent dose recovered in the urine unchanged,,,32,%,mean,SD,18,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,509,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Percent dose recovered in the urine unchanged,,,39,%,mean,SD,12,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,510,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Percent dose recovered in the urine unchanged,,,40,%,mean,SD,11,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,511,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Percent dose recovered in the urine unchanged,,,35,%,mean,SD,11,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,512,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral volume of distribution,,,743,liters,mean,SD,714,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,513,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral volume of distribution,,,768,liters,mean,SD,364,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,514,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral volume of distribution,,,632,liters,mean,SD,396,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,515,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral volume of distribution,,,534,liters,mean,SD,364,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,516,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral volume of distribution,,,7.2,l/kg,mean,SD,4.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,517,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral volume of distribution,,,7.1,l/kg,mean,SD,3.2,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,518,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral volume of distribution,,,5.1,l/kg,mean,SD,2.1,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,519,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral volume of distribution,,,5.1,l/kg,mean,SD,2.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,520,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Creatinine clearance,,,191,ml/min,mean,SD,70,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,521,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Creatinine clearance,,,240,ml/min,mean,SD,70,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,522,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Creatinine clearance,,,207,ml/min,mean,SD,56,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,523,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Creatinine clearance,,,165,ml/min,mean,SD,44,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,524,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Area under the concentration-time curve,,,6544,ngh/ml,mean,SD,2834,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,525,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Area under the concentration-time curve,,,6144,ngh/ml,mean,SD,3381,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,526,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Area under the concentration-time curve,,,6937,ngh/ml,mean,SD,1839,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,527,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Area under the concentration-time curve,,,9804,ngh/ml,mean,SD,3140,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,528,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Time to maximal concentration,,,1.4,h,mean,SD,0.2,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,529,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Time to maximal concentration,,,2,h,mean,SD,0.7,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,530,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Time to maximal concentration,,,2,h,mean,SD,0.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,531,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Time to maximal concentration,,,1.8,h,mean,SD,0.3,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,532,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Maximal concentration,,,1218,ng/ml,mean,SD,465,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,533,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Maximal concentration,,,1063,ng/ml,mean,SD,485,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,534,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Maximal concentration,,,1135,ng/ml,mean,SD,304,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,535,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Maximal concentration,,,1611,ng/ml,mean,SD,386,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,536,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral clearance,,,1457,ml/min,mean,SD,560,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,537,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral clearance,,,1629,ml/min,mean,SD,648,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,538,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral clearance,,,1283,ml/min,mean,SD,418,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,539,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral clearance,,,928,ml/min,mean,SD,285,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,540,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral clearance,,,15.1,ml/min/kg,mean,SD,4.1,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,541,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral clearance,,,16.6,ml/min/kg,mean,SD,5.4,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,542,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral clearance,,,11.9,ml/min/kg,mean,SD,3.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,543,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral clearance,,,10.7,ml/min/kg,mean,SD,2.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,544,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Renal clearance,,,524,ml/min,mean,SD,221,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,545,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Renal clearance,,,710,ml/min,mean,SD,276,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,546,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Renal clearance,,,549,ml/min,mean,SD,63,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,547,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Renal clearance,,,415,ml/min,mean,SD,147,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,548,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Renal clearance,,,5.5,ml/min/kg,mean,SD,1.9,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,549,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Renal clearance,,,7.3,ml/min/kg,mean,SD,2.7,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,550,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Renal clearance,,,5.1,ml/min/kg,mean,SD,0.5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,551,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Renal clearance,,,4.7,ml/min/kg,mean,SD,1.4,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,552,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Percentage of dose recovered in the urine unchanged,,,37,%,mean,SD,12,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,553,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Percentage of dose recovered in the urine unchanged,,,44,%,mean,SD,6,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,554,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Percentage of dose recovered in the urine unchanged,,,46,%,mean,SD,14,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,555,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Percentage of dose recovered in the urine unchanged,,,45,%,mean,SD,5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,556,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral volume of distribution,,,509,liters,mean,SD,213,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,557,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral volume of distribution,,,542,liters,mean,SD,229,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,558,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral volume of distribution,,,432,liters,mean,SD,168,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,559,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral volume of distribution,,,303,liters,mean,SD,66,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,560,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral volume of distribution,,,5.3,l/kg,mean,SD,1.8,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,561,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral volume of distribution,,,5.6,l/kg,mean,SD,2.1,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,562,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral volume of distribution,,,4,l/kg,mean,SD,1.5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,563,2025-12-02T16:05:12.001940
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral volume of distribution,,,3.6,l/kg,mean,SD,1.2,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,564,2025-12-02T16:05:12.001940
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Renal clearance,,,456,ml/min,mean,SD,192,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,475,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Renal clearance,,,723,ml/min,mean,SD,243,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,476,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Renal clearance,,,625,ml/min,mean,SD,130,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,477,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Renal clearance,,,477,ml/min,mean,SD,132,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,478,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Renal clearance,,,5,ml/min/kg,mean,SD,1.9,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,479,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Renal clearance,,,7,ml/min/kg,mean,SD,2.3,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,480,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Renal clearance,,,5.5,ml/min/kg,mean,SD,1,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,481,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Renal clearance,,,4.9,ml/min/kg,mean,SD,1.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,482,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Secretion clearance,,,266,ml/min,mean,SD,160,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,483,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Secretion clearance,,,480,ml/min,mean,SD,190,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,484,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Secretion clearance,,,419,ml/min,mean,SD,78,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,485,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Secretion clearance,,,313,ml/min,mean,SD,98,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,486,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Secretion clearance,,,2.8,ml/min/kg,mean,SD,1.1,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,487,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Secretion clearance,,,4.7,ml/min/kg,mean,SD,1.8,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,488,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Secretion clearance,,,3.7,ml/min/kg,mean,SD,0.6,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,489,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Secretion clearance,,,3.2,ml/min/kg,mean,SD,0.9,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,490,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral clearance,,,1935,ml/min,mean,SD,1662,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,491,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral clearance,,,2038,ml/min,mean,SD,848,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,492,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral clearance,,,1759,ml/min,mean,SD,960,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,493,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral clearance,,,1590,ml/min,mean,SD,864,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,494,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral clearance,,,18.8,ml/min/kg,mean,SD,10.9,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,495,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral clearance,,,19.5,ml/min/kg,mean,SD,7.5,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,496,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral clearance,,,15.2,ml/min/kg,mean,SD,7.1,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,497,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral clearance,,,15.6,ml/min/kg,mean,SD,6.5,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,498,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Half-life,,,4.3,h,mean,SD,0.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,499,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Half-life,,,4.3,h,mean,SD,0.9,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,500,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Half-life,,,4.1,h,mean,SD,0.6,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,501,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Half-life,,,3.8,h,mean,SD,1,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,502,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Percent dose recovered in the urine unchanged,,,32,%,mean,SD,18,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,503,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Percent dose recovered in the urine unchanged,,,39,%,mean,SD,12,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,504,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Percent dose recovered in the urine unchanged,,,40,%,mean,SD,11,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,505,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Percent dose recovered in the urine unchanged,,,35,%,mean,SD,11,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,506,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral volume of distribution,,,743,liters,mean,SD,714,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,507,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral volume of distribution,,,768,liters,mean,SD,364,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,508,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral volume of distribution,,,632,liters,mean,SD,396,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,509,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral volume of distribution,,,534,liters,mean,SD,364,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,510,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral volume of distribution,,,7.2,l/kg,mean,SD,4.9,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,511,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral volume of distribution,,,7.1,l/kg,mean,SD,3.2,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,512,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral volume of distribution,,,5.1,l/kg,mean,SD,2.1,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,513,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral volume of distribution,,,5.1,l/kg,mean,SD,2.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,514,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Creatinine clearance,,,191,ml/min,mean,SD,70,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,515,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Creatinine clearance,,,240,ml/min,mean,SD,70,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,516,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Creatinine clearance,,,207,ml/min,mean,SD,56,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,517,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Creatinine clearance,,,165,ml/min,mean,SD,44,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,518,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Area under the concentration-time curve,,,6544,ngh/ml,mean,SD,2834,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,519,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Area under the concentration-time curve,,,6144,ngh/ml,mean,SD,3381,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,520,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Area under the concentration-time curve,,,6937,ngh/ml,mean,SD,1839,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,521,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Area under the concentration-time curve,,,9804,ngh/ml,mean,SD,3140,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,522,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Time to maximal concentration,,,1.4,h,mean,SD,0.2,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,523,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Time to maximal concentration,,,2,h,mean,SD,0.7,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,524,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Time to maximal concentration,,,2,h,mean,SD,0.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,525,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Time to maximal concentration,,,1.8,h,mean,SD,0.3,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,526,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Maximal concentration,,,1218,ng/ml,mean,SD,465,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,527,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Maximal concentration,,,1063,ng/ml,mean,SD,485,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,528,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Maximal concentration,,,1135,ng/ml,mean,SD,304,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,529,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Maximal concentration,,,1611,ng/ml,mean,SD,386,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,530,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral clearance,,,1457,ml/min,mean,SD,560,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,531,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral clearance,,,1629,ml/min,mean,SD,648,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,532,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral clearance,,,1283,ml/min,mean,SD,418,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,533,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral clearance,,,928,ml/min,mean,SD,285,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,534,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral clearance,,,15.1,ml/min/kg,mean,SD,4.1,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,535,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral clearance,,,16.6,ml/min/kg,mean,SD,5.4,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,536,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral clearance,,,11.9,ml/min/kg,mean,SD,3.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,537,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral clearance,,,10.7,ml/min/kg,mean,SD,2.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,538,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Renal clearance,,,524,ml/min,mean,SD,221,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,539,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Renal clearance,,,710,ml/min,mean,SD,276,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,540,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Renal clearance,,,549,ml/min,mean,SD,63,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,541,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Renal clearance,,,415,ml/min,mean,SD,147,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,542,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Renal clearance,,,5.5,ml/min/kg,mean,SD,1.9,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,543,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Renal clearance,,,7.3,ml/min/kg,mean,SD,2.7,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,544,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Renal clearance,,,5.1,ml/min/kg,mean,SD,0.5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,545,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Renal clearance,,,4.7,ml/min/kg,mean,SD,1.4,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,546,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Percentage of dose recovered in the urine unchanged,,,37,%,mean,SD,12,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,547,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Percentage of dose recovered in the urine unchanged,,,44,%,mean,SD,6,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,548,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Percentage of dose recovered in the urine unchanged,,,46,%,mean,SD,14,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,549,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Percentage of dose recovered in the urine unchanged,,,45,%,mean,SD,5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,550,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral volume of distribution,,,509,liters,mean,SD,213,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,551,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral volume of distribution,,,542,liters,mean,SD,229,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,552,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral volume of distribution,,,432,liters,mean,SD,168,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,553,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral volume of distribution,,,303,liters,mean,SD,66,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,554,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral volume of distribution,,,5.3,l/kg,mean,SD,1.8,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,555,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral volume of distribution,,,5.6,l/kg,mean,SD,2.1,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,556,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral volume of distribution,,,4,l/kg,mean,SD,1.5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,557,2025-12-02T16:05:15.923463
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral volume of distribution,,,3.6,l/kg,mean,SD,1.2,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,558,2025-12-02T16:05:15.923463
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Renal clearance,,,456,ml/min,mean,SD,192,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,475,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Renal clearance,,,723,ml/min,mean,SD,243,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,476,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Renal clearance,,,625,ml/min,mean,SD,130,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,477,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Renal clearance,,,477,ml/min,mean,SD,132,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,478,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Renal clearance,,,5,ml/min/kg,mean,SD,1.9,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,479,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Renal clearance,,,7,ml/min/kg,mean,SD,2.3,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,480,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Renal clearance,,,5.5,ml/min/kg,mean,SD,1,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,481,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Renal clearance,,,4.9,ml/min/kg,mean,SD,1.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,482,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Secretion clearance,,,266,ml/min,mean,SD,160,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,483,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Secretion clearance,,,480,ml/min,mean,SD,190,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,484,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Secretion clearance,,,419,ml/min,mean,SD,78,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,485,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Secretion clearance,,,313,ml/min,mean,SD,98,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,486,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Secretion clearance,,,2.8,ml/min/kg,mean,SD,1.1,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,487,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Secretion clearance,,,4.7,ml/min/kg,mean,SD,1.8,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,488,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Secretion clearance,,,3.7,ml/min/kg,mean,SD,0.6,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,489,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Secretion clearance,,,3.2,ml/min/kg,mean,SD,0.9,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,490,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral clearance,,,1935,ml/min,mean,SD,1662,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,491,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral clearance,,,2038,ml/min,mean,SD,848,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,492,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral clearance,,,1759,ml/min,mean,SD,960,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,493,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral clearance,,,1590,ml/min,mean,SD,864,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,494,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral clearance,,,18.8,ml/min/kg,mean,SD,10.9,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,495,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral clearance,,,19.5,ml/min/kg,mean,SD,7.5,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,496,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral clearance,,,15.2,ml/min/kg,mean,SD,7.1,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,497,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral clearance,,,15.6,ml/min/kg,mean,SD,6.5,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,498,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Half-life,,,4.3,h,mean,SD,0.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,499,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Half-life,,,4.3,h,mean,SD,0.9,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,500,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Half-life,,,4.1,h,mean,SD,0.6,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,501,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Half-life,,,3.8,h,mean,SD,1,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,502,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,1st trimest,10-14 weeks,4.0,Percent dose recovered in the urine unchanged,,,32,%,mean,SD,18,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,503,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,2nd trimest,22-26 weeks,10.0,Percent dose recovered in the urine unchanged,,,39,%,mean,SD,12,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,504,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,3rd trimest,34-38 weeks,10.0,Percent dose recovered in the urine unchanged,,,40,%,mean,SD,11,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,505,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,urine,maternal,Postpartum,,15.0,Percent dose recovered in the urine unchanged,,,35,%,mean,SD,11,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,506,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral volume of distribution,,,743,liters,mean,SD,714,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,507,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral volume of distribution,,,768,liters,mean,SD,364,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,508,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral volume of distribution,,,632,liters,mean,SD,396,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,509,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral volume of distribution,,,534,liters,mean,SD,364,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,510,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Apparent oral volume of distribution,,,7.2,l/kg,mean,SD,4.9,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,511,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Apparent oral volume of distribution,,,7.1,l/kg,mean,SD,3.2,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,512,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Apparent oral volume of distribution,,,5.1,l/kg,mean,SD,2.1,,,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,513,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Apparent oral volume of distribution,,,5.1,l/kg,mean,SD,2.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,514,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,1st trimest,10-14 weeks,4.0,Creatinine clearance,,,191,ml/min,mean,SD,70,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,515,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,2nd trimest,22-26 weeks,10.0,Creatinine clearance,,,240,ml/min,mean,SD,70,,,,<0.01,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,516,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,3rd trimest,34-38 weeks,10.0,Creatinine clearance,,,207,ml/min,mean,SD,56,,,,<0.05,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,517,2025-12-02T16:05:22.346295
20118196.0,Metformin,Metformin,plasma,maternal,Postpartum,,15.0,Creatinine clearance,,,165,ml/min,mean,SD,44,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,518,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Area under the concentration-time curve,,,6544,ngh/ml,mean,SD,2834,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,519,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Area under the concentration-time curve,,,6144,ngh/ml,mean,SD,3381,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,520,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Area under the concentration-time curve,,,6937,ngh/ml,mean,SD,1839,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,521,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Area under the concentration-time curve,,,9804,ngh/ml,mean,SD,3140,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,522,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Time to maximal concentration,,,1.4,h,mean,SD,0.2,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,523,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Time to maximal concentration,,,2,h,mean,SD,0.7,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,524,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Time to maximal concentration,,,2,h,mean,SD,0.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,525,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Time to maximal concentration,,,1.8,h,mean,SD,0.3,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,526,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Maximal concentration,,,1218,ng/ml,mean,SD,465,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,527,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Maximal concentration,,,1063,ng/ml,mean,SD,485,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,528,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Maximal concentration,,,1135,ng/ml,mean,SD,304,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,529,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Maximal concentration,,,1611,ng/ml,mean,SD,386,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,530,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral clearance,,,1457,ml/min,mean,SD,560,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,531,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral clearance,,,1629,ml/min,mean,SD,648,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,532,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral clearance,,,1283,ml/min,mean,SD,418,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,533,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral clearance,,,928,ml/min,mean,SD,285,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,534,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral clearance,,,15.1,ml/min/kg,mean,SD,4.1,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,535,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral clearance,,,16.6,ml/min/kg,mean,SD,5.4,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,536,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral clearance,,,11.9,ml/min/kg,mean,SD,3.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,537,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral clearance,,,10.7,ml/min/kg,mean,SD,2.7,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,538,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Renal clearance,,,524,ml/min,mean,SD,221,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,539,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Renal clearance,,,710,ml/min,mean,SD,276,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,540,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Renal clearance,,,549,ml/min,mean,SD,63,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,541,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Renal clearance,,,415,ml/min,mean,SD,147,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,542,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Renal clearance,,,5.5,ml/min/kg,mean,SD,1.9,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,543,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Renal clearance,,,7.3,ml/min/kg,mean,SD,2.7,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,544,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Renal clearance,,,5.1,ml/min/kg,mean,SD,0.5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,545,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Renal clearance,,,4.7,ml/min/kg,mean,SD,1.4,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,546,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,1st trimest,10-14 weeks,5.0,Percentage of dose recovered in the urine unchanged,,,37,%,mean,SD,12,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,547,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,2nd trimest,22-26 weeks,7.0,Percentage of dose recovered in the urine unchanged,,,44,%,mean,SD,6,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,548,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,3rd trimest,34-38 weeks,4.0,Percentage of dose recovered in the urine unchanged,,,46,%,mean,SD,14,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,549,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,urine,maternal,postpartum,,6.0,Percentage of dose recovered in the urine unchanged,,,45,%,mean,SD,5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,550,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral volume of distribution,,,509,liters,mean,SD,213,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,551,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral volume of distribution,,,542,liters,mean,SD,229,,,,< 0.05 compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,552,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral volume of distribution,,,432,liters,mean,SD,168,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,553,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral volume of distribution,,,303,liters,mean,SD,66,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,554,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,1st trimest,10-14 weeks,5.0,Apparent oral volume of distribution,,,5.3,l/kg,mean,SD,1.8,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,555,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,2nd trimest,22-26 weeks,7.0,Apparent oral volume of distribution,,,5.6,l/kg,mean,SD,2.1,,,,N.S. compared with postpartum,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,556,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,3rd trimest,34-38 weeks,4.0,Apparent oral volume of distribution,,,4,l/kg,mean,SD,1.5,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,557,2025-12-02T16:05:22.346295
20118196.0,metformin,metformin,plasma,maternal,postpartum,,6.0,Apparent oral volume of distribution,,,3.6,l/kg,mean,SD,1.2,,,,,500 mg of metformin twice daily,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,558,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,0,h,0.16,mg/L,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,565,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,2,h,0.86,mg/L,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,566,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,12,h,0.14,mg/L,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,567,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,t1/2,,,3.8,h,median,,,minmax,2.8,5.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,568,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,tmax,,,2,h,median,,,minmax,0.5,3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,569,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,,,1.4,mg/L,median,,,minmax,0.5,2.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,570,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,AUC0-12,,,6.4,mg h/L,median,,,minmax,1.1,9.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,571,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmean,,,0.5,mg/L,median,,,minmax,0.2,0.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,572,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Fluctuation,,,89,%,median,,,minmax,79,95,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,573,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cl/f,,,105,L/h,median,,,minmax,60,274,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,574,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Vd/f,,,551,L,median,,,minmax,385,1173,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,575,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,delivery,,8.0,concentration,,,0.4,mg/L,median,,,minmax,0.1,"2,4",,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,576,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,umbilical ord plasma,pediatric,,fetus,8.0,concentration,,,0.3,mg/L,median,,,minmax,0.1,1.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,577,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,umbilical/maternal plasma,maternal/pediatric,delivery,fetus,8.0,umbilical/maternal,,,0.7,,median,,,minmax,0.4,1.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,578,2025-12-02T16:05:09.448543
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,0,h,0.16,mg/L,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,565,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,2,h,0.86,mg/L,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,566,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,12,h,0.14,mg/L,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,567,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,t1/2,,,3.8,h,median,,,minmax,2.8,5.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,568,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,tmax,,,2,h,median,,,minmax,0.5,3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,569,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,,,1.4,mg/L,median,,,minmax,0.5,2.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,570,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,AUC0-12,,,6.4,mg h/L,median,,,minmax,1.1,9.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,571,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmean,,,0.5,mg/L,median,,,minmax,0.2,0.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,572,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Fluctuation,,,89,%,median,,,minmax,79,95,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,573,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cl/f,,,105,L/h,median,,,minmax,60,274,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,574,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Vd/f,,,551,L,median,,,minmax,385,1173,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,575,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,delivery,,8.0,concentration,,,0.4,mg/L,median,,,minmax,0.1,"2,4",,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,576,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,umbilical ord plasma,pediatric,,fetus,8.0,concentration,,,0.3,mg/L,median,,,minmax,0.1,1.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,577,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,umbilical/maternal plasma,maternal/pediatric,delivery,fetus,8.0,umbilical/maternal,,,0.7,,median,,,minmax,0.4,1.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,578,2025-12-02T16:05:12.001940
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,0,h,0.16,mg/L,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,559,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,2,h,0.86,mg/L,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,560,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,12,h,0.14,mg/L,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,561,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,t1/2,,,3.8,h,median,,,minmax,2.8,5.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,562,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,tmax,,,2,h,median,,,minmax,0.5,3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,563,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,,,1.4,mg/L,median,,,minmax,0.5,2.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,564,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,AUC0-12,,,6.4,mg h/L,median,,,minmax,1.1,9.2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,565,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmean,,,0.5,mg/L,median,,,minmax,0.2,0.9,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,566,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Fluctuation,,,89,%,median,,,minmax,79,95,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,567,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cl/f,,,105,L/h,median,,,minmax,60,274,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,568,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Vd/f,,,551,L,median,,,minmax,385,1173,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,569,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,delivery,,8.0,concentration,,,0.4,mg/L,median,,,minmax,0.1,"2,4",,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,570,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,umbilical ord plasma,pediatric,,fetus,8.0,concentration,,,0.3,mg/L,median,,,minmax,0.1,1.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,571,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,umbilical/maternal plasma,maternal/pediatric,delivery,fetus,8.0,umbilical/maternal,,,0.7,,median,,,minmax,0.4,1.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,572,2025-12-02T16:05:15.923463
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,0,h,0.16,mg/L,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,559,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,2,h,0.86,mg/L,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,560,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,12,h,0.14,mg/L,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,561,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,t1/2,,,3.8,h,median,,,minmax,2.8,5.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,562,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,tmax,,,2,h,median,,,minmax,0.5,3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,563,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,,,1.4,mg/L,median,,,minmax,0.5,2.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,564,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,AUC0-12,,,6.4,mg h/L,median,,,minmax,1.1,9.2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,565,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmean,,,0.5,mg/L,median,,,minmax,0.2,0.9,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,566,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Fluctuation,,,89,%,median,,,minmax,79,95,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,567,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cl/f,,,105,L/h,median,,,minmax,60,274,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,568,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Vd/f,,,551,L,median,,,minmax,385,1173,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,569,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,plasma,maternal,delivery,,8.0,concentration,,,0.4,mg/L,median,,,minmax,0.1,"2,4",,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,570,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,umbilical ord plasma,pediatric,,fetus,8.0,concentration,,,0.3,mg/L,median,,,minmax,0.1,1.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,571,2025-12-02T16:05:22.346295
21538144.0,metformin,metformin,umbilical/maternal plasma,maternal/pediatric,delivery,fetus,8.0,umbilical/maternal,,,0.7,,median,,,minmax,0.4,1.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,572,2025-12-02T16:05:22.346295
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,concentration,,,0.27,mg/l,mean,,,minmax,0.15,0.39,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,579,2025-12-02T16:05:09.448543
12436333.0,metformin,metformin,plasma,maternal,lactation,,7.0,concentration,,,0.79,mg/l,mean,,,minmax,0.26,1.05,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,580,2025-12-02T16:05:09.448543
12436333.0,metformin,metformin,breast milk/plasma,maternal,lactation,,7.0,milk-to-plasma ratio,,,0.35,,mean,,,minmax,0.2,0.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,581,2025-12-02T16:05:09.448543
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,infant absolute dose,,,0.04,mg/kg/day,mean,,,minmax,0.02,0.06,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,582,2025-12-02T16:05:09.448543
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,infant relative to weight-normalized maternal dose,,,0.28,%,mean,,,minmax,0.16,0.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,583,2025-12-02T16:05:09.448543
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,concentration,,,0.27,mg/l,mean,,,minmax,0.15,0.39,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,579,2025-12-02T16:05:12.001940
12436333.0,metformin,metformin,plasma,maternal,lactation,,7.0,concentration,,,0.79,mg/l,mean,,,minmax,0.26,1.05,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,580,2025-12-02T16:05:12.001940
12436333.0,metformin,metformin,breast milk/plasma,maternal,lactation,,7.0,milk-to-plasma ratio,,,0.35,,mean,,,minmax,0.2,0.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,581,2025-12-02T16:05:12.001940
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,infant absolute dose,,,0.04,mg/kg/day,mean,,,minmax,0.02,0.06,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,582,2025-12-02T16:05:12.001940
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,infant relative to weight-normalized maternal dose,,,0.28,%,mean,,,minmax,0.16,0.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,583,2025-12-02T16:05:12.001940
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,concentration,,,0.27,mg/l,mean,,,minmax,0.15,0.39,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,573,2025-12-02T16:05:15.923463
12436333.0,metformin,metformin,plasma,maternal,lactation,,7.0,concentration,,,0.79,mg/l,mean,,,minmax,0.26,1.05,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,574,2025-12-02T16:05:15.923463
12436333.0,metformin,metformin,breast milk/plasma,maternal,lactation,,7.0,milk-to-plasma ratio,,,0.35,,mean,,,minmax,0.2,0.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,575,2025-12-02T16:05:15.923463
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,infant absolute dose,,,0.04,mg/kg/day,mean,,,minmax,0.02,0.06,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,576,2025-12-02T16:05:15.923463
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,infant relative to weight-normalized maternal dose,,,0.28,%,mean,,,minmax,0.16,0.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,577,2025-12-02T16:05:15.923463
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,concentration,,,0.27,mg/l,mean,,,minmax,0.15,0.39,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,573,2025-12-02T16:05:22.346295
12436333.0,metformin,metformin,plasma,maternal,lactation,,7.0,concentration,,,0.79,mg/l,mean,,,minmax,0.26,1.05,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,574,2025-12-02T16:05:22.346295
12436333.0,metformin,metformin,breast milk/plasma,maternal,lactation,,7.0,milk-to-plasma ratio,,,0.35,,mean,,,minmax,0.2,0.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,575,2025-12-02T16:05:22.346295
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,infant absolute dose,,,0.04,mg/kg/day,mean,,,minmax,0.02,0.06,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,576,2025-12-02T16:05:22.346295
12436333.0,metformin,metformin,breast milk,maternal,lactation,,7.0,infant relative to weight-normalized maternal dose,,,0.28,%,mean,,,minmax,0.16,0.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,577,2025-12-02T16:05:22.346295
12545145.0,metformin,metformin,breast milk/plasma,maternal,lactation,,5.0,milk-to-plasma ratio,,,0.47,,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,584,2025-12-02T16:05:09.448543
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,concentration,,,0.17,mg/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,585,2025-12-02T16:05:09.448543
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,infant absolute dose,,,0.041,mg/kg/d,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,586,2025-12-02T16:05:09.448543
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,infant relative dose,,,0.2,%,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,587,2025-12-02T16:05:09.448543
12545145.0,metformin,metformin,plasma,maternal,lactation,,3.0,peak concenetration,,,,mg/l,,,,minmax,0.5,0.7,,Steady-state study,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,588,2025-12-02T16:05:09.448543
12545145.0,metformin,metformin,plasma,maternal,lactation,,3.0,half life,,,,h,,,,minmax,2.4,3.9,,Steady-state study,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,589,2025-12-02T16:05:09.448543
12545145.0,metformin,metformin,breast milk,maternal,lactation,,3.0,concentration,,,,mg/l,,,,minmax,0.13,0.27,,Steady-state study,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,590,2025-12-02T16:05:09.448543
12545145.0,metformin,metformin,plasma,maternal,lactation,,5.0,peak concenetration,,,0.8,mg/l,median,,,minmax,0.5,1,,Single-dose study,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,591,2025-12-02T16:05:09.448543
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,AUC0-,,,4.66,mg/Lxh,median,,,minmax,3.11,6.36,,Single-dose study,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,592,2025-12-02T16:05:09.448543
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,Cmax,,,0.07,mg/l,median,,,minmax,0.05,0.11,,Single-dose study,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,593,2025-12-02T16:05:09.448543
12545145.0,metformin,metformin,breast milk/plasma,maternal,lactation,,5.0,milk-to-plasma ratio,,,0.47,,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,584,2025-12-02T16:05:12.001940
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,concentration,,,0.17,mg/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,585,2025-12-02T16:05:12.001940
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,infant absolute dose,,,0.041,mg/kg/d,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,586,2025-12-02T16:05:12.001940
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,infant relative dose,,,0.2,%,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,587,2025-12-02T16:05:12.001940
12545145.0,metformin,metformin,plasma,maternal,lactation,,3.0,peak concenetration,,,,mg/l,,,,minmax,0.5,0.7,,Steady-state study,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,588,2025-12-02T16:05:12.001940
12545145.0,metformin,metformin,plasma,maternal,lactation,,3.0,half life,,,,h,,,,minmax,2.4,3.9,,Steady-state study,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,589,2025-12-02T16:05:12.001940
12545145.0,metformin,metformin,breast milk,maternal,lactation,,3.0,concentration,,,,mg/l,,,,minmax,0.13,0.27,,Steady-state study,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,590,2025-12-02T16:05:12.001940
12545145.0,metformin,metformin,plasma,maternal,lactation,,5.0,peak concenetration,,,0.8,mg/l,median,,,minmax,0.5,1,,Single-dose study,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,591,2025-12-02T16:05:12.001940
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,AUC0-,,,4.66,mg/Lxh,median,,,minmax,3.11,6.36,,Single-dose study,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,592,2025-12-02T16:05:12.001940
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,Cmax,,,0.07,mg/l,median,,,minmax,0.05,0.11,,Single-dose study,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,593,2025-12-02T16:05:12.001940
12545145.0,metformin,metformin,breast milk/plasma,maternal,lactation,,5.0,milk-to-plasma ratio,,,0.47,,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,578,2025-12-02T16:05:15.923463
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,concentration,,,0.17,mg/l,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,579,2025-12-02T16:05:15.923463
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,infant absolute dose,,,0.041,mg/kg/d,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,580,2025-12-02T16:05:15.923463
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,infant relative dose,,,0.2,%,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,581,2025-12-02T16:05:15.923463
12545145.0,metformin,metformin,plasma,maternal,lactation,,3.0,peak concenetration,,,,mg/l,,,,minmax,0.5,0.7,,Steady-state study,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,582,2025-12-02T16:05:15.923463
12545145.0,metformin,metformin,plasma,maternal,lactation,,3.0,half life,,,,h,,,,minmax,2.4,3.9,,Steady-state study,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,583,2025-12-02T16:05:15.923463
12545145.0,metformin,metformin,breast milk,maternal,lactation,,3.0,concentration,,,,mg/l,,,,minmax,0.13,0.27,,Steady-state study,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,584,2025-12-02T16:05:15.923463
12545145.0,metformin,metformin,plasma,maternal,lactation,,5.0,peak concenetration,,,0.8,mg/l,median,,,minmax,0.5,1,,Single-dose study,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,585,2025-12-02T16:05:15.923463
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,AUC0-,,,4.66,mg/Lxh,median,,,minmax,3.11,6.36,,Single-dose study,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,586,2025-12-02T16:05:15.923463
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,Cmax,,,0.07,mg/l,median,,,minmax,0.05,0.11,,Single-dose study,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,587,2025-12-02T16:05:15.923463
12545145.0,metformin,metformin,breast milk/plasma,maternal,lactation,,5.0,milk-to-plasma ratio,,,0.47,,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,578,2025-12-02T16:05:22.346295
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,concentration,,,0.17,mg/l,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,579,2025-12-02T16:05:22.346295
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,infant absolute dose,,,0.041,mg/kg/d,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,580,2025-12-02T16:05:22.346295
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,infant relative dose,,,0.2,%,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,581,2025-12-02T16:05:22.346295
12545145.0,metformin,metformin,plasma,maternal,lactation,,3.0,peak concenetration,,,,mg/l,,,,minmax,0.5,0.7,,Steady-state study,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,582,2025-12-02T16:05:22.346295
12545145.0,metformin,metformin,plasma,maternal,lactation,,3.0,half life,,,,h,,,,minmax,2.4,3.9,,Steady-state study,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,583,2025-12-02T16:05:22.346295
12545145.0,metformin,metformin,breast milk,maternal,lactation,,3.0,concentration,,,,mg/l,,,,minmax,0.13,0.27,,Steady-state study,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,584,2025-12-02T16:05:22.346295
12545145.0,metformin,metformin,plasma,maternal,lactation,,5.0,peak concenetration,,,0.8,mg/l,median,,,minmax,0.5,1,,Single-dose study,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,585,2025-12-02T16:05:22.346295
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,AUC0-,,,4.66,mg/Lxh,median,,,minmax,3.11,6.36,,Single-dose study,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,586,2025-12-02T16:05:22.346295
12545145.0,metformin,metformin,breast milk,maternal,lactation,,5.0,Cmax,,,0.07,mg/l,median,,,minmax,0.05,0.11,,Single-dose study,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,587,2025-12-02T16:05:22.346295
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,peak concenetration,,,1.06,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,594,2025-12-02T16:05:09.448543
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,trough concentration,,,0.42,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,595,2025-12-02T16:05:09.448543
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,average concentration,,,0.74,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,596,2025-12-02T16:05:09.448543
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,peak concenetration,,,0.42,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,597,2025-12-02T16:05:09.448543
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,trough concentration,,,0.39,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,598,2025-12-02T16:05:09.448543
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,average concentration,,,0.41,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,599,2025-12-02T16:05:09.448543
15932841.0,metformin,metformin,breast milk/serum,maternal,lactation,,5.0,milk-to-serum ratio,,,0.64,%,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,600,2025-12-02T16:05:09.448543
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,estimated infant dose,,,0.65,,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,601,2025-12-02T16:05:09.448543
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,peak concenetration,,,1.06,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,594,2025-12-02T16:05:12.001940
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,trough concentration,,,0.42,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,595,2025-12-02T16:05:12.001940
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,average concentration,,,0.74,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,596,2025-12-02T16:05:12.001940
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,peak concenetration,,,0.42,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,597,2025-12-02T16:05:12.001940
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,trough concentration,,,0.39,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,598,2025-12-02T16:05:12.001940
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,average concentration,,,0.41,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,599,2025-12-02T16:05:12.001940
15932841.0,metformin,metformin,breast milk/serum,maternal,lactation,,5.0,milk-to-serum ratio,,,0.64,%,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,600,2025-12-02T16:05:12.001940
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,estimated infant dose,,,0.65,,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,601,2025-12-02T16:05:12.001940
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,peak concenetration,,,1.06,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,588,2025-12-02T16:05:15.923463
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,trough concentration,,,0.42,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,589,2025-12-02T16:05:15.923463
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,average concentration,,,0.74,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,590,2025-12-02T16:05:15.923463
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,peak concenetration,,,0.42,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,591,2025-12-02T16:05:15.923463
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,trough concentration,,,0.39,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,592,2025-12-02T16:05:15.923463
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,average concentration,,,0.41,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,593,2025-12-02T16:05:15.923463
15932841.0,metformin,metformin,breast milk/serum,maternal,lactation,,5.0,milk-to-serum ratio,,,0.64,%,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,594,2025-12-02T16:05:15.923463
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,estimated infant dose,,,0.65,,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,595,2025-12-02T16:05:15.923463
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,peak concenetration,,,1.06,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,588,2025-12-02T16:05:22.346295
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,trough concentration,,,0.42,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,589,2025-12-02T16:05:22.346295
15932841.0,metformin,metformin,serum,maternal,lactation,,5.0,average concentration,,,0.74,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,590,2025-12-02T16:05:22.346295
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,peak concenetration,,,0.42,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,591,2025-12-02T16:05:22.346295
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,trough concentration,,,0.39,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,592,2025-12-02T16:05:22.346295
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,average concentration,,,0.41,ug/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,593,2025-12-02T16:05:22.346295
15932841.0,metformin,metformin,breast milk/serum,maternal,lactation,,5.0,milk-to-serum ratio,,,0.64,%,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,594,2025-12-02T16:05:22.346295
15932841.0,metformin,metformin,breast milk,maternal,lactation,,5.0,estimated infant dose,,,0.65,,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,595,2025-12-02T16:05:22.346295
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,6.0,AUC0-4 during pregnancy compared to postpartum,,,69,%,mean,,,95% CI,53.6,84.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,602,2025-12-02T16:05:09.448543
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,7.0,AUC0-4 during pregnancy compared to postpartum,,,80,%,mean,,,95% CI,51.3,107.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,603,2025-12-02T16:05:09.448543
16492218.0,metformin,metformin,serum,maternal,3rd trimest,,7.0,rario of AUC0-8 to AUC0-4,,,1.63,,mean,,,95% CI,1.56,1.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,604,2025-12-02T16:05:09.448543
16492218.0,metformin,metformin,serum,maternal,postpartum,,7.0,rario of AUC0-8 to AUC0-4,,,1.74,%,mean,,,95% CI,1.54,1.84,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,605,2025-12-02T16:05:09.448543
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,7.0,peak concentration in pregnancy compared to postpartum,,,81,%,mean,,,95% CI,47.3,114.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,606,2025-12-02T16:05:09.448543
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,6.0,AUC0-4 during pregnancy compared to postpartum,,,69,%,mean,,,95% CI,53.6,84.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,602,2025-12-02T16:05:12.001940
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,7.0,AUC0-4 during pregnancy compared to postpartum,,,80,%,mean,,,95% CI,51.3,107.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,603,2025-12-02T16:05:12.001940
16492218.0,metformin,metformin,serum,maternal,3rd trimest,,7.0,rario of AUC0-8 to AUC0-4,,,1.63,,mean,,,95% CI,1.56,1.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,604,2025-12-02T16:05:12.001940
16492218.0,metformin,metformin,serum,maternal,postpartum,,7.0,rario of AUC0-8 to AUC0-4,,,1.74,%,mean,,,95% CI,1.54,1.84,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,605,2025-12-02T16:05:12.001940
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,7.0,peak concentration in pregnancy compared to postpartum,,,81,%,mean,,,95% CI,47.3,114.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,606,2025-12-02T16:05:12.001940
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,6.0,AUC0-4 during pregnancy compared to postpartum,,,69,%,mean,,,95% CI,53.6,84.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,596,2025-12-02T16:05:15.923463
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,7.0,AUC0-4 during pregnancy compared to postpartum,,,80,%,mean,,,95% CI,51.3,107.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,597,2025-12-02T16:05:15.923463
16492218.0,metformin,metformin,serum,maternal,3rd trimest,,7.0,rario of AUC0-8 to AUC0-4,,,1.63,,mean,,,95% CI,1.56,1.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,598,2025-12-02T16:05:15.923463
16492218.0,metformin,metformin,serum,maternal,postpartum,,7.0,rario of AUC0-8 to AUC0-4,,,1.74,%,mean,,,95% CI,1.54,1.84,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,599,2025-12-02T16:05:15.923463
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,7.0,peak concentration in pregnancy compared to postpartum,,,81,%,mean,,,95% CI,47.3,114.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,600,2025-12-02T16:05:15.923463
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,6.0,AUC0-4 during pregnancy compared to postpartum,,,69,%,mean,,,95% CI,53.6,84.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,596,2025-12-02T16:05:22.346295
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,7.0,AUC0-4 during pregnancy compared to postpartum,,,80,%,mean,,,95% CI,51.3,107.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,597,2025-12-02T16:05:22.346295
16492218.0,metformin,metformin,serum,maternal,3rd trimest,,7.0,rario of AUC0-8 to AUC0-4,,,1.63,,mean,,,95% CI,1.56,1.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,598,2025-12-02T16:05:22.346295
16492218.0,metformin,metformin,serum,maternal,postpartum,,7.0,rario of AUC0-8 to AUC0-4,,,1.74,%,mean,,,95% CI,1.54,1.84,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,599,2025-12-02T16:05:22.346295
16492218.0,metformin,metformin,serum,maternal,3rd trimester/postpartum,,7.0,peak concentration in pregnancy compared to postpartum,,,81,%,mean,,,95% CI,47.3,114.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,600,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,t1/2,,,3.75,h,median,,,25th percentile-75th percentile,3.5,4.8,,PCOS,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,607,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,t1/2,,,4,h,median,,,25th percentile-75th percentile,3.4,4.6,,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,608,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,tmax,,,2,h,median,,,25th percentile-75th percentile,1.37,2.62,,PCOS,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,609,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,tmax,,,3,h,median,,,25th percentile-75th percentile,2,3,,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,610,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,,,1.42,ug/mL,median,,,25th percentile-75th percentile,0.74,1.72,,PCOS,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,611,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Cmax,,,1.21,ug/mL,median,,,25th percentile-75th percentile,0.81,1.38,,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,612,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,AUC12,,,6.42,ug h/ml,median,,,25th percentile-75th percentile,4.52,9.68,,PCOS,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,613,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,AUC12,,,6.73,ug h/ml,median,,,25th percentile-75th percentile,4.8,9.52,,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,614,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmean,,,0.53,ug/ml,median,,,25th percentile-75th percentile,0.38,0.81,,PCOS,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,615,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Cmean,,,0.56,ug/ml,median,,,25th percentile-75th percentile,0.4,0.79,,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,616,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Fluctuation,,,179.56,%,median,,,minmax,162.7,238.36,,PCOS,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,617,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Fluctuation,,,181.73,%,median,,,minmax,134.31,208.36,,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,618,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,CL/F,,,105.39,L/h,median,,,25th percentile-75th percentile,68.88,152.9,,PCOS,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,619,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,CL/F,,,98.38,L/h,median,,,25th percentile-75th percentile,69.59,138.09,,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,620,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Vd/F,,,550.51,L,median,,,25th percentile-75th percentile,406.07,1037.08,,PCOS,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,621,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Vd/F,,,490.98,L,median,,,25th percentile-75th percentile,418.56,798.23,,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,622,2025-12-02T16:05:09.448543
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,t1/2,,,3.75,h,median,,,25th percentile-75th percentile,3.5,4.8,,PCOS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,607,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,t1/2,,,4,h,median,,,25th percentile-75th percentile,3.4,4.6,,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,608,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,tmax,,,2,h,median,,,25th percentile-75th percentile,1.37,2.62,,PCOS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,609,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,tmax,,,3,h,median,,,25th percentile-75th percentile,2,3,,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,610,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,,,1.42,ug/mL,median,,,25th percentile-75th percentile,0.74,1.72,,PCOS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,611,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Cmax,,,1.21,ug/mL,median,,,25th percentile-75th percentile,0.81,1.38,,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,612,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,AUC12,,,6.42,ug h/ml,median,,,25th percentile-75th percentile,4.52,9.68,,PCOS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,613,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,AUC12,,,6.73,ug h/ml,median,,,25th percentile-75th percentile,4.8,9.52,,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,614,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmean,,,0.53,ug/ml,median,,,25th percentile-75th percentile,0.38,0.81,,PCOS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,615,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Cmean,,,0.56,ug/ml,median,,,25th percentile-75th percentile,0.4,0.79,,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,616,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Fluctuation,,,179.56,%,median,,,minmax,162.7,238.36,,PCOS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,617,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Fluctuation,,,181.73,%,median,,,minmax,134.31,208.36,,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,618,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,CL/F,,,105.39,L/h,median,,,25th percentile-75th percentile,68.88,152.9,,PCOS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,619,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,CL/F,,,98.38,L/h,median,,,25th percentile-75th percentile,69.59,138.09,,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,620,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Vd/F,,,550.51,L,median,,,25th percentile-75th percentile,406.07,1037.08,,PCOS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,621,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Vd/F,,,490.98,L,median,,,25th percentile-75th percentile,418.56,798.23,,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,622,2025-12-02T16:05:12.001940
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,t1/2,,,3.75,h,median,,,25th percentile-75th percentile,3.5,4.8,,PCOS,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,601,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,t1/2,,,4,h,median,,,25th percentile-75th percentile,3.4,4.6,,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,602,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,tmax,,,2,h,median,,,25th percentile-75th percentile,1.37,2.62,,PCOS,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,603,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,tmax,,,3,h,median,,,25th percentile-75th percentile,2,3,,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,604,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,,,1.42,ug/mL,median,,,25th percentile-75th percentile,0.74,1.72,,PCOS,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,605,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Cmax,,,1.21,ug/mL,median,,,25th percentile-75th percentile,0.81,1.38,,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,606,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,AUC12,,,6.42,ug h/ml,median,,,25th percentile-75th percentile,4.52,9.68,,PCOS,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,607,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,AUC12,,,6.73,ug h/ml,median,,,25th percentile-75th percentile,4.8,9.52,,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,608,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmean,,,0.53,ug/ml,median,,,25th percentile-75th percentile,0.38,0.81,,PCOS,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,609,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Cmean,,,0.56,ug/ml,median,,,25th percentile-75th percentile,0.4,0.79,,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,610,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Fluctuation,,,179.56,%,median,,,minmax,162.7,238.36,,PCOS,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,611,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Fluctuation,,,181.73,%,median,,,minmax,134.31,208.36,,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,612,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,CL/F,,,105.39,L/h,median,,,25th percentile-75th percentile,68.88,152.9,,PCOS,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,613,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,CL/F,,,98.38,L/h,median,,,25th percentile-75th percentile,69.59,138.09,,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,614,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Vd/F,,,550.51,L,median,,,25th percentile-75th percentile,406.07,1037.08,,PCOS,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,615,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Vd/F,,,490.98,L,median,,,25th percentile-75th percentile,418.56,798.23,,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,616,2025-12-02T16:05:15.923463
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,t1/2,,,3.75,h,median,,,25th percentile-75th percentile,3.5,4.8,,PCOS,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,601,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,t1/2,,,4,h,median,,,25th percentile-75th percentile,3.4,4.6,,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,602,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,tmax,,,2,h,median,,,25th percentile-75th percentile,1.37,2.62,,PCOS,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,603,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,tmax,,,3,h,median,,,25th percentile-75th percentile,2,3,,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,604,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmax,,,1.42,ug/mL,median,,,25th percentile-75th percentile,0.74,1.72,,PCOS,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,605,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Cmax,,,1.21,ug/mL,median,,,25th percentile-75th percentile,0.81,1.38,,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,606,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,AUC12,,,6.42,ug h/ml,median,,,25th percentile-75th percentile,4.52,9.68,,PCOS,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,607,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,AUC12,,,6.73,ug h/ml,median,,,25th percentile-75th percentile,4.8,9.52,,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,608,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Cmean,,,0.53,ug/ml,median,,,25th percentile-75th percentile,0.38,0.81,,PCOS,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,609,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Cmean,,,0.56,ug/ml,median,,,25th percentile-75th percentile,0.4,0.79,,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,610,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Fluctuation,,,179.56,%,median,,,minmax,162.7,238.36,,PCOS,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,611,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Fluctuation,,,181.73,%,median,,,minmax,134.31,208.36,,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,612,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,CL/F,,,105.39,L/h,median,,,25th percentile-75th percentile,68.88,152.9,,PCOS,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,613,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,CL/F,,,98.38,L/h,median,,,25th percentile-75th percentile,69.59,138.09,,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,614,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,8.0,Vd/F,,,550.51,L,median,,,25th percentile-75th percentile,406.07,1037.08,,PCOS,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,615,2025-12-02T16:05:22.346295
23018469.0,metformin,metformin,plasma,maternal,third trimester,,9.0,Vd/F,,,490.98,L,median,,,25th percentile-75th percentile,418.56,798.23,,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,616,2025-12-02T16:05:22.346295
28069720.0,metformin,metformin,urine,maternal,1st trimester,10-14 weeks gestation,6.0,CLR,,,542,ml/min,mean,SD,200,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,623,2025-12-02T16:05:09.448543
28069720.0,metformin,metformin,urine,maternal,2nd trimester,22-26 weeks gestation,15.0,CLR,,,775,ml/min,mean,SD,252,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,624,2025-12-02T16:05:09.448543
28069720.0,metformin,metformin,urine,maternal,3rd trimester,34-38 weeks gestation,13.0,CLR,,,653,ml/min,mean,SD,166,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,625,2025-12-02T16:05:09.448543
28069720.0,metformin,metformin,urine,maternal,postpartum,>= 12 weeks,14.0,CLR,,,467,ml/min,mean,SD,131,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,626,2025-12-02T16:05:09.448543
28069720.0,metformin,metformin,urine,maternal,1st trimester,10-14 weeks gestation,6.0,CLsec,,,354,ml/min,mean,SD,184,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,627,2025-12-02T16:05:09.448543
28069720.0,metformin,metformin,urine,maternal,2nd trimester,22-26 weeks gestation,15.0,CLsec,,,538,ml/min,mean,SD,202,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,628,2025-12-02T16:05:09.448543
28069720.0,metformin,metformin,urine,maternal,3rd trimester,34-38 weeks gestation,13.0,CLsec,,,438,ml/min,mean,SD,110,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,629,2025-12-02T16:05:09.448543
28069720.0,metformin,metformin,urine,maternal,postpartum,>= 12 weeks,14.0,CLsec,,,304,ml/min,mean,SD,95,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,630,2025-12-02T16:05:09.448543
28069720.0,metformin,metformin,urine,maternal,1st trimester,10-14 weeks gestation,6.0,CLR,,,542,ml/min,mean,SD,200,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,623,2025-12-02T16:05:12.001940
28069720.0,metformin,metformin,urine,maternal,2nd trimester,22-26 weeks gestation,15.0,CLR,,,775,ml/min,mean,SD,252,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,624,2025-12-02T16:05:12.001940
28069720.0,metformin,metformin,urine,maternal,3rd trimester,34-38 weeks gestation,13.0,CLR,,,653,ml/min,mean,SD,166,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,625,2025-12-02T16:05:12.001940
28069720.0,metformin,metformin,urine,maternal,postpartum,>= 12 weeks,14.0,CLR,,,467,ml/min,mean,SD,131,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,626,2025-12-02T16:05:12.001940
28069720.0,metformin,metformin,urine,maternal,1st trimester,10-14 weeks gestation,6.0,CLsec,,,354,ml/min,mean,SD,184,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,627,2025-12-02T16:05:12.001940
28069720.0,metformin,metformin,urine,maternal,2nd trimester,22-26 weeks gestation,15.0,CLsec,,,538,ml/min,mean,SD,202,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,628,2025-12-02T16:05:12.001940
28069720.0,metformin,metformin,urine,maternal,3rd trimester,34-38 weeks gestation,13.0,CLsec,,,438,ml/min,mean,SD,110,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,629,2025-12-02T16:05:12.001940
28069720.0,metformin,metformin,urine,maternal,postpartum,>= 12 weeks,14.0,CLsec,,,304,ml/min,mean,SD,95,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,630,2025-12-02T16:05:12.001940
28069720.0,metformin,metformin,urine,maternal,1st trimester,10-14 weeks gestation,6.0,CLR,,,542,ml/min,mean,SD,200,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,617,2025-12-02T16:05:15.923463
28069720.0,metformin,metformin,urine,maternal,2nd trimester,22-26 weeks gestation,15.0,CLR,,,775,ml/min,mean,SD,252,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,618,2025-12-02T16:05:15.923463
28069720.0,metformin,metformin,urine,maternal,3rd trimester,34-38 weeks gestation,13.0,CLR,,,653,ml/min,mean,SD,166,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,619,2025-12-02T16:05:15.923463
28069720.0,metformin,metformin,urine,maternal,postpartum,>= 12 weeks,14.0,CLR,,,467,ml/min,mean,SD,131,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,620,2025-12-02T16:05:15.923463
28069720.0,metformin,metformin,urine,maternal,1st trimester,10-14 weeks gestation,6.0,CLsec,,,354,ml/min,mean,SD,184,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,621,2025-12-02T16:05:15.923463
28069720.0,metformin,metformin,urine,maternal,2nd trimester,22-26 weeks gestation,15.0,CLsec,,,538,ml/min,mean,SD,202,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,622,2025-12-02T16:05:15.923463
28069720.0,metformin,metformin,urine,maternal,3rd trimester,34-38 weeks gestation,13.0,CLsec,,,438,ml/min,mean,SD,110,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,623,2025-12-02T16:05:15.923463
28069720.0,metformin,metformin,urine,maternal,postpartum,>= 12 weeks,14.0,CLsec,,,304,ml/min,mean,SD,95,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,624,2025-12-02T16:05:15.923463
28069720.0,metformin,metformin,urine,maternal,1st trimester,10-14 weeks gestation,6.0,CLR,,,542,ml/min,mean,SD,200,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,617,2025-12-02T16:05:22.346295
28069720.0,metformin,metformin,urine,maternal,2nd trimester,22-26 weeks gestation,15.0,CLR,,,775,ml/min,mean,SD,252,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,618,2025-12-02T16:05:22.346295
28069720.0,metformin,metformin,urine,maternal,3rd trimester,34-38 weeks gestation,13.0,CLR,,,653,ml/min,mean,SD,166,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,619,2025-12-02T16:05:22.346295
28069720.0,metformin,metformin,urine,maternal,postpartum,>= 12 weeks,14.0,CLR,,,467,ml/min,mean,SD,131,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,620,2025-12-02T16:05:22.346295
28069720.0,metformin,metformin,urine,maternal,1st trimester,10-14 weeks gestation,6.0,CLsec,,,354,ml/min,mean,SD,184,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,621,2025-12-02T16:05:22.346295
28069720.0,metformin,metformin,urine,maternal,2nd trimester,22-26 weeks gestation,15.0,CLsec,,,538,ml/min,mean,SD,202,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,622,2025-12-02T16:05:22.346295
28069720.0,metformin,metformin,urine,maternal,3rd trimester,34-38 weeks gestation,13.0,CLsec,,,438,ml/min,mean,SD,110,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,623,2025-12-02T16:05:22.346295
28069720.0,metformin,metformin,urine,maternal,postpartum,>= 12 weeks,14.0,CLsec,,,304,ml/min,mean,SD,95,,,,<0.01,for comparison to postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,624,2025-12-02T16:05:22.346295
15866611.0,metformin,metformin,serum,maternal,delivery,,15.0,concentration,,,1.5,umol/L,median,,,IQR,0.5,3.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,631,2025-12-02T16:05:09.448543
15866611.0,metformin,metformin,umbilical artery  serum,pediatric,,fetus,15.0,concentration,,,2.81,umol/L,median,,,IQR,1.25,5.3,0.017,versus maternal serum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,632,2025-12-02T16:05:09.448543
15866611.0,metformin,metformin,umbilical vein serum ,pediatric,,fetus,15.0,concentration,,,3.16,umol/L,median,,,IQR,1.36,5.02,0.033,versus maternal serum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,633,2025-12-02T16:05:09.448543
15866611.0,metformin,metformin,serum,maternal,delivery,,15.0,concentration,,,1.5,umol/L,median,,,IQR,0.5,3.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,631,2025-12-02T16:05:12.001940
15866611.0,metformin,metformin,umbilical artery  serum,pediatric,,fetus,15.0,concentration,,,2.81,umol/L,median,,,IQR,1.25,5.3,0.017,versus maternal serum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,632,2025-12-02T16:05:12.001940
15866611.0,metformin,metformin,umbilical vein serum ,pediatric,,fetus,15.0,concentration,,,3.16,umol/L,median,,,IQR,1.36,5.02,0.033,versus maternal serum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,633,2025-12-02T16:05:12.001940
15866611.0,metformin,metformin,serum,maternal,delivery,,15.0,concentration,,,1.5,umol/L,median,,,IQR,0.5,3.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,625,2025-12-02T16:05:15.923463
15866611.0,metformin,metformin,umbilical artery  serum,pediatric,,fetus,15.0,concentration,,,2.81,umol/L,median,,,IQR,1.25,5.3,0.017,versus maternal serum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,626,2025-12-02T16:05:15.923463
15866611.0,metformin,metformin,umbilical vein serum ,pediatric,,fetus,15.0,concentration,,,3.16,umol/L,median,,,IQR,1.36,5.02,0.033,versus maternal serum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,627,2025-12-02T16:05:15.923463
15866611.0,metformin,metformin,serum,maternal,delivery,,15.0,concentration,,,1.5,umol/L,median,,,IQR,0.5,3.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,625,2025-12-02T16:05:22.346295
15866611.0,metformin,metformin,umbilical artery  serum,pediatric,,fetus,15.0,concentration,,,2.81,umol/L,median,,,IQR,1.25,5.3,0.017,versus maternal serum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,626,2025-12-02T16:05:22.346295
15866611.0,metformin,metformin,umbilical vein serum ,pediatric,,fetus,15.0,concentration,,,3.16,umol/L,median,,,IQR,1.36,5.02,0.033,versus maternal serum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,627,2025-12-02T16:05:22.346295
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,37.0,trough concentration,,,730,ng/ml,mean,SD,440,minmax,275,2420,,All,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,634,2025-12-02T16:05:09.448543
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,12.0,trough concentration,,,392,ng/ml,mean,SD,65,minmax,275,486,,Lowest tertile,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,635,2025-12-02T16:05:09.448543
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,12.0,trough concentration,,,619,ng/ml,mean,SD,58,minmax,509,729,,Middle tertile,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,636,2025-12-02T16:05:09.448543
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,13.0,trough concentration,,,1144,ng/ml,mean,SD,512,minmax,731,2420,,Highest tertile,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,637,2025-12-02T16:05:09.448543
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,58.0,concentration,,,457,ng/ml,mean,SD,335,minmax,42,1370,,All,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,638,2025-12-02T16:05:09.448543
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,19.0,concentration,,,142,ng/ml,mean,SD,48,minmax,42,232,,Lowest tertile,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,639,2025-12-02T16:05:09.448543
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,19.0,concentration,,,361,ng/ml,mean,SD,115,minmax,236,610,,Middle tertile,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,640,2025-12-02T16:05:09.448543
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,20.0,concentration,,,848,ng/ml,mean,SD,232,minmax,613,1370,,Highest tertile,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,641,2025-12-02T16:05:09.448543
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,37.0,trough concentration,,,730,ng/ml,mean,SD,440,minmax,275,2420,,All,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,634,2025-12-02T16:05:12.001940
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,12.0,trough concentration,,,392,ng/ml,mean,SD,65,minmax,275,486,,Lowest tertile,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,635,2025-12-02T16:05:12.001940
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,12.0,trough concentration,,,619,ng/ml,mean,SD,58,minmax,509,729,,Middle tertile,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,636,2025-12-02T16:05:12.001940
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,13.0,trough concentration,,,1144,ng/ml,mean,SD,512,minmax,731,2420,,Highest tertile,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,637,2025-12-02T16:05:12.001940
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,58.0,concentration,,,457,ng/ml,mean,SD,335,minmax,42,1370,,All,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,638,2025-12-02T16:05:12.001940
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,19.0,concentration,,,142,ng/ml,mean,SD,48,minmax,42,232,,Lowest tertile,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,639,2025-12-02T16:05:12.001940
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,19.0,concentration,,,361,ng/ml,mean,SD,115,minmax,236,610,,Middle tertile,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,640,2025-12-02T16:05:12.001940
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,20.0,concentration,,,848,ng/ml,mean,SD,232,minmax,613,1370,,Highest tertile,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,641,2025-12-02T16:05:12.001940
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,37.0,trough concentration,,,730,ng/ml,mean,SD,440,minmax,275,2420,,All,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,628,2025-12-02T16:05:15.923463
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,12.0,trough concentration,,,392,ng/ml,mean,SD,65,minmax,275,486,,Lowest tertile,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,629,2025-12-02T16:05:15.923463
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,12.0,trough concentration,,,619,ng/ml,mean,SD,58,minmax,509,729,,Middle tertile,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,630,2025-12-02T16:05:15.923463
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,13.0,trough concentration,,,1144,ng/ml,mean,SD,512,minmax,731,2420,,Highest tertile,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,631,2025-12-02T16:05:15.923463
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,58.0,concentration,,,457,ng/ml,mean,SD,335,minmax,42,1370,,All,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,632,2025-12-02T16:05:15.923463
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,19.0,concentration,,,142,ng/ml,mean,SD,48,minmax,42,232,,Lowest tertile,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,633,2025-12-02T16:05:15.923463
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,19.0,concentration,,,361,ng/ml,mean,SD,115,minmax,236,610,,Middle tertile,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,634,2025-12-02T16:05:15.923463
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,20.0,concentration,,,848,ng/ml,mean,SD,232,minmax,613,1370,,Highest tertile,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,635,2025-12-02T16:05:15.923463
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,37.0,trough concentration,,,730,ng/ml,mean,SD,440,minmax,275,2420,,All,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,628,2025-12-02T16:05:22.346295
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,12.0,trough concentration,,,392,ng/ml,mean,SD,65,minmax,275,486,,Lowest tertile,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,629,2025-12-02T16:05:22.346295
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,12.0,trough concentration,,,619,ng/ml,mean,SD,58,minmax,509,729,,Middle tertile,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,630,2025-12-02T16:05:22.346295
24633859.0,metformin,metformin,serum,maternal,3rd trimester,36 GW,13.0,trough concentration,,,1144,ng/ml,mean,SD,512,minmax,731,2420,,Highest tertile,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,631,2025-12-02T16:05:22.346295
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,58.0,concentration,,,457,ng/ml,mean,SD,335,minmax,42,1370,,All,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,632,2025-12-02T16:05:22.346295
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,19.0,concentration,,,142,ng/ml,mean,SD,48,minmax,42,232,,Lowest tertile,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,633,2025-12-02T16:05:22.346295
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,19.0,concentration,,,361,ng/ml,mean,SD,115,minmax,236,610,,Middle tertile,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,634,2025-12-02T16:05:22.346295
24633859.0,metformin,metformin,umbilical cord blood,pediatric,,fetus,20.0,concentration,,,848,ng/ml,mean,SD,232,minmax,613,1370,,Highest tertile,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,635,2025-12-02T16:05:22.346295
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,Cmax,,,38.6,ng/ml,mean,SD,18,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,642,2025-12-02T16:05:09.448543
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,half life,,,1.3,hr,mean,SD,0.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,643,2025-12-02T16:05:09.448543
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,AUC,,,83.2,ng hr/ml,mean,SD,42.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,644,2025-12-02T16:05:09.448543
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,Clearance,,,2,L/hr/kg,mean,SD,0.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,645,2025-12-02T16:05:09.448543
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,26.6,ng/ml,mean,SD,11.3,,,,,40 mg/day,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,646,2025-12-02T16:05:09.448543
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,66.5,ng/ml,mean,SD,9,,,,,60 mg/day,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,647,2025-12-02T16:05:09.448543
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,81.3,ng/ml,mean,SD,18.1,,,,,80 mg/day,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,648,2025-12-02T16:05:09.448543
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,102.5,ng/ml,mean,SD,7.7,,,,,120 mg/day,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,649,2025-12-02T16:05:09.448543
1608848.0,nifiedipine,nifiedipine,cord blood/maternal serum,maternal/pediatric,delivery,fetus,15.0,fetal cord: maternal serum ratio concentration,,,0.93,,mean,SD,0.2,minmax,0.57,1.16,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,650,2025-12-02T16:05:09.448543
1608848.0,nifiedipine,nifiedipine,amniotic fluid: maternal serum,maternal,delivery,,15.0,amniotic fluid: maternal serum ratio concentration,,,0.56,,mean,SD,0.15,minmax,0.36,0.85,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,651,2025-12-02T16:05:09.448543
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,Cmax,,,38.6,ng/ml,mean,SD,18,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,642,2025-12-02T16:05:12.001940
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,half life,,,1.3,hr,mean,SD,0.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,643,2025-12-02T16:05:12.001940
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,AUC,,,83.2,ng hr/ml,mean,SD,42.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,644,2025-12-02T16:05:12.001940
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,Clearance,,,2,L/hr/kg,mean,SD,0.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,645,2025-12-02T16:05:12.001940
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,26.6,ng/ml,mean,SD,11.3,,,,,40 mg/day,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,646,2025-12-02T16:05:12.001940
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,66.5,ng/ml,mean,SD,9,,,,,60 mg/day,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,647,2025-12-02T16:05:12.001940
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,81.3,ng/ml,mean,SD,18.1,,,,,80 mg/day,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,648,2025-12-02T16:05:12.001940
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,102.5,ng/ml,mean,SD,7.7,,,,,120 mg/day,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,649,2025-12-02T16:05:12.001940
1608848.0,nifiedipine,nifiedipine,cord blood/maternal serum,maternal/pediatric,delivery,fetus,15.0,fetal cord: maternal serum ratio concentration,,,0.93,,mean,SD,0.2,minmax,0.57,1.16,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,650,2025-12-02T16:05:12.001940
1608848.0,nifiedipine,nifiedipine,amniotic fluid: maternal serum,maternal,delivery,,15.0,amniotic fluid: maternal serum ratio concentration,,,0.56,,mean,SD,0.15,minmax,0.36,0.85,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,651,2025-12-02T16:05:12.001940
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,Cmax,,,38.6,ng/ml,mean,SD,18,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,636,2025-12-02T16:05:15.923463
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,half life,,,1.3,hr,mean,SD,0.5,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,637,2025-12-02T16:05:15.923463
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,AUC,,,83.2,ng hr/ml,mean,SD,42.6,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,638,2025-12-02T16:05:15.923463
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,Clearance,,,2,L/hr/kg,mean,SD,0.8,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,639,2025-12-02T16:05:15.923463
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,26.6,ng/ml,mean,SD,11.3,,,,,40 mg/day,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,640,2025-12-02T16:05:15.923463
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,66.5,ng/ml,mean,SD,9,,,,,60 mg/day,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,641,2025-12-02T16:05:15.923463
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,81.3,ng/ml,mean,SD,18.1,,,,,80 mg/day,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,642,2025-12-02T16:05:15.923463
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,102.5,ng/ml,mean,SD,7.7,,,,,120 mg/day,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,643,2025-12-02T16:05:15.923463
1608848.0,nifiedipine,nifiedipine,cord blood/maternal serum,maternal/pediatric,delivery,fetus,15.0,fetal cord: maternal serum ratio concentration,,,0.93,,mean,SD,0.2,minmax,0.57,1.16,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,644,2025-12-02T16:05:15.923463
1608848.0,nifiedipine,nifiedipine,amniotic fluid: maternal serum,maternal,delivery,,15.0,amniotic fluid: maternal serum ratio concentration,,,0.56,,mean,SD,0.15,minmax,0.36,0.85,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,645,2025-12-02T16:05:15.923463
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,Cmax,,,38.6,ng/ml,mean,SD,18,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,636,2025-12-02T16:05:22.346295
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,half life,,,1.3,hr,mean,SD,0.5,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,637,2025-12-02T16:05:22.346295
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,AUC,,,83.2,ng hr/ml,mean,SD,42.6,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,638,2025-12-02T16:05:22.346295
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,Clearance,,,2,L/hr/kg,mean,SD,0.8,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,639,2025-12-02T16:05:22.346295
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,26.6,ng/ml,mean,SD,11.3,,,,,40 mg/day,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,640,2025-12-02T16:05:22.346295
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,66.5,ng/ml,mean,SD,9,,,,,60 mg/day,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,641,2025-12-02T16:05:22.346295
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,81.3,ng/ml,mean,SD,18.1,,,,,80 mg/day,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,642,2025-12-02T16:05:22.346295
1608848.0,nifiedipine,nifiedipine,serum,maternal,pregnancy,,15.0,concentration,,,102.5,ng/ml,mean,SD,7.7,,,,,120 mg/day,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,643,2025-12-02T16:05:22.346295
1608848.0,nifiedipine,nifiedipine,cord blood/maternal serum,maternal/pediatric,delivery,fetus,15.0,fetal cord: maternal serum ratio concentration,,,0.93,,mean,SD,0.2,minmax,0.57,1.16,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,644,2025-12-02T16:05:22.346295
1608848.0,nifiedipine,nifiedipine,amniotic fluid: maternal serum,maternal,delivery,,15.0,amniotic fluid: maternal serum ratio concentration,,,0.56,,mean,SD,0.15,minmax,0.36,0.85,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,645,2025-12-02T16:05:22.346295
17464806.0,nifiedipine,nifiedipine,serum,maternal,2nd and 3rd trimester,22-34 GW,24.0,concentration,12,h,32.9,ng/ml,mean,SD,25.1,minmax,6,101,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,652,2025-12-02T16:05:09.448543
17464806.0,nifiedipine,nifiedipine,serum,maternal,2nd and 3rd trimester,22-34 GW,24.0,concentration,12,h,32.9,ng/ml,mean,SD,25.1,minmax,6,101,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,652,2025-12-02T16:05:12.001940
17464806.0,nifiedipine,nifiedipine,serum,maternal,2nd and 3rd trimester,22-34 GW,24.0,concentration,12,h,32.9,ng/ml,mean,SD,25.1,minmax,6,101,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,646,2025-12-02T16:05:15.923463
17464806.0,nifiedipine,nifiedipine,serum,maternal,2nd and 3rd trimester,22-34 GW,24.0,concentration,12,h,32.9,ng/ml,mean,SD,25.1,minmax,6,101,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,646,2025-12-02T16:05:22.346295
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,30,min,36,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,653,2025-12-02T16:05:09.448543
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,75,min,113,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,654,2025-12-02T16:05:09.448543
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,2,h,90,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,655,2025-12-02T16:05:09.448543
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,3,h,55,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,656,2025-12-02T16:05:09.448543
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,4,h,51,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,657,2025-12-02T16:05:09.448543
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,overall concentration,,,67,ng/ml,mean,SD,28,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,658,2025-12-02T16:05:09.448543
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,peak concentration,1.2  0.1,h,127,ng/ml,mean,SD,44,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,659,2025-12-02T16:05:09.448543
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,Css,,,32,ng/ml,mean,SD,13,,,,,after ingestion of a 20 mg nifedipine slow-release tablet,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,660,2025-12-02T16:05:09.448543
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,peak concentration,0.9  0.6,h,49,ng/ml,mean,SD,29,,,,,after ingestion of a 20 mg nifedipine slow-release tablet,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,661,2025-12-02T16:05:09.448543
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,30,min,36,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,653,2025-12-02T16:05:12.001940
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,75,min,113,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,654,2025-12-02T16:05:12.001940
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,2,h,90,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,655,2025-12-02T16:05:12.001940
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,3,h,55,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,656,2025-12-02T16:05:12.001940
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,4,h,51,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,657,2025-12-02T16:05:12.001940
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,overall concentration,,,67,ng/ml,mean,SD,28,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,658,2025-12-02T16:05:12.001940
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,peak concentration,1.2  0.1,h,127,ng/ml,mean,SD,44,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,659,2025-12-02T16:05:12.001940
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,Css,,,32,ng/ml,mean,SD,13,,,,,after ingestion of a 20 mg nifedipine slow-release tablet,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,660,2025-12-02T16:05:12.001940
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,peak concentration,0.9  0.6,h,49,ng/ml,mean,SD,29,,,,,after ingestion of a 20 mg nifedipine slow-release tablet,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,661,2025-12-02T16:05:12.001940
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,30,min,36,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,647,2025-12-02T16:05:15.923463
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,75,min,113,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,648,2025-12-02T16:05:15.923463
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,2,h,90,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,649,2025-12-02T16:05:15.923463
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,3,h,55,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,650,2025-12-02T16:05:15.923463
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,4,h,51,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,651,2025-12-02T16:05:15.923463
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,overall concentration,,,67,ng/ml,mean,SD,28,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,652,2025-12-02T16:05:15.923463
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,peak concentration,1.2  0.1,h,127,ng/ml,mean,SD,44,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,653,2025-12-02T16:05:15.923463
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,Css,,,32,ng/ml,mean,SD,13,,,,,after ingestion of a 20 mg nifedipine slow-release tablet,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,654,2025-12-02T16:05:15.923463
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,peak concentration,0.9  0.6,h,49,ng/ml,mean,SD,29,,,,,after ingestion of a 20 mg nifedipine slow-release tablet,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,655,2025-12-02T16:05:15.923463
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,30,min,36,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,647,2025-12-02T16:05:22.346295
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,75,min,113,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,648,2025-12-02T16:05:22.346295
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,2,h,90,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,649,2025-12-02T16:05:22.346295
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,3,h,55,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,650,2025-12-02T16:05:22.346295
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,concentration,4,h,51,ng/ml,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,651,2025-12-02T16:05:22.346295
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,overall concentration,,,67,ng/ml,mean,SD,28,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,652,2025-12-02T16:05:22.346295
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,peak concentration,1.2  0.1,h,127,ng/ml,mean,SD,44,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,653,2025-12-02T16:05:22.346295
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,Css,,,32,ng/ml,mean,SD,13,,,,,after ingestion of a 20 mg nifedipine slow-release tablet,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,654,2025-12-02T16:05:22.346295
17667209.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,5.0,peak concentration,0.9  0.6,h,49,ng/ml,mean,SD,29,,,,,after ingestion of a 20 mg nifedipine slow-release tablet,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,655,2025-12-02T16:05:22.346295
18271884.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,31.0,concentration at steady state,,,53.9,ug/ml,mean,SE,6.5,minmax,6.5,148,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,662,2025-12-02T16:05:09.448543
18271884.0,nifiedipine,nifiedipine,plasma,maternal,delivery,,21.0,concentration,,,19.8,ug/ml,mean,SE,4.7,minmax,0.2,95.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,663,2025-12-02T16:05:09.448543
18271884.0,nifiedipine,nifiedipine,umbilical cord plasma,pediatric,,fetus,21.0,concentration,,,12.7,ug/ml,mean,SE,2.9,minmax,0.2,56.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,664,2025-12-02T16:05:09.448543
18271884.0,nifiedipine,nifiedipine,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,21.0,umbilical cord/maternal plasma ratio,,,0.77,,mean,SE,0.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,665,2025-12-02T16:05:09.448543
18271884.0,nifiedipine,nifiedipine,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,21.0,umbilical cord/maternal plasma ratio,,,0.64,,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,666,2025-12-02T16:05:09.448543
18271884.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,31.0,concentration at steady state,,,53.9,ug/ml,mean,SE,6.5,minmax,6.5,148,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,662,2025-12-02T16:05:12.001940
18271884.0,nifiedipine,nifiedipine,plasma,maternal,delivery,,21.0,concentration,,,19.8,ug/ml,mean,SE,4.7,minmax,0.2,95.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,663,2025-12-02T16:05:12.001940
18271884.0,nifiedipine,nifiedipine,umbilical cord plasma,pediatric,,fetus,21.0,concentration,,,12.7,ug/ml,mean,SE,2.9,minmax,0.2,56.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,664,2025-12-02T16:05:12.001940
18271884.0,nifiedipine,nifiedipine,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,21.0,umbilical cord/maternal plasma ratio,,,0.77,,mean,SE,0.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,665,2025-12-02T16:05:12.001940
18271884.0,nifiedipine,nifiedipine,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,21.0,umbilical cord/maternal plasma ratio,,,0.64,,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,666,2025-12-02T16:05:12.001940
18271884.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,31.0,concentration at steady state,,,53.9,ug/ml,mean,SE,6.5,minmax,6.5,148,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,656,2025-12-02T16:05:15.923463
18271884.0,nifiedipine,nifiedipine,plasma,maternal,delivery,,21.0,concentration,,,19.8,ug/ml,mean,SE,4.7,minmax,0.2,95.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,657,2025-12-02T16:05:15.923463
18271884.0,nifiedipine,nifiedipine,umbilical cord plasma,pediatric,,fetus,21.0,concentration,,,12.7,ug/ml,mean,SE,2.9,minmax,0.2,56.9,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,658,2025-12-02T16:05:15.923463
18271884.0,nifiedipine,nifiedipine,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,21.0,umbilical cord/maternal plasma ratio,,,0.77,,mean,SE,0.1,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,659,2025-12-02T16:05:15.923463
18271884.0,nifiedipine,nifiedipine,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,21.0,umbilical cord/maternal plasma ratio,,,0.64,,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,660,2025-12-02T16:05:15.923463
18271884.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,31.0,concentration at steady state,,,53.9,ug/ml,mean,SE,6.5,minmax,6.5,148,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,656,2025-12-02T16:05:22.346295
18271884.0,nifiedipine,nifiedipine,plasma,maternal,delivery,,21.0,concentration,,,19.8,ug/ml,mean,SE,4.7,minmax,0.2,95.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,657,2025-12-02T16:05:22.346295
18271884.0,nifiedipine,nifiedipine,umbilical cord plasma,pediatric,,fetus,21.0,concentration,,,12.7,ug/ml,mean,SE,2.9,minmax,0.2,56.9,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,658,2025-12-02T16:05:22.346295
18271884.0,nifiedipine,nifiedipine,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,21.0,umbilical cord/maternal plasma ratio,,,0.77,,mean,SE,0.1,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,659,2025-12-02T16:05:22.346295
18271884.0,nifiedipine,nifiedipine,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,21.0,umbilical cord/maternal plasma ratio,,,0.64,,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,660,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,Cmax,0-1,h,108.7,ug/l,mean,SE,22.6,,,,,first hour after loading dose 40 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,667,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,Cmax,0-1,h,97.5,ug/l,median,,,minmax,19.9,292,,first hour after loading dose 40 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,668,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,concentration,5,h,57.3,ug/l,mean,,,,,,,all,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,669,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,concentration,5,h,59.5,ug/l,median,,,,,,,all,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,670,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,63.5,ug/l,mean,SE,13.6,,,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,671,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,64.9,ug/l,median,,,,,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,672,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,51.04,ug/l,mean,SE,9.32,,,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,673,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,58.2,ug/l,median,,,,,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,674,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,32,ug/l,mean,S.E.,9,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,675,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,25,ug/l,median,,,minmax,6.9,67.2,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,676,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,14.5,ug/l,mean,S.E.,1.8,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,677,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,14.6,ug/l,median,,,minmax,6,20,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,678,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,220,mg/l h,mean,S.E.,60.5,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,679,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,174.1,mg/l h,median,,,minmax,91.1,542.2,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,680,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,173.5,mg/l h,mean,S.E.,9.9,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,681,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,181.8,mg/l h,median,,,minmax,143,211,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,682,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,45.4,mg/l h,mean,S.E.,13.2,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,683,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,31.34,mg/l h,median,,,minmax,18.4,115.6,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,684,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,24.7,mg/l h,mean,S.E.,2.3,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,685,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,26,mg/l h,median,,,minmax,16.1,30.8,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,686,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.2,l/h,mean,S.E.,0.5,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,687,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2,l/h,median,,,minmax,0.6,3.7,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,688,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.9,l/h,mean,S.E.,0.2,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,689,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.7,l/h,median,,,minmax,2.3,3.4,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,690,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,31.6,ml/(h kg),mean,S.E.,6.3,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,691,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,31.9,ml/(h kg),median,,,minmax,8.6,54.4,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,692,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,43,ml/(h kg),mean,S.E.,4.4,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,693,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,38.5,ml/(h kg),median,,,minmax,32.4,62.3,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,694,2025-12-02T16:05:09.448543
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,Cmax,0-1,h,108.7,ug/l,mean,SE,22.6,,,,,first hour after loading dose 40 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,667,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,Cmax,0-1,h,97.5,ug/l,median,,,minmax,19.9,292,,first hour after loading dose 40 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,668,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,concentration,5,h,57.3,ug/l,mean,,,,,,,all,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,669,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,concentration,5,h,59.5,ug/l,median,,,,,,,all,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,670,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,63.5,ug/l,mean,SE,13.6,,,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,671,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,64.9,ug/l,median,,,,,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,672,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,51.04,ug/l,mean,SE,9.32,,,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,673,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,58.2,ug/l,median,,,,,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,674,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,32,ug/l,mean,S.E.,9,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,675,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,25,ug/l,median,,,minmax,6.9,67.2,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,676,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,14.5,ug/l,mean,S.E.,1.8,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,677,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,14.6,ug/l,median,,,minmax,6,20,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,678,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,220,mg/l h,mean,S.E.,60.5,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,679,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,174.1,mg/l h,median,,,minmax,91.1,542.2,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,680,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,173.5,mg/l h,mean,S.E.,9.9,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,681,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,181.8,mg/l h,median,,,minmax,143,211,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,682,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,45.4,mg/l h,mean,S.E.,13.2,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,683,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,31.34,mg/l h,median,,,minmax,18.4,115.6,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,684,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,24.7,mg/l h,mean,S.E.,2.3,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,685,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,26,mg/l h,median,,,minmax,16.1,30.8,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,686,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.2,l/h,mean,S.E.,0.5,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,687,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2,l/h,median,,,minmax,0.6,3.7,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,688,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.9,l/h,mean,S.E.,0.2,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,689,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.7,l/h,median,,,minmax,2.3,3.4,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,690,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,31.6,ml/(h kg),mean,S.E.,6.3,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,691,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,31.9,ml/(h kg),median,,,minmax,8.6,54.4,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,692,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,43,ml/(h kg),mean,S.E.,4.4,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,693,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,38.5,ml/(h kg),median,,,minmax,32.4,62.3,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,694,2025-12-02T16:05:12.001940
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,Cmax,0-1,h,108.7,ug/l,mean,SE,22.6,,,,,first hour after loading dose 40 mg,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,661,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,Cmax,0-1,h,97.5,ug/l,median,,,minmax,19.9,292,,first hour after loading dose 40 mg,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,662,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,concentration,5,h,57.3,ug/l,mean,,,,,,,all,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,663,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,concentration,5,h,59.5,ug/l,median,,,,,,,all,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,664,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,63.5,ug/l,mean,SE,13.6,,,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,665,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,64.9,ug/l,median,,,,,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,666,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,51.04,ug/l,mean,SE,9.32,,,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,667,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,58.2,ug/l,median,,,,,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,668,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,32,ug/l,mean,S.E.,9,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,669,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,25,ug/l,median,,,minmax,6.9,67.2,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,670,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,14.5,ug/l,mean,S.E.,1.8,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,671,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,14.6,ug/l,median,,,minmax,6,20,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,672,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,220,mg/l h,mean,S.E.,60.5,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,673,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,174.1,mg/l h,median,,,minmax,91.1,542.2,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,674,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,173.5,mg/l h,mean,S.E.,9.9,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,675,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,181.8,mg/l h,median,,,minmax,143,211,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,676,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,45.4,mg/l h,mean,S.E.,13.2,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,677,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,31.34,mg/l h,median,,,minmax,18.4,115.6,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,678,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,24.7,mg/l h,mean,S.E.,2.3,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,679,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,26,mg/l h,median,,,minmax,16.1,30.8,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,680,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.2,l/h,mean,S.E.,0.5,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,681,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2,l/h,median,,,minmax,0.6,3.7,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,682,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.9,l/h,mean,S.E.,0.2,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,683,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.7,l/h,median,,,minmax,2.3,3.4,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,684,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,31.6,ml/(h kg),mean,S.E.,6.3,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,685,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,31.9,ml/(h kg),median,,,minmax,8.6,54.4,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,686,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,43,ml/(h kg),mean,S.E.,4.4,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,687,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,38.5,ml/(h kg),median,,,minmax,32.4,62.3,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,688,2025-12-02T16:05:15.923463
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,Cmax,0-1,h,108.7,ug/l,mean,SE,22.6,,,,,first hour after loading dose 40 mg,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,661,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,Cmax,0-1,h,97.5,ug/l,median,,,minmax,19.9,292,,first hour after loading dose 40 mg,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,662,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,concentration,5,h,57.3,ug/l,mean,,,,,,,all,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,663,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,14.0,concentration,5,h,59.5,ug/l,median,,,,,,,all,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,664,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,63.5,ug/l,mean,SE,13.6,,,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,665,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,64.9,ug/l,median,,,,,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,666,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,51.04,ug/l,mean,SE,9.32,,,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,667,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,concentration,5,h,58.2,ug/l,median,,,,,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,668,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,32,ug/l,mean,S.E.,9,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,669,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,25,ug/l,median,,,minmax,6.9,67.2,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,670,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,14.5,ug/l,mean,S.E.,1.8,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,671,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,C120h,120,h,14.6,ug/l,median,,,minmax,6,20,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,672,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,220,mg/l h,mean,S.E.,60.5,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,673,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,174.1,mg/l h,median,,,minmax,91.1,542.2,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,674,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,173.5,mg/l h,mean,S.E.,9.9,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,675,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,AUC0-120h,120,h,181.8,mg/l h,median,,,minmax,143,211,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,676,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,45.4,mg/l h,mean,S.E.,13.2,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,677,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,31.34,mg/l h,median,,,minmax,18.4,115.6,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,678,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,24.7,mg/l h,mean,S.E.,2.3,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,679,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,"AUC0-120h, nom",120,h,26,mg/l h,median,,,minmax,16.1,30.8,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,680,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.2,l/h,mean,S.E.,0.5,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,681,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2,l/h,median,,,minmax,0.6,3.7,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,682,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.9,l/h,mean,S.E.,0.2,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,683,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Cl,120,h,2.7,l/h,median,,,minmax,2.3,3.4,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,684,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,31.6,ml/(h kg),mean,S.E.,6.3,,,,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,685,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,31.9,ml/(h kg),median,,,minmax,8.6,54.4,,"Group 1, nifedipine slow release 60 mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,686,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,43,ml/(h kg),mean,S.E.,4.4,,,,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,687,2025-12-02T16:05:22.346295
18394772.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,7.0,Clnorm,120,h,38.5,ml/(h kg),median,,,minmax,32.4,62.3,,"Group 2, nifedipineGITS 90mg/d",PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,688,2025-12-02T16:05:22.346295
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,t1/2,,,1.35,hr,mean,SD,0.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,695,2025-12-02T16:05:09.448543
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,Clo,,,3.3,L/hr/kg,mean,SD,1.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,696,2025-12-02T16:05:09.448543
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,AUC,,,40.8,ug hr/L,mean,SD,6.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,697,2025-12-02T16:05:09.448543
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,Cmax,,,18.3,ug/L,mean,SD,1.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,698,2025-12-02T16:05:09.448543
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,t1/2,,,1.35,hr,mean,SD,0.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,695,2025-12-02T16:05:12.001940
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,Clo,,,3.3,L/hr/kg,mean,SD,1.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,696,2025-12-02T16:05:12.001940
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,AUC,,,40.8,ug hr/L,mean,SD,6.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,697,2025-12-02T16:05:12.001940
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,Cmax,,,18.3,ug/L,mean,SD,1.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,698,2025-12-02T16:05:12.001940
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,t1/2,,,1.35,hr,mean,SD,0.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,689,2025-12-02T16:05:15.923463
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,Clo,,,3.3,L/hr/kg,mean,SD,1.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,690,2025-12-02T16:05:15.923463
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,AUC,,,40.8,ug hr/L,mean,SD,6.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,691,2025-12-02T16:05:15.923463
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,Cmax,,,18.3,ug/L,mean,SD,1.9,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,692,2025-12-02T16:05:15.923463
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,t1/2,,,1.35,hr,mean,SD,0.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,689,2025-12-02T16:05:22.346295
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,Clo,,,3.3,L/hr/kg,mean,SD,1.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,690,2025-12-02T16:05:22.346295
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,AUC,,,40.8,ug hr/L,mean,SD,6.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,691,2025-12-02T16:05:22.346295
1951561.0,nifiedipine,nifiedipine,serum,maternal,postpartum,,8.0,Cmax,,,18.3,ug/L,mean,SD,1.9,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,692,2025-12-02T16:05:22.346295
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,AUC,,,86.1,ng/ml/h,mean,SD,61.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,699,2025-12-02T16:05:09.448543
21644845.0,nifiedipine,nifiedipine/oxidized nifedipine,plasma,maternal,3rd trimester,,20.0,nif:ox AUC ratio,,,2.83,,mean,SD,4.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,700,2025-12-02T16:05:09.448543
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,time to peak concentration,,,1,h,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,701,2025-12-02T16:05:09.448543
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,peak concentration,,,53.3,ng/ml,mean,SD,37.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,702,2025-12-02T16:05:09.448543
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,AUC,,,86.1,ng/ml/h,mean,SD,61.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,699,2025-12-02T16:05:12.001940
21644845.0,nifiedipine,nifiedipine/oxidized nifedipine,plasma,maternal,3rd trimester,,20.0,nif:ox AUC ratio,,,2.83,,mean,SD,4.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,700,2025-12-02T16:05:12.001940
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,time to peak concentration,,,1,h,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,701,2025-12-02T16:05:12.001940
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,peak concentration,,,53.3,ng/ml,mean,SD,37.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,702,2025-12-02T16:05:12.001940
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,AUC,,,86.1,ng/ml/h,mean,SD,61.1,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,693,2025-12-02T16:05:15.923463
21644845.0,nifiedipine,nifiedipine/oxidized nifedipine,plasma,maternal,3rd trimester,,20.0,nif:ox AUC ratio,,,2.83,,mean,SD,4.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,694,2025-12-02T16:05:15.923463
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,time to peak concentration,,,1,h,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,695,2025-12-02T16:05:15.923463
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,peak concentration,,,53.3,ng/ml,mean,SD,37.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,696,2025-12-02T16:05:15.923463
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,AUC,,,86.1,ng/ml/h,mean,SD,61.1,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,693,2025-12-02T16:05:22.346295
21644845.0,nifiedipine,nifiedipine/oxidized nifedipine,plasma,maternal,3rd trimester,,20.0,nif:ox AUC ratio,,,2.83,,mean,SD,4.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,694,2025-12-02T16:05:22.346295
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,time to peak concentration,,,1,h,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,695,2025-12-02T16:05:22.346295
21644845.0,nifiedipine,nifiedipine,plasma,maternal,3rd trimester,,20.0,peak concentration,,,53.3,ng/ml,mean,SD,37.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,696,2025-12-02T16:05:22.346295
2216229.0,nifiedipine,nifiedipine,serum,maternal,3rd trimester,,10.0,concentration at the time of the second Doppler examination,,,38.3,ng/mL,mean,SD,26.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,703,2025-12-02T16:05:09.448543
2216229.0,nifiedipine,nifiedipine,serum,maternal,delivery,,10.0,concentration,,,17.6,ng/mL,mean,SD,12.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,704,2025-12-02T16:05:09.448543
2216229.0,nifiedipine,nifiedipine,umbilical vein serum ,pediatric,,fetus,10.0,concentration,,,13.1,ng/mL,mean,SD,14,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,705,2025-12-02T16:05:09.448543
2216229.0,nifiedipine,nifiedipine,umbilical artery serum ,pediatric,,fetus,10.0,concentration,,,10,ng/mL,mean,SD,9.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,706,2025-12-02T16:05:09.448543
2216229.0,nifiedipine,nifiedipine,umbilical venous blood/maternal serum,maternal/pediatric,delivery,fetus,10.0,umbilical venous-maternal ratio of concentration,2.5,h,0.76,,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,707,2025-12-02T16:05:09.448543
2216229.0,nifiedipine,nifiedipine,serum,maternal,3rd trimester,,10.0,concentration at the time of the second Doppler examination,,,38.3,ng/mL,mean,SD,26.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,703,2025-12-02T16:05:12.001940
2216229.0,nifiedipine,nifiedipine,serum,maternal,delivery,,10.0,concentration,,,17.6,ng/mL,mean,SD,12.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,704,2025-12-02T16:05:12.001940
2216229.0,nifiedipine,nifiedipine,umbilical vein serum ,pediatric,,fetus,10.0,concentration,,,13.1,ng/mL,mean,SD,14,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,705,2025-12-02T16:05:12.001940
2216229.0,nifiedipine,nifiedipine,umbilical artery serum ,pediatric,,fetus,10.0,concentration,,,10,ng/mL,mean,SD,9.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,706,2025-12-02T16:05:12.001940
2216229.0,nifiedipine,nifiedipine,umbilical venous blood/maternal serum,maternal/pediatric,delivery,fetus,10.0,umbilical venous-maternal ratio of concentration,2.5,h,0.76,,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,707,2025-12-02T16:05:12.001940
2216229.0,nifiedipine,nifiedipine,serum,maternal,3rd trimester,,10.0,concentration at the time of the second Doppler examination,,,38.3,ng/mL,mean,SD,26.6,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,697,2025-12-02T16:05:15.923463
2216229.0,nifiedipine,nifiedipine,serum,maternal,delivery,,10.0,concentration,,,17.6,ng/mL,mean,SD,12.7,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,698,2025-12-02T16:05:15.923463
2216229.0,nifiedipine,nifiedipine,umbilical vein serum ,pediatric,,fetus,10.0,concentration,,,13.1,ng/mL,mean,SD,14,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,699,2025-12-02T16:05:15.923463
2216229.0,nifiedipine,nifiedipine,umbilical artery serum ,pediatric,,fetus,10.0,concentration,,,10,ng/mL,mean,SD,9.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,700,2025-12-02T16:05:15.923463
2216229.0,nifiedipine,nifiedipine,umbilical venous blood/maternal serum,maternal/pediatric,delivery,fetus,10.0,umbilical venous-maternal ratio of concentration,2.5,h,0.76,,mean,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,701,2025-12-02T16:05:15.923463
2216229.0,nifiedipine,nifiedipine,serum,maternal,3rd trimester,,10.0,concentration at the time of the second Doppler examination,,,38.3,ng/mL,mean,SD,26.6,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,697,2025-12-02T16:05:22.346295
2216229.0,nifiedipine,nifiedipine,serum,maternal,delivery,,10.0,concentration,,,17.6,ng/mL,mean,SD,12.7,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,698,2025-12-02T16:05:22.346295
2216229.0,nifiedipine,nifiedipine,umbilical vein serum ,pediatric,,fetus,10.0,concentration,,,13.1,ng/mL,mean,SD,14,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,699,2025-12-02T16:05:22.346295
2216229.0,nifiedipine,nifiedipine,umbilical artery serum ,pediatric,,fetus,10.0,concentration,,,10,ng/mL,mean,SD,9.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,700,2025-12-02T16:05:22.346295
2216229.0,nifiedipine,nifiedipine,umbilical venous blood/maternal serum,maternal/pediatric,delivery,fetus,10.0,umbilical venous-maternal ratio of concentration,2.5,h,0.76,,mean,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,701,2025-12-02T16:05:22.346295
2256493.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,20.0,concentration at the time of Doppler studies,95,h,60.3,ng/ml,mean,,,minmax,10,90,,the mean interval between starting starting treatment and the first postdrug Doppler study,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,708,2025-12-02T16:05:09.448543
2256493.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,20.0,concentration at the time of Doppler studies,95,h,60.3,ng/ml,mean,,,minmax,10,90,,the mean interval between starting starting treatment and the first postdrug Doppler study,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,708,2025-12-02T16:05:12.001940
2256493.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,20.0,concentration at the time of Doppler studies,95,h,60.3,ng/ml,mean,,,minmax,10,90,,the mean interval between starting starting treatment and the first postdrug Doppler study,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,702,2025-12-02T16:05:15.923463
2256493.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,20.0,concentration at the time of Doppler studies,95,h,60.3,ng/ml,mean,,,minmax,10,90,,the mean interval between starting starting treatment and the first postdrug Doppler study,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,702,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Cmax,,,165,ug/L,mean,SD,112,minmax,40.6,397,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,709,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Cave,,,41.2,ug/L,mean,SD,31,minmax,12.2,119,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,710,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Kel,,,0.55,/h,mean,SD,0.2,minmax,0.1,0.87,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,711,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,t1/2,,,1.68,h,mean,SD,1.56,minmax,0.79,6.91,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,712,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,CL/F,,,128,L/h,mean,SD,80.4,minmax,39.1,274.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,713,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Vd/F,,,295,L,mean,SD,262,minmax,60.6,832,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,714,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Cmax,,,89.9,ug/L,mean,SD,80.9,minmax,14.4,236,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,715,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Cave,,,20.4,ug/L,mean,SD,15,minmax,4.48,56.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,716,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Kel,,,0.59,/h,mean,SD,0.34,minmax,0.15,1.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,717,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,t1/2,,,1.67,h,mean,SD,1.19,minmax,0.54,4.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,718,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Cmax,,,102,ug/L,mean,SD,56.5,minmax,60.8,184,0.2,CYP3A5 high expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,719,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Cmax,,,190,ug/L,mean,SD,121,minmax,40.6,397,0.2,CYP3A5 low expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,720,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Cave,,,14.7,ug/L,mean,SD,2.5,minmax,12.2,18.2,0.002,CYP3A5 high expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,721,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Cave,,,51.8,ug/L,mean,SD,30.8,minmax,20.3,119,0.002,CYP3A5 low expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,722,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Kel,,,0.49,/h,mean,SD,0.18,minmax,0.29,0.71,0.5,CYP3A5 high expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,723,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Kel,,,0.58,/h,mean,SD,0.21,minmax,0.1,0.88,0.5,CYP3A5 low expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,724,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,t1/2,,,1.6,h,mean,SD,0.6,minmax,0.98,2.35,0.5,CYP3A5 high expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,725,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,t1/2,,,1.7,h,mean,SD,1.8,minmax,0.8,6.9,0.5,CYP3A5 low expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,726,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,CL/F,,,232,L/h,mean,SD,37.8,minmax,183,275,9.5e-05,CYP3A5 high expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,727,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,CL/F,,,85.6,L/h,mean,SD,45,minmax,39.1,164,9.5e-05,CYP3A5 low expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,728,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Vd/F,,,524,L,mean,SD,207,minmax,331,788,0.02,CYP3A5 high expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,729,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Vd/F,,,204,L,mean,SD,228,minmax,60.6,832,0.02,CYP3A5 low expressers,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,730,2025-12-02T16:05:09.448543
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Cmax,,,165,ug/L,mean,SD,112,minmax,40.6,397,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,709,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Cave,,,41.2,ug/L,mean,SD,31,minmax,12.2,119,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,710,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Kel,,,0.55,/h,mean,SD,0.2,minmax,0.1,0.87,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,711,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,t1/2,,,1.68,h,mean,SD,1.56,minmax,0.79,6.91,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,712,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,CL/F,,,128,L/h,mean,SD,80.4,minmax,39.1,274.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,713,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Vd/F,,,295,L,mean,SD,262,minmax,60.6,832,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,714,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Cmax,,,89.9,ug/L,mean,SD,80.9,minmax,14.4,236,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,715,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Cave,,,20.4,ug/L,mean,SD,15,minmax,4.48,56.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,716,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Kel,,,0.59,/h,mean,SD,0.34,minmax,0.15,1.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,717,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,t1/2,,,1.67,h,mean,SD,1.19,minmax,0.54,4.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,718,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Cmax,,,102,ug/L,mean,SD,56.5,minmax,60.8,184,0.2,CYP3A5 high expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,719,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Cmax,,,190,ug/L,mean,SD,121,minmax,40.6,397,0.2,CYP3A5 low expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,720,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Cave,,,14.7,ug/L,mean,SD,2.5,minmax,12.2,18.2,0.002,CYP3A5 high expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,721,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Cave,,,51.8,ug/L,mean,SD,30.8,minmax,20.3,119,0.002,CYP3A5 low expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,722,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Kel,,,0.49,/h,mean,SD,0.18,minmax,0.29,0.71,0.5,CYP3A5 high expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,723,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Kel,,,0.58,/h,mean,SD,0.21,minmax,0.1,0.88,0.5,CYP3A5 low expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,724,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,t1/2,,,1.6,h,mean,SD,0.6,minmax,0.98,2.35,0.5,CYP3A5 high expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,725,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,t1/2,,,1.7,h,mean,SD,1.8,minmax,0.8,6.9,0.5,CYP3A5 low expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,726,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,CL/F,,,232,L/h,mean,SD,37.8,minmax,183,275,9.5e-05,CYP3A5 high expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,727,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,CL/F,,,85.6,L/h,mean,SD,45,minmax,39.1,164,9.5e-05,CYP3A5 low expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,728,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Vd/F,,,524,L,mean,SD,207,minmax,331,788,0.02,CYP3A5 high expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,729,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Vd/F,,,204,L,mean,SD,228,minmax,60.6,832,0.02,CYP3A5 low expressers,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,730,2025-12-02T16:05:12.001940
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Cmax,,,165,ug/L,mean,SD,112,minmax,40.6,397,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,703,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Cave,,,41.2,ug/L,mean,SD,31,minmax,12.2,119,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,704,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Kel,,,0.55,/h,mean,SD,0.2,minmax,0.1,0.87,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,705,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,t1/2,,,1.68,h,mean,SD,1.56,minmax,0.79,6.91,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,706,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,CL/F,,,128,L/h,mean,SD,80.4,minmax,39.1,274.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,707,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Vd/F,,,295,L,mean,SD,262,minmax,60.6,832,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,708,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Cmax,,,89.9,ug/L,mean,SD,80.9,minmax,14.4,236,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,709,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Cave,,,20.4,ug/L,mean,SD,15,minmax,4.48,56.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,710,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Kel,,,0.59,/h,mean,SD,0.34,minmax,0.15,1.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,711,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,t1/2,,,1.67,h,mean,SD,1.19,minmax,0.54,4.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,712,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Cmax,,,102,ug/L,mean,SD,56.5,minmax,60.8,184,0.2,CYP3A5 high expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,713,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Cmax,,,190,ug/L,mean,SD,121,minmax,40.6,397,0.2,CYP3A5 low expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,714,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Cave,,,14.7,ug/L,mean,SD,2.5,minmax,12.2,18.2,0.002,CYP3A5 high expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,715,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Cave,,,51.8,ug/L,mean,SD,30.8,minmax,20.3,119,0.002,CYP3A5 low expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,716,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Kel,,,0.49,/h,mean,SD,0.18,minmax,0.29,0.71,0.5,CYP3A5 high expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,717,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Kel,,,0.58,/h,mean,SD,0.21,minmax,0.1,0.88,0.5,CYP3A5 low expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,718,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,t1/2,,,1.6,h,mean,SD,0.6,minmax,0.98,2.35,0.5,CYP3A5 high expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,719,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,t1/2,,,1.7,h,mean,SD,1.8,minmax,0.8,6.9,0.5,CYP3A5 low expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,720,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,CL/F,,,232,L/h,mean,SD,37.8,minmax,183,275,9.5e-05,CYP3A5 high expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,721,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,CL/F,,,85.6,L/h,mean,SD,45,minmax,39.1,164,9.5e-05,CYP3A5 low expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,722,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Vd/F,,,524,L,mean,SD,207,minmax,331,788,0.02,CYP3A5 high expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,723,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Vd/F,,,204,L,mean,SD,228,minmax,60.6,832,0.02,CYP3A5 low expressers,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,724,2025-12-02T16:05:15.923463
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Cmax,,,165,ug/L,mean,SD,112,minmax,40.6,397,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,703,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Cave,,,41.2,ug/L,mean,SD,31,minmax,12.2,119,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,704,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,Kel,,,0.55,/h,mean,SD,0.2,minmax,0.1,0.87,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,705,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,t1/2,,,1.68,h,mean,SD,1.56,minmax,0.79,6.91,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,706,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,14.0,CL/F,,,128,L/h,mean,SD,80.4,minmax,39.1,274.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,707,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Vd/F,,,295,L,mean,SD,262,minmax,60.6,832,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,708,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Cmax,,,89.9,ug/L,mean,SD,80.9,minmax,14.4,236,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,709,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Cave,,,20.4,ug/L,mean,SD,15,minmax,4.48,56.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,710,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,Kel,,,0.59,/h,mean,SD,0.34,minmax,0.15,1.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,711,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,oxidized nifiedipine,plasma,maternal,pregnancy,,14.0,t1/2,,,1.67,h,mean,SD,1.19,minmax,0.54,4.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,712,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Cmax,,,102,ug/L,mean,SD,56.5,minmax,60.8,184,0.2,CYP3A5 high expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,713,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Cmax,,,190,ug/L,mean,SD,121,minmax,40.6,397,0.2,CYP3A5 low expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,714,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Cave,,,14.7,ug/L,mean,SD,2.5,minmax,12.2,18.2,0.002,CYP3A5 high expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,715,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Cave,,,51.8,ug/L,mean,SD,30.8,minmax,20.3,119,0.002,CYP3A5 low expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,716,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Kel,,,0.49,/h,mean,SD,0.18,minmax,0.29,0.71,0.5,CYP3A5 high expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,717,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Kel,,,0.58,/h,mean,SD,0.21,minmax,0.1,0.88,0.5,CYP3A5 low expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,718,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,t1/2,,,1.6,h,mean,SD,0.6,minmax,0.98,2.35,0.5,CYP3A5 high expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,719,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,t1/2,,,1.7,h,mean,SD,1.8,minmax,0.8,6.9,0.5,CYP3A5 low expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,720,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,CL/F,,,232,L/h,mean,SD,37.8,minmax,183,275,9.5e-05,CYP3A5 high expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,721,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,CL/F,,,85.6,L/h,mean,SD,45,minmax,39.1,164,9.5e-05,CYP3A5 low expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,722,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,3.0,Vd/F,,,524,L,mean,SD,207,minmax,331,788,0.02,CYP3A5 high expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,723,2025-12-02T16:05:22.346295
22875663.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,10.0,Vd/F,,,204,L,mean,SD,228,minmax,60.6,832,0.02,CYP3A5 low expressers,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,724,2025-12-02T16:05:22.346295
2603904.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,13.0,trough concentration,,,7.2,ng/ml,mean,SD,5.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,731,2025-12-02T16:05:09.448543
2603904.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,13.0,half life,,,81,min,mean,,,minmax,49,137,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,732,2025-12-02T16:05:09.448543
2603904.0,nifiedipine,nifiedipine,plasma,pediatric,,neonate,5.0,concentration,,,,,,,,minmax,1.8,29.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,733,2025-12-02T16:05:09.448543
2603904.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,13.0,trough concentration,,,7.2,ng/ml,mean,SD,5.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,731,2025-12-02T16:05:12.001940
2603904.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,13.0,half life,,,81,min,mean,,,minmax,49,137,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,732,2025-12-02T16:05:12.001940
2603904.0,nifiedipine,nifiedipine,plasma,pediatric,,neonate,5.0,concentration,,,,,,,,minmax,1.8,29.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,733,2025-12-02T16:05:12.001940
2603904.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,13.0,trough concentration,,,7.2,ng/ml,mean,SD,5.5,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,725,2025-12-02T16:05:15.923463
2603904.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,13.0,half life,,,81,min,mean,,,minmax,49,137,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,726,2025-12-02T16:05:15.923463
2603904.0,nifiedipine,nifiedipine,plasma,pediatric,,neonate,5.0,concentration,,,,,,,,minmax,1.8,29.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,727,2025-12-02T16:05:15.923463
2603904.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,13.0,trough concentration,,,7.2,ng/ml,mean,SD,5.5,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,725,2025-12-02T16:05:22.346295
2603904.0,nifiedipine,nifiedipine,plasma,maternal,pregnancy,,13.0,half life,,,81,min,mean,,,minmax,49,137,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,726,2025-12-02T16:05:22.346295
2603904.0,nifiedipine,nifiedipine,plasma,pediatric,,neonate,5.0,concentration,,,,,,,,minmax,1.8,29.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,727,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Cmax,,,26.41,ng/ml,median,,,25th75th percentiles,23.98,29.88,0.23,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,734,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Cmax,,,23.52,ng/ml,median,,,25th75th percentiles,21.21,27.87,0.23,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,735,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,tmax,,,1.79,h,median,,,25th75th percentiles,1.24,1.96,0.46,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,736,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,tmax,,,1.48,h,median,,,25th75th percentiles,1.03,1.73,0.46,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,737,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,AUC0-12,,,235.99,ng h/ml,median,,,25th75th percentiles,203.72,261.97,0.38,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,738,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,AUC0-12,,,202.23,ng h/ml,median,,,25th75th percentiles,185.54,235.52,0.38,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,739,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Kel,,,0.16,/h,median,,,25th75th percentiles,0.15,0.18,0.72,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,740,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Kel,,,0.14,/h,median,,,25th75th percentiles,0.13,0.25,0.72,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,741,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,t1/2,,,4.34,h,median,,,25th75th percentiles,3.87,4.64,0.28,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,742,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,t1/2,,,5,h,median,,,25th75th percentiles,4.54,5.84,0.28,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,743,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Vd/F,,,560.96,I,median,,,25th75th percentiles,506.85,720.31,0.87,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,744,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Vd/F,,,609.4,I,median,,,25th75th percentiles,357.28,742.05,0.87,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,745,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,ClT/F,,,84.77,l/h,median,,,25th75th percentiles,76.37,98.24,0.38,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,746,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,ClT/F,,,98.94,l/h,median,,,25th75th percentiles,85.14,107.79,0.38,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,747,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,Umbilical vein/maternal vein plasma,maternal/pediatric,delivery,fetus,12.0,Umbilical vein/maternal vein ratio,,,0.53,,median,,,25th75th percentiles,0.35,0.74,0.5,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,748,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,Umbilical vein/maternal vein plasma,maternal/pediatric,delivery,fetus,10.0,Umbilical vein/maternal vein ratio,,,0.44,,median,,,25th75th percentiles,0.36,0.56,0.5,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,749,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,Intervillous space/maternal vein plasma,maternal/pediatric,delivery,fetus,12.0,Intervillous space/maternal vein ratio,,,0.78,,median,,,25th75th percentiles,0.62,0.99,0.97,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,750,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,Intervillous space/maternal vein plasma,maternal/pediatric,delivery,fetus,10.0,Intervillous space/maternal vein ratio,,,0.87,,median,,,25th75th percentiles,0.63,0.92,0.97,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,751,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,Umbilical artery/umbilical vein plasma,pediatric,,fetus,12.0,Umbilical artery/umbilical vein ratio,,,0.82,,median,,,25th75th percentiles,0.66,1.18,0.67,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,752,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,Umbilical artery/umbilical vein plasma,pediatric,,fetus,10.0,Umbilical artery/umbilical vein ratio,,,0.88,,median,,,25th75th percentiles,0.48,1.12,0.67,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,753,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,Amniotic fluid/maternal vein,maternal,delivery,,12.0,Amniotic fluid/maternal vein ratio,,,0.05,,median,,,25th75th percentiles,0.02,0.08,0.79,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,754,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,Amniotic fluid/maternal vein,maternal,delivery,,10.0,Amniotic fluid/maternal vein ratio,,,0.05,,median,,,25th75th percentiles,0.04,0.08,0.79,T2DM,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,755,2025-12-02T16:05:09.448543
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Cmax,,,26.41,ng/ml,median,,,25th75th percentiles,23.98,29.88,0.23,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,734,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Cmax,,,23.52,ng/ml,median,,,25th75th percentiles,21.21,27.87,0.23,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,735,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,tmax,,,1.79,h,median,,,25th75th percentiles,1.24,1.96,0.46,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,736,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,tmax,,,1.48,h,median,,,25th75th percentiles,1.03,1.73,0.46,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,737,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,AUC0-12,,,235.99,ng h/ml,median,,,25th75th percentiles,203.72,261.97,0.38,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,738,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,AUC0-12,,,202.23,ng h/ml,median,,,25th75th percentiles,185.54,235.52,0.38,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,739,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Kel,,,0.16,/h,median,,,25th75th percentiles,0.15,0.18,0.72,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,740,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Kel,,,0.14,/h,median,,,25th75th percentiles,0.13,0.25,0.72,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,741,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,t1/2,,,4.34,h,median,,,25th75th percentiles,3.87,4.64,0.28,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,742,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,t1/2,,,5,h,median,,,25th75th percentiles,4.54,5.84,0.28,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,743,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Vd/F,,,560.96,I,median,,,25th75th percentiles,506.85,720.31,0.87,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,744,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Vd/F,,,609.4,I,median,,,25th75th percentiles,357.28,742.05,0.87,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,745,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,ClT/F,,,84.77,l/h,median,,,25th75th percentiles,76.37,98.24,0.38,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,746,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,ClT/F,,,98.94,l/h,median,,,25th75th percentiles,85.14,107.79,0.38,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,747,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,Umbilical vein/maternal vein plasma,maternal/pediatric,delivery,fetus,12.0,Umbilical vein/maternal vein ratio,,,0.53,,median,,,25th75th percentiles,0.35,0.74,0.5,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,748,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,Umbilical vein/maternal vein plasma,maternal/pediatric,delivery,fetus,10.0,Umbilical vein/maternal vein ratio,,,0.44,,median,,,25th75th percentiles,0.36,0.56,0.5,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,749,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,Intervillous space/maternal vein plasma,maternal/pediatric,delivery,fetus,12.0,Intervillous space/maternal vein ratio,,,0.78,,median,,,25th75th percentiles,0.62,0.99,0.97,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,750,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,Intervillous space/maternal vein plasma,maternal/pediatric,delivery,fetus,10.0,Intervillous space/maternal vein ratio,,,0.87,,median,,,25th75th percentiles,0.63,0.92,0.97,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,751,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,Umbilical artery/umbilical vein plasma,pediatric,,fetus,12.0,Umbilical artery/umbilical vein ratio,,,0.82,,median,,,25th75th percentiles,0.66,1.18,0.67,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,752,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,Umbilical artery/umbilical vein plasma,pediatric,,fetus,10.0,Umbilical artery/umbilical vein ratio,,,0.88,,median,,,25th75th percentiles,0.48,1.12,0.67,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,753,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,Amniotic fluid/maternal vein,maternal,delivery,,12.0,Amniotic fluid/maternal vein ratio,,,0.05,,median,,,25th75th percentiles,0.02,0.08,0.79,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,754,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,Amniotic fluid/maternal vein,maternal,delivery,,10.0,Amniotic fluid/maternal vein ratio,,,0.05,,median,,,25th75th percentiles,0.04,0.08,0.79,T2DM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,755,2025-12-02T16:05:12.001940
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Cmax,,,26.41,ng/ml,median,,,25th75th percentiles,23.98,29.88,0.23,control,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,728,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Cmax,,,23.52,ng/ml,median,,,25th75th percentiles,21.21,27.87,0.23,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,729,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,tmax,,,1.79,h,median,,,25th75th percentiles,1.24,1.96,0.46,control,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,730,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,tmax,,,1.48,h,median,,,25th75th percentiles,1.03,1.73,0.46,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,731,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,AUC0-12,,,235.99,ng h/ml,median,,,25th75th percentiles,203.72,261.97,0.38,control,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,732,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,AUC0-12,,,202.23,ng h/ml,median,,,25th75th percentiles,185.54,235.52,0.38,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,733,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Kel,,,0.16,/h,median,,,25th75th percentiles,0.15,0.18,0.72,control,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,734,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Kel,,,0.14,/h,median,,,25th75th percentiles,0.13,0.25,0.72,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,735,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,t1/2,,,4.34,h,median,,,25th75th percentiles,3.87,4.64,0.28,control,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,736,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,t1/2,,,5,h,median,,,25th75th percentiles,4.54,5.84,0.28,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,737,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Vd/F,,,560.96,I,median,,,25th75th percentiles,506.85,720.31,0.87,control,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,738,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Vd/F,,,609.4,I,median,,,25th75th percentiles,357.28,742.05,0.87,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,739,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,ClT/F,,,84.77,l/h,median,,,25th75th percentiles,76.37,98.24,0.38,control,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,740,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,ClT/F,,,98.94,l/h,median,,,25th75th percentiles,85.14,107.79,0.38,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,741,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,Umbilical vein/maternal vein plasma,maternal/pediatric,delivery,fetus,12.0,Umbilical vein/maternal vein ratio,,,0.53,,median,,,25th75th percentiles,0.35,0.74,0.5,control,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,742,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,Umbilical vein/maternal vein plasma,maternal/pediatric,delivery,fetus,10.0,Umbilical vein/maternal vein ratio,,,0.44,,median,,,25th75th percentiles,0.36,0.56,0.5,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,743,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,Intervillous space/maternal vein plasma,maternal/pediatric,delivery,fetus,12.0,Intervillous space/maternal vein ratio,,,0.78,,median,,,25th75th percentiles,0.62,0.99,0.97,control,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,744,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,Intervillous space/maternal vein plasma,maternal/pediatric,delivery,fetus,10.0,Intervillous space/maternal vein ratio,,,0.87,,median,,,25th75th percentiles,0.63,0.92,0.97,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,745,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,Umbilical artery/umbilical vein plasma,pediatric,,fetus,12.0,Umbilical artery/umbilical vein ratio,,,0.82,,median,,,25th75th percentiles,0.66,1.18,0.67,control,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,746,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,Umbilical artery/umbilical vein plasma,pediatric,,fetus,10.0,Umbilical artery/umbilical vein ratio,,,0.88,,median,,,25th75th percentiles,0.48,1.12,0.67,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,747,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,Amniotic fluid/maternal vein,maternal,delivery,,12.0,Amniotic fluid/maternal vein ratio,,,0.05,,median,,,25th75th percentiles,0.02,0.08,0.79,control,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,748,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,Amniotic fluid/maternal vein,maternal,delivery,,10.0,Amniotic fluid/maternal vein ratio,,,0.05,,median,,,25th75th percentiles,0.04,0.08,0.79,T2DM,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,749,2025-12-02T16:05:15.923463
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Cmax,,,26.41,ng/ml,median,,,25th75th percentiles,23.98,29.88,0.23,control,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,728,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Cmax,,,23.52,ng/ml,median,,,25th75th percentiles,21.21,27.87,0.23,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,729,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,tmax,,,1.79,h,median,,,25th75th percentiles,1.24,1.96,0.46,control,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,730,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,tmax,,,1.48,h,median,,,25th75th percentiles,1.03,1.73,0.46,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,731,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,AUC0-12,,,235.99,ng h/ml,median,,,25th75th percentiles,203.72,261.97,0.38,control,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,732,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,AUC0-12,,,202.23,ng h/ml,median,,,25th75th percentiles,185.54,235.52,0.38,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,733,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Kel,,,0.16,/h,median,,,25th75th percentiles,0.15,0.18,0.72,control,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,734,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Kel,,,0.14,/h,median,,,25th75th percentiles,0.13,0.25,0.72,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,735,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,t1/2,,,4.34,h,median,,,25th75th percentiles,3.87,4.64,0.28,control,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,736,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,t1/2,,,5,h,median,,,25th75th percentiles,4.54,5.84,0.28,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,737,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,Vd/F,,,560.96,I,median,,,25th75th percentiles,506.85,720.31,0.87,control,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,738,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,Vd/F,,,609.4,I,median,,,25th75th percentiles,357.28,742.05,0.87,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,739,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,12.0,ClT/F,,,84.77,l/h,median,,,25th75th percentiles,76.37,98.24,0.38,control,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,740,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,10.0,ClT/F,,,98.94,l/h,median,,,25th75th percentiles,85.14,107.79,0.38,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,741,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,Umbilical vein/maternal vein plasma,maternal/pediatric,delivery,fetus,12.0,Umbilical vein/maternal vein ratio,,,0.53,,median,,,25th75th percentiles,0.35,0.74,0.5,control,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,742,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,Umbilical vein/maternal vein plasma,maternal/pediatric,delivery,fetus,10.0,Umbilical vein/maternal vein ratio,,,0.44,,median,,,25th75th percentiles,0.36,0.56,0.5,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,743,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,Intervillous space/maternal vein plasma,maternal/pediatric,delivery,fetus,12.0,Intervillous space/maternal vein ratio,,,0.78,,median,,,25th75th percentiles,0.62,0.99,0.97,control,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,744,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,Intervillous space/maternal vein plasma,maternal/pediatric,delivery,fetus,10.0,Intervillous space/maternal vein ratio,,,0.87,,median,,,25th75th percentiles,0.63,0.92,0.97,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,745,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,Umbilical artery/umbilical vein plasma,pediatric,,fetus,12.0,Umbilical artery/umbilical vein ratio,,,0.82,,median,,,25th75th percentiles,0.66,1.18,0.67,control,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,746,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,Umbilical artery/umbilical vein plasma,pediatric,,fetus,10.0,Umbilical artery/umbilical vein ratio,,,0.88,,median,,,25th75th percentiles,0.48,1.12,0.67,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,747,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,Amniotic fluid/maternal vein,maternal,delivery,,12.0,Amniotic fluid/maternal vein ratio,,,0.05,,median,,,25th75th percentiles,0.02,0.08,0.79,control,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,748,2025-12-02T16:05:22.346295
28042936.0,nifedipine,nifedipine,Amniotic fluid/maternal vein,maternal,delivery,,10.0,Amniotic fluid/maternal vein ratio,,,0.05,,median,,,25th75th percentiles,0.04,0.08,0.79,T2DM,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,749,2025-12-02T16:05:22.346295
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,38.0,Ctrough,,,22.6,ng/ml,mean,SD,17.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,756,2025-12-02T16:05:09.448543
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,38.0,Ctrough,,,19.2,ng/ml,median,,,minmax,5.5,99.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,757,2025-12-02T16:05:09.448543
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Cmax,,,30.9,ng/ml,mean,SD,15.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,758,2025-12-02T16:05:09.448543
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Cmax,,,24.9,ng/ml,median,,,minmax,9.4,59.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,759,2025-12-02T16:05:09.448543
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Tmax,,,1.7,h,mean,SD,1.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,760,2025-12-02T16:05:09.448543
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Tmax,,,1.26,h,median,,,minmax,1.03,5.13,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,761,2025-12-02T16:05:09.448543
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,AUCtau,,,152.3,(ng/ml) h,mean,SD,91.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,762,2025-12-02T16:05:09.448543
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,AUCtau,,,124.2,(ng/ml) h,median,,,minmax,60.5,470.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,763,2025-12-02T16:05:09.448543
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,CL/F,,,0.17,L/h,mean,SD,0.08,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,764,2025-12-02T16:05:09.448543
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,CL/F,,,0.16,L/h,median,,,minmax,0.04,0.33,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,765,2025-12-02T16:05:09.448543
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,38.0,Ctrough,,,22.6,ng/ml,mean,SD,17.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,756,2025-12-02T16:05:12.001940
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,38.0,Ctrough,,,19.2,ng/ml,median,,,minmax,5.5,99.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,757,2025-12-02T16:05:12.001940
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Cmax,,,30.9,ng/ml,mean,SD,15.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,758,2025-12-02T16:05:12.001940
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Cmax,,,24.9,ng/ml,median,,,minmax,9.4,59.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,759,2025-12-02T16:05:12.001940
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Tmax,,,1.7,h,mean,SD,1.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,760,2025-12-02T16:05:12.001940
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Tmax,,,1.26,h,median,,,minmax,1.03,5.13,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,761,2025-12-02T16:05:12.001940
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,AUCtau,,,152.3,(ng/ml) h,mean,SD,91.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,762,2025-12-02T16:05:12.001940
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,AUCtau,,,124.2,(ng/ml) h,median,,,minmax,60.5,470.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,763,2025-12-02T16:05:12.001940
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,CL/F,,,0.17,L/h,mean,SD,0.08,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,764,2025-12-02T16:05:12.001940
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,CL/F,,,0.16,L/h,median,,,minmax,0.04,0.33,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,765,2025-12-02T16:05:12.001940
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,38.0,Ctrough,,,22.6,ng/ml,mean,SD,17.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,750,2025-12-02T16:05:15.923463
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,38.0,Ctrough,,,19.2,ng/ml,median,,,minmax,5.5,99.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,751,2025-12-02T16:05:15.923463
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Cmax,,,30.9,ng/ml,mean,SD,15.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,752,2025-12-02T16:05:15.923463
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Cmax,,,24.9,ng/ml,median,,,minmax,9.4,59.7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,753,2025-12-02T16:05:15.923463
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Tmax,,,1.7,h,mean,SD,1.1,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,754,2025-12-02T16:05:15.923463
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Tmax,,,1.26,h,median,,,minmax,1.03,5.13,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,755,2025-12-02T16:05:15.923463
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,AUCtau,,,152.3,(ng/ml) h,mean,SD,91.8,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,756,2025-12-02T16:05:15.923463
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,AUCtau,,,124.2,(ng/ml) h,median,,,minmax,60.5,470.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,757,2025-12-02T16:05:15.923463
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,CL/F,,,0.17,L/h,mean,SD,0.08,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,758,2025-12-02T16:05:15.923463
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,CL/F,,,0.16,L/h,median,,,minmax,0.04,0.33,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,759,2025-12-02T16:05:15.923463
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,38.0,Ctrough,,,22.6,ng/ml,mean,SD,17.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,750,2025-12-02T16:05:22.346295
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,38.0,Ctrough,,,19.2,ng/ml,median,,,minmax,5.5,99.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,751,2025-12-02T16:05:22.346295
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Cmax,,,30.9,ng/ml,mean,SD,15.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,752,2025-12-02T16:05:22.346295
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Cmax,,,24.9,ng/ml,median,,,minmax,9.4,59.7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,753,2025-12-02T16:05:22.346295
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Tmax,,,1.7,h,mean,SD,1.1,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,754,2025-12-02T16:05:22.346295
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,Tmax,,,1.26,h,median,,,minmax,1.03,5.13,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,755,2025-12-02T16:05:22.346295
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,AUCtau,,,152.3,(ng/ml) h,mean,SD,91.8,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,756,2025-12-02T16:05:22.346295
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,AUCtau,,,124.2,(ng/ml) h,median,,,minmax,60.5,470.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,757,2025-12-02T16:05:22.346295
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,CL/F,,,0.17,L/h,mean,SD,0.08,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,758,2025-12-02T16:05:22.346295
37987176.0,nifedipine,nifedipine,plasma,maternal,3rd trimester,,32.0,CL/F,,,0.16,L/h,median,,,minmax,0.04,0.33,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,759,2025-12-02T16:05:22.346295
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Css,,,16.8,ug/L,median,,,minmax,<10,33,,nifedipine,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,766,2025-12-02T16:05:09.448543
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Vd,,,6.2,L/kg,mean,SD,1.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,767,2025-12-02T16:05:09.448543
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Kel,,,0.2155,,mean,SD,0.0821,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,768,2025-12-02T16:05:09.448543
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,t1/2,,,3.2,h,mean,,,minmax,2,5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,769,2025-12-02T16:05:09.448543
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Css,,,16.8,ug/L,median,,,minmax,<10,33,,nifedipine,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,766,2025-12-02T16:05:12.001940
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Vd,,,6.2,L/kg,mean,SD,1.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,767,2025-12-02T16:05:12.001940
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Kel,,,0.2155,,mean,SD,0.0821,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,768,2025-12-02T16:05:12.001940
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,t1/2,,,3.2,h,mean,,,minmax,2,5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,769,2025-12-02T16:05:12.001940
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Css,,,16.8,ug/L,median,,,minmax,<10,33,,nifedipine,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,760,2025-12-02T16:05:15.923463
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Vd,,,6.2,L/kg,mean,SD,1.9,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,761,2025-12-02T16:05:15.923463
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Kel,,,0.2155,,mean,SD,0.0821,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,762,2025-12-02T16:05:15.923463
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,t1/2,,,3.2,h,mean,,,minmax,2,5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,763,2025-12-02T16:05:15.923463
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Css,,,16.8,ug/L,median,,,minmax,<10,33,,nifedipine,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,760,2025-12-02T16:05:22.346295
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Vd,,,6.2,L/kg,mean,SD,1.9,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,761,2025-12-02T16:05:22.346295
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,Kel,,,0.2155,,mean,SD,0.0821,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,762,2025-12-02T16:05:22.346295
25407260.0,nifedipine,nifedipine,plasma,maternal,pregnancy,,8.0,t1/2,,,3.2,h,mean,,,minmax,2,5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,763,2025-12-02T16:05:22.346295
30659932.0,nifedipine,nifedipine,plasma,maternal,lactation,,13.0,trough concentration,,,44.3,ng/ml,median,,,minmax,8.32,178.1,0.965,ABCG2 421 CC,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,770,2025-12-02T16:05:09.448543
30659932.0,nifedipine,nifedipine,plasma,maternal,lactation,,6.0,trough concentration,,,40.65,ng/ml,median,,,minmax,11.8,73.8,0.965,ABCG2 421 CA,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,771,2025-12-02T16:05:09.448543
30659932.0,nifedipine,nifedipine,breast milk,maternal,lactation,,13.0,concentration,,,10.5,ng/ml,median,,,,,,0.0793,ABCG2 421 CC,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,772,2025-12-02T16:05:09.448543
30659932.0,nifedipine,nifedipine,breast milk,maternal,lactation,,6.0,concentration,,,29,ng/ml,median,,,,,,0.0793,ABCG2 421 CA,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,773,2025-12-02T16:05:09.448543
30659932.0,nifedipine,nifedipine,breast milk/plasma,maternal,lactation,,13.0,breast milk/plasma concentration ratio,,,0.73,,median,,,minmax,0.06,1.32,0.01,ABCG2 421 CC,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,774,2025-12-02T16:05:09.448543
30659932.0,nifedipine,nifedipine,plasma,maternal,lactation,,13.0,trough concentration,,,44.3,ng/ml,median,,,minmax,8.32,178.1,0.965,ABCG2 421 CC,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,770,2025-12-02T16:05:12.001940
30659932.0,nifedipine,nifedipine,plasma,maternal,lactation,,6.0,trough concentration,,,40.65,ng/ml,median,,,minmax,11.8,73.8,0.965,ABCG2 421 CA,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,771,2025-12-02T16:05:12.001940
30659932.0,nifedipine,nifedipine,breast milk,maternal,lactation,,13.0,concentration,,,10.5,ng/ml,median,,,,,,0.0793,ABCG2 421 CC,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,772,2025-12-02T16:05:12.001940
30659932.0,nifedipine,nifedipine,breast milk,maternal,lactation,,6.0,concentration,,,29,ng/ml,median,,,,,,0.0793,ABCG2 421 CA,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,773,2025-12-02T16:05:12.001940
30659932.0,nifedipine,nifedipine,breast milk/plasma,maternal,lactation,,13.0,breast milk/plasma concentration ratio,,,0.73,,median,,,minmax,0.06,1.32,0.01,ABCG2 421 CC,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,774,2025-12-02T16:05:12.001940
30659932.0,nifedipine,nifedipine,plasma,maternal,lactation,,13.0,trough concentration,,,44.3,ng/ml,median,,,minmax,8.32,178.1,0.965,ABCG2 421 CC,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,764,2025-12-02T16:05:15.923463
30659932.0,nifedipine,nifedipine,plasma,maternal,lactation,,6.0,trough concentration,,,40.65,ng/ml,median,,,minmax,11.8,73.8,0.965,ABCG2 421 CA,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,765,2025-12-02T16:05:15.923463
30659932.0,nifedipine,nifedipine,breast milk,maternal,lactation,,13.0,concentration,,,10.5,ng/ml,median,,,,,,0.0793,ABCG2 421 CC,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,766,2025-12-02T16:05:15.923463
30659932.0,nifedipine,nifedipine,breast milk,maternal,lactation,,6.0,concentration,,,29,ng/ml,median,,,,,,0.0793,ABCG2 421 CA,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,767,2025-12-02T16:05:15.923463
30659932.0,nifedipine,nifedipine,breast milk/plasma,maternal,lactation,,13.0,breast milk/plasma concentration ratio,,,0.73,,median,,,minmax,0.06,1.32,0.01,ABCG2 421 CC,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,768,2025-12-02T16:05:15.923463
30659932.0,nifedipine,nifedipine,plasma,maternal,lactation,,13.0,trough concentration,,,44.3,ng/ml,median,,,minmax,8.32,178.1,0.965,ABCG2 421 CC,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,764,2025-12-02T16:05:22.346295
30659932.0,nifedipine,nifedipine,plasma,maternal,lactation,,6.0,trough concentration,,,40.65,ng/ml,median,,,minmax,11.8,73.8,0.965,ABCG2 421 CA,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,765,2025-12-02T16:05:22.346295
30659932.0,nifedipine,nifedipine,breast milk,maternal,lactation,,13.0,concentration,,,10.5,ng/ml,median,,,,,,0.0793,ABCG2 421 CC,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,766,2025-12-02T16:05:22.346295
30659932.0,nifedipine,nifedipine,breast milk,maternal,lactation,,6.0,concentration,,,29,ng/ml,median,,,,,,0.0793,ABCG2 421 CA,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,767,2025-12-02T16:05:22.346295
30659932.0,nifedipine,nifedipine,breast milk/plasma,maternal,lactation,,13.0,breast milk/plasma concentration ratio,,,0.73,,median,,,minmax,0.06,1.32,0.01,ABCG2 421 CC,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,768,2025-12-02T16:05:22.346295
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,tss,,,30,min,median,,,minmax,20,60,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,775,2025-12-02T16:05:09.448543
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,Css,,,0.026,ug/ml,mean,SD,0.013,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,776,2025-12-02T16:05:09.448543
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,AUCFV (0-120 min),,,2.5,(ug/ml) min,mean,SD,1.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,777,2025-12-02T16:05:09.448543
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TPTss,,,2.6,%,mean,SD,1.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,778,2025-12-02T16:05:09.448543
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TPTA,,,2.1,%,mean,SD,1.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,779,2025-12-02T16:05:09.448543
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TI,,,0.32,,mean,SD,0.19,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,780,2025-12-02T16:05:09.448543
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,tss,,,30,min,median,,,minmax,20,60,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,775,2025-12-02T16:05:12.001940
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,Css,,,0.026,ug/ml,mean,SD,0.013,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,776,2025-12-02T16:05:12.001940
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,AUCFV (0-120 min),,,2.5,(ug/ml) min,mean,SD,1.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,777,2025-12-02T16:05:12.001940
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TPTss,,,2.6,%,mean,SD,1.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,778,2025-12-02T16:05:12.001940
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TPTA,,,2.1,%,mean,SD,1.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,779,2025-12-02T16:05:12.001940
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TI,,,0.32,,mean,SD,0.19,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,780,2025-12-02T16:05:12.001940
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,tss,,,30,min,median,,,minmax,20,60,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,769,2025-12-02T16:05:15.923463
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,Css,,,0.026,ug/ml,mean,SD,0.013,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,770,2025-12-02T16:05:15.923463
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,AUCFV (0-120 min),,,2.5,(ug/ml) min,mean,SD,1.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,771,2025-12-02T16:05:15.923463
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TPTss,,,2.6,%,mean,SD,1.6,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,772,2025-12-02T16:05:15.923463
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TPTA,,,2.1,%,mean,SD,1.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,773,2025-12-02T16:05:15.923463
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TI,,,0.32,,mean,SD,0.19,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,774,2025-12-02T16:05:15.923463
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,tss,,,30,min,median,,,minmax,20,60,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,769,2025-12-02T16:05:22.346295
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,Css,,,0.026,ug/ml,mean,SD,0.013,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,770,2025-12-02T16:05:22.346295
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,AUCFV (0-120 min),,,2.5,(ug/ml) min,mean,SD,1.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,771,2025-12-02T16:05:22.346295
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TPTss,,,2.6,%,mean,SD,1.6,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,772,2025-12-02T16:05:22.346295
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TPTA,,,2.1,%,mean,SD,1.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,773,2025-12-02T16:05:22.346295
10847234.0,azithromycin,azithromycin,placenta perfusate,maternal,delivery,,7.0,TI,,,0.32,,mean,SD,0.19,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,774,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,2.0,concentration,6,h,311,ng/ml,mean,SD,170,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,781,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,2.0,concentration,6,h,42230,ng/ml,mean,SD,4846,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,782,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,2.0,concentration,6,h,1382,ng/ml,mean,SD,549,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,783,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,2.0,concentration,6,h,1041,ng/ml,mean,SD,706,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,784,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,2.0,concentration,6,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,785,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,2.0,concentration,6,h,19.1,ng/ml,mean,SD,5.5,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,786,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,2.0,concentration,6,h,151,ng/ml,mean,SD,46,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,787,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,2.0,concentration,6,h,2130,ng/ml,mean,SD,340,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,788,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,7.0,concentration,12,h,144,ng/ml,mean,SD,79,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,789,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,7.0,concentration,12,h,32620,ng/ml,mean,SD,20572,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,790,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,7.0,concentration,12,h,1792,ng/ml,mean,SD,1107,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,791,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,7.0,concentration,12,h,494,ng/ml,mean,SD,204,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,792,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,7.0,concentration,12,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,793,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,7.0,concentration,12,h,26.4,ng/ml,mean,SD,15.5,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,794,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,7.0,concentration,12,h,30,ng/ml,mean,SD,11,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,795,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,7.0,concentration,12,h,1196,ng/ml,mean,SD,224,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,796,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,5.0,concentration,24,h,63,ng/ml,mean,SD,37,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,797,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,5.0,concentration,24,h,10733,ng/ml,mean,SD,5468,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,798,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,5.0,concentration,24,h,1299,ng/ml,mean,SD,466,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,799,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,5.0,concentration,24,h,599,ng/ml,mean,SD,330,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,800,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,5.0,concentration,24,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,801,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,5.0,concentration,24,h,27.1,ng/ml,mean,SD,12.8,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,802,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,5.0,concentration,24,h,36,ng/ml,mean,SD,27,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,803,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,5.0,concentration,24,h,936,ng/ml,mean,SD,223,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,804,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,5.0,concentration,72,h,60,ng/ml,mean,SD,31,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,805,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,5.0,concentration,72,h,5861,ng/ml,mean,SD,3333,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,806,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,5.0,concentration,72,h,961,ng/ml,mean,SD,419,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,807,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,5.0,concentration,72,h,551,ng/ml,mean,SD,129,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,808,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,5.0,concentration,72,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,809,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,5.0,concentration,72,h,19,ng/ml,mean,SD,6.7,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,810,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,5.0,concentration,72,h,23,ng/ml,mean,SD,13,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,811,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,5.0,concentration,72,h,915,ng/ml,mean,SD,628,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,812,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,1.0,concentration,168,h,<10.4,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,813,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,1.0,concentration,168,h,<1000,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,814,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,1.0,concentration,168,h,36,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,815,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,1.0,concentration,168,h,41,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,816,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,1.0,concentration,168,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,817,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,1.0,concentration,168,h,<10.4,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,818,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,1.0,concentration,168,h,17,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,819,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,1.0,concentration,168,h,40,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,820,2025-12-02T16:05:09.448543
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,2.0,concentration,6,h,311,ng/ml,mean,SD,170,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,781,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,2.0,concentration,6,h,42230,ng/ml,mean,SD,4846,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,782,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,2.0,concentration,6,h,1382,ng/ml,mean,SD,549,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,783,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,2.0,concentration,6,h,1041,ng/ml,mean,SD,706,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,784,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,2.0,concentration,6,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,785,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,2.0,concentration,6,h,19.1,ng/ml,mean,SD,5.5,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,786,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,2.0,concentration,6,h,151,ng/ml,mean,SD,46,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,787,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,2.0,concentration,6,h,2130,ng/ml,mean,SD,340,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,788,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,7.0,concentration,12,h,144,ng/ml,mean,SD,79,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,789,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,7.0,concentration,12,h,32620,ng/ml,mean,SD,20572,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,790,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,7.0,concentration,12,h,1792,ng/ml,mean,SD,1107,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,791,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,7.0,concentration,12,h,494,ng/ml,mean,SD,204,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,792,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,7.0,concentration,12,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,793,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,7.0,concentration,12,h,26.4,ng/ml,mean,SD,15.5,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,794,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,7.0,concentration,12,h,30,ng/ml,mean,SD,11,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,795,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,7.0,concentration,12,h,1196,ng/ml,mean,SD,224,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,796,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,5.0,concentration,24,h,63,ng/ml,mean,SD,37,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,797,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,5.0,concentration,24,h,10733,ng/ml,mean,SD,5468,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,798,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,5.0,concentration,24,h,1299,ng/ml,mean,SD,466,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,799,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,5.0,concentration,24,h,599,ng/ml,mean,SD,330,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,800,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,5.0,concentration,24,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,801,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,5.0,concentration,24,h,27.1,ng/ml,mean,SD,12.8,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,802,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,5.0,concentration,24,h,36,ng/ml,mean,SD,27,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,803,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,5.0,concentration,24,h,936,ng/ml,mean,SD,223,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,804,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,5.0,concentration,72,h,60,ng/ml,mean,SD,31,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,805,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,5.0,concentration,72,h,5861,ng/ml,mean,SD,3333,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,806,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,5.0,concentration,72,h,961,ng/ml,mean,SD,419,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,807,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,5.0,concentration,72,h,551,ng/ml,mean,SD,129,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,808,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,5.0,concentration,72,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,809,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,5.0,concentration,72,h,19,ng/ml,mean,SD,6.7,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,810,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,5.0,concentration,72,h,23,ng/ml,mean,SD,13,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,811,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,5.0,concentration,72,h,915,ng/ml,mean,SD,628,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,812,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,1.0,concentration,168,h,<10.4,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,813,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,1.0,concentration,168,h,<1000,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,814,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,1.0,concentration,168,h,36,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,815,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,1.0,concentration,168,h,41,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,816,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,1.0,concentration,168,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,817,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,1.0,concentration,168,h,<10.4,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,818,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,1.0,concentration,168,h,17,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,819,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,1.0,concentration,168,h,40,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,820,2025-12-02T16:05:12.001940
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,2.0,concentration,6,h,311,ng/ml,mean,SD,170,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,775,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,2.0,concentration,6,h,42230,ng/ml,mean,SD,4846,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,776,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,2.0,concentration,6,h,1382,ng/ml,mean,SD,549,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,777,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,2.0,concentration,6,h,1041,ng/ml,mean,SD,706,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,778,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,2.0,concentration,6,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,779,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,2.0,concentration,6,h,19.1,ng/ml,mean,SD,5.5,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,780,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,2.0,concentration,6,h,151,ng/ml,mean,SD,46,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,781,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,2.0,concentration,6,h,2130,ng/ml,mean,SD,340,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,782,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,7.0,concentration,12,h,144,ng/ml,mean,SD,79,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,783,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,7.0,concentration,12,h,32620,ng/ml,mean,SD,20572,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,784,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,7.0,concentration,12,h,1792,ng/ml,mean,SD,1107,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,785,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,7.0,concentration,12,h,494,ng/ml,mean,SD,204,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,786,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,7.0,concentration,12,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,787,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,7.0,concentration,12,h,26.4,ng/ml,mean,SD,15.5,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,788,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,7.0,concentration,12,h,30,ng/ml,mean,SD,11,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,789,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,7.0,concentration,12,h,1196,ng/ml,mean,SD,224,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,790,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,5.0,concentration,24,h,63,ng/ml,mean,SD,37,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,791,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,5.0,concentration,24,h,10733,ng/ml,mean,SD,5468,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,792,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,5.0,concentration,24,h,1299,ng/ml,mean,SD,466,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,793,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,5.0,concentration,24,h,599,ng/ml,mean,SD,330,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,794,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,5.0,concentration,24,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,795,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,5.0,concentration,24,h,27.1,ng/ml,mean,SD,12.8,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,796,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,5.0,concentration,24,h,36,ng/ml,mean,SD,27,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,797,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,5.0,concentration,24,h,936,ng/ml,mean,SD,223,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,798,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,5.0,concentration,72,h,60,ng/ml,mean,SD,31,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,799,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,5.0,concentration,72,h,5861,ng/ml,mean,SD,3333,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,800,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,5.0,concentration,72,h,961,ng/ml,mean,SD,419,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,801,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,5.0,concentration,72,h,551,ng/ml,mean,SD,129,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,802,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,5.0,concentration,72,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,803,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,5.0,concentration,72,h,19,ng/ml,mean,SD,6.7,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,804,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,5.0,concentration,72,h,23,ng/ml,mean,SD,13,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,805,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,5.0,concentration,72,h,915,ng/ml,mean,SD,628,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,806,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,1.0,concentration,168,h,<10.4,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,807,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,1.0,concentration,168,h,<1000,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,808,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,1.0,concentration,168,h,36,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,809,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,1.0,concentration,168,h,41,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,810,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,1.0,concentration,168,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,811,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,1.0,concentration,168,h,<10.4,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,812,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,1.0,concentration,168,h,17,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,813,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,1.0,concentration,168,h,40,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,814,2025-12-02T16:05:15.923463
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,2.0,concentration,6,h,311,ng/ml,mean,SD,170,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,775,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,2.0,concentration,6,h,42230,ng/ml,mean,SD,4846,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,776,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,2.0,concentration,6,h,1382,ng/ml,mean,SD,549,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,777,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,2.0,concentration,6,h,1041,ng/ml,mean,SD,706,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,778,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,2.0,concentration,6,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,779,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,2.0,concentration,6,h,19.1,ng/ml,mean,SD,5.5,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,780,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,2.0,concentration,6,h,151,ng/ml,mean,SD,46,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,781,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,2.0,concentration,6,h,2130,ng/ml,mean,SD,340,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,782,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,7.0,concentration,12,h,144,ng/ml,mean,SD,79,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,783,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,7.0,concentration,12,h,32620,ng/ml,mean,SD,20572,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,784,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,7.0,concentration,12,h,1792,ng/ml,mean,SD,1107,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,785,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,7.0,concentration,12,h,494,ng/ml,mean,SD,204,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,786,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,7.0,concentration,12,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,787,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,7.0,concentration,12,h,26.4,ng/ml,mean,SD,15.5,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,788,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,7.0,concentration,12,h,30,ng/ml,mean,SD,11,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,789,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,7.0,concentration,12,h,1196,ng/ml,mean,SD,224,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,790,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,5.0,concentration,24,h,63,ng/ml,mean,SD,37,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,791,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,5.0,concentration,24,h,10733,ng/ml,mean,SD,5468,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,792,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,5.0,concentration,24,h,1299,ng/ml,mean,SD,466,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,793,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,5.0,concentration,24,h,599,ng/ml,mean,SD,330,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,794,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,5.0,concentration,24,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,795,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,5.0,concentration,24,h,27.1,ng/ml,mean,SD,12.8,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,796,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,5.0,concentration,24,h,36,ng/ml,mean,SD,27,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,797,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,5.0,concentration,24,h,936,ng/ml,mean,SD,223,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,798,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,5.0,concentration,72,h,60,ng/ml,mean,SD,31,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,799,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,5.0,concentration,72,h,5861,ng/ml,mean,SD,3333,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,800,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,5.0,concentration,72,h,961,ng/ml,mean,SD,419,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,801,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,5.0,concentration,72,h,551,ng/ml,mean,SD,129,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,802,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,5.0,concentration,72,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,803,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,5.0,concentration,72,h,19,ng/ml,mean,SD,6.7,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,804,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,5.0,concentration,72,h,23,ng/ml,mean,SD,13,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,805,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,5.0,concentration,72,h,915,ng/ml,mean,SD,628,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,806,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,serum,maternal,delivery,,1.0,concentration,168,h,<10.4,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,807,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,urine,maternal,delivery,,1.0,concentration,168,h,<1000,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,808,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,myometrium ,maternal,delivery,,1.0,concentration,168,h,36,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,809,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,1.0,concentration,168,h,41,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,810,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,cerebrospinal fluid ,maternal,delivery,,1.0,concentration,168,h,<15.6,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,811,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,umbilical cord serum,maternal,delivery,,1.0,concentration,168,h,<10.4,ng/ml,mean,SD,,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,812,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,1.0,concentration,168,h,17,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,813,2025-12-02T16:05:22.346295
12634646.0,azithromycin,azithromycin,placenta,maternal,delivery,,1.0,concentration,168,h,40,ng/ml,mean,SD,0,,,,,time afterazithromycin adminishtration,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,814,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,T1/2,,,6.7,h,median,,,minmax,6.4,7.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,821,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,CL,,,73.2,L/hr,median,,,minmax,59,87.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,822,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Vc,,,27.7,L,median,,,minmax,24,35,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,823,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Vp,,,290,L,median,,,minmax,286,292,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,824,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,CLd,,,51,L/hr,median,,,minmax,43.9,56,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,825,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Tau,,,0.096,,median,,,minmax,0.06,0.22,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,826,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,T1/2,,,15.6,hr,median,,,minmax,15.5,15.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,827,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,CL,,,0.17,L/hr,median,,,minmax,0.17,0.17,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,828,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,V,,,3.87,L,median,,,minmax,3.85,3.88,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,829,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,AUC0-,,,6030,ng h/ml,mean,SD,2170,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,830,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Cmin,,,147,ng/ml,mean,SD,43,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,831,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Cmax,,,4500,ng/ml,mean,SD,2430,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,832,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,30.0,Cmed,,,102,ng/g,median,SD,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,833,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,placenta tissure,maternal,delivery,,30.0,Cmed,,,221,ng/g,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,834,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,myometrial tissue,maternal,delivery,,30.0,Cmed,,,402,ng/g,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,835,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,myometrial tissue,maternal,delivery,,30.0,Cmax,,,7774,ng/g,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,836,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,30.0,Cmax,,,717,ng/g,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,837,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,placenta tissure,maternal,delivery,,30.0,Cmax,,,961,ng/g,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,838,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,30.0,Cmed,0.92,h,33,ng/ml,median,,,,,,,at a median time of 0.92 hours post-dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,839,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,umbilical cord plasma,pediatric,,fetus,30.0,Cmed,0.95,h,150,ng/ml,median,,,,,,,at a median time of 0.95 hours post-dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,840,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,Cmed,30.7,h,1713,ng/ml,median,,,,,,,At a median of 30.7 hours post-dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,841,2025-12-02T16:05:09.448543
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,T1/2,,,6.7,h,median,,,minmax,6.4,7.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,821,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,CL,,,73.2,L/hr,median,,,minmax,59,87.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,822,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Vc,,,27.7,L,median,,,minmax,24,35,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,823,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Vp,,,290,L,median,,,minmax,286,292,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,824,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,CLd,,,51,L/hr,median,,,minmax,43.9,56,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,825,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Tau,,,0.096,,median,,,minmax,0.06,0.22,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,826,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,T1/2,,,15.6,hr,median,,,minmax,15.5,15.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,827,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,CL,,,0.17,L/hr,median,,,minmax,0.17,0.17,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,828,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,V,,,3.87,L,median,,,minmax,3.85,3.88,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,829,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,AUC0-,,,6030,ng h/ml,mean,SD,2170,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,830,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Cmin,,,147,ng/ml,mean,SD,43,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,831,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Cmax,,,4500,ng/ml,mean,SD,2430,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,832,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,30.0,Cmed,,,102,ng/g,median,SD,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,833,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,placenta tissure,maternal,delivery,,30.0,Cmed,,,221,ng/g,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,834,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,myometrial tissue,maternal,delivery,,30.0,Cmed,,,402,ng/g,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,835,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,myometrial tissue,maternal,delivery,,30.0,Cmax,,,7774,ng/g,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,836,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,30.0,Cmax,,,717,ng/g,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,837,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,placenta tissure,maternal,delivery,,30.0,Cmax,,,961,ng/g,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,838,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,30.0,Cmed,0.92,h,33,ng/ml,median,,,,,,,at a median time of 0.92 hours post-dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,839,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,umbilical cord plasma,pediatric,,fetus,30.0,Cmed,0.95,h,150,ng/ml,median,,,,,,,at a median time of 0.95 hours post-dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,840,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,Cmed,30.7,h,1713,ng/ml,median,,,,,,,At a median of 30.7 hours post-dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,841,2025-12-02T16:05:12.001940
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,T1/2,,,6.7,h,median,,,minmax,6.4,7.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,815,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,CL,,,73.2,L/hr,median,,,minmax,59,87.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,816,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Vc,,,27.7,L,median,,,minmax,24,35,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,817,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Vp,,,290,L,median,,,minmax,286,292,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,818,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,CLd,,,51,L/hr,median,,,minmax,43.9,56,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,819,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Tau,,,0.096,,median,,,minmax,0.06,0.22,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,820,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,T1/2,,,15.6,hr,median,,,minmax,15.5,15.8,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,821,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,CL,,,0.17,L/hr,median,,,minmax,0.17,0.17,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,822,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,V,,,3.87,L,median,,,minmax,3.85,3.88,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,823,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,AUC0-,,,6030,ng h/ml,mean,SD,2170,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,824,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Cmin,,,147,ng/ml,mean,SD,43,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,825,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Cmax,,,4500,ng/ml,mean,SD,2430,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,826,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,30.0,Cmed,,,102,ng/g,median,SD,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,827,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,placenta tissure,maternal,delivery,,30.0,Cmed,,,221,ng/g,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,828,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,myometrial tissue,maternal,delivery,,30.0,Cmed,,,402,ng/g,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,829,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,myometrial tissue,maternal,delivery,,30.0,Cmax,,,7774,ng/g,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,830,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,30.0,Cmax,,,717,ng/g,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,831,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,placenta tissure,maternal,delivery,,30.0,Cmax,,,961,ng/g,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,832,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,30.0,Cmed,0.92,h,33,ng/ml,median,,,,,,,at a median time of 0.92 hours post-dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,833,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,umbilical cord plasma,pediatric,,fetus,30.0,Cmed,0.95,h,150,ng/ml,median,,,,,,,at a median time of 0.95 hours post-dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,834,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,Cmed,30.7,h,1713,ng/ml,median,,,,,,,At a median of 30.7 hours post-dose,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,835,2025-12-02T16:05:15.923463
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,T1/2,,,6.7,h,median,,,minmax,6.4,7.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,815,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,CL,,,73.2,L/hr,median,,,minmax,59,87.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,816,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Vc,,,27.7,L,median,,,minmax,24,35,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,817,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Vp,,,290,L,median,,,minmax,286,292,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,818,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,CLd,,,51,L/hr,median,,,minmax,43.9,56,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,819,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Tau,,,0.096,,median,,,minmax,0.06,0.22,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,820,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,T1/2,,,15.6,hr,median,,,minmax,15.5,15.8,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,821,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,CL,,,0.17,L/hr,median,,,minmax,0.17,0.17,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,822,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,V,,,3.87,L,median,,,minmax,3.85,3.88,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,823,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,AUC0-,,,6030,ng h/ml,mean,SD,2170,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,824,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Cmin,,,147,ng/ml,mean,SD,43,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,825,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,plasma,maternal,delivery,,30.0,Cmax,,,4500,ng/ml,mean,SD,2430,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,826,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,30.0,Cmed,,,102,ng/g,median,SD,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,827,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,placenta tissure,maternal,delivery,,30.0,Cmed,,,221,ng/g,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,828,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,myometrial tissue,maternal,delivery,,30.0,Cmed,,,402,ng/g,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,829,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,myometrial tissue,maternal,delivery,,30.0,Cmax,,,7774,ng/g,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,830,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,adipose tissue ,maternal,delivery,,30.0,Cmax,,,717,ng/g,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,831,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,placenta tissure,maternal,delivery,,30.0,Cmax,,,961,ng/g,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,832,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,amniotic fluid,maternal,delivery,,30.0,Cmed,0.92,h,33,ng/ml,median,,,,,,,at a median time of 0.92 hours post-dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,833,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,umbilical cord plasma,pediatric,,fetus,30.0,Cmed,0.95,h,150,ng/ml,median,,,,,,,at a median time of 0.95 hours post-dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,834,2025-12-02T16:05:22.346295
25595580.0,azithromycin,azithromycin,breast milk,maternal,delivery,,30.0,Cmed,30.7,h,1713,ng/ml,median,,,,,,,At a median of 30.7 hours post-dose,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,835,2025-12-02T16:05:22.346295
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,161.0,concentration,0,h,0,ng/ml,arithmetic mean,CV%,,,,,,Day 0,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,842,2025-12-02T16:05:09.448543
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,158.0,concentration,0,h,194,ng/ml,arithmetic mean,CV%,32.9,,,,,Day 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,843,2025-12-02T16:05:09.448543
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,147.0,concentration,2,h,994,ng/ml,arithmetic mean,CV%,55.5,,,,,Day 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,844,2025-12-02T16:05:09.448543
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,159.0,concentration,8,h,708,ng/ml,arithmetic mean,CV%,46.2,,,,,Day 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,845,2025-12-02T16:05:09.448543
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,155.0,concentration,,,54.4,ng/ml,arithmetic mean,CV%,44.7,,,,,Day 7,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,846,2025-12-02T16:05:09.448543
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,153.0,concentration,,,20.3,ng/ml,arithmetic mean,CV%,156,,,,,Day 14,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,847,2025-12-02T16:05:09.448543
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,161.0,concentration,0,h,0,ng/ml,arithmetic mean,CV%,,,,,,Day 0,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,842,2025-12-02T16:05:12.001940
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,158.0,concentration,0,h,194,ng/ml,arithmetic mean,CV%,32.9,,,,,Day 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,843,2025-12-02T16:05:12.001940
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,147.0,concentration,2,h,994,ng/ml,arithmetic mean,CV%,55.5,,,,,Day 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,844,2025-12-02T16:05:12.001940
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,159.0,concentration,8,h,708,ng/ml,arithmetic mean,CV%,46.2,,,,,Day 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,845,2025-12-02T16:05:12.001940
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,155.0,concentration,,,54.4,ng/ml,arithmetic mean,CV%,44.7,,,,,Day 7,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,846,2025-12-02T16:05:12.001940
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,153.0,concentration,,,20.3,ng/ml,arithmetic mean,CV%,156,,,,,Day 14,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,847,2025-12-02T16:05:12.001940
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,161.0,concentration,0,h,0,ng/ml,arithmetic mean,CV%,,,,,,Day 0,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,836,2025-12-02T16:05:15.923463
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,158.0,concentration,0,h,194,ng/ml,arithmetic mean,CV%,32.9,,,,,Day 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,837,2025-12-02T16:05:15.923463
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,147.0,concentration,2,h,994,ng/ml,arithmetic mean,CV%,55.5,,,,,Day 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,838,2025-12-02T16:05:15.923463
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,159.0,concentration,8,h,708,ng/ml,arithmetic mean,CV%,46.2,,,,,Day 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,839,2025-12-02T16:05:15.923463
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,155.0,concentration,,,54.4,ng/ml,arithmetic mean,CV%,44.7,,,,,Day 7,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,840,2025-12-02T16:05:15.923463
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,153.0,concentration,,,20.3,ng/ml,arithmetic mean,CV%,156,,,,,Day 14,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,841,2025-12-02T16:05:15.923463
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,161.0,concentration,0,h,0,ng/ml,arithmetic mean,CV%,,,,,,Day 0,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,836,2025-12-02T16:05:22.346295
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,158.0,concentration,0,h,194,ng/ml,arithmetic mean,CV%,32.9,,,,,Day 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,837,2025-12-02T16:05:22.346295
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,147.0,concentration,2,h,994,ng/ml,arithmetic mean,CV%,55.5,,,,,Day 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,838,2025-12-02T16:05:22.346295
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,159.0,concentration,8,h,708,ng/ml,arithmetic mean,CV%,46.2,,,,,Day 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,839,2025-12-02T16:05:22.346295
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,155.0,concentration,,,54.4,ng/ml,arithmetic mean,CV%,44.7,,,,,Day 7,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,840,2025-12-02T16:05:22.346295
27861509.0,azithromycin,azithromycin,serum,maternal,2nd or 3rd trimester,,153.0,concentration,,,20.3,ng/ml,arithmetic mean,CV%,156,,,,,Day 14,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,841,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,blood,maternal,third trimester,,11.0,Css,,,4.3,ng/ml,mean,SD,3.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,848,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,umbilical cord serum,pediatric,,fetus,7.0,concentration,,,8.6,ng/ml,mean,SD,2.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,849,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,umbilical cord serum,pediatric,,fetus,7.0,concentration,,,5.1,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,850,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,amniotic fluid,maternal,delivery,,8.0,concentration,,,2.5,ng/ml,mean,SD,1.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,851,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,amniotic fluid,maternal,delivery,,8.0,concentration,,,1.8,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,852,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,serum,maternal,delivery,,8.0,concentration,,,12.4,ng/ml,mean,SD,4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,853,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,serum,maternal,delivery,,8.0,concentration,,,10,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,854,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,umbilical serum/maternal serum,maternal/pediatric,delivery,fetus,8.0,umbilical serum/maternal serum ratio,,,0.8,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,855,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,umbilical serum/maternal serum,maternal/pediatric,delivery,fetus,8.0,umbilical serum/maternal serum ratio,,,0.6,,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,856,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,Amniotic fluid/maternal serum,maternal,delivery,,8.0,Amniotic fluid/maternal serum ratio,,,0.3,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,857,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,Amniotic fluid/maternal serum,maternal,delivery,,8.0,Amniotic fluid/maternal serum ratio,,,0.2,,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,858,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,serum,maternal,postpartum,,6.0,concentration,,,4.4,ng/ml,mean,SD,1.3,,,,,72 hrs after delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,859,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,serum,maternal,postpartum,,6.0,concentration,,,5.7,ng/ml,median,,,,,,,72 hrs after delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,860,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,breast milk,maternal,postpartum,,6.0,concentration,,,3.5,ng/ml,median,,,minmax,<1,10.3,,1 to 8 h after drug intake,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,861,2025-12-02T16:05:09.448543
1814844.0,nifedipine,nifedipine,blood,maternal,third trimester,,11.0,Css,,,4.3,ng/ml,mean,SD,3.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,848,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,umbilical cord serum,pediatric,,fetus,7.0,concentration,,,8.6,ng/ml,mean,SD,2.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,849,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,umbilical cord serum,pediatric,,fetus,7.0,concentration,,,5.1,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,850,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,amniotic fluid,maternal,delivery,,8.0,concentration,,,2.5,ng/ml,mean,SD,1.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,851,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,amniotic fluid,maternal,delivery,,8.0,concentration,,,1.8,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,852,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,serum,maternal,delivery,,8.0,concentration,,,12.4,ng/ml,mean,SD,4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,853,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,serum,maternal,delivery,,8.0,concentration,,,10,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,854,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,umbilical serum/maternal serum,maternal/pediatric,delivery,fetus,8.0,umbilical serum/maternal serum ratio,,,0.8,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,855,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,umbilical serum/maternal serum,maternal/pediatric,delivery,fetus,8.0,umbilical serum/maternal serum ratio,,,0.6,,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,856,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,Amniotic fluid/maternal serum,maternal,delivery,,8.0,Amniotic fluid/maternal serum ratio,,,0.3,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,857,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,Amniotic fluid/maternal serum,maternal,delivery,,8.0,Amniotic fluid/maternal serum ratio,,,0.2,,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,858,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,serum,maternal,postpartum,,6.0,concentration,,,4.4,ng/ml,mean,SD,1.3,,,,,72 hrs after delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,859,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,serum,maternal,postpartum,,6.0,concentration,,,5.7,ng/ml,median,,,,,,,72 hrs after delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,860,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,breast milk,maternal,postpartum,,6.0,concentration,,,3.5,ng/ml,median,,,minmax,<1,10.3,,1 to 8 h after drug intake,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,861,2025-12-02T16:05:12.001940
1814844.0,nifedipine,nifedipine,blood,maternal,third trimester,,11.0,Css,,,4.3,ng/ml,mean,SD,3.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,842,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,umbilical cord serum,pediatric,,fetus,7.0,concentration,,,8.6,ng/ml,mean,SD,2.4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,843,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,umbilical cord serum,pediatric,,fetus,7.0,concentration,,,5.1,ng/ml,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,844,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,amniotic fluid,maternal,delivery,,8.0,concentration,,,2.5,ng/ml,mean,SD,1.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,845,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,amniotic fluid,maternal,delivery,,8.0,concentration,,,1.8,ng/ml,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,846,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,serum,maternal,delivery,,8.0,concentration,,,12.4,ng/ml,mean,SD,4,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,847,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,serum,maternal,delivery,,8.0,concentration,,,10,ng/ml,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,848,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,umbilical serum/maternal serum,maternal/pediatric,delivery,fetus,8.0,umbilical serum/maternal serum ratio,,,0.8,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,849,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,umbilical serum/maternal serum,maternal/pediatric,delivery,fetus,8.0,umbilical serum/maternal serum ratio,,,0.6,,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,850,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,Amniotic fluid/maternal serum,maternal,delivery,,8.0,Amniotic fluid/maternal serum ratio,,,0.3,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,851,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,Amniotic fluid/maternal serum,maternal,delivery,,8.0,Amniotic fluid/maternal serum ratio,,,0.2,,median,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,852,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,serum,maternal,postpartum,,6.0,concentration,,,4.4,ng/ml,mean,SD,1.3,,,,,72 hrs after delivery,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,853,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,serum,maternal,postpartum,,6.0,concentration,,,5.7,ng/ml,median,,,,,,,72 hrs after delivery,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,854,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,breast milk,maternal,postpartum,,6.0,concentration,,,3.5,ng/ml,median,,,minmax,<1,10.3,,1 to 8 h after drug intake,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,855,2025-12-02T16:05:15.923463
1814844.0,nifedipine,nifedipine,blood,maternal,third trimester,,11.0,Css,,,4.3,ng/ml,mean,SD,3.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,842,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,umbilical cord serum,pediatric,,fetus,7.0,concentration,,,8.6,ng/ml,mean,SD,2.4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,843,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,umbilical cord serum,pediatric,,fetus,7.0,concentration,,,5.1,ng/ml,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,844,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,amniotic fluid,maternal,delivery,,8.0,concentration,,,2.5,ng/ml,mean,SD,1.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,845,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,amniotic fluid,maternal,delivery,,8.0,concentration,,,1.8,ng/ml,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,846,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,serum,maternal,delivery,,8.0,concentration,,,12.4,ng/ml,mean,SD,4,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,847,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,serum,maternal,delivery,,8.0,concentration,,,10,ng/ml,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,848,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,umbilical serum/maternal serum,maternal/pediatric,delivery,fetus,8.0,umbilical serum/maternal serum ratio,,,0.8,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,849,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,umbilical serum/maternal serum,maternal/pediatric,delivery,fetus,8.0,umbilical serum/maternal serum ratio,,,0.6,,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,850,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,Amniotic fluid/maternal serum,maternal,delivery,,8.0,Amniotic fluid/maternal serum ratio,,,0.3,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,851,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,Amniotic fluid/maternal serum,maternal,delivery,,8.0,Amniotic fluid/maternal serum ratio,,,0.2,,median,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,852,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,serum,maternal,postpartum,,6.0,concentration,,,4.4,ng/ml,mean,SD,1.3,,,,,72 hrs after delivery,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,853,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,serum,maternal,postpartum,,6.0,concentration,,,5.7,ng/ml,median,,,,,,,72 hrs after delivery,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,854,2025-12-02T16:05:22.346295
1814844.0,nifedipine,nifedipine,breast milk,maternal,postpartum,,6.0,concentration,,,3.5,ng/ml,median,,,minmax,<1,10.3,,1 to 8 h after drug intake,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,855,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,0-24,h,22,ng/ml,median,,,IQR,3,182,0.09,Azithromycine 1 g once,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,862,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,0-24,h,2,ng/ml,median,,,IQR,0,10,0.09,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,863,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,24-96,h,22,ng/ml,median,,,IQR,6,42,0.75,Azithromycine 1 g once,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,864,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,24-96,h,17,ng/ml,median,,,IQR,8,38,0.75,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,865,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,>=96,h,11,ng/ml,median,,,IQR,7,56,0.03,Azithromycine 1 g once,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,866,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,>=96,h,46,ng/ml,median,,,IQR,23,196,0.03,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,867,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,0-24,h,657,ng/ml,median,,,IQR,309,1724,0.01,Azithromycine 1 g once,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,868,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,0-24,h,22,ng/ml,median,,,IQR,3,253,0.01,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,869,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,24-96,h,25,ng/ml,median,,,IQR,9,70,0.08,Azithromycine 1 g once,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,870,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,24-96,h,108,ng/ml,median,,,IQR,39,236,0.08,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,871,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,>=96,h,4,ng/ml,median,,,IQR,4,4,0.03,Azithromycine 1 g once,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,872,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,>=96,h,211,ng/ml,median,,,IQR,168,263,0.03,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,873,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,0-24,h,20,ng/ml,mean,,,95% CI,-0.8,288,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,874,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,24-96,h,1,ng/ml,mean,,,95% CI,-8,15,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,875,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,>=96,h,-27,ng/ml,mean,,,95% CI,-154,-1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,876,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,0-24,h,637,ng/ml,mean,,,95% CI,101,1547,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,877,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,24-96,h,-50,ng/ml,mean,,,95% CI,-225,7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,878,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,>=96,h,-207,ng/ml,mean,,,95% CI,-271,-155,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,879,2025-12-02T16:05:09.448543
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,0-24,h,22,ng/ml,median,,,IQR,3,182,0.09,Azithromycine 1 g once,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,862,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,0-24,h,2,ng/ml,median,,,IQR,0,10,0.09,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,863,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,24-96,h,22,ng/ml,median,,,IQR,6,42,0.75,Azithromycine 1 g once,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,864,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,24-96,h,17,ng/ml,median,,,IQR,8,38,0.75,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,865,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,>=96,h,11,ng/ml,median,,,IQR,7,56,0.03,Azithromycine 1 g once,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,866,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,>=96,h,46,ng/ml,median,,,IQR,23,196,0.03,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,867,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,0-24,h,657,ng/ml,median,,,IQR,309,1724,0.01,Azithromycine 1 g once,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,868,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,0-24,h,22,ng/ml,median,,,IQR,3,253,0.01,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,869,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,24-96,h,25,ng/ml,median,,,IQR,9,70,0.08,Azithromycine 1 g once,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,870,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,24-96,h,108,ng/ml,median,,,IQR,39,236,0.08,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,871,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,>=96,h,4,ng/ml,median,,,IQR,4,4,0.03,Azithromycine 1 g once,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,872,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,>=96,h,211,ng/ml,median,,,IQR,168,263,0.03,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,873,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,0-24,h,20,ng/ml,mean,,,95% CI,-0.8,288,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,874,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,24-96,h,1,ng/ml,mean,,,95% CI,-8,15,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,875,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,>=96,h,-27,ng/ml,mean,,,95% CI,-154,-1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,876,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,0-24,h,637,ng/ml,mean,,,95% CI,101,1547,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,877,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,24-96,h,-50,ng/ml,mean,,,95% CI,-225,7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,878,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,>=96,h,-207,ng/ml,mean,,,95% CI,-271,-155,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,879,2025-12-02T16:05:12.001940
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,0-24,h,22,ng/ml,median,,,IQR,3,182,0.09,Azithromycine 1 g once,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,856,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,0-24,h,2,ng/ml,median,,,IQR,0,10,0.09,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,857,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,24-96,h,22,ng/ml,median,,,IQR,6,42,0.75,Azithromycine 1 g once,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,858,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,24-96,h,17,ng/ml,median,,,IQR,8,38,0.75,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,859,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,>=96,h,11,ng/ml,median,,,IQR,7,56,0.03,Azithromycine 1 g once,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,860,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,>=96,h,46,ng/ml,median,,,IQR,23,196,0.03,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,861,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,0-24,h,657,ng/ml,median,,,IQR,309,1724,0.01,Azithromycine 1 g once,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,862,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,0-24,h,22,ng/ml,median,,,IQR,3,253,0.01,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,863,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,24-96,h,25,ng/ml,median,,,IQR,9,70,0.08,Azithromycine 1 g once,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,864,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,24-96,h,108,ng/ml,median,,,IQR,39,236,0.08,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,865,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,>=96,h,4,ng/ml,median,,,IQR,4,4,0.03,Azithromycine 1 g once,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,866,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,>=96,h,211,ng/ml,median,,,IQR,168,263,0.03,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,867,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,0-24,h,20,ng/ml,mean,,,95% CI,-0.8,288,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,868,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,24-96,h,1,ng/ml,mean,,,95% CI,-8,15,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,869,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,>=96,h,-27,ng/ml,mean,,,95% CI,-154,-1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,870,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,0-24,h,637,ng/ml,mean,,,95% CI,101,1547,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,871,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,24-96,h,-50,ng/ml,mean,,,95% CI,-225,7,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,872,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,>=96,h,-207,ng/ml,mean,,,95% CI,-271,-155,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,873,2025-12-02T16:05:15.923463
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,0-24,h,22,ng/ml,median,,,IQR,3,182,0.09,Azithromycine 1 g once,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,856,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,0-24,h,2,ng/ml,median,,,IQR,0,10,0.09,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,857,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,24-96,h,22,ng/ml,median,,,IQR,6,42,0.75,Azithromycine 1 g once,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,858,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,24-96,h,17,ng/ml,median,,,IQR,8,38,0.75,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,859,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,>=96,h,11,ng/ml,median,,,IQR,7,56,0.03,Azithromycine 1 g once,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,860,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,3.0,concentration,>=96,h,46,ng/ml,median,,,IQR,23,196,0.03,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,861,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,0-24,h,657,ng/ml,median,,,IQR,309,1724,0.01,Azithromycine 1 g once,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,862,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,0-24,h,22,ng/ml,median,,,IQR,3,253,0.01,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,863,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,24-96,h,25,ng/ml,median,,,IQR,9,70,0.08,Azithromycine 1 g once,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,864,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,24-96,h,108,ng/ml,median,,,IQR,39,236,0.08,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,865,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,>=96,h,4,ng/ml,median,,,IQR,4,4,0.03,Azithromycine 1 g once,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,866,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,3.0,concentration,>=96,h,211,ng/ml,median,,,IQR,168,263,0.03,Azithromycine 500 mg daily for 7 d,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,867,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,0-24,h,20,ng/ml,mean,,,95% CI,-0.8,288,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,868,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,24-96,h,1,ng/ml,mean,,,95% CI,-8,15,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,869,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,amniotic fluid,maternal,pregnancy,,6.0,mean difference concentration between the two groups,>=96,h,-27,ng/ml,mean,,,95% CI,-154,-1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,870,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,0-24,h,637,ng/ml,mean,,,95% CI,101,1547,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,871,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,24-96,h,-50,ng/ml,mean,,,95% CI,-225,7,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,872,2025-12-02T16:05:22.346295
38977063.0,azithromycin,azithromycin,plasma,maternal,pregnancy,,6.0,mean difference concentration between the two groups,>=96,h,-207,ng/ml,mean,,,95% CI,-271,-155,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,873,2025-12-02T16:05:22.346295
10583022.0,fluoxetine,fluoxetine,plasma,maternal,lactation,,14.0,concentration,,,185,nug/l,mean,,,95% CI,116,254,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,880,2025-12-02T16:05:09.448543
10583022.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,14.0,concentration,,,131,nug/l,mean,,,95% CI,65,197,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,881,2025-12-02T16:05:09.448543
10583022.0,fluoxetine,fluoxetine,breast milk/plasma,maternal,lactation,,14.0,breast milk/plasma concentration ratio,,,0.68,,mean,,,95% CI,0.52,0.84,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,882,2025-12-02T16:05:09.448543
10583022.0,fluoxetine,norfluoxetine,plasma,maternal,lactation,,14.0,concentration,,,210,,mean,,,95% CI,142,278,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,883,2025-12-02T16:05:09.448543
10583022.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,14.0,concentration,,,124,,mean,,,95% CI,65,193,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,884,2025-12-02T16:05:09.448543
10583022.0,fluoxetine,norfluoxetine,breast milk/plasma,maternal,lactation,,14.0,breast milk/plasma concentration ratio,,,0.56,,mean,,,95% CI,0.35,0.77,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,885,2025-12-02T16:05:09.448543
10583022.0,fluoxetine,fluoxetine,plasma,maternal,lactation,,14.0,concentration,,,185,nug/l,mean,,,95% CI,116,254,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,880,2025-12-02T16:05:12.001940
10583022.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,14.0,concentration,,,131,nug/l,mean,,,95% CI,65,197,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,881,2025-12-02T16:05:12.001940
10583022.0,fluoxetine,fluoxetine,breast milk/plasma,maternal,lactation,,14.0,breast milk/plasma concentration ratio,,,0.68,,mean,,,95% CI,0.52,0.84,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,882,2025-12-02T16:05:12.001940
10583022.0,fluoxetine,norfluoxetine,plasma,maternal,lactation,,14.0,concentration,,,210,,mean,,,95% CI,142,278,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,883,2025-12-02T16:05:12.001940
10583022.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,14.0,concentration,,,124,,mean,,,95% CI,65,193,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,884,2025-12-02T16:05:12.001940
10583022.0,fluoxetine,norfluoxetine,breast milk/plasma,maternal,lactation,,14.0,breast milk/plasma concentration ratio,,,0.56,,mean,,,95% CI,0.35,0.77,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,885,2025-12-02T16:05:12.001940
10583022.0,fluoxetine,fluoxetine,plasma,maternal,lactation,,14.0,concentration,,,185,nug/l,mean,,,95% CI,116,254,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,874,2025-12-02T16:05:15.923463
10583022.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,14.0,concentration,,,131,nug/l,mean,,,95% CI,65,197,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,875,2025-12-02T16:05:15.923463
10583022.0,fluoxetine,fluoxetine,breast milk/plasma,maternal,lactation,,14.0,breast milk/plasma concentration ratio,,,0.68,,mean,,,95% CI,0.52,0.84,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,876,2025-12-02T16:05:15.923463
10583022.0,fluoxetine,norfluoxetine,plasma,maternal,lactation,,14.0,concentration,,,210,,mean,,,95% CI,142,278,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,877,2025-12-02T16:05:15.923463
10583022.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,14.0,concentration,,,124,,mean,,,95% CI,65,193,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,878,2025-12-02T16:05:15.923463
10583022.0,fluoxetine,norfluoxetine,breast milk/plasma,maternal,lactation,,14.0,breast milk/plasma concentration ratio,,,0.56,,mean,,,95% CI,0.35,0.77,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,879,2025-12-02T16:05:15.923463
10583022.0,fluoxetine,fluoxetine,plasma,maternal,lactation,,14.0,concentration,,,185,nug/l,mean,,,95% CI,116,254,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,874,2025-12-02T16:05:22.346295
10583022.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,14.0,concentration,,,131,nug/l,mean,,,95% CI,65,197,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,875,2025-12-02T16:05:22.346295
10583022.0,fluoxetine,fluoxetine,breast milk/plasma,maternal,lactation,,14.0,breast milk/plasma concentration ratio,,,0.68,,mean,,,95% CI,0.52,0.84,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,876,2025-12-02T16:05:22.346295
10583022.0,fluoxetine,norfluoxetine,plasma,maternal,lactation,,14.0,concentration,,,210,,mean,,,95% CI,142,278,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,877,2025-12-02T16:05:22.346295
10583022.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,14.0,concentration,,,124,,mean,,,95% CI,65,193,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,878,2025-12-02T16:05:22.346295
10583022.0,fluoxetine,norfluoxetine,breast milk/plasma,maternal,lactation,,14.0,breast milk/plasma concentration ratio,,,0.56,,mean,,,95% CI,0.35,0.77,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,879,2025-12-02T16:05:22.346295
11720696.0,fluoxetine,fluoxetine,serum,pediatric,,infant,6.0,concentration,,,,ng/ml,,,,minmax,<1,84,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,886,2025-12-02T16:05:09.448543
11720696.0,fluoxetine,norfluoxetine,serum,pediatric,,infant,17.0,concentration,,,,ng/ml,,,,minmax,<1,265,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,887,2025-12-02T16:05:09.448543
11720696.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,9.0,concentration,,,,ng/ml,,,,minmax,6,235,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,888,2025-12-02T16:05:09.448543
11720696.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,9.0,concentration,,,,ng/ml,,,,minmax,<2,222,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,889,2025-12-02T16:05:09.448543
11720696.0,fluoxetine,fluoxetine,serum,pediatric,,infant,6.0,concentration,,,,ng/ml,,,,minmax,<1,84,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,886,2025-12-02T16:05:12.001940
11720696.0,fluoxetine,norfluoxetine,serum,pediatric,,infant,17.0,concentration,,,,ng/ml,,,,minmax,<1,265,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,887,2025-12-02T16:05:12.001940
11720696.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,9.0,concentration,,,,ng/ml,,,,minmax,6,235,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,888,2025-12-02T16:05:12.001940
11720696.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,9.0,concentration,,,,ng/ml,,,,minmax,<2,222,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,889,2025-12-02T16:05:12.001940
11720696.0,fluoxetine,fluoxetine,serum,pediatric,,infant,6.0,concentration,,,,ng/ml,,,,minmax,<1,84,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,880,2025-12-02T16:05:15.923463
11720696.0,fluoxetine,norfluoxetine,serum,pediatric,,infant,17.0,concentration,,,,ng/ml,,,,minmax,<1,265,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,881,2025-12-02T16:05:15.923463
11720696.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,9.0,concentration,,,,ng/ml,,,,minmax,6,235,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,882,2025-12-02T16:05:15.923463
11720696.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,9.0,concentration,,,,ng/ml,,,,minmax,<2,222,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,883,2025-12-02T16:05:15.923463
11720696.0,fluoxetine,fluoxetine,serum,pediatric,,infant,6.0,concentration,,,,ng/ml,,,,minmax,<1,84,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,880,2025-12-02T16:05:22.346295
11720696.0,fluoxetine,norfluoxetine,serum,pediatric,,infant,17.0,concentration,,,,ng/ml,,,,minmax,<1,265,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,881,2025-12-02T16:05:22.346295
11720696.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,9.0,concentration,,,,ng/ml,,,,minmax,6,235,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,882,2025-12-02T16:05:22.346295
11720696.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,9.0,concentration,,,,ng/ml,,,,minmax,<2,222,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,883,2025-12-02T16:05:22.346295
12242061.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,3,242,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,890,2025-12-02T16:05:09.448543
12242061.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,18,314,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,891,2025-12-02T16:05:09.448543
12242061.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,3,242,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,890,2025-12-02T16:05:12.001940
12242061.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,18,314,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,891,2025-12-02T16:05:12.001940
12242061.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,3,242,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,884,2025-12-02T16:05:15.923463
12242061.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,18,314,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,885,2025-12-02T16:05:15.923463
12242061.0,fluoxetine,fluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,3,242,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,884,2025-12-02T16:05:22.346295
12242061.0,fluoxetine,norfluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,18,314,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,885,2025-12-02T16:05:22.346295
14595087.0,Fluoxetine,Fluoxetine,plasma,maternal,lactation,,11.0,concentration,,,124.5,ng/ml,mean,SD,62.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,948,2025-12-02T16:05:09.448543
14595087.0,Fluoxetine,Norfluoxetine,plasma,maternal,lactation,,11.0,concentration,,,141.5,ng/ml,mean,SD,56.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,949,2025-12-02T16:05:09.448543
14595087.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,infant,11.0,concentration,,,3.2,ng/ml,mean,SD,2.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,950,2025-12-02T16:05:09.448543
14595087.0,Fluoxetine,Fluoxetine,plasma,maternal,lactation,,11.0,concentration,,,124.5,ng/ml,mean,SD,62.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,948,2025-12-02T16:05:12.001940
14595087.0,Fluoxetine,Norfluoxetine,plasma,maternal,lactation,,11.0,concentration,,,141.5,ng/ml,mean,SD,56.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,949,2025-12-02T16:05:12.001940
14595087.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,infant,11.0,concentration,,,3.2,ng/ml,mean,SD,2.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,950,2025-12-02T16:05:12.001940
14595087.0,Fluoxetine,Fluoxetine,plasma,maternal,lactation,,11.0,concentration,,,124.5,ng/ml,mean,SD,62.5,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,942,2025-12-02T16:05:15.923463
14595087.0,Fluoxetine,Norfluoxetine,plasma,maternal,lactation,,11.0,concentration,,,141.5,ng/ml,mean,SD,56.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,943,2025-12-02T16:05:15.923463
14595087.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,infant,11.0,concentration,,,3.2,ng/ml,mean,SD,2.2,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,944,2025-12-02T16:05:15.923463
14595087.0,Fluoxetine,Fluoxetine,plasma,maternal,lactation,,11.0,concentration,,,124.5,ng/ml,mean,SD,62.5,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,942,2025-12-02T16:05:22.346295
14595087.0,Fluoxetine,Norfluoxetine,plasma,maternal,lactation,,11.0,concentration,,,141.5,ng/ml,mean,SD,56.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,943,2025-12-02T16:05:22.346295
14595087.0,Fluoxetine,Norfluoxetine,plasma,pediatric,,infant,11.0,concentration,,,3.2,ng/ml,mean,SD,2.2,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,944,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1,g/mL,mean,SD,0.5,minmax,0.3,2,0.0354,Week 20 vs. week 36,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1029,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,0.8,g/mL,mean,SD,0.5,minmax,0,1.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1030,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,0.8,g/mL,mean,SD,1.3,minmax,0,3.7,0.0354,Week 20 vs. week 36,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1031,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.3,g/mL,mean,SD,0.5,minmax,0.9,2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1032,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,3,g/mL,mean,SD,2.5,minmax,0.7,7.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1033,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,2.8,g/mL,mean,SD,2.4,minmax,0.1,6.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1034,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,2.7,g/mL,mean,SD,3.7,minmax,0,10.7,0.016,Week 36/12 weeks pp,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1035,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,5.7,g/mL,mean,SD,2.7,minmax,1.3,9.4,0.016,Week 36/12 weeks pp,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1036,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,4,g/mL,mean,SD,2.8,minmax,0.9,9,0.0255,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1037,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,3.6,g/mL,mean,SD,2.8,minmax,0.1,7.6,0.0255,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1038,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,3.5,g/mL,mean,SD,4.9,minmax,0,14.4,0.0255,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1039,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,7,g/mL,mean,SD,2.9,minmax,2.3,10.4,0.0255,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1040,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1.5,g/mL,mean,SD,0.8,minmax,0.4,2.4,0.4055,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1041,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,1.2,g/mL,mean,SD,0.8,minmax,0.1,2.2,0.4055,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1042,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,1.9,g/mL,mean,SD,3,minmax,0,9.2,0.4055,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1043,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.9,g/mL,mean,SD,0.8,minmax,0.7,3.1,0.4055,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1044,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,3.1,g/mL,mean,SD,1.6,minmax,1.2,5.7,0.7539,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1045,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,3,g/mL,mean,SD,1.9,minmax,0.3,5.8,0.7539,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1046,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,3.5,g/mL,mean,SD,3.9,minmax,0.6,12.5,0.7539,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1047,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,3.5,g/mL,mean,SD,1.9,minmax,1.9,6.8,0.7539,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1048,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,4.5,g/mL,mean,SD,2.2,minmax,1.6,7.6,0.644,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1049,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,4.2,g/mL,mean,SD,2.6,minmax,0.4,7.8,0.644,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1050,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,5.4,g/mL,mean,SD,6.9,minmax,0.7,21.8,0.644,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1051,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,5.4,g/mL,mean,SD,2.6,minmax,3.2,9.9,0.644,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1052,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1,,mean,SD,0.7,minmax,0.2,2.5,0.001,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1053,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,0.9,,mean,SD,0.8,minmax,0.3,2.9,0.001,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1054,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,0.6,,mean,SD,0.8,minmax,0,2.4,0.001,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1055,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.4,,mean,SD,0.7,minmax,0.7,2.4,0.001,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1056,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,2.5,g/mL,mean,SD,1.2,minmax,0.6,3.9,0.193,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1057,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,2,g/mL,mean,SD,1.3,minmax,0.1,3.4,0.193,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1058,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,2.7,g/mL,mean,SD,4.3,minmax,0,13,0.193,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1059,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,3.3,g/mL,mean,SD,1.2,minmax,1.5,5,0.193,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1060,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,6.1,g/mL,mean,SD,3.4,minmax,1.9,12.7,0.192,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1061,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,5.7,g/mL,mean,SD,3.5,minmax,0.4,12,0.192,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1062,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,6.2,g/mL,mean,SD,7.3,minmax,0.8,23.2,0.192,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1063,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,9.2,g/mL,mean,SD,3.3,minmax,3.2,11.9,0.192,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1064,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,8.5,g/mL,mean,SD,4.2,minmax,2.5,16.6,0.194,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1065,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,7.8,g/mL,mean,SD,4.7,minmax,0.6,15.3,0.194,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1066,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,8.9,g/mL,mean,SD,11.5,minmax,1.1,36.2,0.194,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1067,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,12.4,g/mL,mean,SD,4.2,minmax,5.5,16.9,0.194,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1068,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,4.4,g/mL,mean,SD,3,minmax,2.4,10.1,0.1936,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1069,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,4.8,g/mL,mean,SD,2.6,minmax,2.5,8.8,0.1936,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1070,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,4.1,g/mL,mean,SD,2.2,minmax,1.8,7.4,0.1936,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1071,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX,plasma,maternal,Delivery,,4.0,concentration,,,2.3,g/mL,mean,SD,3.3,minmax,0.5,7.3,0.1936,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1072,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,4.3,g/mL,mean,SD,5.4,minmax,0.5,8.1,0.1936,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1073,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,4.2,g/mL,mean,SD,1.4,minmax,1.8,5.7,0.1936,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1074,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,4.7,g/mL,mean,SD,2,minmax,2,7.5,0.0491,week 30 vs. delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1075,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,4.5,g/mL,mean,SD,1.9,minmax,1.8,7.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1076,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,NOR,plasma,maternal,Delivery,,4.0,concentration,,,2.1,g/mL,mean,SD,0.9,minmax,1.3,3.1,0.0491,week 30 vs. delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1077,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,3.7,g/mL,mean,SD,2.1,minmax,2.2,5.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1078,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,8.6,g/mL,mean,SD,2.4,minmax,5.8,13.5,0.1355,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1079,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,9.6,g/mL,mean,SD,2.3,minmax,5.5,12,0.1355,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1080,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,8.6,g/mL,mean,SD,2.7,minmax,5.9,13.2,0.1355,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1081,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,Delivery,,4.0,concentration,,,4.4,g/mL,mean,SD,3,minmax,2,8.8,0.1355,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1082,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,8,g/mL,mean,SD,7.5,minmax,2.7,13.3,0.1355,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1083,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,1.4,,mean,SD,1.4,minmax,0.4,3.9,0.1884,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1084,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,1.4,,mean,SD,1.5,minmax,0.4,4.2,0.1884,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1085,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,1.3,,mean,SD,1.3,minmax,0.4,4.2,0.1884,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1086,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,Delivery,,4.0,concentration,,,1.4,,mean,SD,2.2,minmax,0.2,4.7,0.1884,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1087,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,0.9,,mean,SD,0.9,minmax,0.2,1.6,0.1884,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1088,2025-12-02T16:05:09.448543
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1,g/mL,mean,SD,0.5,minmax,0.3,2,0.0354,Week 20 vs. week 36,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1029,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,0.8,g/mL,mean,SD,0.5,minmax,0,1.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1030,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,0.8,g/mL,mean,SD,1.3,minmax,0,3.7,0.0354,Week 20 vs. week 36,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1031,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.3,g/mL,mean,SD,0.5,minmax,0.9,2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1032,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,3,g/mL,mean,SD,2.5,minmax,0.7,7.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1033,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,2.8,g/mL,mean,SD,2.4,minmax,0.1,6.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1034,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,2.7,g/mL,mean,SD,3.7,minmax,0,10.7,0.016,Week 36/12 weeks pp,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1035,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,5.7,g/mL,mean,SD,2.7,minmax,1.3,9.4,0.016,Week 36/12 weeks pp,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1036,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,4,g/mL,mean,SD,2.8,minmax,0.9,9,0.0255,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1037,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,3.6,g/mL,mean,SD,2.8,minmax,0.1,7.6,0.0255,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1038,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,3.5,g/mL,mean,SD,4.9,minmax,0,14.4,0.0255,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1039,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,7,g/mL,mean,SD,2.9,minmax,2.3,10.4,0.0255,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1040,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1.5,g/mL,mean,SD,0.8,minmax,0.4,2.4,0.4055,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1041,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,1.2,g/mL,mean,SD,0.8,minmax,0.1,2.2,0.4055,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1042,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,1.9,g/mL,mean,SD,3,minmax,0,9.2,0.4055,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1043,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.9,g/mL,mean,SD,0.8,minmax,0.7,3.1,0.4055,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1044,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,3.1,g/mL,mean,SD,1.6,minmax,1.2,5.7,0.7539,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1045,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,3,g/mL,mean,SD,1.9,minmax,0.3,5.8,0.7539,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1046,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,3.5,g/mL,mean,SD,3.9,minmax,0.6,12.5,0.7539,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1047,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,3.5,g/mL,mean,SD,1.9,minmax,1.9,6.8,0.7539,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1048,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,4.5,g/mL,mean,SD,2.2,minmax,1.6,7.6,0.644,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1049,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,4.2,g/mL,mean,SD,2.6,minmax,0.4,7.8,0.644,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1050,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,5.4,g/mL,mean,SD,6.9,minmax,0.7,21.8,0.644,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1051,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,5.4,g/mL,mean,SD,2.6,minmax,3.2,9.9,0.644,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1052,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1,,mean,SD,0.7,minmax,0.2,2.5,0.001,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1053,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,0.9,,mean,SD,0.8,minmax,0.3,2.9,0.001,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1054,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,0.6,,mean,SD,0.8,minmax,0,2.4,0.001,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1055,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.4,,mean,SD,0.7,minmax,0.7,2.4,0.001,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1056,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,2.5,g/mL,mean,SD,1.2,minmax,0.6,3.9,0.193,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1057,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,2,g/mL,mean,SD,1.3,minmax,0.1,3.4,0.193,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1058,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,2.7,g/mL,mean,SD,4.3,minmax,0,13,0.193,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1059,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,3.3,g/mL,mean,SD,1.2,minmax,1.5,5,0.193,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1060,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,6.1,g/mL,mean,SD,3.4,minmax,1.9,12.7,0.192,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1061,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,5.7,g/mL,mean,SD,3.5,minmax,0.4,12,0.192,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1062,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,6.2,g/mL,mean,SD,7.3,minmax,0.8,23.2,0.192,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1063,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,9.2,g/mL,mean,SD,3.3,minmax,3.2,11.9,0.192,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1064,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,8.5,g/mL,mean,SD,4.2,minmax,2.5,16.6,0.194,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1065,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,7.8,g/mL,mean,SD,4.7,minmax,0.6,15.3,0.194,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1066,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,8.9,g/mL,mean,SD,11.5,minmax,1.1,36.2,0.194,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1067,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,12.4,g/mL,mean,SD,4.2,minmax,5.5,16.9,0.194,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1068,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,4.4,g/mL,mean,SD,3,minmax,2.4,10.1,0.1936,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1069,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,4.8,g/mL,mean,SD,2.6,minmax,2.5,8.8,0.1936,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1070,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,4.1,g/mL,mean,SD,2.2,minmax,1.8,7.4,0.1936,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1071,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX,plasma,maternal,Delivery,,4.0,concentration,,,2.3,g/mL,mean,SD,3.3,minmax,0.5,7.3,0.1936,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1072,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,4.3,g/mL,mean,SD,5.4,minmax,0.5,8.1,0.1936,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1073,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,4.2,g/mL,mean,SD,1.4,minmax,1.8,5.7,0.1936,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1074,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,4.7,g/mL,mean,SD,2,minmax,2,7.5,0.0491,week 30 vs. delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1075,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,4.5,g/mL,mean,SD,1.9,minmax,1.8,7.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1076,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,NOR,plasma,maternal,Delivery,,4.0,concentration,,,2.1,g/mL,mean,SD,0.9,minmax,1.3,3.1,0.0491,week 30 vs. delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1077,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,3.7,g/mL,mean,SD,2.1,minmax,2.2,5.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1078,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,8.6,g/mL,mean,SD,2.4,minmax,5.8,13.5,0.1355,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1079,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,9.6,g/mL,mean,SD,2.3,minmax,5.5,12,0.1355,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1080,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,8.6,g/mL,mean,SD,2.7,minmax,5.9,13.2,0.1355,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1081,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,Delivery,,4.0,concentration,,,4.4,g/mL,mean,SD,3,minmax,2,8.8,0.1355,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1082,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,8,g/mL,mean,SD,7.5,minmax,2.7,13.3,0.1355,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1083,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,1.4,,mean,SD,1.4,minmax,0.4,3.9,0.1884,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1084,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,1.4,,mean,SD,1.5,minmax,0.4,4.2,0.1884,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1085,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,1.3,,mean,SD,1.3,minmax,0.4,4.2,0.1884,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1086,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,Delivery,,4.0,concentration,,,1.4,,mean,SD,2.2,minmax,0.2,4.7,0.1884,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1087,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,0.9,,mean,SD,0.9,minmax,0.2,1.6,0.1884,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1088,2025-12-02T16:05:12.001940
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1,g/mL,mean,SD,0.5,minmax,0.3,2,0.0354,Week 20 vs. week 36,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1023,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,0.8,g/mL,mean,SD,0.5,minmax,0,1.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1024,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,0.8,g/mL,mean,SD,1.3,minmax,0,3.7,0.0354,Week 20 vs. week 36,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1025,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.3,g/mL,mean,SD,0.5,minmax,0.9,2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1026,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,3,g/mL,mean,SD,2.5,minmax,0.7,7.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1027,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,2.8,g/mL,mean,SD,2.4,minmax,0.1,6.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1028,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,2.7,g/mL,mean,SD,3.7,minmax,0,10.7,0.016,Week 36/12 weeks pp,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1029,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,5.7,g/mL,mean,SD,2.7,minmax,1.3,9.4,0.016,Week 36/12 weeks pp,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1030,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,4,g/mL,mean,SD,2.8,minmax,0.9,9,0.0255,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1031,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,3.6,g/mL,mean,SD,2.8,minmax,0.1,7.6,0.0255,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1032,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,3.5,g/mL,mean,SD,4.9,minmax,0,14.4,0.0255,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1033,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,7,g/mL,mean,SD,2.9,minmax,2.3,10.4,0.0255,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1034,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1.5,g/mL,mean,SD,0.8,minmax,0.4,2.4,0.4055,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1035,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,1.2,g/mL,mean,SD,0.8,minmax,0.1,2.2,0.4055,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1036,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,1.9,g/mL,mean,SD,3,minmax,0,9.2,0.4055,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1037,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.9,g/mL,mean,SD,0.8,minmax,0.7,3.1,0.4055,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1038,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,3.1,g/mL,mean,SD,1.6,minmax,1.2,5.7,0.7539,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1039,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,3,g/mL,mean,SD,1.9,minmax,0.3,5.8,0.7539,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1040,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,3.5,g/mL,mean,SD,3.9,minmax,0.6,12.5,0.7539,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1041,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,3.5,g/mL,mean,SD,1.9,minmax,1.9,6.8,0.7539,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1042,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,4.5,g/mL,mean,SD,2.2,minmax,1.6,7.6,0.644,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1043,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,4.2,g/mL,mean,SD,2.6,minmax,0.4,7.8,0.644,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1044,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,5.4,g/mL,mean,SD,6.9,minmax,0.7,21.8,0.644,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1045,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,5.4,g/mL,mean,SD,2.6,minmax,3.2,9.9,0.644,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1046,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1,,mean,SD,0.7,minmax,0.2,2.5,0.001,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1047,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,0.9,,mean,SD,0.8,minmax,0.3,2.9,0.001,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1048,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,0.6,,mean,SD,0.8,minmax,0,2.4,0.001,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1049,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.4,,mean,SD,0.7,minmax,0.7,2.4,0.001,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1050,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,2.5,g/mL,mean,SD,1.2,minmax,0.6,3.9,0.193,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1051,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,2,g/mL,mean,SD,1.3,minmax,0.1,3.4,0.193,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1052,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,2.7,g/mL,mean,SD,4.3,minmax,0,13,0.193,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1053,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,3.3,g/mL,mean,SD,1.2,minmax,1.5,5,0.193,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1054,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,6.1,g/mL,mean,SD,3.4,minmax,1.9,12.7,0.192,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1055,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,5.7,g/mL,mean,SD,3.5,minmax,0.4,12,0.192,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1056,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,6.2,g/mL,mean,SD,7.3,minmax,0.8,23.2,0.192,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1057,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,9.2,g/mL,mean,SD,3.3,minmax,3.2,11.9,0.192,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1058,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,8.5,g/mL,mean,SD,4.2,minmax,2.5,16.6,0.194,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1059,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,7.8,g/mL,mean,SD,4.7,minmax,0.6,15.3,0.194,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1060,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,8.9,g/mL,mean,SD,11.5,minmax,1.1,36.2,0.194,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1061,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,12.4,g/mL,mean,SD,4.2,minmax,5.5,16.9,0.194,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1062,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,4.4,g/mL,mean,SD,3,minmax,2.4,10.1,0.1936,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1063,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,4.8,g/mL,mean,SD,2.6,minmax,2.5,8.8,0.1936,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1064,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,4.1,g/mL,mean,SD,2.2,minmax,1.8,7.4,0.1936,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1065,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX,plasma,maternal,Delivery,,4.0,concentration,,,2.3,g/mL,mean,SD,3.3,minmax,0.5,7.3,0.1936,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1066,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,4.3,g/mL,mean,SD,5.4,minmax,0.5,8.1,0.1936,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1067,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,4.2,g/mL,mean,SD,1.4,minmax,1.8,5.7,0.1936,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1068,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,4.7,g/mL,mean,SD,2,minmax,2,7.5,0.0491,week 30 vs. delivery,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1069,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,4.5,g/mL,mean,SD,1.9,minmax,1.8,7.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1070,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,NOR,plasma,maternal,Delivery,,4.0,concentration,,,2.1,g/mL,mean,SD,0.9,minmax,1.3,3.1,0.0491,week 30 vs. delivery,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1071,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,3.7,g/mL,mean,SD,2.1,minmax,2.2,5.2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1072,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,8.6,g/mL,mean,SD,2.4,minmax,5.8,13.5,0.1355,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1073,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,9.6,g/mL,mean,SD,2.3,minmax,5.5,12,0.1355,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1074,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,8.6,g/mL,mean,SD,2.7,minmax,5.9,13.2,0.1355,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1075,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,Delivery,,4.0,concentration,,,4.4,g/mL,mean,SD,3,minmax,2,8.8,0.1355,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1076,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,8,g/mL,mean,SD,7.5,minmax,2.7,13.3,0.1355,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1077,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,1.4,,mean,SD,1.4,minmax,0.4,3.9,0.1884,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1078,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,1.4,,mean,SD,1.5,minmax,0.4,4.2,0.1884,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1079,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,1.3,,mean,SD,1.3,minmax,0.4,4.2,0.1884,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1080,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,Delivery,,4.0,concentration,,,1.4,,mean,SD,2.2,minmax,0.2,4.7,0.1884,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1081,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,0.9,,mean,SD,0.9,minmax,0.2,1.6,0.1884,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1082,2025-12-02T16:05:15.923463
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1,g/mL,mean,SD,0.5,minmax,0.3,2,0.0354,Week 20 vs. week 36,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1023,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,0.8,g/mL,mean,SD,0.5,minmax,0,1.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1024,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,0.8,g/mL,mean,SD,1.3,minmax,0,3.7,0.0354,Week 20 vs. week 36,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1025,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.3,g/mL,mean,SD,0.5,minmax,0.9,2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1026,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,3,g/mL,mean,SD,2.5,minmax,0.7,7.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1027,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,2.8,g/mL,mean,SD,2.4,minmax,0.1,6.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1028,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,2.7,g/mL,mean,SD,3.7,minmax,0,10.7,0.016,Week 36/12 weeks pp,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1029,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,5.7,g/mL,mean,SD,2.7,minmax,1.3,9.4,0.016,Week 36/12 weeks pp,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1030,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,4,g/mL,mean,SD,2.8,minmax,0.9,9,0.0255,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1031,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,3.6,g/mL,mean,SD,2.8,minmax,0.1,7.6,0.0255,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1032,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,3.5,g/mL,mean,SD,4.9,minmax,0,14.4,0.0255,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1033,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + S-FLX,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,7,g/mL,mean,SD,2.9,minmax,2.3,10.4,0.0255,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1034,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1.5,g/mL,mean,SD,0.8,minmax,0.4,2.4,0.4055,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1035,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,1.2,g/mL,mean,SD,0.8,minmax,0.1,2.2,0.4055,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1036,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,1.9,g/mL,mean,SD,3,minmax,0,9.2,0.4055,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1037,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.9,g/mL,mean,SD,0.8,minmax,0.7,3.1,0.4055,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1038,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,3.1,g/mL,mean,SD,1.6,minmax,1.2,5.7,0.7539,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1039,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,3,g/mL,mean,SD,1.9,minmax,0.3,5.8,0.7539,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1040,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,3.5,g/mL,mean,SD,3.9,minmax,0.6,12.5,0.7539,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1041,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,3.5,g/mL,mean,SD,1.9,minmax,1.9,6.8,0.7539,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1042,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,4.5,g/mL,mean,SD,2.2,minmax,1.6,7.6,0.644,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1043,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,4.2,g/mL,mean,SD,2.6,minmax,0.4,7.8,0.644,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1044,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,5.4,g/mL,mean,SD,6.9,minmax,0.7,21.8,0.644,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1045,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-NOR + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,5.4,g/mL,mean,SD,2.6,minmax,3.2,9.9,0.644,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1046,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,1,,mean,SD,0.7,minmax,0.2,2.5,0.001,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1047,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,0.9,,mean,SD,0.8,minmax,0.3,2.9,0.001,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1048,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,0.6,,mean,SD,0.8,minmax,0,2.4,0.001,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1049,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,(R-FLX + S-FLX) / (R-NOR + S-NOR),plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,1.4,,mean,SD,0.7,minmax,0.7,2.4,0.001,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1050,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,2.5,g/mL,mean,SD,1.2,minmax,0.6,3.9,0.193,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1051,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,2,g/mL,mean,SD,1.3,minmax,0.1,3.4,0.193,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1052,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,2.7,g/mL,mean,SD,4.3,minmax,0,13,0.193,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1053,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + R-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,3.3,g/mL,mean,SD,1.2,minmax,1.5,5,0.193,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1054,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,6.1,g/mL,mean,SD,3.4,minmax,1.9,12.7,0.192,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1055,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,5.7,g/mL,mean,SD,3.5,minmax,0.4,12,0.192,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1056,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,6.2,g/mL,mean,SD,7.3,minmax,0.8,23.2,0.192,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1057,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,S-FLX + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,9.2,g/mL,mean,SD,3.3,minmax,3.2,11.9,0.192,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1058,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,20 weeks,9.0,concentration,,,8.5,g/mL,mean,SD,4.2,minmax,2.5,16.6,0.194,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1059,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,30 weeks,9.0,concentration,,,7.8,g/mL,mean,SD,4.7,minmax,0.6,15.3,0.194,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1060,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,pregnancy,36 weeks,8.0,concentration,,,8.9,g/mL,mean,SD,11.5,minmax,1.1,36.2,0.194,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1061,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,R-FLX + R-NOR + S-FLX + S-NOR,plasma,maternal,postpartum,12 weeks PP,6.0,concentration,,,12.4,g/mL,mean,SD,4.2,minmax,5.5,16.9,0.194,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1062,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,4.4,g/mL,mean,SD,3,minmax,2.4,10.1,0.1936,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1063,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,4.8,g/mL,mean,SD,2.6,minmax,2.5,8.8,0.1936,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1064,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,4.1,g/mL,mean,SD,2.2,minmax,1.8,7.4,0.1936,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1065,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX,plasma,maternal,Delivery,,4.0,concentration,,,2.3,g/mL,mean,SD,3.3,minmax,0.5,7.3,0.1936,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1066,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,4.3,g/mL,mean,SD,5.4,minmax,0.5,8.1,0.1936,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1067,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,4.2,g/mL,mean,SD,1.4,minmax,1.8,5.7,0.1936,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1068,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,4.7,g/mL,mean,SD,2,minmax,2,7.5,0.0491,week 30 vs. delivery,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1069,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,4.5,g/mL,mean,SD,1.9,minmax,1.8,7.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1070,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,NOR,plasma,maternal,Delivery,,4.0,concentration,,,2.1,g/mL,mean,SD,0.9,minmax,1.3,3.1,0.0491,week 30 vs. delivery,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1071,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,3.7,g/mL,mean,SD,2.1,minmax,2.2,5.2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1072,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,8.6,g/mL,mean,SD,2.4,minmax,5.8,13.5,0.1355,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1073,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,9.6,g/mL,mean,SD,2.3,minmax,5.5,12,0.1355,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1074,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,8.6,g/mL,mean,SD,2.7,minmax,5.9,13.2,0.1355,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1075,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,Delivery,,4.0,concentration,,,4.4,g/mL,mean,SD,3,minmax,2,8.8,0.1355,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1076,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX + NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,8,g/mL,mean,SD,7.5,minmax,2.7,13.3,0.1355,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1077,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,20 weeks,7.0,concentration,,,1.4,,mean,SD,1.4,minmax,0.4,3.9,0.1884,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1078,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,30 weeks,8.0,concentration,,,1.4,,mean,SD,1.5,minmax,0.4,4.2,0.1884,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1079,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,pregnancy,36 weeks,7.0,concentration,,,1.3,,mean,SD,1.3,minmax,0.4,4.2,0.1884,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1080,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,Delivery,,4.0,concentration,,,1.4,,mean,SD,2.2,minmax,0.2,4.7,0.1884,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1081,2025-12-02T16:05:22.346295
20631556.0,Fluoxetine,FLX / NOR,plasma,maternal,postpartum,12 weeks PP,2.0,concentration,,,0.9,,mean,SD,0.9,minmax,0.2,1.6,0.1884,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1082,2025-12-02T16:05:22.346295
21824458.0,Venlafaxine,Venlafaxine,cord/maternal plasma,maternal/pediatric,delivery,fetus,2.0,cord-to-maternal concentration ratio,,,1.22,,mean,SD,0.59,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1089,2025-12-02T16:05:09.448543
21824458.0,Venlafaxine,O-desmethylvenlafaxine,cord/maternal plasma,maternal/pediatric,delivery,fetus,2.0,cord-to-maternal concentration ratio,,,0.68,,mean,SD,0.17,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1090,2025-12-02T16:05:09.448543
21824458.0,Venlafaxine,Venlafaxine,cord/maternal plasma,maternal/pediatric,delivery,fetus,2.0,cord-to-maternal concentration ratio,,,1.22,,mean,SD,0.59,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1089,2025-12-02T16:05:12.001940
21824458.0,Venlafaxine,O-desmethylvenlafaxine,cord/maternal plasma,maternal/pediatric,delivery,fetus,2.0,cord-to-maternal concentration ratio,,,0.68,,mean,SD,0.17,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1090,2025-12-02T16:05:12.001940
21824458.0,Venlafaxine,Venlafaxine,cord/maternal plasma,maternal/pediatric,delivery,fetus,2.0,cord-to-maternal concentration ratio,,,1.22,,mean,SD,0.59,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1083,2025-12-02T16:05:15.923463
21824458.0,Venlafaxine,O-desmethylvenlafaxine,cord/maternal plasma,maternal/pediatric,delivery,fetus,2.0,cord-to-maternal concentration ratio,,,0.68,,mean,SD,0.17,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1084,2025-12-02T16:05:15.923463
21824458.0,Venlafaxine,Venlafaxine,cord/maternal plasma,maternal/pediatric,delivery,fetus,2.0,cord-to-maternal concentration ratio,,,1.22,,mean,SD,0.59,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1083,2025-12-02T16:05:22.346295
21824458.0,Venlafaxine,O-desmethylvenlafaxine,cord/maternal plasma,maternal/pediatric,delivery,fetus,2.0,cord-to-maternal concentration ratio,,,0.68,,mean,SD,0.17,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1084,2025-12-02T16:05:22.346295
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,17.4,293,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1139,2025-12-02T16:05:09.448543
8932542.0,Fluoxetine,norfluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,23.4,379.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1140,2025-12-02T16:05:09.448543
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,11.0,infant dose,,,0.077,mg/day,mean,SD,0.054,minmax,0.023,0.189,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1141,2025-12-02T16:05:09.448543
8932542.0,Fluoxetine,norfluoxetine,breast milk,maternal,lactation,,11.0,infant dose,,,0.084,mg/day,mean,SD,0.043,minmax,0.031,0.169,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1142,2025-12-02T16:05:09.448543
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,11.0,estimated infant daily dose,,,0.165,mg,mean,SD,0.092,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1143,2025-12-02T16:05:09.448543
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,17.4,293,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1139,2025-12-02T16:05:12.001940
8932542.0,Fluoxetine,norfluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,23.4,379.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1140,2025-12-02T16:05:12.001940
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,11.0,infant dose,,,0.077,mg/day,mean,SD,0.054,minmax,0.023,0.189,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1141,2025-12-02T16:05:12.001940
8932542.0,Fluoxetine,norfluoxetine,breast milk,maternal,lactation,,11.0,infant dose,,,0.084,mg/day,mean,SD,0.043,minmax,0.031,0.169,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1142,2025-12-02T16:05:12.001940
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,11.0,estimated infant daily dose,,,0.165,mg,mean,SD,0.092,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1143,2025-12-02T16:05:12.001940
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,17.4,293,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1133,2025-12-02T16:05:15.923463
8932542.0,Fluoxetine,norfluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,23.4,379.1,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1134,2025-12-02T16:05:15.923463
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,11.0,infant dose,,,0.077,mg/day,mean,SD,0.054,minmax,0.023,0.189,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1135,2025-12-02T16:05:15.923463
8932542.0,Fluoxetine,norfluoxetine,breast milk,maternal,lactation,,11.0,infant dose,,,0.084,mg/day,mean,SD,0.043,minmax,0.031,0.169,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1136,2025-12-02T16:05:15.923463
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,11.0,estimated infant daily dose,,,0.165,mg,mean,SD,0.092,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1137,2025-12-02T16:05:15.923463
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,17.4,293,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1133,2025-12-02T16:05:22.346295
8932542.0,Fluoxetine,norfluoxetine,breast milk,maternal,lactation,,10.0,concentration,,,,ng/ml,,,,minmax,23.4,379.1,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1134,2025-12-02T16:05:22.346295
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,11.0,infant dose,,,0.077,mg/day,mean,SD,0.054,minmax,0.023,0.189,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1135,2025-12-02T16:05:22.346295
8932542.0,Fluoxetine,norfluoxetine,breast milk,maternal,lactation,,11.0,infant dose,,,0.084,mg/day,mean,SD,0.043,minmax,0.031,0.169,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1136,2025-12-02T16:05:22.346295
8932542.0,Fluoxetine,Fluoxetine,breast milk,maternal,lactation,,11.0,estimated infant daily dose,,,0.165,mg,mean,SD,0.092,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1137,2025-12-02T16:05:22.346295
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,tmax,,,3.9,h,mean,,,95% CI,2.2,5.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1144,2025-12-02T16:05:09.448543
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,tmax,,,5.7,h,mean,,,95% CI,2.2,9.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1145,2025-12-02T16:05:09.448543
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,Cmax,,,154,ug//l,mean,,,95% CI,102,207,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1146,2025-12-02T16:05:09.448543
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,Cmax,,,50,ug//l,mean,,,95% CI,23,77,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1147,2025-12-02T16:05:09.448543
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,average concentration,,,97,ug//l,mean,,,95% CI,56,138,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1148,2025-12-02T16:05:09.448543
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,average concentration,,,36,ug//l,mean,,,95% CI,15,58,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1149,2025-12-02T16:05:09.448543
10971311.0,citalopram,citalopram,breast milk/plasma,maternal,lactation,,7.0,M/PAUC,,,1.8,,mean,,,95% CI,1.2,2.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1150,2025-12-02T16:05:09.448543
10971311.0,citalopram,Demethylcitalopram,breast milk/plasma,maternal,lactation,,7.0,M/PAUC,,,1.8,,mean,,,95% CI,1.1,2.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1151,2025-12-02T16:05:09.448543
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,tmax,,,3.9,h,mean,,,95% CI,2.2,5.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1144,2025-12-02T16:05:12.001940
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,tmax,,,5.7,h,mean,,,95% CI,2.2,9.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1145,2025-12-02T16:05:12.001940
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,Cmax,,,154,ug//l,mean,,,95% CI,102,207,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1146,2025-12-02T16:05:12.001940
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,Cmax,,,50,ug//l,mean,,,95% CI,23,77,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1147,2025-12-02T16:05:12.001940
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,average concentration,,,97,ug//l,mean,,,95% CI,56,138,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1148,2025-12-02T16:05:12.001940
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,average concentration,,,36,ug//l,mean,,,95% CI,15,58,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1149,2025-12-02T16:05:12.001940
10971311.0,citalopram,citalopram,breast milk/plasma,maternal,lactation,,7.0,M/PAUC,,,1.8,,mean,,,95% CI,1.2,2.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1150,2025-12-02T16:05:12.001940
10971311.0,citalopram,Demethylcitalopram,breast milk/plasma,maternal,lactation,,7.0,M/PAUC,,,1.8,,mean,,,95% CI,1.1,2.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1151,2025-12-02T16:05:12.001940
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,tmax,,,3.9,h,mean,,,95% CI,2.2,5.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1138,2025-12-02T16:05:15.923463
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,tmax,,,5.7,h,mean,,,95% CI,2.2,9.2,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1139,2025-12-02T16:05:15.923463
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,Cmax,,,154,ug//l,mean,,,95% CI,102,207,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1140,2025-12-02T16:05:15.923463
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,Cmax,,,50,ug//l,mean,,,95% CI,23,77,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1141,2025-12-02T16:05:15.923463
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,average concentration,,,97,ug//l,mean,,,95% CI,56,138,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1142,2025-12-02T16:05:15.923463
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,average concentration,,,36,ug//l,mean,,,95% CI,15,58,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1143,2025-12-02T16:05:15.923463
10971311.0,citalopram,citalopram,breast milk/plasma,maternal,lactation,,7.0,M/PAUC,,,1.8,,mean,,,95% CI,1.2,2.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1144,2025-12-02T16:05:15.923463
10971311.0,citalopram,Demethylcitalopram,breast milk/plasma,maternal,lactation,,7.0,M/PAUC,,,1.8,,mean,,,95% CI,1.1,2.5,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1145,2025-12-02T16:05:15.923463
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,tmax,,,3.9,h,mean,,,95% CI,2.2,5.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1138,2025-12-02T16:05:22.346295
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,tmax,,,5.7,h,mean,,,95% CI,2.2,9.2,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1139,2025-12-02T16:05:22.346295
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,Cmax,,,154,ug//l,mean,,,95% CI,102,207,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1140,2025-12-02T16:05:22.346295
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,Cmax,,,50,ug//l,mean,,,95% CI,23,77,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1141,2025-12-02T16:05:22.346295
10971311.0,citalopram,citalopram,breast milk,maternal,lactation,,7.0,average concentration,,,97,ug//l,mean,,,95% CI,56,138,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1142,2025-12-02T16:05:22.346295
10971311.0,citalopram,Demethylcitalopram,breast milk,maternal,lactation,,7.0,average concentration,,,36,ug//l,mean,,,95% CI,15,58,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1143,2025-12-02T16:05:22.346295
10971311.0,citalopram,citalopram,breast milk/plasma,maternal,lactation,,7.0,M/PAUC,,,1.8,,mean,,,95% CI,1.2,2.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1144,2025-12-02T16:05:22.346295
10971311.0,citalopram,Demethylcitalopram,breast milk/plasma,maternal,lactation,,7.0,M/PAUC,,,1.8,,mean,,,95% CI,1.1,2.5,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1145,2025-12-02T16:05:22.346295
38841362.0,Sertraline,Sertraline,plasma,maternal,lactation,,15.0,concentration,,,41,g/L,mean,,,minmax,5,200,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1228,2025-12-02T16:05:09.448543
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,concentration,,,87,g/L,mean,,,minmax,12,288,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1229,2025-12-02T16:05:09.448543
38841362.0,Sertraline,Sertraline,plasma,maternal,lactation,,15.0,AUC,,,725,,mean,,,minmax,417,1185,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1230,2025-12-02T16:05:09.448543
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,AUC,,,1670,,mean,,,minmax,1029,2219,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1231,2025-12-02T16:05:09.448543
38841362.0,Sertraline,Sertraline,breast milk/maternal plasma,maternal,lactation,,15.0,M/P ratio,,,2.3,,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1232,2025-12-02T16:05:09.448543
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,AID,,,10,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1233,2025-12-02T16:05:09.448543
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,RID,,,1,%,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1234,2025-12-02T16:05:09.448543
38841362.0,Sertraline,Sertraline,plasma,pediatric,,neonate,15.0,concentration,,,<2,g/L,,,,minmax,<2,2.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1235,2025-12-02T16:05:09.448543
38841362.0,Citalopram,Citalopram,plasma,maternal,lactation,,13.0,concentration,,,63,g/L,mean,,,minmax,16,131,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1236,2025-12-02T16:05:09.448543
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,concentration,,,119,g/L,mean,,,minmax,36,274,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1237,2025-12-02T16:05:09.448543
38841362.0,Citalopram,Citalopram,plasma,maternal,lactation,,13.0,AUC,,,1432,,mean,,,minmax,417,2814,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1238,2025-12-02T16:05:09.448543
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,AUC,,,2578,,mean,,,minmax,902,4139,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1239,2025-12-02T16:05:09.448543
38841362.0,Citalopram,Citalopram,breast milk/maternal plasma,maternal,lactation,,13.0,M/P ratio,,,1.8,,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1240,2025-12-02T16:05:09.448543
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,AID,,,16,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1241,2025-12-02T16:05:09.448543
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,RID,,,6,%,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1242,2025-12-02T16:05:09.448543
38841362.0,Citalopram,Citalopram,plasma,pediatric,,neonate,13.0,concentration,,,<4,g/L,,,,minmax,<4,15,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1243,2025-12-02T16:05:09.448543
38841362.0,Paroxetine,Paroxetine,plasma,maternal,lactation,,9.0,concentration,,,130,g/L,mean,,,minmax,34,223,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1244,2025-12-02T16:05:09.448543
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,concentration,,,63,g/L,mean,,,minmax,6,142,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1245,2025-12-02T16:05:09.448543
38841362.0,Paroxetine,Paroxetine,plasma,maternal,lactation,,9.0,AUC,,,1473,,mean,,,minmax,1055,1857,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1246,2025-12-02T16:05:09.448543
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,AUC,,,859,,mean,,,minmax,600,1111,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1247,2025-12-02T16:05:09.448543
38841362.0,Paroxetine,Paroxetine,breast milk/maternal plasma,maternal,lactation,,9.0,M/P ratio,,,0.6,,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1248,2025-12-02T16:05:09.448543
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,AID,,,5,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1249,2025-12-02T16:05:09.448543
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,RID,,,2,%,,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1250,2025-12-02T16:05:09.448543
38841362.0,Paroxetine,Paroxetine,plasma,pediatric,,neonate,9.0,concentration,,,<6,g/L,,,,minmax,<6,6.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1251,2025-12-02T16:05:09.448543
38841362.0,Sertraline,Sertraline,plasma,maternal,lactation,,15.0,concentration,,,41,g/L,mean,,,minmax,5,200,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1228,2025-12-02T16:05:12.001940
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,concentration,,,87,g/L,mean,,,minmax,12,288,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1229,2025-12-02T16:05:12.001940
38841362.0,Sertraline,Sertraline,plasma,maternal,lactation,,15.0,AUC,,,725,,mean,,,minmax,417,1185,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1230,2025-12-02T16:05:12.001940
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,AUC,,,1670,,mean,,,minmax,1029,2219,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1231,2025-12-02T16:05:12.001940
38841362.0,Sertraline,Sertraline,breast milk/maternal plasma,maternal,lactation,,15.0,M/P ratio,,,2.3,,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1232,2025-12-02T16:05:12.001940
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,AID,,,10,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1233,2025-12-02T16:05:12.001940
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,RID,,,1,%,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1234,2025-12-02T16:05:12.001940
38841362.0,Sertraline,Sertraline,plasma,pediatric,,neonate,15.0,concentration,,,<2,g/L,,,,minmax,<2,2.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1235,2025-12-02T16:05:12.001940
38841362.0,Citalopram,Citalopram,plasma,maternal,lactation,,13.0,concentration,,,63,g/L,mean,,,minmax,16,131,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1236,2025-12-02T16:05:12.001940
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,concentration,,,119,g/L,mean,,,minmax,36,274,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1237,2025-12-02T16:05:12.001940
38841362.0,Citalopram,Citalopram,plasma,maternal,lactation,,13.0,AUC,,,1432,,mean,,,minmax,417,2814,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1238,2025-12-02T16:05:12.001940
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,AUC,,,2578,,mean,,,minmax,902,4139,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1239,2025-12-02T16:05:12.001940
38841362.0,Citalopram,Citalopram,breast milk/maternal plasma,maternal,lactation,,13.0,M/P ratio,,,1.8,,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1240,2025-12-02T16:05:12.001940
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,AID,,,16,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1241,2025-12-02T16:05:12.001940
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,RID,,,6,%,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1242,2025-12-02T16:05:12.001940
38841362.0,Citalopram,Citalopram,plasma,pediatric,,neonate,13.0,concentration,,,<4,g/L,,,,minmax,<4,15,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1243,2025-12-02T16:05:12.001940
38841362.0,Paroxetine,Paroxetine,plasma,maternal,lactation,,9.0,concentration,,,130,g/L,mean,,,minmax,34,223,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1244,2025-12-02T16:05:12.001940
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,concentration,,,63,g/L,mean,,,minmax,6,142,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1245,2025-12-02T16:05:12.001940
38841362.0,Paroxetine,Paroxetine,plasma,maternal,lactation,,9.0,AUC,,,1473,,mean,,,minmax,1055,1857,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1246,2025-12-02T16:05:12.001940
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,AUC,,,859,,mean,,,minmax,600,1111,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1247,2025-12-02T16:05:12.001940
38841362.0,Paroxetine,Paroxetine,breast milk/maternal plasma,maternal,lactation,,9.0,M/P ratio,,,0.6,,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1248,2025-12-02T16:05:12.001940
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,AID,,,5,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1249,2025-12-02T16:05:12.001940
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,RID,,,2,%,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1250,2025-12-02T16:05:12.001940
38841362.0,Paroxetine,Paroxetine,plasma,pediatric,,neonate,9.0,concentration,,,<6,g/L,,,,minmax,<6,6.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1251,2025-12-02T16:05:12.001940
38841362.0,Sertraline,Sertraline,plasma,maternal,lactation,,15.0,concentration,,,41,g/L,mean,,,minmax,5,200,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1222,2025-12-02T16:05:15.923463
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,concentration,,,87,g/L,mean,,,minmax,12,288,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1223,2025-12-02T16:05:15.923463
38841362.0,Sertraline,Sertraline,plasma,maternal,lactation,,15.0,AUC,,,725,,mean,,,minmax,417,1185,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1224,2025-12-02T16:05:15.923463
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,AUC,,,1670,,mean,,,minmax,1029,2219,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1225,2025-12-02T16:05:15.923463
38841362.0,Sertraline,Sertraline,breast milk/maternal plasma,maternal,lactation,,15.0,M/P ratio,,,2.3,,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1226,2025-12-02T16:05:15.923463
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,AID,,,10,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1227,2025-12-02T16:05:15.923463
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,RID,,,1,%,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1228,2025-12-02T16:05:15.923463
38841362.0,Sertraline,Sertraline,plasma,pediatric,,neonate,15.0,concentration,,,<2,g/L,,,,minmax,<2,2.6,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1229,2025-12-02T16:05:15.923463
38841362.0,Citalopram,Citalopram,plasma,maternal,lactation,,13.0,concentration,,,63,g/L,mean,,,minmax,16,131,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1230,2025-12-02T16:05:15.923463
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,concentration,,,119,g/L,mean,,,minmax,36,274,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1231,2025-12-02T16:05:15.923463
38841362.0,Citalopram,Citalopram,plasma,maternal,lactation,,13.0,AUC,,,1432,,mean,,,minmax,417,2814,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1232,2025-12-02T16:05:15.923463
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,AUC,,,2578,,mean,,,minmax,902,4139,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1233,2025-12-02T16:05:15.923463
38841362.0,Citalopram,Citalopram,breast milk/maternal plasma,maternal,lactation,,13.0,M/P ratio,,,1.8,,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1234,2025-12-02T16:05:15.923463
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,AID,,,16,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1235,2025-12-02T16:05:15.923463
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,RID,,,6,%,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1236,2025-12-02T16:05:15.923463
38841362.0,Citalopram,Citalopram,plasma,pediatric,,neonate,13.0,concentration,,,<4,g/L,,,,minmax,<4,15,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1237,2025-12-02T16:05:15.923463
38841362.0,Paroxetine,Paroxetine,plasma,maternal,lactation,,9.0,concentration,,,130,g/L,mean,,,minmax,34,223,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1238,2025-12-02T16:05:15.923463
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,concentration,,,63,g/L,mean,,,minmax,6,142,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1239,2025-12-02T16:05:15.923463
38841362.0,Paroxetine,Paroxetine,plasma,maternal,lactation,,9.0,AUC,,,1473,,mean,,,minmax,1055,1857,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1240,2025-12-02T16:05:15.923463
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,AUC,,,859,,mean,,,minmax,600,1111,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1241,2025-12-02T16:05:15.923463
38841362.0,Paroxetine,Paroxetine,breast milk/maternal plasma,maternal,lactation,,9.0,M/P ratio,,,0.6,,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1242,2025-12-02T16:05:15.923463
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,AID,,,5,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1243,2025-12-02T16:05:15.923463
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,RID,,,2,%,,,,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1244,2025-12-02T16:05:15.923463
38841362.0,Paroxetine,Paroxetine,plasma,pediatric,,neonate,9.0,concentration,,,<6,g/L,,,,minmax,<6,6.4,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1245,2025-12-02T16:05:15.923463
38841362.0,Sertraline,Sertraline,plasma,maternal,lactation,,15.0,concentration,,,41,g/L,mean,,,minmax,5,200,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1222,2025-12-02T16:05:22.346295
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,concentration,,,87,g/L,mean,,,minmax,12,288,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1223,2025-12-02T16:05:22.346295
38841362.0,Sertraline,Sertraline,plasma,maternal,lactation,,15.0,AUC,,,725,,mean,,,minmax,417,1185,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1224,2025-12-02T16:05:22.346295
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,AUC,,,1670,,mean,,,minmax,1029,2219,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1225,2025-12-02T16:05:22.346295
38841362.0,Sertraline,Sertraline,breast milk/maternal plasma,maternal,lactation,,15.0,M/P ratio,,,2.3,,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1226,2025-12-02T16:05:22.346295
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,AID,,,10,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1227,2025-12-02T16:05:22.346295
38841362.0,Sertraline,Sertraline,breast milk,maternal,lactation,,15.0,RID,,,1,%,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1228,2025-12-02T16:05:22.346295
38841362.0,Sertraline,Sertraline,plasma,pediatric,,neonate,15.0,concentration,,,<2,g/L,,,,minmax,<2,2.6,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1229,2025-12-02T16:05:22.346295
38841362.0,Citalopram,Citalopram,plasma,maternal,lactation,,13.0,concentration,,,63,g/L,mean,,,minmax,16,131,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1230,2025-12-02T16:05:22.346295
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,concentration,,,119,g/L,mean,,,minmax,36,274,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1231,2025-12-02T16:05:22.346295
38841362.0,Citalopram,Citalopram,plasma,maternal,lactation,,13.0,AUC,,,1432,,mean,,,minmax,417,2814,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1232,2025-12-02T16:05:22.346295
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,AUC,,,2578,,mean,,,minmax,902,4139,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1233,2025-12-02T16:05:22.346295
38841362.0,Citalopram,Citalopram,breast milk/maternal plasma,maternal,lactation,,13.0,M/P ratio,,,1.8,,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1234,2025-12-02T16:05:22.346295
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,AID,,,16,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1235,2025-12-02T16:05:22.346295
38841362.0,Citalopram,Citalopram,breast milk,maternal,lactation,,13.0,RID,,,6,%,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1236,2025-12-02T16:05:22.346295
38841362.0,Citalopram,Citalopram,plasma,pediatric,,neonate,13.0,concentration,,,<4,g/L,,,,minmax,<4,15,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1237,2025-12-02T16:05:22.346295
38841362.0,Paroxetine,Paroxetine,plasma,maternal,lactation,,9.0,concentration,,,130,g/L,mean,,,minmax,34,223,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1238,2025-12-02T16:05:22.346295
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,concentration,,,63,g/L,mean,,,minmax,6,142,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1239,2025-12-02T16:05:22.346295
38841362.0,Paroxetine,Paroxetine,plasma,maternal,lactation,,9.0,AUC,,,1473,,mean,,,minmax,1055,1857,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1240,2025-12-02T16:05:22.346295
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,AUC,,,859,,mean,,,minmax,600,1111,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1241,2025-12-02T16:05:22.346295
38841362.0,Paroxetine,Paroxetine,breast milk/maternal plasma,maternal,lactation,,9.0,M/P ratio,,,0.6,,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1242,2025-12-02T16:05:22.346295
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,AID,,,5,g/kg/dag,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1243,2025-12-02T16:05:22.346295
38841362.0,Paroxetine,Paroxetine,breast milk,maternal,lactation,,9.0,RID,,,2,%,,,,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1244,2025-12-02T16:05:22.346295
38841362.0,Paroxetine,Paroxetine,plasma,pediatric,,neonate,9.0,concentration,,,<6,g/L,,,,minmax,<6,6.4,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1245,2025-12-02T16:05:22.346295
16190933.0,gabapentin,gabapentin,umbilical cord /maternal plasma,maternal/pediatric,delivery,fetus,6.0,umbilical-to-maternal plasma concentration ratio,,,1.74,,mean,,,minmax,1.3,2.11,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1383,2025-12-02T16:05:09.448543
16190933.0,gabapentin,gabapentin,milk/maternal plasma,maternal,lactation,,5.0,milk/maternal serum concentration ratio,,,1,,mean,,,minmax,0.7,1.3,,from 2 weeks to 3 months,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1384,2025-12-02T16:05:09.448543
16190933.0,gabapentin,gabapentin,milk,maternal,lactation,,5.0,estimated relative infant dose,,,,mg/kg/day,,,,minmax,0.2,1.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1385,2025-12-02T16:05:09.448543
16190933.0,gabapentin,gabapentin,umbilical cord /maternal plasma,maternal/pediatric,delivery,fetus,6.0,umbilical-to-maternal plasma concentration ratio,,,1.74,,mean,,,minmax,1.3,2.11,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1383,2025-12-02T16:05:12.001940
16190933.0,gabapentin,gabapentin,milk/maternal plasma,maternal,lactation,,5.0,milk/maternal serum concentration ratio,,,1,,mean,,,minmax,0.7,1.3,,from 2 weeks to 3 months,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1384,2025-12-02T16:05:12.001940
16190933.0,gabapentin,gabapentin,milk,maternal,lactation,,5.0,estimated relative infant dose,,,,mg/kg/day,,,,minmax,0.2,1.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1385,2025-12-02T16:05:12.001940
16190933.0,gabapentin,gabapentin,umbilical cord /maternal plasma,maternal/pediatric,delivery,fetus,6.0,umbilical-to-maternal plasma concentration ratio,,,1.74,,mean,,,minmax,1.3,2.11,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1377,2025-12-02T16:05:15.923463
16190933.0,gabapentin,gabapentin,milk/maternal plasma,maternal,lactation,,5.0,milk/maternal serum concentration ratio,,,1,,mean,,,minmax,0.7,1.3,,from 2 weeks to 3 months,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1378,2025-12-02T16:05:15.923463
16190933.0,gabapentin,gabapentin,milk,maternal,lactation,,5.0,estimated relative infant dose,,,,mg/kg/day,,,,minmax,0.2,1.3,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1379,2025-12-02T16:05:15.923463
16190933.0,gabapentin,gabapentin,umbilical cord /maternal plasma,maternal/pediatric,delivery,fetus,6.0,umbilical-to-maternal plasma concentration ratio,,,1.74,,mean,,,minmax,1.3,2.11,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1377,2025-12-02T16:05:22.346295
16190933.0,gabapentin,gabapentin,milk/maternal plasma,maternal,lactation,,5.0,milk/maternal serum concentration ratio,,,1,,mean,,,minmax,0.7,1.3,,from 2 weeks to 3 months,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1378,2025-12-02T16:05:22.346295
16190933.0,gabapentin,gabapentin,milk,maternal,lactation,,5.0,estimated relative infant dose,,,,mg/kg/day,,,,minmax,0.2,1.3,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1379,2025-12-02T16:05:22.346295
21081764.0,gabapentin,gabapentin,plasma,maternal,delivery,,24.0,plasma concentration,,,7.5,umol/L,mean,SD,3.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1386,2025-12-02T16:05:09.448543
21081764.0,gabapentin,gabapentin,umbilical vein plasma,pediatric,,fetus,24.0,plasma concentration,,,6.4,umol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1387,2025-12-02T16:05:09.448543
21081764.0,gabapentin,gabapentin,umbilical artery plasma,pediatric,,fetus,24.0,plasma concentration,,,5.1,umol/L,mean,SD,3.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1388,2025-12-02T16:05:09.448543
21081764.0,gabapentin,gabapentin,umbilical vein /maternal plasma,maternal/pediatric,delivery,fetus,24.0,umbilical vein to maternal vein ratio,,,0.86,,mean,SD,0.12,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1389,2025-12-02T16:05:09.448543
21081764.0,gabapentin,gabapentin,plasma,maternal,delivery,,24.0,plasma concentration,,,7.5,umol/L,mean,SD,3.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1386,2025-12-02T16:05:12.001940
21081764.0,gabapentin,gabapentin,umbilical vein plasma,pediatric,,fetus,24.0,plasma concentration,,,6.4,umol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1387,2025-12-02T16:05:12.001940
21081764.0,gabapentin,gabapentin,umbilical artery plasma,pediatric,,fetus,24.0,plasma concentration,,,5.1,umol/L,mean,SD,3.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1388,2025-12-02T16:05:12.001940
21081764.0,gabapentin,gabapentin,umbilical vein /maternal plasma,maternal/pediatric,delivery,fetus,24.0,umbilical vein to maternal vein ratio,,,0.86,,mean,SD,0.12,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1389,2025-12-02T16:05:12.001940
21081764.0,gabapentin,gabapentin,plasma,maternal,delivery,,24.0,plasma concentration,,,7.5,umol/L,mean,SD,3.7,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1380,2025-12-02T16:05:15.923463
21081764.0,gabapentin,gabapentin,umbilical vein plasma,pediatric,,fetus,24.0,plasma concentration,,,6.4,umol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1381,2025-12-02T16:05:15.923463
21081764.0,gabapentin,gabapentin,umbilical artery plasma,pediatric,,fetus,24.0,plasma concentration,,,5.1,umol/L,mean,SD,3.1,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1382,2025-12-02T16:05:15.923463
21081764.0,gabapentin,gabapentin,umbilical vein /maternal plasma,maternal/pediatric,delivery,fetus,24.0,umbilical vein to maternal vein ratio,,,0.86,,mean,SD,0.12,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1383,2025-12-02T16:05:15.923463
21081764.0,gabapentin,gabapentin,plasma,maternal,delivery,,24.0,plasma concentration,,,7.5,umol/L,mean,SD,3.7,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1380,2025-12-02T16:05:22.346295
21081764.0,gabapentin,gabapentin,umbilical vein plasma,pediatric,,fetus,24.0,plasma concentration,,,6.4,umol/L,mean,SD,3.3,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1381,2025-12-02T16:05:22.346295
21081764.0,gabapentin,gabapentin,umbilical artery plasma,pediatric,,fetus,24.0,plasma concentration,,,5.1,umol/L,mean,SD,3.1,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1382,2025-12-02T16:05:22.346295
21081764.0,gabapentin,gabapentin,umbilical vein /maternal plasma,maternal/pediatric,delivery,fetus,24.0,umbilical vein to maternal vein ratio,,,0.86,,mean,SD,0.12,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1383,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,"AUC(0,24h)",,,1645,ug h/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1390,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,plasma concentration,,,94,ug/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1391,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,tmax,,,2.2,h,median,,,,,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1392,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,"AUC(0,24h)",,,632,ug h/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1393,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,plasma concentration,,,46,ug/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1394,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,tmax,,,5.7,h,median,,,,,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1395,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,M/PAUC ratio,,,0.39,,mean,,,,,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1396,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,relative infant dose,,,1.35,% of the weight-adjusted maternal dose,mean,,,,,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1397,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,relative infant dose,,,0.48,% of the weight-adjusted maternal dose,median,,,,,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1398,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative infant dose,,,1.13,% of the weight-adjusted maternal dose,mean,,,,,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1399,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative infant dose,,,0.46,% of the weight-adjusted maternal dose,median,,,,,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1400,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,4.0,plasma concentration,,,32,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1401,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,4.0,prefeed milk concentration,,,17,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1402,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,4.0,postfeed milk concentration,,,25,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1403,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,4.0,M/P prefeed ,,,0.7,,mean,,,,,,,Study 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1404,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,4.0,M/P postfeed,,,1.23,,mean,,,,,,,Study 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1405,2025-12-02T16:05:09.448543
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,"AUC(0,24h)",,,1645,ug h/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1390,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,plasma concentration,,,94,ug/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1391,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,tmax,,,2.2,h,median,,,,,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1392,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,"AUC(0,24h)",,,632,ug h/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1393,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,plasma concentration,,,46,ug/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1394,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,tmax,,,5.7,h,median,,,,,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1395,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,M/PAUC ratio,,,0.39,,mean,,,,,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1396,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,relative infant dose,,,1.35,% of the weight-adjusted maternal dose,mean,,,,,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1397,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,relative infant dose,,,0.48,% of the weight-adjusted maternal dose,median,,,,,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1398,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative infant dose,,,1.13,% of the weight-adjusted maternal dose,mean,,,,,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1399,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative infant dose,,,0.46,% of the weight-adjusted maternal dose,median,,,,,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1400,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,4.0,plasma concentration,,,32,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1401,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,4.0,prefeed milk concentration,,,17,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1402,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,4.0,postfeed milk concentration,,,25,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1403,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,4.0,M/P prefeed ,,,0.7,,mean,,,,,,,Study 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1404,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,4.0,M/P postfeed,,,1.23,,mean,,,,,,,Study 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1405,2025-12-02T16:05:12.001940
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,"AUC(0,24h)",,,1645,ug h/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1384,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,plasma concentration,,,94,ug/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1385,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,tmax,,,2.2,h,median,,,,,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1386,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,"AUC(0,24h)",,,632,ug h/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1387,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,plasma concentration,,,46,ug/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1388,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,tmax,,,5.7,h,median,,,,,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1389,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,M/PAUC ratio,,,0.39,,mean,,,,,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1390,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,relative infant dose,,,1.35,% of the weight-adjusted maternal dose,mean,,,,,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1391,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,relative infant dose,,,0.48,% of the weight-adjusted maternal dose,median,,,,,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1392,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative infant dose,,,1.13,% of the weight-adjusted maternal dose,mean,,,,,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1393,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative infant dose,,,0.46,% of the weight-adjusted maternal dose,median,,,,,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1394,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,4.0,plasma concentration,,,32,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1395,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,4.0,prefeed milk concentration,,,17,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1396,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,4.0,postfeed milk concentration,,,25,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1397,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,4.0,M/P prefeed ,,,0.7,,mean,,,,,,,Study 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1398,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,4.0,M/P postfeed,,,1.23,,mean,,,,,,,Study 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1399,2025-12-02T16:05:15.923463
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,"AUC(0,24h)",,,1645,ug h/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1384,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,plasma concentration,,,94,ug/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1385,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,6.0,tmax,,,2.2,h,median,,,,,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1386,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,"AUC(0,24h)",,,632,ug h/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1387,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,plasma concentration,,,46,ug/l,mean,,,,,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1388,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,tmax,,,5.7,h,median,,,,,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1389,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,M/PAUC ratio,,,0.39,,mean,,,,,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1390,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,relative infant dose,,,1.35,% of the weight-adjusted maternal dose,mean,,,,,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1391,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,6.0,relative infant dose,,,0.48,% of the weight-adjusted maternal dose,median,,,,,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1392,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative infant dose,,,1.13,% of the weight-adjusted maternal dose,mean,,,,,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1393,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,6.0,relative infant dose,,,0.46,% of the weight-adjusted maternal dose,median,,,,,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1394,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,plasma,maternal,lactation,,4.0,plasma concentration,,,32,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1395,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,4.0,prefeed milk concentration,,,17,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1396,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk,maternal,lactation,,4.0,postfeed milk concentration,,,25,ug/l,mean,,,,,,,Study 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1397,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,4.0,M/P prefeed ,,,0.7,,mean,,,,,,,Study 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1398,2025-12-02T16:05:22.346295
10417489.0,paroxetine,paroxetine,breast milk/plasma,maternal,lactation,,4.0,M/P postfeed,,,1.23,,mean,,,,,,,Study 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1399,2025-12-02T16:05:22.346295
10671385.0,paroxetine,paroxetine,breast milk,maternal,lactation,,16.0,concentration,,,41.6,ng/ml,mean,SD,24.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1408,2025-12-02T16:05:09.448543
10671385.0,paroxetine,paroxetine,breast milk,maternal,lactation,,16.0,concentration,,,41.6,ng/ml,mean,SD,24.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1408,2025-12-02T16:05:12.001940
10671385.0,paroxetine,paroxetine,breast milk,maternal,lactation,,16.0,concentration,,,41.6,ng/ml,mean,SD,24.7,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1402,2025-12-02T16:05:15.923463
10671385.0,paroxetine,paroxetine,breast milk,maternal,lactation,,16.0,concentration,,,41.6,ng/ml,mean,SD,24.7,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1402,2025-12-02T16:05:22.346295
11105735.0,paroxetine,paroxetine,serum,maternal,lactation,,25.0,serum concentration,,,45.2,ng/ml,mean,SD,65.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1409,2025-12-02T16:05:09.448543
11105735.0,paroxetine,paroxetine,breast milk,maternal,lactation,,25.0,concentration,,,19.2,ng/ml,mean,SD,27.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1410,2025-12-02T16:05:09.448543
11105735.0,paroxetine,paroxetine,breast milk/maternal serum,maternal,lactation,,25.0,milk-to-plasma ratio,,,0.53,,mean,SD,0.41,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1411,2025-12-02T16:05:09.448543
11105735.0,paroxetine,paroxetine,breast milk,maternal,lactation,,25.0,normalized daily infant dose,,,2.88,ug/kg/d,mean,SD,4.135,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1412,2025-12-02T16:05:09.448543
11105735.0,paroxetine,paroxetine,breast milk,maternal,lactation,,25.0,% of the weight-normalized maternal dose,,,1.1,%,mean,SD,1.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1413,2025-12-02T16:05:09.448543
11105735.0,paroxetine,paroxetine,serum,maternal,lactation,,25.0,serum concentration,,,45.2,ng/ml,mean,SD,65.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1409,2025-12-02T16:05:12.001940
11105735.0,paroxetine,paroxetine,breast milk,maternal,lactation,,25.0,concentration,,,19.2,ng/ml,mean,SD,27.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1410,2025-12-02T16:05:12.001940
11105735.0,paroxetine,paroxetine,breast milk/maternal serum,maternal,lactation,,25.0,milk-to-plasma ratio,,,0.53,,mean,SD,0.41,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1411,2025-12-02T16:05:12.001940
11105735.0,paroxetine,paroxetine,breast milk,maternal,lactation,,25.0,normalized daily infant dose,,,2.88,ug/kg/d,mean,SD,4.135,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1412,2025-12-02T16:05:12.001940
11105735.0,paroxetine,paroxetine,breast milk,maternal,lactation,,25.0,% of the weight-normalized maternal dose,,,1.1,%,mean,SD,1.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1413,2025-12-02T16:05:12.001940
11105735.0,paroxetine,paroxetine,serum,maternal,lactation,,25.0,serum concentration,,,45.2,ng/ml,mean,SD,65.6,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1403,2025-12-02T16:05:15.923463
11105735.0,paroxetine,paroxetine,breast milk,maternal,lactation,,25.0,concentration,,,19.2,ng/ml,mean,SD,27.6,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1404,2025-12-02T16:05:15.923463
11105735.0,paroxetine,paroxetine,breast milk/maternal serum,maternal,lactation,,25.0,milk-to-plasma ratio,,,0.53,,mean,SD,0.41,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1405,2025-12-02T16:05:15.923463
11105735.0,paroxetine,paroxetine,breast milk,maternal,lactation,,25.0,normalized daily infant dose,,,2.88,ug/kg/d,mean,SD,4.135,,,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1406,2025-12-02T16:05:15.923463
11105735.0,paroxetine,paroxetine,serum,maternal,lactation,,25.0,serum concentration,,,45.2,ng/ml,mean,SD,65.6,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1403,2025-12-02T16:05:22.346295
11105735.0,paroxetine,paroxetine,breast milk,maternal,lactation,,25.0,concentration,,,19.2,ng/ml,mean,SD,27.6,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1404,2025-12-02T16:05:22.346295
11105735.0,paroxetine,paroxetine,breast milk/maternal serum,maternal,lactation,,25.0,milk-to-plasma ratio,,,0.53,,mean,SD,0.41,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1405,2025-12-02T16:05:22.346295
11105735.0,paroxetine,paroxetine,breast milk,maternal,lactation,,25.0,normalized daily infant dose,,,2.88,ug/kg/d,mean,SD,4.135,,,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1406,2025-12-02T16:05:22.346295
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,8.0,concentration,1,hr,178.5,ug/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1415,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,concentration,24,hr,17.5,ug/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1416,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,concentration,10,hr,97,ug/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1417,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,placental tissue,maternal,1st trimester,,24.0,concentration,1,hr,57,ug/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1418,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,placental tissue,maternal,1st trimester,,24.0,concentration,4,hr,18,ug/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1419,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,8.0,concentration,1,hr,229.5,ug/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1420,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,8.0,concentration,4,hr,454,ug/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1421,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,concentration,24,hr,62,ug/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1422,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,placental tissue,maternal,1st trimester,,24.0,concentration,2.5,hr,120,ug/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1423,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,placental tissue,maternal,1st trimester,,24.0,concentration,4,hr,112.5,ug/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1424,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,Elimination rate constant,0-24,hr,0.054,/h,median,,,50% inerqurtile range,0.042,0.062,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1425,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,Elimination half-life,0-24,hr,12.5,h,median,,,50% inerqurtile range,9,16,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1426,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,AUC0-,0-24,hr,1998,ug h/l,median,,,50% inerqurtile range,1578,2083,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1427,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,Apparent volume of distribution,0-24,hr,1.9,l/kg,median,,,50% inerqurtile range,1.1,2.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1428,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,total plasma clearance,0-24,hr,1.4,ml/min,median,,,50% inerqurtile range,1.3,1.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1429,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,Elimination rate constant,0-24,hr,0.07,/h,median,,,50% inerqurtile range,0.054,0.083,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1430,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,Elimination half-life,0-24,hr,10,h,median,,,50% inerqurtile range,6,13,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1431,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,AUC0-,0-24,hr,6464,ug h/l,median,,,50% inerqurtile range,4817,10278,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1432,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,Apparent volume of distribution,0-24,hr,0.7,l/kg,median,,,50% inerqurtile range,0.5,1.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1433,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,total plasma clearance,0-24,hr,1.1,ml/min,median,,,50% inerqurtile range,0.7,1.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1434,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,24.0,AUC0-4,0-4,hr,389,ug h/l,median,,,50% inerqurtile range,280,434,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1435,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,24.0,penetration,0-4,hr,,%,median,,,50% inerqurtile range,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1436,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,placental tissue,maternal,1st trimester,,24.0,AUC0-4,0-4,hr,118,ug h/l,median,,,50% inerqurtile range,73,155,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1437,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,24.0,AUC0-4,0-4,hr,847,ug h/l,median,,,50% inerqurtile range,770,1084,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1441,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,24.0,penetration,0-4,hr,,%,median,,,50% inerqurtile range,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1442,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,placental tissue,maternal,1st trimester,,24.0,AUC0-4,0-4,hr,415.5,ug h/l,median,,,50% inerqurtile range,363,541,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1443,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,placental tissue,maternal,1st trimester,,24.0,penetration,0-4,hr,49,%,median,,,50% inerqurtile range,43,56,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1444,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,amniotic fluid,maternal,1st trimester,,24.0,AUC0-4,0-4,hr,0,ug h/l,median,,,50% inerqurtile range,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1445,2025-12-02T16:05:09.448543
3239381.0,oxazepam,oxazepam,amniotic fluid,maternal,1st trimester,,24.0,penetration,0-4,hr,0,%,median,,,50% inerqurtile range,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1446,2025-12-02T16:05:09.448543
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,8.0,concentration,1,hr,178.5,ug/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1415,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,concentration,24,hr,17.5,ug/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1416,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,concentration,10,hr,97,ug/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1417,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,placental tissue,maternal,1st trimester,,24.0,concentration,1,hr,57,ug/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1418,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,placental tissue,maternal,1st trimester,,24.0,concentration,4,hr,18,ug/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1419,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,8.0,concentration,1,hr,229.5,ug/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1420,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,8.0,concentration,4,hr,454,ug/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1421,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,concentration,24,hr,62,ug/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1422,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,placental tissue,maternal,1st trimester,,24.0,concentration,2.5,hr,120,ug/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1423,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,placental tissue,maternal,1st trimester,,24.0,concentration,4,hr,112.5,ug/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1424,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,Elimination rate constant,0-24,hr,0.054,/h,median,,,50% inerqurtile range,0.042,0.062,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1425,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,Elimination half-life,0-24,hr,12.5,h,median,,,50% inerqurtile range,9,16,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1426,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,AUC0-,0-24,hr,1998,ug h/l,median,,,50% inerqurtile range,1578,2083,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1427,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,Apparent volume of distribution,0-24,hr,1.9,l/kg,median,,,50% inerqurtile range,1.1,2.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1428,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,9.0,total plasma clearance,0-24,hr,1.4,ml/min,median,,,50% inerqurtile range,1.3,1.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1429,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,Elimination rate constant,0-24,hr,0.07,/h,median,,,50% inerqurtile range,0.054,0.083,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1430,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,Elimination half-life,0-24,hr,10,h,median,,,50% inerqurtile range,6,13,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1431,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,AUC0-,0-24,hr,6464,ug h/l,median,,,50% inerqurtile range,4817,10278,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1432,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,Apparent volume of distribution,0-24,hr,0.7,l/kg,median,,,50% inerqurtile range,0.5,1.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1433,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,9.0,total plasma clearance,0-24,hr,1.1,ml/min,median,,,50% inerqurtile range,0.7,1.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1434,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,24.0,AUC0-4,0-4,hr,389,ug h/l,median,,,50% inerqurtile range,280,434,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1435,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,serum,maternal,1st trimester,,24.0,penetration,0-4,hr,,%,median,,,50% inerqurtile range,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1436,2025-12-02T16:05:12.001940
3239381.0,diazepam,diazepam,placental tissue,maternal,1st trimester,,24.0,AUC0-4,0-4,hr,118,ug h/l,median,,,50% inerqurtile range,73,155,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1437,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,24.0,AUC0-4,0-4,hr,847,ug h/l,median,,,50% inerqurtile range,770,1084,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1441,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,serum,maternal,1st trimester,,24.0,penetration,0-4,hr,,%,median,,,50% inerqurtile range,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1442,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,placental tissue,maternal,1st trimester,,24.0,AUC0-4,0-4,hr,415.5,ug h/l,median,,,50% inerqurtile range,363,541,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1443,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,placental tissue,maternal,1st trimester,,24.0,penetration,0-4,hr,49,%,median,,,50% inerqurtile range,43,56,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1444,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,amniotic fluid,maternal,1st trimester,,24.0,AUC0-4,0-4,hr,0,ug h/l,median,,,50% inerqurtile range,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1445,2025-12-02T16:05:12.001940
3239381.0,oxazepam,oxazepam,amniotic fluid,maternal,1st trimester,,24.0,penetration,0-4,hr,0,%,median,,,50% inerqurtile range,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1446,2025-12-02T16:05:12.001940
24134697.0,diazepam,diazepam,umbilical venous cord/maternal plasma,maternal/pediatric,delivery,fetus,31.0,feto: maternal concentration ratio,t1/t2,min,1.3,,mean,SD,0.48,minmax,0.59,2.27,,control group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1447,2025-12-02T16:05:09.448543
24134697.0,diazepam,diazepam,umbilical venous cord/maternal plasma,maternal/pediatric,delivery,fetus,30.0,feto: maternal concentration ratio,t1/t2,min,2.26,,mean,SD,1.23,minmax,0.25,4.21,0.05 vs. control group,hypertension group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1448,2025-12-02T16:05:09.448543
24134697.0,diazepam,diazepam,umbilical venous cord/maternal plasma,maternal/pediatric,delivery,fetus,14.0,feto: maternal concentration ratio,t1/t2,min,2.01,,mean,SD,1.1,minmax,0.42,3.77,0.05 vs. control group,diabetes group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1449,2025-12-02T16:05:09.448543
24134697.0,diazepam,diazepam,umbilical venous cord/artery cod plasma,pedatric,,fetus,31.0,umbilical cord arterial: venous concentration ratio,t2,min,0.97,,mean,SD,0.32,minmax,0.1,1.6,,control group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1450,2025-12-02T16:05:09.448543
24134697.0,diazepam,diazepam,umbilical venous cord/artery cod plasma,pedatric,,fetus,30.0,umbilical cord arterial: venous concentration ratio,t2,min,1.08,,mean,SD,0.6,minmax,0.33,2.5,,hypertension group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1451,2025-12-02T16:05:09.448543
24134697.0,diazepam,diazepam,umbilical venous cord/artery cod plasma,pedatric,,fetus,14.0,umbilical cord arterial: venous concentration ratio,t2,min,1.02,,mean,SD,0.77,minmax,0.17,2.97,,diabetes group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1452,2025-12-02T16:05:09.448543
24134697.0,diazepam,diazepam,umbilical venous cord/maternal plasma,maternal/pediatric,delivery,fetus,31.0,feto: maternal concentration ratio,t1/t2,min,1.3,,mean,SD,0.48,minmax,0.59,2.27,,control group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1447,2025-12-02T16:05:12.001940
24134697.0,diazepam,diazepam,umbilical venous cord/maternal plasma,maternal/pediatric,delivery,fetus,30.0,feto: maternal concentration ratio,t1/t2,min,2.26,,mean,SD,1.23,minmax,0.25,4.21,0.05 vs. control group,hypertension group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1448,2025-12-02T16:05:12.001940
24134697.0,diazepam,diazepam,umbilical venous cord/maternal plasma,maternal/pediatric,delivery,fetus,14.0,feto: maternal concentration ratio,t1/t2,min,2.01,,mean,SD,1.1,minmax,0.42,3.77,0.05 vs. control group,diabetes group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1449,2025-12-02T16:05:12.001940
24134697.0,diazepam,diazepam,umbilical venous cord/artery cod plasma,pedatric,,fetus,31.0,umbilical cord arterial: venous concentration ratio,t2,min,0.97,,mean,SD,0.32,minmax,0.1,1.6,,control group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1450,2025-12-02T16:05:12.001940
24134697.0,diazepam,diazepam,umbilical venous cord/artery cod plasma,pedatric,,fetus,30.0,umbilical cord arterial: venous concentration ratio,t2,min,1.08,,mean,SD,0.6,minmax,0.33,2.5,,hypertension group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1451,2025-12-02T16:05:12.001940
24134697.0,diazepam,diazepam,umbilical venous cord/artery cod plasma,pedatric,,fetus,14.0,umbilical cord arterial: venous concentration ratio,t2,min,1.02,,mean,SD,0.77,minmax,0.17,2.97,,diabetes group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1452,2025-12-02T16:05:12.001940
2721106.0,diazepam,total diazepam,plasma,maternal,delivery,,4.0,Varea ,,,2.37,L/kg,mean,SD,0.47,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1453,2025-12-02T16:05:09.448543
2721106.0,diazepam,total diazepam,plasma,maternal,delivery,,4.0,t1/2,,,30.2,hr,mean,SD,5.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1454,2025-12-02T16:05:09.448543
2721106.0,diazepam,total diazepam,plasma,maternal,delivery,,4.0,CL,,,0.94,ml/min/kg,mean,SD,0.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1455,2025-12-02T16:05:09.448543
2721106.0,diazepam,diazepam,blood,maternal,delivery,,4.0,Varea ,,,5,L/kg,mean,SD,1.46,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1456,2025-12-02T16:05:09.448543
2721106.0,diazepam,diazepam,blood,maternal,delivery,,4.0,t1/2,,,29.3,hr,mean,SD,4.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1457,2025-12-02T16:05:09.448543
2721106.0,diazepam,diazepam,blood,maternal,delivery,,4.0,Blood CL,,,2.04,ml/min/kg,mean,SD,0.76,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1458,2025-12-02T16:05:09.448543
2721106.0,diazepam,free diazepam,plasma,maternal,delivery,,4.0,mean free fraction,,,2.19,%,mean,SD,0.54,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1459,2025-12-02T16:05:09.448543
2721106.0,diazepam,free diazepam,plasma,maternal,delivery,,4.0,free Varea,,,77.7,L/kg,mean,SD,22.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1460,2025-12-02T16:05:09.448543
2721106.0,diazepam,free diazepam,plasma,maternal,delivery,,4.0,free t1/2,,,20.9,hr,mean,SD,4.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1461,2025-12-02T16:05:09.448543
2721106.0,diazepam,free diazepam,plasma,maternal,delivery,,4.0,free plasma clearance,,,42.5,ml/min/kg,mean,SD,5.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1462,2025-12-02T16:05:09.448543
2721106.0,diazepam,total diazepam,umbilibal venous/maternal plasma,maternal/pediatric,delivery,fetus,5.0,umbilical vein to maternal vein total plasma concentration,,,1.73,,mean,SD,0.47,minmax,1.32,2.48,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1463,2025-12-02T16:05:09.448543
2721106.0,diazepam,free diazepam,umbilibal venous/maternal plasma,maternal/pediatric,delivery,fetus,5.0,umbilical vein to maternal vein free plasma concentration,,,0.92,,mean,SD,0.09,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1464,2025-12-02T16:05:09.448543
2721106.0,diazepam,total diazepam,plasma,maternal,delivery,,4.0,Varea ,,,2.37,L/kg,mean,SD,0.47,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1453,2025-12-02T16:05:12.001940
2721106.0,diazepam,total diazepam,plasma,maternal,delivery,,4.0,t1/2,,,30.2,hr,mean,SD,5.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1454,2025-12-02T16:05:12.001940
2721106.0,diazepam,total diazepam,plasma,maternal,delivery,,4.0,CL,,,0.94,ml/min/kg,mean,SD,0.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1455,2025-12-02T16:05:12.001940
2721106.0,diazepam,diazepam,blood,maternal,delivery,,4.0,Varea ,,,5,L/kg,mean,SD,1.46,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1456,2025-12-02T16:05:12.001940
2721106.0,diazepam,diazepam,blood,maternal,delivery,,4.0,t1/2,,,29.3,hr,mean,SD,4.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1457,2025-12-02T16:05:12.001940
2721106.0,diazepam,diazepam,blood,maternal,delivery,,4.0,Blood CL,,,2.04,ml/min/kg,mean,SD,0.76,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1458,2025-12-02T16:05:12.001940
2721106.0,diazepam,free diazepam,plasma,maternal,delivery,,4.0,mean free fraction,,,2.19,%,mean,SD,0.54,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1459,2025-12-02T16:05:12.001940
2721106.0,diazepam,free diazepam,plasma,maternal,delivery,,4.0,free Varea,,,77.7,L/kg,mean,SD,22.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1460,2025-12-02T16:05:12.001940
2721106.0,diazepam,free diazepam,plasma,maternal,delivery,,4.0,free t1/2,,,20.9,hr,mean,SD,4.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1461,2025-12-02T16:05:12.001940
2721106.0,diazepam,free diazepam,plasma,maternal,delivery,,4.0,free plasma clearance,,,42.5,ml/min/kg,mean,SD,5.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1462,2025-12-02T16:05:12.001940
2721106.0,diazepam,total diazepam,umbilibal venous/maternal plasma,maternal/pediatric,delivery,fetus,5.0,umbilical vein to maternal vein total plasma concentration,,,1.73,,mean,SD,0.47,minmax,1.32,2.48,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1463,2025-12-02T16:05:12.001940
2721106.0,diazepam,free diazepam,umbilibal venous/maternal plasma,maternal/pediatric,delivery,fetus,5.0,umbilical vein to maternal vein free plasma concentration,,,0.92,,mean,SD,0.09,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1464,2025-12-02T16:05:12.001940
2105100.0,diazepam,diazepam,breast milk,maternal,lactation,,5.0,post-feed:pre-feed milk ratio,,,1.56,,mean,SD,0.18,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1465,2025-12-02T16:05:09.448543
2105100.0,diazepam,N-Desmethyldiazepam,breast milk,maternal,lactation,,5.0,post-feed:pre-feed milk ratio,,,1.56,,mean,SD,0.22,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1466,2025-12-02T16:05:09.448543
2105100.0,diazepam,Oxazepam,breast milk,maternal,lactation,,5.0,post-feed:pre-feed milk ratio,,,1.11,,mean,SD,0.24,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1467,2025-12-02T16:05:09.448543
2105100.0,diazepam,Temazepam,breast milk,maternal,lactation,,4.0,post-feed:pre-feed milk ratio,,,1.9,,mean,SD,0.44,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1468,2025-12-02T16:05:09.448543
2105100.0,diazepam,diazepam,milk/plasma,maternal,lactation,,5.0,Milk: plasma ratio,,,0.2,,mean,SD,0.03,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1469,2025-12-02T16:05:09.448543
2105100.0,diazepam,N-Desmethyldiazepam,milk/plasma,maternal,lactation,,6.0,Milk: plasma ratio,,,0.13,,mean,SD,0.01,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1470,2025-12-02T16:05:09.448543
2105100.0,diazepam,Oxazepam,milk/plasma,maternal,lactation,,5.0,Milk: plasma ratio,,,0.1,,mean,SD,0.004,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1471,2025-12-02T16:05:09.448543
2105100.0,diazepam,Temazepam,milk/plasma,maternal,lactation,,5.0,Milk: plasma ratio,,,0.14,,mean,SD,0.02,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1472,2025-12-02T16:05:09.448543
2105100.0,diazepam,diazepam,breast milk,maternal,lactation,,5.0,post-feed:pre-feed milk ratio,,,1.56,,mean,SD,0.18,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1465,2025-12-02T16:05:12.001940
2105100.0,diazepam,N-Desmethyldiazepam,breast milk,maternal,lactation,,5.0,post-feed:pre-feed milk ratio,,,1.56,,mean,SD,0.22,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1466,2025-12-02T16:05:12.001940
2105100.0,diazepam,Oxazepam,breast milk,maternal,lactation,,5.0,post-feed:pre-feed milk ratio,,,1.11,,mean,SD,0.24,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1467,2025-12-02T16:05:12.001940
2105100.0,diazepam,Temazepam,breast milk,maternal,lactation,,4.0,post-feed:pre-feed milk ratio,,,1.9,,mean,SD,0.44,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1468,2025-12-02T16:05:12.001940
2105100.0,diazepam,diazepam,milk/plasma,maternal,lactation,,5.0,Milk: plasma ratio,,,0.2,,mean,SD,0.03,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1469,2025-12-02T16:05:12.001940
2105100.0,diazepam,N-Desmethyldiazepam,milk/plasma,maternal,lactation,,6.0,Milk: plasma ratio,,,0.13,,mean,SD,0.01,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1470,2025-12-02T16:05:12.001940
2105100.0,diazepam,Oxazepam,milk/plasma,maternal,lactation,,5.0,Milk: plasma ratio,,,0.1,,mean,SD,0.004,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1471,2025-12-02T16:05:12.001940
2105100.0,diazepam,Temazepam,milk/plasma,maternal,lactation,,5.0,Milk: plasma ratio,,,0.14,,mean,SD,0.02,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1472,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,blood,maternal,delivery,,30.0,concentration,,,544,ng/ml,mean,,,minmax,218,902,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1473,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,blood,maternal,delivery,,30.0,concentration,,,526,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1474,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,30.0,concentration,,,449,ng/ml,mean,,,minmax,232,760,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1475,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,30.0,concentration,,,418,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1476,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,capillary blood,pedatric,,newborn,30.0,concentration,,,175,ng/ml,mean,,,minmax,71,328,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1477,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,capillary blood,pedatric,,newborn,30.0,concentration,,,170,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1478,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,umbilical cord blood/maternal blood,maternal/pediatric,delivery,fetus,30.0,UC/M ratio,,,0.84,,mean,,,minmax,0.49,1.43,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1479,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,umbilical cord blood/maternal blood,maternal/pediatric,delivery,fetus,30.0,UC/M ratio,,,0.77,,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1480,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,capillary blood/maternal blood,maternal/pediatric,delivery,newborn,30.0,C/M ratio,,,0.33,,mean,,,minmax,0.16,0.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1481,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,capillary blood/maternal blood,maternal/pediatric,delivery,newborn,30.0,C/M ratio,,,0.3,,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1482,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,blood,maternal,after 2 h of delivery,,28.0,concentration,,,91,ng/ml,mean,,,minmax,38,161,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1483,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,blood,maternal,after 2 h of delivery,,28.0,concentration,,,92,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1484,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,capillary blood,pedatric,after 2 h of delivery,newborn,29.0,concentration,,,63,ng/ml,mean,,,minmax,<20,149,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1485,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,capillary blood,pedatric,after 2 h of delivery,newborn,29.0,concentration,,,57,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1486,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,capillary blood/maternal blood,maternal/pediatric,after 2 h of delivery,newborn,28.0,C/M ratio,,,0.67,,mean,,,minmax,0.21,1.68,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1487,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,capillary blood/maternal blood,maternal/pediatric,after 2 h of delivery,newborn,28.0,C/M ratio,,,0.63,,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1488,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,blood,maternal,after 2 h of delivery,,30.0,concentration,,,31,ng/ml,mean,,,minmax,20,71,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1489,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,blood,maternal,after 2 h of delivery,,30.0,concentration,,,28,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1490,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,capillary blood,pedatric,after 2 h of delivery,newborn,30.0,concentration,,,36,ng/ml,mean,,,minmax,ND,79,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1491,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,capillary blood,pedatric,after 2 h of delivery,newborn,30.0,concentration,,,34,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1492,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,capillary blood/maternal blood,maternal/pediatric,after 2 h of delivery,newborn,26.0,C/M ratio,,,1.27,,median,,,minmax,<0.44,3.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1493,2025-12-02T16:05:09.448543
7397084.0,diazepam,diazepam,blood,maternal,delivery,,30.0,concentration,,,544,ng/ml,mean,,,minmax,218,902,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1473,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,blood,maternal,delivery,,30.0,concentration,,,526,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1474,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,30.0,concentration,,,449,ng/ml,mean,,,minmax,232,760,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1475,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,30.0,concentration,,,418,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1476,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,capillary blood,pedatric,,newborn,30.0,concentration,,,175,ng/ml,mean,,,minmax,71,328,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1477,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,capillary blood,pedatric,,newborn,30.0,concentration,,,170,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1478,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,umbilical cord blood/maternal blood,maternal/pediatric,delivery,fetus,30.0,UC/M ratio,,,0.84,,mean,,,minmax,0.49,1.43,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1479,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,umbilical cord blood/maternal blood,maternal/pediatric,delivery,fetus,30.0,UC/M ratio,,,0.77,,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1480,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,capillary blood/maternal blood,maternal/pediatric,delivery,newborn,30.0,C/M ratio,,,0.33,,mean,,,minmax,0.16,0.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1481,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,capillary blood/maternal blood,maternal/pediatric,delivery,newborn,30.0,C/M ratio,,,0.3,,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1482,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,blood,maternal,after 2 h of delivery,,28.0,concentration,,,91,ng/ml,mean,,,minmax,38,161,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1483,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,blood,maternal,after 2 h of delivery,,28.0,concentration,,,92,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1484,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,capillary blood,pedatric,after 2 h of delivery,newborn,29.0,concentration,,,63,ng/ml,mean,,,minmax,<20,149,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1485,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,capillary blood,pedatric,after 2 h of delivery,newborn,29.0,concentration,,,57,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1486,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,capillary blood/maternal blood,maternal/pediatric,after 2 h of delivery,newborn,28.0,C/M ratio,,,0.67,,mean,,,minmax,0.21,1.68,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1487,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,capillary blood/maternal blood,maternal/pediatric,after 2 h of delivery,newborn,28.0,C/M ratio,,,0.63,,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1488,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,blood,maternal,after 2 h of delivery,,30.0,concentration,,,31,ng/ml,mean,,,minmax,20,71,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1489,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,blood,maternal,after 2 h of delivery,,30.0,concentration,,,28,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1490,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,capillary blood,pedatric,after 2 h of delivery,newborn,30.0,concentration,,,36,ng/ml,mean,,,minmax,ND,79,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1491,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,capillary blood,pedatric,after 2 h of delivery,newborn,30.0,concentration,,,34,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1492,2025-12-02T16:05:12.001940
7397084.0,diazepam,diazepam,capillary blood/maternal blood,maternal/pediatric,after 2 h of delivery,newborn,26.0,C/M ratio,,,1.27,,median,,,minmax,<0.44,3.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1493,2025-12-02T16:05:12.001940
13006.0,diazepam,diazepam,plasma,maternal/pediatric,,fetus,8.0,feto-maternal concentration ratio,,,0.9,,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1494,2025-12-02T16:05:09.448543
13006.0,diazepam,N-demethyldiazepam,plasma,maternal/pediatric,,fetus,8.0,feto-maternal concentration ratio,,,0.3,,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1495,2025-12-02T16:05:09.448543
13006.0,diazepam,diazepam,plasma,maternal/pediatric,,fetus,8.0,feto-maternal concentration ratio,,,0.9,,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1494,2025-12-02T16:05:12.001940
13006.0,diazepam,N-demethyldiazepam,plasma,maternal/pediatric,,fetus,8.0,feto-maternal concentration ratio,,,0.3,,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1495,2025-12-02T16:05:12.001940
20359.0,diazepam,diazepam,blood,maternal,labor,,39.0,concentration,,,,ng/ml,,,,minmax,553,2121,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1496,2025-12-02T16:05:09.448543
20359.0,diazepam,diazepam,blood,maternal,labor,,39.0,concentration,,,,ng/ml,,,,minmax,553,2121,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1496,2025-12-02T16:05:12.001940
699483.0,diazepam,diazepam,blood,maternal,labor,,15.0,concentration,,,991,ng/ml,mean,SD,57,,,,,Group I,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1497,2025-12-02T16:05:09.448543
699483.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,15.0,concentration,,,674,ng/ml,mean,SD,378,,,,,Group I,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1498,2025-12-02T16:05:09.448543
699483.0,diazepam,diazepam,umbilical cord blood/maternal blood,maternal/pediatric,labor,fetus,15.0,umbilical cord/mother ratio,,,0.76,,mean,SD,0.38,,,,,Group I,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1499,2025-12-02T16:05:09.448543
699483.0,diazepam,diazepam,,,,,15.0,concentration,2,hr,102,ng/ml,mean,SD,28,,,,,Group I,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1500,2025-12-02T16:05:09.448543
699483.0,diazepam,diazepam,blood,maternal,labor,,15.0,concentration,,,890,ng/ml,mean,SD,239,,,,,Group II,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1501,2025-12-02T16:05:09.448543
699483.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,15.0,concentration,,,788,ng/ml,mean,SD,357,,,,,Group II,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1502,2025-12-02T16:05:09.448543
699483.0,diazepam,diazepam,umbilical cord blood/maternal blood,maternal/pediatric,labor,fetus,15.0,umbilical cord/mother ratio,,,0.88,,mean,SD,0.31,,,,,Group II,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1503,2025-12-02T16:05:09.448543
699483.0,diazepam,diazepam,blood,maternal,labor,,15.0,concentration,,,103,ng/ml,mean,SD,34,,,,,Group II,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1504,2025-12-02T16:05:09.448543
699483.0,diazepam,diazepam,blood,maternal,labor,,15.0,concentration,,,991,ng/ml,mean,SD,57,,,,,Group I,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1497,2025-12-02T16:05:12.001940
699483.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,15.0,concentration,,,674,ng/ml,mean,SD,378,,,,,Group I,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1498,2025-12-02T16:05:12.001940
699483.0,diazepam,diazepam,umbilical cord blood/maternal blood,maternal/pediatric,labor,fetus,15.0,umbilical cord/mother ratio,,,0.76,,mean,SD,0.38,,,,,Group I,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1499,2025-12-02T16:05:12.001940
699483.0,diazepam,diazepam,,,,,15.0,concentration,2,hr,102,ng/ml,mean,SD,28,,,,,Group I,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1500,2025-12-02T16:05:12.001940
699483.0,diazepam,diazepam,blood,maternal,labor,,15.0,concentration,,,890,ng/ml,mean,SD,239,,,,,Group II,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1501,2025-12-02T16:05:12.001940
699483.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,15.0,concentration,,,788,ng/ml,mean,SD,357,,,,,Group II,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1502,2025-12-02T16:05:12.001940
699483.0,diazepam,diazepam,umbilical cord blood/maternal blood,maternal/pediatric,labor,fetus,15.0,umbilical cord/mother ratio,,,0.88,,mean,SD,0.31,,,,,Group II,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1503,2025-12-02T16:05:12.001940
699483.0,diazepam,diazepam,blood,maternal,labor,,15.0,concentration,,,103,ng/ml,mean,SD,34,,,,,Group II,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1504,2025-12-02T16:05:12.001940
24101397.0,diazepam,diazepam,hair,maternal,labor,,6.0,concentration,,,30.8,pg/mg,mean,SD,15.3,,,,,administriation period I trimester,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1505,2025-12-02T16:05:09.448543
24101397.0,diazepam,diazepam,hair,maternal,labor,,14.0,concentration,,,31.6,pg/mg,mean,SD,36,,,,,administriation period I trimester,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1506,2025-12-02T16:05:09.448543
24101397.0,diazepam,diazepam,hair,maternal,labor,,26.0,concentration,,,34.1,pg/mg,mean,SD,42.4,,,,,administriation period I trimester,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1507,2025-12-02T16:05:09.448543
24101397.0,diazepam,diazepam,hair,pedatric,,newborn,14.0,concentration,,,53.5,pg/mg,mean,SD,36.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1508,2025-12-02T16:05:09.448543
24101397.0,diazepam,Nordazepam,hair,maternal,labor,,6.0,concentration,,,64.5,pg/mg,mean,SD,61.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1509,2025-12-02T16:05:09.448543
24101397.0,diazepam,Nordazepam,hair,maternal,labor,,17.0,concentration,,,52.9,pg/mg,mean,SD,48.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1510,2025-12-02T16:05:09.448543
24101397.0,diazepam,Nordazepam,hair,maternal,labor,,28.0,concentration,,,89.9,pg/mg,mean,SD,122.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1511,2025-12-02T16:05:09.448543
24101397.0,diazepam,Nordazepam,hair,pedatric,,newborn,27.0,concentration,,,108.1,pg/mg,mean,SD,144.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1512,2025-12-02T16:05:09.448543
24101397.0,diazepam,diazepam,hair,maternal,labor,,6.0,concentration,,,30.8,pg/mg,mean,SD,15.3,,,,,administriation period I trimester,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1505,2025-12-02T16:05:12.001940
24101397.0,diazepam,diazepam,hair,maternal,labor,,14.0,concentration,,,31.6,pg/mg,mean,SD,36,,,,,administriation period I trimester,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1506,2025-12-02T16:05:12.001940
24101397.0,diazepam,diazepam,hair,maternal,labor,,26.0,concentration,,,34.1,pg/mg,mean,SD,42.4,,,,,administriation period I trimester,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1507,2025-12-02T16:05:12.001940
24101397.0,diazepam,diazepam,hair,pedatric,,newborn,14.0,concentration,,,53.5,pg/mg,mean,SD,36.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1508,2025-12-02T16:05:12.001940
24101397.0,diazepam,Nordazepam,hair,maternal,labor,,6.0,concentration,,,64.5,pg/mg,mean,SD,61.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1509,2025-12-02T16:05:12.001940
24101397.0,diazepam,Nordazepam,hair,maternal,labor,,17.0,concentration,,,52.9,pg/mg,mean,SD,48.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1510,2025-12-02T16:05:12.001940
24101397.0,diazepam,Nordazepam,hair,maternal,labor,,28.0,concentration,,,89.9,pg/mg,mean,SD,122.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1511,2025-12-02T16:05:12.001940
24101397.0,diazepam,Nordazepam,hair,pedatric,,newborn,27.0,concentration,,,108.1,pg/mg,mean,SD,144.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1512,2025-12-02T16:05:12.001940
4441031.0,diazepam,diazepam,umbilical cord plasma,pedatric,,fetus,14.0,concentration,40-120,min,113,ng/ml,mean,SEM,24,,,,,time after the injection,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1513,2025-12-02T16:05:09.448543
4441031.0,diazepam,diazepam,plasma,maternal,pregnant/abortion,,14.0,concentration,40-120,min,80,ng/ml,mean,SEM,14,,,,,time after the injection,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1514,2025-12-02T16:05:09.448543
4441031.0,diazepam,diazepam,umbilical cord/maternal plasma,maternal/pediatric,pregnant/abortion,fetus,14.0,feto-maternal concentration ratio,40-120,min,1.2,,mean,,,,,,,time after the injection,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1515,2025-12-02T16:05:09.448543
4441031.0,diazepam,diazepam,umbilical cord plasma,pedatric,,fetus,14.0,concentration,40-120,min,113,ng/ml,mean,SEM,24,,,,,time after the injection,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1513,2025-12-02T16:05:12.001940
4441031.0,diazepam,diazepam,plasma,maternal,pregnant/abortion,,14.0,concentration,40-120,min,80,ng/ml,mean,SEM,14,,,,,time after the injection,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1514,2025-12-02T16:05:12.001940
4441031.0,diazepam,diazepam,umbilical cord/maternal plasma,maternal/pediatric,pregnant/abortion,fetus,14.0,feto-maternal concentration ratio,40-120,min,1.2,,mean,,,,,,,time after the injection,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1515,2025-12-02T16:05:12.001940
7318882.0,diazepam,diazepam,whole blood,maternal,delivery,,30.0,concentration,5,min,527,ug/l,mean,SD,175,,,,,time after delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1516,2025-12-02T16:05:09.448543
7318882.0,diazepam,diazepam,whole blood,maternal,delivery,,30.0,concentration,5,min,548,ug/l,median,,,,,,,time after delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1517,2025-12-02T16:05:09.448543
7318882.0,diazepam,diazepam,whole blood,maternal,delivery,,30.0,concentration,2,hr,133,ug/l,median,,,,,,,time after delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1518,2025-12-02T16:05:09.448543
7318882.0,diazepam,diazepam,whole blood,pedatric,,newborn,30.0,concentration,5,min,291,ug/l,mean,SD,167,,,,,time after delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1519,2025-12-02T16:05:09.448543
7318882.0,diazepam,diazepam,whole blood,pedatric,,newborn,30.0,concentration,5,min,255,ug/l,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1520,2025-12-02T16:05:09.448543
7318882.0,diazepam,diazepam,whole blood,pedatric,,newborn,30.0,concentration,2,hr,90,ug/l,median,,,,,,,time after delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1521,2025-12-02T16:05:09.448543
7318882.0,diazepam,diazepam,whole blood,maternal/pediatric,delivery,newborn,30.0,child/mother ratio,5,min,0.57,,mean,SD,0.38,,,,,time after delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1522,2025-12-02T16:05:09.448543
7318882.0,diazepam,diazepam,whole blood,maternal/pediatric,delivery,newborn,30.0,child/mother ratio,5,min,0.49,,median,,,,,,,time after delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1523,2025-12-02T16:05:09.448543
7318882.0,diazepam,diazepam,whole blood,maternal/pediatric,delivery,newborn,30.0,child/mother ratio,2,hr,0.71,,median,,,,,,,time after delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1524,2025-12-02T16:05:09.448543
7318882.0,diazepam,diazepam,whole blood,maternal,delivery,,30.0,concentration,5,min,527,ug/l,mean,SD,175,,,,,time after delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1516,2025-12-02T16:05:12.001940
7318882.0,diazepam,diazepam,whole blood,maternal,delivery,,30.0,concentration,5,min,548,ug/l,median,,,,,,,time after delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1517,2025-12-02T16:05:12.001940
7318882.0,diazepam,diazepam,whole blood,maternal,delivery,,30.0,concentration,2,hr,133,ug/l,median,,,,,,,time after delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1518,2025-12-02T16:05:12.001940
7318882.0,diazepam,diazepam,whole blood,pedatric,,newborn,30.0,concentration,5,min,291,ug/l,mean,SD,167,,,,,time after delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1519,2025-12-02T16:05:12.001940
7318882.0,diazepam,diazepam,whole blood,pedatric,,newborn,30.0,concentration,5,min,255,ug/l,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1520,2025-12-02T16:05:12.001940
7318882.0,diazepam,diazepam,whole blood,pedatric,,newborn,30.0,concentration,2,hr,90,ug/l,median,,,,,,,time after delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1521,2025-12-02T16:05:12.001940
7318882.0,diazepam,diazepam,whole blood,maternal/pediatric,delivery,newborn,30.0,child/mother ratio,5,min,0.57,,mean,SD,0.38,,,,,time after delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1522,2025-12-02T16:05:12.001940
7318882.0,diazepam,diazepam,whole blood,maternal/pediatric,delivery,newborn,30.0,child/mother ratio,5,min,0.49,,median,,,,,,,time after delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1523,2025-12-02T16:05:12.001940
7318882.0,diazepam,diazepam,whole blood,maternal/pediatric,delivery,newborn,30.0,child/mother ratio,2,hr,0.71,,median,,,,,,,time after delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1524,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,serum,maternal,pregnant/abortion,,65.0,concentration,,,444.1,ng/ml,mean,SD,202.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1525,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,urine,maternal,pregnant/abortion,,40.0,concentration,,,21.8,ng/ml,mean,SD,8.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1526,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,coelomic fluid,maternal,pregnant/abortion,,20.0,concentration,,,7.3,ng/ml,mean,SD,1.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1527,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,amniotic fluid,maternal,pregnant/abortion,,38.0,concentration,,,7.1,ng/ml,mean,SD,1.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1528,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,serum,maternal,pregnant/abortion,,17.0,concentration,10-13,min,568.2,ng/ml,mean,SD,227.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1529,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,urine,maternal,pregnant/abortion,,6.0,concentration,10-13,min,12.3,ng/ml,mean,SD,4.9,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1530,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,coelomic fluid,maternal,pregnant/abortion,,4.0,concentration,10-13,min,6.3,ng/ml,mean,SD,0.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1531,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,amniotic fluid,maternal,pregnant/abortion,,4.0,concentration,10-13,min,6.6,ng/ml,mean,SD,1.7,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1532,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,serum,maternal,pregnant/abortion,,17.0,concentration,14-17,min,507.4,ng/ml,mean,SD,118.3,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1533,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,urine,maternal,pregnant/abortion,,12.0,concentration,14-17,min,16.9,ng/ml,mean,SD,13.4,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1534,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,coelomic fluid,maternal,pregnant/abortion,,6.0,concentration,14-17,min,6.9,ng/ml,mean,SD,1.1,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1535,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,amniotic fluid,maternal,pregnant/abortion,,12.0,concentration,14-17,min,6.9,ng/ml,mean,SD,1.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1536,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,serum,maternal,pregnant/abortion,,16.0,concentration,18-21,min,343.1,ng/ml,mean,SD,172.8,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1537,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,urine,maternal,pregnant/abortion,,11.0,concentration,18-21,min,28,ng/ml,mean,SD,26.3,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1538,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,coelomic fluid,maternal,pregnant/abortion,,5.0,concentration,18-21,min,6.7,ng/ml,mean,SD,1.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1539,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,amniotic fluid,maternal,pregnant/abortion,,12.0,concentration,18-21,min,7.7,ng/ml,mean,SD,1.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1540,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,serum,maternal,pregnant/abortion,,15.0,concentration,22-25,min,287.7,ng/ml,mean,SD,94.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1541,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,urine,maternal,pregnant/abortion,,11.0,concentration,22-25,min,30.1,ng/ml,mean,SD,26.5,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1542,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,coelomic fluid,maternal,pregnant/abortion,,5.0,concentration,22-25,min,9.2,ng/ml,mean,SD,2.4,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1543,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,amniotic fluid,maternal,pregnant/abortion,,10.0,concentration,22-25,min,6.8,ng/ml,mean,SD,1.1,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1544,2025-12-02T16:05:09.448543
8671346.0,diazepam,diazepam,serum,maternal,pregnant/abortion,,65.0,concentration,,,444.1,ng/ml,mean,SD,202.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1525,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,urine,maternal,pregnant/abortion,,40.0,concentration,,,21.8,ng/ml,mean,SD,8.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1526,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,coelomic fluid,maternal,pregnant/abortion,,20.0,concentration,,,7.3,ng/ml,mean,SD,1.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1527,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,amniotic fluid,maternal,pregnant/abortion,,38.0,concentration,,,7.1,ng/ml,mean,SD,1.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1528,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,serum,maternal,pregnant/abortion,,17.0,concentration,10-13,min,568.2,ng/ml,mean,SD,227.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1529,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,urine,maternal,pregnant/abortion,,6.0,concentration,10-13,min,12.3,ng/ml,mean,SD,4.9,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1530,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,coelomic fluid,maternal,pregnant/abortion,,4.0,concentration,10-13,min,6.3,ng/ml,mean,SD,0.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1531,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,amniotic fluid,maternal,pregnant/abortion,,4.0,concentration,10-13,min,6.6,ng/ml,mean,SD,1.7,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1532,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,serum,maternal,pregnant/abortion,,17.0,concentration,14-17,min,507.4,ng/ml,mean,SD,118.3,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1533,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,urine,maternal,pregnant/abortion,,12.0,concentration,14-17,min,16.9,ng/ml,mean,SD,13.4,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1534,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,coelomic fluid,maternal,pregnant/abortion,,6.0,concentration,14-17,min,6.9,ng/ml,mean,SD,1.1,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1535,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,amniotic fluid,maternal,pregnant/abortion,,12.0,concentration,14-17,min,6.9,ng/ml,mean,SD,1.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1536,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,serum,maternal,pregnant/abortion,,16.0,concentration,18-21,min,343.1,ng/ml,mean,SD,172.8,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1537,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,urine,maternal,pregnant/abortion,,11.0,concentration,18-21,min,28,ng/ml,mean,SD,26.3,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1538,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,coelomic fluid,maternal,pregnant/abortion,,5.0,concentration,18-21,min,6.7,ng/ml,mean,SD,1.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1539,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,amniotic fluid,maternal,pregnant/abortion,,12.0,concentration,18-21,min,7.7,ng/ml,mean,SD,1.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1540,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,serum,maternal,pregnant/abortion,,15.0,concentration,22-25,min,287.7,ng/ml,mean,SD,94.6,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1541,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,urine,maternal,pregnant/abortion,,11.0,concentration,22-25,min,30.1,ng/ml,mean,SD,26.5,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1542,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,coelomic fluid,maternal,pregnant/abortion,,5.0,concentration,22-25,min,9.2,ng/ml,mean,SD,2.4,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1543,2025-12-02T16:05:12.001940
8671346.0,diazepam,diazepam,amniotic fluid,maternal,pregnant/abortion,,10.0,concentration,22-25,min,6.8,ng/ml,mean,SD,1.1,,,,,the time from drug injection to sampling ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1544,2025-12-02T16:05:12.001940
533212.0,diazepam,diazepam,blood,maternal,labor,,32.0,concentration,,,1248,ng/ml,mean,,,minmax,603,2923,,at delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1545,2025-12-02T16:05:09.448543
533212.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,32.0,concentration,,,174,ng/ml,mean,,,minmax,ND,1418,,at delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1546,2025-12-02T16:05:09.448543
533212.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,32.0,concentration,,,60,ng/ml,median,,,,,,,at delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1547,2025-12-02T16:05:09.448543
533212.0,diazepam,diazepam,blood,maternal,labor,,32.0,concentration,,,116,ng/ml,mean,,,minmax,65,186,,2 hours after delivery,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1548,2025-12-02T16:05:09.448543
533212.0,diazepam,diazepam,blood,maternal,labor,,32.0,concentration,,,1248,ng/ml,mean,,,minmax,603,2923,,at delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1545,2025-12-02T16:05:12.001940
533212.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,32.0,concentration,,,174,ng/ml,mean,,,minmax,ND,1418,,at delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1546,2025-12-02T16:05:12.001940
533212.0,diazepam,diazepam,umbilical cord blood,pedatric,,fetus,32.0,concentration,,,60,ng/ml,median,,,,,,,at delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1547,2025-12-02T16:05:12.001940
533212.0,diazepam,diazepam,blood,maternal,labor,,32.0,concentration,,,116,ng/ml,mean,,,minmax,65,186,,2 hours after delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1548,2025-12-02T16:05:12.001940
2119270.0,Flecainide,Flecainide,milk/plasma,maternal,lactation,,11.0,ratio of average daily concentration in milk to the next day morning trough plasma concentration,1,day,1.9,,mean,SD,0.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1549,2025-12-02T16:05:09.448543
2119270.0,Flecainide,Flecainide,milk/plasma,maternal,lactation,,11.0,ratio of average daily concentration in milk to the next day morning trough plasma concentration,2,day,3.7,,mean,SD,3.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1550,2025-12-02T16:05:09.448543
2119270.0,Flecainide,Flecainide,milk/plasma,maternal,lactation,,11.0,ratio of average daily concentration in milk to the next day morning trough plasma concentration,3,day,3.2,,mean,SD,2.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1551,2025-12-02T16:05:09.448543
2119270.0,Flecainide,Flecainide,milk/plasma,maternal,lactation,,11.0,ratio of average daily concentration in milk to the next day morning trough plasma concentration,4,day,3.5,,mean,SD,2.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1552,2025-12-02T16:05:09.448543
2119270.0,Flecainide,Flecainide,milk/plasma,maternal,lactation,,11.0,ratio of average daily concentration in milk to the next day morning trough plasma concentration,5,day,0.6,,mean,SD,0.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1553,2025-12-02T16:05:09.448543
2119270.0,Flecainide,Flecainide,milk/plasma,maternal,lactation,,11.0,ratio of average daily concentration in milk to the next day morning trough plasma concentration,1,day,1.9,,mean,SD,0.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1549,2025-12-02T16:05:12.001940
2119270.0,Flecainide,Flecainide,milk/plasma,maternal,lactation,,11.0,ratio of average daily concentration in milk to the next day morning trough plasma concentration,2,day,3.7,,mean,SD,3.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1550,2025-12-02T16:05:12.001940
2119270.0,Flecainide,Flecainide,milk/plasma,maternal,lactation,,11.0,ratio of average daily concentration in milk to the next day morning trough plasma concentration,3,day,3.2,,mean,SD,2.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1551,2025-12-02T16:05:12.001940
2119270.0,Flecainide,Flecainide,milk/plasma,maternal,lactation,,11.0,ratio of average daily concentration in milk to the next day morning trough plasma concentration,4,day,3.5,,mean,SD,2.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1552,2025-12-02T16:05:12.001940
2119270.0,Flecainide,Flecainide,milk/plasma,maternal,lactation,,11.0,ratio of average daily concentration in milk to the next day morning trough plasma concentration,5,day,0.6,,mean,SD,0.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1553,2025-12-02T16:05:12.001940
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,22.0,concentration at initial conversion to sinus rhythm,,,460,ug/L,median,,,minmax,250,866,,permanent responders,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1557,2025-12-02T16:05:09.448543
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,3.0,concentration at initial conversion to sinus rhythm,,,441,ug/L,median,,,minmax,266,789,,nonsustained  responders,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1558,2025-12-02T16:05:09.448543
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,3.0,concentration in SVT,,,463,ug/L,median,,,minmax,380,690,,nonsustained responders,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1559,2025-12-02T16:05:09.448543
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,7.0,concentration in SVT,,,468,ug/L,median,,,minmax,223,840,,nonresponders,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1560,2025-12-02T16:05:09.448543
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,28.0,concentration at conversion to sinus rhythm,,,450,ug/L,median,,,minmax,250,866,,short ventriculoatrial tachycardia,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1561,2025-12-02T16:05:09.448543
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,4.0,concentration at conversion to sinus rhythm,,,490,ug/L,median,,,minmax,252,58,,long ventriculoatrial tachycardia,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1562,2025-12-02T16:05:09.448543
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,22.0,concentration at initial conversion to sinus rhythm,,,460,ug/L,median,,,minmax,250,866,,permanent responders,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1557,2025-12-02T16:05:12.001940
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,3.0,concentration at initial conversion to sinus rhythm,,,441,ug/L,median,,,minmax,266,789,,nonsustained  responders,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1558,2025-12-02T16:05:12.001940
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,3.0,concentration in SVT,,,463,ug/L,median,,,minmax,380,690,,nonsustained responders,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1559,2025-12-02T16:05:12.001940
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,7.0,concentration in SVT,,,468,ug/L,median,,,minmax,223,840,,nonresponders,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1560,2025-12-02T16:05:12.001940
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,28.0,concentration at conversion to sinus rhythm,,,450,ug/L,median,,,minmax,250,866,,short ventriculoatrial tachycardia,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1561,2025-12-02T16:05:12.001940
25068572.0,Flecainide,Flecainide,serum,maternal,pregnant,,4.0,concentration at conversion to sinus rhythm,,,490,ug/L,median,,,minmax,252,58,,long ventriculoatrial tachycardia,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1562,2025-12-02T16:05:12.001940
31532233.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,AUC,,,1.9,ug h/ml,mean,SD,0.005,,,,,15 mg (twice daily),PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1563,2025-12-02T16:05:09.448543
31532233.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,Cavg,,,0.16,ug/ml,mean,SD,0.0004,,,,,15 mg (twice daily),PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1564,2025-12-02T16:05:09.448543
31532233.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,Cmax,,,0.3,ug/ml,mean,SD,0.02,,,,,15 mg (twice daily),PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1565,2025-12-02T16:05:09.448543
31532233.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,Tmax,,,1,hr,mean,,,,,,,15 mg (twice daily),PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1566,2025-12-02T16:05:09.448543
31532233.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,estimated infant dose,,,0.01,mg/kg per 12 hours,mean,,,,,,,15 mg (twice daily),PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1567,2025-12-02T16:05:09.448543
31532233.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,AUC,,,1.9,ug h/ml,mean,SD,0.005,,,,,15 mg (twice daily),PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1563,2025-12-02T16:05:12.001940
31532233.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,Cavg,,,0.16,ug/ml,mean,SD,0.0004,,,,,15 mg (twice daily),PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1564,2025-12-02T16:05:12.001940
31532233.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,Cmax,,,0.3,ug/ml,mean,SD,0.02,,,,,15 mg (twice daily),PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1565,2025-12-02T16:05:12.001940
31532233.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,Tmax,,,1,hr,mean,,,,,,,15 mg (twice daily),PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1566,2025-12-02T16:05:12.001940
31532233.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,estimated infant dose,,,0.01,mg/kg per 12 hours,mean,,,,,,,15 mg (twice daily),PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1567,2025-12-02T16:05:12.001940
32488251.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,AUC0-24h,,,693.77,ng h/ml,mean,SD,23.84,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1575,2025-12-02T16:05:09.448543
32488251.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,Cavg0-24h,,,28.91,ng/ml,mean,SD,0.99,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1576,2025-12-02T16:05:09.448543
32488251.0,Rivaroxaban,Rivaroxaban,plasma,maternal,lactation,,2.0,AUC0-24h,,,2569.55,ng h/ml,mean,SD,312.73,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1577,2025-12-02T16:05:09.448543
32488251.0,Rivaroxaban,Rivaroxaban,plasma,maternal,lactation,,2.0,Cavg0-24h,,,107.06,ng/ml,mean,SD,13.03,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1578,2025-12-02T16:05:09.448543
32488251.0,Rivaroxaban,Rivaroxaban,breast milk/plasma,maternal,lactation,,2.0,Cavg milk/plasma ratio,,,0.27,,mean,SD,0.02,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1579,2025-12-02T16:05:09.448543
32488251.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,absolute infant dose,,,0.0043,mg/kg per day,,,,,,,,Absolute infant dose was calculated as the product from Cavgin milk and an assumed milk intake of 0.15 L/kg per day.,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1580,2025-12-02T16:05:09.448543
32488251.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,RID,,,1.63,%,mean,SD,0.01,,,,,"Relative infant dose is the absolute infant dose expressed as a percentage of the weight-adjusted maternal dose, based on an average maternal weight of 75 kg (mg/kg per day).",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1581,2025-12-02T16:05:09.448543
32488251.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,AUC0-24h,,,693.77,ng h/ml,mean,SD,23.84,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1575,2025-12-02T16:05:12.001940
32488251.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,Cavg0-24h,,,28.91,ng/ml,mean,SD,0.99,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1576,2025-12-02T16:05:12.001940
32488251.0,Rivaroxaban,Rivaroxaban,plasma,maternal,lactation,,2.0,AUC0-24h,,,2569.55,ng h/ml,mean,SD,312.73,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1577,2025-12-02T16:05:12.001940
32488251.0,Rivaroxaban,Rivaroxaban,plasma,maternal,lactation,,2.0,Cavg0-24h,,,107.06,ng/ml,mean,SD,13.03,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1578,2025-12-02T16:05:12.001940
32488251.0,Rivaroxaban,Rivaroxaban,breast milk/plasma,maternal,lactation,,2.0,Cavg milk/plasma ratio,,,0.27,,mean,SD,0.02,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1579,2025-12-02T16:05:12.001940
32488251.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,absolute infant dose,,,0.0043,mg/kg per day,,,,,,,,Absolute infant dose was calculated as the product from Cavgin milk and an assumed milk intake of 0.15 L/kg per day.,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1580,2025-12-02T16:05:12.001940
32488251.0,Rivaroxaban,Rivaroxaban,breast milk,maternal,lactation,,2.0,RID,,,1.63,%,mean,SD,0.01,,,,,"Relative infant dose is the absolute infant dose expressed as a percentage of the weight-adjusted maternal dose, based on an average maternal weight of 75 kg (mg/kg per day).",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1581,2025-12-02T16:05:12.001940
19657707.0,Zolpidem,Zolpidem,umbilical cord plasma,pedatric,,fetus,6.0,concentration,,,8.2,ng/ml,mean,SD,4.8,,,,,hrs post dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1582,2025-12-02T16:05:09.448543
19657707.0,Zolpidem,Zolpidem,plasma,maternal,delivery,,6.0,concentration,,,17.3,ng/ml,mean,SD,26.2,,,,,hrs post dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1583,2025-12-02T16:05:09.448543
19657707.0,Zolpidem,Zolpidem,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,6.0,cord/maternal ratio,,,1.34,,mean,SD,0.98,,,,,hrs post dose,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1584,2025-12-02T16:05:09.448543
19657707.0,Zolpidem,Zolpidem,umbilical cord plasma,pedatric,,fetus,6.0,concentration,,,8.2,ng/ml,mean,SD,4.8,,,,,hrs post dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1582,2025-12-02T16:05:12.001940
19657707.0,Zolpidem,Zolpidem,plasma,maternal,delivery,,6.0,concentration,,,17.3,ng/ml,mean,SD,26.2,,,,,hrs post dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1583,2025-12-02T16:05:12.001940
19657707.0,Zolpidem,Zolpidem,umbilical cord/maternal plasma,maternal/pediatric,delivery,fetus,6.0,cord/maternal ratio,,,1.34,,mean,SD,0.98,,,,,hrs post dose,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1584,2025-12-02T16:05:12.001940
2612539.0,Zolpidem,Zolpidem,plasma,maternal,lactation,,5.0,tmax,,,,hr,,,,minmax,1.75,3.75,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1585,2025-12-02T16:05:09.448543
2612539.0,Zolpidem,Zolpidem,plasma,maternal,lactation,,5.0,Cmax,,,,ng/ml,,,,minmax,90,364,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1586,2025-12-02T16:05:09.448543
2612539.0,Zolpidem,Zolpidem,plasma,maternal,lactation,,5.0,t1/2,,,2.6,hr,mean,SEM,0.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1587,2025-12-02T16:05:09.448543
2612539.0,Zolpidem,Zolpidem,plasma,maternal,lactation,,5.0,AUC,,,1437,ng h/ml,mean,SEM,307,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1588,2025-12-02T16:05:09.448543
2612539.0,Zolpidem,Zolpidem,breast milk,maternal,lactation,,5.0,clearance,3,hr,1.48,ml/h,mean,SEM,0.38,minmax,0.68,2.61,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1589,2025-12-02T16:05:09.448543
2612539.0,Zolpidem,Zolpidem,breast milk/plasma,maternal,lactation,,5.0,milk/plasma concentration ratio,3,hr,0.13,,mean,SEM,0.01,minmax,0.11,0.18,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1590,2025-12-02T16:05:09.448543
2612539.0,Zolpidem,Zolpidem,plasma,maternal,lactation,,5.0,tmax,,,,hr,,,,minmax,1.75,3.75,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1585,2025-12-02T16:05:12.001940
2612539.0,Zolpidem,Zolpidem,plasma,maternal,lactation,,5.0,Cmax,,,,ng/ml,,,,minmax,90,364,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1586,2025-12-02T16:05:12.001940
2612539.0,Zolpidem,Zolpidem,plasma,maternal,lactation,,5.0,t1/2,,,2.6,hr,mean,SEM,0.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1587,2025-12-02T16:05:12.001940
2612539.0,Zolpidem,Zolpidem,plasma,maternal,lactation,,5.0,AUC,,,1437,ng h/ml,mean,SEM,307,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1588,2025-12-02T16:05:12.001940
2612539.0,Zolpidem,Zolpidem,breast milk,maternal,lactation,,5.0,clearance,3,hr,1.48,ml/h,mean,SEM,0.38,minmax,0.68,2.61,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1589,2025-12-02T16:05:12.001940
2612539.0,Zolpidem,Zolpidem,breast milk/plasma,maternal,lactation,,5.0,milk/plasma concentration ratio,3,hr,0.13,,mean,SEM,0.01,minmax,0.11,0.18,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1590,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,amount of duloxetine in breast milk,12,hr,7.41,ug/day,mean,SD,4.55,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1591,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,milk volume in 12 h,12,hr,378,ml/h,mean,SD,115,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1592,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,"Cav,ss",12,hr,42.5,ng/ml,mean,SD,18,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1593,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,breast milk/plasma,maternal,lactation,,6.0,M/P ratio,12,hr,0.267,,mean,SD,0.096,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1594,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,bodyweight-normalized infant dose,12,hr,1.72,ug/kg/day,mean,SD,1.03,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1595,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,bodyweight-normalized maternal dose,12,hr,1210,ug/kg/day,mean,SD,253,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1596,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,breast milk/plasma,maternal,lactation,,6.0,infant dose expressed as % of maternal dose,12,hr,0.141,%,mean,SD,0.082,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1597,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,"Cmax, ss",,,16.5,ng/ml,mean,%CV,70.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1598,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,"tmax,ss",,,3,hr,median,,,minmax,0,6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1599,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,"AUC12,ss",,,115,ng h/mL,mean,%CV,76.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1600,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,"Cav,ss",,,9.96,ng/ml,mean,%CV,76.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1601,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,"Cmax, ss",,,53.5,ng/ml,mean,%CV,47.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1602,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,"tmax,ss",,,6,hr,median,,,minmax,6,9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1603,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,"AUC12,ss",,,463,ng h/mL,mean,%CV,55.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1604,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,"Cav,ss",,,38.6,ng/ml,mean,%CV,55.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1605,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,CLss/F,,,86.4,L/h,mean,%CV,55.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1606,2025-12-02T16:05:09.448543
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,amount of duloxetine in breast milk,12,hr,7.41,ug/day,mean,SD,4.55,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1591,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,milk volume in 12 h,12,hr,378,ml/h,mean,SD,115,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1592,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,"Cav,ss",12,hr,42.5,ng/ml,mean,SD,18,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1593,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,breast milk/plasma,maternal,lactation,,6.0,M/P ratio,12,hr,0.267,,mean,SD,0.096,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1594,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,bodyweight-normalized infant dose,12,hr,1.72,ug/kg/day,mean,SD,1.03,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1595,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,bodyweight-normalized maternal dose,12,hr,1210,ug/kg/day,mean,SD,253,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1596,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,breast milk/plasma,maternal,lactation,,6.0,infant dose expressed as % of maternal dose,12,hr,0.141,%,mean,SD,0.082,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1597,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,"Cmax, ss",,,16.5,ng/ml,mean,%CV,70.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1598,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,"tmax,ss",,,3,hr,median,,,minmax,0,6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1599,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,"AUC12,ss",,,115,ng h/mL,mean,%CV,76.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1600,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,breast milk,maternal,lactation,,6.0,"Cav,ss",,,9.96,ng/ml,mean,%CV,76.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1601,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,"Cmax, ss",,,53.5,ng/ml,mean,%CV,47.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1602,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,"tmax,ss",,,6,hr,median,,,minmax,6,9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1603,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,"AUC12,ss",,,463,ng h/mL,mean,%CV,55.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1604,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,"Cav,ss",,,38.6,ng/ml,mean,%CV,55.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1605,2025-12-02T16:05:12.001940
18193916.0,Duloxetine,Duloxetine,plasma,maternal,lactation,,6.0,CLss/F,,,86.4,L/h,mean,%CV,55.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1606,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,8.0,Cmax,,,91.1,ng/ml,median,,,95% CI,53.5,129.5,<0.05: (SR) vs. (RS),"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1607,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,6.0,Cmax,,,101.4,ng/ml,median,,,95% CI,50.6,138.1,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1608,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,8.0,Cmax,,,87.3,ng/ml,median,,,95% CI,52.7,124.8,<0.05: (SS) vs. (RS),"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1609,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,6.0,Cmax,,,100.3,ng/ml,median,,,95% CI,58.7,147.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1610,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,8.0,Cmax,,,101.7,ng/ml,median,,,95% CI,57.3,157,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1611,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,6.0,Cmax,,,96.3,ng/ml,median,,,95% CI,69,135.7,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1612,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,8.0,Cmax,,,123.1,ng/ml,median,,,95% CI,66.8,165.6,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1613,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)Labetalol,plasma,maternal,3rd trimester,,6.0,Cmax,,,120.5,ng/ml,median,,,95% CI,90,140.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1614,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,8.0,t1/2 ,,,6.3,hr,median,,,95% CI,4.6,8.9,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1615,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,6.0,t1/2 ,,,7.6,hr,median,,,95% CI,2.8,16.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1616,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,8.0,t1/2 ,,,8.6,hr,median,,,95% CI,5.7,12.2,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1617,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,6.0,t1/2 ,,,8.4,hr,median,,,95% CI,4.7,16.4,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1618,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,8.0,t1/2 ,,,7.1,hr,median,,,95% CI,5.1,12.2,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1619,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,6.0,t1/2 ,,,11.4,hr,median,,,95% CI,4.3,20.1,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1620,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,8.0,t1/2 ,,,5.4,hr,median,,,95% CI,2.9,10.9,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1621,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,6.0,t1/2 ,,,7.4,hr,median,,,95% CI,2.1,17.1,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1622,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,8.0,Vd,,,0.5,L/kg,median,,,95% CI,0.3,0.9,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1623,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,6.0,Vd,,,0.6,L/kg,median,,,95% CI,0.3,1.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1624,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,8.0,Vd,,,0.8,L/kg,median,,,95% CI,0.4,1.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1625,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,6.0,Vd,,,0.8,L/kg,median,,,95% CI,0.6,0.9,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1626,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,8.0,Vd,,,0.6,L/kg,median,,,95% CI,0.3,1.1,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1627,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,6.0,Vd,,,0.7,L/kg,median,,,95% CI,0.5,0.8,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1628,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,8.0,Vd,,,0.5,L/kg,median,,,95% CI,0.4,0.8,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1629,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,6.0,Vd,,,0.5,L/kg,median,,,95% CI,0.3,0.7,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1630,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,8.0,AUC0-,,,160.1,ng h/ml,median,,,95% CI,112.2,260.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1631,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,6.0,AUC0-,,,99.7,ng h/ml,median,,,95% CI,60.6,164.7,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1632,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,8.0,AUC0-,,,154.4,ng h/ml,median,,,95% CI,106.9,196.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1633,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,6.0,AUC0-,,,130.5,ng h/ml,median,,,95% CI,97.9,176.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1634,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,8.0,AUC0-,,,127.2,ng h/ml,median,,,95% CI,92.3,200,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1635,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,6.0,AUC0-,,,120.1,ng h/ml,median,,,95% CI,93.1,153.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1636,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,8.0,AUC0-,,,141.9,ng h/ml,median,,,95% CI,100.1,191.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1637,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,6.0,AUC0-,,,105.1,ng h/ml,median,,,95% CI,76.6,176.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1638,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,8.0,Cl,,,0.8,L/h/kg,median,,,95% CI,0.5,1.2,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1639,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,6.0,Cl,,,1,L/h/kg,median,,,95% CI,0.6,1.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1640,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,8.0,Cl,,,0.9,L/h/kg,median,,,95% CI,0.5,1.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1641,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,6.0,Cl,,,0.8,L/h/kg,median,,,95% CI,0.5,1.1,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1642,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,8.0,Cl,,,0.9,L/h/kg,median,,,95% CI,0.5,1.7,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1643,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,6.0,Cl,,,0.9,L/h/kg,median,,,95% CI,0.5,1.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1644,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,8.0,Cl,,,0.8,L/h/kg,median,,,95% CI,0.6,1.5,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1645,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,6.0,Cl,,,0.9,L/h/kg,median,,,95% CI,0.6,1.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1646,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,Cmax,,,118.7,ng/ml,median,,,95% CI,19.7,359.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1647,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,Cmax,,,128.6,ng/ml,median,,,95% CI,46.9,213.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1648,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,Cmax,,,108.4,ng/ml,median,,,95% CI,22.5,350.6,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1649,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,Cmax,,,188.4,ng/ml,median,,,95% CI,70.6,304.1,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1650,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,Cmax,,,131.6,ng/ml,median,,,95% CI,45.3,312.1,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1651,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,Cmax,,,155.6,ng/ml,median,,,95% CI,50.8,226.4,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1652,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,Cmax,,,109.6,ng/ml,median,,,95% CI,27.8,345.9,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1653,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,Cmax,,,124.1,ng/ml,median,,,95% CI,28.9,257.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1654,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,AUC0-,,,276.4,ng h/ml,median,,,95% CI,176.8,718.3,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1655,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,AUC0-,,,577.2,ng h/ml,median,,,95% CI,277.5,786.7,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1656,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,AUC0-,,,417.6,ng h/ml,median,,,95% CI,308.5,767.7,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1657,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,AUC0-,,,685.2,ng h/ml,median,,,95% CI,305.3,965.8,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1658,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,AUC0-,,,275.8,ng h/ml,median,,,95% CI,103.7,796.3,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1659,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,AUC0-,,,553.1,ng h/ml,median,,,95% CI,299.7,812.4,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1660,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,AUC0-,,,180.8,ng h/ml,median,,,95% CI,104.8,486.2,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1661,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,AUC0-,,,462.7,ng h/ml,median,,,95% CI,316.8,570.9,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1662,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,% comjugation,,,60.4,,median,,,95% CI,47.8,74.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1663,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,% comjugation,,,78.8,,median,,,95% CI,70.2,88.8,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1664,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,% comjugation,,,75.9,,median,,,95% CI,69.8,82.7,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1665,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,% comjugation,,,80.7,,median,,,95% CI,72.6,87.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1666,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,% comjugation,,,67.9,,median,,,95% CI,60.9,80.3,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1667,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,% comjugation,,,79.9,,median,,,95% CI,68.4,90.6,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1668,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,% comjugation,,,60.4,,median,,,95% CI,47.8,74.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1669,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,% comjugation,,,80.3,,median,,,95% CI,62.1,90.4,,"intravenous administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1670,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,9.0,Cmax,,,16.9,ng/ml,median,,,95% CI,11.9,31.8,<0.05: (SR) vs. (RR),"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1671,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,7.0,Cmax,,,42.7,ng/ml,median,,,95% CI,29.7,62.5,<0.05: non-diabetics vs. diabetics,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1672,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,9.0,Cmax,,,20.8,ng/ml,median,,,95% CI,14.5,35.7,<0.05: (SS) vs. (RR),"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1673,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,7.0,Cmax,,,32.8,ng/ml,median,,,95% CI,23.3,49.7,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1674,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,9.0,Cmax,,,14.4,ng/ml,median,,,95% CI,7.5,19.9,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1675,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,7.0,Cmax,,,14.3,ng/ml,median,,,95% CI,4.1,29.9,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1676,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,9.0,Cmax,,,16.2,ng/ml,median,,,95% CI,9.8,27.7,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1677,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,7.0,Cmax,,,29.1,ng/ml,median,,,95% CI,13,40.1,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1678,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,9.0,tmax,,,1.6,hr,median,,,95% CI,0.9,2.4,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1679,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,7.0,tmax,,,1.6,hr,median,,,95% CI,1.2,2.1,<0.05: (SR) vs. (RR),"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1680,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,9.0,tmax,,,1.6,hr,median,,,95% CI,1,2.5,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1681,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,7.0,tmax,,,1.4,hr,median,,,95% CI,1,2,<0.05:(SS) vs. (RR),"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1682,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,9.0,tmax,,,1.4,hr,median,,,95% CI,0.9,2.3,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1683,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,7.0,tmax,,,1.2,hr,median,,,95% CI,0.8,1.7,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1684,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,9.0,tmax,,,1.7,hr,median,,,95% CI,1,2.1,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1685,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,7.0,tmax,,,1.4,hr,median,,,95% CI,0.7,1.9,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1686,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,4th trimester,,9.0,t1/2 ,,,5.5,hr,median,,,95% CI,4,8.9,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1687,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,5th trimester,,7.0,t1/2 ,,,4.8,hr,median,,,95% CI,2.8,6.6,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1688,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,6th trimester,,9.0,t1/2 ,,,5.9,hr,median,,,95% CI,4.4,10.7,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1689,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,7th trimester,,7.0,t1/2 ,,,3.9,hr,median,,,95% CI,2,5.8,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1690,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,8th trimester,,9.0,t1/2 ,,,5.5,hr,median,,,95% CI,4.7,6,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1691,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,9th trimester,,7.0,t1/2 ,,,3.5,hr,median,,,95% CI,1.4,11.9,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1692,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,10th trimester,,9.0,t1/2 ,,,4.7,hr,median,,,95% CI,3.5,6.6,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1693,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,11th trimester,,7.0,t1/2 ,,,3.1,hr,median,,,95% CI,0.4,8.2,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1694,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,9.0,Vd/F,,,22.8,L/kg,median,,,95% CI,13.3,31.1,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1695,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,7.0,Vd/F,,,6.2,L/kg,median,,,95% CI,4,8.3,<0.05: (SR) vs. (RR),"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1696,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,9.0,Vd/F,,,14.9,L/kg,median,,,95% CI,11.3,28.6,<0.05: (SS) vs. (RS),"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1697,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,7.0,Vd/F,,,5.6,L/kg,median,,,95% CI,3.9,7.3,"<0.05: (SS) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1698,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,9.0,Vd/F,,,32.3,L/kg,median,,,95% CI,18.6,55.2,<0.05: non-diabetics vs. diabetics,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1699,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,7.0,Vd/F,,,11.4,L/kg,median,,,95% CI,6.2,16.3,<0.05: non-diabetics vs. diabetics,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1700,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,9.0,Vd/F,,,35.3,L/kg,median,,,95% CI,18.8,50.8,<0.05: non-diabetics vs. diabetics,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1701,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,7.0,Vd/F,,,9.2,L/kg,median,,,95% CI,3.5,16.6,<0.05: non-diabetics vs. diabetics,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1702,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,9.0,AUC0-,,,84.2,ng h/ml,median,,,95% CI,63.8,119.3,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1703,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,7.0,AUC0-,,,162.7,ng h/ml,median,,,95% CI,120.2,89.2,"<0.05: (SR) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1704,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,9.0,AUC0-,,,89.4,ng h/ml,median,,,95% CI,79.7,140.1,<0.05: (SS) vs. (RR),"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1705,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,7.0,AUC0-,,,157.9,ng h/ml,median,,,95% CI,125,191.4,"<0.05: (SS) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1706,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,9.0,AUC0-,,,45.6,ng h/ml,median,,,95% CI,40.3,74.4,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1707,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,7.0,AUC0-,,,60.9,ng h/ml,median,,,95% CI,43.3,83.2,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1708,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,9.0,AUC0-,,,78.3,ng h/ml,median,,,95% CI,50.2,85.3,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1709,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,7.0,AUC0-,,,114.6,ng h/ml,median,,,95% CI,52.9,154.2,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1710,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,9.0,CI/F,,,2.9,L/h/kg,median,,,95% CI,2,4.9,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1711,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,7.0,CI/F,,,1.4,L/h/kg,median,,,95% CI,1.1,1.8,"<0.05: (SR) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1712,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,9.0,CI/F,,,2.1,L/h/kg,median,,,95% CI,1.9,3.7,<0.05: (SS) vs. (RR),"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1713,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,7.0,CI/F,,,1.4,L/h/kg,median,,,95% CI,1.1,1.8,"<0.05: (SS) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1714,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,9.0,CI/F,,,4.4,L/h/kg,median,,,95% CI,3.6,7.4,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1715,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,7.0,CI/F,,,3.7,L/h/kg,median,,,95% CI,2.6,5,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1716,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,9.0,CI/F,,,3.7,L/h/kg,median,,,95% CI,3,6.1,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1717,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,7.0,CI/F,,,2,L/h/kg,median,,,95% CI,1.3,4.2,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1718,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,Cmax,,,74.8,ng/ml,median,,,95% CI,59.6,124.1,<0.05: (SR) vs. (SS),"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1719,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,Cmax,,,85,ng/ml,median,,,95% CI,45.8,101.2,<0.05: (SR) vs. (SS),"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1720,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,Cmax,,,208.2,ng/ml,median,,,95% CI,159.1,328.1,<0.05: (SS) vs. (RS),"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1721,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,Cmax,,,249.5,ng/ml,median,,,95% CI,180.9,318.3,<0.05: (SS) vs. (RS),"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1722,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,Cmax,,,213.4,ng/ml,median,,,95% CI,138.8,272.4,<0.05: (RR) vs. (RS),"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1723,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,Cmax,,,214.3,ng/ml,median,,,95% CI,175.8,262.6,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1724,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,Cmax,,,78.5,ng/ml,median,,,95% CI,53.3,107.3,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1725,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,Cmax,,,64.7,ng/ml,median,,,95% CI,54.2,93.9,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1726,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,tmax,,,1.1,hr,median,,,95% CI,0.1,4.4,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1727,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,tmax,,,1.4,hr,median,,,95% CI,1.2,2.3,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1728,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,tmax,,,1.6,hr,median,,,95% CI,0.7,4.2,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1729,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,tmax,,,1.7,hr,median,,,95% CI,1.2,2.6,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1730,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,tmax,,,1.6,hr,median,,,95% CI,1.1,2.8,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1731,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,tmax,,,1.5,hr,median,,,95% CI,1.1,2.6,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1732,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,tmax,,,1.6,hr,median,,,95% CI,1,3.1,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1733,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,tmax,,,2.2,hr,median,,,95% CI,1.4,2.8,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1734,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,AUC0-,,,265.5,ng h/ml,median,,,95% CI,235.3,554.1,<0.05: (SR) vs. (SS),"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1735,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,AUC0-,,,372.9,ng h/ml,median,,,95% CI,216.6,481.3,<0.05: (SR) vs. (SS),"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1736,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,AUC0-,,,1004.7,ng h/ml,median,,,95% CI,886.2,1255.9,<0.05: (SS) vs. (RS),"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1737,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,AUC0-,,,1072.1,ng h/ml,median,,,95% CI,753.7,1520.2,<0.05: (SS) vs. (RS),"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1738,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,AUC0-,,,820.4,ng h/ml,median,,,95% CI,631.2,1000.3,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1739,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,AUC0-,,,805.7,ng h/ml,median,,,95% CI,522.1,1184.2,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1740,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,AUC0-,,,329.4,ng h/ml,median,,,95% CI,195.8,371.9,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1741,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,AUC0-,,,360.9,ng h/ml,median,,,95% CI,235.9,467.3,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1742,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,% comjugation,,,77.9,,median,,,95% CI,72.4,85.5,"<0.05: (SR) vs. (RS), (SR) vs. (SS)","oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1743,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,% comjugation,,,68.4,,median,,,95% CI,59.6,75.3,"<0.05: (SR) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1744,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,% comjugation,,,90.8,,median,,,95% CI,88.2,92.9,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1745,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,% comjugation,,,87.9,,median,,,95% CI,90.1,95.2,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1746,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,% comjugation,,,93.3,,median,,,95% CI,91.3,95.1,<0.05: (RR) vs. (RS),"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1747,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,% comjugation,,,93.6,,median,,,95% CI,90.1,95.2,<0.05: (RR) vs. (RS),"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1748,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,% comjugation,,,78.8,,median,,,95% CI,74,84.5,,"oral administration, non-diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1749,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,% comjugation,,,78.4,,median,,,95% CI,68.6,86.3,,"oral administration, diabetics",PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1750,2025-12-02T16:05:09.448543
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,8.0,Cmax,,,91.1,ng/ml,median,,,95% CI,53.5,129.5,<0.05: (SR) vs. (RS),"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1607,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,6.0,Cmax,,,101.4,ng/ml,median,,,95% CI,50.6,138.1,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1608,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,8.0,Cmax,,,87.3,ng/ml,median,,,95% CI,52.7,124.8,<0.05: (SS) vs. (RS),"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1609,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,6.0,Cmax,,,100.3,ng/ml,median,,,95% CI,58.7,147.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1610,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,8.0,Cmax,,,101.7,ng/ml,median,,,95% CI,57.3,157,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1611,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,6.0,Cmax,,,96.3,ng/ml,median,,,95% CI,69,135.7,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1612,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,8.0,Cmax,,,123.1,ng/ml,median,,,95% CI,66.8,165.6,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1613,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)Labetalol,plasma,maternal,3rd trimester,,6.0,Cmax,,,120.5,ng/ml,median,,,95% CI,90,140.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1614,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,8.0,t1/2 ,,,6.3,hr,median,,,95% CI,4.6,8.9,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1615,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,6.0,t1/2 ,,,7.6,hr,median,,,95% CI,2.8,16.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1616,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,8.0,t1/2 ,,,8.6,hr,median,,,95% CI,5.7,12.2,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1617,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,6.0,t1/2 ,,,8.4,hr,median,,,95% CI,4.7,16.4,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1618,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,8.0,t1/2 ,,,7.1,hr,median,,,95% CI,5.1,12.2,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1619,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,6.0,t1/2 ,,,11.4,hr,median,,,95% CI,4.3,20.1,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1620,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,8.0,t1/2 ,,,5.4,hr,median,,,95% CI,2.9,10.9,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1621,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,6.0,t1/2 ,,,7.4,hr,median,,,95% CI,2.1,17.1,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1622,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,8.0,Vd,,,0.5,L/kg,median,,,95% CI,0.3,0.9,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1623,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,6.0,Vd,,,0.6,L/kg,median,,,95% CI,0.3,1.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1624,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,8.0,Vd,,,0.8,L/kg,median,,,95% CI,0.4,1.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1625,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,6.0,Vd,,,0.8,L/kg,median,,,95% CI,0.6,0.9,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1626,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,8.0,Vd,,,0.6,L/kg,median,,,95% CI,0.3,1.1,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1627,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,6.0,Vd,,,0.7,L/kg,median,,,95% CI,0.5,0.8,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1628,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,8.0,Vd,,,0.5,L/kg,median,,,95% CI,0.4,0.8,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1629,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,6.0,Vd,,,0.5,L/kg,median,,,95% CI,0.3,0.7,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1630,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,8.0,AUC0-,,,160.1,ng h/ml,median,,,95% CI,112.2,260.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1631,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,6.0,AUC0-,,,99.7,ng h/ml,median,,,95% CI,60.6,164.7,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1632,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,8.0,AUC0-,,,154.4,ng h/ml,median,,,95% CI,106.9,196.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1633,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,6.0,AUC0-,,,130.5,ng h/ml,median,,,95% CI,97.9,176.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1634,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,8.0,AUC0-,,,127.2,ng h/ml,median,,,95% CI,92.3,200,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1635,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,6.0,AUC0-,,,120.1,ng h/ml,median,,,95% CI,93.1,153.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1636,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,8.0,AUC0-,,,141.9,ng h/ml,median,,,95% CI,100.1,191.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1637,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,6.0,AUC0-,,,105.1,ng h/ml,median,,,95% CI,76.6,176.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1638,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,8.0,Cl,,,0.8,L/h/kg,median,,,95% CI,0.5,1.2,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1639,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,6.0,Cl,,,1,L/h/kg,median,,,95% CI,0.6,1.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1640,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,8.0,Cl,,,0.9,L/h/kg,median,,,95% CI,0.5,1.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1641,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,6.0,Cl,,,0.8,L/h/kg,median,,,95% CI,0.5,1.1,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1642,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,8.0,Cl,,,0.9,L/h/kg,median,,,95% CI,0.5,1.7,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1643,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,6.0,Cl,,,0.9,L/h/kg,median,,,95% CI,0.5,1.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1644,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,8.0,Cl,,,0.8,L/h/kg,median,,,95% CI,0.6,1.5,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1645,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,6.0,Cl,,,0.9,L/h/kg,median,,,95% CI,0.6,1.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1646,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,Cmax,,,118.7,ng/ml,median,,,95% CI,19.7,359.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1647,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,Cmax,,,128.6,ng/ml,median,,,95% CI,46.9,213.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1648,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,Cmax,,,108.4,ng/ml,median,,,95% CI,22.5,350.6,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1649,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,Cmax,,,188.4,ng/ml,median,,,95% CI,70.6,304.1,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1650,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,Cmax,,,131.6,ng/ml,median,,,95% CI,45.3,312.1,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1651,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,Cmax,,,155.6,ng/ml,median,,,95% CI,50.8,226.4,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1652,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,Cmax,,,109.6,ng/ml,median,,,95% CI,27.8,345.9,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1653,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,Cmax,,,124.1,ng/ml,median,,,95% CI,28.9,257.2,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1654,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,AUC0-,,,276.4,ng h/ml,median,,,95% CI,176.8,718.3,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1655,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,AUC0-,,,577.2,ng h/ml,median,,,95% CI,277.5,786.7,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1656,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,AUC0-,,,417.6,ng h/ml,median,,,95% CI,308.5,767.7,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1657,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,AUC0-,,,685.2,ng h/ml,median,,,95% CI,305.3,965.8,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1658,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,AUC0-,,,275.8,ng h/ml,median,,,95% CI,103.7,796.3,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1659,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,AUC0-,,,553.1,ng h/ml,median,,,95% CI,299.7,812.4,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1660,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,AUC0-,,,180.8,ng h/ml,median,,,95% CI,104.8,486.2,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1661,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,AUC0-,,,462.7,ng h/ml,median,,,95% CI,316.8,570.9,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1662,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,% comjugation,,,60.4,,median,,,95% CI,47.8,74.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1663,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,% comjugation,,,78.8,,median,,,95% CI,70.2,88.8,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1664,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,% comjugation,,,75.9,,median,,,95% CI,69.8,82.7,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1665,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,% comjugation,,,80.7,,median,,,95% CI,72.6,87.5,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1666,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,% comjugation,,,67.9,,median,,,95% CI,60.9,80.3,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1667,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,% comjugation,,,79.9,,median,,,95% CI,68.4,90.6,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1668,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,8.0,% comjugation,,,60.4,,median,,,95% CI,47.8,74.4,,"intravenous administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1669,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,6.0,% comjugation,,,80.3,,median,,,95% CI,62.1,90.4,,"intravenous administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1670,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,9.0,Cmax,,,16.9,ng/ml,median,,,95% CI,11.9,31.8,<0.05: (SR) vs. (RR),"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1671,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,7.0,Cmax,,,42.7,ng/ml,median,,,95% CI,29.7,62.5,<0.05: non-diabetics vs. diabetics,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1672,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,9.0,Cmax,,,20.8,ng/ml,median,,,95% CI,14.5,35.7,<0.05: (SS) vs. (RR),"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1673,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,7.0,Cmax,,,32.8,ng/ml,median,,,95% CI,23.3,49.7,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1674,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,9.0,Cmax,,,14.4,ng/ml,median,,,95% CI,7.5,19.9,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1675,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,7.0,Cmax,,,14.3,ng/ml,median,,,95% CI,4.1,29.9,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1676,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,9.0,Cmax,,,16.2,ng/ml,median,,,95% CI,9.8,27.7,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1677,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,7.0,Cmax,,,29.1,ng/ml,median,,,95% CI,13,40.1,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1678,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,9.0,tmax,,,1.6,hr,median,,,95% CI,0.9,2.4,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1679,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,7.0,tmax,,,1.6,hr,median,,,95% CI,1.2,2.1,<0.05: (SR) vs. (RR),"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1680,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,9.0,tmax,,,1.6,hr,median,,,95% CI,1,2.5,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1681,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,7.0,tmax,,,1.4,hr,median,,,95% CI,1,2,<0.05:(SS) vs. (RR),"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1682,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,9.0,tmax,,,1.4,hr,median,,,95% CI,0.9,2.3,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1683,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,7.0,tmax,,,1.2,hr,median,,,95% CI,0.8,1.7,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1684,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,9.0,tmax,,,1.7,hr,median,,,95% CI,1,2.1,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1685,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,7.0,tmax,,,1.4,hr,median,,,95% CI,0.7,1.9,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1686,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,4th trimester,,9.0,t1/2 ,,,5.5,hr,median,,,95% CI,4,8.9,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1687,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,5th trimester,,7.0,t1/2 ,,,4.8,hr,median,,,95% CI,2.8,6.6,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1688,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,6th trimester,,9.0,t1/2 ,,,5.9,hr,median,,,95% CI,4.4,10.7,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1689,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,7th trimester,,7.0,t1/2 ,,,3.9,hr,median,,,95% CI,2,5.8,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1690,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,8th trimester,,9.0,t1/2 ,,,5.5,hr,median,,,95% CI,4.7,6,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1691,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,9th trimester,,7.0,t1/2 ,,,3.5,hr,median,,,95% CI,1.4,11.9,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1692,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,10th trimester,,9.0,t1/2 ,,,4.7,hr,median,,,95% CI,3.5,6.6,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1693,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,11th trimester,,7.0,t1/2 ,,,3.1,hr,median,,,95% CI,0.4,8.2,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1694,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,9.0,Vd/F,,,22.8,L/kg,median,,,95% CI,13.3,31.1,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1695,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,7.0,Vd/F,,,6.2,L/kg,median,,,95% CI,4,8.3,<0.05: (SR) vs. (RR),"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1696,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,9.0,Vd/F,,,14.9,L/kg,median,,,95% CI,11.3,28.6,<0.05: (SS) vs. (RS),"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1697,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,7.0,Vd/F,,,5.6,L/kg,median,,,95% CI,3.9,7.3,"<0.05: (SS) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1698,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,9.0,Vd/F,,,32.3,L/kg,median,,,95% CI,18.6,55.2,<0.05: non-diabetics vs. diabetics,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1699,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,7.0,Vd/F,,,11.4,L/kg,median,,,95% CI,6.2,16.3,<0.05: non-diabetics vs. diabetics,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1700,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,9.0,Vd/F,,,35.3,L/kg,median,,,95% CI,18.8,50.8,<0.05: non-diabetics vs. diabetics,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1701,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,7.0,Vd/F,,,9.2,L/kg,median,,,95% CI,3.5,16.6,<0.05: non-diabetics vs. diabetics,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1702,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,9.0,AUC0-,,,84.2,ng h/ml,median,,,95% CI,63.8,119.3,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1703,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,7.0,AUC0-,,,162.7,ng h/ml,median,,,95% CI,120.2,89.2,"<0.05: (SR) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1704,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,9.0,AUC0-,,,89.4,ng h/ml,median,,,95% CI,79.7,140.1,<0.05: (SS) vs. (RR),"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1705,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,7.0,AUC0-,,,157.9,ng h/ml,median,,,95% CI,125,191.4,"<0.05: (SS) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1706,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,9.0,AUC0-,,,45.6,ng h/ml,median,,,95% CI,40.3,74.4,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1707,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,7.0,AUC0-,,,60.9,ng h/ml,median,,,95% CI,43.3,83.2,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1708,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,9.0,AUC0-,,,78.3,ng h/ml,median,,,95% CI,50.2,85.3,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1709,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,7.0,AUC0-,,,114.6,ng h/ml,median,,,95% CI,52.9,154.2,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1710,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR) Labetalol,plasma,maternal,3rd trimester,,9.0,CI/F,,,2.9,L/h/kg,median,,,95% CI,2,4.9,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1711,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR )Labetalol,plasma,maternal,3rd trimester,,7.0,CI/F,,,1.4,L/h/kg,median,,,95% CI,1.1,1.8,"<0.05: (SR) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1712,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,9.0,CI/F,,,2.1,L/h/kg,median,,,95% CI,1.9,3.7,<0.05: (SS) vs. (RR),"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1713,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS) Labetalol,plasma,maternal,3rd trimester,,7.0,CI/F,,,1.4,L/h/kg,median,,,95% CI,1.1,1.8,"<0.05: (SS) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1714,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,9.0,CI/F,,,4.4,L/h/kg,median,,,95% CI,3.6,7.4,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1715,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR) Labetalol,plasma,maternal,3rd trimester,,7.0,CI/F,,,3.7,L/h/kg,median,,,95% CI,2.6,5,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1716,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,9.0,CI/F,,,3.7,L/h/kg,median,,,95% CI,3,6.1,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1717,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS) Labetalol,plasma,maternal,3rd trimester,,7.0,CI/F,,,2,L/h/kg,median,,,95% CI,1.3,4.2,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1718,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,Cmax,,,74.8,ng/ml,median,,,95% CI,59.6,124.1,<0.05: (SR) vs. (SS),"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1719,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,Cmax,,,85,ng/ml,median,,,95% CI,45.8,101.2,<0.05: (SR) vs. (SS),"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1720,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,Cmax,,,208.2,ng/ml,median,,,95% CI,159.1,328.1,<0.05: (SS) vs. (RS),"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1721,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,Cmax,,,249.5,ng/ml,median,,,95% CI,180.9,318.3,<0.05: (SS) vs. (RS),"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1722,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,Cmax,,,213.4,ng/ml,median,,,95% CI,138.8,272.4,<0.05: (RR) vs. (RS),"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1723,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,Cmax,,,214.3,ng/ml,median,,,95% CI,175.8,262.6,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1724,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,Cmax,,,78.5,ng/ml,median,,,95% CI,53.3,107.3,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1725,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,Cmax,,,64.7,ng/ml,median,,,95% CI,54.2,93.9,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1726,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,tmax,,,1.1,hr,median,,,95% CI,0.1,4.4,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1727,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,tmax,,,1.4,hr,median,,,95% CI,1.2,2.3,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1728,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,tmax,,,1.6,hr,median,,,95% CI,0.7,4.2,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1729,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,tmax,,,1.7,hr,median,,,95% CI,1.2,2.6,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1730,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,tmax,,,1.6,hr,median,,,95% CI,1.1,2.8,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1731,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,tmax,,,1.5,hr,median,,,95% CI,1.1,2.6,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1732,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,tmax,,,1.6,hr,median,,,95% CI,1,3.1,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1733,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,tmax,,,2.2,hr,median,,,95% CI,1.4,2.8,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1734,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,AUC0-,,,265.5,ng h/ml,median,,,95% CI,235.3,554.1,<0.05: (SR) vs. (SS),"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1735,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,AUC0-,,,372.9,ng h/ml,median,,,95% CI,216.6,481.3,<0.05: (SR) vs. (SS),"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1736,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,AUC0-,,,1004.7,ng h/ml,median,,,95% CI,886.2,1255.9,<0.05: (SS) vs. (RS),"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1737,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,AUC0-,,,1072.1,ng h/ml,median,,,95% CI,753.7,1520.2,<0.05: (SS) vs. (RS),"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1738,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,AUC0-,,,820.4,ng h/ml,median,,,95% CI,631.2,1000.3,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1739,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,AUC0-,,,805.7,ng h/ml,median,,,95% CI,522.1,1184.2,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1740,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,AUC0-,,,329.4,ng h/ml,median,,,95% CI,195.8,371.9,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1741,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,AUC0-,,,360.9,ng h/ml,median,,,95% CI,235.9,467.3,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1742,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,% comjugation,,,77.9,,median,,,95% CI,72.4,85.5,"<0.05: (SR) vs. (RS), (SR) vs. (SS)","oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1743,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SR)-labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,% comjugation,,,68.4,,median,,,95% CI,59.6,75.3,"<0.05: (SR) vs. (RR), non-diabetics vs. diabetics","oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1744,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,% comjugation,,,90.8,,median,,,95% CI,88.2,92.9,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1745,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(SS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,% comjugation,,,87.9,,median,,,95% CI,90.1,95.2,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1746,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,% comjugation,,,93.3,,median,,,95% CI,91.3,95.1,<0.05: (RR) vs. (RS),"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1747,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RR)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,% comjugation,,,93.6,,median,,,95% CI,90.1,95.2,<0.05: (RR) vs. (RS),"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1748,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,9.0,% comjugation,,,78.8,,median,,,95% CI,74,84.5,,"oral administration, non-diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1749,2025-12-02T16:05:12.001940
20848091.0,Labetalol,(RS)-Labetalol glucuronide,plasma,maternal,3rd trimester,,7.0,% comjugation,,,78.4,,median,,,95% CI,68.6,86.3,,"oral administration, diabetics",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1750,2025-12-02T16:05:12.001940
2309815.0,Labetalol,Labetalol,blood,maternal,3rd trimester,,,concentration,0,h,39.3,ng/ml,mean,SD,41,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1751,2025-12-02T16:05:09.448543
2309815.0,Labetalol,Labetalol,blood,maternal,3rd trimester,,,concentration,8,h,36,ng/ml,mean,SD,6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1752,2025-12-02T16:05:09.448543
2309815.0,Labetalol,Labetalol,serum,maternal,3rd trimester,,,t1/2,,,1.7,hr,mean,SD,0.27,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1753,2025-12-02T16:05:09.448543
2309815.0,Labetalol,Labetalol,serum,maternal,3rd trimester,,,Cl,,,21.8,mg/kg/min,mean,SD,6.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1754,2025-12-02T16:05:09.448543
2309815.0,Labetalol,Labetalol,cord/maternal serum,maternal/pediatric,delivery,fetus,,fetal cord/maternal serum ratio,,,0.5,,mean,SD,0.15,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1755,2025-12-02T16:05:09.448543
2309815.0,Labetalol,Labetalol,amniotic fluid/maternal serum,maternal,delivery,,,amniotic fluid/maternal serum ratio,,,0.16,,mean,SD,0.13,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1756,2025-12-02T16:05:09.448543
2309815.0,Labetalol,Labetalol,blood,maternal,3rd trimester,,,concentration,0,h,39.3,ng/ml,mean,SD,41,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1751,2025-12-02T16:05:12.001940
2309815.0,Labetalol,Labetalol,blood,maternal,3rd trimester,,,concentration,8,h,36,ng/ml,mean,SD,6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1752,2025-12-02T16:05:12.001940
2309815.0,Labetalol,Labetalol,serum,maternal,3rd trimester,,,t1/2,,,1.7,hr,mean,SD,0.27,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1753,2025-12-02T16:05:12.001940
2309815.0,Labetalol,Labetalol,serum,maternal,3rd trimester,,,Cl,,,21.8,mg/kg/min,mean,SD,6.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1754,2025-12-02T16:05:12.001940
2309815.0,Labetalol,Labetalol,cord/maternal serum,maternal/pediatric,delivery,fetus,,fetal cord/maternal serum ratio,,,0.5,,mean,SD,0.15,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1755,2025-12-02T16:05:12.001940
2309815.0,Labetalol,Labetalol,amniotic fluid/maternal serum,maternal,delivery,,,amniotic fluid/maternal serum ratio,,,0.16,,mean,SD,0.13,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1756,2025-12-02T16:05:12.001940
24297680.0,Labetalol,Labetalol,plasma,maternal,pregnant/postpartum,,57.0,concentration,,,,ng/ml,,,,minmax,10,1381,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1757,2025-12-02T16:05:09.448543
24297680.0,Labetalol,Labetalol,plasma,maternal,2nd trimester,,29.0,concentration,,,,ng/ml,,,,minmax,10.2,585,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1758,2025-12-02T16:05:09.448543
24297680.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,47.0,concentration,,,,ng/ml,,,,minmax,10,1231,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1759,2025-12-02T16:05:09.448543
24297680.0,Labetalol,Labetalol,plasma,maternal,postpartum,,34.0,concentration,,,,ng/ml,,,,minmax,10.1,1381,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1760,2025-12-02T16:05:09.448543
24297680.0,Labetalol,Labetalol,plasma,maternal,pregnant/postpartum,,57.0,concentration,,,,ng/ml,,,,minmax,10,1381,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1757,2025-12-02T16:05:12.001940
24297680.0,Labetalol,Labetalol,plasma,maternal,2nd trimester,,29.0,concentration,,,,ng/ml,,,,minmax,10.2,585,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1758,2025-12-02T16:05:12.001940
24297680.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,47.0,concentration,,,,ng/ml,,,,minmax,10,1231,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1759,2025-12-02T16:05:12.001940
24297680.0,Labetalol,Labetalol,plasma,maternal,postpartum,,34.0,concentration,,,,ng/ml,,,,minmax,10.1,1381,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1760,2025-12-02T16:05:12.001940
6849783.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,10.0,Cl,,,2.16,l/min,median,,,minmax,1.54,3.14,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1779,2025-12-02T16:05:09.448543
6849783.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,10.0,Vss,,,274,l,median,,,minmax,250,547,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1780,2025-12-02T16:05:09.448543
6849783.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,10.0,t1/2,,,147,min,median,,,minmax,111,167,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1781,2025-12-02T16:05:09.448543
6849783.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,10.0,Cl,,,24.8,ml/min/kg,median,,,minmax,19.7,38.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1782,2025-12-02T16:05:09.448543
6849783.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,10.0,Vss,,,3.7,l/kg,median,,,minmax,2.4,6.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1783,2025-12-02T16:05:09.448543
6849783.0,Labetalol,Labetalol,plasma,maternal,postpartum,,7.0,Cl,,,2.35,l/min,median,,,minmax,1.56,3.85,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1784,2025-12-02T16:05:09.448543
6849783.0,Labetalol,Labetalol,plasma,maternal,postpartum,,7.0,Vss,,,407,l,median,,,minmax,248,701,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1785,2025-12-02T16:05:09.448543
6849783.0,Labetalol,Labetalol,plasma,maternal,postpartum,,7.0,t1/2,,,152,min,median,,,minmax,116,195,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1786,2025-12-02T16:05:09.448543
6849783.0,Labetalol,Labetalol,plasma,maternal,postpartum,,7.0,Cl,,,34.8,ml/min/kg,median,,,minmax,27.6,51.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1787,2025-12-02T16:05:09.448543
6849783.0,Labetalol,Labetalol,plasma,maternal,postpartum,,7.0,Vss,,,6.3,l/kg,median,,,minmax,3.3,9.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1788,2025-12-02T16:05:09.448543
6849783.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,10.0,Cl,,,2.16,l/min,median,,,minmax,1.54,3.14,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1779,2025-12-02T16:05:12.001940
6849783.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,10.0,Vss,,,274,l,median,,,minmax,250,547,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1780,2025-12-02T16:05:12.001940
6849783.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,10.0,t1/2,,,147,min,median,,,minmax,111,167,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1781,2025-12-02T16:05:12.001940
6849783.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,10.0,Cl,,,24.8,ml/min/kg,median,,,minmax,19.7,38.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1782,2025-12-02T16:05:12.001940
6849783.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,10.0,Vss,,,3.7,l/kg,median,,,minmax,2.4,6.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1783,2025-12-02T16:05:12.001940
6849783.0,Labetalol,Labetalol,plasma,maternal,postpartum,,7.0,Cl,,,2.35,l/min,median,,,minmax,1.56,3.85,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1784,2025-12-02T16:05:12.001940
6849783.0,Labetalol,Labetalol,plasma,maternal,postpartum,,7.0,Vss,,,407,l,median,,,minmax,248,701,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1785,2025-12-02T16:05:12.001940
6849783.0,Labetalol,Labetalol,plasma,maternal,postpartum,,7.0,t1/2,,,152,min,median,,,minmax,116,195,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1786,2025-12-02T16:05:12.001940
6849783.0,Labetalol,Labetalol,plasma,maternal,postpartum,,7.0,Cl,,,34.8,ml/min/kg,median,,,minmax,27.6,51.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1787,2025-12-02T16:05:12.001940
6849783.0,Labetalol,Labetalol,plasma,maternal,postpartum,,7.0,Vss,,,6.3,l/kg,median,,,minmax,3.3,9.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1788,2025-12-02T16:05:12.001940
8227470.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,7.0,t1/2,,,5.8,hr,mean,SD,0.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1789,2025-12-02T16:05:09.448543
8227470.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,7.0,CL/F,,,43.7,ml/min/kg,mean,SD,5.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1790,2025-12-02T16:05:09.448543
8227470.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,7.0,t1/2,,,5.8,hr,mean,SD,0.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1789,2025-12-02T16:05:12.001940
8227470.0,Labetalol,Labetalol,plasma,maternal,3rd trimester,,7.0,CL/F,,,43.7,ml/min/kg,mean,SD,5.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1790,2025-12-02T16:05:12.001940
19265649.0,Bupropion,Bupropion,serum,maternal,lactation,,4.0,trough concentration,,,33.8,ng/ml, mean, SD,57,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1871,2025-12-02T16:05:09.448543
19265649.0,Bupropion,Bupropion,serum,maternal,lactation,,4.0,peak concentration,,,76.9,ng/ml, mean, SD,64.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1872,2025-12-02T16:05:09.448543
19265649.0,Bupropion,Bupropion,urine,maternal,lactation,,4.0,trough concentration,,,37.8,ng/ml, mean, SD,46,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1873,2025-12-02T16:05:09.448543
19265649.0,Bupropion,Bupropion,urine,maternal,lactation,,4.0,peak concentration,,,958.3,ng/ml, mean, SD,969.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1874,2025-12-02T16:05:09.448543
19265649.0,Bupropion,Bupropion,breast milk,maternal,lactation,,4.0,trough concentration,,,9.2,ng/ml, mean, SD,2.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1875,2025-12-02T16:05:09.448543
19265649.0,Bupropion,Bupropion,breast milk,maternal,lactation,,4.0,peak concentration,,,64.1,ng/ml, mean, SD,46.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1876,2025-12-02T16:05:09.448543
19265649.0,Bupropion,Bupropion,breast milk/serum,maternal,lactation,,4.0,peak milk/serum ratio,,,1.3,, mean, SD,1.47,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1877,2025-12-02T16:05:09.448543
19265649.0,Bupropion,Bupropion,breast milk,maternal,lactation,,4.0,infant dose,,,21.5,mg, mean, SD,13.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1878,2025-12-02T16:05:09.448543
19265649.0,Bupropion,Bupropion,breast milk,maternal,lactation,,4.0,% of maternal dose,,,5.7,mg, mean, SD,3.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1879,2025-12-02T16:05:09.448543
19265649.0,Bupropion,Bupropion,serum,maternal,lactation,,4.0,trough concentration,,,33.8,ng/ml, mean, SD,57,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1871,2025-12-02T16:05:12.001940
19265649.0,Bupropion,Bupropion,serum,maternal,lactation,,4.0,peak concentration,,,76.9,ng/ml, mean, SD,64.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1872,2025-12-02T16:05:12.001940
19265649.0,Bupropion,Bupropion,urine,maternal,lactation,,4.0,trough concentration,,,37.8,ng/ml, mean, SD,46,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1873,2025-12-02T16:05:12.001940
19265649.0,Bupropion,Bupropion,urine,maternal,lactation,,4.0,peak concentration,,,958.3,ng/ml, mean, SD,969.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1874,2025-12-02T16:05:12.001940
19265649.0,Bupropion,Bupropion,breast milk,maternal,lactation,,4.0,trough concentration,,,9.2,ng/ml, mean, SD,2.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1875,2025-12-02T16:05:12.001940
19265649.0,Bupropion,Bupropion,breast milk,maternal,lactation,,4.0,peak concentration,,,64.1,ng/ml, mean, SD,46.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1876,2025-12-02T16:05:12.001940
19265649.0,Bupropion,Bupropion,breast milk/serum,maternal,lactation,,4.0,peak milk/serum ratio,,,1.3,, mean, SD,1.47,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1877,2025-12-02T16:05:12.001940
19265649.0,Bupropion,Bupropion,breast milk,maternal,lactation,,4.0,infant dose,,,21.5,mg, mean, SD,13.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1878,2025-12-02T16:05:12.001940
19265649.0,Bupropion,Bupropion,breast milk,maternal,lactation,,4.0,% of maternal dose,,,5.7,mg, mean, SD,3.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1879,2025-12-02T16:05:12.001940
14985597.0,Bupropion,Bupropion,breast milk,maternal,lactation,,10.0,concentration,,,45.2,ng/ml,mean,SD,49.5,minmax,4.2,168.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1978,2025-12-02T16:05:09.448543
14985597.0,Bupropion,Bupropion,plasma,maternal,lactation,,10.0,concentration,,,25,ng/ml,mean,SD,24.6,minmax,2.9,84.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1979,2025-12-02T16:05:09.448543
14985597.0,Bupropion,Bupropion,urine,maternal,lactation,,10.0,concentration,,,1042,ng/ml,mean,SD,2139,minmax,32.7,7056.4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1980,2025-12-02T16:05:09.448543
14985597.0,Bupropion,Bupropion,saliva,maternal,lactation,,10.0,concentration,,,68.5,ng/ml,mean,SD,131.4,minmax,3.2,439,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1981,2025-12-02T16:05:09.448543
14985597.0,Bupropion,hydroxybupropion,breast milk,maternal,lactation,,10.0,concentration,,,104.6,ng/ml,mean,SD,62.2,minmax,9,242.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1982,2025-12-02T16:05:09.448543
14985597.0,Bupropion,hydroxybupropion,plasma,maternal,lactation,,10.0,concentration,,,940.2,ng/ml,mean,SD,697.7,minmax,64.8,2672.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1983,2025-12-02T16:05:09.448543
14985597.0,Bupropion,hydroxybupropion,urine,maternal,lactation,,10.0,concentration,,,2026.4,ng/ml,mean,SD,1873,minmax,125.7,5032.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1984,2025-12-02T16:05:09.448543
14985597.0,Bupropion,hydroxybupropion,saliva,maternal,lactation,,10.0,concentration,,,184.5,ng/ml,mean,SD,143.9,minmax,25.1,522.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1985,2025-12-02T16:05:09.448543
14985597.0,Bupropion,erythrogydrobupropion,breast milk,maternal,lactation,,10.0,concentration,,,72.1,ng/ml,mean,SD,38.3,minmax,25.4,142.9,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1986,2025-12-02T16:05:09.448543
14985597.0,Bupropion,erythrogydrobupropion,plasma,maternal,lactation,,10.0,concentration,,,84.1,ng/ml,mean,SD,46.1,minmax,19.9,196.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1987,2025-12-02T16:05:09.448543
14985597.0,Bupropion,erythrogydrobupropion,urine,maternal,lactation,,10.0,concentration,,,2396.2,ng/ml,mean,SD,1857,minmax,370.1,5972.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1988,2025-12-02T16:05:09.448543
14985597.0,Bupropion,erythrogydrobupropion,saliva,maternal,lactation,,10.0,concentration,,,202.9,ng/ml,mean,SD,131.1,minmax,71.7,491.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1989,2025-12-02T16:05:09.448543
14985597.0,Bupropion,threohydrobupropion,breast milk,maternal,lactation,,10.0,concentration,,,459,ng/ml,mean,SD,278.4,minmax,192.7,1052.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1990,2025-12-02T16:05:09.448543
14985597.0,Bupropion,threohydrobupropion,plasma,maternal,lactation,,10.0,concentration,,,370.2,ng/ml,mean,SD,182.9,minmax,121.4,746.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1991,2025-12-02T16:05:09.448543
14985597.0,Bupropion,threohydrobupropion,urine,maternal,lactation,,10.0,concentration,,,18791.3,ng/ml,mean,SD,16227,minmax,2484.5,45625.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1992,2025-12-02T16:05:09.448543
14985597.0,Bupropion,threohydrobupropion,saliva,maternal,lactation,,10.0,concentration,,,1229.5,ng/ml,mean,SD,794.1,minmax,469.3,3089.1,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1993,2025-12-02T16:05:09.448543
14985597.0,Bupropion,Bupropion,breast milk,maternal,lactation,,10.0,concentration,,,0.19,nM/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1994,2025-12-02T16:05:09.448543
14985597.0,Bupropion,Bupropion,breast milk,maternal,lactation,,10.0,infant dose,,,6.75,ug/kg/day,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1995,2025-12-02T16:05:09.448543
14985597.0,Bupropion,Bupropion,breast milk,maternal,lactation,,10.0,infant dose,,,28.1,nM/kg/day,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1996,2025-12-02T16:05:09.448543
14985597.0,Bupropion,Bupropion,breast milk,maternal,lactation,,10.0,infant dose (% maternal bupropion dose),,,0.13,%,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1997,2025-12-02T16:05:09.448543
14985597.0,Bupropion,hydroxybupropion,breast milk,maternal,lactation,,10.0,concentration,,,0.41,nM/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1998,2025-12-02T16:05:09.448543
14985597.0,Bupropion,hydroxybupropion,breast milk,maternal,lactation,,10.0,infant dose,,,15.75,ug/kg/day,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1999,2025-12-02T16:05:09.448543
14985597.0,Bupropion,hydroxybupropion,breast milk,maternal,lactation,,10.0,infant dose,,,61.5,nM/kg/day,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2000,2025-12-02T16:05:09.448543
14985597.0,Bupropion,hydroxybupropion,breast milk,maternal,lactation,,10.0,infant dose (% maternal bupropion dose),,,0.3,%,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2001,2025-12-02T16:05:09.448543
14985597.0,Bupropion,erythrogydrobupropion,breast milk,maternal,lactation,,10.0,concentration,,,0.3,nM/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2002,2025-12-02T16:05:09.448543
14985597.0,Bupropion,erythrogydrobupropion,breast milk,maternal,lactation,,10.0,infant dose,,,10.8,ug/kg/day,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2003,2025-12-02T16:05:09.448543
14985597.0,Bupropion,erythrogydrobupropion,breast milk,maternal,lactation,,10.0,infant dose,,,44.6,nM/kg/day,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2004,2025-12-02T16:05:09.448543
14985597.0,Bupropion,erythrogydrobupropion,breast milk,maternal,lactation,,10.0,infant dose (% maternal bupropion dose),,,0.21,%,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2005,2025-12-02T16:05:09.448543
14985597.0,Bupropion,threohydrobupropion,breast milk,maternal,lactation,,10.0,concentration,,,1.9,nM/ml,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2006,2025-12-02T16:05:09.448543
14985597.0,Bupropion,threohydrobupropion,breast milk,maternal,lactation,,10.0,infant dose,,,68.85,ug/kg/day,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2007,2025-12-02T16:05:09.448543
14985597.0,Bupropion,threohydrobupropion,breast milk,maternal,lactation,,10.0,infant dose,,,284.5,nM/kg/day,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2008,2025-12-02T16:05:09.448543
14985597.0,Bupropion,threohydrobupropion,breast milk,maternal,lactation,,10.0,infant dose (% maternal bupropion dose),,,1.37,%,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2009,2025-12-02T16:05:09.448543
14985597.0,Bupropion,total,breast milk,maternal,lactation,,10.0,infant dose,,,418.7,nM/kg/day,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2010,2025-12-02T16:05:09.448543
14985597.0,Bupropion,total,breast milk,maternal,lactation,,10.0,infant dose (% maternal bupropion dose),,,2.01,%,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2011,2025-12-02T16:05:09.448543
14985597.0,Bupropion,Bupropion,breast milk,maternal,lactation,,10.0,concentration,,,45.2,ng/ml,mean,SD,49.5,minmax,4.2,168.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1978,2025-12-02T16:05:12.001940
14985597.0,Bupropion,Bupropion,plasma,maternal,lactation,,10.0,concentration,,,25,ng/ml,mean,SD,24.6,minmax,2.9,84.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1979,2025-12-02T16:05:12.001940
14985597.0,Bupropion,Bupropion,urine,maternal,lactation,,10.0,concentration,,,1042,ng/ml,mean,SD,2139,minmax,32.7,7056.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1980,2025-12-02T16:05:12.001940
14985597.0,Bupropion,Bupropion,saliva,maternal,lactation,,10.0,concentration,,,68.5,ng/ml,mean,SD,131.4,minmax,3.2,439,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1981,2025-12-02T16:05:12.001940
14985597.0,Bupropion,hydroxybupropion,breast milk,maternal,lactation,,10.0,concentration,,,104.6,ng/ml,mean,SD,62.2,minmax,9,242.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1982,2025-12-02T16:05:12.001940
14985597.0,Bupropion,hydroxybupropion,plasma,maternal,lactation,,10.0,concentration,,,940.2,ng/ml,mean,SD,697.7,minmax,64.8,2672.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1983,2025-12-02T16:05:12.001940
14985597.0,Bupropion,hydroxybupropion,urine,maternal,lactation,,10.0,concentration,,,2026.4,ng/ml,mean,SD,1873,minmax,125.7,5032.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1984,2025-12-02T16:05:12.001940
14985597.0,Bupropion,hydroxybupropion,saliva,maternal,lactation,,10.0,concentration,,,184.5,ng/ml,mean,SD,143.9,minmax,25.1,522.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1985,2025-12-02T16:05:12.001940
14985597.0,Bupropion,erythrogydrobupropion,breast milk,maternal,lactation,,10.0,concentration,,,72.1,ng/ml,mean,SD,38.3,minmax,25.4,142.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1986,2025-12-02T16:05:12.001940
14985597.0,Bupropion,erythrogydrobupropion,plasma,maternal,lactation,,10.0,concentration,,,84.1,ng/ml,mean,SD,46.1,minmax,19.9,196.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1987,2025-12-02T16:05:12.001940
14985597.0,Bupropion,erythrogydrobupropion,urine,maternal,lactation,,10.0,concentration,,,2396.2,ng/ml,mean,SD,1857,minmax,370.1,5972.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1988,2025-12-02T16:05:12.001940
14985597.0,Bupropion,erythrogydrobupropion,saliva,maternal,lactation,,10.0,concentration,,,202.9,ng/ml,mean,SD,131.1,minmax,71.7,491.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1989,2025-12-02T16:05:12.001940
14985597.0,Bupropion,threohydrobupropion,breast milk,maternal,lactation,,10.0,concentration,,,459,ng/ml,mean,SD,278.4,minmax,192.7,1052.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1990,2025-12-02T16:05:12.001940
14985597.0,Bupropion,threohydrobupropion,plasma,maternal,lactation,,10.0,concentration,,,370.2,ng/ml,mean,SD,182.9,minmax,121.4,746.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1991,2025-12-02T16:05:12.001940
14985597.0,Bupropion,threohydrobupropion,urine,maternal,lactation,,10.0,concentration,,,18791.3,ng/ml,mean,SD,16227,minmax,2484.5,45625.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1992,2025-12-02T16:05:12.001940
14985597.0,Bupropion,threohydrobupropion,saliva,maternal,lactation,,10.0,concentration,,,1229.5,ng/ml,mean,SD,794.1,minmax,469.3,3089.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1993,2025-12-02T16:05:12.001940
14985597.0,Bupropion,Bupropion,breast milk,maternal,lactation,,10.0,concentration,,,0.19,nM/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1994,2025-12-02T16:05:12.001940
14985597.0,Bupropion,Bupropion,breast milk,maternal,lactation,,10.0,infant dose,,,6.75,ug/kg/day,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1995,2025-12-02T16:05:12.001940
14985597.0,Bupropion,Bupropion,breast milk,maternal,lactation,,10.0,infant dose,,,28.1,nM/kg/day,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1996,2025-12-02T16:05:12.001940
14985597.0,Bupropion,Bupropion,breast milk,maternal,lactation,,10.0,infant dose (% maternal bupropion dose),,,0.13,%,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1997,2025-12-02T16:05:12.001940
14985597.0,Bupropion,hydroxybupropion,breast milk,maternal,lactation,,10.0,concentration,,,0.41,nM/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1998,2025-12-02T16:05:12.001940
14985597.0,Bupropion,hydroxybupropion,breast milk,maternal,lactation,,10.0,infant dose,,,15.75,ug/kg/day,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,1999,2025-12-02T16:05:12.001940
14985597.0,Bupropion,hydroxybupropion,breast milk,maternal,lactation,,10.0,infant dose,,,61.5,nM/kg/day,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2000,2025-12-02T16:05:12.001940
14985597.0,Bupropion,hydroxybupropion,breast milk,maternal,lactation,,10.0,infant dose (% maternal bupropion dose),,,0.3,%,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2001,2025-12-02T16:05:12.001940
14985597.0,Bupropion,erythrogydrobupropion,breast milk,maternal,lactation,,10.0,concentration,,,0.3,nM/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2002,2025-12-02T16:05:12.001940
14985597.0,Bupropion,erythrogydrobupropion,breast milk,maternal,lactation,,10.0,infant dose,,,10.8,ug/kg/day,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2003,2025-12-02T16:05:12.001940
14985597.0,Bupropion,erythrogydrobupropion,breast milk,maternal,lactation,,10.0,infant dose,,,44.6,nM/kg/day,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2004,2025-12-02T16:05:12.001940
14985597.0,Bupropion,erythrogydrobupropion,breast milk,maternal,lactation,,10.0,infant dose (% maternal bupropion dose),,,0.21,%,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2005,2025-12-02T16:05:12.001940
14985597.0,Bupropion,threohydrobupropion,breast milk,maternal,lactation,,10.0,concentration,,,1.9,nM/ml,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2006,2025-12-02T16:05:12.001940
14985597.0,Bupropion,threohydrobupropion,breast milk,maternal,lactation,,10.0,infant dose,,,68.85,ug/kg/day,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2007,2025-12-02T16:05:12.001940
14985597.0,Bupropion,threohydrobupropion,breast milk,maternal,lactation,,10.0,infant dose,,,284.5,nM/kg/day,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2008,2025-12-02T16:05:12.001940
14985597.0,Bupropion,threohydrobupropion,breast milk,maternal,lactation,,10.0,infant dose (% maternal bupropion dose),,,1.37,%,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2009,2025-12-02T16:05:12.001940
14985597.0,Bupropion,total,breast milk,maternal,lactation,,10.0,infant dose,,,418.7,nM/kg/day,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2010,2025-12-02T16:05:12.001940
14985597.0,Bupropion,total,breast milk,maternal,lactation,,10.0,infant dose (% maternal bupropion dose),,,2.01,%,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2011,2025-12-02T16:05:12.001940
8527284.0,Alprazolam,Alprazolam,serum,maternal,lactation,,8.0,Cmax,,,8.88,ng/ml,mean,SD,2.69,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2025,2025-12-02T16:05:09.448543
8527284.0,Alprazolam,Alprazolam,serum,maternal,lactation,,8.0,Cmax,,,8.88,ng/ml,mean,SD,2.69,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2025,2025-12-02T16:05:12.001940
3208682.0,Clonidine,Clonidine,umbilical cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,5.0,fetal and maternal concentration ratio,,,0.87,,mean,SD,0.14,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2034,2025-12-02T16:05:09.448543
3208682.0,Clonidine,Clonidine,breast milk/maternal plasma,maternal,lactation,,5.0,milk to plasma concentration ratio,,12,h,ng/ml,,,,minmax,1.5,4,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2035,2025-12-02T16:05:09.448543
3208682.0,Clonidine,Clonidine,breast milk,maternal,lactation,,5.0,concentration,,12,h,ng/ml,,,,minmax,0.8,2.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2036,2025-12-02T16:05:09.448543
3208682.0,Clonidine,Clonidine,plasma,maternal,lactation,,5.0,concentration,,12,h,ng/ml,,,,minmax,0.4,1.5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2037,2025-12-02T16:05:09.448543
3208682.0,Clonidine,Clonidine,umbilical cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,5.0,fetal and maternal concentration ratio,,,0.87,,mean,SD,0.14,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2034,2025-12-02T16:05:12.001940
3208682.0,Clonidine,Clonidine,breast milk/maternal plasma,maternal,lactation,,5.0,milk to plasma concentration ratio,,12,h,ng/ml,,,,minmax,1.5,4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2035,2025-12-02T16:05:12.001940
3208682.0,Clonidine,Clonidine,breast milk,maternal,lactation,,5.0,concentration,,12,h,ng/ml,,,,minmax,0.8,2.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2036,2025-12-02T16:05:12.001940
3208682.0,Clonidine,Clonidine,plasma,maternal,lactation,,5.0,concentration,,12,h,ng/ml,,,,minmax,0.4,1.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2037,2025-12-02T16:05:12.001940
19116263.0,Clonidine,Clonidine,plasma,maternal,pregnancy,,17.0,peak concentration,,,574,pg/ml,mean,SD,279,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2038,2025-12-02T16:05:09.448543
19116263.0,Clonidine,Clonidine,plasma,maternal,pregnancy,,17.0,apparent oral clearance,,,440,ml/min,mean,SD,168,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2039,2025-12-02T16:05:09.448543
19116263.0,Clonidine,Clonidine,urine,maternal,pregnancy,,17.0,renal clearance,,,153,ml/min,mean,SD,67,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2040,2025-12-02T16:05:09.448543
19116263.0,Clonidine,Clonidine,urine,maternal,pregnancy,,17.0,excreted unchanged clonidine in the urine,,,36,%,mean,SD,11,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2041,2025-12-02T16:05:09.448543
19116263.0,Clonidine,Clonidine,umbilical cord venous plasma/maternal plasma,maternal,delivery,,6.0,umbilical cord to maternal plasma concentration ratio,,,1,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2042,2025-12-02T16:05:09.448543
19116263.0,Clonidine,Clonidine,umbilical cord arterial plasma/maternal plasma,maternal,delivery,,6.0,umbilical cord to maternal plasma concentration ratio,,,1,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2043,2025-12-02T16:05:09.448543
19116263.0,Clonidine,Clonidine,plasma,maternal,delivery,,6.0,concentration,,,404,pg/ml,mean,SD,164,minmax,164,603,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2044,2025-12-02T16:05:09.448543
19116263.0,Clonidine,Clonidine,umbilical cord venous plasma,maternal,delivery,,6.0,concentration,,,394,pg/ml,mean,SD,142,minmax,191,586,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2045,2025-12-02T16:05:09.448543
19116263.0,Clonidine,Clonidine,umbilical cord arterial plasma,maternal,delivery,,6.0,concentration,,,402,pg/ml,mean,SD,147,minmax,204,614,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2046,2025-12-02T16:05:09.448543
19116263.0,Clonidine,Clonidine,plasma,maternal,pregnancy,,17.0,peak concentration,,,574,pg/ml,mean,SD,279,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2038,2025-12-02T16:05:12.001940
19116263.0,Clonidine,Clonidine,plasma,maternal,pregnancy,,17.0,apparent oral clearance,,,440,ml/min,mean,SD,168,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2039,2025-12-02T16:05:12.001940
19116263.0,Clonidine,Clonidine,urine,maternal,pregnancy,,17.0,renal clearance,,,153,ml/min,mean,SD,67,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2040,2025-12-02T16:05:12.001940
19116263.0,Clonidine,Clonidine,urine,maternal,pregnancy,,17.0,excreted unchanged clonidine in the urine,,,36,%,mean,SD,11,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2041,2025-12-02T16:05:12.001940
19116263.0,Clonidine,Clonidine,umbilical cord venous plasma/maternal plasma,maternal,delivery,,6.0,umbilical cord to maternal plasma concentration ratio,,,1,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2042,2025-12-02T16:05:12.001940
19116263.0,Clonidine,Clonidine,umbilical cord arterial plasma/maternal plasma,maternal,delivery,,6.0,umbilical cord to maternal plasma concentration ratio,,,1,,mean,SD,0.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2043,2025-12-02T16:05:12.001940
19116263.0,Clonidine,Clonidine,plasma,maternal,delivery,,6.0,concentration,,,404,pg/ml,mean,SD,164,minmax,164,603,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2044,2025-12-02T16:05:12.001940
19116263.0,Clonidine,Clonidine,umbilical cord venous plasma,maternal,delivery,,6.0,concentration,,,394,pg/ml,mean,SD,142,minmax,191,586,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2045,2025-12-02T16:05:12.001940
19116263.0,Clonidine,Clonidine,umbilical cord arterial plasma,maternal,delivery,,6.0,concentration,,,402,pg/ml,mean,SD,147,minmax,204,614,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2046,2025-12-02T16:05:12.001940
7605757.0,Clonidine,Clonidine,plasma,maternal,delivery,,12.0,concentration,60,min,0.31,pg/ml,mean,SD,0.16,,,,,bupivacaine + clonidine,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2047,2025-12-02T16:05:09.448543
7605757.0,Clonidine,Clonidine,amniotic fluid,maternal,delivery,,9.0,concentration,60,min,0.18,pg/ml,mean,SD,0.03,,,,,bupivacaine + clonidine,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2048,2025-12-02T16:05:09.448543
7605757.0,Clonidine,Clonidine,plasma,maternal,delivery,,8.0,concentration,,,0.62,pg/ml,mean,SD,0.13,,,,,bupivacaine + clonidine,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2049,2025-12-02T16:05:09.448543
7605757.0,Clonidine,Clonidine,umbilical cord plasma,pedatric,,fetus,8.0,concentration,,,0.56,pg/ml,mean,SD,0.12,,,,,bupivacaine + clonidine,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2050,2025-12-02T16:05:09.448543
7605757.0,Clonidine,Clonidine,plasma,maternal,delivery,,12.0,concentration,60,min,0.31,pg/ml,mean,SD,0.16,,,,,bupivacaine + clonidine,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2047,2025-12-02T16:05:12.001940
7605757.0,Clonidine,Clonidine,amniotic fluid,maternal,delivery,,9.0,concentration,60,min,0.18,pg/ml,mean,SD,0.03,,,,,bupivacaine + clonidine,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2048,2025-12-02T16:05:12.001940
7605757.0,Clonidine,Clonidine,plasma,maternal,delivery,,8.0,concentration,,,0.62,pg/ml,mean,SD,0.13,,,,,bupivacaine + clonidine,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2049,2025-12-02T16:05:12.001940
7605757.0,Clonidine,Clonidine,umbilical cord plasma,pedatric,,fetus,8.0,concentration,,,0.56,pg/ml,mean,SD,0.12,,,,,bupivacaine + clonidine,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2050,2025-12-02T16:05:12.001940
20598025.0,Cefixime, Cefixime, Maternal plasma, maternal,pregnancy,,6.0, concentration,,,2.59, g/mL, Mean,SD,1.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2051,2025-12-02T16:05:09.448543
20598025.0,Cefixime, Cefixime, Maternal plasma, maternal,pregnancy,,6.0, concentration,,,2.59, g/mL, Mean,SD,1.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2051,2025-12-02T16:05:12.001940
17380592.0,dexamphetamine,dexamphetamine,breast milk, maternal,lactation,,4.0,Cmax,,,219,ug/L,median,,,IQR,99,406,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2057,2025-12-02T16:05:09.448543
17380592.0,dexamphetamine,dexamphetamine,breast milk, maternal,lactation,,4.0,Cav,,,140,ug/L,median,,,IQR,70,260,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2058,2025-12-02T16:05:09.448543
17380592.0,dexamphetamine,dexamphetamine,plasma, maternal,lactation,,4.0,concentration,,,38,ug/L,median,,,IQR,24,86,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2059,2025-12-02T16:05:09.448543
17380592.0,dexamphetamine,dexamphetamine,breast milk/maternal plasma, maternal,lactation,,4.0,M/P,,,3.3,,median,,,IQR,2.2,4.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2060,2025-12-02T16:05:09.448543
17380592.0,dexamphetamine,dexamphetamine,breast milk,maternal,lactation,,4.0,absolute infant dose,,,21,ug/kg/day,median,,,IQR,11,39,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2061,2025-12-02T16:05:09.448543
17380592.0,dexamphetamine,dexamphetamine,breast milk,maternal,lactation,,4.0,relative infant dose,,,5.7,%,median,,,IQR,4,10.6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2062,2025-12-02T16:05:09.448543
17380592.0,dexamphetamine,dexamphetamine,breast milk, maternal,lactation,,4.0,Cmax,,,219,ug/L,median,,,IQR,99,406,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2057,2025-12-02T16:05:12.001940
17380592.0,dexamphetamine,dexamphetamine,breast milk, maternal,lactation,,4.0,Cav,,,140,ug/L,median,,,IQR,70,260,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2058,2025-12-02T16:05:12.001940
17380592.0,dexamphetamine,dexamphetamine,plasma, maternal,lactation,,4.0,concentration,,,38,ug/L,median,,,IQR,24,86,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2059,2025-12-02T16:05:12.001940
17380592.0,dexamphetamine,dexamphetamine,breast milk/maternal plasma, maternal,lactation,,4.0,M/P,,,3.3,,median,,,IQR,2.2,4.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2060,2025-12-02T16:05:12.001940
17380592.0,dexamphetamine,dexamphetamine,breast milk,maternal,lactation,,4.0,absolute infant dose,,,21,ug/kg/day,median,,,IQR,11,39,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2061,2025-12-02T16:05:12.001940
17380592.0,dexamphetamine,dexamphetamine,breast milk,maternal,lactation,,4.0,relative infant dose,,,5.7,%,median,,,IQR,4,10.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2062,2025-12-02T16:05:12.001940
9323536.0,methamphetamine,methamphetamine,blood,pedatric,,fetus,8.0,concentration,,,0.36,ug/ml,mean,,,minmax,0.03,1.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2063,2025-12-02T16:05:09.448543
9323536.0,amphetamine,amphetamine,blood,pedatric,,fetus,8.0,concentration,,,0.05,ug/ml,mean,,,minmax,0,0.08,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2064,2025-12-02T16:05:09.448543
9323536.0,methamphetamine,methamphetamine,blood,pedatric,,fetus,8.0,concentration,,,0.36,ug/ml,mean,,,minmax,0.03,1.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2063,2025-12-02T16:05:12.001940
9323536.0,amphetamine,amphetamine,blood,pedatric,,fetus,8.0,concentration,,,0.05,ug/ml,mean,,,minmax,0,0.08,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2064,2025-12-02T16:05:12.001940
27595432.0,amphetamine,amphetamine,hair,maternal,pregnancy,,9.0,concentration,,,,pg/mg,,,,minmax,33.4,1204,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2065,2025-12-02T16:05:09.448543
27595432.0,methamphetamine,methamphetamine,hair,maternal,pregnancy,,5.0,concentration,,,,pg/mg,,,,minmax,24.2,130,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2066,2025-12-02T16:05:09.448543
27595432.0,"3,4-methylenedioxyamphetamine","3,4-methylenedioxyamphetamine",hair,maternal,pregnancy,,3.0,concentration,,,,pg/mg,,,,minmax,65.6,189,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2067,2025-12-02T16:05:09.448543
27595432.0,"3,4-methylenedioxymethamphetamine","3,4-methylenedioxymethamphetamine",hair,maternal,pregnancy,,6.0,concentration,,,,pg/mg,,,,minmax,39.4,191.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2068,2025-12-02T16:05:09.448543
27595432.0,amphetamine,amphetamine,hair,maternal,pregnancy,,9.0,concentration,,,,pg/mg,,,,minmax,33.4,1204,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2065,2025-12-02T16:05:12.001940
27595432.0,methamphetamine,methamphetamine,hair,maternal,pregnancy,,5.0,concentration,,,,pg/mg,,,,minmax,24.2,130,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2066,2025-12-02T16:05:12.001940
27595432.0,"3,4-methylenedioxyamphetamine","3,4-methylenedioxyamphetamine",hair,maternal,pregnancy,,3.0,concentration,,,,pg/mg,,,,minmax,65.6,189,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2067,2025-12-02T16:05:12.001940
27595432.0,"3,4-methylenedioxymethamphetamine","3,4-methylenedioxymethamphetamine",hair,maternal,pregnancy,,6.0,concentration,,,,pg/mg,,,,minmax,39.4,191.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2068,2025-12-02T16:05:12.001940
3768252.0,lorazepam,lorazepam,plasma,maternal,lactation,,6.0,CLb/F,,,162.4,ml/min,mean,SD,75,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2120,2025-12-02T16:05:09.448543
3768252.0,lorazepam,lorazepam,plasma,maternal,lactation,,6.0,"t1/2, z",,,7.5,h,mean,SD,2.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2121,2025-12-02T16:05:09.448543
3768252.0,lorazepam,lorazepam,breast milk/maternal plasma,maternal,lactation,,6.0,milk to plasma concentration ratio,,,0.142,,mean,SD,0.0454,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2122,2025-12-02T16:05:09.448543
3768252.0,lorazepam,lorazepam,plasma,maternal,lactation,,6.0,CLb/F,,,162.4,ml/min,mean,SD,75,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2120,2025-12-02T16:05:12.001940
3768252.0,lorazepam,lorazepam,plasma,maternal,lactation,,6.0,"t1/2, z",,,7.5,h,mean,SD,2.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2121,2025-12-02T16:05:12.001940
3768252.0,lorazepam,lorazepam,breast milk/maternal plasma,maternal,lactation,,6.0,milk to plasma concentration ratio,,,0.142,,mean,SD,0.0454,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2122,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,serum,maternal,lactation,,12.0,Cmax,,,161.9,ng/ml,mean,SD,16.7,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2123,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,serum,maternal,lactation,,12.0,Tmax,,,2.7,h,mean,SD,0.4,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2124,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,serum,maternal,lactation,,12.0,AUC0-24h,,,1848,ng h/ml,mean,SD,168,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2125,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,serum,maternal,lactation,,12.0,T1/2,,,21.7,h,Geometric mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2126,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,serum,maternal,lactation,,12.0,Css,,,77.3,ng/ml,mean,SD,6.9,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2127,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,breast milk,maternal,lactation,,12.0,Cmax,,,442.9,ng/ml,mean,SD,47.1,,,,"<0.001, significantly different from value in serum",during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2128,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,breast milk,maternal,lactation,,12.0,Tmax,,,6,h,mean,SD,0.9,,,,"<0.05, significantly different from value in serum",during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2129,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,breast milk,maternal,lactation,,12.0,AUC0-24h,,,8566,ng h/ml,mean,SD,969.2,,,,"<0.001, significantly different from value in serum",during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2130,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,breast milk,maternal,lactation,,12.0,T1/2,,,21.8,h,Geometric mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2131,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,breast milk,maternal,lactation,,12.0,Css,,,356.9,ng/ml,mean,SD,40.3,,,,"<0.001, significantly different from value in serum",during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2132,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,breast milk/serum,maternal,lactation,,12.0,milk to serum Cmax ratio,,,2.7,,mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2133,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,breast milk/serum,maternal,lactation,,12.0,milk to serum Tmax ratio,,,2.2,,mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2134,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,breast milk/serum,maternal,lactation,,12.0,milk to serum AUC0-24h ratio,,,4.6,,mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2135,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,breast milk/serum,maternal,lactation,,12.0,milk to serum T1/2 ratio,,,1,,mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2136,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,breast milk/serum,maternal,lactation,,12.0,milk to serum Css ratio,,,4.6,,mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2137,2025-12-02T16:05:09.448543
6117304.0,Nadolol,Nadolol,serum,maternal,lactation,,12.0,Cmax,,,161.9,ng/ml,mean,SD,16.7,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2123,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,serum,maternal,lactation,,12.0,Tmax,,,2.7,h,mean,SD,0.4,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2124,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,serum,maternal,lactation,,12.0,AUC0-24h,,,1848,ng h/ml,mean,SD,168,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2125,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,serum,maternal,lactation,,12.0,T1/2,,,21.7,h,Geometric mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2126,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,serum,maternal,lactation,,12.0,Css,,,77.3,ng/ml,mean,SD,6.9,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2127,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,breast milk,maternal,lactation,,12.0,Cmax,,,442.9,ng/ml,mean,SD,47.1,,,,"<0.001, significantly different from value in serum",during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2128,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,breast milk,maternal,lactation,,12.0,Tmax,,,6,h,mean,SD,0.9,,,,"<0.05, significantly different from value in serum",during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2129,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,breast milk,maternal,lactation,,12.0,AUC0-24h,,,8566,ng h/ml,mean,SD,969.2,,,,"<0.001, significantly different from value in serum",during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2130,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,breast milk,maternal,lactation,,12.0,T1/2,,,21.8,h,Geometric mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2131,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,breast milk,maternal,lactation,,12.0,Css,,,356.9,ng/ml,mean,SD,40.3,,,,"<0.001, significantly different from value in serum",during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2132,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,breast milk/serum,maternal,lactation,,12.0,milk to serum Cmax ratio,,,2.7,,mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2133,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,breast milk/serum,maternal,lactation,,12.0,milk to serum Tmax ratio,,,2.2,,mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2134,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,breast milk/serum,maternal,lactation,,12.0,milk to serum AUC0-24h ratio,,,4.6,,mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2135,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,breast milk/serum,maternal,lactation,,12.0,milk to serum T1/2 ratio,,,1,,mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2136,2025-12-02T16:05:12.001940
6117304.0,Nadolol,Nadolol,breast milk/serum,maternal,lactation,,12.0,milk to serum Css ratio,,,4.6,,mean,,,,,,,during the 24 h period after the final administration of nadolol,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2137,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,Cl,,,46.9,L/h,mean,SD,20.7,,,,0.77,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2138,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,Cl,,,4.8,L/h,mean,SD,18,,,,0.77,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2139,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,Cl,,,0.63,L/h/kg,mean,SD,0.18,,,,0.41,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2140,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,Cl,,,0.71,L/h/kg,mean,SD,0.24,,,,0.41,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2141,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,"Vd,ss",,,287,L,mean,SD,217,,,,0.19,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2142,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,"Vd,ss",,,185,L,mean,SD,75.3,,,,0.19,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2143,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,"Vd,ss",,,4.02,L/kg,mean,SD,2.98,,,,0.42,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2144,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,"Vd,ss",,,3.07,L/kg,mean,SD,1.58,,,,0.42,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2145,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,Distribution half-life,,,0.35,h,mean,SD,0.28,,,,0.07,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2146,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,Distribution half-life,,,0.88,h,mean,SD,0.89,,,,0.07,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2147,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,Elimination half-life,,,4.22,h,mean,SD,2.84,,,,0.96,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2148,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,Elimination half-life,,,4.34,h,mean,SD,5.16,,,,0.96,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2149,2025-12-02T16:05:09.448543
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,Cl,,,46.9,L/h,mean,SD,20.7,,,,0.77,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2138,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,Cl,,,4.8,L/h,mean,SD,18,,,,0.77,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2139,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,Cl,,,0.63,L/h/kg,mean,SD,0.18,,,,0.41,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2140,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,Cl,,,0.71,L/h/kg,mean,SD,0.24,,,,0.41,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2141,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,"Vd,ss",,,287,L,mean,SD,217,,,,0.19,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2142,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,"Vd,ss",,,185,L,mean,SD,75.3,,,,0.19,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2143,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,"Vd,ss",,,4.02,L/kg,mean,SD,2.98,,,,0.42,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2144,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,"Vd,ss",,,3.07,L/kg,mean,SD,1.58,,,,0.42,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2145,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,Distribution half-life,,,0.35,h,mean,SD,0.28,,,,0.07,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2146,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,Distribution half-life,,,0.88,h,mean,SD,0.89,,,,0.07,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2147,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,3rd trimester,,12.0,Elimination half-life,,,4.22,h,mean,SD,2.84,,,,0.96,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2148,2025-12-02T16:05:12.001940
3608376.0,Propranolol,Propranolol,blood,maternal,postpartum,,12.0,Elimination half-life,,,4.34,h,mean,SD,5.16,,,,0.96,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2149,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,6.0,,,,-0.211,/h,mean,SEM,0.048,,,,,Oral,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2150,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,6.0,,,,-0.186,/h,mean,SEM,0.008,,,,,Oral,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2151,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,6.0,t1/2,,,3.9,h,mean,SEM,0.5,,,,,Oral,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2152,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,6.0,t1/2,,,3.8,h,mean,SEM,0.2,,,,,Oral,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2153,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,6.0,AUC0-,,,1.29,ug h/ml,mean,SEM,0.463,,,,,Oral,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2154,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,6.0,AUC0-,,,1.92,ug h/ml,mean,SEM,0.942,,,,,Oral,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2155,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,6.0,Bioavailability,,,71.7,%,mean,SEM,30.8,,,,,Oral,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2156,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,6.0,Bioavailability,,,69,%,mean,SEM,42.9,,,,,Oral,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2157,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,5.0,,,,-0.415,/h,mean,SEM,0.084,,,,,IV,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2158,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,,,,-0.255,/h,mean,SEM,0.032,,,,,IV,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2159,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,5.0,t1/2,,,2.1,h,mean,SEM,0.6,,,,0.5>p>0.1,IV,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2160,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,t1/2,,,3,h,mean,SEM,0.5,,,,0.5>p>0.1,IV,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2161,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,AUC0-,,,0.283,ug h/ml,mean,SEM,0.08,,,,,IV,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2162,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,AUC0-,,,0.279,ug h/ml,mean,SEM,0.033,,,,,IV,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2163,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,V,,,1.9,l/kg,mean,SEM,0.5,,,,>0.5,IV,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2164,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,V,,,2.7,l/kg,mean,SEM,0.5,,,,>0.5,IV,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2165,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,Cl,,,11.3,ml/min/kg,mean,SEM,2.6,,,,>0.5,IV,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2166,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,Cl,,,10.6,ml/min/kg,mean,SEM,1.3,,,,>0.5,IV,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2167,2025-12-02T16:05:09.448543
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,6.0,,,,-0.211,/h,mean,SEM,0.048,,,,,Oral,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2150,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,6.0,,,,-0.186,/h,mean,SEM,0.008,,,,,Oral,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2151,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,6.0,t1/2,,,3.9,h,mean,SEM,0.5,,,,,Oral,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2152,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,6.0,t1/2,,,3.8,h,mean,SEM,0.2,,,,,Oral,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2153,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,6.0,AUC0-,,,1.29,ug h/ml,mean,SEM,0.463,,,,,Oral,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2154,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,6.0,AUC0-,,,1.92,ug h/ml,mean,SEM,0.942,,,,,Oral,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2155,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,6.0,Bioavailability,,,71.7,%,mean,SEM,30.8,,,,,Oral,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2156,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,6.0,Bioavailability,,,69,%,mean,SEM,42.9,,,,,Oral,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2157,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,5.0,,,,-0.415,/h,mean,SEM,0.084,,,,,IV,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2158,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,,,,-0.255,/h,mean,SEM,0.032,,,,,IV,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2159,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,pregnancy,,5.0,t1/2,,,2.1,h,mean,SEM,0.6,,,,0.5>p>0.1,IV,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2160,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,t1/2,,,3,h,mean,SEM,0.5,,,,0.5>p>0.1,IV,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2161,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,AUC0-,,,0.283,ug h/ml,mean,SEM,0.08,,,,,IV,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2162,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,AUC0-,,,0.279,ug h/ml,mean,SEM,0.033,,,,,IV,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2163,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,V,,,1.9,l/kg,mean,SEM,0.5,,,,>0.5,IV,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2164,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,V,,,2.7,l/kg,mean,SEM,0.5,,,,>0.5,IV,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2165,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,Cl,,,11.3,ml/min/kg,mean,SEM,2.6,,,,>0.5,IV,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2166,2025-12-02T16:05:12.001940
6519163.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,Cl,,,10.6,ml/min/kg,mean,SEM,1.3,,,,>0.5,IV,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2167,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,1st trimester,,3.0,Cmax,,,50.1,ug/l,mean,SD,33.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2168,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,1st trimester,,3.0,Cmax,,,153.4,ug/l,mean,SD,43.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2169,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,1st trimester,,3.0,Cmax,,,17.6,ug/l,mean,SD,5.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2170,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,1st trimester,,3.0,Cmax,,,46.5,ug/l,mean,SD,21.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2171,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,1st trimester,,3.0,Cmax,,,350.4,ug/l,mean,SD,153.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2172,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,1st trimester,,3.0,Tmax,,,2.2,h,mean,SD,0.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2173,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,1st trimester,,3.0,Tmax,,,2.3,h,mean,SD,0.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2174,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,1st trimester,,3.0,Tmax,,,1,h,mean,SD,0.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2175,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,1st trimester,,3.0,Tmax,,,4.5,h,mean,SD,0.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2176,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,1st trimester,,3.0,Tmax,,,2.6,h,mean,SD,1.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2177,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,1st trimester,,3.0,terminal t1/2,,,11.8,h,mean,SD,13.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2178,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,1st trimester,,3.0,terminal t1/2,,,3.2,h,mean,SD,1.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2179,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,1st trimester,,3.0,terminal t1/2,,,2.6,h,mean,SD,0.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2180,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,1st trimester,,3.0,terminal t1/2,,,6.5,h,mean,SD,5.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2181,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,1st trimester,,3.0,terminal t1/2,,,4.4,h,mean,SD,1.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2182,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,1st trimester,,3.0,AUC3- h,,,338.4,ug/l,mean,SD,61.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2183,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,1st trimester,,3.0,AUC3- h,,,710.2,ug/l,mean,SD,395.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2184,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,1st trimester,,3.0,AUC3- h,,,30,ug/l,mean,SD,25.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2185,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,1st trimester,,3.0,AUC3- h,,,594.5,ug/l,mean,SD,515.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2186,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,1st trimester,,3.0,AUC3- h,,,2126.6,ug/l,mean,SD,2397.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2187,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,2nd trimester,,5.0,Cmax,,,89.9,ug/l,mean,SD,58.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2188,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,2nd trimester,,5.0,Cmax,,,241.6,ug/l,mean,SD,125.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2189,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,2nd trimester,,5.0,Cmax,,,18.2,ug/l,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2190,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,2nd trimester,,5.0,Cmax,,,61.6,ug/l,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2191,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,2nd trimester,,5.0,Cmax,,,216.8,ug/l,mean,SD,77.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2192,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,2nd trimester,,5.0,Tmax,,,2.6,h,mean,SD,0.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2193,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,2nd trimester,,5.0,Tmax,,,2.9,h,mean,SD,0.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2194,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,2nd trimester,,5.0,Tmax,,,3.2,h,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2195,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,2nd trimester,,5.0,Tmax,,,5,h,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2196,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,2nd trimester,,5.0,Tmax,,,2.6,h,mean,SD,0.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2197,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,2nd trimester,,5.0,terminal t1/2,,,8.5,h,mean,SD,12,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2198,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,2nd trimester,,5.0,terminal t1/2,,,3.2,h,mean,SD,1.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2199,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,2nd trimester,,5.0,terminal t1/2,,,2.6,h,mean,SD,1.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2200,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,2nd trimester,,5.0,terminal t1/2,,,4.2,h,mean,SD,1.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2201,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,2nd trimester,,5.0,terminal t1/2,,,3.2,h,mean,SD,1.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2202,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,2nd trimester,,5.0,AUC3- h,,,393.9,ug/l,mean,SD,139.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2203,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,2nd trimester,,5.0,AUC3- h,,,926.8,ug/l,mean,SD,509.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2204,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,2nd trimester,,5.0,AUC3- h,,,37.8,ug/l,mean,SD,53.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2205,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,2nd trimester,,5.0,AUC3- h,,,492.4,ug/l,mean,SD,30.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2206,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,2nd trimester,,5.0,AUC3- h,,,955.7,ug/l,mean,SD,673.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2207,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,3rd trimester,,10.0,Cmax,,,76.6,ug/l,mean,SD,29.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2208,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,3rd trimester,,10.0,Cmax,,,218.5,ug/l,mean,SD,73.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2209,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,3rd trimester,,10.0,Cmax,,,17.8,ug/l,mean,SD,17.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2210,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,3rd trimester,,10.0,Cmax,,,119.3,ug/l,mean,SD,107.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2211,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,3rd trimester,,10.0,Cmax,,,159.8,ug/l,mean,SD,55.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2212,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,3rd trimester,,10.0,Tmax,,,2.6,h,mean,SD,1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2213,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,3rd trimester,,10.0,Tmax,,,3.4,h,mean,SD,0.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2214,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,3rd trimester,,10.0,Tmax,,,2.6,h,mean,SD,0.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2215,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,3rd trimester,,10.0,Tmax,,,4.5,h,mean,SD,2.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2216,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,3rd trimester,,10.0,Tmax,,,3,h,mean,SD,0.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2217,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,3rd trimester,,10.0,terminal t1/2,,,4,h,mean,SD,1.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2218,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,3rd trimester,,10.0,terminal t1/2,,,3.2,h,mean,SD,0.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2219,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,3rd trimester,,10.0,terminal t1/2,,,4.3,h,mean,SD,3.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2220,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,3rd trimester,,10.0,terminal t1/2,,,5.1,h,mean,SD,2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2221,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,3rd trimester,,10.0,terminal t1/2,,,3.3,h,mean,SD,0.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2222,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,3rd trimester,,10.0,AUC3- h,,,371.2,ug/l,mean,SD,257,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2223,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,3rd trimester,,10.0,AUC3- h,,,1136.7,ug/l,mean,SD,744.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2224,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,3rd trimester,,10.0,AUC3- h,,,46.8,ug/l,mean,SD,45.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2225,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,3rd trimester,,10.0,AUC3- h,,,635.6,ug/l,mean,SD,409.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2226,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,3rd trimester,,10.0,AUC3- h,,,780.8,ug/l,mean,SD,337.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2227,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,Cmax,,,71.6,ug/l,mean,SD,40.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2228,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,postpartum,,5.0,Cmax,,,161.6,ug/l,mean,SD,56.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2229,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,postpartum,,5.0,Cmax,,,7,ug/l,mean,SD,1.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2230,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,postpartum,,5.0,Cmax,,,78.5,ug/l,mean,SD,59.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2231,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,postpartum,,5.0,Cmax,,,403.7,ug/l,mean,SD,2326,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2232,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,Tmax,,,2.4,h,mean,SD,0.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2233,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,postpartum,,5.0,Tmax,,,3,h,mean,SD,0.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2234,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,postpartum,,5.0,Tmax,,,2.4,h,mean,SD,1.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2235,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,postpartum,,5.0,Tmax,,,4.7,h,mean,SD,1.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2236,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,postpartum,,5.0,Tmax,,,2.1,h,mean,SD,0.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2237,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,terminal t1/2,,,4.5,h,mean,SD,1.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2238,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,postpartum,,5.0,terminal t1/2,,,3.7,h,mean,SD,0.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2239,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,postpartum,,5.0,terminal t1/2,,,4.2,h,mean,SD,5.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2240,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,postpartum,,5.0,terminal t1/2,,,7.4,h,mean,SD,5.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2241,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,postpartum,,5.0,terminal t1/2,,,4.2,h,mean,SD,1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2242,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,AUC3- h,,,380.6,ug/l,mean,SD,179.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2243,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,postpartum,,5.0,AUC3- h,,,1013,ug/l,mean,SD,621.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2244,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,postpartum,,5.0,AUC3- h,,,28.3,ug/l,mean,SD,46.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2245,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,postpartum,,5.0,AUC3- h,,,850.1,ug/l,mean,SD,618.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2246,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,postpartum,,5.0,AUC3- h,,,2517.8,ug/l,mean,SD,2468.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2247,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,pregnancy/postpartum,,23.0,Cmax,,,71.6,ug/l,mean,SD,39.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2248,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,pregnancy/postpartum,,23.0,Cmax,,,202.7,ug/l,mean,SD,83.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2249,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,pregnancy/postpartum,,23.0,Cmax,,,14.7,ug/l,mean,SD,13.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2250,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,pregnancy/postpartum,,23.0,Cmax,,,93.1,ug/l,mean,SD,83.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2251,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,pregnancy/postpartum,,23.0,Cmax,,,250.1,ug/l,mean,SD,158.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2252,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,pregnancy/postpartum,,23.0,Tmax,,,2.5,h,mean,SD,0.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2253,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,pregnancy/postpartum,,23.0,Tmax,,,3,h,mean,SD,0.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2254,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,pregnancy/postpartum,,23.0,Tmax,,,2.3,h,mean,SD,1.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2255,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,pregnancy/postpartum,,23.0,Tmax,,,4.6,h,mean,SD,1.8,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2256,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,pregnancy/postpartum,,23.0,Tmax,,,2.5,h,mean,SD,1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2257,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,pregnancy/postpartum,,23.0,terminal t1/2,,,5.6,h,mean,SD,6.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2258,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,pregnancy/postpartum,,23.0,terminal t1/2,,,3.4,h,mean,SD,1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2259,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,pregnancy/postpartum,,23.0,terminal t1/2,,,3.8,h,mean,SD,3.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2260,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,pregnancy/postpartum,,23.0,terminal t1/2,,,5.8,h,mean,SD,3.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2261,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,pregnancy/postpartum,,23.0,terminal t1/2,,,3.7,h,mean,SD,1.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2262,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,pregnancy/postpartum,,23.0,AUC3- h,,,373.9,ug/l,mean,SD,192.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2263,2025-12-02T16:05:09.448543
6653642.0,Propranolol,PGLUC,plasma,maternal,pregnancy/postpartum,,23.0,AUC3- h,,,1008.6,ug/l,mean,SD,616.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2264,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHP,plasma,maternal,pregnancy/postpartum,,23.0,AUC3- h,,,37.8,ug/l,mean,SD,40.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2265,2025-12-02T16:05:09.448543
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,pregnancy/postpartum,,23.0,AUC3- h,,,670.5,ug/l,mean,SD,435.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2266,2025-12-02T16:05:09.448543
6653642.0,Propranolol,NLA,plasma,maternal,pregnancy/postpartum,,23.0,AUC3- h,,,1371.8,ug/l,mean,SD,1527.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2267,2025-12-02T16:05:09.448543
6653642.0,Propranolol,Propranolol,plasma,maternal,1st trimester,,3.0,Cmax,,,50.1,ug/l,mean,SD,33.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2168,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,1st trimester,,3.0,Cmax,,,153.4,ug/l,mean,SD,43.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2169,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,1st trimester,,3.0,Cmax,,,17.6,ug/l,mean,SD,5.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2170,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,1st trimester,,3.0,Cmax,,,46.5,ug/l,mean,SD,21.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2171,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,1st trimester,,3.0,Cmax,,,350.4,ug/l,mean,SD,153.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2172,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,1st trimester,,3.0,Tmax,,,2.2,h,mean,SD,0.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2173,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,1st trimester,,3.0,Tmax,,,2.3,h,mean,SD,0.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2174,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,1st trimester,,3.0,Tmax,,,1,h,mean,SD,0.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2175,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,1st trimester,,3.0,Tmax,,,4.5,h,mean,SD,0.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2176,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,1st trimester,,3.0,Tmax,,,2.6,h,mean,SD,1.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2177,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,1st trimester,,3.0,terminal t1/2,,,11.8,h,mean,SD,13.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2178,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,1st trimester,,3.0,terminal t1/2,,,3.2,h,mean,SD,1.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2179,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,1st trimester,,3.0,terminal t1/2,,,2.6,h,mean,SD,0.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2180,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,1st trimester,,3.0,terminal t1/2,,,6.5,h,mean,SD,5.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2181,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,1st trimester,,3.0,terminal t1/2,,,4.4,h,mean,SD,1.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2182,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,1st trimester,,3.0,AUC3- h,,,338.4,ug/l,mean,SD,61.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2183,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,1st trimester,,3.0,AUC3- h,,,710.2,ug/l,mean,SD,395.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2184,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,1st trimester,,3.0,AUC3- h,,,30,ug/l,mean,SD,25.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2185,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,1st trimester,,3.0,AUC3- h,,,594.5,ug/l,mean,SD,515.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2186,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,1st trimester,,3.0,AUC3- h,,,2126.6,ug/l,mean,SD,2397.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2187,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,2nd trimester,,5.0,Cmax,,,89.9,ug/l,mean,SD,58.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2188,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,2nd trimester,,5.0,Cmax,,,241.6,ug/l,mean,SD,125.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2189,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,2nd trimester,,5.0,Cmax,,,18.2,ug/l,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2190,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,2nd trimester,,5.0,Cmax,,,61.6,ug/l,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2191,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,2nd trimester,,5.0,Cmax,,,216.8,ug/l,mean,SD,77.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2192,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,2nd trimester,,5.0,Tmax,,,2.6,h,mean,SD,0.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2193,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,2nd trimester,,5.0,Tmax,,,2.9,h,mean,SD,0.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2194,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,2nd trimester,,5.0,Tmax,,,3.2,h,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2195,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,2nd trimester,,5.0,Tmax,,,5,h,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2196,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,2nd trimester,,5.0,Tmax,,,2.6,h,mean,SD,0.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2197,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,2nd trimester,,5.0,terminal t1/2,,,8.5,h,mean,SD,12,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2198,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,2nd trimester,,5.0,terminal t1/2,,,3.2,h,mean,SD,1.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2199,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,2nd trimester,,5.0,terminal t1/2,,,2.6,h,mean,SD,1.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2200,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,2nd trimester,,5.0,terminal t1/2,,,4.2,h,mean,SD,1.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2201,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,2nd trimester,,5.0,terminal t1/2,,,3.2,h,mean,SD,1.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2202,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,2nd trimester,,5.0,AUC3- h,,,393.9,ug/l,mean,SD,139.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2203,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,2nd trimester,,5.0,AUC3- h,,,926.8,ug/l,mean,SD,509.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2204,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,2nd trimester,,5.0,AUC3- h,,,37.8,ug/l,mean,SD,53.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2205,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,2nd trimester,,5.0,AUC3- h,,,492.4,ug/l,mean,SD,30.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2206,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,2nd trimester,,5.0,AUC3- h,,,955.7,ug/l,mean,SD,673.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2207,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,3rd trimester,,10.0,Cmax,,,76.6,ug/l,mean,SD,29.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2208,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,3rd trimester,,10.0,Cmax,,,218.5,ug/l,mean,SD,73.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2209,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,3rd trimester,,10.0,Cmax,,,17.8,ug/l,mean,SD,17.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2210,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,3rd trimester,,10.0,Cmax,,,119.3,ug/l,mean,SD,107.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2211,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,3rd trimester,,10.0,Cmax,,,159.8,ug/l,mean,SD,55.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2212,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,3rd trimester,,10.0,Tmax,,,2.6,h,mean,SD,1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2213,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,3rd trimester,,10.0,Tmax,,,3.4,h,mean,SD,0.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2214,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,3rd trimester,,10.0,Tmax,,,2.6,h,mean,SD,0.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2215,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,3rd trimester,,10.0,Tmax,,,4.5,h,mean,SD,2.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2216,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,3rd trimester,,10.0,Tmax,,,3,h,mean,SD,0.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2217,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,3rd trimester,,10.0,terminal t1/2,,,4,h,mean,SD,1.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2218,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,3rd trimester,,10.0,terminal t1/2,,,3.2,h,mean,SD,0.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2219,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,3rd trimester,,10.0,terminal t1/2,,,4.3,h,mean,SD,3.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2220,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,3rd trimester,,10.0,terminal t1/2,,,5.1,h,mean,SD,2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2221,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,3rd trimester,,10.0,terminal t1/2,,,3.3,h,mean,SD,0.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2222,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,3rd trimester,,10.0,AUC3- h,,,371.2,ug/l,mean,SD,257,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2223,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,3rd trimester,,10.0,AUC3- h,,,1136.7,ug/l,mean,SD,744.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2224,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,3rd trimester,,10.0,AUC3- h,,,46.8,ug/l,mean,SD,45.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2225,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,3rd trimester,,10.0,AUC3- h,,,635.6,ug/l,mean,SD,409.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2226,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,3rd trimester,,10.0,AUC3- h,,,780.8,ug/l,mean,SD,337.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2227,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,Cmax,,,71.6,ug/l,mean,SD,40.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2228,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,postpartum,,5.0,Cmax,,,161.6,ug/l,mean,SD,56.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2229,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,postpartum,,5.0,Cmax,,,7,ug/l,mean,SD,1.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2230,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,postpartum,,5.0,Cmax,,,78.5,ug/l,mean,SD,59.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2231,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,postpartum,,5.0,Cmax,,,403.7,ug/l,mean,SD,2326,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2232,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,Tmax,,,2.4,h,mean,SD,0.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2233,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,postpartum,,5.0,Tmax,,,3,h,mean,SD,0.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2234,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,postpartum,,5.0,Tmax,,,2.4,h,mean,SD,1.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2235,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,postpartum,,5.0,Tmax,,,4.7,h,mean,SD,1.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2236,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,postpartum,,5.0,Tmax,,,2.1,h,mean,SD,0.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2237,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,terminal t1/2,,,4.5,h,mean,SD,1.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2238,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,postpartum,,5.0,terminal t1/2,,,3.7,h,mean,SD,0.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2239,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,postpartum,,5.0,terminal t1/2,,,4.2,h,mean,SD,5.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2240,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,postpartum,,5.0,terminal t1/2,,,7.4,h,mean,SD,5.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2241,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,postpartum,,5.0,terminal t1/2,,,4.2,h,mean,SD,1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2242,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,postpartum,,5.0,AUC3- h,,,380.6,ug/l,mean,SD,179.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2243,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,postpartum,,5.0,AUC3- h,,,1013,ug/l,mean,SD,621.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2244,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,postpartum,,5.0,AUC3- h,,,28.3,ug/l,mean,SD,46.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2245,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,postpartum,,5.0,AUC3- h,,,850.1,ug/l,mean,SD,618.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2246,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,postpartum,,5.0,AUC3- h,,,2517.8,ug/l,mean,SD,2468.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2247,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,pregnancy/postpartum,,23.0,Cmax,,,71.6,ug/l,mean,SD,39.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2248,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,pregnancy/postpartum,,23.0,Cmax,,,202.7,ug/l,mean,SD,83.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2249,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,pregnancy/postpartum,,23.0,Cmax,,,14.7,ug/l,mean,SD,13.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2250,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,pregnancy/postpartum,,23.0,Cmax,,,93.1,ug/l,mean,SD,83.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2251,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,pregnancy/postpartum,,23.0,Cmax,,,250.1,ug/l,mean,SD,158.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2252,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,pregnancy/postpartum,,23.0,Tmax,,,2.5,h,mean,SD,0.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2253,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,pregnancy/postpartum,,23.0,Tmax,,,3,h,mean,SD,0.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2254,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,pregnancy/postpartum,,23.0,Tmax,,,2.3,h,mean,SD,1.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2255,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,pregnancy/postpartum,,23.0,Tmax,,,4.6,h,mean,SD,1.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2256,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,pregnancy/postpartum,,23.0,Tmax,,,2.5,h,mean,SD,1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2257,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,pregnancy/postpartum,,23.0,terminal t1/2,,,5.6,h,mean,SD,6.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2258,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,pregnancy/postpartum,,23.0,terminal t1/2,,,3.4,h,mean,SD,1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2259,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,pregnancy/postpartum,,23.0,terminal t1/2,,,3.8,h,mean,SD,3.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2260,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,pregnancy/postpartum,,23.0,terminal t1/2,,,5.8,h,mean,SD,3.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2261,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,pregnancy/postpartum,,23.0,terminal t1/2,,,3.7,h,mean,SD,1.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2262,2025-12-02T16:05:12.001940
6653642.0,Propranolol,Propranolol,plasma,maternal,pregnancy/postpartum,,23.0,AUC3- h,,,373.9,ug/l,mean,SD,192.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2263,2025-12-02T16:05:12.001940
6653642.0,Propranolol,PGLUC,plasma,maternal,pregnancy/postpartum,,23.0,AUC3- h,,,1008.6,ug/l,mean,SD,616.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2264,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHP,plasma,maternal,pregnancy/postpartum,,23.0,AUC3- h,,,37.8,ug/l,mean,SD,40.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2265,2025-12-02T16:05:12.001940
6653642.0,Propranolol,4OHPGLUC,plasma,maternal,pregnancy/postpartum,,23.0,AUC3- h,,,670.5,ug/l,mean,SD,435.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2266,2025-12-02T16:05:12.001940
6653642.0,Propranolol,NLA,plasma,maternal,pregnancy/postpartum,,23.0,AUC3- h,,,1371.8,ug/l,mean,SD,1527.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2267,2025-12-02T16:05:12.001940
6845404.0,Propranolol,Propranolol,breast milk,maternal,lactation,,3.0,t1/2,,,6.5,h,mean,SD,3.4,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2268,2025-12-02T16:05:09.448543
6845404.0,Propranolol,Naphthoxylactic acid,breast milk,maternal,lactation,,3.0,t1/2,,,4.2,h,mean,SD,0.9,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2269,2025-12-02T16:05:09.448543
6845404.0,Propranolol,Propranolol,plasma,maternal,lactation,,3.0,t1/2,,,2.6,h,mean,SD,1.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2270,2025-12-02T16:05:09.448543
6845404.0,Propranolol,Naphthoxylactic acid,plasma,maternal,lactation,,3.0,t1/2,,,4.2,h,mean,SD,1.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2271,2025-12-02T16:05:09.448543
6845404.0,Propranolol,Propranolol glucuronide,plasma,maternal,lactation,,3.0,t1/2,,,4.3,h,mean,SD,1.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2272,2025-12-02T16:05:09.448543
6845404.0,Propranolol,Propranolol,breast milk,maternal,lactation,,3.0,t1/2,,,6.5,h,mean,SD,3.4,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2268,2025-12-02T16:05:12.001940
6845404.0,Propranolol,Naphthoxylactic acid,breast milk,maternal,lactation,,3.0,t1/2,,,4.2,h,mean,SD,0.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2269,2025-12-02T16:05:12.001940
6845404.0,Propranolol,Propranolol,plasma,maternal,lactation,,3.0,t1/2,,,2.6,h,mean,SD,1.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2270,2025-12-02T16:05:12.001940
6845404.0,Propranolol,Naphthoxylactic acid,plasma,maternal,lactation,,3.0,t1/2,,,4.2,h,mean,SD,1.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2271,2025-12-02T16:05:12.001940
6845404.0,Propranolol,Propranolol glucuronide,plasma,maternal,lactation,,3.0,t1/2,,,4.3,h,mean,SD,1.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2272,2025-12-02T16:05:12.001940
6884410.0,Propranolol,Propranolol,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,9.0,ratio of cord plasma level to maternal plasma level,,,0.315,,mean,SD,0.165,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2273,2025-12-02T16:05:09.448543
6884410.0,Propranolol,Propranolol glucuronide,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,9.0,ratio of cord plasma level to maternal plasma level,,,0.857,,mean,SD,0.356,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2274,2025-12-02T16:05:09.448543
6884410.0,Propranolol,4-Hydroxy-propranolol,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,9.0,ratio of cord plasma level to maternal plasma level,,,1.38,,mean,SD,1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2275,2025-12-02T16:05:09.448543
6884410.0,Propranolol,4-Hydroxy-propranolol glucuronide,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,9.0,ratio of cord plasma level to maternal plasma level,,,0.71,,mean,SD,0.45,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2276,2025-12-02T16:05:09.448543
6884410.0,Propranolol,Naphthoxylactic acid,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,9.0,ratio of cord plasma level to maternal plasma level,,,3,,mean,SD,1.57,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2277,2025-12-02T16:05:09.448543
6884410.0,Propranolol,Propranolol,plasma,maternal,delivery,,9.0,protein binding ,,,87.5,%,mean,SD,1.6,,,,,<0.001,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2278,2025-12-02T16:05:09.448543
6884410.0,Propranolol,Propranolol,cord plasma,pediatric,,fetus,9.0,protein binding ,,,67.2,%,mean,SD,3.9,,,,,<0.001,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2279,2025-12-02T16:05:09.448543
6884410.0,Propranolol,Naphthoxylactic acid,plasma,maternal,delivery,,9.0,protein binding ,,,97.6,%,mean,SD,0.4,,,,,<0.02,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2280,2025-12-02T16:05:09.448543
6884410.0,Propranolol,Naphthoxylactic acid,cord plasma,pediatric,,fetus,9.0,protein binding ,,,98.6,%,mean,SD,0.2,,,,,<0.02,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2281,2025-12-02T16:05:09.448543
6884410.0,Propranolol,Propranolol,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,9.0,ratio of cord plasma level to maternal plasma level,,,0.315,,mean,SD,0.165,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2273,2025-12-02T16:05:12.001940
6884410.0,Propranolol,Propranolol glucuronide,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,9.0,ratio of cord plasma level to maternal plasma level,,,0.857,,mean,SD,0.356,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2274,2025-12-02T16:05:12.001940
6884410.0,Propranolol,4-Hydroxy-propranolol,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,9.0,ratio of cord plasma level to maternal plasma level,,,1.38,,mean,SD,1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2275,2025-12-02T16:05:12.001940
6884410.0,Propranolol,4-Hydroxy-propranolol glucuronide,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,9.0,ratio of cord plasma level to maternal plasma level,,,0.71,,mean,SD,0.45,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2276,2025-12-02T16:05:12.001940
6884410.0,Propranolol,Naphthoxylactic acid,cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,9.0,ratio of cord plasma level to maternal plasma level,,,3,,mean,SD,1.57,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2277,2025-12-02T16:05:12.001940
6884410.0,Propranolol,Propranolol,plasma,maternal,delivery,,9.0,protein binding ,,,87.5,%,mean,SD,1.6,,,,,<0.001,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2278,2025-12-02T16:05:12.001940
6884410.0,Propranolol,Propranolol,cord plasma,pediatric,,fetus,9.0,protein binding ,,,67.2,%,mean,SD,3.9,,,,,<0.001,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2279,2025-12-02T16:05:12.001940
6884410.0,Propranolol,Naphthoxylactic acid,plasma,maternal,delivery,,9.0,protein binding ,,,97.6,%,mean,SD,0.4,,,,,<0.02,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2280,2025-12-02T16:05:12.001940
6884410.0,Propranolol,Naphthoxylactic acid,cord plasma,pediatric,,fetus,9.0,protein binding ,,,98.6,%,mean,SD,0.2,,,,,<0.02,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2281,2025-12-02T16:05:12.001940
7742161.0,Propranolol,R-propranolol,cord serum,pediatric,,fetus,19.0,% free R,,,38.8,,mean,SD,8.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2282,2025-12-02T16:05:09.448543
7742161.0,Propranolol,R-propranolol,serum,maternal,delivery,,19.0,% free R,,,22.4,,mean,SD,6.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2283,2025-12-02T16:05:09.448543
7742161.0,Propranolol,S-propranolol,cord serum,pediatric,,fetus,19.0,% free S,,,40.4,,mean,SD,10.6,,,,,<0.001,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2284,2025-12-02T16:05:09.448543
7742161.0,Propranolol,S-propranolol,serum,maternal,delivery,,19.0,% free S,,,20.7,,mean,SD,6.6,,,,,<0.001,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2285,2025-12-02T16:05:09.448543
7742161.0,Propranolol,R-propranolol/S-propranolol,cord serum,pediatric,,fetus,19.0,R/S ratio,,,0.973,,mean,SD,0.068,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2286,2025-12-02T16:05:09.448543
7742161.0,Propranolol,R-propranolol/S-propranolol,serum,maternal,delivery,,19.0,R/S ratio,,,1.099,,mean,SD,0.072,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2287,2025-12-02T16:05:09.448543
7742161.0,Propranolol,R-propranolol,cord serum,pediatric,,fetus,19.0,% free R,,,38.8,,mean,SD,8.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2282,2025-12-02T16:05:12.001940
7742161.0,Propranolol,R-propranolol,serum,maternal,delivery,,19.0,% free R,,,22.4,,mean,SD,6.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2283,2025-12-02T16:05:12.001940
7742161.0,Propranolol,S-propranolol,cord serum,pediatric,,fetus,19.0,% free S,,,40.4,,mean,SD,10.6,,,,,<0.001,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2284,2025-12-02T16:05:12.001940
7742161.0,Propranolol,S-propranolol,serum,maternal,delivery,,19.0,% free S,,,20.7,,mean,SD,6.6,,,,,<0.001,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2285,2025-12-02T16:05:12.001940
7742161.0,Propranolol,R-propranolol/S-propranolol,cord serum,pediatric,,fetus,19.0,R/S ratio,,,0.973,,mean,SD,0.068,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2286,2025-12-02T16:05:12.001940
7742161.0,Propranolol,R-propranolol/S-propranolol,serum,maternal,delivery,,19.0,R/S ratio,,,1.099,,mean,SD,0.072,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2287,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,t1/2 ,,,3.14,h,mean,SD,0.43,,,,,Phenobarbital treated,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2288,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,t1/2 ,,,6.1,h,mean,SD,1.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2289,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,9.0,t1/2 ,,,4.4,h,mean,SD,0.4,,,,,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2290,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,AUC,,,2.13,nmol h/ml,mean,SD,0.32,,,,,Phenobarbital treated,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2291,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,AUC,,,2.16,nmol h/ml,mean,SD,0.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2292,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,9.0,AUC,,,1.65,nmol h/ml,mean,SD,0.23,,,,,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2293,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,V central compartment,,,177.5,l,mean,SD,59.5,,,,,Phenobarbital treated,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2294,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,V central compartment,,,292.1,l,mean,SD,101.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2295,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,9.0,V central compartment,,,397.4,l,mean,SD,19.4,,,,,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2296,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,Distribution volume (steady state),,,324.37,l,mean,SD,158.47,,,,,Phenobarbital treated,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2297,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,Distribution volume (steady state),,,432.1,l,mean,SD,76,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2298,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,9.0,Distribution volume (steady state),,,514.8,l,mean,SD,46.3,,,,,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2299,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,V peripheral compartment,,,146.9,,mean,SD,105.4,,,,,Phenobarbital treated,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2300,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,V peripheral compartment,,,140,,mean,SD,42.1,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2301,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,9.0,V peripheral compartment,,,100.4,,mean,SD,42.9,,,,,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2302,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,serum distribution coefficient,,,3.75,l/kg,mean,SD,1.47,,,,,Phenobarbital treated,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2303,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,serum distribution coefficient,,,5.5,l/kg,mean,SD,0.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2304,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,8.0,serum distribution coefficient,,,8.7,l/kg,mean,SD,0.9,,,,,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2305,2025-12-02T16:05:09.448543
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,t1/2 ,,,3.14,h,mean,SD,0.43,,,,,Phenobarbital treated,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2288,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,t1/2 ,,,6.1,h,mean,SD,1.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2289,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,9.0,t1/2 ,,,4.4,h,mean,SD,0.4,,,,,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2290,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,AUC,,,2.13,nmol h/ml,mean,SD,0.32,,,,,Phenobarbital treated,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2291,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,AUC,,,2.16,nmol h/ml,mean,SD,0.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2292,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,9.0,AUC,,,1.65,nmol h/ml,mean,SD,0.23,,,,,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2293,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,V central compartment,,,177.5,l,mean,SD,59.5,,,,,Phenobarbital treated,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2294,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,V central compartment,,,292.1,l,mean,SD,101.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2295,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,9.0,V central compartment,,,397.4,l,mean,SD,19.4,,,,,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2296,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,Distribution volume (steady state),,,324.37,l,mean,SD,158.47,,,,,Phenobarbital treated,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2297,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,Distribution volume (steady state),,,432.1,l,mean,SD,76,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2298,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,9.0,Distribution volume (steady state),,,514.8,l,mean,SD,46.3,,,,,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2299,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,V peripheral compartment,,,146.9,,mean,SD,105.4,,,,,Phenobarbital treated,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2300,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,V peripheral compartment,,,140,,mean,SD,42.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2301,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,9.0,V peripheral compartment,,,100.4,,mean,SD,42.9,,,,,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2302,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,8.0,serum distribution coefficient,,,3.75,l/kg,mean,SD,1.47,,,,,Phenobarbital treated,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2303,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,maternal,pregnancy,,7.0,serum distribution coefficient,,,5.5,l/kg,mean,SD,0.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2304,2025-12-02T16:05:12.001940
3427136.0,Propranolol,Propranolol,serum,nonpregnancy,,,8.0,serum distribution coefficient,,,8.7,l/kg,mean,SD,0.9,,,,,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2305,2025-12-02T16:05:12.001940
7046334.0,Propranolol,Propranolol,plasma,maternal,delivery,,8.0,concentration,3,h,71,ng/ml,mean,SD,48,,,,,time after administration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2306,2025-12-02T16:05:09.448543
7046334.0,Propranolol,Propranolol,Umbilical vein plasma,pediatric,,fetus,8.0,concentration,3,h,18,ng/ml,mean,SD,8,,,,,time after administration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2307,2025-12-02T16:05:09.448543
7046334.0,Propranolol,Propranolol,Umbilical vein plasma/maternal plasma,maternal/pediatric,delivery,fetus,8.0,maternal/fetal ratio of concentration,3,h,3.9,,mean,SD,1.6,,,,,time after administration,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2308,2025-12-02T16:05:09.448543
7046334.0,Sotalol,Sotalol,plasma,maternal,delivery,,8.0,concentration,3,h,0.68,ng/ml,mean,SD,0.24,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2309,2025-12-02T16:05:09.448543
7046334.0,Sotalol,Sotalol,Umbilical vein plasma,pediatric,,fetus,8.0,concentration,3,h,0.32,ng/ml,mean,SD,0.09,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2310,2025-12-02T16:05:09.448543
7046334.0,Sotalol,Sotalol,Umbilical vein plasma/maternal plasma,maternal/pediatric,delivery,fetus,8.0,maternal/fetal ratio of concentration,3,h,2.1,,mean,SD,0.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2311,2025-12-02T16:05:09.448543
7046334.0,Propranolol,Propranolol,plasma,maternal,delivery,,8.0,concentration,3,h,71,ng/ml,mean,SD,48,,,,,time after administration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2306,2025-12-02T16:05:12.001940
7046334.0,Propranolol,Propranolol,Umbilical vein plasma,pediatric,,fetus,8.0,concentration,3,h,18,ng/ml,mean,SD,8,,,,,time after administration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2307,2025-12-02T16:05:12.001940
7046334.0,Propranolol,Propranolol,Umbilical vein plasma/maternal plasma,maternal/pediatric,delivery,fetus,8.0,maternal/fetal ratio of concentration,3,h,3.9,,mean,SD,1.6,,,,,time after administration,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2308,2025-12-02T16:05:12.001940
7046334.0,Sotalol,Sotalol,plasma,maternal,delivery,,8.0,concentration,3,h,0.68,ng/ml,mean,SD,0.24,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2309,2025-12-02T16:05:12.001940
7046334.0,Sotalol,Sotalol,Umbilical vein plasma,pediatric,,fetus,8.0,concentration,3,h,0.32,ng/ml,mean,SD,0.09,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2310,2025-12-02T16:05:12.001940
7046334.0,Sotalol,Sotalol,Umbilical vein plasma/maternal plasma,maternal/pediatric,delivery,fetus,8.0,maternal/fetal ratio of concentration,3,h,2.1,,mean,SD,0.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2311,2025-12-02T16:05:12.001940
12932617.0,Sotalol,Sotalol,Umbilical vein plasma/maternal plasma,maternal/pediatric,delivery,fetus,12.0,fetal/maternal ratio of concentration,,,1.11,,mean,SD,0.63,minmax,0.67,2.87,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2312,2025-12-02T16:05:09.448543
12932617.0,Sotalol,Sotalol,amniotic fluid/umbilical cord venous plasma ratio,maternal/pediatric,delivery,fetus,7.0,amniotic fluid/fetal blood concentration ratio,,,3.2,,mean,SD,1.4,minmax,1.28,5.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2313,2025-12-02T16:05:09.448543
12932617.0,Sotalol,Sotalol,amniotic fluid/maternal plasma ratio,maternal/pediatric,delivery,fetus,7.0,amniotic fluid/maternal blood concentration ratio,,,2.94,,mean,SD,1.6,minmax,1,6,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2314,2025-12-02T16:05:09.448543
12932617.0,Sotalol,Sotalol,Umbilical vein plasma/maternal plasma,maternal/pediatric,delivery,fetus,12.0,fetal/maternal ratio of concentration,,,1.11,,mean,SD,0.63,minmax,0.67,2.87,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2312,2025-12-02T16:05:12.001940
12932617.0,Sotalol,Sotalol,amniotic fluid/umbilical cord venous plasma ratio,maternal/pediatric,delivery,fetus,7.0,amniotic fluid/fetal blood concentration ratio,,,3.2,,mean,SD,1.4,minmax,1.28,5.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2313,2025-12-02T16:05:12.001940
12932617.0,Sotalol,Sotalol,amniotic fluid/maternal plasma ratio,maternal/pediatric,delivery,fetus,7.0,amniotic fluid/maternal blood concentration ratio,,,2.94,,mean,SD,1.6,minmax,1,6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2314,2025-12-02T16:05:12.001940
36768172.0,Sotalol,Sotalol,Umbilical vein plasma/maternal plasma,maternal/pediatric,delivery,fetus,43.0,fetal/maternal ratio of concentration,,,1,,median,,,"Q1, Q3",0.97,1.07,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2315,2025-12-02T16:05:09.448543
36768172.0,Sotalol,Sotalol,Umbilical vein plasma/maternal plasma,maternal/pediatric,delivery,fetus,43.0,fetal/maternal ratio of concentration,,,1,,median,,,"Q1, Q3",0.97,1.07,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2315,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,,,,0.112,,mean,SEM,0.013,,,,,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2316,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,,,,0.077,,mean,SEM,0.013,,,,,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2317,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,t1/2,,,6.6,h,mean,SEM,0.6,,,,,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2318,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,t1/2,,,9.3,h,mean,SEM,0.7,,,,,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2319,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,AUC0-,,,9.3,ug h/ml,mean,SEM,1.1,,,,,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2320,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,AUC0-,,,15.3,ug h/ml,mean,SEM,0.2,,,,,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2321,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,Cl,,,2.4,ml/min/kg,mean,SEM,0.3,,,,<0.05,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2322,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,Cl,,,1.5,ml/min/kg,mean,SEM,0.1,,,,<0.05,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2323,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,V,,,1.3,l/kg,mean,SEM,0.1,,,,,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2324,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,V,,,1.2,l/kg,mean,SEM,0.1,,,,,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2325,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,,,,0.07,,mean,SEM,0.01,,,,,Oral 400 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2326,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,,,,0.09,,mean,SEM,0.005,,,,,Oral 400 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2327,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,t1/2,,,10.9,h,mean,SEM,1.4,,,,,Oral 400 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2328,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,t1/2,,,10.3,h,mean,SEM,0.7,,,,,Oral 400 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2329,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,AUC0-,,,31.1,ug h/ml,mean,SEM,2,,,,,Oral 400 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2330,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,AUC0-,,,55.8,ug h/ml,mean,SEM,3.1,,,,,Oral 400 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2331,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,Bioavailability,,,86.2,%,mean,SEM,12.8,,,,,Oral 400 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2332,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,Bioavailability,,,91.1,%,mean,SEM,4.5,,,,,Oral 400 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2333,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,urine,maternal,pregnancy,,6.0,urinary excretion ,48,h,46,%,mean,,,,,,,Oral 400 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2334,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,urine,maternal,pregnancy,,6.0,urinary excretion ,48,h,100,%,mean,,,,,,,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2335,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,urine,maternal,postpartum,,6.0,urinary excretion ,,,57,%,mean,,,,,,,Oral 400 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2336,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,urine,maternal,postpartum,,6.0,urinary excretion ,,,88,%,mean,,,,,,,IV 100 mg,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2337,2025-12-02T16:05:09.448543
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,,,,0.112,,mean,SEM,0.013,,,,,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2316,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,,,,0.077,,mean,SEM,0.013,,,,,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2317,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,t1/2,,,6.6,h,mean,SEM,0.6,,,,,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2318,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,t1/2,,,9.3,h,mean,SEM,0.7,,,,,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2319,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,AUC0-,,,9.3,ug h/ml,mean,SEM,1.1,,,,,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2320,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,AUC0-,,,15.3,ug h/ml,mean,SEM,0.2,,,,,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2321,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,Cl,,,2.4,ml/min/kg,mean,SEM,0.3,,,,<0.05,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2322,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,Cl,,,1.5,ml/min/kg,mean,SEM,0.1,,,,<0.05,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2323,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,V,,,1.3,l/kg,mean,SEM,0.1,,,,,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2324,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,V,,,1.2,l/kg,mean,SEM,0.1,,,,,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2325,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,,,,0.07,,mean,SEM,0.01,,,,,Oral 400 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2326,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,,,,0.09,,mean,SEM,0.005,,,,,Oral 400 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2327,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,t1/2,,,10.9,h,mean,SEM,1.4,,,,,Oral 400 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2328,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,t1/2,,,10.3,h,mean,SEM,0.7,,,,,Oral 400 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2329,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,AUC0-,,,31.1,ug h/ml,mean,SEM,2,,,,,Oral 400 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2330,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,AUC0-,,,55.8,ug h/ml,mean,SEM,3.1,,,,,Oral 400 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2331,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,pregnancy,,6.0,Bioavailability,,,86.2,%,mean,SEM,12.8,,,,,Oral 400 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2332,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,plasma,maternal,postpartum,,6.0,Bioavailability,,,91.1,%,mean,SEM,4.5,,,,,Oral 400 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2333,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,urine,maternal,pregnancy,,6.0,urinary excretion ,48,h,46,%,mean,,,,,,,Oral 400 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2334,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,urine,maternal,pregnancy,,6.0,urinary excretion ,48,h,100,%,mean,,,,,,,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2335,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,urine,maternal,postpartum,,6.0,urinary excretion ,,,57,%,mean,,,,,,,Oral 400 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2336,2025-12-02T16:05:12.001940
6861867.0,Sotalol,Sotalol,urine,maternal,postpartum,,6.0,urinary excretion ,,,88,%,mean,,,,,,,IV 100 mg,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2337,2025-12-02T16:05:12.001940
7426541.0,Sotalol,Sotalol,plasma,maternal,delivery,,12.0,concentration,,,1.8,ug/ml,mean,SEM,0.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2338,2025-12-02T16:05:09.448543
7426541.0,Sotalol,Sotalol,umbilical cord plasma,pediatric,,fetus,12.0,concentration,,,1.7,ug/ml,mean,SEM,0.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2339,2025-12-02T16:05:09.448543
7426541.0,Sotalol,Sotalol,umbilical cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,12.0,maternal: fetal ratio,,,1:1.05,,mean,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2340,2025-12-02T16:05:09.448543
7426541.0,Sotalol,Sotalol,amniotic fluid,maternal,delivery,,12.0,concentration,,,7,ug/ml,mean,SEM,2.7,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2341,2025-12-02T16:05:09.448543
7426541.0,Sotalol,Sotalol,breast milk,maternal,lactation,,5.0,concentration,,,10.5,ug/ml,mean,SEM,1.1,minmax,4.8,20.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2342,2025-12-02T16:05:09.448543
7426541.0,Sotalol,Sotalol,plasma,maternal,lactation,,5.0,concentration,,,2.3,ug/ml,mean,SEM,0.3,minmax,0.8,5,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2343,2025-12-02T16:05:09.448543
7426541.0,Sotalol,Sotalol,breast milk/maternal plasma,maternal,lactation,,5.0,Milk: plasma ratio,,,5.4:1,,mean,,,minmax,2.2,8.8,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2344,2025-12-02T16:05:09.448543
7426541.0,Sotalol,Sotalol,plasma,maternal,delivery,,12.0,concentration,,,1.8,ug/ml,mean,SEM,0.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2338,2025-12-02T16:05:12.001940
7426541.0,Sotalol,Sotalol,umbilical cord plasma,pediatric,,fetus,12.0,concentration,,,1.7,ug/ml,mean,SEM,0.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2339,2025-12-02T16:05:12.001940
7426541.0,Sotalol,Sotalol,umbilical cord plasma/maternal plasma,maternal/pediatric,delivery,fetus,12.0,maternal: fetal ratio,,,1:1.05,,mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2340,2025-12-02T16:05:12.001940
7426541.0,Sotalol,Sotalol,amniotic fluid,maternal,delivery,,12.0,concentration,,,7,ug/ml,mean,SEM,2.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2341,2025-12-02T16:05:12.001940
7426541.0,Sotalol,Sotalol,breast milk,maternal,lactation,,5.0,concentration,,,10.5,ug/ml,mean,SEM,1.1,minmax,4.8,20.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2342,2025-12-02T16:05:12.001940
7426541.0,Sotalol,Sotalol,plasma,maternal,lactation,,5.0,concentration,,,2.3,ug/ml,mean,SEM,0.3,minmax,0.8,5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2343,2025-12-02T16:05:12.001940
7426541.0,Sotalol,Sotalol,breast milk/maternal plasma,maternal,lactation,,5.0,Milk: plasma ratio,,,5.4:1,,mean,,,minmax,2.2,8.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2344,2025-12-02T16:05:12.001940
21030064.0,Octocrylene,Octocrylene,breast milk,maternal,lactation,,7.0,concentration,,,22.57,ng/g lipid,mean,SD,25.46,,,,,Cohort 2004,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2345,2025-12-02T16:05:09.448543
21030064.0,Octocrylene,Octocrylene,breast milk,maternal,lactation,,9.0,concentration,,,15.08,ng/g lipid,mean,SD,10.08,,,,,Cohort 2005,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2346,2025-12-02T16:05:09.448543
21030064.0,Octocrylene,Octocrylene,breast milk,maternal,lactation,,20.0,concentration,,,39.63,ng/g lipid,mean,SD,25.21,,,,,Cohort 2006,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2347,2025-12-02T16:05:09.448543
21030064.0,Octocrylene,Octocrylene,breast milk,maternal,lactation,,36.0,concentration,,,30.18,ng/g lipid,mean,SD,24.51,minmax,4.7,134.95,,ALL cohort,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2348,2025-12-02T16:05:09.448543
21030064.0,Octocrylene,Octocrylene,breast milk,maternal,lactation,,36.0,concentration,,,28.32,ng/g lipid,median,0.95,70.64,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2349,2025-12-02T16:05:09.448543
21030064.0,Octocrylene,Octocrylene,breast milk,pediatric,,infant,35.0,daily intake by infants,,,195.7,ng/kg body weight per day,mean,SD,142.6,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2350,2025-12-02T16:05:09.448543
21030064.0,Octocrylene,Octocrylene,breast milk,pediatric,,infant,35.0,daily intake by infants,,,182,ng/kg body weight per day,median,,,minmax,23.2,563.7,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2351,2025-12-02T16:05:09.448543
21030064.0,Octocrylene,Octocrylene,breast milk,maternal,lactation,,7.0,concentration,,,22.57,ng/g lipid,mean,SD,25.46,,,,,Cohort 2004,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2345,2025-12-02T16:05:12.001940
21030064.0,Octocrylene,Octocrylene,breast milk,maternal,lactation,,9.0,concentration,,,15.08,ng/g lipid,mean,SD,10.08,,,,,Cohort 2005,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2346,2025-12-02T16:05:12.001940
21030064.0,Octocrylene,Octocrylene,breast milk,maternal,lactation,,20.0,concentration,,,39.63,ng/g lipid,mean,SD,25.21,,,,,Cohort 2006,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2347,2025-12-02T16:05:12.001940
21030064.0,Octocrylene,Octocrylene,breast milk,maternal,lactation,,36.0,concentration,,,30.18,ng/g lipid,mean,SD,24.51,minmax,4.7,134.95,,ALL cohort,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2348,2025-12-02T16:05:12.001940
21030064.0,Octocrylene,Octocrylene,breast milk,maternal,lactation,,36.0,concentration,,,28.32,ng/g lipid,median,0.95,70.64,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2349,2025-12-02T16:05:12.001940
21030064.0,Octocrylene,Octocrylene,breast milk,pediatric,,infant,35.0,daily intake by infants,,,195.7,ng/kg body weight per day,mean,SD,142.6,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2350,2025-12-02T16:05:12.001940
21030064.0,Octocrylene,Octocrylene,breast milk,pediatric,,infant,35.0,daily intake by infants,,,182,ng/kg body weight per day,median,,,minmax,23.2,563.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2351,2025-12-02T16:05:12.001940
18709157.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,367.0,concentration,,,,ug/L,,25th percentile,2.6,minmax,LOD,92700,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2352,2025-12-02T16:05:09.448543
18709157.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,367.0,concentration,,,,ug/L,,50th percentile,7.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2353,2025-12-02T16:05:09.448543
18709157.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,367.0,concentration,,,,ug/L,,75th percentile,31,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2354,2025-12-02T16:05:09.448543
18709157.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,367.0,concentration,,,,ug/L,,25th percentile,2.6,minmax,LOD,92700,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2352,2025-12-02T16:05:12.001940
18709157.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,367.0,concentration,,,,ug/L,,50th percentile,7.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2353,2025-12-02T16:05:12.001940
18709157.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,367.0,concentration,,,,ug/L,,75th percentile,31,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2354,2025-12-02T16:05:12.001940
21900077.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,191.0,concentration,,,,ug/L,,5th percentile,0.2,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2355,2025-12-02T16:05:09.448543
21900077.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,191.0,concentration,,,,ug/L,,50th percentile,1.3,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2356,2025-12-02T16:05:09.448543
21900077.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,191.0,concentration,,,,ug/L,,95th percentile,74.5,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2357,2025-12-02T16:05:09.448543
21900077.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,191.0,concentration,,,,ug/L,,5th percentile,0.2,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2355,2025-12-02T16:05:12.001940
21900077.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,191.0,concentration,,,,ug/L,,50th percentile,1.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2356,2025-12-02T16:05:12.001940
21900077.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,191.0,concentration,,,,ug/L,,95th percentile,74.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2357,2025-12-02T16:05:12.001940
23469879.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,105.0,concentration,,,52.2,ng/ml,GM,"25th, 50th, 75th, 95th percentiles","11.5, 31.3, 172, 2150, 39700",95% CI,41,66.4,,PROTECT,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2358,2025-12-02T16:05:09.448543
23469879.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,365.0,concentration,,,38.6,ng/ml,GM,"25th, 50th, 75th, 95th percentiles","8.6, 35.6, 148, 1256, 21500",95% CI,28.9,51.6,,NHANES 07-08,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2359,2025-12-02T16:05:09.448543
23469879.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,415.0,concentration,,,36.3,ng/ml,GM,"25th, 50th, 75th, 95th percentiles","7.6, 27.4, 145, 3340, 8970",95% CI,22.6,58.4,,NHANES 09-10,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2360,2025-12-02T16:05:09.448543
23469879.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,105.0,concentration,,,52.2,ng/ml,GM,"25th, 50th, 75th, 95th percentiles","11.5, 31.3, 172, 2150, 39700",95% CI,41,66.4,,PROTECT,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2358,2025-12-02T16:05:12.001940
23469879.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,365.0,concentration,,,38.6,ng/ml,GM,"25th, 50th, 75th, 95th percentiles","8.6, 35.6, 148, 1256, 21500",95% CI,28.9,51.6,,NHANES 07-08,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2359,2025-12-02T16:05:12.001940
23469879.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,415.0,concentration,,,36.3,ng/ml,GM,"25th, 50th, 75th, 95th percentiles","7.6, 27.4, 145, 3340, 8970",95% CI,22.6,58.4,,NHANES 09-10,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2360,2025-12-02T16:05:12.001940
23562958.0,Oxybenzone,Oxybenzone,urine,maternal,delivery,,567.0,concentration,,,0.08,ng/ml,GM,"50th, 75th, 90th, 95 th percentiles","0.08, 0.16, 0.42, 0.77",,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2361,2025-12-02T16:05:09.448543
23562958.0,Oxybenzone,Oxybenzone,urine,maternal,delivery,,567.0,concentration,,,400.72,ng/ml,maximum,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2362,2025-12-02T16:05:09.448543
23562958.0,Oxybenzone,Oxybenzone,urine,maternal,delivery,,567.0,concentration,,,0.08,ng/ml,GM,"50th, 75th, 90th, 95 th percentiles","0.08, 0.16, 0.42, 0.77",,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2361,2025-12-02T16:05:12.001940
23562958.0,Oxybenzone,Oxybenzone,urine,maternal,delivery,,567.0,concentration,,,400.72,ng/ml,maximum,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2362,2025-12-02T16:05:12.001940
23712115.0,Oxybenzone,Oxybenzone,whole blood,pediatric,,children,10.0,concentration,,,0.43,ng/ml,GM,,,minmax,<0.52,2.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2363,2025-12-02T16:05:09.448543
23712115.0,Oxybenzone,Oxybenzone,whole blood,pediatric,,children,10.0,concentration,,,<0.52,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2364,2025-12-02T16:05:09.448543
23712115.0,Oxybenzone,Oxybenzone,cord blood,pediatric,,fetus,22.0,concentration,,,0.52,ng/ml,GM,,,minmax,<0.41,2.55,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2365,2025-12-02T16:05:09.448543
23712115.0,Oxybenzone,Oxybenzone,cord blood,pediatric,,fetus,22.0,concentration,,,0.59,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2366,2025-12-02T16:05:09.448543
23712115.0,Oxybenzone,Oxybenzone,blood,maternal,delivery,,20.0,concentration,,,0.38,ng/ml,GM,,,minmax,<0.41,2.3,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2367,2025-12-02T16:05:09.448543
23712115.0,Oxybenzone,Oxybenzone,blood,maternal,delivery,,20.0,concentration,,,<0.41,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2368,2025-12-02T16:05:09.448543
23712115.0,Oxybenzone,Oxybenzone,whole blood,adults,,,23.0,concentration,,,1.51,ng/ml,GM,,,minmax,<0.52,3.38,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2369,2025-12-02T16:05:09.448543
23712115.0,Oxybenzone,Oxybenzone,whole blood,adults,,,23.0,concentration,,,2.09,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2370,2025-12-02T16:05:09.448543
23712115.0,Oxybenzone,Oxybenzone,urine,adults,,,100.0,concentration,,,0.26,ng/ml,GM,,,minmax,<0.11,45.2,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2371,2025-12-02T16:05:09.448543
23712115.0,Oxybenzone,Oxybenzone,urine,adults,,,100.0,concentration,,,<0.22,ng/ml,median,,,,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2372,2025-12-02T16:05:09.448543
23712115.0,Oxybenzone,Oxybenzone,whole blood,pediatric,,children,10.0,concentration,,,0.43,ng/ml,GM,,,minmax,<0.52,2.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2363,2025-12-02T16:05:12.001940
23712115.0,Oxybenzone,Oxybenzone,whole blood,pediatric,,children,10.0,concentration,,,<0.52,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2364,2025-12-02T16:05:12.001940
23712115.0,Oxybenzone,Oxybenzone,cord blood,pediatric,,fetus,22.0,concentration,,,0.52,ng/ml,GM,,,minmax,<0.41,2.55,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2365,2025-12-02T16:05:12.001940
23712115.0,Oxybenzone,Oxybenzone,cord blood,pediatric,,fetus,22.0,concentration,,,0.59,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2366,2025-12-02T16:05:12.001940
23712115.0,Oxybenzone,Oxybenzone,blood,maternal,delivery,,20.0,concentration,,,0.38,ng/ml,GM,,,minmax,<0.41,2.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2367,2025-12-02T16:05:12.001940
23712115.0,Oxybenzone,Oxybenzone,blood,maternal,delivery,,20.0,concentration,,,<0.41,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2368,2025-12-02T16:05:12.001940
23712115.0,Oxybenzone,Oxybenzone,whole blood,adults,,,23.0,concentration,,,1.51,ng/ml,GM,,,minmax,<0.52,3.38,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2369,2025-12-02T16:05:12.001940
23712115.0,Oxybenzone,Oxybenzone,whole blood,adults,,,23.0,concentration,,,2.09,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2370,2025-12-02T16:05:12.001940
23712115.0,Oxybenzone,Oxybenzone,urine,adults,,,100.0,concentration,,,0.26,ng/ml,GM,,,minmax,<0.11,45.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2371,2025-12-02T16:05:12.001940
23712115.0,Oxybenzone,Oxybenzone,urine,adults,,,100.0,concentration,,,<0.22,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2372,2025-12-02T16:05:12.001940
23714150.0,Oxybenzone,Oxybenzone,urine,male,,,250.0,concentration,,,0.07,ng/ml,geometric mean,"50th, 75th, 90th, 95 th percentiles","0.07, 0.16, 0.37, 0.68",95% CI,0.06,0.84,,total,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2373,2025-12-02T16:05:12.001940
23714150.0,Oxybenzone,Oxybenzone,urine,male,,,80.0,concentration,,,0.08,ng/ml,geometric mean,"50th, 75th, 90th, 95 th percentiles","0.07, 0.15, 0.34, 0.68",95% CI,0.05,0.11,,case,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2374,2025-12-02T16:05:12.001940
23714150.0,Oxybenzone,Oxybenzone,urine,male,,,170.0,concentration,,,0.07,ng/ml,geometric mean,"50th, 75th, 90th, 95 th percentiles","0.07, 0.16, 0.37, 0.68",95% CI,0.06,0.08,,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2375,2025-12-02T16:05:12.001940
23714150.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,250.0,concentration,,,0.1,ng/ml,geometric mean,"50th, 75th, 90th, 95 th percentiles","0.1, 0.28, 0.62, 1.42",95% CI,0.09,0.13,,total,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2376,2025-12-02T16:05:12.001940
23714150.0,Oxybenzone,Oxybenzone,urine,maternal,abortion,,80.0,concentration,,,0.14,ng/ml,geometric mean,"50th, 75th, 90th, 95 th percentiles","0.19, 0.37, 0.71, 1.06",95% CI,0.1,0.21,,case,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2377,2025-12-02T16:05:12.001940
23714150.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,170.0,concentration,,,0.09,ng/ml,geometric mean,"50th, 75th, 90th, 95 th percentiles","0.08, 0.23, 0.56, 1.45",95% CI,0.07,0.12,,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2378,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,71.0,first sample concentration,,,,ng/ml,,5th percentile,4.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2379,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,71.0,first sample concentration,,,,ng/ml,,50th percentile,53.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2380,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,71.0,first sample concentration,,,,ng/ml,,95th percentile,2220,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2381,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,71.0,second sample concentration,,,,ng/ml,,5th percentile,5.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2382,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,71.0,second sample concentration,,,,ng/ml,,50th percentile,77,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2383,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,71.0,second sample concentration,,,,ng/ml,,95th percentile,6740,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2384,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,71.0,third samples concentration,,,,ng/ml,,5th percentile,8.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2385,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,71.0,third samples concentration,,,,ng/ml,,50th percentile,76.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2386,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,71.0,third samples concentration,,,,ng/ml,,95th percentile,3180,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2387,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,amniotic fluid,maternal,pregnancy,,69.0,concentration,,,,ng/ml,,50th percentile,0.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2388,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,amniotic fluid,maternal,pregnancy,,69.0,concentration,,,,ng/ml,,95th percentile,15.7,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2389,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine/amniotic fluid,maternal,pregnancy,,69.0,ratio of first urine sample: amniotic fluid,,,,,,5th percentile,8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2390,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine/amniotic fluid,maternal,pregnancy,,69.0,ratio of first urine sample: amniotic fluid,,,,,,50th percentile,110,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2391,2025-12-02T16:05:12.001940
23942273.0,Oxybenzone,Oxybenzone,urine/amniotic fluid,maternal,pregnancy,,69.0,ratio of first urine sample: amniotic fluid,,,,,,95th percentile,1648,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2392,2025-12-02T16:05:12.001940
24529000.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,506.0,concentration,,,59.5,ng/l,mean,,,95% CI,49.7,71.3,,NCS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2393,2025-12-02T16:05:12.001940
24529000.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,174.0,concentration,,,38.9,ng/l,mean,,,95% CI,24.5,61.6,,NHANES 2005-2010,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2394,2025-12-02T16:05:12.001940
24529000.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,506.0,concentration,,,42.9,ng/l,median,,,95% CI,33.3,57.7,,NCS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2395,2025-12-02T16:05:12.001940
24529000.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,174.0,concentration,,,26.5,ng/l,median,,,95% CI,14.1,78.8,,NHANES 2005-2010,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2396,2025-12-02T16:05:12.001940
25435060.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,106.0,concentration,,,58,ng/ml,mean,SD,7.57,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2397,2025-12-02T16:05:12.001940
25435060.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,106.0,concentration,,,4,,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2398,2025-12-02T16:05:12.001940
25435060.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,106.0,concentration,,,13.3,,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2399,2025-12-02T16:05:12.001940
25435060.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,106.0,concentration,,,34.5,,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2400,2025-12-02T16:05:12.001940
25435060.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,106.0,concentration,,,209,,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2401,2025-12-02T16:05:12.001940
25435060.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,106.0,concentration,,,2573,,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2402,2025-12-02T16:05:12.001940
25463527.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,34.0,concentration,,,4.7,ug/L,median,,,,,,,visit 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2403,2025-12-02T16:05:12.001940
25463527.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,34.0,concentration,,,3200,ug/L,maximum,,,,,,,visit 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2404,2025-12-02T16:05:12.001940
25463527.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,34.0,concentration,,,22.3,ug/L,75th percentile,,,,,,,visit 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2405,2025-12-02T16:05:12.001940
25463527.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,34.0,concentration,,,1440,ug/L,95th percentile,,,,,,,visit 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2406,2025-12-02T16:05:12.001940
25463527.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,33.0,concentration,,,36.7,ug/L,median,,,,,,,visit 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2407,2025-12-02T16:05:12.001940
25463527.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,33.0,concentration,,,3200,ug/L,maximum,,,,,,,visit 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2408,2025-12-02T16:05:12.001940
25463527.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,33.0,concentration,,,0.7,ug/L,25th percentile,,,,,,,visit 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2409,2025-12-02T16:05:12.001940
25463527.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,33.0,concentration,,,158,ug/L,75th percentile,,,,,,,visit 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2410,2025-12-02T16:05:12.001940
25463527.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,33.0,concentration,,,1880,ug/L,95th percentile,,,,,,,visit 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2411,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,all time periods,45.0,total concentration,,,6.1,ug/L,GM,,,,,,,complete sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2412,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,17 weeks,45.0,total concentration,,,4.4,ug/L,GM,,,,,,,complete sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2413,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,23 weeks,45.0,total concentration,,,7,ug/L,GM,,,,,,,complete sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2414,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,29 weeks,45.0,total concentration,,,7.3,ug/L,GM,,,,,,,complete sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2415,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,all time periods,30.0,total concentration,,,6.7,ug/L,GM,,,,,,,random sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2416,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,17 weeks,30.0,total concentration,,,5.3,ug/L,GM,,,,,,,random sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2417,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,23 weeks,30.0,total concentration,,,6.5,ug/L,GM,,,,,,,random sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2418,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,29 weeks,30.0,total concentration,,,8.7,ug/L,GM,,,,,,,random sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2419,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,all time periods,15.0,total concentration,,,5,ug/L,GM,,,,,,,high-BPA sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2420,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,17 weeks,15.0,total concentration,,,3,ug/L,GM,,,,,,,high-BPA sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2421,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,23 weeks,15.0,total concentration,,,7.9,ug/L,GM,,,,,,,high-BPA sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2422,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,29 weeks,15.0,total concentration,,,5.2,ug/L,GM,,,,,,,high-BPA sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2423,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,all time periods,45.0,adjusted total concentration,,,8.5,ug/L,GM,,,,,,,complete sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2424,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,17 weeks,45.0,adjusted total concentration,,,8.8,ug/L,GM,,,,,,,complete sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2425,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,23 weeks,45.0,adjusted total concentration,,,8.3,ug/L,GM,,,,,,,complete sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2426,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,29 weeks,45.0,adjusted total concentration,,,8.5,ug/L,GM,,,,,,,complete sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2427,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,all time periods,30.0,adjusted total concentration,,,8.5,ug/L,GM,,,,,,,random sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2428,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,17 weeks,30.0,adjusted total concentration,,,8.4,ug/L,GM,,,,,,,random sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2429,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,23 weeks,30.0,adjusted total concentration,,,7.7,ug/L,GM,,,,,,,random sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2430,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,29 weeks,30.0,adjusted total concentration,,,9.4,ug/L,GM,,,,,,,random sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2431,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,all time periods,15.0,adjusted total concentration,,,8.6,ug/L,GM,,,,,,,high-BPA sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2432,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,17 weeks,15.0,adjusted total concentration,,,9.6,ug/L,GM,,,,,,,high-BPA sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2433,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,23 weeks,15.0,adjusted total concentration,,,9.5,ug/L,GM,,,,,,,high-BPA sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2434,2025-12-02T16:05:12.001940
25782115.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,29 weeks,15.0,adjusted total concentration,,,7,ug/L,GM,,,,,,,high-BPA sample,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2435,2025-12-02T16:05:12.001940
26575635.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,213.0,concentration,,,8.65,ng/ml,geometric mean,,,96% CI,5.66,13.2,,male infant,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2436,2025-12-02T16:05:12.001940
26575635.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,213.0,concentration,,,7.68,ng/ml,geometric mean,,,96% CI,5.08,11.6,,female infant,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2437,2025-12-02T16:05:12.001940
26575635.0,Oxybenzone,Oxybenzone,urine,paternal,,,212.0,concentration,,,7.47,ng/ml,geometric mean,,,96% CI,4.94,11.3,,male infant,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2438,2025-12-02T16:05:12.001940
26575635.0,Oxybenzone,Oxybenzone,urine,paternal,,,212.0,concentration,,,5.5,ng/ml,geometric mean,,,96% CI,3.86,7.95,,female infant,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2439,2025-12-02T16:05:12.001940
27037776.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,173.0,concentration,,,10.4,ug/L,geometric mean,,,minmax,<LOD,92700,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2440,2025-12-02T16:05:12.001940
27037776.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,173.0,concentration,,,2.9,ug/L,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2441,2025-12-02T16:05:12.001940
27037776.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,173.0,concentration,,,19.5,ug/L,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2442,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,serum,maternal,pregnancy,,74.0,concentration,,,<LOD,ng/ml,50th percentile,,,,,,,collected at the time of amniocentesis,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2443,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,serum,maternal,pregnancy,,74.0,concentration,,,0.39,ng/ml,75th percentile,,,,,,,collected at the time of amniocentesis,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2444,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,serum,maternal,pregnancy,,74.0,concentration,,,0.79,ng/ml,90th percentile,,,,,,,collected at the time of amniocentesis,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2445,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,serum,maternal,pregnancy,,74.0,concentration,,,71.8,ng/ml,maximum,,,,,,,collected at the time of amniocentesis,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2446,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,184.0,concentration,,,2.59,ng/ml,50th percentile,,,,,,,collected at the time of amniocentesis,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2447,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,184.0,concentration,,,10.4,ng/ml,75th percentile,,,,,,,collected at the time of amniocentesis,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2448,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,184.0,concentration,,,96.2,ng/ml,90th percentile,,,,,,,collected at the time of amniocentesis,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2449,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,184.0,concentration,,,10034,ng/ml,maximum,,,,,,,collected at the time of amniocentesis,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2450,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,184.0,concentration,,,<LOD,ng/ml,minimum,,,,,,,collected at the time of amniocentesis,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2451,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,amniotic fluid,maternal,pregnancy,,15.0,concentration,,,<LOD,ng/ml,90th percentile,,,,,,,collected at the time of amniocentesis,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2452,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,amniotic fluid,maternal,pregnancy,,15.0,concentration,,,11.6,ng/ml,maximum,,,,,,,collected at the time of amniocentesis,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2453,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,serum,maternal,delivery,,17.0,concentration,,,0.27,ng/ml,50th percentile,,,,,,,collected at the time of delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2454,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,serum,maternal,delivery,,17.0,concentration,,,0.64,ng/ml,75th percentile,,,,,,,collected at the time of delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2455,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,serum,maternal,delivery,,17.0,concentration,,,1.96,ng/ml,90th percentile,,,,,,,collected at the time of delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2456,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,serum,maternal,delivery,,17.0,concentration,,,10.1,ng/ml,maximum,,,,,,,collected at the time of delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2457,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,serum,maternal,delivery,,17.0,concentration,,,<LOD,ng/ml,minimum,,,,,,,collected at the time of delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2458,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,cord blood,maternal,fetus,,4.0,concentration,,,<LOD,ng/ml,75th percentile,,,,,,,collected at the time of delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2459,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,cord blood,maternal,fetus,,4.0,concentration,,,0.85,ng/ml,90th percentile,,,,,,,collected at the time of delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2460,2025-12-02T16:05:12.001940
29100749.0,Oxybenzone,Oxybenzone,cord blood,maternal,fetus,,4.0,concentration,,,2.93,ng/ml,maximum,,,,,,,collected at the time of delivery,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2461,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,Oxybenzone,breast milk,maternal,lactation,,79.0,concentration,,,72.4,ng/g milk,mean,SD,224.5,minmax,<LOD,799.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2462,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,Oxybenzone,breast milk,maternal,lactation,,79.0,estimated neonate daily intake ,,,28.7,ug/d/kg body weight,mean,SD,32.4,"1st, 3rd quartile",6.2,51.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2463,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,Oxybenzone,breast milk,maternal,lactation,,79.0,estimated neonate daily intake ,,,13.1,ug/d/kg body weight,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2464,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,4HB,breast milk,maternal,lactation,,79.0,concentration,,,4.3,ng/g milk,mean,SD,0.6,minmax,3.9,4.7,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2465,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,4DHB,breast milk,maternal,lactation,,79.0,concentration,,,27.9,ng/g milk,mean,SD,7.6,minmax,19.9,43.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2466,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,4MBC,breast milk,maternal,lactation,,79.0,concentration,,,6.7,ng/g milk,mean,SD,5.8,minmax,<LOD,10.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2467,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,4HB,breast milk,maternal,lactation,,79.0,estimated neonate daily intake ,,,0.8,ug/d/kg body weight,mean,SD,0.3,"1st, 3rd quartile",,0.8,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2468,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,4HB,breast milk,maternal,lactation,,79.0,estimated neonate daily intake ,,,,ug/d/kg body weight,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2469,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,4DHB,breast milk,maternal,lactation,,79.0,estimated neonate daily intake ,,,4.3,ug/d/kg body weight,mean,SD,1,"1st, 3rd quartile",3.7,5.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2470,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,4DHB,breast milk,maternal,lactation,,79.0,estimated neonate daily intake ,,,4,ug/d/kg body weight,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2471,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,4MBC,breast milk,maternal,lactation,,79.0,estimated neonate daily intake ,,,1.2,ug/d/kg body weight,mean,SD,0.6,"1st, 3rd quartile",,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2472,2025-12-02T16:05:12.001940
29232646.0,Oxybenzone,4MBC,breast milk,maternal,lactation,,79.0,estimated neonate daily intake ,,,1.2,ug/d/kg body weight,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2473,2025-12-02T16:05:12.001940
29294443.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,476.0,subject-specific average concentration ,,,14,ug/L,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2474,2025-12-02T16:05:12.001940
29294443.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,476.0,subject-specific average concentration ,,,46.5,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2475,2025-12-02T16:05:12.001940
29294443.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,476.0,subject-specific average concentration ,,,179,ug/L,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2476,2025-12-02T16:05:12.001940
29294443.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,476.0,subject-specific average concentration ,,,736,ug/L,90th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2477,2025-12-02T16:05:12.001940
29294443.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,476.0,subject-specific average concentration ,,,1852,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2478,2025-12-02T16:05:12.001940
29362228.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,183.0,concentration,,,2.57,ng/ml,mean,,,minmax,<LOD,10034,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2479,2025-12-02T16:05:12.001940
29366524.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,10 weeks,439.0,concentration,,,52.62,ug/L,geometric mean,SD,8.16,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2480,2025-12-02T16:05:12.001940
29366524.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,18 weeks,439.0,concentration,,,61.66,ug/L,geometric mean,SD,8.11,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2481,2025-12-02T16:05:12.001940
29366524.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,26 weeks,439.0,concentration,,,51.62,ug/L,geometric mean,SD,8.76,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2482,2025-12-02T16:05:12.001940
29366524.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,35 weeks,439.0,concentration,,,57.94,ug/L,geometric mean,SD,9.02,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2483,2025-12-02T16:05:12.001940
29366524.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,439.0,concentration,,,55.82,ug/L,geometric mean,SD,8.48,,,,,All,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2484,2025-12-02T16:05:12.001940
29458359.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,concentration,,,<LOD,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2485,2025-12-02T16:05:12.001940
29458359.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,concentration,,,2.2,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2486,2025-12-02T16:05:12.001940
29458359.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,concentration,,,63.7,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2487,2025-12-02T16:05:12.001940
29477955.0,Oxybenzone,Oxybenzone,urine,maternal,preconception,,346.0,concentration,,,173,ng/ml,SG-adjusted GM,SD,18.4,IQR 25th-75th,63.7,451,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2488,2025-12-02T16:05:12.001940
29477955.0,Oxybenzone,Oxybenzone,urine,maternal,preconception,,346.0,concentration,,,150.2,ng/ml,SG-adjusted median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2489,2025-12-02T16:05:12.001940
29477955.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,346.0,concentration,,,145.9,ng/ml,SG-adjusted GM,SD,15.4,IQR 25th-75th,55,377,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2490,2025-12-02T16:05:12.001940
29477955.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,346.0,concentration,,,137.6,ng/ml,SG-adjusted median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2491,2025-12-02T16:05:12.001940
29477955.0,Oxybenzone,Oxybenzone,urine,paternal,preconception,,184.0,concentration,,,60.3,ng/ml,SG-adjusted GM,SD,7.5,IQR 25th-75th,28.1,118.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2492,2025-12-02T16:05:12.001940
29477955.0,Oxybenzone,Oxybenzone,urine,paternal,preconception,,184.0,concentration,,,62.5,ng/ml,SG-adjusted median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2493,2025-12-02T16:05:12.001940
29550712.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,165.0,concentration,,,6.8,ug/L,median,,,minmax,<LOD,9290,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2494,2025-12-02T16:05:12.001940
29550712.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,165.0,concentration,,,2.7,ug/L,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2495,2025-12-02T16:05:12.001940
29550712.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,165.0,concentration,,,22,ug/L,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2496,2025-12-02T16:05:12.001940
29803919.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,uncorrected concentration,,,21,ng/ml,GM,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2497,2025-12-02T16:05:12.001940
29803919.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,uncorrected concentration,,,3.9,ng/ml,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2498,2025-12-02T16:05:12.001940
29803919.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,uncorrected concentration,,,13.7,ng/ml,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2499,2025-12-02T16:05:12.001940
29803919.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,uncorrected concentration,,,120.6,ng/ml,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2500,2025-12-02T16:05:12.001940
29803919.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,uncorrected concentration,,,693,ng/ml,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2501,2025-12-02T16:05:12.001940
29803919.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,specific gravity-corrected concentration,,,27,ng/ml,GM,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2502,2025-12-02T16:05:12.001940
29803919.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,specific gravity-corrected concentration,,,4.8,ng/ml,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2503,2025-12-02T16:05:12.001940
29803919.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,specific gravity-corrected concentration,,,16.6,ng/ml,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2504,2025-12-02T16:05:12.001940
29803919.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,specific gravity-corrected concentration,,,155.7,ng/ml,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2505,2025-12-02T16:05:12.001940
29803919.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,452.0,specific gravity-corrected concentration,,,1005.8,ng/ml,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2506,2025-12-02T16:05:12.001940
30316544.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,1005.0,concentration,,,41.6,ng/ml,GM,SD,6.5,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2507,2025-12-02T16:05:12.001940
30316544.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,1005.0,concentration,,,11.2,ng/ml,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2508,2025-12-02T16:05:12.001940
30316544.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,1005.0,concentration,,,27.3,ng/ml,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2509,2025-12-02T16:05:12.001940
30316544.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,1005.0,concentration,,,119.8,ng/ml,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2510,2025-12-02T16:05:12.001940
30316544.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,1005.0,concentration,,,1585.9,ng/ml,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2511,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,922.0,concentration,,,39.45,ug/l,GM,SD,6.63,,,,,All,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2512,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,922.0,concentration,,,10.36,ug/l,25th percentile,,,,,,,All,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2513,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,922.0,concentration,,,26.5,ug/l,50th percentile,,,,,,,All,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2514,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,922.0,concentration,,,124.85,ug/l,75th percentile,,,,,,,All,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2515,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,671.0,concentration,,,42.06,ug/l,GM,SD,6.37,,,,,Visit 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2516,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,671.0,concentration,,,11.35,ug/l,25th percentile,,,,,,,Visit 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2517,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,671.0,concentration,,,29.27,ug/l,50th percentile,,,,,,,Visit 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2518,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,671.0,concentration,,,126.61,ug/l,75th percentile,,6.49,,,,,Visit 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2519,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,675.0,concentration,,,39.83,ug/l,GM,SD,,,,,,Visit 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2520,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,675.0,concentration,,,10.35,ug/l,25th percentile,,,,,,,Visit 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2521,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,675.0,concentration,,,26.62,ug/l,50th percentile,,,,,,,Visit 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2522,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,675.0,concentration,,,128.77,ug/l,75th percentile,,,,,,,Visit 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2523,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,523.0,concentration,,,35.88,ug/l,GM,SD,7.17,,,,,Visit 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2524,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,523.0,concentration,,,8.87,ug/l,25th percentile,,,,,,,Visit 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2525,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,523.0,concentration,,,23.67,ug/l,50th percentile,,,,,,,Visit 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2526,2025-12-02T16:05:12.001940
30412856.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,523.0,concentration,,,112.91,ug/l,75th percentile,,,,,,,Visit 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2527,2025-12-02T16:05:12.001940
30517665.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,128.0,concentration,,,23.5,ng/g creatinine,geometric mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2528,2025-12-02T16:05:12.001940
30517665.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,128.0,concentration,,,4.5,ng/g creatinine,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2529,2025-12-02T16:05:12.001940
30517665.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,128.0,concentration,,,15.4,ng/g creatinine,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2530,2025-12-02T16:05:12.001940
30517665.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,128.0,concentration,,,136.9,ng/g creatinine,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2531,2025-12-02T16:05:12.001940
30517665.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,128.0,concentration,,,590.9,ng/g creatinine,90th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2532,2025-12-02T16:05:12.001940
30517665.0,Oxybenzone,Oxybenzone,urine,pedatric,,Peripubertal,17.0,concentration,,,17.2,ng/g creatinine,geometric mean,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2533,2025-12-02T16:05:12.001940
30517665.0,Oxybenzone,Oxybenzone,urine,pedatric,,Peripubertal,17.0,concentration,,,5.8,ng/g creatinine,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2534,2025-12-02T16:05:12.001940
30517665.0,Oxybenzone,Oxybenzone,urine,pedatric,,Peripubertal,17.0,concentration,,,13.6,ng/g creatinine,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2535,2025-12-02T16:05:12.001940
30517665.0,Oxybenzone,Oxybenzone,urine,pedatric,,Peripubertal,17.0,concentration,,,36.5,ng/g creatinine,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2536,2025-12-02T16:05:12.001940
30517665.0,Oxybenzone,Oxybenzone,urine,pedatric,,Peripubertal,17.0,concentration,,,148,ng/g creatinine,90th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2537,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,1st trimester,,847.0,concentration,,,0.1,ng/ml,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2538,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,1st trimester,,847.0,concentration,,,0.59,ng/ml,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2539,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,1st trimester,,847.0,concentration,,,1.73,ng/ml,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2540,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,847.0,concentration,,,<LOD,ng/ml,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2541,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,847.0,concentration,,,0.43,ng/ml,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2542,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,847.0,concentration,,,1.19,ng/ml,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2543,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,847.0,concentration,,,<LOD,ng/ml,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2544,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,847.0,concentration,,,0.4,ng/ml,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2545,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,847.0,concentration,,,1.26,ng/ml,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2546,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,1st trimester,,847.0,SG adjusted concentration,,,0.14,ng/ml,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2547,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,1st trimester,,847.0,SG adjusted concentration,,,0.72,ng/ml,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2548,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,1st trimester,,847.0,SG adjusted concentration,,,2.08,ng/ml,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2549,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,847.0,SG adjusted concentration,,,<LOD,ng/ml,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2550,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,847.0,SG adjusted concentration,,,0.44,ng/ml,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2551,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,847.0,SG adjusted concentration,,,1.33,ng/ml,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2552,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,847.0,SG adjusted concentration,,,<LOD,ng/ml,25th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2553,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,847.0,SG adjusted concentration,,,0.44,ng/ml,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2554,2025-12-02T16:05:12.001940
30557721.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,847.0,SG adjusted concentration,,,1.3,ng/ml,75th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2555,2025-12-02T16:05:12.001940
30624098.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,473.0,concentration,,,0.22,ug/l,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2556,2025-12-02T16:05:12.001940
30624098.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,473.0,concentration,,,2.23,ug/l,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2557,2025-12-02T16:05:12.001940
30624098.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,473.0,concentration,,,79.4,ug/l,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2558,2025-12-02T16:05:12.001940
31077917.0,Oxybenzone,Oxybenzone,urine,maternal,pre-pregnancy,,304.0,concentration,,,22.3,ug/l,median,,,IQR,11.6,39,<0.001,Q1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2559,2025-12-02T16:05:12.001940
31077917.0,Oxybenzone,Oxybenzone,urine,maternal,pre-pregnancy,,304.0,concentration,,,96.7,ug/l,median,,,IQR,73.5,119,<0.001,Q2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2560,2025-12-02T16:05:12.001940
31077917.0,Oxybenzone,Oxybenzone,urine,maternal,pre-pregnancy,,304.0,concentration,,,237,ug/l,median,,,IQR,185,316,<0.001,Q3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2561,2025-12-02T16:05:12.001940
31077917.0,Oxybenzone,Oxybenzone,urine,maternal,pre-pregnancy,,304.0,concentration,,,1126,ug/l,median,,,IQR,728,2295,<0.001,Q4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2562,2025-12-02T16:05:12.001940
31077917.0,Oxybenzone,Oxybenzone,urine,maternal,pre-pregnancy,,304.0,concentration,,,147,ug/l,median,,,IQR,58,462,<0.001,total cohort,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2563,2025-12-02T16:05:12.001940
31077917.0,Oxybenzone,Oxybenzone,urine,maternal,pre-pregnancy,,304.0,concentration,,,,ug/l,,,,minmax,0.19,57.4,,Q1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2564,2025-12-02T16:05:12.001940
31077917.0,Oxybenzone,Oxybenzone,urine,maternal,pre-pregnancy,,304.0,concentration,,,,ug/l,,,,minmax,57.7,145,,Q2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2565,2025-12-02T16:05:12.001940
31077917.0,Oxybenzone,Oxybenzone,urine,maternal,pre-pregnancy,,304.0,concentration,,,,ug/l,,,,minmax,146,462,,Q3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2566,2025-12-02T16:05:12.001940
31077917.0,Oxybenzone,Oxybenzone,urine,maternal,pre-pregnancy,,304.0,concentration,,,,ug/l,,,,minmax,463,7794,,Q4,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2567,2025-12-02T16:05:12.001940
31081626.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,941.0,unadjusted concentration,,,0.36,ng/ml,mean,,,95% CI,0.33,0.39,,overall,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2568,2025-12-02T16:05:12.001940
31081626.0,Oxybenzone,Oxybenzone,urine,maternal,1st trimester,,941.0,unadjusted concentration,,,0.52,ng/ml,mean,,,95% CI,0.46,0.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2569,2025-12-02T16:05:12.001940
31081626.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,941.0,unadjusted concentration,,,0.31,ng/ml,mean,,,95% CI,0.27,0.35,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2570,2025-12-02T16:05:12.001940
31081626.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,941.0,unadjusted concentration,,,0.29,ng/ml,mean,,,95% CI,0.25,0.33,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2571,2025-12-02T16:05:12.001940
31081626.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,941.0,adjusted concentration,,,0.39,ng/ml,mean,,,95% CI,0.36,0.43,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2572,2025-12-02T16:05:12.001940
31081626.0,Oxybenzone,Oxybenzone,urine,maternal,1st trimester,,941.0,adjusted concentration,,,0.58,ng/ml,mean,,,95% CI,0.51,0.67,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2573,2025-12-02T16:05:12.001940
31081626.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,941.0,adjusted concentration,,,0.33,ng/ml,mean,,,95% CI,0.29,0.38,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2574,2025-12-02T16:05:12.001940
31081626.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,941.0,adjusted concentration,,,0.32,ng/ml,mean,,,95% CI,0.28,0.37,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2575,2025-12-02T16:05:12.001940
31081626.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,941.0,unadjusted concentration,,,0.47,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2576,2025-12-02T16:05:12.001940
31081626.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,941.0,adjusted concentration,,,0.53,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2577,2025-12-02T16:05:12.001940
31288179.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,481.0,gravity corrected concentration,,,11.5,ng/ml,25th percentiles,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2578,2025-12-02T16:05:12.001940
31288179.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,481.0,gravity corrected concentration,,,42.3,ng/ml,50th percentiles,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2579,2025-12-02T16:05:12.001940
31288179.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,481.0,gravity corrected concentration,,,250,ng/ml,75th percentiles,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2580,2025-12-02T16:05:12.001940
31288179.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,481.0,gravity corrected concentration,,,2914,ng/ml,95th percentiles,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2581,2025-12-02T16:05:12.001940
32120140.0,Oxybenzone,Oxybenzone,urine,maternal,preconception,,417.0,SG-adjusted concentration,,,63.4,ng/ml,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2582,2025-12-02T16:05:12.001940
32120140.0,Oxybenzone,Oxybenzone,urine,paternal,,,229.0,SG-adjusted concentration,,,161,ng/ml,,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2583,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,477.0,concentration,,,0.27,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2584,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,477.0,concentration,,,1.18,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2585,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,477.0,concentration,,,35.6,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2586,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,477.0,adjusted for specific gravity concentration,,,0.26,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2587,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,477.0,adjusted for specific gravity concentration,,,1.04,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2588,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,2nd trimester,,477.0,adjusted for specific gravity concentration,,,32.3,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2589,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,456.0,concentration,,,0.22,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2590,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,456.0,concentration,,,0.97,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2591,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,456.0,concentration,,,27.5,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2592,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,456.0,adjusted for specific gravity concentration,,,0.21,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2593,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,456.0,adjusted for specific gravity concentration,,,0.89,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2594,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,maternal,3rd trimester,,456.0,adjusted for specific gravity concentration,,,22.5,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2595,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,2 months,152.0,concentration,,,<LOD,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2596,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,2 months,152.0,concentration,,,0.16,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2597,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,2 months,152.0,concentration,,,3.5,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2598,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,2 months,152.0,adjusted for specific gravity concentration,,,0.11,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2599,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,2 months,152.0,adjusted for specific gravity concentration,,,0.65,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2600,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,2 months,152.0,adjusted for specific gravity concentration,,,11.5,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2601,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,12 months,100.0,concentration,,,0.11,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2602,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,13 months,100.0,concentration,,,0.38,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2603,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,14 months,100.0,concentration,,,2.36,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2604,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,15 months,100.0,adjusted for specific gravity concentration,,,0.17,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2605,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,16 months,100.0,adjusted for specific gravity concentration,,,0.52,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2606,2025-12-02T16:05:12.001940
32248023.0,Oxybenzone,Oxybenzone,urine,pedatric,,17 months,100.0,adjusted for specific gravity concentration,,,4.39,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2607,2025-12-02T16:05:12.001940
32279061.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,8.0,concentration,,,0.8,ug/L,GM,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2608,2025-12-02T16:05:12.001940
32279061.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,8.0,concentration,,,<LOD,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2609,2025-12-02T16:05:12.001940
32279061.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,8.0,concentration,,,<LOD,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2610,2025-12-02T16:05:12.001940
32279061.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,8.0,concentration,,,17.2,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2611,2025-12-02T16:05:12.001940
32279061.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,8.0,concentration,,,378.5,ug/L,max,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2612,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,serum,maternal,postpartum,,97.0,concentration,,,0.14,ng/ml,median,,,minmax,<0.01,25.1,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2613,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,serum,maternal,postpartum,,97.0,concentration,,,0.1,ng/ml,GM,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2614,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,cord serum,maternal,fetus,,97.0,concentration,,,0.16,ng/ml,median,,,minmax,<0.01,56.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2615,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,cord serum,maternal,fetus,,97.0,concentration,,,0.13,ng/ml,GM,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2616,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,serum,maternal,postpartum,,15.0,concentration,,,0.12,ng/ml,median,,,minmax,<0.01,0.32,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2617,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,serum,maternal,postpartum,,15.0,concentration,,,0.05,ng/ml,GM,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2618,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,cord serum,maternal,fetus,,15.0,concentration,,,0.07,ng/ml,median,,,minmax,<0.01,0.3,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2619,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,cord serum,maternal,fetus,,15.0,concentration,,,0.04,ng/ml,GM,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2620,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,urine,maternal,delivery,,15.0,concentration,,,0.42,ng/ml,median,,,minmax,<0.01,8.72,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2621,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,urine,maternal,delivery,,15.0,concentration,,,0.43,ng/ml,GM,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2622,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,amniotic fluid,maternal,fetus,,15.0,concentration,,,0.12,ng/ml,median,,,minmax,<0.01,0.38,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2623,2025-12-02T16:05:12.001940
32320878.0,Oxybenzone,Oxybenzone,amniotic fluid,maternal,fetus,,15.0,concentration,,,0.08,ng/ml,GM,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2624,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,0.996,Percentage,Detection Rate,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2625,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,131.6,ng/mL,Geometric Mean,,,minmax,102.5,168.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2626,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,50.4,ng/mL,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2627,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,118.3,ng/mL,Median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2628,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,431.3,ng/mL,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2629,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,1318.3,ng/mL,90th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2630,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,2469.3,ng/mL,95th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2631,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,9000,ng/mL,Maximum,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2632,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,166.6,ng/mL,Geometric Mean,,,minmax,130.1,213.4,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2633,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,58.7,ng/mL,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2634,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,153.6,ng/mL,Median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2635,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,494.5,ng/mL,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2636,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,1710.3,ng/mL,90th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2637,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,2370.2,ng/mL,95th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2638,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Preconception,,178.0,concentration,,,8313.8,ng/mL,Maximum,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2639,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,0.995,Percentage,Detection Rate,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2640,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,106.4,ng/mL,Geometric Mean,,,minmax,81.7,138.6,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2641,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,29.8,ng/mL,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2642,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,78.5,ng/mL,Median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2643,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,364.7,ng/mL,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2644,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,1304.2,ng/mL,90th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2645,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,3397.7,ng/mL,95th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2646,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,9115.3,ng/mL,Maximum,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2647,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,142.4,ng/mL,Geometric Mean,,,minmax,109.5,185.2,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2648,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,39,ng/mL,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2649,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,124.6,ng/mL,Median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2650,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,500.3,ng/mL,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2651,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,1710.2,ng/mL,90th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2652,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,3818.3,ng/mL,95th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2653,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 1,,194.0,concentration,,,7888,ng/mL,Maximum,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2654,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,0.988,Percentage,Detection Rate,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2655,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,132.4,ng/mL,Geometric Mean,,,minmax,95.8,182.9,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2656,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,33,ng/mL,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2657,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,130.9,ng/mL,Median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2658,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,667,ng/mL,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2659,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,1990,ng/mL,90th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2660,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,4577.2,ng/mL,95th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2661,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,21728.9,ng/mL,Maximum,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2662,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,189.1,ng/mL,Geometric Mean,,,minmax,139.4,256.5,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2663,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,40.1,ng/mL,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2664,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,169.1,ng/mL,Median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2665,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,811.8,ng/mL,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2666,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,2960.5,ng/mL,90th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2667,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,5358.2,ng/mL,95th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2668,2025-12-02T16:05:12.001940
32345324.0,Oxybenzone,Oxybenzone,Urine,Maternal,Trimester 2,,170.0,concentration,,,17383.1,ng/mL,Maximum,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2669,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,Maternal,delivery,,386.0,unadjusted concentration,,,0.37,ug/l,median,,,minmax,0.08,485,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2670,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,Maternal,delivery,,386.0,unadjusted concentration,,,0.2,ug/l,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2671,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,Maternal,delivery,,386.0,unadjusted concentration,,,0.81,ug/l,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2672,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,Maternal,delivery,,386.0,creatinine-adjusted concentration,,,0.6,ug/l,median,,,minmax,0.07,432,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2673,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,Maternal,delivery,,386.0,creatinine-adjusted concentration,,,0.3,ug/l,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2674,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,Maternal,delivery,,386.0,creatinine-adjusted concentration,,,1.15,ug/l,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2675,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,pedatric,,children,386.0,unadjusted concentration,,,1.39,ug/l,median,,,minmax,<LOD,852,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2676,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,pedatric,,children,386.0,unadjusted concentration,,,0.66,ug/l,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2677,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,pedatric,,children,386.0,unadjusted concentration,,,3.36,ug/l,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2678,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,pedatric,,children,386.0,creatinine-adjusted concentration,,,1.76,ug/l,median,,,minmax,<LOD,783,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2679,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,pedatric,,children,386.0,creatinine-adjusted concentration,,,0.98,ug/l,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2680,2025-12-02T16:05:12.001940
32653713.0,Oxybenzone,Oxybenzone,Urine,pedatric,,children,386.0,creatinine-adjusted concentration,,,783,ug/l,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2681,2025-12-02T16:05:12.001940
34952328.0,Oxybenzone,Oxybenzone,Urine,maternal,3rd trimester,,407.0,creatinine-adjusted concentration,,,0.12,ug/g,min,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2682,2025-12-02T16:05:12.001940
34952328.0,Oxybenzone,Oxybenzone,Urine,maternal,3rd trimester,,407.0,creatinine-adjusted concentration,,,10028.7,ug/g,max,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2683,2025-12-02T16:05:12.001940
34952328.0,Oxybenzone,Oxybenzone,Urine,maternal,3rd trimester,,407.0,creatinine-adjusted concentration,,,1.15,ug/g,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2684,2025-12-02T16:05:12.001940
34952328.0,Oxybenzone,Oxybenzone,Urine,maternal,3rd trimester,,407.0,creatinine-adjusted concentration,,,3.24,ug/g,50th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2685,2025-12-02T16:05:12.001940
34952328.0,Oxybenzone,Oxybenzone,Urine,maternal,3rd trimester,,407.0,creatinine-adjusted concentration,,,20,ug/g,75th Percentile,,17.9,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2686,2025-12-02T16:05:12.001940
35421480.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,133.0,concentration,,,116,ug/l,geometric mean,SE,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2687,2025-12-02T16:05:12.001940
35421480.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,133.0,concentration,,,685,ug/L,mean,SD,2269,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2688,2025-12-02T16:05:12.001940
35421480.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,133.0,concentration,,,<LOD,ug/L,10th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2689,2025-12-02T16:05:12.001940
35421480.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,133.0,concentration,,,33.7,ug/L,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2690,2025-12-02T16:05:12.001940
35421480.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,133.0,concentration,,,92,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2691,2025-12-02T16:05:12.001940
35421480.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,133.0,concentration,,,418,ug/L,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2692,2025-12-02T16:05:12.001940
35421480.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,133.0,concentration,,,4011,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2693,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,2nd trimester,,478.0,raw concentration,,,0.3,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2694,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,2nd trimester,,478.0,raw concentration,,,1.2,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2695,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,2nd trimester,,478.0,raw concentration,,,35.3,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2696,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,3rd trimester,,478.0,raw concentration,,,0.2,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2697,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,3rd trimester,,478.0,raw concentration,,,1,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2698,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,3rd trimester,,478.0,raw concentration,,,27.5,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2699,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,2nd trimester,,478.0,standardized concentration,,,0.2,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2700,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,2nd trimester,,478.0,standardized concentration,,,0.8,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2701,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,2nd trimester,,478.0,standardized concentration,,,20.5,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2702,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,3rd trimester,,478.0,standardized concentration,,,0.2,ug/L,5th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2703,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,3rd trimester,,478.0,standardized concentration,,,0.7,ug/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2704,2025-12-02T16:05:12.001940
35700189.0,Oxybenzone,Oxybenzone,Urine,maternal,3rd trimester,,478.0,standardized concentration,,,15.6,ug/L,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2705,2025-12-02T16:05:12.001940
35839910.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,64.0,SG-adjusted concentration,,,48.17,ng/ml,GM,,,95% CI,28.25,82.16,<0.01,GDM cases,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2706,2025-12-02T16:05:12.001940
35839910.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,64.0,SG-adjusted concentration,,,9.71,ng/ml,25th Percentile,,,,,,,GDM cases,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2707,2025-12-02T16:05:12.001940
35839910.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,64.0,SG-adjusted concentration,,,31.45,ng/ml,50th Percentile,,,,,,,GDM cases,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2708,2025-12-02T16:05:12.001940
35839910.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,64.0,SG-adjusted concentration,,,225.65,ng/ml,75th Percentile,,,,,,,GDM cases,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2709,2025-12-02T16:05:12.001940
35839910.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,237.0,SG-adjusted concentration,,,18.6,ng/ml,GM,,,95% CI,14.89,23.24,<0.01,controls,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2710,2025-12-02T16:05:12.001940
35839910.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,237.0,SG-adjusted concentration,,,5.88,ng/ml,25th Percentile,,,,,,,controls,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2711,2025-12-02T16:05:12.001940
35839910.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,237.0,SG-adjusted concentration,,,12.62,ng/ml,50th Percentile,,,,,,,controls,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2712,2025-12-02T16:05:12.001940
35839910.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,237.0,SG-adjusted concentration,,,36.64,ng/ml,75th Percentile,,,,,,,controls,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2713,2025-12-02T16:05:12.001940
36227336.0,Oxybenzone,Oxybenzone,Urine,maternal,1st trimester,,111.0,concentration,,,42.7,ng/ml,median,,,IQR,13.2,219.4,0.68,GDM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2714,2025-12-02T16:05:12.001940
36227336.0,Oxybenzone,Oxybenzone,Urine,maternal,1st trimester,,222.0,concentration,,,58.4,ng/ml,median,,,IQR,18.3,168.7,0.68,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2715,2025-12-02T16:05:12.001940
36227336.0,Oxybenzone,Oxybenzone,Urine,maternal,2nd trimester,,111.0,concentration,,,53.9,ng/ml,median,,,IQR,15.6,156.9,0.99,GDM,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2716,2025-12-02T16:05:12.001940
36227336.0,Oxybenzone,Oxybenzone,Urine,maternal,2nd trimester,,222.0,concentration,,,54.6,ng/ml,median,,,IQR,14.2,137.4,0.99,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2717,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,221.0,concentration,,,1.7,ug/g,median,,,IQR,0.5,7.3,,Full cohort,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2718,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,88.0,concentration,,,1.4,ug/g,median,,,IQR,0.4,6.8,,Age 21-27 years,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2719,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,71.0,concentration,,,2,ug/g,median,,,IQR,0.7,6.5,,Age 28-30 years,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2720,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,62.0,concentration,,,2.7,ug/g,median,,,IQR,0.6,12.1,,Age 31-42 years,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2721,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,21.0,concentration,,,1.3,ug/g,median,,,IQR,0.4,13,,BMI Underweight,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2722,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,175.0,concentration,,,1.7,ug/g,median,,,IQR,0.5,4.5,,BMI Normal weight,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2723,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,25.0,concentration,,,3.6,ug/g,median,,,IQR,0.8,20.5,,BMI overweight,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2724,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,212.0,concentration,,,1.8,ug/g,median,,,IQR,0.5,7.5,,White,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2725,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,9.0,concentration,,,0.5,ug/g,median,,,IQR,0.2,3.8,,Non-White,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2726,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,208.0,concentration,,,1.9,ug/g,median,,,IQR,0.5,9,,No Smoking at intake,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2727,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,13.0,concentration,,,0.6,ug/g,median,,,IQR,0.2,1.4,,Smoking at intake,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2728,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,41.0,concentration,,,2.5,ug/g,median,,,IQR,0.4,12.1,,0 Alcoho use at intake,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2729,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,128.0,concentration,,,1.7,ug/g,median,,,IQR,0.5,6.5,,1-7 drinks/month alcohol use at intake,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2730,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,52.0,concentration,,,1.7,ug/g,median,,,IQR,0.6,9.6,,>=18 drinks/month alcohol use at intake,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2731,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,75.0,concentration,,,1.9,ug/g,median,,,IQR,0.4,7.1,,<=1920 mg/month caffeine at intake,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2732,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,79.0,concentration,,,1.7,ug/g,median,,,IQR,0.8,11.7,,1921-5000 mg/month caffeine at intake,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2733,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,67.0,concentration,,,1.6,ug/g,median,,,IQR,0.6,6.6,,>=6000 mg/month caffeine at intake,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2734,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,66.0,concentration,,,0.8,ug/g,median,,,IQR,0.3,2.3,,Winter,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2735,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,52.0,concentration,,,3.1,ug/g,median,,,IQR,0.7,11.8,,Spring,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2736,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,55.0,concentration,,,3,ug/g,median,,,IQR,0.8,13.3,,Summer,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2737,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,39.0,concentration,,,2,ug/g,median,,,IQR,0.6,4.5,,Fall,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2738,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,508.0,concentration,,,1.5,ug/g,median,,,IQR,0.6,7,,Non-conception,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2739,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,198.0,concentration,,,2,ug/g,median,,,IQR,0.5,7.7,,all conceptions,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2740,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,48.0,concentration,,,1.2,ug/g,median,,,IQR,0.5,5.4,,early loss,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2741,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,15.0,concentration,,,10.9,ug/g,median,,,IQR,0.7,130.9,,clinical loss,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2742,2025-12-02T16:05:12.001940
36346334.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,135.0,concentration,,,2.1,ug/g,median,,,IQR,0.5,7,,live birth,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2743,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,16 weeks,190.0,creatinine-standardized concentration,,,22.4,ng/ml,GM,GSD,6.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2744,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,16 weeks,190.0,creatinine-standardized concentration,,,5.63,ng/ml,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2745,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,16 weeks,190.0,creatinine-standardized concentration,,,16.9,ng/ml,50th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2746,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,16 weeks,190.0,creatinine-standardized concentration,,,72.5,ng/ml,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2747,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,16 weeks,190.0,creatinine-standardized concentration,,,703,ng/ml,95th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2748,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,26 weeks,197.0,creatinine-standardized concentration,,,23.1,ng/ml,GM,GSD,6.1,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2749,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,26 weeks,197.0,creatinine-standardized concentration,,,5.9,ng/ml,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2750,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,26 weeks,197.0,creatinine-standardized concentration,,,15.7,ng/ml,50th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2751,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,26 weeks,197.0,creatinine-standardized concentration,,,76.4,ng/ml,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2752,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,26 weeks,197.0,creatinine-standardized concentration,,,646,ng/ml,95th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2753,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,215.0,creatinine-standardized concentration,,,23,ng/ml,GM,GSD,5.3,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2754,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,215.0,creatinine-standardized concentration,,,5.95,ng/ml,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2755,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,215.0,creatinine-standardized concentration,,,18.2,ng/ml,50th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2756,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,215.0,creatinine-standardized concentration,,,70.3,ng/ml,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2757,2025-12-02T16:05:12.001940
36525700.0,Oxybenzone,Oxybenzone,Urine,maternal,pregnancy,,215.0,creatinine-standardized concentration,,,569,ng/ml,95th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2758,2025-12-02T16:05:12.001940
36568115.0,Oxybenzone,Oxybenzone,serum,maternal,pregnancy,,100.0,concentration,,,0.4,ng/ml,10th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2759,2025-12-02T16:05:12.001940
36568115.0,Oxybenzone,Oxybenzone,serum,maternal,pregnancy,,100.0,concentration,,,0.7,ng/ml,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2760,2025-12-02T16:05:12.001940
36568115.0,Oxybenzone,Oxybenzone,serum,maternal,pregnancy,,100.0,concentration,,,0.9,ng/ml,50th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2761,2025-12-02T16:05:12.001940
36568115.0,Oxybenzone,Oxybenzone,serum,maternal,pregnancy,,100.0,concentration,,,1.3,ng/ml,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2762,2025-12-02T16:05:12.001940
36568115.0,Oxybenzone,Oxybenzone,serum,maternal,pregnancy,,100.0,concentration,,,1.7,ng/ml,90th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2763,2025-12-02T16:05:12.001940
36568115.0,Oxybenzone,Oxybenzone,serum,maternal,pregnancy,,100.0,concentration,,,22.2,ng/ml,Maximum,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2764,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,concentration,,,86.09,ng/ml,artimetic mean,SD,306.42,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2765,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,concentration,,,6.89,ng/ml,geometric mean,GSD,8.73,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2766,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,concentration,,,4.96,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2767,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,concentration,,,1.47,ng/ml,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2768,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,concentration,,,24.11,ng/ml,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2769,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,concentration,,,381.27,ng/ml,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2770,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,SG adjusted concentration,,,92.48,ng/ml,artimetic mean,SD,288.85,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2771,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,SG adjusted concentration,,,8.83,ng/ml,geometric mean,GSD,7.8,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2772,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,SG adjusted concentration,,,2.12,ng/ml,median,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2773,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,SG adjusted concentration,,,1.99,ng/ml,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2774,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,SG adjusted concentration,,,6.14,ng/ml,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2775,2025-12-02T16:05:12.001940
36701050.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,450.0,SG adjusted concentration,,,28.29,ng/ml,95th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2776,2025-12-02T16:05:12.001940
36857904.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,442.0,standardized concentration,,,0.44,g/L,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2777,2025-12-02T16:05:12.001940
36857904.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,442.0,standardized concentration,,,0.87,g/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2778,2025-12-02T16:05:12.001940
36857904.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,442.0,standardized concentration,,,2.41,g/L,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2779,2025-12-02T16:05:12.001940
36857904.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,442.0,concentration,,,0.6,g/L,25th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2780,2025-12-02T16:05:12.001940
36857904.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,442.0,concentration,,,1.18,g/L,50th percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2781,2025-12-02T16:05:12.001940
36857904.0,Oxybenzone,Oxybenzone,urine,maternal,pregnancy,,442.0,concentration,,,3.39,g/L,75th Percentile,,,,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,PK param (summary data),PKparam_summary,2782,2025-12-02T16:05:12.001940
